<SEC-DOCUMENT>0001493152-21-014430.txt : 20210721
<SEC-HEADER>0001493152-21-014430.hdr.sgml : 20210721
<ACCEPTANCE-DATETIME>20210615170656
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001493152-21-014430
CONFORMED SUBMISSION TYPE:	DRS/A
PUBLIC DOCUMENT COUNT:		28
FILED AS OF DATE:		20210615
<PUBLIC-REL-DATE>20210721
DATE AS OF CHANGE:		20210615

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RenovoRx, Inc.
		CENTRAL INDEX KEY:			0001574094
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				271448452
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DRS/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	377-04576
		FILM NUMBER:		211019353

	BUSINESS ADDRESS:	
		STREET 1:		333 W. SANTA CLARA STREET, SUITE 900
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95110
		BUSINESS PHONE:		408-800-2649

	MAIL ADDRESS:	
		STREET 1:		333 W. SANTA CLARA STREET, SUITE 900
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95110
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRS/A
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>As confidentially submitted
to the Securities and Exchange Commission on June 15, 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>as Amendment No. 2
to the draft Registration Statement</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No.
333- [&nbsp;&nbsp;]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; width: 100%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
S-1 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
STATEMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>UNDER
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>THE
SECURITIES ACT OF 1933 </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>RenovoRx,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Exact
name of registrant as specified in its charter) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2834</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>27-1448452</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State
                                            or other jurisdiction of</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>incorporation
        or organization)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Primary
                                            Standard Industrial</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Classification
        Code Number)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(I.R.S.
                                            Employer</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Identification
        No.)</B></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4546
El Camino Real, Suite B1 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Los
Altos, CA 94022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(650)-284-4433</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address,
including zip code, and telephone number, including area code, of registrant&rsquo;s principal executive offices) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shaun
Bagai </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chief
Executive Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RenovoRx,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4546
El Camino Real, Suite B1 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Los
Altos, CA 94022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(650)-284-4433</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Name,
address, including zip code, and telephone number, including area code, of agent for service) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Copies
of all communications to: </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jeffrey
                                            J. Fessler</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sheppard
        Mullin Richter &amp; Hampton LLP</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>30
        Rockefeller Plaza</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
        York, New York 10112</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(212)
        653-8700</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Robert
                                            Charron</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Charles
        Phillips</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ellenoff
        Grossman &amp; Schole LLP</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1345
        Avenue of the Americas</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
        York, New York 10105</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(212)
        370-1300</B></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approximate
date of commencement of proposed sale to the public: </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As
soon as practicable after this Registration Statement becomes effective. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, check the following box. [X]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act of 1933, please
check the following box and list the Securities Act registration statement number of the earlier effective registration statement for
the same offering. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
&ldquo;smaller reporting company&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">[&nbsp;&nbsp;]</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
    filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">[X]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">[X]</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">[X]</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CALCULATION
OF REGISTRATION FEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proposed
    Maximum<BR> Aggregate Offering<BR> Price<SUP>(1)(2)</SUP></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount
    of<BR> Registration Fee</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    Stock, $0.0001 par value per share</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriter
    warrants to purchase shares of common stock<SUP>(3)</SUP></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(o) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Includes initial public offering price of shares that the underwriter has the option to purchase to cover over-allotments, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Represents warrants issuable to the representative or its designees to purchase a number of shares of common stock equal to 5% of the
number of shares of common stock being offered at an exercise price equal to 120% of the initial public offering price. See &ldquo;Underwriting.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date
as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; width: 100%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #FF4338"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell
these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #FF4338"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #FF4338"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUBJECT
TO COMPLETION, DATED JUNE 15, 2021 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRELIMINARY
PROSPECTUS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="logo_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>]
Shares of Common Stock </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is our initial public offering. We are offering up to [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] of shares of common stock pursuant
to this prospectus. Prior to this offering, there has been no public market for our common stock. We anticipate that the initial public
offering price of our shares will be between $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] and $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have applied to list our common stock on the Nasdaq Capital Market under the symbol &ldquo;RNXT.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &ldquo;emerging growth company&rdquo; under the federal securities laws and have elected to comply with certain reduced public
company reporting requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our common stock involves a high degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page 29.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Per
    Share</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Initial
    public offering price</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
    discounts and commissions<SUP>(1)</SUP></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds
    to us, before expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
We refer you to &ldquo;Underwriting&rdquo; beginning on page 111 for additional information regarding underwriter&rsquo;s compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have granted a 45-day option to the representative of the underwriter to purchase up to [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
additional shares of common stock solely to cover over-allotments, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriter expects to deliver the shares to purchasers on or about &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 16pt"><B>Roth
Capital Partners</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
date of this prospectus is</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
OF CONTENTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PAGE</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">PROSPECTUS
    SUMMARY</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_002"><FONT STYLE="font-size: 10pt">THE
    OFFERING</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">7</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_003"><FONT STYLE="font-size: 10pt">RISK
    FACTORS</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_004"><FONT STYLE="font-size: 10pt">CAUTIONARY
    STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#v_001"><FONT STYLE="font-size: 10pt">MARKET
    AND INDUSTRY DATA</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">37</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_005"><FONT STYLE="font-size: 10pt">TRADEMARKS,
    SERVICE MARKS AND TRADE NAMES</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_006"><FONT STYLE="font-size: 10pt">USE
    OF PROCEEDS</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">39</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_007"><FONT STYLE="font-size: 10pt">DIVIDEND
    POLICY</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_008"><FONT STYLE="font-size: 10pt">CAPITALIZATION</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_009"><FONT STYLE="font-size: 10pt">DILUTION</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">42</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#n_002"><FONT STYLE="font-size: 10pt">MANAGEMENT&rsquo;S
    DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">44</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#k_003">BUSINESS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><A HREF="#k_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MANAGEMENT, EXECUTIVE COMPENSATION AND CORPORATE GOVERNANCE</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#M_001">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">102</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><A HREF="#k_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">103</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><A HREF="#k_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF SECURITIES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><A HREF="#k_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNDERWRITING</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">111</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><A HREF="#k_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">119</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><A HREF="#k_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">119</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><A HREF="#k_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE TO FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">119</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><A HREF="#k_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL STATEMENTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
we nor the underwriter have authorized anyone to provide you with information other than that contained in this prospectus. We and the
underwriter take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may
give you. We and the underwriter are offering to sell, and seeking offers to buy, the securities offered hereby only in jurisdictions
where offers and sales are permitted. The information contained in this prospectus is accurate only as of the date on the front cover
page of this prospectus, or other earlier date stated in this prospectus, regardless of the time of delivery of this prospectus or of
any sale of our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
action is being taken in any jurisdiction outside the United States to permit a public offering of our securities or possession or distribution
of this prospectus in that jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States
are required to inform themselves about and to observe any restrictions as to this offering and the distribution of this prospectus applicable
to that jurisdiction. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus includes industry data and forecasts that we have obtained from industry publications and surveys, public filings and internal
company sources. Industry publications and surveys and forecasts generally state that the information contained therein has been obtained
from sources believed to be reliable, but there can be no assurance as to the accuracy or completeness of the included information. Statements
as to our market position and market estimates are based on independent industry publications, government publications, third party forecasts,
management&rsquo;s estimates and assumptions about our markets and our internal research. While we are not aware of any misstatements
regarding the market, industry or similar data presented herein, such data involve risks and uncertainties and are subject to change
based on various factors, including those discussed under the headings &ldquo;Risk Factors&rdquo; and &ldquo;Cautionary Statement Concerning
Forward-Looking Statements&rdquo; in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_001"></A>PROSPECTUS
SUMMARY </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary highlights information contained elsewhere in this prospectus. It does not contain all of the information you need
to consider in making your investment decision. Before making an investment decision, you should read this entire prospectus carefully
and you should consider, among other things, the matters set forth under &ldquo;Risk Factors&rdquo; and our financial statements and
related notes thereto appearing elsewhere in this prospectus. In this prospectus, except as otherwise indicated, &ldquo;RenovoRx,&rdquo;
the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;our,&rdquo; and &ldquo;us&rdquo; refer to RenovoRx, Inc., a Delaware corporation,
and its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors and conducting
a Phase 3 registrational trial for our lead product candidate RenovoGem&trade;. Our therapy platform, RenovoRx Trans-Arterial Micro-Perfusion,
or RenovoTAMP&trade; utilizes approved chemotherapeutics with validated mechanisms of action and well-established safety and side effect
profiles, with the goal of increasing their efficacy, improving their safety, and widening their therapeutic window. RenovoTAMP combines
our patented U.S. Food and Drug Administration, or FDA, cleared delivery system, RenovoCath<SUP>&reg;</SUP>, with small molecule chemotherapeutic
agents that can be forced across the vessel wall using pressure, targeting these anti-cancer drugs locally to the solid tumors. While
we anticipate investigating other chemotherapeutic agents for intra-arterial delivery via RenovoTAMP, our clinical work to date has focused
on gemcitabine, which is a generic drug. Our first product candidate, RenovoGem, is a drug and device combination consisting of intra-arterial
gemcitabine and RenovoCath. FDA has determined that RenovoGem will be regulated as, and if approved we expect will be reimbursed as,
a new oncology drug product. We have secured FDA Orphan Drug Designation for RenovoGem in our first two indications: pancreatic cancer
and cholangiocarcinoma (bile duct cancer, or CCA). We have completed our RR1 Phase 1/2 and RR2 observational registry studies, with 20
and 25 patients respectively, in locally advanced pancreatic cancer, or LAPC. These studies demonstrated a median overall survival of
27.9 months in patients treated with RenovoGem and radiation. Based on previous large randomized clinical trials, the expected
survival of LAPC patients is 12-15 months in patients receiving only intravenous (IV) systemic chemotherapy or IV chemotherapy plus radiation
(which are both considered standard of care). Unlike the randomized trials that established these standard-of-care results, our RR1 and
RR2 clinical trials did not prospectively control the standard of care therapy received prior to RenovoTAMP. Based on FDA safety
review of our Phase 1/2 study the FDA allowed us to proceed to evaluate RenovoGem within our Phase 3 registration Investigational New
Drug, or IND, clinical trial. Our Phase 3 trial is 40% enrolled as of April 30, 2021 and we expect to report data from a planned interim
data readout in the second half of 2022. We intend to evaluate RenovoGem in a second indication in a Phase 2/3 trial in hilar CCA (cancer
that occurs in the bile ducts that lead out of the liver and join with the gallbladder, also called extrahepatic cholangiocarcinoma,
or HCCA). We plan to propose the trial to the FDA and potentially launch in the first half of 2022. In addition, we may evaluate RenovoGem
in other indications, potentially including locally advanced lung cancer, locally advanced uterine tumors, and glioblastoma (an aggressive
type of cancer that can occur in the brain or spinal cord). To date, we have used gemcitabine, but in the future we may develop other
chemotherapeutic agents for intra-arterial delivery via RenovoCath.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
RenovoTAMP therapy platform is focused on optimizing drug concentration in solid tumors using approved small molecule chemotherapeutics
that enable physicians to isolate segments of the vascular anatomy closest to tumors and force chemotherapy across the blood vessel wall
to bathe these difficult-to-reach tumors in chemotherapy. More specifically, our patented approach combines local delivery via our patented
RenovoCath delivery system utilizing pressure to force small molecule chemotherapy into the tumor tissue with pre-treatment of the local
blood vessels and tissue with standard-of-care radiation therapy to decrease chemotherapy washout. We believe there are many advantages
to our approach:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Application
                                            of Approved Small Molecule Chemotherapeutic Agents</I>: We use approved small molecule chemotherapeutic
                                            agents such as gemcitabine.</FONT></TD></TR>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Targeted
                                            Approach:</I> With our approach, we have demonstrated in our clinical studies up to 100 times
                                            higher local drug concentration compared to systemic chemotherapy. We believe our approach
                                            decreases systemic exposure and improves patient outcomes.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Delivery
                                            Method Independent of Tumor Vascularity:</I> We invented a novel combination platform and
                                            delivery system to deliver small molecule chemotherapeutic agents in solid tumors resistant
                                            to systemic chemotherapy due to lack of tumor blood vessels or tumor feeders.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Broad
                                            Application for Solid Tumor Indications:</I> Our platform is not restricted to a single small
                                            molecule chemotherapeutic agent or solid tumor type. As such, our platform and delivery system
                                            may be applied for use in additional solid tumor indications, including in solid tumors without
                                            identifiable tumor feeders.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
lead product candidate, RenovoGem, is a combination of gemcitabine and our patented delivery system, RenovoCath, and is regulated by
the FDA as a novel oncology drug product. Our RenovoTAMP platform therapy utilizes pressure mediated delivery of gemcitabine across the
arterial wall to bathe the pancreatic tumor tissue in 120mL of saline with 1,000mg/m<SUP>2</SUP> of the drug over a 20-minute delivery
time (approximately a total of 1,500-2,000mg of drug dependent upon patient Body Surface Area). RenovoCath is an adjustable double balloon
catheter designed to isolate the proximal and distal vessel and adjust the distance between the balloons to exclude any branching blood
vessel offshoots.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the field of oncology has seen progress in treating a handful of deadly cancers over the last few decades, there is a common limitation
in chemotherapy: enhanced dosing of the drug to impact the tumor while minimizing systemic toxicity. The characteristics of the vasculature,
within and surrounding the tumor, can be a limiting step in this goal. For example, LAPC and HCCA are more difficult to treat due to
the lack of blood vessels that feed these tumors, making it difficult to expose tumors to chemotherapy, which is typically delivered
intravenously. Trans-arterial chemoembolization (TACE) is an established first line therapy for certain solid tumors. A key component
of this approach is to identify and isolate vessels feeding the tumor, known as tumor feeders. However, in patients with pancreatic cancer,
no tumor feeder vessels are visible during angiography. In the absence of visible tumor feeders, we can introduce drugs directly across
the arterial wall into the surrounding tissue via pressurized diffusion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently evaluating RenovoGem in patients with LAPC in a Phase 3 trial entitled &ldquo;<B><U>T</U></B>argeted <B><U>I</U></B>ntra-arterial
<B><U>Ge</U></B>mcitabine vs. Continuation of IV (intravenous) Gemcitabine Plus Nab-Paclitaxel Following Induction With Sequential IV
Gemcitabine Plus Nab-Paclitaxel and <B><U>R</U></B>adiotherapy for Locally Advanced <B><U>Pa</U></B>ncreatic <B><U>C</U></B>ancer&rdquo;,
or TIGeR-PaC, trial at 28 US and Belgian sites. The trial is designed to enroll 340 subjects. 135 patients were enrolled as
of April 30, 2021. A planned interim data readout is expected during the second half of 2022. We have secured Orphan Drug Designation
for RenovoGem, which would provide us with seven years of exclusivity to market intra-arterial use of gemcitabine for LAPC upon New Drug
Application, or NDA, approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we intend to evaluate RenovoGem in patients with HCCA, and we have secured FDA Orphan Drug Designation for this indication.
We intend to potentially pursue additional indications including locally advanced lung cancer, locally advanced uterine tumors, and glioblastoma.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
our initial indication, LAPC, we have completed two studies. We launched RR1, our first-in-human, dose escalation, Phase 1/2 safety study
in May 2015 to evaluate our RenovoTAMP platform by delivering intra-arterial gemcitabine via our patented RenovoCath delivery system.
In this safety study, 20 patients with a diagnosis of Stage 3 pancreatic cancer were enrolled. We established the maximum tolerated
dose of 1000mg/m<SUP>2</SUP> of intra-arterial gemcitabine delivered via RenovoCath. The most common serious adverse events were neutropenia
followed by sepsis. After completion of enrollment and demonstration of an early survival efficacy signal in this study, we launched
our RR2 observational registry study in June 2016. The key inclusion criteria was a diagnosis of advanced or borderline resectable
pancreatic adenocarcinoma confirmed by histology or cytology. The primary endpoints were survival, tumor response and performance of
RenovoCath. A combination analysis of these two studies demonstrated that survival in &ldquo;all comers&rdquo; (n=31) receiving at
least one cycle (two treatments over one month) was 29% at two years. Looking at the prior-radiation therapy subset (n=10), 24-month
survival was 60% with a median overall survival (mOS) of 27.9 months. This compares favorably both to IV chemotherapy alone, with 24-month
survival of 12%, and to chemotherapy + radiation with 24-month survival of 5% and mOS of 12-15 months as demonstrated in historical studies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to submit our proposed Phase 2/3 clinical trial to evaluate RenovoGem in HCCA, BENEFICIAL, to the FDA as part of a pre-IND submission
in the fourth quarter of 2021 and to launch the clinical trial in the first half of 2022. Intra-venous (IV), or systemic, delivery
of gemcitabine has been considered standard of care for several solid tumors, and the drug&rsquo;s anti-cancer tumor effects are well
profiled. We intend to explore the application of our RenovoTAMP platform in additional indications including locally advanced lung cancer,
locally advanced uterine cancer, and glioblastoma. We have completed and presented data on a lung cancer application in pre-clinical
studies, and additional pre-clinical experiments in lung cancer may be conducted. Beyond our initial anti-cancer product candidate, RenovoGem,
multiple small molecule therapeutics could be incorporated into our RenovoTAMP platform, and we will opportunistically look to develop
other potential product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management team, Board of Directors, and Scientific Advisors provide us with expertise across multiple sectors to drive success through
clinical development and subsequent commercialization of our novel therapy platform. Our Chief Executive Officer, Shaun Bagai, has extensive
experience running clinical trials as well as launching, creating, and developing new markets for novel therapies at Trans Vascular,
Medtronic, Ardian, and HeartFlow. Dr. Ramtin Agah, our Co-Founder and Chief Medical Officer, is a practicing cardiovascular specialist
who has 20 years of research experience in vascular biology and disease in both academia and industry. Our Board of Directors includes
a wide range of public and private company management and Board experience including drug/device combination and oncology experience.
Clinical advisors include experts in surgical oncology, interventional radiology, radiation oncology, and medical oncology. Dr. Daniel
Von Hoff, a medical oncologist, was instrumental as the Principal Investigator who brought to market standard of care therapies for pancreatic
cancer. Dr. Mike Pishvaian, also a medical oncologist, has extensive experience in running oncology studies and is an Associate sociate
Professor, and Department of Oncology Director of the Gastrointestinal, Developmental Therapeutics, and Clinical Research Programs at
the NCR Kimmel Cancer Center at Sibley Memorial Hospital Johns Hopkins University School of Medicine. Dr. Pishvaian is the Principal
Investigator/Global Study Chair of our TIGeR-PaC Phase 3 study. Dr. Peter Muscarella is a surgical oncologist and the Director of Pancreatic
Surgery, General Surgery Site Director, Weiler Hospital Associate Program Director, and General Surgery Residency Training Program at
Montefiore Medical Center, Bronx, NY. Dr. Karyn Goodman serves as our Radiation Monitor for our TIGeR-PaC Phase 3 study and Professor
and Vice Chair of Clinical Research, Department of Radiation Oncology at the Icahn School of Medicine at Mount Sinai, and Associate Director
of Clinical Research at the Tisch Cancer Institute at Mount Sinai. We have two interventional radiology scientific advisors: Dr. Reza
Malek, Neurointerventional Radiologist at Minimally Invasive Surgical Solutions and Dr. Jacob Cynamon, Professor of Clinical Radiology
of the Albert Einstein College of Medicine, Chief of the Division of Vascular and Interventional Radiology, and Program Director of the
Vascular and Interventional Radiology Fellowship Program at the Montefiore Medical Center, Bronx, NY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
Risk Factors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
prospects should be considered in light of the risks, uncertainties, expenses and difficulties frequently encountered by similar companies.
Our ability to realize our business objectives and execute our strategies is subject to risks and uncertainties, including, among others,
the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are a clinical stage company and may never earn a profit.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            will need to raise substantial additional capital to develop and commercialize RenovoGem,
                                            and our failure to obtain funding when needed may force us to delay, reduce or eliminate
                                            our product development programs or collaboration efforts. As a result, there is substantial
                                            doubt about our ability to operate as a going concern.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            product candidates&rsquo; commercial viability remains subject to current and future preclinical
                                            studies, clinical trials, regulatory approvals, and the risks generally inherent in the development
                                            of a pharmaceutical product candidate. If we are unable to successfully advance or develop
                                            our product candidates, our business will be materially harmed.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            product candidates may exhibit undesirable side effects when used alone or in combination
                                            with other approved pharmaceutical products or investigational new drugs, which may delay
                                            or preclude further development or regulatory approval or limit their use if approved.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the results of preclinical studies or clinical trials for our product candidates are negative,
                                            we could be delayed or precluded from the further development or commercialization of our
                                            product candidates, which could materially harm our business.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are unable to satisfy regulatory requirements, we may not be able to commercialize our
                                            product candidates.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            our product candidates are unable to compete effectively with marketed drugs targeting similar
                                            indications as our product candidates, our commercial opportunity will be reduced or eliminated.
                                            We may delay or terminate the development of our product candidates at any time if we believe
                                            the perceived market or commercial opportunity does not justify further investment, which
                                            could materially harm our business.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            future success depends on our ability to retain our key personnel and to attract, retain,
                                            and motivate qualified personnel.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are unable to protect our intellectual property effectively, we may be unable to prevent
                                            third parties from using our technologies, which would impair our competitive advantage.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            patents issued to us may not be broad enough to provide any meaningful protection, one or
                                            more of our competitors may develop more effective technologies, designs, or methods without
                                            infringing our intellectual property rights and one or more of our competitors may design
                                            around our proprietary technologies.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            market price of our common stock may be volatile and fluctuate substantially, which could
                                            result in substantial losses for purchasers of our common stock in this offering.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have broad discretion in the use of our cash and cash equivalents, including the net proceeds
                                            we receive in this offering, and may not use them effectively.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we face other risks and uncertainties that may materially affect our business prospects, financial condition, and results of
operations. You should consider the risks discussed in &ldquo;Risk Factors&rdquo; and elsewhere in this prospectus before investing in
our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Information </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were incorporated in the State of Delaware on December 17, 2012. Our principal executive offices are located at 4546 El Camino Real,
Suite B1, Los Altos, CA 94022. Our telephone number is (650) 284-4433. Our website address is https://renovorx.com. Information
contained in our website does not constitute any part of, and is not incorporated into, this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Implications
of Being an Emerging Growth Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the completion of this offering, we will qualify as an &ldquo;emerging growth company&rdquo; under Jumpstart Our Business Act of 2012,
as amended, or the JOBS Act. As a result, we will be permitted to, and intend to, rely on exemptions from certain disclosure requirements.
For so long as we are an emerging growth company, we will not be required to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
have an auditor report on our internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation
or a supplement to the auditor&rsquo;s report providing additional information about the audit and the financial statements (i.e., an
auditor discussion and analysis);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
submit certain executive compensation matters to stockholder advisory votes, such as &ldquo;say-on-pay&rdquo; and &ldquo;say-on-frequency;&rdquo;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons
of the chief executive officer&rsquo;s compensation to median employee compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition period
provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended, or the Securities Act, for complying with new or revised accounting
standards. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would
otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period. Our financial
statements may therefore not be comparable to those of companies that comply with such new or revised accounting standards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will remain an emerging growth company for up to five years from the date of the first sale of equity securities pursuant to an effective
registration statement, or until the earliest of (i) the last day of the first fiscal year in which our total annual gross revenues exceed
$1.07 billion, (ii) the date that we become a &ldquo;large accelerated filer&rdquo; as defined in Rule 12b-2 under the Securities Exchange
Act of 1934, as amended, or the Exchange Act, which would occur if the market value of our common stock that is held by non-affiliates
exceeds $700 million as of the last business day of our most recently completed second fiscal quarter or (iii) the date on which we have
issued more than $1 billion in non-convertible debt during the preceding three year period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_002"></A>THE
OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 39%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock offered by us</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
    shares of common stock, $0.0001 par value per share.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed
    initial public offering price</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
    per share, the midpoint of the range set forth on the cover page of this prospectus.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over-allotment
    option</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    underwriter has an option for a period of 45 days to acquire up to an additional [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
    shares of common stock from us at the public offering price, less the underwriting discount, solely for the purpose of covering over-allotments,
    if any.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of common stock outstanding before this offering<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
    shares of common stock.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    outstanding after this offering</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
    shares of common stock (or [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares of common stock if the underwriter exercises
    its over-allotment option in full), after the sale of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares in this offering
    and after the Preferred Stock Conversions and the Note Conversions (as defined below).</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of proceeds</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    estimate that we will receive net proceeds of approximately $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] (or approximately
    $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] if the underwriter exercises its over-allotment option in full) from the sale
    of common stock by us in this offering assuming an initial public offering price of $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
    per share (the midpoint of the price range set forth on the cover of this prospectus). We plan to use the net proceeds of this offering
    primarily for completion of our currently ongoing Phase 3 trial for the locally advanced pancreatic cancer indication for RenovoGem,
    the launch of our Phase 2/3 trial for our second indication of hilar cholangiocarcinoma for RenovoGem, and working capital and general
    corporate purposes. See &ldquo;Use of Proceeds.&rdquo; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    factors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
    in our common stock involves a high degree of risk and purchasers of our common stock may lose part or all of their investment. See
    &ldquo;Risk Factors&rdquo; for a discussion of factors you should carefully consider before deciding to invest in our common stock.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed
    trading market and symbol</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have applied to list our common stock for trading on the Nasdaq Capital Market under the symbol &ldquo;RNXT.&rdquo; No assurance
    can be given that our application will be approved.</FONT></TD></TR>
</TABLE>











<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; width: 25%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
number of shares outstanding is based on shares outstanding as of March 31, 2021 and excludes the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
4,755,668 shares of our common stock issuable upon the exercise of outstanding options with a weighted-average exercise price
of $0.08 per share;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
3,542,669 shares of Series A-1 Preferred Stock, 3,546,095 shares of Series A-2 Preferred Stock, 2,660,230 shares of Series A-3 Preferred
Stock and 7,928,359 shares of Series B Preferred Stock which will convert into 3,542,669, 3,546,095, 2,660,230 and 7,928,359 shares of
common stock, respectively, upon the closing of this offering (the &ldquo;Preferred Stock Conversions&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares of common stock to be issued upon conversion of the March 2020 Notes upon the
closing of this offering (the &ldquo;Note Conversions&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
up to an additional [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares of our common stock issuable under our 2013 Equity Incentive
Plan; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares of our common stock underlying the warrants to be issued to the representative
of the underwriters in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUMMARY
FINANCIAL INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set forth our summary financial data for the periods and as of the dates indicated. The summary statements of operations
data for the years ended December 31, 2019 and 2020 have been derived from our audited financial statements included elsewhere in this
prospectus. The summary statements of operations data for the three months ended March 31, 2020 and 2021 and the summary balance sheet
data as of March 31, 2021 have been derived from our unaudited interim condensed financial statements included elsewhere in this prospectus.
Our unaudited interim condensed financial statements have been prepared on a basis consistent with our audited financial statements and,
in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation
of the financial information set forth in those statements. Our historical results are not necessarily indicative of the results that
may be expected for any other period in the future and our interim results are not necessarily indicative of our expected results for
the year ending December 31, 2021. You should read the following summary financial data set forth below in conjunction with our financial
statements and the related notes included elsewhere in this prospectus and the information in the sections titled &ldquo;Selected Financial
Data&rdquo; and Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo; contained elsewhere
in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Year
    Ended December 31,</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Three
    Months Ended &nbsp;March 31,</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2019</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2020</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2020</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2021</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(unaudited)</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="14" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(in thousands, except
    per share data)</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Statements of Operations Data:</B></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating expenses:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Research
    and development</FONT></TD><TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,997</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,386</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">805</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">635</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">General
    and administrative</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">899</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">818</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">248</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">418</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    operating expenses</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,896</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,204</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,053</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,053</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss from operations</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,896</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,204</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,053</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,053</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest income (expense),
    net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">63</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(587</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(230</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other income (expense),
    net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss on change in fair
    value of warrant liability</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gain
    on loan extinguishment</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">140</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    other income (expense), net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">57</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(594</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(95</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,839</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,798</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,051</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,148</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss per share &ndash; basic and diluted</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.35</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.34</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.10</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.10</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    average shares used to compute net loss per share &ndash; basic and diluted</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,886</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,072</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,974</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,209</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pro
    forma net loss per share &ndash; basic and diluted</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    average shares used to compute pro forma net loss per share &ndash; basic and diluted</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
  unaudited pro forma net loss per share for the years ended December 31, 2019 and 2020 and the three months ended March 31, 2020 and
  2021 was computed using the weighted-average number of shares of common stock outstanding, including the pro forma effect of the conversion
  of all outstanding shares of convertible preferred stock and convertible notes into shares of common stock, as if such conversion had
  occurred at the beginning of the period, or their issuance dates, if later.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    of March 31, 2021</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Actual</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pro
    forma <SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pro
    forma as adjusted <SUP>(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="10" STYLE="text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">(in thousands)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance Sheet Data:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 52%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash and cash equivalents</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">837</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">837</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Working (deficit) capital</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,636</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">206</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,278</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,278</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible note, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,843</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,589</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">747</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible preferred stock</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,451</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stockholders&rsquo; (deficit) equity</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(15,762</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">531</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The pro forma balance sheet data gives
  effect to the automatic conversion of all outstanding shares of our preferred stock, including the shares of preferred stock issuable
  upon the automatic conversion of our outstanding convertible notes, including the related accrued interest and derivative liability,
  into XX shares of common stock immediately prior to the closing of this offering.</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The pro forma as adjusted balance sheet
  data gives effect to the issuance and sale of XXX shares of our common stock in this offering at an assumed initial public offering
  price of $XX per share, which is the midpoint of the estimated price range set forth on the cover of this prospectus, after deducting
  estimated underwriting discounts and commissions and estimated offering expenses payable by us. The pro forma as adjusted information
  is illustrative only and will depend on the actual initial public offering price and other terms of this offering determined at pricing.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_003"></A>RISK
FACTORS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>An
investment in our securities involve a high degree of risk. You should carefully consider the risks described below, together with the
financial and other information contained in this prospectus, before you decide to purchase our securities. If any of the following risks
actually occurs, our business, financial condition, results of operations, cash flows and prospects could be materially and adversely
affected. In that event, the trading price of our common stock and the market value of the securities offered hereby could decline, and
you may lose all or part of your investment. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Business </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are a clinical stage company and may never earn a profit.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a clinical stage company and have incurred losses since our formation. As of March 31, 2021, we have an accumulated total deficit
of approximately $16.1 million. For both three-month periods ended March 31, 2020 and 2021, we had a net loss of approximately $1.1 million.
</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To date, we have experienced negative cash flow from development of
our product candidate, RenovoGem, our platform technology, Renovo Trans-Arterial Micro-Perfusion, or RenovoTAMP, and our RenovoCath delivery
system. We have not generated any revenue from operations, and we expect to incur substantial net losses for the foreseeable future as
we seek to further develop and commercialize RenovoGem. We cannot predict the extent of these future net losses, or when we may attain
profitability, if ever. If we are unable to generate significant revenue from RenovoGem or attain profitability, we will not be able
to sustain operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of the numerous risks and uncertainties associated with developing and commercializing RenovoGem, we are unable to predict the extent
of any future losses or when we will attain profitability, if ever. We may never become profitable and you may never receive a return
on an investment in our common stock. An investor in our common stock must carefully consider the substantial challenges, risks and uncertainties
inherent in the attempted development and commercialization of RenovoGem. We may never successfully commercialize RenovoGem, and our
business may not be successful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will need to raise substantial additional capital to develop and commercialize RenovoGem, and our failure to obtain funding when needed
may force us to delay, reduce or eliminate our product development programs or collaboration efforts. If we do not obtain adequate and
timely funding, we may not be able to continue as a going concern.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2021, our cash and cash equivalents were approximately $0.8 million, and our working capital deficit was approximately $3.6
million.</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Due to our recurring losses from operations and the expectation
that we will continue to incur losses in the future, we will be required to raise additional capital to complete the development and
commercialization of our product candidates. We have historically relied upon private sales of our equity as well as debt financings
to fund our operations. In order to raise additional capital, we may seek to sell additional equity and/or debt securities, obtain a
credit facility or other loan or enter into collaborations, licenses or other similar arrangements, which we may not be able to do on
favorable terms, or at all. Our ability to obtain additional financing will be subject to a number of factors, including market conditions,
our operating performance and investor sentiment. If we are unable to raise additional capital when required or on acceptable terms,
we may have to significantly delay, scale back or discontinue the development and/or commercialization of our product candidate, restrict
our operations or obtain funds by entering into agreements on unfavorable terms. Failure to obtain additional capital at acceptable terms
would result in a material and adverse impact on our operations. As a result, there is substantial doubt about our ability to operate
as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
financial statements have been prepared on a going concern basis and do not include any adjustments that may result from the outcome
of this uncertainty. If we fail to raise additional working capital, or do so on commercially unfavorable terms, it would materially
and adversely affect our business, prospects, financial condition and results of operations, and we may be unable to continue as a going
concern. If we seek additional financing to fund our business activities in the future and there remains substantial doubt about our
ability to continue as a going concern, investors or other financing sources may be unwilling to provide additional funding to us on
commercially reasonable terms, if at all. If we are unable to continue as a going concern, we might have to liquidate our assets and
the value we receive for our assets in liquidation or dissolution could be significantly lower than the values reflected in our financial
statements, and our shareholders may lose their entire investment in our ordinary shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
product candidates&rsquo; commercial viability remains subject to current and future preclinical studies, clinical trials, regulatory
approvals, and the risks generally inherent in the development of a pharmaceutical product candidate. If we are unable to successfully
advance or develop our product candidate, our business will be materially harmed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the near-term, failure to successfully advance the development of our product candidate may have a material adverse effect on us. To
date, we have not successfully developed or commercially marketed, distributed, or sold any product candidate. The success of our business
depends primarily upon our ability to successfully advance the development of our current and future product candidates through preclinical
studies and clinical trials, have the product candidates approved for sale by the FDA or regulatory authorities in other countries, and
ultimately have the product candidates successfully commercialized by us or a commercial partner. We cannot assure you that the results
of our ongoing preclinical studies or clinical trials will support or justify the continued development of our product candidate, or
that we will receive approval from the FDA, or similar regulatory authorities in other countries, to advance the development of our product
candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
product candidates must satisfy rigorous regulatory standards of safety and efficacy before we can advance or complete their clinical
development, or they can be approved for sale. To satisfy these standards, we must engage in expensive and lengthy preclinical studies
and clinical trials, develop acceptable manufacturing processes, and obtain regulatory approval. Despite these efforts, our product candidates
may not:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">offer
                                            therapeutic or other medical benefits over existing drugs or other product candidates in
                                            development to treat the same patient population;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            proven to be safe and effective in current and future preclinical studies or clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
                                            the desired effects;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            free from undesirable or unexpected effects;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">meet
                                            applicable regulatory standards;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            capable of being formulated and manufactured in commercially suitable quantities and at an
                                            acceptable cost; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
                                            successfully commercialized by us or by collaborators.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot assure you that the results of late-stage clinical trials will be favorable enough to support the continued development of our
product candidates. A number of companies in the pharmaceutical and biopharmaceutical industries have experienced significant delays,
setbacks and failures in all stages of development, including late-stage clinical trials, even after achieving promising results in preclinical
testing or early-stage clinical trials. Accordingly, results from completed preclinical studies and early-stage clinical trials of our
product candidates may not be predictive of the results we may obtain in later-stage trials. Furthermore, even if the data collected
from preclinical studies and clinical trials involving our product candidates demonstrate a favorable safety and efficacy profile, such
results may not be sufficient to support the submission of an NDA to obtain regulatory approval from the FDA in the U.S., or other similar
regulatory agencies in other jurisdictions, which is required to market and sell the product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
product candidates will require significant additional research and development efforts, the commitment of substantial financial resources,
and regulatory approvals prior to advancing into further clinical development or being commercialized by us or collaborators. We cannot
assure you that our product candidates will successfully progress through the drug development process or will result in commercially
viable products. We do not expect our product candidates to be commercialized by us or collaborators for at least several years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
product candidates may exhibit undesirable side effects when used alone or in combination with other approved pharmaceutical products
or investigational new drugs, which may delay or preclude further development or regulatory approval or limit their use if approved.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Throughout
the drug development process, we must continually demonstrate the safety and tolerability of our product candidates to obtain regulatory
approval to further advance clinical development or to market them. Even if our product candidates demonstrate clinical efficacy, any
unacceptable adverse side effects or toxicities, when administered alone or in the presence of other pharmaceutical products, which can
arise at any stage of development, may outweigh potential benefits. In preclinical studies and clinical trials we have conducted to date,
our product candidate&rsquo;s tolerability profile is based on studies and trials that have involved a small number of subjects
or patients over a limited period of time. We may observe adverse or significant adverse events or drug-drug interactions in future preclinical
studies or clinical trial candidates, which could result in the delay or termination of development, prevent regulatory approval, or
limit market acceptance if ultimately approved.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raising
additional capital may cause dilution to our existing stockholders, including purchasers of common stock in this offering, restrict our
operations or require us to relinquish rights to our product candidates on unfavorable terms to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may seek additional capital through a variety of means, including through public or private equity, debt financings or other sources,
including up-front payments and milestone payments from strategic collaborations. To the extent that we raise additional capital through
the sale of equity or convertible debt or equity securities, your ownership interest will be diluted, and the terms may include liquidation
or other preferences that adversely affect your rights as a stockholder. Such financing may result in dilution to stockholders, imposition
of debt covenants, increased fixed payment obligations or other restrictions that may affect our business. If we raise additional funds
through up-front payments or milestone payments pursuant to strategic collaborations with third parties, we may have to relinquish valuable
rights to our product candidates or grant licenses on terms that are not favorable to us. In addition, we may seek additional capital
due to favorable market conditions or strategic considerations even if we believe we have sufficient funds for our current or future
operating plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
the results of preclinical studies or clinical trials for our product candidates, including those that are subject to existing or future
license or collaboration agreements, are unfavorable or delayed, we could be delayed or precluded from the further development or commercialization
of our product candidates, which could materially harm our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to further advance the development of, and ultimately receive regulatory approval to sell, our product candidates, we must conduct
extensive preclinical studies and clinical trials to demonstrate their safety and efficacy to the satisfaction of the FDA or similar
regulatory authorities in other countries, as the case may be. Preclinical studies and clinical trials are expensive, complex, can take
many years to complete, and have highly uncertain outcomes. Delays, setbacks, or failures can occur at any time, or in any phase of preclinical
or clinical testing, and can result from concerns about safety or toxicity, a lack of demonstrated efficacy or superior efficacy over
other similar products that have been approved for sale or are in more advanced stages of development, poor study or trial design, and
issues related to the formulation or manufacturing process of the materials used to conduct the trials. The results of prior preclinical
studies or clinical trials are not necessarily predictive of the results we may observe in later stage clinical trials. In many cases,
product candidates in clinical development may fail to show desired safety and efficacy characteristics despite having favorably demonstrated
such characteristics in preclinical studies or earlier stage clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we may experience numerous unforeseen events during, or as a result of, preclinical studies and the clinical trial process,
which could delay or impede our ability to advance the development of, receive regulatory approval for, or commercialize our product
candidate, including, but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">communications
                                            with the FDA, or similar regulatory authorities in different countries, regarding the scope
                                            or design of a trial or trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
                                            authorities, including an Institutional Review Board (&ldquo;IRB&rdquo;) or Ethical Committee
                                            (&ldquo;EC&rdquo;), not authorizing us to commence or conduct a clinical trial at a prospective
                                            trial site;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enrollment
                                            in our clinical trials being delayed, or proceeding at a slower pace than we expected, because
                                            we have difficulty recruiting patients or participants dropping out of our clinical trials
                                            at a higher rate than we anticipated;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            third-party contractors, upon whom we rely for conducting preclinical studies, clinical trials
                                            and manufacturing of our trial materials, may fail to comply with regulatory requirements
                                            or meet their contractual obligations to us in a timely manner;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">having
                                            to suspend or ultimately terminate our clinical trials if participants are being exposed
                                            to unacceptable health or safety risks;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IRBs,
                                            ECs, or regulators requiring that we hold, suspend or terminate our preclinical studies and
                                            clinical trials for various reasons, including non-compliance with regulatory requirements;
                                            and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            supply or quality of drug material or the supply of our RenovoCath device necessary to conduct
                                            our preclinical studies or clinical trials being insufficient, inadequate, or unavailable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if the data collected from preclinical studies or clinical trials involving our product candidates demonstrate a favorable safety and
efficacy profile, such results may not be sufficient to support the submission of an NDA to obtain regulatory approval from the FDA in
the U.S., or other similar foreign regulatory authorities in foreign jurisdictions, which is required to market and sell the product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
third party vendors upon whom we intend to rely on to conduct our preclinical studies or clinical trials do not perform or fail to comply
with strict regulations, these studies or trials of our product candidate may be delayed, terminated, or fail, or we could incur significant
additional expenses, which could materially harm our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have limited resources dedicated to designing, conducting, and managing preclinical studies and clinical trials. We intend to rely on
third parties, including clinical research organizations, consultants, and principal investigators, to assist us in designing, managing,
monitoring and conducting our preclinical studies and clinical trials. We intend to rely on these vendors and individuals to perform
many facets of the drug development process, including certain preclinical studies, the recruitment of sites and patients for participation
in our clinical trials, maintenance of good relations with the clinical sites, and ensuring that these sites are conducting our trials
in compliance with the trial protocol, including safety monitoring and applicable regulations. If these third parties fail to perform
satisfactorily, or do not adequately fulfill their obligations under the terms of our agreements with them, we may not be able to enter
into alternative arrangements without undue delay or additional expenditures, and therefore the preclinical studies and clinical trials
of our product candidate may be delayed or prove unsuccessful. Further, the FDA, or other similar foreign regulatory authorities, may
inspect some of the clinical sites participating in our clinical trials in the U.S., or our third-party vendors&rsquo; sites, to determine
if our clinical trials are being conducted according to Good Clinical Practices. If we or the FDA determine that our third-party vendors
are not in compliance with, or have not conducted our clinical trials according to, applicable regulations we may be forced to delay,
repeat, or terminate such clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have limited capacity for recruiting and managing clinical trials, which could impair our timing to initiate or complete clinical trials
of our product candidate and materially harm our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have limited capacity to recruit and manage the clinical trials necessary to obtain FDA approval or approval by other regulatory authorities.
By contrast, larger pharmaceutical and bio-pharmaceutical companies often have substantial staff with extensive experience in conducting
clinical trials with multiple product candidates across multiple indications. In addition, they may have greater financial resources
to compete for the same clinical investigators and patients that we are attempting to recruit for our clinical trials. If potential competitors
are successful in completing drug development for their product candidates and obtain approval from the FDA, they could limit the demand
to participate in clinical trials of our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, we may be at a competitive disadvantage that could delay the initiation, recruitment, timing, completion of our clinical trials
and obtaining regulatory approvals, if at all, for our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We,
and our collaborators, if any, must comply with extensive government regulations in order to advance our product candidates through the
development process and ultimately obtain and maintain marketing approval for our products in the U.S. and abroad.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
product candidates that we, or our collaborators, are developing or may develop require regulatory approval to advance through
clinical development and to ultimately be marketed and sold and are subject to extensive and rigorous domestic and foreign government
regulation. In the U.S., the FDA regulates, among other things, the development, testing, manufacture, safety, efficacy, record-keeping,
labeling, storage, approval, advertising, promotion, sale, and distribution of pharmaceutical and biopharmaceutical products.
Our product candidates are also subject to similar regulation by foreign governments to the extent we seek to develop or market
them in those countries. We, or our collaborators, must provide the FDA and foreign regulatory authorities, if applicable, with
preclinical and clinical data, as well as data supporting an acceptable manufacturing process, that appropriately demonstrate
our product candidate&rsquo;s safety and efficacy before it can be approved for the targeted indications. Our product candidates
have not been approved for sale in the U.S. or any foreign market, and we cannot predict whether we or our collaborators will
obtain regulatory approval for any product candidates we are developing or plan to develop. The regulatory review and approval
process can take many years, is dependent upon the type, complexity, novelty of, and medical need for the product candidate, requires
the expenditure of substantial resources, and involves post-marketing surveillance and vigilance and potentially post-marketing
studies or Phase 4 clinical trials. In addition, we or our collaborators may encounter delays in, or fail to gain, regulatory
approval for our product candidate based upon additional governmental regulation resulting from future legislative, administrative
action or changes in FDA&rsquo;s or other similar foreign regulatory authorities&rsquo; policy or interpretation during the period
of product development. Delays or failures in obtaining regulatory approval to advance our product candidate through clinical
development, and ultimately commercialize them, may:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adversely
                                            impact our ability to raise sufficient capital to fund the development of our product candidates;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adversely
                                            affect our ability to further develop or commercialize our product candidates;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">diminish
                                            any competitive advantages that we or our collaborators may have or attain; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adversely
                                            affect the receipt of potential milestone payments and royalties from collaborators, if any,
                                            from the sale of our products or product revenues in the future.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
any regulatory approvals, if granted, may later be withdrawn. If we or our collaborators fail to comply with applicable regulatory requirements
at any time, or if post-approval safety concerns arise, we or our collaborators may be subject to restrictions or a number of actions,
including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays,
                                            suspension, or termination of clinical trials related to our products;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
                                            by regulatory authorities to review pending applications or supplements to approved applications;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
                                            recalls or seizures;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">suspension
                                            of manufacturing;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">withdrawals
                                            of previously approved marketing applications; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fines,
                                            civil penalties, and criminal prosecutions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
at any time we or our collaborators may voluntarily suspend or terminate the preclinical or clinical development of a product candidate,
or withdraw any approved product from the market if we believe that it may pose an unacceptable safety risk to patients, or if the product
candidate or approved product no longer meets our business objectives. The ability to develop or market a pharmaceutical product outside
of the U.S. is contingent upon receiving appropriate authorization from the respective foreign regulatory authorities. Foreign regulatory
approval processes typically include many, if not all, of the risks and requirements associated with the FDA regulatory process for drug
development and may include additional risks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Clinical
trials involve a lengthy and expensive process with an uncertain outcome, and results of earlier studies and trials may not be predictive
of future trial results.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
product candidates may not prove to be safe and efficacious in clinical trials and may not meet all the applicable regulatory requirements
needed to receive regulatory approval. In order to receive regulatory approval for the commercialization of our product candidates, we
must conduct, at our own expense, extensive preclinical testing and clinical trials to demonstrate safety and efficacy of our product
candidate for the intended indication of use. Clinical testing is expensive, can take many years to complete, if at all, and its outcome
is uncertain. Failure can occur at any time during the clinical trial process.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of preclinical studies and early clinical trials of new drugs do not necessarily predict the results of later-stage clinical
trials. The design of our clinical trials is based on many assumptions about the expected effects of our product candidate, and if those
assumptions are incorrect, they may not produce statistically significant results. Preliminary results may not be confirmed on full analysis
of the detailed results of a clinical trial. Product candidates in later stages of clinical development may fail to show safety and efficacy
sufficient to support intended use claims despite having progressed through earlier clinical testing. The data collected from clinical
trials of our product candidate may not be sufficient to support the filing of an NDA or to obtain regulatory approval in the United
States or elsewhere. Because of the uncertainties associated with drug development and regulatory approval, we cannot determine if or
when we will have an approved product for commercialization or achieve sales or profits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Delays
in clinical testing could result in increased costs to us and delay our ability to generate revenue.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may experience delays in clinical testing of our product candidate. We do not know whether planned clinical trials will begin on time,
will need to be redesigned or will be completed on schedule, if at all. Clinical trials can be delayed for a variety of reasons, including
pandemics, delays in obtaining regulatory approval to commence a clinical trial, in securing clinical trial agreements with prospective
sites with acceptable terms, in obtaining IRB approval to conduct a clinical trial at a prospective site, in recruiting patients to participate
in a clinical trial or in obtaining sufficient supplies of clinical trial materials, including RenovoCath. Many factors affect patient
enrollment, including the size of the patient population, the proximity of patients to clinical sites, the eligibility criteria for the
clinical trial, the existing body of safety and efficacy data with respect to the study drug, competing clinical trials, new drugs approved
for the conditions we are investigating and health epidemics such as the COVID-19 pandemic. Clinical investigators will need to decide
whether to offer their patients enrollment in clinical trials of our product candidate versus treating these patients with commercially
available drugs that have established safety and efficacy profiles. Any delays in completing our clinical trials will increase our costs,
slow down our product development, timeliness and approval process and delay our ability to generate revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
regulatory approval processes of the FDA and comparable foreign authorities are lengthy, time consuming and inherently unpredictable,
and if we are ultimately unable to obtain regulatory approval for our product candidates, our business will be substantially harmed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
time required to obtain approval by the FDA and comparable foreign authorities is unpredictable but typically takes many years following
the commencement of clinical trials and depends upon numerous factors, including the substantial discretion of the regulatory authorities.
In addition, approval policies, regulations, or the type and amount of clinical data necessary to gain approval may change during the
course of a product candidate&rsquo;s clinical development and may vary among jurisdictions. We have not obtained regulatory approval
for any product candidate and it is possible that our existing product candidate or any product candidate we may seek to develop in the
future will ever obtain regulatory approval may fail to receive regulatory approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
product candidate could fail to receive regulatory approval for many reasons, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            FDA or comparable foreign regulatory authorities may disagree with the design or implementation
                                            of our clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may be unable to demonstrate to the satisfaction of the FDA or comparable foreign regulatory
                                            authorities that a product candidate is safe and effective for its proposed indication;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            results of clinical trials may not meet the level of statistical significance required for
                                            approval by the FDA or comparable foreign regulatory authorities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            FDA or comparable foreign regulatory authorities may disagree with our interpretation of
                                            data from preclinical studies or clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            data collected from clinical trials of our product candidates may not be sufficient to support
                                            the submission of an NDA or other submission or to obtain regulatory approval in the United
                                            States or elsewhere;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            FDA or comparable foreign regulatory authorities may fail to approve the manufacturing processes
                                            or facilities of third-party manufacturers with which we contract for clinical and commercial
                                            supplies; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            approval policies or regulations of the FDA or comparable foreign regulatory authorities
                                            may significantly change in a manner rendering our clinical data insufficient for approval.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
lengthy approval process as well as the unpredictability of future clinical trial results may result in our failing to obtain regulatory
approval to market our product candidates, which would significantly harm our business, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, even if we were to obtain approval, regulatory authorities may approve our product candidates for fewer or more limited indications
than we request, may grant approval contingent on the performance of costly post-marketing clinical trials, or may approve a product
candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of that
product candidate. Any of the foregoing scenarios could materially harm the commercial prospects for our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not previously submitted an NDA to the FDA, nor similar drug approval filings to comparable foreign authorities, for our product
candidates, and we cannot be certain that our product candidates will be successful in clinical trials or receive regulatory approval.
Further, our product candidates may not receive regulatory approval even if they are successful in clinical trials. If we do not receive
regulatory approvals for our product candidates, we may not be able to continue our operations. Even if we successfully obtain regulatory
approvals to market one or more of our product candidates, our revenues will be dependent on many factors including the size of the markets
in the territories for which we gain regulatory approval and have commercial rights. If the markets for patients that we are targeting
for our product candidates are not as significant as we estimate, we may not generate significant revenues from sales of such products,
if approved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to seek regulatory approval and to commercialize our product candidates, directly or with collaborators in the United States, the
European Union, and other foreign countries which we have not yet identified. While the scope of regulatory approval is similar in other
countries, to obtain separate regulatory approval in many other countries we must comply with numerous and varying regulatory requirements
of such countries regarding safety and efficacy and governing, among other things, clinical trials and commercial sales, pricing, and
distribution of our product candidates, and we cannot predict success in these jurisdictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be required to suspend or discontinue clinical trials due to unexpected side effects or other safety risks that could preclude approval
of our product candidates.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
clinical trials may be suspended at any time for a number of reasons. For example, we may voluntarily suspend or terminate our clinical
trials if at any time we believe that they present an unacceptable risk to the clinical trial patients. In addition, the FDA or other
regulatory agencies may order the temporary or permanent discontinuation of our clinical trials at any time if they believe that the
clinical trials are not being conducted in accordance with applicable regulatory requirements or that they present an unacceptable safety
risk to the clinical trial patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administering
our product candidates to humans may produce undesirable side effects. These side effects could interrupt, delay or halt clinical trials
of our product candidates and could result in the FDA or other regulatory authorities denying further development or approval of our
product candidate for any or all targeted indications. Ultimately, our product candidates may prove to be unsafe for human use. Moreover,
we could be subject to significant liability if any volunteer or patient suffers, or appears to suffer, adverse health effects as a result
of participating in our clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we fail to comply with healthcare regulations, we could face substantial enforcement actions, including civil and criminal penalties
and our business, operations and financial condition could be adversely affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a developer of pharmaceuticals, certain federal and state healthcare laws and regulations pertaining to fraud and abuse, false claims
and patients&rsquo; privacy rights are and will be applicable to our business. We could be subject to healthcare fraud and abuse laws
and patient privacy laws of both the federal government and the states in which we conduct our business. The laws include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            federal healthcare program anti-kickback law, which prohibits, among other things, persons
                                            from soliciting, receiving or providing remuneration, directly or indirectly, to induce either
                                            the referral of an individual, for an item or service or the purchasing or ordering of a
                                            good or service, for which payment may be made under federal healthcare programs such as
                                            the Medicare and Medicaid programs;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">federal
                                            false claims laws which prohibit, among other things, individuals, or entities from knowingly
                                            presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other
                                            third-party payors that are false or fraudulent, and which may apply to entities like us
                                            which provide coding and billing information to customers;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            federal Health Insurance Portability and Accountability Act of 1996, which prohibits executing
                                            a scheme to defraud any healthcare benefit program or making false statements relating to
                                            healthcare matters and which also imposes certain requirements relating to the privacy, security
                                            and transmission of individually identifiable health information;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Federal Food, Drug, and Cosmetic Act, which among other things, strictly regulates drug manufacturing
                                            and product marketing, prohibits manufacturers from marketing drug products for off-label
                                            use and regulates the distribution of drug samples; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">state
                                            law equivalents of each of the above federal laws, such as anti-kickback and false claims
                                            laws which may apply to items or services reimbursed by any third-party payor, including
                                            commercial insurers, and state laws governing the privacy and security of health information
                                            in certain circumstances, many of which differ from each other in significant ways and often
                                            are not preempted by federal laws, thus complicating compliance efforts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our operations are found to be in violation of any of the laws described above or any governmental regulations that apply to us, we may
be subject to penalties, including civil and criminal penalties, damages, fines, and the curtailment or restructuring of our operations.
Any penalties, damages, fines, curtailment or restructuring of our operations could adversely affect our ability to operate our business
and our financial results. Although compliance programs can mitigate the risk of investigation and prosecution for violations of these
laws, the risks cannot be entirely eliminated. Any action against us for violation of these laws, even if we successfully defend against
it, could cause us to incur significant legal expenses and divert management&rsquo;s attention from the operation of our business. Moreover,
achieving and sustaining compliance with applicable federal and state privacy, security and fraud laws may prove costly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unable to satisfy regulatory requirements, we may not be able to commercialize our product candidate.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
need FDA approval prior to marketing our product candidates in the United States. If we fail to obtain FDA approval to market our product
candidates, we will be unable to sell our product candidates in the United States and we will not generate any revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA&rsquo;s review and approval process, including among other things, evaluation of preclinical studies and clinical trials of a product
candidate as well as the manufacturing process and facility, is lengthy, expensive, and uncertain. To receive approval, we must, among
other things, demonstrate with substantial evidence from well-designed and well-controlled pre-clinical testing and clinical trials that
the product candidates are both safe and effective for each indication for which approval is sought. Satisfaction of these requirements
typically takes several years, and the time needed to satisfy them may vary substantially, based on the type, complexity and novelty
of the pharmaceutical product. We cannot predict if or when we will submit an NDA for approval for our product candidate currently under
development. Any approvals we may obtain may not cover all of the clinical indications for which we are seeking approval or may contain
significant limitations on the conditions of use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA has substantial discretion in the NDA review process and may either refuse to file our NDA for substantive review or may decide that
our data is insufficient to support approval of our product candidates for the claimed intended uses. Following any regulatory approval
of our product candidates, we will be subject to continuing regulatory obligations such as safety reporting, required and additional
post marketing obligations, and regulatory oversight of promotion and marketing. Even if we receive regulatory approvals, the FDA may
subsequently seek to withdraw approval of our NDA if we determine that new data or a reevaluation of existing data show the product is
unsafe for use under the conditions of use upon the basis of which the NDA was approved, or based on new evidence of adverse effects
or adverse clinical experience, or upon other new information. If the FDA does not file or approve our NDA or withdraws approval of our
NDA, the FDA may require that we conduct additional clinical trials, preclinical or manufacturing studies and submit that data before
it will reconsider our application. Depending on the extent of these or any other requested studies, approval of any applications that
we submit may be delayed by several years, may require us to expend more resources than we have available, or may never be obtained at
all. In addition, we have obtained FDA clearance for our RenovoCath delivery system. In the event adverse events arise with respect to
the RenovoCath delivery system, the FDA could revoke its clearance which would have a material adverse effect on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will also be subject to a wide variety of foreign regulations governing the development, manufacture, and marketing of our products to
the extent we seek regulatory approval to develop and market our product candidates in a foreign jurisdiction. As of the date hereof
we have not identified any foreign jurisdictions which we intend to seek approval from. Whether or not FDA approval has been obtained,
approval of a product candidate by the comparable regulatory authorities of foreign countries must still be obtained prior to marketing
the product candidate in those countries. The approval process varies, and the time needed to secure approval in any region such as the
European Union or in a country with an independent review procedure may be longer or shorter than that required for FDA approval. We
cannot assure you that clinical trials conducted in one country will be accepted by other countries or that an approval in one country
or region will result in approval elsewhere.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
our product candidates are unable to compete effectively with marketed drugs targeting similar indications as our product candidates,
our commercial opportunity will be reduced or eliminated.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face competition generally from established pharmaceutical and biotechnology companies, as well as from academic institutions, government
agencies and private and public research institutions. Many of our competitors have significantly greater financial resources and expertise
in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals and marketing
approved products than we do. Small or early-stage companies may also prove to be significant competitors, particularly through collaborative
arrangements with large, established companies. We are aware of a number of companies in Phase 3 clinical trials for the treatment of
LAPC including Angiodynamics, Bausch Health, Fibrogen, NovoCure, and SynCore Biotechnology. In addition, we are aware of a number of
companies in Phase 1 and Phase 2 clinical trials for the treatment of LAPC including one interventional company, TriSalus Lifesciences.
Our commercial opportunity will be reduced or eliminated if our competitors develop and commercialize any products that are safer, more
effective, have fewer side effects or are less expensive than our product candidates. These potential competitors compete with us in
recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites, and patient enrollment for
clinical trials, as well as in acquiring technologies and technology licenses complementary to our programs or advantageous to our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
approved and commercialized, RenovoGem would compete with several currently approved prescription therapies for the treatment of LAPC
and hilar cholangiocarcinoma. To our knowledge, other potential competitors are in earlier stages of development. If potential competitors
are successful in completing drug development for their product candidates and obtain approval from the FDA, they could limit the demand
for RenovoGem.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that our ability to compete effectively will depend upon our ability to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">successfully
                                            identify and develop key points of product differentiation from currently available therapies;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">successfully
                                            and timely complete clinical trials and submit for and obtain all requisite regulatory approvals
                                            in a cost-effective manner;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintain
                                            a proprietary position for our products and manufacturing processes and other related product
                                            technology;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">attract
                                            and retain key personnel;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">develop
                                            relationships with physicians prescribing these products; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">build
                                            an adequate sales and marketing infrastructure for our products, if approved.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we will be competing against significantly larger companies with established track records, we will have to demonstrate that, based on
experience, clinical data, side-effect profiles and other factors, our products, if approved, are competitive with other products. If
we are unable to compete effectively and differentiate our products from other marketed drugs, we may never generate meaningful revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may expend our limited resources to pursue one or more product candidates or indications within our product development strategy, which
has and may continue to change over time, and fail to capitalize on product candidates or indications that may be more profitable or
for which there is a greater likelihood of success.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we have limited financial and managerial resources, we intend to focus on developing product candidates for specific indications that
we identify as most likely to succeed, in terms of their potential both to gain regulatory approval and to achieve commercialization.
As a result, we may forego or delay pursuit of opportunities with other product candidates or in other indications with greater commercial
potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities.
Our spending on current and future research and development programs and product candidates for specific indications may not yield any
commercially viable product candidates. If we do not accurately evaluate the commercial potential or target market for a particular product
candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing, or other royalty arrangements
in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to the product
candidate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
the manufacturers upon whom we rely fail to produce our product candidates, in the volumes that we require on a timely basis, or fail
to comply with stringent regulations applicable to pharmaceutical drug manufacturers, we may face delays in the development and commercialization
of our product candidates.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently possess internal manufacturing capacity. We plan to utilize the services of GMP, FDA inspected contract
manufacturers to manufacture our clinical supplies. Any curtailment in the availability of gemcitabine, however, could result
in production or other delays with consequent adverse effects on us. In addition, because regulatory authorities must generally
approve raw material sources for pharmaceutical products, changes in raw material suppliers may result in production delays or
higher raw material costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
obtain our RenovoCath delivery system from a single source. Gemcitabine is supplied from our clinical sites own pharmacies and used off-label
for intra-arterial use within our clinical study. We continue to pursue supply agreements for gemcitabine and our RenovoCath delivery
system. We may be required to agree to minimum volume requirements, exclusivity arrangements or other restrictions with the contract
manufacturers. We may not be able to enter into long-term agreements on commercially reasonable terms, or at all. If we change or add
manufacturers, the FDA and comparable foreign regulators may require approval of the changes. Approval of these changes could require
new testing by the manufacturer and compliance inspections to ensure the manufacturer is conforming to all applicable laws and regulations
and GMP.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
manufacture of pharmaceutical products requires significant expertise and capital investment, including the development of advanced manufacturing
techniques and process controls. Manufacturers of pharmaceutical products may encounter difficulties in production, particularly in scaling
up production. These problems include difficulties with production costs and yields, quality control, including stability of the product
and quality assurance testing, shortages of qualified personnel, as well as compliance with federal, state, and foreign regulations.
In addition, any delay or interruption in the supply of clinical trial supplies could delay the completion of our clinical trials, increase
the costs associated with conducting our clinical trials and, depending upon the period of delay, require us to commence new clinical
trials at significant additional expense or to terminate a clinical trial.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will be responsible for ensuring that our future contract manufacturers comply with the GMP requirements of the FDA and other
regulatory authorities from which we seek to obtain product approval. These requirements include, among other things, quality
control, quality assurance and the maintenance of records and documentation. The approval process for NDAs includes an insepction
of the manufacturer&rsquo;s compliance with GMP requirements. We will be responsible for regularly assessing a contract manufacturer&rsquo;s
compliance with GMP requirements through record reviews and periodic audits and for ensuring that the contract manufacturer takes
responsibility and corrective action for any identified deviations. Manufacturers of our product candidates may be unable to comply
with these GMP requirements and with other FDA and foreign regulatory requirements, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we will oversee compliance of our contract manufacturers, ultimately, we will not have control over our manufacturers&rsquo;
compliance with these regulations and standards. A failure to comply with these requirements may result in fines and civil penalties,
suspension of production, suspension or delay in product approval, product seizure or recall, or withdrawal of product approval.
If the safety of our product candidates is compromised due to a manufacturers&rsquo; failure to adhere to applicable laws or for
other reasons, we may not be able to obtain regulatory approval for or successfully commercialize our product candidates, and
we may be held liable for any injuries sustained as a result. Any of these factors could cause a delay of clinical trials, regulatory
submissions, approvals, or commercialization of RenovoGem or other product candidates, entail higher costs or result in us being
unable to effectively commercialize our product candidates. Furthermore, if our manufacturers fail to deliver the required commercial
quantities on a timely basis and at commercially reasonable prices, we may be unable to meet demand for any approved products
and would lose potential revenues.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be able to manufacture our product candidates in commercial quantities, which would prevent us from commercializing our product
candidates.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, our product candidates have been manufactured in small quantities for preclinical studies and clinical trials. If our product candidates
are approved by the FDA or comparable regulatory authorities in other countries for commercial sale, we will need to manufacture such
product candidates in larger quantities. We may not be able to successfully increase the manufacturing capacity for our product candidates
in a timely or economic manner, or at all. Significant scale-up of manufacturing may require additional validation studies, which the
FDA must review and approve. If we are unable to successfully increase the manufacturing capacity for a product candidate, the clinical
trials as well as the regulatory approval or commercial launch of that product candidate may be delayed or there may be a shortage in
supply. Our product candidates require precise, high quality manufacturing. Our failure to achieve and maintain these high-quality manufacturing
standards in collaboration with our third-party manufacturers, including the incidence of manufacturing errors, could result in patient
injury or death, product recalls or withdrawals, delays or failures in product testing or delivery, cost overruns or other problems that
could harm our business, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
product candidates, if approved for sale, may not gain acceptance among physicians, patients, and the medical community, thereby limiting
our potential to generate revenues.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our product candidates are approved for commercial sale by the FDA or other regulatory authorities, the degree of market acceptance of
any approved product by physicians, healthcare professionals and third-party payors and our profitability and growth will depend on a
number of factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">demonstration
                                            of safety and efficacy;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in the practice guidelines and the standard of care for the targeted indication;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">relative
                                            convenience and ease of administration;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            prevalence and severity of any adverse side effects;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">budget
                                            impact of adoption of our product on relevant drug formularies and the availability, cost,
                                            and potential advantages of alternative treatments, including less expensive generic drugs;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pricing,
                                            reimbursement, and cost effectiveness, which may be subject to regulatory control;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">effectiveness
                                            of our or any of our or our partners&rsquo; sales and marketing strategies;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            product labeling or product insert required by the FDA or regulatory authority in other countries;
                                            and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            availability of adequate third-party insurance coverage or reimbursement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any product candidate that we develop does not provide a treatment regimen that is as beneficial as, or is perceived as being as beneficial
as, the current standard of care or otherwise does not provide patient benefit, that product candidate, if approved for commercial sale
by the FDA or other regulatory authorities, likely will not achieve market acceptance. Our ability to effectively promote and sell any
approved products will also depend on pricing and cost-effectiveness, including our ability to produce a product at a competitive price
and our ability to obtain sufficient third-party coverage or reimbursement. If any product candidate is approved but does not achieve
an adequate level of acceptance by physicians, patients and third-party payors, our ability to generate revenues from that product would
be substantially reduced. In addition, our efforts to educate the medical community and third-party payors on the benefits of our product
candidates may require significant resources, may be constrained by FDA rules and policies on product promotion, and may never be successful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Guidelines
and recommendations published by various organizations can impact the use of our products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
agencies promulgate regulations and guidelines directly applicable to us and to our product. In addition, professional societies, practice
management groups, private health and science foundations and organizations involved in various diseases from time to time may also publish
guidelines or recommendations to the healthcare and patient communities. Recommendations of government agencies or these other groups
or organizations may relate to such matters as usage, dosage, route of administration and use of concomitant therapies. Recommendations
or guidelines suggesting the reduced use of our products or the use of competitive or alternative products that are followed by patients
and healthcare providers could result in decreased use of our proposed products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
third-party contract manufacturers upon whom we rely to formulate and manufacture our product candidates do not perform, fail to manufacture
according to our specifications or fail to comply with strict regulations, our preclinical studies or clinical trials could be adversely
affected and the development of our product candidate could be delayed or terminated or we could incur significant additional expenses.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not own or operate any manufacturing facilities. We intend to rely on GMP, FDA inspected third-party contractors, at
least for the foreseeable future, to formulate and manufacture these preclinical and clinical materials. Our reliance on third-party
contract manufacturers exposes us to a number of risks, any of which could delay or prevent the completion of our preclinical
studies or clinical trials, or the regulatory approval or commercialization of our product candidate, result in higher costs,
or deprive us of potential product revenues. Some of these risks include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            third-party contractors failing to develop an acceptable formulation to support later-stage
                                            clinical trials for, or the commercialization of, our product candidates;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         contract manufacturers failing to manufacture our product candidates according to their
                                         own standards, our specifications or Current Good Manufacturing Practice (&ldquo;cGMP&rdquo;),
                                         or otherwise manufacturing material that we or the FDA may deem to be unsuitable
                                         in our clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            contract manufacturers being unable to increase the scale of, increase the capacity for,
                                            or reformulate the form of our product candidate. We may experience a shortage in supply,
                                            or the cost to manufacture our products may increase to the point where it adversely affects
                                            the cost of our product candidates. We cannot assure you that our contract manufacturers
                                            will be able to manufacture our product candidates at a suitable scale, or we will be able
                                            to find alternative manufacturers acceptable to us that can do so;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            contract manufacturers placing a priority on the manufacture of their own products, or other
                                            customers&rsquo; products;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            contract manufacturers failing to perform as agreed or not remaining in the contract manufacturing
                                            business; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            contract manufacturers&rsquo; plants being closed as a result of regulatory sanctions or
                                            a natural disaster.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>In
the event that we need to change our third-party contract manufacturers, our preclinical studies, clinical trials or the commercialization
of our product candidate could be delayed, adversely affected or terminated, or such a change may result in significantly higher costs.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to regulatory restrictions inherent in an IND or NDA, or for economic reasons, various steps in the manufacture of our product
candidate may need to be sole-sourced. We currently obtain our RenovoCath delivery system from a single supplier. In accordance
with cGMP regulations, changing manufacturers may require the re-validation of manufacturing processes and procedures,
and may require further preclinical studies or clinical trials to show comparability between the materials produced by different
manufacturers. Changing our current or future contract manufacturers may be difficult for us and could be costly, which could
result in our inability to manufacture our product candidate for an extended period of time and therefore a delay in the development
of our product candidate. Further, in order to maintain our development time lines in the event of a change in our third-party
contract manufacturer, we may incur significantly higher costs to manufacture our product candidate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
currently do not have any internal drug discovery capabilities, and therefore we are dependent on identifying drugs that are off patent
or on in-licensing or acquiring development programs from third parties in order to obtain additional product candidates.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
in the future we decide to further expand our pipeline, we will be dependent on identifying drugs that are off patent or on in-licensing
or acquiring product candidates as we do not have significant internal discovery capabilities at this time. We may face substantial competition
from other biotechnology and pharmaceutical companies, many of which may have greater resources then we have, in obtaining in-licensing,
sponsored research or acquisition opportunities. In-licensing or acquisition opportunities may not be available to us on terms we find
acceptable, if at all. In-licensed compounds that appear promising in research or in preclinical studies may fail to progress into further
preclinical studies or clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
a product liability claim is successfully brought against us for uninsured liabilities, or such claim exceeds our insurance coverage,
we could be forced to pay substantial damage awards that could materially harm our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
use of any of our existing or future product candidates in clinical trials and the sale of any approved pharmaceutical products may expose
us to significant product liability claims. We have product liability insurance coverage for our proposed clinical trials; however, such
insurance coverage may not protect us against any or all of the product liability claims that may be brought against us now or in the
future. We may not be able to acquire or maintain adequate product liability insurance coverage at a commercially reasonable cost or
in sufficient amounts or scope to protect us against potential losses. In the event a product liability claim is brought against us,
we may be required to pay legal and other expenses to defend the claim, as well as uncovered damage awards resulting from a claim brought
successfully against us. In the event our product candidate is approved for sale by the FDA and commercialized, we may need to substantially
increase the amount of our product liability coverage. Defending any product liability claim or claims could require us to expend significant
financial and managerial resources, which could have an adverse effect on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may delay or terminate the development of our product candidates at any time if we believe the perceived market or commercial opportunity
does not justify further investment, which could materially harm our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
though the results of preclinical studies and clinical trials that have been conducted or may be conducted in the future may support
further development of our product candidates, we may delay, suspend or terminate the future development of a product candidate at any
time for strategic, business, financial or other reasons, including the determination or belief that the emerging profile of the product
candidate is such that it may not receive FDA approval, gain meaningful market acceptance, generate a significant return to shareholders,
or otherwise provide any competitive advantages in its intended indication or market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
future success depends on our ability to retain our key personnel and to attract, retain and motivate qualified personnel.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are highly dependent on the development, regulatory, commercialization, and business development expertise of Shaun Bagai, our Chief
Executive Officer, as well as the other principal members of our management, scientific and clinical teams. Although we have employment
agreements, offer letters or consulting agreements with our executive officers, these agreements do not prevent them from terminating
their services at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we lose one or more of our executive officers or key employees, our ability to implement our business strategy successfully could be
seriously harmed. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of time
because of the limited number of individuals in our industry with the breadth of skills and experience required to successfully develop
product candidates, gain regulatory approval, and commercialize new products. Competition to hire from this limited pool is intense,
and we may be unable to hire, train, retain or motivate these additional key personnel on acceptable terms given the competition among
numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific
and clinical personnel from universities and research institutions. In addition, we rely on consultants and advisors, including scientific
and clinical advisors, to assist us in formulating our research and development and commercialization strategy. Our consultants and advisors
may be engaged by entities other than us and may have commitments under consulting or advisory contracts with other entities that may
limit their availability to us. If we are unable to continue to attract and retain highly qualified personnel, our ability to develop
and commercialize product candidates will be limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will need to increase the size of our organization, and we may experience difficulties in managing growth.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a small company with 6 employees as of April 30, 2021. Future growth of our company will impose significant additional
responsibilities on members of management, including the need to identify, attract, retain, motivate and integrate highly skilled personnel.
We may increase the number of employees in the future depending on the progress of our development and commercialization of our product
candidates. Our future financial performance and our ability to commercialize our product candidate and to compete effectively will depend,
in part, on our ability to manage any future growth effectively. To that end, we must be able to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">manage
                                            our clinical studies effectively;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">integrate
                                            additional management, administrative, manufacturing, and regulatory personnel;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintain
                                            sufficient administrative, accounting and management information systems and controls; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">hire
                                            and train additional qualified personnel.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no guarantee that we will be able to accomplish these tasks, and our failure to accomplish any of them could materially adversely
affect our business, prospects, and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Business
disruptions could seriously harm future revenue and financial condition and increase our costs and expenses.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations, and those of our third-party manufacturers, contract research organizations, or CROs, and other contractors and consultants,
could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires,
extreme weather conditions, medical epidemics and other natural or man-made disasters or business interruptions, for which we are predominantly
self-insured. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase
our costs and expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
corporate headquarters are located in Silicon Valley, California, an area prone to wildfires and earthquakes. These and other natural
disasters could severely disrupt our operations, and have a material adverse effect on our business, results of operations, financial
condition and prospects. If a natural disaster, power outage or other event occurred that prevented us from using all or a significant
portion of our headquarters, that damaged critical infrastructure, such as the manufacturing facilities of our third-party contract manufacturers,
or that otherwise disrupted operations, it may be difficult or, in certain cases, impossible for us to continue our business for a substantial
period of time. Any disaster recovery and business continuity plans we have in place may prove inadequate in the event of a serious disaster
or similar event. We may incur substantial expenses as a result of the limited nature of our disaster recovery and business continuity
plans, which, could have a material adverse effect on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Security
threats to our information technology infrastructure and/or our physical buildings could expose us to liability and damage our reputation
and business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is essential to our business strategy that our and our vendors, partners, clinical trial sites, and third-party providers&rsquo; technology
and network infrastructure and physical buildings remain secure and are perceived by our customers and corporate partners to be secure.
Despite security measures, however, any network infrastructure may be vulnerable to cyber-attacks by hackers and other security threats.
We may face cyber-attacks that attempt to penetrate our network security, sabotage, or otherwise disable our research and development
activities, products and services, misappropriate our or our customers&rsquo; and partners&rsquo; proprietary information, which may
include personally identifiable information, or cause interruptions of our internal systems and services. Despite security measures,
we also cannot guarantee security of our physical buildings. Physical building penetration or any cyber-attacks could negatively affect
our reputation, damage our network infrastructure and our ability to deploy our products and services, harm our relationship with customers
and partners that are affected, and expose us to financial liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
there are a number of state, federal, and international laws protecting the privacy and security of health information and personal data.
For example, the Health Insurance Portability and Accountability Act of 1996 (&ldquo;HIPAA&rdquo;) imposes limitations on the use and
disclosure of an individual&rsquo;s healthcare information by healthcare providers, healthcare clearinghouses, and health insurance plans,
or, collectively, covered entities, and also grants individuals rights with respect to their health information. HIPAA also imposes compliance
obligations and corresponding penalties for non-compliance on individuals and entities that provide services to healthcare providers
and other covered entities. As part of the American Recovery and Reinvestment Act of 2009 (&ldquo;ARRA&rdquo;), the privacy and security
provisions of HIPAA were amended. ARRA also made significant increases in the penalties for improper use or disclosure of an individual&rsquo;s
health information under HIPAA and extended enforcement authority to state attorneys general. As amended by ARRA and subsequently by
the final omnibus rule adopted in 2013, HIPAA also imposes notification requirements on covered entities in the event that certain health
information has been inappropriately accessed or disclosed: notification requirements to individuals, federal regulators, and in some
cases, notification to local and national media. Notification is not required under HIPAA if the health information that is improperly
used or disclosed is deemed secured in accordance with encryption or other standards developed by the U.S. Department of Health and Human
Services. Most states have laws requiring notification of affected individuals and/or state regulators in the event of a breach of personal
information, which is a broader class of information than the health information protected by HIPAA. Many state laws impose significant
data security requirements, such as encryption or mandatory contractual terms, to ensure ongoing protection of personal information.
Activities outside of the U.S. implicate local and national data protection standards, impose additional compliance requirements, and
generate additional risks of enforcement for non-compliance. We may be required to expend significant capital and other resources to
ensure ongoing compliance with applicable privacy and data security laws, to protect against security breaches and hackers or to alleviate
problems caused by such breaches.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
and our third-party contract manufacturers must comply with environmental, health and safety laws and regulations, and failure to comply
with these laws and regulations could expose us to significant costs or liabilities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
and our third-party manufacturers are subject to numerous environmental, health and safety laws and regulations, including those governing
laboratory procedures and the use, generation, manufacture, distribution, storage, handling, treatment, remediation and disposal of hazardous
materials and wastes. Hazardous chemicals, including flammable and biological materials, are involved in certain aspects of our business,
and we cannot eliminate the risk of injury or contamination from the use, generation, manufacture, distribution, storage, handling, treatment
or disposal of hazardous materials and wastes. In the event of contamination or injury, or failure to comply with environmental, health
and safety laws and regulations, we could be held liable for any resulting damages and any such liability could exceed our assets and
resources. We could also incur significant costs associated with civil or criminal fines and penalties for failure to comply with such
laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we maintain workers&rsquo; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting
from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain
insurance for environmental liability or toxic tort claims that may be asserted against us in connection with our storage or disposal
of biological, hazardous or radioactive materials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental,
health and safety laws and regulations are becoming increasingly more stringent. We may incur substantial costs in order to comply with
current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our
research, development or production efforts. Our failure to comply with these laws and regulations also may result in substantial fines,
penalties or other sanctions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
with respect to the operations of our third-party contract manufacturers, it is possible that if they fail to operate in compliance with
applicable environmental, health and safety laws and regulations or properly dispose of wastes associated with our products, we could
be held liable for any resulting damages, suffer reputational harm or experience a disruption in the manufacture and supply of our product
candidates or products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>A
variety of risks associated with operating internationally could materially adversely affect our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doing
business internationally involves a number of risks, including but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">multiple,
                                            conflicting and changing laws and regulations, such as privacy regulations, tax laws, export
                                            and import restrictions, employment laws, regulatory requirements and other governmental
                                            approvals, permits and licenses;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            by us to obtain and maintain regulatory approvals for the use of our products in various
                                            countries;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additional
                                            potentially relevant third-party patent rights;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">complexities
                                            and difficulties in obtaining protection and enforcing our intellectual property;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
                                            in staffing and managing foreign operations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">complexities
                                            associated with managing multiple payor reimbursement regimes, government payors or patient
                                            self-pay systems;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limits
                                            in our ability to penetrate international markets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">financial
                                            risks, such as longer payment cycles, difficulty collecting accounts receivable, the impact
                                            of local and regional financial crises on demand and payment for our products and exposure
                                            to foreign currency exchange rate fluctuations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">natural
                                            disasters, political and economic instability, including wars, terrorism and political unrest,
                                            outbreak of disease, boycotts, curtailment of trade and other business restrictions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">certain
                                            expenses including, among others, expenses for travel, translation, and insurance; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
                                            and compliance risks that relate to maintaining accurate information and control over sales
                                            and activities that may fall within the purview of the U.S. Foreign Corrupt Practices Act,
                                            its books and records provisions, or its anti-bribery provisions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of these factors could significantly harm any current or future international operations and, consequently, our results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>General
economic or business conditions may have a negative impact on our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuing
concerns over U.S. healthcare reform legislation and energy costs, geopolitical issues, the availability and cost of credit and government
stimulus programs in the U.S. and other countries have contributed to increased volatility. If the economic climate deteriorates or is
poor, our business, as well as the financial condition of our suppliers and our third-party payors, could be negatively impacted, which
could materially adversely affect our business, prospects and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Healthcare
reform measures could adversely affect our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States and foreign jurisdictions, there have been, and continue to be, a number of legislative and regulatory changes and
proposed changes to the healthcare system that could affect our future results of operations. In particular, there have been and continue
to be a number of initiatives at the U.S. federal and state levels that seek to reduce healthcare costs. In 2010, the Patient Protection
and Affordable Care Act (the &ldquo;PPACA&rdquo;) was enacted, which includes measures to significantly change the way healthcare is
financed by both governmental and private insurers. Among the provisions of the PPACA of greatest importance to the pharmaceutical and
biotechnology industry are the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            annual, nondeductible fee on any entity that manufactures or imports certain branded prescription
                                            drugs and biologic agents, apportioned among these entities according to their market share
                                            in certain government healthcare programs;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">implementation
                                            of the federal physician payment transparency requirements, sometimes referred to as the
                                            &ldquo;Physician Payments Sunshine Act&rdquo;;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            licensure framework for follow-on biologic products;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and
                                            conduct comparative clinical effectiveness research, along with funding for such research;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishment
                                            of a Center for Medicare Innovation at the Centers for Medicare &amp; Medicaid Services to
                                            test innovative payment and service delivery models to lower Medicare and Medicaid spending,
                                            potentially including prescription drug spending;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug
                                            Rebate Program, to 23.1% and 13% of the average manufacturer price for most branded and generic
                                            drugs, respectively and capped the total rebate amount for innovator drugs at 100% of the
                                            AMP;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program
                                            are calculated for certain drugs and biologics, including our product candidates, that are
                                            inhaled, infused, instilled, implanted or injected;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">extension
                                            of manufacturers&rsquo; Medicaid rebate liability to covered drugs dispensed to individuals
                                            who are enrolled in Medicaid managed care organizations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expansion
                                            of eligibility criteria for Medicaid programs by, among other things, allowing states to
                                            offer Medicaid coverage to additional individuals and by adding new mandatory eligibility
                                            categories for individuals with income at or below 133% of the federal poverty level, thereby
                                            potentially increasing manufacturers&rsquo; Medicaid rebate liability;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            new Medicare Part D coverage gap discount program, in which manufacturers must agree to offer
                                            50% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries
                                            during their coverage gap period, as a condition for the manufacturer&rsquo;s outpatient
                                            drugs to be covered under Medicare Part D; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expansion
                                            of the entities eligible for discounts under the Public Health program.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of the provisions of the PPACA have yet to be implemented, and there have been legal and political challenges to certain aspects
of the PPACA. During President Trump&rsquo;s administration, he signed two executive orders and other directives designed to delay,
circumvent, or loosen certain requirements mandated by the PPACA. Concurrently, Congress has considered legislation that would
repeal or repeal and replace all or part of the PPACA. While Congress has not passed repeal legislation, the PPACA includes
a provision repealing, effective January 1, 2019, the tax-based shared responsibility payment imposed by the PPACA on certain
individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &ldquo;individual
mandate&rdquo;. Congress may consider other legislation to repeal or replace elements of the PPACA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of the details regarding the implementation of the PPACA are yet to be determined, and at this time, the full effect that the PPACA would
have on our business remains unclear.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Individual
states have become increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical product
pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access, and marketing cost
disclosure and transparency measures, and to encourage importation from other countries and bulk purchasing. Legally mandated price controls
on payment amounts by third-party payors or other restrictions could harm our business, results of operations, financial condition and
prospects. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine
what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. This could
reduce ultimate demand for our products or put pressure on our product pricing, which could negatively affect our business, results of
operations, financial condition and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, given recent federal and state government initiatives directed at lowering the total cost of healthcare, Congress and state
legislatures will likely continue to focus on healthcare reform, the cost of prescription drugs and biologics and the reform of the Medicare
and Medicaid programs. While we cannot predict the full outcome of any such legislation, it may result in decreased reimbursement for
drugs and biologics, which may further exacerbate industry-wide pressure to reduce prescription drug prices. This could harm our ability
to generate revenues. Increases in importation or re-importation of pharmaceutical products from foreign countries into the United States
could put competitive pressure on our ability to profitably price our products, which, in turn, could adversely affect our business,
results of operations, financial condition and prospects. We might elect not to seek approval for or market our products in foreign jurisdictions
in order to minimize the risk of re-importation, which could also reduce the revenue we generate from product sales. It is also possible
that other legislative proposals having similar effects will be adopted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
regulatory authorities&rsquo; assessment of the data and results required to demonstrate safety and efficacy can change over time and
can be affected by many factors, such as the emergence of new information, including on other products, changing policies and agency
funding, staffing and leadership. We cannot be sure whether future changes to the regulatory environment will be favorable or unfavorable
to our business prospects. For example, average review times at the FDA for marketing approval applications can be affected by a variety
of factors, including budget and funding levels and statutory, regulatory and policy changes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
outbreak of the novel coronavirus disease, COVID-19, could materially adversely impact our business, results of operations and financial
condition, including our clinical trials.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2020, the World Health Organization declared the outbreak of COVID-19 as a &ldquo;Public Health Emergency of International Concern,&rdquo;
which continues to spread throughout the world and has adversely impacted global commercial activity and contributed to significant volatility
in financial markets. The COVID-19 outbreak and government responses are creating disruption in global supply chains and adversely impacting
many industries. The outbreak could have a continued material adverse impact on economic and market conditions. We continue to monitor
the impact of the COVID-19 outbreak closely. The extent to which the COVID-19 outbreak will impact our operations or financial results
is uncertain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
outbreak and government measures taken in response have also had a significant impact, both direct and indirect, on businesses and commerce,
as worker shortages have occurred; supply chains have been disrupted; activity at facilities and production have been suspended; and
demand for certain goods and services, such as medical services and supplies, has spiked, while demand for other goods and services,
such as travel, has fallen. While the extent of the impact of the COVID-19 pandemic on our business and financial results is uncertain,
a continued and prolonged public health crisis such as the COVID-19 pandemic could have a material adverse effect on our business, financial
condition and results of operations. As a result of the COVID-19 pandemic, we may experience disruptions that could severely impact our
business and clinical trials, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                            or difficulties in enrolling and retaining patients in our clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
                                            or difficulties in clinical site initiation, including difficulties in recruiting clinical
                                            site investigators and clinical site staff;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">diversion
                                            of healthcare resources away from the conduct of clinical trials, including the diversion
                                            of hospitals serving as our clinical trial sites and hospital staff supporting the conduct
                                            of our clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interruption
                                            of key clinical trial activities, such as clinical trial site data monitoring, due to limitations
                                            on travel imposed or recommended by federal or state governments, employers and others or
                                            interruption of clinical trial subject visits and study procedures (such as endoscopies that
                                            are deemed non-essential), which may impact the integrity of subject data and clinical study
                                            endpoints;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interruption
                                            or delays in the operations of the FDA or other regulatory authorities, which may impact
                                            review and approval timelines;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interruption
                                            of, or delays in receiving, supplies of our product candidates from our contract manufacturing
                                            organizations due to staffing shortages, production slowdowns or stoppages and disruptions
                                            in delivery systems;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
                                            on employee and consulting resources that would otherwise be focused on the conduct of our
                                            clinical trials, including because of sickness of employees, consultants or their families
                                            or the desire of employees or consultants to avoid contact with large groups of people;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interruption
                                            or delays to our outsourced clinical activities; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in clinical site procedures and requirements as well as regulatory requirements for conducting
                                            clinical trials during the pandemic.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be required to develop and implement additional clinical trial policies and procedures designed to help protect subjects from the
COVID-19 virus. For example, in March 2020, the FDA issued guidance, which FDA subsequently updated, on conducting clinical trials during
the pandemic, which describes a number of considerations for sponsors of clinical trials impacted by the pandemic, including the requirement
to include in the clinical trial report contingency measures implemented to manage the trial, and any disruption of the trial as a result
of the COVID-19 pandemic; a list of all subjects affected by the COVID-19 pandemic related study disruption by unique subject identifier
and by investigational site and a description of how the individual&rsquo;s participation was altered; and analyses and corresponding
discussions that address the impact of implemented contingency measures (e.g., participant discontinuation from investigational product
and/or study, alternative procedures used to collect critical safety and/or efficacy data) on the safety and efficacy results reported
for the trial.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
COVID-19 pandemic continues to evolve rapidly, with the status of operations and government restrictions evolving weekly. The extent
to which the outbreak impacts our business and clinical trials will depend on future developments, which are highly uncertain and cannot
be predicted with confidence, such as the duration of the pandemic, travel restrictions and social distancing in the United States and
other countries, business closures or business disruptions and the effectiveness of actions taken in the United States and other countries
to contain and treat the disease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ultimate impact of the COVID-19 pandemic on our business operations is highly uncertain and subject to change and will depend on future
developments, which cannot be accurately predicted, including the duration of the pandemic, the ultimate geographic spread of the disease,
additional or modified government actions, new information that will emerge concerning the severity and impact of COVID-19 and the actions
taken to contain COVID-19, including vaccination efforts, or address its impact in the short and long term, among others. We do not yet
know the full extent of potential delays or impacts on our business, our clinical trials, our research programs, healthcare systems or
the global economy. We will continue to monitor the situation closely.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our business could be materially adversely affected by other business disruptions to us or our third-party providers that could
materially adversely affect our potential future revenue and financial condition and increase our costs and expenses. Our operations,
and those of our CROs, third party manufacturers, and other contractors, consultants and third parties could be subject to other global
pandemics, earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather
conditions, medical epidemics and other natural or man-made disasters or business interruptions, for which we are predominantly self-insured.
The occurrence of any of these business disruptions could materially adversely affect our operations and financial condition and increase
our costs and expenses. We rely on third-party manufacturers to produce and process our product candidate. Our ability to obtain clinical
supplies of our product candidates could be disrupted if the operations of these suppliers are affected by a man-made or natural disaster
or other business interruption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Intellectual Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unable to protect our intellectual property effectively, we may be unable to prevent third parties from using our technologies,
which would impair our competitive advantage.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on patent protection as well as a combination of trademark, copyright and trade secret protection, and other contractual restrictions,
to protect our proprietary technologies, all of which provide limited protection and may not adequately protect our rights or permit
us to gain or keep any competitive advantage. We may not be successful in defending challenges made in connection with our patents and
patent applications. If we fail to protect our intellectual property, we will be unable to prevent third parties from using our technologies
and they will be able to compete more effectively against us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to our patents, we rely on contractual restrictions to protect our proprietary technology. We require our employees and third
parties to sign confidentiality agreements and our employees are also required to sign agreements assigning to us all intellectual property
arising from their work for us. Nevertheless, we cannot guarantee that these measures will be effective in protecting our intellectual
property rights. Any failure to protect our intellectual property rights could materially adversely affect our business, prospects and
financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
currently pending or future patent applications may not result in issued patents and any patents issued to us may be challenged, invalidated,
or held unenforceable. Furthermore, we cannot be certain that we were the first to make the invention claimed in our issued patents or
pending patent applications in the U.S., or that we were the first to file for protection of the inventions claimed in our foreign issued
patents or pending patent applications. In addition, there are numerous recent changes to the patent laws and proposed changes to the
rules of the USPTO, which may have a significant impact on our ability to protect our technology and enforce our intellectual property
rights. For example, in September 2011, the U.S. enacted sweeping changes to the U.S. patent system under the Leahy-Smith America Invents
Act, including changes that transitioned the U.S. from a &ldquo;first-to-invent&rdquo; system to a &ldquo;first-to-file&rdquo; system
and alter the processes for challenging issued patents. These changes could increase the uncertainties and costs surrounding the prosecution
of our patent applications and the enforcement or defense of our issued patents. In addition, we may become subject to interference proceedings
conducted in the patent and trademark offices of various countries to determine our entitlement to patents, and these proceedings may
conclude that other patents or patent applications have priority over our patents or patent applications. It is also possible that a
competitor may successfully challenge our patents through various proceedings and those challenges may result in the elimination or narrowing
of our patents, and therefore reduce our patent protection. Accordingly, rights under any of our issued patents, patent applications
or future patents may not provide us with commercially meaningful protection for our products or afford us a commercial advantage against
our competitors or their competitive products or processes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest
and our business may be adversely affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
unregistered trademarks or trade names may be challenged, infringed, circumvented, or declared generic or determined to be infringing
on other marks. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition
among potential collaborators or customers in our markets of interest. At times, competitors may adopt trade names or trademarks similar
to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential
trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations
of our unregistered trademarks or trade names. Over the long term, if we are unable to successfully register our trademarks and trade
names and establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively, and our
business may be adversely affected. Our efforts to enforce or protect our proprietary rights related to trademarks, trade secrets, domain
names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources
and could adversely impact our financial condition or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
patents issued to us may not be broad enough to provide any meaningful protection, one or more of our competitors may develop more effective
technologies, designs or methods without infringing our intellectual property rights and one or more of our competitors may design around
our proprietary technologies.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are not able to protect our proprietary technology, trade secrets and know-how, our competitors may use our inventions to develop
competing products. Our patents may not protect us against our competitors, and patent litigation is very expensive. We may not have
sufficient cash available to pursue any patent litigation to its conclusion because we currently do not generate revenues other than
licensing, milestone and royalty income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot rely solely on our current patents to be successful. The standards that the USPTO and foreign patent offices use to grant patents,
and the standards that U.S. and foreign courts use to interpret patents, are not the same, are not always applied predictably or uniformly
and can change, particularly as new technologies develop. As such, the degree of patent protection obtained in the U.S. may differ substantially
from that obtained in various foreign countries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot be certain of the level of protection, if any, that will be provided by our patents if they are challenged in court, where our
competitors may raise defenses such as invalidity, unenforceability, or possession of a valid license. In addition, the type and extent
of any patent claims that may be issued to us in the future are uncertain. Any patents that are issued may not contain claims that will
permit us to stop competitors from using similar technology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may incur substantial costs as a result of litigation or other proceedings relating to patent and other intellectual property rights.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
parties may challenge the validity, inventorship or ownership of our patents and other intellectual property rights, resulting in costly
litigation or other time-consuming and expensive proceedings, which could deprive us of valuable rights. If we become involved in any
intellectual property litigation, interference or other judicial or administrative proceedings, we will incur substantial expenses and
the attention of our technical and management personnel will be diverted. An adverse determination may subject us to significant liabilities
or require us to seek licenses that may not be available from third parties on commercially favorable terms, if at all. Further, if such
claims are proven valid, through litigation or otherwise, we may be required to pay substantial monetary damages, which can be tripled
if the infringement is deemed willful, or be required to discontinue or significantly delay development, marketing, selling and licensing
of the affected products and intellectual property rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
competitors may have filed, and may in the future file, patent applications covering technology similar to ours. Any such patent application
may have priority over our patent applications and could further require us to obtain rights to issued patents covering such technologies.
There may be third-party patents, patent applications and other intellectual property relevant to our potential products that may block
or compete with our potential products or processes. If another party has filed a U.S. patent application on inventions similar to ours,
we may have to participate in an interference proceeding declared by the USPTO to determine priority of invention in the U.S. The costs
of these proceedings could be substantial, and it is possible that such efforts would be unsuccessful, resulting in a loss of our U.S.
patent position with respect to such inventions. In addition, we cannot assure you that we would prevail in any of these suits or that
the damages or other remedies that we are ordered to pay, if any, would not be substantial. Claims of intellectual property infringement,
misappropriation or other violations against us may require us to enter into royalty or license agreements with third parties that may
not be available on acceptable terms, if at all. We may also be subject to injunctions against the further development and use of our
technology, which could materially adversely affect our business, prospects and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially
greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could materially adversely
affect our ability to raise the funds necessary to continue our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Obtaining
and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements
imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Periodic
maintenance fees on any issued patent are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime
of the patent. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary,
fee payment and other provisions during the patent application process and following the issuance of a patent. While an inadvertent lapse
can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in
which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of
patent rights in the relevant jurisdiction. Noncompliance events that could result in abandonment or lapse of a patent or patent application
include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure
to properly legalize and submit formal documents. In certain circumstances, even inadvertent noncompliance events may permanently and
irrevocably jeopardize patent rights. In such an event, our competitors might be able to enter the market, which would have a material
adverse effect on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
rely on confidentiality agreements to protect our trade secrets. If these agreements are breached by our employees or other parties,
our trade secrets may become known to our competitors.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on trade secrets which we seek to protect through confidentiality agreements with our employees and other parties. If these agreements
are breached, our competitors may obtain and use our trade secrets to gain a competitive advantage over us. We may not have any remedies
against our competitors and any remedies that may be available to us may not be adequate to protect our business or compensate us for
the damaging disclosure. In addition, we may have to expend resources to protect our interests from possible infringement by others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to this Offering and Our Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>No
active trading market for our common stock currently exists, and an active trading market may not develop.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to this offering, there has not been an active trading market for our common stock. If an active trading market for our common stock
does not develop following this offering, you may not be able to sell your shares quickly or at the market price. Our ability to raise
capital to continue to fund operations by selling shares of our common stock and our ability to acquire other companies or technologies
by using shares of our common stock as consideration may also be impaired. The initial public offering price of our common stock will
be determined by negotiations between us and the underwriters and may not be indicative of the market prices of our common stock that
will prevail in the trading market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
market price of our common stock may be volatile and fluctuate substantially, which could result in substantial losses for purchasers
of our common stock in this offering.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of our common stock is likely to be highly volatile and may be subject to wide fluctuations in response to a variety of
factors, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            delay in the commencement, enrollment and ultimate completion of our clinical trials;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            delay in submitting an NDA and any adverse development or perceived adverse development with
                                            respect to the FDA&rsquo;s review of that NDA;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            to successfully develop and commercialize RenovoGem;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
                                            to obtain additional funding;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
                                            or legal developments in the United States and other countries applicable to RenovoGem or
                                            any other product candidate;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
                                            regulatory decisions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in the structure of healthcare payment systems;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
                                            to obtain adequate product supply for RenovoGem, RenovoCath or any other product candidate,
                                            or the inability to do so at acceptable prices;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">introduction
                                            of new products, services or technologies by our competitors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            to meet or exceed financial projections we provide to the public;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            to meet or exceed the estimates and projections of the investment community;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in the market valuations of companies similar to ours;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">market
                                            conditions in the pharmaceutical and biotechnology sectors, and the issuance of new or changed
                                            securities analysts&rsquo; reports or recommendations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            of significant acquisitions, strategic collaborations, joint ventures or capital commitments
                                            by us or our competitors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                            lawsuits, including patent or stockholder litigation, and disputes or other developments
                                            relating to our proprietary rights, including patents, litigation matters and our ability
                                            to obtain patent protection for our technologies;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
                                            or departures of key scientific or management personnel;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
                                            of our common stock by us or our stockholders in the future;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">trading
                                            volume of our common stock;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                                            economic, industry and market conditions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">health
                                            epidemics and outbreaks, including the COVID-19 pandemic, or other natural or manmade disasters
                                            which could significantly disrupt our preclinical studies and clinical trials, and therefore
                                            our receipt of necessary regulatory approvals could be delayed or prevented; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            other factors described in this &ldquo;Risk Factors&rdquo; section.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market
prices of equity securities of many companies. These fluctuations have often been unrelated or disproportionate to the operating performance
of those companies. Broad market and industry factors, as well as general economic, political, regulatory and market conditions, may
negatively affect the market price of our common stock, regardless of our actual operating performance. The market price of our common
stock may decline below the initial public offering price, and you may lose some or all of your investment. In particular, stock markets
have experienced extreme volatility due to the ongoing COVID-19 pandemic and investor concerns and uncertainty related to the impact
of the pandemic on the economies of countries worldwide.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have broad discretion in the use of our cash and cash equivalents, including the net proceeds we receive in this offering, and may not
use them effectively. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management has broad discretion to use our cash and cash equivalents, including the net proceeds we receive in this offering, to fund
our operations and could spend these funds in ways that do not improve our results of operations or enhance the value of our common stock,
and you will not have the opportunity as part of your investment decision to assess whether the net proceeds are being used appropriately.
The failure by our management to apply these funds effectively could result in financial losses that could have a material adverse effect
on our business, cause the price of our common stock to decline. Pending their use to fund our operations, we may invest our cash and
cash equivalents, including the net proceeds from this offering, in a manner that does not produce income or that loses value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
could be subject to securities class action litigation.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the past, securities class action litigation has often been brought against companies following a decline in the market price of their
securities. This risk is especially relevant for us because biotechnology companies have experienced significant share price volatility
in recent years. If we face such litigation, it could result in substantial costs and a diversion of management&rsquo;s attention and
resources, which could harm our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, the market
price for the shares and trading volume could decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for our common stock will depend in part on the research and reports that securities or industry analysts publish about
us or our business. If research analysts do not establish and maintain adequate research coverage or if one or more of the analysts who
covers us downgrades our common stock or publishes inaccurate or unfavorable research about our business, the market price for our common
stock would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly,
we could lose visibility in the financial markets, which, in turn, could cause the market price or trading volume for our common stock
to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
do not expect to pay dividends in the foreseeable future after this offering, and you must rely on price appreciation of your shares
for return on your investment.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have paid no cash dividends on any class of our stock to date and we do not anticipate paying cash dividends in the near term. For the
foreseeable future, we intend to retain any earnings to finance the development and expansion of our business, and we do not anticipate
paying any cash dividends on our stock. Accordingly, investors must be prepared to rely on sales of their shares after price appreciation
to earn an investment return, which may never occur. Investors seeking cash dividends should not purchase our shares. Any determination
to pay dividends in the future will be made at the discretion of our board of directors and will depend on our results of operations,
financial condition, contractual restrictions, restrictions imposed by applicable law and other factors our board deems relevant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>As
our initial public offering price is substantially higher than our net tangible book value per share, you will experience immediate and
substantial dilution.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you purchase shares in this offering, you will pay more for your shares of common stock than the amount paid by our existing stockholders
for their shares on a per share basis. As a result, you will experience immediate and substantial dilution in net tangible book value
per share in relation to the price that you paid for your shares. We expect the dilution as a result of the offering and the automatic
conversion of all outstanding shares of our preferred stock, including the shares of preferred stock issuable upon the automatic conversion
of our outstanding convertible note immediately prior to the closing of this offering, to be $[ ] per share to new investors purchasing
our shares in this offering. In addition, you will experience further dilution to the extent that our shares are issued upon the exercise
of any warrants or exercise of stock options under any stock incentive plans. See &ldquo;Dilution&rdquo; for a more complete description
of how the value of your investment in our shares will be diluted upon completion of this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time
to new compliance initiatives and corporate governance practices.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company, and particularly after we no longer qualify as an emerging growth company, we will incur significant legal, accounting
and other expenses that we did not incur previously. The Sarbanes-Oxley Act of 2002 (&ldquo;SOX&rdquo;), the Dodd-Frank Wall Street Reform
and Consumer Protection Act, the listing requirements of Nasdaq, and other applicable securities rules and regulations impose various
requirements on U.S. reporting public companies, including the establishment and maintenance of effective disclosure and financial controls
and corporate governance practices. Our management and other personnel will need to devote a substantial amount of time to these compliance
initiatives. Moreover, these rules and regulations will increase our legal and financial compliance costs and will make some activities
more time-consuming and costly. For example, we expect that these rules and regulations may make it more expensive for us to obtain director
and officer liability insurance, which in turn could make it more difficult for us to attract and retain qualified senior management
personnel or members for our board of directors. In addition, these rules and regulations are often subject to varying interpretations,
and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies.
This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure
and governance practices. Pursuant to Section 404 of SOX (&ldquo;Section 404&rdquo;), we will be required to furnish a report by our
senior management on our internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we remain an emerging growth company, we will not be required to include an attestation report on internal control over financial reporting
issued by our independent registered public accounting firm. To prepare for eventual compliance with Section 404, once we no longer qualify
as an emerging growth company, we will be engaged in a process to document and evaluate our internal control over financial reporting,
which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside
consultants and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue
steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement
a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that
we will not be able to conclude, within the prescribed timeframe or at all, that our internal control over financial reporting is effective
as required by Section 404.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have identified material weaknesses in our internal control over financial reporting. Failure to maintain effective internal controls
could cause our investors to lose confidence in us and adversely affect the market price of our common stock. If our internal controls
are not effective, we may not be able to accurately report our financial results or prevent fraud.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
internal control over financial reporting is necessary for us to provide reliable financial reports in a timely manner. In connection
with the audit of our financial statements as of and for the years ended December 31, 2019 and 2020 and the review of our financial
statements for the three month periods ended March 31, 2020 and 2021, we identified material weaknesses in our internal control over
financial reporting. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting,
such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented
or detected on a timely basis. Specifically, we have determined that we lack a sufficient number of qualified accounting and financial
reporting personnel with an appropriate level of knowledge, training and experience to address complex accounting issues, sufficient
written policies and procedures for accounting and financial reporting in accordance with GAAP, and adequate management review controls.
In addition, we have determined that our financial statement close process includes significant control gaps mainly driven by the small
size of our accounting and finance staff and, as a result, a significant lack of appropriate segregation of duties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above material weaknesses could result in a misstatement of our account balances or disclosures that would result in a material misstatement
of our annual or interim financial statements that would not be prevented or detected. To address the material weaknesses, we have implemented,
and are continuing to implement, measures designed to improve internal control over financial reporting, including expanding our accounting
and finance team to add additional qualified accounting and finance resources, which may include third party consultants, and new financial
processes. We intend to continue to take steps to remediate the material weaknesses through the hiring or engagement of additional experienced
accounting and financial reporting personnel, formalizing documentation of policies and procedures and further evolving the accounting
processes, including implementing appropriate segregation of duties. We expect to incur additional costs to remediate these weaknesses,
including personnel, consulting and other costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may not be successful in implementing these changes or in developing other internal controls, which may undermine our ability to provide
accurate, timely and reliable reports on our financial and operating results. Further, we will not be able to fully assess whether the
steps we are taking will remediate the material weakness in our internal control over financial reporting until we have completed our
implementation efforts and sufficient time passes in order to evaluate their effectiveness. In addition, until we remediate these weaknesses,
or if we identify additional material weaknesses in our internal control over financial reporting, we may not detect errors on a timely
basis and our financial statements may be materially misstated. Moreover, in the future we may engage in business transactions, such
as acquisitions, reorganizations or implementation of new information systems that could negatively affect our internal control over
financial reporting and result in material weaknesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we identify new material weaknesses in our internal control over financial reporting, if we are unable to comply with the requirements
of Section 404 of the Sarbanes-Oxley Act in a timely manner, or if we are unable to assert that our internal control over financial reporting
is effective, we may be late with the filing of our periodic reports, investors may lose confidence in the accuracy and completeness
of our financial reports, and the market price of our common stock could be negatively affected. As a result of such failures, we could
also become subject to investigations by the stock exchange on which our securities are listed, the SEC, or other regulatory authorities,
and become subject to litigation from investors and stockholders, which could harm our reputation, financial condition or divert financial
and management resources from our core business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are an &ldquo;emerging growth company,&rdquo; and the reduced reporting requirements applicable to emerging growth companies may make
our common stock less attractive to investors.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &ldquo;emerging growth company,&rdquo; as defined in the Jumpstart Our Business Startups Act (&ldquo;the JOBS Act&rdquo;). For
as long as we continue to be an emerging growth company, we may take advantage of exemptions from various reporting requirements that
are applicable to other public companies that are not emerging growth companies, including exemption from compliance with the auditor
attestation requirements of Section 404, reduced disclosure obligations regarding executive compensation and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously
approved. We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth
anniversary of the closing of this offering, (b) in which we have total annual gross revenue of at least $1.07 billion or (c) in which
we are deemed to be a large accelerated filer, which means the market value of our common stock held by non-affiliates exceeds $700 million
as of the end of our prior second fiscal quarter, and (2) the date on which we have issued more than $1.0 billion in non-convertible
debt during the prior three-year period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, under the JOBS Act, emerging growth companies may delay adopting new or revised accounting standards until such time as those
standards apply to private companies. We may elect not to avail ourselves of this exemption from new or revised accounting standards
and, therefore, may be subject to the same new or revised accounting standards as other public companies that are not emerging growth
companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find
our common stock less attractive as a result, there may be a less active trading market for our common stock and our share price may
be more volatile.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Anti-takeover
provisions contained in our certificate of incorporation and bylaws to be adopted upon the closing of this offering, as well as provisions
of Delaware law, could impair a takeover attempt.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation, bylaws and Delaware law contain or will contain provisions which could have the effect of rendering more
difficult, delaying or preventing an acquisition deemed undesirable by our board of directors. Our corporate governance documents include
or will include provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">classifying
                                            our board of directors into three classes;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorizing
                                            &ldquo;blank check&rdquo; preferred stock, which could be issued by our board of directors
                                            without stockholder approval and may contain voting, liquidation, dividend, and other rights
                                            superior to our common stock;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limiting
                                            the liability of, and providing indemnification to, our directors and officers;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limiting
                                            the ability of our stockholders to call and bring business before special meetings;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">requiring
                                            advance notice of stockholder proposals for business to be conducted at meetings of our stockholders
                                            and for nominations of candidates for election to our board of directors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">controlling
                                            the procedures for the conduct and scheduling of board of directors and stockholder meetings;
                                            and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">providing
                                            our board of directors with the express power to postpone previously scheduled annual meetings
                                            and to cancel previously scheduled special meetings.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a Delaware corporation, we are also subject to provisions of Delaware law, including Section 203 of the Delaware General Corporation
law, which prevents some stockholders holding more than 15% of our outstanding common stock from engaging in certain business combinations
without approval of the holders of substantially all of our outstanding common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
provision of our certificate of incorporation, bylaws or Delaware law that has the effect of delaying or deterring a change in control
could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the
price that some investors are willing to pay for our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
certificate of incorporation, as amended, designates the Court of Chancery of the State of Delaware as the sole and exclusive forum for
certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders&rsquo; ability
to obtain a favorable judicial forum for disputes with us or our directors, officers or other employees.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation requires that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery
of the State of Delaware will, to the fullest extent permitted by law, be the sole and exclusive forum for each of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            derivative action or proceeding brought on our behalf;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            action asserting a claim for breach of any fiduciary duty owed by any director, officer or
                                            other employee of ours to the Company or our stockholders, creditors or other constituents;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            action asserting a claim against us or any director or officer of ours arising pursuant to,
                                            or a claim against us or any of our directors or officers, with respect to the interpretation
                                            or application of any provision of, the DGCL, our certificate of incorporation or bylaws;
                                            or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            action asserting a claim governed by the internal affairs doctrine;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provided,
that, if and only if the Court of Chancery of the State of Delaware dismisses any of the foregoing actions for lack of subject matter
jurisdiction, any such action or actions may be brought in another state court sitting in the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exclusive forum provision is limited to the extent permitted by law, and it will not apply to claims arising under the Securities Exchange
Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), or for any other federal securities laws which provide for exclusive federal
jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly,
both state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions
and the threat of inconsistent or contrary rulings by different courts, among other considerations, our second amended and restated certificate
of incorporation provides that the federal district courts of the United States of America will be the exclusive forum for resolving
any complaint asserting a cause of action arising under the Securities Act. While the Delaware courts have determined that such choice
of forum provisions are facially valid, a stockholder may nevertheless seek to bring such a claim arising under the Securities Act against
us, our directors, officers, or other employees in a venue other than in the federal district courts of the United States of America.
In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our second
amended and restated certificate of incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we believe this provision benefits us by providing increased consistency in the application of Delaware law in the types of lawsuits
to which it applies, this provision may limit or discourage a stockholder&rsquo;s ability to bring a claim in a judicial forum that it
finds favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and
our directors, officers and other employees. Alternatively, if a court were to find the choice of forum provision contained in our certificate
of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action
in other jurisdictions, which could adversely affect our business and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
note that there is uncertainty as to whether a court would enforce the provision and that investors cannot waive compliance with the
federal securities laws and the rules and regulations thereunder. Although we believe this provision benefits us by providing increased
consistency in the application of Delaware law in the types of lawsuits to which it applies, the provision may have the effect of discouraging
lawsuits against our directors and officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_004"></A>CAUTIONARY
STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains certain &ldquo;forward-looking statements&rdquo; with respect to our business, financial condition, liquidity and
results of operations. Words such as &ldquo;anticipates,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo; &ldquo;plans,&rdquo; &ldquo;predicts,&rdquo;
&ldquo;believes,&rdquo; &ldquo;seeks,&rdquo; &ldquo;estimates,&rdquo; &ldquo;could,&rdquo; &ldquo;would,&rdquo; &ldquo;will,&rdquo; &ldquo;may,&rdquo;
&ldquo;can,&rdquo; &ldquo;continue,&rdquo; &ldquo;potential,&rdquo; &ldquo;should,&rdquo; and the negative of these terms or other comparable
terminology often identify forward-looking statements. These forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties that could cause actual results to differ materially from the results contemplated by the forward-looking
statements. See &ldquo;Risk Factors&rdquo; beginning on page 9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    estimates regarding sufficiency of our cash resources, anticipated capital requirements and our need for additional financing; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    commencement of clinical trials and the results and timing of those clinical trials; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to successfully commercialize our product candidates and generate revenue; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">submission
    and timing of applications for regulatory approval and approval thereof; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to successfully negotiate and enter into agreements with distribution, strategic and corporate partners; and </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    estimates of potential market opportunities and our ability to successfully realize these opportunities. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of the important factors that will determine these results are beyond our ability to control or predict. You are cautioned not to put
undue reliance on any forward-looking statements, which speak only as of the date of this prospectus. Except as otherwise required by
law, we do not assume any obligation to publicly update or release any revisions to these forward-looking statements to reflect events
or circumstances after such applicable date or to reflect the occurrence of unanticipated events. You should, however, review the factors
and risks we describe in the &ldquo;Risk Factors&rdquo; section hereof beginning on page 9 and in reports we will file from time to time
with the SEC after the date of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="v_001"></A><FONT STYLE="font-size: 10pt"><B>MARKET
AND INDUSTRY DATA</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
obtained the industry, statistical and market data included in this prospectus from our own internal estimates and research as well as
from industry and general publications and research, surveys and studies conducted by third parties. All of the market data used in this
prospectus involve a number of assumptions and limitations, and the sources of such data cannot guarantee the accuracy or completeness
of such information. While we are not aware of any misstatements regarding the third-party information and we believe that each of these
studies and publications is reliable, the industry in which we operate is subject to a high degree of uncertainty and risk due to a variety
of important factors, including those described in the section titled &ldquo;Risk Factors.&rdquo; These and other factors could cause
results to differ materially from those expressed in the estimates made by third parties and by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_005"></A>TRADEMARKS,
SERVICE MARKS AND TRADE NAMES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own or have rights to use a number of registered and common law trademarks, service marks and/or trade names in connection with our business
in the United States and/or in certain foreign jurisdictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solely
for convenience, the trademarks, service marks, logos and trade names referred to in this prospectus are without the <SUP>&reg; </SUP>and
&trade; symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable
law, our rights or the rights of the applicable licensors to these trademarks, service marks and trade names. This prospectus contains
additional trademarks, service marks and trade names of others, which are the property of their respective owners. All trademarks, service
marks and trade names appearing in this prospectus are, to our knowledge, the property of their respective owners. We do not intend our
use or display of other companies&rsquo; trademarks, service marks, copyrights or trade names to imply a relationship with, or endorsement
or sponsorship of us by, any other companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have trademarks for the names RENOVORX, RENOVOGEM, RENOVOCATH, TAMP and DELIVERING THERAPY WHERE IT MATTERS. We have a trademark pending
for RenovoTAMP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_006"></A>USE
OF PROCEEDS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate that the net proceeds from this offering will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million
if the underwriter exercises its over-allotment option in full), after deducting the underwriting discount and estimated offering expenses
payable by us, based on an assumed initial public offering price of $[&nbsp;&nbsp;&nbsp;] per share (the midpoint of the price range
set forth on the cover of this prospectus).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately $8.4 million
  to fund our ongoing TIGeR-PaC Phase 3 clinical trial of RenovoGem in LAPC patients through mid 2023, including our planned interim
  analysis in our TIGeR-PaC Phase 3 clinical trial which we expect will take place in the second half of 2022; </FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">approximately $3.6 million to fund the
  launch of our planned BENEFICIAL Phase 2/3 clinical trial of RenovoGem in HCCA patients, which we expect to commence in the first half
  of 2022, through mid 2023; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the balance for working capital and general
  corporate purposes, including the costs of operating as a public company. </FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate that our current capital resources, along with the net proceeds from this offering, will be sufficient to fund our operating
expenses and capital expenditure requirements through mid 2023. However, the net proceeds from this offering, together with our current
cash, will not be sufficient for us to fund the development of RenovoGem through regulatory approval, and we will need to raise additional
capital to complete the development and commercialization of RenovoGem. At this time, we cannot predict with certainty the amount of
capital needed to complete the development and commercialization of RenovoGem, but we anticipate seeking additional capital in the future
to fund such capital needs through further equity offerings and/or debt borrowings. We cannot guarantee that we will be able to raise
additional capital on reasonable terms or at all.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may also use a portion of the net proceeds of this offering to acquire or invest in complementary businesses, products, or technologies,
or to obtain the right to use such complementary technologies. We have no commitments with respect to any acquisition or investment,
and we are not currently involved in any negotiations with respect to any such transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, we cannot specify with certainty all of the particular uses for the net proceeds to be received upon
the completion of this offering. The amounts and timing of our actual expenditures will depend on numerous factors, including the status
of our product development efforts, sales and marketing activities, technological advances, amount of cash generated or used by our operations
and competition. Accordingly, our management will have broad discretion in the application of the net proceeds and investors will be
relying on the judgment of our management regarding the application of the proceeds of this offering. Pending such use, we intend to
invest the net proceeds in interest-bearing investment-grade securities or government securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_007"></A>DIVIDEND
POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid cash dividends on our common stock. We currently intend to retain all available funds and any future earnings
for use in the operation of our business and do not anticipate paying any cash dividends on our common stock in the near future. We may
enter into credit agreements or other borrowing arrangements in the future that will restrict our ability to declare or pay cash dividends
on our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
future determination to declare dividends will be made at the discretion of our board of directors and will depend on our financial condition,
operating results, capital requirements, contractual restrictions, general business conditions and other factors that our board of directors
may deem relevant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_008"></A>CAPITALIZATION
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our total capitalization as of March 31, 2021:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
on an actual basis;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
on a pro forma basis giving effect to the automatic conversion of all outstanding shares of our preferred stock, including the shares
of preferred stock issuable upon the automatic conversion of our outstanding convertible note into [&nbsp;&nbsp;] shares of common stock
immediately prior to the closing of this offering;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
on a pro forma as adjusted basis giving further effect to the sale and issuance by us of [&nbsp;&nbsp;&nbsp;] shares of common stock
in this offering at the assumed initial public offering price of $[&nbsp;&nbsp;&nbsp;] per share (the midpoint of the price range set
forth on the cover of this prospectus) and after deducting underwriting discounts and commissions and estimated offering expenses payable
by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this table together with our financial statements, the related notes included elsewhere in this prospectus and the information
under &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="10" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March
    31, 2021</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Actual</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pro
    forma</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pro
    forma as adjusted</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="10" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
    thousands, except for share and per share data)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">837</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">837</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&nbsp;</FONT></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    note</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,843</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    preferred stock:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
    A-1 Preferred Stock, $0.0001 par value, 3,542,669 shares authorized and issued and outstanding, actual; no shares authorized or issued
    and outstanding, pro forma and pro forma as adjusted</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">639</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
    A-2 Preferred Stock, $0.0001 par value, 3,546,095 shares authorized and issued and outstanding, actual; no shares authorized or issued
    and outstanding, pro forma and pro forma as adjusted</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,099</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
    A-3 Preferred Stock, $0.0001 par value, 2,660,230 shares authorized and issued and outstanding, actual; no shares authorized or issued
    and outstanding, pro forma and pro forma as adjusted</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
    B Preferred Stock, $0.0001 par value, 12,611,461 shares authorized and 7,928,359 shares issued and outstanding, actual; no shares
    authorized or issued and outstanding, pro forma and pro forma as adjusted</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,547</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders&rsquo;
    (deficit) equity:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock, $0.0001 par value, 42,000,000 shares authorized and 11,415,994 shares issued and outstanding, actual; [&nbsp;&nbsp;]
    shares authorized, pro forma and pro forma as adjusted; [&nbsp;&nbsp;] shares issued and outstanding, pro forma; and [&nbsp;&nbsp;]&nbsp;&nbsp;shares
    issued and outstanding, pro forma as adjusted</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    paid-in capital</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">345</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,636</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    deficit</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16,108</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16,108</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    stockholders&rsquo; (deficit) equity </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15,762</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">531</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    capitalization</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,311</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">531</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
$1.00 increase (decrease) in the assumed initial public offering price of $[&nbsp;&nbsp;&nbsp;] per share, the midpoint of the price
range listed on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted amount of each of cash and cash
equivalents, working capital, total assets and total stockholders&rsquo; equity by approximately $[&nbsp;&nbsp;&nbsp;], assuming that
the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting
discounts and commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of [&nbsp;&nbsp;&nbsp;]
shares in the number of shares offered by us at the assumed initial public offering price of $[&nbsp;&nbsp;&nbsp;] per share, the midpoint
of the price range listed on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted amount of each of
cash and cash equivalents, working capital, total assets and total stockholders&rsquo; equity by approximately $[&nbsp;&nbsp;&nbsp;].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_009"></A>DILUTION
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you purchase shares of our common stock in this offering, your interest will be diluted to the extent of the difference between the initial
public offering price per share and our net tangible book value per share after this offering. Dilution results from the fact that the
assumed initial public offering price per share is substantially in excess of the net tangible book value per share attributable to the
existing stockholders for our presently outstanding common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net tangible book value (deficit) was approximately $(3.3) million or $(0.29) per share, as of March 31, 2021. Our
net tangible book value represents the amount of our total tangible assets (which is calculated by subtracting net intangible assets,
deferred tax assets, and prepaid offering expenses from our total assets), less the amount of our total liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
pro forma net tangible book value as of March 31, 2021, was $[&nbsp;&nbsp;&nbsp;] million, or $[&nbsp;&nbsp;&nbsp;] per share
of our common stock. Pro forma net tangible book value represents the amount of our total tangible assets less our total liabilities.
Pro forma net tangible book value per share represents pro forma net tangible book value divided by the total number of shares outstanding
as of March 31, 2021, after giving effect to the automatic conversion of all outstanding shares of our preferred stock, including
the shares of preferred stock issuable upon the automatic conversion of our outstanding convertible note into [&nbsp;&nbsp;&nbsp;] shares
of common stock immediately prior to the closing of this offering as if such conversions had occurred on March 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving further effect to the sale and issuance by us of [&nbsp;&nbsp;&nbsp;] shares of common stock in this offering at the assumed initial
public offering price of $[&nbsp;&nbsp;&nbsp;] per share, (the midpoint of the price range as set forth on the cover page of this prospectus),
after deducting underwriting discounts and commissions and estimated offering expenses payable by us, our pro forma as adjusted net tangible
book value as of March 31, 2021 would have been $[&nbsp;&nbsp;&nbsp;] or $[&nbsp;&nbsp;&nbsp;] per share. This represents an immediate
increase in pro forma net tangible book value of $[&nbsp;&nbsp;&nbsp;] per share to our existing stockholders, and an immediate dilution
in pro forma as adjusted net tangible book value of $[&nbsp;&nbsp;&nbsp;] per share to new investors. The following table illustrates
this per share dilution:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 68%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assumed
    initial public offering price per share</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Historical net tangible
    book value deficit per share as of March 31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.29</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase
    in net tangible book value per share attributable to pro forma adjustment described above</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pro forma as adjusted
    net tangible book value per share (deficit) as of March 31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase
    in pro forma net tangible book value per share attributable to this offering</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pro
    forma as adjusted net tangible book value per share, after this offering</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dilution
    per share to new investors in this offering</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the underwriter&rsquo;s over-allotment option is exercised in full, our pro forma as adjusted net tangible book value per share after
this offering would be $[&nbsp;&nbsp;&nbsp;] and dilution per share to new investors purchasing common stock in this offering would be
$[&nbsp;&nbsp;&nbsp;] at the assumed initial public offering price of $[&nbsp;&nbsp;&nbsp;] per share, (the midpoint of the price range
as set forth on the cover page of this prospectus) and after deducting the estimated underwriting discounts and commissions and estimated
offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma as adjusted information discussed above is illustrative only. Our pro forma as adjusted net tangible book value following the
completion of this offering is subject to adjustment based on the actual initial public offering price of our shares and other terms
of this offering determined at pricing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables summarize the differences between our existing stockholders and the investors purchasing shares in this offering with
respect to the number of shares purchased from us, the total consideration paid and the average price per share paid, at the assumed
initial public offering price of $[&nbsp;&nbsp;&nbsp;] per share, (the midpoint of the price range as set forth on the cover page of
this prospectus) before deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares
    Purchased</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Consideration</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Average
    Price</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Percent</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Percent</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">per
    Share</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 30%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,415,994</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">45,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    A-1 Preferred Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,542,669</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">660,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.19</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    A-2 Preferred Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,546,095</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,150,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.32</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    A-3 Preferred Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,660,230</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,100,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.79</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    B Preferred Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,928,359</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,308,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.05</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">New
    investors</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table above assumes no exercise of the underwriter&rsquo;s over-allotment option. If the underwriter&rsquo;s over-allotment option is
exercised in full, upon completion of this offering, the percentage of common stock held by existing holders would be reduced to [&nbsp;&nbsp;&nbsp;]%,
and the percentage of common stock held by new investors purchasing common stock in this offering would be increased to [&nbsp;&nbsp;&nbsp;]%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares outstanding is based on shares outstanding as of March 31, 2021 and except as noted above excludes the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
4,755,668 shares of our common stock issuable upon the exercise of outstanding options with a weighted-average exercise price
of $0.08 per share;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
3,542,669 shares of Series A-1 Preferred Stock, 3,546,095 shares of Series A-2 Preferred Stock, 2,660,230 shares of Series A-3 Preferred
Stock and 7,928,359 shares of Series B Preferred Stock which will convert into 3,542,669, 3,546,095, 2,660,230 and 7,928,359 shares of
common stock, respectively, upon the closing of this offering (the &ldquo;Preferred Stock Conversions&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
[&nbsp;&nbsp;&nbsp;] shares of common stock to be issued upon conversion of the March 2020 Notes upon the closing of this offering (the
&ldquo;Note Conversions&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
up to an additional [&nbsp;&nbsp;&nbsp;] shares of our common stock issuable under our 2013 Equity Incentive Plan; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
[&nbsp;&nbsp;&nbsp;] shares of our common stock underlying the warrants to be issued to the representative of the underwriter in connection
with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="n_002"></A><FONT STYLE="font-size: 10pt"><B>MANAGEMENT&rsquo;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Unless
the context otherwise requires, all references in this section to the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us, or &ldquo;our&rdquo;
refer to the business of RenovoRx, Inc. You should read the following discussion and analysis of our financial condition and results
of operations together with the &ldquo;Selected Financial Data&rdquo; section of this prospectus and our financial statements and the
related notes appearing elsewhere in this prospectus. This discussion contains forward-looking statements that reflect our plans, estimates,
and beliefs that involve risks and uncertainties. As a result of many factors, such as those set forth under the &ldquo;Risk Factors&rdquo;
and &ldquo;Special Note Regarding Forward-Looking Statements&rdquo; sections and elsewhere in this proxy statement/prospectus, our actual
results may differ materially from those anticipated in these forward-looking statements.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors and conducting
a Phase 3 registrational trial for our lead product candidate RenovoGem&trade;. Our therapy platform, RenovoRx Trans-Arterial Micro-Perfusion,
or RenovoTAMP&trade; utilizes approved chemotherapeutics with validated mechanisms of action and well-established safety and side effect
profiles, with the goal of increasing their efficacy, improving their safety, and widening their therapeutic window. RenovoTAMP combines
our patented FDA cleared delivery system, RenovoCath<SUP>&reg;</SUP>, with small molecule chemotherapeutic agents that can be forced
across the vessel wall using pressure, targeting these anti-cancer drugs locally to the solid tumors. While we anticipate investigating
other chemotherapeutic agents for intra-arterial delivery via RenovoTAMP, our clinical work to date has focused on gemcitabine, which
is a generic drug. Our first product candidate, RenovoGem, is a drug and device combination consisting of intra-arterial gemcitabine
and RenovoCath. FDA has determined that RenovoGem will be regulated as, and if approved we expect will be reimbursed as, a new oncology
drug product. We have secured FDA Orphan Drug Designation for RenovoGem in our first two indications: pancreatic cancer and cholangiocarcinoma
(bile duct cancer, or CCA). We have completed our RR1 Phase 1/2 and RR2 observational registry studies, with 20 and 25 patients respectively,
in locally advanced pancreatic cancer, or LAPC. These studies demonstrated a median overall survival of 27.9 months in patients treated
with RenovoGem and radiation. Based on previous large randomized clinical trials, the expected survival of LAPC patients is 12-15
months in patients receiving only intravenous (IV) systemic chemotherapy or IV chemotherapy plus radiation (which are both considered
standard of care). Unlike the randomized trials that established these standard-of-care results, our RR1 and RR2 clinical trials did
not prospectively control the standard of care therapy received prior to RenovoTAMP. Based on FDA safety review of our Phase 1/2
study the FDA allowed us to proceed to evaluate RenovoGem within our Phase 3 registration Investigational New Drug, or IND, clinical
trial. Our Phase 3 trial is 40% enrolled as of April 30, 2021 and we expect to report data from a planned interim data readout in the
second half of 2022. We intend to evaluate RenovoGem in a second indication in a Phase 2/3 trial in hilar CCA (cancer that occurs in
the bile ducts that lead out of the liver and join with the gallbladder, also called extrahepatic cholangiocarcinoma, or HCCA). We plan
to propose the trial to the FDA and potentially launch in the first half of 2022. In addition, we may evaluate RenovoGem in other indications,
potentially including locally advanced lung cancer, locally advanced uterine tumors, and glioblastoma (an aggressive type of cancer that
can occur in the brain or spinal cord). To date, we have used gemcitabine, but in the future we may develop other chemotherapeutic agents
for intra-arterial delivery via RenovoCath.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception, we have devoted substantially all of our efforts to developing our cancer therapy platform and product candidates, raising
capital and organizing and staffing our company. To date, we have funded our operations with proceeds from the issuance of convertible
preferred stock and convertible notes. Through March 31, 2021, we received total net proceeds of $15.0 million of which $11.8 million
was from the issuance of convertible preferred stock, $3.0 million from convertible notes and $140,000 from a loan under the Paycheck
Protection Program, or PPP. In April 2021, the Company entered into a series of convertible note agreements with certain current and
new investors to provide an aggregate $2.0 million in cash proceeds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred significant operating losses and generated negative cash flows from operations since our inception. As of March 31, 2021,
we had cash and cash equivalents of $837,000. We also had net losses of $1.1 million in each of the three months ended March 31, 2020
and March 31, 2021. As of March 31, 2021, we had an accumulated deficit of $16.1 million. We expect to continue to incur significant
expenses, increasing operating losses and negative cash flows from operations in 2021 and for the foreseeable future. We do not expect
to generate revenues from product sales unless and until we successfully complete development and obtain regulatory approval for one
or more product candidates. We expect that our expenses will increase substantially in connection with our ongoing research and development
activities, particularly as we:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance
                                            clinical development of RenovoGem and our platform technology by continuing to enroll patients
                                            in our ongoing TIGeR-PaC Phase 3 clinical trial, expanding the number of clinical trials
                                            including our planned clinical trial in HCCA, and advancing RenovoGem through preclinical
                                            and clinical development in additional indications;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hire
                                            additional research, development, and engineering personnel;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintain,
                                            expand, enforce, defend, and protect our intellectual property portfolio; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expand
                                            our operational, financial and management systems and increase personnel, including personnel
                                            to support our clinical development, manufacturing and commercialization efforts and our
                                            operations as a public company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the variables described above, if and when any of our product candidates successfully complete development, we will incur
substantial additional costs associated with establishing a sales, marketing, medical affairs and distribution infrastructure to commercialize
products for which we may obtain marketing approval, regulatory filings, marketing approval, and post-marketing requirements, in addition
to other commercial costs. We cannot reasonably estimate these costs at this time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, we will need significant additional funding to support our continuing operations. Until such time, if ever, as we can generate
substantial product revenue, we expect to finance our cash needs through equity issuances, debt financings and collaborations, licenses
or other similar arrangements. We currently have no credit facility or committed sources of capital. To the extent that we raise additional
capital through the future sale of equity or debt, the ownership interests of our stockholders will be diluted and the terms of these
securities may include liquidation or other preferences that adversely affect the rights of our existing common stockholders. If we raise
additional funds through the issuance of debt securities, these securities could contain covenants that would restrict our operations.
We may require additional capital beyond our currently anticipated amounts and additional capital may not be available on reasonable
terms, or at all. If we raise additional funds through collaboration arrangements or other strategic transactions in the future, we may
have to relinquish valuable rights to our technologies or future revenue streams or grant licenses on terms that may not be favorable
to us. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit,
reduce or terminate development or future commercialization efforts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
giving effect to the anticipated net proceeds from this offering, we expect that our existing cash on hand will be insufficient to fund
our operating expenses and capital expenditures for at least one year from the date of our financial statements. We will need to raise
additional capital to finance our operations, which cannot be assured. We have concluded that this circumstance raises substantial doubt
about our ability to continue as a going concern for at least one year from the date of issuance date of our financial statements. See
Note 2 to our audited financial statements and Note 2 to our unaudited interim condensed financial statements, each included elsewhere
in this prospectus, for additional information on our assessment. Similarly, our independent registered public accounting firm included
an explanatory paragraph in its report on our audited financial statements as of and for the year ended December 31, 2020, describing
the existence of substantial doubt about our ability to continue as a going concern.</FONT></P>
<P STYLE="margin-right: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="margin-right: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Impact
of COVID-19</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, a novel strain of coronavirus, which causes the disease known as COVID-19, was reported to have surfaced in Wuhan, China.
Since then, COVID-19 has spread globally. In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. The
ongoing COVID-19 global and national health emergency has caused significant disruption in the international and U.S. economies and financial
markets. The spread of COVID-19 has caused illness, quarantines, cancellation of events and travel, business and school shutdowns, reduction
in business activity and financial transactions, labor shortages, supply chain interruptions and overall economic and financial market
instability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
response to public health directives and orders and to help minimize the risk of the virus to employees, we have taken precautionary
measures, including implementing work-from home policies for certain employees. The COVID-19 global pandemic also has negatively affected,
and we expect will continue to negatively affect, our clinical studies. For example, we have faced challenges in conducting our clinical
trials, including recruiting subjects and accommodating patient visits. Additionally, our service providers and their operations may
be disrupted, temporarily closed or experience worker or supply shortages, which could result in additional disruptions or delays in
shipments of purchased materials or the continued development of our product candidates. To date, we have not suffered material supply
chain disruptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not able to estimate the duration of the pandemic and the potential impact on our business. As the global pandemic of COVID-19 continues
to evolve, it could result in significant long-term disruption of global financial markets, reducing our ability to raise additional
capital when needed and on acceptable terms, if at all, which could negatively affect our liquidity. The extent to which the COVID-19
pandemic impacts our clinical development and regulatory efforts will depend on future developments that are highly uncertain and cannot
be predicted with confidence, such as the ultimate geographic spread of the disease, the duration of the outbreak, travel restrictions,
quarantines and social distancing requirements in the United States and other countries, business closures or business disruptions and
the effectiveness of actions taken in the United States and other countries to contain and treat the virus. We will continue to monitor
the COVID-19 situation closely.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2020, we received $140,000 in funding as a promissory note under the PPP. This promissory note was subsequently
forgiven in February 2021. See Note 6 to the unaudited condensed interim financial statements appearing at the end of this
prospectus for additional information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Components
of Our Results of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenue</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not generated any revenue from product sales and do not expect to generate any revenue from the sale of products for several years,
if at all. If our development efforts for our current or future product candidates are successful and result in marketing approval or
collaboration or license agreements with third parties, we may generate revenue in the future from a combination of product sales or
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">payments from collaboration or license agreements that we may
enter into with third parties.</FONT></P>
<P STYLE="margin-right: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Operating
Expenses</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Research
and Development</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses consist of costs related to the research and development of our platform technology. Clinical trial costs are
a significant component of research and development expenses and include costs associated with third-party contractors. We outsource
a substantial portion of our clinical trial activities, utilizing the service of third-party clinical trial sites and contract research
organizations to assist us with the execution of our clinical trials. In addition, we have FDA 510(k) clearance for the RenovoCath delivery
device, which comprises part of the RenovoGem product. Accordingly, we were able to charge our clinical trial sites for the RenovoCath
delivery device. To date, proceeds from clinical trial sites have been adequate to cover our direct costs of manufacturing the RenovoCath
delivery devices for which they have paid. Any proceeds we receive from the clinical trial sites for their purchase of the RenovoCath
delivery device are offset against our research and development expenses. We expect our research and development expenses to increase
for the foreseeable future as we continue the development of our product candidates and enroll subjects in our ongoing clinical trials,
initiate future clinical trials and pursue regulatory approval of our product candidates. It is difficult to predict with any certainty
the duration and completion costs of our current or future clinical trials of our product candidates or if, when or to what extent we
will achieve regulatory approval and generate revenue from the commercialization and sale of our product candidates. The duration, costs
and timing of clinical trials and other development of our product candidates will depend on a variety of factors, including uncertainties
in clinical trial enrollment, timing and extent of future clinical trials, development of new product candidates and significant and
changing government regulation. We may never succeed in achieving regulatory approval for any of our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and development expenses include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses incurred under
  agreements with clinical trial sites, contract research organizations, and consultants that conduct our clinical trials,</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs of acquiring and
  developing clinical trial materials,</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">personnel costs, including
  salaries, benefits, bonuses, and stock-based compensation for employees engaged in preclinical and clinical research and development,</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs related to compliance
  with regulatory requirements,</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">travel expenses, and</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">facilities, insurance, and other allocated
  expenses which include direct and allocated expenses for rent, insurance and other general overhead costs.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred. Costs for certain development activities, such as clinical trials and preclinical studies,
are recognized based on evaluation of progress to completion of specific tasks using data such as subject enrollment, clinical site activations
or information provided to us by third party vendors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the impact of the COVID-19 pandemic and work-from-home policies and other operational limitations mandated by federal, state, and
local governments as a result of the pandemic, certain of our research and development activities have been delayed and may be further
delayed until such operational limitations are lifted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>General
and Administrative</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses consist of salaries, benefits, and stock-based compensation for personnel in executive, finance and administrative
functions, professional services and associated costs related to accounting, tax, audit, legal, intellectual property and other matters,
consulting costs, conferences, travel and allocated expenses for rent, insurance and other general overhead costs. Following the listing
of our common stock on Nasdaq, we expect to continue to incur additional expenses as a result of operating as a public company, including
costs to comply with the rules and regulations of the Securities and Exchange Commission, or SEC, and Nasdaq listing standards and increased
expenses in the areas of insurance, professional services and investor relations. As a result, we expect our general and administrative
expenses to increase for the foreseeable future. General and administrative expenses are expensed as incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
Income (Expense), Net</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Interest
Income (Expense) Net</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income (expense), net consists of interest income earned from our cash and cash equivalents net of interest expense. Interest expense
consists of charges relating to the amortization of the debt discount and debt issuance costs as well as interest on amounts outstanding
on our convertible notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Income (Expense), Net</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
income (expense), net comprise primarily investment expenses and foreign currency exchange gains and losses. We expect our foreign currency
exchange gains and losses to continue to fluctuate in the future due to changes in foreign currency exchange rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Gain
on Loan Extinguishment</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
on loan extinguishment resulted from the forgiveness and cancellation of the Company&rsquo;s PPP loan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Income
Tax Expense</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for income taxes using the asset and liability method. Under this method, deferred income tax assets and liabilities are recorded
based on the estimated future tax effects of differences between the financial statement and income tax basis of existing assets and
liabilities. Deferred income tax assets and liabilities are recorded net and classified as noncurrent on the balance sheets. A valuation
allowance is provided against our deferred income tax assets when their realization is not reasonably assured.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to income taxes in the federal and state jurisdictions. Tax regulations within each jurisdiction are subject to the interpretation
of the related tax laws and regulations and require significant judgment to apply. In accordance with the authoritative guidance on accounting
for uncertainty in income taxes, we recognize tax liabilities for uncertain tax positions when it is more likely than not that a tax
position will not be sustained upon examination and settlement with various taxing authorities. Liabilities for uncertain tax positions
are measured based upon the largest amount of benefit that is more-likely-than-not (greater than 50%) of being realized upon settlement.
Our policy is to recognize interest and/or penalties related to income tax matters in income tax expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, was enacted. The CARES Act includes several
significant provisions for corporations, including the usage of net operating losses, interest deductions and payroll benefits. Corporate
taxpayers may carryback net operating losses, or NOLs, originating during 2018 through 2020 for up to five years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the significant components of&nbsp;our results of operations for the periods presented (in thousands):</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Years
    Ended December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Three
    Months Ended March 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Statements of Operations Data:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">(unaudited)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating expenses:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 36%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Research
    and development</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,997</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,386</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">805</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">635</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">General
    and administrative</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">899</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">818</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">248</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">418</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    operating expenses</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,896</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,204</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,053</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,053</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss from operations</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,896</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,204</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,053</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,053</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other income (expense),
    net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest income (expense),
    net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">63</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(587</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(230</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other income (expense),
    net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss on change in fair
    value of warrant liability</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gain
    on loan extinguishment</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">140</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    other income (expense), net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">57</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(594</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(95</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,839</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,798</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,051</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,148</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Comparison
of the Three Months Ended March 31, 2020 and 2021</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our results of operations for the three months ended March 31, 2020 and 2021 (in thousands, except percentages):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Three
    Months Ended &nbsp;March 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">(unaudited)</FONT></TD><TD STYLE="text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating expenses:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 38%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Research
    and development</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">805</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">635</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(170</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(21</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">General
    and administrative</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">248</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">418</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">170</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">69</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    operating expenses</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,053</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,053</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss from operations</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,053</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,053</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other income (expense), net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest income (expense),
    net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(230</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(232</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(116</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other expense, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gain
    on loan extinguishment</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">140</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">140</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    other income (expense), net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(95</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(97</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,850</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,051</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,148</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">97</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Research
and Development</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses decreased $170,000, or 21%, in the three months ended March&nbsp;31, 2021 compared to the three months ended
March 31, 2020. This decrease was due a reduction of $50,000 in clinical development spending related to travel and off-site meetings
due to the COVID-19 pandemic, a $42,000 reduction in expenses for preclinical studies due to the completion of sample analysis activities,
and a $12,000 reduction in regulatory expenses due to lower support for European filings and vendor audits. Also contributing to the
decrease in research and development expense was an increase of $45,000 in offsetting clinical supply usage and corresponding vendor
payments from clinical trial sites. Vendor payments for delivery devices represents the cash payment made by vendors for the RenovoCath
delivery devices used in clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>General
and Administrative Expenses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses increased $170,000, or 69%, in the three months ended March 31, 2021 compared to the three months ended March
31, 2020. This increase was due to an increase in professional expenses of $285,000 primarily as a result of preparing for this offering
offset by a reduction in spending on legal costs of $68,000 due to reduced spending on intellectual property and a decrease of $37,000
in executive-level clinical support costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Interest
Income (Expense), Net</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
interest expense for the three-month period ended March 31, 2021 comprises both the stated interest on the note of 5% per annum, or $37,000,
as well as the amortization of the discount and debt issuance costs associated with the 2020 Convertible Notes of $193,000. Interest
income for the three months ended March 31, 2020 was de minimis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Expense, Net</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expense, net for the three months ended March 31, 2021 was de minimis. There was no other expense for the three months ended March 31,
2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 1, 2021, the Company entered into an amendment to the 2020 Convertible Notes which extends the maturity date of the 2020 Convertible
Notes from March 31, 2021 to October 30, 2021 and provides for the conversion of the 2020 Convertible Notes into shares of the Company&rsquo;s
common stock upon a Qualified Financing. No other terms to the 2020 Convertible Notes were amended. This amendment was accounted for
as a troubled debt restructuring pursuant to FASB ASC Topic 470-60, &ldquo;<I>Troubled Debt Restructurings by Debtors</I>&rdquo;. As
the future undiscounted cash flows of the 2020 Convertible Notes were greater than their carrying amount, the carrying amount was not
adjusted and no gain was recognized as a result of the modification of terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Gain
on Loan Extinguishment</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
gain on loan extinguishment of $140,000 for the three months ended March 31, 2021 resulted from the forgiveness and cancellation of the
Company&rsquo;s PPP loan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Comparison
of the Years Ended December 31, 2019 and 2020 </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    Ended December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">(in thousands,
    except percentages)</FONT></TD><TD STYLE="text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating expenses:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 38%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Research
    and development</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,997</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,386</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(611</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(20</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">General
    and administrative</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">899</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">818</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(81</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(9</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    operating expenses</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,896</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,204</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(692</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(18</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss from operations</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,896</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,204</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">692</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">18</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other income (expense), net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest income (expense),
    net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">63</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(587</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(650</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,032</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other income (expense),
    net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(9</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(450</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss
    on change in fair value of warrant liability</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(100</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 30pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    other income (expense), net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">57</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(594</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(651</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,142</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,839</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,798</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">41</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Research
and Development</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our research and development expenses, personnel and our outsourced spending by functional area (in thousands):</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    Ended December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase/</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Decrease)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Clinical development</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,021</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,518</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(503</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vendor payments for delivery devices</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(113</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(241</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(128</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preclinical research and development</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">416</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">238</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(178</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Regulatory</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">247</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">339</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">92</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Personnel</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">426</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">532</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;106</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    research and development expenses</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,997</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,386</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(611</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses were $3.0 million for the year ended December 31, 2019 compared to $2.4 million for the year ended December
31, 2020, a net decrease of $0.6 million. This net decrease can be attributed to a number of factors. The decrease in clinical development
costs of $0.5 million for the year ended December 31, 2020 is primarily due to the initiation of the European portion of our clinical
trial and startup of clinical trial sites in the U.S. in 2019 that did not recur in 2020. Vendor payments for delivery devices represents
the cash payment made by vendors for the RenovoCath delivery devices used in clinical trials. To date, proceeds from clinical trial sites
have been adequate to cover our direct costs of manufacturing the RenovoCath delivery devices for which they have paid. Preclinical research
and development decreased by $0.2 million for the year ended December 31, 2020 due to higher costs associated with early-stage product
development in 2019. Regulatory expenses increased by approximately $0.1 million for the year ended December 31, 2020 due to a higher
level of support required for communications and filings with the FDA. Our personnel-related expenses increased by $0.1 million in the
year ended December 31, 2020 driven primarily by increased staffing costs to support our ongoing clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>General
and Administrative Expenses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our general and administrative expenses (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    Ended December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase/</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Decrease)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Personnel</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">560</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">576</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Legal fees</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">201</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">170</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(31</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Professional services
    and other</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">138</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">72</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(66</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total general and administrative</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">expenses</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">899</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">818</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(81</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses were $0.9 million for the year ended December 31, 2019 compared to $0.8 million for the year ended December
31, 2020, a decrease of $0.1 million. The decrease in general and administrative expenses was primarily attributable to reductions in
expenses related to legal, professional services, consulting, recruiting, medical conferences and communications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Interest
Income (Expense), Net (in thousands)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    Ended December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase/</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Decrease)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest income</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">63</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(60</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest expense</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(590</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(590</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest income (expense),
    net</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">63</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(587</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(650</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income (expense), net decreased by $0.7 million from the year ended December 31, 2019 to the year ended December 31, 2020. The decrease
in interest income is due to interest earned on lower cash balances and lower interest rates throughout 2020 compared to 2019. Interest
expense increased by $0.6 million during the year ended December 31, 2020 primarily as a result of the 2020 Convertible Notes we issued
in 2020. Interest expense comprises both the stated interest on the note of 5% per annum or $0.1 million as well as the amortization
of the discount and debt issuance costs associated with the 2020 Convertible Notes of $0.5 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Expense, Net</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expense, net increased by $9,000 from the year ended December 31, 2019 to the year ended December 31, 2020, a de minimis amount</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Loss
on Change in Fair Value of Warrant Liability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
on change in fair value of warrant liability decreased by $8,000 from the year ended December 31, 2019 to the year ended December 31,
2020, a de minimis amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidity
and Capital Resources</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2019 and December 31, 2020, our net losses were $3.8 million in each of those years, and for the three months
ended March 31, 2020 and March 31, 2021 we incurred net losses of $1.1 million in each of those periods. As of March 31, 2021, we had
an accumulated deficit of $16.1 million. We expect to incur additional losses and increased operating expenses in future periods. Since
our inception, our primary sources of liquidity have been the issuance of convertible preferred stock and convertible notes. &nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 and March 31, 2021, we had $1.8 million and $837,000 in cash and cash equivalents, respectively. During the three
months ended March 31, 2021, we used $1.0 million of cash in operations. Our primary requirements for liquidity have been to fund our
clinical trial activity and general corporate and working capital needs. Our cash and cash equivalents at these dates was primarily from
$3.0 million in net proceeds from convertible notes and a promissory note with Silicon Valley Bank for proceeds of $140,000 pursuant
to the PPP under the CARES Act. In February 2021, we received notification and confirmation from Silicon Valley Bank that our PPP loan
including related accrued interest has been forgiven in its entirety by the U.S. Small Business Administration and automatically cancelled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on our planned operations, we expect that the proceeds from this offering plus our current cash and cash equivalents will be sufficient
to fund our operations for at least 12 months after the date of this prospectus. After this offering, we intend to raise additional capital
through equity offerings and/or debt financings. Adequate funding may not be available to us on acceptable terms, or at all. If we are
unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce or eliminate our clinical trials or other
operations. If any of these events occur, our ability to achieve our operational goals would be adversely affected. Our future capital
requirements and the adequacy of available funds will depend on many factors, including those described in &ldquo;Risk Factors.&rdquo;
Depending on the severity and direct impact of these factors on us, we may be unable to secure additional financing to meet our operating
requirements on terms favorable to us, or at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sources
of Liquidity</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception, we have not generated any revenue from product sales and we have incurred significant operating losses. We do not have
any products that have achieved regulatory marketing approval and we do not expect to generate revenue from sales of any product candidates
for several years, if ever.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, we have funded our operations primarily through the issuance and sale of convertible preferred stock and debt. From our inception
through March 31, 2021, we had raised net cash proceeds of $14.9 million from the issuance and sale of our convertible preferred stock
and convertible notes. We also received $140,000 from a loan under the PPP which was forgiven in February 2021. As of March 31, 2021,
we had cash and cash equivalents of $837,000 and an accumulated deficit of $16.1 million. In April 2021, we entered into a series of
convertible note agreements with certain existing and new investors to provide an aggregate $2.0 million in cash proceeds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash
Flows</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
primary uses of cash are to fund our operations including research and development and general and administrative expenses. We will continue
to incur operating losses in the future and expect that our research and development and general and administrative expenses will continue
to increase as we continue our research and development efforts with respect to clinical development of our product candidates and further
develop our platform. We expect that we will use a substantial portion of the net proceeds of this offering, in combination with our
existing cash and cash equivalents, for these purposes and for the increased expenses associated with being a public company. Cash used
to fund operating expenses is impacted by the timing of when we pay expenses, as reflected in the change in our outstanding accounts
payable and accrued expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our cash flows for the periods indicated (in thousands):</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Years
    Ended December 31,</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Three
    Months Ended March 31,</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">(unaudited)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash provided by (used in):</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    activities</FONT></TD><TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,350</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,528</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,039</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(992</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investing activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Financing
    activities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,199</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,312</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">34</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Decrease) increase
    in cash and cash equivalents</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,351</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(329</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">273</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(958</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cash
Used in Operating Activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities for the three months ended March 31, 2020 and 2021 was approximately $1.0 million in each of the periods,
consisting primarily of our net losses in both periods of $1.1 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities for the year ended December 31, 2019 of $3.4 million was primarily attributable to a $3.8 million net
loss, partially offset by a net increase in operating assets and liabilities of $0.4 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities for the year ended December 31, 2020 of $3.5 million was primarily attributable to a $3.8 million net
loss and a decrease in operating assets and liabilities of $0.2 million, partially offset by amortization of debt issuance costs and
amortization of debt discount of $0.5 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cash
Used in Investing Activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no investing activities for the three months ended March 31, 2020 and March 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in investing activities during the year ended December 31, 2019 was insignificant. There were no investing activities during
the year ended December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cash
Provided by Financing Activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities in the three months ended March 31, 2020 was $1.3 million, consisting primarily of $1.3 million
in proceeds from the issuance of convertible notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing in the three months ended March 31, 2021 was $34,000 and consisted of proceeds from the exercise of stock
options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had no financing activities in 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities during the year ended December 31, 2020 of $3.2 million was primarily attributable to $3.0 million
in proceeds from the issuance of the 2020 Convertible Notes and $140,000 in proceeds from the PPP loan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contractual
Obligations and Other Commitments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our contractual obligations as of December 31, 2020 (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payments
    due by period</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less
    than 1 year</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">1
    to 3 years</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">3
    to 5 years</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 36%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020 Convertible Notes</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,038</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,038</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">PPP loan</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">140</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">117</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">23</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,178</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,155</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">23</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt"></P>

<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2021, the Company received notification and confirmation from Silicon Valley Bank that its PPP loan totaling $140,000 has
been forgiven in its entirety by the U.S. Small Business Administration and automatically cancelled. There have been no other significant
changes in our contractual obligations as of March 31, 2021 compared to December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Critical
Accounting Policies and Significant Judgments and Estimates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying management&rsquo;s discussion and analysis of our financial condition and results of operations are based upon our financial
statements and the related disclosures, which have been prepared in accordance with accounting principles generally accepted in the United
States or GAAP. The preparation of these financial statements requires us to make estimates, assumptions and judgments that affect the
reported amounts in our financial statements and accompanying notes. We base our estimates on historical experience and on various other
assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about
the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these
estimates under different assumptions or conditions. To the extent that there are material differences between these estimates and actual
results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected. While
our significant accounting policies are described in the notes to our financial statements included elsewhere in this prospectus, we
believe that the following critical accounting policies are most important to understanding and evaluating our reported financial results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
critical accounting policy is defined as one that is both material to the presentation of our financial statements and requires management
to make difficult, subjective, or complex judgments that could have a material effect on our financial condition and results of operations.
Specifically, critical accounting estimates have the following attributes: (i) we are required to make assumptions about matters that
are highly uncertain at the time of the estimate&#894; and (ii) different estimates we could reasonably have used, or changes in the
estimate that are reasonably likely to occur, would have a material effect on our financial condition or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe the following policies to be the most critical to an understanding of our financial condition and results of operations because
they require us to make estimates, assumptions and judgments about matters that are inherently uncertain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;<I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Clinical
Trial Expenses</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
make payments in connection with clinical trials under contracts with clinical trial sites and contract research organizations that support
conducting and managing clinical trials. The financial terms of these agreements are subject to negotiation and vary from contract to
contract and may result in uneven payment flows. Generally, these agreements set forth the scope of work to be performed at a fixed fee,
unit price or on a time and materials basis. A portion of the obligation to make payments under these contracts depends on factors such
as the successful enrollment or treatment of patients or the completion of other clinical trial milestones.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses
related to clinical trials are accrued based on estimates and/or representations from service providers regarding work performed, including
actual level of patient enrollment, completion of patient studies and progress of the clinical trials. Other incidental costs related
to patient enrollment or treatment are accrued when reasonably certain. If the amounts we are obligated to pay under clinical trial agreements
are modified (for instance, as a result of changes in the clinical trial protocol or scope of work to be performed), the accruals are
adjusted accordingly. Revisions to contractual payment obligations are charged to expense in the period in which the facts that give
rise to the revision become reasonably certain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock-Based
Compensation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
calculate the fair value of stock options using the Black-Scholes option pricing model, which incorporates various assumptions including
assumptions including the fair value of our common stock, volatility, expected life, and risk-free interest rate. Compensation related
to service-based awards is recognized starting on the grant date on a straight-line basis over the vesting period, which is generally
four years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determining
the grant date fair value of options using the Black-Scholes option pricing model requires management to make assumptions and judgments.
If any of the assumptions used in the Black-Scholes model change significantly, stock-based compensation for future awards may differ
materially compared with the awards granted previously. The assumptions and estimates are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fair
Value of Common Stock</I>&mdash;Given the absence of a public trading market, our Board of Directors considered numerous objective and
subjective factors to determine the fair value of our common stock at each grant date. These factors included, but were not limited to:
(i) contemporaneous third-party valuations of common stock; (ii) the prices for preferred stock sold to outside investors; (iii) the
rights and preferences of preferred stock relative to common stock; (iv) the lack of marketability of our common stock; (v) developments
in the business; and (vi) the likelihood of achieving a liquidity event, such as an IPO or sale of the business, given prevailing market
conditions. The methodology to determine the fair value of our common stock included estimating the fair value of the enterprise using
the &ldquo;backsolve&rdquo; method, which is a market approach that assigns an implied enterprise value by accounting for all share class
rights and preferences based on the latest round of financing. The total equity value implied was then applied in the context of an option
pricing model to determine the value of each class of our shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
this offering, we will rely on the closing price of our common stock as reported on the date of grant to determine the fair value of
our common stock, as shares of our common stock will be traded in the public market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Expected
Term</I>&mdash;The expected term represents the period that the stock-based awards are expected to be outstanding. We determine the expected
term using the simplified method. The simplified method deems the term to be the average of the time-to-vesting and the contractual life
of the options. For stock options granted to non-employees, the expected term equals the remaining contractual term of the option from
the vesting date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Expected
Volatility</I>&mdash;Given the absence of a public trading market, the expected volatility was estimated by taking the average historic
price volatility for industry peers, consisting of several public companies in our industry that are either similar in size, stage, or
financial leverage, over a period equivalent to the expected term of the awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Risk-Free
Interest Rate</I>&mdash;The risk-free interest rate is calculated using the average of the published interest rates of U.S. Treasury
zero-coupon issues with maturities that are commensurate with the expected term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dividend
Rate</I>&mdash;The dividend yield assumption is zero as we have no plans to make dividend payments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Convertible
Instruments and Embedded Derivatives</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
evaluate all of our agreements to determine whether such instruments have derivatives or contain features that qualify as embedded derivatives.
We account for certain redemption features that are associated with the terms of convertible notes as liabilities at fair value and adjusts
the instruments to their fair value at the end of each reporting period. For derivative financial instruments that are accounted for
as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with
changes in the fair value reported in other income (expense), net in the statements of operations. Derivative instrument liabilities
are classified in the balance sheets as current or non-current based on whether or not net-cash settlement of the derivative instrument
could be required within 12 months of the balance sheet date. As of December 31, 2020 and March 31, 2021, our only derivative financial
instrument was related to the 2020 Convertible Notes, which contained certain redemptive features.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Emerging
Growth Company and Smaller Reporting Company Status</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &ldquo;emerging growth company&rdquo; as defined in the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act.
Under the JOBS Act, companies have extended transition periods available for complying with new or revised accounting standards. We have
elected this exemption to delay adopting new or revised accounting standards. We will remain an emerging growth company until the earlier
of (1) December 31, 2026, (2) the last day of the fiscal year in which we have total annual gross revenues of at least $1.07 billion,
(3) the date on which we are deemed to be a &ldquo;large accelerated filer&rdquo; as defined in Rule 12b-2 under the Exchange Act, or
(4) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period. An
emerging growth company may take advantage of specified reduced reporting requirements and is relieved of certain other significant requirements
that are otherwise generally applicable to public companies. As an emerging growth company,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may present only two years of audited financial statements, plus unaudited condensed financial
                                            statements for any interim period, and related Management&rsquo;s Discussion and Analysis
                                            of Financial Condition and Results of Operations in this prospectus;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may avail ourselves of the exemption from the requirement to obtain an attestation and report
                                            from our auditors on the assessment of our internal control over financial reporting pursuant
                                            to the Sarbanes-Oxley Act;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may provide reduced disclosure about our executive compensation arrangements; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            do not require stockholder non-binding advisory votes on executive compensation or golden
                                            parachute arrangements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have elected to take advantage of certain of the reduced disclosure obligations in the registration statement of which this prospectus
is a part and may elect to take advantage of other reduced reporting requirements in future filings. As a result, the information that
we provide to our stockholders may be different than you might receive from other public reporting companies in which you hold equity
interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also a &ldquo;smaller reporting company,&rdquo; meaning that the market value of our stock held by non-affiliates plus the proposed
aggregate amount of gross proceeds to us as a result of this offering is less than $700.0 million and our annual revenue is less than
$100.0 million during the most recently completed fiscal year. We may continue to be a smaller reporting company after this offering
if either (1) the market value of our stock held by nonaffiliates is less than $250.0 million or (2) our annual revenue is less than
$100.0 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700.0
million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions
from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company
we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and,
similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Recently
Issued and Adopted Accounting Pronouncements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
Note 2 to our audited financial statements included elsewhere in this prospectus for more information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Off-Balance
Sheet Arrangements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the periods presented, we did not have any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Quantitative
and Qualitative Disclosures about Market Risk</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are exposed to market risks in the ordinary course of our business. These risks primarily include interest rate risks, foreign currency
exchange, risks and inflation risks. Periodically, we maintain deposits in accredited financial institutions in excess of federally insured
limits. We deposit our cash in financial institutions that we believe have high credit quality and have not experienced any losses on
such accounts and do not believe we are exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking
relationships.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Interest
Rate Risk</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cash and cash equivalents consisted primarily of cash on hand at December 31, 2020 and March 31, 2021. The fair value of our cash and
cash equivalents would not be significantly affected by either an increase or decrease in interest rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
exposure to risks related to interest rates is minimal. The interest rate for our 2020 Convertible Note is a fixed rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Foreign
Currency Exchange Risk</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not currently exposed to significant market risk related to changes in foreign currency exchange rates. However, we have contracted
with and may continue to contract with vendors such as contract research organizations and clinical trial sites that are located in Europe.
We may be subject to fluctuations in foreign currency rates in connection with certain of these agreements. Transactions denominated
in currencies other than the U.S. dollar are recorded based on exchange rates at the time such transactions arise. While we have not
engaged in hedging our foreign currency transactions to date, we may evaluate the costs and benefits of initiating such a program and
may in the future, hedge selected significant transactions denominated in currencies other than the U.S. dollar as we expand our clinical
trial sites globally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Inflation
Risk</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inflation
generally affects us by increasing our labor and clinical trial costs. We do not believe that inflation had a material effect on our
business, financial condition or results of operations during the year ended December 31, 2020 and the three-month period ended March
31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Internal
Control Over Financial Reporting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Internal
control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements in accordance with generally accepted accounting principles in the United States, or GAAP.
Under standards established by the Public Company Accounting Oversight Board, or PCAOB, a deficiency in internal control over financial
reporting exists when the design or operation of a control does not allow management or personnel, in the normal course of performing
their assigned functions, to prevent or detect misstatements on a timely basis. The PCAOB defines a material weakness as a deficiency,
or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material
misstatement of annual or interim financial statements will not be prevented or detected on a timely basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
preparation for our initial public offering, we identified material weaknesses in our internal control over financial reporting related
to our control environment. Specifically, we have determined that we lack a sufficient number of qualified accounting and financial reporting
personnel with an appropriate level of knowledge, training and experience to address complex accounting issues, sufficient written policies
and procedures for accounting and financial reporting in accordance with GAAP, and adequate management review controls. In addition,
we have determined that our financial statement close process includes significant control gaps mainly driven by the small size of our
accounting and finance staff and, as a result, a significant lack of appropriate segregation of duties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
address these material weaknesses, we have implemented, and are continuing to implement, measures designed to improve internal controls
over financial reporting, including expanding our accounting and finance team to add additional qualified accounting and finance resources,
which may include third party consultants, and have implemented new financial processes. We intend to continue to take steps to remediate
the material weaknesses through the hiring or engagement of additional experienced accounting and financial reporting personnel, formalizing
documentation of policies and procedures and further evolving the accounting processes, including implementing appropriate segregation
of duties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
process of designing and implementing an effective accounting and financial reporting system is a continuous effort that requires us
to anticipate and react to changes in our business and the economic and regulatory environments and to expend significant resources to
maintain an accounting and financial reporting system that is adequate to satisfy our reporting obligations. As we continue to evaluate
and take actions to improve our internal control over financial reporting, we may determine to take additional actions to address control
deficiencies or determine to modify certain of the remediation measures described above. We cannot assure you that the measures we have
taken to date, or any measures we may take in the future, will be sufficient to remediate the material weakness we have identified or
avoid potential future material weaknesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="k_003"></A>BUSINESS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors and conducting
a Phase 3 registrational trial for our lead product candidate RenovoGem&trade;. Our therapy platform, RenovoRx Trans-Arterial Micro-Perfusion,
or RenovoTAMP&trade; utilizes approved chemotherapeutics with validated mechanisms of action and well-established safety and side effect
profiles, with the goal of increasing their efficacy, improving their safety, and widening their therapeutic window. RenovoTAMP combines
our patented FDA cleared delivery system, RenovoCath<SUP>&reg;</SUP>, with small molecule chemotherapeutic agents that can be forced
across the vessel wall using pressure, targeting these anti-cancer drugs locally to the solid tumors. While we anticipate investigating
other chemotherapeutic agents for intra-arterial delivery via RenovoTAMP, our clinical work to date has focused on gemcitabine, which
is a generic drug. Our first product candidate, RenovoGem, is a drug and device combination consisting of intra-arterial gemcitabine
and RenovoCath. FDA has determined that RenovoGem will be regulated as, and if approved we expect will be reimbursed as, a new oncology
drug product. We have secured FDA Orphan Drug Designation for RenovoGem in our first two indications: pancreatic cancer and cholangiocarcinoma
(bile duct cancer, or CCA). We have completed our RR1 Phase 1/2 and RR2 observational registry studies, with 20 and 25 patients respectively,
in locally advanced pancreatic cancer, or LAPC. These studies demonstrated a median overall survival of 27.9 months in patients treated
with RenovoGem and radiation. Based on previous large randomized clinical trials, the expected survival of LAPC patients is 12-15
months in patients receiving only intravenous (IV) systemic chemotherapy or IV chemotherapy plus radiation (which are both considered
standard of care). Unlike the randomized trials that established these standard-of-care results, our RR1 and RR2 clinical trials did
not prospectively control the standard of care therapy received prior to RenovoTAMP. Based on FDA safety review of our Phase 1/2
study the FDA allowed us to proceed to evaluate RenovoGem within our Phase 3 registration Investigational New Drug, or IND, clinical
trial. Our Phase 3 trial is 40% enrolled as of April 30, 2021 and we expect to report data from a planned interim data readout in the
second half of 2022. We intend to evaluate RenovoGem in a second indication in a Phase 2/3 trial in hilar CCA (cancer that occurs in
the bile ducts that lead out of the liver and join with the gallbladder, also called extrahepatic cholangiocarcinoma, or HCCA). We plan
to propose the trial to the FDA and potentially launch in the first half of 2022. In addition, we may evaluate RenovoGem in other indications,
potentially including locally advanced lung cancer, locally advanced uterine tumors, and glioblastoma (an aggressive type of cancer that
can occur in the brain or spinal cord). To date, we have used gemcitabine, but in the future we may develop other chemotherapeutic agents
for intra-arterial delivery via RenovoCath.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
RenovoTAMP therapy platform is focused on optimizing drug concentration in solid tumors using approved small molecule chemotherapeutics
that enable physicians to isolate segments of the vascular anatomy closest to tumors and force chemotherapy across the blood vessel wall
to bathe these difficult-to-reach tumors in chemotherapy. More specifically, our patented approach combines local delivery via our patented
RenovoCath delivery system utilizing pressure to force small molecule chemotherapy into the tumor tissue with pre-treatment of the local
blood vessels and tissue with standard-of-care radiation therapy to decrease chemotherapy washout. We believe there are many advantages
to our approach:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Application
    of Approved Small Molecule Chemotherapeutic Agents</I>: We use approved small molecule chemotherapeutic agents such as gemcitabine.
    </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Targeted
    Approach</I>: With our approach, we have demonstrated in our clinical studies up to 100 times higher local drug concentration compared
    to systemic chemotherapy. We believe our approach decreases systemic exposure and improves patient outcomes. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Delivery
    Method Independent of Tumor Vascularity</I>: We invented a novel combination platform and delivery system to deliver small molecule
    chemotherapeutic agents in solid tumors resistant to systemic chemotherapy due to lack of tumor blood vessels or tumor feeders. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Broad
    Application for Solid Tumor Indications</I>: Our platform is not restricted to a single small molecule chemotherapeutic agent or
    solid tumor type. As such, our platform and delivery system may be applied for use in additional solid tumor indications, including
    in solid tumors without identifiable tumor feeders. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
lead product candidate, RenovoGem, is a combination of gemcitabine and our patented delivery system, RenovoCath, and is regulated by
the FDA as a novel oncology drug product. Our RenovoTAMP platform therapy utilizes pressure mediated delivery of the small molecule gemcitabine
across the arterial wall to bathe the pancreatic tumor tissue in 120mL of saline with 1,000mg/m<SUP>2</SUP> of the drug over a 20-minute
delivery time (approximately a total of 1,500-2,000mg of drug dependent upon patient Body Surface Area). RenovoCath is an adjustable
double balloon catheter designed to isolate the proximal and distal vessel and adjust the distance between the balloons to exclude any
branching blood vessel offshoots.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the field of oncology has seen progress in treating a handful of deadly cancers over the last few decades, there is a common limitation
in chemotherapy: enhanced dosing of the drug to impact the tumor while minimizing systemic toxicity. The characteristics of the vasculature,
within and surrounding the tumor, can be a limiting step in this goal. For example, LAPC and HCCA are more difficult to treat due to
the lack of blood vessels that feed these tumors, making it difficult to expose tumors to chemotherapy, which is typically delivered
intravenously. Trans-arterial chemoembolization (TACE) is an established first line therapy for solid tumors. A key component of this
approach is to identify and isolate vessels feeding the tumor, known as tumor feeders. However, in patients with pancreatic cancer, no
tumor feeder vessels are visible during angiography. In the absence of visible tumor feeders, we can introduce drugs directly across
the arterial wall into the surrounding tissue via pressurized diffusion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently evaluating RenovoGem in patients with LAPC in our TIGeR-PaC Phase 3 trial at 28 US and Belgian sites. The trial
is designed to enroll 340 subjects. As of April 30, 2021, 135 patients were enrolled, accounting for 40% of expected total
enrollment. A planned interim data readout is expected during the second half of 2022. We have secured Orphan Drug Designation for RenovoGem;
which would provide us with seven years of exclusivity to market intra-arterial use of gemcitabine for LAPC upon NDA approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we intend to evaluate RenovoGem in patients with HCCA, and we have secured FDA Orphan Drug Designation for the broader CCA
indication. We intend to potentially pursue additional indications including locally advanced lung cancer, locally advanced uterine tumors
and glioblastoma.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
our initial indication, LAPC, we have completed two studies. We launched RR1, our first-in-human, dose escalation, Phase 1/2 safety study
in May 2015 to evaluate our RenovoTAMP platform by delivering intra-arterial gemcitabine via our patented RenovoCath delivery system.
In this safety study, 20 patients with a diagnosis of Stage 3 pancreatic cancer were enrolled. After completion of enrollment and demonstration
of an early survival efficacy signal in this study, we launched our RR2 observational registry study in June 2016 to examine the
tolerability and initial efficacy of the RenovoTAMP procedure. A combination analysis of these two studies demonstrated
that survival in &ldquo;all comers&rdquo; (n=31) receiving at least one cycle (two treatments over one month) was 29% at two years. Looking
at the prior-radiation therapy subset (n=10), 24-month survival was 60% with a median overall survival (mOS) of 27.9 months. This compares
favorably to IV chemotherapy, with 24-month survival of 12%, and to chemotherapy + radiation with 24-month survival of 5% and mOS of
12-15 months as demonstrated in historical studies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to submit our proposed Phase 2/3 clinical trial to evaluate RenovoGem in HCCA, BENEFICIAL, to the FDA as part of a pre-IND submission
in the fourth quarter of 2021 and to launch the clinical trial in the first half of 2022. Gemcitabine has been considered standard
of care for several solid tumors, and the drug&rsquo;s anti-cancer tumor effects are well profiled. We intend to explore applications
of our RenovoTAMP platform in additional indications including locally advanced lung cancer, locally advanced uterine cancer, and glioblastoma.
We have completed and presented data on a lung cancer application in pre-clinical studies, and additional pre-clinical experiments in
lung cancer may be conducted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are using gemcitabine in our initial anti-cancer product candidate, RenovoGem, however, multiple small molecule therapeutics are compatible
with our RenovoTAMP platform. We intend to opportunistically develop additional anti-cancer product candidates using small molecule therapeutics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management team, Board of Directors, and Scientific Advisors provide us with expertise across multiple sectors to drive success through
clinical development and subsequent commercialization of our novel therapy platform. Our Chief Executive Officer, Shaun Bagai, has extensive
experience running clinical trials and launching, creating, and developing new markets for novel therapies at Trans Vascular, Medtronic,
Ardian, and HeartFlow. Dr. Ramtin Agah, our Co-Founder and Chief Medical Officer, is a practicing cardiovascular specialist who has 20
years of research experience in vascular biology and disease in both academia and industry. Our Board of Directors includes a wide range
of public and private company management and Board experience including drug/device combination and oncology experience. Clinical advisors
include experts in surgical oncology, interventional radiology, radiation oncology, and medical oncology. Dr. Daniel Von Hoff, a medical
oncologist, was instrumental as the Principal Investigator who brought to market standard of care therapies for pancreatic cancer. Dr.
Mike Pishvaian, also a medical oncologist, has extensive experience in running oncology studies and is an Associate sociate Professor,
and Department of Oncology Director of the Gastrointestinal, Developmental Therapeutics, and Clinical Research Programs at the NCR Kimmel
Cancer Center at Sibley Memorial Hospital Johns Hopkins University School of Medicine. Dr. Pishvaian is the Principal Investigator/Global
Study Chair of our TIGeR-PaC Phase 3 study. Dr. Peter Muscarella is a surgical oncologist and the Director of Pancreatic Surgery, General
Surgery Site Director, Weiler Hospital Associate Program Director, and General Surgery Residency Training Program at Montefiore Medical
Center, Bronx, NY. Dr. Karyn Goodman serves as our Radiation Monitor for our TIGeR-PaC Phase 3 study and Professor and Vice Chair of
Clinical Research, Department of Radiation Oncology at the Icahn School of Medicine at Mount Sinai, and Associate Director of Clinical
Research at the Tisch Cancer Institute at Mount Sinai. We have two interventional radiology scientific advisors: Dr. Reza Malek, Neurointerventional
Radiologist at Minimally Invasive Surgical Solutions and Dr. Jacob Cynamon, Professor of Clinical Radiology of the Albert Einstein College
of Medicine, Chief of the Division of Vascular and Interventional Radiology, and Program Director of the Vascular and Interventional
Radiology Fellowship Program at the Montefiore Medical Center, Bronx, NY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Research
and Development Pipeline</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
portfolio of cancer therapies is based on our RenovoTAMP therapy platform. Our current pipeline is summarized below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: rgb(0,0,153)"><B>RenovoGem
Product Pipeline Addresses Multiple Indications</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure01_01.jpg" ALT=""></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099">Figure
1 RenovoGem Clinical Pipeline detailing our potential portfolio of cancer therapies based on our RenovoTAMP therapy platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Strategy</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RenovoGem
is a combination of intra-arterial gemcitabine and our patented delivery system, RenovoCath, and is regulated by the FDA as a novel oncology
drug product. Our near-term goal is to develop RenovoGem utilizing our RenovoTAMP platform to address the unmet medical needs of LAPC
and HCCA patients. We intend to broaden application of our platform, by exploring additional cancer indications including locally advanced
lung cancer, locally advanced uterine cancer, and glioblastoma. Our long-term goal is to expand applications of our RenovoTAMP platform
beyond RenovoGem by acquiring or licensing other small molecule therapies to continue to address unmet medical needs of cancer patients.
To achieve our near-term and long-term goals, we intend to pursue the following strategies:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Advance
    our lead product candidate, RenovoGem for use in our first indication, LAPC. </I></B>In our Phase 1/2 study, we demonstrated a median
    survival of approximately 28 months from diagnosis which compares favorably to 12-15 months in historical controls in locally advanced
    pancreatic cancer patients. We are currently conducting our TIGeR-PaC Phase 3 clinical trial with a target enrollment of 340 patients.
    As of April 30, 2021, we have enrolled 135 patients. We expect to receive an interim data readout on the primary endpoint
    of overall survival by the second half of 2022. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Advance
    RenovoGem for use in our second indication, HCCA</I></B><I>.</I> We have secured Orphan Drug Designation for the broader CCA indication
    and intend to launch a Phase 2/3 trial for the treatment of HCCA in the first half of 2022. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Expand
    RenovoGem for use in additional solid tumors indications.</I></B> We plan to potentially launch IND studies to explore the application
    of RenovoGem for the treatment of locally advanced lung cancer and other solid tumor indications with data on the use of systemic
    or intravenously administered gemcitabine such as locally advanced uterine tumors and glioblastoma. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Use
    RenovoTAMP with different chemotherapeutic agents.</I></B> Our delivery system, RenovoCath, can be used to deliver almost any small
    molecule therapeutic agent to solid tumors. RenovoTAMP has the potential to overcome limitations of systemic toxicity by local delivery
    of small molecule therapeutic agents to the tumor. We may to use our platform to develop products with drugs that are available generically
    or we may enter strategic collaborations to access other companies&rsquo; proprietary drugs. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Explore
    collaborations with biotechnology and pharmaceutical companies.</I></B> We have exclusive global development and commercialization
    rights for RenovoGem and RenovoCath including issued patents on methods of RenovoTAMP for all indications that we may pursue. While
    we may develop these products independently, we may also enter strategic relationships with biotechnology or pharmaceutical companies
    to advance our product candidates.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Strengths </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Solid
    tumor targeting via local therapy.</I></B> Our platform has the potential to efficiently target locally advanced solid tumors. Many
    solid tumors cannot be surgically removed and are difficult to treat. Our innovative therapy platform delivers anti-cancer drugs
    directly to the tumor and does not rely on the existence of extensive vasculature also known as tumor feeders. We believe that RenovoTAMP,
    which locally delivers directly to the tumor a drug that is standard of care in systemic administration, is a promising approach
    to improve outcomes in locally advanced solid tumors.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Preliminary
    data indicate that our approach is feasible and well-tolerated with promising survival results</I></B>. Our Phase 1/2 data demonstrated
    that RenovoGem via the RenovoTAMP therapy platform is well tolerated with multiple survival signals.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Pipeline
    with broad utility. </I></B>We believe that the flexibility of our platform combined with our exclusive global development and commercialization
    rights, gives us the ability to grow our product pipeline by targeting a broad range of solid tumor indications and by using additional
    chemotherapeutic agents. Furthermore, our platform has been used throughout the duration of our clinical trials with demonstrated
    adoption of the RenovoTAMP technique by physicians.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Current
Treatments and Limitations of Approaches</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
solid tumors are typically treated using one or a combination of treatment modalities: surgery, radiation, and pharmacological therapies
(chemotherapy). For solid tumors, when possible, surgical resection of the tumor is the most frequently employed treatment approach.
If the tumor is detected at an early stage and is localized to the affected organ, surgery may be an effective and potentially curative
treatment of the entire tumor is removed. In most cases, surgery is initially completed prior to commencing additional treatment approaches.
However, multiple solid tumor types, including LAPC and HCCA are diagnosed at stages that preclude surgery as a treatment approach. In
many of these circumstances, the tumor has grown into adjacent anatomical structures making the surgery difficult or impossible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intra-venous
(IV), or systemic chemotherapy, is considered standard of care for most solid tumors, but limitations include less than acceptable efficacy,
systemic toxicities, and side effects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the treatment of localized solid tumors, TACE is an established first line therapy. Many companies have used this approach to treat tumors
of the liver, uterus, and prostate. Many solid tumors have a dedicated blood supply; small blood vessels, called tumor feeders, that
branch off of larger native arteries and terminate in the tumors to provide nutrition to the tumors. A key aspect of TACE is to identify
and isolate these tumor feeders during x-ray angiography and then deliver the desired therapy including chemotherapy and embolic agents.
In patients LAPC, no tumor feeder vessels are visible during angiography due to the avascular (lack of blood vessels) nature of these
tumors. This limitation has rendered TACE ineffective in the treatment of patients with LAPC, HCCA, and with a subset of other solid
tumors. The limitations of TACE translate to low survival rates in these tumor subtypes despite attempts with novel therapies including
targeted therapies that address a specific molecule on one or more tumor types and immuno-oncology treatment approaches, which harness
the body&rsquo;s immune system to treat cancer. For example, early studies targeting immunotherapies in pancreatic cancer have limited
success due to the inability of immune cells to penetrate the tumor tissue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Platform: RenovoTAMP</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Figure 2 below, the panel on the left depicts visualization of the actual tumor, hepatocellular carcinoma, or primary liver cancer, under
x-ray angiography as dye injected through the arteries reaches the tumor itself. Further, visible tumor feeders can be reached by simple
end-hole catheters to deliver targeted therapy to these liver tumors. The panel on the right demonstrates the typical lack of tumor feeders
to the pancreatic tumor. Given the lack of tumor feeders, the dye does not reach the tumor, rendering the tumor &ldquo;invisible&rdquo;
under x-ray angiography. Rather one can see the native/large blood vessel being &ldquo;pinched&rdquo; by the tumor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>Tumors
in Liver are Different from Hypovascular Tumors in the Pancreas</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure02_01.jpg" ALT="" STYLE="height: 246px; width: 626px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099">Figure
2 Liver tumors are highly vascularized versus pancreas tumors that are avascular, therefore systemic chemotherapy and local TACE approaches
can more easily deliver chemotherapy to liver tumors than to pancreatic tumors. The panel on the left depicts tumor feeders originating
from the native liver arteries. Under x-ray angiography, dye injected in the native liver arteries drain into the tumor feeders and clearly
define the tumor. The panel on the right depicts the &ldquo;invisible&rdquo; pancreatic tumor. From a dye injection through the arteries
near the pancreas, one can only visualize a narrowing of the artery due to the tumor pinching on the artery, but tumor feeders, and thus,
the tumor itself are not visible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2009 our founder Dr. Ramtin Agah, an experienced interventional cardiologist with a degree in biomedical engineering, invented the concept
for RenovoTAMP as a way to deliver chemotherapy locally to treat poorly vascularized tumors. He joined forces with Kamran Najmabadi,
who brought significant medical device engineering experience, to found RenovoRx in 2009. We contracted with a contract manufacturer
to prototype and manufacture its RenovoCath delivery devices. We received our first FDA 510(k) clearance for RenovoCath in 2014, a second
clearance to use the RenovoCath for infusion of chemotherapy agents in 2017, and a further clearance for use with a power-injector in
2019. We are evaluating RenovoGem under an IND and expect that RenovoGem, if approved, will be regulated and reimbursed as a drug.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
overcome the limitation of lack of tumor feeder vessels, we explored a different approach to locally deliver anti-cancer drugs. By isolating
a section of the blood vessel and then increasing the intravascular pressure in the isolated segment we can introduce chemotherapy directly
across the arterial wall into the surrounding tissue via pressurized diffusion or Trans-Arterial Micro-Perfusion (TAMP<SUP>&reg;</SUP>).
To isolate the vessel and create this pressure gradient, we developed a patented adjustable double balloon catheter to occlude the proximal
and distal part of the vessel (RenovoCath). Using this technique with the RenovoCath delivery system we were able to validate our hypothesis
by demonstrating &gt;99% gemcitabine pressurized diffusion in explanted pig aorta and iliac arteries across the arterial wall in the
absence of feeder vessels. This mechanism of action was further supported via exploratory acute animal studies measuring the pressure
gradient within the artery during double balloon occlusion. Figure 3 demonstrates the change in intra-arterial pressure over time from
catheter introduction to balloon inflation, start of infusion, and pressure plateau when chemotherapy is forced out of vessel. These
changes in pressure are a result of pressure declining as the first balloon blocks blood inflow and then rising as the drug is administered
and fills up the space between the balloons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>RenovoCath
Pressurizes Isolated Vessel Segment, Allowing RenovoTAMP</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure03_01.jpg" ALT="" STYLE="height: 328px; width: 600px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><I>Figure
3</I> Occluding the vessel with the <I>RenovoCath</I> while changing the balloon-to-balloon distance to exclude all branches established
an intravascular interstitial pressure in the isolated segment of approximately 20mmHg. With subsequent infusion of fluids between the
balloons at 6mls/minute, the intravascular pressure increases until above 45mmHg, trans-arterially forcing the small molecule drug across
the arterial wall via diffusion (RenovoTAMP).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
RenovoTAMP platform therapy utilizes pressure mediated delivery of the small molecule gemcitabine across the arterial wall to bathe the
pancreatic tumor tissue in 120mL of saline with 1,000mg/m<SUP>2</SUP> of the drug over a 20-minute delivery time (approximately a total
of 1,500-2,000mg of drug dependent upon patient Body Surface Area). This blanketing approach of large fluid volume delivery over time
may enable the drug to approach these difficult-to-reach tumors. Some advantages of RenovoTAMP include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ideal
    for solid tumors where resection is not possible due to proximity/impingement of tumor on blood vessels, nerves, or other key structures</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    need for identifying tumor feeder vessels to deliver the drug. These generally do not exist in avascular or hypovascular tumors such
    as LAPC and HCCA </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    solid tumors without identifiable feeder vessels, technically easier than direct cannulation of small tumor feeders </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">High
    local concentration of drug into the tumor tissue</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential
    for decreased systemic exposure of drug due to local metabolism prior to systemic exposure</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
isolating the vessel adjacent to the tumor and creating a pressure gradient across the arterial wall between the isolated vessel segment
and the surrounding tissue or tumor, we are able to force the small molecule chemotherapy across the vessel directly into surrounding
tissue or tumor. To accomplish this, we needed a minimally invasive technique to isolate the blood vessel next to the tumor, exclude
any branches that can cause washout of chemotherapy away from the target, and then infuse the chemotherapy into the isolated segment
to achieve pressure mediated diffusion through the vessel wall and into the tumor tissue. We accomplished this with our patented RenovoCath
delivery system. RenovoCath is a double balloon catheter with the ability to adjust the balloon-to-balloon distance to tailor the treatment
zone to each patient&rsquo;s unique anatomy. The RenovoCath delivery system is inserted into the body through the femoral artery and
positioned in the artery closest to the tumor using standard interventional technique, by an interventional radiologist. Once the balloons
are inflated and the position is confirmed, chemotherapy is delivered through the handle, exiting the device between the balloons and
forced through the vessel wall into the tissue over 20 minutes, depicted below in Figure 4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>RenovoCath
Delivers Therapeutic Agent Between Two Balloons</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure04_01.jpg" ALT="" STYLE="height: 418px; width: 670px">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099">Figure
4 RenovoCath delivery system illustrating two balloon configuration to isolate the target vessel segment, and Chemotherapy delivery port/exit
hole to infuse target vessel segment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the procedure is complete, RenovoCath is discarded, and the patient is generally discharged the same day. The average procedure is 90
minutes, and the procedure is repeated every two weeks for as long as local chemotherapy is warranted. Interventional Radiologists using
the device are typically proctored for their first 2-3 cases only. In addition, platform training for our primary indication should transfer
to other indications with ease. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RenovoGem
for LAPC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disease
Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pancreatic
cancer is one of the deadliest cancers in the U.S. with very poor outcomes. In 2021, it is estimated that 60,430 Americans will be diagnosed
with pancreatic cancer in the US and more than 48,220 will die of the disease. Pancreatic cancer currently has a 5-year overall survival
rate of 5-10% (Stages I-IV) and is expected to quickly become the second leading cause of cancer-related deaths.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Current
Treatment Landscape and Limitations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pancreatic
cancer has limited treatment options including one or a combination of surgery, radiation, chemotherapy, and/or some targeted therapies.
Only a small subset of pancreatic cancer patients is eligible for surgery at the time of presentation (Stage I-II: 15-20%); the rest
are distributed between having tumors with unresectable LAPC (Stage III: 30%) and metastatic pancreatic cancer (Stage IV: 50%). The curative
prognosis for these patients is poor with a 5-year survival of only 7%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chemotherapy,
which can be used in the neoadjuvant setting (before surgery) to attempt to decrease tumor size in the borderline resectable or resectable
patients, in the adjuvant setting (after surgery), or first line in the metastatic/advanced setting, is the forefront of systemic therapy.
Specifically, gemcitabine is a nucleoside metabolic inhibitor that exhibits antitumor activity by blocking the synthesis of new DNA,
which results in cell death. Gemcitabine administered as an intravenous (IV) infusion has an established role in the treatment of both
unresectable LAPC and metastatic pancreatic cancer, or metastatic PC, since its introduction in the US as Gemzar&reg; (gemcitabine for
injection) in 1996 with an FDA approved indication as such and remains in the guidelines as standard of care. It has been demonstrated
to provide clinical benefit for subjects (decreased pain and improved performance status) as well as to improve the time to tumor progression
and survival for subjects with metastatic PC and LAPC. However, major improvement in the survival curve of all pancreatic cancer subjects
has been a clinical challenge, with an average median survival time for LAPC stalled at 12-15 months from time of diagnosis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 65; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
key limitation of conventional chemotherapy in these tumors can be attributed to their avascular nature and desmoplasia (fibrosis or
the growth of scar tissue) that impedes drug delivery. Pancreatic tumor cells have a thick and poorly perfused stroma, or connective
tissue, and high interstitial pressure. This can potentially constrict blood vessels leading to an avascular or hypovascular environment
that impedes chemotherapy from reaching tumor cells in high enough volume rendering them relatively chemo resistant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
patients with metastatic disease, two chemotherapy combination regimens have shown superiority to gemcitabine, albeit with increased
toxicity. First, the combination of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) in a relatively young cohort of
metastatic pancreatic cancer patients appears superior to gemcitabine by improving survival from 6.8 to 11.1 months. Second, in the Metastatic
Pancreatic Adenocarcinoma Clinical Trial (MPACT) trial, the combination of gemcitabine plus nab-paclitaxel (Abraxane) demonstrated an
OS benefit of 9 weeks versus gemcitabine alone at the cost of increased toxicity. Despite these modest advances, there is room for improvement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
major focus of clinicians is to determine the most optimal method to treat patients with LAPC, patients with localized disease who are
not surgical candidates, roughly 30% of all pancreatic cancer patients. IV, or systemic, administration of chemotherapy has yielded unsatisfactory
results in these patients. Various localized treatments have included high dose local radiation, attempts at local injection of drugs
directly, and use of adenoviral vector to deliver toxic agents. The aforementioned treatment options demonstrated limited success in
the treatment of LAPC. The lack of successful treatment options represents a recognized unmet medical need for these patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Standard
of care chemotherapy for the treatment of pancreatic cancer has historically shifted a couple of times with the addition of erlotinib
to gemcitabine 15 years ago resulting in a 14-day survival benefit. More recently, the addition of Abraxane to gemcitabine was approved
in 2013 with immediate deep market penetration based on an 8-week survival benefit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Solution </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our product candidate, RenovoGem, has the potential to address the recognized unmet medical need. Utilizing our patented
RenovoTAMP therapy platform, we believe RenovoGem can enhance local drug concentration, thereby increasing efficacy and decreasing systemic
exposure and toxicity to improve patient outcomes. RenovoGem is a drug and device combination therapy of intra-arterial gemcitabine and
our proprietary RenovoCath delivery system which forces anti-cancer drug into the tissue. RenovoGem is regulated by the FDA as a novel
oncology drug product. We do not intend to sell RenovoCath alone. Instead, we intend to sell RenovoCath only in combination with intra-arterial
gemcitabine or potentially with other therapeutic agents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on third-party primary research/market analysis of the U.S. market, we believe that over 5,000 patients per year would be excellent
candidates and undergo RenovoGem treatment once approved in the U.S. The independent oncologists interviewed stated their dissatisfaction
with current standard of care and the strong desire for a therapy like ours to extend potential survival while maintaining quality
of life. Further, the analysis suggests, based on analogous oncology drugs with only a <I>modest</I> efficacy benefit, a novel
drug can expect 50-80%+ penetration in a first line setting. The results of the Key Opinion Leader, or KOL interviews revealed
that a majority of oncologists would refer 90%+ of their LAPC patients who are eligible for the procedure for RenovoTAMP if the
current Phase 3 trial demonstrates at least a 4-month survival benefit over systemic chemotherapy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 66; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>RenovoTAMP
Therapy Platform and First Product Candidate, RenovoGem</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure06_01.jpg" ALT="" STYLE="height: 332px; width: 626px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099">Figure
5 We invented a new therapy platform, RenovoTAMP, that uses pressure to force small molecule chemotherapeutics across the vessel wall
into the tissue using our patented RenovoCath delivery system. Our first product candidate, RenovoGem, is a drug-device combination of
intra-arterial gemcitabine and the RenovoCath delivery system and is in development for LAPC and HCCA with Orphan Drug Designation secured
for both indications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clinical
Development of RenovoGem in LAPC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Pre-Clinical
Studies and Data </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
RenovoCath is introduced via standard interventional technique to the arterial vessel segment next to the targeted tissue, both balloons
are inflated and the vessel segment is isolated from the rest of the circulatory system. With inflation of balloons, the pressure is
observed to drop within the vessel. However, with infusion of fluids between the balloons, the intravascular pressure increases beyond
45mmHg until plateauing, generating a gradient and trans-arterially forcing the infusate across the arterial wall via diffusion or Trans-Arterial
Micro-Perfusion (TAMP). A key aspect of this approach is to adjust the distance between the balloons to exclude any side branches in
the isolated segment to allow the increase in pressure gradient, rather than drug washout via the side branches. Figure 6 shows a comparison
between proper balloon positioning with no side branches allowing drug across the arterial wall versus improper balloon positioning with
side branches washing out drug via the side branches in an animal study.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>Infusion
Pressure Achieved When Side Branches Are Excluded</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure07_01.jpg" ALT="" STYLE="height: 222px; width: 626px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure07_02.jpg" ALT="" STYLE="height: 215px; width: 626px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099">Figure
<I>6</I> Top panel demonstrates proper balloon positioning with no side branch. Pressure increases with infusion and reaches plateau
of approximately 75mmHg higher than initial pressure. Bottom panel demonstrates improper balloon positioning with side branch between
the balloons. Pressure increases with infusion and reaches plateau of approximately only 15mmHg higher than initial pressure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
diffusion of fluids across the arterial wall in RenovoTAMP, we expected to be able to deliver small molecules into the surrounding tissue.
We performed following studies to validate this hypothesis:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gemcitabine
    can cross the arterial wall via RenovoTAMP, with 99% crossing the arterial wall into the tissue.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
explanted (dissected out of the animal and used separately in a saline water bath) pig iliac and aortic artery, with introduction of
RenovoCath and infusion of gemcitabine in the isolated vessel segment, we were able to measure (in a time dependent fashion) the amount
of gemcitabine crossing the arterial wall into the surrounding fluid. We isolated the arterial vessel segment using RenovoCath and then
delivered 60mg/minute of gemcitabine into the isolated area over 20 minutes. By the end of the infusion, we measured 1188 mg of gemcitabine
in the surrounding fluid around the vessel and 9 mg in the analyzed tissue of the vessel. This demonstrated that 99% of the drug crosses
the arterial wall and only 0.75% is retained in the arterial tissue (Figure 7).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>99%
of Chemotherapy Crosses Arterial Wall with RenovoTAMP Delivery</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure05_01.jpg" ALT="" STYLE="height: 355px; width: 670px">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><I>Figure
7 RenovoTAMP: delivery of chemotherapy through the RenovoCath and into the tissue to bathe the tumor in chemotherapy. With gemcitabine,
99% of the drug crosses the arterial wall and less than 0.75% is retained in the arterial tissue.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Infusion
    of gemcitabine via RenovoTAMP has demonstrated vascular safety with acceptable toxicity in the pig model and does not cause loss
    of vessel integrity or inflammation.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Six
pigs were treated with gemcitabine via RenovoTAMP (6mL/min for 20 minutes). Target vessels included selection of the superficial femoral
artery (SFA) and splenic arteries from each animal (either test or saline control). A total of 6 vessels (3 SFA and 3 splenic arteries)
were treated with an equal number of control vessels. All animals survived the 7-day in-life period although two of the animals with
gemcitabine treatment in the splenic artery experienced atypical pain during the post-operative phase and required additional pain management
with eventual complete recovery.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Analysis
of the vessels demonstrated preserved vessel shape with intact endothelial cells (cells on the inside of the vessels). Minimal to no
inflammation was observed. The only vessel toxicity observed was a reduction of smooth muscles cells in the vessel wall, primarily close
to the inside of the vessel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RenovoTAMP
                                            can achieve targeted local drug (dye) delivery</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>I.</I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Targeted
    small molecule delivery (dye) into pancreatic tissue</I></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
further validated our approach for tissue drug delivery using acute animal experiments. Using both dye and gemcitabine infusion via the
RenovoTAMP therapy, we were able to demonstrate that fully isolating a segment of a vessel (by blocking inflow and outflow in the target
vessel with the RenovoCath double balloons as well as side branches) can lead to dye penetration greater than 4.0 cm from the vessel
wall and drug tissue concentration (gemcitabine) up to 100-fold greater than systemic administration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
an acute pig experiment, RenovoCath was introduced into the gastro-duodenal artery (GDA), a side branch was excluded (using small implants
that block the artery, coils), and then dye was introduced at 6mls/minute over 2 minutes. Analysis demonstrated that the blue dye diffused
covered approximately 10.56 cm<SUP>2</SUP> (2.2 cm x 4.8 cm) of the pancreas.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>Dye
Demonstrates RenovoTAMP Delivery of Agent into Pancreatic Tissue</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure08_01.jpg" ALT="" STYLE="height: 200px; width: 626px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><I>Figure
8 RenovoCath was introduced into the GDA and a side branch was excluded by coiling. This test was conducted in an acute porcine model
and demonstrated a dye coverage area of approximately 10.56 cm<SUP>2</SUP> for a 2-minute dye infusion. All dimensions in above figure
are in cm.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
study was repeated in 6 other vessel targets to validate the impact of vessel isolation on dye penetration into the surrounding tissue
with similar results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>II.</I></B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Small
    molecule delivery (dye and gemcitabine) locally into lung tissue</I></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
another set of acute animal experiments, the pulmonary artery was isolated via access through the internal jugular vein. Six ml of methylene
blue dye was injected over 1 min and gemcitabine was subsequently delivered locally at rate of 6mls/minute for 20 minutes to the lung
tissue using the RenovoTAMP procedure</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dense
dye staining localized to the area of the isolated vessel segment was observed. Again, analysis established penetration into surrounding
tissue (4cm). Furthermore, RenovoTAMP achieved greater than 100-fold tissue concentration of gemcitabine versus the tissue level achieved
by IV (systemic) delivery of gemcitabine at the same infusion rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>Dye
Staining Demonstrates RenovoTAMP Delivery of Agent to Lung Tissue</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure09_01.jpg" ALT="" STYLE="height: 232px; width: 478px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><I>Figure
9 Dense dye staining localized to the area of the isolated pulmonary artery segment and penetrating 4cm into surrounding tissue following
1 minute dye infusion. In addition, gemcitabine was delivered via RenovoTAMP for 20 minutes demonstrating 100-fold increase in tissue
concentration of gemcitabine compared to IV delivery of gemcitabine at the same infusion rate.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
concluded that RenovoTAMP can achieve drug penetration into the surrounding tissue and can achieve high dose of local tissue concentration.
The tissue concentration with intravenous infusion and/or distant from RenovoTAMP site (likely after recirculation through systemic system)
are two orders of magnitudes lower than tissue levels achieved with RenovoTAMP (p&lt;0.02).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>RenovoTAMP
Increases Local Tissue Concentration of Gemcitabine Compared to IV Infusion.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure10_01.jpg" ALT="" STYLE="height: 337px; width: 670px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099">Figure
10 Local <I>tissue concentration of gemcitabine. control (Blue): IV infusion versus RenovoTAMP (Orange): RenovoTAMP: intra-arterial infusion.
The tissue concentration with intravenous infusion and/or distant from RenovoTAMP site (likely after recirculation through systemic system)
are 100-fold lower than tissue levels achieved with RenovoTAMP.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
animal lung study successfully validated the efficacy and ability for RenovoCath to deliver small molecules locally to lung tissue with
the RenovoTAMP therapy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>III.</I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Increase
    in local tissue delivery of gemcitabine in LAPC should enhance tumor reduction and therapeutic response</I></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
relevant mouse models of pancreatic tumors, it has been demonstrated that targeted intra-arterial (IA) infusion of gemcitabine into the
pancreas after surgical isolation of arterial blood flow, has a superior therapeutic effect with greater reduction in tumor volume compared
to the same concentration administered by conventional systemic (IV) injection. To achieve a comparable reduction in tumor growth as
seen with IA treatment, gemcitabine had to be given IV at over 300 times the dose which was associated with some toxicity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RenovoTAMP
and Radiation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Traditionally
the goal of radiation includes a) debulking the tumor and/or b) acting as a chemo-sensitizer. In our RR1 dose escalation safety study
and RR2 observational registry study, the benefit of RenovoTAMP seems to be enhanced in patients with prior radiation. As we were observing
this effect months after radiation and several randomized studies have not demonstrated a benefit of chemotherapy + radiation versus
chemotherapy alone, we hypothesized that a direct effect of radiation on the vasculature may be enhancing the effect of RenovoTAMP. One
of the side effects of radiation is a decrease in the micro-vasculature in the irradiated tissue including the small blood vessels that
exist in the vessel walls themselves. Therefore, we postulated that by eliminating microvasculature in and around the vessel wall, radiation
may enhance drug penetration into the tissue via RenovoTAMP (Figure 11). As such a possible enhancing effect of radiation on RenovoTAMP
may involve decreasing washout of the drug as it crosses the arterial wall by preventing draining into the surrounding microvasculature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
completed a pig study where we observed the impact of RenovoTAMP in recruiting the vasa vasorum (small blood vessels within the larger
blood vessel walls) around the vessel during drug/dye infusion. It was discovered that the dye drained into the vasa vasorum and other
small vessels in the adjacent tissue (Figure 11); as these vessels can directly connect to the adjacent venous system, the microvascular
networks can serve as an &ldquo;escape route&rdquo; for drugs. Ultimately this direct washout can reduce the amount of drug concentration
in the tissue. Radiation pretreatment may enhance the impact of RenovoTAMP by attenuating this escape route.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>RenovoTAMP
Combined with Radiation Reduces Venous Outflow by Decreasing the Microvasculature</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure11_01.jpg" ALT="" STYLE="height: 209px; width: 626px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><I>Figure
11 Mechanism of RenovoTAMP and radiation reduces venous outflow by decreasing the microvasculature networks that could act as an &ldquo;escape
route&rdquo; for the drugs. The photo on the left illustrates this effect in a dye infusion study in the porcine animal model. The panel
on the right demonstrates venous chemotherapy washout without radiation versus less venous escape routes for chemotherapy following radiation.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 71; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
further advanced this theory by conducting a pig study to directly test whether radiation can enhance tissue uptake by RenovoTAMP. In
a single-animal study, we examined the use of Stereotactic Body Radiation Therapy (SBRT) pre-treatment on one leg followed by RenovoTAMP
versus RenovoTAMP without prior radiation therapy on the opposite leg. The leg of the animal that was pre-treated with radiation demonstrated
more pronounced tissue staining with methylene blue dye and increased gemcitabine concentration via punch biopsy. Based on these findings,
we believe that the benefit of prior radiation on clinical outcomes with RenovoTAMP may be improved by the effect of radiation on microvasculature
between the vessel wall and the tumor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>Dye
test Demonstrates that RenovoTAMP Plus Radiation Increases Concentration of Gemcitabine</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure12_01.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><I>Figure
12 To demonstrate the effect of radiation pre-treatment, we delivered radiation therapy to the left leg of a pig. After waiting for one
month for the vascular effect to take place, we performed RenovoTAMP on the left and right leg arteries with blue dye and gemcitabine.
Dissection revealed better dye penetration into the tissue on the left (irradiated) leg, and punch biopsy demonstrated higher gemcitabine
concentration in the left leg.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have demonstrated that the RenovoTAMP therapy allows targeted small molecule drug delivery into the tissue surrounding the vessel wall,
without need to identify tumor feeders. The mechanism of action is the exclusion of distal (downstream) and side branch vessels in the
isolated segment and subsequently achieving a pressure gradient by infusing the drug over time. The pressure gradient results in a diffusion-mediated
delivery of drug into the surrounding tissue. With the use of gemcitabine, the procedure appears safe in terms of local toxicity in the
vasculature. Using this approach, we can achieve increased drug delivery into the surrounding tissue in the range of 4cm-tissue penetration
and concentration orders of magnitude larger than what can be achieved with IV infusion. Lastly, RenovoTAMP appears to be enhanced by
prior radiation of tissue, possibly through its effect on decreasing the microvasculature and subsequent potential chemotherapy washout.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 72; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAPC
Clinical Development</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RenovoTAMP
has been studied in a phase 1/2 dose-ranging study of 20 subjects with locally advanced pancreatic cancer (RR1) and in an observational
study that enrolled 25 additional subjects with pancreatic cancer (RR2); two subjects from the RR1 safety study continued to receive
treatment in the RR2 observational registry study. We subsequently launched a Phase 3 registration trial (TIGeR-PaC) and as of April
30, 2021 we have enrolled 135 patients in this study.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Phase
1/2 Dose-Ranging Study: RR1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Study
Design</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
phase 1/2 safety study of our RenovoTAMP therapy has been completed in subjects with LAPC (Phase 1/2 RenovoCath/Gem RR1). This multicenter,
prospective, open label, interventional, nonrandomized, intra-subject dose escalation study evaluated IA gemcitabine delivered locally
to the pancreas using the RenovoCath in 20 subjects with locally advanced pancreatic cancer. The primary objectives of the study were
(1) to establish the maximum tolerated dose (MTD) and (2) to study the safety and tolerability of intra-arterial (IA) gemcitabine administered
by RenovoCath at doses ranging from 250 mg/m<SUP>2 </SUP>to 1000 mg /m<SUP>2</SUP>. Secondary endpoints included overall survival, CA
19-9 marker change, change in tumor size based on RECIST 1.1 (Response Evaluation Criteria in Solid Tumors) criteria, and pain
scores and narcotic use. Adverse events were collected from the first IA gemcitabine infusion until 3 months following the final IA gemcitabine
infusion. Subjects were followed for survival.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treatment
constituted introducing RenovoCath to target vessel (adjacent to tumor) via catheterization, occluding the targeted segments via the
RenovoCath balloons, and infusing gemcitabine in the occluded segment. To minimize ischemia (damage due to cessation of blood flow) the
infusion was limited to 20 minutes and anticoagulants (heparin) was given during the procedure. Tissue markers were followed post procedure
to ensure lack of local tissue damage-toxicity (AST, ALT, Lipase and Amylase).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treatment
was administered in four 28-day cycles, each of which consisted of two IA doses of gemcitabine, one on day 1 and one on day 15, with
a two-week rest period between cycles. The first six subjects received a starting does of 250mg/m<SUP>2</SUP>, and doses increased by
250 mg/m<SUP>2</SUP> in each subsequent cycle culminating with the full dose of 1,000 mg/m<SUP>2</SUP>. After the initial six subjects,
the starting dose increased to 500 mg/m<SUP>2</SUP> for one cycle, after which dosing increased to 750 mg/m<SUP>2 </SUP>for the second
cycle, and then the full 1,000 mg/m<SUP>2</SUP> dose for the remaining 2 cycles. Each subject underwent CT scanning prior to the first
procedure for the selection of the optimal target vessel most proximal to the tumor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Study
Subjects and RenovoGem Exposure </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
median age of subjects was 66.7 years with a gender distribution of 9 men and 11 women. Prior treatment included chemotherapy and radiation
therapy in 6 (30%), chemotherapy alone in 5 (25%) and no prior therapy in 9 (45%) subjects. Collectively the 20-subject cohort received
101 IA treatments. Importantly, 9 of the 20 subjects had a biliary stent or drain in place before the first IA procedure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trial
Results</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Safety</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was no evidence of local tissue toxicity in any patients post procedure as measured by liver and pancreatic enzymes. Adverse Events were
reported in 11 subjects, including catheterization/procedure-related events with arterial dissections at treatment sites (3), pseudoaneurysm
in a visceral artery (1) away from the treatment site and site complications (2) out of 101 procedures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Serious
adverse events were reported in 9 subjects during the study. Overall survival (including deaths that occurred following disease progression)
was followed in all study subjects. The number of subjects with serious adverse events is shown in Table 1 below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>Table
1 Summary of Serious Adverse Events for 9 subjects in RR1 Dose Ranging Study</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 58%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Serious
    Adverse Event</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">N=20</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cardiac
    Arrest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1/20 (5%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dehydration</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1/20 (5%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Duodenal
    obstruction</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1/20 (5%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gastritis</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1/20 (5%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Infection</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1/20 (5%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intraoperative
    arterial injury-dissection</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/20 (15%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intraoperative
    arterial injury-lower extremity</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1/20 (5%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pain-Abdominal
    NOS</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1/20 (5%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Respiratory
    failure</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">1/20 (5%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sepsis</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/20 (15%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Neutropenia</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4/20
    (20%)</FONT></TD></TR>
</TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099">This
table shows serious adverse events reported in 9 of the 20 subjects during the study. Several subjects had more than one serious adverse
event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Efficacy</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal evaluation of efficacy was survival. All subjects were followed for survival after the end of IA gemcitabine treatment. All
subjects have died, with the longest having an overall survival of 35.9 months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>Subjects
Who Received More Cycles Survived Longer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure13_01.jpg" ALT="" STYLE="height: 315px; width: 626px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><I>Figure
13 This chart shows survival as a function of total number of IA treatment cycles received. Subjects receiving all 4 cycles (n=8) had
a median survival time of 21.7 months, compared to a median survival time of 10.9 months for all subjects (n=20).</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>Subjects
Who Received Greater Cumulative Exposure Survived Longer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure14_01.jpg" ALT="" STYLE="height: 315px; width: 626px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><I>Figure
14 Splitting the entire cohort into equal tertiles based on total dose received, patients receiving the lowest total dose (&lt;2.5g/m2;
n=7) demonstrated the lowest median overall survival (8.1 months) compared to patients in the group receiving the next higher total dose
(&gt;2.5g/m2, but &lt;4g/m2; n=6; median OS=10.9 months), and patients in the group receiving the highest total dose (&gt;4g/m2; n=7;
median OS=27.5 months).</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fifteen
subjects received more than 1 cycle of intra-arterial gemcitabine treatment. The blue line depicts subjects without any prior treatment
or received prior chemotherapy only (n=10; median OS=13.6 months). The green line depicts subjects who received prior chemoradiation
(n=5; median OS=28.2 months). P &lt; 0.05 for survival between the two subsets. Survival appeared to be longer in subjects who had prior
chemoradiation as shown below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>Subjects
Who Had Prior Radiation Exposure Survived Longer Than Those Who Did Not</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure15_01.jpg" ALT="" STYLE="height: 310px; width: 626px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099">Figure
15 Survival of subjects with or without Prior Chemoradiation. Subjects with prior chemoradiation (n=5) had a median survival time of
28.2 months, compared with a median survival time of 13.6 months for subjects without prior chemoradiation (n=10).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Disease
progression based on RECIST 1.1 Criteria</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
RECIST 1.1 criteria was used to compare the baseline and follow up CT images submitted by sites. Follow up CT scans obtained 5
months after initiation of IA gemcitabine therapy were submitted for 17 of the 20 subjects and were compared to the baseline images.
Six of the 17 subjects (35.3%) experienced tumor progression, 1 (5.9%) had a partial response, and 10 (58.8%) demonstrated stable disease
5 months post treatment initiation. Two of the 6 subjects with tumor progression received less than 1 cycle (only 1 treatment) of IA
gemcitabine. Among 15 subjects who received more than 1 cycle (2 treatments), 26.7% had disease progression, 6.7% had partial response
and 66.7% had stable disease 5 months post IA therapy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>CA
19-9 Tumor Marker Change</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA19-9
is a protein that can be detected in serum and is a biomarker of pancreatic cancer; its levels can be used to assess tumor response to
therapy. Twelve of 20 subjects had measurable CA 19-9 tumor markers. The final CA 19-9 tumor marker levels were lower in 7 of 12 (58%)
and greater in 5 of 12 (42%) subjects. It is notable that, final tumor marker levels were lower in 4 of 5 subjects with prior chemoradiation
and higher in 5 of 7 subjects without prior chemoradiation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Observational
Registry Study RR2</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
launched the RR2 observational registry study in January 2016 to further explore the clinical utility of the RenovoTAMP procedure.
The key inclusion criteria included patients with locally advanced or borderline resectable pancreatic adenocarcinoma confirmed by
histology or cytology. This was an observational patient registry study with endpoints of safety and survival following intra-arterial
gemcitabine treatment with RenovoCath. The study was conducted at 7 sites in the US and subsequently closed on August 2019 except for
one US site (that did not participate in the Phase 3 study). This last site the study was officially closed in September 2020. Over the
3 years that the trial was open, we enrolled 25 subjects with LAPC. Two of the subjects participated in our Phase 1/2 RenovoCath/Gem
RR1 trial, in which each received 8 IA gemcitabine infusions prior to enrollment in the RR2 study for observation of additional IA gemcitabine
infusions. A summary of data updated through January 2021 is presented below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
study initially enrolled LAPC subjects without regard to prior radiation or chemotherapy; after the observation of longer survival of
subjects with prior chemoradiation versus subjects who had not had prior radiotherapy, entry into the registry was restricted to subjects
with LAPC who had received prior radiation beginning April 2017. Of note, one subject who had prior pancreatic cancer surgery (Whipple
procedure) would not normally have been enrolled in the study but was included for safety observations as her physician had previously
planned IA gemcitabine therapy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investigators
in the study reported all Serious Adverse Events from the first IA gemcitabine infusion to at least 60 days post-last procedure but reporting
of non-serious adverse events was optional. All subjects received gemcitabine 1000 mg/m<SUP>2</SUP> every two weeks, except one who received
500 mg/m<SUP>2</SUP>, typically for a total of 8 doses. Subjects were followed post treatment for survival.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Study
Subjects and RenovoGem Exposure</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Twenty-five
subjects were enrolled at 7 sites. The study enrolled 15 women (60%) and 10 men (40%); with a mean and median age of 73. Of the 25, 10
(40%) had no prior therapy, 8 (32%) had radiotherapy and chemotherapy, 6 had chemotherapy alone and 1 (4.5%) had surgery (Whipple procedure).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
subjects were continuations from the previous Phase 1/2 RenovoCath/Gem RR1 study, and as a result, received more than eight treatments
(total in both studies). The treatment received summary is shown in Table 2:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>Table
2 Dosing Treatments Tally for RR2 Observational Registry Study, for 25 Subjects Enrolled at 7 Sites</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 0pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Number
                                            of Dosing Treatments</B></FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>N=25</B></FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 0pt; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5/25
    (20%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/25
    (12%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">4/25
    (16%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">5/25
    (20%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2/25
    (8%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">7</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2/25
    (8%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">8</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2/25
    (8%)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&gt;8</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2/25
    (8%)</FONT></TD></TR>
</TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099">Twenty-five
subjects, 15 women (60%) and 10 men (40%); with a mean and median age of 73 were enrolled at 7 sites. Of 25, 10 (40%) had no prior therapy,
8 (32%) had radiotherapy and chemotherapy, 6 had chemotherapy alone and 1 (4.5%) had surgery (Whipple procedure).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trial
Results</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Safety</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were number of adverse events reported. The most common were nausea (36%), vomiting (28%), abdominal pain (32%), followed by vascular
access complications (16%). The less common adverse events reported (&lt; 5%) included rash, allergic reaction, retroperitoneal hemorrhage,
sepsis, ischemic bowel, arterial spasm, atrial fibrillation, chest pain, back pain, hypoglycemia, pruritis, and other GI issues. No deaths
were noted in the immediate post-treatment period. No deaths were considered related to study treatment. Survival is summarized as an
efficacy evaluation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary
of Key Safety Observations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
    pancreatitis nor local tissue toxicity was reported in LAPC subjects without prior surgery.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
    was no instance of arterial dissection in this study.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    incidence of sepsis was lower in this study (1/25 subjects receiving 94 infusions) compared with the incidence in Phase 1/2 RenovoCath/Gem
    RR1 (3/20 subjects receiving 101 infusions). The subject with sepsis did not have a biliary stent or drain and the source of the
    sepsis was not identified. No sepsis events were noted after 51 infusions in 12 subjects with biliary stents, who received peri-procedure
    antibiotics. The incidence of sepsis in the RR2 observational registry is similar to that of pancreatic cancer subjects receiving
    myelosuppressive chemotherapeutic regiment in other studies. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Efficacy</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluding
the subject with prior or post pancreatic cancer surgery, median survival (n=22) from the time of first IA gemcitabine treatment was
5.43 months, as illustrated in and median overall survival was 13.0 months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>Survival
of all Subjects from first IA Gemcitabine Treatment (Median 5.43 Months)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure16_01.jpg" ALT="" STYLE="height: 310px; width: 626px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><I>Figure
16 Overall RR2 observational registry study cohort (N=22) survival from first IA treatment until date of death.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>Overall
Survival of All Subjects (Median Overall Survival 13 Months)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure17_01.jpg" ALT="" STYLE="height: 312px; width: 626px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><I>Figure
17 Overall RR2 observational registry study cohort (N=22) overall survival from date of diagnosis.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
in Phase 1/2 RenovoCath/Gem RR1, subjects with prior radiation and chemotherapy demonstrated longer survival than other subjects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>Subjects
with Prior Chemo or Prior Chemoradiation Survive Longer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure18_01.jpg" ALT="" STYLE="height: 313px; width: 626px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><I>Figure
18 Survival as function of previous treatment received for RR2 registry study subjects. As in RR1 study, subjects with prior radiation
and chemotherapy demonstrated longer survival than other subjects.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
summary the results of RR2 observational registry, build on the finding of the Phase 1/2 RenovoCath/Gem RR1 study, where the use of RenovoCath
in this patient population can be undertaken with adequate safety, with adequate attention to procedural technique including careful
use/manipulation of guide catheter to prevent arterial dissection, and administration of peri-procedure antibiotics in patients with
prior biliary stent/drain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>RR1
and RR2 Conclusions</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patients
</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">with LAPC treated with RenovoTAMP showed efficacy signals:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Survival
    of patients with LAPC following RenovoTAMP was similar to that observed in the previous Phase 1/2 RenovoCath/Gem RR1 study. </FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patients
    with biliary stents or drains who received RenovoTAMP who received prophylactic peri-procedure antibiotics experienced no episodes
    of sepsis. </FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LAPC
    patients who received prior radiation and chemotherapy had longer survival than those without prior radiotherapy. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Based
on the FDA&rsquo;s safety review of our phase 1/2 study and clinical outcome, the FDA allowed us to proceed to evaluate RenovoGem within
our Phase 3 registration clinical trial.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>TIGeR-PaC
Phase 3 Trial (RR3)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
completion of RR1 and RR2 we obtained FDA approval for Phase 3 IND study in Feb 2018 comparing RenovoTAMP with intra-arterial gemcitabine
to standard of care. In the FDA pre-IND meeting, the FDA confirmed the study design and endpoints and indicated that this Phase 3 study
should result in New Drug Application approval if successful. Simultaneously in April 2018 we obtained Orphan drug designation for use
of RenovoGem in patients with LAPC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary endpoint of the study is overall survival, from time of randomization until death. Secondary endpoints include but not limited
to progression free survival and quality of life questionnaire results. The study is a multi-center, open-label, randomized active-controlled
study of subjects with locally advanced pancreatic adenocarcinoma which is unresectable according to NCCN guidelines. The study is currently
enrolling patients in the US and Belgium.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
study design is follows: all patients receive a four-month induction phase of IV chemotherapy and radiation prior to randomizing to 4
cycles (8 treatments) of RenovoTAMP or 4 cycles of continuation of IV chemotherapy. While RenovoTAMP data versus historical controls
predicts a much greater survival benefit, the TIGeR-PaC study is powered to detect a 6-month survival benefit. The TIGeR-PaC SAP includes
an interim analysis with the potential of early FDA approval or Breakthrough Status with a strong efficacy signal early in the study.
A study flowchart is shown below. Subjects with stable or responding disease after approximately 4 months in induction therapy and who
are not surgical candidates will then be randomized 1:1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>TIGeR-PaC
Study Flowchart with Chemoradiation Induction Phase</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure19_01.jpg" ALT="" STYLE="height: 242px; width: 626px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><I>Figure
19 TIGeR-PaC Study Flowchart. All subjects undergo a 4-month induction phase that includes IV gemcitabine + Abraxane and radiation therapy.
If the subjects are stable with LAPC post-induction, they are randomized 1:1 into control group (IV gemcitabine + Abraxane) versus treatment
group (intra-arterial gemcitabine via RenovoTAMP therapy). Subjects are then administered continuation therapy until disease progression
and followed through survival.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
study currently has 28 active clinical sites. As of April 30, 2021, 135 participants have enrolled in the study and ultimately
approximately 340 participants are expected to be enrolled in the study with 200 participants randomized in the US and Europe. An interim
analysis is planned when a total of 65 deaths (randomized patients) have been observed and is projected to be in the second half
of 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is projected that enrollment and randomization of the entire cohort will be completed in 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clinical
Pharmacokinetic (PK) Data in Patients with LAPC Treated with Gemcitabine via RenovoTAMP</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect intra-arterial gemcitabine delivered via the RenovoTAMP technique to have distinct PK from IV gemcitabine dosing. Furthermore,
with local delivery of gemcitabine into the tissue via RenovoTAMP and drainage into the liver prior to systemic circulation, lower systemic
levels of gemcitabine would be anticipated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are collecting blood samples for PK analysis in 15 patients from our TIGeR-PaC Phase 3 study (Figure 20, below). Our initial data on
the first 5 patients demonstrate a 3-fold decrease in Cmax, or maximum serum concentration of a drug, with RenovoTAMP compared
to established levels for IV gemcitabine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 9; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #000099"><B>Systemic
Levels of Gemcitabine Reduced by 2/3 with RenovoTAMP versus IV Gemcitabine</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><IMG SRC="figure20_01.jpg" ALT="" STYLE="height: 288px; width: 626px"></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><I>Figure
20 Initial blood PK data demonstrated a 3-fold decrease in systemic concentration of gemcitabine (Cmax) with RenovoTAMP compared to established
levels for IV gemcitabine.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Second
Solid Tumor Indication</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HCCA
Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cholangiocarcinoma
is the second most common primary malignant tumor of the liver with over 7,000 new cases diagnosed annually in the US. Cholangiocarcinoma
(CCA) develops after malignant transformation of the biliary tract mucosa. The global market of CCA was estimated to be $385 million
in 2018 and the US accounted for the largest market size of CCA. Furthermore, the market size for global CCA therapeutics is estimated
to grow by $83 million during 2019-2023 with a compound annual growth rate of 6%. Advanced age, male gender, primary sclerosing cholangitis
(PSC), inflammatory bowel disease, pancreatitis, and cirrhosis are some predisposing factors for development of CCA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the tumor location CCA is defined as intra-hepatic, or within the liver, and extra-hepatic, or hilar. The HCCA subset of CCA patients
are about 3000 cases per year. HCCA is a disease with an exceptionally poor prognosis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HCCA
Current Treatment Landscape and Limitations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
patients with HCCA have localized disease with possible extension of the tumor around the bile duct. Based on local extension of the
disease, treatment options include surgery, chemotherapy, and radiation therapy. Surgical resection offers the only chance for curative
therapy for patients with HCCA; however, the surgery is associated with high mortality and morbidity and most patients are not candidates.
Systemic chemotherapy is a primary mode of treatment in these patients as a form of palliation, which is associated with morbidity and
limited improvement in survival.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
standard chemotherapy treatment in these patients is based on the ABC-2 Trial: a randomized trial of 410 patients with unresectable CCA
(the study included both intrahepatic, within the liver, and hilar cholangiocarcinoma patients). <FONT STYLE="background-color: white">Patients
were treated with gemcitabine plus cisplatin, consisting of a three-week cycle, with treatments on Days 1 and 8 and dosing of </FONT>gemcitabine
<FONT STYLE="background-color: white">at 1000mg/m<SUP>2</SUP> and cisplatin at 25mg/m<SUP>2</SUP>. Reported median O.S. for patients
on such a regimen (11.7 months) was greater than patients receiving gemcitabine alone (8.1 months). Commonly observed Grade 3-4 toxicity
of this standard of care treatment include anemia, leukopenia, neutropenia, thrombocytopenia, lethargy, nausea/vomiting, and anorexia.
</FONT>In the ABC-02 trial the efficacy of gemcitabine/cisplatin combination was not significantly different from that of gemcitabine
alone in patients with hilar cholangiocarcinoma. For this reason, a practice standard of care has not been established for hilar cholangiocarcinoma.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 10; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RenovoGem
for the Treatment of HCCA</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Similar
to RenovoGem for LAPC, we believe that RenovoGem may overcome the current treatment limitations of HCCA. In this setting, patients with
HCCA have several features that make them attractive for treatment via our RenovoTAMP therapy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Local
    disease with possible extension of disease to local vasculature</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avascular
    nature of the tumor lends itself to our RenovoTAMP approach, overcoming the limitations in drug delivery by targeting the periductal
    proper hepatic artery or left or right hepatic artery</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gemcitabine,
    used as a target molecule for this tumor type, has already been demonstrated to be safe in terms of local toxicity targeted via our
    approach to this vasculature and organ</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    bile duct around the hilum is usually within 1-14mm (mean of 3.8 mm) of the hepatic artery: a reasonable target for RenovoTAMP therapy
    given the potential 4cm tissue penetration of drug</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-indent: -36.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clinical
Development of RenovoGem in HCCA</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BENEFICIAL
Study Design and Rationale </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA granted us Orphan Drug Designation in June of 2020 for the treatment of CCA with RenovoTAMP. Shortly after the granted designation
we began working on the BENEFICIAL study protocol. We intend to meet with the FDA to propose a phase 2/3 trial for approval of RenovoTAMP
for HCCA and, if approved by the FDA, to initiate such a study in the first half of 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect the study duration will be up to 4.5 years, with an estimated 30 months of enrollment and 2 years of follow-up to have 150 subjects
enrolled and 100 subjects randomized. The study is a multi-center, open-label, randomized active-controlled study of subjects with hilar
cholangiocarcinoma which is unresectable according to NCCN guidelines. We intend to conduct the study in up to 8 U.S. sites.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary endpoint of the study is time to treatment failure (progression or if the subject can no longer tolerate treatment) from randomization.
Secondary endpoints include, but not limited to, overall survival, time to progression from randomization to radiologic progression,
progression free survival and tumor response by RECIST 1.1 guidelines.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are four phases to the study after screening: Induction, Randomization Treatment, Continuing Therapy and Survival follow-up. All subjects
receive an initial four-month induction phase of IV chemotherapy (gemcitabine + cisplatin) and radiation. Subjects with stable or responding
disease after approximately 3 months of induction therapy, and who are not surgical candidates, will then be randomized 1:1 to either
4 cycles (8 treatments) of RenovoTAMP or 5 cycles of IV chemotherapy in addition to the 3 received during induction. Subjects will receive
capecitabine during continuing therapy after completion of randomization treatment without disease progression or treatment intolerance.
Subjects will be followed for up to three years for survival.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
inclusion criteria include biopsy proven cholangiocarcinoma within 6 weeks of consent, unresectable cholangiocarcinoma (stage 4A included),
measurable disease as per RECIST 1.1 must be present, and ECOG Performance Status score of 0-1. Key exclusion criteria include contraindications
to angiography and selective visceral catheterization, location of tumor more than 15mm from targeted IA therapy location as per imaging,
cirrhosis (Child-Pugh &gt; Class B7) and clinically evident ascites.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>BENEFICIAL
Study Flowchart</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: #1F497D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure21_01.jpg" ALT="" STYLE="height: 228px; width: 626px"></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099">Figure
21 BENEFICIAL study flowchart. All subjects undergo a 4-month induction phase that includes IV gemcitabine + Cisplatin and radiation
therapy. If the subjects are stable with LAPC post-induction, they are randomized 1:1 into control group (IV gemcitabine + Cisplatin)
versus treatment group (intra-arterial gemcitabine via RenovoTAMP therapy). Subjects are then administered continuation therapy until
treatment failure (cessation of continuation therapy, change in continuation therapy, progression, and/or death).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Market
Opportunity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently developing RenovoGem for LAPC, intend to develop it for HCCA, and potentially for locally advanced lung cancer, locally
advanced uterine cancer and glioblastoma. We estimate that the total annualized addressable market opportunity for RenovoGem for our
first market, LAPC, in the United States is approximately $0.5 billion and globally can exceed $1 billion based on a third-party market
research analysis. The total cost of care of a patient on the standard of care treatment of gemcitabine + Abraxane is estimated at $67,216,
which if applied to 60,000 pancreatic cancer cases per year would total $4 billion per year for the total U.S. pancreatic cancer market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beyond
our initially targeted subset of LAPC patients, we see potential to evaluate RenovoGem in additional settings where it may help to get
more patients to surgery, prolong life, enhance systemic therapy or provide local therapy with fewer side effects than alternative treatments.
These may include patients with stage 1 or stage 2 pancreatic cancer receiving neoadjuvant as well as in subpopulations of patients with
metastases who also have locally advanced disease. From third-party market research, a number of physicians mentioned a role for local
therapy as an adjunct for systemic chemotherapy as well as for patients who decline systemic chemotherapy. Beyond pancreatic cancer,
there are additional markets we will be exploring.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below
is published epidemiology data showing the 2021 estimated annual incidence of the following tumor types in the United States to be greater
than 350,000 patients in the aggregate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099"><B>Market
Opportunity for RenovoTAMP</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: #1F497D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="figure22_01.jpg" ALT="" STYLE="height: 455px; width: 626px"></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000099">Figure
22 Market Opportunity of target cancers, showing overall incidence in blue, and those treatable via RenovoTAMP in orange.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&#9679;</FONT></TD>
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Pancreatic Cancers compared to Locally Advanced Pancreatic Cancers (LAPC)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&#9679;</FONT></TD>
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Cholangiocarcinoma (CCA) compared to Hilar CCA</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&#9679;</FONT></TD>
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Non-Small Cell Lung Cancers (NSCLC) compared to Stage 3 NSCLC</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&#9679;</FONT></TD>
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Glioma compared to Glioblastoma</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&#9679;</FONT></TD>
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Uterine cancers versus Transcatheter arterial chemoembolization (TACE) eligible uterine cancers </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intellectual
Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Our
success depends in part on our ability to obtain patents and trademarks, maintain trade secret and know-how protection, enforce our proprietary
rights against infringers, and operate without infringing on the proprietary rights of </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">third
<FONT STYLE="background-color: white">parties. Because of the length of time and expense associated with developing new products and
bringing them through the regulatory approval process, the health care industry places considerable emphasis on obtaining patent protection
and maintaining trade secret protection for new technologies, products, processes, know-how, and methods. </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Our
intellectual property protection stems from several issued device and method patents on our RenovoCath delivery system that optimizes
delivery of the anti-cancer drug and the RenovoTAMP therapy platform. Our issued patents also </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
<FONT STYLE="background-color: white">exclusivity as it relates to utilizing RenovoCath with anti-cancer drugs. </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have 6 US patents issued, 1 European patent issued, and 1 patent pending in each of China, Japan, Europe, and India. In addition,
we have two pending US patents, one of which is allowed, that we expect will be issued in the second or third quarter of
2021. We continue to explore additional opportunities to further bolster our IP position. Table 3 below describes our issued pat<FONT STYLE="font-size: 10pt">ents,
all of which have been assigned to us.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Table
3 <FONT STYLE="font-style: normal">RenovoRx has Significant Patent Protection with 7 Issued Patents</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Family</B></FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>App.
                                            No.</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing
                                            Date</B></FONT></P></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
    of Patent Protection</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent
    Focus</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent
    #</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Estimated</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expiration</B></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dual
    Balloon Methods and Apparatuses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/958711
    <BR>Filed: 12/2/2010</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Utility patent</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Methods:
    isolating splenic artery with 2 balloons (sliding inner catheter)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    8,821,476</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    25, 2033</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dual
    Balloon Methods and Apparatuses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14/870833
    <BR>Filed: 9/30/2015</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Utility patent</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apparatus:
    2 balloons, seal to isolate lumen, and infusion aperture</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    9,463,304</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    2, 2030</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dual
    Balloon Methods and Apparatuses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14/293603
    <BR>Filed: 6/2/2014</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Utility patent</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apparatus:
    2 balloons (sliding inner catheter), 2 ports for fluid handling</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    9,457,171</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    16, 2031</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dual
    Balloon Methods and Apparatuses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15/351922
    <BR>File: 11/15/2016 <BR></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Utility patent</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kits
    for chemotherapy including catheter with 2 balloons, an infusion aperture and 2 ports</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    10,512,761</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    16, 2031</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dual
    Balloon Methods and Apparatuses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/8351107
    <BR>Filed: 12/2/2010</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.U.
    Utility patent, nationalized in BE, CH, DE, ES, FR, GB, IE, IT and NL</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    two occlusion element, adjustable delivery apparatus having inner and outer catheter, seal to isolate lumen</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.U.
    2506913</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    2, 2030</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Side
    Branch Isolation Device and Methods</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14/958428
    <BR>Filed: 12/3/2015</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Utility patent</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apparatuses
    and Methods: 3 balloon catheters for isolating side branches</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    10,099,040</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    3, 2035</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trans-Arterial
    Micro-Perfusion (TAMP)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15/807011
    <BR>Filed: 11/8/2017</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Utility patent</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Methods
    delivering radiation to devascularize then TAMP</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.,
    10,695,543</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    28, 2038</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dual
    Balloon Methods and Apparatuses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16/685950
    <BR>Filed: 11/15/2019</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Utility patent <BR>(Pending application)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Methods
    of treating bile duct</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PENDING</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    16, 2031*</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trans-Arterial
    Micro-Perfusion (TAMP)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16/685974
    <BR>Filed: 11/15/2019</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Utility patent <BR>(Pending application)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Devascularization
    in conjunction with TAMP</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PENDING
    and ALLOWED</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    8, 2037*</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dual
    Balloon Methods and Apparatuses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
    1632MUMNP2012 <BR>Filed: 12/2/2010 <BR></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
    Utility patent <BR>(Pending application)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    two occlusion element, adjustable delivery apparatus having inner and outer catheter, seal to isolate lumen</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PENDING</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    2, 2030*</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trans-Arterial
    Micro-Perfusion (TAMP)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CN
    2018800033529 <BR>Filed: 5/18/2018</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CN
    Utility patent <BR>(Pending application)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Devascularization
    in conjunction with TAMP</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PENDING</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    8, 2037*</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trans-Arterial
    Micro-Perfusion (TAMP)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EP
    187315908 <BR>Filed: 5/18/2018</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EP
    Utility patent <BR>(Pending application)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Devascularization
    in conjunction with TAMP</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PENDING</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    8, 2037*</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trans-Arterial
    Micro-Perfusion (TAMP)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JP
    2020514151 <BR>Filed: 5/18/2018</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JP
    Utility patent <BR>(Pending application)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Devascularization
    in conjunction with TAMP</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PENDING</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    8, 2037*</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><B>&nbsp;</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have additional market exclusivity protection with Orphan Drug Designation for seven years post-approval. Gemcitabine is generic; however,
we have exclusivity for the intra-arterial route of administration. RenovoGem is regulated by the FDA as a novel oncology drug product.
We intend to make intra-arterial gemcitabine and RenovoCath available as a combined product and not to make either component available
separately. Once approved, we will have exclusivity over the use of intra-arterial gemcitabine as it will be approved by the FDA in combination
with RenovoCath.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
appropriate, we actively pursue protection of our proprietary products, technologies, processes, and methods by filing United States
and international patent and trademark applications. We seek to pursue additional patent protection for technology invented through research
and development, manufacturing, and clinical use of our technology that will enable us to expand our patent portfolio around advances
to our current systems, technology, and methods for our current applications as well as beyond the treatment of cancers in the liver.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that the pending patent applications will result in the issuance of patents, that patents issued to or licensed by
us will not be challenged or circumvented by competitors, or that these patents will be found to be valid or sufficiently broad to protect
our technology or provide us with a competitive advantage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
maintain our proprietary position, we also rely on trade secrets and proprietary technological experience to protect proprietary manufacturing
processes, technology, and know-how relating to our business. We rely, in part, on confidentiality agreements with our marketing partners,
employees, advisors, vendors and consultants to protect our trade secrets and proprietary technological expertise. In addition, we also
seek to maintain our trade secrets through maintenance of the physical security of the premises where our trade secrets are located.
There can be no assurance that these agreements will not be breached, that we will have adequate remedies for any breach, that others
will not independently develop equivalent proprietary information or that third parties will not otherwise gain access to our trade secrets
and proprietary knowledge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
certain circumstances, United States patent law allows for the extension of a patent&rsquo;s duration for a period of up to five years
after FDA approval. We intend to seek extension for one of our patents after FDA approval if it has not expired prior to the date of
approval. In addition to our proprietary protections, the FDA has granted us two orphan drug designations that provide us a seven-year
period of exclusive marketing beginning on the date that our NDA is approved by the FDA for the designated orphan drug. While the exclusivity
only applies to the indication for which the drug has been approved, we believe that this exclusivity will provide us with added protection
once commercialization of an orphan drug designated product begins.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
has been and continues to be substantial litigation regarding patent and other intellectual property rights in the pharmaceutical and
medical device areas. If a third party asserts a claim against us, we may be forced to expend significant time and money defending such
actions and an adverse determination in any patent litigation could subject us to significant liabilities to third parties, require us
to redesign our product, require us to seek licenses from third parties, and, if licenses are not available, prevent us from manufacturing,
selling or using our system. Additionally, we plan to enforce our intellectual property rights vigorously and may find it necessary to
initiate litigation to enforce our patent rights or to protect our trade secrets or know-how. Patent litigation can be costly and time
consuming and there can be no assurance that the outcome will be favorable to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Manufacturing
and Supply </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on a single-source contract manufacturer, Medical Murray, North Barrington, IL, for the device component, RenovoCath, of the drug-device
combination and are subject to regulatory requirements of the FDA&rsquo;s Quality System Regulation (QSR), for medical devices sold in
the United States, and the European Medical Device Directive 93/42/EEC and amendments, or MDD, for medical devices marketed in the European
Union. We have an agreement in place with Medical Murray to produce the RenovoCath through October 2024 with automatic annual renewal
until termination by either party with 12 months&rsquo; notice. While we believe Medical Murray has the capabilities to scale RenovoCath
production to peak forecasted commercial volumes, manufacturing can be transferred to additional vendors if needed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA monitors compliance with QSR through periodic inspections of both our facility and the facility of our contact manufacturer. Our
European Union Notified Body, British Standards Institute (BSI), monitors compliance with the MDD requirements through both annual scheduled
audits and periodic unannounced audits of our facilities as well as our contract manufacturer&rsquo;s facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
failure or the failure of our contract manufacturer to maintain acceptable quality requirements could result in the shutdown of our manufacturing
operations or the recall of products which could be detrimental to our company. If our contract manufacturer fails to maintain acceptable
quality requirements, we may have to qualify a new contract manufacturer and could experience a material adverse effect to manufacturing
and manufacturing delays as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not own or operate and do not intend to establish our own gemcitabine manufacturing facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
our TIGeR-PaC Phase 3 trial, hospitals are sourcing generic gemcitabine labeled for IV use from their own respective pharmacies to use
in conjunction with the RenovoCath for the RenovoTAMP procedures. In the commercial setting, we expect to rely on contract manufacturing
organizations for gemcitabine production, relabeling and co-packaging with the RenovoCath. The formulation of gemcitabine used in the
TIGeR-PaC Phase 3 trial and in the commercial setting will be identical, however, the labeling of gemcitabine will be intra-arterial
gemcitabine to be used exclusively in conjunction with the RenovoCath.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Government
Regulation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products are subject to extensive and rigorous government regulation by foreign regulatory agencies and the FDA. Foreign regulatory agencies,
the FDA and comparable regulatory agencies in state and local jurisdictions impose extensive requirements upon the clinical development,
pre-market clearance and approval, manufacturing, labeling, marketing, advertising and promotion, pricing, storage and distribution of
pharmaceutical and medical device products. Failure to comply with applicable foreign regulatory agency or FDA requirements may result
in Warning Letters, fines, civil or criminal penalties, suspension or delays in clinical development, recall or seizure of products,
partial or total suspension of production or withdrawal of a product from the market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>United
States Regulatory Environment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the US, the FDA regulates drug and device products under the FDCA, and its implementing regulations. RenovoGem is subject
to regulation as a combination product, which means it is composed of both a drug component and device component. Each
component of a combination product is subject to the requirements established by the FDA for that type of component and if
marketed individually, each component would be subject to different regulatory pathways and reviewed by different centers within
the FDA. A combination product, however, is assigned to a center that will have primary jurisdiction over its pre-market review
and regulation based on a determination of its primary mode of action, which is the single mode of action that provides the most
important therapeutic action. In the case of RenovoGem, the primary mode of action is attributable to the drug component
of the product, which means that the Center for Drug Evaluation and Research, has primary jurisdiction over its pre-market development
and review.</FONT> Combination products where the drug provides the primary mechanism of action are often referred to as &ldquo;drug-led
combination&rdquo; products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
process required by the FDA before drug product candidates, including drug-led combination products, may be marketed in
the United States generally involves the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">submission
    to the FDA of an IND, which must become effective before human clinical trials may begin and must be updated periodically, but at
    least annually;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">completion
    of extensive preclinical laboratory tests and preclinical animal studies, all performed in accordance with the FDA&rsquo;s Good Laboratory
    Practice, or GLP, regulations;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">performance
    of adequate and well-controlled human clinical trials to establish the safety and efficacy of the product candidate for each proposed
    indication;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">submission
    to the FDA of an NDA after completion of all pivotal clinical trials;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    determination by the FDA within 60 days of its receipt of an NDA to file the NDA for review;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">satisfactory
    completion of an FDA pre-approval inspection of the manufacturing facilities at which the product is produced and tested to assess
    compliance with current good manufacturing practice, or cGMP, regulations; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FDA
    review and approval of an NDA prior to any commercial marketing or sale of the drug in the United States.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
development and approval process requires substantial time, effort and financial resources, and we cannot be certain that any approvals
for our product will be granted on a timely basis, if at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of preclinical tests (which include laboratory evaluation as well as GLP studies to evaluate toxicity in animals) for a particular
product candidate, together with related manufacturing information and analytical data, are submitted as part of an IND to the FDA. The
IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA, within the 30-day time period, raises concerns
or questions about the conduct of the proposed clinical trial, including concerns that human research subjects will be exposed to unreasonable
health risks. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin.
IND submissions may not result in FDA authorization to commence a clinical trial. A separate submission to an existing IND must also
be made for each successive clinical trial conducted during product development. Further, an independent institutional review board,
or IRB, for each medical center proposing to conduct the clinical trial must review and approve the plan for any clinical trial before
it commences at that center and it must monitor the study until completed. The FDA, the IRB or the sponsor may suspend a clinical trial
at any time on various grounds, including a finding that the subjects or patients are being exposed to an unacceptable health risk. Clinical
testing also must satisfy extensive good clinical practice regulations and regulations for informed consent and privacy of individually
identifiable information. Similar requirements to the United States IND are required in the EU and other jurisdictions in which we may
conduct clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 16; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clinical
Trials</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of NDA submission and approval, clinical trials are typically conducted in the following sequential phases, which may overlap:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
    1 Clinical Trials. Studies are initially conducted in a limited population to test the product candidate for safety, dose tolerance,
    absorption, distribution, metabolism and excretion, typically in healthy humans, but in some cases in patients.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
    2 Clinical Trials. Studies are generally conducted in a limited patient population to identify possible adverse effects and safety
    risks, explore the initial efficacy of the product for specific targeted indications and to determine dose range or pharmacodynamics.
    Multiple Phase 2 clinical trials may be conducted by the sponsor to obtain information prior to beginning larger and more expensive
    Phase 3 clinical trials.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
    3 Clinical Trials. These are commonly referred to as pivotal studies. When Phase 2 evaluations demonstrate that a dose range of the
    product is effective and has an acceptable safety profile, Phase 3 clinical trials are undertaken in large patient populations to
    further evaluate dosage, provide substantial evidence of clinical efficacy and further test for safety in an expanded and diverse
    patient population at multiple, geographically dispersed clinical trial centers.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase
    4 Clinical Trials. The FDA may approve an NDA for a product candidate, but require that the sponsor conduct additional clinical trials
    to further assess the drug after NDA approval under a post-approval commitment. In addition, a sponsor may decide to conduct additional
    clinical trials after the FDA has approved an NDA. Post-approval trials are typically referred to as Phase 4 clinical trials.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsors
of clinical trials may submit proposals for the design, execution, and analysis for their pivotal trials under a Special Protocol
Assessment, or SPA. A SPA is an evaluation by the FDA of a protocol with the goal of reaching an agreement that the Phase
3 trial protocol design, clinical endpoints, and statistical analyses are acceptable to support regulatory approval of the drug
product candidate with respect to effectiveness for the indication studied. Under a SPA, the FDA agrees to not later alter its
position with respect to adequacy of the design, execution or analyses of the clinical trial intended to form the primary basis
of an effectiveness claim in an NDA, without the sponsor&rsquo;s agreement, unless the FDA identifies a substantial scientific
issue essential to determining the safety or efficacy of the drug after testing begins.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to initiating our currently ongoing Phase 3 clinical trial(s), we submitted a proposal for the design, execution and analysis under a
SPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
Drug Applications (NDAs)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of drug development, preclinical studies and clinical trials are submitted to the FDA as part of an NDA. NDAs also must
contain extensive chemistry, manufacturing and control information. An NDA must be accompanied by a significant user fee, which
may be waived in certain circumstances. Once the submission has been accepted for filing, the FDA&rsquo;s goal is to review applications
within ten months of submission or, if the application relates to an unmet medical need in a serious or life-threatening indication,
six months from submission. The review process is often significantly extended by FDA requests for additional information or clarification.
The FDA may refer the application to an advisory committee for review, evaluation and recommendation as to whether the application
should be approved. For new oncology products, the FDA will often solicit an opinion from an Oncologic Drugs Advisory Committee,
or ODAC, a panel of expert authorities knowledgeable in the fields of general oncology, pediatric oncology, hematologic oncology,
immunologic oncology, biostatistics, and other related professions. The ODAC panel reviews and evaluates data concerning the safety
and effectiveness of marketed and investigational human drug products for use in the treatment of cancer, and makes appropriate
recommendations to the Commissioner of Food and Drugs. The FDA is not bound by the recommendation of an advisory committee. The
FDA may deny approval of an NDA by issuing a Complete Response Letter, or CRL, if the applicable regulatory criteria are not satisfied.
A CRL may require additional clinical data and/or an additional pivotal Phase 3 clinical trial(s), and/or other significant, expensive
and time-consuming requirements related to clinical trials, preclinical studies or manufacturing. Data from clinical trials are
not always conclusive and the FDA may interpret data differently than we or our collaborators interpret data. Approval may be
contingent on a Risk Evaluation and Mitigation Strategy, or REMS, that limits the labeling, distribution or promotion of a drug
product. Once issued, the FDA may withdraw product approval if ongoing regulatory requirements are not met or if safety problems
occur after the product reaches the market. In addition, the FDA may require testing, including Phase IV clinical trials, and
surveillance programs to monitor the safety effects of approved products which have been commercialized, and the FDA has the power
to prevent or limit further marketing of a product based on the results of these post-marketing programs or other information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are three primary regulatory pathways for an NDA under Section 505 of the FDCA: Section 505 (b)(1), Section 505 (b)(2) and Section 505(j).
A Section 505 (b)(1) application is used for approval of a new drug (for clinical use) whose active ingredients have not been previously
approved. A Section 505 (b)(2) application is used for a new drug that relies on data not developed by the applicant. Section 505(b)(2)
of the FDCA was enacted as part of the Drug Price Competition and Patent Term Restoration Act of 1984, also known as the Hatch-Waxman
Act. This statutory provision permits the approval of an NDA where at least some of the information required for approval comes from
studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference. The Hatch-Waxman Act
permits the applicant to rely in part upon the FDA&rsquo;s findings of safety and effectiveness for previously approved products. Section
505(j) application, also known as an abbreviated NDA, is used for a generic version of a drug that has already been approved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NDA review process for drug-led combination includes a review of the device constituent. In this case, the device constituent
for RenovoGem is RenovoCath, which is cleared by the FDA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Orphan
Drug Exclusivity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
jurisdictions, including the United States, may designate drugs for relatively small patient populations as orphan drugs. Pursuant to
the Orphan Drug Act, the FDA grants orphan drug designation to drugs intended to treat a rare disease or condition, which is generally
a disease or condition that affects fewer than 200,000 individuals in the United States. The orphan designation is granted for a combination
of a drug entity and an indication and therefore it can be granted for an existing drug with a new (orphan) indication. Applications
are made to the Office of Orphan Products Development at the FDA and a decision or request for more information is rendered in 60 days.
NDAs for designated orphan drugs are exempt from user fees, obtain additional clinical protocol assistance, are eligible for tax credits
up to 50% of research and development costs, and are granted a seven-year period of exclusivity upon approval. The FDA cannot approve
the same drug for the same condition during this period of exclusivity, except in certain circumstances where a new product demonstrates
superiority to the original treatment. Exclusivity begins on the date that the marketing application is approved by the FDA for the designated
orphan drug, and an orphan designation does not limit the use of that drug in other applications outside the approved designation in
either a commercial or investigational setting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have received orphan drug designations for RenovoGem for LAPC and for HCCA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
granting of orphan drug designations does not mean that the FDA has approved a new drug. Companies must still pursue the rigorous development
and approval process that requires substantial time, effort and financial resources, and we cannot be certain that any approvals for
our product will be granted at all, or on a timely basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Regulatory Requirements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Products
manufactured or distributed pursuant to FDA approvals are subject to continuing regulation by the FDA, including recordkeeping,
annual product quality review and reporting requirements. Adverse event experiences with the product, including both
drug-related and device-related adverse events (including device malfunctions), must be reported to the FDA in a timely fashion
and pharmacovigilance programs to proactively look for these adverse events are mandated by the FDA. Drug and device manufacturers
and their subcontractors are required to register their establishments with the FDA and certain state agencies and are subject
to periodic unannounced inspections by the FDA and certain state agencies for compliance with ongoing regulatory requirements,
including cGMP, which impose certain procedural and documentation requirements upon us and our third-party manufacturers. Following
such inspections, the FDA may issue notices on Form 483, Untitled Letters or Warning Letters that could cause us or our
third-party manufacturers to modify certain activities. A Form 483 Notice, if issued at the conclusion of an FDA inspection,
list conditions the FDA investigators believe may have violated cGMP or other FDA regulations or guidelines. In addition to Form
483 Notices and Untitled Letters or Warning Letters, failure to comply with the statutory and regulatory requirements can subject
a manufacturer to possible legal or regulatory action, such as suspension of manufacturing, seizure of product, injunctive action
or possible civil penalties. We cannot be certain that we or our present or future third-party manufacturers or suppliers will
be able to comply with the cGMP regulations and other ongoing FDA regulatory requirements. If we or our present or future third-party
manufacturers or suppliers are not able to comply with these requirements, the FDA may require us to recall our products from
distribution or withdraw any potential approvals of an NDA for that product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA closely regulates the post-approval marketing and promotion of drugs, including standards and regulations for direct-to-consumer
advertising, dissemination of off-label information, industry-sponsored scientific and educational activities and promotional activities
involving the Internet. Drugs may be marketed only for the approved indications and in accordance with the provisions of the approved
label. Further, if there are any modifications to the drug, including changes in indications, labeling, or manufacturing processes or
facilities, we may be required to submit and obtain FDA approval of a new or supplemental NDA, which may require us to develop additional
data or conduct additional preclinical studies and clinical trials. Failure to comply with these requirements can result in adverse publicity,
Warning Letters, corrective advertising and potential civil and criminal penalties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Physicians
may prescribe legally available products for uses that are not described in the product&rsquo;s labeling and that differ from those tested
by us and approved by the FDA. Such off-label uses are common across medical specialties, in particular in oncology. Physicians may believe
that such off-label uses are the best treatment for many patients in varied circumstances. The FDA does not regulate the behavior of
physicians in their choice of treatments. The FDA does, however, impose stringent restrictions on manufacturers&rsquo; communications
regarding off-label use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Foreign
Regulatory Environment </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we seek to market RenovoGem in foreign jurisdictions, we could become subject to a variety of foreign regulations regarding development,
approval, commercial sales, and distribution of our products in addition to regulations in the United States. Whether or not we obtain
FDA approval for a product, we must obtain the necessary approvals by the comparable regulatory authorities of foreign countries before
we can commence clinical trials or marketing of the product in those countries. The approval process varies from country to country and
can involve additional product testing and additional review periods. The review process may take longer or shorter than that required
to obtain FDA approval. The requirements governing, among other things, the conduct of clinical trials, product licensing, pricing and
reimbursement vary greatly from country to country. Regulatory approval in one country does not ensure regulatory approval in another,
but a failure or delay in obtaining regulatory approval in one country may negatively impact the regulatory process in others. If we
fail to comply with applicable foreign regulatory requirements, we may be subject to fines, suspension or withdrawal of regulatory approvals,
product recalls, seizure of products, operating restrictions, and/or criminal prosecution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reimbursement</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are developing a new drug product, RenovoGem, which is intra-arterial gemcitabine delivered via the proprietary RenovoCath delivery system.
If the drug is approved, it is expected to be sold together with the catheter used to administer the drug in the National Drug Code (NDC)
created when the drug receives FDA approval. The reimbursement pathway involves separate payments for the drug product and for the occlusion
procedure to administer it. As to the latter, it is anticipated that the procedure is accurately described by an existing code with existing
payment levels. Given the expectation that the drug will be a novel, non-generic drug, a unique code and payment based on pricing information
for the product should be established.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the reasons discussed above, we believe there is a clear path to reimbursement for RenovoGem and its related procedure in both the hospital
outpatient and physician office settings (which may include freestanding entities such as catheterization laboratories). As is typical
for a product still in clinical development, it is difficult to predict whether there would be any Medicare coverage obstacles, which
there usually are not for FDA approved drugs being used for on-label use. We believe the most important step we can take to enhance reimbursement
for our products is the development of published, peer-reviewed clinical literature supporting their clinical benefit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Competition</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
oncology biotechnology and pharmaceutical industries are characterized by rapidly advancing technologies and strong competition. While
we believe that our knowledge, leadership, experience, scientific resources, intellectual property, regulatory barriers, and the advanced
stage of our clinical development provide us with competitive advantages, we may face competition from major pharmaceutical companies,
specialty pharmaceutical companies, and biotechnology companies, worldwide. Many potential competitors have substantially greater scientific,
research, financial, technical, and/or human resources than we do.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
companies are active in the oncology market both in terms of commercially marketed products and products in development that could potentially
compete with our products and product candidates for the treatment of solid tumors. Any product candidates that we successfully develop
and commercialize may compete directly with approved and/or new therapies that may be approved in the future. Our competitors may also
obtain FDA or foreign regulatory approval for their products more rapidly than we may obtain approval for our product candidates which
could result in our competitors establishing a strong market position prior to us entering the market. Key competitive factors affecting
the success of our product candidates, if approved, are likely to be their safety, efficacy, convenience, price, and the availability
of reimbursement from government and other third-party payors. Many companies are developing new therapeutics and we cannot predict what
the standard of care will be as our product candidate progresses through clinical development.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
there are a handful of companies in Phase 3 clinical trials for the treatment of LAPC including Angiodynamics, Bausch Health, Fibrogen,
NovoCure, and SynCore Biotechnology. We are aware of a number of companies in Phase 1 and Phase 2 clinical trials for the treatment of
LAPC including one interventional company, TriSalus Lifesciences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Many
of our competitors have substantially greater financial, technological, research and development, marketing and personnel resources.
In </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">addition<FONT STYLE="background-color: white">, some
of our competitors have considerable experience in conducting clinical trials, regulatory, manufacturing and commercialization capabilities.
Our competitors may develop alternative treatment methods, or achieve earlier product development, in which case the likelihood of us
achieving meaningful revenues or profitability will be substantially reduced.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employees</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2021, we had 6 full-time employees. <FONT STYLE="background-color: white">None of our employees is represented
by a labor union or covered by a collective </FONT>bargaining <FONT STYLE="background-color: white">agreement. We believe our relationship
with our employees is good. We have 8 key consultants in the areas of quality, regulatory, finance, legal, IT, clinical, and marketing.
</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Facilities</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
administrative headquarters is located at 4546 El Camino Real, Ste. 223, Los Altos, CA 94019. The office space is approximately 900 square
feet, and the rent is $3,600/month. We believe that our facilities are adequate for our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Legal
Proceedings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we are engaged in various legal actions, claims and proceedings arising in the ordinary course of business, none of which
are expected to be material.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="k_002"></A>MANAGEMENT,
EXECUTIVE COMPENSATION AND CORPORATE GOVERNANCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Directors
and Executive Officers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following sets forth information about our directors, director nominees, and executive officers as of the date of this prospectus:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 58%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shaun
    R. Bagai</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Manners</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ramtin
    Agah</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Medical Officer, Founder, Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laurence
    J. Marton</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Una
    S. Ryan</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maky
    Zanganeh</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kristen
    Angela</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Macfarlane</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> David Diamond </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 71 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Director </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Shaun
R. Bagai.</I></B> Mr. Bagai has served as our Chief Executive Officer and director since June 2014. Prior to joining us, Mr. Bagai led
Global Market Development for HeartFlow, Inc. from 2011 to 2014, which included directing Japanese market research, regulatory/payer
collaboration, and Key Opinion Leader development to create value resulting in a company investment to form HeartFlow-Japan. During his
tenure at HeartFlow, he successfully orchestrated their largest clinical trial to date and contracted HeartFlow&rsquo;s first global
customers. In addition, Mr. Bagai has launched new technologies into regional and global marketplaces in both large corporations and
growth-phase novel technology companies. He was instrumental in developing the European market for renal denervation for the treatment
of hypertension which led to the acquisition of the first renal denervation company, Ardian, Inc. by Medtronic in 2011. Mr. Bagai is
a graduate from the University of California, Santa Barbara with a BSc. in Biology/Pre-Med. Mr. Bagai was selected to serve on our board
of directors due to his tenure with our company and his industry experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Paul
Manners.</I></B> Mr. Manners has served as our Chief Financial Officer since July 2019. In addition, since 2011 he has held several positions
for Sandstone Diagnostics, an early stage medical device company, and is currently Senior Director Finance. Previously, Mr. Manners was
a VP Finance &amp; Marketing in Chiron/Novartis&rsquo; Diagnostic Division from 2003 to 2010 and the Chief Financial Officer, VP Sales
&amp; Customer Service for Amira Medical from 1997 to 2002. In addition, he has previously held various accounting and finance positions
in various units for Johnson &amp; Johnson from 1973 until 1996. Mr. Manners received an MBA from Rider University and a BBA from Northeastern
University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Ramtin
Agah, MD</I></B> Dr. Agah has served as the Chief Medical Officer and Co-Founder of the Company since December 2009 and has acted as
Chairman of the Board of Directors since May 2018. Dr. Agah is currently an Interventional Cardiologist at El Camino Hospital, Mountain
View, a role he began in September 2005. He also has acted as a physician consultant for Abbott Vascular since July 2012. Previously,
Dr. Agah was an Assistant Professor of Internal Medicine with the Division of Cardiology, University of Utah. Dr. Agah completed a Fellowship
in Interventional Cardiology with Cleveland Clinic Foundation, a Residency in Internal Medicine with Baylor College of Medicine, Houston,
Texas, and a Fellowship in Cardiology with U.C.S.F. in San Francisco, CA. He is a MD graduate of University of Texas Southwestern Medical
School. Dr. Agah was selected to serve on our board of directors due to his tenure with our company and his industry experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Laurence
J. Marton.</I></B> Dr. Marton has served as our director since December 2012. Dr. Marton is currently the Executive Chairman of Omniox,
Pharma, a role he began in July 2020. In addition, in the nonprofit sector, Dr. Marton serves on the Board of Trustees of the American
Association for Cancer Research Foundation, and on the Board of Directors of Cancer Commons, Rapid Science, and the Bay Area American
Committee for the Weizmann Institute of Science. In the for-profit sector, he serves on the Board of Directors of TOMA Biosciences, Microsonic
Systems and Pathologica, is Chair of the Scientific Advisory Board of PharmaJet, and is on the Advisory Boards of Gem Pharmaceuticals
and Silicom Ventures. Previously, Dr. Marton was Dean of the University of Wisconsin Medical School and Chaired the Department of Laboratory
Medicine at UCSF, where he was a Professor in the Departments of Laboratory Medicine and Neurological Surgery. His research has resulted
in more than 195 original publications, 60 scientific reviews and chapters, four books, and numerous patents. Dr. Marton received his
MD from the Albert Einstein College of Medicine and his BA from Yeshiva University. Mr. Morton was selected to serve on our board of
directors due to his tenure with our company and his industry experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Una
S. Ryan, PhD, OBE.</I></B> Dr. Ryan has served as our director since 2013. Dr. Ryan is currently the Managing Director of Golden Seeds
(Silicon Valley), an angel investing group focused on women-led companies since 2009. &nbsp;Her board positions include Cortexyme, Inc.,
Elemental Machines, and Cambridge America. From 2010 until 2013, Dr. Ryan acted as President and CEO of Diagnostics For All, a nonprofit
organization developing inexpensive diagnostics for global health and agricultural uses. Previously, from 1993 to 2008, she was President
and CEO of AVANT Immunotherapeutics, Inc. a company developing vaccines and immunotherapeutics for cancer, travelers, food safety, and
global health, and also a member of its Board of Directors. Dr. Ryan has held a number of positions in academia, including Research Professor
of Surgery at Washington University School of Medicine in St. Louis and Professor of Medicine at the University of Miami School of Medicine.
She was also Chair of the Massachusetts Biotechnology Council, served on its Board, as well as the Biotechnology Industry Organization,
New England Healthcare Institute, Board of Associates of the Whitehead Institute, Strategy &amp; Policy Council of the MIT Center for
Biomedical Innovation, Massachusetts Life Sciences Collaborative Leadership Council and the Goddard Council on science, technology, engineering
and mathematics education. Dr. Ryan holds a PhD in Cellular and Molecular Biology from Cambridge University and BS degrees in Zoology,
Microbiology and Chemistry from Bristol University. In 2007, Dr. Ryan received the Albert Einstein Award for outstanding achievement
in the life sciences, and in 2009, she received an Honorary Doctor of Science degree from Bristol University. Dr. Ryan was selected to
serve on our board of directors due to her tenure with our company and her industry experience.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Maky
Zanganeh, DDS, MBA.</I></B> Dr, Zanganeh has served as our director since 2018. Dr. Zanganeh has more than 16 years of strategic planning,
management, corporate, clinical, business and marketing experience in the pharmaceutical, medical device and technology industries. She
has been the Chief Operating Officer of Summit Therapeutics since 2020 and the Founder and Chief Executive Officer of Maky Zanganeh
and Associates, Inc., an investment, consulting and management group since 2016. Previously, from 2008 to 2016, Dr. Zanganeh was the
Chief Operating Officer at Pharmacyclics, Inc., where she oversaw all clinical, research, commercial and business-related matters. &nbsp;In
addition, from 1997 to 2002 Dr. Zanganeh held senior and executive positions including International Product Manager for IRCAD-EITS,
General Director Pos De Competitive for Therapeutic Innovation and President Director General (Chief Executive Officer) of Europe, Middle
East and Africa and World-Wide Vice President of Training and Education for Computer Motion. Dr. Zanganeh&rsquo;s current directorships
include Human Longevity Inc., Radial Medical and Pulse Biosciences. Dr. Zanganeh earned her Doctor of Dental Surgery and her Master of
Business Administration in International Business in France. She is a licensed investment advisor (Series 65) and has her dentistry license.
She earned the Fierce Biotech &ldquo;2013 Top Women in Biotech&rdquo; Award and the Ernst &amp; Young Entrepreneur of the Year Award
in 2013. Dr. Zanganeh was selected to serve on our board of directors due to her industry experience.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Kristen
Angela</I></B></FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I> Macfarlane.</I></B> Ms. Macfarlane has served
as our director since September 2018. She currently acts as Chief Executive Officer for Voyant Biotherapeutics, LLC, an early-stage biotech
company dedicated to solving age-related macular degeneration since 2018. In addition to serving as CEO of ForSight Labs, LLC an ophthalmic
incubator formed in 2005, from 2007 to 2016, from 2008 to 2016, Ms. Macfarlane served as the operating Chief Executive Officer for three
ForSight companies, which included acting as a founding Chief Executive Officer through the acquisition of ForSight VISION4, Inc. (acquired
by ROCHE), and ForSight VISION5, Inc., (Acquired by Allergan). Previously, Ms. Macfarlane served as Chief Technology Counsel to The Foundry,
a medical technology incubator, and Technology Counsel for Thomas J. Fogarty, M.D., a renowned physician/entrepreneur where she participated
in formation development of nine companies from 1999 to 2004. She previously served on the senior management teams and counsel at TransVascular,
Inc. (acquired by Medtronic), AneuRx, Inc. (acquired by Medtronic), and VidaMed Inc. (through IPO). Ms. Macfarlane is an inventor on
25 U.S. issued patents and received her BA in Business Administration from San Francisco State University, and her J.D. from Golden Gate
University School of Law. She currently serves on the board of the Fogarty Institute for Innovation and is a mentor in the Ferolyn Powell
Leadership Program. Ms. Macfarlane was selected to serve on our board of directors due to her industry experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <B><I>David Diamond.</I></B> Mr. Diamond<I>&nbsp;</I>was
appointed to the Board on May 9, 2021. Mr. Diamond currently provides strategic guidance and operational oversight to CEOs and boards
of directors in the Life Sciences industry. Mr. Diamond has significant experience assisting management teams and boards of directors
with capital financing and strategic business planning nationally and internationally and has built strong relationships with prominent
investment bankers. He currently serves as the National Life Sciences and Technology Practice Lead at Mayer Hoffman McCann P.C., a national
CPA firm since 2015 and has over 30 years of experience in both public accounting and industry. Mr. Diamon also serves as a director
of Oncolytics Biotech, Inc. Mr. Diamond previously served as a Board member for Kreston International ($2 billion CPA network), a member
of the board of San Diego Venture Group and was a Founding Member of UCSD Connect. He is a Certified Director in Corporate Governance
from UCLA Anderson Graduate School of Management and an active CPA, licensed in the United States, Israel and South Africa. Mr. Diamond
was selected to serve on our board of directors due to his extensive experience extensive experience as a strategic guide and oversight
to CEOs and Boards of companies in the life sciences space. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Family
Relationships</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no other family relationships among any of our officers or directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Involvement
in Certain Legal Proceedings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the best of our knowledge, none of our directors or executive officers were involved in any legal proceedings described in Item 401(f)
of Regulation S-K in the past ten years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Governance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Board&rsquo;s Role in Risk Oversight</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors oversees that the assets of our company are properly safeguarded, that the appropriate financial and other controls
are maintained, and that our business is conducted wisely and in compliance with applicable laws and regulations and proper governance.
Included in these responsibilities is the board&rsquo;s oversight of the various risks facing our company. In this regard, our board
seeks to understand and oversee critical business risks. Our board does not view risk in isolation. Risks are considered in virtually
every business decision and as part of our business strategy. Our board recognizes that it is neither possible nor prudent to eliminate
all risk. Indeed, purposeful and appropriate risk-taking is essential for our company to be competitive on a global basis and to achieve
its objectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the board oversees risk management, company management is charged with managing risk. Management communicates routinely with the board
and individual directors on the significant risks identified and how they are being managed. Directors are free to, and indeed often
do, communicate directly with senior management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board administers its risk oversight function as a whole by making risk oversight a matter of collective consideration. Once the board
establishes committees, it is anticipated that much of the work will be delegated to such committees, which will meet regularly and report
back to the full board. It is anticipated that the audit committee will oversee risks related to our financial statements, the financial
reporting process, accounting and legal matters, that the compensation committee will evaluate the risks and rewards associated with
our compensation philosophy and programs, and that the nominating and corporate governance committee will evaluate risk associated with
management decisions and strategic direction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Independence</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has undertaken a review of the independence of each director. Based on information provided by each director concerning
his background, employment and affiliations, our board of directors has determined that Mr. Marton,  Mr. Diamond and
Mses. Ryan, Zanganeh and Macfarlane do not have a relationship that would interfere with the exercise of independent judgment in carrying
out the responsibilities of a director and that each of these directors is &ldquo;independent&rdquo; as that term is defined under the
listing standards of the Nasdaq Capital Market. In making these determinations, our board of directors considered the current and prior
relationships that each non-employee director has with our company and all other facts and circumstances our board of directors deemed
relevant in determining their independence, including the beneficial ownership of our capital stock by each non-employee director, and
the transactions involving them described in the section titled &ldquo;Certain Relationships and Related Person Transactions.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Committees
of the Board of Directors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board has established an audit committee, a compensation and nominating and corporate governance committee, each with its own charter
that has been approved by the board. Upon completion of this offering, we intend to make each committee&rsquo;s charter available on
our website at www.renovorx.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">board of directors may, from time to time, designate one or more additional
committees, which shall have the duties and powers granted to it by our board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Audit
Committee</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our audit committee are Una Ryan and Laurence Marton. [&nbsp;&nbsp;] serves as chairperson of the committee. All members
of our audit committee meet the independence requirements of Rule 10A-3 under the Exchange Act and the applicable rules of the Nasdaq
Capital Market, or the Nasdaq rules. Our board of directors has determined that [&nbsp;&nbsp;] is an audit committee financial expert,
as defined by the rules of the SEC, and satisfies the financial sophistication requirements of the Nasdaq rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee will oversee our accounting and financial reporting processes and the audits of the financial statements of our company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee will be responsible for, among other things: (i) retaining and overseeing our independent registered public accounting
firm; (ii) assisting the board in its oversight of the integrity of our financial statements, the qualifications, independence and performance
of our independent registered public accounting firm and our compliance with legal and regulatory requirements; (iii) reviewing and approving
the plan and scope of the internal and external audit; (iv) pre-approving any audit and non-audit services provided by our independent
registered public accounting firm; (v) approving the fees to be paid to our independent registered public accounting firm; (vi) reviewing
with our chief executive officer and chief financial officer and independent registered public accounting firm the adequacy and effectiveness
of our internal controls; (vii) reviewing hedging transactions; and (viii) reviewing and assessing annually the audit committee&rsquo;s
performance and the adequacy of its charter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Compensation
Committee</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
members of our compensation committee are Maky Zanganeh and Kristen Angela Macfarlane. Maky Zanganeh serves as the chairperson
of the committee. The compensation committee will assist the board in reviewing and approving the compensation structure, including all
forms of compensation, relating to our directors and executive officers.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation committee will be responsible for, among other things: (i) reviewing and approving the remuneration of our executive officers;
(ii) reviewing the compensation of our independent directors; (iii) making recommendations to the board regarding equity-based and incentive
compensation plans, policies and programs; and (iv) reviewing and assessing annually the compensation committee&rsquo;s performance and
the adequacy of its charter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Nominating
and Corporate Governance Committee</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
members of our nominating and governance committee are Una Ryan, Kristen Angela Macfarlane and Laurence Marton. Una Ryan serves
as the chairperson of the committee. The nominating and corporate governance committee will assist the board of directors in selecting
individuals qualified to become our directors and in determining the composition of the board and its committees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
nominating and corporate governance committee will be responsible for, among other things: (i) identifying and evaluating individuals
qualified to become members of the board by reviewing nominees for election to the board submitted by stockholders and recommending to
the board director nominees for each annual meeting of stockholders and for election to fill any vacancies on the board, (ii) advising
the board with respect to board organization, desired qualifications of board members, the membership, function, operation, structure
and composition of committees (including any committee authority to delegate to subcommittees), and self-evaluation and policies, (iii)
advising on matters relating to corporate governance and monitoring developments in the law and practice of corporate governance, (iv)
overseeing compliance with our code of ethics, and (v) approving any related party transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
nominating and corporate governance committee&rsquo;s methods for identifying candidates for election to our board of directors (other
than those proposed by our stockholders, as discussed below) will include the solicitation of ideas for possible candidates from a number
of sources&mdash;members of our board of directors, our executives, individuals personally known to the members of our board of directors,
and other research. The nominating and corporate governance committee may also, from time-to-time, retain one or more third-party search
firms to identify suitable candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
making director recommendations, the nominating and corporate governance committee may consider some or all of the following factors:
(i) the candidate&rsquo;s judgment, skill, experience with other organizations of comparable purpose, complexity and size, and subject
to similar legal restrictions and oversight; (ii) the interplay of the candidate&rsquo;s experience with the experience of other board
members; (iii) the extent to which the candidate would be a desirable addition to the board and any committee thereof; (iv) whether or
not the person has any relationships that might impair his or her independence; and (v) the candidate&rsquo;s ability to contribute to
the effective management of our company, taking into account the needs of our company and such factors as the individual&rsquo;s experience,
perspective, skills and knowledge of the industry in which we operate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Code
of Business Conduct and Ethics</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to adopt a code of ethics that applies to all of our directors, officers and employees, including our principal executive officer,
principal financial officer and principal accounting officer. Such code of ethics addresses, among other things, honesty and ethical
conduct, conflicts of interest, compliance with laws, regulations and policies, including disclosure requirements under the federal securities
laws, and reporting of violations of the code. Upon our listing on the Nasdaq Capital Market, our code of business conduct and ethics
will be available under the Corporate Governance section of our website.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will be required to disclose any amendment to, or waiver from, a provision of our code of ethics applicable to our principal executive
officer, principal financial officer, principal accounting officer, controller, or persons performing similar functions. We intend to
use our website as a method of disseminating this disclosure, as permitted by applicable SEC rules. Any such disclosure will be posted
to our website within four business days following the date of any such amendment to, or waiver from, a provision of our code of ethics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive
and Director Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>As
an emerging growth company under the JOBS Act we have opted to comply with the executive compensation disclosure rules applicable to
&ldquo;smaller reporting companies,&rdquo; which require compensation disclosure for our principal executive officer and the two most
highly compensated executive officers (other than our principal executive officer) serving as executive officers at the end of our most
recently completed fiscal year (collectively, our &ldquo;Named Executive Officers&rdquo;). This section describes the executive compensation
program in place for our Named Executive Officers during the year ended December 31, 2020, who are the individuals who served as our
principal executive officer and two most highly compensated executive officers.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section discusses the material components of the executive compensation program for our executive officers who are named in the &ldquo;Summary
Compensation Table&rdquo; below and the non-employee members of our board of directors. In 2020, our &ldquo;<I>Named Executive Officers</I>&rdquo;
and their positions were:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shaun
    Bagai, Chief Executive Officer;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Matters, Chief Financial Officer; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ramtin
    Agah, MD, Chief Medical Officer.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2020
Summary Compensation Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information concerning the compensation of our Named Executive Officers for the year ended December 31, 2020
and 2019 (<I>in thousands</I>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name
    &amp; Principal Position</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salary</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salary/
                                            Bonus</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option
    Awards&nbsp;($)<SUP>(1)</SUP></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    ($)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 35%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shaun
    Bagai, CEO</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">253</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">253</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">240</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">30</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">270</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Paul
    Manners, CFO</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">37</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">37</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">19</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">39</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ramtin
    Agah, MD, CMO</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">120</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">120</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">78</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">78</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount disclosed represents the aggregate grant date fair value of the award as calculated in accordance with ASC 718. The assumptions
    used in calculating the grant date fair value of the award disclosed in this column are set forth in the notes to our audited financial
    statements included elsewhere in this prospectus. This amount does not correspond to the actual value that may be recognized upon
    vesting of the award.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compensation
Arrangements with our Executive Officers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Shaun
R. Bagai</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shaun
R. Bagai has been our Chief Executive Officer since 2014, initially as a consultant. We entered into an offer letter in December 2015
with Mr. Bagai that set forth the terms and conditions of his employment. The letter became effective on January 1, 2016. The offer letter
was amended in June 2017 and December 2020. The most recent amended offer letter provides for (i) an annual base salary of $300,000;
(ii) a $2,500 monthly stipend for Mr. Bagai&rsquo;s health insurance expenses, which will continue until we begin offering health insurance
as a benefit to all employees; (iii) a $70,000 bonus to be paid in connection with this initial public offering; and (iv) an additional
performance bonus upon achievement of certain clinical and company milestones established by the Board in 2021. Upon consummation
of the offering, Mr. Bagai&rsquo;s annual base salary will be $363,000. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Paul
Manners</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into a consulting agreement in July 2019 with Paul Manners, our Chief Financial Officer that set forth the terms and conditions
of the services he was to render. The agreement was amended in December 2020. The amended agreement establishes an hourly consulting
rate of one hundred and fifty dollars ($150) per hour. We also agreed to reimburse Mr. Manners for any reasonable out-of-pocket business
expenses incurred in connection with the services, provided such expenses are approved in advance by us and fully documented our satisfaction.
For the years ended December 31, 2019 and 2020 and the three months ended March 31, 2020 and 2021, we paid Mr. Manners $19,000, $37,000,
$12,000 and $54,000, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mr.
Manners was also granted an option to purchase one hundred and forty thousand (140,000) shares of our common stock at the fair market
value as determined by the Board as of the grant date, pursuant to our 2013 Equity Incentive Plan. The option will fully vest July
9, 2021.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Ramtin
Agah</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2013, we entered into a consulting agreement with Dr. Agah, one of our co-founders, whereby he would provide consulting services
as our Chief Medical Officer by overseeing Company-sponsored clinical trials. The agreement is for a term of 15 years with automatic
one-year renewals. The sole compensation payable to Dr. Agah is the continued vesting of shares of common stock held by Dr. Agah. In
July 2018, he was awarded options for the purchase of 200,000 shares of our common stock with 25% vested after one year and the remaining
75% vesting ratably over 36 months. We entered into an amendment to the agreement with Dr. Agah in 2019 providing cash compensation to
Dr. Agah of $10,000 per month for additional services. Consulting fees paid to Dr. Agah were $78,000, $120,000, $30,000 and $30,000 for
the years ended December 31, 2019 and 2020 and March 31, 2020 and 2021, respectively. Upon consummation of the offering, Dr. Agah&rsquo;s
compensation will be $260,000 per year provided he spends 60% of his time on Company matters. On June 7, 2021 we granted to Dr. Agah options
to purchase 100,000 shares of common stock at an exercise price of $0.49 per share which vests in 24 equal consecutive monthly installments commencing on June 14, 2021. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our non-employee directors received option awards during the year ended December 31, 2020. We did not compensate our board during
the last fiscal year. Under our non-employee director compensation policy, each non-employee director received the following annual
compensation for his or her service: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> Committee membership </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Annual retainer non-employee board
    member </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Audit </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Compensation </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Corporate Governance/Nominating </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%"> Chair </TD><TD STYLE="width: 2%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 14%; text-align: right"> 36,000 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 2%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 14%; text-align: right"> 15,000 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 2%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 14%; text-align: right"> 10,000 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 2%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 14%; text-align: right"> 10,000 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> Member </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 36,000 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 5,000 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 5,000 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 5,000 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Equity
compensation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding
equity awards at March 31, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information concerning the outstanding equity awards held by each of our Named Executive Officers as of March
31, 2021:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
    Awards<SUP>(1)</SUP></B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option
    Grant Date</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of<BR> Securities<BR> Underlying<BR> Unexercised<BR> Options (#)<BR> Exercisable</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of<BR> Securities<BR> Underlying<BR> Unexercised<BR> Options (#)<BR> Unexercisable</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option<BR>
    Exercise<BR> Price<BR> ($)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option
    Expiration Date</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shaun
    Bagai</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    6, 2014<SUP>(2)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,230,285</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.03</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">August
    5, 2024</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    19, 2017<SUP>(3)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">281,250</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">18,750</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">May
    18, 2027</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    11, 2018<SUP>(4)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">437,500</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">162,500</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.13</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">July
    10, 2028</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Paul
    Manners</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    5, 2020<SUP>(5)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">23,334</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.14</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">February
    4, 2030</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ramtin
    Agah, MD</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    19, 2017<SUP>(2)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">300,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">May
    18, 2027</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    11, 2018<SUP>(6)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">145,833</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">54,167</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.13</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">July
    10, 2028</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of the outstanding equity awards was granted pursuant to our 2013 Equity Incentive Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    shares underlying this option are fully vested and immediately exercisable.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    shares underlying this option vest, subject to Mr. Bagai&rsquo;s continued role as a service provider to us, 25% on the one-year
    anniversary of the June 1, 2017 vesting commencement date and then in 48 equal monthly installments. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    shares underlying this option vest, subject to Mr. Bagai&rsquo;s continued role as a service provider to us, 25% on the one-year
    anniversary of the April, 19, 2018 vesting commencement date and then in 48 equal monthly installments. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    shares underlying this option vest, subject to Mr. Manner&rsquo;s continued role as a service provider to us, 25% on the six-month
    anniversary of the July 9, 2019 vesting commencement date and then in 24 equal monthly installments. On March 19, 2021 Mr. Manners
    exercised 116,666 options.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    shares underlying this option vest, subject to Dr. Agah&rsquo;s continued role as a service provider to us, 25% on the one-year anniversary
    of the April 19, 2018 vesting commencement date and then in 36 equal monthly installments. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incentive
plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Equity
Incentive Plans</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>2021
Omnibus Equity Incentive Plan</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
[&nbsp;&nbsp;] 2021 our board of directors adopted, and our stockholders approved, the RenovoRx, Inc. 2021 Omnibus Equity Incentive Plan,
or the 2021 Plan, which will become effective immediately prior to the closing of this offering. We intend to use the 2021 Plan following
the closing of this offering to provide incentives that will assist us to attract, retain, and motivate employees, including officers,
consultants, and directors. We may provide these incentives through the grant of stock options, stock appreciation rights, restricted
stock, RSUs, performance shares, and units and other cash-based or share-based awards </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
Available</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum number of shares of common stock reserved and available for issuance under the 2021 Plan will be equal to the sum of (i) ______
shares of common stock; (ii) the number of shares of common stock reserved, but unissued under the 2013 Plan, and (iii) the number of
shares of common stock underlying forfeited awards under the 2013 Plan; provided that shares of common stock issued under the 2021 Plan
with respect to an Exempt Award will not count against the share limit. We use the term &ldquo;Exempt Award&rdquo; to mean (i) an award
granted in assumption of, or in substitution for, outstanding awards previously granted by another business entity acquired by us or
any of our subsidiaries or with which we or any of our subsidiaries merge, or (ii) an award that a participant purchases at fair market
value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Administration</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2021 Plan is administered by the Board or by one or more committees of directors appointed by the Board (the &ldquo;<B>Administrator</B>&rdquo;).
The Board may delegate different levels of authority to different committees with administrative and grant authority under the 2021 Plan.
Any committee delegated administrative authority under the 2021 Plan may further delegate its authority under the Plan to another committee
of directors, and any such delegate shall be deemed to be an Administrator of the 2021 Plan. The Administrator comprised solely of directors
may also delegate, to the extent permitted by Section 157 of the Delaware General Corporation Law and any other applicable law, to one
or more officers of the Company, its powers under this Plan (a) to designate Eligible Persons who will receive grants of awards under
this Plan, and (b) to determine the number of shares subject to, and the other terms and conditions of, such awards. It is anticipated
that the Administrator (either generally or with respect to specific transactions) will be constituted so as to comply, as necessary
or desirable, with the requirements of Section 162(m)of Internal Revenue Code of 1986, as amended (the &ldquo;<B>Code</B>&rdquo;), and
Rule 16b-3 promulgated under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eligibility</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awards
may be granted pursuant to the 2021 Plan only to persons who are eligible persons. Under the 2021 Plan, &ldquo;Eligible Person&rdquo;
means any person who is either: (a) an officer (whether or not a director) or employee of the Company or one of its subsidiaries; (b)
a director of the Company or one of its subsidiaries; or (c) a consultant who renders bona fide services to the Company or one of its
subsidiaries; provided, however, that Incentive Stock Options (&ldquo;<B>ISOs</B>&rdquo;) may be granted only to employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2021 Plan permits the grant of: (a) stock options, which may be intended as ISOs or as nonqualified stock options (options not meeting
the requirements to qualify as ISOs); (b) stock appreciation rights (&ldquo;<B>SARs</B>&rdquo;); (c) restricted stock; (d) restricted
stock units; (e) cash incentive awards; or (f) other awards, including: (i) stock bonuses, performance stock, performance units, dividend
equivalents, or similar rights to purchase or acquire shares, whether at a fixed or variable price or ratio related to the common stock,
upon the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any
combination thereof; or (ii) any similar securities with a value derived from the value of or related to the common stock and/or returns
thereon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consideration
for Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price for any award granted under the 2021 Plan or the common stock to be delivered pursuant to any such award, as applicable,
may be paid by means of any lawful consideration as determined by the Administrator, including, without limitation, one or a combination
of the following methods:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">services
    rendered by the recipient of such award;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cash,
    check payable to the order of the Company, or electronic funds transfer;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">notice
    and third party payment in such manner as may be authorized by the Administrator;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    delivery of previously owned and fully vested shares of common stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
    a reduction in the number of shares otherwise deliverable pursuant to the award; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
    to such procedures as the Administrator may adopt, pursuant to a &ldquo;cashless exercise&rdquo; with a third party who provides
    financing for the purposes of (or who otherwise facilitates) the purchase or exercise of awards.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certain
Federal Tax Consequences</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of the federal income tax consequences of the 2021 Plan transactions is based upon federal income tax laws in effect
as of April 2, 2021. This summary does not purport to be complete, and does not discuss state, local or non-U.S. tax consequences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Nonqualified
Stock Options.</I></B> The grant of a nonqualified stock option under the 2021 Plan will not result in any federal income tax consequences
to the participant or to the Company. Upon exercise of a nonqualified stock option, the participant will recognize ordinary compensation
income equal to the excess of the fair market value of the shares of Common stock at the time of exercise over the option exercise price.
If the participant is an employee, this income is subject to withholding for federal income and employment tax purposes. The Company
is entitled to an income tax deduction in the amount of the income recognized by the participant, subject to possible limitations imposed
by the Code, including Section 162(m) thereof. Any gain or loss on the participant&rsquo;s subsequent disposition of the shares will
be treated as long-term or short-term capital gain or loss, depending on the sales proceeds received and whether the shares are held
for more than one year following exercise. The Company does not receive a tax deduction for any subsequent capital gain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Incentive
Options.</I></B> The grant of an ISO under the 2021 Plan will not result in any federal income tax consequences to the participant or
to the Company. A participant recognizes no federal taxable income upon exercising an ISO (subject to the alternative minimum tax rules
discussed below), and the Company receives no deduction at the time of exercise. In the event of a disposition of stock acquired upon
exercise of an ISO, the tax consequences depend upon how long the participant has held the shares. If the participant does not dispose
of the shares within two years after the ISO was granted, nor within one year after the ISO was exercised, the participant will recognize
a long-term capital gain (or loss) equal to the difference between the sale price of the shares and the exercise price. The Company is
not entitled to any deduction under these circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the participant fails to satisfy either of the foregoing holding periods (referred to as a &ldquo;disqualifying disposition&rdquo;),
he or she will recognize ordinary compensation income in the year of the disposition. The amount of ordinary compensation income generally
is the lesser of (i) the difference between the amount realized on the disposition and the exercise price or (ii) the difference between
the fair market value of the stock at the time of exercise and the exercise price. Such amount is not subject to withholding for federal
income and employment tax purposes, even if the participant is an employee of the Company. Any gain in excess of the amount taxed as
ordinary income will generally be treated as a short-term capital gain. The Company, in the year of the disqualifying disposition, is
entitled to a deduction equal to the amount of ordinary compensation income recognized by the participant, subject to possible limitations
imposed by the Code, including Section 162(m) thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
&ldquo;spread&rdquo; under an ISO &mdash; i.e., the difference between the fair market value of the shares at exercise and the exercise
price &mdash; is classified as an item of adjustment in the year of exercise for purposes of the alternative minimum tax. If a participant&rsquo;s
alternative minimum tax liability exceeds such participant&rsquo;s regular income tax liability, the participant will owe the alternative
minimum tax liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Restricted
Stock.</I></B> Restricted stock is generally taxable to the participant as ordinary compensation income on the date that the restrictions
lapse (i.e. the date that the stock vests), in an amount equal to the excess of the fair market value of the shares on such date over
the amount paid for such stock (if any). If the participant is an employee, this income is subject to withholding for federal income
and employment tax purposes. The Company is entitled to an income tax deduction in the amount of the ordinary income recognized by the
participant, subject to possible limitations imposed by the Code, including Section 162(m) thereof. Any gain or loss on the participant&rsquo;s
subsequent disposition of the shares will be treated as long-term or short-term capital gain or loss treatment depending on the sales
price and how long the stock has been held since the restrictions lapsed. The Company does not receive a tax deduction for any subsequent
gain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participants
receiving restricted stock awards may make an election under Section 83(b) of the Code (&ldquo;<B>Section 83(b) Election</B>&rdquo;)
to recognize as ordinary compensation income in the year that such restricted stock is granted, the amount equal to the excess of the
fair market value on the date of the issuance of the stock over the amount paid for such stock. If such an election is made, the recipient
recognizes no further amounts of compensation income upon the lapse of any restrictions and any gain or loss on subsequent disposition
will be long-term or short-term capital gain or loss to the recipient. The Section 83(b) Election must be made within 30 days from the
time the restricted stock is issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
Awards.</I></B> Other awards (such as restricted stock units) are generally treated as ordinary compensation income as and when common
stock or cash are paid to the participant upon vesting or settlement of such awards. If the participant is an employee, this income is
subject to withholding for income and employment tax purposes. The Company is generally entitled to an income tax deduction equal to
the amount of ordinary income recognized by the recipient, subject to possible limitations imposed by the Code, including Section 162(m)
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Section
162(m) Limitation.</I></B> In general, under Section 162(m), income tax deductions of publicly-held corporations may be limited to the
extent total compensation (including base salary, annual bonus, stock option exercises and non-qualified benefits paid) for certain executive
officers exceeds $1 million (less the amount of any &ldquo;excess parachute payments&rdquo; as defined in Section 280G of the Code) in
any one year. Prior to the Tax Cuts and Jobs Act of 2017 (the &ldquo;TCJA&rdquo;), covered employees generally consisted of our Chief
Executive Officer and each of the next three highest compensated officers serving at the end of the taxable year other than our Chief
Financial Officer, and compensation that qualified as &ldquo;performance-based&rdquo; under Section 162(m) was exempt from this $1 million
deduction limitation. As part of the TCJA, the ability to rely on this exemption was, with certain limited exceptions, eliminated; in
addition, the definition of covered employees was expanded to generally include all named executive officers. Certain awards under the
2013 Plan granted prior to November 2, 2017 may be grandfathered from the changes made by the TCJA under certain limited transition relief,
however, for grants after that date and any grants which are not grandfathered, we will no longer be able to take a deduction for any
compensation in excess of $1 million that is paid to a covered employee. There is no guarantee that we will be able to take a deduction
for any compensation in excess of $1 million that is paid to a covered employee under the 2013 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Amended
and Restated 2013 Equity Incentive Plan</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2013 Plan was originally adopted by our board of directors and approved by our stockholders in January 23, 2013. The maximum aggregate
number of shares of common stock that may be issued under the 2013 Plan is 6,606,504. Upon the closing of this offering, our board
of directors will terminate the 2013 Plan and we will not grant any further awards under such plan, but the 2013 Plan will continue to
govern outstanding awards granted thereunder. Our compensation committee administers the 2013 Plan and has the authority, among other
things, to construe and interpret the terms of the 2013 Plan and awards granted thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
January 23, 2013, our Board of Directors adopted the 2013 Equity Incentive Plan, or the 2013 Plan. The following summary describes the
material terms of the 2013 Plan. This summary is not a complete description of all provisions of the 2013 Plan and is qualified in its
entirety by reference to the 2013 Plan, which is filed as an exhibit to the registration statement of which this prospectus is a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
purpose of the 2013 Plan is to secure and retain the services of the eligible recipients, to provide incentives for such persons to exert
maximum efforts for the success of the Company, and to provide a means by which such eligible recipients may be given an opportunity
to benefit from increases in value of the common stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Administration.
</I></B>The plan is administered by the Board. The Board shall have authority in its discretion to determine the eligible persons to
whom, and the time or times at which, awards may be granted, the number of shares, units or other rights subject to each award, the exercise,
base or purchase price of an award (if any), the time or times at which an award will become vested, exercisable or payable, the performance
criteria, performance goals and other conditions of an award, the duration of the award, and all other terms of the award, including
the fair market value thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Available
shares. </I></B>The maximum aggregate number of shares of common stock which may be issued under all awards granted to participants under
the plan initially shall be 6,346,504 shares. All 6,346,504 of such authorized shares initially available may be issued in respect of
incentive stock options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Eligibility
for participation.</I></B> An incentive stock option may only be granted to an employee of ours or any subsidiary of ours. Awards other
than incentive stock options may be granted to employees, directors and consultants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Types
of awards. </I></B>The 2013 Plan provides for the grant of nonqualified stock options, incentive stock options (&ldquo;ISOs&rdquo;),
stock appreciation rights (&ldquo;SARs&rdquo;), restricted stock and stock units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&#9679;
<B>Stock options and SARs.</B></I> The Board may grant stock options, including ISOs, and SARs. A stock option is a right entitling the
holder to acquire our common shares upon payment of the applicable exercise price. A SAR is a right entitling the holder upon exercise
to receive an amount (payable in cash or shares of equivalent value) equal to the excess of the fair market value of the shares subject
to the right over the base value from which appreciation is measured. The exercise price of each stock option, and the base value of
each SAR, granted under the 2013 Plan shall be no less than 100% of the fair market value of a share of common stock on the date of grant.
Each stock option and SAR will have a maximum term of not more than ten years from the date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&#9679;
<B>Restricted and unrestricted stock and stock units.</B></I> The administrator of the 2013 Plan may grant awards of shares, stock units,
restricted stock and restricted stock units. A stock unit is an unfunded and unsecured promise, denominated in shares, to deliver shares
or cash measured by the value of shares in the future, and a restricted stock unit is a stock unit that is subject to the satisfaction
of specified performance or other vesting conditions. Restricted stock are shares subject to restrictions requiring that they be redelivered
or forfeited to the company if specified conditions are not satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Change
in control. </I></B>An award under the 2013 Plan may be subject to additional acceleration of vesting and exercisability upon or after
a &lsquo;Change in Control&rsquo; as may be provided in the applicable award agreement for such stock award or as may be provided in
any other written agreement between the Company and the participant, but in the absence of such provision, no such acceleration shall
occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Stockholder
rights. </I></B>Except as otherwise provided in the applicable award agreement, and with respect to an award of restricted stock, a participant
will have no rights as a stockholder with respect to shares of our common stock covered by any award until the participant becomes the
record holder of such shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Amendments
and termination.</I></B> The Board of Directors may suspend or terminate the 2013 Plan at any time and may amend the 2013 Plan at any
time and from time to time in such respects as the Board of Directors may deem advisable or in our best interests; provided, however,
that stockholder approval is required for any amendment to the 2013 Plan that (i) increases the number of shares of common stock available
for issuance under the 2013 Plan, or (ii) changes the persons or class of persons eligible to receive awards under the 2013 Plan.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="M_001"></A>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RELATED
STOCKHOLDER MATTERS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
solely upon information made available to us, the following table sets forth information regarding the beneficial ownership of our common
stock as of the date of this prospectus, held by: (i) each director and director nominees; (ii) each of the named executive officers;
(iii) all of our directors and executive officers as a group; and (iv) each additional person or group who is known by us to own beneficially
more than 5% of our common stock. Except as indicated in the footnotes below, the address of the persons or groups named below is c/o
RenovoRx, Inc., 4546 El Camino Real, Suite B1 Los Altos, California 94022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
percentage of shares beneficially owned is computed on the basis of 11,357,661 shares of our common stock outstanding as of March 31,
2021. Shares of our common stock that a person has the right to acquire within 60 days after March 31, 2021 are deemed outstanding for
purposes of computing the percentage ownership of the person holding such rights, but are not deemed outstanding for purposes of computing
the percentage ownership of any other person, except with respect to the percentage ownership of all directors and executive officers
as a group. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of<BR>
    Shares<BR> Beneficially<BR> Owned</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Percentage
    of<BR> Shares Beneficially Owned</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name
    of Beneficial Owner</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
    to<BR> Offering</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
    to <BR>
    Offering</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">After
    <BR>
    Offering</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; font-style: italic; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">5%
    or Greater Stockholders</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kamran
    Najmabadi<SUP>(1)</SUP></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,225,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">44.6</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; font-style: italic; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Executive
    Officers and Directors</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shaun
    R. Bagai<SUP>(2)</SUP></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,992,785</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14.9</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Manners<SUP>(3)</SUP></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">128,333</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ramtin
    Agah<SUP>(4)</SUP></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,329,166</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">45.1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laurence
    J. Marton<SUP>(5)</SUP></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">366,256</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Una
    S. Ryan<SUP>(6)</SUP></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">53,333</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maky
    Zanganeh<SUP>(7)</SUP></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">106,666</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kristen
    Angela</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Macfarlane<SUP>(8)</SUP></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">106,666</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Directors
    and Officers as a Group (7 persons)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,083,205</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">55.9</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Represents less than 1% of the beneficial ownership of the outstanding shares of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 4,875,000 shares held of record by Mr. Najmabadi, our founder and technical engineering advisor, and 350,000 shares subject to
    options exercisable within 60 days of April 1, 2021. The address for Mr. Najmabadi is c/o RenovoRx, 4546 El Camino Real, Ste. B1,
    Los Altos, CA 94022.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 1,992,785 shares subject to options exercisable within 60 days of April 1, 2021 held by Mr. Bagai.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 116,666 shares held of record by Mr. Manners and 11,167 shares subject to options exercisable within 60 days of April 1, 2021.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 4,875,000 shares held of record by Dr. Agah and 454,166 shares subject to options exercisable within 60 days of April 1, 2021.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 366,256 shares subject to options exercisable within 60 days of April 1, 2021 held by Dr. Marton.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 53,333 shares subject to options exercisable within 60 days of April 1, 2021 held by Dr. Ryan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 106,666 shares subject to options exercisable within 60 days of April 1, 2021 held by Dr. Zanganeh.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 106,666 shares subject to options exercisable within 60 days of April 1, 2021 held by Ms. Macfarlane.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="k_004"></A>CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following includes a summary of transactions since January 1, 2019 to which we have been a party in which the amount involved exceeded
or will exceed the lesser of $120,000 or 1% of the average of our total assets as of December 31, 2020 and 2019, and in which any of
our directors, executive officers or, to our knowledge, beneficial owners of more than 5% of our capital stock or any member of the immediate
family of any of the foregoing persons had or will have a direct or indirect material interest, other than equity and other compensation,
termination, change in control and other arrangements, which are described under &ldquo;Executive and Director Compensation.&rdquo; We
also describe below certain other transactions with our directors, executive officers, and stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2013, we entered into an agreement, or the Agreement, with Dr. Agah, one of our co-founders, whereby he would provide consulting
services as our Chief Medical Officer by overseeing Company-sponsored clinical trials. The Agreement is for a term of 15 years with automatic
one-year renewals. The sole compensation payable to Dr. Agah was continued vesting of shares of common stock held by Dr. Agah. We entered
into an amendment to the Agreement in 2019 providing cash compensation to Dr. Agah of $10,000 per month for additional services. Consulting
fees paid to Dr. Agah were $78,000, $120,000 and $30,000 for the years ended December 31, 2019 and 2020 and the three months ended March
31, 2021, respectively. On June 7, 2021 we granted to Dr. Agah options to purchase 100,000 shares of common stock at an exercise price
of $0.49 per share which vests in 24 equal consecutive monthly installments commencing on June 14, 2021. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2019, we entered into a consulting agreement, the CFO Agreement, with the Mr. Manners, our Chief Financial Officer.&nbsp; In February
2020, we granted Mr. Manners an option to purchase 140,000 shares of common stock, of which 25% were vested upon grant and the remaining
75% vested ratably over 18 months. We entered into an amendment to the CFO Agreement in December 2020 providing for cash compensation
of $150 per hour. Consulting fees paid to Mr. Manners were $19,000, $37,000 and $54,000 for the years ended December 31, 2019 and 2020
and the three months ended March 31, 2021, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr,
Kamran Najmabadi, another of our co-founders,&nbsp;has served as&nbsp;our&nbsp;consulting technical engineering advisor on manufacturing
and intellectual property matters since January 2020.&nbsp; Previously Mr. Najmabadi was our CEO from inception&nbsp;in December 2009
until January 2013;&nbsp;Chief Technical and Operations Officer from&nbsp;January 2013 until&nbsp;January 2019; and Chief Technology
Officer from January 2019 to January 2020.&nbsp; Mr. Najmabadi currently receives cash compensation quarterly of $3,000. &nbsp;He received
option grants in 2016 and 2018, which are now fully vested.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Policies
and Procedures for Related Person Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors intends to adopt a written related person transaction policy, to be effective upon the closing of this offering, setting
forth the policies and procedures for the review and approval or ratification of related person transactions. This policy will cover,
with certain exceptions set forth in Item 404 of Regulation S-K under the Securities Act, any transaction, arrangement or relationship,
or any series of similar transactions, arrangements or relationships, in which we were or are to be a participant, where the amount involved
exceeds the lesser of $120,000 or 1% of the average of our total assets as of December 31, 2019 and 2020 and a related person had, has
or will have a direct or indirect material interest, including without limitation, purchases of goods or services by or from the related
person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness and employment by us
of a related person. In reviewing and approving any such transactions, our audit committee is tasked to consider all relevant facts and
circumstances, including, but not limited to, whether the transaction is on terms comparable to those that could be obtained in an arm&rsquo;s
length transaction and the extent of the related person&rsquo;s interest in the transaction. All of the transactions described in this
section occurred prior to the adoption of this policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="k_005"></A>DESCRIPTION
OF SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
completion of this offering, our authorized capital stock will consist of ________ shares of common stock, par value $0.001 per share,
and _____ shares of preferred stock, par value $0.001 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2021, there were 11,415,994 shares of common stock issued and outstanding. In addition, as of March 31, 2021, the
following series of convertible preferred stock was authorized and issued and outstanding, which shares of preferred stock are convertible
into an aggregate of 17,677,353 shares of common stock upon closing of this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred
    Series</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT></P>
                                                                                 <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidation</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Value</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif">B</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,611,461</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,928,359</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,745,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-3</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,660,230</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,660,230</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,227,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,546,095</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,546,095</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,150,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">A-1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,542,669</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,542,669</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">660,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,360,455</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,677,353</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,782,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description of our capital stock and provisions of our Second Amended and Restated Certificate of Incorporation and Amended
and Restated Bylaws to be effective upon the completion of this offering is only a summary. You should also refer to our Second Amended
and Restated Certificate of Incorporation, a copy of which is filed as an exhibit to the registration statement of which this prospectus
is a part, and our Amended and Restated Bylaws, a copy of which is filed as an exhibit to the registration statement of which this prospectus
is a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Voting
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our common stock are entitled to one vote per share on matters to be voted on by stockholders and also are entitled to receive such
dividends, if any, as may be declared from time to time by our board of directors in its discretion out of funds legally available therefor.
Holders of our common stock have exclusive voting rights for the election of our directors and all other matters requiring stockholder
action, except with respect to amendments to our certificate of incorporation that alter or change the powers, preferences, rights or
other terms of any outstanding preferred stock if the holders of such affected series of preferred stock are entitled to vote on such
an amendment or filling vacancies on the board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dividends
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of common stock are entitled to share ratably in any dividends declared by our board of directors, subject to any preferential dividend
rights of any outstanding preferred stock. Dividends consisting of shares of common stock may be paid to holders of shares of common
stock. We do not intend to pay cash dividends in the foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Liquidation
and Dissolution </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
our liquidation or dissolution, the holders of our common stock will be entitled to receive pro rata all assets remaining available for
distribution to stockholders after payment of all liabilities and provision for the liquidation of any shares of preferred stock at the
time outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors will have the authority, without further action by the stockholders, to issue up to _______ shares of preferred stock
in one or more series and to fix the designations, powers, preferences, privileges, and relative participating, optional, or special
rights as well as the qualifications, limitations, or restrictions of the preferred stock, including dividend rights, conversion rights,
voting rights, terms of redemption, and liquidation preferences, any or all of which may be greater than the rights of the common stock.
Our board of directors, without stockholder approval, will be able to issue convertible preferred stock with voting, conversion, or other
rights that could adversely affect the voting power and other rights of the holders of common stock. Preferred stock could be issued
quickly with terms calculated to delay or prevent a change of control or make removal of management more difficult. Additionally, the
issuance of preferred stock may have the effect of decreasing the market price of our common stock, and may adversely affect the voting
and other rights of the holders of common stock. At present, we have no plans to issue any shares of preferred stock following this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exclusive
Forum</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Sixth Amended and Restated Certificate of Incorporation to be effective upon completion of this offering provides that
unless we consent in writing to the selection of an alternative forum, the State of Delaware is the sole and exclusive forum for: (i)
any derivative action or proceeding brought on behalf of us, (ii) any action asserting a claim of breach of a fiduciary duty owed by
any director, officer or other employee of our Company to us or our stockholders, (iii) any action asserting a claim against us, our
directors, officers or employees arising pursuant to any provision of the DGCL or our Sixth Amended and Restated Certificate of
Incorporation or our Amended and Restated Bylaws to be effective upon completion of this offering, or (iv) any action asserting a claim
against us, our directors, officers, employees or agents governed by the internal affairs doctrine, except for, as to each of (i) through
(iv) above, any claim as to which the Court of Chancery determines that there is an indispensable party not subject to the jurisdiction
of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten
days following such determination), which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery,
or for which the Court of Chancery does not have subject matter jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
our Sixth Amended and Restated Certificate of Incorporation to be effective upon completion of this offering provide that
unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America will
be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act or the Securities
Exchange Act of 1934, as amended. Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock
are deemed to have notice of and consented to this provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Takeover
Effects of Delaware law and Our Sixth Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions of Delaware law, our Sixth Amended and Restated Certificate of Incorporation and our Amended and Restated Bylaws to
be adopted upon the closing of this offering, described below may have the effect of delaying, deferring or discouraging another party
from acquiring control of us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Section
203 of the Delaware General Corporation Law</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to Section 203 of the Delaware General Corporation Law, which prohibits a Delaware corporation from engaging in any business
combination with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder,
with the following exceptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">before
    such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in
    the stockholder becoming an interested stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned
    at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining
    the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (i) by
    persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to
    determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting
    of the stockholder, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock that
    is not owned by the interested stockholder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, Section 203 defines business combination to include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    merger or consolidation involving the corporation and the interested stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
    to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation
    to the interested stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series
    of the corporation beneficially owned by the interested stockholder; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    receipt by the interested stockholder of the benefit of any loss, advances, guarantees, pledges or other financial benefits by or
    through the corporation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, Section 203 defines an &ldquo;interested stockholder&rdquo; as an entity or person who, together with the person&rsquo;s affiliates
and associates, beneficially owns, or within three years prior to the time of determination of interested stockholder status did own,
15% or more of the outstanding voting stock of the corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Board
of Directors Vacancies</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Sixth Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws authorize only our board of directors
to fill vacant directorships. In addition, the number of directors constituting our board of directors may be set only by resolution
of the majority of the incumbent directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stockholder
Action; Special Meeting of Stockholders</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Sixth Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws provide that our stockholders may not
take action by written consent. Our Sixth Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws further
provide that special meetings of our stockholders may be called by a majority of the board of directors, the Chief Executive Officer,
or the Chairman of the board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Advance
Notice Requirements for Stockholder Proposals and Director Nominations</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Amended and Restated Bylaws provide that stockholders seeking to bring business before our annual meeting of stockholders, or to nominate
candidates for election as directors at our annual meeting of stockholders, must provide timely notice of their intent in writing. To
be timely, a stockholder&rsquo;s notice must be delivered to the secretary at our principal executive offices not later than the close
of business on the 90<SUP>th</SUP> day nor earlier than the close of business on the 120<SUP>th</SUP> day prior to the first anniversary
of the preceding year&rsquo;s annual meeting; provided, however, that in the event the date of the annual meeting is more than 30 days
before or more than 60 days after such anniversary date, or if no annual meeting was held in the preceding year, notice by the stockholder
to be timely must be so delivered not earlier than the close of business on the 120<SUP>th</SUP> day prior to such annual meeting and
not later than the close of business on the later of the 90<SUP>th</SUP> day prior to such annual meeting or the 10<SUP>th</SUP> day
following the day on which a public announcement of the date of such meeting is first made by us. These provisions may preclude our stockholders
from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Authorized
but Unissued Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized but unissued shares of common stock and preferred stock are available for future issuance without stockholder approval and
may be utilized for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions
and employee benefit plans. The existence of authorized but unissued and unreserved common stock and preferred stock could render more
difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise. If we issue
such shares without stockholder approval and in violation of limitations imposed by the Nasdaq Capital Market or any stock exchange on
which our stock may then be trading, our stock could be delisted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Transfer
Agent and Registrar </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our common stock is [&nbsp;&nbsp;].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SHARES
ELIGIBLE FOR FUTURE SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
completion of this offering, we will have [&nbsp;&nbsp;] shares of common stock issued and outstanding. All of the shares sold in this
offering will be freely transferable without restriction under the Securities Act unless purchased by one of our affiliates as that term
is defined in Rule 144 under the Securities Act, which generally includes directors, executive officers and 10% stockholders. Sales of
substantial amounts of our shares in the public market could adversely affect prevailing market prices of our shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
outstanding shares prior to this offering are &ldquo;restricted securities&rdquo; as that term is defined in Rule 144 and may be sold
only if they are sold pursuant to an effective registration statement under the Securities Act or an exemption from the registration
requirements of the Securities Act such as those provided in Rules 144 and 701 promulgated under the Securities Act, which rules are
summarized below. Restricted shares may also be sold outside of the United States in accordance with Regulation S under the Securities
Act. This prospectus may not be used in connection with any resale of our shares acquired in this offering by our affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule
144</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, under Rule 144 of the Securities Act, a person or entity that has beneficially owned our common stock for at least six months
and is not our &ldquo;affiliate&rdquo; will be entitled to sell our common stock, subject only to the availability of current public
information about us, and will be entitled to sell shares held for at least one year without any restriction. A person or entity that
is our &ldquo;affiliate&rdquo; and has beneficially owned our common stock for at least six months will be able to sell, within a rolling
three month period, the number of shares that does not exceed the greater of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
1% of the then outstanding common stock, which immediately after this offering will equal approximately [&nbsp;&nbsp;] shares if the
maximum number of shares being offered by us; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the average weekly trading volume of our common stock on the Nasdaq Capital Market during the four calendar weeks preceding the date
on which notice of the sale is filed with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
by affiliates under Rule 144 must be made through unsolicited brokers&rsquo; transactions. They are also subject to manner of sale provisions,
notice requirements and the availability of current public information about us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule
701</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, under Rule 701 of the Securities Act as currently in effect, each of our employees, directors or consultants who purchases our
common stock from us pursuant to a compensatory stock or option plan or other written agreement relating to compensation is eligible
to resell such common stock 90 days after we become a reporting company under the Exchange Act in reliance on Rule 144, but without compliance
with some of the restrictions, such as the holding period, contained in Rule 144. However, the Rule 701 shares would remain subject to
lock-up arrangements and would only become eligible for sale when the lock-up period expires.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MATERIAL
U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS OF THE COMPANY&rsquo;S COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the material U.S. federal income tax consequences to non-U.S. holders (as defined below) of the ownership and
disposition of the Company&rsquo;s common stock but does not purport to be a complete analysis of all the potential tax considerations
relating thereto. This summary is based upon the provisions of the Internal Revenue Code of 1986, as amended, or the Internal Revenue
Code, Treasury regulations promulgated thereunder, administrative rulings and judicial decisions, all as of the date hereof. These authorities
may be changed, possibly retroactively, so as to result in U.S. federal income tax consequences different from those set forth below.
No ruling on the U.S. federal, state, or local tax considerations relevant to the Company&rsquo;s operations or to the purchase, ownership
or disposition of its shares, has been requested from the IRS or other tax authority. No assurance can be given that the IRS would not
assert, or that a court would not sustain, a position contrary to any of the tax consequences described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary also does not address the tax considerations arising under the laws of any non-U.S., state or local jurisdiction, or under U.S.
federal gift and estate tax laws, except to the limited extent set forth below. In addition, this discussion does not address tax considerations
applicable to an investor&rsquo;s particular circumstances or to investors that may be subject to special tax rules, including, without
limitation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">banks,
    insurance companies or other financial institutions, regulated investment companies or real estate investment trusts;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    subject to the alternative minimum tax or Medicare contribution tax on net investment income;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt
    organizations or governmental organizations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">controlled
    foreign corporations, passive foreign investment companies and corporations that accumulate earnings to avoid U.S. federal income
    tax;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">brokers
    or dealers in securities or currencies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">traders
    in securities that elect to use a mark-to-market method of accounting for their securities holdings;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    that own, or are deemed to own, more than five percent of the Company&rsquo;s capital stock (except to the extent specifically set
    forth below);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US
    expatriates and certain former citizens or long-term residents of the United States;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">partnerships
    or entities classified as partnerships for U.S. federal income tax purposes or other pass- through entities (and investors therein);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    who hold the Company&rsquo;s common stock as a position in a hedging transaction, &ldquo;straddle,&rdquo; &ldquo;conversion transaction&rdquo;
    or other risk reduction transaction or integrated investment;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    who hold or receive the Company&rsquo;s common stock pursuant to the exercise of any employee stock option or otherwise as compensation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    who do not hold the Company&rsquo;s common stock as a capital asset within the meaning of Section 1221 of the Internal Revenue Code;
    or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    deemed to sell the Company&rsquo;s common stock under the constructive sale provisions of the Internal Revenue Code.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if a partnership or entity classified as a partnership for U.S. federal income tax purposes holds the Company&rsquo;s common
stock, the tax treatment of a partner generally will depend on the status of the partner and upon the activities of the partnership.
Accordingly, partnerships that hold the Company&rsquo;s common stock, and partners in such partnerships, should consult their tax advisors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>You
are urged to consult your tax advisor with respect to the application of the U.S. federal income tax laws to your particular situation,
as well as any tax consequences of the purchase, ownership and disposition of the Company&rsquo;s common stock arising under the U.S.
federal estate or gift tax rules or under the laws of any state, local, non-U.S., or other taxing jurisdiction or under any applicable
tax treaty.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Non-U.S.
Holder Defined</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this discussion, you are a non-U.S. holder (other than a partnership) if you are any holder other than:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual citizen or resident of the United States (for U.S. federal income tax purposes);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    corporation or other entity taxable as a corporation created or organized in the United States or under the laws of the United States,
    any state thereof, or the District of Columbia;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    estate whose income is subject to U.S. federal income tax regardless of its source; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    trust (x) whose administration is subject to the primary supervision of a U.S. court and which has one or more &ldquo;U.S. persons&rdquo;
    (within the meaning of Section 7701(a)(30) of the Internal Revenue Code) who have the authority to control all substantial decisions
    of the trust or (y) which has made a valid election to be treated as a U.S. person</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Distributions</I></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in &ldquo;Dividend Policy,&rdquo; we have never declared or paid cash dividends on our common stock and does not anticipate
paying any dividends on our common stock in the foreseeable future. However, if we do make distributions on our common stock, those payments
will constitute dividends for U.S. tax purposes to the extent paid from our current or accumulated earnings and profits, as determined
under U.S. federal income tax principles. To the extent those distributions exceed both our current and accumulated earnings and profits,
they will constitute a return of capital and will first reduce your basis in our common stock, but not below zero, and then will be treated
as gain from the sale of stock as described below under &ldquo;&mdash;Gain on Disposition of Common Stock.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion below on effectively connected income, backup withholding and foreign accounts, any dividend paid to a non-U.S. holder
generally will be subject to U.S. withholding tax either at a rate of 30% of the gross amount of the dividend or such lower rate as may
be specified by an applicable income tax treaty. In order to receive a reduced treaty rate, a non-U.S. holder must provide us with an
IRS Form W-8BEN, IRS Form W-8BEN-E, or other appropriate version of IRS Form W-8 certifying qualification for the reduced rate. A non-U.S.
holder of shares of our common stock eligible for a reduced rate of U.S. withholding tax pursuant to an income tax treaty may obtain
a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. If the non-U.S. holder holds the
stock through a financial institution or other agent acting on the non-U.S. holder&rsquo;s behalf, the non-U.S. holder will be required
to provide appropriate documentation to the agent, which then will be required to provide certification to us or our paying agent, either
directly or through other intermediaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
received by a non-U.S. holder that are effectively connected with such non-U.S. holder&rsquo;s conduct of a U.S. trade or business (and,
if required by an applicable income tax treaty, attributable to a permanent establishment maintained by a non-U.S. holder in the United
States) are generally exempt from the withholding tax described above. In order to obtain this exemption, a non-U.S. holder must provide
us with an IRS Form W-8ECI or other applicable IRS Form W-8 properly certifying such exemption. Such effectively connected dividends,
although not subject to withholding tax, are taxed at the same graduated rates applicable to U.S. persons, net of certain deductions
and credits. In addition, if a non-U.S. holder is a corporate non-U.S. holder, dividends received by such non-U.S. holder that are effectively
connected with such non-U.S. holder&rsquo;s conduct of a U.S. trade or business may also be subject to a branch profits tax at a rate
of 30% or such lower rate as may be specified by an applicable income tax treaty. You should consult your tax advisor regarding any applicable
tax treaties that may provide for different rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Gain
on Disposition of Common Stock</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion below regarding backup withholding and foreign accounts, a non-U.S. holder generally will not be required to pay U.S.
federal income tax on any gain realized upon the sale or other disposition of our common stock unless:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  gain is effectively connected with the non-U.S. holder&rsquo;s conduct of a U.S. trade or business (and, if required by an applicable
  income tax treaty, the gain is attributable to a permanent establishment maintained by such non-U.S. holder in the United States);</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  gain is effectively connected with the non-U.S. holder&rsquo;s conduct of a U.S. trade or business (and, if required by an applicable
  income tax treaty, the gain is attributable to a permanent establishment maintained by such non-U.S. holder in the United States);</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  non-U.S. holders are a non-resident alien individual who is present in the United States for a period or periods aggregating 183 days
  or more during the taxable year in which the sale or disposition occurs and certain other conditions are met; or</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
  common stock constitutes a United States real property interest by reason of its status as a &ldquo;United States real property holding
  corporation,&rdquo; or USRPHC, for U.S. federal income tax purposes at any time within the shorter of (i) the five-year period preceding
  the non-U.S. holder&rsquo;s disposition of our common stock, or (ii) the non-U.S. holder&rsquo;s holding period for our common stock.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that we are not currently and will not become a USRPHC for U.S. federal income tax purposes, and the remainder of this discussion
so assumes. However, because the determination of whether we are a USRPHC depends on the fair market value of our U.S. real property
relative to the fair market value of our other business assets, there can be no assurance that we will not become a USRPHC in the future.
Even if we become a USRPHC, however, as long as our common stock is regularly traded on an established securities market, such common
stock will be treated as U.S. real property interests only if the non-U.S. holder&rsquo;s actually or constructively hold more than five
percent of such regularly traded common stock at any time during the shorter of (i) the five-year period preceding the non-U.S. holder&rsquo;s
disposition of our common stock, or (ii) the non-U.S. holder&rsquo;s holding period for our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gains
described in the first bullet point above, generally will be subject to U.S. federal income tax on a net income basis at the regular
graduated U.S. federal income tax rates, and a corporate non-U.S. holder described in the first bullet above also may be subject to the
branch profits tax at a 30% rate, or such lower rate as may be specified by an applicable income tax treaty. An individual non-U.S. holder
described in the second bullet above, you will be required to pay a flat 30% tax (or such lower rate specified by an applicable income
tax treaty) on the gain derived from the sale, which gain may be offset by U.S. source capital losses for the year (provided the non-U.S.
holder has timely filed U.S. federal income tax returns with respect to such losses). You should consult any applicable income tax or
other treaties that may provide for different rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Backup
Withholding and Information Reporting</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
we must report annually to the IRS, regardless of whether any tax was withheld, the amount of dividends paid to a non-U.S. holder, the
non-U.S. holder&rsquo;s name and address and the amount of tax withheld, if any. A similar report will be sent to the non-U.S. holder.
Pursuant to applicable income tax treaties or other agreements, the IRS may make these reports available to tax authorities in the non-U.S.
holder&rsquo;s country of residence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
of dividends or of proceeds on the disposition of stock made to a non-U.S. holder may be subject to information reporting and backup
withholding at a current rate of 24% unless such non-U.S. holder establishes an exemption, for example, by properly certifying such non-U.S.
holder&rsquo;s non-U.S. status on an IRS Form W-8BEN, IRS Form W-8BEN-E, or another appropriate version of IRS Form W-8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Backup
withholding is not an additional tax; rather, the U.S. federal income tax liability of persons subject to backup withholding will be
reduced by the amount of tax withheld. If withholding results in an overpayment of taxes, a refund or credit may generally be obtained
from the IRS, provided that the required information is furnished to the IRS in a timely manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Foreign
Account Tax Compliance</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Foreign Account Tax Compliance Act, or FATCA, imposes withholding tax at a rate of 30% on dividends on and gross proceeds from the sale
or other disposition of our common stock paid to &ldquo;foreign financial institutions&rdquo; (as specially defined under these rules),
unless such institution enters into an agreement with the U.S. government to withhold on certain payments and to collect and provide
to the U.S. tax authorities substantial information regarding the U.S. account holders of such institution (which includes certain equity
and debt holders of such institution, as well as certain account holders that are foreign entities with U.S. owners) or otherwise establishes
an exemption. FATCA also generally imposes a U.S. federal withholding tax of 30% on dividends on and gross proceeds from the sale or
other disposition of our common stock paid to a &ldquo;non-financial foreign entity&rdquo; (as specially defined for purposes of these
rules) unless such entity provides the withholding agent with a certification identifying certain substantial direct and indirect U.S.
owners of the entity, certifies that there are none or otherwise establishes an exemption. The withholding provisions under FATCA generally
apply to dividends on our common stock, and under current transition rules, are expected to apply with respect to the gross proceeds
from the sale or other disposition of our common stock on or after January 1, 2019. An intergovernmental agreement between the United
States and an applicable foreign country may modify the requirements described in this paragraph. Non-U.S. holders should consult their
own tax advisors regarding the possible implications of this legislation on their investment in our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Each
prospective investor should consult its own tax advisor regarding the particular U.S. federal, state and local and non-U.S. tax consequences
of purchasing, holding and disposing of our common stock, including the consequences of any proposed change in applicable laws.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="k_006"></A>UNDERWRITING
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into an underwriting agreement with Roth Capital Partners, LLC. Subject to the terms and conditions of the underwriting
agreement, we have agreed to sell to the underwriter, and the underwriter has agreed to purchase from us, shares of our common stock.
We have applied to list our common stock on the Nasdaq Capital Market under the symbol &ldquo;RNXT.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms and subject to the conditions contained in the underwriting agreement, we have agreed to sell to the underwriter named below,
and the underwriter has agreed to purchase from us, the respective number of shares of common stock set forth opposite its name below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Underwriter</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of Shares</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 76%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Roth
    Capital Partners, LLC</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 20%; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriting agreement provides that the obligation of the underwriters to purchase the shares of common stock offered by this prospectus
is subject to certain conditions. The underwriter is obligated to purchase all of the shares of common stock offered hereby if any of
the shares are purchased.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have granted the underwriters an option to buy up to an additional shares of common stock from us at the initial public offering price,
less the underwriting discounts and commissions, to cover over-allotments, if any. The underwriter may exercise this option at any time,
in whole or in part, during the 45-day period after the date of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Discounts,
Commissions and Expenses </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriter proposes to offer to the shares of common stock purchased pursuant to the underwriting agreement to the public at the initial
public offering price set forth on the cover page of this prospectus and to certain dealers at that price less a concession not in excess
of $ per share. After this offering, the initial public offering price and concession may be changed by the underwriter. No such change
shall change the amount of proceeds to be received by us as set forth on the cover page of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the common stock to be purchased by the underwriter, the underwriter will be deemed to have received compensation
in the form of underwriting commissions and discounts. The underwriter&rsquo;s commissions and discounts will be 7.0% of the gross proceeds
of this offering, or $ per share of common stock, based on the public offering price per share set forth on the cover page of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also agreed to reimburse Roth Capital Partners at closing for legal expenses incurred by it in connection with the offering up to
a maximum of $150,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the underwriting discounts and commissions payable to the underwriter by us in connection with this offering (assuming
both the exercise and non-exercise of the over-allotment option to purchase additional shares of common stock we have granted to the
underwriters):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Per
    Share</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Without
    Over- allotment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">With
    Over- allotment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Without
    Over- allotment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">With
    Over- allotment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Initial
    public offering price</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Underwriting
    discounts and commissions paid by us</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 41; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Representative&rsquo;s
Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will issue to Roth Capital Partners or its designees warrants to purchase an aggregate number of shares of our common stock equal to
5.0% of the number of shares of common stock issued in this offering, at an exercise price per share equal to 120% of the initial public
offering price (the &ldquo;Representative&rsquo;s Warrants&rdquo;). The Representative&rsquo;s Warrants will be exercisable, in whole
or in part, six months after issuance and will expire on the fifth anniversary of the commencement of sales in this offering in accordance
with FINRA Rule 5110(g)(8)(A). The Representative&rsquo;s Warrants will provide for one demand registration right at the Company&rsquo;s
expense and an additional demand registration right at the holder&rsquo;s expense and unlimited piggyback registration rights at the
Company&rsquo;s expense for a period of five years following the date of commencement of sales of this offering. Pursuant to FINRA
Rule 5110(e), the Representative&rsquo;s Warrants and any shares of common stock issued upon exercise of the Representative&rsquo;s Warrants
shall not be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put or
call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately
following the date of commencement of sales of this offering, except the transfer of any security: (i) by operation of law or by reason
of reorganization of the issuer; (ii) to any FINRA member firm participating in the offering and the officers, partners, registered persons
or affiliates thereof, if all securities so transferred remain subject to the lock-up restriction set forth above for the remainder of
the time period; (iii) if the aggregate amount of our securities held by the Representative or related persons does not exceed 1% of
the securities being offered; (iv) that is beneficially owned on a pro-rata basis by all equity owners of an investment fund, provided
that no participating member manages or otherwise directs investments by the fund and the participating members in the aggregate do not
own more than 10% of the equity in the fund; (v) the exercise or conversion of any security, if all securities remain subject to the
lock-up restriction set forth above for the remainder of the time period; (vi) if we meet the registration requirements of Forms S-3,
F-3 or F-10; or (vii) back to us in a transaction exempt from registration with the SEC. The Representative&rsquo;s Warrants and the
shares of common stock underlying the Representative&rsquo;s Warrants are registered in the registration statement of which this prospectus
is a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Right
of First Refusal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have granted the underwriter an 18-month right first refusal to act as the exclusive placement agent or sole book-running manager and
sole lead managing underwriter for any private or public offering of equity, equity-linked or debt securities undertaken by us, provided
that this offering is consummated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the underwriting agreement, we have agreed to indemnify the underwriters against certain liabilities, including liabilities under
the Securities Act, or to contribute to payments that the underwriters or such other indemnified parties may be required to make in respect
of those liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
Agreements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
and each of our directors, officers and stockholders have agreed not to offer, sell, agree to sell, directly or indirectly, or otherwise
dispose of any shares of common stock or any securities convertible into or exchangeable for shares of common stock for a period of days
after the closing date of the offering pursuant to the underwriting agreement without the prior written consent of Roth Capital Partners.
These lock-up agreements provide for limited exceptions and their restrictions may be waived at any time by Roth Capital Partners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Electronic
Distribution </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus may be made available in electronic format on websites or through other online services maintained by the underwriters or
by their affiliates. In those cases, prospective investors may view offering terms online and prospective investors may be allowed to
place orders online. Other than this prospectus and the accompanying prospectus in electronic format, the information on the underwriters&rsquo;
websites or our website and any information contained in any other websites maintained by the underwriters or by us is not part of this
prospectus or the registration statement of which this prospectus forms a part, has not been approved and/or endorsed by us or the underwriter
in its capacity as underwriter, and should not be relied upon by investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price
Stabilization, Short Positions and Penalty Bids </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the offering the underwriters may engage in stabilizing transactions, over-allotment transactions, syndicate covering
transactions and penalty bids in accordance with Regulation M under the Exchange Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stabilizing
    transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over-allotment
    involves sales by the underwriters of shares in excess of the number of shares the underwriters are obligated to purchase, which
    creates a syndicate short position. The short position may be either a covered short position or a naked short position. In a covered
    short position, the number of shares over-allotted by the underwriters is not greater than the number of shares that they may purchase
    in the over-allotment option. In a naked short position, the number of shares involved is greater than the number of shares in the
    over-allotment option. The underwriters may close out any covered short position by either exercising their over-allotment option
    and/or purchasing shares in the open market. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Syndicate
    covering transactions involve purchases of the common stock in the open market after the distribution has been completed in order
    to cover syndicate short positions. In determining the source of shares to close out the short position, the underwriters will consider,
    among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase
    shares through the over-allotment option. A naked short position occurs if the underwriters sell more shares than could be covered
    by the over-allotment option. This position can only be closed out by buying shares in the open market. A naked short position is
    more likely to be created if the underwriters are concerned that there could be downward pressure on the price of the shares in the
    open market after pricing that could adversely affect investors who purchase in the offering. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Penalty
    bids permit the underwriters to reclaim a selling concession from a syndicate member when the common stock originally sold by the
    syndicate member is purchased in a stabilizing or syndicate covering transaction to cover syndicate short positions. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
stabilizing transactions, syndicate covering transactions and penalty bids may have the effect of raising or maintaining the market price
of our common stock or preventing or retarding a decline in the market price of the common stock. As a result, the price of our common
stock may be higher than the price that might otherwise exist in the open market. These transactions may be discontinued at any time</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
we nor the underwriters make any representation or prediction as to the direction or magnitude of any effect that the transactions described
above may have on the price of our shares of common stock. In addition, neither we nor the underwriters make any representation that
the underwriter will engage in these transactions or that any transaction, if commenced, will not be discontinued without notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offer
restrictions outside the United States</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than in the United States, no action has been taken by us or the underwriter that would permit a public offering of the securities offered
by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be
offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with
the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result
in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are
advised to inform themselves about and to observe any restrictions relating to this offering and the distribution of this prospectus.
This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in
any jurisdiction in which such an offer or a solicitation is unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Australia</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is not a disclosure document under Chapter 6D of the Australian Corporations Act, has not been lodged with the Australian
Securities and Investments Commission and does not purport to include the information required of a disclosure document under Chapter
6D of the Australian Corporations Act. Accordingly, (i) the offer of the securities under this prospectus is only made to persons to
whom it is lawful to offer the securities without disclosure under Chapter 6D of the Australian Corporations Act under one or more exemptions
set out in section 708 of the Australian Corporations Act, (ii) this prospectus is made available in Australia only to those persons
as set forth in clause (i) above, and (iii) the offeree must be sent a notice stating in substance that by accepting this offer, the
offeree represents that the offeree is such a person as set forth in clause (i) above, and, unless permitted under the Australian Corporations
Act, agrees not to sell or offer for sale within Australia any of the securities sold to the offeree within 12 months after its transfer
to the offeree under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Canada</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors,
as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted
clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale
of the securities must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements
of applicable securities laws. Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies
for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies
for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&rsquo;s
province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&rsquo;s
province or territory for particulars of these rights or consult with a legal advisor. Pursuant to section 3A.3 of National Instrument
33-105 Underwriting Conflicts (NI 33-105), the underwriter is not required to comply with the disclosure requirements of NI33-105 regarding
underwriter conflicts of interest in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>China</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this document does not constitute a public offer of the securities, whether by way of sale or subscription, in the People&rsquo;s
Republic of China (excluding, for purposes of this paragraph, Hong Kong Special Administrative Region, Macau Special Administrative Region
and Taiwan). The securities may not be offered or sold directly or indirectly in the PRC to legal or natural persons other than directly
to &ldquo;qualified domestic institutional investors.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>European
Economic Area&thinsp;&mdash;&thinsp;Belgium, Germany, Luxembourg and Netherlands</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this document has been prepared on the basis that all offers of securities will be made pursuant to an exemption under
the Directive 2003/71/EC (&ldquo;Prospectus Directive&rdquo;), as implemented in Member States of the European Economic Area (each, a
&ldquo;Relevant Member State&rdquo;), from the requirement to produce a prospectus for offers of securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
offer to the public of securities has not been made, and may not be made, in a Relevant Member State except pursuant to one of the following
exemptions under the Prospectus Directive as implemented in that Relevant Member State:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    legal entities that are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose
    corporate purpose is solely to invest in securities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    any legal entity that has two or more of (i) an average of at least 250 employees during its last fiscal year; (ii) a total balance
    sheet of more than &euro;43,000,000 (as shown on its last annual unconsolidated or consolidated financial statements) and (iii) an
    annual net turnover of more than &euro;50,000,000 (as shown on its last annual unconsolidated or consolidated financial statements);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    fewer than 100 natural or legal persons (other than qualified investors within the meaning of Article 2(1)(e) of the Prospectus Directive)
    subject to obtaining our prior consent or any underwriter for any such offer; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    any other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no such offer of securities shall
    require us to publish a prospectus pursuant to Article 3 of the Prospectus Directive.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>France</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document is not being distributed in the context of a public offering of financial securities (offre au public de titres financiers)
in France within the meaning of Article L.411-1 of the French Monetary and Financial Code (Code mon&eacute;taire et financier) and Articles
211-1 et seq. of the General Regulation of the French Autorit&eacute; des march&eacute;s financiers (&ldquo;AMF&rdquo;). The securities
have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document and any other offering material relating to the securities have not been, and will not be, submitted to the AMF for approval
in France and, accordingly, may not be distributed or caused to distributed, directly or indirectly, to the public in France.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
offers, sales and distributions have been and shall only be made in France to (i) qualified investors (investisseurs qualifi&eacute;s)
acting for their own account, as defined in and in accordance with Articles L.411-2-II-2 and D.411-1 to D.411-3, D. 744-1, D.754-1 and
D.764-1 of the French Monetary and Financial Code and any implementing regulation and/or (ii) a restricted number of non-qualified investors
(cercle restreint d&rsquo;investisseurs) acting for their own account, as defined in and in accordance with Articles L.411-2-II-2&deg;
and D.411-4, D.744-1, D.754-1 and D.764-1 of the French Monetary and Financial Code and any implementing regulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Article 211-3 of the General Regulation of the AMF, investors in France are informed that the securities cannot be distributed (directly
or indirectly) to the public by the investors otherwise than in accordance with Articles L.411-1, L.411-2, L.412-1 and L.621-8 to L.621-8-3
of the French Monetary and Financial Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ireland</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this document does not constitute a prospectus under any Irish laws or regulations and this document has not been filed
with or approved by any Irish regulatory authority as the information has not been prepared in the context of a public offering of securities
in Ireland within the meaning of the Irish Prospectus (Directive 2003/71/EC) Regulations 2005 (the &ldquo;Prospectus Regulations&rdquo;).
The securities have not been offered or sold, and will not be offered, sold or delivered directly or indirectly in Ireland by way of
a public offering, except to (i) qualified investors as defined in Regulation 2(l) of the Prospectus Regulations and (ii) fewer than
100 natural or legal persons who are not qualified investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Israel</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities offered by this prospectus have not been approved or disapproved by the Israeli Securities Authority (the ISA), or ISA, nor
have such securities been registered for sale in Israel. The shares may not be offered or sold, directly or indirectly, to the public
in Israel, absent the publication of a prospectus. The ISA has not issued permits, approvals or licenses in connection with this offering
or publishing the prospectus; nor has it authenticated the details included herein, confirmed their reliability or completeness, or rendered
an opinion as to the quality of the securities being offered. Any resale in Israel, directly or indirectly, to the public of the securities
offered by this prospectus is subject to restrictions on transferability and must be effected only in compliance with the Israeli securities
laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Italy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering of the securities in the Republic of Italy has not been authorized by the Italian Securities and Exchange Commission (Commissione
Nazionale per le Societ&agrave; e la Borsa, &ldquo;CONSOB&rdquo; pursuant to the Italian securities legislation and, accordingly, no
offering material relating to the securities may be distributed in Italy and such securities may not be offered or sold in Italy in a
public offer within the meaning of Article 1.1(t) of Legislative Decree No. 58 of 24 February 1998 (&ldquo;Decree No. 58&rdquo;), other
than:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    Italian qualified investors, as defined in Article 100 of Decree no. 58 by reference to Article 34-ter of CONSOB Regulation no. 11971
    of 14 May 1999 (&ldquo;Regulation no. 1197l&rdquo;) as amended (&ldquo;Qualified Investors&rdquo;); and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    other circumstances that are exempt from the rules on public offer pursuant to Article 100 of Decree No. 58 and Article 34-ter of
    Regulation No. 11971 as amended.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
offer, sale or delivery of the securities or distribution of any offer document relating to the securities in Italy (excluding placements
where a Qualified Investor solicits an offer from the issuer) under the paragraphs above must be:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">made
    by investment firms, banks or financial intermediaries permitted to conduct such activities in Italy in accordance with Legislative
    Decree No. 385 of 1 September 1993 (as amended), Decree No. 58, CONSOB Regulation No. 16190 of 29 October 2007 and any other applicable
    laws; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    compliance with all relevant Italian securities, tax and exchange controls and any other applicable laws.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
subsequent distribution of the securities in Italy must be made in compliance with the public offer and prospectus requirement rules
provided under Decree No. 58 and the Regulation No. 11971 as amended, unless an exception from those rules applies. Failure to comply
with such rules may result in the sale of such securities being declared null and void and in the liability of the entity transferring
the securities for any damages suffered by the investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Japan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities have not been and will not be registered under Article 4, paragraph 1 of the Financial Instruments and Exchange Law of Japan
(Law No. 25 of 1948), as amended (the &ldquo;FIEL&rdquo;) pursuant to an exemption from the registration requirements applicable to a
private placement of securities to Qualified Institutional Investors (as defined in and in accordance with Article 2, paragraph 3 of
the FIEL and the regulations promulgated thereunder). Accordingly, the securities may not be offered or sold, directly or indirectly,
in Japan or to, or for the benefit of, any resident of Japan other than Qualified Institutional Investors. Any Qualified Institutional
Investor who acquires securities may not resell them to any person in Japan that is not a Qualified Institutional Investor, and acquisition
by any such person of securities is conditional upon the execution of an agreement to that effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
Zealand</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock offered hereby have not been offered or sold, and will not be offered or sold, directly or indirectly in New Zealand
and no offering materials or advertisements have been or will be distributed in relation to any offer of shares in New Zealand, in each
case other than:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    persons whose principal business is the investment of money or who, in the course of and for the purposes of their business, habitually
    invest money;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    persons who in all the circumstances can properly be regarded as having been selected otherwise than as members of the public;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    persons who are each required to pay a minimum subscription price of at least NZ$500,000 for the shares before the allotment of those
    shares (disregarding any amounts payable, or paid, out of money lent by the issuer or any associated person of the issuer); or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    other circumstances where there is no contravention of the Securities Act 1978 of New Zealand (or any statutory modification or reenactment
    of, or statutory substitution for, the Securities Act 1978 of New Zealand).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Portugal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document is not being distributed in the context of a public offer of financial securities (oferta p&uacute;blica de valores mobili&aacute;rios)
in Portugal, within the meaning of Article 109 of the Portuguese Securities Code (C&oacute;digo dos Valores Mobili&aacute;rios). The
securities have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in Portugal. This document
and any other offering material relating to the securities have not been, and will not be, submitted to the Portuguese Securities Market
Commission (Comiss&atilde;o do Mercado de Valores Mobili&aacute;rios) for approval in Portugal and, accordingly, may not be distributed
or caused to distributed, directly or indirectly, to the public in Portugal, other than under circumstances that are deemed not to qualify
as a public offer under the Portuguese Securities Code. Such offers, sales and distributions of securities in Portugal are limited to
persons who are &ldquo;qualified investors&rdquo; (as defined in the Portuguese Securities Code). Only such investors may receive this
document and they may not distribute it or the information contained in it to any other person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sweden</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document has not been, and will not be, registered with or approved by Finansinspektionen (the Swedish Financial Supervisory Authority).
Accordingly, this document may not be made available, nor may the securities be offered for sale in Sweden, other than under circumstances
that are deemed not to require a prospectus under the Swedish Financial Instruments Trading Act (1991:980) (Sw. lag (1991:980) om handel
med finansiella instrument). Any offering of securities in Sweden is limited to persons who are &ldquo;qualified investors&rdquo; (as
defined in the Financial Instruments Trading Act). Only such investors may receive this document and they may not distribute it or the
information contained in it to any other person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Switzerland</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (&ldquo;SIX&rdquo;) or on any
other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards
for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses
under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland.
Neither this document nor any other offering material relating to the securities may be publicly distributed or otherwise made publicly
available in Switzerland.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
this document nor any other offering material relating to the securities have been or will be filed with or approved by any Swiss regulatory
authority. In particular, this document will not be filed with, and the offer of securities will not be supervised by, the Swiss Financial
Market Supervisory Authority (FINMA).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document is personal to the recipient only and not for general circulation in Switzerland.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>United
Arab Emirates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
this document nor the securities have been approved, disapproved or passed on in any way by the Central Bank of the United Arab Emirates
or any other governmental authority in the United Arab Emirates, nor have we received authorization or licensing from the Central Bank
of the United Arab Emirates or any other governmental authority in the United Arab Emirates to market or sell the securities within the
United Arab Emirates. This document does not constitute and may not be used for the purpose of an offer or invitation. We may not render
services relating to the securities within the United Arab Emirates, including the receipt of applications and/or the allotment or redemption
of such shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
offer or invitation to subscribe for securities is valid or permitted in the Dubai International Financial Centre.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>United
Kingdom</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the information in this document nor any other document relating to the offer has been delivered for approval to the Financial Services
Authority in the United Kingdom and no prospectus (within the meaning of section 85 of the Financial Services and Markets Act 2000, as
amended (&ldquo;FSMA&rdquo;)) has been published or is intended to be published in respect of the securities. This document is issued
on a confidential basis to &ldquo;qualified investors&rdquo; (within the meaning of section 86(7) of FSMA) in the United Kingdom, and
the securities may not be offered or sold in the United Kingdom by means of this document, any accompanying letter or any other document,
except in circumstances which do not require the publication of a prospectus pursuant to section 86(1) FSMA. This document should not
be distributed, published or reproduced, in whole or in part, nor may its contents be disclosed by recipients to any other person in
the United Kingdom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
invitation or inducement to engage in investment activity (within the meaning of section 21 of FSMA) received in connection with the
issue or sale of the securities has only been communicated or caused to be communicated and will only be communicated or caused to be
communicated in the United Kingdom in circumstances in which section 21(1) of FSMA does not apply us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United Kingdom, this document is being distributed only to, and is directed at, persons (i) who have professional experience in matters
relating to investments falling within Article 19(5) (investment professionals) of the Financial Services and Markets Act 2000 (Financial
Promotions) Order 2005 (&ldquo;FPO&rdquo;), (ii) who fall within the categories of persons referred to in Article 49(2)(a) to (d) (high
net worth companies, unincorporated associations, etc.) of the FPO or (iii) to whom it may otherwise be lawfully communicated (together
&ldquo;relevant persons&rdquo;). The investments to which this document relates are available only to, and any invitation, offer or agreement
to purchase will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document
or any of its contents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="k_007"></A>LEGAL
MATTERS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the securities offered hereby will be passed upon by Sheppard Mullin Richter &amp; Hampton LLP, New York, New York. Ellenoff
Grossman &amp; Schole LLP, New York, New York, is acting as counsel for the underwriter in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="k_008"></A>EXPERTS
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements as of December 31, 2019 and 2020 and for the years then ended included in this prospectus and in the registration
statement have been so included in reliance on the report of Frank, Rimerman &amp; Co. LLP, an independent registered public accounting
firm, (the report on the financial statements contains an explanatory paragraph regarding the Company&rsquo;s ability to continue as
a going concern) appearing elsewhere herein and in the registration statement, given on the authority of said firm as experts in auditing
and accounting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="k_009"></A>WHERE
TO FIND MORE INFORMATION </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus, which constitutes a part of the registration statement, does not contain all the information set forth in the registration
statement, some of which is contained in exhibits to the registration statement as permitted by the rules and regulations of the SEC.
For further information with respect to us and our securities, we refer you to the registration statement, including the exhibits filed
as a part of the registration statement. Statements contained in this prospectus concerning the contents of any contract or any other
document are not necessarily complete. If a contract or document has been filed as an exhibit to the registration statement, please see
the copy of the contract or document that has been filed. Each statement in this prospectus relating to a contract or document filed
as an exhibit is qualified in all respects by the filed exhibit. You may obtain copies of this information by mail from the Public Reference
Section of the SEC, 100 F Street, N.E., Room 1580, Washington, D.C. 20549, at prescribed rates. You may obtain information on the operation
of the public reference rooms by calling the SEC at 1-800-SEC-0330. The SEC also maintains an internet website that contains reports
and other information about issuers, like us, that file electronically with the SEC. The address of that website is www.sec.gov. You
may also request a copy of these filings, at no cost, by writing us at:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RenovoRx,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4546
El Camino Real, Suite B1 </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Los
Altos, California 94022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Shaun R. Bagai, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail:
info@renovorx.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
(650) 284-4433</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the information and reporting requirements of the Exchange Act and, in accordance with this law, file periodic reports,
proxy statements and other information with the SEC. These periodic reports, proxy statements and other information are available for
inspection and copying at the SEC&rsquo;s public reference facilities and the website of the SEC referred to above. We also maintain
a website at www.RenovoRx.com. Information contained in, or accessible through, our website is not a part of this prospectus, and the
inclusion of our website address in this prospectus is only as an inactive textual reference. You may access these materials free of
charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="k_010"></A>INDEX
TO FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Page</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audited
                                            Financial Statements for the Years Ended December 31, 2019 and 2020</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_011">Report
    of Independent Registered Public Accounting Firm</A></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-2</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_012">Balance
    Sheets</A></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-3</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_013">Statements
    of Operations</A></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-4</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_014">Statements
    of Convertible Preferred Stock and Stockholders&rsquo; Deficit</A></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-5</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_015">Statements
    of Cash Flows</A></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-6</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_016">Notes
    to Financial Statements</A></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-7</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Unaudited
Condensed Interim Financial Statements for the Three Months Ended March 31, 2020 and 2021</B></FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#aaa_01">Condensed
    Balance Sheets as of December 31, 2020 and March 31, 2021</A></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-28</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#aaa_02">Condensed
    Statements of Operations for the Three Months Ended March 31, 2020 and 2021 (unaudited)</A></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-29</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#aaa_03">Condensed
    Statements of Convertible Preferred Stock and Stockholders&rsquo; Deficit for the Three Months Ended March 31, 2020 and 2021 (unaudited)</A></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-30</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#aaa_04">Condensed
    Statements of Cash Flows for the Three Months Ended March 31, 2020 and 2021 (unaudited)</A></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-31</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><A HREF="#aaaaa_002"><FONT STYLE="font-family: Times New Roman, Times, Serif">Notes
    to Unaudited Condensed Interim Financial Statements</FONT></A></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-32</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U><A NAME="k_011"></A>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.15pt">To
the Stockholders and the Board of Directors of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.15pt">RenovoRx,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.15pt">Los
Altos, CA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Opinion
on the Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">We
have audited the accompanying balance sheets of RenovoRx, Inc. (the &ldquo;Company&rdquo;) as of December 31, 2019 and 2020 and
the related statements of operations, convertible preferred stock and stockholders&rsquo; deficit, and cash flows for each of
the years in the two-year period ended December 31, 2020, and the related notes (collectively referred to as the &ldquo;financial
statements&rdquo;). In our opinion, the financial statements present fairly, in all material respects, the financial position
of the Company as of December 31, 2019 and 2020, and the results of its operations and its cash flows for each of the years in
the two-year period ended December 31, 2020, in conformity with accounting principles generally accepted in the United States
of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Going
Concern</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed
in Note 2 to the financial statements, the Company has incurred recurring losses from operations, has negative cash flows from
operating activities and has an accumulated deficit that raise substantial doubt about its ability to continue as a going concern.
Management&rsquo;s plans in regard to these matters are also described in Note 2. The financial statements do not include any
adjustments that might result from the outcome of this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Basis
for Opinion</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">These
financial statements are the responsibility of the Company&rsquo;s management. Our responsibility is to express an opinion on
the Company&rsquo;s financial statements based on our audits. We are a public accounting firm registered with the Public Company
Accounting Oversight Board (United States) (the &ldquo;PCAOB&rdquo;) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the U.S. Securities and Exchange
Commission (the &ldquo;SEC&rdquo;) and the PCAOB.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but
not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s internal control over financial reporting.
Accordingly, we express no such opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that our audits provide a reasonable basis for our opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Frank, Rimerman
    +Co. LLP</I></FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We have served as
    the Company&rsquo;s auditor since 2019.</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">San Francisco, California</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 12, 2021, except for Note 14, as to which the
    date is June 15, 2021 </FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RenovoRx,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="k_012"></A>Balance
Sheets </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
thousands, except share and per share data)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    of December 31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current
    assets:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    and cash equivalents</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,104</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,795</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Restricted
    cash</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaid
    expenses and other current assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">142</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    current assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,266</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,910</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deposits</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,270</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,914</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities,
    Convertible Preferred Stock and Stockholders&rsquo; Deficit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current
    liabilities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">538</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">162</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">232</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">311</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Promissory
    note, current portion</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">117</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible
    note</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,650</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liability</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">856</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    liability</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    current liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">805</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,096</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Promissory
    note, net of current portion</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">23</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">805</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,119</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Commitments
    and contingencies (Note 11)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible
    preferred stock, $0.0001 par value; 22,360,455 shares authorized; 17,543,161 and 17,677,353 shares issued and outstanding at December
    31, 2019 and 2020, respectively (aggregate liquidation preference of $12,757 and $12,782, respectively)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,391</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,451</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stockholders&rsquo;
    deficit:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    stock, $0.0001 par value; 42,000,000 shares authorized; 10,885,936 and 11,165,703 shares issued and outstanding, respectively</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional
    paid-in capital</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">235</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">303</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated
    deficit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(11,162</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(14,960</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    stockholders&rsquo; deficit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(10,926</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(14,656</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    liabilities, convertible preferred stock and</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">stockholders&rsquo;
    deficit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,270</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,914</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RenovoRx,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="k_013"></A>Statements
of Operations </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
thousands, except per share data)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    Ended December 31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    expenses:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Research
    and development</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,997</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,386</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">General
    and administrative</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">899</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">818</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    operating expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,896</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,204</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss
    from operations</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,896</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,204</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    income (expenses), net:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest
    income (expense), net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">63</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(587</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    income (expense), net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss
    on change in fair value of warrant liability</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    other income (expense), net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">57</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(594</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,839</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,798</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss per share - basic and diluted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.34</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    average shares of common stock - basic and diluted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,886</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><P STYLE="font-family: Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,072</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RenovoRx,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="k_014"></A>Statements
of Convertible Preferred Stock and Stockholders&rsquo; Deficit</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
thousands, except share data)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Convertible</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred
    Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Paid-In</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stockholders&rsquo;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Capital</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deficit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deficit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 37%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance
    at <B>January 1, 2019</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,543,161</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,391</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,885,936</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">197</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,323</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7,125</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock-based
    compensation expense</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">38</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">38</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,839</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,839</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance
    at December 31, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,543,161</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,391</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,885,936</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">235</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(11,162</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(10,926</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issuance
    of restricted stock award to nonemployee for service</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">122,393</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issuance
    of Series A-1 convertible preferred stock upon exercise of warrant</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">134,192</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issuance
    of common stock upon exercise of stock options</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">157,374</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">18</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">18</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    liability transferred to mezzanine equity</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock-based
    compensation expense</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,798</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,798</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance
    at December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,677,353</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,451</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-left: Black 1.5pt solid; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,165,703</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">303</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(14,960</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(14,656</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RenovoRx,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="k_015"></A>Statements
of Cash Flows </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
thousands)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Years
    Ended December 31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    flows from operating activities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,839</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,798</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Adjustments
    to reconcile net loss to net cash used in operating activities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock-based
    compensation expense</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">38</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issuance
    of restricted stock award to nonemployee</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss
    on change in fair value of warrant liability</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization
    of debt discount</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">477</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization
    of debt issuance cost</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes
    in operating assets and liabilities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaid
    expenses and other current assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(24</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">343</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(376</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">124</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(21</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 30pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest
    accrued on convertible notes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">101</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 40pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    cash used in operating activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,350</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,528</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    flows from investing activities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change
    in deposits</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 40pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    cash used in investing activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    flows from financing activities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds
    from convertible notes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,038</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payment
    of debt issuance costs</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(22</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds
    from promissory note</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">140</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds
    from exercise of Series A-1 warrant</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds
    from exercise of stock options</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">18</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 40pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    cash provided by financing activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,199</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    decrease in cash, cash equivalents and restricted cash</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,351</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(329</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash,
    cash equivalents and restricted cash, beginning of year</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,475</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,124</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash,
    cash equivalents and restricted cash, end of year</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,124</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,795</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Supplemental
    disclosure of non-cash investing and financing activities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liability</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">856</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    liability transferred to equity</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="k_016"></A>1.
Organization</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Description
of the Business</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">RenovoRx,
Inc. (&ldquo;RenovoRx&rdquo; or the &ldquo;Company&rdquo;) was incorporated in Delaware in December 2012 and operates from its headquarters
in Los Altos, California. The Company is a clinical-stage biopharmaceutical company focused on developing therapies for the local
treatment of solid tumors and conducting a Phase 3 registrational trial for its lead product candidate RenovoGem&trade;. The Company&rsquo;s
therapy platform, RenovoRx Trans-Arterial Micro-Perfusion, or RenovoTAMP&trade; utilizes approved chemotherapeutics with validated mechanisms
of action and well-established safety and side effect profiles, with the goal of increasing their efficacy, improving their safety, and
widening their therapeutic window. RenovoTAMP combines the Company&rsquo;s patented FDA cleared delivery system, RenovoCath<SUP>&reg;</SUP>,
with small molecule chemotherapeutic agents that can be forced across the vessel wall using pressure, targeting these anti-cancer drugs
locally to the solid tumors. While the Company anticipates investigating other chemotherapeutic agents for intra-arterial delivery via
RenovoTAMP, the Company&rsquo;s clinical work to date has focused on gemcitabine, which is a generic drug. The Company&rsquo;s first
product candidate, RenovoGem, is a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath. FDA has determined
that RenovoGem will be regulated as, and if approved the Company expects will be reimbursed as, a new oncology drug product. The Company
has secured FDA Orphan Drug Designation for RenovoGem in its first two indications: pancreatic cancer and cholangiocarcinoma (bile duct
cancer, or CCA). The Company has completed its RR1 Phase 1/2 and RR2 observational registry studies, with 20 and 25 patients respectively,
in locally advanced pancreatic cancer, or LAPC. These studies demonstrated a median overall survival of 27.9 months in patients treated
with RenovoGem and radiation versus expected survival of 12-15 months in patients receiving only intravenous (IV) systemic chemotherapy
dosed at 1,000mg/m<SUP>2</SUP> based on historical control data. Unlike the historical controls, the Company&rsquo;s RR1 and RR2 studies
were not randomized or controlled for potential confinement. Based on FDA safety review of the Company&rsquo;s Phase 1/2 study the FDA
allowed the Company to proceed to evaluate RenovoGem within its Phase 3 registration Investigational New Drug, or IND, clinical trial.
This Phase 3 trial is 40% enrolled as of April 30, 2021 and the Company expects to report data from a planned interim data readout in
the second half of 2022. The Company intends to evaluate RenovoGem in a second indication in a Phase 2/3 trial in hilar CCA (cancer that
occurs in the bile ducts that lead out of the liver and join with the gallbladder, also called extrahepatic cholangiocarcinoma, or HCCA).
The Company plans to propose the trial to the FDA and potentially launch in the first half of 2022. In addition, the Company may evaluate
RenovoGem in other indications, potentially including locally advanced lung cancer, locally advanced uterine tumors, and glioblastoma
(an aggressive type of cancer that can occur in the brain or spinal cord). To date, the Company has used gemcitabine, but in the future
it may develop other chemotherapeutic agents for intra-arterial delivery via RenovoCath.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
Summary of Significant Accounting Policies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Basis
of Presentation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements and the related disclosures have been prepared in conformity with accounting principles generally accepted
in the United States (&ldquo;GAAP&rdquo;), applicable rules and regulations of the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;)
and include all adjustments necessary for the fair presentation of the Company&rsquo;s financial position for the periods presented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Liquidity
and Going Concern</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of
liabilities in the normal course of business. In order to continue its operations, the Company must raise additional equity or debt financings
and achieve profitable operations. Although management has historically been successful in raising capital, there can be no assurance
that the Company will be able to obtain additional equity or debt financing on terms acceptable to the Company, or at all. The failure
to obtain sufficient funds on acceptable terms when needed could have a material adverse effect on the Company&rsquo;s business, financial
position, results of operations, and future cash flows. The Company is seeking to complete an initial public offering (&ldquo;IPO&rdquo;)
of its common stock. Upon the closing of an IPO, on specified terms, the Company&rsquo;s outstanding convertible preferred stock will
automatically convert into shares of common stock (see Note 8). In the event the Company does not complete an IPO, the Company expects
to seek additional funding through other capital sources including through the sale of equity, debt financings or other capital sources
including collaborations with other companies or other strategic transactions. However, the Company may be unable to raise additional
funds or enter into such agreements or arrangements when needed on acceptable terms, or at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a company with no commercial operating history, the Company is subject to all of the risks and expenses associated with a start-up company.
The Company must among other things respond to competitive developments, attract, retain and motivate qualified personnel and support
ongoing clinical trials for its product candidate. The Company has generated operating losses and negative cash flows from operations
in each year since inception. The Company has not generated any revenue from product sales to date and will continue to incur significant
research and development and other expenses related to its ongoing operations. The Company has incurred net losses of $3.8 million for
each of the years ended December 31, 2019 and 2020, and had an accumulated deficit of $15.0 million at December 31, 2020. The Company
has funded its operations primarily through the sale and issuance of convertible preferred stock and convertible notes. The Company has
reviewed the relevant conditions and events surrounding its ability to continue as a going concern including among others: historical
losses, projected future results, including the effects of the novel coronavirus (&ldquo;COVID-19&rdquo;), cash requirements for the
upcoming year, terms of the Company&rsquo;s current debt arrangements, funding capacity, net working capital, total stockholders&rsquo;
deficit and future access to capital. These factors along with the Company&rsquo;s cash and cash equivalents, raise substantial doubt
about the Company&rsquo;s ability to continue as a going concern for at least one year from the date the financial statements are issued.
The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification
of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty. If future financing
is not achieved, the Company may be required to curtail spending to reduce cash outflows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Risks
and Uncertainties</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to a number of risks associated with companies at a similar stage, including the risk associated with the development
of products that must receive regulatory approval before market launch, dependence on key individuals, competition from larger and established
companies, volatility of the industry, ability to obtain adequate financing to support growth, the ability to attract and retain additional
qualified personnel to manage the anticipated growth of the Company and general economic conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the World Health Organization declared COVID-19 a pandemic. The COVID-19 pandemic has negatively impacted the global economy,
disrupted global supply chains and created significant volatility and disruption of financial markets. The full extent to which the COVID-19
pandemic will directly or indirectly impact the Company&rsquo;s business, results of operations and financial condition, including expenses,
clinical trials and research and development costs, will depend on future developments that are highly uncertain, including as a result
of new information that may emerge concerning COVID-19 and the actions taken to contain or treat COVID-19, as well as the economic impact
on local, regional, national and international markets. The Company has made estimates of the impact of COVID-19 within its financial
statements and there may be changes to those estimates in future periods. Actual results could materially differ from those estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Use
of Estimates</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, income and expenses as well as the disclosure of contingent assets and liabilities, at the date of
the financial statements during the reporting periods. Significant estimates and assumptions made in the accompanying financial statements
include, but are not limited to, the accrual of certain liabilities, the valuation of financial instruments, the valuation allowance
related to deferred income tax assets, the fair value of the Company&rsquo;s common stock and the fair value of options granted under
the Company&rsquo;s equity incentive plan. Actual results could differ from materially from these estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Concentration
of Credit Risk and Significant Suppliers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents. At December 31,
2019, the Company maintained approximately $2.1 million in cash, cash equivalents and restricted cash, and at December 31, 2020, the
Company maintained $1.8 million in cash and cash equivalents, with one financial institution. The Company is exposed to credit risk in
the event of default by the financial institutions to the extent that cash and cash equivalent deposits are in excess of the $250,000
insured by the Federal Deposit Insurance Corporation. These deposits routinely exceed the insurable limit. To date, the Company has not
experienced any losses on its cash and cash equivalents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is dependent on third-party manufacturers to supply products and services for its research and development activities, including
preclinical and clinical development. In particular, the Company relies, and expects to continue to rely, on a small number of third-party
manufacturers to manufacture and supply its RenovoCath devices and its product candidates for clinical trials. These activities could
be adversely affected by a significant interruption in the supply of these items.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Deferred
Offering Costs</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes certain legal, professional, accounting and other third-party fees that are directly associated with in-process financings
as deferred offering costs until such financings are consummated. After consummation of the financing, these costs are recorded as a
reduction of the proceeds received from the financing. If a planned financing is abandoned, the deferred offering costs are expensed
as a charge to operating expenses in the statement of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no deferred offering costs on the Company&rsquo;s balance sheets at December 31, 2019 and 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Net
Loss per Share</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
net loss per common share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding during
the period, without consideration of common stock equivalents. Diluted net loss per share is computed by dividing net loss by the weighted-average
number of shares of common stock and common stock equivalents of potentially dilutive securities outstanding for the period determined
using the treasury stock and if-converted methods. For the years ended December 31, 2019 and 2020, the Company&rsquo;s potentially dilutive
common stock equivalents are comprised of convertible preferred stock, convertible notes, options outstanding under the Company&rsquo;s
stock option plan and the warrant to purchase Series A-1 preferred stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Fair
Value of Financial Instruments</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes
the inputs to valuation methodologies used to measure fair value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &ndash; Valuations based on quoted prices for identical assets and liabilities in active markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &ndash; Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets
and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other
inputs that are observable or can be corroborated by observable market data.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &ndash; Valuations based on unobservable inputs reflecting the Company&rsquo;s assumptions, consistent with reasonably available assumptions
made by other market participants. These valuations require significant judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated fair value of financial instruments disclosed in the financial statements has been determined by using available market information
and appropriate valuation methodologies. In certain cases where there is limited activity or less transparency around inputs to valuation,
securities are classified as Level 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying value of all remaining current assets and current liabilities approximates fair value because of their short-term nature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash
and Cash Equivalents and Restricted Cash</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments purchased with a remaining maturity date upon acquisition of three months or less to
be cash equivalents. Cash and cash equivalents consist primarily of cash held in checking and money market accounts. As of December 31,
2019, the Company had restricted cash of $20,000, which consisted of reserve funds held at one financial institution to collateralize
the Company&rsquo;s credit cards. The Company held no funds in restricted cash at December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets to the amounts
shown in the statements of cash flows (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 64%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    and cash equivalents</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,104</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,795</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Restricted
    cash</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    cash and cash equivalents and restricted cash shown in the statements of cash flows</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,124</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,795</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Convertible
Instruments and Embedded Derivatives</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded
derivatives. The Company accounts for certain redemption features that are associated with convertible notes as liabilities at fair value
and adjusts the instruments to their fair value at the end of each reporting period. For derivative financial instruments that are accounted
for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with
changes in the fair value reported in other income (expense), net in the statements of operations. Derivative instrument liabilities
are classified in the balance sheets as current or non-current based on whether or not net-cash settlement of the derivative instrument
could be required within 12 months of the balance sheet date. The Company had no derivative liability as of December 31, 2019. As of
December 31, 2020, the Company&rsquo;s only derivative financial instrument was related to the 2020 Convertible Notes (defined in Note
5), which contained certain redemptive features (see Note 5).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Research
and Development Costs</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs, which include direct and allocated expenses, are expensed in the period incurred. Research and development costs
include primarily clinical development-related expenses, pre-clinical research and development expenses, employee compensation and related
benefits, regulatory support and related services, clinical consulting, travel-related expenses and allocated expenses for rent, insurance
and other general overhead costs. The Company also receives payments from vendors in performing clinical trials on behalf of the Company
for the delivery device used by such vendors in performing such clinical trials. These payments are offset against the Company&rsquo;s
research and development expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Clinical
Trial Expenses</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company makes payments in connection with clinical trials under contracts with clinical trial sites and contract research organizations
that support conducting and managing clinical trials. The financial terms of these agreements are subject to negotiation, vary from contract
to contract and may result in uneven payment flows. Generally, these agreements set forth the scope of work to be performed at a fixed
fee or unit price or on a time and materials basis. A portion of the obligation to make payments under these contracts depends on factors
such as the successful enrollment or treatment of patients or the completion of other clinical trial milestones.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses
related to clinical trials are accrued based on estimates and/or representations from service providers regarding work performed, including
actual levels of patient enrollment, completion of patient studies and progress of the clinical trials. Other incidental costs related
to patient enrollment or treatment are accrued when reasonably certain. If the amounts the Company is obligated to pay under clinical
trial agreements are modified (for instance, as a result of changes in the clinical trial protocol or scope of work to be performed),
the accruals are adjusted accordingly. Revisions to contractual payment obligations are charged to expense in the period in which the
facts that give rise to the revision become reasonably certain. As noted above, the Company receives payments from vendors performing
clinical trials on behalf of the Company for the delivery device used by such vendors in performing such clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>General
and Administrative</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses consist primarily of personnel costs, including employee compensation and related benefits and consulting.
Additionally, these expenses include professional fees, including audit, legal, recruiting services and allocated expenses for rent,
insurance and other general overhead costs. General and administrative expenses are expensed in the period incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Convertible
Preferred Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records preferred stock at fair value on the date of issuance, net of issuance costs. The preferred stock is recorded outside
of stockholders&rsquo; deficit because the shares contain liquidation features that are not solely within the Company&rsquo;s control.
As a result, the preferred stock is classified as mezzanine equity (temporary equity). The Company has elected not to adjust the carrying
value of the preferred stock to the liquidation preferences of such shares because it is uncertain whether or when an event would occur
that would obligate the Company to pay the liquidation preferences to holders of shares of preferred stock. Subsequent adjustments to
the carrying values to the liquidation preferences will be made only when it becomes probable that such a liquidation event will occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock-Based
Compensation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company calculates the fair value of stock options using the Black-Scholes option pricing model, which incorporates various assumptions
including volatility, expected life and risk-free interest rate. Compensation related to service-based awards is recognized starting
on the grant date on a straight-line basis over the vesting period, which is generally four years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
determination of the fair value of each stock award using this option-pricing model is affected by the Company&rsquo;s assumptions regarding
a number of complex and subjective variables. These variables include, but are not limited to, the fair value of the common stock at
the date of grant, the expected term of the awards, the expected stock price volatility over the term of the awards, the risk-free interest
rate, and the dividend rate as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fair
Value of Common Stock</I>&mdash;Given the absence of a public trading market, the Company&rsquo;s Board of Directors considered numerous
objective and subjective factors to determine the fair value of the Company&rsquo;s common stock at each grant date. These factors included,
but were not limited to: (i) contemporaneous third-party valuations of common stock; (ii) the prices for preferred stock sold to outside
investors; (iii) the rights and preferences of preferred stock relative to Common stock; (iv) the lack of marketability of the Company&rsquo;s
common stock; (v) developments in the business; and (vi) the likelihood of achieving a liquidity event, such as an IPO or sale of the
business, given prevailing market conditions. The methodology to determine the fair value of the Company&rsquo;s common stock included
estimating the fair value of the enterprise using the &ldquo;backsolve&rdquo; method, which is a market approach that assigns an implied
enterprise by accounting for all share class rights and preferences based on the latest round of financing. The total equity value implied
was then applied in the context of an option pricing model to determine the value of each class of the Company&rsquo;s shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Expected
Term</I>&mdash;The expected term represents the period that the stock-based awards are expected to be outstanding. The Company determines
the&#9;expected term using the simplified method. The simplified method deems the term to be the average of the time-to-vesting and the
contractual life of the options. For stock options granted to non-employees, the expected term equals the remaining contractual term
of the option from the vesting date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Expected
Volatility</I>&mdash;Given the absence of a public trading market, the expected volatility was estimated by taking the average historic
price volatility for industry peers, consisting of several public companies in the Company&rsquo;s industry that are either similar in
size, stage, or financial leverage, over a period equivalent to the expected term of the awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Risk-Free
Interest Rate</I>&mdash;The risk-free interest rate is calculated using the average of the published interest rates of U.S. Treasury
zero-coupon issues with maturities that are commensurate with the expected term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dividend
Rate</I>&mdash;The dividend yield assumption is zero as the Company has no plans to make dividend payments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generally grants stock options to its employees for a fixed number of shares with an exercise price equal to the fair value of
the underlying shares on the date of grant. The Company accounts for all stock option grants using the fair value method and stock-based
compensation is recognized as the underlying options vest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Preferred
Stock Warrant Liability</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its warrants as either equity or liability based upon the characteristics and provisions of each instrument. Warrants
classified as derivative liabilities are recorded on the Company&rsquo;s accompanying balance sheets at their fair value on the date
of issuance and are revalued at each subsequent balance sheet date, with fair value changes recognized as increases or reductions to
other income (expense), net in the statements of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Income
Taxes</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes using the asset and liability method. Under this method, deferred income tax assets and liabilities
are recorded based on the estimated future tax effects of differences between the financial statement and income tax basis of existing
assets and liabilities. Deferred income tax assets and liabilities are recorded net and classified as noncurrent on the balance sheets.
A valuation allowance is provided against the Company&rsquo;s deferred income tax assets when their realization is not reasonably assured.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to income taxes in the federal and state jurisdictions. Tax regulations within each jurisdiction are subject to the
interpretation of the related tax laws and regulations and require significant judgment to apply. In accordance with the authoritative
guidance on accounting for uncertainty in income taxes, the Company recognizes tax liabilities for uncertain tax positions when it is
more likely than not that a tax position will not be sustained upon examination and settlement with various taxing authorities. Liabilities
for uncertain tax positions are measured based upon the largest amount of benefit that is more-likely-than-not (greater than 50%) of
being realized upon settlement. The Company&rsquo;s policy is to recognize interest and/or penalties related to income tax matters in
income tax expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Segment
Reporting</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
Accounting Standards Board (&ldquo;FASB&rdquo;) Accounting Standards Codification (&ldquo;ASC&rdquo;) Topic 280, <I>Segment Reporting</I>,
requires use of the &ldquo;management approach&rdquo; model for segment reporting. The management approach model is based on the way
a company&rsquo;s management organizes segments within the company for making operating decisions and assessing performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determined it has one reportable segment, the development of a platform technology to deliver de-risked small molecules for localized
treatment of solid cancer tumors. The segment is based on financial information that is utilized by the Company&rsquo;s Chief Operating
Decision Maker who is the Company&rsquo;s Chief Executive Officer, to assess performance and allocate resources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Emerging
Growth Company Status</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements, or Accounting Standards Updates (&ldquo;ASU&rdquo;) are issued by the FASB or other standard
setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued
standards that are not yet effective will not have a material impact on the Company&rsquo;s financial position or results of operations
upon adoption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an &ldquo;emerging growth company&rdquo; (&ldquo;EGC&rdquo;) under the Jumpstart Our Business Startups Act (&ldquo;JOBS Act&rdquo;),
the Company may elect to take advantage of certain forms of relief from various reporting requirements that are applicable to public
companies. The relief afforded under the JOBS Act includes an extended transition period for the implementation of new or revised accounting
standards. The Company has elected to take advantage of this extended transition period and, as a result, the Company&rsquo;s financial
statements may not be comparable to those of companies that implement accounting standards as of the effective dates for public companies.
The Company may take advantage of the relief afforded under the JOBS Act up until the last day of the fiscal year following the fifth
anniversary of an offering or such earlier time that it is no longer an EGC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Recently
Adopted Accounting Pronouncements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.9in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2018, the FASB issued ASU No. 2018-07, <I>Improvements to Nonemployee Share-Based Payment Accounting. </I> The standard simplifies
the accounting for share-based payments granted to nonemployees for goods and services and aligns most of the guidance on such payments
to the nonemployees with the requirements for share-based payments granted to employees. ASU 2018-07 is effective for the Company for
annual reporting periods beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020
with early adoption permitted. The guidance should be applied to new awards granted after the date of adoption. The Company adopted this
new standard on January 1, 2020 and the adoption of this standard did not have an impact on its financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2018, the FASB issued ASU 2018-13, <I>Fair Value Measurement (Topic 820), Disclosure Framework &mdash; Changes to the Disclosure
Requirements for Fair Value Measurement</I>. The standard eliminates, adds and modifies certain disclosure requirements for fair value
measurements. Entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of
the fair value hierarchy, but public companies will be required to disclose the range and weighted average of significant unobservable
inputs used to develop Level 3 fair value measurements. The standard is effective for annual reporting periods beginning after December
15, 2019, and for interim periods within those periods. The Company adopted this new standard on January 1, 2020, with no material impact
on its financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 1, 2019, the Company adopted FASB ASU 2016-18, <I>Statement of Cash Flows (Topic 230): Restricted Cash</I>, which requires that
a statement of cash flows explain the change during the period in the total of cash, cash equivalents and restricted cash. Therefore,
amounts described as restricted cash should be included with cash and cash equivalents when reconciling the beginning of period and end
of period amounts shown on the statement of cash flows. The Company adopted this guidance on January 1, 2019. The adoption of ASU 2016-18
did not have an impact on the Company&rsquo;s financial results, but it did result in a change in the presentation of restricted cash
and cash equivalents within the statements of cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Recent
Accounting Pronouncements Not Yet Adopted</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2016, the FASB issued ASU No. 2016-02, <I>Leases (Topic 842)</I>. The guidance requires lessees to recognize assets and liabilities
related to long-term leases on the balance sheet and expands disclosure requirements regarding leasing arrangements. In July 2018, the
FASB issued additional guidance, which offers a transition option to entities adopting the new lease standards, and a package of practical
expedients an entity can elect to utilize to reduce the level of effort required for adoption. Under the transition option, entities
can elect to apply the new guidance using a modified retrospective approach at the beginning of the year in which the new lease standard
is adopted, rather than to the earliest comparative period presented in their financial statements. In November 2019, the FASB issued
ASU 2019-10 deferring the effective date for private entities for fiscal years beginning after December 15, 2020 and interim periods
within fiscal years beginning after December 15, 2021. In June 2020, the FASB issued ASU 2020-05 which further defers the effective date
for private entities for fiscal years beginning after December 15, 2021 and interim periods within fiscal years beginning after December
15, 2022. The Company is currently evaluating its contracts to determine whether there will be a significant impact from the adoption
of this guidance on its financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU No. 2016-13, <I>Financial Instruments &ndash; Credit Losses</I>, which requires the measurement of expected
credit losses for financial instruments carried at amortized cost, such as accounts receivable, held at the reporting date based on historical
experience, current conditions and reasonable forecasts. The main objective of this standard is to provide financial statement users
with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit
held by a reporting entity at each reporting date. In November 2018, the FASB issued ASU No. 2018-19, <I>Codification Improvements to
Topic 326, Financing Instruments &ndash; Credit Losses, </I>which included an amendment of the effective date. The standard is effective
for the Company for annual reporting periods beginning after December 15, 2022, and for interim periods within those periods. Early adoption
is permitted. The Company plans to adopt this new standard on January 1, 2023 and does not believe that adoption will have a significant
impact on its financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued ASU No. 2019-12, <I>Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</I>, which simplifies
the accounting for income taxes. For the Company, ASU 2019-12 is effective on a prospective basis for annual reporting periods beginning
after December 15, 2021 and for interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted.
The Company plans to adopt this new standard on January 1, 2022 and does not believe that adoption will have a significant impact on
its financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, <I>Debt &ndash; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &ndash; Contracts in Entity&rsquo;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in
an Entity</I>, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including
convertible instruments and contracts on an entity&rsquo;s own equity. ASU 2020-06 is effective on a prospective basis for annual reporting
periods beginning after December 15, 2023 and for interim periods within those periods. Early adoption is permitted. The Company has
not yet determined the impact that this new standard will have on its financial position and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accrued
                                            Expenses</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -36.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the components of accrued expenses is as follows (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    clinical trials</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">219</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">171</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">101</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    personnel</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">39</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">232</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">311</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fair
                                            Value Measurements</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth by level, within the fair value hierarchy, the financial assets and liabilities that are measured at fair
value on a recurring basis at December 31, 2019 and 2020 (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    Value Measurements at December 31, 2019 using:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assets:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    3</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 44%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Money
    market funds</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,087</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,087</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,087</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,087</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; text-indent: -0.2in; padding-left: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    A-1 preferred stock warrant liability</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    Value Measurements at December 31, 2020 using:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assets:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    3</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 44%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Money
    market funds</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,703</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,703</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,703</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,703</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liability &ndash; 2020 Convertible Notes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">856</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">856</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">856</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">856</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in the fair value of the Series A-1 preferred stock warrant liability is summarized below (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 76%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value as of January 1, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change
    in fair value recorded in other income (expense), net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value as of December 31, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change
    in fair value upon warrant exercise in January 2020 recorded in other income (expense), net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value as of January 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Transfer
    of warrant liability to mezzanine equity upon exercise of warrant</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value as of December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series A-1 preferred stock warrant liability consisted of the fair value of the warrant to purchase Series A-1 convertible preferred
stock and was based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value
hierarchy. The fair value of the Series A-1 preferred stock warrant liability was determined using the &ldquo;backsolve&rdquo; method
to estimate the enterprise value of the Company and the Option Pricing Model to allocate the enterprise value of the Company. The enterprise
value was allocated among the various share classes and warrant using the Option Pricing Model. Generally, increases or decreases in
the fair value of the underlying convertible preferred stock would result in a directionally similar impact in the fair value measurement
of the warrant liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">There
was no derivative liability as of December 31, 2019.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in the fair value of the derivative liability for the year ended December 31, 2020 is summarized below (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value as of December 31, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 76%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liability upon issuance of 2020 Convertible Notes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">856</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change
    in fair value recorded in other income (expense), net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value as of December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">856</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
derivative liability in the table above related to the 2020 Convertible Notes and represents the fair value of the redemption-like contingent
conversion feature. The Company calculated the fair value of the derivative liability using a probability weighted discounted cash flow
analysis. The inputs used to determine the estimated fair value of the derivative were based primarily on the probability of an underlying
event occurring that would trigger the embedded derivative and the timing of such event. The Company&rsquo;s derivative liability is
measured at fair value on a recurring basis and is classified as a Level 3 liability. The Company records subsequent adjustments to reflect
the increase or decrease in estimated fair value at each reporting date in other income (expense), net in the statements of operations
(see Note 5).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no transfers among Level 1, Level 2 or Level 3 categories during any of the periods presented. The Company had no other financial
assets or liabilities that were required to be measured at fair value on a recurring basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Convertible
                                            Notes</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the Company entered into a note purchase agreement for the issuance of up to $4.0 million of convertible promissory notes.
The Company entered into a series of convertible note payable agreements (the &ldquo;2020 Convertible Notes&rdquo;) for aggregate borrowings
of approximately $3.0 million. Outstanding borrowings under the 2020 Convertible Notes and accrued interest are due in March 2021, if
not previously converted. The 2020 Notes bear interest at the rate of 5% per annum. The 2020 Notes cannot be prepaid prior to the maturity
date unless approved in writing by the Company and requisite holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the 2020 Convertible Notes, the outstanding principal and accrued interest are automatically convertible into equity shares in the
next equity financing round with total proceeds of not less than $10.0 million (a &ldquo;Qualified Financing&rsquo;), at a conversion
price per share equal to 80% of the price per share paid by investors purchasing such equity securities in a Qualified Financing. For
purposes of the 2020 Convertible Notes, equity securities mean the Company&rsquo;s preferred stock or any securities providing for rights
to purchase the Company&rsquo;s preferred stock or securities convertible into or exchangeable for the Company&rsquo;s preferred stock
issued in the Qualified Financing. If the Company consummates a Change of Control prior to a Qualified Financing, the Company will repay
each holder in cash an amount equal to the greater of (a) two times (2x) the entire outstanding principal balance of the 2020 Convertible
Notes or (b) the amount the holder would receive if the 2020 Convertible Notes had been converted into shares of the Company&rsquo;s
Series B convertible preferred stock immediately prior to the consummation of the Change in Control, at a conversion price equal to the
Series B convertible preferred stock Original Issue Price ($1.1030, adjusted for any stock dividends, combinations, splits, and recapitalizations).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated whether the 2020 Convertible Notes contain embedded features that meet the definition of derivatives under FASB ASC
Topic 815, <I>Derivatives and Hedging</I>. The Company determined that these redemption features contained rights and obligations for
conversion contingent upon a potential future financing event or a change in control. Thus, the embedded redemption features were bifurcated
from the face value of the note and accounted for as a derivative liability to be remeasured at the end of each reporting period. The
derivative liability had a fair value of approximately $856,000 on the issuance date with the offsetting amount being recorded as a debt
discount. The Company also incurred $22,000 of debt issuance costs. The derivative liability is subject to fair value remeasurement at
the end of each reporting period. The discount and debt issuance costs are being amortized to interest expense using the effective interest
method over the expected term of the 2020 Convertible Notes. The Company recognized approximately $477,000 of amortization of debt discount
and $12,000 of amortization of debt issuance costs as interest expense in the statement of operations for the year ended December 31,
2020. The effective interest rate on the 2020 Convertible Notes was 30.8%. During the year ended December 31, 2020, the Company also
recognized interest expense in the statement of operations of approximately $101,000 related to the 2020 Convertible Notes. The Company
incurred no interest expense during the year ended December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Promissory
                                            Note</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -36.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 22, 2020, the Company entered into a promissory note with Silicon Valley Bank that provided for the receipt by the Company of loan
proceeds of $140,000 (the &ldquo;PPP Loan&rdquo;) pursuant to the Paycheck Protection Program under the Coronavirus Aid, Relief and Economic
Security Act (the &ldquo;CARES Act&rdquo;). Under certain conditions, the loan and accrued interest are forgivable, if the loan proceeds
are used for eligible purposes, including payroll, benefits, rent and utilities, and maintaining payroll levels. In October 2020, t<FONT STYLE="background-color: white">he
Paycheck Protection Program Flexibility Act of 2020 extended the deferral period for borrower payments of principal, interest, and fees
on all PPP loans from 6 months to 10 months. </FONT>As of December 31, 2020, payments were deferred for 10 months. The PPP Loan matures
on April 22, 2022 and bears interest at a rate of 1.0% per annum. The PPP Loan contains events of default and other provisions customary
for a loan of this type. The Company has recorded the PPP Loan as a promissory note in the December 31, 2020 balance sheet as both a
current and non-current liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrant
                                            Liability</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -36.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with the January 2013 Series A-1 convertible preferred stock financing, the Company issued a warrant to purchase 134,192
shares of the Company&rsquo;s Series A-1 convertible preferred stock at $0.1863 per share. The warrant was to expire on the earlier of
(a) the date that was seven (7) years after the date of the original issuance of the warrant, (b) the date of consummation of an acquisition
or (c) the effective date of an IPO. The Company accounts for stock warrants in accordance with FASB ASC Topic 480, <I>Distinguishing
Liabilities from Equity</I>, either as derivative liabilities or as equity instruments depending on the specific terms of the warrant
agreement. As described in Note 8, all of the Company&rsquo;s issued and outstanding convertible preferred stock is classified in mezzanine
equity. The Company determined that the warrant should be classified as a liability, because it is exercisable for shares of Series A-1
preferred stock that are puttable upon a deemed liquidation event. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">In
2019, the fair value of the warrant liability of $35,000 was included in current liabilities as the seven-year expiration date was January
23, 2020. <FONT STYLE="font-size: 10pt">The warrant was exercised on January 23, 2020 for proceeds of $25,000. Upon exercise, the warrant
liability associated with this warrant was adjusted to its fair value of $35,000. The fair value of $35,000 was subsequently transferred
to mezzanine equity as of the date of exercise. The Company also recognized a non-cash loss on settlement of the warrant of $8,000 which
was recorded in other income (expense), net in the statement of operations as of December 31, 2020.</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Convertible
                                            Preferred Stock and Stockholders&rsquo; Deficit</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Common
Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the December 2019 fifth amended and restated certificate of incorporation, the Company is authorized to issue 42,000,000 shares of
common stock with a par value of $0.0001 per share. Each holder of common stock is entitled to one vote per share of common stock held.
The Company&rsquo;s common stock reserved for future issuance related to the convertible preferred stock and common stock options as
of December 31, 2019 and 2020 are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    of December 31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    A-1 convertible preferred stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,542,669</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,542,669</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    A-2 convertible preferred stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,546,095</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,546,095</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    A-3 convertible preferred stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,660,230</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,660,230</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    B convertible preferred stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,611,461</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,611,461</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    stock options outstanding</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,016,875</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,986,334</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    stock options reserved for issuance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">313,693</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">64,467</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,691,023</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,411,256</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares that would be issued upon a conversion of the 2020 Convertible Notes have been excluded from the table above as the number of
common shares that would be issued is contingent upon the occurrence of a future Qualified Financing and the conversion price per share
would be equal to 80% of the price per share paid by the investors in the future Qualified Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Convertible
Preferred Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company was authorized to issue two classes of stock consisting of common stock and preferred stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the Company filed an amendment to its Certificate of Incorporation to re-designate its issuable convertible preferred
stock. Series D convertible preferred stock was re-designated as Series B, Series C convertible preferred stock was re-designated as
Series A-3 convertible preferred stock (Series A-3), Series B convertible preferred stock was re-designated as Series A-2 convertible
preferred stock (Series A-2) and Series A convertible preferred stock was re-designated as Series A-1 convertible preferred stock (Series
A-1). The re-designation did not change any of the rights, privileges or preferences of any series of preferred stock. The accompanying
financial statements and notes to the financial statements have been updated to reflect these re-designations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total number of shares the Company is authorized to issue is 64,360,455 of which 42,000,000 shares shall be common stock and 22,360,455
shares shall be preferred stock with both the common stock and preferred stock having a par value of $0.0001 per share. As of December
31, 2019 and 2020, the Board of Directors designated the convertible preferred stock as follows (in thousands, except shares):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred
    Series</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares
    <BR> Authorized</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares
    Issued and Outstanding</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Carrying Value</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liquidation
    Value</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    A-1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,542,669</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,408,477</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">579</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">635</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series A-2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,546,095</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,546,095</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,099</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,150</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series A-3</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,660,230</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,660,230</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,166</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,227</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    B</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,611,461</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,928,359</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,547</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,745</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,360,455</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,543,161</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,391</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,757</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred
    Series</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares
    <BR> Authorized</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares
    Issued and Outstanding</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Carrying Value</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liquidation
    Value</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    A-1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,542,669</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,542,669</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">639</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">660</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series A-2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,546,095</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,546,095</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,099</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,150</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series A-3</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,660,230</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,660,230</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,166</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,227</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    B</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,611,461</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,928,359</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,547</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,745</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,360,455</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,677,353</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,451</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,782</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
classes of convertible preferred stock have a par value of $0.0001 per share and are not redeemable at the option of the holder. Any
shares of convertible preferred stock that are redeemed, purchased, converted or exchanged by the Company will be cancelled and retired
and will not be reissued or transferred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Voting</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of shares of the convertible preferred stock are entitled to vote, together with the holders of the common stock and not as a
separate class, on all matters submitted to stockholders to vote. Each holder of convertible preferred stock is entitled to one vote
for each share of common stock into which their shares would convert.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
long as any shares of Series A-2 and Series A-1 remain outstanding, the holders of Series A-2 and Series A-1, voting together as a separate
class, are entitled to elect one member of the Company&rsquo;s Board of Directors. The holders of common stock, voting as a separate
class, are entitled to elect two members of the Company&rsquo;s Board of Directors. The holders of common stock and convertible preferred
stock, voting together on an as-if-converted basis, are entitled to elect three members of the Company&rsquo;s Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Protective
Provisions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of convertible preferred stock have certain protective provisions. As long as any shares of preferred stock remain outstanding,
the Company cannot, without the approval of a majority of the voting power of preferred stock then outstanding, voting together as a
single class on an as-converted basis, take any actions to, among other things: (i) amend the Company&rsquo;s Certificate of Incorporation
or Bylaws; (ii) increase or decrease the total number of authorized shares of common stock or convertible preferred stock; (iii) authorize
or designate any new series of stock or any other securities convertible into equity securities; (iv) redeem or repurchase shares of
convertible preferred stock or common stock or pay or declare dividends; (v) result in any agreement for merger, consolidation or sale
of control (including any liquidation event, asset transfer or acquisition); (vi) create or authorize the issuance of any debt security;
or (vii) increase the number of shares available for issuance under the Company&rsquo;s equity incentive plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Conversion
Rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
shares of the convertible preferred stock may, at the option of the holder, be converted at any time after the date of issuance into
fully paid and nonassessable shares of common stock. The number of shares of common stock to which the holder of the convertible preferred
stock is entitled upon conversion will be determined by multiplying the conversion rate by the number of shares of Series A-1, A-2, A-3
and B being converted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of convertible preferred stock automatically converts into the number of shares of common stock determined in accordance with the
then-effective and applicable convertible preferred stock conversion price, (i) at any time upon the affirmative vote or written consent
or agreement of the holders of at least a two-thirds of the outstanding shares of Series A-1, A-2, A-3 and B, or (ii) immediately upon
the closing of the sale of shares of common stock to the public in a firm-commitment underwritten public offering of common stock resulting
in at least $50.0 million of gross cash proceeds to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
conversion rate is determined by dividing the Original Issue Price for each series of convertible preferred stock of such shares of each
series by the original conversion price of the series. The conversion price is equal to the Original Issue Price for the respective series
of convertible preferred stock, as adjusted for any stock splits, dividends, reclassifications and the like. As of December 31, 2020,
the conversion price for each share of convertible preferred stock is equal to the Original Issue Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dividends</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of preferred stock are entitled to receive non-cumulative dividends prior to and in preference to any declaration or payment
of dividends on common stock, when and if declared by the Board of Directors. Dividends would be payable at the non-cumulative rates
of 6% of the Original Issue Price per share with Original Issue Price per share is defined as follows: $0.1863 for Series A-1, $0.3243
for Series A-2, $0.8370 for Series A-3, and $1.1030 for Series B, as adjusted for any recapitalizations and the like. After payment of
the above dividends to holders of convertible preferred stock, any additional dividends will be distributed pro rata amongst the holders
of common stock. No dividends have been declared or paid as of December 31, 2019 and 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Liquidation
Rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the holders of convertible preferred
stock then outstanding are entitled to be paid, out of the available funds and assets, and prior and in preference to any payment or
distribution of any such funds on any shares of common stock, an amount per share equal to the Original Issue Price for the convertible
preferred stock, plus all accrued and declared but unpaid dividends. The holders of convertible preferred stock have liquidation preferences
over the common stockholders in the following amounts: $0.1863, $0.3243, $0.8370 and $1.1030 for Series A-1, Series A-2, Series A-3,
and Series B, respectively. The liquidation preferences totaled approximately $12.8 million as of December 31, 2019 and 2020. If, upon
the occurrence of a liquidation, dissolution or winding up of the Company, the assets and funds to be distributed among the holders of
convertible preferred stock are insufficient to permit the payment to such holders, then the entire assets and funds of the Company legally
available for distribution will be distributed ratably among the holders of convertible preferred stock in proportion to the preferential
amount each such holder is otherwise entitled to receive. After the liquidation preferences of the holders of convertible preferred stock
have been satisfied, the remaining assets of the Company will be distributed ratably among the holders of outstanding shares of common
stock and convertible preferred stock on an as-if-converted basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
at any time after the Series B convertible preferred stock issue date, the Company sells or issues additional shares of common stock
for no consideration or at a price below the then-effective convertible preferred stock conversion price, then the existing convertible
preferred stock conversion price on the sale or issue date will be reduced.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Mezzanine
Equity</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
convertible preferred stock does not have a mandatory redemption date. However, while it is not mandatorily redeemable, the convertible
preferred stock was reclassified into mezzanine equity because it will become redeemable at the option of the stockholders upon the occurrence
of certain deemed liquidation events that are considered not solely within the Company&rsquo;s control. That is, unless a majority of
the holders of the then outstanding convertible preferred stock, on an as-if-converted to common stock basis, elect otherwise, deemed
liquidation events include a sale of all or substantially all of the Company&rsquo;s assets or a sale of at least fifty percent (50%)
of the issued and outstanding voting securities, capital stock, or other comparable equity or ownership interest in the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
issuance of the convertible preferred stock, the Company assessed the embedded conversion and liquidation features of the securities.
The Company determined that the convertible preferred stock did not require the Company to separately account for the liquidation features.
The Company also concluded that no beneficial conversion feature existed upon the issuance date of the convertible preferred stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock-Based
                                            Compensation</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2013, the Board of Directors of the Company adopted the 2013 Equity Incentive Plan (the &ldquo;2013 Plan&rdquo;). The 2013 Plan
provides for the grant of incentive and nonqualified stock options, stock appreciation rights, restricted stock awards and restricted
stock units to employees, directors and consultants. The 2013 Plan allows for up to 6,346,504 shares of the Company&rsquo;s common stock
to be issued with respect to awards granted. The exercise price of incentive stock options and nonqualified stock options will be no
less than 100% of the fair value per share of the Company&rsquo;s common stock on the grant date. If an individual owns capital stock
representing more than 10% of the voting shares, the exercise price of each share will be at least 110% of the fair market value on the
date of grant. Fair value is determined by the Board of Directors. The Company&rsquo;s stock options generally have 10-year contractual
terms (five years for stockholders owning greater than 10% of all classes of stock) and generally vest over a four-year period from the
date of grant. The Board of Directors determines the period over which options vest and become exercisable. The Company has a repurchase
option for shares issued under unvested options exercisable upon the voluntary or involuntary termination of the purchaser&rsquo;s employment
with, or service to, the Company for any reason.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Activity
under the 2013 Plan for the years ended December 31, 2019 and December 31, 2020 is set forth below (in thousands except shares, per share
amounts and years):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares
    Available for Grant</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of Shares</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Life (Years)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 35%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    at January 1, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">53,019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,927,549</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.08</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.75</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">232</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Authorized</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">350,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(283,500</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">283,500</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.13</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    cancelled</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">194,174</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(194,174</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.10</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    at December 31, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">313,693</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,016,875</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.08</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.75</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">232</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(243,500</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">243,500</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.14</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(157,374</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.11</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    cancelled</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">116,667</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(116,667</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.13</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Restricted
    stock award granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(122,393</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    at December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">64,467</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,986,334</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.08</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.84</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">276</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vested
    and exercisable at December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,238,068</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.08</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.47</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">269</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vested
    and expected to vest at December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,984,459</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.08</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.84</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">276</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value of options outstanding, vested and exercisable, and vested and expected to vest were calculated as the difference
between the exercise price of the option and the estimated fair value of the Company&rsquo;s common stock, as determined by the Board
of Directors, as of December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2019, the Company recognized $38,000 in stock-based compensation expense. During the year ended December
31, 2020, the Company recognized $50,000 in stock-based compensation expense comprised of $33,000 from stock option grants and $17,000
from the issuance of a restricted stock award to a consultant for services rendered. The compensation expense is allocated on a departmental
basis, based on the classification of the option holder. No income tax benefits have been recognized in the statements of operations
for stock-based compensation arrangements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the Black-Scholes option pricing model to estimate the fair value of each option grant on the date of grant or any other
measurement date. The following sets forth the weighted average assumptions used to determine the fair value of stock options during
the years ended December 31, 2019 and 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Years
    Ended December 31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected
    term (years)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.98</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.24</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Risk-free
    interest rate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.88</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.29</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Volatility
    factor</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">37</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">38</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividend
    yield</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
volatility is based on historical volatilities of public companies operating in the Company&rsquo;s industry. The expected term of the
options represents the period of time options are expected to be outstanding and is estimated considering vesting terms and historical
exercise and post-vesting employment termination behavior. The risk-free interest rate is based on the U.S. Treasury yield curve in effect
at the time of grant. The weighted-average fair value of options granted was $0.05 per share in both 2019 and 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
stock-based compensation for unvested employee options granted and outstanding as of December 31, 2020 is $38,000, to be recognized over
a weighted-average remaining requisite service period of 1.56 years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, options outstanding had a weighted-average remaining contractual life of 5.8 years. As of December 31, 2020, 4,238,068
options were vested and exercisable with a weighted-average exercise price of $0.08 and a weighted-average remaining contractual life
of 5.5 years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2020, the Company granted 122,393 shares of restricted common stock under the 2013 Plan to a consultant as partial consideration
for services rendered, with a deemed fair value of $0.14 per share or $17,000. The fair value of this restricted stock award was expensed
on the date of grant as they were fully vested on that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation is included in the statements of operations in general and administrative and research and development, depending on the
nature of the services provided. Stock-based compensation expense recorded to operations for stock options was as follows (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Years
    ended December 31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">General
    and administrative</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">23</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Research
    and development</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">38</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also issued a restricted stock award to a consultant during the year ended December 31, 2020 for which $17,000 in stock-based
compensation was included in general and administrative in the statement of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Income
                                            Taxes</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2019 and 2020, the Company&rsquo;s income tax provision is zero due to a full valuation allowance against
the deferred tax assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
differences between the statutory tax expense (benefit) rate and the effective tax expense (benefit) rate, were as follows (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Statutory
    federal income tax rate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(806</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(799</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase
    (decrease) resulting from:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change
    in valuation allowance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">999</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">844</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Permanent
    Items</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">107</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
    year true ups</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(12</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax
    credits</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(184</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(125</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">State</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(28</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Income
    tax provision/(benefit)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of our deferred tax assets and liabilities consist of (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deferred
    tax assets:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    operating loss carryforwards</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,516</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,146</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax
    credit carryforwards</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">405</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">607</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock
    based compensation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">18</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">24</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fixed
    assets/intangible assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">65</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">74</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Charitable
    contributions</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accruals
    and other</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,008</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,852</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Valuation
    allowance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,008</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,852</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    deferred tax assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have established a valuation allowance to offset net deferred tax assets as of December 31, 2019 and 2020 due to the uncertainty of realizing
future tax benefits from such assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company had U.S. federal and state net operating loss (&ldquo;NOL&rdquo;) carryforward amounts of $12.9 million
and $6.4 million. The federal NOL carryforward consists of $4.7 million that has a carryforward of 20 years and begin to expire in 2030
and can and can be used to offset 100% of taxable income while $8.2 million can be carried forward indefinitely and may be able to be
used against 100% of taxable income through the tax year ending December 31, 2020, as updated for the Coronavirus Aid, Relief, and Economic
Security Act (P.L. 116-136), otherwise known as the CARES Act. The state NOL carryforward will begin to expire in 2033.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, we had federal and state tax credit carryforwards of $0.7 million and $0.2 million, respectively. The federal tax
credit carryforwards will begin to expire in 2033. The state tax credit carryforwards do not expire.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows Financial Accounting Standards Board No. 48, <I>Accounting for Uncertainty in Income Taxes &ndash; an interpretation
of FASB No. 109</I>, as codified in FASB ASC 740-10, <I>Income Taxes</I>. At December 31, 2020, the Company recorded unrecognized tax
benefits related to federal and state tax credits of $0.2 million. The Company&rsquo;s policy is to recognize interest and penalties
related to income tax matters in income tax expense. The Company did not have tax-related interest and penalties at December 31, 2020.
The Company does not expect significant changes to its unrecognized tax benefits in the next twelve months. If recognized, none of the
unrecognized tax benefits would affect the effective tax rate:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summarizes the activity related to the Company&rsquo;s unrecognized tax benefits for the years ended December 31, 2019 and
December 31, 2020 (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance at January
    1, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax
    positions related to the current year:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additions</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">77</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Reductions</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax
    positions related to the prior year:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additions</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">65</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Reductions</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Settlements</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Lapses
    in statute</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance at December
    31, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">142</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax
    positions related to the current year:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additions</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">70</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Reductions</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax
    positions related to the prior year:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additions</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Reductions</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Settlements</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Lapses
    in Statute</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance
    at December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">212</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
utilization of NOLs and tax credit carryforwards to offset future taxable income may be subject to an annual limitation as a result of
ownership changes that have occurred previously or that may occur in the future. Under Sections 382 and 383 of the Internal Revenue Code
(&ldquo;IRC&rdquo;) a corporation that undergoes an ownership change may be subject to limitations on its ability to utilize its pre-change
NOLs and other tax attributes otherwise available to offset future taxable income and/or tax liability. An ownership change is defined
as a cumulative change of 50% or more in the ownership positions of certain stockholders during a rolling three-year period. The Company
has not completed a formal study to determine if any ownership changes within the meaning of IRC Section 382 and 383 have occurred. If
an ownership change has occurred, the Company&rsquo;s ability to use its NOLs or tax credit carryforwards may be restricted, which could
require the Company to pay federal or state income taxes earlier than would be required if such limitations were not in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. The Company is subject to U.S. federal
and state income tax examination for calendar tax years beginning in 2010 due to net operating losses that are being carried forward
for tax purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (&ldquo;CARES Act&rdquo;) was enacted and signed into law in response
to the COVID-19 pandemic. GAAP requires recognition of the tax effects of new legislation during the reporting period that includes the
enactment date. The CARES Act includes changes to the tax provisions that benefits business entities and makes certain technical corrections
to the 2017 Tax Cuts and Jobs Act. The tax relief measures for businesses include a five-year net operating loss carryback, suspension
of the annual deduction limitation of 80% of taxable income from net operating losses generated in a tax year beginning after December
31, 2017, changes in the deductibility of interest, acceleration of alternative minimum tax credit refunds, payroll tax relief, technical
corrections on net operating loss carryforwards for fiscal year taxpayers and allows accelerated deduction qualified improvement property.
The CARES Act also provides other non-tax benefits to assist those impacted by the pandemic. The Company filed for and received a PPP
loan. We evaluated the impact of the CARES Act and determined that there was no material impact for the year ended December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 29, 2020, California Assembly Bill 85 was signed into law. The legislation suspends the California net operating loss deductions
for 2020, 2021, and 2022 for certain taxpayers and imposes a limitation of certain California tax credits for 2020, 2021, and 2022. The
legislation disallows the use of California net operating loss deductions if the taxpayer recognizes business income and its adjusted
gross income is greater than $1.0 million. The carryover periods for net operating loss deductions disallowed by this provision will
be extended. Additionally, any business credit will only offset a maximum of $5.0 million of California tax. Given our loss position
in the current year, the new legislation did not impact the current year provision or our financial statements for the year ended December
31, 2020. We will continue to monitor possible California net operating loss and credit limitations in future periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 27, 2020, the Consolidated Appropriations Act, 2021 was enacted and signed into law to further COVID-19 economic relief and
extend certain expiring tax provisions. The relief package includes a tax provision clarifying that businesses with forgiven PPP loans
can deduct regular business expenses that are paid for with the loan proceeds. Additional pandemic relief tax measures include an expansion
of the employee retention credit, enhanced charitable contribution deductions, and a temporary full deduction for business expenses for
food and beverages provided by a restaurant. The provisions did not have a material impact on our financial statements for the year ended
December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Net
                                            Loss per Share</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -36.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
and diluted net loss per common share was calculated as follows (in thousands except per share amounts):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -36.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    ended December 31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Numerator:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,839</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,798</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Denominator:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    average shares used in computing net loss per share &ndash; basic and diluted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,886</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,072</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss per share &ndash; basic and diluted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.34</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2019 and 2020, the Company had a net loss and as such, all outstanding shares of potentially dilutive securities
were excluded from the calculation of diluted net loss per share as the inclusion would be anti-dilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potentially
dilutive securities not included in the computation of diluted net loss per share because to do so would be antidilutive are as follows
(in common stock equivalent shares):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    ended December 31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible
    preferred stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,543,161</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,677,353</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    to purchase common stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,016,875</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,986,334</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    A-1 preferred stock warrant</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">134,192</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,694,228</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,663,687</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table above omits the potentially dilutive shares into which the 2020 Convertible Notes would convert.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commitments
                                            and Contingencies</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Operating
Lease</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases its headquarters in Los Altos, California under a non-cancelable operating lease agreement which expired and became month-to-month
on July 31, 2019. As a result, there are no future minimum lease payments for 2020. Rent expense under the operating lease was $42,000
and $44,000 in 2019 and 2020, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Legal
Proceedings</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. Management is not currently
aware of any matters that will have a material adverse effect on the financial position, results of operations or cash flows of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Guarantees
and Indemnifications</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the normal course of business, the Company enters into agreements that contain a variety of representations and provide for general indemnification.
The Company&rsquo;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the
future. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations.
As of December 31, 2020, the Company is not subject to any material indemnification claims whose assertion is probable or reasonably
possible. Consequently, the Company has not recorded any related liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Related
                                            Party Transactions</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2013, the Company entered into a consulting agreement (the &ldquo;Agreement&rdquo;) with one of the Company&rsquo;s co-founders
whereby the co-founder provides consulting services as the Company&rsquo;s Chief Medical Officer (&ldquo;CMO&rdquo;) by overseeing Company-sponsored
clinical trials. The Agreement is for a term of 15 years with automatic one-year renewals. The sole compensation payable to the
CMO is the continued vesting of shares of common stock of the Company held by the CMO. In July 2018, the CMO was awarded options for
the purchase of 200,000 shares of the Company&rsquo;s common stock with 25% vested after one year and the remaining 75% vesting ratably
over 36 months. The Company and the CMO entered into an amendment to the Agreement in 2019 providing cash compensation to the CMO of
$10,000 per month for additional services. Consulting fees paid to the CMO were $78,000 and $120,000 for the years ended December 31,
2019 and 2020, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2019, the Company entered into a consulting agreement (the &ldquo;CFO Agreement&rdquo;) with the Company&rsquo;s Chief Financial
Officer (&ldquo;CFO&rdquo;). In February 2020, the Company granted the CFO an option to purchase 140,000 shares of the Company&rsquo;s
common stock, of which 25% were vested at the grant date and the remaining 75% vested ratably over 18 months. The Company entered into
an amendment to the Agreement in December 2020 increasing the cash compensation to $150 per hour. Consulting fees paid to the CFO were
$19,000 and $37,000 for the years ended December 31, 2019 and 2020, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Najmabadi,&nbsp;another co-founder of the Company&nbsp;has served as&nbsp;our&nbsp;consulting technical engineering advisor on manufacturing
and intellectual property matters since January 2020. Previously he was CEO of the Company&nbsp;from inception&nbsp;in December 2009
until January 2013;&nbsp;Chief Technical and Operations Officer from&nbsp;January 2013 until&nbsp;January 2019; and Chief Technology
Officer from January 2019 to January 2020. He currently receives cash compensation quarterly compensation of $3,000.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsequent
                                            Events</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the financial statements as of December 31, 2020 and for the year then ended, the Company evaluated subsequent events through May
12, 2021, the date on which those financial statements were issued.<FONT STYLE="font-size: 8pt">&nbsp;</FONT> <FONT STYLE="font-size: 10pt">The
Company has concluded that no events or transactions have occurred that require disclosure in the accompanying financial statements,
other than the following:</FONT></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2021, the Company received notification and confirmation from Silicon Valley Bank that its PPP loan and related accrued interest
has been forgiven in its entirety by the U.S. Small Business Administration and automatically cancelled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 1, 2021, the Company entered into an amendment to the 2020 Convertible Notes which provides for the extension of the maturity date
of the 2020 Convertible Notes from March 2021 to October 30, 2021 and the conversion of the 2020 Convertible Notes into shares of the
Company&rsquo;s common stock upon a Qualified Financing that is an IPO. No other terms to the 2020 Convertible Notes were amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2021, the Company entered into a note purchase agreement and a series of convertible note payable agreements (the &ldquo;2021 Convertible
Notes&rdquo;) for aggregate borrowings of approximately $2.0 million. Outstanding borrowings under the 2021 Convertible Notes and accrued
interest are due in April 2022, if not previously converted. The 2021 Notes bear interest at the rate of 5% per annum. Pursuant to the
2021 Convertible Notes, the outstanding principal and accrued interest are automatically convertible into equity shares a Qualified Financing
at a conversion price per share equal to 87.5% of the price per share paid by investors purchasing such equity securities in a Qualified
Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In June 2021, the Company amended the 2013 Plan
to increase the number of shares of common stock reserved for issuance by 260,000 and also granted 287,000 stock options with a weighted
average exercise price of $0.49 per share and a grant fair value of approximately $56,000. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 75; Options: NewSection; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="aaa_01"></A>RenovoRx,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Condensed
Balance Sheets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(in
thousands, except share and per share data)</B></FONT><B> </B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">March 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(Note 2)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(Unaudited)</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Assets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left; padding-left: 10pt">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">1,795</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">837</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">115</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">116</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,910</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">953</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">325</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,914</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,278</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Liabilities, Convertible Preferred Stock and Stockholders&rsquo; Deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">162</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">472</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">311</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">413</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Promissory note, current</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">117</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Convertible note</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,650</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,843</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Derivative liability</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">856</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">861</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,096</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,589</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Promissory note, net of current portion</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">23</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,119</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,589</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Commitments and contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Convertible preferred stock, $0.0001 par value; 22,360,455 shares authorized;
    17,677,353 shares issued and outstanding at December 31, 2020 and March 31, 2021 (aggregate liquidation preference of $12,782 at
    December31, 2020 and March 31, 2021)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,451</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,451</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stockholders&rsquo; deficit:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Common stock, $0.0001 par value; 42,000,000 shares authorized; 11,165,703 and 11,415,994 shares issued and outstanding at December 31, 2020 and March 31, 2021,respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">303</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">345</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(14,960</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(16,108</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total stockholders&rsquo; deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(14,656</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(15,762</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total liabilities, convertible preferred stock and stockholders&rsquo; deficit</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,914</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,278</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">The accompanying notes
are an integral part of these financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 76; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="aaa_02"></A>RenovoRx,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Condensed
Statements of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(in
thousands, except per share data)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended March
    31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 64%; text-align: left">Research and development</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">805</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">635</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">General and administrative</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">248</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">418</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,053</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,053</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Loss from operations</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,053</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,053</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Other income (expense), net:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest income (expense), net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(230</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Other expense, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Gain on loan extinguishment</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">140</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total other income (expense), net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(95</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,051</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,148</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss per share - basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.10</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.10</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Weighted average shares of common stock - basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,974</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">11,209</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 77; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="aaa_03"></A>RenovoRx,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.4pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Condensed
Statements of Convertible Preferred Stock and Stockholders&rsquo; Deficit</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(in
thousands, except share amounts)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Convertible Preferred Stock</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Common Stock</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Additional<BR>
    Paid-In</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Total<BR>
    Stockholders&rsquo;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Capital</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Deficit</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Deficit</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 37%; font-weight: bold">Balance at December 31, 2019</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">17,543,161</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">12,391</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid; width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">10,885,936</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">1</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">235</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">(11,162</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">(10,926</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Issuance of restricted stock award to</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">nonemployee for service</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">122,393</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Issuance of common stock upon</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>exercise of stock options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">83,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Issuance of Series A-1 convertible</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">preferred stock upon exercise</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>of warrant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">134,192</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Warrant liability transferred to</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">mezzanine equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stock-based compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,051</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,051</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Balance at March 31, 2020</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">17,677,353</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">12,451</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">11,091,662</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">273</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(12,213</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(11,939</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Balance at December 31, 2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,677,353</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">12,451</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,165,703</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">303</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(14,960</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(14,656</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Issuance of common stock upon</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>exercise of stock options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">250,291</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stock-based compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,148</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,148</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Balance at March 31, 2021</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">17,677,353</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">12,451</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-left: Black 1.5pt solid; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">11,415,994</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">345</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(16,108</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(15,762</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 78; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="aaa_04"></A>RenovoRx,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Condensed
Statements of Cash Flows</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(in
thousands)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended March
    31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0pt; font-weight: bold; text-align: left">Cash flows from operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 64%; text-align: left">Net loss</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">(1,051</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">(1,148</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Stock-based compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left">Loss on change in fair value of derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Gain on loan extinguishment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(140</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left">Amortization of debt discount</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">188</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Amortization of debt issuance cost</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left">Changes in operating assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 30pt; text-align: left">Prepaid expenses and other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(66</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 30pt; text-align: left">Other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(321</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 30pt; text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(132</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">310</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 30pt; text-align: left; padding-bottom: 1.5pt">Accrued expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">200</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">102</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 40pt; text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,039</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(992</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0pt; font-weight: bold; text-align: left">Cash flows from financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Proceeds from convertible notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,290</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Payment of debt issuance costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Proceeds from exercise of Series A-1 warrant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Proceeds from exercise of stock options</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">11</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">34</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 40pt; text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,312</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">34</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0pt; text-align: left">Increase (decrease) in cash, cash equivalents and restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">273</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(958</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0pt; text-align: left; padding-bottom: 1.5pt">Cash, cash equivalents and restricted cash, beginning
    of period</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,124</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,795</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0pt; text-align: left; padding-bottom: 2.5pt">Cash, cash equivalents and restricted cash, end
    of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,397</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">837</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0pt; font-weight: bold; text-align: left">Supplemental disclosure of non-cash investing and financing
    activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Derivative liability</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">363</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">861</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0pt; font-weight: bold; text-align: left">Supplemental disclosure of non-cash activity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Debt issuance costs - 2021 Convertible Notes</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>



<!-- Field: Page; Sequence: 79; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="aaaaa_002"></A>1.
Organization</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Description
of the Business</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RenovoRx,
Inc. (&ldquo;RenovoRx&rdquo; or the &ldquo;Company&rdquo;) was incorporated in Delaware in December 2012 and operates from its
headquarters in Los Altos, California. The Company is a clinical-stage biopharmaceutical company focused on developing therapies
for the local treatment of solid tumors and conducting a Phase 3 registrational trial for its lead product candidate RenovoGem&trade;.
The Company&rsquo;s therapy platform, RenovoRx Trans-Arterial Micro-Perfusion, or RenovoTAMP&trade; utilizes approved chemotherapeutics
with validated mechanisms of action and well-established safety and side effect profiles, with the goal of increasing their efficacy,
improving their safety, and widening their therapeutic window. RenovoTAMP combines the Company&rsquo;s patented FDA cleared delivery
system, RenovoCath<SUP>&reg;</SUP>, with small molecule chemotherapeutic agents that can be forced across the vessel wall using
pressure, targeting these anti-cancer drugs locally to the solid tumors. While the Company anticipates investigating other chemotherapeutic
agents for intra-arterial delivery via RenovoTAMP, to date the Company&rsquo;s clinical work has focused on gemcitabine, which
is a generic drug. The Company&rsquo;s first product candidate, RenovoGem, is a drug and device combination consisting of intra-arterial
gemcitabine and RenovoCath. FDA has determined that RenovoGem will be regulated as, and if approved the Company expects will be
reimbursed as, a new oncology drug product. The Company has secured FDA Orphan Drug Designation for RenovoGem in its first two
indications: pancreatic cancer and cholangiocarcinoma (bile duct cancer, or CCA). The Company has completed its RR1 Phase 1/2
and RR2 observational registry studies, with 20 and 25 patients respectively, in locally advanced pancreatic cancer, or LAPC.
These studies demonstrated a median overall survival of 27.9 months in patients treated with RenovoGem and radiation versus expected
survival of 12-15 months in patients receiving only intravenous (IV) systemic chemotherapy dosed at 1,000mg/m<SUP>2</SUP> based
on historical control data. Unlike the historical controls, the Company&rsquo;s RR1 and RR2 studies were not randomized or controlled
for potential confinement. Based on FDA safety review of the Company&rsquo;s Phase 1/2 study the FDA allowed the Company to proceed
to evaluate RenovoGem within its Phase 3 registration Investigational New Drug, or IND, clinical trial. This Phase 3 trial is
40% enrolled as of April 30, 2021 and the Company expects to report data from a planned interim data readout in the second half
of 2022. The Company intends to evaluate RenovoGem in a second indication in a Phase 2/3 trial in hilar CCA (cancer that occurs
in the bile ducts that lead out of the liver and join with the gallbladder, also called extrahepatic cholangiocarcinoma, or HCCA).
The Company plans to propose the trial to the FDA and potentially launch in the first half of 2022. In addition, the Company may
evaluate RenovoGem in other indications, potentially including locally advanced lung cancer, locally advanced uterine tumors,
and glioblastoma (an aggressive type of cancer that can occur in the brain or spinal cord). To date, the Company has used gemcitabine,
but in the future it may develop other chemotherapeutic agents for intra-arterial delivery via RenovoCath.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
Summary of Significant Accounting Policies</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Unaudited
Financial Statements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed interim financial statements should be read in conjunction with the audited financial statements
and notes thereto included elsewhere in this prospectus. The unaudited condensed interim balance sheet as of December 31, 2020
included herein was derived from the audited financial statements as of that date. The results of operations for the three months
ended March 31, 2021 are not necessarily indicative of the results for the fiscal year ending December 31, 2021 or any future
interim period. The financial statement data and the other financial information contained in these notes to the unaudited condensed
interim financial statements related to the three-month periods are also unaudited. Certain disclosures have been condensed or
omitted from the unaudited condensed interim financial statements.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Basis
of Presentation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed interim financial statements are presented in U.S. dollars and have been prepared in
conformity with accounting principles generally accepted in the United States of America (&ldquo;GAAP&rdquo;) and applicable
rules and regulations of the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;) for interim reporting. Any reference
in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards
Codification (&ldquo;ASC&rdquo;) and as amended by Accounting Standards Update (&ldquo;ASU&rdquo;) of the Financial
Accounting Standards Board (&ldquo;FASB&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 80; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of management, the accompanying unaudited condensed interim financial statements include all normal and recurring
adjustments (which consist primarily of accruals, estimates and assumptions that impact the financial statements) considered
necessary to present fairly the Company&rsquo;s financial position as of March 31, 2021 and its results of operations and
changes in convertible preferred stock and stockholders&rsquo; deficit for the three months ended March 31, 2020 and 2021 and
cash flows for the three months ended March 31, 2020 and 2021. Operating results for the three months ended March 31, 2021
are not necessarily indicative of the results that may be expected for the year ending December 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Liquidity
and Going Concern</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of
liabilities in the normal course of business. In order to continue its operations, the Company must raise additional equity or debt financings
and achieve profitable operations. Although management has historically been successful in raising capital, there can be no assurance
that the Company will be able to obtain additional equity or debt financing on terms acceptable to the Company, or at all. The failure
to obtain sufficient funds on acceptable terms when needed could have a material adverse effect on the Company&rsquo;s business, financial
position, results of operations, and future cash flows. The Company is seeking to complete an initial public offering (&ldquo;IPO&rdquo;)
of its common stock. Upon the closing of an IPO, on specified terms, the Company&rsquo;s outstanding convertible preferred stock will
automatically convert into shares of common stock (see Note 8). In the event the Company does not complete an IPO, the Company expects
to seek additional funding through other capital sources including through the sale of equity, debt financings or other capital sources
including collaborations with other companies or other strategic transactions. However, the Company may be unable to raise additional
funds or enter into such agreements or arrangements when needed on acceptable terms, or at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a company with no commercial operating history, the Company is subject to all of the risks and expenses associated with a start-up company.
The Company must among other things respond to competitive developments, attract, retain and motivate qualified personnel and support
ongoing clinical trials for its product candidate. The Company has generated operating losses and negative cash flows from operations
in each year since inception and anticipates that it will continue to incur net losses into the foreseeable future. The Company has not
generated any revenue from product sales to date and will continue to incur significant research and development and other expenses related
to its ongoing operations. As of March 31, 2021, the Company had cash and cash equivalents of $837,000 and had an accumulated deficit
of $16.1 million. In April 2021, the Company entered into a series of convertible note agreements with several lenders including current
investors to provide an aggregate $2.0 million in cash proceeds. The Company has funded its operations primarily through the sale and
issuance of convertible preferred stock and convertible notes. The Company has reviewed the relevant conditions and events surrounding
its ability to continue as a going concern including among others: historical losses, projected future results, including the effects
of the novel coronavirus (&ldquo;COVID-19&rdquo;), cash requirements for the upcoming year, terms of the Company&rsquo;s current debt
arrangements, funding capacity, net working capital, total stockholders&rsquo; deficit and future access to capital. These factors along
with the Company&rsquo;s cash and cash equivalents raise substantial doubt about the Company&rsquo;s ability to continue as a going concern
for at least one year from the date the financial statements are issued. The financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that
may result from the outcome of this uncertainty. If future financing is not achieved, the Company may be required to curtail spending
to reduce cash outflows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 81; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Risks
and Uncertainties</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to a number of risks associated with companies at a similar stage, including the risk associated with the development
of products that must receive regulatory approval before market launch, dependence on key individuals, competition from larger and established
companies, volatility of the industry, ability to obtain adequate financing to support growth, the ability to attract and retain additional
qualified personnel to manage the anticipated growth of the Company and general economic conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the World Health Organization declared COVID-19 a pandemic. The COVID-19 pandemic has negatively impacted the global economy,
disrupted global supply chains and created significant volatility and disruption of financial markets. The full extent to which the COVID-19
pandemic will directly or indirectly impact the Company&rsquo;s business, results of operations and financial condition, including expenses,
clinical trials and research and development costs, will depend on future developments that are highly uncertain, including as a result
of new information that may emerge concerning COVID-19 and the actions taken to contain or treat COVID-19, as well as the economic impact
on local, regional, national and international markets. The Company has made estimates of the impact of COVID-19 within its financial
statements and there may be changes to those estimates in future periods. Actual results could materially differ from those estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Use
of Estimates</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of unaudited condensed interim financial statements in conformity with GAAP requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities, income and expenses as well as the disclosure of
contingent assets and liabilities, at the date of the financial statements during the reporting periods. Significant
estimates and assumptions made in the accompanying unaudited condensed interim financial statements include, but are not
limited to, the accrual of certain liabilities, the valuation of financial instruments, the fair value of the Company&rsquo;s
common stock and the fair value of options granted under the Company&rsquo;s equity incentive plan. Actual results could
differ from materially from these estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.2pt"><B><I>Recent
Accounting Pronouncements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">From
time to time, new accounting pronouncements, or Accounting Standard Updates (&ldquo;ASU&rdquo;) are issued by the Financial Accounting
Standards Board (&ldquo;FASB&rdquo;), or other standard setting bodies and adopted by the Company as of the specified effective
date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material
impact on the Company&rsquo;s financial position or results of operations upon adoption.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Concentration
of Credit Risk and Significant Suppliers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents. At December 31,
2020 and March 31, 2021, the Company maintained $1.8 million and $837,000 in cash and cash equivalents, respectively, with one financial
institution. The Company is exposed to credit risk in the event of default by the financial institutions to the extent that cash and
cash equivalent deposits are in excess of the $250,000 insured by the Federal Deposit Insurance Corporation. These deposits routinely
exceed the insurable limit. To date, the Company has not experienced any losses on its cash and cash equivalents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is dependent on third-party manufacturers to supply products and services for its research and development activities, including
preclinical and clinical development. In particular, the Company relies, and expects to continue to rely, on a small number of third-party
manufacturers to manufacture and supply its RenovoCath devices and its product candidates for clinical trials. These activities could
be adversely affected by a significant interruption in the supply of these items.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Deferred
Offering Costs</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes certain legal, professional, accounting and other third-party fees that are directly associated with in-process financings
as deferred offering costs until such financings are consummated. After consummation of the financing, these costs are recorded as a
reduction of the proceeds received from the financing. If a planned financing is abandoned, the deferred offering costs are expensed
as a charge to operating expenses in the statements of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were zero and $321,000 in deferred offering costs included in other assets in the Company&rsquo;s condensed balance sheets at December
31, 2020 and March 31, 2021, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 82; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Net
Loss per Share</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
net loss per common share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding during
the period, without consideration of common stock equivalents. Diluted net loss per share is computed by dividing net loss by the weighted-average
number of shares of common stock and common stock equivalents of potentially dilutive securities outstanding for the period determined
using the treasury stock and if-converted methods. Potentially dilutive common stock equivalents are comprised of convertible preferred
stock, convertible notes and options outstanding under the Company&rsquo;s stock option plan. For the three months ended March 31, 2020
and 2021, there was no difference in the number of shares used to calculate basic and diluted shares outstanding as the inclusion of
the potentially dilutive securities would be anti-dilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Fair
Value of Financial Instruments</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes
the inputs to valuation methodologies used to measure fair value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &ndash; Valuations based on quoted prices for identical assets and liabilities in active markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &ndash; Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets
and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other
inputs that are observable or can be corroborated by observable market data.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &ndash; Valuations based on unobservable inputs reflecting the Company&rsquo;s assumptions, consistent with reasonably available assumptions
made by other market participants. These valuations require significant judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated fair value of financial instruments disclosed in the financial statements has been determined by using available market information
and appropriate valuation methodologies. In certain cases where there is limited activity or less transparency around inputs to valuation,
securities are classified as Level 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying value of all remaining current assets and current liabilities approximates fair value because of their short-term nature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash
and Cash Equivalents</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments purchased with a remaining maturity date upon acquisition of three months or less to
be cash equivalents. Cash and cash equivalents consist primarily of cash held in checking and money market accounts. As of March 31,
2020, the Company had restricted cash of $20,000, which consisted of reserve funds held at one financial institution to collateralize
the Company&rsquo;s credit cards. The Company held no funds in restricted cash at December 31, 2020 or March 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Convertible
Instruments and Embedded Derivatives</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded
derivatives. The Company accounts for certain redemption features that are associated with convertible notes as liabilities at fair value
and adjusts the instruments to their fair value at the end of each reporting period. For derivative financial instruments that are accounted
for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with
changes in the fair value reported in other income (expense), net in the condensed statements of operations. Derivative instrument liabilities
are classified in the condensed balance sheets as current or non-current based on whether or not net-cash settlement of the derivative
instrument could be required within 12 months of the balance sheet date. As of December 31, 2020 and March 31, 2021, the Company&rsquo;s
only derivative financial instrument was related to the 2020 Convertible Notes (defined in Note 5), which contained certain redemptive
features (see Note 5).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 83; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Research
and Development Costs</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs, which include direct and allocated expenses, are expensed in the period incurred. Research and development costs
include primarily clinical development-related expenses, pre-clinical research and development expenses, employee compensation and related
benefits, regulatory support and related services, clinical consulting, travel-related expenses and allocated expenses for rent, insurance
and other general overhead costs. The Company also receives payments from vendors in performing clinical trials on behalf of the Company
for the delivery device used by such vendors in performing such clinical trials. These payments are offset against the Company&rsquo;s
research and development expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Clinical
Trial Expenses</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company makes payments in connection with clinical trials under contracts with clinical trial sites and contract research organizations
that support conducting and managing clinical trials. The financial terms of these agreements are subject to negotiation, vary from contract
to contract and may result in uneven payment flows. Generally, these agreements set forth the scope of work to be performed at a fixed
fee or unit price or on a time and materials basis. A portion of the obligation to make payments under these contracts depends on factors
such as the successful enrollment or treatment of patients or the completion of other clinical trial milestones.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses
related to clinical trials are accrued based on estimates and/or representations from service providers regarding work performed, including
actual levels of patient enrollment, completion of patient studies and progress of the clinical trials. Other incidental costs related
to patient enrollment or treatment are accrued when reasonably certain. If the amounts the Company is obligated to pay under clinical
trial agreements are modified (for instance, as a result of changes in the clinical trial protocol or scope of work to be performed),
the accruals are adjusted accordingly. Revisions to contractual payment obligations are charged to expense in the period in which the
facts that give rise to the revision become reasonably certain. As noted above, the Company receives payments from vendors performing
clinical trials on behalf of the Company for the delivery device used by such vendors in performing such clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>General
and Administrative</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses consist primarily of personnel costs, including employee compensation and related benefits and consulting.
Additionally, these expenses include professional fees, including audit, legal, recruiting services and allocated expenses for rent,
insurance and other general overhead costs. General and administrative expenses are expensed in the period incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Convertible
Preferred Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records preferred stock at fair value on the date of issuance, net of issuance costs. The preferred stock is recorded outside
of stockholders&rsquo; deficit because the shares contain liquidation features that are not solely within the Company&rsquo;s control.
As a result, the preferred stock is classified as mezzanine equity (temporary equity). The Company has elected not to adjust the carrying
value of the preferred stock to the liquidation preferences of such shares because it is uncertain whether or when an event would occur
that would obligate the Company to pay the liquidation preferences to holders of shares of preferred stock. Subsequent adjustments to
the carrying values to the liquidation preferences will be made only when it becomes probable that such a liquidation event will occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock-Based
Compensation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company calculates the fair value of stock options using the Black-Scholes option pricing model, which incorporates various assumptions
including volatility, expected life and risk-free interest rate. Compensation related to service-based awards is recognized starting
on the grant date on a straight-line basis over the vesting period, which is generally four years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 84; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
determination of the fair value of each stock award using this option-pricing model is affected by the Company&rsquo;s assumptions regarding
a number of complex and subjective variables. These variables include, but are not limited to, the fair value of the common stock at
the date of grant, the expected term of the awards, the expected stock price volatility over the term of the awards, the risk-free interest
rate, and the dividend rate as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fair
Value of Common Stock</I>&mdash;Given the absence of a public trading market, the Company&rsquo;s Board of Directors considered numerous
objective and subjective factors to determine the fair value of the Company&rsquo;s common stock at each grant date. These factors included,
but were not limited to: (i) contemporaneous third-party valuations of common stock; (ii) the prices for preferred stock sold to outside
investors; (iii) the rights and preferences of preferred stock relative to Common stock; (iv) the lack of marketability of the Company&rsquo;s
common stock; (v) developments in the business; and (vi) the likelihood of achieving a liquidity event, such as an IPO or sale of the
business, given prevailing market conditions. The methodology to determine the fair value of the Company&rsquo;s common stock included
estimating the fair value of the enterprise using the &ldquo;backsolve&rdquo; method, which is a market approach that assigns an implied
enterprise by accounting for all share class rights and preferences based on the latest round of financing. The total equity value implied
was then applied in the context of an option pricing model to determine the value of each class of the Company&rsquo;s shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Expected
Term</I>&mdash;The expected term represents the period that the stock-based awards are expected to be outstanding. The Company determines
the&#9;expected term using the simplified method. The simplified method deems the term to be the average of the time-to-vesting and the
contractual life of the options. For stock options granted to non-employees, the expected term equals the remaining contractual term
of the option from the vesting date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Expected
Volatility</I>&mdash;Given the absence of a public trading market, the expected volatility was estimated by taking the average historic
price volatility for industry peers, consisting of several public companies in the Company&rsquo;s industry that are either similar in
size, stage, or financial leverage, over a period equivalent to the expected term of the awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Risk-Free
Interest Rate</I>&mdash;The risk-free interest rate is calculated using the average of the published interest rates of U.S. Treasury
zero-coupon issues with maturities that are commensurate with the expected term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dividend
Rate</I>&mdash;The dividend yield assumption is zero as the Company has no plans to make dividend payments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generally grants stock options to its employees for a fixed number of shares with an exercise price equal to the fair value of
the underlying shares at date of grant. The Company accounts for all stock option grants using the fair value method and stock-based
compensation is recognized as the underlying options vest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Income
Taxes</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining quarterly provisions for income taxes, the Company uses the annual estimated effective tax rate applied to the actual year-to-date
profit or loss, adjusted for discrete items arising in that quarter. The Company&rsquo;s annual estimated effective tax rate differs
from the U.S. federal statutory rate primarily as a result of state taxes, foreign taxes, and changes in the Company&rsquo;s valuation
allowance against its deferred tax assets. For the three months ended March 31, 2020 and 2021, the Company recorded an immaterial provision
for income taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Segment
Reporting</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
Accounting Standards Board (&ldquo;FASB&rdquo;) ASC Topic 280, <I>Segment Reporting</I>, requires use of the &ldquo;management approach&rdquo;
model for segment reporting. The management approach model is based on the way a Company&rsquo;s management organizes segments within
the company for making operating decisions and assessing performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 85; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determined it has one reportable segment, the development of a platform technology to deliver de-risked small molecules for localized
treatment of solid cancer tumors. The segment is based on financial information that is utilized by the Company&rsquo;s Chief Operating
Decision Maker who is the Company&rsquo;s Chief Executive Officer, to assess performance and allocate resources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Emerging
Growth Company Status</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements, or Accounting Standards Updates (&ldquo;ASU&rdquo;) are issued by the FASB or other standard
setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued
standards that are not yet effective will not have a material impact on the Company&rsquo;s financial position or results of operations
upon adoption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an &ldquo;emerging growth company&rdquo; (&ldquo;EGC&rdquo;) under the Jumpstart Our Business Startups Act (&ldquo;JOBS Act&rdquo;),
the Company may elect to take advantage of certain forms of relief from various reporting requirements that are applicable to public
companies. The relief afforded under the JOBS Act includes an extended transition period for the implementation of new or revised accounting
standards. The Company has elected to take advantage of this extended transition period and, as a result, the Company&rsquo;s financial
statements may not be comparable to those of companies that implement accounting standards as of the effective dates for public companies.
The Company may take advantage of the relief afforded under the JOBS Act up until the last day of the fiscal year following the fifth
anniversary of an offering or such earlier time that it is no longer an EGC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
Accrued Expenses</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the components of accrued expenses is as follows (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">March
    31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 56%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    clinical trials</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">171</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">254</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">101</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">138</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    personnel</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">39</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">311</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">413</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
Fair Value Measurements</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth by level, within the fair value hierarchy, the financial assets and liabilities that are measured at fair
value on a recurring basis at December 31, 2020 and March 31, 2021 (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 11pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    Value Measurements at December 31, 2020 using:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assets:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;Level
                                            1</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;Level
                                            2 &nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;Level
                                            3 &nbsp; &nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
                                            &nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; width: 44%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Money
    market funds</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,703</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,703</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 11pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,703</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,703</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities:</FONT></TD><TD STYLE="font: 11pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 11pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 11pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 11pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liability &ndash; 2020 Convertible Notes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">856</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">856</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left; width: 44%"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">$-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">856</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">856</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 86; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Fair
    Value Measurements at March 31, 2021 using:</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assets:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Level
    1</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Level
    2</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Level
    3</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Total</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt; width: 44%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Money
    market funds</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">803</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">803</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">803</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">803</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liability &ndash; 2020 Convertible Notes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">861</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">861</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">861</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">861</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in the fair value of the derivative liability is summarized below (in thousands):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Three
                                            Months Ended</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March
                                            31</B></FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 64%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value at beginning of the period</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">856</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Initial
    fair value of instruments issued</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">363</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change
    in fair value of instruments</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value at end of the period</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">363</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">861</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
derivative liability in the table above related to the 2020 Convertible Notes and represents the fair value of the redemption-like contingent
conversion feature. The Company calculated the fair value of the derivative liability using a probability weighted discounted cash flow
analysis. The inputs used to determine the estimated fair value of the derivative were based primarily on the probability of an underlying
event occurring that would trigger the embedded derivative and the timing of such event. The Company&rsquo;s derivative liability is
measured at fair value on a recurring basis and is classified as a Level 3 liability. The Company records subsequent adjustments to reflect
the increase or decrease in estimated fair value at each reporting date in other income (expense), net in the condensed statements of
operations (see Note 5).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no transfers among Level 1, Level 2 or Level 3 categories during any of the periods presented. The Company had no other financial
assets or liabilities that were required to be measured at fair value on a recurring basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
Convertible Notes</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the Company entered into a note purchase agreement for the issuance of up to $4.0 million of convertible promissory notes.
The Company entered into a series of convertible note payable agreements (the &ldquo;2020 Convertible Notes&rdquo;) for aggregate borrowings
of approximately $3.0 million. Outstanding borrowings under the 2020 Convertible Notes and accrued interest are due in March 2021, if
not previously converted. The 2020 Notes bear interest at the rate of 5% per annum. The 2020 Notes cannot be prepaid prior to the maturity
date unless approved in writing by the Company and requisite holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 87; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated whether the 2020 Convertible Notes contain embedded features that meet the definition of derivatives under FASB ASC
815, <I>Derivatives and Hedging</I>. The Company determined that these redemption features contained rights and obligations for conversion
contingent upon a potential future financing event or a change in control. Thus, the embedded redemption features were bifurcated from
the face value of the note and accounted for as a derivative liability to be remeasured at the end of each reporting period. The fair
value of the derivative liability at December 31, 2020 and March 31, 2021 was $856,000 and $861,000, respectively with the offsetting
amount being recorded as a debt discount. Debt issuance costs were $22,000 at December 31, 2020. There were no debt issuance costs during
the three months ended March 31, 2021. The derivative liability is subject to fair value remeasurement at the end of each reporting period.
The discount and debt issuance costs are being amortized to interest expense using the effective interest method over the expected term
of the 2020 Convertible Notes. There was no amortization of debt discount or debt issuance costs for the three months ended March 31,
2020. For the three months ended March 31, 2021, the Company recognized $193,000 for amortization of the debt discount and debt issuance
costs, of which $188,000 pertains to the debt discount and $5,000 pertains to debt issuance costs. This amortization expense is recognized
as interest expense in the condensed statements of operations for the three months ended March 31, 2021. For the three months ended March
31, 2020 and 2021, the effective interest rate of the 2020 Convertible Notes was 30.8% compared to the stated rate of 5%. As a result,
the Company&rsquo;s reported interest expense was significantly higher than the contractual cash interest payments. During the three
months ended March 31, 2020 and 2021, the Company recognized interest expense in the condensed statements of operations of zero and $37,000,
respectively, related to the 2020 Convertible Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 1, 2021, the Company entered into an amendment to the 2020 Convertible Notes which extends the maturity date of the 2020 Convertible
Notes from March 31, 2021 to October 30, 2021 and provides for the conversion of the 2020 Convertible Notes into shares of the Company&rsquo;s
common stock upon a Qualified Financing that is an IPO. No other terms to the 2020 Convertible Notes were amended. This amendment was
accounted for as a troubled debt restructuring pursuant to FASB ASC Topic 470-60, &ldquo;<I>Troubled Debt Restructurings by Debtors</I>&rdquo;.
As the future undiscounted cash flows of the 2020 Convertible Notes were greater than their carrying amount, the carrying amount was
not adjusted and no gain was recognized as a result of the modification of terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
Promissory Note</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 22, 2020, the Company entered into a promissory note with Silicon Valley Bank that provided for the receipt by the Company of loan
proceeds of $140,000 (the &ldquo;PPP Loan&rdquo;) pursuant to the Paycheck Protection Program under the Coronavirus Aid, Relief and Economic
Security Act (the &ldquo;CARES Act&rdquo;). Under certain conditions, the loan and accrued interest are forgivable, if the loan proceeds
are used for eligible purposes, including payroll, benefits, rent and utilities, and maintaining payroll levels. In October 2020, the
Paycheck Protection Program Flexibility Act of 2020 extended the deferral period for borrower payments of principal, interest, and fees
on all PPP loans from 6 months to 10 months. As of December 31 2020, payments were deferred for 10 months. The PPP Loan matures on April
22, 2022 and bears interest at a rate of 1.0% per annum. The PPP Loan contains events of default and other provisions customary for a
loan of this type. The Company has recorded the PPP Loan as a promissory note in the December 31, 2020 balance sheet as both a current
and non-current liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2021, the Company received notification and confirmation from Silicon Valley Bank that its PPP loan and related accrued interest
have been forgiven in their entirety by the U.S. Small Business Administration and automatically cancelled. During the three-months ended
March 31, 2021, a gain on loan extinguishment of $140,000 was recognized and included in other income (expense), net in the condensed
statements of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.
Warrant Liability</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with the January 2013 Series A-1 convertible preferred stock financing, the Company issued a warrant to purchase 134,192
shares of the Company&rsquo;s Series A-1 convertible preferred stock at $0.1863 per share. The warrant was to expire on the earlier of
(a) the date that was seven (7) years after the date of the original issuance of the warrant, (b) the date of consummation of an acquisition
or (c) the effective date of an IPO. The warrant was exercised on January 23, 2020 for proceeds of $25,000. Upon exercise, the warrant
liability associated with this warrant was adjusted to its fair value of $35,000 and the fair value was subsequently transferred to mezzanine
equity as of the date of exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 88; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.
Common Stock</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s common stock reserved for future issuance related to the convertible preferred stock and common stock options as of March
31, 2020 and 2021 are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    of March 31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    A-1 convertible preferred stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,542,669</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,542,669</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    A-2 convertible preferred stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,546,095</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,546,095</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    A-3 convertible preferred stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,660,230</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,660,230</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series
    B convertible preferred stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,611,461</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,611,461</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    stock options outstanding</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,012,875</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,755,668</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    stock options reserved for issuance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">111,967</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">44,842</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,485,297</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,160,965</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares that would be issued upon a conversion of the 2020 Convertible Notes have been excluded from the table above as the number of
common shares that would be issued is contingent upon the occurrence of a future Qualified Financing and the conversion price per share
would be equal to 80% of the price per share paid by the investors in the future Qualified Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.
Stock-Based Compensation</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Activity
under the 2013 Plan for the three-month period ended March 31, 2021 is set forth below (in thousands except shares, per share amounts
and years):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
                                            Available for Grant</B></FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of Shares</B></FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted
                                            Average Exercise Price</B></FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Life (Years)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aggregate
                                            Intrinsic Value</B></FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 35%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    at December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">64,467</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,986,334</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.08</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.84</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">276</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(54,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">54,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.16</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(250,291</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.14</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    forfeited</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">34,375</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(34,375</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.13</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    at March 31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">44,842</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,755,668</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.08</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.41</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">369</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vested
    and exercisable at <BR>March 31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,150,142</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.08</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.05</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">352</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vested
    and expected to vest at <BR>March 31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,755,668</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.08</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.41</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">369</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three-month period ended March 31, 2020, the Company recognized $10,000 in stock-based compensation expense from stock option grants.
During the three-month period ended March 31, 2021, the Company recognized $8,000 in stock-based compensation expense. The compensation
expense is allocated on a departmental basis, based on the classification of the option holder. No income tax benefits have been recognized
in the condensed statements of operations for stock-based compensation arrangements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following sets forth the weighted average assumptions used to determine the fair value of stock options for the three months ended March
31, 2020 and 2021:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Three
                                            Months Ended</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March
                                            31,</B></FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected
    term (years)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.64</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.51</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Risk-free
    interest rate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.60</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.72</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Volatility
    factor</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">37</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">42</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividend
    yield</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted-average fair value of options granted was $0.05 per share and $0.06 per share in the three-months ended March 31, 2020 and 2021,
respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
stock-based compensation for unvested employee options granted and outstanding as of March 31, 2021 is $30,000, to be recognized over
a weighted-average remaining requisite service period of 1.46 years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.
Income Tax</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no income tax expense for the three months ended March 31, 2020 and 2021. During the three months ended March 31, 2020 and
2021, the Company had a net operating loss (&ldquo;NOL&rdquo;) for each period that generated deferred tax assets for NOL carryforwards.
Deferred income tax assets and liabilities are recognized for temporary differences between the financial statements and income tax carrying
values using tax rates in effect for the years such differences are expected to reverse. Due to uncertainties surrounding our ability
to generate future taxable income and consequently realize such deferred income tax assets, the Company has determined that it is more-likely-than-not
that these deferred tax assets will not be realized. Accordingly, the Company has established a full valuation allowance against its
deferred tax assets as of March 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s policy is to recognize any interest and penalties related to unrecognized tax benefits as a component of income tax expense.
As of the three months ended March 31, 2020 and 2021, the Company had no accrued interest or penalties related to uncertain tax positions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 89; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.
Net Loss per Share</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
and diluted net loss per common share was calculated as follows (in thousands except per share amounts):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Three
                                            Months Ended</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March
                                            31,</B></FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Numerator:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,051</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,148</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Denominator:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    average shares used in computing net loss per share &ndash; basic and diluted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,974</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,209</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss per share &ndash; basic and diluted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.10</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.10</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three-month periods ended March 31, 2020 and 2021, the Company had a net loss and as such, all outstanding shares of potentially
dilutive securities were excluded from the calculation of diluted net loss per share as the inclusion would be anti-dilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potentially
dilutive securities not included in the computation of diluted net loss per share because to do so would be antidilutive are as follows
(in common stock equivalent shares):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Three
                                            Months Ended</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March
                                            31,</B></FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible
    preferred stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,677,353</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,677,353</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    to purchase common stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,012,875</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,755,668</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,690,228</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,433,021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table above omits the potentially dilutive shares into which the 2020 Convertible Notes would convert.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.
Related Party Transactions</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2013, the Company entered into a consulting agreement (the &ldquo;Agreement&rdquo;) with one of the Company&rsquo;s co-founders
whereby the co-founder provides consulting services as the Company&rsquo;s Chief Medical Officer (&ldquo;CMO&rdquo;) by overseeing Company-sponsored
clinical trials. An amendment to the Agreement was signed in 2019 providing cash compensation to the CMO of $10,000 per month for additional
services. Consulting fees paid to the CMO were $30,000 for each of the three-month periods ended March 31, 2020 and 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2019, the Company entered into a consulting agreement (the &ldquo;CFO Agreement&rdquo;) with the Company&rsquo;s Chief Financial
Officer (&ldquo;CFO&rdquo;) providing for compensation of $50 per hour. In February 2020, the Company granted the CFO an option to purchase
140,000 shares of the Company&rsquo;s common stock, of which 25% were vested at the grant date and the remaining 75% vested ratably over
18 months. The Company entered into an amendment to the Agreement in December 2020 increasing the cash compensation to $150 per hour.
Consulting fees paid to the CFO were $12,000 and $54,000 for the three months ended March 31, 2020 and 2021, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Another
co-founder of the Company has served as our consulting technical engineering advisor on manufacturing and intellectual property matters
since January 2020. Previously he was CEO of the Company from inception in December 2009 until January 2013; Chief Technical and Operations
Officer from January 2013 until January 2019; and Chief Technology Officer from January 2019 to January 2020. He currently receives cash
compensation quarterly compensation of $3,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.
Subsequent Events</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated all events occurring through May 12, 2021, the date on which the unaudited condensed interim financial statements were issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2021, the Company entered into a note purchase agreement and a series of convertible note payable agreements (the &ldquo;2021 Convertible
Notes&rdquo;) for aggregate borrowings of approximately $2.0 million. Outstanding borrowings under the 2021 Convertible Notes and accrued
interest are due in April 2022, if not previously converted. The 2021 Notes bear interest at the rate of 5% per annum. Pursuant to the
2021 Convertible Notes, the outstanding principal and accrued interest are automatically convertible into equity shares a Qualified Financing
at a conversion price per share equal to 87.5% of the price per share paid by investors purchasing such equity securities in a Qualified
Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In June 2021, the Company amended the 2013 Plan
to increase the number of shares of common stock reserved for issuance by 260,000 and also granted 287,000 stock options with a weighted
average exercise price of $0.49 per share and a grant fair value of approximately $56,000. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 90; Value: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="logo_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
Shares of Common Stock </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 16pt"><B>Roth
Capital Partners</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 91 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
II </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
NOT REQUIRED IN PROSPECTUS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
13.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
                   Expenses of Issuance and Distribution. </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the costs and expenses, other than underwriter fees to be paid by us in connection with the sale of the shares
of our common stock being registered hereby. All amounts are estimates except for the SEC registration fee, the FINRA filing fee and
the NASDAQ listing fee. All such expenses will be borne by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 80%; text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">SEC
    registration fee</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">FINRA
    filing fee</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">NASDAQ
    listing fee</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Legal
    fees and expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounting
    fees and expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Printing
    and engraving expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Transfer
    agent and registrar fees and expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
14.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification
                   of Directors and Officers.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
102(b)(7) of Delaware&rsquo;s General Corporation Law (&ldquo;DGCL&rdquo;) allows a corporation to provide in its certificate of incorporation
that a director of the corporation will not be personally liable to the corporation or its stockholders for monetary damages for breach
of fiduciary duty as a director, except where the director breached the duty of loyalty, failed to act in good faith, engaged in intentional
misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware
corporate law or obtained an improper personal benefit. Our amended and restated certificate of incorporation provides for this limitation
of liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the DGCL, or Section 145, provides that a Delaware corporation may indemnify any person who was, is or is threatened to be made,
party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other
than an action by or in the right of such corporation), by reason of the fact that such person is or was an officer, director, employee
or agent of such corporation or is or was serving at the request of such corporation as a director, officer, employee or agent of another
corporation or enterprise. The indemnity may include expenses (including attorneys&rsquo; fees), judgments, fines and amounts paid in
settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding, provided such person acted
in good faith and in a manner he reasonably believed to be in or not opposed to the corporation&rsquo;s best interests and, with respect
to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was illegal. A Delaware corporation
may indemnify any persons who are, were or are a party to any threatened, pending or completed action or suit by or in the right of the
corporation by reason of the fact that such person is or was a director, officer, employee or agent of another corporation or enterprise.
The indemnity may include expenses (including attorneys&rsquo; fees) actually and reasonably incurred by such person in connection with
the defense or settlement of such action or suit, provided such person acted in good faith and in a manner he reasonably believed to
be in or not opposed to the corporation&rsquo;s best interests, provided that no indemnification is permitted without judicial approval
if the officer, director, employee or agent is adjudged to be liable to the corporation. Where an officer or director is successful on
the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him against the expenses which
such officer or director has actually and reasonably incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 92; Options: NewSection; Value: 120 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 further authorizes a corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee
or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee or agent of another
corporation or enterprise, against any liability asserted against him and incurred by him in any such capacity, or arising out of his
or her status as such, whether or not the corporation would otherwise have the power to indemnify him under Section 145.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated bylaws provide that we must indemnify our directors and officers to the fullest extent permitted by the DGCL and
must also pay expenses incurred in defending any such proceeding in advance of its final disposition upon delivery of an undertaking,
by or on behalf of an indemnified person, to repay all amounts so advanced if it should be determined ultimately that such person is
not entitled to be indemnified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will enter into indemnification agreements with certain of our executive officers and directors pursuant to which we will agree to indemnify
such persons against all expenses and liabilities incurred or paid by such person in connection with any proceeding arising from the
fact that such person is or was an officer or director of our company, and to advance expenses as incurred by or on behalf of such person
in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnification rights set forth above shall not be exclusive of any other right which an indemnified person may have or hereafter acquire
under any statute, provision of our certificate of incorporation, our bylaws, agreement, vote of stockholders or disinterested directors
or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain standard policies of insurance that provide coverage (1) to our directors and officers against loss rising from claims made
by reason of breach of duty or other wrongful act and (2) to us with respect to indemnification payments that we may make to such directors
and officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
                                            15.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recent
                                            Sales of Unregistered Securities</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; background-color: white">During
the past three years, we issued the following securities, which were not registered under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; background-color: white">In
March 2020, the Company entered into a note purchase agreement for the issuance of up to $4.0 million of convertible promissory notes.
The Company entered into a series of convertible note payable agreements (the &ldquo;2020 Convertible Notes&rdquo;) for aggregate borrowings
of approximately $3.0 million. Outstanding borrowings under the 2020 Convertible Notes and accrued interest are due in March 2021, if
not previously converted. The 2020 Notes bear interest at the rate of 5% per annum. The 2020 Notes cannot be prepaid prior to the maturity
date unless approved in writing by the Company and requisite holders. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; background-color: white">On
April 22, 2020, the Company entered into a promissory note with Silicon Valley Bank that provided for the receipt by the Company of loan
proceeds of $140,000 (the &ldquo;PPP Loan&rdquo;) pursuant to the Paycheck Protection Program under the Coronavirus Aid, Relief and Economic
Security Act (the &ldquo;CARES Act&rdquo;). Under certain conditions, the loan and accrued interest are forgivable, if the loan proceeds
are used for eligible purposes, including payroll, benefits, rent and utilities, and maintaining payroll levels. In October 2020, the
Paycheck Protection Program Flexibility Act of 2020 extended the deferral period for borrower payments of principal, interest, and fees
on all PPP loans from 6 months to 10 months. As of December 31, 2020, payments were deferred for 10 months. The PPP Loan matures on April
22, 2022 and bears interest at a rate of 1.0% per annum. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In April 2021, the Company entered into a
note purchase agreement and a series of convertible note payable agreements (the &ldquo;2021 Convertible Notes&rdquo;) for aggregate
borrowings of approximately $2.0 million. Outstanding borrowings under the 2021 Convertible Notes and accrued interest are due in
April 2022, if not previously converted. The 2021 Notes bear interest at the rate of 5% per annum. Pursuant to the 2021 Convertible
Notes, the outstanding principal and accrued interest are automatically convertible into equity shares in a Qualified Financing at a
conversion price per share equal to 87.5% of the price per share paid by investors purchasing such equity securities in a Qualified
Financing. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">We
deemed the offers, sales and issuances of the securities described above to be exempt from registration under the Securities Act in reliance
on Section 4(2) of the Securities Act, including Regulation D and Rule 506 promulgated thereunder, relative to transactions by an issuer
not involving a public offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 93; Value: 120 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
    16.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibits
    and Financial Statement Schedules</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 82%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.1</B></FONT>** </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form of Underwriting Agreement.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.1*</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Fifth
    Amended and Restated Certificate of Incorporation of Company </B></FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <B>3.2</B> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <B><A HREF="ex3-2.htm">Certificate of Amendment of Fifth Amended and Restated Certificate of Incorporation of the Company</A></B> </TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.3</B></FONT>* </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
    of Sixth Amended and Restated Certificate of Incorporation, to be effective immediately prior to the closing of the offering</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.4*</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>By-Laws
    of the Company</B></FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.5*</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
    of Amended and Restated By-Laws of the Company, to be effective immediately prior to the closing of the offering</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.1</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex4-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form of Representative&rsquo;s Warrant</B></FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.1**</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Opinion
    of Sheppard, Mullin, Richter &amp; Hampton, LLP</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.1</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex10-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>2013 Stock Incentive Plan</B></FONT></FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.2*</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Consulting
    Agreement with Ramtin Agah, MD</B></FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.3*</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Amended
    Consulting Agreement with Ramtin Agah, MD</B></FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.4*</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Consulting
    Agreement with Paul Manners</B></FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.5*</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Amended
    Consulting Agreement with Paul Manners</B></FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.6**</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
    of 2021 Equity Incentive Plan</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.7**</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
    of Indemnification Agreement</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.8*</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Form
    of April 2021 Convertible Promissory Note</FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.9*</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Form
    of March 2020 Convertible Promissory Note</B></FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.10*</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Form
    of Amendment to 2020 Convertible Promissory Note</B></FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.11+*</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Master
    Supply Agreement dated October 28, 2019 by and between Medical Murray, Inc. and RenovoRx, Inc.</B></FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23.1**</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consent
    of Sheppard Mullin Richter &amp; Hampton, LLP (included in Exhibit 5.1)</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23.2</B></FONT>** </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consent
    of Frank, Rimerman &amp; Co. LLP, independent registered public accounting firm.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>24.1</B></FONT>** </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Power of Attorney (included on the signature page)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> * Previously filed </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**
To be filed by amendment</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+
<FONT STYLE="background-color: white">Portions of this exhibit (indicated by asterisks) have been redacted in compliance with
Regulation&nbsp;S-K Item&nbsp;601(b)(10)(iv).</FONT></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 94; Value: 120 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
17.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Undertakings</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The undersigned registrant hereby undertakes as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration
Fee&rdquo; table in the effective registration statement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or
any material change to such information in the registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
be deemed to be the initial <I>bona fide</I> offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule
424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other
than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the
date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is
part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement
or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first
use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such date of first use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
That, for the purpose of determining any liability under the Securities Act of 1933 to any purchaser in the initial distribution of the
securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to
this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are
offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the
purchaser and will be considered to offer or sell such securities to such purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
424;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
the undersigned registrant;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 95; Value: 120 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or our securities provided by or on behalf of the undersigned registrant; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the undersigned pursuant to the foregoing provisions, or otherwise, the undersigned has been advised that in the opinion of
the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event
that a claim for indemnification against such liabilities (other than the payment by the undersigned of expenses incurred or paid by
a director, officer or controlling person of the undersigned in the successful defense of any action, suit or proceeding) is asserted
by such director, officer or controlling person in connection with the securities being registered, the undersigned will, unless in the
opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question
whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of
such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 96; Value: 120 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, RenovoRx, Inc., a Delaware corporation, has duly caused this Registration Statement
on Form S-1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Los Altos, state of California,
on June [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RENOVORX,
    INC.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shaun
    R. Bagai&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="poa_001"></A>POWER
OF ATTORNEY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
person whose signature appears below constitutes and appoints each of Shaun R. Bagai and Paul Manners as his or her true and lawful attorneys-in-fact
and agents with full power of substitution and resubstitution, for him and his name, place and stead, in any and all capacities, to sign
any or all amendments (including post-effective amendments) to this registration statement and to file a new registration statement under
Rule 461, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite
and necessary to be done in and about the foregoing, as fully to all intents and purposes as he or she might or could do in person, hereby
ratifying and confirming all that said attorneys-in-fact and agents, or their substitutes, may lawfully do or cause to be done by virtue
hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this Amendment to Registration Statement on Form S-1 has been signed by the following
persons in the capacities indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURE</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TITLE</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DATE</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shaun
    R. Bagai</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    </FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Manners</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial Officer)</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    </FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ramtin
    Agah</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    </FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laurence
    J. Marton</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> June <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;],
    2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Una
    S. Ryan</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> June <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;],
    2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maky
    Zanganeh</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> June <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;],
    2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kristen
    Angela</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Macfarlane</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    </FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> David Diamond </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Director </TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2021</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 97; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>2
<FILENAME>filename2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 3.2</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF AMENDMENT OF</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FIFTH
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </B>OF</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RENOVORX,
INC.</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RenovoRx,
Inc., a corporation organized and existing under the laws of the State of Delaware (the &ldquo;<B>Company</B>&rdquo;), certifies that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The name of the Company is RenovoRx, Inc. The Company&rsquo;s original Certificate of Incorporation was filed with the Secretary of State
of the State of Delaware on December 17, 2012.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
This Certificate of Amendment of Fifth Amended and Restated Certificate of Incorporation was duly adopted in accordance with Section
242 of the Delaware General Corporation Law, with the approval of such amendment by the Company&rsquo;s stockholders having been given
by written consent without a meeting in accordance with Sections 228 and 242 of the Delaware General Corporation Law, and amends the
provisions of the Company&rsquo;s Fifth Amended and Restated Certificate of Incorporation, as currently in effect, as set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Article Fourth, Part E, Section 2(c)(i) of the Company&rsquo;s Fifth Amended and Restated Certificate of Incorporation is hereby amended
and restated in its entirety as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;The
size of the Board shall be no more than eight (8) directors; provided, however, that upon a Board Restructuring Event (as defined in
that certain Amended and Restated Voting Agreement dated on or about the date hereof), the size of the Board of Directors shall be reduced
to seven (7) directors.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
Article Fourth, Part E, Section 2(c)(vii) of the Company&rsquo;s Fifth Amended and Restated Certificate of Incorporation is hereby amended
and restated in its entirety as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;If
the holders of shares of Series Preferred or Common Stock, as the case may be, fail to elect a sufficient number of directors to fill
all directorships for which they are entitled to elect directors, voting exclusively and as a separate class, pursuant to this Section
IV.E.2(c), then any directorship not so filled shall remain vacant until such time as the holders of the Series Preferred (or any particular
series of Preferred Stock) or Common Stock, as the case may be, elect a person to fill such directorship by vote or written consent in
lieu of a meeting; and no such directorship may be filled by stockholders of the Company other than by the stockholders of the Company
that are entitled to elect a person to fill such directorship, voting exclusively and as a separate class. The holders of record of the
shares of Common Stock and of any other class or series of voting stock (including the Preferred Stock), exclusively and voting together
as a single class, shall be entitled to elect the balance of the total number of directors of the Company. Any director may be removed
during his or her term of office without cause, by, and only by, the affirmative vote of the holders of the shares of the class or series
of stock entitled to elect such director or directors, given either at a meeting of such stockholders or pursuant to a written consent
of stockholders, and any vacancy thereby created may be filled by the holders of that class or series of stock represented at the meeting
or pursuant to written consent; provided that such director shall be deemed removed immediately upon the termination of the right of
the appointing stockholders to elect such director. At any meeting held for the purpose of electing a director, the presence in person
or by proxy of the holders of a majority of the outstanding shares of the class or series entitled to elect such director shall constitute
a quorum for the purpose of electing such director.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page Follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, this Certificate of Amendment has been signed this _____ day of ______, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RENOVORX,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shaun
    R. Bagai</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif"><B>Signature
Page to</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif"><B>the
Certificate of Amendment of Fifth Amended and Restated Certificate of Incorporation of</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif"><B>RenovoRx,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 2; Options: NewSection Last; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>filename3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.1 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDERWRITER
COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>RenovoRx,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: _______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: _______</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: ______</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
UNDERWRITER COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its
assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after _____<SUP>1</SUP> (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m.
(New York City time) on _____<SUP>2</SUP> (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase
from RenovoRx, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ shares (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Underwriting Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP>Insert the date that is the 6 month anniversary of the effective date of the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2
</SUP>Insert the date that is the 5 year anniversary of the effective date of the Registration Statement, provided that, if such date
is not a Trading Day, insert the immediately preceding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. ______).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means _______________, the current transfer agent of the Company, with a mailing address of _______________ and a facsimile
number of _______________, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Underwriting
Agreement</U>&rdquo; means the underwriting agreement, dated as of _________, between the Company and Roth Capital Partners, LLC as representative
of the underwriters named therein, as amended, modified or supplemented from time to time in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice
of Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States
bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the
date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a
portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be $_____, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the
    Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid
    Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution
    of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading
    Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo;
    on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date
    of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof
    after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise
were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a
certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day
after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement
Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier
of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant
Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant
Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading
Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after
such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain
a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein,
&ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of
this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that
the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for
the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise, other than cash (including, without limitation, any distribution of stock or other securities, property or options by way
of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions
consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than
50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making
or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business
combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall
have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence
of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this
Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation,
and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction
by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction
(without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination
of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and
approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver
to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity
(or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and
power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor
Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at
its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior
to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for
the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the
holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares
of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect
the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant
constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously
file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant
during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise Price to any amount and
for any period of time deemed appropriate by the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Pursuant to FINRA Rule 5110(e), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant
shall be sold, transferred, assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put or call
transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately
following the date of commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any
security:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
    operation of law or by reason of reorganization of the Company;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    any FINRA member firm participating in the offering and the officers, partners, registered persons or affiliates thereof, if all
    securities so transferred remain subject to the lock-up restriction in this Section 4(a) for the remainder of the time period;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the aggregate amount of securities of the Company held by the Holder or related person does not exceed 1% of the securities being
    offered;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
    is beneficially owned on a pro-rata basis by all equity owners of an investment fund, provided that no participating member manages
    or otherwise directs investments by the fund, and participating members in the aggregate do not own more than 10% of the equity in
    the fund; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    exercise or conversion of any security, if all securities received remain subject to the lock-up restriction in this Section 4(a)
    for the remainder of the time period;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the Company meets the registration requirements of Forms S-3, F-3 or F-10; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">back
    to the Company in a transaction exempt from registration with the Commission.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the foregoing restriction, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Demand Registrations</U>. To the extent the Company does not maintain an effective registration statement for the Warrant Shares,
then for a period commencing on the Initial Exercise Date and terminating on the Termination Date, the Holder is entitled to one &ldquo;demand&rdquo;
registration right at the Company&rsquo;s expense and one &ldquo;demand&rdquo; registration right at the Holder&rsquo;s expense, each
such right to be exercised not later than the Termination Date. Upon receipt of a demand registration request from the registered Holder,
the Company shall file a registration statement on Form S-3 (&ldquo;Form S-3&rdquo;) or, if Form S-3 is not available, on any other appropriate
form, including Form S-1, within 60 days of demand thereof and cause such registration statement to become effective within 120 days
thereof. A registration requested pursuant to this Section 4 shall not be deemed to have been effected: (i) unless a registration statement
with respect thereto has become effective or (ii) if, after it has become effective, such registration is interfered with by any stop
order, injunction or other order or requirement of the Commission or other governmental agency or court of competent jurisdiction for
any reason, other than by reason of some act or omission by the Holder. The Company shall use its commercially reasonable efforts to
cause any registration statement filed pursuant to the demand rights granted under this Section 5 to remain effective for a period of
at least nine (9) consecutive months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6</U>. <U>Piggy-Back Registrations</U>. If, at any time while this Warrant is outstanding, there is not an effective registration statement
covering all of the Warrant Shares and the Company shall determine to prepare and file with the Commission a registration statement relating
to an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form
S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely
in connection with any acquisition of any entity or business or equity securities issuable in connection with the Company&rsquo;s stock
option or other employee benefit plans, then the Company shall deliver to each Holder a written notice of such determination and, if
within fifteen days after the date of the delivery of such notice, any such Holder shall so request in writing, the Company shall include
in such registration statement all or any part of such Warrant Shares such Holder requests to be registered; <U>provided</U>, <U>however</U>,
that the Company shall not be required to register any Warrant Shares pursuant to this Section 6 that are eligible for resale pursuant
to Rule 144 (without volume restrictions or current public information requirements) or that are the subject of a then effective registration
statement that is available for resales or other dispositions by such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
7</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Exercise, shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally recognized
overnight courier service, addressed to the Company, at ___________, Attention: <B>___________</B>, facsimile number: _________, email
address: ___________, or such other facsimile number, email address or address as the Company may specify for such purposes by notice
to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing
and delivered personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder
at the facsimile number, e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication
or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication
is delivered via facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New
York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via
facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or
later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by
U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be
given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company
or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand, and the Holder, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>RenovoRx,
    Inc. </B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">RenovoRx,
    Inc.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if
any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U></U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U></U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>filename4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>RenovoRx,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Amended
and Restated 2013 Equity Incentive Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Termination
Date: January 22, 2023</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.&nbsp;<FONT STYLE="font-variant: small-caps">General.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;Eligible
Stock Award Recipients.</B> The persons eligible to receive Stock Awards are Employees, Directors and Consultants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;Available
Stock Awards.</B> The Plan provides for the grant of the following Stock Awards: (i) Incentive Stock Options, (ii) Nonstatutory Stock
Options, (iii) Stock Appreciation Rights, (iv) Restricted Stock Awards, and (v) Restricted Stock Unit Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;Purpose.
</B>The Company, by means of the Plan, seeks to secure and retain the services of the group of persons eligible to receive Stock Awards
as set forth in Section 1(a), to provide incentives for such persons to exert maximum efforts for the success of the Company and any
Affiliate, and to provide a means by which such eligible recipients may be given an opportunity to benefit from increases in value of
the Common Stock through the granting of Stock Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.&nbsp;<FONT STYLE="font-variant: small-caps">Administration.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;Administration
by Board.</B> The Board shall administer the Plan unless and until the Board delegates administration of the Plan to a Committee or Committees,
as provided in Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;Powers
of Board.</B> The Board shall have the power, subject to, and within the limitations of, the express provisions of the Plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;</B>To
determine from time to time (A) which of the persons eligible under the Plan shall be granted Stock Awards; (B) when and how each Stock
Award shall be granted; (C) what type or combination of types of Stock Award shall be granted; (D) the provisions of each Stock Award
granted (which need not be identical), including the time or times when a person shall be permitted to receive cash or Common Stock pursuant
to a Stock Award; (E) the number of shares of Common Stock with respect to which a Stock Award shall be granted to each such person;
and (F) the Fair Market Value applicable to a Stock Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&nbsp;</B>To
construe and interpret the Plan and Stock Awards granted under it, and to establish, amend and revoke rules and regulations for administration
of the Plan. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in any Stock
Award Agreement, in a manner and to the extent it shall deem necessary or expedient to make the Plan or Stock Award fully effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iii)&nbsp;</B>To
settle all controversies regarding the Plan and Stock Awards granted under it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iv)&nbsp;</B>To
accelerate the time at which a Stock Award may first be exercised or the time during which a Stock Award or any part thereof will vest
in accordance with the Plan, notwithstanding the provisions in the Stock Award stating the time at which it may first be exercised or
the time during which it will vest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(v)&nbsp;</B>To
suspend or terminate the Plan at any time. Suspension or termination of the Plan shall not impair rights and obligations under any Stock
Award granted while the Plan is in effect except with the written consent of the affected Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(vi)&nbsp;</B>To
amend the Plan in any respect the Board deems necessary or advisable, including, without limitation, amendments relating to Incentive
Stock Options and certain nonqualified deferred compensation under Section 409A of the Code and/or to bring the Plan or Stock Awards
granted under the Plan into compliance therewith, subject to the limitations, if any, of applicable law. However, except as provided
in Section 9(a) relating to Capitalization Adjustments, to the extent required by applicable law, stockholder approval shall be required
for any amendment of the Plan that either (A) materially increases the number of shares of Common Stock available for issuance under
the Plan, (B) materially expands the class of individuals eligible to receive Stock Awards under the Plan, (C) materially increases the
benefits accruing to Participants under the Plan or materially reduces the price at which shares of Common Stock may be issued or purchased
under the Plan, (D) materially extends the term of the Plan, or (E) expands the types of Stock Awards available for issuance under the
Plan. Except as provided above, rights under any Stock Award granted before amendment of the Plan shall not be impaired by any amendment
of the Plan unless (1) the Company requests the consent of the affected Participant, and (2) such Participant consents in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(vii)&nbsp;</B>To
submit any amendment to the Plan for stockholder approval, including, but not limited to, amendments to the Plan intended to satisfy
the requirements of Section 422 of the Code regarding Incentive Stock Options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(viii)&nbsp;</B>To
approve forms of Stock Award Agreements for use under the Plan and to amend the terms of any one or more Stock Awards, including, but
not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Stock Award Agreement,
subject to any specified limits in the Plan that are not subject to Board discretion; <I>provided however,</I> that, the rights under
any Stock Award shall not be impaired by any such amendment unless (i) the Company requests the consent of the affected Participant,
and (ii) such Participant consents in writing. Notwithstanding the foregoing, subject to the limitations of applicable law, if any, and
without the affected Participant&rsquo;s consent, the Board may amend the terms of any one or more Stock Awards if necessary to maintain
the qualified status of the Stock Award as an Incentive Stock Option or to bring the Stock Award into compliance with Section 409A of
the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ix)&nbsp;</B>Generally,
to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company
and that are not in conflict with the provisions of the Plan or Stock Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(x)&nbsp;</B>To
adopt such procedures and sub-plans as are necessary or appropriate to permit participation in the Plan by Employees, Directors or Consultants
who are foreign nationals or employed outside the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(xi)&nbsp;</B>To
effect, at any time and from time to time, with the consent of any adversely affected Participant, (A) the reduction of the exercise
price (or strike price) of any outstanding Option or SAR under the Plan, (B) the cancellation of any outstanding Option or SAR under
the Plan and the grant in substitution therefore of (1) a new Option or SAR under the Plan or another equity plan of the Company covering
the same or a different number of shares of Common Stock, (2) a Restricted Stock Award, (3) a Restricted Stock Unit Award, (4) cash and/or
(5) other valuable consideration (as determined by the Board, in its sole discretion), or (C) any other action that is treated as a repricing
under generally accepted accounting principles; <I>provided, however</I>, that no such reduction or cancellation may be effected if it
is determined, in the Company&rsquo;s sole discretion, that such reduction or cancellation would result in any such outstanding Option
becoming subject to the requirements of Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;Delegation
to Committee.</B> The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration
of the Plan is delegated to a Committee, the Committee shall have, in connection with the administration of the Plan, the powers theretofore
possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee of the Committee
any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board shall thereafter be
to the Committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be
adopted from time to time by the Board. The Board may retain the authority to concurrently administer the Plan with the Committee and
may, at any time, revest in the Board some or all of the powers previously delegated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;Delegation
to an Officer.</B> The Board may delegate to one or more Officers of the Company the authority to do one or both of the following: (i)
designate Officers and Employees of the Company or any of its Subsidiaries to be recipients of Options and Stock Appreciation Rights
(and, to the extent permitted by applicable law, other Stock Awards) and the terms thereof, and (ii) determine the number of shares of
Common Stock to be subject to such Stock Awards granted to such Officers and Employees; <I>provided, however, </I>that the Board resolutions
regarding such delegation shall specify the total number of shares of Common Stock that may be subject to the Stock Awards granted by
such Officer and that such Officer may not grant a Stock Award to himself or herself. Notwithstanding the foregoing, the Board may not
delegate authority to an Officer to determine the Fair Market Value pursuant to Section 13(t) below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;Effect
of Board&rsquo;s Decision.</B> All determinations, interpretations and constructions made by the Board in good faith shall not be subject
to review by any person and shall be final, binding and conclusive on all persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.&nbsp;<FONT STYLE="font-variant: small-caps">Shares
Subject to the Plan.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;Share
Reserve</B>. Subject to the provisions of Section 9(a) relating to Capitalization Adjustments, the aggregate number of shares of Common
Stock that may be issued pursuant to Stock Awards beginning on the Effective Date shall not exceed six million six hundred six thousand
five hundred four (6,606,504) shares (the <B><I>&ldquo;Share Reserve&rdquo;</I></B>). Furthermore, if a Stock Award (i) expires
or otherwise terminates without having been exercised in full or (ii) is settled in cash (<I>i.e.</I>, the holder of the Stock Award
receives cash rather than stock), such expiration, termination or settlement shall not reduce (or otherwise offset) the number of shares
of Common Stock that may be issued pursuant to the Plan. For clarity, the limitation in this Section 3(a) is a limitation in the number
of shares of Common Stock that may be issued pursuant to the Plan. Accordingly, this Section 3(a) does not limit the granting of Stock
Awards except as provided in Section 7(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;Reversion
of Shares to the Share Reserve</B>. If any shares of Common Stock issued pursuant to a Stock Award are forfeited back to the Company
because of the failure to meet a contingency or condition required to vest such shares in the Participant, then the shares which are
forfeited shall revert to and again become available for issuance under the Plan. Also, any shares reacquired by the Company pursuant
to Section 8(g) or as consideration for the exercise of an Option shall again become available for issuance under the Plan. Notwithstanding
the provisions of this Section 3(b), any such shares shall not be subsequently issued pursuant to the exercise of Incentive Stock Options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;Incentive
Stock Option Limit. </B>Notwithstanding anything to the contrary in this Section 3(c), subject to the provisions of Section 9(a) relating
to Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of
Incentive Stock Options shall be two times the Share Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;Source
of Shares.</B> The stock issuable under the Plan shall be shares of authorized but unissued or reacquired Common Stock, including shares
repurchased by the Company on the open market or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.&nbsp;<FONT STYLE="font-variant: small-caps">Eligibility.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;Eligibility
for Specific Stock Awards</B>. Incentive Stock Options may be granted only to employees of the Company or a &ldquo;parent corporation&rdquo;
or &ldquo;subsidiary corporation&rdquo; thereof (as such terms are defined in Sections 424(e) and (f) of the Code). Stock Awards other
than Incentive Stock Options may be granted to Employees, Directors and Consultants; <I>provided, however</I>, Nonstatutory Stock Options
and SARs may not be granted to Employees, Directors and Consultants who are providing Continuous Service only to any &ldquo;parent&rdquo;
of the Company, as such term is defined in Rule 405, unless the stock underlying such Stock Awards is treated as &ldquo;service recipient
stock&rdquo; under Section 409A of the Code because the Stock Awards are granted pursuant to a corporate transaction (such as a spin
off transaction) or unless such Stock Awards comply with the distribution requirements of Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;Ten
Percent Stockholders</B>. A Ten Percent Stockholder shall not be granted an Incentive Stock Option unless the exercise price of such
Option is at least one hundred ten percent (110%) of the Fair Market Value on the date of grant and the Option is not exercisable after
the expiration of five (5) years from the date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;Consultants.
</B>A Consultant shall not be eligible for the grant of a Stock Award if, at the time of grant, either the offer or the sale of the Company&rsquo;s
securities to such Consultant is not exempt under Rule 701 because of the nature of the services that the Consultant is providing to
the Company, because the Consultant is not a natural person, or because of any other provision of Rule 701, unless the Company determines
that such grant need not comply with the requirements of Rule 701 and will satisfy another exemption under the Securities Act as well
as comply with the securities laws of all other relevant jurisdictions<FONT STYLE="font-variant: small-caps"><B>.</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.&nbsp;<FONT STYLE="font-variant: small-caps">Provisions
Relating to Options and Stock Appreciation Rights.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Option or SAR shall be in such form and shall contain such terms and conditions as the Board shall deem appropriate. All Options shall
be separately designated Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are issued,
a separate certificate or certificates shall be issued for shares of Common Stock purchased on exercise of each type of Option. If an
Option is not specifically designated as an Incentive Stock Option, then the Option shall be a Nonstatutory Stock Option. The provisions
of separate Options or SARs need not be identical; <I>provided, however</I>, that each Option Agreement or Stock Appreciation Right Agreement
shall conform to (through incorporation of provisions hereof by reference in the applicable Stock Award Agreement or otherwise) the substance
of each of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;Term.
</B>Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, no Option or SAR shall be exercisable after the expiration
of ten (10) years from the date of its grant or such shorter period specified in the Stock Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;Exercise
Price.</B> Subject to the provisions of Section 4(b) regarding Incentive Stock Options granted to Ten Percent Stockholders, the exercise
price (or strike price) of each Option or SAR shall be not less than one hundred percent (100%) of the Fair Market Value of the Common
Stock subject to the Option or SAR on the date the Option or SAR is granted. Notwithstanding the foregoing, an Option or SAR may be granted
with an exercise price (or strike price) lower than one hundred percent (100%) of the Fair Market Value of the Common Stock subject to
the Option or SAR if such Option or SAR is granted pursuant to an assumption of or substitution for another option or stock appreciation
right pursuant to a Corporate Transaction and in a manner consistent with the provisions of Sections 409A and 424(a) of the Code (whether
or not such Stock Awards are Incentive Stock Options). Each SAR will be denominated in shares of Common Stock equivalents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;Consideration
for Options.</B> The purchase price of Common Stock acquired pursuant to the exercise of an Option shall be paid, to the extent permitted
by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment set forth below.
The Board shall have the authority to grant Options that do not permit all of the following methods of payment (or otherwise restrict
the ability to use certain methods) and to grant Options that require the consent of the Company to utilize a particular method of payment.
The permitted methods of payment are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;</B>by
cash, check, bank draft or money order payable to the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&nbsp;</B>pursuant
to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of the stock subject
to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the
aggregate exercise price to the Company from the sales proceeds;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iii)&nbsp;</B>by
delivery to the Company (either by actual delivery or attestation) of shares of Common Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iv)&nbsp;</B>if
the Option is a Nonstatutory Stock Option, by a &ldquo;net exercise&rdquo; arrangement pursuant to which the Company will reduce the
number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not
exceed the aggregate exercise price; <I>provided, however,</I> that the Company shall accept a cash or other payment from the Participant
to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares
to be issued; <I>provided, further,</I> that shares of Common Stock will no longer be subject to an Option and will not be exercisable
thereafter to the extent that (A) shares issuable upon exercise are reduced to pay the exercise price pursuant to the &ldquo;net exercise,&rdquo;
(B) shares are delivered to the Participant as a result of such exercise, and (C) shares are withheld to satisfy tax withholding obligations;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(v)&nbsp;</B>according
to a deferred payment or similar arrangement with the Optionholder; <I>provided, however</I>, that interest shall compound at least annually
and shall be charged at the minimum rate of interest necessary to avoid (A) the imputation of interest income to the Company and compensation
income to the Optionholder under any applicable provisions of the Code, and (B) the classification of the Option as a liability for financial
accounting purposes; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(vi)&nbsp;</B>in
any other form of legal consideration that may be acceptable to the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;Exercise
and Payment of a SAR.</B> To exercise any outstanding Stock Appreciation Right, the Participant must provide written notice of exercise
to the Company in compliance with the provisions of the Stock Appreciation Right Agreement evidencing such Stock Appreciation Right.
The appreciation distribution payable on the exercise of a Stock Appreciation Right will be not greater than an amount equal to the excess
of (A) the aggregate Fair Market Value (on the date of the exercise of the Stock Appreciation Right) of a number of shares of Common
Stock equal to the number of Common Stock equivalents in which the Participant is vested under such Stock Appreciation Right, and with
respect to which the Participant is exercising the Stock Appreciation Right on such date, over (B) the strike price that will be determined
by the Board at the time of grant of the Stock Appreciation Right. The appreciation distribution in respect to a Stock Appreciation Right
may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined by the Board
and contained in the Stock Appreciation Right Agreement evidencing such Stock Appreciation Right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;Transferability
of Options and SARs.</B> The Board may, in its sole discretion, impose such limitations on the transferability of Options and SARs as
the Board shall determine. In the absence of such a determination by the Board to the contrary, the following restrictions on the transferability
of Options and SARs shall apply:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;Restrictions
on Transfer.</B> An Option or SAR shall not be transferable except by will or by the laws of descent and distribution and shall be exercisable
during the lifetime of the Participant only by the Participant; <I>provided, however</I>, that the Board may, in its sole discretion,
permit transfer of the Option or SAR to such extent as permitted by Rule 701 and in a manner consistent with applicable tax and securities
laws upon the Participant&rsquo;s request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&nbsp;Domestic
Relations Orders.</B> Notwithstanding the foregoing, an Option or SAR may be transferred pursuant to a domestic relations order; <I>provided,
however,</I> that if an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result
of such transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iii)&nbsp;Beneficiary
Designation.</B> Notwithstanding the foregoing, the Participant may, by delivering written notice to the Company, in a form provided
by or otherwise satisfactory to the Company and any broker designated by the Company to effect Option exercises, designate a third party
who, in the event of the death of the Participant, shall thereafter be entitled to exercise the Option or SAR and receive the Common
Stock or other consideration resulting from such exercise. In the absence of such a designation, the executor or administrator of the
Participant&rsquo;s estate shall be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting
from such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;Vesting
Generally.</B> The total number of shares of Common Stock subject to an Option or SAR may vest and therefore become exercisable in periodic
installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the time or times when
it may or may not be exercised (which may be based on the satisfaction of performance goals or other criteria) as the Board may deem
appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of this Section 5(f) are subject to any Option
or SAR provisions governing the minimum number of shares of Common Stock as to which an Option or SAR may be exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)&nbsp;Termination
of Continuous Service.</B> Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the Participant
and the Company, in the event that a Participant&rsquo;s Continuous Service terminates (other than upon the Participant&rsquo;s death
or Disability), the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such
Stock Award as of the date of termination of Continuous Service) but only within such period of time ending on the earlier of (i) the
date three (3) months following the termination of the Participant&rsquo;s Continuous Service (or such longer or shorter period specified
in the Stock Award Agreement, which period shall not be less than thirty (30) days if necessary to comply with applicable state laws
or (ii) the expiration of the term of the Option or SAR as set forth in the Stock Award Agreement. If, after termination of Continuous
Service, the Participant does not exercise his or her Option or SAR within the time specified herein or in the Stock Award Agreement
(as applicable), the Option or SAR shall terminate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)&nbsp;Extension
of Termination Date.</B> Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the Participant
and the Company, if the exercise of an Option or SAR following the termination of the Participant&rsquo;s Continuous Service (other than
upon the Participant&rsquo;s death or Disability) would be prohibited at any time solely because the issuance of shares of Common Stock
would violate the registration requirements under the Securities Act, then the Option or SAR shall terminate on the earlier of (i) the
expiration of a period of three (3) months after the termination of the Participant&rsquo;s Continuous Service during which the exercise
of the Option or SAR would not be in violation of such registration requirements, or (ii) the expiration of the term of the Option or
SAR as set forth in the Stock Award Agreement. In addition, unless otherwise provided in a Participant&rsquo;s Award Agreement, if the
sale of any Common Stock received upon exercise of an Option or SAR following the termination of the Participant&rsquo;s Continuous Service
would violate the Company&rsquo;s insider trading policy, then the Option or SAR shall terminate on the earlier of (i) the expiration
of a period equal to the applicable post-termination exercise period after the termination of the Participant&rsquo;s Continuous Service
during which the exercise of the Option or SAR would not be in violation of the Company&rsquo;s insider trading policy, or (ii) the expiration
of the term of the Option or SAR as set forth in the applicable Stock Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;Disability
of Participant.</B> Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the Participant and
the Company, in the event that a Participant&rsquo;s Continuous Service terminates as a result of the Participant&rsquo;s Disability,
the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR
as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date twelve
(12) months following such termination of Continuous Service (or such longer or shorter period specified in the Stock Award Agreement,
which period shall not be less than six (6) months if necessary to comply with applicable state laws), or (ii) the expiration of the
term of the Option or SAR as set forth in the Stock Award Agreement. If, after termination of Continuous Service, the Participant does
not exercise his or her Option or SAR within the time specified herein or in the Stock Award Agreement (as applicable), the Option or
SAR shall terminate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(j)&nbsp;Death
of Participant.</B> Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the Participant and
the Company, in the event that (i) a Participant&rsquo;s Continuous Service terminates as a result of the Participant&rsquo;s death,
or (ii) the Participant dies within the period (if any) specified in the Stock Award Agreement after the termination of the Participant&rsquo;s
Continuous Service for a reason other than death, then the Option or SAR may be exercised (to the extent the Participant was entitled
to exercise such Option or SAR as of the date of death) by the Participant&rsquo;s estate, by a person who acquired the right to exercise
the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or SAR upon the Participant&rsquo;s death,
but only within the period ending on the earlier of (i) the date eighteen (18) months following the date of death (or such longer or
shorter period specified in the Stock Award Agreement, which period shall not be less than six (6) months if necessary to comply with
applicable state laws), or (ii) the expiration of the term of such Option or SAR as set forth in the Stock Award Agreement. If, after
the Participant&rsquo;s death, the Option or SAR is not exercised within the time specified herein or in the Stock Award Agreement (as
applicable), the Option or SAR shall terminate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(k)&nbsp;Termination
for Cause.</B> Except as explicitly provided otherwise in a Participant&rsquo;s Stock Award Agreement, if a Participant&rsquo;s Continuous
Service is terminated for Cause, the Option or SAR shall terminate upon the termination date of such Participant&rsquo;s Continuous Service,
and the Participant shall be prohibited from exercising his or her Option or SAR from and after the time of such termination of Continuous
Service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(l)&nbsp;Non-Exempt
Employees</B>. No Option or SAR granted to an Employee who is a non-exempt employee for purposes of the Fair Labor Standards Act of 1938,
as amended, shall be first exercisable for any shares of Common Stock until at least six months following the date of grant of the Option
or SAR. Notwithstanding the foregoing, consistent with the provisions of the Worker Economic Opportunity Act, in the event of the Participant&rsquo;s
death or Disability, upon a Corporate Transaction or a Change in Control in which the vesting of such Options or SARs accelerates, or
upon the Participant&rsquo;s retirement (as such term may be defined in the Participant&rsquo;s Stock Award Agreement or in another applicable
agreement or in accordance with the Company&rsquo;s then current employment policies and guidelines) any such vested Options and SARs
may be exercised earlier than six months following the date of grant. The foregoing provision is intended to operate so that any income
derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular
rate of pay.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(m)&nbsp;Early
Exercise of Options.</B> An Option may, but need not, include a provision whereby the Optionholder may elect at any time before the Optionholder&rsquo;s
Continuous Service terminates to exercise the Option as to any part or all of the shares of Common Stock subject to the Option prior
to the full vesting of the Option. Subject to the &ldquo;Repurchase Limitation&rdquo; in Section 8(l), any unvested shares of Common
Stock so purchased may be subject to a repurchase right in favor of the Company or to any other restriction the Board determines to be
appropriate. Provided that the &ldquo;Repurchase Limitation&rdquo; in Section 8(l) is not violated, the Company shall not be required
to exercise its repurchase right until at least six (6) months (or such longer or shorter period of time required to avoid classification
of the Option as a liability for financial accounting purposes) have elapsed following exercise of the Option unless the Board otherwise
specifically provides in the Option Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(n)&nbsp;Right
of Repurchase</B>. Subject to the &ldquo;Repurchase Limitation&rdquo; in Section 8(l), the Option or SAR may include a provision whereby
the Company may elect to repurchase all or any part of the vested shares of Common Stock acquired by the Participant pursuant to the
exercise of the Option or SAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(o)&nbsp;Right
of First Refusal</B>. The Option or SAR may include a provision whereby the Company may elect to exercise a right of first refusal following
receipt of notice from the Participant of the intent to transfer all or any part of the shares of Common Stock received upon the exercise
of the Option or SAR. Such right of first refusal shall be subject to the &ldquo;Repurchase Limitation&rdquo; in Section 8(l). Except
as expressly provided in this Section 5(o) or in the Stock Award Agreement, such right of first refusal shall otherwise comply with any
applicable provisions of the Bylaws of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.&nbsp;<FONT STYLE="font-variant: small-caps">Provisions
of Restricted Stock Awards and Restricted Stock Units.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;Restricted
Stock Awards.</B> Each Restricted Stock Award Agreement shall be in such form and shall contain such terms and conditions as the Board
shall deem appropriate. To the extent consistent with the Company&rsquo;s Bylaws, at the Board&rsquo;s election, shares of Common Stock
may be (x) held in book entry form subject to the Company&rsquo;s instructions until any restrictions relating to the Restricted Stock
Award lapse; or (y) evidenced by a certificate, which certificate shall be held in such form and manner as determined by the Board. The
terms and conditions of Restricted Stock Award Agreements may change from time to time, and the terms and conditions of separate Restricted
Stock Award Agreements need not be identical; <I>provided, however</I>, that each Restricted Stock Award Agreement shall conform to (through
incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;Consideration</B>.
A Restricted Stock Award may be awarded in consideration for (A) cash or cash equivalents, (B) past or future services actually or to
be rendered to the Company or an Affiliate, or (C) any other form of legal consideration that may be acceptable to the Board in its sole
discretion and permissible under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&nbsp;Vesting</B>.
Subject to the &ldquo;Repurchase Limitation&rdquo; in Section 8(l), shares of Common Stock awarded under the Restricted Stock Award Agreement
may be subject to forfeiture to the Company in accordance with a vesting schedule to be determined by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iii)&nbsp;Termination
of Participant&rsquo;s Continuous Service</B>. If a Participant&rsquo;s Continuous Service terminates, the Company may receive through
a forfeiture condition or a repurchase right, any or all of the shares of Common Stock held by the Participant that have not vested as
of the date of termination of Continuous Service under the terms of the Restricted Stock Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iv)&nbsp;Transferability</B>.
Rights to acquire shares of Common Stock under the Restricted Stock Award Agreement shall be transferable by the Participant only upon
such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board shall determine in its sole discretion,
so long as Common Stock awarded under the Restricted Stock Award Agreement remains subject to the terms of the Restricted Stock Award
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(v)&nbsp;Dividends.
</B>A Restricted Stock Award Agreement may provide that any dividends paid on Restricted Stock will be subject to the same vesting and
forfeiture restrictions as apply to the shares subject to the Restricted Stock Award to which they relate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;Restricted
Stock Unit Awards. </B>Each Restricted Stock Unit Award Agreement shall be in such form and shall contain such terms and conditions as
the Board shall deem appropriate. The terms and conditions of Restricted Stock Unit Award Agreements may change from time to time, and
the terms and conditions of separate Restricted Stock Unit Award Agreements need not be identical, <I>provided, however, </I>that each
Restricted Stock Unit Award Agreement shall conform to (through incorporation of the provisions hereof by reference in the Agreement
or otherwise) the substance of each of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;Consideration.
</B>At the time of grant of a Restricted Stock Unit Award, the Board will determine the consideration, if any, to be paid by the Participant
upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award. The consideration to be paid (if any) by the
Participant for each share of Common Stock subject to a Restricted Stock Unit Award may be paid in any form of legal consideration that
may be acceptable to the Board in its sole discretion and permissible under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&nbsp;Vesting.
</B>At the time of the grant of a Restricted Stock Unit Award, the Board may impose such restrictions or conditions to the vesting of
the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iii)&nbsp;Payment</B>.
A Restricted Stock Unit Award may be settled by the delivery of shares of Common Stock, their cash equivalent, any combination thereof
or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iv)&nbsp;Additional
Restrictions. </B>At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems appropriate, may impose such restrictions
or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to a Restricted Stock Unit Award
to a time after the vesting of such Restricted Stock Unit Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(v)&nbsp;Dividend
Equivalents. </B>Dividend equivalents may be credited in respect of shares of Common Stock covered by a Restricted Stock Unit Award,
as determined by the Board and contained in the Restricted Stock Unit Award Agreement. At the sole discretion of the Board, such dividend
equivalents may be converted into additional shares of Common Stock covered by the Restricted Stock Unit Award in such manner as determined
by the Board. Any additional shares covered by the Restricted Stock Unit Award credited by reason of such dividend equivalents will be
subject to all the terms and conditions of the underlying Restricted Stock Unit Award Agreement to which they relate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(vi)&nbsp;Termination
of Participant&rsquo;s Continuous Service. </B>Except as otherwise provided in the applicable Restricted Stock Unit Award Agreement,
such portion of the Restricted Stock Unit Award that has not vested will be forfeited upon the Participant&rsquo;s termination of Continuous
Service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(vii)&nbsp;Compliance
with Section 409A of the Code.</B> Notwithstanding anything to the contrary set forth herein, any Restricted Stock Unit Award granted
under the Plan that is not exempt from the requirements of Section 409A of the Code shall contain such provisions so that such Restricted
Stock Unit Award will comply with the requirements of Section 409A of the Code. Such restrictions, if any, shall be determined by the
Board and contained in the Restricted Stock Unit Award Agreement evidencing such Restricted Stock Unit Award. For example, such restrictions
may include, without limitation, a requirement that any Common Stock that is to be issued in a year following the year in which the Restricted
Stock Unit Award vests must be issued in accordance with a fixed pre-determined schedule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.&nbsp;<FONT STYLE="font-variant: small-caps">Covenants
of the Company.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;Availability
of Shares.</B> During the terms of the Stock Awards, the Company shall keep available at all times the number of shares of Common Stock
reasonably required to satisfy such Stock Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;Securities
Law Compliance.</B> The Company shall seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such
authority as may be required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise of the Stock Awards; <I>provided,
however,</I> that this undertaking shall not require the Company to register under the Securities Act the Plan, any Stock Award or any
Common Stock issued or issuable pursuant to any such Stock Award. If, after reasonable efforts, the Company is unable to obtain from
any such regulatory commission or agency the authority that counsel for the Company deems necessary for the lawful issuance and sale
of Common Stock under the Plan, the Company shall be relieved from any liability for failure to issue and sell Common Stock upon exercise
of such Stock Awards unless and until such authority is obtained. A Participant shall not be eligible for the grant of a Stock Award
or the subsequent issuance of Common Stock pursuant to the Stock Award if such grant or issuance would be in violation of any applicable
securities law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;No
Obligation to Notify. </B>The Company shall have no duty or obligation to any Participant to advise such holder as to the time or manner
of exercising such Stock Award. Furthermore, the Company shall have no duty or obligation to warn or otherwise advise such holder of
a pending termination or expiration of a Stock Award or a possible period in which the Stock Award may not be exercised. The Company
has no duty or obligation to minimize the tax consequences of a Stock Award to the holder of such Stock Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.&nbsp;<FONT STYLE="font-variant: small-caps">Miscellaneous.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;Use
of Proceeds from Sales of Common Stock. </B>Proceeds from the sale of shares of Common Stock pursuant to Stock Awards shall constitute
general funds of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;Corporate
Action Constituting Grant of Stock Awards.</B> Corporate action constituting a grant by the Company of a Stock Award to any Participant
shall be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument,
certificate, or letter evidencing the Stock Award is communicated to, or actually received or accepted by, the Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;Stockholder
Rights.</B> No Participant shall be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares
of Common Stock subject to such Stock Award unless and until (i) such Participant has satisfied all requirements for exercise of the
Stock Award pursuant to its terms, if applicable, and (ii) the issuance of the Common Stock subject to such Stock Award has been entered
into the books and records of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;No
Employment or Other Service Rights.</B> Nothing in the Plan, any Stock Award Agreement or any other instrument executed thereunder or
in connection with any Stock Award granted pursuant thereto shall confer upon any Participant any right to continue to serve the Company
or an Affiliate in the capacity in effect at the time the Stock Award was granted or shall affect the right of the Company or an Affiliate
to terminate (i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant
to the terms of such Consultant&rsquo;s agreement with the Company or an Affiliate, or (iii) the service of a Director pursuant to the
Bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate
is incorporated, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;Incentive
Stock Option $100,000 Limitation.</B> To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common
Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under
all plans of the Company and any Affiliates) exceeds one hundred thousand dollars ($100,000), the Options or portions thereof that exceed
such limit (according to the order in which they were granted) shall be treated as Nonstatutory Stock Options, notwithstanding any contrary
provision of the applicable Option Agreement(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;Investment
Assurances.</B> The Company may require a Participant, as a condition of exercising or acquiring Common Stock under any Stock Award,
(i) to give written assurances satisfactory to the Company as to the Participant&rsquo;s knowledge and experience in financial and business
matters and/or to employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial
and business matters and that he or she is capable of evaluating, alone or together with the purchaser representative, the merits and
risks of exercising the Stock Award; and (ii) to give written assurances satisfactory to the Company stating that the Participant is
acquiring Common Stock subject to the Stock Award for the Participant&rsquo;s own account and not with any present intention of selling
or otherwise distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, shall
be inoperative if (x) the issuance of the shares upon the exercise or acquisition of Common Stock under the Stock Award has been registered
under a then currently effective registration statement under the Securities Act, or (y) as to any particular requirement, a determination
is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable securities laws.
The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems
necessary or appropriate in order to comply with applicable securities laws, including, but not limited to, legends restricting the transfer
of the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)&nbsp;Withholding
Obligations.</B> Unless prohibited by the terms of a Stock Award Agreement, the Company may, in its sole discretion, satisfy any federal,
state or local tax withholding obligation relating to a Stock Award by any of the following means or by a combination of such means:
(i) causing the Participant to tender a cash payment; (ii) withholding shares of Common Stock from the shares of Common Stock issued
or otherwise issuable to the Participant in connection with the Stock Award; <I>provided, however</I>, that no shares of Common Stock
are withheld with a value exceeding the minimum amount of tax required to be withheld by law (or such lesser amount as may be necessary
to avoid classification of the Stock Award as a liability for financial accounting purposes); (iii) withholding payment from any amounts
otherwise payable to the Participant; (iv) withholding cash from a Stock Award settled in cash; or (v) by such other method as may be
set forth in the Stock Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)&nbsp;Electronic
Delivery</B>. Any reference herein to a &ldquo;written&rdquo; agreement or document shall include any agreement or document delivered
electronically or posted on the Company&rsquo;s intranet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;Deferrals.
</B>To the extent permitted by applicable law, the Board, in its sole discretion, may determine that the delivery of Common Stock or
the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Stock Award may be deferred and may establish
programs and procedures for deferral elections to be made by Participants. Deferrals by Participants will be made in accordance with
Section 409A of the Code. Consistent with Section 409A of the Code, the Board may provide for distributions while a Participant is still
an employee or otherwise providing services to the Company. The Board is authorized to make deferrals of Stock Awards and determine when,
and in what annual percentages, Participants may receive payments, including lump sum payments, following the Participant&rsquo;s termination
of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with
applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(j)&nbsp;Compliance
with Section 409A. </B>To the extent that the Board determines that any Stock Award granted hereunder is subject to Section 409A of the
Code, the Stock Award Agreement evidencing such Stock Award shall incorporate the terms and conditions necessary to avoid the consequences
specified in Section 409A(a)(1) of the Code. To the extent applicable, the Plan and Stock Award Agreements shall be interpreted in accordance
with Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(k)&nbsp;Compliance
with Exemption Provided by Rule 12h-1(f)</B>. If: (i) the aggregate of the number of Optionholders and the number of holders of all other
outstanding compensatory employee stock options to purchase shares of Common Stock equals or exceeds five hundred (500), and (ii) the
assets of the Company at the end of the Company&rsquo;s most recently completed fiscal year exceed $10 million, then the following restrictions
shall apply during any period during which the Company does not have a class of its securities registered under Section 12 of the Exchange
Act and is not required to file reports under Section 15(d) of the Exchange Act: (A) the Options and, prior to exercise, the shares of
Common Stock acquired upon exercise of the Options may not be transferred until the Company is no longer relying on the exemption provided
by Rule 12h-1(f) promulgated under the Exchange Act (&ldquo;<B><I>Rule 12h-1(f)</I></B>&rdquo;), except: (1) as permitted by Rule 701(c)
promulgated under the Securities Act, (2) to a guardian upon the disability of the Optionholder, or (3) to an executor upon the death
of the Optionholder (collectively, the &ldquo;<B><I>Permitted Transferees</I></B>&rdquo;); <I>provided, however</I>, the following transfers
are permitted: (i) transfers by the Optionholder to the Company, and (ii) transfers in connection with a change of control or other acquisition
involving the Company, if following such transaction, the Options no longer remain outstanding and the Company is no longer relying on
the exemption provided by Rule 12h-1(f); <I>provided further</I>, that any Permitted Transferees may not further transfer the Options;
(B) except as otherwise provided in (A) above, the Options and shares of Common Stock acquired upon exercise of the Options are restricted
as to any pledge, hypothecation, or other transfer, including any short position, any &ldquo;put equivalent position&rdquo; as defined
by Rule 16a-1(h) promulgated under the Exchange Act, or any &ldquo;call equivalent position&rdquo; as defined by Rule 16a-1(b) promulgated
under the Exchange Act by the Optionholder prior to exercise of an Option until the Company is no longer relying on the exemption provided
by Rule 12h-1(f); and (C) at any time that the Company is relying on the exemption provided by Rule 12h-1(f), the Company shall deliver
to Optionholders (whether by physical or electronic delivery or written notice of the availability of the information on an internet
site) the information required by Rule 701(e)(3), (4), and (5) promulgated under the Securities Act every six (6) months, including financial
statements that are not more than one hundred eighty (180) days old; <I>provided, however</I>, that the Company may condition the delivery
of such information upon the Optionholder&rsquo;s agreement to maintain its confidentiality.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(l)&nbsp;Repurchase
Limitation</B>. The terms of any repurchase right shall be specified in the Stock Award Agreement. The repurchase price for vested shares
of Common Stock shall be the Fair Market Value of the shares of Common Stock on the date of repurchase. The repurchase price for unvested
shares of Common Stock shall be the lower of (i) the Fair Market Value of the shares of Common Stock on the date of repurchase or (ii)
their original purchase price. However, the Company shall not exercise its repurchase right until at least six (6) months (or such longer
or shorter period of time necessary to avoid classification of the Stock Award as a liability for financial accounting purposes) have
elapsed following delivery of shares of Common Stock subject to the Stock Award, unless otherwise specifically provided by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.&nbsp;<FONT STYLE="font-variant: small-caps">Adjustments
upon Changes in Common Stock; Other Corporate Events.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;Capitalization
Adjustments</B>. In the event of a Capitalization Adjustment, the Board shall appropriately and proportionately adjust: (i) the class(es)
and maximum number of securities subject to the Plan pursuant to Section 3(a), (ii) the class(es) and maximum number of securities that
may be issued pursuant to the exercise of Incentive Stock Options pursuant to Section 3(c), and (iii) the class(es) and number of securities
and price per share of stock subject to outstanding Stock Awards. The Board shall make such adjustments, and its determination shall
be final, binding and conclusive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;Dissolution
or Liquidation</B>. Except as otherwise provided in the Stock Award Agreement, in the event of a dissolution or liquidation of the Company,
all outstanding Stock Awards (other than Stock Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture
condition or the Company&rsquo;s right of repurchase) shall terminate immediately prior to the completion of such dissolution or liquidation,
and the shares of Common Stock subject to the Company&rsquo;s repurchase rights or subject to a forfeiture condition may be repurchased
or reacquired by the Company notwithstanding the fact that the holder of such Stock Award is providing Continuous Service, <I>provided,
however,</I> that the Board may, in its sole discretion, cause some or all Stock Awards to become fully vested, exercisable and/or no
longer subject to repurchase or forfeiture (to the extent such Stock Awards have not previously expired or terminated) before the dissolution
or liquidation is completed but contingent on its completion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;Corporate
Transaction. </B>The following provisions shall apply to Stock Awards in the event of a Corporate Transaction unless otherwise provided
in the instrument evidencing the Stock Award or any other written agreement between the Company or any Affiliate and the holder of the
Stock Award or unless otherwise expressly provided by the Board at the time of grant of a Stock Award. Except as otherwise stated in
the Stock Award Agreement, in the event of a Corporate Transaction, then, notwithstanding any other provision of the Plan, the Board
shall take one or more of the following actions with respect to Stock Awards, contingent upon the closing or completion of the Corporate
Transaction:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;&nbsp;</B>arrange
for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&rsquo;s parent company) to assume or
continue the Stock Award or to substitute a similar stock award for the Stock Award (including, but not limited to, an award to acquire
the same consideration paid to the stockholders of the Company pursuant to the Corporate Transaction);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&nbsp;</B>arrange
for the assignment of any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to the Stock
Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&rsquo;s parent company);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iii)&nbsp;</B>accelerate
the vesting, in whole or in part, of the Stock Award (and, if applicable, the time at which the Stock Award may be exercised) to a date
prior to the effective time of such Corporate Transaction as the Board shall determine (or, if the Board shall not determine such a date,
to the date that is five (5) days prior to the effective date of the Corporate Transaction), with such Stock Award terminating if not
exercised (if applicable) at or prior to the effective time of the Corporate Transaction;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iv)&nbsp;</B>arrange
for the lapse of any reacquisition or repurchase rights held by the Company with respect to the Stock Award;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(v)&nbsp;</B>cancel
or arrange for the cancellation of the Stock Award, to the extent not vested or not exercised prior to the effective time of the Corporate
Transaction, in exchange for such cash consideration, if any, as the Board, in its sole discretion, may consider appropriate; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(vi)&nbsp;</B>make
a payment, in such form as may be determined by the Board equal to the excess, if any, of (A) the value of the property the holder of
the Stock Award would have received upon the exercise of the Stock Award, over (B) any exercise price payable by such holder in connection
with such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board need not take the same action with respect to all Stock Awards or with respect to all Participants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;Change
in Control.</B> A Stock Award may be subject to additional acceleration of vesting and exercisability upon or after a Change in Control
as may be provided in the Stock Award Agreement for such Stock Award or as may be provided in any other written agreement between the
Company or any Affiliate and the Participant, but in the absence of such provision, no such acceleration shall occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.&nbsp;<FONT STYLE="font-variant: small-caps">Termination
or Suspension of the Plan.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;Plan
Term.</B> The Board may suspend or terminate the Plan at any time. Unless sooner terminated by the Board pursuant to Section 2, the Plan
shall automatically terminate on the day before the tenth (10th) anniversary of the earlier of (i) the date the Plan is adopted by the
Board, or (ii) the date the Plan is approved by the stockholders of the Company. No Stock Awards may be granted under the Plan while
the Plan is suspended or after it is terminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;No
Impairment of Rights.</B> Suspension or termination of the Plan shall not impair rights and obligations under any Stock Award granted
while the Plan is in effect except with the written consent of the affected Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.&nbsp;<FONT STYLE="font-variant: small-caps">Effective
Date of Plan.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Plan shall become effective on the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.&nbsp;<FONT STYLE="font-variant: small-caps">Choice
of Law.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
law of the State of Delaware shall govern all questions concerning the construction, validity and interpretation of this Plan, without
regard to that state&rsquo;s conflict of laws rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.&nbsp;<FONT STYLE="font-variant: small-caps">Definitions.
</FONT></B>As used in the Plan, the following definitions shall apply to the capitalized terms indicated below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;</B>&ldquo;<B><I>Affiliate</I></B>&rdquo;
means, at the time of determination, any &ldquo;parent&rdquo; or &ldquo;majority-owned subsidiary&rdquo; of the Company, as such terms
are defined in Rule 405 of the Securities Act. The Board shall have the authority to determine the time or times at which &ldquo;parent&rdquo;
or &ldquo;majority-owned subsidiary&rdquo; status is determined within the foregoing definition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;</B>&ldquo;<B><I>Board</I></B>&rdquo;
means the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;</B>&ldquo;<B><I>Capitalization
Adjustment</I></B>&rdquo; means any change that is made in, or other events that occur with respect to, the Common Stock subject to the
Plan or subject to any Stock Award after the Effective Date without the receipt of consideration by the Company (through merger, consolidation,
reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, stock split, liquidating dividend,
combination of shares, exchange of shares, change in corporate structure, or any similar equity restructuring transaction, as that term
is used in Statement of Financial Accounting Standards No. 123 (revised). Notwithstanding the foregoing, the conversion of any convertible
securities of the Company shall not be treated as a Capitalization Adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;</B>&ldquo;<B><I>Cause</I></B>&rdquo;
shall have the meaning ascribed to such term in any written agreement between the Participant and the Company defining such term and,
in the absence of such agreement, such term means with respect to a Participant, the occurrence of any of the following events: (i) such
Participant&rsquo;s commission of any felony or any crime involving fraud, dishonesty or moral turpitude under the laws of the United
States or any state thereof; (ii) such Participant&rsquo;s attempted commission of, or participation in, a fraud or act of dishonesty
against the Company; (iii) such Participant&rsquo;s intentional, material violation of any contract or agreement between the Participant
and the Company or of any statutory duty owed to the Company; (iv) such Participant&rsquo;s unauthorized use or disclosure of the Company&rsquo;s
confidential information or trade secrets; or (v) such Participant&rsquo;s gross misconduct. The determination that a termination of
the Participant&rsquo;s Continuous Service is either for Cause or without Cause shall be made by the Company in its sole discretion.
Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of
outstanding Stock Awards held by such Participant shall have no effect upon any determination of the rights or obligations of the Company
or such Participant for any other purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)&nbsp;</B>&ldquo;<B><I>Change
in Control</I></B>&rdquo; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of
the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;</B>any
Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than fifty percent (50%)
of the combined voting power of the Company&rsquo;s then outstanding securities other than by virtue of a merger, consolidation or similar
transaction. Notwithstanding the foregoing, a Change in Control shall not be deemed to occur (A) on account of the acquisition of securities
of the Company directly from the Company, (B) on account of the acquisition of securities of the Company by an investor, any affiliate
thereof or any other Exchange Act Person that acquires the Company&rsquo;s securities in a transaction or series of related transactions
the primary purpose of which is to obtain financing for the Company through the issuance of equity securities or (C) solely because the
level of Ownership held by any Exchange Act Person (the &ldquo;<B><I>Subject Person</I></B>&rdquo;) exceeds the designated percentage
threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing
the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result
of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any
additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then
outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control shall be
deemed to occur;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&nbsp;</B>there
is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the
consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own,
directly or indirectly, either (A) outstanding voting securities representing more than fifty percent (50%) of the combined outstanding
voting power of the surviving Entity in such merger, consolidation or similar transaction or (B) more than fifty percent (50%) of the
combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each
case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to
such transaction;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iii)&nbsp;</B>there
is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company
and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of
the Company and its Subsidiaries to an Entity, more than fifty percent (50%) of the combined voting power of the voting securities of
which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities
of the Company immediately prior to such sale, lease, license or other disposition; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iv)&nbsp;</B>individuals
who, on the date this Plan is adopted by the Board, are members of the Board (the &ldquo;<B><I>Incumbent Board</I></B>&rdquo;) cease
for any reason to constitute at least a majority of the members of the Board; <I>provided, however,</I> that if the appointment or election
(or nomination for election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board
then still in office, such new member shall, for purposes of this Plan, be considered as a member of the Incumbent Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing definition or any other provision of this Plan, (A) the term Change in Control shall not include a sale of assets, merger
or other transaction effected exclusively for the purpose of changing the domicile of the Company, and (B) the definition of Change in
Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant shall supersede
the foregoing definition with respect to Stock Awards subject to such agreement; <I>provided, however,</I> that if no definition of Change
in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition shall apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&nbsp;</B>&ldquo;<B><I>Code</I></B>&rdquo;
means the Internal Revenue Code of 1986, as amended, as well as any applicable regulations and guidance thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)&nbsp;
</B>&ldquo;<B><I>Committee</I></B>&rdquo; means a committee of one (1) or more Directors to whom authority has been delegated by the
Board in accordance with Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)&nbsp;
</B>&ldquo;<B><I>Common Stock</I></B>&rdquo; means the common stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;</B>&ldquo;<B><I>Company</I></B>&rdquo;
means RenovoRx, Inc., a Delaware corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(j)&nbsp;</B>&ldquo;<B><I>Consultant</I></B>&rdquo;
means any person, including an advisor, who is (i) engaged by the Company or an Affiliate to render consulting or advisory services and
is compensated for such services, or (ii) serving as a member of the board of directors of an Affiliate and is compensated for such services.
However, service solely as a Director, or payment of a fee for such service, shall not cause a Director to be considered a &ldquo;Consultant&rdquo;
for purposes of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(k)&nbsp;</B>&ldquo;<B><I>Continuous
Service</I></B>&rdquo; means that the Participant&rsquo;s service with the Company or an Affiliate, whether as an Employee, Director
or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or
an Affiliate as an Employee, Director, or Consultant or a change in the Entity for which the Participant renders such service, provided
that there is no interruption or termination of the Participant&rsquo;s service with the Company or an Affiliate, shall not terminate
a Participant&rsquo;s Continuous Service; <I>provided, however</I>, if the Entity for which a Participant is rendering service ceases
to qualify as an Affiliate, as determined by the Board in its sole discretion, such Participant&rsquo;s Continuous Service shall be considered
to have terminated on the date such Entity ceases to qualify as an Affiliate. For example, a change in status from an employee of the
Company to a consultant of an Affiliate or to a Director shall not constitute an interruption of Continuous Service. To the extent permitted
by law, the Board or the chief executive officer of the Company, in that party&rsquo;s sole discretion, may determine whether Continuous
Service shall be considered interrupted in the case of (i) any leave of absence approved by the Board or chief executive officer, including
sick leave, military leave or any other personal leave, or (ii) transfers between the Company, an Affiliate, or their successors. Notwithstanding
the foregoing, a leave of absence shall be treated as Continuous Service for purposes of vesting in a Stock Award only to such extent
as may be provided in the Company&rsquo;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable
to the Participant, or as otherwise required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(l)&nbsp;</B>&ldquo;<B><I>Corporate
Transaction</I></B>&rdquo; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of
the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)&nbsp;</B>the
consummation of a sale or other disposition of all or substantially all, as determined by the Board in its sole discretion, of the consolidated
assets of the Company and its Subsidiaries;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&nbsp;</B>the
consummation of a sale or other disposition of at least ninety percent (90%) of the outstanding securities of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iii)&nbsp;</B>the
consummation of a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(iv)&nbsp;</B>the
consummation of a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares
of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue
of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(m)&nbsp;</B>&ldquo;<B><I>Director</I></B>&rdquo;
means a member of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(n)&nbsp;</B>&ldquo;<B><I>Disability</I></B>&rdquo;
means the inability of a Participant to engage in any substantially gainful activity by reason of any medically determinable physical
or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period
of not less than twelve (12) months as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i) of the Code and shall be determined by the
Board on the basis of such medical evidence as the Board deems warranted under the circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(o)&nbsp;</B>&ldquo;<B><I>Effective
Date</I></B>&rdquo; means the effective date of this Plan, which is the earlier of (i) the date that this Plan is first approved by the
Company&rsquo;s stockholders, or (ii) the date this Plan is adopted by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(p)&nbsp;</B>&ldquo;<B><I>Employee</I></B>&rdquo;
means any person employed by the Company or an Affiliate. However, service solely as a Director, or payment of a fee for such services,
shall not cause a Director to be considered an &ldquo;Employee&rdquo; for purposes of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(q)&nbsp;</B>&ldquo;<B><I>Entity</I></B>&rdquo;
means a corporation, partnership, limited liability company or other entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(r)&nbsp;</B>&ldquo;<B><I>Exchange
Act</I></B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(s)&nbsp;</B>&ldquo;<B><I>Exchange
Act Person</I></B>&rdquo; means any natural person, Entity or &ldquo;group&rdquo; (within the meaning of Section 13(d) or 14(d) of the
Exchange Act), except that &ldquo;Exchange Act Person&rdquo; shall not include (i) the Company or any Subsidiary of the Company, (ii)
any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under
an employee benefit plan of the Company or any Subsidiary of the Company, (iii) an underwriter temporarily holding securities pursuant
to a registered public offering of such securities, (iv) an Entity Owned, directly or indirectly, by the stockholders of the Company
in substantially the same proportions as their Ownership of stock of the Company; or (v) any natural person, Entity or &ldquo;group&rdquo;
(within the meaning of Section 13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly,
of securities of the Company representing more than fifty percent (50%) of the combined voting power of the Company&rsquo;s then outstanding
securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(t)&nbsp;</B>&ldquo;<B><I>Fair
Market Value</I></B>&rdquo; means, as of any date, the value of the Common Stock determined by the Board in compliance with Section 409A
of the Code or, in the case of an Incentive Stock Option, in compliance with Section 422 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(u)&nbsp;</B>&ldquo;<B><I>Incentive
Stock Option</I></B>&rdquo; means an option that qualifies as an &ldquo;incentive stock option&rdquo; within the meaning of Section 422
of the Code and the regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(v)&nbsp;</B>&ldquo;<B><I>Nonstatutory
Stock Option</I></B>&rdquo; means an Option that does not qualify as an Incentive Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(w)&nbsp;</B>&ldquo;<B><I>Officer</I></B>&rdquo;
means any person designated by the Company as an officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(x)&nbsp;</B>&ldquo;<B><I>Option</I></B>&rdquo;
means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(y)&nbsp;</B>&ldquo;<B><I>Option
Agreement</I></B>&rdquo; means a written agreement between the Company and an Optionholder evidencing the terms and conditions of an
Option grant. Each Option Agreement shall be subject to the terms and conditions of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(z)&nbsp;</B>&ldquo;<B><I>Optionholder</I></B>&rdquo;
means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(aa)&nbsp;</B>&ldquo;<B><I>Own</I></B>,&rdquo;
&ldquo;<B><I>Owned</I></B>,&rdquo; &ldquo;<B><I>Owner</I></B>,&rdquo; &ldquo;<B><I>Ownership</I></B>&rdquo; A person or Entity shall
be deemed to &ldquo;Own,&rdquo; to have &ldquo;Owned,&rdquo; to be the &ldquo;Owner&rdquo; of, or to have acquired &ldquo;Ownership&rdquo;
of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise,
has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(bb)&nbsp;</B>&ldquo;<B><I>Participant</I></B>&rdquo;
means a person to whom a Stock Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Stock
Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(cc)&nbsp;</B>&ldquo;<B><I>Plan</I></B>&rdquo;
means this RenovoRx, Inc. 2013 Equity Incentive Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(dd)&nbsp;</B>&ldquo;<B><I>Restricted
Stock Award</I></B>&rdquo; means an award of shares of Common Stock which is granted pursuant to the terms and conditions of Section
6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ee)&nbsp;</B>&ldquo;<B><I>Restricted
Stock Award Agreement</I></B>&rdquo; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing
the terms and conditions of a Restricted Stock Award. Each Restricted Stock Award Agreement shall be subject to the terms and conditions
of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ff)&nbsp;</B>&ldquo;<B><I>Restricted
Stock Unit Award</I></B>&rdquo; means a right to receive shares of Common Stock which is granted pursuant to the terms and conditions
of Section 6(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(gg)&nbsp;</B>&ldquo;<B><I>Restricted
Stock Unit Award Agreement</I></B>&rdquo; means a written agreement between the Company and a holder of a Restricted Stock Unit
Award evidencing the terms and conditions of a Restricted Stock Unit Award grant. Each Restricted Stock Unit Award Agreement shall
be subject to the terms and conditions of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(hh)&nbsp;</B>&ldquo;<B><I>Rule
405</I></B>&rdquo; means Rule 405 promulgated under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)&nbsp;</B>&ldquo;<B><I>Rule
701</I></B>&rdquo; means Rule 701 promulgated under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(jj)&nbsp;</B>&ldquo;<B><I>Securities
Act</I></B>&rdquo; means the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(kk)&nbsp;</B>&ldquo;<B><I>Stock
Appreciation Right</I></B>&rdquo; or &ldquo;<B><I>SAR</I></B>&rdquo; means a right to receive the appreciation on Common Stock that is
granted pursuant to the terms and conditions of Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ll)&nbsp;</B>&ldquo;<B><I>Stock
Appreciation Right Agreement</I></B>&rdquo; means a written agreement between the Company and a holder of a Stock Appreciation Right
evidencing the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement shall be subject to
the terms and conditions of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(mm)&nbsp;</B>&ldquo;<B><I>Stock
Award</I></B>&rdquo; means any right to receive Common Stock granted under the Plan, including an Incentive Stock Option, a Nonstatutory
Stock Option, a Restricted Stock Award, a Restricted Stock Unit Award, or a Stock Appreciation Right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(nn)&nbsp;</B>&ldquo;<B><I>Stock
Award Agreement</I></B>&rdquo; means a written agreement between the Company and a Participant evidencing the terms and conditions of
a Stock Award grant. Each Stock Award Agreement shall be subject to the terms and conditions of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(oo)&nbsp;</B>&ldquo;<B><I>Subsidiary</I></B>&rdquo;
means, with respect to the Company, (i) any corporation of which more than fifty percent (50%) of the outstanding capital stock having
ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock
of any other class or classes of such corporation shall have or might have voting power by reason of the happening of any contingency)
is at the time, directly or indirectly, Owned by the Company, and (ii) any partnership, limited liability company or other entity in
which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution)
of more than fifty percent (50%) .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(pp)&nbsp;</B>&ldquo;<B><I>Ten
Percent Stockholder</I></B>&rdquo; means a person who Owns (or is deemed to Own pursuant to Section 424(d) of the Code) stock
possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>logo_001.jpg
<TEXT>
begin 644 logo_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !W 30# 2(  A$! Q$!_\0
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M-GHZC\R!_6I:S-6N"KV5JA_>7%R@ _V5^=C],+C\:TZ;5DA=1:***0PHHHH
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M"8P[#(7-:XZ48KFE5E*I[1O4M127*MCC_AYX/N/!FAW%A<74=PTMP9@T:D
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MUJ*[Q]BM[FX!Z/Y9C3_OIL9_#-/DE:]A71JT5 GGLH+LJ-_=49 HI#)Z***
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MU@/K%$JG]!5ZDS165WU*M86BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** *MG"MO T:XVB1R !T!8G'ZU:HHH>X!1110
? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>figure01_01.jpg
<TEXT>
begin 644 figure01_01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #B EH# 2(  A$! Q$!_\0
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MEG>2M'INZ%4*X@;NX!_B]#5;_A>?B[_GGIG_ (#M_P#%5P5I_P @W4O]R/\
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M*7+@[)^S6OEZ?YCO4_F*7_"\_%W_ #STS_P';_XJC_A>?B[_ )YZ9_X#M_\
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MGA,-./-[-?TR95*B=KGI7_"\_%W_ #STS_P';_XJC_A>?B[_ )YZ9_X#M_\
M%5YK15_4<-_(B?;3[GJ=O\;/%DMM>2-'IN88@RX@;J75?[WH35;_ (7GXN_Y
MYZ9_X#M_\57!67_'EJ7_ %P7_P!&I5*DL#AKOW$/VL^YZ5_PO/Q=_P \],_\
M!V_^*H_X7GXN_P">>F?^ [?_ !5>:T4_J.&_D0O;3[GI1^.GBT=4TO\ [\-_
M\71_PO/Q=_SSTS_OPW_Q=4/ AAA\-^)KJX@$@MTMY(\1([Y$F7";P1RHY]JV
M%T[2/%/@^:]73H['Y]1N[=8& ,6U4,:'CY@3NX^N*Y9T\+"33I*R:5_4T4JC
M5^8K?\+S\7?\\],_\!V_^*H_X7GXN_YYZ9_X#M_\54MSX%\/VMUHT<CSC[49
M8[@+<+*(W"(8V8KVRW.WMTZ&N?UOP_H^E^%H;N-YIKZ:65/,AE5X8F24J8V/
M!^[@@XR>O2G"G@Y-)4]_+_@^0-U5U-O_ (7GXN_YYZ9_WX;_ .+H_P"%Y^+O
M^>>F?^ [?_%5E:G;7:?#*Q>[TBSB!N%>"ZC6-)%BVD;6P=S,[9;GH![C'%5K
M3PN&FF_9K1V)E4J+J>E?\+S\7?\ //3/_ =O_BJ/^%Y^+O\ GGIG_@.W_P 5
M7FM%:?4<-_(B?;3[GJ<7QL\5O874YCTW?$T87]PV/FW9_B]JK?\ "\_%W_//
M3/\ P';_ .*K@K?_ )!%_P#[\/\ -JI4E@L-=^XANK/N>E?\+S\7?\\],_\
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MWKB*UAA<--R7LUH3*I45M3TK_A>?B[_GGIG_ (#M_P#%4?\ "\_%W_//3/\
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M9]OP1GRT#A_^&?;W_H8;;_P%/_Q5'_#/M[_T,-M_X"G_ .*KN/\ A:5C_P!
MV[_[[7_&C_A:5C_T#;O_ +[7_&CVV9]OP06H'#_\,^WO_0PVW_@*?_BJ/^&?
M;W_H8;;_ ,!3_P#%5W'_  M*Q_Z!MW_WVO\ C1_PM*Q_Z!MW_P!]K_C1[;,^
MWX(+4#C+;X"ZC:745S#XBM!+$P=2UEN&1Z@M@CV-%Q\!M2NKF2XF\26[2R-N
M8_9".?H&XKL_^%I6/_0-N_\ OM?\:/\ A:5C_P! V[_[[7_&E[7,KWM^""U
MXC_AGZ^_Z&*W_P# 5O\ XJC_ (9^OO\ H8K?_P !6_\ BJ[?_A:5C_T#;O\
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M_ 5O_BJ/^&?K[_H8K?\ \!6_^*KM_P#A:5C_ - V[_[[7_&C_A:5C_T#;O\
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MMS_M>]0?\,_7W_0Q6_\ X"M_\57;_P#"TK'_ *!MW_WVO^-'_"TK'_H&W?\
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M?W[?_OU_]>C_ (3G6C_';_\ ?K_Z]']GUO+[P]M$]+V"C8*\T_X3G6O[]O\
M]^O_ *]'_"<ZU_?M_P#OU_\ 7H_L^MY?>'MHGI>P4;!7FG_"<ZU_?M_^_7_U
MZ/\ A.=:_OV__?K_ .O1_9];R^\/;1/2]@HV"O-/^$YUK^_;_P#?K_Z]'_"<
MZU_?M_\ OU_]>C^SZWE]X>VB>E[!1L%>:?\ "<ZU_?M_^_7_ ->C_A.=:_OV
M_P#WZ_\ KT?V?6\OO#VT3TO8*-@KS/\ X3K6?[]M_P!^O_KTO_"<ZU_?M_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^HKJ'T#1Y7E=]*LF:8,LA,"_.&.2#QR"1D^II8M!TB"X6XBTRT296+"185#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]!5Q]=MDL(;LQRXF1I%CP VU1EF/.  .^>X]:LQ:780L&CM(5*XP0O3&<?\
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M_$U9H8PHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>figure02_01.jpg
<TEXT>
begin 644 figure02_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (O!98# 2(  A$! Q$!_\0
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M/_XBOKO]0LQ_GC^/^1A]:@?T!T5_/Y_PW=^T#_T5/7/SC_\ B*/^&[OV@?\
MHJ>N?G'_ /$4?Z@YC_/'\?\ (/K4#^@.BOY_/^&[OV@?^BIZY^<?_P 11_PW
M=^T#_P!%3US\X_\ XBC_ %!S'^>/X_Y!]:@?T!T5_/Y_PW=^T#_T5/7/SC_^
M(H_X;N_:!_Z*GKGYQ_\ Q%'^H.8_SQ_'_(/K4#^@.BOY_/\ AN[]H'_HJ>N?
MG'_\11_PW=^T#_T5/7/SC_\ B*/]0<Q_GC^/^0?6H'] =%?S^?\ #=W[0/\
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M/UUHK\AX=+_;LG4E/&.HD#_J*6E21Z'^W?+G;XRU#CUU6S%/^PZ7_0;2_P#
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M_P"$0_;W/3Q??'_N,6=/^Q*7_092_P# @]H_Y6?K717Y*GP?^WO_ -#???\
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M#!?^ 2#VE3^0_;[_ (2+2O\ H)V?_@0G^-'_  D6E?\ 03L__ A/\:_#Y/\
M@GWK[_\ ,QVP_P"W4_\ Q=3+_P $\_$+9_XJ2U_\!6_^+I?V3E'_ $,%_P"
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MCTG_ *"EG_X$)_C7XDP?\$Z_$,W3Q-:C_MT;_P"+I_\ P[F\19Q_PD]I_P"
MC?\ Q=+^RLH_Z&"_\ D'M)_R'[9_\)'I/_04L_\ P(3_ !H_X2/2?^@I9_\
M@0G^-?B?_P .X_$>"?\ A)[3_P !&_\ BZK-_P $\/$*MC_A)K7/_7HW_P 7
M1_964?\ 0P7_ (!(/:3_ )#]N?\ A(])_P"@I9_^!"?XT?\ "1Z3_P!!2S_\
M"$_QK\4(_P#@F_XDD3</$]I_X"-_\73E_P"";OB5CC_A)[3_ ,!&_P#BZ7]E
M91_T,%_X!(/:3_D/VM_X2/2?^@I9_P#@0G^-'_"1Z3_T%+/_ ,"$_P :_%)O
M^";OB5?^9FM/_ 1O_BZC_P"'<?B/_H9K3_P$;_XNC^RLH_Z&"_\  )![2?\
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MMQ&8N:AW'SRN>/2BP%B:Z+R9+<"G0W'RNV:I(ADDR3Q4^42-F'.*+(">.^;
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M0'X:?]BSIG_I+'7T^(_Y$F&_Q3,%_%9Z!1117S)N%?@/_P % O\ D\OXH?\
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M7\*,R'_5BLCQ Y^1>W6M>'_5BL7Q /FC_&OVFG\1\KA_XJ/TO_9[\"^&+_\
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M80"WK6/=:D%O&L$;$Q'Y5%J_B*U\.[1.&WL/EXZFJ6FR"XU/^T"C%I5 4$4
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M_) _AK_V+.F?^DL=?G9_P5,_Y(_X,X_YC;?^B'K]$_V??^2"?#7_ +%G3?\
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MLZ,W#5;L+5))AD@TP)]%L9+B8%AQ7;QVZVL( &#5/388;:,-QFK@E\Z3CI2
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MU:,BKDYZ5EW%Q'#D9H Q/BLP_P"%1^+Q_P!0JY_]%-7RM_P13_Y%'XJ_]?\
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M?\% _&-_\2?V@=(\#::ZRQ:7'#900!^&N[@J6)]#@QK[8/K7W=X=\/V'PO\
MAGH7A2QC5(=+LH[?Y !O<+\[GW9LDGU-?H5>7]B\/4Z,-*N*]Z7^#M\U;[Y'
M&OWM9M[1':]J;OB-6QNZFN5N[HMF./YF[FH;F_N-0D.W*@=#1+=Q:=;L\FW=
MCDU^>G89YU26.3]\,;:<OBJ-LQQ1[V''2LN&5M6GD49*'H]))9#3X\KQZMWH
M GCU67[;N<[!N^[VK>_MB)LHIVAABN*+FZ8^6=Q6K]K,LPV/E9%&?K0!T$S
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MDF!B*GL:B5@UN>] %F%561@.,C-9S2#^T .IJ\[C;E.NW'TJB(?+N58G<>]
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M19KMO]G ^5?J2?H:_02/79(TP6J*>Z:X7>6)KS\9Q[F5>#AAX1IWZ[OY7T_
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MC @\&IHHF4;QSZU5%R?.8CH#0!(LA;=Z^]$<F(V&13)9%924^]3;=0\;9X-
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M9:;>N8AN:@"&X4?V@D:=N2/6M2-UVE,8QVK$9FM]6B:5@#M!K6&9"S] W0T
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M:[W1M%5(P67-/T/2%V*VT5TUO"L:X YJ1E..Q"\ 5)%&=V#6E!'NISVVWD4
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M)ZM4L$,>2#TQBJEF&^U3R'G/2K+1^7CYLD\T ,M[-;>20L=R,<XJ]:^7&Q*
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M:@!@O%D8E H11DFKEO=026Y'&33!HJ)9(5?YGY-1+I9CA8JW/I0 @@BEG+8
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MZBX5KQ0ZT6 R95;=P:D2)EP2:D>)HCR*565NIYH 9,AV9'%1B?8AS2W5PP
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MWD@DO%7H,5:DD:9@Q&&!Q540_:-1);Y=HH =)"5CY/3I5A9&:) 3CTIUTHV
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M$^&O_8LZ;_Z2QU^>/_!5*%(_@YX+*]?[;8?^0'K]#OV?/^2!_#7_ +%G3?\
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MEJ .W63RI @[UA>,I$N[BSL$.)&<-706:F1L2 ;Q7':PCR?$&U8D^6$''XT
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M*S'<Z/0_#T=G@2+77K# L.U5'2N-M?%4-TPP1706>I),H&[-189'=:.DQ9@
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M$UN_!*TDE_!,N%(YH YGXH7AD^$OC '_ *!5S_Z*:OEC_@BG_P BC\5?^O\
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M)JUWJUY;^6N>-PKTF2X%U<--'PN>*SM/LX$TQ46,1[B<X&*T((5\L*HVC(H
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MDR6X[U,ZM(I4'%+;VX9\,W6@!VV-H0<TL:HJ[A3-RK(\:\@4R2X6)67J2,4
M2-=QQR XJ-[P--\AS4=O:F4C>>#TJ7[+'"S,IR3Q0!"EE+<S&4G"^E7EC*J
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M@#Q7X_::X:WNK?@JP8XKO/ ^OQ:IX1M;:-QYNP BJGQ4T0:AH,THZQKFO'_
M/C(:3=F..7YXSC9F@#Z(@MS#"BL.5JRTB[5QPWI5+P[JRZWH\5RZ[7;M6BUF
M&97SVH A1BS'<<BK*LC2#C.T56E41R#:>M3V:AINGUH HZSJ<>EVKLS8)Z"N
M7\,Z;+K&HM?W.3$IRN:P?'7B8:IXTMM#@8[LUZ/IMO\ V;;V]N5VJHY]Z +\
MS%ER>IXJO,=J >HJPLGG3\\+BH)&&>>>>* &6EJBY./EZFKWR+@CIZ4R!1G'
M\)%+*J=NU %;5F"K'/'P^:9>7B009?ES@"DU&ZA@A4R'"U2FO;6Z59'8!%H
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M%*G"+ND?//CK]@OP%\2/%VK^([[6M=LM0U.X:YF6&2(QJS=< IG'XUP6N?\
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M$4_^10^*G_7_ &'_ *+FKZ?!?\B7&?XH?F8O^+$_2JBBBOE#J"OR._8GP?\
M@H1\<,_W==_].L-?KC7Y'?L3X/\ P4(^.&>/EUW_ -.L-?4Y1_N>-_P?J85/
MBCZGWUJ"L<Y.0*H^:VWY3\WK6M>%'CE4=:Q5+18P,BOEC<G5GD02L,X&#3XR
M&;+?**C68PX&,HW44^8 (1C!ZB@!\FSS%VGBFJQ#=.E0%O+ [FI8FW/ACUH
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M&[;ZUG-"1I111W$9!.#6<T/DS$%LC-:4.FRKEE/%8NH6\\4Y))QFH+-&,KN
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MB)9ZDH!=:U8M4ANI (V!_&HLR@T_2!&QQ5B\M?)X[UHP*RQ@[:IZI,54RD<
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M(&C]E5..]6[>%54&JGG"3GK5V)AY= &!\6;<-\)O%YS_ ,PJZ_\ 135\M?\
M!%/_ )%'XJ?]?]A_Z+FKZA^*5S_Q:GQ>O_4*N?\ T4U?+W_!%/\ Y%'XJ?\
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M E>8!OW8S67>V]S-<!AR/2M2,)'PHR1WI8VQ*78C'I0!GVMOY+!CS)6GYA;
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M.: &C3UCDR5R:N6T0.[(XI(K_<0K)DU?A6+<!D#/6@#XP_X*B'_BT?@X=/\
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M]K<8+N3[5-J2@V8V'$O>EDUI#"%("MTVXJE/J<%GDLWF2-T6@":VD%G&K/\
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MO)N\M@R]#0 2-Y*@9R363Y<MO>/(R;D/3BM-86:,,WX4^1MORE<CUH @N/\
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M.*^&OC7_ ,%"-5N+N]\/?#K1WTE@QMCJE\@:ZWYVD1Q<A3GH3D^PKT/]C/\
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MWC+PWI1NG\T(!DMSQ7UK#X9M["\=K>".,'G&T5P_QIT:/5O ^I6S1!Y%B9@
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M+?*IQ5V.&\N&!VL!2 UOBYK F^$'C$9ZZ3=?^BFKX[_X(I?\BC\5?^OZP_\
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M^&O_ &+.F_\ I+'7YV_\%3$V_!SP9W_XGC?^B'K]$OV?/^2!_#7_ +%G3?\
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MA"S'%=[) C(1FN0UR&.*;[U" H6+88 =,UT]G@*,USMAY;-D'O70++'&H^;
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MWG)!XQ4BQCS"U5O+5F+,<CTH :!]HP@Z+4Z[865 ,^M,MEVL2!4BXWN2/<4
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M<AMV@::-3]X8% %22W(4.SG9GIZUJPM$\<:J"*SI+9K>,"0[CG@5/"I\Q-M
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MHK(^%?A\7DT^L7 ^:0Y7=6+X?T&7QSK1OI@3: YY]*].T>VCL_-A@XA08&*
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M< SW4<><'J:N0C+$ <#O0 Y8CLW@<TYI&VC(QZU+)'NC4 \]ZAN)!&H4'F@
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MXCX5ZGZ-VUHS6=N?]@?RJSQ'&0>:KVMQ)_9]OC^X/Y4Z0NRY-?&G24[J0%@
M*C7)[4V56$F3TH:0A>*8B*\M?.C/->9^,KB2Q#J.E>ER7!V'UKR[QX);AG"C
M-4@//UU1&NE[L37H-EYDVE_*.=M>9:?H-U)JBLZMMW<5[?X<T&6:S3CC%7(E
M'F=MX3OM0U@LY8QYS7INGZ)#8VRHWWL5T>G:*L,A&P;OI5BZ\/R2OD<5%[EV
M,^QMTB2IVB*@LO-7[?0W7 8U>_LL!,5('(SJUT=C<4B^&_,%=%-I.R0' J_#
M:[%'% &3IGA-%C.35RU\/I;R=<"M5&,2\#BIH<2]3@T 4'T]68#/%78[*%5
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M>*SO$V@17D;#O4VC76),9[U=OVW;CVQ2 \OAC/A^\^4\9K<3QJ=ZIFB_T?\
MM*ZXYYI%\#LLRMCBF!T-AJC7JC'2K[6;S+DG%)I>C+9VZ\<XK8M[?S%I 9\.
MEAHP":GCTA5&0:O_ &<QC%/A1MI)Z4AG/:G9*J=:72=/!YQ5_4XPV2*72I F
M0:8$5U:JJX(%<[J5FG.<?E76WL>\$BN=O[5VSZ4 <=?:+;R,3M!-%CIT=OC
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M!W=J '^>58C%5)F=;CD9]*N1,K1[SSBH]T;,>[=: $B9H\L1QZ5-#)YTH!&
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M%3IWF^#_ (+)X7^VFP/^V#U^B7[/G_) _AK_ -BSIO\ Z2QU^>W_  52A"_
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MS/DQ4EFGS9S4_P!A#+QUI]M8LK<T +)'SPU-:%8UWDU--8R*V>U0S1-, !2
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M &!>LU]#)=O*3(3\F*P_[-U'7;N-[EL1Q^_6NFT_3A+8QHW\.:L2!;.$ 8H
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M,SXRZ^M<[\4V9HM-*C#F91Q]:Z.V,L3;]N >M9_BO39=6LXWA7?+"P95Z]*
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M<5'YRJNTKL;L?6@"9XPD;,>AZ50:W:3E21@U--</*J(!@#O5F/9''M(P>^:
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MR#%6(]S*,T7L;-(,"@8C7YC3 M1L0F!6?JSA8SDXJ1M3BMP<FN;U;6A>;@E
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M+IR(P?NFO5-$EM=7A+JX''2N(US0))GE5$8,2<8%5_"\EWI,ACF5D.<<YYH
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MBM#[.7[5.+',?W:+@<+\4I&;X5^*P?\ H&7/_HIJ\ _X(J_\BA\5/^O^P_\
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M9/\ ] '_ )4D'+4_F_ _(3_A[3<=_A;;G_N-M_\ &*:?^"LUP6S_ ,*NM_\
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M^P'D1_\ /-?^^11Y$?\ SS7_ +Y%']H9/_T ?^5)!R5/Y_P/Q_;_ (*Q3LK
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M,8_YXU7\"_M_7'@6QO;.V\$036UP^\(=292GX^4<U^XWD1_\\U_[Y%'D1_\
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M?\#\?X_^"L4\?/\ PJZW/_<;;_XQ3E_X*R3J^[_A5MO_ .#MO_C%?K]Y$?\
MSS7_ +Y%'D1_\\U_[Y%+^T,G_P"@#_RI(.2I_/\ @?CZO_!5^Y69G/PPMSGH
M/[:;C_R!4K?\%:+YHR@^&5NH_P"PTW_QBOU]\B/_ )YK_P!\BCR(_P#GFO\
MWR*/[0R?_H _\J2#DJ?S_@?BYK7_  4TO]:NHI7\ P1B,YVC5F.?_(-2S?\
M!3:YEDW_ /"NH!P!C^UV_P#C-?L]Y$?_ #S7_OD4>1'_ ,\U_P"^15?VADW_
M $+_ /RI,.2I_/\ @?BY+_P4NGD3'_"NX5/J-7;_ .,TL'_!3":$ 'X=0O\
M76&_^,U^T7D1_P#/-?\ OD4>1'_SS7_OD4?VADW_ $+_ /RI,.2I_/\ @?C6
MO_!4.5<8^&D'_@Y;_P",5J67_!5Y[-"/^%5V[D]_[<8?^V]?L!Y$?_/-?^^1
M1Y$?_/-?^^12_M#)_P#H7_\ E20<M3^?\#\@X_\ @K(ZR%F^%-NP/;^W&_\
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M^$%Y_P"$Y?\ ^-0R_MA?M/2]?A%>C_N6[^OV&HI_VO@_^@*'XA[*7\Q^.?\
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M=LS[@2I$66YYW^U=[\-]'^(?PM_:I\7:AIWA?6M+^!>I::;F2+4+F(PV5W'
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MHC17Y:?\%$O#-[\.?&W@+XS>'KN^D\+>(I89M3T=;R9+=YU"RC*A@ )H]P(
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MU=KXIV3:3N=84444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)ZJI?:#WQ7KU%9XK.L1B<&L!91I<W-97M>UM+MVW;LK*[]!PHJ$^>]V?$/\
MP4?_ &:/B?\ M!7WP_F\"65OK6GZ0]PUYIMQ>1VZB1C&5D/F, XPK+QR,\#D
MUA?&[]FWXQ^,OVP/AE\5K#PUIUYI.E1:>;VUMM3BC^QF)V:6/=(5,GWCAE7V
MQQS]]T5ZF$XJQN#P]+#0A!QIQJ15T[VJ?%>S7R>GS,YX6$Y.3;UM^!\"_MM?
ML^_%;XN?M(?#WQ?X/\#2ZMHOA9;9YIWU2R@^T,ESYS+&LDP;IQE@.:^LOC=\
M+8?C]\$_$'@[4(Y=)?6K+:@F*L]K.,/&6V,5)5U7."0<'DUZ117G5\]Q-:EA
M*:2B\-\#5[[WUNVM]=D:*BDY-N_,?#7[(7@O]H[]G?PI=_#?4_ .DZIHD=R[
MZ7XB.MP"&UWOER\08RNGWG"A5;)P<9R/MG2+6XL=+M;>[NVOKJ.-5EN74*96
MQRV!P,GM5RBN?-,TGFU>6)J4XPE)WERIJ[[N[?X65];#ITO9JR;9\"_MV?LZ
M_%;XQ?M!> O$W@KP:^L:-X:A@>6Y?4K.W$TBW'FLB+)*&X  R0!D\9JI\:?@
M!\7/''[<'@OXLZ5\/KE_#&BR:=YRS:K8).RQ.6D(3S^V\@#/)7WK]!:*]W#\
M6XS"T:5&%*#5.$J:NI7Y9VYK^]OIY&$L)&3;YGJ[]/\ (^ OVMO@%\6_BM^U
M5X%\<>&? <U[X<\,&S:2:75;&&2X*3^;($1ILC P!NQDY[<U4_:Q^/EOX'_:
MPT"V\<?#*[\5>'M-T-+[1UTN)1J$-V[ O+YJ')";2NU7 !.[GBOT(KPUOV<]
M1\/_ !_UOXI^%/%$=G>:]:16FJ:7K%B;V%Q& %,+B1'AZ#*@E2<\5V9=Q%1G
M[.GCX14:-*4(6YXMN36\DY-/?5*W31.ZSJ89QNX:W>NWF>$?LZ_MO_!Z'XC6
MG@O3_AOJWPUU'Q/=<7VI6Z#[;=.V$$K[C(S.QV@G(R0.,UFZ/\ _BOI__!0N
M_P#C%+X"N3X.FEEB5X]4L#.8S:>0LGEF<'!8 XZ@'UKZ9USX R?$/XD>&O%?
MCK5;+68?#,_VS2='LM-6"".YVX$TCNSR.5/S* RJ& ."0"/8JRQ&>X;!U)U,
MMIZUJ;A4YI2G:[^S)\KO9*][I="XT9324W:STV_X)^?G[)/[.?Q8^%O[7/C?
MQYXE\$RV'AGQ))J#QW"ZG92O!YUQYT>]$F)Z<';G!([<TWP#\ _B]H?[?FL_
M%Z^^'MQ#X1U*ZN(PRZM8--%$\0C65D$_/W02HY /<BOT%I*QJ\78RM5K5I4H
M7JT_9/27P^7O;[:^6VXUA(I)*3T=^G^1\=_\%*O@C;?&?X0:-J&EF!_$FDZW
M:6EG(C*7<74\=NT0]3NDC;&1]ROI_P"&?@2P^&/P_P! \*:8I6RTFSCM4+$D
MMM7EB3R23DDGN:^?OV=OV(;CX#^+;V\F^(.H>)O#;ZC)J]OHEW:(N+QD,:SR
MREBTC*C-Z L0V,@5]3UQ9MCHQPM+*L-7]K1IN4D[./Q6TL^VO_@3+I0;FZLH
MV;_K^O0*^,+?]AU[?]O6?XJ1VT<?@F2W_M5H5E4!]4(VE#'G<5W#S\XQO ^E
M?9]%>5E^:8K+/:_5I6]I%P?H_P!>S-JE.-2W-T/EC_@HC\#?B!\?/@SIV@>
M!'=W4.J1W-YILEQ'!]JB",!\[D+\K$-@GG\*^?OVB/V0_C9\2OAG\#8=+\,Z
M7_:O@^P6QO=(M]2A41%/*"R>8[*I#"/E5SM]6K]***]S+>*L;E5*C1H0@U2E
M*2NG>\ERN]FKZ?/SMH85<+"JW*3>IX+XTTWQUXF\5/H7B/X<67C/X5ZEH5JE
MWI_VRU,]KJ >0RA1*R"1-OE_-N4@J"O>O$/V?/V";SP]\-_CAX>\0QMX?TSQ
MY-Y&EZ2;A+F33[:)Y'MGD=&*EP77(#'A!SS7W317'1X@Q>%P\L-ADH1ERMVO
MO!IIV;:O=*[2N[>I3P\92YI._P#P3X1_9$\"_M)?LR^'=2^'M]X TOQ-X?$\
MD^E:R/$$,4%K(Y&X,AS*8BV7P$# EN#GC:_X*"?LJ_$']H+PIX"U'PL+'6/$
MOAUW^UV/F+:I<^8(RSQF1MJX:/[K-T;KD8/VI175_K/BHYG'-Z=*$:R;;LG:
M3:L[IR>Z;ORVUUW%]6CR.FY.WY?@?FO^T]\ OV@_CU\7/ 'C)?AK:6=AX?BM
MB;"'7;-Y]R2K)+N9I%7DK\NTD8 R<G [W_@H]\"_BE^TG:>!M+\$>!IKR#2O
M/O+N\NM3LH%625440A6FR678<M]WD8)YQ]UT5TTN+L70K82M3HTU]64E!6E;
MWM[^_KY:^MR?JL;27,_>]/\ (^"OVMOV>?B_\8_BE\&?&WASPK%=V/AV*WFO
M= U35+>/[-/'<+(ZN0[(RNJ*I:,OPO2I=6_9L^+6G_\ !0;3?C#;>'K'5O"]
MP(_M$D.IQ1?8U-K]G=2KG>Y7[V54AO;H/O"BLJ7%>,HT(X>-.'*H3I[2^&;N
M_M;I[/[[C>&BWS7?1].GR/@+X\? 'XL>)OV[?"_Q6T/P%<:KX3T%K)'DCU2Q
MBFN%B+%V1))U(^^<!L9QVKZW_: T_7?$'P3\7:3X>T*XUO6]6TN:QM[&.X@A
M(>6,IEGE=4 7=DX)Z<9KT:BO.Q.>5\4\+[2G'_9THQ^+5)W7-[W?M8TC145)
M)OWO3_(_/7]EWX0?'W]G#]FOXA^&+#X>%_'&JWHFTJ7^V+ P()(EB>1F\_AH
MPI8#N2/>M#]CWX _$3]E;P!XH\07?PPU'Q7\5-:=T$:ZKIJ0QQ#E%,[7.<,_
MSN0N>G!QFOOJBO5Q'%N*Q2Q$:E&%J\E*=E-<W+M&_/?EZV77J8K"133YGIMM
M_D? W[4'[)GQ8^)E]\+?BYX6@L5^+FA65H-7TQ[J..)YXF\U3&Q8(=KLZGY@
M&7')KZB^&6K?$KQ]9QGX@^#K3P/;);&*ZTZ/4HKY[V5E*MS'E4B .0-VXD]@
M.?5Z*\O%9[7QF%IX6M3B_9WY96?-%-WY5K:RZ73:Z,UCAU&7,I/_ #/@3]FO
M]GCXS_L?_$3Q_HWAOPE8>,O _B!E.GZI+J\-LULT9<0M,C'>1MD(<*I^Z-M.
M_83_ &:OC!\"/C9XTU[QGX<T]-*\2)();VWU.)C')YQD#+$I8E6R>"01Q7WS
M17I8CBS&8JGB(5:<+UXQC.5I7?+L_BLGZ*S[&<<+&+34GIMM_D?+?PML_P!I
MN/\ :C\2S^,YM-/P@9[C^SXXWMB!'N_T<1A/WP?&-WF<?>QVKZDHHKYK'8WZ
M].,_9QA9*-H*R=NK\WU?4Z80Y$U=OU"BBBO.- HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&
M.U20,GT'>EHH _-W]LC]G7XS_'/]I3PUX]\+_#6Z_LC0+6SMPM_K&G127+0W
M,LQ90+@[5(D &>>.E?H=X:U2\UG1X+J_T:[T&[<?/8WLD,DD9]VA=T/X-6I1
M7T.8YU6S+"X?"5*<8QHIJ+7->S[WDT_N.>G15.4IW;OZ?Y'PK^V%^S7\6OB1
M^U-\.?'OA/2K3Q+X9T%;5VL;R_BMTMY([@R2$ASD[QLY4,?E''%00_LR_%G2
MO^"AT/Q:&AV.H^$;J3,]Y#J$4?V>-K7R2-C'S&93Z+AL=LU]XT5Z5+BO&T</
M'#*$.54Y4MG?ED[OKOV:MYW,I86$I<]WNG]Q\!_$[]G_ .+&K_\ !0/2/BWI
M?@6:^\':7-;1&8:G8QRS1I 8WD2-I@<98D!L$XZ"H_AS^SW\6-!_X*!:O\7-
M0\"S0^#]1N+F(3+JEBTL4;P"))&C$^<94$@9(!Z&OT HK3_6W&>Q]A[*%O9>
MQVE?D_\  M_/\!?5(\W-S/>_3_(_/[Q?^RS\7/@C^V#??&+X1Z%8^,]&UIY9
M;_1[C4(K*1?.(,\>Z1E&"X#JPS@\%>.?IOQ1<?$KQ9\&?'OV[P?;P:WJ>F7%
MEI'AFTU"%YE:2)D#3W+,L62S@D+D*%X+$X'LU%>=B\_KX[V,L13A*=)12E9\
MS47=)VE;YI)VZFBP\8W46TGT/C;_ ()L_!;XB?L^^!O%'A;Q[X2ET1[S4O[2
MMKY;^TN(9 8HXS'B*5F##R\\KC!ZYKG?VI_V4_B9'^TUX;^./P>LK'5M6M?*
M-_I-Q=1VS2O&"A.Z0A65XSL/((P",]ONNBNG_6?&+,ZN:*$>:JFI1L^62:LT
MTW?6W<'AXNFJ;;T^\\5FC^*_Q/\ AGXJ34M)@^'&N7>D36>FZ='J$5\XN7BQ
MYTDJ#:H#950IZ?,<'@?'GPL_8[^->B_L?_%'X8ZEX<TS3-7U>]CO[*1M2AF>
M]*F/=&2K%4XC!#LW?! ZU^EM%1@^),3E].5+#TH*+G"=K/1P=U9\UVN_,WY6
M)EAHSLY2;9\;?L_^ ?CG\$?V8O GAFS\(Z?+XBTK7I?[5TFYU.W*76ER>>[8
MD!*H^YXP ">5&>"165X=_8WG;]LSPS\4="\%CX;^%=+M'N;ZS>YMG-W?,DB$
M11P2.$7$@R3M!VG YK[>HIOB;%^TKUJ<(QE6YU)KFU4]].:SM=VNG:X_JT?=
M5WIZ?Y!7P/\  _\ 9P^,OP3_ &QOB/XNM?#>F:CX5\77-X4UJ34HU2UCGNQ<
M!S#GS'90"NW: 21\V*^^**\S+\VK9;2KT:<8RC6CRR4D^]TU9K5/Y=T:5*2J
M6;;5CX9_:*_9G^)K?MH>#/C7X&T*U\6:;9+;K>Z<U_%:S1F,/&^/-*J048$$
M$G=G( QGC_!?[._QQM_V^(/C/X@\!P1:#<7<C3+IVL6DIMX7M&MTX:168KE2
MV!SAMN>*_1:BO=H\6XVEA_J_LX/]TZ-VI7Y'TTDE?L[&,L+&4N:[WOTW^X^#
M?CS\#/BOXN_;L\%?%+0_ ,]_X3\-BSMI)VU6QBDN4CDE>22-&F#  3<!@"2O
M;-5_BQ\!_BQXF_;V\+_%O3? %S<^$=':TB=CJM@D\B(C!W5&G'0R'@\G;[U]
M]45%+BO%T5!1I0]RDZ2TE\#WO[V_GY[; \*FV^9[WZ?Y'Y_?%[X!_%OQ-^WE
MX=^+.D> +BY\)Z3+9Q.[ZK8)-+&B%9'5#/GC>V <$[>V:[W3_P!FGQ5\%?VS
MM6^+/A#1?^$H\*>*;6:+5=/@NX8;RQGD*.\B"9T612\8;&X$;F&.!G[$HJ)\
M48R=.%'DCR1I^RM:7O0W5_>W3U35ONT!86*;:;NW?I_D?'OP!_9=\3Q?M1>.
MOCQX\T]-$O\ 47ECT70([J.XEAC95C\R9T)3?Y:!=JL1EVYX%>>_LX_ 'XO>
M ?VV/%?Q*\0> )[/PMXA>]A6:/5;&62V2656CDD19\D83D*"06[XK]!**/\
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M^VU\0/B3J=SX>U+PKKD%WY&NW.M0?N+>X93;.(PQ? "+&,@ @<-4?[%'P/\
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M('\&Z.\26WV15:T4XBW%@N2.Q)(/49.#S4[?!7P')Y@;PEI!$AB9E^R)@F,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:Q_9&G37@TZ%LE7G,:G9D MCKM!;&.: /4**\<\4_M<?"WP?=>"(;_Q$S?\
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MK6CH/[5/P\\1?$S3_ MO?W\&N:G"\^FO>Z9<6]KJ*H@=_LT[H$FPIR=A/0T
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MTO2-'DL=&\/%AN^P1VZ)M#Q@J@Y9V"L> <5^JL=O%"28XD0G^ZH%*(8P,!%
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MFW\=C),HG>WAD)EE"?>*+D9;&!D>M?:T<21 A$5!_LC%))!',07C5R.FY0:
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MI6\:2##JK#_:&:;)!'-C?&KXZ;E!H ATRZL]0L8+W3Y8;BSND6>*XMV#)*K
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%0->VZL5:>($'!!<4 3T444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3\-^';;3GDU6[5$N56YGB4$Q;Y+C@/@K&H+;3\M '2>&?VX+W6?AWJ7CR_\
MA!XMTSPC#X=AUVQU)3%/_:,DCQQK:PHIW;RTAP6 RJ%L %<]OX-_:.U#5?BU
M<_#CQ)X)N- \2_\ ".1^);2*UU".\2Y@9S&T6XB/9*KC;@_*<'#8P3X_I]S\
M5=(_X)PZ)IW@3PYKVB_$?0]&LM+FTNZM#;:AB$QI<FW#J06:,.48 ]>!N&*Y
M_P !:;K7AC]K+PU\0=-^#/C31/!UYX'DTRYN+R!)[Y+A+EY&EN@)'D:1EV
M[I'R,+P< '46_P#P4.O;[X::OX^MO@OXI?PKH.J7&G:Y?27MHOV!8I$1I F\
MM-C>=P0$*5/S$<U[IXP^.BZ?XTT+P;X4T23Q;XIU73FUC[.+I;6WL[$$*)YY
M6#%=[,%10C%B&X 4D?%OAS2?&4'[!OQI\'3?#;QG#XHU[7=2;3=+;1)O-GBN
MYEDCDZ8"J-V[)XVXYR,^C:UJ'Q#^'/Q?\!?&W0?AQXD\4>&]9\'6WAGQ%X:M
M[/R]6TN:*4R))Y+X9\%W4X^4XSG!4T <]^V9\4M)_:._X)[^/O$<WA:[T'5]
M%UNVTF:RU*%);BQNX]2MHIA$Z_>!#E=RXR"1[5]%>!/VC-5U+XR:?\-_$'PW
MUOPB-0TJ?4=&U>_N;>6*_B@,2R#9$[&-AYJG:QR 1D#->0?MF:O\1/BG^Q[K
MVFI\-]?'B?Q)J5H^E>'M/M#=W%G:P75O-NO'CRD;L(G.T$X+JO.&(ZWQ9XPU
M:_\ VK/@GJ=IX#\7SZ'::!J%KJ&J_P!C3+;V4E\MHT2R$C(*FV(DX^3>,]&P
M :?Q _;2@\"^"K_X@CP;=:E\,K#5DTJ?7XK^))G4SBW>ZBMR/GA64[,EU9B"
M0NW#'9\3?M27<GB;QCHWP_\ !4WQ N/"6FV>HZDMOJ4=K))]I0R11VZ,I,K>
M4 Y)VC#  LW%?/\ \'O#7BKX+V]Y\*/$/[.L7CC4K*^DCT'QI:Z=:MI]Y:RR
MLZ2WD\@S&T88[N"Q"X"YP6TOVD?!\GC?Q5XIB/PW\;:'\1_#>G10>#O'W@:U
MFC34V:"-A!+)'\B()MRE93L502&7- 'VYI>HR:IH=I?I;F&6YMDG%O,=I1F4
M-L8XXP3@\?A7S?H'[9&MZY\.OBOXC/PPN[74_AS?O9:GH,FJQ_:)1&GF2RQM
MY>W:$(9?[XR1VS[O\+X_$T?PW\+IXTD@E\7+IMN-6>V $;77EKYI7'&-V>G'
MI7S[XX^!'B__ (:^&N:!% ?AOX[T46WC>.1!@R6F! %Y^]*KK&?EQL23)R5P
M =MIO[1^J:]\/?A7XET;P?!JUQX]N8HX--M]93?:0O&TIF9S& XCC1FD"\J1
M@;C7.>!_&GA\_%S]H6^\,?#HZ+\0M"ALQJ=]JMX$76,6S/;G*&01)L4$8&2&
M!8 YQB?LD? 'Q5\,?B%XNM/$BR?\(AX1NKK3? 2.20EA=R+<S')8[MN(85)
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M7;Z:=6U&-KQ;2UT^W)VQ"64JW[R5@=B!3PI+%1@GX\M5\::;_P $V]$\#_\
M"L?&=SXXM]7AC.B+HLPD"PZLE\9"V,",Q84-W?(QP<>Q-)XJ^&G[5EU\5O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)K<HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** $8%E(!VDC@^E>)_"/]G75_ _C27Q
M7XS^(^L?$W6X89K72I=5M(+=--AF</,(UB !9RB L>BJ  !Q7MM% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>figure03_01.jpg
<TEXT>
begin 644 figure03_01.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0@"%$# 2(  A$! Q$!_\0
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M2A54FE:>RUM^OX&%>,G#FC.4'&[]UM7OZ;_,^1?V+?VW?B%^TKK7Q?T7XF?
M[4?@E-\(+G^SM;GU?6K/4K:34(T\^\B::W14@%G"&:7>V54%CG%<5??\%&/$
MGB)/B-XY^#GP5U;XC?!'X1ZI>Z9XQ^(=OJ]K:I>R::,ZM)X>TYHOM.IQZ<,D
M-;[@PY?=7FOA#POXQ^$W_!,GXU_$&ZBN#\3?BEX1\=?$/Q+<9;^T4N?$$=U;
MQ232\R.\&F*&0!5C6.0LJ@LQ/1_\$MM#T>/_ ()D^$8S%%=Q:OX4\;WNJR2*
MC/?75W!=-=/,YR\DA9 6>0E@4X(P,>B\-0<9XA1CR+&82@HKX;57-226RNU;
MSY=SA]M6?+23ES-2GS)N[5-)M7WU35UJ?I3\&/B_X,^.WPW\,_%+P!J0U3PO
MXIT\7MC/\GF0N?\ 76EPJ#Y)[5SY4BGG</F&37JM?AW_ ,$+=7U.Y_9P^*.A
MRF=O#GAGXX^-['PO(\QEB^R2ZI=-<P0D E;>*Z1610QCB'[M-D9V5^XE>?C,
M.L+BJ]%-M1JRM=WM%I.*5^B5OZO?NPU9UZ,:C5KN4?5Q=F_O"BBO)KWQWXFF
M\1ZUH7ASPK%JR: ULE_=SZG%:_/<Q^<@52@ S&#QR>I[5S>77H;GK--PW][_
M ,=%>3'Q;\10=O\ PA>D[MVP@^(8!M;T;BC_ (2[XA_]"7I7_A00?X4W"JK-
MTI-/;E3>W<3OTE&/^)I7]+M'K.&_O?\ CHIU>2?\)=\0_P#H2]*_\*"#_"D_
MX2WXB?\ 0FZ7_P"%!;?_ !-+EF]Z=1?]NR_05G_S\I_^!1_S/7**\C_X2WXB
M?]";I?\ X4%M_P#$TO\ PEOQ$_Z$G3O_  H;7_XFCDE_)5_\!F%G_P _*?\
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M;_\ Q-'+4_D_/_(?*N__ ),SUG(]1^8HR/4?F*\F_P"$J^(__0E:;_X/K?\
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M_P#0C:?_ .#^W_\ B:/^$K^(_P#T(VG_ /@_M_\ XFCEJ?R?G_D!ZQ17D_\
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M3_T(NG_^#V#_  H ]8HKR?\ X2GXD_\ 0BZ?_P"#V#_"C_A*?B3_ -"+I_\
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M7_0BZ?\ ^#R+_P")H_X2?XE?]"+I_P#X/(O_ (F@#U:BO*?^$G^)7_0BZ?\
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M:GJEK+J6N^*-4C542^\2:]=&]UAD88:6VANG<Q2,VX E(ML8"#Z_INU0.@
MQ[8)Y'XGKZ]\TZL*E25:I.M.3E*H[MR;;;^;;\O1(VIPC3@H1244VTDDE=[N
MRTNWJWU"O(O"9/\ PG/Q4Y)Q=Z+U)/W=(8+G.<X '7.<9.37KM>1>$_^1Y^*
MO_7WHW_IH>I6Z?\ >C^,E<OO_AD_R/DN_NK[^T;Y?[1U$ 74Q %U.!E)PBX
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M?4_F:,GU/YFBR[+[E_D%WW?WLF^U7O\ T$=1_P# N?\ ^.4?:KW_ *".H_\
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MU7G_ #^WO_@9<_\ QVH**.2'\L?N0$_VJ\_Y_;W_ ,#+G_X[2_;+S_G\O/\
MP+N/_CE5Z*.2'\L?N0%C[9>?\_EY_P"!=Q_\<H^V7G_/Y>?^!=Q_\<JO11R0
M_EC]R LI<WAZZA>'_MZGZ?A)_+VS3O/O?^?^]_\  J?_ ..5!'W_  _K4E')
M#^6/W(!_GWO_ #_WO_@5/_\ '*//O?\ G_O?_ J?_P".4RBCDA_+'[D!(UQ=
M@+B_O<GK_I4__P <]?\ /2G_ &J[_P"?N[_\"KC_ ..558\I]?0>H_Q_S@4^
MHE&-X^['?LNZ-*?7Y?J3_:KO_G[N_P#P*N/_ (Y1]JN_^?N[_P# JX_^.5!1
M5\D/Y8_<B+ON_O9/]JN_^?N[_P# JX_^.4?:KO\ Y^[O_P "KC_XY4%%')#^
M6/W(+ON_O9:%Q>$ G4+WW_TJ?K_W\I?/O?\ G_O?_ J?_P".5"GW3]?\*?1R
M0_EC]R"[[O[V/\^]_P"?^]_\"I__ (Y1Y][_ ,_][_X%3_\ QRF44.$+/W8[
M/HNS!2DMI-?-D_VJ[_Y^[O\ \"KC_P".5\W_ +1UYJ*:5X8:'5M2M"T]XA-O
M?W<)98ON!_*F3>5_VLY_B)KZ)KYP_:0(&D^&,NB_Z5?^_;/?(]>#7+625&32
M2:E#5:/5ZZ^9T7?=_>SV[P3=7K>$M!9]1O7:33869GNKAF9G@WN2SR%N6YQD
M  X&.E=1]JN_^?N[_P# JX_^.5R7@CCPGX> Z?V7!_Z2BNFJDE?9;+IZA=]W
M][)_M5W_ ,_=W_X%7'_QRI$NKHYS=77;_EYG]_\ II52I(^_X?UIV79?<A2E
M*SU>W=EO[5=_\_=W_P"!5Q_\<H^U7?\ S]W?_@5<?_'*@HHLNR^Y&'/.[]Z6
MR^T^[\R?[5=_\_=W_P"!5Q_\<H^U7?\ S]W?_@5<?_'*@HHLNR^Y'1=]W][)
M_M5W_P _=W_X%7'_ ,<H^U7?_/W=_P#@5<?_ !RH**++LON07?=_>R?[5=_\
M_=W_ .!5Q_\ '*/M5W_S]W?_ (%7'_QRH**++LON07?=_>R?[5=_\_=W_P"!
M5Q_\<H^U7?\ S]W?_@5<?_'*@HHLNR^Y!=]W][+:75T<YNKKM_R\S^__ $TI
M_P!IN?\ GZNO_ F?_P".55C[_A_6I*++LON07?=_>R;[3<_\_5U_X$S_ /QR
MC[3<_P#/U=?^!,__ ,<J&BBR[+[D%WW?WLF^TW/_ #]77_@3/_\ '*/M-S_S
M]77_ ($S_P#QRH:*++LON07?=_>R;[3<_P#/U=?^!,__ ,<H^TW/_/U=?^!,
M_P#\<J&BBR[+[D%WW?WLF^TW/_/U=?\ @3/_ /'*/M-S_P _5U_X$S__ !RH
M:*++LON07?=_>R]]IN?^?JZ_\"9__CE'VFY_Y^KK_P "9_\ XY4-%1!)N5TM
M_P!6%WW?WLF^TW/_ #]77_@3/_\ '*/M-S_S]77_ ($S_P#QRH:*NR[+[D%W
MW?WLF^TW/_/U=?\ @3/_ /'*/M-S_P _5U_X$S__ !RH:*F4(M.\8NR=KI.P
M7?=_>R;[3<_\_5U_X$S_ /QRC[3<_P#/U=?^!,__ ,<J&BL.2'\L?N07?=_>
MR;[3<_\ /U=?^!,__P <KROXU75ZGPZU&1-2OXI%EAQ)%>7,4@W_ 'L/%*K<
MG/4\=L<UZ=7EGQL _P"%;ZEQ_P M;;^8_P 3^9H<8J$FHI/39)=QQ;YEJ_O,
MSX W5_)X"9KC4M0N7%\0'GO;J:3'IYDDK,?3).>?KGVS[3<_\_5U_P"!,_\
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M\<J*B@"3SI_^?BX_\")O_BZ7SY_^>\__ '^E_P#BZBHH E\^?_GO/_W^E_\
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MJO4D??\ #^M1.,5:T4M^B M?:;G_ )^;C_O_ "__ !='VFY_Y^;C_O\ R_\
MQ=0T5G9=E]R F^TW/_/S<?\ ?^7_ .+H^TW/_/S<?]_Y?_BZAHHLNR^Y 3?:
M;G_GYN/^_P#+_P#%T?:;G_GYN/\ O_+_ /%U#119=E]R F^TW/\ S\W'_?\
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M10 4444 21]_P_K4E1Q]_P /ZU)0 4444 /3J?I_45+42=3]/ZBI: "BBB@
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MMF0XD0MGID[NQ^G?Z%:)):))+RT *DC[_A_6HZDC[_A_6@%NO5?FB2BBB@Z
MHHHK![OU?YLYWN_5_FPHHHI %%%%-;KU7YH%NO5?FBQ1116YT!1112>S]'^0
M!1116 !1110 4444 %%%% !4J=#]?Z"HJE3H?K_04 /HHHH **** "BBB@ H
MHHH DC[_ (?UJ2HX^_X?UJ2@ HHHK.GU^7Z@%%%%: %%%% !1110!8HHHKG
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M\B5K?_7SHW_I50(U:*** /8**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KR+PG_ ,CS\5?^OO1O_30]>NUY%X3_ .1Y^*O_
M %]Z-_Z:'IK=?XH?^E!W_P $OT/D;4?^0C?_ /7U<?\ I4:JU:U'_D(W_P#U
M]7'_ *5&JM?6QV7^"'Y'SRZ_XY?F%%%%4,<GWA^/\C4U1)@LH'4Y]\_A[5,O
MS?=#-UY"R_\ LD<P_3MSUJ9J5N94?:J.[]K[-QOM:%U[2]GI9VMYC7GMI=]A
M**F-O,JO(RA8T^\\DD5O$GU:>3=]<D\_IRGB'QMX'\(VLMYXH\:>%M MH?\
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MWKJZV*FI7UO=,];#4J-).-'#T:*C9?NZ5.G>U[7Y8*]NG:_F3M-,^-\LK =
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M=;+T7Y(**** >S]'^3+%%%%<Y@%%%% !1110;K9>B_)!1110,**** "BBB@
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MK^24 %21]_P_K4=21]_P_K03+X7Z?Y$E%%%!AU?HOS84444'2%%%% !1110
M4444 21]_P /ZU)4<??\/ZU)0 4444 %%%% !1110 4444 6****B&\O7]6
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M5''W_#^M25T+9>B_) 1R=OQ_I4E1R=OQ_I4E8/=^K_, HHHI %%%% !1110
M5*G0_7^@J*I4Z'Z_T% #Z*** "BBB@TI]?E^H4444&CV?H_R84444'.2IT/U
M_H*?3$Z'Z_T%/H **** "BBB@TI]?E^H4444&@4444 3)]T?C_,TZFI]T?C_
M #-.H,'N_5_F%87C3_D2M;_Z^=&_]*JW:PO&G_(E:W_U\Z-_Z54"-6BBB@#V
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M\B\)_P#(\_%7_K[T;_TT/7KM>1>$_P#D>?BK_P!?>C?^FAZ:W7^*'_I0=_\
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M)11108=7Z+\V%%%%!TA1110 4444 %%%% $D??\ #^M25''W_#^M24 %%%%
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M_P $/R/GEU_QR_,****H8Y/O#\?Y&IJA3[P_'^1J:LZG3Y_H 4445:V7HOR
M****8!4J=#]?Z"HJE3H?K_05G4Z?/]#2GU^7ZCZ***S- HHHH **** "I(^_
MX?UJ.I(^_P"']: )****.ZZ-.+\XO=/NGU0XRE%WC)Q=FKIM.SW6G1]4/5V1
M_,4C?C:2RJ^Y?[KAPP=?]EPR^U?CM_P4F_X(\?!+]N_2+WQAX;M[#X9?'FQM
M;F32?$VDV,5IIWB>YMF+FW\1QQ,D3>:QRKM!O!/RD=OV&H]/;N>2<=V)Y8GN
M6))[DU]!PQQ7Q#P7FN&SSA?-*V49E@ITZ\:U'VE6$Z%"7-4I5\$IJCC,/*+<
M)TZL:G+&HW"+O)/BQN7X+,L-/!8VG?#5+MRA%.K3D^M*5N:+D[.;BUS<L;WL
MC^$O]FW]NG]M?_@C3\96^ G[47AKQ+XH^"Z:@MH-.U5;F>&/34NC:#5/!^KW
M:R)Y2X\_[#]J\S;P5V\5_9O^S7^T[\&?VMOAOIGQ/^"7BRP\2:+?6L,M_I:2
MI%KFAW+<-;:I9%YY+4$_Q2QDCL16!^U;^R!\#/VS/AK?_#3XU^%K#5;>>&3^
MR?$T*0V^O>'[V3_475K<NK7.X==KR.A;YF4MS7\;'QL_9:_;K_X(??&N/XJ_
M K7_ !#XP^!UWJ,-XNL:7;7-]X=U/3()-\ND^+=.MU^S6UZ;?Y?ML\(5?O!L
MX-?TM4I\!?2-H?6,%'+^!/&&K1@Z>&Q%6G@>%.,J[B_:U'7BJ*P.8XF5!.%.
M2BJ53$M7M)GR+>8\*-1J0K8[AMU+15-N6,PUG[CYE>=.$G+WTK0DH*]K(_O#
M!XP5PW?G^F?\_K17Y5?\$Z/^"LWP#_;[\.6FC07]EX ^-FG65K_PD'@+6;R*
MT&H3A/+N;KP]<S.Z7\33_,8XQA?NHJK\M?JP4*.492&5\$%Q*4;^Y)&L4#A.
MVY6S[U_,_$O#.>\(YQB\BXBRS%Y7FN!J.CB,/B:;5-N#:4L)B(KV.,PTOBIX
MFG.I*I"<7.7PGV6%QM#'T*>(H5J-2$XJ2C2Y>>E%I<L:W+_R\M=.^MTQE%%%
M>"=!)'W_  _K4E1Q]_P_K4E !1110 ].I^G]14M1)U/T_J*EH **** "BBB@
M HHHH-ULO1?D@HHHH![/T?Y,L4445SF 4444 %%%%!NMEZ+\D%%%% PHHHH
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M:DJ./O\ A_6I* "BBB@ HHHK![OU?Y@6****W6R]%^2 **** "BBB@ HHHH
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M[=W_  7!^-O_  O;]H/7O$'A3X$'56NI=:OUO;;1H=+:3S&TOP9I-P]NDSF
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M:C_6N2LVJ,FFTU*&JT>KUU\SH/;?"=U/>>&M#GN9#---803RR,%W/*\.]F.
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M@%%%% !1110 4444 %%%% $D??\ #^M25''W_#^M24 %%%% !1116#W?J_S
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M\(1X3_Z 5C_WP_\ \71_PA'A/_H!6/\ WP__ ,751S.@KWIU7_7F+ZI+N_\
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M'V6(PF)2]HZL4XRG",[/DYHNUD[76VE_G7S8O[Z_G1YL7]]?SK[8/@OPL/\
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MOL6]%'7U#V#[_D?)&]/[R_\ ?0_QKSGXC^!$\?VVF6G]H"R.GO*Y8!3EIO\
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M?V6ODOT:#V;[K\3Y5R/4?F*,CU'YBOJK_A%O#W_0)M/^^&_^*H_X1;P]_P!
MFT_[X;_XJE]:79_<O_D@]F^Z_$^5<CU'YBC(]1^8KZJ_X1;P]_T";3_OAO\
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M ,31N']X_D/_ (FOJ7_A%_#_ /T"K7_OEO\ XJC_ (1?P_\ ] JU_P"^6_\
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MPM(_Z!]O_P!\G_&I]HNS_ #P7<G^6'^%&Y/\L/\ "O>O["TC_H'V_P#WR?\
M&C^PM(_Z!]O_ -\G_&CVB[/\ /!=R?Y8?X4;D_RP_P *]Z_L+2/^@?;_ /?)
M_P :/["TC_H'V_\ WR?\:/:+L_P \%W)_EA_A1N3_+#_  KWK^PM(_Z!]O\
M]\G_ !H_L+2/^@?;_P#?)_QH]HNS_ #P7<G^6'^%&Y/\L/\ "O>O["TC_H'V
M_P#WR?\ &C^PM(_Z!]O_ -\G_&CVB[/\ /"(WC.>>O3D=OP_SZ\4_</[Z_\
M?+U[J-#T@=-/MQ_P _XTG]A:1_SXP_\ C_\ \51SKL_P \+W#^^O_?+T;A_?
M7_OEZ]T_L+2/^?&'_P ?_P#BJ/["TC_GQA_\?_\ BJ.==G^ 'A>X?WU_[Y>C
M</[Z_P#?+U[I_86D?\^,/_C_ /\ %4?V%I'_ #XP_P#C_P#\542:>RMWVU \
M4R/4?F*,CU'YBO;/[#TG_GP@_)O_ (JC^P])_P"?"#\F_P#BJ<96O>[VL!XG
MD>H_,49'J/S%>V?V'I/_ #X0?DW_ ,51_8>D_P#/A!^3?_%57.NS_#_,#Q/(
M]1^8HR/4?F*]L_L/2?\ GP@_)O\ XJC^P])_Y\(/R;_XJCG79_A_F!XGD>H_
M,49'J/S%>V?V'I/_ #X0?DW_ ,51_8>D_P#/A!^3?_%4<Z[/\/\ ,#Q/(]1^
M8I\<J=-R^_WOS/\ @*]I_L/2?^?"#\F_^*H&B:4.EC"._P#'_P#%4<Z[/\ /
M&=Z_\]$_)J1I(ROWEXY_B_7'Y\?I7M']BZ5_SY0_DW_Q5']BZ7C'V*''_ O_
M (JESKL_P \7WQ[,97_Q[Z^OX>OM3(W!QR.?]H'I_GUKVO\ L72O^?*'_P >
M_P#BJ!HFE#I8P?\ ?)_QJ923M96M<#QO<G^6'^%&Y/\ +#_"O9?[&TO_ )\8
M/^^3_C1_8VE_\^,'_?)_QHC+EOI>X'C6Y/\ +#_"O!/'7P73QEXYL/&C:V+0
M6)C86?E@Y,7^KY*[CM^I#9&[-?<']C:7_P ^,'_?)_QI@T?3,9-E <=" 7W?
M7 SQ].:OVB[/\ /'=R_*,_="JOS#@*GEJ.G.$XYY/4Y/-&Y/\L/\*]E_L;2_
M^?&#_OD_XT?V-I?_ #XP?]\G_&HE+FMI:P'C6Y/\L/\ "C<G^6'^%>R_V-I?
M_/C!_P!\G_&C^QM+_P"?&#_OD_XU('C6Y/\ +#_"GM*FW[R^_P!X9_#MV]/>
MO8O[&TO_ )\8/^^3_C2G1],/'V*'\F_^*H \;CDCY^9<?\"_S^6>O-/WK_ST
M3\FKV$:/IBXQ9PC'LW_Q5']CZ9_SY0_D?\:N,K7O=_,#QN22/CYEQ_P+_/YX
MZ<4_>O\ ST3\FKV$Z/IC9S9PG/LW_P 51_8^F?\ /E#^1_QI2:>RMWVU \>W
MK_ST3\FHWK_ST3\FKV'^Q],_Y\H?R/\ C1_8^F?\^4/Y'_&I \>WK_ST3\FH
MWK_ST3\FKV'^Q],_Y\H?R/\ C1_8^F?\^4/Y'_&@#Q[>O_/1/R:C>O\ ST3\
MFKV'^Q],_P"?*'\C_C1_8^F?\^4/Y'_&@#Q[>O\ ST3\FJ=&7:.>O/0_X>E>
MM?V/IG_/E#^1_P :4:3IPX%I'^;_ /Q5 'DV]?7]#_A1O7U_0_X5ZU_96G_\
M^L?YM_\ %4?V5I__ #ZQ_FW_ ,50!Y+O7U_0_P"%&]?7]#_A7K7]E:?_ ,^L
M?YM_\51_96G_ //K'^;?_%4%1ERWTO<\EWKZ_H?\*-Z^OZ'_  KUK^RM/_Y]
M8_S;_P"*H_LK3_\ GUC_ #;_ .*H'*5[6NOF>2[U]?T/^%&]?7]#_A7K7]E:
M?_SZQ_FW_P 51_96G_\ /K'^;?\ Q5!!Y3&XYYX^AZ_E4F]?7]#_ (5ZF-+T
M\=+6/_Q[_P"*I?[-L/\ GVC_ /'O_BJ /*]Z^OZ'_"C>OK^A_P *]4_LVP_Y
M]H__ ![_ .*H_LVP_P"?:/\ \>_^*H \KWKZ_H?\*-Z^OZ'_  KU3^S;#_GV
MC_\ 'O\ XJC^S;#_ )]H_P#Q[_XJ@J,N6^E[GE>]?7]#_A1O7U_0_P"%>J?V
M;8?\^T?_ (]_\51_9MA_S[1_^/?_ !5!?M%V?X'E>]?7]#_A1O7U_0_X5ZI_
M9MA_S[1_^/?_ !5']FV'_/M'_P"/?_%4$RG>UKKY_P"1YDLB8X[=B&X_S]:7
M>OK^A_PKTP:98#C[-'_X]_\ %4G]EV'_ #[)^;__ !5!!YIO7U_0_P"%8GC%
MD/@?6SD$_:M'Y.1G_2OPYKV;^R[#_GV3\W_^*KS[XHVT%OX)U7R8DCW7.F[L
M#.=MY !D$GH&8?B: ,^BBB@#V"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *88T8$,H(8 ,#R"!D $'J,$\'@Y.1R:?11_PWRNG;[TG\D W:OIZ
M]SW.3WZ9[=!VI!&@QA< <@ D*#N+9"YV@ECDD#)/4FGT4+2[6C>[772VOR27
MIH#U5GJNSV^X;L7T_#)P!QD 9P%.!E1\IQR#3J** "O*?!G_ "/_ ,4/^O[0
M?_377JU>4^#/^1_^*'_7]H/_ *:Z /5J;L7T_4_XTZBDDELD@&[%]/U/^-&Q
M?3]3_C3J*8#=B^GZG_&C8OI^I_QIU% #=B^GZG_&C8OI^I_QIU% #=B^GZG_
M !HV+Z?J?\:=10 W8OI^I_QHV+Z?J?\ &G44 -V+Z?J?\:-B^GZG_&G44 -V
M+Z?J?\:-B^GZG_&G44 -V+Z?J?\ &C8OI^I_QIU% #=B^GZG_&C8OI^I_P :
M=10 W8OI^I_QHV+Z?J?\:=10 W8OI^I_QHV+Z?J?\:=10 W8OI^I_P :-B^G
MZG_&G44 -V+Z?J?\:7:.!CITY/>EHI65T[*Z32=M4G:Z3[.ROWL@$VCCV&!R
M>GYU"$5=JXYZ<DD8)Z<D^GX= <5/3"O P3D=_7_/:H<8)OW4G.,HR=M)*6C4
MNCOY[Z]Q=4^U]>JOV?YGYA?\%-/^"9'P3_X*0?!R^\%^-]-M=(^(6CV=[-X
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MMD?\&\/[7-]\"/CQIFN>)?V>M?UE4O;&3[3)X>US0II1"GBSP5<3>;!#/!&
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MZM7E/@S_ )'_ .*'_7]H/_IKH ]6HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *^3/B;^SM?^/?B9I/CN'7(;&#339,UJZ,?,,#H\I#8+#+QJ<9&,8 &2*^
MLZ:0,9YXSC )//7CGZ<CCIQ0 R-/+2.,G<555!]D^[TQT'?KZFI:/Z44 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %>;?%C_ )$G4_\ KYT[_P!+;>O2
M:\V^+'_(DZG_ -?.G?\ I;;T 9%%%% 'L%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5Y3X,_Y'_P"*'_7]H/\ Z:Z]6KRG
MP9_R/_Q0_P"O[0?_ $UT >K4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4FT8QCC.>IZTM%)I-
M6:33Z/5:;: )@ 8'3ZFHQ#&&5L-N4  EW/08&06(8XZE@2>Y-2T5,H1:^%-I
MIK39Q^%KS5W;M<32>C2:O?7OW/D[]L+]CKX*?MM?!SQ%\%_C;X8M-=T'6+.Z
MCT[4FMXWU;PYJ,ZE+?6-&NV*R6]U;9R%601R [74E5Q_ ;XC\._MP?\ !MW^
MV3#K^@/JOC3]G+QAK DB=4FF\'>.O"\USY8L;YV7[)IWBRWM08O,+07((WF7
MS/F'^E"54C! (SG#?,/P!S@>PX%?,W[5/[*GP;_;&^#_ (G^"WQL\*6'B7PM
MXDL+F"*>XM(I=1T&^GC*0:OH]RVU[6[MBVY3$ZAP,/G@K^X>$?C"^!ZM?AGB
MK+I<4^'/$$HT<_X;Q#5:.&@_:4Y9ME2KNI3PF*PWUF=6JJ,*<\7R4X1:Q$:%
M6G\[GF0O,>3&X*4,+FF%C.=#$12A.J[1<:=:I&TIQ]Q1@I-I<S5K-G!?L/?M
MT?!#]O;X):'\8_@SXDM[Z*ZM+9?$OAF26,Z]X1U@@?:=+U:R4"1'#9"7 !@9
M<%7#!E'VIN./O<_0<?X@\'(!_7G_ #:_BA\*?VVO^#<7]L&U^(?P]O-9\7_L
MX^)M9"6FH,MQ=>&/%OABXN\CPSXA4$V6G>)8;7Y!=.L0Z$N7(:O[I/V!O^"@
M?P-_X*#?!31OBS\(->LC?&UMXO&7@R>\ADUWP;K>%^T:=J%LJB4VY?(2]">3
M@_*0PS75XO>$-+A3#8;C;@/,5Q9X89_4G7RK.L)!U*^2U*DJ4O[(S>A'FE1E
MA95OJZKU.12E2E1J-UZ4YRY<@SZ6+<\#FM/ZEG.&E&G5IS_=T\5%N:A4HQ>C
MDE!NI:^LHN[4K+[M+D!LL> ,84>O;CG//7/X&IZA!QGCIGJ <<]>W'3^?J*F
MK\%CI*27,DK-QDW)\TFVY*3;O"2LHQ5E'E=E&]CZWWOM<M]/A5M+=0IBDGDY
M QWQC\\#^7XT^H 63"\DGJ?_ *QZ]?Q[<#DES.45&#;M)\[GRPA9*W-&ZY^:
M^FCM9ZJ^K2O=?\#\>A)G SNSGID?KP,\?3^8Q TL@V@;06^4%F"EG'7:FUCM
MP"<DDX[$#<<[5]9TW0=.O-6US4;+2M,L()+J^U'4KJ&SL+.!#S+<7LQCM[>%
M0?F>5A@D<DY!_DE_X*M?\''?ACX9:AK?[.'[!Z?\+,^,4T[>'[WXB:?$VIZ1
MHNH,A3['X8M;;<VMZP)B-L\<<MHN, ')K[C@+PYXP\2<WI93PKEDL;54E/&X
MW%2>"RC+L)3O+$8O%XZIR8>G&E2YJD:4ZW/6Y?=@U:1Y69YQ@\IHRJUZBG42
ME[/#1LZM9JR2IJ]W9M*6CMS)^3_:W_@HK_P5B_9B_P""=/@74-4^)/BRPU_X
ME3V;R>%OA5H5U!>>)M4N&!2WEU"WC?=I6GF7AYKLHYZ(N#D?Q:ZCK_\ P5"_
MX.+?CHMMHMKK'P\_9KTS4Q:R1P/>V/PY\*Z.;L9FO)0+>/Q+K1MSL=)9+I&8
M[B"V6KZN_P"">/\ P03_ &B_V[?'=G^V!_P4H\6>*[;0/$%[;^(H?!GB">Z/
MC7Q?&CF5(=2^TDC1_#COR+.!;:9ONGY>*_N&^#/P3^%OP"\!Z/\ #7X1^"-$
M\"^"]!M%M=/T;1;..WC(7 $MQ(@,]W<-R&N+J2:=P?F<@9/]%8CB/PT^CK2J
MY5P3/ ^)'BMR3^N<8XK#TL1D'#%:<.6IA<MHUH5J=:O2JSJPC5H-24L-!SKQ
M7[L^3IX;-^+)JMCU+ 9$I<RP=Y0K8J+?VXJW/R<B:<E9<[Y8ZMGYY?\ !-C_
M ()#?LR?\$X_!=O#X,T"R\:?%F^MT'B3XL^(+"&?7[RX_BBTG>LBZ+9 \;;!
M;9F^\WH?UG,49QE>F,<MQCICG@^XY_*HT1,MA"#MVDG&6P<A2<9(SSR?7WJQ
M7\L9_P 2Y[Q?FN*SWB3-L5G.:8RI.5;%XNK4JRBI-_N:2J3G[*A"_+3HTU"G
M",8J,=$S[/!8#!X##QPF#H0I8:%G&'*KN5VW*>EY.^J<FW=O8844Y^]R,'#N
M/Y-P?<<^]/HHKQ[)?))?);+Y=/S.WK?KM?R6WW!1110 4444 %%%% !1110
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M]Y;V<NJW>I0W1N+,7 9+>"V>)2)!(J%&D8DHJ$YPVX 8^NZ^ /V[P/\ A'O
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M>;!#%!'LQT"111)U[[<]L]*^BJ^1/V,N?A'%GG_3Y^O(^7.W / Q[?C7UW0
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M5.M++LFH_7LTFW3?LXJIAL)--).=1)PFY\SLN:T7!WUT-3]J_P#X*>_M\?\
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MT<DQ/US*<NQ/,Y.>#HPDVVVZE*/LYN3=[R<HN[NV[!1117Q)Z@4444 %%%%
M!1110 4444 %?,G[1_P7USXQ:7X=LM&O[>R?1[N_FF-QL&];F*.- ,C'2->F
M", ]^?INHR,C&3V_A)Z<CKG.#^??- '*^"=$N?#/A'P_H%W*DL^DZ79:?-+'
MR))(%"2.,# !&#P !R1BNNIIPO)P!SV[GDG-.H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M\G^,W@74/B-X#U7PMI=Q%:W=\4:.:? C#(3M))S^';CD'->L4F >V01ZY'Y'
MC\J /#_@)\,]4^%7@B/PSJ]U!>7(N6E\VW(VD./FS@8Z^G3'8&O<:0=>AX'4
M@?IC^G%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7Q#\8_CGXV\%_%_0O!FCFR
M_L?4'LUN'G0O*BS?ZP JA<;L_P + CJN.WV]7Y?_ +1Y(_:+\)X)&9-//!(_
MY;VR=01_#(X_'/4 @ _3N!F>&-F.6902< 9/T  _(5+5>WX@A_ZY0G\6 )_/
M].U6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV3\H_P >/?FGTS;\I ()SS_A_P#K]Z?7\VQ5FTDDK+5=7K>_X?-L^U"BBBJ
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M/A=X$3PWX@DMI;\7K2[[1B\)3 Q@DD^O)QGM[>]T@ '3CM@=/RZ4M !1110
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MA]9I=&W]Q]58;^]_XZ*3</[Q_(?_ !-?*W_"\/$W_0+TW\VI_P#PO#Q%_P!
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MIW_"[?$G_0-L/^^Q1]0Q7_3K_P "?^0U7IROK:W?_@-'U'17RY_PNWQ)_P!
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M /7H^I5_Y?S%[>/9GTU4!' ZY/!Z\X5>0,\=SQV^E?-G_"Z?$'_0+L_^^_\
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M_/X5\Y_\+AU__H'V'YR?XT?\+AU__H'V'YR?XT?4Z_\ )^/_   ]M'^G_P
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MI2DGMT/;/@!\3-8^*G@=/$FMVUM:WC71B*6JE8?+QD ;@ <8/.,G/7T]TKX
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M>_\ ,GGCY_<>WT5XA_PLS5_^?*T_[[_^RH_X69J__/E:?]]__94U1GY?-O\
M6Y2DGMT/;Z*\3_X65J__ #XV?_?3_P"-'_"RM7_Y\;/_ +Z?_&FJ$WV^]O\
M)#/;**\3_P"%E:O_ ,^-G_WT_P#C1_PLK5_^?&S_ .^G_P :'0FNWWM?F@/;
M**\2_P"%EZO_ ,^%M_WW1_PLO5_^?"V_[[I.C/R^3?Z6 ]MHKQ+_ (67J_\
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M_P"%'_"P]6_Y\X/^^E_PH]E*6W3LVO\ (#V6BO&O^%AZM_SYP?\ ?2_X4?\
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MM1_Y][?_ +Z'^- 'HU%><_\ "7:C_P ^]O\ ]]#_ !H_X2[4?^?>W_[Z'^-
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MOYG]YA=]W][_ ,Q:*3)]4_[[%&3ZI_WV*.:7\S^\+ON_O?\ F+28'O\ F?\
M&C!]3^G^%&#ZG]/\*.:7\S^\W25EZ+\@P/?\S_C1@>_YG_&C!]3^G^%&#ZG]
M/\*.:7\S^\++L&![_F?\:,#W_,_XT8/J?T_PHP?4_I_A1S2_F?WA9=@P/?\
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MY,^Y7+).22Y92YXJVB4HP>BV7RZB8'O^9_QHP/?\S_C2T5JFULVO0Q$P/?\
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MP<U<-5)/5.UT]5UZ FULVCS'X1>&-5\)^$_[)UB$17@N?-\L<COSD=OTKTS
M]!^0I>3U)/N22?S))_6BM$DDDDDELEHE\@;;W;8F!Z#\A4L??\/ZU'4D??\
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M"RV_^2Z_HK^V7/\ SU/_ 'RG_P 31]LN?^>I_P"^4_\ B:?^NW!/_1H\D_\
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M<XW_ ,(,,?SL?\/2OVN_^D4G[2W_ (+;?_Y+H_X>E?M=_P#2*3]I;_P6V_\
M\EU_1/\ ;+G_ )ZG_OE/_B:/MES_ ,]3_P!\I_\ $T?Z[<$?]&AR3_Q,.*?_
M )I#^S<9_P!#G&_^$&&/YV?^'I?[77_2*3]I?_P7VW_R33O^'I?[7'_2*/\
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M0 4444 %%%% !1110!)'W_#^M25''W_#^M24 %%%%9T^OR_4 HHHK0 HHHH
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M7VGANPU">*QT/35!N->\2:A<_P#'II^BZ1'NN[Z^E_Y:K#&8DZ!1UKY;OO\
M@J!^SQX8T.?Q;\3_  =\7?@]X.CCM);+Q7\0/#IT_1=8-V\4-I;6$L5O(S7%
MW+/'N68VXC(PI7.*]S!\,\49Q0>(P649C6PM6:PT:M)X:%2ICDW55##RQ$H5
M*U)0I5%&IAE4512DIO2*>53&X6$O9.HFEI4DVVZ?\MFW[O-K>UKV1^B=%9^@
M:E;^)=(T77-))GT_Q#IMCJNEMQOEL=72*?39VQP#)%/&''1>I&>:\H\&?M!_
M"7X@?%;X@_!/PEXHM-6^)7PL@L9O''AV*:(W.CPZE_QZ3W"*=V[_ )ZJF%3N
M!7DQPV*Q$L?..&J^RP,,96Q]-PK2K99&FZ6!J5<1*A&5*G0H8N=+^(XPC.;<
M7>Y<J]!*G!5:485I+V<YVYZBBUS<C;OIS*]NZ/9Z*\(_:%_:)\#_ +,W@NV\
M=>/-*\3:Y8W^K1:)IFB^#[(:GKM_J-Z?W$4-J$?,4(!_>$#)^^6Z5\57W_!7
M?]GO2_'^A?"35/@Y^T9I_P 5/$]@-2\/>!)_"NF)KFKV'>[M5:Z,1&0?EPR@
M#O7M97P?Q9G6$EC,MR''X^C:JL3'"0PLYT</AJ,(8W'4[8FE5IT:4*<<0I.'
M*I3G)33<C#%YEE6 J2^LUXX>RIQ7MU7E&HYIW=-4U)>[I=O>ZMU/U,]>?_K4
M5^9NJ_\ !5W]GK0? OC+X@ZW\-/CMIFD?#B]:S\?6-UX6CBU7PDL.?-OM7A9
M-K:<>,SVV,=0><#UG]G_ /;S^%7[3GPC\2_'#X2^ OBSJ?@#0+-[ZQN+_0H+
M2_\ &4,4'F2?\(E"V%N,-@DW ;GH%'%;XS@;C+ X.KC\?D.+PF$AC:&7SQM>
M.%H8'ZS*&%KX;#*K'%5&L75P=>EBI0BTJL)5'5O"3DE3S/+JE9T<+B*.*K0I
MNHZ<%6TIS5W.2K)7Y$KQ:^'7NK_;-%?FI^S]_P %5_V=?VH/B#XH^&/P@\"?
M&C5O%7@8:@/&L5WX;BMK;PO>:;:/=MI6J2.H,5_=>284BP"K2C'S;2O+>"_^
M"P?[.?Q'\:^-OAKX$^$/[17B?X@_#258?'_A+3O"FG?VMX4>:<QVAU:&2ZSL
MNAC8\  (SM&XAAO_ ,0]XY=;'8>'#N;0KX'+XX[,8U*>$53+LLQM24,-F&)I
MPQ-*E2I8B4J57 5F^>=&HK.W*Y9/-LJIP@I8VE"%6=14JE1UI.<X./MH*5)2
M=J3E!6EMS>[U/U4HKX?\!?\ !0#X/^.+[XCZ1?\ @/XO?#G6_A7X-N_'?BC1
M?'_AL:9?W7AK3_\ 6W>A/$CV]Y=3=H2) /X46O"O&G_!87]F_P"''AWPUXQ\
M?_"/]HCPGX0\:ZQ;^'O!WB+5_"=O;V7B/6[F2*""RL(W*S%II)TVD@DG 4#D
M$P_ G&F+QBPU#AK.,5B^>%\-0I8=K$1Q-*6*H+#0CC=7'#+V\U!2_=1DVE%-
MJIYQE=."<L?ADM=>7&7>V_N?H?JPG4_3^HJ6O@'PS_P45^%WB#Q3=^!KKX-?
M'KPKXSB\*7OC'2_#OB?PU#97GB71=/M/M5ZNBRQK);SZG$NTI;9VR= O/'DG
MPP_X+ _LZ_&Q_$\'PB^#?[1?C^Z\#:I_8GC2UT/PMITESX9U?][_ ,2S5HIK
MN+R+T^1)^[&T?T;X XXDL3*'#N9U%@:>&>.Q<8Y=#"4:6-Q4L+2K/VN,J4U^
M_A[",HR2]K&I%N[=D\YR=.DGF.&3K<W+IC->7EO;W>G,KGZLT5\->#?^"@'P
MN\;^%_BCXCTOX6_&RUU+X.1B;QKX"U+PY%;>-$M/+\]]0T^P,8AOK2&+&7MY
M23W /-?/?A'_ (+,?LN>._"&O_$3PE\,_C[KGP]\(:E<Z1XO\9V'A:&;0_#=
M]8?\?\>I3(KS*UK_ ,M (5 [J*RH>'_&M=UJE#AK-\1+ XG!PQ\U6RJ."HXG
M,,+/$82E.2Q%E"=-+DH)I5IU(63DHQ=_VIEKDJ2QE*4I)SBZ?MH.T+-W]JE?
M=?#>VM]T?K317DGP.^/'PF_:3^'6D?%;X*^+K#QIX'UM,V>IV+$&"?S/(DL[
M^)R7MIX9>2C!7[$'I4GQN^,&B_ ;X=ZO\3?$?AGQ;XJT30X&N=3T_P &:>MY
MJ]O90QS3W&HB"5GS:11P.&8@G'.1U'SKRW%K'K)ZN#QN&S2-7ZM6PF(A*EBJ
M68^W4(8&=*?+",O:5**3=E4I5Z:NXV.B.(H2PRQBJ?[/-RC*?,[0]G;5.^G-
MS.]M[+L>KT5^3WP__P""QW[,/Q5^'OBOXJ?#GX:?'WQAX"\%2M;^)/$.D^$X
MY;:PNH?^/NWCB5&FE:VY,@QD=">Y^OOV1OVR_@#^W%\/KGXE?L^^)I-:T73-
M2?2==TC4Q%;^)- OH/\ 76^KZ:NR6RE)[2Q[0.F*]O,^">,\DPN.S'.^'LTP
M-'+\0L'FDZE+!RR[+L7B(TW1AC)86=3%8->SE3E2O&$)2J2<W=&=''82M.%*
MEB8<TU.=-2E>554TG/EN[OE35_57/J.BO@'QQ_P4;^$7@']H.#]F75?A?\;;
M_P")MY>V]MI2Z5X;AGT76+"YF2/_ (2"TO,$G1X?.7=."?EB(.6W,WW_ ,8#
M?WP2!V7\>I_'U%>?F.19QD4,NJ9GE]3!X;,Z=*>!]O6P^)J8JAB(\TL90JT:
ME2?L)1<'0]KRR@FU'7F2UAB\+6A4JT'-U83C2J4Y.3AS2NHN$6[)W4KV782B
MO,_C#\8?AY\ ?AUKWQ7^*^O0^&_ GAJ-9=6UBX9$6%IKBV2&WA5L>8P5W&<,
MQW G) -=CX:\1:/XO\-Z'XO\.WL.H>'O$FEV6LZ-?QGS(;O3]1M?M=C.CQM@
M^;_J9 ,A&/&&YKAC@L3'!TL=+!8QY-5Q]?+\/CK3YL7C*2CS86C6E[KJ)S4^
M5SO[.,M+7*C4HO$/">T;Q<(>VG3YG=1:YDFF]M'T-NBOS5^*_P#P52^ GP8^
M-=I^SSXR^&GQP?XK:T]Q'X2T'3/#5O,/&8MA^\NO#UP7,4EGG/SSDD#OD<^G
M_ [_ (*#_LZ?'?XHZG\#-.N/$_PT^-FD0?:YOA?\4[%?#_BB_M/,\AYM+M=@
MBNVAD^\(YF&>HQQ7T.(X%XSP67PS?$<.YJLN>$>+CBU]0KTZN E*TL;3H4*D
M\3.C%<L77C3:HRC-N<6V<RS/ U:G*JW+54I0G3C*RBX:;7LF];Z:V/MNBOC?
MXQ?MO?#WX-_%&;X/3?#/XP?$GQM9Z"?$NIV_PX\/QZO8Z5I?(!O[J152.7/\
M 8DCL,<_-7A7_@L1^S;X\T7QGXG\$?"/]HGQ3X;^&VJZAH/Q!U?2?"5O<0^%
M=<TB?9K&G:C"I:=Y-/'!-NI,@Z@,=U5A>!N+\?A/[1P>0X[%X2%+#U?;X582
MMA*%#%58TL'5K3^M4ZBGB\1:DHXA)^[.$5K)-5<RP5&2IU,3AZ525_91KJK/
MVEK<_*J:?PWCS<W\RMU/U=HK\Q?BW_P5N_9@^">I_#G3/&WA#XQX^+UIID_P
MUU*P\-H^G>+;W6+7[7;:-ITKIF/5(AB$V\Y+%N6W'IU%Y_P4K^&.A7^@6WC;
MX#?M(> M/\1:UI^@6GB#Q+X.ABT2UU'5[J*TTU;VXMS,T<,QGCF=_EV+P3@Y
MK6IP#QEAZ='%U^&L=3A7IXNI@Y5Y8/#T<=4PDJD<1"@IXN4:L:%15XU5!2Y.
M2FG'1)3#-<NG)P6-H2G'^*L/AZT_9WOR\WM(^[S:VM:]G?9'Z)45^;GQN_X*
ME? /]G[XQ:-\"?B!\/?C*/B%XIF2U\%66F:!!<6GC>>:W\P?\([*<E_*8YQ.
M3T^;>ORUWGPA_P""BG[.7Q=^+4GP#F_X2[X4_&H0_:;3X=?%33ET#7=7A_NZ
M/%M,-W)[+</QV[US2X&XRI993S.7#.8TZ$\OGFU+%<L,?1E@(SDIUI4<-7=6
M5&,U.#K1A)4^1W<4KBAF.4U:KI+'2E&+2JR<'1=.I)OV,$_=NJC4DTG]E=S[
MGJQ7YQ?MB_\ !4/]FW]A'Q?HG@_]H#1?B;92^);> :!XAT3P\+GPSJ=_<R""
M/2HK]\JNK>9G]P\@0D@!0.OTO#^TGX6D_9Y/[2TO@GX@6O@I-";Q-)X<N=.A
M3QE'H4$?GOJ<MBJ>6+6:,\;1N ^ZX()K"MPEQ)0R_)\PGDV)IY=GU:E2RG'*
M$8X;,L?-QBL%@JU>O5G*;G.,9TJCA&E*4%.,4T="Q>&=6I1<HJM0BJE6G>UJ
M3NZ4VKZ>TC&3OK>VMSZ&HKXT_9!_;G^$?[;VB:OXF^#7AKXB:=X;T6=K.77?
M&6@/I5AJ%VG_ !\P:<YV&>:U_@*G9)_$IK[+KR\WRS,LDQ>,RO-\'7RS,\-[
M%XK+<7*A+&85U9PY75EA93P_LZT-:,82YE%351*Z1I2K4L31>)I6Y95%37+L
MG!VE;UOKWMJ<1\4O^22?%S_LFGC'_P!-8K\/?^"&'_)A-I_V67XL_P#J4&OW
M"^*7_)(_B[_V33QC_P"FL5^'O_!##_DPFT_[++\6?_4H-?H>2_\ )IN/8?9_
MUZX*CR_9Y88;/7"-MN6+E)Q6R<G;=GEXC3B#!I:+ZAF6BT6V&/V!HHHK\_?Q
M6Z).RZ+]Y4V/1ZP_Z\TOSF%%%% R2/O^']:DJ./O^']:DH *_-C_ (*]?"E/
MB[_P3U^/FA- 9Y]#\/CQ39Q##$2Z4OVN$Q*F,RQ+SN()?^/=7Z3UY_\ %SPG
M:^/?A)\4?!E\B2Q>(O!.O:?'"J;UEN)M-^SPC PQ&_\ @!VDGD&O>X5S:60<
M3\-9W"4H_P!F<0Y+BZDHR<6L/ALRPN(KOF334>2'O=&K)Z''F&'^MY?C\):_
MUG!8BC9JZ;E'FLUU^']>A_.+_P &O?Q6?Q/^S/\ &'X6W\_^F^!/%UM<Z;9R
M;@ZVNIVOVN_=(AAL-_JG+!C&PW1E'&:_IZK^)W_@W<\6W/P=_P""@'[1/P'U
M>1XH];MO%ME9V+-L']H:?J%S%:!5;,A>&%(T W?, =ZMEL_VQLC*70_>1BA]
M=V/0=/I7ZU])K*(95XQ9_B<-&*P'$^%RCB["3C%*,_[7P-"GB6N5)-RKX:52
MH]Y5)RG*\FV_+X.Q#KY%AX-WE@JM; O5NWL)M\JOM%.;LN@E%%%?@Y] %%%%
M $J=#]?Z"GTQ.A^O]!3Z "BBBA[/T?Y, KQ'XW>%M<\5:=H,.B6GVM[2XOGN
M<DCRUG_U6,8![G)Z^_;VZE#%<;21C:!CC[GW<^N/?.>^:YVDU9I-/H]5IMIY
M'08'A:SGT_PYHUE=KLNK33[>&9?^F@7;SV'R\8&/4\UO4N3SS]XJ3]4^[],>
M@P#WS24 %21]_P /ZU'4D??\/ZT$R^%^G^1)11108=7Z+\V%%%%!TA1110 4
M444 %%%% $D??\/ZU)4<??\ #^M24 %%%% !1110 4444 %%%% %BBBBHAO+
MU_5@%%%%6 4444GL_1_D 4445@ 5P/Q4T>_U[P5?:5I,'VF^FF4I"20-B_=&
M0<\>N<^N:[ZI!P%(R#G&02#@D]^M5%*2<?YK6T[7 \G^#_A_5?#'A Z;K%O]
MGO6O=YB!)ROU/OZ&O5*7)/4D\YZG.?KU_I25I%**Y?Y=].X!4D??\/ZU'4D?
M?\/ZU0+=>J_-$E%%%!T!1116#W?J_P V<[W?J_S84444@"BBBFMUZK\T"W7J
MOS18HHHK<Z HHHI/9^C_ " ****P **** "BBB@ HHHH *E3H?K_ $%15*G0
M_7^@H ?1110 4444 %%%% !1110!)'W_  _K4E1Q]_P_K4E !1116=/K\OU
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M HHHH *DC[_A_6HZDC[_ (?UK.IT^?Z 24445F 4444 %%%% !1110 4444
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MF%87C3_D2M;_ .OG1O\ TJK=K"\:?\B5K?\ U\Z-_P"E5 C5HHHH ]@HHHH
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M+NK6YM9?@1X 6.ZA>!\:_P" R%25620;QXI5@71V&1@C.58%5(\6_9X\$_\
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M9?X(?D?/+K_CE^844450QR?>'X_R-35"GWA^/\C4U9U.GS_0 HHHJULO1?D
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MK)UJKY*%*@GS5<16FN2E2CNXQ5DG62_<I)7BGKX?_P %-/'U]^W%^UO\&/\
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M_@I3_P!(@O%/_AQ[C_Y"H_X>N_\ !2G_ *1!>*?_  X]Q_\ (5?L1_:NJ?\
M02O_ /P,N/\ XY1_:NJ?]!*__P# RX_^.57^M_"'_1FN!O\ Q)N-/_G\/ZAF
M7_118_\ \ RK_P"4GX[_ /#UW_@I3_TB"\4_^''N/_D*D_X>O_\ !2G_ *1
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M&:X&_P#$FXT_^?P?4,R_Z*+'_P#@&5?_ "D_'#_AZY_P4J_Z1 ^*O_#C7/\
M\A4O_#UW_@I3_P!(?_%/_AQKK_Y#K]CO[5U3_H)7_P#X&7'_ ,<H_M75/^@E
M?_\ @9<?_'*F7&/!\;?\:AX%H[[\0<:5>;_S.OEM^-_(/J&9?]%%C_\ P'*O
M_E)^.*?\%7?^"E(.1_P1_P#%&>I_XN/=>_<VGO4__#U[_@I1_P!(@/%'_AQ[
MG_Y$K]B%U34R0#J5_C_K\N?3_KI4_P#:NJ?]!*__ / RX_\ CE3_ *Y\'?\
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M?!W_ $:?@3_P]<9__/L:R[,O^BAS#_P#*W^=$_&W_AZ__P %*/\ I$)XF_\
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M !RE_KOP;_T:?@/_ ,/?&?\ \^R7@,R;5N(LPZ[1RKR_Z<_UT/QH_P"'KO\
MP4K_ .D/WBC_ ,./=_\ R%1_P]=_X*5_](?O%'_AQ[O_ .0J_9?^U=4_Z"5_
M_P"!EQ_\<H_M75/^@E?_ /@9<?\ QRC_ %WX-_Z-/P'_ .'OC/\ ^?9K_9V9
M67_&0YA_X!E3_P#<.A^-'_#UW_@I7_TA^\4?^''N_P#Y"H_X>N_\%*_^D/WB
MC_PX]W_\A5^R_P#:NJ?]!*__ / RX_\ CE']JZI_T$K_ /\  RX_^.4?Z[\&
M_P#1I^ __#WQG_\ /L7]GYE_T468?^"\J_\ E)^-'_#UW_@I7_TA^\4?^''N
M_P#Y"H_X>N_\%*_^D/WBC_PX]W_\A5^R_P#:NJ?]!*__ / RX_\ CE']JZI_
MT$K_ /\  RX_^.4?Z[\&_P#1I^ __#WQG_\ /L/[/S+_ **+,/\ P7E7_P I
M/QH_X>O?\%*/^D0'BC_PX]S_ /(E(?\ @HQ_P5R\<;K?P5_P3/TKX>2/^YCN
MO&?CMK@I+_SU*2"2(@#L4(P.1GFOV9_M;5/^@C??^!4__P 74;ZCJ$F1)?7D
MF?[]U.WY9D.#[CFE+C;A'D<J'A'P'+%1E!T9_P!I<48M05WS\V'QO$5/#U8R
MM&\)T<1%VM*,4_>?]EYC4C)//\XFM+K#X7+9MIWOS5:<:<Z/DXMN6NW+K^&W
MB']D;_@JO^V5\O[9/[6.D? CX:ZK+OU?X5_ 6TAM=0UC2/,W_P!G/XHL9[62
MWNS!\N]I5FZ-YA89K])?V7?V.OV>OV/?"[>%_@7X%L=%N[Y"GB'Q=J+1:IXN
M\17I&#=ZCK1#75Q,W):1IR2>6);FOIC)R2"03][!(#'R_*W. 0';9QO8%OXL
M[N:<F<J,G"]%))4<==I.TGW(KS\]X\XBSK!K*E'!9'P_4Y73R#A[ X;)LME.
MG9\V+H8!4UF$J;Y'1EC:F(=)NHX:U:E^O#Y1A,,U4G3Q&(Q#34J^85WBZMNJ
MI1J2FL.I?\O%3Y54M#FOR1M-[Y.3G)R<G/WLG.3N_BR3N[YHHHKXKD4.MY-6
MD]W:[:7>UY-KU=K*R7H]ET244NT5LEV2Z(**** "BBB@"2/O^']:DJ./O^']
M:DH ****4O=3FU>*3IN+U4O:*UFMN@72UDDTM=>_1^JZ'DWQ^\#I\4/@1\8_
MAR\$4R^,OAUXBTF**1 4\UK"YF(^7:P;S(U8,I##;@$+E3_(A_P;1^.W\ _M
M7?M.? &Z9[<7MGKEPMM,Q :YT?6KG3A%&@PY=HXTDPIY"DD8)S_:6L8E9H"1
MBZAN(#Z 7<3PW /L\4CKVV9RFU@"/X5?V>)O^&2/^#@[Q!X-8'2?#7B;XF:O
MI$DP)@2>PUJTFOK0X4@-&UW,B[@=S. "V#BOZ:\$K\0>&WCKP/5;E7K<)X?B
MO T)>]"IC\EJU^:O&F[Q^L.G4P\'62]IRTJ4>:T(I?'<2IX;,^'\SBW'EQLJ
M-2<79SC5E02A.2UE&R?NMM;Z']TY^\P[#I^9_P **?(-LCKMP=R,,Y^Y- 9(
MAWS\W.<9.<$XX#*_F50<5>7QR<75C_SZK>SA[6E%?9BJG-/E5ES3E*UY-O[.
M:_>5&MI5')6T24HQ:271:A1113))4Z'Z_P!!3Z8G0_7^@I] !1110]GZ/\F
M5Y]\0?B!;?#^UTZ[N=/EU!+]ID5$D"D,F=OW"IX_(^AKT&OG#]I  :3X9P /
M]+OS@# RF=O XXP/KWS7)6;5&33::E#5:/5ZZ^9T'OFDZFNKZ58:G'%Y0OK6
M&9(LDA2_WCDDDY],X],=*TZY?P3QX4\/#TTNV _&$.>>OWN<]>W3BNHJEO\
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M;"BBBD 4444UNO5?F@6Z]5^:+%%%%;G0%%%%)[/T?Y %%%%8 %%%% !1110
M4444 %2IT/U_H*BJ5.A^O]!0 ^BBB@ HHHH **** "BBB@"2/O\ A_6I*CC[
M_A_6I* "BBBLZ?7Y?J 4445H 4444 %%%% %BBBBN< HHHH ****Z "BBB@
MJ2/O^']:CJ2/O^']:SJ=/G^@$E%%%9@%%%% !1110 4444 %%%% $D??\/ZU
M)4<??\/ZU)0 4444 %%%%8/=^K_,"Q1116ZV7HOR0!1110 4444 %%%% !4J
M=#]?Z"HJE3H?K_04 /IC]!]?Z&GTQ^@^O]#2E\+ 3_EG_G^]1'W_  _K1_RS
M_P _WJ(^_P"']:SE\,/G^@$E%%%.GU^7Z@%>(>-OC79^"O&MEX+FT.6]N+V2
M%4N_.9 H?[PVHRKDCN1QV([^WU\(_';_ )+KX?X'^NL.<#/S@;N<9Y_3MBM
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MWW?]?(****.:7?\ +_Y$+ON_Z^04444<TN_Y?_(FZ;LM7LOR7D%%%%'-+O\
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MM/H **** "BBB@ HHHH **** +%%%%1#>7K^K ****L HHHI/9^C_( HHHK
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M70]5T[2+N\TV"6Q\V^MX7>!?('[WG!]/P[8K[2IVYANP2-Q9CZ9;J0.@]L8
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M#)5#"8>+UI?6??C6K0@TXJJY4H.51+F;Y6WHCU#)YY.3CG)W8$GFXW?>QO\
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MW_Q5>.?&.^L?@W8Z1?:S*;Y-8GN(85@4CRC;V_F.#@ G#$-D[ASC.,U]P5\
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M^&_^)KV2BE]8J_U;_P"2 \;_ .%:7G_03M_^^&_^)H_X5I>?]!.W_P"^&_\
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M_P *[NO^@C!_WR?_ (FO6Z*?MZG;\(__ "0'DG_"N[K_ *",'_?)_P#B:/\
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M_$UZ+@>@_(48'H/R%--K9M >=?\ "$3?\_J_]\C_ .)KY]\>?%31/ 7CC3O
MU]!<W-]J,ELL=RB_N5%SRG3&<]N,_P Z^Q\#T'Y"OR__ &C.?VC/"A/_ #UT
MSCM^ZN+5$^7IPDCCI\V[+9(!!=]W][ ^^5\&2.L;+=KAH]QX_B_SZ<?3G#O^
M$(F_Y_5_[Y'_ ,37?6_^HAZ?ZF'L/X@-WYU/@>@_(4-M[ML#SK_A")O^?U?^
M^1_\31_PA$W_ #^K_P!\C_XFO1<#T'Y"C ]!^0I >>?\(5<?\_J_]\#_ .(I
M[>#+AN&NXS_P$C^0KT# ]!^0I: //AX-N!TNX_3[I/\ ,4O_  AUS_S^1_\
M?!_PKT"BG=]W]X'GQ\&W!ZW<?I]TC^0I?^$.N?\ G\C_ .^#_A7H%%(#S_\
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M+119=E]R 3 ]_P S_C1@>_YG_&EHHLNR^Y )@>_YG_&C ]_S/^-+119=E]R
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7YM_M ^&/$>H?'WPOJ-AH.J7MC#+I?G7MM 7MEV,DD^7*G&6CC)&>,87
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M5L?#&OZK=>')M61GBN_&?B"XDN;"YMI9"RW*Z/:3RP>63) 3M=D:98Y%]?\
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M/?VF@_#?X6:8ZZKXDO[_ %%S!!KFKZ-8,+_3/#%DY$VH:S=QP6,*+C><G/\
M,M\.U_X.D/VT]#@\*^/M>^#?[*?PQ\6,;/Q'XWL?".D^&/B7X=TLD9N] TQ+
MVYN[R_[;!<VR#J< 8K]X/V!_^"8?PV_8RENOB5XM\>^-/VC/VI/$FBV.D^-_
MVBOBWJEQK_B^[L+>/8^C^'%OGFE\-^'G&=UC$YDF<!Y9&8'/@Y]P'P_P#AY_
MZV^(/#/$F:866*>!X4X(S7$9UAGBI*G&>)S7-:V&PV#RW+HSC0^L?5XUL=BW
M"G0I.$54FM:.*>(E)T<-5I)64Y5(\M[W<;*VMDGK?K]_Z8Z'/JLFCZ5)KH@@
MUEM-L9-7@MR&MH]2-K'_ &C# VW+6\-RS>7("21@9QP=RJY +-C'&  &('#
MX(R H) W <-CY@<U8K\:C4]I*K)Z3=2;E!0=*,+SFXJ%*3DU346HPGS.-2,8
MR23NCT[-)7W?IV3Z>H44458@HHHH **** "BBB@ HHHH *\I\&?\C_\ %#_K
M^T'_ --=>K5Y3X,_Y'_XH?\ 7]H/_IKH ]6HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKSGX2 #X9^"2.WAS35'IA8 1QTR"2<XR>Y->C4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M<1X_\=:5\._#=WXGUH2OI]F\2R+;KNF8/UPI!';T&/Q%=O7SA^U5_P D;\0G
M R);7''N?\: /2_AK\2-$^*'AY/$F@).EFTOD[;A0K%L9X_7M^>>/1*^1/V,
M1_Q:2,]S?SGV^7[N!T&/8?6OKN@ HHHH **** "BBB@ HHHH **** "BBB@
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MVI^-8OM9>>T35KJY(\(:9'(X1 -.09CAC_=J<AHVZU_H9"-  H7 7H 3@=,
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M 4444 %>4^#/^1_^*'_7]H/_ *:Z]6KRGP9_R/\ \4/^O[0?_370!ZM1110
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YM\6/^1)U/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%<CXV\9:1X"T"Y\1Z[))%IUH\2S/$@9AO.,D$' .#GH>!C%==7SA^U4!_P *
M;\1\9S+:@@\CKCH<@?ACGGK0!ZKX ^(7A_XD:$OB'PW-)-I[3&+?*NTY^G^>
M!U.:[JOD/]C$ ?".+  _T^<X  'R\+P../U[YKZ\H **** "BBB@ HHHH **
M*86&<9'0<XSG\C2=^EOOM^C ?14>]?[S?]\G_P"(IV]?7]#_ (4>]V7W_P#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB.XC,;A& )^4@'GGGJ.,8KZVJK:6-G81""RM8+2$'<(K>)(8\^NV,*/TJU0
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M%V[XNM?U?O/<_GL_X4/_ ,'"/_1X'[+/_AKKC_XNC_A0_P#P<(_]'@?LL_\
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M_P#F8/[-C_T'9A_X5U_\S^>S_A0__!PC_P!'@?LL_P#AKKC_ .+H_P"%#_\
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M\&>'/ WA32H([>PT+PQIEOI5C"D8PKF*T1!-.PXDN9S-<S'_ %TTF,UZ$JX
M"D@+T"EP![8 Z>@QBO6?B#PSE-L)PKX=</2P\5>68<74*W%6:XF7PPK2J.M@
M\LPL9.,JCP>&P]6G2E-TW7JQA"W-'*,;7M5Q^:XI5]7+ZC6J8;#ZZ\BH0FHK
MV>W/:\[N[=D?SW?\*)_X.$/^CP?V6?\ PUMS_P#%T[_A0_\ P<(_]'@?LL_^
M&NN/_BZ_H2VCD$C\>X_!NGU%+A?4?^._X5#\5\UEI_JGX;<J^&#X!X=I<E][
M2A0G5J7LOXTY.-O=?O2.O^S(I)?7\Q;6[>+K7^;3U/Y[/^%#_P#!PC_T>!^R
MS_X:ZX_^+H_X4/\ \'"/_1X'[+/_ (:ZX_\ BZ_H3POJ/_'?\*,+ZC_QW_"C
M_B*F:?\ 1(^&O_B$9'_\S"_LV/\ T'9A_P"%=?\ S/Y[/^%#_P#!PC_T>!^R
MS_X:ZX_^+H_X4/\ \'"/_1X'[+/_ (:ZX_\ BZ_H3POJ/_'?\*,+ZC_QW_"C
M_B*F:?\ 1(^&O_B$9'_\S!_9L?\ H.S#_P *Z_\ F?SV?\*'_P"#A'_H\#]E
MG_PUUQ_\71_PH?\ X.$?^CP/V6?_  UUQ_\ %U_0GA?4?^._X487U'_CO^%'
M_$5,T_Z)'PU_\0C(_P#YF#^S8_\ 0=F'_A77_P S^>S_ (4/_P '"/\ T>!^
MRS_X:ZX_^+H_X4/_ ,'"/_1X'[+/_AKKC_XNOZ$\+ZC_ ,=_PHPOJ/\ QW_"
MC_B*F:?]$CX:_P#B$9'_ /,P?V;'_H.S#_PKK_YG\]G_  H?_@X1_P"CP/V6
M?_#77'_Q='_"A_\ @X1_Z/ _99_\-=<?_%U_0GA?4?\ CO\ A1A?4?\ CO\
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M87U'_CO^%?SN_P#!8H8_;6_X)#J/N_\ #0WBX@=OG\/688'L3CC/..H-?:<
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M@ KS;XL?\B3J?_7SIW_I;;UZ37FWQ8_Y$G4_^OG3O_2VWH R**** /8****
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M5G6HPH*<ER0A5]K&T>:]K:1W6VC[*U@HHHK\G.\**** "BBB@ HHHH ****
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MX>?$[_@H=\2/V6O^&Q_AE\:?A3\1M4\1^#=0\=Z7\&M,T"VN-(T^T2&YN_\
MA'?[8M+F:*XU32[6W!1&%M+-,[1SM+A<Y?\ P4)_:9_;4^&?_!.GP)^V-\(/
M'GACX>_$#1/#GAC4OB)X.\0^&YM2M-3U+6Y!;ZA:V"@?Z*VGS;BH,2(X!WY/
M!^^P_A;F&(SG+<BI9]P]4Q.99Y_JU44<1F,:F"SNI1JSCAJ\)X1XB-#FHU84
M\9"+H2E&4J4I1U/(6=X=TJU>,<3&E1P]3$1]EAX5O;0I<O,G.3M"UX]4VI/J
MM/W]\T@C+<$;<?)NW$G!Z[<].,XXY[FEWL!@N2V>/E7G/;ICKCG''H:_$_PA
MX%_X*%^-?V=/!_QBM/VS/!FB>(_%?@'P[XOAMM:\$S6_AZ&]UJSLKU;*XG>Y
M 2"3[4+=2J!]S )AN1Z?^UY^WIXJ_88_9I^#[?$#1;#XA?M4_%JZTCX=>"?
MFA2116_BCXCW[1V]S=P*BILTBU:XBN':.)8,-MVK&"IX)^'F88C,\/DN2YGE
M7$6:8G-\RR:>6Y2\?'$4:^6T<1BL;B*M;'83!TJ> PE##59U<70JSC&*DI."
M4.;6&<T/JZQ5?#8G#4)T:&(A4K.G:I[?F5*$%3E+E;<;--14N;K9V_6!9'8L
MH8;MO X.UA[[<'/((Y/3 !H,C85B^TXR5 !S[@E>!U'U%?E#X9^%?_!3._\
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M^.N#@G!QGH<97:>"2.A![9%1F5A_&#RN1F/*@]<?7U(./;G'S%X%\$?':/\
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M)/ J->&>,!5D$S38P1("*]/*O"S'YSC\-@,NXDX>E'%Y3G&>8#%5*V8/"8K
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MBQ_R).I_]?.G?^EMO7I->;?%C_D2=3_Z^=._]+;>@#(HHHH ]@HHHH ****
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M?TR?TJ*GPNRO?[/227O236SNDU9[IVZAV\FK>O0_A$_X.L?A_+X _:>_9/\
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MNGY:'X"?\&[&Z[_9A^/.L73&;4-6_:=^*TMY.['S)F@\1:Q#$93G!V1 *
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MXXL;S2+W77U[Q1H^G7PE6ZM= US5I;S22\,X+6_VBT:,>2 B0JJ[%7O\R?\
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M8?'7A#38IK]?@/\ $_7]-G2WU+3;! R6'AO5YKB:VFE:7[* Y<QB>,E?V?\
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ME?Y?_P""96IZ;KW[&'P=U[1;N"[T?6M-N-3TF[BQY5Q9W,F^&:!3]T%P^0H
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MZE2KBI2Q$W*52$X6C1CS-4X*25E-W^#/AFO_  IG_@X^^,MS\4(TTJU^//P
MAM/@]K6K K;ZE=V]_:S2Z'I<]S)' UQ+&TB_V?;?OV)(*G-?N#^WGXX\'_#S
M]CK]HSQ-X^OK2Q\.0_"3QC93R7K1O'=W%]HUU8V-G'$R2QW%U<W,\8BMDMYP
MS)S&V?FQ/VCOV$?@Y^U%X3\"Z7\4WUB[^('PT-I=>"OC+I5S'HOQ"\/ZU9I$
M9-;LM1LTBC9[GRP9+6:.:S!.5@/ ;P:__P""6FA_$*]\/0_M(?M*?&_]I+P5
MX7O+'4M.^'?Q$OM-@\+->:9)'-92W\6CVUI-?+%+&C/;W<TD%P%*7$<JLPKY
M7'\2\(<2YAP1G^;YEC,LK\(Y/D&19MEF&RC$U*V84N$ZD/[,QF2595Z>!A_:
M&$H86.,GCJ]&I0KRG4IJI)U#MA@,RP6&S; TL-]>ACI8J5/$>V5.HO[2;J3C
M.3O*4:,)QC#6\(QBHVBT?G'_ ,$S/AUXU^&G_!#/0K'QOIUYI%WKOB3Q-XVT
M:&_06\B^%O$WB.VO=#N;F.XFF:UMFM7VE)\F-<?*!L(I?\%!?V7/B#\#OB'\
M$_\ @I5^QOI3VOQ:\ ^$/!5]\=?ASHMM)!8?%GP':Z?9OJUPMC!$'N=2M[<W
M"['17=F,A/F*A7]H/VNOV++;]J;X4:3\&]+^,/Q'^!/@C3H(+2ZT_P"$_P#9
M6E+JNF6RJEOILC75M*L%I B((XX60# <@L68^W_!#X)CX2_"OPW\-->\:^(O
MBVWAS2(="3Q5X[BT^X\0:CI<%L+6"TU!K6WBMIE%N/*9WB,LV2T\DC[7&]?Q
M.H4LPS#C##XBA+,.)>)^)L3Q!P36P>+G@\;PMGF"R[+88/-,54=7+JWUBE@N
M>I5POM,3EV-6%Q%&4''G''):G+#+W1="EA<MPE+"YA&M[2LJ]-576IPJW]K2
MBVX*=I+VFETU%)?EI_P22_:7\ _M>>-?VI?CO\.C<0Z/XK\9VQU33+U/+O=$
MUV"WLDU/2+^!T#17-E<1S?($4$.PP-JA?W(KX_\ V=?V,?@Q^RUXJ^+WB?X0
M:0WAN/XS^*;GQ?XDT&W>&'1;;6[LM)<S:7:HF(?.<LS(3M ^55 7%?8%? <=
MYOD^=\3XW&\/X?$83)/JV68?+,+BYNIB<-A<+E^'P[PU>>U2>&Q$*^'A7NY5
MZ-*C6F^:32]?*:.(H8*G3Q3D\1&=2,^:7,^6,K0EOO)7;>[^05_.Y_P5I#>)
MO^"@/_!)CPC8X;4=+^,OC'Q'=L,D16HT6SMUWKU"&09WX R<9[5_1"&R<>HW
M#'0CMGC_ #^%?SE3WC_M=?\ !=NSM=%N(]0\!_L0?"R:X\0-&$=8O'7B*18(
MX#*JB-]SJBR(S,8]@"JI)S]+X1QC@\^SSB.O>.!X9X&XUQF(J/X?K.:</XO(
M,JHR>W^T9AF<(1B]92BDDVCAXC7ML'A\!%M5,PS'!48-:.V'K0QM1=[.GAI)
MK9K<_HP7U;)X;VX&0,].,#J/YYJ>H"-V1QP/KC() ^O7J>GX9GK\GCS)J+32
M5.'_ ($I.-_)N"3?R/H++5[W;?HFDTEY*^GJ%%%%: %,^;C!'3N,?T]Q3Z@)
MR%/<KG\L_GVJ)IRY8WY8RERN2;4D[-I1:LU>S3MJ)W2YDKM6271N32VZ^6FA
M)NX[CT;''U_'![5_"%_P<U?M5>(/VA?VD_@K_P $\/A/?2:LVF:YI=SXLT[3
MY6=[OQCK<J0:58W"0J9&6WLY@)H2XA#1-))%YA+#^RK]K+]HCPO^RM^SY\3_
M (Y^+[ZTMM.\">&-0U.SCO)$@&H:K':O_9NG1;L+)<WETH"1JNW[P*$*0?XA
MO^" WP \3_\ !0/_ (*,_%[]O_XPVTNM>'/A]XFU#Q-H]Q?A[F&Y\8:G<7 T
M'3CYOEPR1V6F2K<;=K)&\&W:"37]0_1PRK!</4^*_&[B/#J.4>'6 Q*X=HXJ
MG&=/-.,,10Q-#*Z=.-6+C4CAYR52K;GE"52C)M22/BN+<3/%RPO#>$F_K&95
M8/&2@WSX?"1E!R;:U49*4G).T6H[/0_LG_X)W?LIZ%^QK^R-\'?@7H=K%;W?
MA_PEIMQXDNHXTCFU'Q->VT=QJ$]V5&9)U*I;N[$G]W@'!(K[G"@=!_.H H (
M'R8!4 =,9XX!P.<#H,<8XR:L5_.6;YKC\]S7,LZS2M[?,LVQV+S#&U'*4W*O
MB\36Q#]Z;<G&$:L:<+MI0IQBK**2^OPV'IX6A1PU**C3PU"CAX)62E"E"*52
MRTO-MMOJ]7=MA1117G&X4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7FWQ8_P"1)U/_ *^=._\ 2VWKTFO-OBQ_R).I_P#7
MSIW_ *6V] &11110![!1110 4444 %0,2,D9!(+9].PYQ_7ICBIZ802>3UZ?
MESZG&<< ^]9U$WR)3<+5*<Y65W*$9IR@NJY[Q4G9VC>^C8TTGJKH_&/_ (*J
MZ#^TY\6O%7[,7[/?[)'[2GCK]FOXL?$3QCKFN:[XD\+3VL5A>_"?PQ#:W'CD
M7"3V=Q+/K%M:2PSZ2F/)AE4I(C)(5?\ +_\ X+'?M=_';_@FU^SA\)_V'O@+
M^T?\8?CK^V+^U+K[:=I7Q%^(VSQ%\3=%\ 74J:)J5_X8GT6TA@L]2O->\BTT
MV">UN"EO+J+1[4CCV?O?^V]^R]\0?C]X7\)>*_@/\2(/@]^T7\)M;_X2+X8?
M$*]TLZ[I4?VD0+K?A3Q!INU_M7A[Q+:PPV^IQK!)YD:+D $Y_&[]C_\ X(Z?
MM7>+OV^;7_@HC_P4Y^-?AKXL_%+X?R,WPA\!>!+<67@_PS?000VFGZQ:VT3+
M;Z7I5K;QW5S#ID4"-_:MY+/+&6C@D3^E_##.N!\%E&19UQ5FG#BRO@3!9QCZ
MW!53A[ XGBCC+C*>*QN(X?H5LVJY54J8KANA5K8'&8A8G'/"X:E@IX.>&KQK
MQBO(Q4,5*I]6P]2=.IBKRC6YG&G1H4$G6BK.T:E6,THI<KDXW6J;7G'[.'[
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M_P"@=<_]]K7S/@>@_(48'H/R%'U/"?R5/O?^0?6:G9_?_P $^F/^%WZ/_P!
MZY_[[6G?\+NT?_H&W?YK_C7S4G.<@=NP]_:I*/J>$_DJ?>_\BHXFHKW2^?\
MP[/I'_A=VC_] V[_ #7_ !H_X7=H_P#T#;O\U_QKYNHH^IX3^2I][_R']:G_
M "Q/I!?C=I!ZZ9>?FN?Y=/PI_P#PNS2/^@;=_P"?PKYN4 GGT_PJ?)]3^9H^
MIX3^2I][_P @^M3_ )8GT5_PNS2/^@;=_P"?PH_X79I'_0-N_P#/X5\ZY/J?
MS-&3ZG\S1]3PG\E3[W_D'UJ?\L3Z*_X79I'_ $#;O_/X4?\ "[-(_P"@;=_Y
M_"OG7)]3^9HR?4_F:/J>$_DJ?>_\B98FHVK+O>WRW/HK_A=FD?\ 0-N_\_A1
M_P +LTC_ *!MW_G\*^=<GU/YFC)]3^9H^IX3^2I][_R-HUYVU2^?]?F?17_"
M[-(_Z!MW_G\*/^%V:1_T#;O_ #^%?.N3ZG\S1D^I_,U,L)AM+1J?B_T'[>=G
MHCZ,_P"%T:7_ - ^Y_(T?\+HTO\ Z!]S^1KYZHJ'A,-_+57HFOS,EB9IO1?.
M^A]"_P#"Z-+_ .@?<_D:/^%T:7_T#[G\C7SU12^J8;M5)EB:C:LN][?+<^A?
M^%T:7_T#[G\C1_PNC2_^@?<_D:^>J*/JF&[53:->=M4OG_7YGT+_ ,+HTO\
MZ!]S^1H_X71I?_0/N?R-?/5%'U3#=JH_;R[(^A?^%T:7_P! ^Y_(T?\ "Z-+
M_P"@?<_D:^>J*/JF&[50]O+LCZ%_X71I?_0/N?R-2_\ "YM)_P"@;>?FO^%?
M.M%'U.@_AYEWYW^7ZDNO/2R3]/\ @GT5_P +FTG_ *!MY^:_X4O_  N71_\
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M0 <#^.'>WURW.3R.@P.*ZC ]!^0I1H4I14E:S]>ENS)N^[^]GO7_  M[3/\
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M3H=*/$=FN<6\G)R<L3S^)./PQ0/$=FJA1;R@+P/F)(_$G)_$US7V>;_GA/\
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MGZ'BF#6[0,&%O-E1M'S-P.>,'CN>U<_]GN/^>$O_ 'ZF_P#C5'V>X_YX2_\
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M0*4L?+<#YM4O0IB=1*F#M^5F!!P>/E-?IQY%Q_S[W'_?M_\ XS7I^(L+\?\
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M'TZ4@U.V7&(WX& "[E<9S]T@J>>>0?RK#\F?_GC/_P!\/_\ &:/)G_YXS_\
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MLUDD5U@5DC8??7[??P;^,'B#2?AM^T!^SCH>A>)OCS^SQXF'B;0?"6M Q_\
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M%%%EV&%%%%%EV ****++L!)'W_#^M25''W_#^M24678 HHHH **** "BBB@
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MU.<7_P#+C\1/^&0?^"U__243PQ_X3$G_ ,AT_P#X9 _X+7_])1/#/_A,3?\
MR!7[<45,O$W/%;_A \//_%<\+K\LN!\.X/\ Y^Y__P"'G%?_ "X_$?\ X8__
M ."U_P#TE'\*_P#A,3?_ "#1_P ,?_\ !:__ *2C^%?_  F)O_D&OVXHJ'XG
M9YTR#P]^7AUPO_\ .YD_ZNX/_G]G_P#X><5_\O/Q'_X8_P#^"U__ $E'\*_^
M$Q-_\@T?\,?_ /!:_P#Z2C^%?_"8F_\ D&OVXHI?\1.SW_H0>'O_ (KKA?\
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M1'W_  _K43\5^(M/^$'P^6__ #;CA5?EEH?ZN8+_ )^Y_P#^'G%?_+S\*_\
MABG_ (+;?])1?"?_ (2I_P#D"G?\,4?\%M/^DH_A/_PDS_\ (-?NM11#Q7XB
MU_X0?#Y[?\VXX5?YY:'^KF"_Y^Y__P"'G%?_ "\_"G_ABC_@MI_TE'\)_P#A
M)G_Y!KYU^(O[.'_!8C0?'VE>$M<_X*5Z/?3WK6\;7^G: T#QISQ\UD(U]25
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M[+?U"BBB@84445T %%%% !4D??\ #^M1U)'W_#^M9U.GS_0"2BBBLP"BBB@
MHHHI.,6TVDW&]FUJK[V=U:]E?N 444462T25O\P>N^OJ%%%%.R["LNQ)'W_#
M^M25''W_  _K4E%EV"R[!11119=@LNP4445@]WY-V\@LNQ8HHHK9;+T_1!9=
M@HHHIV78++L%?E-_P7$_Y16_M5_]@#P__P"I/HU?JS7Y3?\ !<3_ )16_M5_
M]@#P_P#^I/HU?:>&O_)Q_#]=/]=N%Y6Z<T<U?++U5W9[J[L>=FZ7]F8QVU6'
MQ%GU7^S5MGT/M+]CW_DSW]ES_LCGA;_TE:OH>OGC]CW_ ),]_9<_[(YX6_\
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MA%;N.[D\-^+_  ]?SZ/KNFNH82VJ&\M)+BWM[G;<P13(DP8IS\S/_P %Y/\
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M?>C?^FAZ]=KR+PG_ ,CS\5?^OO1O_30]-;K_ !0_]*#O_@E^A\C:C_R$;_\
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M_2\D_P"33>)/_91>'?\ Z<XD/$QG_(^R'_!F/Y84_<JBBBOS67\2O_V$3_\
M2:9[?\W_ %\G^;"BBBD 4444 21]_P /ZU)4<??\/ZU)0 4445G3Z_+]0"BB
MBM "BBB@ HHHH L4445S@%%%% !11170 4444 %21]_P_K4=21]_P_K6=3I\
M_P! )****S **** "BBB@ HHHH **** )(^_X?UJ2HX^_P"']:DH **** "B
MBBL'N_5_F!8HHHK=;+T7Y( HHHH *_*;_@N)_P HK?VJ_P#L >'_ /U)]&K]
M6:_*;_@N)_RBM_:K_P"P!X?_ /4GT:OM/#7_ ).1X?\ _9:<,?\ JU/.S?\
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M.4Y:R>CD]9-1O9-[M*[MV#;8****0!1110 4444 %2IT/U_H*BJ5.A^O]!0
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M/ZU'4D??\/ZT 24444 %%%% !1110 4444 %%%% $D??\/ZU)4<??\/ZU)0
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M  <E?MO_ /"LOA-X:_9'\#ZK+'XO^);0ZUXZEL&EBFTKPY%+YME;@(S2!+N
M;)5+ X(R3UK[OPSX&QWB-QQP_P )X)RH0S'&TOK^8<K<,#EM*I"ICJCG[:E[
M.K/#0G&C*[?/+2SW\W.<RIY3EF*QTX.I*E%*E!:KGDI6D_.-DXO=:V/V2_X)
MV_MX>"/V^_@UK'Q4\'1II%_X?\3:OX>U;P^DD8NK"UM[_P"SZ1=SX(5+;48/
MWGE*JP*O*H,YJ]^V'_P3I_94_;>\.W6F?&+X>Z/#XE>+RM,^(/AVUM+'Q/IM
MUL\LW'G6R6OGOLXS=+-R=_WN:_BH_P""#'[;)_92_:[TKX?^);^:W^%WQO\
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M_:Q7[AZC_P @CQ%_V+GB'_TTWE?AY_P;Y?\ )G/QR_[.D^(?_I^UBOTO)/\
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M+B?\HK?VJ_\ L >'_P#U)]&K[3PU_P"3D>'_ /V6G#'_ *M3SLW_ .17C?\
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MFL]/\4?M#>+M/M)O'WCQ[.*2;23/;[O[!T.>5I'BMXWY?[.L3R'F1FX-8_\
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MD[?C_2I*CD[?C_2I*P>[]7^8!1112 **** "BBB@ J5.A^O]!452IT/U_H*
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MXB;?#@>'M:),ES% ZJ^EW@821LDC<],HO'45^'?_  ;WIO\ V.OCD%FMP/\
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MTZ4)5*LJ4*<=92JUHTFEKK"+:]IYVORZ7W/2F^7KQW]>/UI C2'8J%F'0*)
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MXT?\*E\=_P#0.@_[_K_C1'%85;U5Y6:_5A[&I_*SSBBO1_\ A4OCO_H'0?\
M?]?\:/\ A4OCO_H'0?\ ?]?\:KZUA?\ G[^*_P P]C4_E9YQ4J=#]?Z"O0O^
M%2^._P#H'0?]_P!?\:4?"CQV.FF0?]_C_C2=?#SMR5H*V_.X]=K7:^9I"E45
M_=?3]3S^BO0?^%4^//\ H&P?]_?_ *]._P"%4^//^@9;?]__ /[.LY5:"MS5
MH/MR2BOOM+[B_95/Y)?<>>45Z)_PJKQO_P! V'_P)2C_ (55XW_Z!L/_ ($I
M4^VPW_/W_P F7_R0>RJ?R2^X\[HKT3_A57C?_H&P_P#@2E'_  JKQO\ ] V'
M_P "4H]MAO\ G[_Y,O\ Y(/95/Y)?<>=U)'W_#^M>@?\*J\;_P#0-A_\"4I1
M\*O'8Z:9#_X$I_\ $TU5HOX:T%WYFGZ6NW\P]E4_DE]QP5%=[_PJWQY_T#(/
M^_U2?\*L\;?] ^#_ +_K_C0ZM%?%6@^W*TO6]FOD'LJG\DON//J*]!_X59XV
M_P"@?!_W_7_&C_A5GC;_ *!\'_?]?\:7ML-_S]_\F7_R0>RJ?R2^X\^HKT'_
M (59XV_Z!\'_ '_7_&C_ (5=XU_Z!L'_ '^/_P 51[;#?\_?_)E_\D'LJG\D
MON//J*]!_P"%7>-?^@;!_P!_C_\ %4?\*N\:_P#0-@_[_'_XJCVV&_Y^_P#D
MR_\ D@]E4_DE]QY]17H/_"KO&O\ T#8/^_Q_^*H_X5=XU_Z!L'_?X_\ Q5'M
ML-_S]_\ )E_\D'LJG\DON."C[_A_6I*[P?"WQP.FFP?]_A_\52_\*N\<_P#0
M-@_[_#_XJCVV&_Y^_P#DR_\ D@]E4_DE]QP5%=[_ ,*N\<_] V#_ +_#_P"*
MH_X5=XY_Z!L'_?X?_%4>VPW_ #]_\F7_ ,D'LJG\DON.%3J?I_45+7<K\+_&
MPY_LZ#Z^=GC\Q4G_  J[QO\ \^%M_P!_O_KT>VPW_/W_ ,F7_P D'LJG\DON
M."HKO?\ A5WC?_GPMO\ O]_]>C_A5WC?_GPMO^_W_P!>CVV&_P"?O_DR_P#D
M@]E4_DE]QP5%=[_PJ[QO_P ^%M_W^_\ KT?\*N\;_P#/A;?]_O\ Z]'ML-_S
M]_\ )E_\D'LJEU[K^:_(X*BN]_X5?XW_ .?"V_[_ /\ ]>C_ (5=XW_Y\+;_
M +_?_7H]MAO^?O\ Y,O_ )(W4*B2O'\+_P##'!45WO\ PJ[QO_SX6W_?[_Z]
M'_"KO&__ #X6W_?[_P"O4RKX=6M5_P#)O\FQ2C4=K1?6^B7Z'%45W?\ PK+Q
MK_T#X/\ O^*/^%9>-?\ H'P?]_Q6;KT-.6:??7_.QDZ53^1_)?Y(X2BN[_X5
MEXU_Z!\'_?\ %'_"LO&O_0/@_P"_XJ?;4OYU]Z_S!4JG\C^:_P T<)17=_\
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M_%?%VN_\$6O^"P_[,\DNI_ KXOZQXJTC3L>1+X7\5W]I'< '_GQO[NXSGO\
M)P/K7]YW_"OO%6<FRBR#G)F&<^N2,Y]^M.7P!XL!RMFG'839'XKC'YBOU[+?
MI3>+&%C"AFV/R3BW#M*,L+Q7D>59A"=..DXRQ=&BZTO:1:4Y8F4V[1=.WOW\
M2OP7DDWS8>.88"JKV<,54E!M[<O+*T.3NK7NK;'\#-I^W=_P7N_9"<P?$CPA
MX[\9:'IC;A:^)_#][XBTZ5.P$NG6?G-QC/SD^]?2WPZ_X.C?B5X8:VT_]IC]
MEMHYU_=7+^%;>7PK*)!_RT-MKJ!E_P!U0%]J_M,N_AYXFU&,0ZGHVG:G%MV^
M5>)!<1X[[DDC93GU8$]LXKYS^(__  3]_9]^+T=POQ&_9Q^%'BJ:Z^_>WGA^
MPDOHCW*3,%DSTY#9]Z]27C7X/Y])KC?P+X;HXFK98C&<(9EBLFQ->4[^TJT:
M-!0I*5-KFC%.*3DT]].?_5W/L%=X+B2I3@[<M#&^UQGM.794_:>TC1M?W_AY
M[QWY=/QN^#__  <:?\$^?B0+2V\5:KXD^&6J7/W[;6K)KZWA('(:ZMW5/?DU
M^H'PR_;L_8U^,D=I_P *[_:(^'^J7-TI4VM[JMII4L;CN?MMROXY&/;IGX<^
M+_\ P;6?L)_%%KNZT7P/K_PXUNYZ7>A>(Y1IT .?N:3';LA!Y'WSCCWK\OOB
MC_P:6>-M(GN+_P" /[1;6TH;=;V^M1R:>P8?]-D992.G#2$=*?\ 9'T5.)4G
MEW&O&7A[B*NJPO$.!EF.#H3J?!&GBZ.'Q,Z].FTU4E7JT>6+@XN5Y\J^M<<8
M/2>78/,J*M>I3Y*=1J.[2C:2<D[I)/;N?UI:7<6&LQM-H.IZ5XAA7[TOA_4;
M?7(F_P!V:Q;RSWZ<YXJT\,T1VR12(QZB1'B*^ZED93WZYK^'75O^"1__  7H
M_90E>_\ A!\2O$OB70-&.[;X7^)%R4N(_P#L&MYOF#D<E3CC!Z5EZ;_P5&_X
M+C_LGR"P^-_P6\6>(O#VC-&9;SQ)\.;I8+I(_P#7_P#%1*TX;=USMRO\(&.5
M+Z-T<XBY^'_BKX?<6*:YJ%"684<OQE925Z4:T,5C+8><O>45[.AS24DU*RY7
M'C!4)*&99)F&7S?VU&IB*=1K2;2E&U-0NGH_>4O[KM_<V01V/XC'^-)7\B7P
MK_X.H-/M9+>U^/W[-M_I;C]U<W.@WEU$?,_YZ_9E5W4>RJJ^V*_33X5_\'"7
M_!-[XCV\7]M>-?$W@#59_P#5Z=J6B7$]N.OWKMRV.G=AQ7P^=^ /C!D,N7&\
M"9SC(KG?UK(G@\YP,HPM[_M<#B)RC&2:<.:[DK\OPL].CQ3D&(LGC9QGI:,H
M>PY6]U)>[S[=;VMYG[<T5\6^ _\ @H]^PA\2!"WA[]J#X5Z?YOW%\3>(K;1R
MV.Q\S?M[]Q7U%X9^)GP@\:A3X.^-7PE\2^;_ *G^R?&FF7F_Z[9(?TQ_6OSC
M'\,\1Y5/DS+ACB+ R7-_'RK,,.K1LI7E6P^(ISY;J_LY+EO[R:E&WKTL;@*D
M;PQF%KJ5N5+$PI2AIM+WTY<WII;S.PHKIH?">J78W6=[X>O <$"WUFT)_P#'
M;B?/TYQZ]*N#X?\ BH_,MI9LIY4K?0ON'_ 3_A7B3G"G)>TYZ<HWYHXBE7C9
MNVZA0I-[._,I>26M^A.EHW*"3^'V==5K^MI2MTMWN]['&T5V9^'_ (J!4?88
M.>I6ZAE ^OSP_P Q_2@?#_Q46Q]AA ]6F']#Q^.?3CK63KTI-M8C#U%_+0C5
MBX?X_:*-^;[-K[.Y3_#6SMOL<I177?\ "!>*_P#GRA_[_"C_ (0+Q7_SY0_]
M_A0JE+6TDOZ]1'(T5UW_  @7BO\ Y\H?^_PH_P"$"\5_\^4/_?X57M:?\\?O
M Y&BNN_X0+Q7_P ^4/\ W^%'_"!>*_\ GRA_[_"I=2F_MKY-?CJ-)O8Y&BNO
M_P"$"\5?\^47_?P?_%4Q_ _B-(Y)I8;."*-=[S3WJP1*.!@B6 8'J3. #C)J
M'*FK7G4Y+I25*FJE1MZ149+G<&V[:4:CDVMK:DHRC%R<HPA'XG*WX/IL[[')
MUY9\;,'X<ZD 209;?)P,)]3TZ@8!_&O$OVEOV_?V//V1[&^F^,WQR\%P:O81
MAY/"?A;5K77_ !2&_P"><VF6\BJI_P!R4?SK^;_]JW_@YC\.^,K74OAM^RM\
M#=6\3RW\S6EOX@UU+EYYIC_Q[7-MI;%2RIV5HC&V#O5A7ZAPGX->)/'$8RX>
MX3S>.!J\CAFN;0I9;DSA)RYJF(Q^.^K7A347).A"/NM\U[PMXF,XAR7 J];'
M>U:NI83#Q52O6:VC3DFW2Y7=-IKFYEK[J/ZDO@.]O8_#>?4=3N['2--AU'_2
M-4U:Z73M+A3R-^^:_N=D*C?S\N./:ODS]I?_ (*U_L'_ ++,%_#XX^-6A^(O
M$=BOEMX:\'.NM7;WG>%)[2XDC8=\C/Z5_*AX6^!'_!=S_@IBEK:_9/&_PN^%
MUV;=##J<E[\-?#+V5PNS[4NG%8WU<Q)PQ4P>IR:_4/\ 9G_X-1O#FCRV/BG]
MJWXJW_CO56,,UYX<\.79M(I9F^];2:XQ,I)[R8\P'HW05^JTO"#PGX%L_%;Q
M<RO&9A22GB.#. J;S',8SI:U*%;-7S4:+DY1A!T:UIVJ\S]R)XKS_B#,G;(.
M'9X>D[J&)S.KS)J6TW"M:.EF[--KLSY?^/?_  <W?%WXA7UYX(_8D_9\N1-=
M3R6MIXA\0:;/XHU^0R']Q<65CH\4DE@H/3[6I0]P:^8-$_8L_P""W_\ P4XU
M)=>^,GB[QOX,\$ZLZ22W'BO5[O0](@LYONRP:3;M8SRM%W$N[/&[)//]IGP!
M_P"";O[.7[,.G6EG\&O@-X%\/WEM''&_B*[LK.]\2W9BP4-UJ;*SSE>I:>1V
M/\1(KZU/@GQ4R)%]BMQ'&KI'$KQK&B/]Y4C0!57T"@!?X<43\?N!>#^;"^$/
MAGD>3U:2=.'$_%5!YWQ&W#2C7I4J]*IA:4[NI.:E*2DW3M\ Z7#.8YA4]IGV
M<XIU;WJ8? U*M'#4%+>*C3E&E/FM:ZB[<KVYM?Y8OV8?^#8S]F/X;-I_B']I
M#Q]K?QJ\3)'#<W6C:=*]CX2G9_O+<+?/)J,S-ZRS,WICFOW\^"W[,'[//[.F
MDVND_!;X.^!_ T-I%'##=6.@V$E]+%%PBM/=)=3%E_OF0R,/O,:^GO\ A!O%
M0);[&@9BI+FX.\[/N_.6W8'H#@]P:=_P@WBKM8PCW$B@_@1@C\#7XSQ?XJ<>
M<>2JKBKC#-,VH59.4LNCBGA,M@I-6C_96#JT,+"*22@ITY:1M%+WK_28#),I
MRV3>#PE-U(\O^U5*,'7FU?5591<[K6^O5-W9S!GG)!\V0!6W(BNR11GTBA4B
M*)/^F<:)'_LU+]LG/^M:.Z'0"^@@OPH]$%['.$7_ &5 'M72?\()XG_Y\X_^
M_HH_X03Q/_SYQ_\ ?T5^>M45;E:5K)6;BUR_#9QDFK=/>T[GIU7S.\M7+XF[
M.]MKW6MNA\S?$3]F?]G7XN6]W!\1O@E\//% NQMGN[GP[IL-Y(/9H(K=E/\
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MCS[]*_2?P)\9O@Q\3[&/4OA]\6_AYXJM)_\ CW_L[Q3I;W3_ %T_S_M0.?\
M]5?@O\:/^#5']E;QO]JNOA1XP\6_"RYY-M:W]Y=Z];&0G_5EFCD8+_TUSO']
MX=:_-7QQ_P &RO\ P4*^#=U-K_[-O[05GK#6@S86\/B6[\-:F?\ @:EH/S0@
MC!Z8I?ZC?1LXI?\ QBWBYGO!N(GK##<<Y7"K@Z<ZB]RGB:\</1CRTY)Q<Z>-
MV=Y/8?\ :/&&#_W_ (>ACZ2ORU\'B_92BE\3J0ISO-S33BG%\O+*V[1_;$]G
M=K$)OLMQY1;<LWD2K&R>G1C]<<^]5<8'S'YAV9O+!_%HCU_3UK^$9Y_^#C3]
MA2=4U#2OB7\1=/LCD/);7?Q5LC!_=+*K.>_S$EAC&XUZ[X$_X.8/VN?A)>Q>
M'/VG?V:OMUY;^7_:%R-.N?#-\OE_Z[_0I@D"[N,[9AMZ+CK7%C/HO\9XFFZW
M!O$W O'U!WE3Q/#^>X;#.I%V=*V$QE=1C.JN:RA6K*\&I<GN\U4^-L!%^SQN
M!S#+YJR?/1G5BW]KWG'7E=MKW3Z']K6]?7]#_A3J_ERTC_@ZP_90>VMUUKX#
M>-[:]5<7GE7=X8HV]1EOT'&.PKL+7_@Z5_8HGV^?\*_B#;;QP5CO&"_]]RG.
M/?)]J^3Q'T=?&S"-4\3X<Y_"?O<M2%3+<;0K6M=T983%)QC'2[J_%S+DVD>G
M_K;P[RQD\UH0O]FO0JP:V=E[*&OGS;:6W9_2[17\YMC_ ,'.O[!EU_K_  IX
M[M/9K2Z'_H3Y_P ]N*ZJR_X.5_\ @GG=?ZZ/QQ:=?O:/<D?3YIS^''-<%;P(
M\9:7*Y^'W$48ZV5/+J564[6OMB6U;IM>_D5#BOAV=[9IE\[6OS5,51M>^UXK
MFO;Y6\S^@BBOPDL?^#C;_@FS=8^T>)/&EI]?#MS)G\I?IZ5U=E_P<+?\$P+G
M_7_$SQC:^F_PG</_ .@R<_\ ZZ\^KX-^*]&RGX=\7TWKK/)L3)3M:_+]7IXI
M:7UYN3=<O-K;1<3</RO;,\LC;?\ X4)4_P#T]"=_^W;6ZWNC]L*E3H?K_05^
M/%C_ ,%\/^"6E^,1_&OQ#"W'_'SX9G3UST '\\?K776/_!;_ /X)C:@/]&^/
MS1<_\O.FQ)WQ_P ]Q7FXGPM\2\/&%6OP#Q8U"I""I0X<S&M4J1J/EFZ5L!)Q
MJ4U:I%I7]VZ^&Y:X@R.HN6&;Y5%J49.4LUI)V5[I/V*=FOBL]=+GYU?\'%EA
M^U9\(?!OP_\ VH/V=_BWXW\&^#=.FF\)_$GP]X<OFM;.-]4B>&SOKI$BDVQ3
M12,KLIC1-VX;6 :OYQ?^"3.K_MC_ !W_ &G?A_\ LY?!OXQ^/?"?@'7/%X\=
M_$J/1KMXK"WT_P"V/?:GJ=^@#(L=Z[M$[;D)+$*5(%?V.?'G_@H[_P $L_VG
M?@?\2_@AXO\ V@?#T^A_$#POJ&E12WL,&ZROQ:$6>JH'F5DGAN?GC*,H!^4#
M9\M?E)_P0QO/V#OV%] ^,GB_XG_M&?#7_A:GB[Q5?Z'H$\FKV3?9?A]!>WDF
MFR17#*66>^;[,7A P @7.UW#?UYP#Q)G'#'@+QCD.>^&N.Q/%F726!X?ABN!
ML1B9YU#&JNLIS'%.67TYXG&9+?%2>)K.K5P\JD)0G2;N_P ]S?#4<?Q3@<;A
M.(,.\+)U)2^KYE[>%",/9<Z2A[-455ZI+]YRN]^5(_KCM+*#2M/T_28)99H=
M-LX+ 7,V6N;E[>TQ=RN6+$M<7/S!R=RGY8V1<BIZ^,[/_@HU^P?J7_'O^U-\
M)X\X.;KQ-9H>&+#!Z@Y')!YZ'(XK?D_;R_8@AL+C47_:O^![0VT>YXH_&UBU
MR3ZJFS#?0#I^=?Q?4X1XP52,*G#?$E><_>YI\.<0QG7Q4VYXF<9T<)B%.G&5
M2%&E[5PC"%)0IWBFH_IBS+*(I1I9G@_9PA&/,I4_>G%6FV[ZR;5VWJ^MSZMH
MK\H/B1_P7!_X)G_##[1#JWQU;7[V%<)%X5TY-4@D?U5UG1OPW8]J^#OB%_P=
M"_L2>%GN;;PA\/?'?C>9%Q#.8;K3(7?U#"213U^A[=Z^KROP8\7,Y]G_ &?P
M!Q%&G4M>MBL"L#12E\+4\SI89M6NY.#ERJW/:\;\>(XCR#"V^L9KA4Y<W)"/
MM)2GRVYK*@I;7C\5M].MOZ42.,@,?H/\":>J%ONJQ!SDA9'VC_@$8S^/^./X
MU_&G_!U5XUOY9;?X2_LL_;/-;R[:;5+R[>16Z^8(T@ND?GLR,/48KP?4O^"V
MO_!9_P"-6?\ A2?[/.KV,%ZVZ%=&^%]]XDQ'Z%B('7V)8'/>OO\ "?15\6ZJ
M=7,L/PWD6'2BYUL[XERK"N$7?F<:5#%\\^1*]1.-XWC;=GESXWR!>[0CB\5)
M7M'"TL1)3[*4JBO&_P!EQWUOLC^ZN"POY-WEV5R^/O;4?Y?KF(?YS[5D:AKG
MAG1LG7O%_A'0=HRW]M^(].T8K]?MS'_]?M7\*L7AC_@Y-_:?P]O'\4?!":A]
MX275Q\/=GUWJY7_@)7T^G5Z7_P $"_\ @M%\;/\ DLGQUNM'%V?](_MWXCWV
MJ^7]-LG'?[N../2O0E]'CAS*4I\5^/7AQDO*KRP>5M9SC)*'\6+<\0E2E3O%
M0<(5%5<I7MR*_.^+,77M]1X6S%]JE:O5<9W^%\C5HI:W76Z[']@'C7]LK]D;
MX<"8>./VB?AGHS09\W[/X@T_4,?007;9_P _C\3?$3_@N/\ \$TOANTPO?CQ
M;>(1;]?[!TRXN?-^FV5O_'<=:_%OP-_P:3_$W66AE^,7[32L#_Q\KIL<VH$$
M=QY_F,P_/K7VY\._^#4G]D'PQ]G?QOXT\<>/S'DRK;WUSHOF\\\*@ ^B@8Z@
M5G_JE]%K([/-_%+COB;$+:APYD5&CA)2A\<:M6K@(<L:KE%47&N[*-1MK1DK
M,>-\6G]6R3"X6">L\15@Y).]FE)WDTDVU:]VK^?,?$?_ (.B/V'/#7G_ /"#
M>"O'GC\Q_P"K%L]OI'F_0WI/X'IWKXL\8_\ !UAXTULR)\#/V3+V60G%L/$1
M'B(2<Y_Y@ZD]0<D?@,\5^]?PZ_X(#_\ !.[X;"!],_9_@\1R6W5O&&LG7P_U
M%Q;,IYSU!YK[5\&_L _LT?#T1+X(_9F^#_AYHA^[DT_POID!7H.OEMGD'DY]
M.F,D>-?HO9*_^$OPQXMXDK0_Y?9_G<L'0FX? Y4:&+KIJIJZBE2I<ME92NU%
MQP/&F*NJF;X/"JZYH1P\8RCS7NHSA!.5K;WT^9_%QJ?_  74_P""RWQVG:W^
M%_P 'A 7#9M6\)_#SQ#9-&O_ %UO;5X&[G,@)]\<UE1_M:_\'*$#'6#9?&":
MTO?WR6YTNU\F*+'^JQY .>OS$[NO/<?WNV'PO&E)''I'A'PWI20+MC2PL+2W
M5!Z;8H@#SG[P)^E;O_"-^+M@CV#RUZ1^:GECZ)C:![8Q1+Q]X%P[]GD_T>O"
MVAA%I*>8U*N;XNM&/\/F=2B_82BN;GY6_:N2O_#1<>$\TJWEB>*,=4GNE1Q.
M)H1@WNK1JQ4D^FFB7F?P'I_P47_X.%O#7_(6\#_$"^\KA_MGAF\EW]?^>-B,
M?AWJQ'_P60_X+B^',?VM\$M7O<9_X_/ASK<OK_SQMQ^.:_OA?P=XAE_UVFV$
MOKO6W?\ ]"0_RJG)\/[Z7_6^&]#?_?L[5OYH:A>/W M>_P!:^CSX;XI0W>&;
MR[DOO;GH_O>:VG+_  ^77XD34X2S&G;V/%.8T6[W4L5BJO-;:UZLN6UWZWZV
M/X.8?^#@S_@KQX<(75OV9M'O<8W->?"WQ9,#UYQ%; #U[?0UNVG_  <R_P#!
M2BS8#6?V0_!$D8X:2+X5^,;8GZB2V 'X >WO_=))\,8I01)X.\-2!NN_3K-B
M?Q,1/Y'WK)N_@IX?O@5O/ASX*N W42Z+I[9_.'C\*:\;/!RO[N+^C;PO/^9X
M;B"IAW"^]N6$;WMI;:WGJH<-9]&_+Q5CY;;1E4OOO[6:M_V[OUV1_$_9?\'1
M?[7%MM/B+]D+1AC[WV?P?KMF3]?M,7'O@CICBNOLO^#J_P")5MC_ (2#]DBY
M^7._[/;36G7_ *^%X_#'MBO[!;[]EGX5:GG^T/@I\-KS=U\_0-/DS^<5<E?_
M +"_[.NIY_M#]F_X0WF[KY_A/3GS^<7'X4+Q3^CU4_C?1_EA.?X_J7%>*JW[
MVYFO9\NO+R[WU^%#_L+BF.M+B.H]K_6Z*5[;<G+S7Z\W-:WNVOJ?RH6?_!V?
MX5AQ_P )!^R9XJ.!\_V37-%M,Y_Z[W)QT]OUKM]._P"#M'X"7!5;_P#9:^(=
MCC[Q3Q9H4V?_ !T@?D.]?TDWO_!-G]D'4<_;OV2O@C=;NOG>$-/?/_?0./PQ
M7$ZG_P $FOV%]5!$_P"R!\%K?=U^P>%=.@S^.Y3_ /K--<=_1=Q%_;>#G%M"
M3WGAN*\1.,+WN^2MC</HMTHJ75/ETN?V=QI&ZAGF!=OY\.W?MJL-7^=^7_M[
MI^$^E_\ !U;^R7=;?[0^"GQ$TS=][S-5TZ?9]?*Q_G'X^CZ5_P '0_["=WL_
MM'PEX]TS=R=XBGVCW\K&/QK]4-3_ ."*G[ &J[OM'[,7@:VWYW?V?';6V<>F
MW9C/MC^5>?:G_P $!_\ @G3JV[S_ -G^.VW_ 'O[/UHVV?IBV3'X8_'FDN(_
MHFXB_/P7XE87O_9V;X>7LK_\_?K>*Q/M-OW?L^3:7-S7C9K"\<K5YAE-:VWM
M76PUO\/L\L_>7Z\WPV5MV?&VE_\ !S!_P3<N\?;]0\<Z;O\ [^C7EP4^OE6H
MSVZ@UU4/_!R5_P $PGZ^+_&29]?#NI=L^MO]/3K7L&H?\&X'_!-;4L^9\'?%
MUKN(S_9_CJ>V_+]RN/PQZU@2?\&SO_!,Z487X9_$6$^H^(5R<_\ ?49!Z^U3
M]:^B'6;:H^,5*WQ0IO)ZO(WT<JL.FMG'>SOT+3XYAI?()[:RK5I?^EX2@]?+
MG\^7KR,7_!Q[_P $OI.3X]\5)]?#FJ#^=N?\_KJP_P#!Q-_P3!FZ_$KQ#%_O
M^'M2&/\ R7/Z_I3Y?^#8S_@F[+_JO _Q$@^GCZY;_P!#@;]:RKC_ (-?_P#@
MGC-_J_#WC^'_ +G.\?T.?F5N<T2?T0=/]K\7\/>]_K%/)Y7[<GLJ<K6O[W-;
M=6V9$Y\>.W*N'NM[3F_OM$Z2'_@X2_X)AS?\U8U2+U\W0[H?^U!_]?M6K%_P
M7]_X)C3=/C'=1_71[G^LI'?^5>7S?\&N'[ 4G^JL_'\7O_PE]V?QPT9K*F_X
M-8_V%I?N7/CZ'M_R,-X>/Q0_G^7LEA/H@U-8YWXK+NG0P=1?+V,8<OGS7OI:
MUF1[7Q CM'AUW_F<WMVNOO/?(/\ @O)_P3*GZ?' 1_72;C^LOIS6Q!_P7,_X
M)FSGY?CU:+]=-N!V]YOUKY4F_P"#5/\ 8FD_U&N>/(3ZC7;L_AEHS_C61/\
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M[5^?ELOAN[M\0\10_B\,U9W^'V-:M&UM^;DP]>][JU^7K:^MO[?4\2>$9?\
M4^-?!DGM'XETN4_^.SC]3^=68]4T23_5^(O#LO3_ %>MV,OK_P \V_QZ5_#:
M_P#P;S_\%@=*_P"07^T29?\ =\=7T?\ )OY>O;@BH_\ P0N_X+B:9N_LSX]:
MH^.GE_$N]7O[/S^?/O5+P*\,JW\#Z1? KM\'UG+,1@;7[\^82]K?KMR:?S$/
MBG.:?Q\*8V5]N7$8I[;W_P"$_3?J?W5(]M-_Q[WUA-_URO()?_0&%?&_[?G[
M%'@_]O;]FCQ/^S]XP>"Q75+N#4_#_B=1')/X<U6"^1Y-1M)%5668VZ31DNS)
MY9V[<!=O\B+_ /!'7_@X$TK_ )!OQH\3..<F/XO7"8S_ +J__7Z^M4Y_^"7G
M_!QU:K+;6WQ7\=312QR0R*OQJN5'ERAUD (CRF1*_P RE64G*,"H(]3)O _(
M,GS; YSDGTD/#+#8[*IO'X3&TJE;"XG#U:%G"-*5+%3E.=3F;7O0:<%;FYG;
M*MQ1C*]&KA\;PAF$\-52C4BJ]=\RZ)J>&HWC?=6FM%?ETO\ UJ>&/B/^QK_P
M3G_9X^'GPA\8?&CX<^#-#^&?A6UTDVMOK>FZGJ>HW%I%Y=S?7VGVLJ2FXN$X
MRVY@<E2&&1^1?[2G_!T%^QO\*VO-)^"'A'Q7\;-?B>2U@O;<P:-HJ7;']R'^
MV%IKA5.!^X;YCU!Z5\$?!;_@UQ_:Q^,^I6_C']LG]H0Z2]^XGU+2K>_N/%>L
M*!_RR::5UA!]0@7/&1@Y/[P_LU?\&^'[ O[-ZV5_)\*5^+'B>UCB:;6?B#>-
MJNFR31<QR)H=Q!-Y;#^]$R9SAMV*PQN6_1JX2S#%8OBGC/B?Q;XHQ5>MFV/R
M_AS#1P62U,;C*U2M6IU\SKR4E"OB'.:<*DG*7MI5/>DFZI8GB_&4*6&P.#P>
M1Y9&/)A_:T:=7%^S:7N\[3J4_9+9)1^+1OI_-!XO_P""QG_!9S]O349O"_[,
MWPIUGX<Z!J1>U@D^'OA74K&2ZT]SB":[UN^M&@N'3^]#(6;/+&NF^'/_  ;U
M_P#!2W]K;4+/QC^U]\<KOP'INHM]IN(_%>O:GKVJ2*?^67V+3[R*W@7_ &9H
M=H_NU_==X3^$VB_#[3+;2/ G@OPMX-TJT2..ULM"TVTT^"!(B?+6)(8EV;3_
M '3\W\6:Z;_A'-9<DBW4Y^]AR W^^!@./4,".F1TKSJOTF)Y'[7!^%7AUP=X
M>TN54Z>90R["9UQ'&$4XT*E?,,71>&C5BG.495?;WE*3BX<KYNBGP9[=QK9S
MGV-S&<'>-&%2NJ=%RUJ1Y)3<;3:BDDDK1L[G\[?[-'_!MK_P3_\ @;]@U3Q]
MIGB+XX^([?;-(_C":W.B0W,?W9+&VMY+<;@>HV;6Q\P-?MW\,O@K\&_@II5M
MH_PF^%O@GP-8VT4<$2Z)H&GQO)'%_JP)IX)YU(X_>+*)&_B8U[2?#6LD<VJ$
M DC+9VGOM_N_\!QBE_X1K6O^?9<>F_@?0=OPQ7XCQ3XB<;<9XB>(XFXISW.:
M\W4=1XO,JOU62J-7C2P.#KT\OHQ7*DXT:$5)**E?E1])@\KRK )?4L'3IU$E
MSUI4::J3M?E?/R<S:O)O7K?J8<DTLJ R2.^/N!F)6(9^["A.V!?]B$(OM3(V
M(! )V_)\N?E^7.T[>F1ZXR>YK>_X1G6<8^RKC_?_ !I%\,ZV/^76/G_:8_\
MLPKXF*4$U%**EK))6N]=7NV]7UZG?)*::FN9.UU+5.VUUL[=-#&R>!DD#G:Q
M++^*ME3]""*2MS_A&M:_Y]E_[ZH_X1K6O^?9?^^JVIR:O:36W6WZZ_.X12C%
M1BE&*VBE9+T70PZ^#_CKM7X[>'@P 'FZ>"7<#CZC_/I7Z&?\(UK7_/LO_?5>
M;^(/@)HOBK7[?Q1K.G3RZS:-&;=X+W9#&8C^[.T@1OMZX=&#9^8&K=GJ[/S=
MAG6CE8_:*WQ_X"#_ !-)6Y_PC6M<#[,O 51\W9$\M1^"#'J>IR>:/^$:UK_G
MV7_OJLZCO;6]K]?0##HK<_X1K6O^?9?^^J/^$:UK_GV7_OJLP,.IG^Z?P_F*
MUO\ A&M:_P"?9?\ OJI#X<UH\&V7\_\ [*@##C[_ (?UJ2MA/#FLCK;+_P!]
M'^A_P^M/_P"$<U?_ )X#\_\ Z];IJRU6RZKLO,# D[?C_2I*V'\.:R>ELO\
MWT?ZG_'ZTO\ PCFL_P#/ ?\ ?0_^)K.=M+6ZWM8#&HK;_P"$<U?_ )X#\_\
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M_P#OL_\ Q5<MX[LKFT\%:S]J0)ON=-VX.>$NOE_+\0>,YH MT444 >P4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% %>>(S0RQ!S&98BOF#&5)& V
M#QW''L:_)CQ?_P $@_@OXT\=^)_B+JGQ4^,T'B;Q9>?:]5O=.\6WUD67'_'E
M!Y%W$B6W7]W'&B?[(.<?K?3-AZ[O3MP,=,#. ?< &M:6(KX:7/0J.E)JSE%\
MLK=DUK9W=UUZF52C3J\O/%2Y;VND[7M>U_1'QW^RQ^Q=\,OV3K#Q+:^#=7\4
M^)K_ ,67"S:IK'C75[G6=1:W1S*+.WDNY;DI;+(=S6\92)AM1DV@"O/?%?\
MP3A^!WB/Q)XHU*QO/%'ACPIX^U(:OX\^'WA[4I;'PMXHO0XF,]S;(X^S>;)E
MIHX/+AG'RS1S+\M?H-M/][KGMSSZ'.1^%*54\$9!!!!)(((P=P)PV1QD@G%"
MQ-?FE)591E*2E)TYN+E)7M*7+:\E=V=KZO74(T*2^Q%^ZXJ\4[1E;FBK])67
M,MG97V.:\(^$/#G@7PUI'A/PII=GHGA[0K*'3M-TVQB\BVM;.!=L<<:@[MP
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MDKI=N%]3R/?OG^[*YT31KM62\TC3+I'&&2XLK692/</&P)]^OZ8\H\2_LU_
M+QB)%\3_  :^'&LB7AS>>%-()/;K%;1D?\!Q5OQO\'LV3CGOT=N&TWI+$Y'F
MV,RF4>?^)*G2A3I1J-V3@KQ]G;25ILF7#>>TN65#BG%SY?ACBHNW=*T9S3[.
MZ?30_E-\!?\ !W5\([KR5^)O[.7B_P .$?\ 'RVB275SY7T%ZJC_ #QQ7V1X
M"_X.FO\ @G+XOEC@U@_$;P5(7VNVO:/9>4H_ZZ6]V_YXQD>]?J/XY_X)1_\
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MHS^S)<$FT^.GC^VS@DO96K]&#@X;?@JP!4C!7D @$@_UX4N/I_WT/\:[\/\
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M8S[WD /'T8_G["O2:\V^+'_(DZG_ -?.G?\ I;;T 9%%%% 'L%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4F![_F?\:6BDTGND_4!,#W_,_P"-
M+110DELDO0 HHHI@%>4^#/\ D?\ XH?]?V@_^FNO5J\I\&?\C_\ %#_K^T'_
M --= 'JU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %>1?'3_DBWQ8_[)UXR_\ 3!?UZ[7D?QTQ_P *7^+
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MX;_#C0OA?H"^'?#QG-@)&E'VIM\QD?[Q+?,Q!SG;G [ 5Z'0,**** "BBB@
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YM\6/\
MD2=3_P"OG3O_ $MMZ])KS;XL?\B3J?\ U\Z=_P"EMO0!D4444 >P4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7E/@S_D?_
M (H?]?V@_P#IKKU:O*?!G_(__%#_ *_M!_\ 370!ZM1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?_GL'^KU?_H><0?^%V%_^5'\X_\ PN'_ (.//^C>/V3?_!]-_P#+&C_A</\
MP<>?]&\?LF_^#Z;_ .6-?T<;3Z?^.)_\11M/I_XXG_Q%'_$4<'_T:SPP_P##
M%F/_ ,]@_P!7J_\ T/.(/_"["_\ RH_G'_X7#_P<>?\ 1O'[)O\ X/IO_EC1
M_P +A_X.//\ HWC]DW_P?3?_ "QK^CC:?3_QQ/\ XBC:?3_QQ/\ XBC_ (BC
M@_\ HUGAA_X8LQ_^>P?ZO5_^AYQ!_P"%V%_^5'\X_P#PN'_@X\_Z-X_9-_\
M!]-_\L:/^%P_\''G_1O'[)O_ (/IO_EC7]'&T^G_ (XG_P 11M/I_P".)_\
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M_P#!]-_\L:_H<\,M)+X?TB1V9W>QA9F8!BQ*\DDJ2<GW]N@K<VGT_P#'$_\
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M87_Y4?SC_P#"X?\ @X\_Z-X_9-_\'TW_ ,L:/^%P_P#!QY_T;Q^R;_X/IO\
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M%D=UJM]=:C<_;Y@9[J5II2JCY07<D]/?\,U]5T %%%% !1110 4444 %%%%
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M,/&C*UD[.:6?Y;*=:A&I5G/!XA8.LYT94U&L_?7,Y))MQG'7HDM#]?2>A#$
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MB<YR[!/%1Q.+E".#HPKUZCP\_=56I&G23ER6?/*=E%;]S]PR6.0&(.,YST[
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M3V=N$<P:NMG9I-7ZI/H>-G7^[X7_ +&F3_\ JSH']#Q'&.V7/XC.*DJ,]O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %1DCD-ST.,+@<=@W7UYS_ $J2
MOSD^/OC?Q;HWQZ\-:/I?B"\LM,G>R66RA=EA<2SVT;AE()^99'4D'(SE<':0
M ?HU@9SW%+4,+LT43,<LT43,< 9+ %C@  9] ,#MBIJ "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "O-OBQ_R).I_]?.G?^EMO7I->;?%C_D2=3_Z^=._
M]+;>@#(HHHH ]@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "O*?!G_(_P#Q0_Z_M!_]-=>K5Y3X,_Y'_P"*'_7]H/\ Z:Z
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MOUZZB&*,YRO7).&8$DXR200<\#GJ,<4IC0G)7GUR0>F.<'GCCGM1O'M^9_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7Y?_M'D_P##1?A/I_K-.[X_Y>;/Z?UQZCK7Z@5\T?$']G+2_'_C
M_2_'EQXBOK&ZTPQE;&*T1X)3$R.A,C/O&&C0\8SC# Y((!]'V_\ J(/^N,'_
M *"*L5&BB-4CY.U54>@"_='KP!WR3W)J2@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+C_^*HY)?R5?_ 9ASP_FC]Y>WCT/Z?XT[!]3^G^%9_\ :.F_\_ME_P"!<?\
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MH]U_7R+N#ZG]/\*,'U/Z?X52^W:=_P _EK_X$1__ !='V[3O^?RU_P# B/\
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M]E_S_0?^!4'^-'_$4,3_ -$#X9_^(A0_^;BEDT/^AMFC_P"Y[$?_ "P_GO\
M^$0_X.+_ /H??V+/^_'B+_XW2?\ "(_\'%O_ $/W[%?_ 'Y\0_\ Q%?T(_;[
M+_G^@_\  J#_ !IW]H6/_/W;?^!4?_Q='_$4,3_T0/AG_P"(A0_^;A_V-%;9
MIFGSQM=_G4/Y[/\ A$?^#BW_ *'[]BO_ +\^(?\ XBC_ (1'_@XM_P"A^_8K
M_P"_/B'_ .(K^A/^T+'_ )^[;_P*C_\ BZ/[0L?^?NV_\"H__BZ/^(H8G_H@
M?#/_ ,1"A_\ -P?V.O\ H:9G_P"%E;_Y8?SV?\(C_P '%O\ T/W[%?\ WY\0
M_P#Q%'_"(_\ !Q;_ -#]^Q7_ -^?$/\ \17]"?\ :%C_ ,_=M_X%1_\ Q=']
MH6/_ #]VW_@5'_\ %T?\10Q/_1 ^&?\ XB%#_P";@_L=?]#3,_\ PLK?_+#^
M>S_A$?\ @XM_Z'[]BO\ [\^(?_B*/^$1_P"#BW_H?OV*_P#OSXA_^(K^A/\
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MMK0U#P%X2OM1OXY;^ZT2QENY9;J/S'N)(0\C/\ZC+-DXVA1T4  "NV^WV?\
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M_H@?#+_Q$:'_ ,WA_8\?^AKF?_A97_\ EA_/5_PB/_!Q;_T/W[%?_?GQ#_\
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MCSKO_G^N/^_LG^-,R?;\A_A1D^WY#_"K48V7NQV71?Y"YI?S2^]_YC_.N_\
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MQ_GW?_/Y<_\ ?U__ (JCS[O_ )_+G_OZ_P#\53**++LON7^07?=_>Q_GW?\
MS^7/_?U__BJ?]IN?^?FX_P"_\O\ \74-%%EV7W+_ ""[[O[V3?:;G_GYN/\
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M +^-_C1YEQ_S]3_]_&_QI**.6/\ +'_P&/\ \B%WW?WL<TLP"XNI\GK^\?\
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M_GO/_P!_I?\ XNCSY_\ GO/_ -_I?_BZBHHLNR^Y?Y&'-*[U>RZONR7SY_\
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MZ;_GM-_W]D_^*J.BFMUZK\P3=UJ]UU\RWYDO_/67_O[)_P#%4>9+_P ]9?\
MO[)_\53**VLNR^Y&X_S)?^>LO_?V3_XJCS)?^>LO_?V3_P"*IE%)I6>BV?0!
M_F2_\]9?^_LG_P 51YDO_/67_O[)_P#%4RBL0'^9+_SUE_[^R?\ Q5'F2_\
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MR ?YDO\ SUE_[^R?_%4>9+_SUE_[^R?_ !5,HHLNR^Y /\R7_GK+_P!_9/\
MXJCS)?\ GK+_ -_9/_BJ9119=E]R ?YDO_/67_O[)_\ %4>9+_SUE_[^R?\
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ME1JK7UL=E_@A^1\\NO\ CE^844450QR?>'X_R-35"GWA^/\ (U-6=3I\_P!
M"BBBK6R]%^0!1113 *E3H?K_ $%15*G0_7^@K.IT^?Z&E/K\OU'T445F:!11
M10 4444 %21]_P /ZU'4D??\/ZT 24444 %%%% !1110 4444 %%%% $D??\
M/ZU)4<??\/ZU)0 4444 /3J?I_45+42=3]/ZBI: "BBB@ HHHH ****#=;+T
M7Y(**** >S]'^3+%%%%<Y@%%%% !1110;K9>B_)!1110,**** "BBB@ IR?>
M'X_R--IR?>'X_P C0!-1110 4444 %%%% $D??\ #^M25''W_#^M24 %%%%
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M"2/O^']:DJ./O^']:DH **** "BBBL'N_5_F!8HHHK=;+T7Y( HHHH ****
M"BBB@ J5.A^O]!452IT/U_H* 'TQ^@^O]#3Z8_0?7^AI2^%@)_RS_P _WJ(^
M_P"']:/^6?\ G^]1'W_#^M9R^&'S_0"2BBBG3Z_+]0"@?, 0F['(.T^7_P!]
M'YCSCN317R)\6_B'XO\ #OQ9TCP]I&H-;:/=26:SVKVP=Y!-Q(,Y9TW=?D9<
M?PX%: ?7=%*.B'UCA8_5[<2,?Q<Y]!T&!Q25G4Z?/] "BBBLP"IG^Z?P_F*A
MJ9_NG\/YB@!L??\ #^M25''W_#^M25T+9>B_) 1R=OQ_I4E1R=OQ_I4E8/=^
MK_, HHHI %%%% !1110 5*G0_7^@J*I4Z'Z_T% #Z*** "BBB@TI]?E^H444
M4&CV?H_R84444'.2IT/U_H*?3$Z'Z_T%/H **** "BBB@TI]?E^H4444&@44
M44 3)]T?C_,TZFI]T?C_ #-.H,'N_5_F%87C3_D2M;_Z^=&_]*JW:PO&G_(E
M:W_U\Z-_Z54"-6BBB@#V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *\B\)_P#(\_%7_K[T;_TT/7KM>1>$_P#D>?BK_P!?
M>C?^FAZ:W7^*'_I0=_\ !+]#Y&U'_D(W_P#U]7'_ *5&JM6M1_Y"-_\ ]?5Q
M_P"E1JK7UL=E_@A^1\\NO^.7YA1115#')]X?C_(U-4*?>'X_R-35G4Z?/] "
MBBBK6R]%^0!1113 *E3H?K_05%4J=#]?Z"LZG3Y_H:4^OR_4?11169H%%%%
M!1110 5)'W_#^M1U)'W_  _K0!)1110 4444 %%%% !1110 4444 21]_P /
MZU)4<??\/ZU)0 4444 /3J?I_45+42=3]/ZBI: "BBB@ HHHH ****#=;+T7
MY(**** >S]'^3+%%%%<Y@%%%% !1110;K9>B_)!1110,**** "BBB@ IR?>'
MX_R--IR?>'X_R- $U%%% !1110 4444 21]_P_K4E1Q]_P /ZU)0 4444"ZK
MT?YH8W5/K_44^F-U3Z_U%/K'[?\ V]^IO'X5Z?YA1116QB%%%% $J=#]?Z"G
MTQ.A^O\ 04^@ HHHH>S]'^3 *^<?VCR5TKPP5)7_ $K4?NDCU]",].]?1U>7
M_%#P%<_$"RTFTM;^/3GT^XD>1Y8S+N6;F3@<#=STZ?PXKEJ1YX2CWM^%_P#,
MZ#J/!1_XI3P^.QTRV)X!R3;8/_ZNE=16/H.G2:1HVG:6[>;+8VJ0O(< ,$7:
MHP!@87C)&2.223FMBBG'DA&/:_XV_P @"I(^_P"']:CJ2/O^']:HF7POT_R)
M****##J_1?FPHHHH.D**** "BBB@ HHHH DC[_A_6I*CC[_A_6I* "BBB@ H
MHHH **** "BBB@"Q11140WEZ_JP"BBBK ****3V?H_R ****P *\L^-G/PXU
M/(!^>W/(!/?OUKU.N0\?^&I_%WA>XT&VNXK.2[F4K<2HTFQ$^Z"%^7C/4@DG
MJ:;LX3B[>]:WRN!P'[/_ /R(4H))QJ&!N)8]<=6R>E>W5P'PU\(7'@CPZ=%N
M;R*^=KGS3/$C19]]K<?D ,]1@UW]:4K*$8JWNWO\P"I(^_X?UJ.I(^_X?UJP
M6Z]5^:)****#H"BBBL'N_5_FSG>[]7^;"BBBD 4444UNO5?F@6Z]5^:+%%%%
M;G0%%%%)[/T?Y %%%%8 %%%% !1110 4444 %2IT/U_H*BJ5.A^O]!0 ^BBB
M@ HHHH **** "BBB@"2/O^']:DJ./O\ A_6I* "BBBLZ?7Y?J 4445H 4444
M %%%% %BBBBN< HHHH ****Z "BBB@ J2/O^']:CJ2/O^']:SJ=/G^@$E%%%
M9@%%%% !1110 4444 %%%% $D??\/ZU)4<??\/ZU)0 4444 %%%%8/=^K_,"
MQ1116ZV7HOR0!1110 4444 %%%% !4J=#]?Z"HJE3H?K_04 /IC]!]?Z&GTQ
M^@^O]#2E\+ 3_EG_ )_O41]_P_K1_P L_P#/]ZB/O^']:SE\,/G^@$E%%%.G
MU^7Z@%?!_P =E7_A>GA_"JN9M.R54*>@_B4 _K7WA7SS\0O@OJ/C3X@Z;XT@
MUNUL+:Q-BSV4L+23$P_ZT_*,\CJ. .P&:T ^A^BP^\4&?_ 3_P"L*2EQ]T<_
M*BHO'1E3RU/7G"<8/7J<GFDK.IT^?Z %%%%9@%3/]T_A_,5#4S_=/X?S% #8
M^_X?UJ2HX^_X?UJ2NA;+T7Y(".3M^/\ 2I*CD[?C_2I*P>[]7^8!1112 ***
M* "BBB@ J5.A^O\ 05%4J=#]?Z"@!]%%% !1110:4^OR_4****#1[/T?Y,**
M**#G)4Z'Z_T%/IB=#]?Z"GT %%%% !1110:4^OR_4****#0**** )D^Z/Q_F
M:=34^Z/Q_F:=08/=^K_,*PO&G_(E:W_U\Z-_Z55NUA>-/^1*UO\ Z^=&_P#2
MJ@1JT444 >P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7D7A/_ )'GXJ_]?>C?^FAZ]=KR+PG_ ,CS\5?^OO1O_30]-;K_
M !0_]*#O_@E^A\C:C_R$;_\ Z^KC_P!*C56K6H_\A&__ .OJX_\ 2HU5KZV.
MR_P0_(^>77_'+\PHHHJACD^\/Q_D:FJ%/O#\?Y&IJSJ=/G^@!1115K9>B_(
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M0 4444 %%%% !1110!)'W_#^M25''W_#^M24 %%%%9T^OR_4 HHHK0 HHHH
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M **** "O(O"?_(\_%7_K[T;_ --#UZ[7D7A/_D>?BK_U]Z-_Z:'IK=?XH?\
MI0=_\$OT/D;4?^0C?_\ 7U<?^E1JK5K4?^0C?_\ 7U<?^E1JK7UL=E_@A^1\
M\NO^.7YA1115#')]X?C_ "-35"GWA^/\C4U9U.GS_0 HHHJULO1?D 4444P"
MI4Z'Z_T%15*G0_7^@K.IT^?Z&E/K\OU'T445F:!1110 4444 %21]_P_K4=2
M1]_P_K0!)1110 4444 %%%% !1110 4444 21]_P_K4E1Q]_P_K4E !1110
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MWZO\V<[W?J_S84444@"BBBFMUZK\T"W7JOS18HHHK<Z HHHI/9^C_( HHHK
M HHHH **** "BBB@ J5.A^O]!452IT/U_H* 'T444 %%%% !1110 4444 21
M]_P_K4E1Q]_P_K4E !1116=/K\OU ****T **** "BBB@"Q1117. 4444 %%
M%%= !1110 5)'W_#^M1U)'W_  _K6=3I\_T DHHHK, HHHH **** "BBB@ H
MHHH DC[_ (?UJ2HX^_X?UJ2@ HHHH ****P>[]7^8%BBBBMULO1?D@"BBB@
MHHHH **** "I4Z'Z_P!!452IT/U_H* 'TQ^@^O\ 0T^F/T'U_H:4OA8"?\L_
M\_WJ(^_X?UH_Y9_Y_O41]_P_K6<OAA\_T DHHHIT^OR_4 KX0^.RC_A>GA_/
M.9M.&223T'<DD?4'-?=]?-WQ&^#'B+QI\1=+\9:?J%C;V5DUBSVT[ 3,T/\
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MKFDU&+F_L_J=!Z^..F!WZ"BL7P[J$NJZ%I&HW*D3WUK#/(L8'5OO$@ !<]P
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M2 ****:W7JOS0+=>J_-%BBBBMSH"BBBD]GZ/\@"BBBL "BBB@ HHHH ****
M"I4Z'Z_T%15*G0_7^@H ?1110 4444 %%%% !1110!)'W_#^M25''W_#^M24
M %%%%9T^OR_4 HHHK0 HHHH **** +%%%%<X!1110 4445T %%%% !4D??\
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MYT;_ -*J!&K1110![!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY?4?]]-_\:KZ;_X51JW_ $.G_EOZ7_C1_P *HU;_ *'3_P M_2_\:/[2I?\
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M/^9\XY'JWY/_ /&*,CU;\G_^,5]'?\*KUG_H=F_\$&F?_%4?\*KUG_H=F_\
M!!IG_P 51_:2_DC]W_ &L(E]IO[_ -3YQR/5OR?_ .,49'JWY/\ _&*^CO\
MA5>L_P#0[-_X(-,_^*H_X57K/_0[-_X(-,_^*H_M)?R1^[_@%K#+K*7WL^<<
MCU;\G_\ C%&1ZM^3_P#QBOH[_A5>L_\ 0[-_X(-,_P#BJ/\ A5>L_P#0[-_X
M(-,_^*I/,>T%\E_P!_5X_P TOO?^9\\[Q_=;_P ?_P#C=+N']T_F?_C=?0O_
M  JO6?\ H=F_\$&F?_%4O_"K=:_Z'A__  0Z;_\ %5/]H+_GVON7^1$L)%VM
M)K[_ -&?/.X?W3^9_P#C=&X?W3^9_P#C=?0W_"K=:_Z'A_\ P0Z;_P#%4?\
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M,_QH_M!?\^U]R_R']7_F;7:VG^1\_P"]?[Q_\>_^,T;U_O'_ ,>_^,U] _\
M"KM;_P"AW;_P0:7_ (T?\*NUO_H=V_\ !!I?^-']H+_GVON7^0?5X_S2^]_Y
MGS]O7^\?_'O_ (S1O7^\?_'O_C-?0/\ PJ[6_P#H=V_\$&E_XT?\*NUO_H=V
M_P#!!I?^-']H+_GVON7^0?5X_P TOO?^9\_;U_O'_P >_P#C-&]?[Q_\>_\
MC-?0/_"KM;_Z'=O_  0:7_C1_P *NUO_ *'=O_!!I?\ C1_:"_Y]K[E_D'U>
M/\TOO?\ F>!QGK][D9Y)XQZ_N?>I,CU;\G_^,5[P/A=K8Z>.'_\ !!IG^-+_
M ,*OUS_H>7_\$&F?XT?V@O\ GVON7^0?5X_S2^]_YG@V1ZM^3_\ QBC(]6_)
M_P#XQ7O/_"K]<_Z'E_\ P0:9_C1_PJ_7/^AY?_P0:9_C42Q][6@E\DOR2#ZO
M'^:7WO\ S/ F893KZ]_KWA]OY5)D>K?D_P#\8KWC_A5VMG'_ !7#\=/^)#IG
M_P 52?\ "L=<_P"AWE_\)_3/_BJCZ[UY%^!2H+_GY)>K?X'A&1ZM^3__ !BC
M(]6_)_\ XQ7N_P#PK'7/^AWE_P#"?TS_ .*IW_"K]<_Z'E__  0:9_C5QQ]K
MW@G\D_S3$\-'^=OT;/!LCU;\G_\ C%&1ZM^3_P#QBO>?^%7ZY_T/+_\ @@TS
M_&C_ (5?KG_0\O\ ^"#3/\:O^T%_S[7W+_(7U>/\TOO?^9X8KIM[COU;/X?N
MO;OTI^Y?4?\ ?3?_ !JO</\ A5^N=/\ A.'_ /!!I?\ CQ^%+_PK#7/^AX;_
M ,)_2Z/[07_/M?<O\@^K_P K;[WU_P SP[<OJ/\ OIO_ (U1N7U'_?3?_&J]
MQ_X5AKG_ $/#?^$_I=-_X5EKG_0[R?\ A/:7_C42Q][6@EOT2_1 J#ZW_']$
M>(;E]1_WTW_QJC<OJ/\ OIO_ (U7M_\ PK+7/^AWD_\ ">TO_&G?\*PUS_H>
M&_\ "?TNH>,[4X_<BU2:ZOYW_4\.W+ZC_OIO_C5&Y?4?]]-_\:KW'_A6&N?]
M#PW_ (3^ET?\*PUS_H>&_P#"?TNE]<?_ #[C]R#V;[K\3P[<OJ/^^F_^-4^-
MU]SD^K?D?W/!^E>W?\*PUS_H>&_\)_2Z4?#'71T\<O\ ^$_I9_F:/KC_ .?<
M?N0I4I/9^MOU/$O,7U;]?_C5'F+ZM^O_ ,:KVW_A66O?]#R__@@TO_&C_A66
MO?\ 0\O_ ."#2_\ &AXKFW7+;M;7UT(]A+S_ *^1XEYB^K?K_P#&J/,7U;]?
M_C5>V?\ "LM?_P"AY;_PG=,_^/TO_"L?$'_0\/\ ^$YIG_Q^A8A=_O\ Z1<:
M<E>\OOU_(\2\Q?5OU_\ C5'F+ZM^O_QJO;?^%8^(/^AX?_PG-,_^/T?\*Q\0
M?]#P_P#X3FF?_'ZKZS'R_KYC]F^Z_$\2\Q?5OU_^-4>8OJWZ_P#QJO;?^%8^
M(/\ H>'_ /"<TS_X_1_PK'Q!_P!#P_\ X3FF?_'Z/K,?+^OF'LWW7XGB7F+Z
MM^O_ ,:H\Q?5OU_^-5[;_P *Q\0?]#P__A.:9_\ 'Z/^%8^(/^AX?_PG-,_^
M/T?68^7]?,/9ONOQ/&H]N.IS^/3V_<\_Y]J=O7T_\>/_ ,17L@^&7B$=/'#_
M /A.:9_\?H_X5EXB_P"AYD_\)W3?_C]'UF/E_7S#V;[K\3QO>OI_X\?_ (BC
M>OI_X\?_ (BO9/\ A67B+_H>9/\ PG=-_P#C]'_"LO$7_0\R?^$[IO\ \?J7
MB%W^[^F'LWW7XGC>]?3_ ,>/_P 11O7T_P#'C_\ $5[)_P *R\1?]#S)_P"$
M[IO_ ,?H_P"%9>(O^AYD_P#"=TW_ ./T+%<NRYK][:>F@>S?=?B>-[U]/_'C
M_P#$4;U]/_'C_P#$5[)_PK+Q%_T/,G_A.Z;_ /'Z/^%9>(O^AYD_\)W3?_C]
M'UQ_\^X_<@]F^Z_$\;WKZ?\ CQ_^(IV1Z?J__P :KV+_ (5EXB_Z'F3_ ,)W
M3?\ X_1_PK+Q%_T/,G_A.Z;_ /'Z'BN;=<MNUM?70/9ONOQ/(_,3U_\ 0_\
MXU1YB>O_ *'_ /&J]=_X5IXC_P"AZE_\)[3?_DBC_A6GB/\ Z'J7_P )[3?_
M )(J?K-OA5[[W_X9![-]U^)Y%YB>O_H?_P :H\Q/7_T/_P"-5Z[_ ,*T\1_]
M#U+_ .$]IO\ \D4?\*T\1_\ 0]2_^$]IO_R136+:^PGZV#V;[K\3R+S$]?\
MT/\ ^-4>8GK_ .A__&J]=_X5IXC_ .AZE_\ ">TW_P"2*/\ A6GB/_H>I?\
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M;KEMVMKZZ%GE>Y?4?]]-_P#&J-R^H_[Z;_XU7JG_  K3Q'_T/4O_ (3VF_\
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M7?BG_H?[C_PG]._^2*/^%=^*?^A_N/\ PG]._P#DBG[==OS X7S$]?\ T/\
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MW_R11[1=G^ '&;U]1^4G_P ;HWKZC\I/_C==G_PKOQ3_ -#_ ''_ (3^G?\
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M ((-/_\ DBC_ (5YXJ_Z*!<_^"#3_P#Y(JO:+L_P YW*^K_]\M_\:HROJ_\
MWRW_ ,:KH_\ A7OBO_HH-U_X(=/_ /DBC_A7OBO_ **#=?\ @AT__P"2*/:+
ML_P YS*^K_\ ?+?_ !JC*^K_ /?+?_&JZ/\ X5[XK_Z*#=?^"'3_ /Y(H_X5
M[XK_ .B@W7_@AT__ .2*/:+L_P  .<ROJ_\ WRW_ ,:I\;K_ 'AUYX?VY/[K
MC^7M70?\*]\5_P#10;K_ ,$.G_\ R10/A[XK'3X@7/\ X(-._P#DBCVB[/\
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M2*D#"W+Z'\I/_C-2,PP>& ]"&]?:+/\ .MG_ (0#Q;_T4*Z_\$&G?_)%'_"
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MS_X3VF?_ !^@"#<G]Y?S?_XS1N3^\OYO_P#&:G_X03QA_P!%"N?_  GM,_\
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M=TFNNHF![_F?\:,#W_,_XTM%4,3 ]_S/^-+110 4F![_ )G_ !I:* $P/?\
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MG*F]XNS_ !7Z'7"7/",U]I7&[%]/U/\ C1L7T_4_XTZBI*&[%]/U/^-.HHH
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M4H*I4J^S52_L[\SYK/6UEWLDM=].QQU<4Z<W&,%+E^+3:^W7U/VN..>0,#)
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MM#P[X?UK7I+>:Z32--O=1^R6Z[I[@6ENT@A10,EI&7C!R 1UP17XD^&_AO\
MME_MTZ=<?&"R_:YM/@OX*OM6UJS\-_#CX?:3%/JNA6FGZC=6$/\ PD6K1RK+
M]O=85E\J9)25 +*0^6Z*&'C751SKK#0ARIUO9.MRN5^7]TD^:_*_3YF%:O[%
MP]WFYKZ?X;?YG[FJ<\$@'W3C^2C_ #[5-@>@_(5^.'PVO?VI/V,_BY\,_AQ\
M9?CK8_M&_#_XP:C>Z'HL=SI46G>.?"5]:6RS+?RD2-<ZUI\I.&=(XE&'08*G
M'[(5-6@J/*XU_K,)W4:WLW1Y^6U_W32<+7[:]V%&O[;GTMRVT];]?D)@>@_(
M48'H/R%+16)N)@>@_(48'H/R%+10 F!Z#\A1@>@_(4M% "8'H/R%&!Z#\A2T
MTD@\=AD^X]/Y_I0 G X(&>GW<D]@Q"@8!QZ >XZ5&&!XZ<9^9%Z#V4YYZ<8_
M/BO@3]M7XS?%?PQJGPP^"GP6USPSX&\<?&2_O;%/B/XQBBGT7PII>GKF\EM[
M2?\ T>]UDAL06\K.C@G]W@G/R;-^P3^W9HLDGBW3?^"B6O\ _"2VTO\ :C-K
M7AP-X6EEC&6M[BR>X=(K!\?,Z-&R#H0,FNRE@HS@IU,3[#G7[N#IN?M=;-*2
M3Y+-Q7=\WD<53&<DY1C#FY&E+ROM^3^X_:\D#M^BX/N.#UZ_I]),#T'Y"OC;
M]C#XZ^+OC5\.=83Q]#I\WC?X>>);WP-XGU[P^L8\,^*=4TH8FUK0'A<PBTNV
MRVV,)"IP(D5<X^RJY9TIT:LZ<XM<K5I>TYN:]WI&[Y;*WK?R.N$N>$9_S*]N
MPF!Z#\A1@>@_(4M%24)@>@_(48'H/R%+10 F!Z#\A1@>@_(4M% "8'H/R%-4
M'G<![# _P_S^5/JM<3BWMY9RLCB*,R^5&H:5@ 3L"\Y)/'USSQ2UYHQ2O?KV
MVM^8FU%-OH2D9X&,]SMVC\,JX/TS0O.,K@?[IY_WMRJ1] .OMQ7XC/HO[77[
M>6N>-_$/@W]IG3OV?/AIX0\9ZWX0T7P-X3TN#4/&4X\/7?V.74_$-_')#=V*
M:B<21+@+C A14'$VGZ?^UK^P9XJ\$:S\2/VD;;]HOX5^-_%&F^$=1\%>(M)@
ML?&UG+J1(&JZ)?M)+<W\UMM.Z%=UN01YD/(![OJ7NW]K'VEN;V?O7M:_IMUV
M.3ZW%2Y6MW9/\#]ML#T'Y"C ]!^0J"";[1!%.,H)8HI<,,%0XR5.1U[>N>:L
M5PZ\THM6MU[[W^ZQUIW2?=7$P/0?D*,#T'Y"EHIC$P/0?D*,#T'Y"EHH 3 ]
M!^0HP/0?D*6B@!,#T'Y"DP#T"GID<<?B!3J^)/VVOCEX\^#?P[\/V/PR.BV'
MCOXC>*+#P?HGB?Q0D;>&/"LM[/9Q2:KJYE*P/,%N/]!@E1[>5TD\Z)L8JZ=-
MU9QA'>3M?LNKT)G+DA*?\JV[GVME<X)!X[*,\]R,DC\1^'%*""<8&<$XVX..
MF1G(Z\'/3O7XHR_L"_MSZI.?%<O_  44\1+XE>;^THY[#PVH\**Q&0@TW[2-
M]D5!()E;(!.0!FOKS]B?XT_$WQI%\1_A-\8=6\/^,OB%\%M<M?#^J^/_  G'
M'%H7B^&YM5NDO8K:$F&UNHLFW>*(K&>,@%#GHJ8-1@YTZOM/9_Q$N9<M]K\R
M75-6T>FJ.2GBI5)QBX\O,[1TWMO^?XGWH5XX S]!_44N!Z#\A0,D9/?G\*6N
M0[1,#T'Y"C ]!^0I:* $P/0?D*,#T'Y"EHH 3 ]!^0HP/0?D*6B@!,#T'Y"H
M-Q(XQGOE-OY95@?Q'YU8K\:?'MQ^U3^V;\6_BS\/_A1\?-,_9T^'7PC\1/X3
MO-/T_2HM0^(/B:]@!+ZN)3*LNF:;-C"/Y<R9PJ8.!710PSK\\G-TX4TN>K;F
M4.>Z7[M/WV^5V]UVLW=&%:O['ETOS-_A;_,_8T,1@'ECV";OS<*JC/H1VZ\U
M8P/0?D*_#+5?A[^V3^PA%8?%K7/VL;;XX_#F'6=,L/$_PT\;Z/#::SJ]K>W(
MBD_X1S5I)3(;Y5(_<Q",XPRIP2/VR\/:RNO^']#U^.%[:/6](TK5X[><;988
MM3L[6\\J52 5D@6X,; X(9/F%*MAO8J$XS]K3J<T8U?A4W3MS?NV_<MS*^B3
MOHW;0HU_;<WN\O+;_P FO_D;>!Z#\A1@>@_(4M%8&XF!Z#\A1CZ\>Y_7GG\:
M6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* L@HHHH **** "BBB@ I,#&,<?Y-+1TI6=TT]OSZ"DTD[[=GU/RJ^-W[*G[
M-'[7/Q7\5S_#WXM>)/AK\>_ D-K8^-=5^%VMW&DZG:QS8^SIKVG1O#!-(3_R
MU8^:2<%SG->9_ O]@S]GJW^-%]I'CG]I3X@?M'?$+X726NKW7@'QOKE\EEX9
MN) !:W&IZ2MRUK=] P2X251A6*[QQTOQ2_: \8^&/C'\2?"G[$7[+]M\2OB2
M+BT3XN_$26Z&E:!!?H"+;3[PRN/[0O+;))6*10__ "T1J\\^'7[0_P"T/\$O
MB=?_ !(_:C_8YT;P!I'CBXT[1/%_QS\"7$5VFGH))(+6?Q/;JS3-9K(T*^<4
M\U\8:0DFO9A'%2HN-*M3BHQ7NU91]K9IW5-R=TG;51WLKMV1YK5%5.:5-NSW
MA&V_\UEKWUVN_,_;:..&%(XH46&.&-8HHT4"..-=H5$53M"J%4* , # P.*L
MUG6-];:I8V>HV,L<]G?6UO>6MPO$<UM<QK-%*I[AXF##!XSR/31KQVK2DG\2
MUD^[;?7J[IW['HP:<4XII=$TU]P4444%!1110 4444 %>)_M 7WP@L/A3XJ/
MQTN=)M/AI>6D.G>()=:!%H([J94B7S%PR2"?:Z2Q%9(V!*NIVU[97S9^U5XH
M^$_@_P""7BSQ!\:M @\6^![%M.:?PM+ ;F77]6>^ABT?3+.V5D\VZNKZ6(*-
MV,$JP93LJZ5W5@H\RDW[KBVK/SZ=M_,BK_#DW9Q2O)-7;7D?EYXP_P"";?PH
M\&>%+SXE^'_VU?C;\*O@H]K%JMI:VWB&]OM$TO2+N<7"BUU*:9KR*T,?"LM@
M)%4\,H%?HU^R1^SA\%O@3X!AOOA+>WOBM?&MO#K>I_$37-3N-7UKQ@+B(/%>
M7&H7DD]Q]D;ADME=8$)R(R  /SF\3_&+_@H-\3_"SZ%H?["7A4?!>_LK>VTW
MP1XQU:">_OO#T<:QVD%S9!X/L<\42H/*=E5@,R;BQ8_=?['G[1K?$C3;OX2^
M-?A7?_ ;XI_#BPM+6_\ AC>.DEK%HL2+'9:CH-S&2+W3T1=I 9MQ)9M^>/3Q
M:Q2I-3K4Y+7FC1E!2MI_&Y+.37V>>]GS6>K."C/#NI!PIU$[O6LFXKSI<WP_
MWN6U_=NMC[I"@=!_.EHHKR%HDM_,](****8!1110 4444 %?FG^TI^SO^S-^
MUC\3V\(#XB:KX$_:)\'Z!'J7]L^ M5NM+\3V/AV>X'E?VEY#06>IV0) $,UP
MY7&"-V0/TLK\JOVAOCG?^!OCIK&@_LM?LVQ?&7]I6;PS;#QAXKCGBT[3?#6@
M>:8[:RUG5Y05BD$QR+5 D;<K(KCBNS!1K3J\N'FJ=;249S:5)*+O+VM].6UK
M7T,,0Z:BHSC)\U[<O2UK_?='BG@C_@GI\"K+XU:=\.OBQ^U?\4?C9XQT:S@\
M3V?PC\5Z]>V\,MI;0;X=3U&VLKFY@GM$;+O%.S1R@%9%;BOVQTW2]/T?3[+2
MM*LX-/TW3K:&SL;*U00P6MK;H(X8(D3 6-$4 +SGJV223^'FD?'O]KWX8_$2
M+XU?M(?L2Z"NGV]E%H_B7XJ^";V&77?"OAEALFGO8F>8WEA"I"LH1F7CD'!K
M]K?"7BO1?&_AK1/%GAR]CU#0_$&GVVIZ9>1X_?65U")(I2.@8GJ,8[8K3,95
MIU8SK555E9QYH->PYHV4O91@E!:<O,XI-Z7Z&>%E3?M(PC*+CR\W-UOS6M]S
M.EHHHKSSK"BBB@ HHHH *1LX..O&/Q-+12E:SNDUV>M^P=?E^IP'Q-U3P+HG
M@'Q9J?Q,FTV#P)::+>GQ3-K,0FTQ=(E4QSB[38S,A1]HVC*,0RLCA7'X[:G_
M ,$W_@SJOAF]^,/P8_:U^+_PC^"NJZ?-XM6T\/>(;Z\\(V6E[IY+F\M(;V[M
M);:R,B38B@,2Q*-L4:HJ*/UM^..M_#SP[\)_'>L?%:UMK[X>V.@7<WBBQND\
MZ"]TR-TC:T\L/&[RSRR1*B*P8OT. 37Y#GX\_MQ^+_"$&@_L_P#[#NAZ'^S]
M=Z-+IOAS1O&^H017&L^%;EI7A*Z6&ADM(M2MYY08I6'D[]\0C?#5Z>!AB.64
MJ56G2IQ:YU5E!*6CY>13O>22ELM-+]$<&)E!-J<9R_E4;Z=_2^A]L_L3?LS_
M   ^%/A8_$GX4^+]4^+NK>/+6)[OXO>)-5N-;U;7[:)OD2UGNWF?3XC@K-%;
MB$7 ($X88!^^J_-O]B_]H6^GDA_9T^)WP)/[-GQ(\-Z<;O0O!<=Q#/X<\1Z+
ML$SWWAN[13]H,$>?,21W9L8!!&#^DE<N*E4G6E*K*4WLI2ES)Q3T4>EEY*VQ
MOAY4W37)&4;6OS)_+?Y_TPHHHKG.@**** "BBB@ I"H/4?SI:9OY '(]?KZ4
M,5M4[[7T[GP!^UG\'?V9OVD?&'A7X0^/O&,WA/XWC3KG6? VH>%]5NM)\9V%
ME"?,EF@N+9[?[78%NMM,SQ$YW*.!7Q>G_!.CX-^'OB7X/^&OQG_;/^,?CV]\
M1,UYH?PEU_Q%?Z>/%%K;[3+$IM+FZDFC^1=ZRS-E 1@JS _5/[6'QHTCX;_%
MWPI8_"'X!GX[?M4W7AJ[D\.)9RK;_P#"*^&9)Q'>76I:I,#':V4@R,( T8(*
M,C$BODR]^-'[=FB>-O#_ ,8?CG^PEX7\36G@M9Y8O$WA?4[=O%/@_0YG\W4K
MRVCF:>6=K*#(55#[AEB"W(]?#PQ4J,53K4X+E=HUI1Y_+V*EK&[T=MWRW6QY
MM66'C7;J4ZLFW_RZNHM_]/5'22_EYKV]ZV[/VV\)>$_#W@7PWI'A/PMIEKH_
MA_0K*'3M-TVSB\JWMK:! D<:*26;"_>>1GD<Y:1W<EJZ:O-OA7\3O#'Q@\!Z
M!\0O"%X;K0_$%I%=VZS(L=U:RNFV6RNX\D)<PRGYU]>  " /2:\J=U4FI\SJ
M)^^W=W;;M:_H[V[I[6/0@O=322@TN6*5K=[_ (!1114EA1110 4444 %86O7
M>C:?HNL:AXA>VBT2TL+N?5I;P"2T73HHFDN&N$?<&3R6?<I!##(Q]T5NUR/C
M.]\/:?X1\1W_ (O^SCPM:Z)JDWB#[4";4Z0EJYNQ,JD,5-J&7J&!PR,K88$5
M>I!+FYW?E:Z/3?;5Z6NR*G\.3=G%+WD]WZ?B?C_=?\$\_@+\9[?5/C3^S9^T
MQ\2OA/X&\07FJ:EJD7P^UJ\D\(2WL+E]:G@L;JZLH[01,-PAM(XH>=H#  GW
MS]AO]EG]G/P8E_\ &7X??$W7?V@_&%^TNAS?%#Q9JUSJMQ;"QD\E[&PTZYGD
MCTF96!61H!"[@[6; KYKTG]HK]JK5="&C_L2?L8:-IOP"BGU2'0]5\3WD>GV
MWB6&6?;J&I:;I;R1^59Z@N?L+7(?S0?WA; ->U_L<?'WQ!X+\2V'[/'QM_9K
MMOV9/%'B1[W5O!8T>>"[\'>.;R2\+7OV"YMU*1:Q(W^D-93,9$0%(U1, >Q5
MCBHT)PJ5H-N*<84I0YTE\2J\MVW9KEN[;GFTGAY58N%.HG=W]JI./_</F5EU
MYK6O[MS]6Z***\9*RM>_FSU$T[I=+!1113&%%%% !1110 5\2?M>^ ?V:/C%
M;^"OA!\<->@\/^*_%M[<K\+[ZPU&]T;Q;!K$*!)9= U"SB6>V8K\K$3I&^,D
M'[Q^VZ_/W]LGXJ^!OAGKWPRFL?@P?C?^T'>76I_\*@\*V!BAU.QGBC\W4=4>
M_>.2*SM2@*EIU=5(S&$)8GHPBD\1!0YD[2:<79)JVLNEEOKTOW,JZ3I2NDTM
MTU=O_#UOZ'Q%XD_X)R?"_P  ^(_"/A3XP?MR?&V72O&^L6^F>'OA_KOB"_LH
M?%TB]-%2\@O979CR"LDO/.X=!7[-?#'X8^#?A!X+T7P%X"T>+1?#>@VAM+"Q
MB9I92'8R/+=73EY)II&.YIIG=R-HW84*?QE\2_%/_@H9K.K^'O&GQ4_8+\%^
M-=*\&ZC%K>E6.GZK!-XE\.B*0O->:9*S+%/J7DC;L3<BX+! WS5^N'P$^-OA
M?X^?#O3/'GAN&\T]IO/L=:\/ZBGEZKX?UNSQ'J6D:C#]P7-K*< E<,#TY8#J
MQL<7[&$Y5:=6#E/G5*2=K./+[7EU?7EYM%KRVUOR86IAW)0A"JIIZ.M=I?\
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MK8-8:<->O[C2[#2]66*.RM(+C[6+^-+Q9X_G%N)HL@H8V) _3W]E[]GGX0_
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M3"BBB@ HHHH **** "O@W]K?X7_LR_'[5O!OP:^*WB=_#/Q6U07-_P##74-
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M2#SR<8QWJ:O#7.KJ;3=WJE9^=_G^NYZ*2Z;65ET^2Z>84444QA1110 4444
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M#OP\OBG]GOXD2Z9\:]/9'^&\'PW\7:YJNJ7WB7;G2[*;2T9+1X+EOED%S$R
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MF]];;V^8G>_EK?OY6/SW_:F_9N^,WB3QMH7QZ_9B\?:9X,^,7A_1I]"N]/\
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M:O\ QY2ER_X.;X;_ &K;VC?8^B****\F'P_-G=U^2_-A1115C"BBB@ HHHH
MI7ME;ZA9W=A<QF2UO;::SN(\E=]O<Q-!,I (PKQDK\N" 2RE6Y'X_:Y^S_\
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MJ44-WX?GC8K&$MGE#2$X! VY<$#GK7RC^U?\0_CWX_\ C9X>_97^!'Q!\/\
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MZ+T.BRU=E=[OOZA1110,**** "BBB@ KYK^*WBKXX:)\3OA-I?PV^'FE>*/
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M37L?+NLWWQ;\0_M ?\('XA^$_AS7/V?/^$7^WGQEJHL]0E_X20CFR_LZZBE
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MP/PU\;)\1/ GA?QK!8WFFIXBTBUU%M.U"!K:]L9+A<M#=0R /&\1!RN.ASZ
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M9W^(/B35WMIY=!N$G,<<:Z==!X[A3#R/*48RQY)+'ZAK\^?^"B7Q[\#?"O\
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M=*K9TVN:.R]Z^MV@P]134HK10MI9)+FOLEZ&[1117(= 4444 %%%% !1110
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M7OV:O"?P+\)^*K6;3?%GC#Q1KEKX@$>D7"[9%T>SMQ,T.H$9*/(HFB(W1NC
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MV?V3?"?PKA\20W.C:KXZ\4^(;37-'TVPNX6M[BX&G1^<Q\R)R!E,QMB2,K(
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M\(?#/0M%^!T>DV_PXMA<-HMOHD[SZ;"6PMVD1>20IB927@W!(VPJ!5 K\\/
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M"CDY/ZG\/\_6EJ(H>Q!_2C3=].HNJU[Z7W^74^,_C]\5OA;X ^-7P&\-:_\
M#/4/B!\2/'>I:AH_@R\L-/BNQX5TR,C^V=7NI+@-%:VT(_B"AB>589R>K_:0
M_:%^#W[+OA_PQXE^)MNMOI_BWQ59^#])^P:5#>33:EJ,9=6>".)I##%MS*R
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MH_&6M> [_4-#^'\NLZ1.8YK#6_)O;:QUO4(IL&=98I_//RW E4[:]/\ V?\
MXP?L\>(/CCX#3XU_L1:O^S1\3[**+P]\/O%OB;0H%\&7%U#!';:?I6G7=LJV
MMMJGV>-56[N8V61E+R2-(QDKM[_PS^W9^QUXC\5Z)\ ?A9X4_:!^$'BOQ;KG
MC#3;+[?#HGC'1=6\13_:+^#4[V94-]:6T_,<LLLK\>6A"?)4FG>$?VW/VRO%
M7@RQ_:"^%/AC]GWX1^#?$5GXIO\ 3O[176O&GB"^L3FUM]/O8 XT]4/^L$<D
M4<PYG60"OH'77U>457?*H636(GSVY;6Y+6:Z:R=EM;5'D<DX5%>A"TI:-TX]
M]7>U[N^_4_9,%"@9""I 92.01D$ 8[=/3^=2U6B@6"&&!,D1)L3))(50.,DD
MGH.223CK5FO =KM[W>_5VVN>O'X8Z):;+2WR"BBB@H**** "BBB@ KX _;[U
M+X$)X \&^$OC=\,=6^+=IX^\7VOA7PMX8T6 SZA%K6J"WLI=99VD1([?2;>Z
MM[XL[%)3;>7*)$>56^_Z\(^//P?C^+WA6RM+.^31_%7A?4$\0>$-9EC$D6G:
MQ:[=AG@VEI+68(BR*BE6VC>C# JZ<H0J0E4=103U]DY1J*5_<DI1::496<K=
M"*D>:#5DU;X6DT_5/<_,+QW^PE_P3M_8P^"MSXW^*OPW3Q+H-MXIMX'U;4H6
MDUJ*\\679%IIL<%K-%;O%;L&&Q(LR;3O#<BONC]CGP;^RGX<\&ZCJG[+&D:%
MH>A>)'M=5\0:=I$DB75OJ%["9K==8TZ1A+:W(B8[<A&9=V6;YF'R#XN_94_:
M_P#VJ/BC\/X_VH?%?@/1O@1\+O%5EXO7P7X'M[H:CX]UO2GWZ6VN/*_V?["7
MSNC!$2G<#$1D5]1_LQ?LU>)_@E\:/VF/&FH7^GS^$_BOXGT+6O"&F6!DB32+
M#3M.^S?8_L[$QP*K[@=B@L>7W=O5Q524Z,O;8VI6KN*<[5I3I.G9>R@E>SE!
M7Y^J;5[V/-I1<*Z4</32OI)4XIKO9I+^O,^Y\=/;I_*BBBO&226G_#GJA111
M3 **** "BBB@ K^=S_@HM9?"'QK\9M6L_@3X)^/&O_M(Z+%#:^+O%'P#DN(=
M,L2X&RT\3(LL5G>ZM#W(!E;&)&?K7]$=?D/\1? /[9?[+WQ5^(7C[]F3P'X4
M^-GP]^*WB)O%/B'P7J-VFE^,-)\02+ADM-7N04?32#D*\PB3((16 QZ.6UG0
MK.K"I&,XI<L)M*%1.ZDG=-.W9I[W./&14X1@XR:ES7J0NI4[6VDM5S?H?F9^
MRYX?\+^#_B]X0G_;?\"?M2LXUVQ/@;Q+\66N8_A;HVNS7>=/77(;>Z>!EN1P
M6O4G2,@;5 X/]3UH]N]K;2V;1M926T,MI]G51$;=D\V)H@H 6)XFB\M5PH7:
M$"BOQ>U.#_@H+^V.--^&?Q3^!_A/]G?X52:GI^H>,=3U;4X/$/B'4K*Q?>UK
MX=^R"1;._E<EDE'DR1C)25%''[)Z%I,/A_1-(T2TEEEMM&TO3M*MWF.Z:2#3
M+>.T$LC,69WDBB0,2S,6^;<6;>;S.JZTJ<W*G=NH_94I)TZ=W'51BHQBY];)
M7Y5>]C/ +D52FHSY8\EJD[WG?FOJ]7RV[O<VZ***\L] **** "BBB@ HHHH
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M\H[#IR>.:=12Y5:UE;M;3[@$VCT[ ?4#. ?4<G@Y'-+1136BLM$MET ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU-U/JDHTXP2DY.<Z:LU[VFB56E+W85J4IOX8\\7>V^B=^WH=J'Y(W#CU!_F
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M=,D\S4([N6W^S;+22!)KA9?W6U[_ (((?LW?L>?MS_L)?ME?L(^ _''@?3_
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M?\-H^-;WX@_M*^%OV@OVG/AU\3O%-Y;Z?8V^I:S\/?CKXZ\)1IH-KHVC>'M
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M ,$%?A!^RS^U-^VS_P %9?@S^V+\-/"GCOX^Z=^T+XI^*OA_3O$.HZ]9ZW-
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M?-_:F&W_ (-1O"LHP)&_X)@_L;G< #N+^!_@@S+R",[F9U 'R-N*XW&O??\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M="+R(P&4*0&^]M=U)XV]0P(P  ,$8P,8P, AC7HI_%W;_P!"8], +_=  7
M EHI<JM[J2=M+*UM%'=6:7*DK;62T;2:;U5GJK\UGJN;^;U\]SC/&/BWPI\/
M/"NO>./&VOZ5X0\)^&M-NM9\1^(==O8M/TG2]-M8Q)<WM_=SR0)%#&J!$:4H
MS';&L3.54_C/=?LQ^*_^"EW[8/P:_:P_:"\(:]X'_8S_ &1=4G\3_LB_ SQ_
MHVJ^'O&WQX^,%\\!G_::^,GP^\1V&G:Y\.O!_AF33=*B^"'PZ\8:78?$.[GT
M^^\8^+]*\*:5KI\(ZU^XS0QLNUE!&0<'+<@D[CNSEB3\S'+-_$3@5#Y:J
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "D  Z4M% "$ \&DV+Z'ICJ>G7U]>_6G44K)VNE[K3CILU>S79J[L^EPN
M)M''MTY/'ZTM%%.W7K_P6_S;?S **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ I-H_KU/Z<\4M%*RO>ROWL F!SQUZTM%%"22LDDM=%IN[O[VVWY
M@%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
K "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>figure04_01.jpg
<TEXT>
begin 644 figure04_01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )8 \L# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Q5>W^ZO\
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M]"Y;]!]1_,UI)T/U_H*S(.J_Y_B%::=#]?Z"N>7POT_R.>IO]WYCZ0]5^O\
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MX/UZ_P"?_P!? ZJ=3_/3\T24'3 ;Z$?B>,?3_/O3 , #T&*NNNX>_P#/_/\
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M_6K@&4 ]\_J:C10P /H"/KC_  S5H1KMXQD]<_R[GT_G7-/XG\OR,1T0PO\
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M7J?RP+V_W5_K4J=3]/ZBHE[?[J_UJ=.A^O\ 05^H4_@I_P#7J7_J4SS']O\
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MAZO)=.4\=0P.)>J_VW$4IUJ-]$TO9PEK;;78_-)/O#\?Y&M&/ ))W<*6R&5
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M;XJ\.3_"CQYX0\:_$/P)X5\ :DK:QXDB\/R:5K/B;QGK6H6-EIVK#0]5FO\
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MP?/P_"G%6-CA\KQ>3X;*,)@FHQS7'U?JM7"T\5&4W06%_P"7DJW,I*"ZRO\
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M(?"OG^8Y?"_3_(E3H?K_ $%2JNXX_E0J9'7&./7_  J15VG.[';TSWQW]/\
MZ].7POT_R.5_''^NY.(QCOZ<=/H/\_E3XU"L",]^OTH'W1W_ -KUX_+WIZ=3
M]/ZBL#0MI]T?C_,TZG1=O]T?TJ4@'&>QS0 +T'T'\JF !4 _YY-,52>>@J15
MVG.<\8Z?_7I2^%^G^0TKM+N)L7W/^?;%+M&#@=1ZG_/6G444NGJRW!)-ZZ \
M>U58=AW[XY[?3V_6H3DC<<>G]:MD;DQZJ*C6'"%3ZY_F.QX'/J?Y5TF96]??
M_$'^E X&!T__ %_XT\KAMOK^)]*'38<>V<_YZT":NFNY&1D$>M-5< @]^O\
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M")_%\D/3J?I_45.GWA^/\C4"=3]/ZBIT^\/Q_D:"2U'W_#^M25''W_#^M24
M%%%% !5R/O\ A_6J=7(^_P"']:RGNO3]61+XHDE%%%06%%%%-;KY_DSHCM_V
M[^B+<?WU^M78QN#C./GS_.J$'5/J?YFK\??_ *Z#^M95.GS_ $&MU\_R98'
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M;+WNEO\ D8U;Z[?NY[;=OC2WUNS+,/.3IGY>N>G8?7_Z_:\-7M"#B;GJ1W_
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M%_W5236M3^Y?\>4^;FU6Q5Y(FO;2619GA:,W=N\A\G&Q8F/^D1H Q8JGS[E
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M%8E/"Z6P\OAPD.:#=_\ #HO5H]G"X'#85Q^JTJ>)JJ[J5:O\)/EDFY_W;O\
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M57)&Y/&GAJ3+;=PVK'?;LD D9XX/<BB/&G";:4<ZRJ[=EZ_>"R?,[K_9>?\
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MR(N%2;E=T+O'N&_!T_M#*U=_VA@)63?+2S%5:CM&3M"G]N7]WJKOH'U/%?\
M0,_P/0UB?:."?\_R_P XI?+?^Z:_*N\_;)_;0\8>+_'4OP/_ &6#JGPF\/\
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M3(;Z'3X/%_P\\*7WA622Z**\FIV?AY_#FJW"Q0F2)8[:^E),F?LCL!- E_\
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MJR?P_P# ?Z5I1=O]T?TJ,3D.02@HO),KLU9_\)?0R6)Q5_\ >?S_ ,C\@_\
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M;/X?_6KF7 /!DVG/)/?Z?\*F:;_^'0Z?[7Q\M/K2UT/S?M_^">WQ:L2&M?\
M@IW_ ,% $)2-"O\ PMH31;H6SYP6]BFA_P!*W;P542 1$!@I8-T4W[$7QTDC
M C_X*@_MZ6S*\3BXC^(FB2RKY0(^<W&C7B%&) .(E;)4API96^_CN[Y_'/\
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M$^ &N"ZW)'LB9+SP5&SK&2IW[@P* -^[+U]$QNY//''M[>WZ&K(=\8Y&XX#
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M5]H^K_(P?^7YHGJ=>@^@_E4%3)]T?C_,US'71^#Y_P"9>B^X/P_D*L?\L_\
M/]ZJ\7W!^'\A4X^XWU_PI2^%^G^1DOCGZ_J:4?W%^E6$Z'Z_T%5X_N+]*L)T
M/U_H*P+)XOOC\/YBM)/NC\?YFLM/O#\?Y&M1/NC\?YF@"PW\/^\/ZU>@_P!6
M?Q_]"%4'Z#Z_T-78?N_Y]3653]'^H%H?>3_='\C5RJ8^ZG^\/YFK:]!]!_*N
M"IT^?Z#C\2]?\R1.I^G]14M0K_%_NG^E/3H?K_05,?B7K_F=$?B7K_F*_P!T
M_A_,4V/O^']:<_W3^'\Q3%Z/]/Z&NNGL_7]#67POT_R+J?P_\!_I5BJ4/W!]
M35Q>@^@_E4SW7I^K,2S4R?='X_S-0+T'T'\JD3J?I_45 %^+M_NC^E35#%V_
MW1_2IJRG\7R0$R?='X_S-.IJ?='X_P S3J@VC\*]/\PJ=>@^@_E4%3KT'T'\
MJJ/Q+U_S"?PR]&3I]T?C_,T\'!!]#FF)]T?C_,TZMCSI?%'U9HM(RA"G+%<*
M#PIR,$/_ +( .?\ :VUPOQ.^%?PX^.O@>^^'7Q2\/C7_  [? BWN!.]EK>BW
MZ+(EIJ_AG5(2MUI.IV$DK-:W]LPD17D@D6:VGGMYNU?[L?\ N_UIT><''8Y/
MTX_KBLJ]"CB:-3#XA4)4:T7"K'$PC4H.#<;JI"6C3:BHZIJHZ4HRA.$)PUA.
MI"49TOXD7>'^)7_2Y^)GCCP'^T%^Q)?:V_BL>(/C+^S3J$4ND+\9/#-C'<^+
MO"N@:O!+ILFE_&;P=8QR:E;I9P2_8XOB1X9@FTY5,5WJUKIUT\$HX?P_X 3Q
MCX)U'2?AIXJ\1:+XJUF[E\0_#2+Q!X@T>[^&?Q.2YT^SM]%\#Q/=6UC;Z&D<
M(GT=7:SNY/M?E7]X=6$CQC]]3<E04<*\,L3P7*-$ES');3@0W$,UK*1'<P20
MN\=Q#*PA:!I#<+- LEO+^5W[0/[!WB_1;?Q#XB_9+C\/ZCX>\1ZDVI^)?V9O
M&EY#9>#4U&\O8AJ&N_"'Q,L,EOX%U"\>0ZE+I,OV?0+F:.6:U?1V@64_E.?\
M&9AE-26,R.&+QV$K/GQ65UIRJ8[!4N92EB<+C)<TJM#E24,+BI1QD82?LJN.
MA!NG]!@LVH8I1HXR?LZD-/:?R.S5_P U\SZ1_9'_ &D!\:/!^D>#O$^A:KX5
M^(OA?08[.[M-66)H]57P_<KH&JVLC0K UMK7AK4?+TO5[.XMGMW-Q:WNCWDE
MK<7-M;?5<D<AQP %9E7;T4J<.G.!R<'\.E?D%\$O#7[1'P4\31_'3X]^ Y?A
M6=/M%\"^%M-F\4:1XH\+:GX>U5-/L]<C^(FIZ++>R^&/$.O36&EKX;\7W>HZ
MOHE@T&R^U%&NX98/U=\'^-O#GC_3)-2T266"\M4MHM9T#4!;QZUX?O)8WF6P
MU*&W+1Y,#0R0WMN38:I 8]0L;B\2>22+[#A;.JF.PBP694J6&S7"I*I2Q7^]
M/!+3+E3_ +_+S/T4CS<QP4:-7VU&'MZ=1W=?^1:^]^-OF;;.XP.?E.<_F/J/
MIGC\C432NPW#Z=.@Y].G3_/-3XQD#L3_ #JOC)'UX^O3^M?6Q^)>O^9P1ER2
M4OY7?\U^I4=P21WY!^G3COZ56<=#^'\ZG<89O9L?GD_TJ,C((]:V-^6WO_S?
M\/\ B4C)AL9^@QQ[?B??]*2X7&UN.G'MG^5/*Y9OID?B1_,\?K3I.$ ]5VY_
M$T$R^%^G^1ELN?WGX?3@CG\C^=1/AE)Y.>,\]_\ ]7?TJT!M!'OD^O>J[=#]
M#_*M8;/U_1&4?B7K_F9^W:=OU/\ +_$4-T/T/\JED[?C_2H'Z#Z_T-=,/A^;
M-GL_1_DR*F/T'U_H:?171#X5\_S.2IT^?Z%9NA^A_E51^I_W1_Z$*NMU;ZFJ
M<@Q]0<?AUKJI_9_KN9E:3M^/]*CJ9UW >QS^A_QJ&O3H_#]WZ@?RFKV_W5_K
M4J=3]/ZBHE[?[J_UJ5.I^G]17ZW3^"G_ ->I?^I3/(?V_P#KZ_U):5<Y^7KC
MVZ?C24H)!R*HTA\/S9(N/?=CG.<]>?;K^-/IBL2<''3_  I] G\:^7Y,*N1]
M_P /ZU3JU%V_W1_2@J7POT_R+*=3]/ZBI:@7J/J/YU/08A1110 5<C[_ (?U
MJG5R/O\ A_6LI[KT_5D2^*))3'Z#Z_T-/J/C>21D 9XQZ#GFIBKM)]RR2HFF
M5%<MMVA3@L<<@CFJUQ=QQ EG"8[D[0IP0"6_@RV%W=MP'4XJMX/\*_$;XS>+
M+7X?_";PS=>)/$EZS1S+&Q&EZ5$62-[O4]3^Y:V*-+$7>7Y#*\,2_O7CQCF&
M+R7)<GS7B/BC-\KX?X7R' XG-<^SS.\PPN593E.5X.E*KBLQS#,<;*.$P>&P
ML5"K.MB'[)25*$HS]M&$]:,:U>K3PM"A+$UJTXTZ6'A#VDJLY.\(1A]J3<;Q
M_E<5+[!1U#Q';6BJJ$33LRQ0P1I+(9)G)$492#$YW2;0BP_O'D*)]UFK[(^"
MW[#_ (U^(.E)\2OCWK:_!/X.6RK?SOK$\=GXGUG3QMDN'M[>\_<:+!<=8GN?
M]-E"KY7+&O;++P+^S#^P#9:;KWQ*EM/C9^T])I<<EOX:#QW>A>&]2N"I,4-D
MO^BV2V,D:YU'60;Y@6CL\).YKXI^,WQZ^,'[3FO2ZO\ $'69K#PW&X;1O!6D
MNUIHNF6,F460QOB:>:?R@%DNL/L$BVW[HOG^'(>-?CO]+.K/+OHD87#^#?@/
M">,RK-/ID>(O#U./%?&N$H59X7-H?1M\.<33]KC,'B/93HX'Q3XSI8?+*N(G
M'&Y7@*^*HY:SZZIEF4<.3AB>*_9\0Y[5IQE0X3R;%>QI8&G9.G5XIS3K55T_
MJW50C37Q'U_XI_;8^'/P5\/ZA\(OV'_AYINA62-]EU7XG:C:LVHZO=HDL+:I
M LP^VZE=N2)([K41]E"+((?OQU\$:F?$WC;6[CQ+X_\ $6K>*M=O)3-+J&IW
M4\I+N=[K%;S_ "VR*W 2V_< >IQ4FFZ3;V2^6L:C:JKA?F"A<!%+]SMSQWY-
M;Z  X"[1C^6/\>P^M?NO@E]&[P;^CK#,\;P%D&(SSC[B:,\1QQXX<<9CC>,?
M%SQ&S.O)5,94XHXUSJ>(S"<7B'4G+)\FI91D&!HK#X=82I[&E)>'G.=YOGWL
MZ6-K2PF7X;_<,JP.'^HY31BM(4UAO^7^(4?BQ/VVG+[0VVL88$Q&,*.,?X_E
M_*M-%51\I_S]/\:BJ9/NC\?YFOW!5)SG*=3XI^OYG@QCR22\_P#,:WWU_#^9
MJ2BE'1OI_45,_B^2/0I]/\/Z(MQ]_P /ZU;7H/H/Y54B^X/P_D*MKT'T'\JY
MI_$_E^1<-Y?UU9(G4_3^HJXO0?0?RJFG4_3^HJ[4F%3^*O5?J/3J?I_45+42
M=3]/ZBI:#>GL_7]"S#T'U_H]:2=3]/ZBLN'J/J?Y5J)U/T_J*'L_1_DRI?"_
M3_(M)T/U_H*M+T'T'\JJIT/U_H*M+T'T'\JXZG3Y_H<%3K_B7YBTJ]1]1_.D
MI5ZCZC^=9G?#X8^B-.+[@_#^0J=.I^G]14$7W!^'\A4Z=3]/ZB@HU(^B_7^M
M6:K1]%^O]:LUC/XG\OR,)?$_7_(*EA^^/H:BJ6'[X^AJ3JH_#]WZFE#U'U/\
MJOQ=O]X?TJA#U'U/\JNQ_>'^\/Y-6-7K_A_4YZWPOU9H1]_P_K5M>@^@_E5*
M/[S?Y[+5U>@^@_E7*1#9?X?_ )$LH<8XSP/Y9S^E74'&<_A_7]*HKT'T'\JN
MQ?<'X?R%*7POT_R.^7\*/^%_H3IU/T_J*TT^Z/Q_F:S$ZGZ?U%:,7W!^'\A6
M!@3IU/T_J*T8ON#\/Y"LY.I^G]15VW^ZW^\?YFE+X7Z?Y&T?A7I_F6TZGZ?U
M%7(^B_7^M4TZGZ?U%7$^X?I_[,*X:O7T1E4W?R_0O_Q_\!_K3UZCZC^=,'\/
M^Z?_ &6GKU'U'\ZYCIH_#_7=EE/O#\?Y&K:]7^O]35->H^H_G5U/NC\?YF@W
MK?9^?Y,MP]!]#_.M"#HWU'\JSX>@^A_G6C%V_P!T?TI2^%^G^1Q1WG_74LIU
M/T_J*;<V-CJ4$MEJ5G#?V4ZE9[:YC$L#KU!E1OE*HP5]Q^>,J)8/])2&G)U/
MT_J*EKGE2IUHRI5J<*U*I&4*E*I#VD*D)1?-"</M0:OS?RQ3G]@ZJ+:E=;II
MKU5['GLVJ:KX)NH(?%:W&O\ @YW":-\0+:&XN/$7@%6!%MI?C:S@9;GQ/X-(
M#"TU"-DN],MXXX]2EM_,2XA]'M+X2M9VEZ8(;V\@-Y:3VKR7>D:U9%X_)U70
MM0(2WN-+*NBP0VB*+,RM%<0QR[9[RQ!@ 9 ;A@5(#;@\91D"O^Z<2(S1ND_[
MIHV=3\Y2N)U2UE\%:>=0TC2[G5_"5K=&^U3PCITAFO=!EDW^;KW@??\ \@Z6
MS#M-?:-;?Z/?VTERQ^:)!7YS6RO,.#YULQX?HRQW#M>M*IB^'L1/VE/#R<KU
M:^48S_E[@X\SJ5,+]F5/^X>DY4LQ]GA\5_O"]W"?XTFU_P"2QF>I1 9)&22,
M.?X=RX''H>:GK)TJ_M+_ $_3]5LM4L]:TK5(A-IVK:>VZVND(PXD7_EVOU)V
M:A8<?8KB+9SYG&N1@G(YSU[D5]=@\9@\QPU+,\!BOK&$Q"5)R_Y]XJWO83_M
MQQDO^W#SI1J4:LJ3VCH_O+$?5?I_2K<??\/ZU33^'_@/]*NIT/U_H*Z1EA.A
M^O\ 05J0]!]#_.LM.A^O]!6I#T'T/\ZNK\"]/T1,_A?]=43U,GW1^/\ ,U#3
MTZGZ?U%<AI1^#Y_YFC%]P?A_(593H?K_ $%5(NW^Z/Z593J?I_44I?"_3_(4
MOB?K_D:4?5?]_P#I4\??\/ZU7B^X/P_D*LIT/U_H*P$31_?7ZUI)T/U_H*RA
M]Y/]X?R-:J=#]?Z"@"S_  ?\!_I5J#[J_P"[_4567H/H/Y59@[_C_2LJGZ/]
M0++]4^@_DU7EZ#Z#^54*OKT'T'\JX*G3Y_H./Q+U_P R1.I^G]14M1)U/T_J
M*EJ8_$O7_,Z(_$O7_,:_W3^'\Q3%Z/\ 3^AIS]!]?Z&F+_%_NG^E==/9^OZ&
MLOA?I_D68?N#ZFKB]!]!_*J</W!]35Q>@^@_E52^%^G^1B3I]T?C_,U(GWA^
M/\C3%Z#Z#^52)U/T_J*YY?"_3_("]#T'T/\ .IZKI_#_ ,!_I5BBK\,/Z[@2
MIT/U_H*?2+T'T'\J6L#6&S]?T05*G0_7^@J*I4Z'Z_T%5'XEZ_YCE\+]/\BR
MGW1^/\S3J8G0_7^@I];'G5/XJ]5^I</^J'^\/_9Z?%G!],G/TXS_ )'-,/\
MJA_O#_V>I+?[K?[Q_F:"P;)X3H3CG/X?UQW_ %IL,CQ;AD+EL_GD\_\ UO;F
MK6 <Y^H^OX?C4$@9 &ZJ3C]#QG\#T]/PI2YK/DA"I/[-.I\$W=>[+U5TO[W(
M&Y4U6STW6]-U#1->T^RUC1M8LY]+U72M1ABN;'4+"]C,%S:7=K-\EQ#/$[1-
M&WR+O$TW[B*6OSS\9:-K7['/BG2/%FF7-Q)^SO</!H^E^*[K^TM5O_@O+-=(
MEIX'^(0/^DZ_\%M1E$EOI7BB\_XFGPZU8LCG^P+B6OT7\LNIQVR?P'?/XXJI
M=V>GZMIVH:)K5C9ZKHVK6-WI6K:5J-O%=Z=J6G:C"]E>6-_9W'^B7MM-#.ZM
M:77[FY;;"/WKQY\7/<BPV>1HUZ3JX3-\'^]P.:.WUW"8N%Y4\JKV7^XUI753
MO0E4ZZG5@\:\(W"K_NU1\M;_  /3\^4P/"7BK1O'FE_VII12*XMO+35-,,T<
MEWIT]S&+BW,QA_<7=C=P_P"D:%J5G_H=_I;1W,.#,]:\J;2S9Z#[OIS_ )[^
M_>OS=OO#/B7]BWQSX;TK2-9DN?@)K^MPZ5\'-;U:YE>?P'JFH2RF;]G/QYJ4
MY^TM\._$-QYQ^%?BN^_XF?A'5TBT:[_T:XTZOT5\/:_IGB[0;+Q!I*W$=M="
M6WFL[R+[+>:3J%E(\&HZ3?6XZ7VG7:O9S_\ /..VA '[SG#(,]KYE[?+,TH1
MP.=Y:G',\-#X*]6%HT<5AO\ J6SA:6$_O2D5C<&J,H8C#?P:[O+_  O7_(>_
M.UO;&?Y#]/\ &JS#;R#]XXQ^N/IQ_2KIXW+Z@C\B*JKQE/?.?P_^O7UD?AE_
MA7Z&?V)_X%^:*4B8)?U4C\^?Z?\ ZN[)#C9[@@_3)JPX!5NQQP?>HR"%!;[W
M3\/Z<]OTJ3G,^0A7#+]TG'_ CVX^AR,YP<U',HR&'?I^//\ /J/I5IT#[AZ9
M(^N<?UJ)?N%6^\.>G;]/;MWJH_$O7_,#/=1@GOVS_>]:J$\D-RWY\<C_  JZ
M6PQ!Z?RX'-5)_O ]MP_F:Z(_$O7_ #-*>S]?T*[+CGMGBFT]^H^G]33*ZZ>S
M]?T,ZGVOZ[%:3HWU_K39?OO]4_\ 0:M,NY6'M_4<54E3&/\ =Q] >GU_6M8_
M$O7_ #.<IU W4_4_SJ? &??K4#=3]3_.O2I? OZZ(#^4Q>W^ZO\ 6G4U>W^Z
MO]:E3J?I_45^PK_EU_UZE_ZDR/(?V_\ KZ_U):***LTA\/S8].I^G]14M1)U
M/T_J*EH$_C7R_)CTZGZ?U%3+U'U'\ZK59CZK]/Z4%2^%^G^1:7H/]\?RJ6HX
M^_X?UJ2@Q"BBB@ JY'W_  _K5.K2G )]QGZ<UC4BY-)2Y/ADY<_L[1A)5)IS
M^RI0IS@WVFU]HRJ2<&I*7*U]KM=I7^Z3^\FW!<Y[\?CU_I6+J.HPVD<C.Q55
M&_AMA8X[2?\ ++ W.S?W%('!S4.KZO;:?#+)*^Q4!9N0"< L K'A"& <G^ZA
M4=:^C_V8_P!DZ^^.\<OQ<^+]Y/X _9U\-N]_JFL7Y32[KQA%8/'-=6FCRR_+
M_9UP4:&^O.IA#P#B<D?">*GBIX>^!_ 69>)WBIG=+AW@_+\7'"8/"X:EC,?F
M?$V?YFZ4.'^$>$^&<OMC>*.(LYQ=7#X/+<KP\Z4\7C,32YJU"E2KXBAVX# 8
MW.,<LKRK"PG524ZF*J3]G"BFG*=6<_L0IPC4G*7V8Q;Z'%?L[_LS?$G]JS7)
M'TB0^$?A;I=P1XL^)&K6_EV,%I"R">'0G/R7=Z8W9X)9<0120F:X_<1R9^L/
MB?\ M5?#/]F;PS=_L]_L2:5I\FJ0QOIGCGXQW?\ Q,-3N-3"O%>75G?GC5]7
M>?RS<W-K_P 2W3]OE6 "/)7E/[3'[8D_Q"TU?@=^SI8Q?#GX%Z%%_9BRZ)##
M93>*;6/?"5,B<OI*#+1]KF4I,>8Q7R)HN@6VG1*B0L1M3YFY:0J &E+]VR>1
MZGZ5_*V1^#/B-]+'.LG\5_IB9/6X3\'<IQ^&SKP=^AQA\5BL9ED,3AY^WR/C
M[Z2F+P7)3XPXV5*6&QF3^'--T^'.$<76A+'U,;F6#Q%"K]3/-,MX<H5<LX8J
M2QV9582HYWQ77CR4Y<VE3 91A;?N,'3FE&IF'_,QE'FZ#;/2K_4=2NM>\1:C
M?ZUKVIS&ZU'5-2NOM=W<W$I\R5VF)_?([_,#_P L,"+HU=S!"D2_(N  %S_G
MZ57@3;R!@;<8]#D?X?\ UZO)]T?C_,U_=>)Q$JT84%2>%HX6&$PM#!82A[*A
M@<)@J,</@L%'"?#A<%2H4Z<(47^YRU0IPR_2I4/D5!0M!U/K-:59UZU7LY<S
M;^^7XEE>@^@_E4B=3]/ZBHD^Z/Q_F:E3J?I_45R3^"7I^L2Y?"_3_(N+T'T'
M\JL+T'T'\JK)]T?C_,U97H/H/Y5-/K\OU.6&\OZZL6BBBE/XODCMI]/\/Z(M
M1=O]T?TJZO0?0?RJE#]W_/J:NKT'T'\JYI_$_E^1N2)U/T_J*N+T'T'\JIIU
M/T_J*NU)QUOC^[\QZ=3]/ZBI:B3J?I_45+0:T^G^']$3P]1]3_*M6+[X_#^8
MK)@^^?\ =/\ ,5J1=O\ =']*4OA?I_D:5/@EZ?JBZ.K?7^@JPO0?0?RJJ/OM
M]/\ "K2]!]!_*N>7POT_R.(6BBBL#MH_!\G^433BZ?@O\C5A.I^G]15>+I^"
M_P C5A.I^G]10;SVC_71&A;]!]1_,U=JA#T'T/\ .KR]!]!_*L9_$_E^1R2^
M)^O^0M21??'X?S%1T].I^G]14FL/A7S_ #-*+K^*_P S5R+JWU;^8JE%]\?A
M_,5<B^\?]YOY5C5Z_P"']0E\+]/\B[#]\?0U?C[_ (?UJJGWA^/\C5J/O^']
M:Y3*/Q+U_P RRG0_7^@J_%]P?A_(5FIC//X?6M*/.!UVXXS^'^?3-*7POT_R
M.S['R_4E7J/J/YUIQ?<'X?R%9B]1]1_.M"#HWU'\JP,7L_E^:+*?>'X_R-7H
M._X_TJ@O4?4?SJ]!U;Z#^=#V?H_R9TT_X<O3]66T^\/Q_D:N1_=;_/=:J)U/
MT_J*M0_?'T-<=3I\_P!#&KT]/U1HC^'_ '3_ .RT]>H^H_G3$^Z/Q_F:>O4?
M4?SKEG\3^7Y'11^'^N[+"]1]1_.KJ?='X_S-4#U7Z_T-7H_N+]*DWK?9^?Y,
MM0]1]3_*M*'H/H?YUG1?P_C_ %K0@[_C_2E+X7Z?Y'%'>?\ 74MIU/T_J*EJ
M!>H^H_G4]8'32W?]=)%U.A^O]!5R!V1D8$C!.=N/, !)W1[_ -R)(R!(CS_N
MHBGFGYHTJA%V_P!T?TJZO0?0?RKFJ7UY>>]W;V?Q_:NUZ+F<O[BF*HD[)[:_
MH_S2//M2TC6? =[J_B_P19R:KH.K#[?XY^&-HI/]N2QL@;Q7X,N7XLO%5I#Y
MEY?6UM_H^O*DQ/S0I7?>']:L_$.F6VKZ5<1:IH=_'YNDZU;KM%XBX6[@OX?^
M7#6[.<K;ZOIW_+&>-&/WJU;>0QDN",CL3P?ND';_ !-&0)8S_P LY8TF_P"6
M=>=:AH^H^!M4U7Q;X,TZ35-&UYTF\>> XG"+J17YCXH\,K_RX^*(E0RW4?77
M4:?!^2O@\TR[%\/8F7$7#ZAB<+B)?\+>0T_]SS##IKVN94O^HJDW"<O^O<ST
M\)5AC(^PQ'\6/NX7_&EI_P"2J1ZFO0?0?RJW%V_W1_2N9TK6K"^>Q,%W'?6&
MJP&ZT+6DM_*M=9A0JL]G*/\ EPU[2976TU73/^64I#\=^HC(QC'S$MNW?>0J
M<;1_LG.>O85]7@,QP>:X2GF.!Q?UC"58JDY?\^\59<V$_P"W&I+_ +<.2M2J
M475B]K._I=?U_P  LP_?'T-:4'5OH/YUEIU/T_J*TX.B_P"?X17;5^!>GZ(X
MG_E^:+5/3J?I_45&.K?7^@J1.I^G]17(=='X/G_F7H.C?4?RJTG4_3^HJK#T
M'T/\ZM)U/T_J*4OA?I_D*7Q/U_R+T'1OJ/Y5<3H?K_053@Z-]1_*K2=3]/ZB
ML!$H^\G^\/Y&M5.A^O\ 05EJ,D#\_I6G$?E ] /RX_K0!:_@_P" _P!*LV_3
M\/Z+5=>@^@_E5BWZ?A_1:RJ?H_U M+U'U'\ZNI]T?C_,U1J^O0?0?RK@J=/G
M^@#U_B_W3_2GIT/U_H*8O\7^Z?Z4].A^O]!4Q^)>O^9UT_T7Z"O]T_A_,4Q>
MC_3^AJ1NA^A_E4%==/9^OZ&I=3H?K_05:7H/H/Y52A^[_GU-6TZ'Z_T%5+X7
MZ?Y'++XH_P")_J64^Z/Q_F:E3J?I_45$GW1^/\S4B?>'X_R-<\OA?I_D464Z
MGZ?U%7:JI]T?C_,U97H/H/Y45?AA_7<"9.A^O]!3Z8G0_7^@I]8&L-GZ_H@I
MZ=3]/ZBF4].I^G]151^)>O\ F4]GZ/\ )EA.I^G]14AZK]?Z&HTZGZ?U%2UL
M>?4_B1]?T1:'^J3\/ZTZVZ_\!/\ Z$*8O^K'U'_H-.AQ\^<_>[?_ %Z!EV@I
MY@(]!G^G]>U1KMSQGIWQ[>E3)][Z_P#Z_P"E #(<I@8X#<Y]!QS^/X9J*[B:
M)U9#\KD,?IS[>I&>QJ=H]LROCJ<?GS_3_P#7V6Y7>F/3:?\ QPC^M-;K2]W9
M^DO=D_E&4G\@V.3\9>#?"/Q,\(>(/A_X\T2V\1>#_%FEW.C:[H]U'YB75I=)
MMWP_\\;RSE\N^L;K_ESN[:&ZS^YKX9^"_B'QO\&?B[X@^$/CV;4KC2-):PTV
M/Q/K#^;!\0/ VI1P6_PX^+EIJ>3O\4Z6TMO\-_B1#_S$-7?0]9_Y>Z_013A&
M7)4'Y68=0CCRWQ[F-G7\:^;OVM/#=W>?#"Y^)VA:2VK^+?@LNI>-X]+B3S[G
MQ/X(M8 WQ2\#FTZWL^N>"4U&71;;_H9++19_^6-?*\58":5+B7+JWL<UX>E&
M$9_]#C):4X5L9@.VM"%>??\ <'HX&:DIX5[8E.F_1KF_]L/HFYB,;D[0,91@
M.<$_*%W?],VBEX[^9GWK-=,'=Z\?GS7FOP0^(5K\1_ ]O/%K">()=+M=&GLO
M$4:%$\6>$?$NEQ^(O _BD#O<ZEX:O;2+5%_Y8ZK:WD??CU+;G<OX_4?XD$5]
M5E^.P^:87#9KA:GLL+F%&&,P]&R7/0Q<8K#JRT5YPJNROMN<GLWAZM6G#X&V
MGY*__ ,VF/T'U_H:E?AB/\]*8W0_0_RKO(GNO3]646.&_P"!'^I_I39E^8'U
MP/S]?R_6ID *G/K^N![BARV,?PYS^//Y=Z"#(G7#Y]L?Y^N*KMC'\NO7G'2M
M"7O_ +Q_K5)NI^I_G51^)>O^8X_$O7_,J'/S;OO;3Z]/QJ&K++AR?4?S.?\
M$5 _WC^'\A71'XEZ_P"9K+X7Z?Y$3]!]?Z&HI.W_ %S/]*G8;AC..<U$Z[5)
MSG@CI['WKKAL_7]$<,M_^WOU90DZ-_N?UJ->@^@_E4DAQG_=_KG^E0[QW!_S
M^-=]+X%_71 ?RD+V_P!U?ZU.G0_7^@J!>W^ZO]:>O4?4?SK]>C_RZ_Z]2_\
M4J1Y%'XJW_7V7_I4B>BBBMC<>G4_3^HJ6HDZGZ?U%2T&;^-?+\F%6$_A_P"
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M2Y(%K97MUDX'V6RGFX]<VT4S[<GJ5"9(RP)4'7B?Q!(H\OPUXAD8C(V:5JC
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MT7YA^'3OZG']*J$;BY_NK_4=/J?TK[DX9?"_3_(J-U/U/\Z2II3NVGVQ_/\
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M!_@!_6D;^'_>']:_M^<IU9SK5-Y7?WO_ #/FE#DIQ7E^J$'WV^G^%/IO\?\
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M?G$ZQN1CU./Z_P!*J.NP[?Q_S_GO5EP&4'K@Y_S]._\ ^NHW!,;/Z>O?'O\
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M=MH)NHQ]YIIF24G)R8O0YKY.=0RD$;A@\?I_6L>]TQ)?FB+1S+ATE1]CQNK
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M#O%%O-/HVK11I*UK<_8[VTN;:>.[L=0L+O\ Y=[_ $^\MX;VS;_EI<01V_\
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MR]!]!_*H*G7H/H/Y4 6H.C?4?RJ>J*?>'X_R-72&8$*"Q)4;5;8[%V5$"/\
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M8L_AYH\;/INI:[<?Q^(O'6JW6H>-=<?_ ):W6II!G_0<5]&;MQQ_<!7\R/\
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M&7Q&U.^36- U[1)+#6]?TD:D+/2-(EU"Z,^FZ=^[;13=06B:??7WS('\@_\
M'Q7VOXN_X(U>+/&7C.XU*?XO^&M'\.I'966C6FGV^IQS:+;6T!DN8+6R33(O
M[2A>:X6/3X[F\:XL]/C:,(5G=UAM_P#@A'X?FOX-6OOV@XX[_ L9[>/P9>ZE
MI<FG3S1>;&+6Z\164$-P\J03N)8BC-$T90!\CUEPSQ(VH1X=Y:<-Y>UR^ARK
M:_MJ7[RGK;WH>\KV6DF<RS#"MJ?UG9W]?ZNSY%_8C^-=QX0_;A^'7Q(^)JPZ
M#;-\5O%7A::]EMK:PM_LOB+3K71/#&I">S_<2P0:3=V$INCB3>%7H[5_5;^T
M!\.6\9Z0+ZPL)=2U71H;DZ39V\R11M#<")6^RF3Y9Q L4<HF'.3@<$D?SV_M
M?_\ !$KXI^._#GC+QY^SA^TK9W'Q=U73_!R-X.\=>&HO"/@C6X_ -K<6UE#H
M6I>'9=5D\)>*-8L4T_3C?WEIJ-HMI8:>]Q% VS4++(_89_X*P_M<_LRZ=X7^
M /\ P5:_9G^-G@30-,\7Z/\ "3PY^U _@'6+KP-I&N:KJT/AOP3HOC/Q'%+<
MZ=KNCW[(DECXSTR=X)B\$=RTSS(T/'B,MS; 7AFV4^PHSNHUE2^M>SCOS+%/
M6%K)<Z_FM]HKVV#J/VF"K\U1:U8_S/JOQ_X8_:#]F7X7_$_0KFVU7QUI<GA[
M['->RV/VJ>*2[N+24W,5C$%BY,:-(+9E;Y)#$L1YD6OS'_X+2>"O&GQ@_:=_
M8OTGPE^SE\0_B[H_PK^'GQTDU/QKX1\4Z=X/TWPYXG^*EWX5L-,\.WVIG,TJ
MW6D^"[N*23II2ZX;<\W K^A'6/MFF:?J+VI$UW#;3-:*P62%I40.CE)D9W@G
M:5)[0';YA*6VX&49^&?$'[)7PL\;Z[%XI\6^(_C'?>()=1?5;NZL?C+X^\.Z
M==WK3VE]()M'T76X](MK-9K>-5TX0*UK'=_9P0LS ^AEN18[,J=1X&5*,(K2
M5?\ @K5:U/[O3KJXG)4Q485(RJ?%&5_S7ZGXG?L_?#WXN_ K]H'PIXRB_9"\
M,_"^!_ GCW3]1\9:U\?E^).LQ7>C6EAJFE):^'KD?99K?3+-&OKY(_WL(F)7
MY!)CZ#^+/[1/[2&FV2?\(S\0]>L?"FAZ?X=LY4\/WVDZOH&BW4/@RQAU6X34
M3_QYW=[/IT.HW.ECYHY+N^(_U-?K=XW^ OPZ\6^$]7T2QTI=+UZ;P[XBT7P]
MXBO+[6]3N/#0\1:=)::B+0W>KSW8BU.#?9WRBWF>_CNI(_+;S2:^4?#7[#TV
MDR>*;B+2O!NDKXA\36]]-HMIK)N-*O=)@L;*V#:Y>W_@^_O9?/2U9[[36LF@
MN[R2=)+@)I927?$\-Y_A'"$<#5Q+J.RJX7V?U57OK4]K^[Y-'\?NW<;ZV.J.
M+H23E-J,4KRGV7?\OO/(OAW^V/K?B;PSX8\>Z]XLO;R*YM39VOB-;@36>J7,
M<"6E]Y-N@\II2]OY;X&1*RX[US?Q%^+\D]MXMTZ_UJ^L-0;PC</JEGJNN&.:
MWN$OM/E'GPG*PFZTN[=K6V8;6^7&"JU]@:A^Q\OB6[TJYUEO FF6VFVEO#;:
M?I^EWTECI\EO=K)MT33=!?PCH-C;M%'#)/)I]K#=[U%S-*IC<&OX;_8NU/3/
M%!UG4_B#\/9](O(Y(=3T31_@K8276L6]_>1AK;4M:\6^(?$ZO,NDQ0?\34^4
M]Y(J21.KQA'RCPQQ)5E!+!>P<IP7MO\ A/\ W:<X7E^Z_>:)M>Y[VNFEPEC\
M#!.:Q',XIM1[Z6M^/X'R=\.O&.O_ !J;^R]&EGLM.T:*!;B\\06NH17<&GW!
M6.S^Q:;=2PW.L22K \ELUNQL/LZRR,ID2(K]#0_!'2L3OJ?C_68[ED)MQI^@
MV4@,B1ML\^6XOL %AL;SOW<"MY9^=DKW7X^^(-.\)?$WX;ZG?+IV@>&-<\&Z
MGX0T_6IH[:TM(=;LM4LM0L=(N9X[:&.QOIM(-]=6WGL9%MK.X6V4P&0KYY>>
M.O $+VT$WC?PA!OEVQR3Z];*DA\U?,+2+^\NBXRJ+'^\DD*(!AF->)F]&.5X
MW'Y;.OS8BGBL/4JQ_F<N5-?^3/[CHPBC5PRK4I<JE-OF[:2=SDO!W[%OCCQS
M8V/B'QS\=-1T7P[J2_;;#0O NE+#J8L)+B:)5N]3OC?6-G>31VY#RV\<<*J7
M F4E4D^IO"/[)?P!\)IO?PK?>,[H.CB_\?:_J'BMX94P-]K;W=P=.B:4Y:1;
M*V1%^:,.JLROW/PGGED^'?AZ:1Y7BGDU>[L&FMWM';2;W5KRYTMUM+C_ $F*
M&2T=6A<?NIU D/S!,>D*V[MVSD?Y_K7ZWE.29)1PN'QE+*_:8JI1A*>(_P"?
M<G%7G\KM?]O'S>)Q.+=6O35?FIQNI1[I-:7^XY-OAG\+25"_#7P/MC4*@_X1
M71H\ 8 &P0S3' 'WV0+ZL"R@R/\ "[X6>8DO_"M? JRA>&_X1?25(SCE";:'
M#YQC:Q;&<+CD=75BO6>&PC33PE.2_EJP=6F_*=/[<?[O5I/H9TJE6Z][EU^+
MMY^7_!/)=7_9]^!/B"9[C4OA=X3>^=0@O;6QET^\B4.K9CFM9H5C4,H.58C(
M4A>,@'P&^&\8B%B?&&FI;%&MAIGCSQ/;I"(U9 %V7WE&,!C^X7KA6'"<^M4H
MSVS^'_UJY)Y;E$W>KEF5R[Q_LO?I;^NQT^UKK58EWZ:GC=Q^S]X>NKK[5:_$
MGXW:2)(WBG@TWXG:W;PO&P^8K!?27D4;%@O[Y(EE'*JX1W#+IW[._A6PLDLE
M^(?QQN86DDED-S\5=?GEDW'D--#:(BH<\A'4@X(XKV@;N^/Z_P"%6$^Z/Q_F
M:S?#N0).;R3*[2W_ .$OI_5CFJ8[%P=HXG7H>!7/[+7POOIHY+KQ-\;9%619
M3;#XW?$*VLIG3/RW4=GX@M5,1#-N3R@N=O0@5M67[-7P1L]0:^/A;5]9N9$$
M&[Q-XS\<^)X44%9"5MM:\175I)S& 9!%YNUG12(Y)%/LR]1]1_.I#]]?I_C2
MH<.</47*I#),OYGK'V67>RJ)W5N2K]B6_O=%==3)YACY>ZZ_,GHX]_+\/P.2
MTGX5?";1#NT?X8^ ["47$=TLJ>%-%^T?:X6"K,'D@%YYFUGQ(URXR>4)*LOH
M NF"!8XHXH=\FV.*/[/&A0JH5((_W2J%8XQR.G3-5%Z+]3_)J<.K?7^@KUJ.
M'HT(<M"G]6A;6EW6FG]=CGE.<YIU-[_B6?-:3@]N>I/MW^M3(?EQ[_RSC]#5
M&K47;_=']*T*"?[Y_P!U_P"=2)]T?C_,U"PR3[-G]32YXQ[YI2^%^G^0GL_1
M_DR8]"/4$?U_I6=)PX7L"#[]3Q6BQP,_E]:INO.?<?G@_P!/UJZ?3_#^B)I?
M;_P_J,N/N#\?Y523J?I_45;;!!7N1TJIS&2..>>_J:ZX;/U_1"AO+^NK&44X
ML2,'%-JS0J.N0/8[OR!_QJBY+!B,9P0?8>GYXS^G-:$RX^;U./SR<?A5)_O'
M\/Y"MH?#\V!0DQ@^NP_EE?PZU5N/N'Z'^E77_P"6G^]_\36>_P!T_A_,5V1^
M&7^%?H3+X7Z?Y&?-_!_NU2;J?J?YU?F.,^Y _2J#<$K^(_#_  SBMJ?V?Z[C
MJ?##T?\ [<0RML4>[!3^()_I^/2L:2++L0#C/J/ZUI7!P?T_050+X)&,X]__
M *U=M/9^OZ'+'>7K^K/Y1TZ+_N)_(T^FKV_W5_K3J_78_P#+K_KU+_U*D>%+
M^(_^OTO_ $IA1116QU1^&7HBQ4Z]!]!_*H*F!PH/HN?TI/ETY_A4Z<I>D:E.
M?YP1*<5K/X+/F].62_5%&_D,=O,X^\H5ASC 0J[./4Q(KRX]$)[5][_\$T5@
M^&_P_P#VQOVN]5>2.#P/X/D\$>'6N(ML5S>6=G+XIU)(I.\QU*YT;3%7NI<G
M&"*_.[Q3="'3;J0[@J0R-N7&5;RWV9'I)(4@^LHXK]"?%MW/\+/^".7PVT7:
M^G:U\??&EM<7$,7)GTS5/%&J:U--+G^"XT+1;"X)]9Q7\<_3RGBL\\(_#+P/
MP5-5\9]*+Z37@WX4X[#2BY+&\%Y;Q''Q0X_P#2:M]?X-X&C@E*]H2Q49-25T
M_I.#8SIYEF6:XI?\D]P[CLQJZVMB/95,/E.O_7G&UC\X/  O+ZUNM;U.3SM4
MUR]N]<U&X8_//J.JW<U[J,X[[9[F4'ZH.G;U96W #T 'X>U<CX8M/LVG0QYY
M,<1DVGY-XB16/7[V5/;N<UUJ#C/K_*O[:S>6%ACHX? 4_JN7X:,\KRJE_P ^
MLLR;!T\#@<!_W!RW#Y=2_P"Y$^9I/GPU*I_S_IT,1_X'4K/_ -N'T445YA05
M<C[_ (?UJG5J+M_NC^E93W7I^K(E\42:F/T'U_H:?14%D2=3]/ZBI:**J/Q+
MU_S''XEZ_P"8J]1]1_.K2=3]/ZBJE68>@^A_G6LOA?I_D;E^+^'\?ZU(YP5X
MR20N<9P'95<_]\%A^-0Q=O\ >']*2[=8XW=_NJC%CZ)A@Y^H0M6=."J5*4)/
MEC*K24Y=J?M:;JM?WU253D_Z>>S)E\+[6M+_  /2?_E-U#Z:_8"\*Q^,/VKM
M(UBZ)?3OAGX2U_QI='_IN]N=)L!GOMCOYG_X#V%?/WC_ ,577Q'^-'Q0\=74
M_P!H;7/&.J2V\_&9+"VO)[#3^3_<M+.-:^Q?V"@WA?X5?MF?&&7S$DT'PA9>
M%+6=ON(\&CZEJ-[CISB\LOH,U\">"[8II\4Q.YIP)'?M(Q+/N]<X?^E?R!X2
M5'QE]-OZ:'B#77)3\+N"OH_?1GRO^;!YGB.'\V\9O$+#Q_Z>YKG^,X>JYA_>
MI4SULW_V?A3A/ _9S;%9IQ2_^O5&:RO+_P#R6%0[]?NCZ#^5+3$X)7T/_P!;
M_"GU_7=1<UY=M?EIN>+1^'^N[%3_ %A_W/\ V85HQ=O]T?TJ@G4_3^HJY'T7
MZ_UKDJ;KT_4WC\2]?\RS5J+M_NC^E5:M1=O]T?TK,*O7_#^I-4Z]!]!_*H*F
M3[H_'^9JH_$O7_,SA\/S8ZK47;_=']*JU-!]\_[I_F*UE\+]/\CIA\*^?YFJ
MG4_3^HJY'T7Z_P!:IIU/T_J*M)T/U_H*XJO7_#^IA5VG_76);HHHKE)H_%\U
M^HJ]1]1_.M.+[@_#^0K,7J/J/YUIQ?<'X?R%!UDZ=3]/ZBM!.I^G]16>G4_3
M^HK03J?I_44I?"_3_(RGNO3]67%Z#Z#^5+2+T'T'\J6L"8_$O7_,M1=O]T?T
MJRG4_3^HJNG4_3^HJPG4_3^HH>S]'^3-R]&<8]P!_*M+.8QCID$_KC_T*L]#
M\@'7) _,"KD7R KWVYP.W( SZ\_Y]>24G&4)*'M+3CS4_P">FYP56'_;U&55
M?,Y:U^6=MU[WRBXR?_DL9&;JR3I$MW:LT=U;R07%O,O6&>"5)4F/H(RN[T^E
M?5?[0DT7CGP'\%_C59(LR7FE'PUXBDZM]O\ *::,GVCN(-2@[\PCM7S1=QA[
M=P>FQV)]-@9B?I@"OI'X70GQK^S!\7? S/YVI>!]77Q5ID?'R0Q>5K"-^ MM
M77C^]Z5_&'TO*D> <_\ HJ_20P]1U)^$7CWD_ASQ1BHPE-XSPV^D'EV+\.L]
MRNT=4L#Q-+A'-93:Y81C*<O=3:^QX5C3Q^'S_(_^8?'Y;/$8#_L-R65#,?RK
M53PJT8L@/7(V,>P,.%0?7:Y_(U>3J?I_45AZ-,LMLA48'EJ /]E0N"?Q9OI^
M.!MI]X?C_(U_9V,P[PN(E2C_ ,NY8C#U/^OUJE;$?^24J)\USSJN4JF]:K*M
M\Z'-2+\/0?0_SJTG4_3^HJI!W_'^E6TZGZ?U%<L?B7K_ )DTOCEZO\D3+U'U
M'\ZOI_#_ ,!_I6?5Z/I%_P !_P#0:RJ?J_U.R6T?Z^R:,'5OH/YU9JM#U'U/
M\JN'[B_7_&O/J?Q(_P")?G(XH?Q9>OZLD7H/H/Y5:CZK]/Z557H/H/Y59@[_
M (_TJI?"_3_([5\#^?YHT*T(OX?Q_K6>G\/_  '^E7HNW^\/Z5SR^%^G^1A+
MXHFE4Z]!]!_*JR?='X_S-6$^Z/Q_F:P-(_$O7_,E3J?I_45=JDG4_3^HJ[6%
M7KZ(UE\+]/\ (N1??'X?S%:"=1_NG_T(UGQ??'X?S%:*=#]?Z"N8Q+"=#]?Z
M"I5_B_W3_2JM7(^_X?UH.FGT_P /Z(MKT'T'\JN0]5^@_F*IKT'T'\JM1]5^
MG]*U^Q\OU,ZG\5>J_4U4^Z/Q_F:=3(_N+]*?7)+XGZ_Y&D?B7K_F6$_A_P"
M_P!*O)]T?C_,U13^'_@/]*O)]T?C_,U(5>O^']2S'T7Z_P!:T(^@_3W.>![9
M]:SX^B_7^M:"]!]!_*LI\O-[T_9QMK4_D335_O:7S(@[*[Z-_P"7ZFA#<S1G
MC.T 97>/G!8#85_C4YRX_@0--_RRKYV^*O@I]!U'5/B?ICWLWAVYBCOOB-H%
ME;YU&"YT@K_97Q2\,)_R[>)]!B,LVL0\_P!M:5 9_P#EV%?0*]!]!_*KUJ^"
M5(#*T<BNAC$N] C,0(W_ '<FP#S?+E^23R_+/+"O*S?*,)GF7_V;C*G).BW5
MPF8?] M=>_0Q'_<.M&C(Z<+B*V&J<\/@D_>_PNZE_P"2N7^9R_PX^(-MXVTB
MW5KRVN-8MK&UOII[0YL]:TO44#Z9XBTN3GS[#4(8PLL'72]02[M_^7BO0#(X
M/T]\_P _\._3T^2==\/7/P<\;V.M:=JMJG@[Q3XBN(/A_:7ENUG8> ?%FN6<
MLU_X N]4T?Y8_AY\0+FV:6UD/[SP]XC-A+'^^$=?2GA3Q+IGC;1(=;T8SPH)
M9]/U33;M!#J6AZSIKBUU#1=5B/S+>Z=<K-"DZ_)?:?\ 8[Z/_19[/'CY!G6-
MQ"KY-GLOJW$&7)PQF'_Z&-*#4<-G?_<_24'_ -NG1C,-1I*-?#_[C7UI?]A3
MUE_[>=G#<2( 5)!'=6V=^Y[_ $_PS7R5_P %%?A!J?[2G[ W[5OP<TR"74?$
MNN_!WQ1K/@:T0I).WQ \$PQ^-?!(M'<@6]U)XE\/Z;!%< AD,Q48\PU]6J&4
M*IZ!?UX_ITQZ'T%;6DLHFC5PC)(_EO'(J,DJ-GS$?>K!04#$,=J!E F86YF!
M]>O06)H8G#O:O2J4GZ34H_J<=.7)4A+^62?YK]3Q[]ACXYM^U#^Q'^S)\;;V
MXM)-?\;_  6\(P^-;:WO8=0:Q^('AK3!X9\;V5Q/'\RW]IXFT74TU.,\><\/
M< #U&!E=<C^%Y8^G97QU^O\ GK7Y._\ !&3QWIFB^//^"EG[&@\-6GP^'[-W
M[;OQ6\7_  _\!Q7CRQV'PD^,&HRZEI-WIUO<:C/<+HUYJMI-JNE26MI%I"Z;
MKMBEC(H9ED_734$ACU/44@"*BWLS%%X.Z=(;C/T_>XS7YYP76IT<;F>!6ZK3
MH+_NGR:_*?\ 5F>IB8Z49_SM?DQBD@ CK@=?_P!1H:1P.W7U^OH!_.EIC]!]
M?Z&OTB/Q+U_S, $KY'?\_P"I(JTC,PPQP!T/N.G3GUYZ#IBJ%7D^Z/Q_F:V,
MJFZ]/U%N[/3M6M?L.LZ;INL6+.)?L>JV4%]9^=$K-%(]O<0S(65@4#*H?:[*
M'VLP-BWTK0K6*&"R\/Z#:11 2Q0VNC:?:I#-,/,F-M;QVT+!0T:_.6(!(&TY
M!#4Z'Z_T%6EZ#Z#^58R^)^O^1!8\TR')P,C(79#&0%XX6/YMO/'\/KSBKL??
M\/ZUFI]X?C_(UHIU/T_J*D3V?H_R9+5BJ]3KT'T'\J4OA?I_D%#>7HOS%HHH
MK Z2=>@^@_E4Z?='X_S-5$ZGZ?U%6T^Z/Q_F:T7P/Y_FCDJ?J_U'4Y/O#\?Y
M&FTJ]1]1_.M([?\ ;OZ(R+BXVC.,<]?J?6@A>HQQSQCG';BF*-QQG'&:;*?E
M"XZ,!GUP"*J/Q+U_S,W\:^7Y,F4[CNZ<8Q^N:LMG:V.N/PQ[^W^>M4TZGZ?U
M%2UL:$Z[MJY]/P_#V]>_2EJ!>H^H_G3X^_X?UI2^%^G^0%B3M^/]*K_\M/\
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M^<^IE9>R&1. V:_/GP_H:>+?C1\#_"$@S%XC^+OPYTN89_Y8S>+=,DF..O\
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M:A*>_(],D_/0&4'MD_SKTW]G34!I7Q_\!.2535?[7T:0CILO=*O6(?\ V6:
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MI^G]15M/NC\?YFJ(^\G^\/Y&KT?W#_O#^1KGE\+]/\CJ+*]!]!_*K*?P_P#
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MC<1F<)36/PU*.88&$JF$>*P5#$/"4ZN-I32@_0XAP2P.<XR='#\F J8O%8?
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M/Q+U_P QZ]1]1_.IZ@7J/J/YU/6LOA?I_D;EM.OXC^358G ,;956Z+\W8O\
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M_/\ ,A/!*Y]_\_G_ )XJ%^H^G]35F7[A_'^1JG6ZW7JOS115E[_[Q_K5!O\
M6'Z'_P!"K1N/NG_=_J:S7(VX/7!V_7(QG\SG'.*]&C\/]=V3+X7Z?Y&?/_K6
M_P ^M4FZGZG^=7Y@3MS]X#/X>WOT_I5*4#:3WP1^AKT(;/TC^<3.K\"]/T13
MDZ-]?ZUER??;ZUIW&?+^7KL'ITY]:SEVX&<?CC/^?Z5U4^OR_4Y3^4.+K_P!
M?YFIZ@BZ_P# %_F:GK])I_9_Z\U/_4IGC3^.7_7V7YR"BBBNF'PKY_F;0V?K
M^B"IUZ#Z#^50CHWT_J*L0CY?H<_^A#^M4[\LDMY0J07^*I3G3C_Y-41T/>FO
MYI1I_P#@WEI?^Y2;X2ZM#X:_:C_9F\17,\EM!IOQR^'"O*G!7^U?$-OH48/L
MTFJ(..Y!XXKZ9_X*8^'3X9_;O\3WOG&2+QG\/_ _B*%#D>48%OM'GZ]/,:S1
MN0.W:OA;QK?3Z)=:!XFMCLN?#GB'P]K]O(?NQW6C:S9ZA:NW^R+FWB!QW8"O
MTX_X*[6<9^//[/'Q%M"DEGXX^$-Q;1RQ?<?[#JEMJ$)XS\Q@U9<=#CKUQ7\B
M^(M;^Q/VBOT-<]G_ ,B[CWZ,WTN?"*'_ &,LMX@X(\6LF7I]1I9B_7L>W@_W
MO!7%E'_H%XBX0Q:_[>R_,<!_[A/AJ#_5I[J?Y@5=7H/H/Y5FV7^I![%(2/Q5
MOZUI+T'T'\J_K^K[M2M3_EJR7W-GB4_@CZ$Z?='X_P S3J:GW1^/\S3JR(G\
M7R05*G0_7^@J*E@ZI]3_ #-*7POT_P C.7POT_R+]%%,?H/K_0UE'XEZ_P"8
MH;/U_1#Z*KU*G0_7^@K8TC\2]?\ ,D7J/J/YU/4"]1]1_.ICU7Z_T-*7POT_
MR-R\G0_7^@JRWW3_ )[U4BZ?@O\ (U<7H/H/Y5C'G4HNG=SC)2BH_%)Q:DX1
M\YQC.FO.:,HV3DW]FTOG":FO_)H1.3\4V#76G3H-^XIN0P@&1)%R8Y$;^!DD
MVN9.P4CO7Z'?M)7/_"\/V)?@#\=X&6;Q!\.;M/!OB^2-/M4@CC#:;+'<RXX?
M[9#%>$=OM]?"UU'YL$BY4''R[NA9OD0#WWNO^>*^XOV%+JQ^(G@3X_?LJZ_<
M1I9>*M(N?%/A>.7I'=7<*6%_-"?^>T6IVUDZ?[(?@XK^+OIP\_!?"W@C])[)
M8QECOHM^.'"O%^=>Q_W^/A)QSAJ?A%XO5<S_ .H/(.&>*LMXHZ^_@*-K7;7T
M_"4HXO'<1<-S_@\5956P]#O_ &[E,%F6'_!S/B72YQ/!&X*Y8*Y7[K ,S(F4
M[#$1!]#CUK8KB]&MM1T"\U/PUK$,UMJWA_4;W2M0MYQ^\ANK*Y:UFC7U0R0-
M/T_Y>!]:[,'(!_S[U_;&,E@ZS>-RRI[7)\?A,NS3)<=_T%99G2ACL#B?^ZIE
MM?+JW_<<^-PL9TXQHU/CPL,3AX_]?H57',/_ ":,!:N1]_P_K5.K4/W?\^IK
MSI?"_3_(]".W_;OZ(LIU/T_J*N)]S\1_[-52/O\ A_6K:]!]!_*L#2>T?ZZ(
ML+T'T'\JD3J?I_45&O0?0?RJ1.I^G]151^)>O^9SPWE_75DM/3J?I_44RGIU
M/T_J*V.BGL_7]#33[H_'^9JTG\/_  '^E54^Z/Q_F:LQ=&^C?R%<E3]7^I%7
MK_A_4O)T/U_H*?3$Z'Z_T%/KF?QKY?DS&G\<?7]&%7X.K?0?SJA5N'JOT'\Q
M5R^%^G^1VEW.,?I5V,Y4?YZ\U2JU%V_W1_2L"9?"_3_(T(NW^Z/Z5-56#[Y_
MW3_,5:K&?Q/Y?D8CTZGZ?U%6X_N'_>'\C57_ ):?Y_NU93H?K_05I4^&/]=6
M==/]%^AH)T/U_H*MI_#_ ,!_I5&+M_NC^E78^B_7^M<4VDVWLI1YO\/-#F_\
MEYC"N[-OLG^-E^I?1MJAC_#D_GD?UKV']F+3FU#XZZ!*$5ET31=?U5PV,<6?
MV%"/<37\8]\G\/'&SY9P<':,>[' 4=_XL5] _LS2#1K;XU?$!@5B\.>!9M.M
MI5XECNIGO[N9X.?];YMG&!Q]TOVK^5?INYG+)_HB^.N#I-+'\8<)99X49.WM
M_;?B3Q?PEP)E?S^H9YFJ7=M'N\&PG/B#+%+^#EN*>8S_ ,.%PV.Q/YT4>)ZU
MJLFN^-?&>LN%']H>)M8E '4*+Z00_P#DOY7YU>7H/H/Y5R&@*S6XD=G9Y0]P
M[2?ZQY9&#3M+V\P%DQ[9[\5UJ-N4'\/\_P!:_I/)\I7#^0<)\/+X>%N"^#^&
M:W_87DG"?#G#D_\ R;AV1PXN<*]7%U*?PXG,*N8?+$SJ8W_W,6(?OCZ&M.LV
M+M_O#^E:*]!]!_*NB?Q/Y?D<A87H/H/Y58AZCZG^55UZ#Z#^521_?7ZU$OA?
MI_D=E'X/O_(U(^B_7^M7DZ'Z_P!!5"+M_O#^E:$7;_>']*XY_%\D<=7XX_UT
M+*]!]!_*E!P5SZC_ !_I35_B_P!X_P!*>O4?4?SK.7POT_R.BG]G^NYI1L2
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MI8H5@0EBTDWGSRSN=T\\T_\ R\74[_/>M_RQD\J/^*M\KRG&<38F>;Y]*-/
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M_P#UU_;6<8;ZMC\70E\5&OST/^P2>*QN'A_Y+A8GS6&JSG'#RJ?%5P]?%?\
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M%N!PM'-,/G671Y,GXLP=/B#+X?\ 0-BL5&,<XRW_ +E,UCB)?]O'5MT/T/\
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M\2]?\RZG4_3^HJVGW1^/\S5)>H^H_G5U/NC\?YFN.?Q?)'9#X?FRPGW1^/\
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M^H/%<28W(>#_ "H917/HLPC+*>%N&\B:MC<Z53BK.(_].Z+E#*8?*G5ECO\
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M9>@^@_E5A>@^@_E4_N[Q=97I*4'42WY(U*<I?A'\#:";2MT49/\ PPE"<_\
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MC!9%@ZTFHP<EZV19;3S?-88;$2Y<GP5L9G#_ )L%0C.O7I_]QE1C0_[CF?\
MM->)-/E\1^'OA7X:(C\-?#C3X=-D@3_5IJ-M']CE7_>6)>/9STSFO$[6-4B
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M)K*YU1&4NT9'IO[47PV^$W_!1K]D7X;^'?A9>ZEH_C?1DT7XR?L3^+ETYO\
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M@MSSM&?R_P#KY[]O2JC\2]?\QQ^)>O\ F+CC/OBH6;/ Z ]?6FGDEL>WY_\
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MZ;[MII\/%Q.?5SN2"#!'^D30\58U74_[6O%:WS'IEG##::5 W6.TBRL<C?\
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M9CRX\ '=;<=Z]'U+6+C2?CMX/\&6$<%OX7AT.&&+1H[?-C;W(M=8N1>PP_\
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M(,NWL"?U-=\*=E>VR^[_ ()B59,#YC]/KU/YU4JS,3@CL,?T_P :8GW1^/\
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M'B5Y[>2;1S8G^TYH)VF"A1U_>GE2:\G>3(/4\?D.?S/^<U4#[F ST8<>G/\
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M&VMFOTL/HLX66(Q4/HU\<<05)>-GAOE%2I.JGX+<?8R5/!\49)A544LM\/\
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M-<?@9Q^L\5YI'^RJ\)*%2$HY?3R]?6)U(\\E#%XGXXN3E_$9]4_'7X(?M?\
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MN2!QZ_XTZJTAQD_[1'\ZV2NTNXHJ\DN[',Y Y)Z]L?\ UJ9YO!Y/3N?<>_\
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M*][^&G[37[2/P8DA/A+XB:KJ>F6[ GP_XF:36+&X4E<Q%YL%/E4KOA_?"-I
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M-8+,,LKXFG3JJ,J+G3J<I/A7*<8HU,CXVX<QKG_!RW.Z/^K6/A)JZITZ^/\
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MW+DF2YGDGGN)69@6-Q<2?+/(S $N.>HX!-:L44:$ +@8X/Y?3MTZ9QU]=*(
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MFDZ>'/"O@GPJ9]N+C2=&MY[F#:,?+>7OS,[':./G+8(X#&N#1$ &$Q_GZ_\
MUO>IXU 8X';W]17%6^C)X+YE)5.+<BXH\2:C:=1>)_B/XC>)5+&)-2=/_5[B
MGB?'\*QIRDHSEA8Y+]4:IV5"\*/(J?$6:4U;#XC"8*/\N R[+Z5%>M2E^\@M
M;<T/>6B6[-?5O%7C#Q,R-KOB76;[8NP6\UV(88%Z;! G[I49<GY<$  #J:HV
MUG$N 54@G<2OS MR<LQ')_\ K^U-7J/J/YU>AZCZG^5?K^2Y#P_PKEM').$.
M',FX/RC#P5.GE?#N38/AW)ITXI)4J>3X#+J5&GB+13>(=2$7RR]Y<R3Y<35J
MXB]?%5/K-:6JJ]F^OY_>:,:;2H5<#@Y^G;^?MGZU>4C@>BC/Z<51@[_C_2KZ
M]!]!_*M/WG-.^W4XX_$O7_,6IT_UI^G]!4%6(_O)_NG^0I'9#X?FS63[H_'^
M9J>+K^*_S-58NGX+_(U.GWA^/\C2E\+]/\C*6_\ V]^K-1/NC\?YFK*]!]!_
M*JR?='X_S-6$^Z/Q_F:XI?$_7_(<?B7K_F7(NW^Z/Z5=CZ+]?ZU0@[_C_2KZ
M]!]!_*N2IU_Q?JS67POT_P BXG4_3^HJ\.C?3^HJA%V_W1_2KU8&4?B7K_F7
M(ON#\/Y"K:]!]!_*JD??\/ZU;7H/H/Y54?B7K_F:R^%^G^1-#]\?0UK)U/T_
MJ*R8?OCZ&M9.I^G]12J_:]/\C*/Q+U_S):>G4_3^HIE/3J?I_45S'73V?K^A
MI)T/U_H*L)T/U_H*KIT/U_H*L)T/U_H*4OA?I_D8+XY^OZEY.I^G]15Q>@^@
M_E5-.I^G]15Q>@^@_E6!9(G4_3^HK23H?K_05FIU/T_J*T8^_P"']: +*]%^
MI_DU3'[B_7_&H5Z+]3_)JF/W%^O^-9U-UZ?J!<BZ-]&_D*M0]!]#_.J4'?\
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M'B-_Z_NEQ.A^O]!4J?>'X_R-1)T/U_H*F3J?I_45$OA?I_D=,/ACZ(OQ=O\
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MWB+0=*:[\00S:++X@NUU7Q=#J)L&L;6QBU:SBEBLKGEO^"'N?^&KO'I /R_
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M7KYB;LF^Q:)P"?2JKMU]2"?S../U/X4PRMCEL?G^7.155YHU).[+=".OX_\
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MU:VKS6T=U'!-%X$G0_7^@I]82RS*U@998LIRQ974BH8C!47"E@:M-3C44:N
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MK[2-<L-%\/Z=9(EJ96MIM*DUV]N9UFW/]@L18V?EO');W,MS%<0^]>,/B_\
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M[C\X_&H)9FR"HR<'..R]R/49QR.>:I%V)))Y^E=D*>F_SMO_ , S/YS8NO\
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MFG4U/NC\?YFG54?B7K_F8/XU\OR98J=>L?U'\C4(."#^?TJ93EP!T&/SR/\
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M?Y^X[5(IP<_A7!.G9WML_N_X!HG9I]C21\@#VX_#M_/FKT3[OE] 3^H_Q_\
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M!F:1(&,]SBI%8+]XX';Z^G\ZAC=F4 ].OX__ *N?;OR:?2E\+]/\AQ^)>O\
MF3ARQ/S97KCW['GKP3SGOTZ595MH4^H _/\ _55%" <GTX^O'],U.C$-_LD<
M?7CMG^@KGE\+]/\ (UE\+]/\BX\FW"YZG/3KV_STIXD.!CUY]O7Z_P ZKYX]
MNM3)]T?C_,UBE=I=S$LI(V<'D8_S].,_X<5;63@<?_J]/K[UG*=ISUJ=6QSQ
MR.__ .OKQ5^S\_P_X(&@D@Z'\!QU]C^?^%74=F&/X>HX[_Y/2L9'W'''3/'X
M>]6%?H#^?^--4]5K?RM_P0-2BJ2-M/7 _P \?U_"G&4 9QP3C))Y/7!ZC_\
M5FJ=+39KS MT5520!OFP!@X^OU)],U))*!]T\Y[CMCG^E:TZ>BTOY?JP)J*K
M+,Q/)&,?3T]Z?YH[[2/\_6M/9VUMMY_\$":BH/.4<J,'V]/T_G2-<X'S'C/?
MU_.FE=I=Q-V3?8L@D'(J0M\H(/?^AXK/^U*2 ""<^G_Z_P"GUH>Y*].N.F.H
MY^O\_P *TC3=UJGKL9N=TU;?S_X!=WMZ_H/\*"S'C/\ *L<WC$G]WUS\V1CJ
M/Y]?PY!IK3%@"3GG[N<8ZC/^?6M?9^4?P_R(-1Y H.>WY?3^>?I^(J2W*[@
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M^"1>8V<Y_P _S_6H7D?OP,\$XYZ]_P"G6BBJ6&BO^7V(_P#!K_R-/9KN_P
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$RZG_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>figure06_01.jpg
<TEXT>
begin 644 figure06_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +T!90# 2(  A$! Q$!_\0
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MVBOQR_X5?^WK_P _GC[_ ,*:/_Y(H_X5?^WK_P _GC[_ ,*:/_Y(H_U/H_\
M0RH_^!(/K#_D9^QM%?CE_P *O_;U_P"?SQ]_X4T?_P D4?\ "K_V]?\ G\\?
M?^%-'_\ )%'^I]'_ *&5'_P)!]8?\C/V-HK\<O\ A5_[>O\ S^>/O_"FC_\
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MH_\ 0RH_^!(/K#_D9^QM%?CE_P *O_;U_P"?SQ]_X4T?_P D4?\ "K_V]?\
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M/_Y(H_U/H_\ 0RH_^!(/K#_D9^QM%?CE_P *O_;U_P"?SQ]_X4T?_P D4?\
M"K_V]?\ G\\??^%-'_\ )%'^I]'_ *&5'_P)!]8?\C/V-HK\<O\ A5_[>O\
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M_P D4?\ "K_V]?\ G\\??^%-'_\ )%'^I]'_ *&5'_P)!]8?\C/V-HK\<O\
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M<O\ A5_[>O\ S^>/O_"FC_\ DBC_ (5?^WK_ ,_GC[_PIH__ )(H_P!3Z/\
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M_P#@2#ZP_P"1G[&T5^.7_"K_ -O7_G\\??\ A31__)%'_"K_ -O7_G\\??\
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M7YI*+BT?=U%%%?!G4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-CH21GH*]!^"/_!-WX5ZC\(M&O/%VGWVJ>)-4LH[J2^AU"6 6AD4,%B1&"'
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MVG(4L&#Y^J^M?H/^SY^RYX/_ &;O!^K^&?#=QJNIZ3JDYN+B+6[A+@$E-C*
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M>%!''%$H544#   X  [5X]^TC^RCX+_:DTW1[/Q?<:M:KI4KS6\FDW*0OE@
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M7Y95JSK2YIR;]3Z.$5%62"BBBL2PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q']MO_DT
MOXJ?]@.?^0KY._X(P?\ (E_$_P#["%E_Z*EKZQ_;;_Y-+^*G_8#G_D*^3O\
M@C!_R)?Q/_["%E_Z*EK](R__ ))+&_\ 7R'YQ.27\>/H?H_1117YN=84444
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MX-/]"+X1_P#)*?!G_8%LO_1"5UE16MK#8VT-M;0QV]O"@CCAB4*B*!@*H'
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M0#>&W?P]&6O*S;AF%7-OJ66-1;AS<LI;:NZ3=^FMGT\CLP&82J815\1IYGZ
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M^%ND):.<_9X([O3;AU'4H9S(#CZ5][? KXY^&?VA/ -OXJ\,32&V:0P7-I<
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M !1110 4444 %%%% !1110!XC^VW_P FE_%3_L!S_P A7R=_P1@_Y$OXG_\
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M[.2_\C3"_P#7R'_I2,ZGP2]#PC_@C9_R1'QQ_P!C%_[;0U^@5?G[_P $;/\
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M_C6S\8^'D\&7.H71@TH&*4)^[$<L4V7&6 E'4>E?(/@'XR?&S]@_6-9T/4_
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MWAR%X,G@%YI=^/\ OE:_2WX0V-KIOPI\'6UE&D5K'H]H(UC^[CR5/]:^5?\
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M6[CW;MDR0[6!/<@@Y]ZUO^"6^@Z:OP7\0:_':1C5KO7)K2:ZQEVBBBB*)GL
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M+#G>,D9Z\5POAWXS?M=^%_A.GPC@^"^J/=VUF='@U\Z=,?+AVE%Q(/W+$*0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'B/[;?_)I?
MQ4_[ <_\A7R=_P $8/\ D2_B?_V$++_T5+7UC^VW_P FE_%3_L!S_P A7R=_
MP1@_Y$OXG_\ 80LO_14M?I&7_P#))8W_ *^0_.)R2_CQ]#]'Z***_-SK"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG54I-=$E*T;>MFV84ZKE.2>R-"BBOE*__9-NO%7[9UK\7[GXEF[M=(*F'PS
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MD,IX'0#ZU]5:K<Q:WX7U%M.U>&U$UM+'%J<,BNL#%2!(#G'RGGKVKT<9EM?
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MF>(R3*L#A<*^6I*+FY=;3EHEVNDK][(WA1C7K3J2VVMZ'YR_MG1Q?$K]O#X
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1'QQ_P!C%_[;0U^@5>MQ=_R/,5_B_1&>'_A1"BBBOD#H"BBB@ HHHH ****
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MI^&OBE^T-??$?6?%5RVCZA=Q7EYX9CL@$G**H*M-YGW69<GY.A(]Z^RZ*\_
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M&X$X')/6OO2BEA,\S' RJ3H5FG/65[2N^[4DU?SW">'I5$E*.Q\\?LV?L0^
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M?/W,YSWKWK_A])J?_1)[/_P?-_\ (]?H+_PSC\)O^B7^#/\ PG[3_P"-T?\
M#./PF_Z)?X,_\)^T_P#C=?HV+XBX=QU>6)Q&7N4Y;OG:O]SL<<:-:*LIGY]?
M\/I-3_Z)/9_^#YO_ )'H_P"'TFI_]$GL_P#P?-_\CU^@O_#./PF_Z)?X,_\
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M#)?YA[.O_/\ @?GU_P /I-3_ .B3V?\ X/F_^1Z/^'TFI_\ 1)[/_P 'S?\
MR/7Z"_\ #./PF_Z)?X,_\)^T_P#C='_#./PF_P"B7^#/_"?M/_C=']K<+_\
M0M?_ (,E_F'LZ_\ /^!^?7_#Z34_^B3V?_@^;_Y'H_X?2:G_ -$GL_\ P?-_
M\CU^@O\ PSC\)O\ HE_@S_PG[3_XW1_PSC\)O^B7^#/_  G[3_XW1_:W"_\
MT+7_ .#)?YA[.O\ S_@?GU_P^DU/_HD]G_X/F_\ D>C_ (?2:G_T2>S_ /!\
MW_R/7Z"_\,X_";_HE_@S_P )^T_^-T?\,X_";_HE_@S_ ,)^T_\ C=']K<+_
M /0M?_@R7^8>SK_S_@?GU_P^DU/_ *)/9_\ @^;_ .1Z/^'TFI_]$GL__!\W
M_P CU^@O_#./PF_Z)?X,_P#"?M/_ (W1_P ,X_";_HE_@S_PG[3_ .-T?VMP
MO_T+7_X,E_F'LZ_\_P"!^?7_  ^DU/\ Z)/9_P#@^;_Y'H_X?2:G_P!$GL__
M  ?-_P#(]?H+_P ,X_";_HE_@S_PG[3_ .-T?\,X_";_ *)?X,_\)^T_^-T?
MVMPO_P!"U_\ @R7^8>SK_P _X'Y]?\/I-3_Z)/9_^#YO_D>C_A])J?\ T2>S
M_P#!\W_R/7Z"_P##./PF_P"B7^#/_"?M/_C='_#./PF_Z)?X,_\ "?M/_C='
M]K<+_P#0M?\ X,E_F'LZ_P#/^!^?7_#Z34_^B3V?_@^;_P"1Z/\ A])J?_1)
M[/\ \'S?_(]?H+_PSC\)O^B7^#/_  G[3_XW1_PSC\)O^B7^#/\ PG[3_P"-
MT?VMPO\ ]"U_^#)?YA[.O_/^!^?7_#Z34_\ HD]G_P"#YO\ Y'H_X?2:G_T2
M>S_\'S?_ "/7Z"_\,X_";_HE_@S_ ,)^T_\ C='_  SC\)O^B7^#/_"?M/\
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M^#/_  G[3_XW1_:W"_\ T+7_ .#)?YA[.O\ S_@?GU_P^DU/_HD]G_X/F_\
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MD]G_ .#YO_D>C_A])J?_ $2>S_\ !\W_ ,CU^@O_  SC\)O^B7^#/_"?M/\
MXW1_PSC\)O\ HE_@S_PG[3_XW1_:W"__ $+7_P"#)?YA[.O_ #_@?GU_P^DU
M/_HD]G_X/F_^1Z/^'TFI_P#1)[/_ ,'S?_(]?H+_ ,,X_";_ *)?X,_\)^T_
M^-T?\,X_";_HE_@S_P )^T_^-T?VMPO_ -"U_P#@R7^8>SK_ ,_X'Y]?\/I-
M3_Z)/9_^#YO_ )'H_P"'TFI_]$GL_P#P?-_\CU^@O_#./PF_Z)?X,_\ "?M/
M_C='_#./PF_Z)?X,_P#"?M/_ (W1_:W"_P#T+7_X,E_F'LZ_\_X'Y]?\/I-3
M_P"B3V?_ (/F_P#D>C_A])J?_1)[/_P?-_\ (]?H+_PSC\)O^B7^#/\ PG[3
M_P"-T?\ #./PF_Z)?X,_\)^T_P#C=']K<+_]"U_^#)?YA[.O_/\ @?GU_P /
MI-3_ .B3V?\ X/F_^1Z/^'TFI_\ 1)[/_P 'S?\ R/7Z"_\ #./PF_Z)?X,_
M\)^T_P#C='_#./PF_P"B7^#/_"?M/_C=']K<+_\ 0M?_ (,E_F'LZ_\ /^!^
M?7_#Z34_^B3V?_@^;_Y'H_X?2:G_ -$GL_\ P?-_\CU^@O\ PSC\)O\ HE_@
MS_PG[3_XW1_PSC\)O^B7^#/_  G[3_XW1_:W"_\ T+7_ .#)?YA[.O\ S_@?
MGU_P^DU/_HD]G_X/F_\ D>C_ (?2:G_T2>S_ /!\W_R/7Z"_\,X_";_HE_@S
M_P )^T_^-T?\,X_";_HE_@S_ ,)^T_\ C=']K<+_ /0M?_@R7^8>SK_S_@?G
MU_P^DU/_ *)/9_\ @^;_ .1Z/^'TFI_]$GL__!\W_P CU^@O_#./PF_Z)?X,
M_P#"?M/_ (W1_P ,X_";_HE_@S_PG[3_ .-T?VMPO_T+7_X,E_F'LZ_\_P"!
M^?7_  ^DU/\ Z)/9_P#@^;_Y'H_X?2:G_P!$GL__  ?-_P#(]?H+_P ,X_";
M_HE_@S_PG[3_ .-T?\,X_";_ *)?X,_\)^T_^-T?VMPO_P!"U_\ @R7^8>SK
M_P _X'Y]?\/I-3_Z)/9_^#YO_D>C_A])J?\ T2>S_P#!\W_R/7Z"_P##./PF
M_P"B7^#/_"?M/_C='_#./PF_Z)?X,_\ "?M/_C=']K<+_P#0M?\ X,E_F'LZ
M_P#/^!^?7_#Z34_^B3V?_@^;_P"1Z/\ A])J?_1)[/\ \'S?_(]?H+_PSC\)
MO^B7^#/_  G[3_XW1_PSC\)O^B7^#/\ PG[3_P"-T?VMPO\ ]"U_^#)?YA[.
MO_/^!^?7_#Z34_\ HD]G_P"#YO\ Y'H_X?2:G_T2>S_\'S?_ "/7Z"_\,X_"
M;_HE_@S_ ,)^T_\ C='_  SC\)O^B7^#/_"?M/\ XW1_:W"__0M?_@R7^8>S
MK_S_ ('Y]?\ #Z34_P#HD]G_ .#YO_D>C_A])J?_ $2>S_\ !\W_ ,CU^@O_
M  SC\)O^B7^#/_"?M/\ XW1_PSC\)O\ HE_@S_PG[3_XW1_:W"__ $+7_P"#
M)?YA[.O_ #_@?GU_P^DU/_HD]G_X/F_^1Z/^'TFI_P#1)[/_ ,'S?_(]?H+_
M ,,X_";_ *)?X,_\)^T_^-T?\,X_";_HE_@S_P )^T_^-T?VMPO_ -"U_P#@
MR7^8>SK_ ,_X'Y]?\/I-3_Z)/9_^#YO_ )'H_P"'TFI_]$GL_P#P?-_\CU^@
MO_#./PF_Z)?X,_\ "?M/_C='_#./PF_Z)?X,_P#"?M/_ (W1_:W"_P#T+7_X
M,E_F'LZ_\_X'Y]?\/I-3_P"B3V?_ (/F_P#D>C_A])J?_1)[/_P?-_\ (]?H
M+_PSC\)O^B7^#/\ PG[3_P"-T?\ #./PF_Z)?X,_\)^T_P#C=']K<+_]"U_^
M#)?YA[.O_/\ @?GU_P /I-3_ .B3V?\ X/F_^1Z/^'TFI_\ 1)[/_P 'S?\
MR/7Z"_\ #./PF_Z)?X,_\)^T_P#C='_#./PF_P"B7^#/_"?M/_C=']K<+_\
M0M?_ (,E_F'LZ_\ /^!^?7_#Z34_^B3V?_@^;_Y'H_X?2:G_ -$GL_\ P?-_
M\CU^@O\ PSC\)O\ HE_@S_PG[3_XW1_PSC\)O^B7^#/_  G[3_XW1_:W"_\
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M>S_\'S?_ "/7Z"_\,X_";_HE_@S_ ,)^T_\ C='_  SC\)O^B7^#/_"?M/\
MXW1_:W"__0M?_@R7^8>SK_S_ ('Y]?\ #Z34_P#HD]G_ .#YO_D>C_A])J?_
M $2>S_\ !\W_ ,CU^@O_  SC\)O^B7^#/_"?M/\ XW1_PSC\)O\ HE_@S_PG
M[3_XW1_:W"__ $+7_P"#)?YA[.O_ #_@?GU_P^DU/_HD]G_X/F_^1Z/^'TFI
M_P#1)[/_ ,'S?_(]?H+_ ,,X_";_ *)?X,_\)^T_^-T?\,X_";_HE_@S_P )
M^T_^-T?VMPO_ -"U_P#@R7^8>SK_ ,_X'Y]?\/I-3_Z)/9_^#YO_ )'H_P"'
MTFI_]$GL_P#P?-_\CU^@O_#./PF_Z)?X,_\ "?M/_C='_#./PF_Z)?X,_P#"
M?M/_ (W1_:W"_P#T+7_X,E_F'LZ_\_X'Y]?\/I-3_P"B3V?_ (/F_P#D>C_A
M])J?_1)[/_P?-_\ (]?H+_PSC\)O^B7^#/\ PG[3_P"-T?\ #./PF_Z)?X,_
M\)^T_P#C=']K<+_]"U_^#)?YA[.O_/\ @?GU_P /I-3_ .B3V?\ X/F_^1Z/
M^'TFI_\ 1)[/_P 'S?\ R/7Z"_\ #./PF_Z)?X,_\)^T_P#C='_#./PF_P"B
M7^#/_"?M/_C=']K<+_\ 0M?_ (,E_F'LZ_\ /^!^?7_#Z34_^B3V?_@^;_Y'
MH_X?2:G_ -$GL_\ P?-_\CU^@O\ PSC\)O\ HE_@S_PG[3_XW1_PSC\)O^B7
M^#/_  G[3_XW1_:W"_\ T+7_ .#)?YA[.O\ S_@?GU_P^DU/_HD]G_X/F_\
MD>C_ (?2:G_T2>S_ /!\W_R/7Z"_\,X_";_HE_@S_P )^T_^-T?\,X_";_HE
M_@S_ ,)^T_\ C=']K<+_ /0M?_@R7^8>SK_S_@?GU_P^DU/_ *)/9_\ @^;_
M .1Z/^'TFI_]$GL__!\W_P CU^@O_#./PF_Z)?X,_P#"?M/_ (W1_P ,X_";
M_HE_@S_PG[3_ .-T?VMPO_T+7_X,E_F'LZ_\_P"!^?7_  ^DU/\ Z)/9_P#@
M^;_Y'H_X?2:G_P!$GL__  ?-_P#(]?H+_P ,X_";_HE_@S_PG[3_ .-T?\,X
M_";_ *)?X,_\)^T_^-T?VMPO_P!"U_\ @R7^8>SK_P _X'Y]?\/I-3_Z)/9_
M^#YO_D>C_A])J?\ T2>S_P#!\W_R/7Z"_P##./PF_P"B7^#/_"?M/_C='_#.
M/PF_Z)?X,_\ "?M/_C=']K<+_P#0M?\ X,E_F'LZ_P#/^!^?7_#Z34_^B3V?
M_@^;_P"1Z/\ A])J?_1)[/\ \'S?_(]?H+_PSC\)O^B7^#/_  G[3_XW1_PS
MC\)O^B7^#/\ PG[3_P"-T?VMPO\ ]"U_^#)?YA[.O_/^!^?7_#Z34_\ HD]G
M_P"#YO\ Y'H_X?2:G_T2>S_\'S?_ "/7Z"_\,X_";_HE_@S_ ,)^T_\ C='_
M  SC\)O^B7^#/_"?M/\ XW1_:W"__0M?_@R7^8>SK_S_ ('Y]?\ #Z34_P#H
MD]G_ .#YO_D>C_A])J?_ $2>S_\ !\W_ ,CU^@O_  SC\)O^B7^#/_"?M/\
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M?O7^8>WE_(S]C:*_'+_ADG]M_P#Z"?BC_P +E/\ Y*H_X9)_;?\ ^@GXH_\
M"Y3_ .2J/]4\#_T-*/WK_,/;R_D9^QM%?CE_PR3^V_\ ]!/Q1_X7*?\ R51_
MPR3^V_\ ]!/Q1_X7*?\ R51_JG@?^AI1^]?YA[>7\C/V-HK\<O\ ADG]M_\
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M4?ZIX'_H:4?O7^8>WE_(S]C:*_'+_ADG]M__ *"?BC_PN4_^2J/^&2?VW_\
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MZIX'_H:4?O7^8>WE_(S]C:*_'+_ADG]M_P#Z"?BC_P +E/\ Y*H_X9)_;?\
M^@GXH_\ "Y3_ .2J/]4\#_T-*/WK_,/;R_D9^QM%?CE_PR3^V_\ ]!/Q1_X7
M*?\ R51_PR3^V_\ ]!/Q1_X7*?\ R51_JG@?^AI1^]?YA[>7\C/V-HK\<O\
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M^&2?VW_^@GXH_P#"Y3_Y*H_X9)_;?_Z"?BC_ ,+E/_DJC_5/ _\ 0TH_>O\
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M/WK_ ##V\OY&?L;17XY?\,D_MO\ _03\4?\ A<I_\E4?\,D_MO\ _03\4?\
MA<I_\E4?ZIX'_H:4?O7^8>WE_(S]C:*_'+_ADG]M_P#Z"?BC_P +E/\ Y*H_
MX9)_;?\ ^@GXH_\ "Y3_ .2J/]4\#_T-*/WK_,/;R_D9^QM%?CE_PR3^V_\
M]!/Q1_X7*?\ R51_PR3^V_\ ]!/Q1_X7*?\ R51_JG@?^AI1^]?YA[>7\C/V
M-HK\<O\ ADG]M_\ Z"?BC_PN4_\ DJC_ (9)_;?_ .@GXH_\+E/_ )*H_P!4
M\#_T-*/WK_,/;R_D9^QM%?CE_P ,D_MO_P#03\4?^%RG_P E4?\ #)/[;_\
MT$_%'_A<I_\ )5'^J>!_Z&E'[U_F'MY?R,_8VBOQR_X9)_;?_P"@GXH_\+E/
M_DJC_ADG]M__ *"?BC_PN4_^2J/]4\#_ -#2C]Z_S#V\OY&?L;17XY?\,D_M
MO_\ 03\4?^%RG_R51_PR3^V__P!!/Q1_X7*?_)5'^J>!_P"AI1^]?YA[>7\C
M/V-HK\<O^&2?VW_^@GXH_P#"Y3_Y*H_X9)_;?_Z"?BC_ ,+E/_DJC_5/ _\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KS/]I[_DVOXL_]BEJW_I'+7IE>9_M/?\FU_%G_ +%+5O\ TCEKMP/^
M]4O\4?S1,OA9\%?\$5_^/[XO_P#7/2?YWE?J#7Y??\$5_P#C^^+_ /USTG^=
MY7Z@U];QQ_R/\1_V[_Z1$Y\-_"04445\*=04444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M '(?&'_DD?C?_L!WW_I.]?FA_P $8_\ DHWQ'_[!-M_Z.:OTO^,/_)(_&_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *_&O]I#5DM_VZ=;A$FV0^*]/4#OR\-?LI
M7@7BW]AOX0^-_BFWQ#U;0+F?Q0UW%?-<)J$R1F:,J5;RPVW^$<8[5]CPSFV&
MRBO5J8I-J4&E9)ZW3ZM::'EX[!_6U!?RNY4_;N^$+?%;]GW7);&W\[7O#Z'5
M[#:N7?R@3+$/7='O '=@M?+O_!++XY16OBC7OAG=7*M;:I$=9TK+#Y9D 6>,
M?[R[' [>6_K7Z3R1K-&\;C<C JRGN#7S[\/_ -@SX-_"_P"(5GXT\.>'[NPU
MVSF>:"0:C.T:,P(($9;;C#'C&*TR_.,+'*,1EF-3=]8-).TO.[5E=+;NR:V"
M<L7#%4W9K1^9^;FF:%X5^%W[36K>%/B[I<UYX8L=7NH-0A22:)C!)O,%R#$R
MN5PT<GRG)&1STKZFUOX2?L >&]$?6+B^\-R0A=_DV7BV_N+H\9QY$=T9,^Q7
MZU],_'O]D/X<?M&20W?BG3)H=9@C\J+5]-F,%RJ=E+8(<#G 8$#->%:;_P $
MC?@];:DMS?ZWXMUB%3DVMU?0JA]LQPJW_CU?4OB+ 8Z%.K7Q5:A-)*4:;:4F
MNJUMKY^G0X<+E\\%*<*<4XMWUW/3/@3!\*_^&4=>U+X/:+/H?@^_MM1F2&Z:
M5IGE57C=V,LCMSLXRW3' Y%?&O\ P27OH[SX]>(PCARGA-MV.V;JW_PK]+?"
M'PG\+> _AU%X&T'2H].\,QV\ELMG$S?<DSO)8G)+%F).<Y-<'\#/V//AA^SG
MXBO];\#Z/=:?J-]:_8II+B^EN 8MZO@!V('S*O/M7SM'.\)3PF84)<\I5FN1
MO5VN_C=][>IZ4L*Y5:51_9_4^7O^"NMW'9Z=\*7D;:INM17)_P"N<'^%;]UX
M1O/B#_P2WTJ'3+=KN\M=&BU**&,$LXAE+L !U.T,?PKZ:^._[,_@']I&QTBT
M\=Z9/J4.E222VH@NY+<HSA0V2A&<A5Z^E=A\/?A_HOPM\%:3X4\/6S6NB:7"
M+>VADD:1E0=BS$D]>]3'/J%'*\'AJ2?M:,^9W^%J\GO>_7L3/!*I6J5);2C8
M_.;_ ()M_M&>"?AF?%'A[Q7KEGX?AUB:*^M-0OY!%;LZIL9'D/RIP 06(!YY
MS@4S_@I-^TKX+^)2^&?#7A/6K7Q#;Z//)?W>H6#B6W\QD,:1QR#B0X9B2N1R
M!G.0/I#XJ?\ !-/X0_$WQ!=ZQ"NL>$KN[<RSIX?N4BA=R<EA&\;JN>?N@=:M
M_"#_ ()R?"+X1^(+76U@U/Q3J=HXDMIM?N%F6%QR&$:(B$@\@D'%?0?VQP_]
M>_MF]3VMO@LK7M;?T_SMT/-6"Q?U;ZFVN7:_6QT'[)?PANO#_P"R/X?\)>)K
M:2"ZU73YI;VTG7#PBY+-Y;#LP5UR#R#D5^;/@CQAJO[-_C'XD>&PS0ZC]DOO
M#4^'PR$MM63/L/F!]P:_:JOG_P"*7["OP?\ C#XVU#Q9XCT"Z?7-0"?:I[/4
M9[992J! S*C 9VJ!GVKQ,GX@H4:^)>8Q;A6?,U%7M*]]FUIK^"-L?EDL13IQ
MHRY90V9X1_P2M^&L-OH?C#X@20@RWTZZ192D'B&+YI=O^\Y7/_7,5\X?M66%
M]\#?VWM2UZXLV>W_ +;L?%NG;LA;I%>.5U!SVFCD4_3L"*_5SX8_#+P[\'_!
M>G^%/"MC_9^BV(80PEV=LDDEF9B2Q)/4US_QO_9Y\#_M":##I?C+2OMGV=B]
MK>0.8KFV8]2D@Y&>,CH<<BML+Q/2IYS6QM:+=*HN6W51TL[7WTU5^K">5_[)
M"A!VE'6_F<1XD_;D^#VF_#:X\3V/CC2;ZZ-L7M]'BN%.H-*5.V-K?/F+\W!+
M */7%?$/_!-/PI?>+_VC+KQ%!$XTK0;*>2YF4?()ISM2//K@N<=>*^@[7_@D
MK\)H=1%Q-XC\8W4&<FTDOH A'IE8 W_CU?5GPM^$OA/X+^%8?#O@_1X-&TN-
MM[)%DO*YZN['EF/J314S+*,KP&(PV5RG.=;1N2226OWNS?WW-/JM?$UJ=3$6
M2AK9=S\POVZOAOK?P)_:*;QE8PR0Z-KEVFK:;J*J3%%>(09(6/0-E0P!^\K'
M'0X^UO@K^WU\*?B5X;M7UWQ1IO@KQ"D2B\L->N4M(Q)CYC%*Y".I.<8.?4"O
M>O&G@?0/B-X=NM"\2Z3:ZUI-R,26MW&'0^A'H1V(Y%?)OBC_ ()1_![7KYY[
M#4O%'AZ)FW?9M/OXWC'L/.B<@?C3CFV59O@J6&S;FA4IJRG%7NO-?)?/6ZO8
M(X.KA:\JF'LXRW3[GR3_ ,% ?B3X9^('QJU+6?#.M6NN:7#I<-L;NS??$TB[
MMP5^C#D<C(]Z^IO^"@GAK4-2_9+\&Z[9P/-#H,UC<7J*I)2&2'RBY]E=DSZ
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M;^$@HHHKX4Z@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M HHHH *\S_:>_P"3:_BS_P!BEJW_ *1RUZ97F?[3W_)M?Q9_[%+5O_2.6NW
M_P"]4O\ %'\T3+X6?!7_  17_P"/[XO_ /7/2?YWE?J#7Y??\$5_^/[XO_\
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M&BM6IOAZC24ES*K-VOK;ECK8(Q?UF3MT_P CXE\1*%_X+)>#\ #.F3$X[_\
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M "BBB@ HHHH *\S_ &GO^3:_BS_V*6K?^D<M>F5YG^T]_P FU_%G_L4M6_\
M2.6NW _[U2_Q1_-$R^%GP5_P17_X_OB__P!<])_G>5^H-?E]_P $5_\ C^^+
M_P#USTG^=Y7Z@U];QQ_R/\1_V[_Z1$Y\-_"04445\*=04444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHM?E^!M7W[4WQCU/);Q?'9 ]K2QB7'Y@US=]\7OB3JN?M?Q$U]@>H@N_)_\
M0 *G\2?9M%O(&TO1K=9<QR"/4&57M< "2.6-\AU//S_B#5>;Q1I$U]&[W-C'
MI]UMN+=!&&ETJX0YV$*,O$Q&,'/!!X/6HUJ22<*45\E_E_7W7)497M*;?S?^
M9@7D&L:_+MU#5=<U=R"Q6ZO9Y\CN<,QXJK9^ ;>9%G@TA&1D:03&-0NU<;FW
M'CC(_.NFM?B98V?B2_OXYYX[&\21I;-2Q,$Q!P]O)U #<@''!((-8:_%#[+;
MP3P6L5MJ2R-]HVX-K=1LNUPT7\);'.TX[@ UTK%XC:*L9O#T-Y'3:=X%MX_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#D/C#_P DC\;_ /8#OO\ TG>OS0_X(Q_\E&^(_P#V
M";;_ -'-7Z7_ !A_Y)'XW_[ =]_Z3O7YH?\ !&/_ )*-\1_^P3;?^CFK](R7
M_DF\S_[<_,XZG\:'S/U>HHHK\W.P**** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** .0^,/_ "2/QO\ ]@.^_P#2=Z_-#_@C'_R4;XC_ /8)MO\
MT<U?I?\ &'_DD?C?_L!WW_I.]?FA_P $8_\ DHWQ'_[!-M_Z.:OTC)?^2;S/
M_MS\SCJ?QH?,_5ZBBBOS<[ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJW_I'+7;@?\ >J7^*/YHF7PL^"O^"*__ !_?%_\ ZYZ3_.\K]0:_+[_@BO\
M\?WQ?_ZYZ3_.\K]0:^MXX_Y'^(_[=_\ 2(G/AOX2"BBBOA3J"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K,U1MDT9]16G65
MKWRQQ/\ [6* *WF4GF55$M'FT 6O,I/,JKYOO2>=0!;\VD\RJOG4>;[T 6O-
MI/,JKYOO2>=[T 6_-I/,JKYU)YM %OS*3S*J^9[TGF^] %OS*3S*J>;[T>;0
M!:\VCS*J>9[T>=[T 6O,H\RJGG>])YM %OS:/-JIYM)YOO0!;\VD\VJOFTGG
M4 6_.H\ZJGG4GF>] %KSJ/-JIYWO1YWO0!:\VCS:J>;2>9[T :%C+_Q,(1_M
M5U-<7I\O_$RMAG^,5VE !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD'CS2OB&\FI:/H[W$,&FK<-$'AMMD4<0*D,JDDNVT@DL>>:A^)_P;\,? /\
M;F^&?ASPC#/;:-<WEC>K:S3--Y#-*ZE%9B6V_*#\Q)YZUZN4Y;A,KK*"J2=>
M5&4FK+DM*.R>]U]QQ5\74K04Z:7+S)>9^CFN?&OP-X:^(&F>!]4\3V%CXMU)
M4>STF9R)IU<L%*C'<HP_"D\?_&SP+\+-4TC3?%OB>PT&_P!78K86]VY5K@AE
M4A>/5E'XU\*?M+1[O^"K7P<)^ZMEI^<_]=KO'ZT[_@J59&Z^-WP%<=([B4M_
MX%6N/ZU\]AN'</6Q."HRFTJU-S>VC2D[+3;0].IB7#G?:WXGZ">+_''A_P
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MZ@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+NY=ER3T XK] J*JGQ3F=.A&@I*T8\MW%7Y;6LW:]ET(E@Z,I<S76_S/C_\
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MYU)YU4O.H\[WH N>=2><*I^=[TGG>] %WSJ3SJI^=[TGG>] &EI4W_$[L/\
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M3SJI^=[TGG>] %SSJ3SJI^=2>=0!=\ZD\ZJ?G>])YWO0!<\X4>=5+SO>CSJ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1?\ H0KZIKY*LY<:YIG_ %]1?^ABOK6@!:*** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1110!R'QA_Y)'XW_ .P'??\ I.]?FA_P1C_Y*-\1_P#L$VW_ *.:OTO^,/\
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MPI=U8E"T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 <A\8?^21^-_^P'??^D[U^:'_
M  1C_P"2C?$?_L$VW_HYJ_2_XP_\DC\;_P#8#OO_ $G>OS0_X(Q_\E&^(_\
MV";;_P!'-7Z1DO\ R3>9_P#;GYG'4_C0^9^KU%%%?FYV!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %>9_M/?\ )M?Q9_[%+5O_ $CEKTRO,_VGO^3:_BS_ -BE
MJW_I'+7;@?\ >J7^*/YHF7PL^"O^"*__ !_?%_\ ZYZ3_.\K]0:_+[_@BO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!R
M'QA_Y)'XW_[ =]_Z3O7YH?\ !&/_ )*-\1_^P3;?^CFK]+_C#_R2/QO_ -@.
M^_\ 2=Z_-#_@C'_R4;XC_P#8)MO_ $<U?I&2_P#)-YG_ -N?F<=3^-#YGZO4
M445^;G8%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5YG^T]_P FU_%G_L4M6_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .0^,/_ "2/QO\ ]@.^
M_P#2=Z_-#_@C'_R4;XC_ /8)MO\ T<U?I?\ &'_DD?C?_L!WW_I.]?FA_P $
M8_\ DHWQ'_[!-M_Z.:OTC)?^2;S/_MS\SCJ?QH?,_5ZBBBOS<[ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O,_P!I[_DVOXL_]BEJW_I'+7IE>9_M/?\ )M?Q
M9_[%+5O_ $CEKMP/^]4O\4?S1,OA9\%?\$5_^/[XO_\ 7/2?YWE?J#7Y??\
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MS49UBW=@%N(G)Z 2*?ZUDO\ 9S_RPC_[Y%5IK>SE^];Q'_@(KI]A66TE_P"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK](R7_DF\S_[<_,XZG\:'S/U>HHHK\W.P**** "BBB@ HHHH **** "BBB@
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M]\7_ /KGI/\ .\K]0:_+[_@BO_Q_?%__ *YZ3_.\K]0:^MXX_P"1_B/^W?\
MTB)SX;^$@HHHKX4Z@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ IK#-.I* *LL?M6?=6^1TK79:JS1Y[4 <Q?6F[/%<SJ5CNSQ7=W5
MOUXK"O[/.>* /,=6T[AN*XG6-,^]Q7KFJ6&X-Q7':OIN0W% 'CFLZ9][BO'?
MBAX!?7K6&[L9Y+#6=/F6[L+^ [9;>=#E74CH<_F"17T=K&F?>XKAM:TO[W%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH *\S_ &GO^3:_BS_V*6K?^D<M>F5YG^T]_P FU_%G_L4M6_\
M2.6NW _[U2_Q1_-$R^%GP5_P17_X_OB__P!<])_G>5^H-?E]_P $5_\ C^^+
M_P#USTG^=Y7Z@U];QQ_R/\1_V[_Z1$Y\-_"04445\*=04444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\S_:>_Y-K^+/\
MV*6K?^D<M>F5YG^T]_R;7\6?^Q2U;_TCEKMP/^]4O\4?S1,OA9\%?\$5_P#C
M^^+_ /USTG^=Y7Z@U^7W_!%?_C^^+_\ USTG^=Y7Z@U];QQ_R/\ $?\ ;O\
MZ1$Y\-_"04445\*=04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4UEIU% %:1*HW, .:U&6J\L?M0!SEU:]<CF
MN>U"RSGBNTN8,YK'OK;(Y% 'G>I:?G=Q7*ZEIO7BO3K^Q!W<5SFH:;UXH \N
MO]+'/%<AXK\%V?B;2;K3[V!)[>9"CQNN001@BO7KW2LY^6L>XTC+'Y: ,W]E
M_P")U[I4W_"KO%MXTU]:)G0=0N6.Z[ME'^H9C]Z1!T[E?<&OHE9);&Y66(X=
M?U]J^6_&GP]_X2*R26W=K/4[1Q/:7<7#PRKRK*?7->S_  ;^)Q^(NARVFJ*M
MKXKTL+%J-KC&_LLR#NC8/T.10!Z[-XLTRUMTEN+I(689\L\M^0KE=0\=:;]H
M,MCH\<L__/S/&JG]!G^58GB:W"ZA$V/O)6<J@=J=A&K?>+M8U#(:Z,"'^& ;
M?UZUC^468NY+.>K,<D_C4E+5"&A0*6H[JZ@L(&GNIX[>%>3)*P51^)K%3QA!
M?R>7I%G=:P_0-;QD1_\ ?9P/RH WZCGGBM8S)-*D2#JSL *AM?"?C#7L;WMM
M"@;^X/-FQ]3\H_(UT>C_  8TBWD6?4I)]7N>OF7DA?GV'0?@*5PL<8WBRUF?
MR].@N=6FS@+9QEE_%CA1^=65\->,-;7>8K?0[<_WCYTN/T _(U['8Z/9:=&$
MMK:.%1T"J!5UH1,I5NE*X['A)^%NGHPDU:ZGU:4<[;AR4!]EZ?I6C&MEI*".
MUMHX57@!5 KT36O"K7"EH3S7G>N^'[^SW$QL1ZTAE>;7F'\55UU]MWWC7.WG
MGQL=RL/PJHDDID'!ZT <SK?BA5\6ZE"^U)5F^7S#A9 0#][L:T8]7B\H/*K0
M#H=XX'XCC'O7#>,8=WBB_P!W]Y21[[13])DEA"K'*RK_ '<Y'Y5^:9KP+0Q5
M:>)P53DE-N33O:[U=GK:[UU3\K+0^LP/$U;"P5&O'FC%636]EMIU^]'>QZA;
M3+E)HV'LPI?M4+$8E0YZ88<UFZ?:17#*9(HV;^]M -;EKX1TFSMY[J*S4S*K
M./F*@D#ID#('TKY"7 F;IM0</+WM/G[J?X'T4>*<$U=QE]W_  ?U*CW2+WIJ
MVEUJ2'RHF$?>1N!5W28=6N_*DM_#T5G;LW-Q(C/(.."%DQ@>Y6M.6QFD)D:X
MFF0=1Y@VY'K@ =>PXKU,'X:XFHT\VQ,5'K&G=M^3D[6^2.#$\71LU@Z3OWE_
MDK_F>L? !O\ BW<:9R8[N=#_ -]FO2*\S_9^DW>![A?[NH3C]0:],K]@HT*6
M%IQH48\L(I)+LEHD?!SJ3JR=2H[R>K?FPHHHK8@**** "BBB@ HHHH ****
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MQ'_;O_I$3GPW\)!1117PIU!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %)MI:* &&.F&/U%344
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M_P"BI^'?_ G_ .M7RG_PYA\,_P#13=6_\%D7_P 71_PYA\,_]%-U;_P61?\
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M?*?_  YA\,_]%-U;_P %D7_Q='_#F'PS_P!%-U;_ ,%D7_Q='U#A'_H-J?\
M@/\ ]J'-7_E1]6?\-O\ P&_Z*GX=_P# G_ZU'_#;_P !O^BI^'?_  )_^M7R
MG_PYA\,_]%-U;_P61?\ Q='_  YA\,_]%-U;_P %D7_Q='U#A'_H-J?^ _\
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M?_%T?\.8?#/_ $4W5O\ P61?_%T?4.$?^@VI_P" _P#VH<U?^5'U9_PV_P#
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M_P!%-U;_ ,%D7_Q='U#A'_H-J?\ @/\ ]J'-7_E1]6?\-O\ P&_Z*GX=_P#
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M9%_\71]0X1_Z#:G_ (#_ /:AS5_Y4?5G_#;_ ,!O^BI^'?\ P)_^M1_PV_\
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M^@VI_P" _P#VH<U?^5'U9_PV_P# ;_HJ?AW_ ,"?_K4?\-O_  &_Z*GX=_\
M G_ZU?*?_#F'PS_T4W5O_!9%_P#%T?\ #F'PS_T4W5O_  61?_%T?4.$?^@V
MI_X#_P#:AS5_Y4?5G_#;_P !O^BI^'?_  )_^M1_PV_\!O\ HJ?AW_P)_P#K
M5\I_\.8?#/\ T4W5O_!9%_\ %T?\.8?#/_13=6_\%D7_ ,71]0X1_P"@VI_X
M#_\ :AS5_P"5'U9_PV_\!O\ HJ?AW_P)_P#K4?\ #;_P&_Z*GX=_\"?_ *U?
M*?\ PYA\,_\ 13=6_P#!9%_\71_PYA\,_P#13=6_\%D7_P 71]0X1_Z#:G_@
M/_VH<U?^5'U9_P -O_ ;_HJ?AW_P)_\ K4?\-O\ P&_Z*GX=_P# G_ZU?*?_
M  YA\,_]%-U;_P %D7_Q='_#F'PS_P!%-U;_ ,%D7_Q='U#A'_H-J?\ @/\
M]J'-7_E1]6?\-O\ P&_Z*GX=_P# G_ZU'_#;_P !O^BI^'?_  )_^M7RG_PY
MA\,_]%-U;_P61?\ Q='_  YA\,_]%-U;_P %D7_Q='U#A'_H-J?^ _\ VH<U
M?^5'U9_PV_\  ;_HJ?AW_P "?_K4?\-O_ ;_ **GX=_\"?\ ZU?*?_#F'PS_
M -%-U;_P61?_ !='_#F'PS_T4W5O_!9%_P#%T?4.$?\ H-J?^ __ &H<U?\
ME1]6?\-O_ ;_ **GX=_\"?\ ZU'_  V_\!O^BI^'?_ G_P"M7RG_ ,.8?#/_
M $4W5O\ P61?_%T?\.8?#/\ T4W5O_!9%_\ %T?4.$?^@VI_X#_]J'-7_E1]
M6?\ #;_P&_Z*GX=_\"?_ *U'_#;_ ,!O^BI^'?\ P)_^M7RG_P .8?#/_13=
M6_\ !9%_\71_PYA\,_\ 13=6_P#!9%_\71]0X1_Z#:G_ (#_ /:AS5_Y4?5G
M_#;_ ,!O^BI^'?\ P)_^M1_PV_\  ;_HJ?AW_P "?_K5\I_\.8?#/_13=6_\
M%D7_ ,71_P .8?#/_13=6_\ !9%_\71]0X1_Z#:G_@/_ -J'-7_E1]6?\-O_
M  &_Z*GX=_\  G_ZU'_#;_P&_P"BI^'?_ G_ .M7RG_PYA\,_P#13=6_\%D7
M_P 71_PYA\,_]%-U;_P61?\ Q='U#A'_ *#:G_@/_P!J'-7_ )4?4$W[9?P
MFE:1OBIX?R?^GG_ZU1G]L3]G\_\ -5/#_P#X$_\ UJ^8_P#AS#X9_P"BFZM_
MX+(O_BZ/^',/AG_HINK?^"R+_P"+K-Y7P=+5XRI_X"__ )$M5<2MD?3/_#7W
M[/9Z_%+P]_X$_P#V-)_PUY^SWMP/BGX?4>US_P#8U\S_ /#F'PS_ -%-U;_P
M61?_ !='_#F'PS_T4W5O_!9%_P#%U/\ 97!W_094_P# 7_\ (C]MBNR/IO\
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M *U'_#;_ ,!O^BI^'?\ P)_^M7RG_P .8?#/_13=6_\ !9%_\71_PYA\,_\
M13=6_P#!9%_\71]0X1_Z#:G_ (#_ /:AS5_Y4?5G_#;_ ,!O^BI^'?\ P)_^
MM1_PV_\  ;_HJ?AW_P "?_K5\I_\.8?#/_13=6_\%D7_ ,71_P .8?#/_13=
M6_\ !9%_\71]0X1_Z#:G_@/_ -J'-7_E1]6?\-O_  &_Z*GX=_\  G_ZU'_#
M;_P&_P"BI^'?_ G_ .M7RG_PYA\,_P#13=6_\%D7_P 71_PYA\,_]%-U;_P6
M1?\ Q='U#A'_ *#:G_@/_P!J'-7_ )4?5G_#;_P&_P"BI^'?_ G_ .M1_P -
MO_ ;_HJ?AW_P)_\ K5\I_P##F'PS_P!%-U;_ ,%D7_Q='_#F'PS_ -%-U;_P
M61?_ !='U#A'_H-J?^ __:AS5_Y4?5G_  V_\!O^BI^'?_ G_P"M1_PV_P#
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M1_Z#:G_@/_VH<U?^5'U9_P -O_ ;_HJ?AW_P)_\ K4?\-O\ P&_Z*GX=_P#
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M52,IJUCZ8HHHK\I.X**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
/ **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>figure07_01.jpg
<TEXT>
begin 644 figure07_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'Y!98# 2(  A$! Q$!_\0
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M_H#>%_\ P$D_^+H_X?-?&G_H#>%__ 23_P"+H _;"BOQ/_X?-?&G_H#>%_\
MP$D_^+H_X?-?&G_H#>%__ 23_P"+H _;"BOQ/_X?-?&G_H#>%_\ P$D_^+H_
MX?-?&G_H#>%__ 23_P"+H _;"BOQ/_X?-?&G_H#>%_\ P$D_^+H_X?-?&G_H
M#>%__ 23_P"+H _;"BOQ/_X?-?&G_H#>%_\ P$D_^+H_X?-?&G_H#>%__ 23
M_P"+H _;"BOQ/_X?-?&G_H#>%_\ P$D_^+H_X?-?&G_H#>%__ 23_P"+H _;
M"BOQ/_X?-?&G_H#>%_\ P$D_^+H_X?-?&G_H#>%__ 23_P"+H _;"BOQ/_X?
M-?&G_H#>%_\ P$D_^+H_X?-?&G_H#>%__ 23_P"+H _;"BOQ/_X?-?&G_H#>
M%_\ P$D_^+H_X?-?&G_H#>%__ 23_P"+H _;"BOQ/_X?-?&G_H#>%_\ P$D_
M^+H_X?-?&G_H#>%__ 23_P"+H _;"BOQ/_X?-?&G_H#>%_\ P$D_^+H_X?-?
M&G_H#>%__ 23_P"+H _;"BOQ/_X?-?&G_H#>%_\ P$D_^+H_X?-?&G_H#>%_
M_ 23_P"+H _;"BOQ/_X?-?&G_H#>%_\ P$D_^+H_X?-?&G_H#>%__ 23_P"+
MH _;"BOQ/_X?-?&G_H#>%_\ P$D_^+H_X?-?&G_H#>%__ 23_P"+H _;"BOQ
M/_X?-?&G_H#>%_\ P$D_^+H_X?-?&G_H#>%__ 23_P"+H _;"BOQ/_X?-?&G
M_H#>%_\ P$D_^+H_X?-?&G_H#>%__ 23_P"+H _;"BOQ/_X?-?&G_H#>%_\
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M6#[OHN : /"\$<8HVGTKW1_A=YZJ#"JLW/RBHI?AN-P M<<8!Q^M 'B*HS'
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M:_X)1_!OP1\4/@O\18_%7A72==>?4DM#-?6B2R+&8<X5R,K@DD;2.>:^@_\
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M[ZN_=]%T*A.?O2W/6M,_;0^"6K:VNDP_$C0X[QV"1_:+CR8Y23@!)'PKY/\
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M7%9/EF"QRP4JDY3YH*UDE:5NOS\NUNH*I5E'FLK%']@']LJ/XO>*OB+>^/\
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MASXB?\%%-3\7?$;Q!I,WAK[7J4%EJ.JRH;&*%$DCMBI<[ -NTCL2<]37N?\
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MW_8MV/\ Z*6O9*\;_8W_ .34_A-_V+=C_P"BEKV2O3,PHHHH **** "BBB@
MHHHH \6_:Z\<0^$O@?XGL!H^L:YJ&NZ==:996>CV,ER[320LJ[MH.Q>?O'C\
M>*X3]EOQ3IWQ@_9UL_ACX@\+>(-!O[/P\FE:G:ZUILEO&ZF/RR8Y&&&SUXY'
MH*^I**]6&,A#"_5U#WE+F4K[/TMV,73O/GOY'YU?\$W_ -CC5O@[\7OB+XE\
M5:=/#-HMQ)HFBSW$943QD[I+A,\,&78 P]6 [UY?_P %.D\1?M!?$GPW;^"O
M GBW5(?#=O<V=W>?V-,(9)&D4_NVQ\P&T\].>*_66BO:I\1U8YC_ &E5AS32
MLM;):6[>OWD>Q]SD3/ABS\"R?M;?L+1?#1-$UCPMXQT#3+.%(->LGM5^UP*-
MNUF&&1MI&X=-W->(?L3_ +0'C/\ 9!T_7?A;X]^%OC'4'-\USIXTFP:9A(P"
MO& <*48J&#*2.37ZK45G'/(^QJX6K1YJ4Y<UN9W3\G;87L&K-/5'P]^V/-\:
M_B5^QKK-[;^';G0M6OM6BG;P_I+M+?0Z3@C9,4^])NVLX3@#CG!KYX^$>L>)
MM;_8!\6_"OPQ\'?$G_"1&":74-6:S$%O<+YRN7#-AY9=@"B, GY?PK]:**>'
MSY8>@J/L%I-36K236R?5_-^MQ2H<WVC\T?\ @E5X@U?X:?#?XC:;KW@OQ+:6
M\,KZN;\Z<_EN$A5#"BD!GE^7(50<YKRO]@?POXN^'7[8+>(_$7@3Q3I>BZR+
MVVANY])E5(FF?<AD)&%'&">Q-?L%16]3B/VDL5+V-O;I)Z[65NP?5](J^Q^,
M?QB\-^+]4_;\NOB79> /%EWX4M?$]E=M<QZ/,6>*W,2R,HQR,QL1ZC'K7[*V
M-VE_9P7,:NL<T:R*LBE6 (R,@]#[5/17F9IFSS.G1@X<OLURK6]U9+]#2G2]
MFV[[GQ-_P4Z\37GBCX.WGPS\/>%?$?B'Q%J$]K=A],TR2:VBCCD#$M(!C)QC
M:,FO-_\ @E7?ZS\)+'Q%X&\7^#?$^A:CK-^MW9W5UI4J6S*L>UE:0C"GCOUK
M](:*VIYS&GEDLL]E[LG=N^M]-=O):$NBW/GN(S;5)/:OQK^*%CXMOOV^)?BI
M9_#KQC>>%+'Q#!<M+%H\OF2Q0[59D&,$':2.>1BOV5HKGRG-/[+E4DH<W.N7
M>VCW*J4_:6UL<AJ=GI?QG^%U]8RQ7,.D^(M-DMWCN86BF6.5"I#(W*G!Z&OR
MK^ :_$3_ ()P?M :_:>)O ^N>(O"6K1?96O-%M3.+A%8M#-&P&"0&.4)!^8^
MU?L'159?FSP5.MAY4^>E4WBW;TL_^ $Z7,U*^J/EW6OCQ\3?&'P<^(WCC1?!
M6H>#-,T[199/#]MK$&=5OKM06\PP*3LCX"A3\S$D],9\&_:*\9?"+]H_X,7L
MOB7X<>)-)^, LECM+&/0)TU$7I7Y%60)MDB+'DL>A[&OT;HJL-FE+#5%4A1Y
M6G=<LFNVC=G=.VOKI8F5*4E;F/SQ^$,_Q"_8K^!OP4T75O#&J^(+35]0U*Y\
M2Z)I=DUW/:6\D8:,8' 9#AF'0Y8>]>5_M3?!?X>?M)?$#P7'\"/"FKV7BW4[
ML/K-U;Z5-96-I;DC,T_F*H213DX7DX(/.W/ZQ45VT>()4:[Q<:=JKO=J5HN[
M;]Z-M;7TUZ$NA=<M]#\T?^"N7P/\9>+E\">*M T>ZUW2])M);"]^Q1-++"S,
MK*[*H)VG!&>QQZUR?[5GQ(\7_M+?LI^ ?#_A?X1^,85T^]M(KFZO+$@/+';2
M1[844EW!.3OV@#IU-?JU13PO$3P]&A3G14G1;<7=K?R_KT"6'YF[/<_.[X$7
M7B;P1_P3G\9>!_$'P]\6:7K]G8W^GP6TFF.7O9+QY#&8DQN*J90&)'&":\__
M ."5MGXB^"OQ \3:/XQ\%>)]&;Q)';16-Y/I,PMP\9D)61R,)PPP3Q^F?U1H
MJ9\0>THXFBZ.E9\SUV>CTT[J_P" _8N\7?8^2O\ @H]^R[JW[2'PAL9/"\"7
M7BSP[<M=VENS!3<0LN)8E)X#'",/4H!7AG['/[7_ (O^%GPPLOA7XC^$7C;6
M?%>BLUKIJ65B0LL><HDK/M$>S.-W(V@&OTHHKDH9PHX%8#$TE4@G>.K33^73
M?MN5*E[_ #Q=F<S\-YO%-UX,TV?QI!8VOB29#)=6NG,6A@+$D1AC]XJ" 6[D
M$U\X_P#!1"Z\8:1X1^'&L^!-'OM<\3Z5XJ@O;:ST^%Y9) D4A=2%!.UERI]B
M:^M**\S#8M8?%+$\B=F]-EKT]#24.:'+<^<_"O[='P[U;PNUYXBCUCPAKL"8
MN_#VJ:5<"[20#YD10A$G/0KU^O%>"?L3_L\:GXB_:8\=?'O4O#5UX/\ #U]<
M7 \/Z3?0^3/*)2-T[1]4&!QGJ7/IFOT%**S E02.AQ3J[XYE3P]*K3PE-Q]H
MK.\KV79:+[W?0CV;DTYN]C\A/VQO!?B_X:?M_67Q&F\(ZQK7AO\ M"PU*"?3
M+1Y5G6-4#QA@" X*D8..W8UVG_!2"Z^,?QJ^%_@_7['P?K.C>!))YGET559[
MW^#R)KN% =F</A<G;D9Y/'ZCT5ZM/B1PEAJDJ"<J*M=MZJUMNC\]3-X?>TMS
M\F?CMK'BSXK_ +!O@OPWX6^$/B31M+\-"R&HW%W:^6&=(RA:"(9DE4L=Q<@8
MSSSFO2O@9X@UFV_X)D^+?"MSX'\3V^J)IM]I%I$=.<M?2W7F;'B3[Q13( S$
M<8/6OT<HJ*G$$9T505!)*I[1>\][WZ_UY!&@XN_-Y'Y9_P#!*>S\0_!7QYXN
MT7QCX,\3Z++XH2SCL+J?29EMP\/GEA(Y&$R)!@GC@CTS]W?M<^"=7^(O[-?Q
M!\.Z#;&\UB^TN1+:W7K*P(;:/<XX]Z]>HKS<=FTL;CXY@H<LERNU[J\;6[=$
MC2-/E@X-GY2_\$R_&7C;X2_\)5X%A^&>O7?B#5M3MY1<WMNUK96<2 I,T\C#
M*E1D@ $L>..M<1^U5X:\7^*_VZI_'ND^ ?%=_P"&]-U;3GEN8-'F/FBU\H2F
M/CYAF-L'//%?LC17LQXFY,=4QT:"YIQL_>?E_DK:=]S+ZO[O+S:'YA?\%5M-
M\0_&35/A_I_A#P;XEUI[.R>^GFM]*E:-%G"[$) ^^-IRO;BM?]H^ZUCQM_P3
MM^'_ (/TCP=XHN?$C+964FG_ -D2B6![50)6D7&54D?*>^17Z345RT<_]C1P
M]%4M*,N9:[O7?3NRG0;;=]S\X_V4_B%XR_9]_8*\9>1X"UIO&7ARYFG73M4T
MZ6..1)W&)5&,R(@RS ?W>P.:^8OAC^U/\#]/\/7LOQ$^%NK^(_%>K7DMYK$N
MGWWV>PNG9R5 MPZJ% P,8Z@GO7ZI_M=?#OQY\4O@7KGA[X<:X- \37#1E)O/
M:#SH@?WD/F*,IN'&?P. <UX1\*?">C^#_ .C>'_%G[)EU-XATZ!;>:>QL=,O
MX;IP,>:)Y9E<[SR=PR">IZU]#@<RPU6E6Q,X>_4G=J-3EDE;NW&ZOKI\]D<U
M2FU)+HO+_ASL/V*_VO/A'\:;>3P5X \/R^";O38#<)H4EO'&C1 @,Z,A*M@L
M,YYYKZCU1;AM-NUM"%NC"XA)[/M.W]<5\E_LZ?LLW>A_M(^(_C+>^$M/^&UA
M=:?_ &9I?A/3Y(W90=OF3S^6/+1FV#Y$)')R3W^OJ^,S=8:.+OA7=-)N[YK/
MJKZW];OU.RBY.'O'XU?LH:AX_P#@G^V!KNN_$OX=>+/&/BJYAN+9KBTL6GF%
MR[*1*K-A-A52-P( 4\<9%,T'2?B%X(_X*-Q>,-?^&OB#S9]=EO38:;;FY_=3
M(RJRRCY& # DYP,&OV8HKZ"7%7-4G4>'5YPY'J]O+LO+\3'ZM_>/RC_X*X_!
MCQIX@^*7ACQQI7A^^U309-&CTZ22QA:9K>9)9'Q(%!P")1@_[)K[T_9O^,>O
M?&71?[2G\#:GX/\ #<%I!%:2:X/*N[N;;^\*Q=HAP Q.6.>!BO:**\7%9Q];
MP-+!U*2O3T4KO9VZ=]+:W]#94G&?,F<Y\0/&]E\._"=[KU_:W][;6H&;?3+5
M[FX<DX 6-1DG)K\8OA)X=\<>#/VPK+XI:G\,O&2>&AXCN=4D6/1IFF2&5Y"#
MMQR0'!(![&OW HJLJSA972JTU3YO:*SUMIY:>;U%4I.HT[['P/\ \%-M3O\
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MED:1E58T R6))P!530Y$L[5VN[*SU-RN"MU&6CQTR,$'-7_"TC:'=33+J/\
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M"[TNS^($-YI-LUEHJWGF10-_RR0@@D>@!.0.V*W@Y<TDX)I*Z]VVMEW_ $_
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M;7]C?_DU/X3?]BW8_P#HI:]DKQO]C?\ Y-3^$W_8MV/_ **6O9*] R"BBB@
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MHH **** //\ ]H3_ )()\2/^Q;U'_P!)I*_F9D^\/H/Y5_3-^T)_R03XD?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2FHMRC=RC%^\K)]=[^5V<;IRE3>FO_#''_\ !1VYB^!/P)\5^)?!5K_8>O\
MC6YL])U2_L!Y3&-1*=^5QAF4E"W7! KO? /P-\)WG[!&G^#)-/@_LJ]\+_:)
MY%1=S7#P^89\_P!_?\V?4"O5OC%\%]+_ &@OA!J/@CQBL:_;H5WSV7)MIUY2
M6/=W5N>?H:\?T?X)_&?0?V?6^#MIXA\.S01VC:3;^,6>5+F&R/ _T8+@R*GR
M ^9Z'K7G4,5"K@J='VO+.%1-MO=)63OUY=K;]D7*+C)NUTT?%>C_ !&UKXB?
M\$G/'5IK\\VH/X=UJRL;*[N27;R?M5N50,>3M#%?8$"NDT;X6^,/V@/&G[,N
MJ?#[PSJFAV7A'0]/&L>)[ZV>QA8(R,ZQL0#,-H<#:"&\S!.,FOJ+QI^PK#%^
MR&OP,\#ZQ::9%=7,-SJ.L:E$TDEQ*LBRM)M4]69%&,X"@"O>?@+X'UCX7_"'
MPQX2UZ\L[Z\T2SCL!=V2,D<J1C:K;6)(. ,\U[%?/,/2HSJ81)R=2;2=]I12
MO;K=INU^I*HRE)*6QZ *6D5@PR""/:@,&Z$&OS@] 6BDW#=C(SZ4M 'B_P"U
MQ\$(OCM\%=9TBW @\2:>O]IZ'?J,26M]"-\;(PY7)&TD=FJY^RC\7F^.'P%\
M*^*;D;=4DM_LNI1_W+N$^7*/Q92?QKUIAN4@]"*^5O\ @GRQM_"?Q4TQ,+::
M?\0-8A@0?PKYV<5[E-NMEM2,O^7<HM?]O737X)F#]VHGW/JNBBBO#-PHHHH
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MN521N4$$C\: .SHKRSQE\7&T&7PMHT+!-8UFT:^FG\AY4M;>-5,DA5023EP
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M/^UK+_GZC_[ZH_M:R_Y^H_\ OJ@"Y15/^UK+_GYC_P"^J7^UK/\ Y^8_^^J
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M_P ]X_\ OJ@"Q15?^T+;_GO'_P!]4?VA;?\ />/_ +ZH L457_M"V_Y[Q_\
M?5']H6W_ #WC_P"^J +%%5_[0MO^>\?_ 'U1_:%M_P ]T_.@"Q15?^T+;_GN
MGYT?VA;?\]T_.@"Q15?^T+;_ )[I^=']H6W_ #W3\Z +%%5_M]O_ ,]D_.C[
M=;_\]E_.@"Q15?[=;_\ /9?SH^W6_P#SV7\Z +%%5_MUO_SV7\Z/MUO_ ,]E
M_.@"Q15?[=;_ //9?SI?MUO_ ,]E_.@">BH/MT'_ #U7\Z/MT'_/5?SH GHJ
M#[=!_P ]5_.C[=!_SU7\Z )Z*@^W0?\ /5?SH^W0?\]5_.@">BH/MUO_ ,]5
M_.C[;!_SU7\Z )Z*@^VP?\]5_.C[;!_SU7\Z )Z*@^VP?\]5_.C[;!_SU7\Z
M /F?]M/_ )&K]GW_ +*!;?\ I-<5]/U\O?MH2))XJ_9\VL&_XN!;=/\ KVGK
MZAKU\5_NF&])?^E&,?CE\CR7]K*W$W[-WQ&E$LUO/;:)=7,$]O*T4D<B1EE9
M64@@@@5\??L_:'<^/O\ @F3J]]?:[JXUZ\EN[A=8.HS?:(YHK@I$V_=N"@*
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MI2QSC:X].V:HW4CH<. LC$C&,D?2K.[Y%8*S;@<Y&,U0NX?M$4?53NXYQTH
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MM #?+7TH\M?2G44 (L:\\4[RU]*5:6@!OEKZ4>6OI3J* $6-?2E\M?2E6G4
M,\M?2CRU]*?10 SRU]*?Y:^E%.H ;Y:^E'EKZ4ZB@!OEKZ4Y8UYXHIRT )Y:
M^E'EKZ4ZB@!OEKZ4>6OI3J* !8U]*7RU_NBA:=0 WRU_NBCRU_NBG44 -\M?
M[HH\M?[HIU% #?+7^Z*/+7^Z*=10 BQKZ4[:/2A:6@!-H]*-H]*6B@!-H]*-
MB^E+10 JJ,=*7:/2A:6@!-H]*-H]*6B@!-H]*-H]*6B@!-H]*<JC'2DIR]*
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M'[3'Q.\$Z/XKT#X.^%IM'U: 7%J\WB$H[(20"5(XZ5O_ /"UOVL/^B,>$O\
MPH__ *U=)^Q,Y_X9'^%_/_,)7_T-J]I\P^M=6,Q='#XFK1AAJ=HR:7Q=';^8
MFG!RBI.3U/G+_A:W[6'_ $1CPE_X4?\ ]:C_ (6M^UA_T1CPE_X4?_UJ^C?,
M/K1YA]:X_P"T:?\ T#4_NG_\F7[/^\SYR_X6M^UA_P!$8\)?^%'_ /6H_P"%
MK?M8?]$8\)?^%'_]:OHWS#ZT>8?6C^T:?_0-3^Z?_P F'LO[S/FZ;XG?M<W2
MA+7X1^";-^IDNM?9UQZ8!'-9FH? ?XZ_'C,'Q=^(]EX2\+/N$OAGP&K(]RI
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M+Y2_ZQOO$\X]J62Z$*8,A(7Y<"ET^0(I9/F.SYI&&#FJ%PLDA\U$!+-GGN:
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MF@!:*,T9H <M+35-.S0 4J]:3-"GF@!]%)FC- "U\[_\%#O^3/?&/_7>T_\
M1HKZ'KYP_P""C&I6EA^R'XGAN;B.&6[NK6*W1C@RN) 2%'<X!->QDR;S+#)?
MSQ_-&5;^'(Z?]A__ )-'^''_ %XM_P"C&KVNOF'_ ()I^+K_ ,6?LGZ;%?\
MED:-J5QIEL8TVDPJ$<;O4YD(SZ 5]/4LXIRI9CB(2WYY?B[A1_AQ] IR]*;F
MG+TKR#46BC-&: "GTP=:=0 M%)FC- #EI::M.S0 449HS0 Y:6FKWIV: "BC
M-&: %6G4U>M.H **** "G4VG4 %%%% !3EIM.7O0 M%%% !1110 JTZFK3J
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M;@")7C!" = /0<"@#F/@C'J$/PB\(IJJNNHKIL(G63.X-M'7/>NQO+87EK-
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MW94:,(WLC\Q?A_\ L2_M7^';$>'=/^*=OX5T'PS)-;:'LN"T=W#*Q+N44,5
M!.!)DJ>!@<U])?L\?L)V7P=\?1^/O$OC;6_'_C1+$6<5]JLI9;<$'?LR2V"2
M<9)P"?4U]445U8K/L9BHR@^6*EORQ2O?>[WUU;UZLF-"$7?<\>^,O[)?PN^/
MLMO<>-?#,.IWT#AEOHG:"X8 8"M)&0S+C^$G%8GPF_89^#/P6U:35?#?A"#^
MTRRM'=ZC(]Y) 1R#&92VPY[CTKWRBO+CC\7&C]7C5DH=KNWW&OLXWO8S_P"Q
MUW[O.?=1_9"[=HE95ZX4 "M"BN LS/["C_YZO^E*-%1>/->M*B@#-_L5#_RU
M:D_L./\ YZM^0K3HH S?[#C_ .>K?E2?V&G_ #U;\JTZ* ,[^Q4'_+5Z0Z(A
M_P"6K?E6E10!FC14'25J4Z.I_P"6K5HT4 9O]C+_ ,]6_*G_ -D@]9GJ_10!
MG_V.O_/5ORH?1;>9MTJ1S/C&Z2-6/YD5H44 4ETU8U"1R&)!T5%  _ 5P'QF
M_9U\"_M >&X-$\<Z.NL6MO+YT$@=HIH6[E)%(9<]P#@]Z],HK6E5G0FJE*3C
M);-:,32:LSYS^'/_  3Z^!?PQU:?4M+\%0WMS+$83_:\SWJ*IZ[4E+ 'WQFO
M3?B5\"_!GQ9\ WO@[Q#HMK<:+<1>6L<42QM;D#"/&0/E9>Q'2N_HKIJ8[%5J
MBK5*LG);-MW1*A%*R1^=<W[+_P"UQ\(=!/@KX=_$S3==\#2L^GVB7P2.YT^U
M?/[PLR9RHXPK-CLHZ#ZD_95_9GTW]G?X+V'@^Z6UU;4Y&DN=5O3'N6YN)/O'
MYAG:  HSV%>X45VXO-\1C*7LI*,;N[<4DY/O*VYG&C&#NC\_/BA^Q#\4_A+\
M7(?%/[,_B(>&M+UN=O[5T>ZN%%I9.W658W!5TY/RA2RGA>.!I6_[#?QV^(=Q
MJ6J?$G]H35K?5_+$-@GAEF@MP "09%41CJ>RYX^\>WWC173_ &_C.1*T>9*W
M,XIR:\V[B]A"]SXX_8/^-7B?Q;_PF'PE^)=VUQX^\"W9M?MDBLLE[: [4D8G
MECD?>X)5D)YR:^M_['3_ )Z-^5?#'[1$-C\&?^"C/P:\='3YK'3O%5NVB7MY
M9?\ +W=N3#&)5!YQYD&2>RCKMK[WK/.*=-SIXNE&T:L>:W1/:27S5_F%%NSB
M^AG?V.G_ #T;\J/['3_GHWY5HT5\^=!G?V.G_/1ORH_L=/\ GHWY5HT4 9W]
MCI_ST;\J/['3_GHWY5HT4 9W]CI_ST;\J/['3_GHWY5HT4 9W]CI_P ]&_*C
M^QT_YZ-^5:-% &=_8Z?\]&_*C^QT_P">C?E6C10!G?V.G_/1ORH_L=/^>C?E
M6C10!G?V.G_/1ORJ6UTU;67>'+'&.:N44 %%%% 'G_[0G_)!/B1_V+>H_P#I
M-)7\S,GWA]!_*OZ9OVA/^2"?$C_L6]1_])I*_F:F&UA@Y^5?Y"EU*^RSU+X+
MQAKA<YQYN2%(R?:OL#PMM_L^W)CV@\;O2OCWX,QJUTDA;&U_NKW/J:^PO#,S
MG1_W<3,J*-RDY&:9)O6L9N)G"LQ3H$SC%1O +.18E=^NXCK^-/MU62S8NA\Q
M>!LXJNR'[<AW,#CYA[4 .FMHED ;,B_P_P"-3IHY:,7(8JJ$$)U'XU+)']I=
M7MW+.QXCQRH]:Z"UT^)X40.<KRV.F: *=K9^9#YF[RY.@W#@?2L?6-+FM]TA
M4+\NXG'7FNGFF;[.T0\M".?6H+/%U;LA&]E7#9Y% ''I;F968CY7Z CFFQMY
M#;XP#QMVMV]Z[.YT/[=L, ",HY["N-U6&2QF:,XWYXQWH +>YVL9"/WG(&\U
M"V/M#L4#'J,&GM(/W4;+^\/78,TDELL>]8Y,D=S0 LEU+)Y3;2H Z ]?:IY=
M:N+I0D@8(.Y//M6>RYF0(2&;J.>U2F%;:29AERHQ^- #8VDN6Y"I&K<[CBM"
MUW75U(K1KY ^5=O!)Z53LXXYE)D<*S'E<<GWJTTJJPCA9HQNR">YH N)#)9Y
M0 J%P-OWJM1W:VY)5?.+<$/3-/<W"_.=S@Y##C-0;4,LJ.K!3R6S_*@"OJ$V
M;@2@[0?X<9XJ6.Z2..-%P[.N<$8)I+J%K*&(A/,)Z;FY(J.28R-$Q0"?.!@8
MQ0!#<VZLN=K$=QZ&H[>W$<C,V0N,DFK4C-"IW.=_4XID"M=;5)PK'YAB@"KM
M^T2 ?FN.WK4TCJ94C&!M7/O5Z:R4Q)Y;K_=]S5"[L79ED$@#9P<\'% #Y6,,
M,N"LN/NGVK*DU:%ED5ESQ@BB\O'?(!!&<%5'3%8OEQK(I^ZV[YMW>@#7=;>6
MW^2%<MQN8]*IG3X%X2)0PX#9SG\:KS:DENI\M<@G'M52+7GC^3RBRKG)- &K
M)9QJH1 N,#IUS4FV,S+'%$L88US4VN7?14"(#N&!3X=2GF4[BS%CDX/% 'I6
MAV(F#3$A60X&3720W(41PH8U93\TF/YUY;:ZQ=+#\A=(^[9_E5^#7)85V3,V
M#STY/O0!ZG)="UAWP389N-RUSNH7CQR.5D^5_P"^>1[BL&'7D\E=TF1U/-9V
MJ:DJLKNQ<#.%7^5 &L76;>J. Y?DD=N]$T*JZO#C<.NW'%<JL]Q-('A!&1C#
M=1FGVTUPJR(V[ Y)S@T =C':QS8!?:N.6QDUS;+%#KD/R8"NQ(QSTJ$7%Y;(
M9%<@C@ M^M<_<>(KJSUI&E/FNQ[COCK0!W&H6\,UP2 I&WY.,=:SOFCD0(H"
MXP#[UFQZU=29$H0Y'>K,%]((\'(1L<=2* ->+Y5WK(,$XQUXQ3O,_?#'S C(
MW?X57ML<E,*,Y.[K0K>7)(P'RXXS0!J)=I);>6&!8'YN.M/NX3,/E&['.!TK
M+L\3,[J/FSZX K1C#0JI7ENXH IW$<*M)Y:<8R>.AK,GW-&""W (85KL?WTD
M;8'?.< UEW$S/(03A^A(YH QKP^1#R>7) ]JIM<+;$Q/\P(QN(SBMVXLDO(X
MW&3M. &'ZUDRQQJ&RG(Z%N@]Z +E@JK:,58X(_,>M6+=5D7@[4XVGIGFJ.GW
M!52A;*+@<=>:TH+<MO5=VU#D'UH L1L[MM("JAPLE21_O+A&QYAC!X/ ^N*>
M]O*(4"*,R#).>GO3X8VA)S@R9P<F@!944R'='L=2"H)X''6HUED,.]@%+$@?
M+UIV5;(E)9N=A(Y'M2QF2:'9&&55./FH CG"3.JR+N3'>J-Q&K*Z;<(1Q@=*
MV+R$6\<8!\T%>?45D77[J(OD-$^2H)YSZ4 >8>-XMD$R1R889;)XS[5\L>*@
MPURXW'//!-?4_CY4DM9B48, <C-?+'BB0OK4^23C YH _HO_ &-_^34_A/\
M]BW9?^BEKV.O'/V-_P#DU/X3_P#8MV7_ **6O8Z "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^-/^"A?/BK]G[_L<E_\
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M_$>F:!JWB'3=-UO5 S66GW5TD<UP%ZE%)R<>U;ZW$30^:)$,6,[PPVX]<U\
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MS$_O+^='F)_>7\ZX_;[G\Z-ON?SH [#S$_O+^='F)_>7\ZX_;[G\Z-ON?SH
M[#S%_O+^='F+_>'YUR"K[G\Z=M]S^= '6^8O]X?G1YB_WA^=<EM]S^=&WW/Y
MT =;YB_WA^='F+_>'YUR6WW/YT;?<_G0!UOF+_>'YT>8O]X?G7**O'6EV^]
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MK(K2*VS&F<@X.X]:!;L9  "NWKSD&JDFH+\@9OG8\DU=\_;!A4.$.[/K0!-
M4554#=SSNZDU!JT;M B1G,H.7]:+>Z7YF8Y##<!CD5!'<M=7#(C<'[S9R2*
M"QAGD^4,3W.>E:EE(8\JC*C$_P 1[54CC:.$^7E@#3TD^1F<(01\N <_2@"6
M:91,T@7>=N-WI5;>4=W<9!YX/)]ZGFN!-;^6AXQTQ@U3@C.Y5+%F4<LWIZ4
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M+#&K%%_WCGVH ^D**\G^$?Q+\>:Y.^E_$CP#_P (;J^<07-A>K>V%U@9.R0
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M/U[T +]A1',CEB&'(S5%%2XWD,V<\'TK7DC@6(!F"2=..0:K(WDR>40&!]J
M)[4"ZV[TW*OX$_2K5["UM"9X_E0'!4?RK,N6$<BN-VT'@>@]#1)<N(6RS%6Y
M(]?2@#*U)I]4?<)6P.1@U/&KPQR$R;LKM&>@XIN[R]N>-W914-UNVY^\,_=/
M % %RQ4QVJLW!SM.><TV=(UV(!E<Y('6DLY> <?NE!YSTXI%D$43,A61B>1W
MH @DMX9OE1-CGJW<?6AHUM9 @+$+]TXX-2V[%MSD#S.GTJ"^G>+: RD]_:@!
MGS2R^:'^8G 4TR;(N-K%C@Y/K6?'(=^U3\P.2V:F23Y0/*8MG)R>M $KL8T5
M=H&XGE:FM6+*P!V1'^(4D>9=D;JIZ_6I;6%8XRI SG &* )))A!'@$,0>_)Q
M5.:3R\[!C/7%)J$\K2!1M4MU"\<5%#(67_68^;GVH L64IDVH>'P<@CD"K8C
M,+LY0'<!DGK5)97>Y:13@CY3D<&IVO,QA7(.[.2.WM0!?A4-D_=XR-IZ$5FS
M7;1J<'##J<9)J_ILB+E91D-]W _G5+5+=UN&\HJYZC/&/K0!GS3".$D!1GGI
MT/:N0LYY9?$;-*N_Y<;NF,FNADD6/>LK D@_3-8=C*9=4F*;8PNT''- '56N
MWS&+1\!L 5;DD$D_ ;[OX50MYL7"H@)+]6:M)<!=K3#S#R<=: (Q))'G&&1N
MO'.:73U\JZ:9<AL\5$[2+)\JD[N6] *FLUVJ<%F4\G)H TUNI+>; &3CD@9!
MSU%0>=M+R*FZ/LK4UF=V!7.P=0*EN(BZEMRA%Q\H_K0 R.3RY$"Q$"0Y&X]*
MLS+YVY57YP0"P' ]:@$?G9D=\D?<53T%:?FPK"H') W/F@"E+'F(^66QTZ<9
MJLT<BX1U9&7JV.M7Y/WC,ZO\A'&VG,HFC7=^[!.22: ,IF 81MB-^RKU;WJ>
M.(22!1C<PP?I4Q=$D(C<2'! XY.>M-A 7"J3&Q% $MNHMW2&,?ZLX?<.*T?M
M154".%+'Y?2LV%F6X*.N]^H8=ZNR*L<B1,N<G)./NT 0;FNKAF1SQSD]C5F*
M-I'522 6PY]*CD4Q_P"IV_[2YR?K3FF??%AAYC_PCO0!8NX8WA+$[8U.,)P6
M]ZS9M\LQR5SM^4)V]S[U?D63RT\[&,\@U5FC!F>9(_W./UH \J^);*;>X)8E
M@F3GIQ7R7XGE:;6)F8;?0>U?6?Q'C6:*4,F['\(-?)WBO/\ ;EP"FP@XQ0!_
M1=^QO_R:G\)_^Q;LO_12U['7CG[&_P#R:G\)_P#L6[+_ -%+7L= !1110 AY
MX/(KXY_:3\<7W@WX[:>LGQ5UOP')<P0_V-H-GI)O8-<F5OG0G:<'D*5!!YSF
MOJ[QE)JL/A/6)-#19-:6TE-DLGW3,%.P'VW8KY"C\<?MDQW.E6FH^!_AW/?W
M"NZ2_:Y0$*@$GH<'GUH T?A'\2I_%G[37C:^GUK5/M;:A8Z5I^BW#21VPMTL
M@]ULA88RLK-N<<Y4#-?8M>8? &X^(FJ>#'NOBMI.D:9XO6\F7R]'RT @XV%6
M/))'7W_*O3Z "F331V\322NL<:C+,QP /K3Z\Z_:)M(+[X'^-HKB-9(CI<Y*
MMT^X: .]NM0M;&W6>XN(X(6( DD8 '/3FDNM1M;)8C<7$<(E;:A=P-Q/8>M>
M66ZMJ7Q(\(V%\/,TE?#4D\<4G*/-F)2?<A"?SKB/AG/-KU]XDAUYBVGV.B.F
MFK,QQY!FG#.,]\)&,]N* /I.J.N?\@>\_P"N3?RKE_@GJ%_JOPC\(WFIES?S
M:;"\QDSN+%1U]ZZW4;9KRQG@5MK2(5#'MF@#S6/[HJ1:W%\#7*J!]KC_ .^#
M3AX)N1_R]Q_]\&@#"HK>_P"$)N?^?N/_ +X-'_"$W/\ S]Q_]\&@##6EK<'@
MJY'_ "]Q_P#?!I?^$+N?^?N/_OB@#"I5ZUN?\(7<_P#/W'_WQ1_PA=S_ ,_4
M?_?!H Q:*V_^$-N/^?I/^^*<O@^=#EKM !R?E_\ KT ?.?[6'[47AK]F_P "
MW,-U(VH>+M8M9(=*T>W/[UBP*>:Q'W4!/7J2,#-97[!'PCN_A'^SKIO]L62V
MGB+Q!.^K7VX$2X?_ %:R9Y#!1R.V:X'X=VZ?M"_\%(/$/B72;2WO_"W@'2SI
M+ZC+^\C:[^8!HP?X@S2#_@!/<5]PR>$[F1B3=)_WQ7T^.<<OP<,!!>]-1G-W
MZZ\L;=+)W]6<U/\ >3<WTT7^9AJQ5LCK7@?QW_8@^&7Q[U#5-?O].ETWQ9/8
M2017UE)Y<;38)261!]]@>,YY'6OI7_A#[C_GZC_[YI1X/N!_R])_WR:\+#8J
MO@ZGM</-QEW1O**DK21^=?P:^)7[7?P<TRTT#6_A1<>.O#6CPG3K95VQ7!"<
M1N)0260*,9*<C'.>OT9\!_VO/"WQ:^&?B?Q5XAA7P+=>$YW@U[3KZ<,UH5Z$
M< D$@J. =P([5]'1^&KV-@1>+Q_LFOF'XR_\$S? 'QB\<7GBA]9U;PS<ZCM;
M4K/1V1;>\=3G>Z,IPQ[X[\]<FOHGC<NS*<OKE)46[/F@GWU3C>VJZVW.?DJ4
M_@=_)GC7@?3=:_;\^.^B?$O5]#72_@OX.FD32+/48][:O*"=Q*YQ]Y5)Z@;=
MO)W8^ZK>5;&!+>SBCL[:,82&W0(B#T ' J[H_P /8?#VB:?H^F>19:;8P);P
M6\,6U415 & /I5C_ (1&?_GY3_OFO'S#&_7)1C"/+3@K1CV7GW;W;-J<.37J
MS'_=FZ:Y\F,73J$:<(/,*CH"W4CVI=QSFM?_ (1&?_GY3_OFE_X1.?\ Y^$_
M[Y->6:&6;B0K@L<5'6Q_PB<__/PG_?)H_P"$3G_Y^$_[Y- &0M+6N/"<X_Y>
M$_[Y-+_PBL__ #\)_P!\T 8]%;'_  BL_P#S\)_WS1_PBL__ #\)_P!\T 9*
MTM:P\*SC_EX3_OFC_A%I_P#GX3_OF@#)HK6_X1:?_GX3_OFC_A%I_P#GX3_O
MF@#*6G5J#PO./^7A/^^:7_A&)_\ GX3_ +YH RJ*U?\ A%Y_^?A/^^:/^$7G
M_P"?A/\ OF@#*IU:?_"+S_\ /PG_ 'S2_P#"-3_\_"_]\T 9=%:G_",S?\_"
M_P#?-'_",S?\_"_]\T 9=.6M+_A&9O\ GX7_ +YI1X;F'_+=?^^: ,VBM/\
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M1^5']CR?\]1^5 %*BKO]CR?\]1^5']CR?\]1^5 %*BKO]CR?\]1^5']CR?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 5[S3[74% N;:&X"YQYL8;&>N,U\,_LAVD?P3_ &UOC?\ "NWU
M6W.A7ZQ^(;*UF1(I//D969(\8R%60C [(#QS7W=7RK^VY^RS!\3?#DWQ&\'/
M=:#\6/"]N]YIFJ:2 EQ=^6I(MW/&<C(4YR"?0D'WLKKP_>82M*T*JM?=)WO%
MO^NIA4CM-;H^JJ*^?OV%_CE-\>_V=?#^MZEJ+ZEXEL]]AK$DT:QR?:4/)*J
M/F4J>!W]<BOH&O*Q6'GA*TZ%3>+:-8R4DI(****YB@HHHH **** "BBB@#S_
M /:$_P"2"?$C_L6]1_\ 2:2OYFIE*L 1CY5/Z"OZ9?VA/^2"?$C_ +%O4?\
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M /2Z*RO"OB*U\7>&]-UJQ)-I?P)<19Z[6&:U: "BBB@ HHHH **** "BBB@
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MR?\ ?1IM% #UFG[SR?\ ?5.\Z;_GM)_WU4:TZ@!WG3?\]I/^^J/.F_Y[2?\
M?5-HH =YTW_/:3_OJCSIO^>TG_?5-HH =YTW_/:3_OJCSIO^>TG_ 'T:;10
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M5_SH\R7_ )ZO^=)10 OF2_\ /5_SH\R7_GJ_YTE% "^9+_SU?\Z/,E_YZO\
MG244 +YDO_/5_P Z/,E_YZO^=)10 OF2_P#/5_SH\R7_ )ZO^=)10 OF2_\
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ML;F0EI-W!.,$?2OE/Q0H769@#FOK3QU:K':,K2#YDR5Z5\G>+L?VY. , <4
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MBB@ HHHH *=3:=0 4444 %%%% !1110 4444 %/IE/H **** "BBB@ HHHH
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M@[1@,* /"_B)CRV7H5'*YYKY+\6,6UVY[\U]4_%!?LOGCDOMKY4\3MNUF?\
M6@#^C#]C?_DU/X3_ /8MV7_HI:]CKQS]C?\ Y-3^$_\ V+=E_P"BEKV.@ HH
MHH *^7/VDO"GB;6?'AO=(\!_#7Q'I]KIXDN;_P 87 2XA )S_"<1CUKZCKY"
M_;!\-^$]2FU6^\8^,M0T3P19BUN/$&E6ED)&U3:_[FS27.[]X>#&H.[/O0!Z
ME^R+X9OO#7PC7[8?"ZK?W]Q?V\'@[G3H(I&!5$;/SG@DMP"3T%>UUY7^SE+I
MUUX#EN],TY]$M+FZ:2/1Y+#[$UBFQ D319.#M"DGN37JE !1110!Y!\4]4\0
M:Y\2- \(Z3;I+IWV"XU:_5YS#]H\MD2*'<.0"S$G'H*Y_P -^)H_BIKFN27=
MO<:7IVGZ GD:>[[3;W!>59B"#R5,2@-_C7L?B#PC9>(+JTNY&EMKZUW+%=6S
M[)%5N&7/H<#CVK/N?AEH<T$$4<#VPB@:U9H7*M)$QRR.>X)Y]>30!!\&==O?
M$WPI\*:KJ)8WUWI\,LQ;J6*]:ZO4+8WEE/ &VF1"N[TS3K.S@T^TAM;:)8+>
M% D<:# 50, "IJ ./7P+*HQ]L'_?%.'@>4?\O8_[YKKJ* .1_P"$(E_Y^Q_W
MS_\ 7H_X0B7_ )^Q_P!\_P#UZZZB@#DE\$RC_E[!_P" TO\ PA<G_/T/^^:Z
MRB@#D_\ A"Y/^?H?]\TH\%R9_P"/H?\ ?-=710!RO_"&R?\ /T/^^:/^$-D_
MY^A_WS7544 <K_PALG_/T/\ OFC_ (0V0?\ +T/^^:ZJB@#EO^$.E_Y^A_WS
M1_PATO\ S]#_ +YKJ:* .6_X0Z7_ )^A_P!\TO\ PA\G_/T/^^:ZBB@#F/\
MA#Y/^?H?]\T?\(?)_P _0_[YKIZ* .8_X1"3_GZ'_?-+_P (C)_S]#_OFNFH
MH YG_A$9/^?H?]\T?\(C)_S]#_OFNFHH YD>$Y!_R\C_ +YI?^$3D_Y^1_WS
M72T4 <U_PB<G_/R/^^:/^$3D_P"?D?\ ?-=+10!S:^%9!_R\C_OFE_X163_G
MX'_?-='10!SG_"*R?\_ _P"^:/\ A%9/^?@?]\UT=% '.KX6D_Y^!_WS2_\
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M]OTK:HH Q?[!?_GM^E.&AN/^6P_*MBB@#'_L-_\ GL/RH_L-_P#GL/RK8HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#$EWR.,+E6X&:KW08\D,69MHVGH/>M%XUWHI<(>H9CP*IW$:9*EOE],\GWH
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M7'INR* /Z.?V-_\ DU/X3_\ 8MV7_HI:]CKQS]C?_DU/X3_]BW9?^BEKV.@
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M\]6_.C?)_P ]6_.@#HJ*YW?)_P ]6_.C?)_SU;\Z .BHKG=\G_/5OSHWR?\
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MS6@MJ]OY9DX[8'/YT #;5^<@[ OK6#KMT?L\B(.,;<*>>>]7M4F9I&C+97C
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M 5&T=\BL?4)!%I["0A'ZX;U]JL27NQ3%M+(!A<#!!%8NH3&_5H)?F"$\?UH
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M^L?YT 9U%:/_  CE[ZQ_G1_PCE[ZQ_G0!GK3JOCP[>CO'^=+_P ([>^L?YT
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M_.E_L2[]8_SH IT5<_L2[]8_SH_L2[]8_P Z *=%7/[$N_6/\Z/[$N_6/\Z
M*JTM6UT6[]8_SI?[&N_6/\Z *=%7/[&N_6/\Z/[&N_6/\Z *=%7/[&N_6/\
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MN/,?VB;5I/#NB&0XVWA./^ FOGO5;X+<-'$4D7&WD<C\*]I_:&\61-JVGZ+
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MIDS".%V)VA5)R.W% 'A^N6NI>)=4EO-3^!L.J7$<SK'>2W]F&E56(5\,P;D
M'!]:],^'=YJMYX<4ZOX:3PG/'*\<>FQSQS!(@?E;='\O(YP.E0Z'JH\0>#[2
M:'5Y[>2[E98;NXC1)7(D;Y0IXY"D#VYK<T?7;/6ENEM9A*]I,UM.O=)%Z@T
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MN]X$<:LRC>Q7<6'.W ]:[/Q1XRG\,Z]/'9:7JGB>\DA0C3]/AC MQS\S2.5
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M,-P!;@^U&=JJN-Q'7O\ @* 'LPD=@0<,.,TB1AD^?)0=67TI68#!R <_+_\
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MO)SUPHP ??&:]1H **** /!/BW\-[7Q]X^M-0T_0=4UC4])8&21=;>PME)3
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M6+?= R:=2-]TX&>.E 'SMXD^'LGBWQ=:>(-/\(:GK.GZ;/++8PW?B)K6T$K
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M^3N91L8GGC)Q7N5>,^,?#OA2WU4W6M>,+KP1?W$C;K6PUH0QS#/#%&& 2.N
M* .R^%\6EVFDW-K8>&X?"EU%-_IFFPJF%D(!SN7ALC'-=I6#X-T+2M!T6*/2
M)FNK>7]X;J2<S/.3_$SDG<:WJ "L?QC9V6H>%=6M-2+BPN+62*;RSAMK*0<>
M_-;%5-5C:;3;E$@CNF:,@0RMM5^.A/84 >#ZWX6\1:_X?M-/'@W5K'2HK5+-
MKK3_ !$+._F@4;<.J+C..V[//6O8_ .GZ1I/@S1K#0;7[%H]K:QP6MMC!B15
M"A3[C&*\N/A'P)'KZZ?)\0-1M+AR-V@IK_[H'N@7[V.V,U[3I]E;Z;906MK&
ML5O"@2-%Z!0.* +%%%% ')_$IK=_#WV>2TN[VZFE5;2&PF\F?S>S+)_!CU[5
MXCH/P=LO#LD9\1>![_\ L^35!JUYJDGB-[V2:X^7;)<H0N]5VI@<A=HP.*]Z
M\:Z7;ZSI(M;R)6LVD!FF-P8&@4?\M%<<AA]17GG@GPMX(OM>5;3QW?\ BNXM
MGWII]WK(N$C8'@[!C./?- 'L*%2BE?NXXQZ4ZDI: "O%_CQX"L_B1J.EV2:/
MJ>L:G8LET%M-5:PAB57R/,8=22.F":]HKS[XE:%H^I.+K7-3D\-VUO$/+UBU
MU'[+,&SRA[%>_.: .4^%_@:Q\+>-VU#4/#5_H&N7$!@BN'UE[Z"=!@E><88=
M>5_&O;*\\^%_A[PQ"LFI:-XCN/%DY'E_;KO4/M;(/[HQPOX"O0Z "BBB@#PC
MXB^%K[QUJUU;Z-H6H:CHB7(:_M6U<65I>R*02I0*Q89 ST![UW/PSTZVAU3Q
M#J#Z/<:#K=^\+WUC+,)47:FQ&C8<;2%]NE<YXZ\/>%X]4EOM=\5W/@:\FE8!
M;#6!;K<+V=D/&X^P_&N^\"Z#H^B:*IT>Z?4(+@^8U]+<&=YS_>+D\T ='111
M0!4U9K9-+NVO!NM1$QE&.JXY_2O Y=+^*$EXLVAMJT7A5N5L[B^M_M9C[;&9
M"5XZ MFO?]05GL;A4A2X<QL!%(<*YQT)]#7BUYX4\$6^N1V=UX^U#1;N8@R:
M#!KVV(,>J!3\P'L"* /5/!#6;>&++["DT4 # I<MNE#ACOWGNV[.36[5/2=-
MM=)TVWM+%!':Q+B-5.>/7/?ZU<H *Y3XE6^EWGAT0:IH2^)5DF40:8R*PFEY
M*_>X&,$Y/3%=76%XRTN#6-'-K=PI)9NX\Z1IS"85P?WBL.0PXH \CL_#-KI=
M]%<Z[\'-$TS3(W5_MUG<17#V^#PS)Y:]#W!.*]W0AD4K]W'%>-^#_"G@:^UX
M06WCR_\ %$]NVY=,N]:%PBD=,H,%L>^:]EZ<#I0 M%%% 'F?Q TM/^$YTW5M
M-T2;Q!X@AT^>S^RFX6&V%O*RDF1F!Q\R#& 3UKF?!/@M+/XE6.M>*- U*PU:
M.*2#26FUIK^RM]PRZQ(0OEL5!&<=.,UW'Q)T+2M65)=:O&T*RMXRRZQ;WYM9
MHFS]T'N,>N:H?##P[X4\Y]2TCQ1<^,+F,%!=7FHB[,0/7:!POUQF@#TFBBB@
M KP;XL> T^)&NRP6?AS4M;L+>XCEO8/[;:PL+N:,@JKHH)DVD+G(QP,YKWFO
M)?B%H'AO^TIM0U[Q-<>")WDV)/8:N+8W*@#!=2,9_#/O0!<^$'AS3-!U+79C
MH%QH/B._=)KU+J\-V70#:FR0_P  ' 4 8]*].KE?A[H&B:/I'G:+?R:NESAG
MU&:Z-S)-Z9?/Z#BNJH **** "BBB@#@/V@?^2#_$?_L7-1_])I*_F6K^FG]H
M+_D@WQ'_ .Q;U'_TFDK^>[X9_";1/&ECI6I:AJ5Y9Z7ON8-4GB5?]'E5-T"K
MD='RN<^]3*2BKLVHT95I<D-STC]G4?\ $ILAA6RP/T-?:NEQK]@B+J0=HQCC
M%?+'P7\$Q^$=%CMYIIUU2&W2ZN+>3&$8W#1A?;*C/XU]91"5K?3RT<?D2(3(
MZN-R$#@$>E"DGL$Z,Z>DNUQMQ'M^<'YR,[<]![UCWK'Y >@X''YFK.JVUU?1
M2O87LMO<0QM(-T2M&^/X6)Y&?45AZQ'<-)++87#-+9M$MU8N@*/O /RMU!&X
M>W6DYI.S-(X6I4CSQLUK^'3U(+R-9..J+R6QSUJM'<(S,N3L ZD5)JT<-EJ%
MK;F>Y*74;AG2+&V56P0I/7\:AN[/^R;YH$OI+N/8C,LR*#&YZC(Z\8HC-2M;
MK^@JF'J4E+GT<;77KM_7J21GR\N2,$<Y[>V*JW2+YBG(=>NX?RJ.2 V\:M-<
M/YL>HBWD4H '@8X$GL13_P"RE>=PU_(T,T,GDR!%RLRMA1^.1^53[6%KFWU&
MOS*-M?7SM_7EJ09^T8W!5 )V\8-5Y+<.JEGP<_C3+B-N)%G#!;:.5X)B%R[=
M0I]<=O:M#0[ :M<CS#)!81D))(J;G+-T"^^:OFC:YA]7J.HJ27O/^OPZE*X/
MFJBD[RO ST%-^5-Q8;EQ\R_X5(NGQR6HM#>W5OJ,DUPD)\I2N8B<;P?7CIZU
M#>:?*^GB^MVO!+:VR7,TC(IMI@3AU4]014>TB;?4J^NFP1JS!=N @X7<>M,W
M>9NW @AB3NJKK-NNDZCY8%\UK(Y$-PQCD@E.T'@KRI]CZ5?6SMYY-,MI&F2:
MXC>6217X*C(QM/&>.M/G5N8S^K351TVU=>O5I=O/T*TRP^6N>JMW/]*AF:)9
M -I#*<J5Z$4LEO###8W]O/->Z6UR+:ZBN $EC)'RE67J/7O4-U$FGZMJ,"N[
M003LD:RG<VW/'--24MOZ_JY$Z,J:YFUTV\[Z_@T*6.UMV"<9':JTBDMN0_,W
MWS[5%]I9I#P5#=#C/%+M"NSD[5VU9@1.  ' YSS]*=',FY@&89YQBH&E)8AI
M 0>G:H]P9&CY)QP?:@"<(LD@4-\F"Q:F>:54C&\9QP>:/+$:HT>^0L.?:FS,
M57:054C^#DY]: ,_5MWEDA<-T"__ %ZS[+<LAB+_ .UCK^%:=\Q^8R$MQTQ[
M5EEA;_-U=O;F@"VDRQ0XZE6(&.AJ62ZW#8,*S'<)!_*J*3EH_E^5A_">]-MY
M 8\.V23]T4 7)I$8JI.'(Y;C\:@NI&9=B@>4>X.35>>ZB61D*[G(X;TJ*XNT
MCMU)RJ],_P J 'VDOEL0P;:3\O-::W4;;D&1Z9..:QK-E+,?+RO&>U3R2_OR
MQZ+T4<X% &O"\4JA<L>._<U.LFV/ Y4=O6LSS3A,8WXX5>U6(G)A'SA<#CWH
M L_:D2-I"K,I&WCM4/VA(454;:N<X7K5?S#&RJQX8_**BDD*LK*5WYX Y% '
M06LR!3EO,..PZ4K2)M*DYXRS+_*L9+PQJ $^]P6!Z^M6O,3YE&%)X'K0!865
M2R(H8G&>>*;,P:$H^%8GC;53<I &YB>^:EFD=L !>5XH CLF .WY9'4\#-7U
M\V23;A49>OS#%8]K-#'N$F59>.!UJS#<6ZSL_)D*YYZ4 ;490J<;<GDK4K>5
M%DN?F)'(-4H9@S#/R@KPI%.1@N/W@*]Q_GM0 ZZ62XD!)8$?=;/6H4<*V=OR
M'CYNQ_PJ<3%8VRR_-\JJO6B&U$DBM(&*\*5 R* .BTZ-H_F=>2HP<YK3MYX_
M,:/;O&,[N<@UE:>=QPA)!XQV'I5Z'.V3@E4R/QH 9=1EV'WL9YR<?A6=/&QC
MR< 'J??VK2(W AR0IZ-GI[UG-$RLV&) Y)[#T- %=EB()56((SA10S;?*"9)
M'+#],8H#&2-B=L9[-SR.]$>0S.N6..%Z4 $T@DW%V*E.B].*<D8!!3*HPSSW
MJ/;YZ%V#*<<<<9I)%!7S2V3C)4G&: +&6X?;A>A^;M6I;P[O**8;;SECPN*Y
M^.1F5F9?+)XR.];%CNCB*+(2<Y- &Q-LER-NX'JP.*S]2D=FY5 && %YQ5I9
M@(%"C#MPQ(R!67J$CR1LHP5(QP>1[T >#_%R1XXY5"HI7(#'H<U\IW3;KF4^
MKG^=?47QCF'ES J-JJ2=O7-?+<C;I&;IDDT ?TA_L;_\FI_"?_L6[+_T4M>Q
MUXY^QO\ \FI_"?\ [%NR_P#12U['0 4444 %%%% !1110 4444 %%%% !7DO
MC+PSJECXBN]0@\"Z7XTCNF!6>YG1+B$8QY>)%(VCKP>_2O6J* .#^&?A>]T6
M2^O+C1K'PS#<A0FD:?('C0@DF1B %W'(!P.PY-=Y110 5%=1-/;2Q*YB9T*A
MUZJ2,9%2T4 >'3>$]6TN:33W^%>@Z\DC'=J1N8@)\G[\@="P)[]:]0\"Z'<^
M'_#L%I=)##*&9_L]LQ,4 )R(T)[#I70T4 %%%% &!XXT.X\0>';BTMEAEE)#
M?9[@D13@'F-R.=IKRV'PGJ^K2I8GX5:#H31D!-4%S$P@_P!N/8@;([=*]QHH
M BMXVAMXXV<R,J@%VZGCK4M%% !7"_$SPW>ZP+*\M=%L?$JVI8G2M1D"(Q/1
MU)!&X>X_*NZHH \D\'^&-3OO$5IJ$O@72_!0MVS)<V\Z/<2C^YB-0-I[Y/X5
MZW110 4444 >5>./#&IV_B2XU6#P;IOC6*X50OVN9(Y[; P57>I!4]>"*U/A
MIX9O=+O+O4)_#VG^$X9XPHTW3Y X9LY,DFT!=W;CUZUZ#10 4444 (PW*1G&
M1UKQ*[\(ZOH]U-:/\,]%\4I,YW:L]Q$KSY/WI0ZDY_$U[=10!S/P^T&Z\/:!
M]GNK>VLG>5I%LK-BT-LIQB-"0.!] .:Z:BB@ K&\8://KWAV\LK9D$TBC"R$
MA'P0=C8YVG&#[&MFB@#PQ?"FKZ@1IQ^$OA_33'Q'J'VJ(QQ'^^FU ^1U'0^]
M>U:;:O8Z=:V\DIGDBB5&E;JY P3^-6:* "BBB@#B_B9X<O-=L[.6UTJQU_[*
M[.VEZB^R*;(&#G!&X8XR,<UR/AOPMJNJZ]8W;^ -*\%FUE#O?0SQO<.H_@41
MJ/E/?)_"O8J* "BBB@ KS'X@^&]2_M[^UK;PCIOC2-HPBQ7LRQS6V.HCWJ5(
M/4]#7IU% 'G/PX\,7UGJD^IS^&=/\'PR1[38V$JNTS9^_)M 7([8R?>O1J**
M "FLNY2 =I(QD=J=10!XGJ7A75]'U"X@/PTT7Q6EQ(Q;5'N(EDE!)YE$BDY&
M<<$_TKT3X>^'[GP[H;0W-K;:<TDAD73[)BT%LIZ(AP/T 'H*ZBB@ HHHH R_
M$VES:UH-]902"*::(HK-G&?0XYP>E>/_ /"*:M-_Q+&^$/AR(+PM]]JB,*G^
M^,)OSW]?>O=** *&A6$NEZ/9VDTQN)88PK2'N:OT44 %<A\2?#=WXATNV^RV
M-IJYMI?-?2[]ML-T,$;6."!C.1D$9%=?10!XSH?A75=8U>TD;X<Z1X0:WE5C
MJ<=Q&TRJ#DB,1J#STY(&#7LU%% !1110!YG\0_#.I/KPUBV\*Z;XRC,2QBUO
M9ECDMR,Y,>\%3NSST/%.^'/A>_M=:DU6;POIW@Z%HBC6=C*KO.Q(^:38 O&.
M.IYKTJB@ HHHH *\9USPOJVDZQ>%?AUI'B]+J5G_ +2DN(TF8$Y D$BGIG'!
MZ#I7LU% '(?#?PW=^'=+N1<V-II"W$OF1Z78ONAMEP!M4X YQDX &377T44
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M;L8P-H5@<!OER1GKFOK?2;?3[73X7B4QK"QCSN8[&8\H<GU]:^;?!?Q:\!^
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M +^1?_$T?\.7/A+_ -#/XE_[^1?_ !-?H/10%S\^/^'+?PE_Z&?Q+_W\B_\
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M/AO^"+OPGD<NWBKQ,S,<DM)$23_WS2-_P1;^$K'/_"4>)1[!XO\ XFOT(HH
M_/?_ (<M?";_ *&GQ-_WW%_\31_PY;^$O_0T>)O^^XO_ (FOT(HH _/?_ARW
M\)?^AH\3?]]Q?_$T?\.6_A+C_D:/$W_?R+_XFOT(HH _/C_ARW\(_P#H:/$_
M_?V'_P"(H_X<M_"/_H:/$_\ W]A_^(K]!Z* /SX_X<M_"/\ Z&CQ/_W\A_\
MB*/^'+?PC_Z&CQ/_ -_8?_B*_0>B@#\^/^'+?PC_ .AH\3_]_8?_ (BD;_@B
MS\)67CQ3XG4^OF0G_P!DK]"** .7^%_P_L?A5\._#O@_39IKC3]#L8K"":X(
M,CHBA06QQGBNHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW9R#\OW,LWR^]=KJOP#T'5OC,_Q+DNKU->;0Y/#_ ):./)%N[;B=N/O9[YH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
L@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>figure07_02.jpg
<TEXT>
begin 644 figure07_02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ( !=P# 2(  A$! Q$!_\0
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MOB'_ -#YXF_\'%Q_\71_PNOXA_\ 0^>)O_!Q<?\ Q= '].M%?S%?\+K^(?\
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M[:I?F)M)79ZW17PO\&?^"BWCG]H2UU^;P#\"7UK^PXDEO(CXIBBDP^[:(U:
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MT445Y1H%%>2_M*?M+>$_V7? /_"3>*6FG,TOV>QTZT ,]W-M)VKD@  #)8\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOKF<22 XZ[,K&/:,5^GO[&-];Z7^Q[\-+R\GCM;2WT".6:>9@J1HH8LS$\
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MZU:)=P+.NV1 >JL/4$$'Z5^=_P#P4 ;;_P $^O@BJ@!3_9G &/\ EP:OIO\
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MH/VB#>B*(T(VD]<^P[U$WRW:VJ(K0L0=R\ ?G6[>:/)HEL&=G43 /&W7!]J
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M%D6:$'YY(V(.>_>N@\5:/H'A_P 6>"KG2O"_@^X^(46FW46N^&M%@3[%)YK
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MX+)Q7U[\'_@_HGP7\*G1](DN[^XN)VO-1U;4IC->:C=,!OGGD/WF. /0
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MD?+U&,Y(R?=_B9^R]I/Q8_9V7X4^(M>U74HX[>)8]>NF5[O[1&<I,V %//\
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M//'2O7_V5_@7J'[./PGL_ EUXAB\26>GS2O972V7V9UCD8N4<;V#$,S8/'!
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MNQR37,2^2%>+=LW+ZYJE:V=K>>5.#@JN'4=/K6EI-Y;WDALE8L8\@2J,<]Z
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MTXJ:;E:4=Y):;:*_7IT#FE9O0]J^&OQ2\*?&+PK#XD\&ZW;:_HLSM&MU;;@
MZG#*RL RD>A /(]:Z#4]1ATG3KF]N!*8+>-I7$,32OM R=J("S'V )-?.'[
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M27.X*Q]5?"WXX^ OC9ITU]X'\5:=XC@A.)EM)/WD7IOC8!USVR!FNYK\4/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+=]ZNI=5D+%3M(R <$CBO5?!_P (/VA_@I\5OBKX\\)P:%XA\.>(_$=W??\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4C_/M0!GR227#-&&&[!)4G#(/8U+:_N[MX1=;%VX3:I/;FI)M)9;@F.6,R8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX8I;PQ,[!'YVYP<>_K7*'2_*CM95D*R"0*V3@[?2NLF8S?ND4,JH5W,<@$T
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M_/.X_P"_8_QHY)=@YEW.FHKFO^$^TW_GG<_]^Q_C2_\ ">Z=_P \[C_OV/\
M&CDEV#F1TE%<W_PGFG?\\[C_ +]C_&C_ (3S3O\ GG<?]^Q_C1R2[!S(Z2BN
M;_X3S3O^>=Q_W['^-'_">:=_<N/^_?\ ]>CEEV#F1TE%<W_PGFG?\\[C_OV/
M\:/^$\T[_GG<?]^Q_C1R2[!S+N=)17.?\)YI_P#SSN/^^!_C1_PG>G_\\[C_
M +X'^-')+L.Z.CHKG?\ A.-/_P">=Q_WP/\ &C_A.-/_ .>=Q_W[_P#KT<LN
MPN9'145SW_"<:?\ \\[C_O@?XT?\)QI__/.X_P"^!_C2Y9=AW1T-%<]_PG&G
M_P#/.X_[X'^-'_"<:?\ \\[C_O@?XT<LNP71T-%<_P#\)M8?\\[C_O@?XT?\
M)M8?\\[C_O@?XT<LNP71T%%<_P#\)M8?\\[C_O@?XTO_  FMA_<N/^^!_C1R
MOL%T;]%8'_":V']RX_[X'^-'_":6']RX_P"^!_C1ROL%T;]%8'_":6']RX_[
MX'^-+_PF=A_<N/\ O@?XT<K[!=&]16#_ ,)G8?W+C_O@?XT?\)G8?W+C_O@?
MXT<K[!=&]16#_P )G8?W+C_O@?XT?\)E8G^"?_O@?XT<K[!=&]16%_PF-E_<
MG_[X'^-'_"8V7]R?_O@?XT<K"Z-VBL+_ (3&R_N3_P#? _QH_P"$PLO[D_\
MWP/\:.5A=&[16'_PF%E_<G_[X'^-'_"7V7]R;_O@?XT<K"YN45A_\)?9?W)O
M^^!_C1_PEUE_<F_[X'^-'*QFY16)_P )=9_W)O\ O@?XT?\ "6V7]V;_ +X_
M^O1RL1MT5B?\);9?W9O^^/\ Z]'_  EME_=F_P"^/_KTN5C-NBL3_A++/^Y-
M_P!\?_7I?^$LL_[DW_?'_P!>GRL1M45B_P#"66?]R;_OC_Z]'_"66?\ <F_[
MX_\ KTN5C-JBL7_A++/^Y-_WQ_\ 7H_X2RS_ +DW_?'_ ->CE8&U16+_ ,)7
M9_W)O^^?_KTO_"56G]R;_OG_ .O3Y6!LT5C?\)5:?W)O^^/_ *]'_"56G]R;
M_OC_ .O2LP-FBL?_ (2BT_N3?]\?_7H_X2BT_N3?]\__ %Z+,#8HK'_X2BT_
MN3?]\_\ UZ/^$HM/[DW_ 'S_ /7HLP-BBL?_ (2BT_N3?]\__7I?^$GM/[DW
M_?/_ ->BS UZ*R/^$FM?[DO_ 'S_ /7H_P"$FM?[DO\ WS_]>BS UZ*R/^$F
MM?[DO_?/_P!>C_A)K7^Y+_WS_P#7HLP->BLK_A)+7^[+_P!\_P#UZ/\ A)+7
M^[+_ -\__7HLP-6BLK_A)+7^[+_WS_\ 7H_X22U_NR_]\_\ UZ+,#5HK+_X2
M*U_NR_\ ?/\ ]>C_ (2*U_NR_P#?/_UZ -2BLO\ X2*U_NR_]\__ %Z/^$BM
M?[LO_?/_ ->BS U**R_^$@MO[LG_ 'S1_P )!;?W9/\ OFBP&I167_PD%M_=
MD_[YH_X2"V_NR?\ ?-%@-2BLO_A(+;^[)_WS3O[>MO[LG_?-%@-*BLW^WK;^
M[)_WS1_;UO\ W9/^^?\ Z](#2HK-_MZW_NR?]\__ %Z7^W+?^[)_WS0!HT5G
M?VY;_P!V3_OFC^W+?^[)_P!\_P#UZ -&BL_^W+?^[)_WS_\ 7I/[<@_NR?\
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MYTH23Y74#<O09_K6SX?41S*K$S;3N/R\<=:PH[$RVN;V9XTEX4+PH_&M?28
MEM&+*YQ#DEFDZN?2@"]'=W&J:JELD**Q9BAZC/O47BGPS9J!Y;L]TN/,!X3_
M .M4]G/+;ZQ:K T2(SDSNWWN*NWVH6\S3W)"S_/]W;DT <(UY<Z3,25>5 NS
M;'T7WI/[0:[5Y(HQN7G$G.<5I?8I=7N'G5<)N'RL, \]*?KWA@*C/YWV>68
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M/ ?C&#30VN^,O/21\+'I-JL13GLQR31H/@G2M/FN'U"XU#5"ORK]LNF(.>V
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M.O9?BY-%=->R-&PC50R$\#CK7C/[-<@D_:F^&#J,!O%VFG_R;CH _I0HHHH
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MPI?^$'U3^_;_ /?9_P *GFCW*LS#I5K;_P"$'U3^_;_]]G_"C_A!]4_OV_\
MWV?\*.:/<+,QJ*VO^$)U3^_;_P#?1_PH_P"$)U3^_;_]]G_"CFCW"S,6BMO_
M (0G4_[]O_WV?\*/^$)U/^_;_P#?9_PHYEW"S[&,O2BMK_A"M3_OV_\ WT?\
M*/\ A"]3_OV__?1_PHYH]PLS'7I2UL#P9J?]^W_[[/\ A2_\(;J7]^#_ +[/
M^%'-'N/E9C45L_\ "&:E_?@_[[/^%'_"&ZE_?@_[[/\ A1S1[CLS(6EK7'@W
M4O[]O_WT?\*/^$-U/^_;_P#?1_PI<R[BLS(HK8_X0W4O[\'_ 'T?\*/^$-U+
M^_!_WT?\*7,NX[,QZ*V/^$-U+^_!_P!]'_"C_A#=2_OP?]]'_"CF7<+,R:*U
M_P#A#]1_OP?]]'_"E_X0_4?[\'_?1_PHYEW"S,>GUJ_\(?J/]^#_ +Z/^%+_
M ,(CJ/\ ?@_[Z/\ A1S(=F9-%:W_  B.H_WX/^^C_A2_\(CJ']^'_OH_X4N9
M!9F13EK5_P"$1U#^_#_WT?\ "@>$M1_OP_\ ?1_PI\R"S,NBM7_A$]0_OP_]
M]'_"C_A$]0_OP_\ ?1_PI<R[A9F52K6I_P (GJ']^'_OH_X4H\)Z@/XX?^^C
M_A2NNX]3+HK5_P"$5U#^_#_WT?\ "C_A%=0_OP_]]'_"BZ!(RJ*U?^$4U#^_
M#_WT?\*/^$5O_P"]#_WT?\*+H9F=J6M3_A%K_'WH?^^C_A1_PBM__?A_[Z/^
M%%T!ET5J?\(M?_WX?^^C_A1_PBM__?A_[Z/^%%T!FK2UI#PO?X^_#_WT?\*7
M_A%[_P#OP_\ ?1_PI70&916G_P (O?\ ]^'_ +Z/^%'_  B]_P#WX?\ OH_X
M470&916G_P (O??WX?\ OH_X4?\ "+W_ /?A_P"^C_A1= 9JTM:0\,WW]^'_
M +Z/^%+_ ,(S??WH?^^C_A1=#Z&916G_ ,(S??WHO^^C_A1_PC-]_>B_[Z/^
M%*Z$9]%:/_"-WO\ >B_[Z/\ A2_\(W>_WHO^^C_A3NBC-HK2_P"$;O?[T/\
MWT?\*/\ A&[W^]%^9_PI7 S:5>M:/_"-WO\ >B_,_P"%+_PCE[_>B_[Z/^%%
MT!GT5H_\([>_WHO^^C_A1_PCM[_>B_[Z/^%%T!G45H_\([>?WHOS/^%'_".W
MG]Z+\S_A1<"A16C_ ,(_>?WHOS/^%'_"/WG]Z+\S_A2N@,ZBM'_A'[S^]%^9
M_P */^$?O/[T7_?1_P *+H"C15_^P;S^]%^9_P */[!O/[T7YG_"D!0HJ_\
MV#>?WHOS/^%']@WG]Z+\S_A3N@*=%7O["N_[T?YG_"C^PKO^]'^9_P *D"C1
M5[^PKO\ O1_F?\*/["N_[T?YG_"@"C3JN?V%=_WH_P S_A3O[#N_[T?YF@"C
M3EZ5<_L.Z_O1_F?\*7^Q;KUC_,T 4Z*N_P!BW7]Z/\S1_8MUZQ_G_P#6H I4
MJU<_L6Z]8_S_ /K4HT:Y'>/\_P#ZU %.BKG]CW/K'^?_ -:E_L>Y]8_S/^%(
M"G15S^Q[G^]'^9_PH_L>Y_O1_F?\*8%.E[5;_L>Y_O1_F?\ "E_L>YQ]Z/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MSLL16D[N;^]G5[."VBCD]4\%^"]%TR[U"\\-Z+%:6D+SS2?V?$=J*I9C]WL
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MK;)$2/)/!*@<5]:U\M_M??\ )9OV9_\ L=#_ .B#7U)7L8^3E@\&Y._NR_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KP[]M_5)=&_9+^*%S 2LG]CR19!QP[*A_1C7
MN-> _M[?\F?_ !0_[!@_]'1UZV4I2S'#I_SP_P#2D95=:<EY,]$^!.DP:%\$
M_ -A;(J0V^@V**JC _U"9_6NQU'4;72+&>]O9TMK2!#)+-(<*BCJ2?2N<^$?
M_)*?!?\ V!;+_P!$)75LH8$$9'H:X\3+FQ$W+N_S%1UI1]$<!8?M!?#/59&C
ML?'WAV]E5#(T=MJ44C*HZL0K$@#U-;/@_P")WA#XA?:?^$7\3Z1XA^RA3.-,
MO8[@Q YP6V$XS@]?2O@[_@F[IMG'^U!^TLB6D"K'JACC58E 1#=7.5'' X''
ML*XKXF_##Q-^R;XFL_VEOA6D]QH-QJM]%XLT!3^Z,9OID8[0,"$@ #C]VP4C
M@\?3SR2A]9GA(U&IVCRWV;DN9+R[>IE[9V3:/T)O/C)\,?$MGKVDS^,- OH+
M>"2+5;7[=&?(B.4<3 '*#J#G%>167A']E:UT\K9:AX530K:XCO)-.M==?^RT
ME3&QY+99O(S\H/S+R1DY-:/[-OC[P?\ &[3?BCXY\+6]O+I>N7-OYA:W59 X
MTRW$D,O'+*Q8$<C)/7-?$7[#?Q(U?X:_"7Q58Z/X)EUK3]9^(-AI-_JK)$]E
M8VLLD<;^9&26/RG:/EV_O!R.ATPF6U.6M&E.4)0<+KFM=RWOZ?.XIU%=72=[
MGZ&_$SQM\&/'G@N+1/&'B_07\-:S )HXFUL6D5[!RORO'(F^,\@@$@]ZR?AS
MHGP(_9K\,Q:EX7U/2?"'AO6W/DR2ZU*;*YD&,M&)I63=@#E>2 *^3/\ @J5\
M.]"^&_P)^$WAS1+&.VTFR\22I;0;!B&.19)#&O'" MC'H!Z5]8_M/:';ZE\!
M])LAI\-U&-8T,);F%64 7UOG (P.,_AFN:.$C['#QC5E[.M)JU[+1VO;:^S*
ME.SDVE=&E\3_  I\%M>UKP]XQ\73:18:VZ'^R=<CU)]/O)D*<B.6*1'D7:>F
M2 #4WP]LO@M\'O"NJZKX4O?#ND:/=3";4=8BU%9C+))DJT]RSLS$\XW-]*^;
MOVJD^*7P)_:<M?C?X9\*1_$KP>FBQZ/?:6L0DN-)C#%G\H*"T>[AO, (^8JW
M&*VO@[X^^$'QC_9\^.GB3X<:8^B76L:9<W'B#PY=1*HM+H63J'5 -NUPI.Y>
M"RDX!R*OZG.6$IS]K*5-\NSNDV_A:Z6OH[6;]1<Z4GHKZGI/PW^!_P"SKX@^
M(ESXN\#MI^K^,K=_M-SJVE>)+JYN06."9&6X.0W0AN".,5ZMK'QR^'?A[5;G
M3=3\<>'["_M6"W%O<:E$CPDG #@M\I)]<5^=?[.?CC4O@_\ \$K/''BOPOY>
MG>(&U"XA6_B0"5#)+%#YF['+*K':3T(%?3W[!OPA\*W7[&OAJ#4M(LM8/BRT
MFO-;EO(%D>^>65\B5CDOA<*,GC;ZT9A@5252MB:LIQA/V:UN]KMZ[+LAPG>R
MBK'TEK_CCP]X5\/KKNL:W8:;HK;<:C=7");_ #?=/F$[<'L<U%HOQ#\+^)?#
MUSKVD>(=,U71;;?YVH65TDT,>T9;<ZD@8')K\YO^"?\ XTOM8^%_[07PQU7.
MK^$_#L5PVGQ73&5(8G\]&A7=_#^[# =B2:I6=CK7_!,GXN:-K]I)>:M\ O'"
MPB]@.97T^9D!)([NHRP(^^F5ZJ*<\A4:M7"\_P"]C\*Z25D[>4K/87M]G;0_
M2+P5\2O"GQ(M[FX\*>(],\1P6K!)I=,NDG6-B,A6*D@'':NEKPS]C'^QKCX%
MVFH: +=]+U+5=4O8)[>(1B9)+Z9E<C YVD#GD8QVKW.OF\91CA\14HPO:+:U
MWTT-Z<N>"EW/EO\ :[_>?&S]F:)>9/\ A,7DVCKM6#D_A7U)7R;XBO1\9OV^
M_#>D61,^B_##1YM0U"5>474+H!(HB>S!,-CV-?65>EF2]EA\)1E\2A=_]O2E
M)?\ DK3^9C1;E.<NE_R05^"/[=G_ "7_ /:#_P"Q@T__ -$M7[W5^"/[=G_)
M?_V@_P#L8-/_ /1+5\[/9>J/4P_Q2_PR_)GF7[/,+R2RM&V&!Q\W0<U]U_#J
MXM_#V@F0Q+>+<#$@QR/>OA3]GV$L),2<&7+(>!7W)\)[BTM](N/[35C9MNV8
M/0_X5H<IEZE<I'<W'FP, [8.SG"_6JVK+%XBTV,B(P1\HJKT_&K>IZE!)+>1
MP1J\>WY?+4\+TZ^U4[.ZMY]/GA:4 (H.QAC/I0!)9W ATX<(I50BQ.=H&.!5
M)HQ-<+&XBDRN_!/&<_RJO=7T>L.56W6W:/CS-WRG [BGV[*MNGG[08?NOU)/
M]W\: -5='6[O%EW![./[W;;QT]Q7.:]()Y'CMV:&")^6(SCV'M5Z^NKB;3_+
M.Z*27< R\8]JJRK;6,<;+ RL0-^\\=.P]* (O[+:& /&_P!H#,#UZD?RK?T_
M7$CEF$SQ)L&YD7K7.WFH7-RWD0%((EZB/],US=UIDDUPI^WDS.,$*,!![F@#
MT3[?87UXURX9HUCVE2VT,?I5;S%N'FPGEJPR%<]2*X4Z/']LMUN[B0Q.O4/U
M;.!^%7[FU\A(PUTQ?N-V<#U]J .M7Q(+-HK4(@,8"C'7ZUIV<TD-X)[27<[-
M^\RV<*:X6'2+J&P4->9;&#( ,\] :FBM)].NG^S7(E=5W/N)#'_&@#O[O78S
M=(DK"4\AG7LM8VK:QI\WBVTE@E=4%F\9!&5;)Y-<U'J%ZMQY<NPPL-P+ ?(/
MZFJL_FQ^(+,RN%#K)'$0/ER>>E '9QZG;6-NVP[P^56,$Y'OBN5\,>([/1M8
MUU%VL+HQW+'/5L%6_D*@6V6^NF3S95FCR/,(P!^'I7$31V_AOQW903W F-ZL
MB GC<1R /3K0!ZY<?$'2H8%CEN5B/5-RYQ]:AD^(6GVORP3"Y64 LP&,&N3.
MEQ>7'-)!&-@) ;DL>P^M5%BM+JU5I8?WQ.0A^7!'^% '6W'C*QNWV>88WZB-
MSDU$T@U!=SSH)T&,YRN#V^M<S]@MY9G<["XVH9%!_*IFM4BW-"A00OG<#\KY
M[?6@#NK#3;2STU;N[=OM"D[26X/I5*&\5IF=W7?-\AWC/?BJ%E,M]$L4JY2-
M1PY/_?6/6M![O3UMPCX8M_J\+TQ0 ]8[:-YDC7,Q3#,O3'O[T^WFMKA(8YF8
M2*#O+<#CIBH=-^U;DE$"A<DL<GYE[FMN)4@N$ @8K)D'?C./4&@#GIKQ%CB>
M,EOG(W'JN>WO4-K%)>3(8PK$$G+C&!_]>M#Q(NGV]Q%^^10H^1%/)]S5?1]_
MG$1.C*P/USGKS0 ]99?LLEM*BRL$VAF7H3V'K5;3-GA.SDO#JLNC0W%L]I<J
MDOEM/$Q^9#CJIXXJ_<-(&B>X^520  ,=_O5X;\8]=T^\^+D&D7-S<#[/;QM;
M6^W]U=2MP%'OF@#N=9^(4=II[6^C0>590J5$QY_ >]>7^([K6_$6I6FCV:FZ
MUN[&Z*R!)6VC/_+:<]AZ*>M=?JGA/Q7I-O9VMEI$<FIS<?:IN;;35(Y=A_$^
M.E=[X-T?PCX-T*33]+U*.\\0W(WZC?W4@,]S(>Y/8#L.U &?\.OA[9_#G19K
M>UG^TZK,PEO-089>5CZ#L.N!70?9/M"L"Y12#D(OS$U';S+92"6:XCE<@H2I
MSQZUIZ?XBL+KY+::.$QG]X"06;W% &9-:6D*E9I-C_>5L'.:AALA<2!F=U+X
M"29_('WKJ9-.MM9NXA%=1!", ;1G\:S;S35TR4QPS_: IY67@$^U $4NFW4?
MESR74DT<?S<<-]/>H9DNYB9))C Y8&.)N?E]ZN7&H Z;%&C8DSM QT'KBLV%
M9E\Q)1N#,"S9^]VH T+/4I5N6-RHDM8N H(P3W(J_'?V$<Q<P?9YA\RENX/>
MJK0VUG)#;^8D;2?>(&0N>U+>:;';F.3*7#9P7)SD>U &FFH>="81Y2\DD]!^
M-6[*V:23:8RLK<+O/R$X[5@I&BPL\(\M\;59QG'K5F/69]-LY&)69-N8]QRV
M: +<WA&UCD*KN^UN-_F;@ N.P]*JR1&&+S(9%FF7<7&>IQ0VM-+;LMPPB9E#
M,P_B]JBMK9;A4V@,6;=&,EL+WH EFLRZHGV5$N6 SCITR,U:LYYX+-+>2;)7
M(+*ORGG[OXTZ:&>2.5I/W,A.$"G'/_ZJ?;V;K=I;F0E)%.\XP >WTH HWGF0
M>>LMO&T2'<I!SU]?>J^J31QK%<QNTEQC>J8.,=AQ5F\EM;2/[-;N))#\I=\M
MDYY_&M/0H89KB.SBVM+QASRI&.AH RM+U"77_,AB'V>Y1 ['J1SWJ+4FNK7]
MU=3QRK(>59L$#MBMY]+?2;J2=CY9<D2-&.1Z 53M=-ACO))GE,AD#']Z.!CI
M^- &'->-';Q/;@R&)\EOXE]!6NFHV]Q;J%CR77+0R9.#W%9D>GS1^9@+O.6/
MIZ]/2M*STQ95BN#.(YVC+",#B@">UAD6U=0T<; X8+TV]@*?8Z6UFJ)<[8$9
MLIN;!&?>H=-\V3='(J;"_P QDXZ=,"MJ>2'5XF@,(D53A3SR1_*@"*\A-A&]
MS',JC.!SGC-=EI$SQQI-<R+<)Y?F!#U'M7'PW5C;-]F$))/56!(;'IGWK?T>
M.6ZFCB7*(5^8.?T H EUC4+B[O+65$8(P('E]!]:R?&NM+IMK:QE<;R >./I
M6IXDU!-(TF1Y6$4RG]V ,Y^E<M>7?_"0:")+E&(899FZ#GC'I0!\_?&ZZ6:T
MG*D0F9]H&>17@O[,XV_M2?"\9S_Q5VF\_P#;W'7M?QKCAAOC'&RNBQDECT''
M%>)_LRKM_:B^%P!R!XNTW_TKCH _I3HHHH **** "BBB@ HHHH *9+*D$3R2
M.L<: LSL<!0.22>PI]>;?M)3:);_  %\>-XC-^-#.D3K=MI9Q<B,K@E#V(SG
M)X !SQFFE=V$]%<Z_3_&WAW5])N=5L=>TN]TNU!,][;WD<D,6!D[W#;5P.>3
M5_2]6L==TZWU#3;RWU"PN%WPW5K*LL4B^JLI((]Q7PSI?VS2Y+72/$[Z+J<]
MOXA\--KGB/P^HCT?4M&*S+:^:FXHC),JAQ]T@QM]T@#WW]F5;@>(?C ;2/R_
M";>+9&T8I_JG'V:#[0T/;R_.W_=XW;\=ZZ)TE&-S.,FW8]THHJFVL6*,RM>V
MZLIP5,JY!].M<QJ7**I?VUI__/\ 6_\ W]7_ !I?[8L/^?VW_P"_J_XT[,5R
MY15/^V+#_G]M_P#OZO\ C1_;%A_S^V__ ']7_&BS"Y<HJG_;%A_S^V__ ']7
M_&C^V+#_ )_;?_OZO^-%F,N453_MBP_Y_;?_ +^K_C1_;%A_S^V__?U?\:+,
M"Y15/^V+#_G]M_\ OZO^-']KV/\ S^V__?U?\:+,"Y153^UK'_G\M_\ OZO^
M-']K6/\ S^6__?U?\:+,"W153^UK'_G\M_\ OZO^-']K6/\ S^6__?U?\:+,
M"W153^UK'_G\M_\ OZO^-']K6/\ S^6__?U?\:+,"W153^UK'_G\M_\ OZO^
M-']K6/\ S^6__?U?\:+,"W153^UK+_G\@_[^K_C1_:ME_P _D'_?Q?\ &BS
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M^?F'_OL468%FBJW]HVG_ #\P_P#?8H_M&T_Y^8?^^Q1J!9HJO_:%K_S\P_\
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M *.,T?\ \)6#_&NW$P6*;E5QM*[MK:HG[NB_Y=]$$7R[0?X?YG9_ W]F6?\
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M>6\9VGY/DZ8]*MZE+(TD<:@F&,$.J<8SUS26=Q;6<C)<1%"T?R*I)'7_  H
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MTOX)TFYT'P;H.F7KB2\L[""WF=3D%TC56(/<9!K:HHKC>NIOL%%%%(84444
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M-M72CKV]3/ZQ&RLO^ ?M/\0/BMX(^$L5C)XT\5:7X:%])Y=JNH3A&E/?:O7
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MAGQI^TA^V=X"A\=W,WB8^#8F6XDO,9@@M0_E*S ?.1,R<MDMW)JM^U?^R/\
M$O\ 9I\5:EI?AN\U#7/!7CFZ:.*+21*?."S"2*WN4 P74E2IY!P3QR*UCDF5
MTU#*J\HJMI-R[KF=XI]/=0.K4=ZBV.H^ /\ P4*^*OA+XU:-XD^*6MWMYX!\
M4.ZSQ7-L1;0PARGG6JJ./+<;3C.0&!R>:Q_V]/%&M_M.?M'>.1X9NEU/PO\
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M\^-Q_P!^C1<-1E%2_8;[_GQN/^_1H_L^^_Y\;C_OT:DHBI5J7^S[[_GQN/\
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MH.OO\.=!L<V\6MN0OV=5'E6L<>=R G;D8'RJ>G%<EX\_X)]_''P_\3/&VE>
M?"VJ?\(C-=-;VUTMZD4=W9O("B-EP751C(8?PFN*.4Y-[#^SJF(BJL?>=32S
M5VN6]^W3OJ/VE2_.EH:7P>_X*6^.=/\ CL^N>.=1N-3\#:I(;>;1(]JQ:?&S
M826(!>L8Y..7YSVQW'_!3C]IK7=+^)N@>#_ GBR\TS3+#3HK^[ETF[:/[1--
MAX]Q7'W8]I'.,/7:_&'_ ()=W.J_!/X?:3X(M;-?B#HZ"'6;ZYE:&WO5?<\C
M9VG++(V%)_@&/2IOV0_^"<FH>'+SQA>_'#0+?6EN[0:5I]DMP;C"9&^<..4(
M"H$(P1S7<\7P["I',Z=E[-./(K7EK922]+O[NQ/+5:Y'U.@UG]M"TNO^">\W
MC"P\317/Q&%E#H-UL;R[F"_D)1I<8X/EJ\@;H<5X;_P2Q^-T>C?%[Q'X<\9^
M+[FWM]<L0;*'5;IFADNT?<3N<X5RA;TST]*EU#_@E5XZ_P"%YW&FZ;&5^%#:
MA'-_:%Q=K]H-GG)4QCEI%!91QZ'O7MG[<?\ P3Y3XK6MOXK^%V@?9/&$;1P7
M]BT@AAO($CV+( 1@2C"Y.1N&<\US^TR*G3G@(5/=Q#<N;3W-G&+]->UOG<=J
MM^:VQ\2_M;>+-<_:&^+WQ,\>V-U]K\*>%KN#3K=C*5$-N9###Y:'^\ZLYQW8
MFO>_VL/VG6^+O[//P8^'?P]U6\U#6O$EE!%K=A;,LD\SQJD*P2E26#-*&8KW
M&":^@?@5_P $_P#2]'_98O\ X<^/[2ZBUOQ%>+J6JW6ER9>WDC)%NB-RK!!R
M1C!+-7%?LE_\$Y=?^!WQ_NO&7BI[75M$T4R-X?\ )RTL\I.$FD3'R%%SQG[Q
M!'2M99OE#BM;O"M^S72?NI+U][7TLPY*G_@6YY5^PW^TKIO[-?PP^-7@SQ??
M0:3KNBF:]TJSD*B6>]5&ADB0D[68.D9"]^37SYX/L_&7P=U3X6?M!ZI<7=U;
MZSK\\ING<K))Y+J)=TASGS5:5>G1&K[O_; _X)RW7Q\^)UGXU\'W5MX?NM1=
M(]>MKB JC 8'VF+:.9"/O*>I .>M>R?&[]D;2_BC^S7I?PBTC_B1P:*EM_96
MH3VGFF)XA@LV,'+@MN(Y.XUDL]RRG-5X;XAKVJM\*Y>5VZ[N_F/V4[6[;'PW
M^TS?G]O3]K6^T+P-?2ZEX<\.^'KB2SN;3$D3M%"TK,H.W:))FCBSSS@USB?M
MAM:_\$][?X6VNH,OB^35'T=XP29/[).921@8 )(AP221N-?>O[%_['J?LEZ+
MKPNKI?$OB#6I%6>^AM6C1;9?NPJ&)."223_A7DOA/_@EKIFA_'Y_'&H:X;[P
MI!J3:K:>'XK%HY-_F>8D3N#M$:M_='( 'K4T\YRA?[+4UHT.5T]-92C>]].K
M?6RT&Z=3=;O<^>/V5Y-8_8-_:FT>Q^)LD>BZ%XCT+S+J?S08%B>/S8W8XY*.
MA0@?Q$XKPWXE+X[^-^K>/_CQY$EUHEGKL:2WK.6%N9&)MXU4\[$54'/ RHZF
MOU+_ &SOV+8/VM+71M1MKYO#?BO2@8([Z6U:2*>W8Y,;@8/RGE2.F6XYKJ/A
MS^R7X8\$_LTS?!B^M;G5='U&)SJMXB-')<W#L&,R]=NUE3:.VP>]%/B?!TU'
M,)1OB)\L9JVBBF[M>;5EOV$Z,OAZ(^(OVQ/C_=?M>6?P3^&G@*ZDO=7URTM[
MK4[83>4C7LH55BF .SY"K.>NW/K67^R?\?&_9Q_9_P#VBO!NK3QP:YI+,VG1
MJ< WDF;.3:PPQ(81L,#@*3Q7U'^R'_P3[C_9C^)>K>,=2U6/Q1<^4UOHZK9,
MC6BL3ND8G_EIMPOR\<MZUQ'[1/\ P3!OOC'\<K_QMHWB6/2='UN[2ZU.QNK9
MVFA8@>:T1 P=V. <8)ZT4\SR;E>5\UL.K24K.[ES<S7W:#Y*GQ]3XU^$.@>)
M?V9/&'P2^-&K/NT;Q%?RS1F%?,D^SK((I0[-\H9U=R!G.!FNV_:]CUO]KC]I
MKXH:AX0:WOM#\":/),TIE94-K:@"5HP<@N9'; 7 8+FOT)_:B_9%LOV@O@KH
M/@'2)3X7/AV6%](F:!GAC1(_+*.@Y.4[]C2?LA_LBV/[+OP\UK0[MU\2:QKT
MC?VIJ$=L8U>':52%,_,% +$Y/5B:G_6;"M?VDU_M"O!1MIRN5T[^4=/4/8R^
M#H?!_C3]JY/$_P#P3[\ _"W2;L2^+KN^_L2]L[9")!9P,&B& <G?OA7I\V'&
M*M?L>^+#^PG^TMXW\+_$O[+IBRZ&X>X;)WR(HN(%C)P/W@R!NQS@<5]!?!K_
M ()=:?\ "OX\6OC:]UW^W?#6EW37FF:,]DPE$@.8?-8DJP0\\<DJ#7?_ +9W
M["UM^U=J6D^(=/U$^&?%EG&+2>\N+=Y8;FV!)5608PZECANX)![8J><91S2R
M^#_<5N:4Y6U4I.ZZ;*UMNP*G4^-[H_+?7='\:^(-+E_:$U2-M1L;KQ:899IP
MPW7(Q.H_ZYD H,'C9CC KZ=_:V^("_M]?'3X6>!?AUJ:W5M)I/VB3@_9X+N1
M#)+O'W@45 C9Z8K[I3]E/PT/V7E^!VR]30_L8B?48X5$[7._S#<=,9,G./3C
M->=?L7_L()^RGXBUKQ-JFJ)XH\174?V2RG@LVB2U@)!?ALG>V #CC QWI5.)
M,#54L7:U6CS*DK:-2T3>EM 5&:]WH]SXO^"?[4%M\&/V,_C'\,+VY_L[QE]O
M:WTV*$GS7\_$-R=Q^7"",].?GKEO@[H>J?L:_&7X%?$?Q&T*Z#XFMEO9#-&R
MO:VTK&&;<G7*HZR ]#D5]A_$;_@EW8^/_P!H*Z\>GQ+);>&M2U/^U-0T-[$F
M5F+[Y(HY%(4(QXY&0":]G_;'_93/[5OP_P!$T*TO?^$:U'1;L365S);&2$1%
M-CQE5P>@7&#QBM)9]ED:BA3^#$7=73X;QM9:=]= ]E.UWTV/S5^/&GZY^US\
M2OCK\4=)>:\T#P@D;6S1XDC:T680H%;C \M9)NG0&NJ^,W[3EC\</V5O@E\&
M_"27<GB=98++5;"+<%+PXAMTR0 _F%A)P?E(YK]%_P!FO]EG0?V</A3J7@:$
M7'B6WUF62;5KF\@V"YWQB,IM&<(%&!SW)ZUXU^SW_P $V].^!?QZF^($VL?V
MWIEB\LNAZ4;-U>V=\A6D<DABBD@8ZGFLX\09;*ZFG;#V='^]:/+9_/76WZ![
M*?3KN?+WP%^(EG_P3_\ C1\=/"NOLSSQ:+)!IDUPA5[FZ0AK5=J$X$@EW$YX
M"YKQ>'X3^(OAW\'_  +\?KJ+4)IKWQ0YWO(5#QQE721G^^&D=9AGG(7/U_37
M]J#_ ()_^$OVG/&%MXLGO=2\+^("B0WUQ90+(EY&HPI96Z2 <;NX !' KTSX
MD?LW>%_B5\!(_A'<65SIOARUMH+>PFMH5,UHT.-DJY&"W!W=,[F]:B/$V$@Z
M==)NI4Y56TZ17+IZWOH/V$G==%L?GQ\>-37_ (*+?M;:;HW@V6:X\/:/X==_
MM-LK$JRQ--)@/A<F9TBSQG ]*XKP/^UA;^"OV"?&GPFFN6@\63ZL;.UMW:4O
M]CE(:<JP^5-I1EQG!WGCFOT<_95_8_\ #/[)4.MR:#/J.NZKJS(LVI:A;JDB
M0KR(D"CA<\GGDX]*\@_X=<^$[SX[WOCW4-9O)]"FU4ZLGAJ&Q6--Q<R&%F'_
M "S#$< =!BBEGF4_[I4O["ER.GIJY1NW?3K?K;;H#I5/B6[W/D;X%Z;>?L%_
MM,?#3Q#X_NIK70=>T$WUS)8H658;B)PL;?W]CB)FQWQCI7GGCCP3XS_:9LOB
M_P#'N,O-HVE:HCS),C>:8I7PBH!E0(H]FX \ BOUB_:H_9-\/?M8Z#H]EK<E
MYH.H:1*S6>IV-LKNL; !HBIX*G /7@BMOX1_LW^%?A)\#_\ A546FS:YX=N8
MYDU-KV+:^H-+_K&DV]., 8/ 4>E*/%=",8X[EOB7:,M-.12;=O-K3_A@^KRO
MR]#\X/C)\9YOVRO#7[._P8\&SSS:A]G@BU5KI2QBNU7R2[G.65(TDE/^RP[B
MJ7P!^-TW[#]U^T+\/];NICK"6DEKI.V-O*DOXV:)9!&PZ.DBR9/\,??(K[G_
M &9_V"_"O[,?Q%UCQCI=]J&MWUS$]M817EN%%A$[98*03N8@!<GL/<UC_'__
M ()Q^"_C]\5G\>7.JZQH5]>O&^JV=O$)8[PHJKE2QS&2JJIQQW&#3CGN4WEE
M[3^JM7O;5SYN;M>W0/95+<WVC\X=/^%?B[]G'PC\(?CX\\B+JVKM=6]K%"5>
M*.)E*EW(V_OEWX'I7J7QSAO?^"A'[27CW7/!EPP\/^%O##7-I<2V[$21VZ;_
M "L 9W22/+MR*_27]H3]FW0?VA_A#;?#V^^V:!IMC+!+I]Q91;VM3$NQ0%)P
MP*$KSZYZUE_LG_LIZ+^R7X8UK2])NKS7[S6;E9KS4+NW$;,BJ52(*,@*,N?4
MECZ"H?%5"=+ZZX_[5'FC%6TY7)/72VBT7S[C^KN_+]D_-N7]K*WOO^">]A\'
M[>^NYO%\FL?8#:K"N#IX?SE /<%B%]<CTK=_9ZOQ_P $\_VNIK/Q]=K;:7>^
M&\SS>0SN1-$D\<>%R4831^6>W'H:^N/A_P#\$S? WP_^.4'Q$CU+4;^UM-0?
M4;+P]+:@6\,A):-2^2S!&((SUVC-=?\ MC?L5Z7^UQ;Z-?&_F\->*=*S#'J0
MMC+'-;LV6BD3@D@Y*D'@D^M:2S[*G4EA()JA6YG4=M5*5K6TZ6\]_(7LJEN9
M[K8_*[Q)\./%GQ0^&OC3]HB\FEG@7Q0L,_VL F7S26WAOXMC&)" .C>U>^_'
MKXL6_P#P4"^*OP*^'7AF\N!'_9\?]KRPQ,L4%X\8:Y*QOC(B2-OFS@@X'O\
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M0"00>]7/ ?[0'P_^)WC+Q+X4\->)K/5/$'AV8P:C8QDAXV!PQ7( =0WREER
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MX'!)K:IQ5A<+C7"DG4H<K5M/B;YKV_#^M96'E*-WN?*VD_\ !.G1M0_8<M_
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M&,8N/<\Y_9[^$=E\$?@WX7\'6UC96<]C91K?&Q3$<]T4'G2DGEBS9.3SC'8
M5F?!S]E_P%\!_%GC#Q#X0L)[&^\4SB>^1YMT*89W"1)@!%S(W'T]!7K-%>/+
M%5Y.HW)^_P#%YZWU^9KRK3R,V;PWI-QKD&M2Z79R:S;Q-!#J#VZ&XCC/5%DQ
MN"GT!QS6E117*VWN4%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUU\<+VW\8-!:_#"QU"4I/#? W>H6W)B"!5^4D%0Q;!&&P.AK];%4(H50%4#
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MBDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,TM !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 44F:,T +129I: "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHI,T +129HS0 M%)2T %%%% !
M1110 4444 %%%% !1110 4444 %?@C^W9_R7_P#:#_[&#3__ $2U?O=7X(_M
MV?\ )?\ ]H/_ +&#3_\ T2U9SV7JCJP_Q2_PR_)G!_ \&STW3W=LI.[C;C.>
M<5]E>&M2&D^'S+OX\O/RG%?(/P1GA?0M,C\O<RLW/0@Y-?7>@6*7>C0&9@R,
M,&+&<#&<UH<ICR>)OMUQ'(%DD?EEC"XP?]JK=Q?">%KM[;#XY&>2163<+9PW
M3"S+K\WSICT]:GN-;A>%8R0%/S# Y!]L4 7KG?'8VYMRUO)*NYXP<E:D70]0
MUBUBO;J?RXHSWZ\],5D1:C-<S*S0OY:D*DFWGW.?2IE\37,=PEM$"D3/L\F1
MN64]QZ4 66FL-+:1D)ND8!"K=%/M22:>\\>^UBPJH2%W_H15"XF4^=M#1&)\
M[7 ^8GM[TQ=0>&ZAFCE<Q+'ME8@C#9XH Q[[0WMXT>59/WB_Z@+TYZ9JA<75
M]:RM';6C3AER4/.U@."*[Q=7COK?RKJ0?:0=T;HOW?6JIM99)K)ROSB5OWB?
MQ@=Z .1BAU;^S0S1M%<,"=H&2:G_ .$?N[S3H#=(T$C'+8'IVKTJQ;3]/::*
MZ9C<,=_3[W?\*IZA\TDMQ9S!48#:DW0GUH X:W^'DUQ(Y$#E0H)=V(6K,WP[
M2U6(;.7.2RD$8]Q73VMY+)'FU&>-K\\<=36K'!'<6\4D]Q&J*FU0&W,,T >>
MW/PT0R>64R@/I4J>!WL[=XH3#$Y;AB.OI]:ZJ/SUGFC+>9$"%#L?F6I[<QM'
M+'<21R"%=R2+S@T <1<>"7DLXU:96EE81^6J$D\Y&*]1\$_LFKJA2]\27LEI
M$XRFGVYVRLO7YF_A^@KLO@3X.MKBZN_$=ZR30V[>59HQW#?U9_J.E>UR0P2L
MDF[YN3NST_"@#R_3?@#\/])62*W\)V;NPW%[@&1GQWR3UJ1?@+X'D=_+\'Z;
M&[#EUCQQ[\\UZ3:*OV@LS@G^')YQ]*ED::=MJQ\/WZXI >81_!GP=#<>7)X3
MTT!5PI,?6K<OPH\)K*'/A736*KC>(\G%=Q+#*D@\Q#@# ;')JG"Z3 R6\R7*
M<C="X=<]^0<<4_,#E+/X9^$O,61O#=CD'<%\L^OUKI?^$)\+7"E6T*QV'C:T
M?;THN)H;&W,L\ZV\(.-TC!5SZ9-.MWDFN$*N<-U&,<4 9,WPQ\&K('_X1^Q]
M$;9P/UJZ?AUX6C@*?V!8F-B#_J\_UK7DMDC*@G>YX'.=M.FO?+MQYS0VZ[@B
MO*X7<>P&3R: ,6^^$_A%I$D?P[9,''+%.14=K\//"L?[N/0+&,XP J8&*W&,
M\DVP2%54XRU68X-I(ZMZ^HH YZ;X7>#XT5G\.:>QW9.(^*/^%>^$=NP^&;&/
M^(E(^*Z69$\M3L.!QNZU1D7=G+C(!XZ$T 8=Y\//![1I&WAJS;NAV9-5X?AU
MX-^T*_\ PC%@TBMG=Y?-=1)&9+7>AVY/XU+#8JRIM=E?&3@=Z ,F'P+X3ACE
M6/P_9*"=K*J]<U3F^'OA&Z<I)X9L9$QMP8\G%=%*RV4<QG>."-1S),P11[DG
MBFW7[JU01')<;A(I!#>X- &5XF\/Z+XF:"YU/2;6]N(H8[1&ECR1$@PB?0"N
M6;X4>"%<-)X;T_(.[(CP5_6NTW?*$E."HR&/>HVMT7"L/,;/ Q^M ')+\-?!
MLDF\^%M.8]F:'D5\\_$U=.T[XG>(-/LHXXK:W:-19Q#"(-BG 'N3FOKJW@CD
M9003)CA5''US7RC\7]'5OBUXFDD+JDDT;,@&< 1J/PH XY39+<A_(VK)A#M'
M5JNM=7D,FW9FW08YZ_C65<6CV.H;C)MAD'R''0]JTX96E;#!RH3F53]X]>*
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MO_G;_7O_ !'U->NUY)J'_(6OO^N[_P S6U'=F50K^6?[[_\ ?1IX1L#]X_\
MWT:*=708C=I_YZ/_ -]&C8W_ #T?_OHTZEIC$\MO^>C_ /?1I=K?WW_[Z-.H
MJ2ANT_WW_P"^C2[6_OO_ -]&EI5H 38?[[_]]&C8?[[_ /?1I]% #=I_OO\
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M]YOSI:*0A=I_O-^=+M/]YOS-+1390FT_WF_,T;3_ 'F_,TM%2 FT_P!YOS-
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M_P!2_P#O?TJ[5+2_]2_^]_2KM @HHHH **** "BBB@ K\$/V[/\ DX#]H/\
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M\$:8+>Y=9)(&C9D.UMPX)..>PQ70>*/A?X2\9:99Z;K_ (=L-3T^U&;:"6+
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MGE)_<7\J7RT_NK^5.HH ;Y:?W5_*CRT_NK^5.HH ;Y:?W5_*CRT_NK^5.HH
M;Y:?W5_*CRT_NK^5.HH ;Y:?W5_*CRT_NK^5.HH ;Y:?W5_*CRT_NK^5.HH
M;Y:?W5_*CRT_NK^5.HH ;Y:?W5_*CRT_NK^5.HH ;Y:?W5_*CRT_NK^5.HH
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M&T>@I:* $VCT'Y4FU?[H_*G44 -VK_='Y4;5_NC\J=10 W:OH/RI=H]!2T4
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M&'K2>>VJ3-+]FV;L9\P@$XZ?G4]KFUD2;R"P;B-5^Z@/J* -J_\ #]BNAO)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110!4U75K+0]-N-0U&[AL;&W0R37%PX2.-1U+,> *@\/\
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MVJ1OIC".",J/O,@)./I5BUO)+5C.856+!7YN!GKC K/;5FN+Z5 CK&2&W$<
MXZ<T (;Q_++J!"S#/[P#D]\"M#3;Y$L9GA41CA5\S^(]^#7/:EN5C?&?<1ZC
MA?I4JRAH09Y5#M]Q@W&<=?QH UI8'FMV(C!6/('.#R:YOSW^V-;#$84]&&=P
M]O>NCT^];!B,)<2#&YB>?<5SEQHM[<:UY/WC*=V 2"@H V[5;0-,WF-&T?\
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M<-WWLYZYK"_9:_Y.8^%'_8U:7_Z51T ?TL4444 %%%% !1110 4444 %%%%
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MT;3H99KV.29G:&4"X^?.3QM+)V/%;05T]3.6^Q]RT4U-VU=Q!;') XS3JQ-
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MZ=XAL]1^T>0E^$)B98_F,8/S;BI/*<@ FJOA'X4_#SPCXT9]'\":'X>U>QC
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MNT445D6%%%% !1110 5^"'[=G_)P'[0?_8P:?_Z):OWOK\$/V[/^3@/V@_\
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MJO7/I]*I?LM?\G,?"C_L:M+_ /2J.@#^EBBBB@ HHHH **** "BBB@ HHHH
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MBBN<U"OF[Q/\/_%]GXY\5:YX'\-^!?'BZI?#[8WBQI;:\LI$B13 LHAD#P@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM %'4(S:W ,LK-;RC ^7#9]Z72[I(W$,;L(U!V/GU[?A5J^D^US)^\\P;N%
M!'2J4=I#'=!68;4 <*G;=0!LM=!K9X;QDDW#<)L<_CZG%4K>QE;&.C+N7 Y
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MT>7P991WEJFK6>I^?=K-/"R&Z>'RQM&2!A6) '-9:? _XZI L(^$T815P/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
H0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>figure05_01.jpg
<TEXT>
begin 644 figure05_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +V!98# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%)NI-U #J*;NHW4 .HINZC=0 ZBF[J-U #J*;NHYH =13-WO2;J
M)**CW4;J )**CW4;J )**B\RG;O>@!]%1[J-U $E%1^92>90!+147F4>90!+
M147F4GF&@":BH?.I/-]J )LBC(J'S*/,H FR*,BHU8FG &@!]%)MI: "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K,UOQ!IOAO3
MI+[5;^WT^SC^]-<2!%'Y]_:M.O&_$'[+_AKQE<7-SXFU36]>NI79HY+F\(6
M$Y 1% 4 >X- '%_$#]M/1M-\VU\'V+ZY<C(%Y.#';@^H'WF_2L[]E?XI>+?B
M/\1O$LGB+5GNK=;-7BLHU"00G?CY5^GJ:^;_ !=X97P3XVU[P\LIN%TV[:W6
M5A@LHP03[X(KVW]B7_D?O$G_ %X)_P"AT ?9E%%17$GDP2..JJ6_(4 ?.G[2
M'[3$O@.\E\,>%_+EUX(#<W4@W): C@ =WQS[9%<C\)?AIXG^+7PUU#Q9K'CG
M7AK4S2#3_)NBD<>SH64## G]*^=O$FH2ZYXFUS4KAB\]U>2R,S=?O' _ 8'X
M5]U_LOQ@? O0 !C=%(3CU+&@#YV^"_[6'B'PGJ4&F^,[M]<T623RVOI /M%O
MSC<2/O*/3J!7V];745Y;Q7$#K)#*H=)%.0RD9!'X5^7GB*T6+7M;@ZK'>SH.
M/21A7WG^R_K4VN?!/P])<.TDD"-;;FZD(Q _3% 'J]<_XX\9:=X \+:CKVJ2
MB*SLXC(WJQ[*!W)/%;^<<G@5\4_M >-]1^/WQ1T_X;^$W,NFVL^V>=3\CRC[
M[G'\$8X]SF@"W^S];^,?CM\4M0\;:OJFH6?AFSN=Z6<<[+#))U2(#NJC!/N1
M7V97-_#_ ,$:?\._"6GZ!ID86WM8PI;&#(W\3GW)YKI* "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=\ KXP^,5E+)%YEGI"_;YV;G+@X0'U^;^5?H+0 4444 %%%% !1110 4444
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M+.RMU'I>[-O0_AGX0\,W<5UI'A;1]+N(01%)9V,41B!Z[-JC;GOC&<<U9NO
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M7).]K[>8G*"/J'1]$T[PWIL.GZ1I]KI>GPC$5K90+#$@]%10 /P%7MU<_P"
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M*;DT9- #J*;NI=U "T4FZC=0 M%)NHR* %HHHH ***3=0 M%)NIM #Z*910
M^BF44 /HIE+DT .HINZEW4 +12;J6@ HHHH *5:2E6@#\X_C5_R6[QO_ -A)
MO_0%KU+]B;_D?_$7_7@O_H=>7?&K_DMOCC_L)-_Z M>H?L3?\C_XB_Z\%_\
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M.YRT\)'RL?<=">]>]U\<?L.V\LGC3Q5<H"+=;**-FQP6WD@9]<5]CT %%%%
M"@9IU,I>: %R*!FO/?B5\<?"?PMM\ZK?K-?-_J]/M2))V/N,_*/<XKY4^)7[
M4WB[Q]')9:/GPUI39!\EMUQ(OH7[?A^= 'U+\2/CYX0^&,+IJ&H?;-1 ^73[
M'$DS'T/.%_$BOD_XC?M/>,OB'YUK9O\ \(WI#<""T<F9U_VI./R'ZUY3':#S
M&DD+2RL<M)(=S,?4D]:L!0O:@"O#8I'ECRQ.2QY)-3LN%.*=10!]$_LJ?$CP
M+\/]#U"UU;55T[7+^YWRO<1L(]@&$ ?&/7C-?5^EZU8:W;K<:?>07L+#(DMY
M X_2OS"DMTDZ@&K&BZIJ_A6\6ZT/5;S2IU.0UK,5&?=>A_$4 ?J'29%?$_@O
M]L;Q=X?\N#Q%96_B"V7 ,T?[F?'U'RD_A7T+\/?VC_!/Q$9(+?41IFI'K8ZA
MB)\_[)/RM^!S[4 >I[J6HUPRAE(8'H12T /HIE+NH =13=U#4 +D4M-6ER*
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MEQ%=07C?VT@M9;659B9I)#$ A7)W C&!7W;O^7&./2DXQC:H'IBE[3FW7;\
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MFZDW4 /6EW5'DTZ@!VZC=3:* '9%+35I=U "T4W=2[J ';J-U)10 9-.IM%
M#J*;10 ZBBC(H 7)HI** (-U-W4<4E !112;JL@6BF44 +S1NIFZF[J '[J:
MS4QFIM #BQII:F,U-9J )%RS 588^7&,=:KV_4L:FDE % $<DF%J'S/6HY),
MFH7D]Z )6DZU'N+5#YF33PVT%B<"@-25I1$N6Y]!522<M4,TQ9LYXJ+=0!.9
M:3>:@:3'2D\RJU#4G\TTY9"WTJH&RW-3*V%H)+:MM%'F%NE4_.!XJS"?,[8^
MM '2:>?]&3Z59JGIK?N0!VJWNK(U%HHHH **** "BBB@ HHHH *7)I** "BB
MB@ HHHH **** "BBB@!>*2BB@ HHIP6@ VTM<UJ'Q*\(Z/?-8WWBC1K*]4[6
MMKB_BCD!]"I;-:.A^)M'\30O-H^JV.JQQG:[V5PDRJ?0E2<46>X&I12;J;0
MX&O,O$GQ@U326O(+#P!XCU2YA=HXV2!5BD(R VXG[I]<5Z73MQH _._6OA?\
M3?$WB#4]:O?!^H+=ZA<-<2*D7 +'H.>PQ75_!G1OB/\ "+QO_;)\!ZGJ%G/"
M;:YA1 'V$@Y7MD$=Z^Y@Q[TN\4 <CX+\=3>+YKB.;PWK&A&&-7W:G (U?)(V
MJ03DC'ZUUM8,WCSP]#XPA\*/K-FGB6:V-W'I9E'GM"#@N$ZXK>H *PO&WC#3
M? /A?4=?U:=8+&RB,CLQQGT4>Y/%;M<M:ZSX/^)O]K:3'-I/B4:5<BWO[-Q'
M<+;S@9"NI! ;!H ^2/@IX;OOVG/C!?\ CKQ&AFT*QF#)"?\ 5EAS% /]E1@M
MZ_C7W!@*  , < "J.D:'IOAVS^R:5I]KIEKN+"&SA6)-QZG:H S5Z@ KQ3]I
MGX)W'Q6T&UOM("#Q!IN[R5<X$\9^]'GL<C(KVK(I0U 'PA^S+X^M?@_\3=9L
M/&);PXE];""234 8DCDC8E0Q/ !#-S63\7M8NOCK\;K\>#K636X%5+6VGMU)
MC=5'S/NZ!<D\^G-?:WCS4O ]G=:/9^,&T7S]3G^RZ=#JR1N9Y>NR,.#D].GK
M71:7HNFZ#;_9]-T^UTZ#_GG:0K$OY* * .!^ ?PCB^$'@E+&1UGU:[;[1?3K
MT:3'"CV4<5Z71G-% !1110 JU\?_ +3'QN^(WA[Q)+X=BL_^$6T>3/D:A;OY
MDEXOJ),?)_N@9'K7U_7.^.O >B_$;0)M(URS6ZMGY5NCQ-V9&[$4 ?FJ(3<3
M/<3R/<3R'+RRL69C[DU8"A>E=G\7O@SK7P:UDI<!K[09F_T74E7C']Q_1A^M
M<7'()!D&@!U%%% !1110 4444 (5#57FL8Y,''(.01U%6:* .X^'_P ?/&_P
MSEC2TU ZMI:X#:?J),B;?]EL[E/T./8U]5_"_P#:=\*?$:2&RED_L/6I./L-
MXPPS>B/P&_G[5\.$9JM<623]5S0!^INVDKX.^%O[3OBGX</!9:J\GB+0EPIC
MG<FXB7_8<]<>AK[*\!_$CP_\2M'74=!OX[J/_EI%TEB/]UUZ@T =/1110 44
M4>V1F@ HK%_X3+2/^$F_X1\WJ?VMY?F_9N^WUK:_6G9K< HJ*XF^SV\DFUGV
M*6VKU..PK%\&^+%\8Z?+=IIUYIJQRF+R[V/8S8[@>E%G:_05^AT/\J;112&%
M%<[9>,$O?%EUH0TV]B:W3>;QX\0/[!NYKHJ;36XKW"D9MJYK!\8>+E\)6MM,
MVG7FH^=*(MMG'O*Y[GVK;CD$EN)2/+5EW$-P1QWHY79,+]"I?:Y9:?9R74DP
M:*-PC&/YL,3C'%6H;B*X#&*19-IPVTYP?0UB0Z7)8W%L-)2U2RFF:6\WY+/D
M?>7WS4LBQ>'[RWCLM,DE&H7!\^2'I&<$[VSVXQ^-5RKH&IHWUT]LT(CMI9_,
M?:3'CY!ZG/:K5<MK7B;2=2T?7(8M7:T.G_N[J>WY> XS^>*R?A'J%CJ&@S7U
MEXAOM?M9I=J2ZA\K*1P0*?LWRW?07-K8[JXD,,,DBQM*5&0B=6]A26LS7%O'
M*\3P.RY,<F-R^QQ6-X=U+5M4NKZ:\M!8V2R&.WB?_6G!P6/;!ZBJ>M?$2RT_
M1Y-1LH6U6.*Y%K(L#!2CYP<Y]#2Y9-V076YOW5X]O-;QK:RS"5MK21XVQ\=3
MSTJQ--';QF21UCC7JS' %8-WXUM;?Q%8Z(D337]PHDDC5@#"F/O'U&>.*V-0
MT^VU2TEM+N(36\G#(W0TG&UKH=^Q95@RAE.0>010U5Y6^PV+&"$RF-/DA0X+
M8' &:K:%JESJVFQW-S82:;,W6WF<,R_B.*72XR_13N#60FK74FO26!TN9+54
M#"^+KL8_W<=:$K@:M%%-61),[75\<':<XI .HIM% #J*;10 ZBFT4 .IM)D4
M;J %INZC/X4E "[J-QI** %YHW4E)D4 +7!_'3XD7/PC^%^J^*K2RCU&>S>!
M!;RL55O,F2,Y(] ^?PKN\BO%_P!LL_\ &.?B3_KM9?\ I5%0!ZAX.UZ3Q1X1
MT;6)85MY+ZUCN&B4Y"EE!P#6P#7*_"G_ ))?X4_[!L'_ * *ZB@!]%,H)H 5
MNM9_B#58M%T6[NIGV!8RJY[L1@#\ZOY%>0?&KQ%)_:4&E(<0PH)I,?Q,V<?E
MC]:N,>9V(E+E5S#T6:17,N0),_A6MI]NU_?+$&,CS,!BN7L9GBTN1L@@\\G!
MKM?A7&VH:P)I%PMM"7^I/ KIEHKG+'5I'JMO"MK;Q0IPL:A13MU(6%)D5QG:
M.:EYIF12$T .HII-'- #J*910 ^BF[J-U #LTF[FFTNZ@!<BEI@-&[WH ?13
M*7=0 [-%,I>: '49IE+NH ?NI:CYIU "[J56IM,DN(X 3(ZK]30!-DT9-9TF
MM0](U,GOT%0-J<LG0A!Z+3LQ71L;@H))P*C:\A7^//TK)\QI/O,6^II5P.].
MPKFE]N3LK&F->MV4"J:L*7S!Z4Q%K[=)_LC\*/MDGK^E5O,S2[Z )#?2Y^]C
M\*7[9-U_I3%([T>8.E $ZWDI["I%NI.^VJGF4W)H O?;/8'Z4C7#2<#Y1^M5
M%-/5J )LGU-%1;J* +&ZDW>]-)INZ@=R2D_&F*V:-U AVZD+4TM3-WO0 \M3
M=WX4W=3&:@!S-3&:F,U,9J 'LWO3&--9J:S;C0&I9A8[<4V>;N.>*;DE/0XJ
MNS<4!J-WG')YJ(L3G)H9J9NJM21Z@TR:3:,9J2-NOMS6?+-N8F@"1F%1-)[U
M"TE-9Z )F>FF2H3)QTIK-0!960\4K2,3M7D^OI5;S,<=ZFA8&@@M01A>>IJW
M$^2:IK)@<5/"^T4%G1:2VZ$U?K)T23=Y@K6S6;W-%L*WM1^%"TM(84444 %%
M%-H =13<TNZ@!:*3=2T %%%% !1110 4444 %%!-% !1110 4JTE*M 'Q=\3
MM(T:/_@I5\,KB]M+)8Y/"^I-+)/&@5BJ'!8G@D9/6JU[I9U[_@H'X*UCX31+
M_8%CIES'XVU#2%QILH*,(8G=1Y;S!MAV@EEQSBE^+&J>&]6_X*2_#/3-3N]-
MN8O^$8U*":WN)4*AV1L(P)X8X; Z]:SO"]\/^"?WQYD\,ZK>>3\#/'-T\^DW
MTV?+T/4&Y:!VZ"-SG#'IQZ$UV]/.QSK?YGV)XW\>V'@A=-BN5DNM0U2Y^QZ?
M808\VYEVEB!D@ !59BQ(  KD?"?Q^TK6OBKJOPXU73KG0_&%G8KJ<5K,5ECO
M;4G!D@="=VT\,IP02..:\-_;7\56G@WQU\$/BI=P?V]\.M#O-0M=:EL3Y\<*
MW44*17!V9!5?+<9_VO>O3/A/X[^#'Q%\=0ZK\.H-+\0:M:VC?:M=L(C_ *#"
MP&(WE(X+?W,]B3BL.3W;V-.;WK7(]!_:XM?&UKXV'A+P'XF\0ZIX3U672;S3
M8XH89=\2AI'S)(JX&<!<[V/1:S)/VV-%U#X1P?$?PUX+\3>)/#44#7.JS6L$
M41TU5.'5A(ZF1UP<K$'P!SCBN._8?\0:6WCC]IS&HVG_ "434+G(G7_5%5 D
MZ_=R#STXKBO@7X@TN3_@FWX\E74;1HUMM91F$RX#,\FT'GJ<C'KFM8TX/2W5
M+[Q.3[GU?XU^/_A#P-\&T^)MY>27/AF:WMY[5K5-\ER9RJPH@S]YF=1R0!R2
M0 35#2_C]:+\4]$\ Z]H=[H6N:]ILFJ:7([)-!<1H1YD9="=LB@J2",8(P37
MSC'\98OA/_P3I^$>KVUE8ZI'=6NC:3->7D0N;72]X&ZZF3/(C*=,CYRO2D\2
M^+/"%A^V=\#-1M_%?]MQ/HNK)-JTUQYD<\C)#M5-OR9.?NH/2G[*.JMW_ .9
MW1[C>>.OA]_PUUIGA>7P=+_PL>30I[B#Q+-9*H%FK -&DQ.YAD] ,#UJ_KO[
M3VE:1\9+[X9V_ACQ%J?B:WTHZI#';68$5VN]4"1R,P4<MRSE4&/O5Y9XRUS3
M8_\ @I=\/X'U"U2=?!5_"8WF4-YC3*53&?O$ D#J0#5^/Q!IC?\ !2"6U&HV
MIN4\!-$T/G+O#_:T.W&>N.<=:RY5?5=!<SM\SU;X)_M Z9\9IO%.GC2-2\.>
M(_"]X+/5]$U)4,]NS*61@8V975@#@J3T/M6-\!O'O@7Q-XB^*?\ PB/A&X\.
MZEI6L>3KI>R6">^NO*#>85!)8[2,9P:\O_9=UK3KG]L?]IV.&_MI9'O-*952
M926"V[AB #R >#Z5?_9#U[3;GXT?M,"+4;64_P#"6I-^[G4_NQ:1J7Z_=!!&
M>F13E%*]O(<9.23?F=#H7[9UEXV\)^*];\)?#[Q9X@_X1K4[G3M1M4@A@DA\
MA5:1R9)%!/) 12S_ "\J,UZ1HOQ[\':W\$X?BL-1-IX-?33JC75PA5HX@"2"
MO7<"",#.3P,U\X_L,^(-+;X:_M!7 U*S,!\?:]/YOGIM\MDCVOG/W3V/0UC_
M  77P?XB_P""5L5GXIO9_P#A&T\/31ZC)I>)KB JY(PH_B#;3@X]\"IY4W9+
MJ.^E[GNNN_M66'@VQ\&ZGXF\):YHND>+YXK32;ATB=_M$J%XH9T5\Q.Z@D=1
M\IR17M]E.;RTAG:*2W,BAO*E #+GL<=Z^#[/XC^#/C-X5^&'A7QS\8O (MO"
M^IV6J7-QI.HL;C5I8(W2&,I)&BP LZLVUG^Z5&,Y'WG;R1S01R0NLD;*&1E.
M5(QP0>XHJ14;!&3D>)?M">.? 'A?QE\,;#QIX/E\1ZGJ&M+!H-\UBLL5A=D#
MY_,8_(< =,DX]JTOBI^TMX?^$?Q(\'^#-3TG6;S4O$[2K92V-H98R8T+,O!W
M,W0  'K7E?[=&MZ?IOB[X!)=WMM;2?\ ";V\FR:94.T*06P3TR0,^XK-_:DU
MK3[?]L[]F%9;ZVC*WNI,P>51@-;$(3D\9. /4UO3I1ERWZIO[B>9WEY'LOPY
M_:-M?&WQ3UGX=:QX9U?P?XJL+)=3CL]4,+BZM&;:)$>&1USGJN<BO8/XJ^4+
M[7=-_P"'D&EVO]H6OVK_ (0B6/RO.7?N,X(7&<YP"<5]8'[PKFJ12M;JBXMN
M]Q:1J3)HR:S+'4FZFTJ]: *6N:#I_B;2;G3=4M(KVQN%*20S*&5@:^'?CG^S
MQJ7PFN)=6TA9M1\*LW^L^_):9Z!^Y7_:_.OO!:CN+:&\MY+>XC6:&12KQN,J
MP/4$4 ?E[#,LJ@@YJ2O>/CY^S#<^%);GQ)X/MY+G2>9+G3$^9[?N6C'=/;J*
M\ MKI9ER* )Z**EL]/O]5DDCT^QN+YXQN9+>,N0/4@4 145+<:3K-FQ6?1-3
MB(&3NLY,?GMJA->&TS]HBEMP.OG(4Q^8H M454CU*&7[LBM]#4ZW"-T- $E%
M(&!I: $9 W45:\-^(M9\"ZW#J^@7TFGWL1!RA^20?W77HP/H:K44 ?;WP-_:
M,TGXJQ+IM_MTKQ-&N7M6.$G_ -J,GK_N]17LN,5^6W[ZTNH;JTF>VNH6#QS1
M-M9&'0@U]C?LZ_M'KX\CB\.>)IHX/$J#$,Q^5+U1Z>CXZCOU'I0!]!UP_B?P
M%<ZMXVTKQ&NN75G:Z<C>98Q_<F[Y-=SM[UPG@7XI0>//$7B+2$TB]L#H\WD/
M-=)A)_=/45K3YE><>F_S)E;1,RO"^I>$_C NLZUH<;PZH@DTY]0:,I)&1E<C
M/I70^ ?#?_"O?#5GHU]K;:I<AF*W%VX$DF3G R>:Z'3-'L='21+"SAM$D8NR
MPH%#,>I..]<YXP^&.F>-M>T/5KVXNXKC2)?-A2WE*(Q_VAW%6YQDW&[4?O%R
MO?J=ACKFO$_BAXR^+>B>*'MO"/A.UU71Q&"MQ(W);N.M9/Q(^+_B/P9^T%X;
MT626.T\&W,#&ZN)H\+OXP-_:M#Q]I_QFO_B18W7A+5=*B\&L8VDCF7,C+U;!
M]Q732H.FXRG:S5]=O^',9SYDTKZ/H>G_  ]U#7=6\)V%UXEL4TW6G4^?;1G(
M0YX_2L^3XL>'H_'EOX12Y,VK31^8!&-R#V+#@&NP12T*A^6VX;'KCFN'\!?!
MS0/A[?:C?6*2W%[?3M.]Q=MYCH2>BGL/:N6+IOF<_DD;:Z6.[_"BOG[]H'XR
M:[X5\;>$-"\)7$5S=7%\B:E;(GF.D1[D=J] \46?CV?QYX;FT2[LX?"ZJ3JD
M,RYE<\8VFK^KRC&,I-+F3?W?YD^T5VDMCN[B\@M%5KB:.%6. 9&"@GTYI;JU
MBOK66"4;X95*L >H-?(7[2GQ U&U^-NDZ#KEGJ4W@J%(KG=IRE2LN?O,_H*^
MF]7O-3NO!\$OA=89Y[B./R9)GP%C8#Y\]R!S3J8=TX0FW\0HU%)M=CE]:\"V
MNB^*]%\0#Q%-I.D:3$+?[!OS%)DX&X^M>EM*FW)955AP<XS7*Z9X=L_!OAN?
M[?(VHA5:ZO)KCYS(X&68 ].G2N,^)'C+PWXA^&VF>)9K.^O+%F\^T\J1H0K
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M59_X5?X4[_\ $M@_] %=3S7+?"G_ ))?X4_[!L'_ * *ZC=0 ;J-U)10 O\
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M/S\^N_&[]:UJX/0/C?X+\5?$[6?A_I.KK>^*-'MUN[ZUCC8K"C' R^-N<D<
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MKQOQ5\+?&O@1G.M^';J&!3C[5"!+$WON7.!]0*_23GUILB),A215=3U5AD4
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MO\*_]@V#_P! %=30 G-'6EIE #L\BOF[XY;;7XF3;A\LMK"X/YC^E?2'3%>
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M<]LA3BOHA6VM7PA^U1X5U;P_\8-5U>[MIIM-U01R6UWL+)P@4ID=""",>F*
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MJ96H N*U2JU5$E%31MQUH M*U.6H5DIZO1J!86G5"&IZM4E:DM.XIBMTIZT
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M_;VUY?\ "'QI\2?@CX+\?'4O!E_K]GH.K16'AZU:,"46AW LKGD@8'>O1/\
MAJ"[^)7Q,U/X5>'K>31/$\FA+?0W\S<0R,N<%?4&M:E%TYR5*$6EJWNONZ+7
M8B,U)+F;N>3?MU7ND_"_XP?#[Q)?:,9="D)EUM+6'*W')'[SL?QKV7]H3Q-X
M0UO]GOP_KTJZU9^'I7M[JTAT)2LP7&54A>WM7'?'+P7X_P!?^$?A;X4ZU;OX
MJ\1:VABO?%4=N/*M2&)!?TXQ7LMU)I/P-^!.CZ)XBUFRL7L[%-/AOKQ 8C/M
MPIP?>KG4A[*AUE%M:/==_P"NA$8RYI]$U]S.?^&O_"O/C)X;3QM?>&X8K:-=
MCW&N6P68!!MRQ->9:/X^\<_#G]HS0_#NEZ!H\?@7Q%.Q@N])MA@PKT+..]>D
MZ#\(_&'BS]FW5/"7B#Q#;W>M:U#)Y>I6\7E(J,<I\H]L5B_VYXD_9=\ ^!_!
M]IX/N/'ES:VQBDU"U7.P[O?GO6=.4>:<(OFNVE%O2UMU?LRFI6BWIL[_ *'L
MOQ<^$]G\6M'L=/N]1O-.BM;I;G-F^TR8.=K>H-9/Q*^#MCXND\.:F^HZG:#P
MV?.BM=/?:)\+@*RCK]*CD^+VOKXCCT[_ (0V\-NVE?;S=?PB7&?)^M;_ ,)?
M&6M>//!Z:MKNA/X=O))I$%E(26"!L*3]17EVK48J5]%Z=3K]R3M;5_H>8^*O
M@1X7\7:KIWC]+&73IXH?-FTN1 L<S]<RIW:L+X7_  UTN;XS:KXSU#6)[[5+
MJR>--& "Q);XP-J#\LU] 6NFW+>(;UY]06:PDB"II[*/D;/+9[YKBM6\4:+;
M^.-+TS2)&AU2VN1'>):V@<F(@G:[]57.#FM(UZLDXW;5ON78R=.*:D?/OQ*N
M/B'IWQ&T+PU\-]6ET5;V&2Z@AU*W0M;1!OFB#$$X)R>?44SXC:9)XH\+Z*C:
M]%I_CW2G>7[#<6T<=Q?2@_*PVJ,\]*]4^,7AK7=<\=:?JDIM]*TVSD:$R(_[
MVYA(!R&_A.:ZZZ^#MMX@CT+63>*=8M763^T# IDDB'*H3[#O7='%0C&#=D_3
M6_F^IE[-R<DCY[NO&WC_ $;7O#^H^)_'=GIDT<L,4VA:? DERQ; VL2"1GOC
M%>F77Q0\5_%B^.@Z%IE]X8U2UO%*ZQ+:K)%Y0.6&X]-P&/QJ#XZ?#]=2U#59
MM.\.V<>M2JC6>JJ^)VE[GVQS4GP]7Q/\&_#<&G-<KKINHI+NYO[B7+K+_< ]
M!TJ92A.$:D4N9= 5XMIO0W?#[>*]=^(/B70_^$XL]0TI8T81Q(C7%K)D;D*X
MQMZ]?6O)?#7B"Z^&7Q?\9Z!J.D3Q#6;@OI]UL 0*JC.T=LGTKU+X5Z#!XTT>
MW\4:<O\ PB]_-J+7%^D>"\^#@AF/.#6EK'A'7O&WQ.T_6KS2HDLM)F:")BX(
MEA8<OTZ^U0JD8N47:UK/IJBW%R2:.%T>.#P/\1+'5QX2U36-1U")86OH"3!%
M&3T(KVSQDUE#HKVMG)I^E:YJ VV+7$*GY^O3OT-,\5);ZYJ5GX<L=8ETC4+<
MK<GR4X>,?PD^G%5?&OPUL_%VH>']<N+]H?[!E-RNT9$A"D<_G7+SJ3BWI_6A
MHHN*:1X[\#?'GB[4-<\;>%/'.IQPZW:W*6=K)%#Y0>,J""G/^U7?_#_P=X;\
M _$Z[LH'U6^UZ:'S7O+MRT6PDG:.V:Y3PKJEUX^^+Z7UQX8B5;!I6BO1)R?0
MM[8 %=GX@^)VJ:+HJW-WI^G0ZJUPT4D+7"AXX1T?/7I6U6[DU%6YDKI/J9PL
ME=O8V/\ A5_AN/Q)J^N^4\M]?.#*LDA920?[OI7EWCSP^=)L]6\,_#Y;?^WM
M8+-*ETYS\PPP![#'I6=XF^-1M?$>A*FM6MMIS3$WCABX"X/7&>]8"_%3P='X
M\M->EFN+R;3Y9&2YL87)<'MSC/I4PC4C9MW_ .!M<SE4AT.L_9Q\/W?P;\ W
M_P .]4CB/B-FDO!YW-L[/T4,>O3I7EFJ>%?&7@GXJ:9<^+KV&#1-0=V;3[5B
M;>,#H"O85Z/??M7?#[QPT,FI>'=92_LYO,B0PA#P>"3GI7$7_P 7O#FM:CK=
MQK>BZIKD-])N@AFF55MUQPHXKJC4J*4I..LM_P#@$2E3LHQEL=?\0/B!KFAV
M5NFDF.325Q$T,3$EMS<  =L5K_"WQ1JEK\0-2UJ[>672YK!4%N <HZCG"UY=
MI?QDTBQCCAN/"UQ<Q1D>6%N%!4#I_#6K_P -1R:%<P2Z9X/90SXG=KE<LGI]
MVL;>[RJ(E4C=-R/I/3=6\8ZUHNH7<$-LGG.#8I*,'R\\[QZXJ;5YM'^']K;:
MM<Z3&EV1F>2SARVX]?PKPJW_ &X;IMZKX&947[N+L8/_ ([6/??MD:I<WUQ.
M?"<4]E(GEM:O<9Q[YQ7,J<KZJR.GVT+;GM^B?#GP_P"*O$0^(.GW=];W%R=[
M1A]JOCL172^(OB1IO@_4+.QO(KB:YNQF,0IGC-?,GAS]KC5]-WV\?A:V@TO.
M8XO/8[*ZN+]H!_%5Y!J$FA6]K=0_+',KG*KWZTY0<G[VJ6VOW"56/3<]Y\;7
M7B>30[>7PFENUZY!9;K@;3_6M+P_<:C%H$$OB!H8;\#]\8SA :\T7]I;2+.Q
M26XL)BJ_*SQOD9_*JFI?M Z)XDLUM&T.\NK&XXDDC<87Z\5AR2LH\OSZFWM(
MWO<]J619%5T8.C#(8=ZP/%?@V+Q7<:7-)>7%K]AF$P6!]H?'9O45SGAGXM:,
M=)47%E=:3;PL(HO/ .X=B.:U;KXH:1!#YJ!Y8LXR" ?RK/EG&5T5S1:U9US8
M[4A4FO/;CXNHTI2STZ28%?D?LY[ ?XU@7GQ6U6>WF"XM;H, (T7( [Y-'LY"
M]I$];WLUP(PN5 RQ]*?/##<Q^7/%%,G7;*H(_6O%QXHO[Z/<+J[4\EF'4X[8
M'O2MJ6I%4=1<;\'^\<Y/>G[/S%[3R/9#-;VJA \42+T5< "H_P"TK12,W$8_
MX%7C2R7B[_-ANI4RNU=K#:?ZTMQ?3P2!]DZR1\F38S ^G44>S7</:/L>R?VA
M:MTN(S_P(4[[;;#'^D1_]]"O$5UZ!9F5[_:9#EBR[3GTJU-<*Q(C\V0-EL]
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M0 4H%)2K0 NT4444 %!-%-H ,FE6DVFG<T %%%% !1110 4444 %.VTVG;J
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MAFQM_':ZT;V07DD!B%J9?D(]0M9\/@F+P[XOO-<TVT>ZN=781WCM( (D R"
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M#7AGQ'#%-<17-T]OJ S.UU(P4GOM&>/RK5E^'#W%Q>:G=W-U-<& 0I':KD9
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M3),HB0CTW;17U#\2OASIOQDUSPMXG\3ZK;Z9\-O"/D:SI>I1W"H9)-H!$V>
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M:-1FBDI7KR*ECF'85GKQ_'5ZQM+B^8);P23N?[BDU)1;CD&TU8CD '%:.F^
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M:?VM]_ZZ'L_A/P/<_&+]F_2A\6;Y;+7A(\UEJ'G1I<6S#A"K$[=^ 1^-<?\
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MT6PD8+*H))/3D$UK6.K+MVGCBO.OA/XRD\8^"YI2JI]GNYX41<$;5D8*>/4
M=>>:Z0S+;E"QPQKRZ=&NL?.$%LVGH4[.)U\FN"+3W.>IVCFHAX@%M8HQ)RQS
MUK@=4\40K-%9QR!BOWOK6/X@\>6]M(D2R95!CBO8JQK\[]BF^567YLA1C9<W
M4],;Q@5Z _G3H_'&WJA/XUXC-\2(5Z;S]%-5'^)R!MHCD)],5R1IYK%WA&7W
M,KEH]6OO/H)?'4&WE&%12>-H/X8R3[FO /\ A9QZ"%C^%*OQ,.>;=OPKHE4S
M>UI0?W$JG1Z-?>>\?\)<C'[F!]:LP>)HCSYA4^F:\&7XF6JK^]$D?U6I8/B%
MIEVP7[8$?L#D5P1^O*=Y1=_0V]E!['O3:X+EB/,&,>M?.'[0WAI/B9X&U7R1
MNN+65GA8<GY1VKJ9/%1L_#&K7<<WFR)"PCVG)+'@#\ZS_A?INJ+X<CLM:MRK
MW*R-N//W\\'\Z^GX;A4=>KBJ[;:M%7[LYZT5"/(NOY([+X*:M;>(/A7X:O+V
M5TN6LU1P1GE<J?Y5V<FGZ9(#^_\ S05X))>:IX-\.Z+IMO&D<:I)MRV,C>:H
MMXWUO!(:(?\  C7SU;AO'5:U1K"IQYG9ZK2^G4T^M4$OXECWVXT73=K'ST9N
MRE,9KA/'5A:6=JL\84,I!XXKSN/QAK4R[C<PJ/J?\*H:EX@O;Y0ES=*R=U7O
M3PO"F;4\53K4Z?(HM=?/?<4L=AN1QE._R_X!V'VS3TPV('&,XV2-_457F\16
M4<FU$?([0Q(G\P:\^O-?*MMW?A5?^V-W\5?O:IJWO.Y\C[:71)'=W'C)(\K'
M$TI[>;,W\EQ63=>)KB9@R)##[K&"1^)S7+/J 9LYYJ-KQNPI\L%L@]I-]3?G
MUB[FSYEU(P_N[CC\JI-?>4"=U9?VACRQX]J19FF^Z"!ZXJMMA6ON:<>I%^Q%
M2?:F8<<&L^.-NPRWO5Z&PGD )! _*IU'H.$\F#G'U)I\<S=!R?\ 9%6H=+5<
M9&35E;=8^,?E18+HJIO;[S;?:KL+;<<;O>ECA5<X3FI[>WENIUBMT:>9C@1Q
M+N)_*BP[AYSJPZT"X?G+_A7=^'_@SXBUID>ZB72K8]7N3\^/9!S^>*]*T/X)
M>'])VR7:R:G,/^>W"?\ ?(K-R2-8P;Z'A>CZ7JFN/LL+.>\.<$Q(2!]3T%=W
MH_P3UV\*27LL=DAZINRU>ZP1QVL*Q01K#$HPJ(, "G<UDZCZ&JIKJ<+H_P (
M=*TU0TS-=./XG&:ZZSTNTT^,)#"JCZ8JW14.39HHI; /EZ# ]J7UI*=_%4C!
M>E+110 4444 .HHHH *?3*?0 4444 /HHHH *5:2G4 %%%% !1110!G?(W0<
MTQE'0]:C>3;BHUD!D#59!)Y;KSV]Z&7;UJ19MW':G[E;B@"JJJS8W &DVA3@
M]:6>'\#U!IBLLHVMPPH 1FQVJ%LU,V5.T_@:B8=:K4-2)AGVII^7O4C5&U!)
M&^34;9[]*E;CK4)<-0!&V-U2S1B:Q3 Y&:B8<Y[4W[05A*D8&>*""MY:M&C]
M,]:JSK][%3^86@VCUJI-)MX/%6 MK'F-L?>]Z;K"%8X2>N*;#,(VY.!BC5)&
MDC!Q\O04 9K<\4T?+1C'6HI#SUH =(P"DXYJOYV>]$C?+C/%26>EW%\P\M,1
M]W;@59!&?WC#)JW#!)<,!$K,?]FM>TTFQL=IF?[3)_=SA15Z35$A79!&B#\@
M*7-V"W<SH]"NI@/,943Z\U=31T5?GE8K_=48H;6D3E^,=ZCEUR%<ER /4FEJ
M5H6%A@M61XD8NARI)[U+/X@U*3K=M$.V,"L&X\40_P#+)"X]1TK&OO$4TS[4
MCW>PI\O<7,D=%=ZY?CAKZ8Y[[\5E2:I>0LSKJ<K+U(:4U3BAN;R,,\; ^AX%
M))"EL#O3=]3@?E561%V$>N:C=RG%[<;,\8<XJ_%)/C+7$S^NZ0XJO#"]P@:*
M- .V6P/Y4K1W#-MV#;W&>#3%J0ZE=3^21#+N?L%R:JPV]T^/-EWGON./TK1F
MB-JOFR(A7T#5-#Y<RY!4'TIAU(K-EA;! ![E1FK*Y\QF9_- Y"[L"HI[1>2#
MM^E58[6=),C _P!KUI:CV-#SXMBO+LC'90"35NU#W>!\P7/4C&*JV\*.#YIW
MMV'2KD=X8AL1=HQUJ2D:-O';1JQ=O,([&I&N%X"H57U]*PY)F4DE@OMWJ22Z
MD-OD< CFE8=RU)JB[BOFJJJ<;C2+J-MN'GW'FJ/7BN+U,0-G;<$RY^95-9_D
MSJPV.LJ8Z="*M11G[1GH=WK&FV4+!)5SU&Y@,_C7-W7B.'>Q4(1G.3(!7-70
MRVUURI]161=VZC("Y&.:M01$IL[N#Q%:29WM"@[YF%2MXJT>/@W-N#[N.*\A
MNHE8'"J165<PY4JP7\*KD1/.SZ!C^*FC6\*PM?0C8,<..:Q[SXEZ/=W00ZG'
M';XRQSR?:OGN\M0&^X,9_&JTR!FP%7;["HY45SL^B;OXD:3#:[;&ZMY3T \T
M#^=<E?>-K^];"74,0S]U'#&O&I(%0':HS]*@\OYB5!4^S$5:270F3;ZGJEYX
MCU!F$9=I#UR>AJ[9S375L'F:0DG[JUY+;ZE=VC9CGF0^S$UK0?$K7M/CPL\<
MR]A-$K?K57,[=V>HKI]SY,GD?NL]0S9S]13--TYK=V69MS#G..<^QKS.#XP:
ME!,IFL8)><DQEE)_4BN@L_C5INX->:9=6V1DM'()1GZ8%+4H]6C\7:IH\"M!
MJ5W&BCE0V1^HK0T?XP:_&Q1Y[>["\CSHL$^V17EL?Q"T#5(75=:6/S.L4R&/
M'U//\ZV-/^QS*7L[F"Y;[O[F8.<8Z]:GECU17-);,]FTGXP7<Z*]WHXV'@FW
MER>/8BNNT?QYI&L*NV9K9VZ)<+L)^E?/EO.[95]\4H.?F? ([\XXI6N&\Q6\
MV0*IW$!AT]CVK-THLU5:2/J..1)EW(ZLOJIR*6OFRT\4:CHJ_P"B7S)AL^6P
M)./KFNKTWXR:A#.8I5AFB3 W3?(3]*Q=&70V5:+W/:**X?3?BQIMUN%S&UN5
M.TLK!A]?I736?B+3;[B&\C9NNTM@UDXM;HV4D]F:5%"X894@CVHJ2AE%%% "
MMUI**=_#0 -2TWZTZ@ HI/>CWH 6BBB@!?NTE(U+0 5S'CS4]1TS3;5M-M);
MN66X6)UAZJISEOTKJ.32TXNSNQ/56,/2;QI(XOMD.V=1PS#+"M22U@G.Z2%)
M#ZLH)K%US5#I^IVWG26L%A@F:::4(5].M9M]\6_"6FK,SZW:R^4,NL+>80,9
M[5?*WL3S*/Q,M^)/ ]CKUQ;7+IF6U;=$N3M!^E6-1\,6FN:,FF:E%Y]N=K;%
M;:,CG Q7/6_QL\.:AILE]ILTEY;(0&DV%$'XD=?:O*[S]H_4==NIK6/1KK1D
MB\W%X8_-&5R5& >A )_#\:VC2JRMT.:6(I1OK<]Q\3^ =#\8Z3#IVK6@N+2
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MDH;1110 JT>M"T?Q4 )3O2D6EYS0 M%%% !110O6@!U%%% "_P -.IH]*=0
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M$=G+=K*\DD,D?F,Z!B,#\J^>]4^.VH:A)+!K>B6=W:/SY2C:RCMTZ&N_;4!
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M:T ,'G%?WIE5>0=H7IT]\UU.DZUI<FCO90:I]DN8V021SR&,QJP&T(QZG.>
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MVS\%VUOR451G-?F^)XXX@S.+_LW#*E![2EJ_7L>M3RO#47^^FY/RV/F7PO\
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M1110 A[4?Q4M% #?XJ=2?Q"EH **** "BBB@!1VI:%Z44 %%%% "_=-.HHH
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MNNUL*?;BJZ6FZ1CC '3FN.6:XB7P1_"Y2H4UNS CT>7<6+8![8J_'I111\Q
MQ6LL Z,Z@"I-L2CAR?H*XJF-QLMY\OW(T5.DNAC?V)$S$MGGWJ==*AV@;=WI
M6BS0_P!UCVZT>>F,"+]:\ZI6K2^*M^+9JN5;1,MM(@4_<!I&L8XUX0>_%:C7
M _YYH/PJ(W;[N H_"N.4D_BJO\2UY(RY-/B;(\L$=>E+;V C7&S/X5HFZE9L
M@@?A0;B4\AZYI>QZSE_7S*NR%;%?^>1_*C^SS_SS/Y5,M[/_ ,]#3OMDQ_Y:
M-6$GANLI?=_P1\TR#^SR?^61_*F/IX'_ "Q/Y59^W3*W^M:D^W3G_EJU<\GA
MN\OZ^9?-(IMIN[CR"!]*8=)C'!B_2K_VZ?/^L:E.I3K_ !_I6+EAOYY?U\RN
M:7D9$VBV[8/E#\15230;1\AH5_[Y%=$-4G]5/U%1R:E)M.8XV/\ NUBY45\-
M:2^7^3*3?5'+R>%;"0\P)_WS5&X\"Z;,"# OY5V?VY&QFVB/X8I/M5LWWK7_
M +Y-2L14C\&*M_X$ORN.R>\/R/.KCX8Z?)G:'0_[+FLRX^$\.&\NYF7/N"/Y
M5ZQOL&ZQ2+]#37AL9.DTB?45UPS#,H?PL6GZR_S1#I47\4/P_P CPJZ^#UXT
MA:&^X]&CS_(UFW7PJUB-LK)#*!TX(KZ'73;=N$NU_P"!#%)_83-]V6%_^!5T
MQS[/J7PVEZ<K_+4CZKA9;JWWGS-=> ]<MU/^AA_]UJQ[SPWJT/W]-F![L%S7
MU;)X>G/_ "Q5OH0:JR^'WVG?:M_WS6ZXRS:C_&PWX-&?]G8>7PR?WH^2WL[B
M%2);>2+UW*15628*2#Q7U?-X=MWSO@Q]5K+O? .D7N?-LH7/^T@-;0\1(1=J
M^'MZ/]&B'E%_@J?A_P $^8$D60;6.?;TJE-=&WFYX0>M?25S\']"F8L+)%;_
M &,K_*L/4/@/I%TV1YR''\+G^M>E2\1,IE\<91^29B\HK]&G]YX;%?!I-@-6
MT;<.O->C-^SS';R,T%_<#/3?AJK3? _5+=?W%ZKC_IHF/Y5Z]'C?(JKLZW+Z
MI_H<\LKQ4=HW^:.$C Y5CGU-6AMCP#^&*Z&;X4^((<@)#(O;:>:HS>!=?M>?
ML+.>GRL#7M4N(LHK?!BH_-I?F<DL'B8[P?W%!95 W#D&HYIMRGU]Z?-H.M6S
M?/IUQ@>BYK+NEO8<F6SF0#_IF:]2GCL)5_AUHR]))_J8.E4C\46ODQ99L<9^
MM5&N TFWJ!5::21I  K@$<EE(KT7X%>#XO%7BYKJZBWZ;I:^?-N'!;^%3_GM
M6SG&U[CBFW8Z;P+\*77[->ZHAR5$JPL.%SR,^]6;KXC"7QW%X9L1]MO5YD53
MB.W7W'K7J-EI^JZQ!J&J2!8+*(,8%/5L=*X#X0?"E_#<VLZO=W,-YXAU2=IK
MB1O^60)XC7V KQO[1PT6W.:/2EAYN-HHW/&2W6J62V5L=[L,'G _'%<CX<_9
MS2ZN3<ZKJ\@R<B"UC5%'MTYKU.W\+WMO,9&MR^>\9S6Y:PSPXS!*#Z;:ZEBJ
M-2/NS37JC.-&<7=IG/\ ASX8Z+HMW$J+-+@]7?\ PKW'2M-M;>SB1(P% KS9
MEN-X80O^"UVF@ZT\ELJ2Q.C@=UJ76H_SK[T4N:]FF=-'!%V1:CNX8]N0B_E4
M2W#[00C&H+FY<@_(P_"I]K2CJYK[T5:78Q/$5O;W&GRB:&-T Z,H-?,/C[P'
MHNO23HUK':RD_++",$5]!^,;W4)+1XK&S:9R,'D"O$/$7@7QMK2,MK'9:8IX
M,L\NXCZ 5RU,\RK"I^WQ$5\T_P B'AZ]1KV<7^1\[Z_\)[7=*HN;CS5R"R+N
M7\<<UYKK5IXOT&&ZGT-WO(+48*$$,Q'9?6OLG0_@^VEVJ)JFN))-G=(T(.2:
M[;3? OABQB$J6;7=PQQY\@KY^'&&659RAA)\[79-+[V>C_9]244ZFGXGR[^S
M/9^*_BIINIV_C'0UT&PMX?/@N)V*2W>& VB/KWKUW6M+\,:A8VF@M81RZ;+M
M9K29Y94D=6*&1D5A@'IP0>.U87[3GPCUS7?#4>H^&+V[MKFQD66-+>4KC!Y!
MQV]JX'X9ZS!I=P+7Q/JEUI.L7=G(8GF'[AGR#A@.N?FY/'%?'K/\=C,3[6<E
M&S:<%I9+9W>]T>W3R^C3H)TWS7[[W/4/!'P.2'Q#-,6N!;:>\L@26W*VK%CC
MR]K$MN S@[B![UZ9X#^"=]X1A>ZAE6\3:JPV\DCYVD?-+R<!CZ # -;WP&\6
M:1XVAEBTRVD6T1?-CN)G#?:"/E9QR>,U[)!HL=L3MED.>J9^7\J]G%YOFN(D
MX4FHP:M=6OZZGD1PU&GNKOS.!T/P+&NH"Z2#;:#YV24!MS$ 9!QQT&?H*R/B
M=\.;>^5+9=+LC8W*,6FN,[H6 _Y9@8^8YXKV'S((5W;0H4<_0=J\K_:<\07V
MD_!G7]6TNWDO)=,B2]>WMP#+)$IRZKDC!VY.<CI6>5XA83$1>(KN<I.SN[[]
MNQ51<T;1C9(\#\:?"_PIX-U'3=7U5!J-Q"5EM[6>X9C 1C!)SZG.>*^H_!'B
M;3/$WA;3]:@5=MS%DJ""%;H17Y(?%;XS>+_&T>HZBUQ:_P!BVMLEP+J>_07<
M-@2N&2-6YDP3\K')]*]\_P""5OQ$UCQ/\*_%FC7]R;BWT_5//LFED#2[)%S(
M",YP&"\]/F('2KX[E]1RMYG&FI3I-;J]DW9L6#7/45.]DS] ;KQ!%%D1A5^E
M8]YX@FFR 3666W-SZUPOQB\;>)O!/@V>]\'^$Y?&?B*1UAM[!)UAC4G_ ):2
M,Q'R@=AR>!QR1_)%;B+-LZK1P]*HH\S26JBM>[=DOF?51P]*BN9J]CO6N)IF
M.\DC\>*TM';3Y+J"V74K5;F5_+V!T9RV"=H'7H,_2O@#PWX2_:J^+GC:WN_'
M.N6W@GPL) SZ/9WBPK+CD(3 2^TYYR_('2OK#]GO]FGP/\+_ !/?>-(VCD\6
MZJ##+=PC8H1BI$:@=% C48&,@<U^K<+\#X+ZQ[3,\="K/^6#YK6WO+1'EXG&
M5'&U.FTN[_R/<9O"=O#&0&D8D97:.GXFL/Q!;RV4<TK2^9'$F7C(PIQ@=,'F
MO1/,&P-N7;ZBLR::.1BKP+^\!S(<#(''7UYK]5Q7 N6U%;"1]G?M>WS/,AC*
MB=YNYX?XP^(UEX7TVW<P374R0";S V8R& X(/.!FO/?$'Q0NM;L9&LM'NQ<2
M11QR\B* ,2-I#9/J,C'2OHV;P#H.O3+/<V'[Y8WC99AN9HVZK]#UJMJ'P<\/
MZEI:::8S%:MAF@QC) Q]0,<?2HP7 .$IU'+$SO'2R271=_0TJ9E)1M1AKW;_
M $/ECQAX?\0WGA]+^75))[158)9PD?;3A264-C&T'KQZ'(Z'R[PW\-=:UR.W
MN+/:MP2DCRW3L\JR%B57:N .,<D5]V7_ ,';'4-%DTN"7[-;*-D'D\"WYR2,
M8//0YK$TGX&V_AO1[FQL6#K-*SG?@[01@D'L .<"OTG Y7EN7+_9Z23[VN_O
M9X5>MBJ[]^3:[=#S:T\,:A='1;62W2<R1%KLS;V&00=Y+'YN1P,=ZJW6BV$C
MD7+27<MO<-Y+VRX+2*O&/X23[ 8KV.Q^%-Q9+9:>+R.XTJW&=SC]XK@<  YX
M_$=:T-!^&]GH;,8VC<J[2(K+\RNQ)..,@Y[U['M$NIS>R;Z'G7@GPO=Z:4N]
M6BMY]0NB98Q-$-\.!C@^ASC\:Z,Z7I-U=26LC37#E"\UPP R1T0$8SC-=1/X
M1VJUQ?>=-,"RHZM\RCL!Z5);^%8-0L$AC5HDSDJQP#SG X]?2LW4OJ6J?2QQ
MMI')9S?:VMUEA=R(X6)!5>S8[?G5[1]/:\\6-JCAW^T0"-8)')1"!R,8QP/Q
MKL5T..VA5'CC\F0E67 4+^%8^H>,M!\-M]ECNS=7:9VPV\>\CV! P#@=*QJ8
MBG!7G*U]#>GAYRT@KVU.K"^9(CM\H4;0.:KZE;_:)0P C3&W>6P!SUKA-1^)
M&JM(D<-M#I48&3+>?.T@()P,< \5XEJ7Q.UI[N.:_OY]42.1GC6+*Q%,GYB!
MQQQ7S./S["Y>U[2]G^ENFY]#@LDQ&.3Y+:'TVNK6%K)/')?17,ENFYTCQD#'
M.3VK@-<^-4>$CL[)5C9S#YDAW%3CJ.WYUY"FK7&NW*(S_:I)MTJ^7$6=6S\H
M8CL<CK6^?A7XG\8Q6<*0?8/+PSB0X7.>2 .:Q688S'495,%3U6U^NVEWMH:R
MP.$P56,,7._>W3Y+<S/$7C+6_$316*ZH8V#>8[1?(,'V'&,?K7.:]JBVS/9Y
MBFE5MTTV3)T' /.<_P"%>QZ/^SKI]G>""]FNKJ>+$A2$A%QG('TKK]+^&]IM
M>[T_2[6PD,N6NYE#N5&02<\]JX?['Q^-4GBZB@Y6O9MZ=DMD=O\ :N"PCBL+
M3<E':Z2U[M[GR_8^'/$&O,K6.EWDZ2@&1FC(1R/?'%=L? GBNPNK6X_LU8>5
M$:[A_='48.3G%>]^(?%2>"M#CU&$17"J4B+J,*[.Q&<?A4'B[7M<NM.TB;0[
M.&YN& =XCEO+! Q@C^*NS <*87":RG*?,U>[[?BD<V+XDQ6)M:*C:]K*^]OD
MV>8Z)\-]3UN^::Y$6DW>[S=RHQ1CC!!&>E=#;_ >QTNW@NM;\12"(2AT4HJ@
M,<X[>]>K^%9+R\T&UDU*U%O?@DO&XQAL\&N-\=:*[^*DOGD$T.Q5:R=F(8CH
M0/ZBO<CE>!YTO9K37O=GC2S'%\KO-Z_U\BI9_L_^&II)-MS<LK'S&9)2,^_'
MUJA-\-? ]CJ$%@C/<%F"!I+AFRY_A'/6NV\1:ZG@?P'>ZM+Y>^*#S/*9L=L!
M:\L^&]QKVI_#74M8T[289M2FG\RQ88)R3DG!Z$=!7H4<'2C"T8)1VV21R5,1
M4G).4FWZL[C_ (4[HL-U:F#2(8[(H7GEG&9$[XQFL75O#.AZ2Z:DVDVL6CR3
MI#&OE9D8D@9!]#67\8OB;XB\(^!=%ANTCAUC4MMO<M&?]7E<L01T/%4K%[#Q
M%X-MSJNILEE9JHTW5FD(S<$_=9/8XK:."I64YP5O1$/$5-E)_>QWQ$U31O#^
MN7.@Z59V-OK&U9%>6,>4$Y^7!SEL&MK3O$%M'#8VD?@^-]2DA7S99(R(P>Y/
MH,<UQOB[X4WMYH__  E7B74EMO$!811>4VY+U1]S(Z*3Q75:UX1\0>.K'PKJ
MU@XTK5H<6^I+'/E(8PN!\O3)'\ZZ51P\4FDO7S_R,?:5)73;MV.JL]/3Q%:7
MRZ?!IMO:X(AOK=?, P.>O?/%4/ RV^DZ]>)J,5Y>;XV8WCH/L:J.<)@=37F/
MA;Q=IR^)(-/%U-!8Z/?&WATP-@R29R9-P/S$\G;74?$'4ET?2TT#0=2D\/QK
MNNXKJ[3,+DY)1V;@,V>*/8J+Y%U%SWU.A\#?%C3/$.I/I069C)=R+;Y4+(JJ
M>AXY!K=\57VIP^++32M'MW$3H\UPTC;49B,*-W;I7GW@233?$GA[4]9T6XM[
MCQ);1%((XXU1HI@,$\=03GFND^'MOJ/Q ^&-];^,Y;JVNX[I_,F;]P0%P>W5
M<]^]*=.,&VEHM'\QQ;:L+8^-KV]\50Q7"PV-[9_)=P.V48$X.S/7CG%=[JVK
M6]GI\EWJ.HK:V3%0)H0 D?( RW7DX'XUXMJ5WX4M_$,5EI2P7:V>$FOKZ;E0
M!PRGJ3G\Z]-E\,6>GZ"]W+IDVMRFU5'L00RON()P#[\U%2*7*]AQ;U-NXU@Z
M?K</G+"FEW$ $-QMR/,]SZ8Q5^Q^V62G^T;FUF+MB/RXMF<]!UJK]EM_%&CV
MB7"&T,:AWT]G!QQ@*X'IQ7/^+IHH=%L9-2=9[VPF#Q06C;3(X& H'TKGT>AI
MMJ:\VL06NOW%E$)/.91(\C?<48Z+7&W/CH7%]J 6WCDM5(CMII1C+=#D=^:S
M=4\3:GXB6:#2K4O=*ZH\2K@1%AGYCWQ72:3X;MK&:*/Q"]I(9BGD1=_,'7]:
MU24=S.[EL+KDFO:MIND1:=!)'%)C[6\+;&'N/:D\=QKX?L],EFA^VAYUCD+D
MX5>Y.*L6>K:O;7$=SK-O-:6]O-/S"P$7DJ#M9QWXJGJ6K7_BGP?J<UM-;7RS
MJ9+5%3DQ>XZYZTUND]ANUB]XBU?Q!]AMCX?LK46N,$S-P5]1BM3PO;06,2RW
MTB'4IADKN!_[Y Z"N+^'OGZ?:QP:U>+96MU_QY6,Q_>#'45+:Z;?Z7\8+.*S
MLW_L.6V9Y)&R1YG]*4H[Q73\0OLSKO\ A$;5O$,^NWL[2J0!'!.W[N,C^(9Z
M&F?$GQ=-X/\ "UQ?62QW%^,>5;MR7Y["I=4TU5#6%['=ZU::E<8*G&VW7J!Q
M_#Q7.:G_ ,(;9^(%U75M;\V:SG$,,<K_ "0$C[F!].]3%<S3EK8MZ+0V->\2
M:M;>%]&OK);:*\NY(EE2YX'S=0/>N6^/GC:_\*:3I-HEO.]IJ3>5>36JDR1+
MCDKCI76:I'K<FI7&J:?J%BVC+9EH;>8#:),9#$]A7'Z/\2=9AFL8_$5OI&KQ
M7TPB@DTDF01^I;-:4TDU*R=B9/I<] \)RVMOX1LI4FF:U2'=YMU]_:.[5;;Q
M!IJV<5W]LC,$HS&ZG.X>U</_ ,+*A\5>*)_#FDRK9"(;?-*C,K X9%'MWK4;
M1]*DNI]'7552^"AW1F#.H/4^U8R@[ZKS*YNQ#<?$274+R.UTN!(A+)Y*75X<
M*S^BCN:Z'1(=<CFE_M6>UECQ\GD(0<^]!FTGPS'IVGR/'"97\JW5ADN^/Y^]
M7]4M7OK&>VCN9+-Y%VK/%C<GN*AVZ*PTGNV6/6DSFHK6%K>VBB>5IV10ID?[
MS8[FB2X"G:OSM[5F6/=E498X%*K!ER.E0K"TGS2G/HHJ;[M  U9FK6:ZAIUW
M:,,K<0O"?Q4C^M:;?=-0O\O-4@/C*S$NFZE+;L-KQ2&)U/;!Q7=Z')+H>O:?
M>QRM(V\9[+M/#<?2J?QR\/OX8\:/?1Q[;+4AYT;+TWCAU^O(/_ JSM!U(7T<
M3R$@J,*N>!7>GS(\UKE9]5VK?*,'CM5BN3\!^)HM>TE-S 74 "2KZ^C?C76*
M<@&N"2L['HQ=U=#:7/:C^*DJ1A1110 4444 %%%% !2?Q4M% !1110 4444
M.7I12>E+0 4JTE*O6@!U%%% !3EZ4VG+TH 6BBB@!U%%% !2]\4E/H ****
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MXJ%Z4M !1110 444H- "T444 %/IE/H **** '#M2TB]*6@ HHI5H 6BBB@
MIVZD7K3J "BBB@#F%PW!-*Z[5)J!FI5N.-K<CUK74R(Y">E5FC8L3T'ZUH-&
M&7<!D5"RT 5?+"CI413;]*L,*B=NU $++FJ\^5X!YJSN&>::Z*6R!0!$OW>1
M3UGV\"HY&Q42L0U!!?63CDU)N 7=5'>>*G:X6./DB@"Y'>$(15:2X^\6Z=J@
M20;NM5FE,S.F<#I56'<6Z8;<XXJFHWD"K[0^9&%[ 40VJJ/6N>IB(PVU8U!L
MK+;LP/'%2K:KPQY(JXJ[1@"D;&TYZUYM2M4J;NR-E%1V&>6,# XI"H7/<T&0
MXZ\4QR,\&N1V7F5J)YVW.WBF-)YHP<DTV3%0><$ZM6<G*6@R7;\O/05"S#G-
M5Y]155^]^M9L^J<G;S]*2I2EHD,UO.6-O>H9KJ-5Y8"L2:ZFDR5/'ZU6;+YR
MY!':NJ.7SGNK&;JPCU-.35TA;:6W53GUK:WR9-9\\8Z@?-UJM]JYVGY6KMAE
M</M,S>([(LW&J3-G"E>_-9C7TTCD[\<U+))R1FLFXE%K,6))5AT'-=<<#0CT
MN9>VFR\\LDC?-(QJO,P7/))^M-CE\R/)/6G;ATQ75&A2CM%&3J3>[*[QC@#A
MJ>N5[#\*<6YR2*56'<ULHI;&;;>X,HJ)UYZ5(S>AJ)FJR2&3.#CBLZ[!:/"M
M@UH2-C-5'4'-,9DO&S*0P);ZU'Y9*G/WL5H2$;L <57FCW<C]*@""&]>/"E=
MP[^M3272,N:J3S"*0 C ]:)&610%.X^U5<+#I)0V:IS-36\U3]T_E4#S''((
M^HHN%ALCU4DE&ZI))0U592#G)I!89(P:J;P[6WCK4S>QJO(QQUH'=CA<;4)#
M'CWJO+J<D?W9'I2NX'!YJNX]:PEAZ53XX)_)%JI..TG]Y87Q!>PJ"+AB*E7Q
MCJ$723-9,B#GT-0.,?2N.IE>"J_'27Y?D;1Q5:.TF=(GQ"OX?O<_C5N#XJ7$
M?WE>N(D-5V;DBO,J\-995WA;T?\ F;QS'$1ZI_(]0M_B\%QOW#ZUHV_Q>MS]
MZ3'UKQEFXZU"S<<\UX];@K+ZGP2:^YF\<VJKXHIGT#:_%:TDQ^]'YUIV_P 2
MK20?ZX?G7S(^>Q(_&H&N)8^5F<?1C7A5O#ZE+^'5^]'5'.%]J'XGUE;^/;5\
M?OA^=7H?&5M)C$JG\:^.)-<U*W;,=T^/KFI(_&VL6I!%QN%?/8CPZQ/_ "[E
M%_-K\SKCFU!_$FOD?9T?B:!OXP?QJPOB"%N-P_.OCB/XH:M#U8$?4UIVOQ;U
M-/O#_P >KP*WA]F<?AC?T:.F.981_:M\F?74>K0MCFK*ZE"W\5?)MO\ &J^C
M^]$QQZ&M2W^.$ZM\T35X-?@C-:?_ "Y?R5_R.B.,PLMIK[SZECOHF_BKYX_:
M(\:'PG\6='N)I?+LX/+F9O8X%4H_CLRC)1JPOVLM"NOB=\%[;QIHR;YELC'(
MJ#)!1B/SKV^&<AQ^"Q-2-:G*,9*S;36GS[#J5J,G%QDG\SZ3\>>+[;4_ .AW
M\,HDA6:-R5/8U%KFL(UY'+&WW@""#7PQ^S5\?Y_'_P ,M3\(7\O_ !,]/A_<
MECRVW./QKU[X8_&BW\;:*D33K]NL_P!S+&6^8%>"#^5?49]+%+"O"N.L;)O\
MF<U+"^^Y1U1]/:5XBN/+&VX?\ZU%\47:]+EOQKQ#2_&QA;:>?QKH(?&4<H&>
M#]:_&ZL<92E[M22]&_\ ,]!4?(]2_P"$JO/^>])_PEEW_P ]J\U_X2J,X^:F
M_P#"31GH^/QK!XC'_P#/V7WO_,/8K^4]'D\479'^O(JO)XDNF_Y>&KS]O$J?
M\],?C43>)$[25PU)XR>]67WO_,I45V.\;79V^_<,P^M5I-49N#*Q_&N%;Q(G
M=ZC;Q1& ?FYKRZF%JU/C;?JV:JF^B.Z_M!><MG\:?_:#-M2-&=V^ZJC)->>M
MXNBC#9()/O4VF^*)-7D:"WN5B>,#')W\L!\N.M81RN56<::6[2^\J4)17,SU
M:.VGM8(WN&6-9,;&>+D'(Y![?7_&O./B!<:1=76O_P!H36NCQI&R3W9;#3[D
M&U"N,9!4&NJN-0GTZ);%+K[5=QV[-<MNR\<7&0F3C=C/%?$]KXBMM:^*/CI]
M0NKS4+:QA%Y;Z:P#-Y2ABN>>#]T]#[@XK]TH<,87"1PZA!.<=6[/6UKWMZGF
MT93J<\V]$>]6]U8:]X@BU2>[^P"^C:2T6%BQEEB7Y68 ?*6(/OR.U=%=?M%Q
MZ7I\-Q>W+,@F:V2.W@\U3QMW,PZ<YY]C4'PUATR2;0/%5]82Z,DULT0T]H<1
M",KS-(2#M([L"![5G^(/AKX9^W-JFG3QFS\0BZM8D^U!K0L$9X9(D'RD J?F
M')W5^BTN'*.:<E2O)Q4.BTOM^!YV)QSH:0BFWWZ'0Z?\3[[X@0^3:,MO<K<)
M%;HS&,*>=[-GD@!>.QS6/XZG\1VD\ES>:HDMC8VLDD]E';^4Y!8JFQE( SD_
M2N*TO6I[&'P_:W%C')?1JEQ)J$,>2[ A8H_,*\,W?V KNY?&EKJFG>)]:O=.
MD46QC@6VFWJHVJ07Y^4@L2/RK['#Y)@<*[QIW]=;GBSQE:JM96]-"#3&LO$&
MAZ=IUS9+#IPL=XTJY_>"VD*%D<L3DMD'&/4=ZX>U\&W&FV::9I26MQJ=F_FR
M70D91M/W5;) R3Z\^M=9X9\&Z#JL5N;@W=E<R!) UI/YLD3QMNY/)VC&[D[<
M<5I:YIR7RM#96DEW/,9+(WL3@9) .XJ>G3 P,C)Q7NP2CI%61P2;EK(X"S\.
M63>.QIDL$D5M;Q3B:.WD)2WN2%9GCQC!;..O8UU.J>&[6.'2FBBF=+:3?]GF
MDWQ_>(4?+R,<CN>,UU_A?P#<Z;JEG=ZG$TUS-:LCM(,D.N,,V,9SR-QR.W>O
M0;'P#:WVCRVUU9PK*&$T<2G:9&ZD\=#GWK3F47=F7*Y*R/.?#'PAME:.>2.2
M_M[F=?+:TEP8&R2<]QC/WNORU[)X7\&MH5P[V(@6XG)6X<H2LO0YV]C20^,O
M#'AG3\:A-'8FV.\PHV7?/?:O.?K6-JG[1&DZ?#=-I6GRSW"X95N05 8]\=<5
MX^*S;"T6U.HKKI>[^X]?#97B:J3A!V?6UCTFWTF"QA8W"J1YH92$R2V.GTK(
MUG6+73?/6\U"'3;=NOF$!P.YQ7ANL?%[Q+XTN%\O5!I,)4L;?3E#,0.I.><U
MPMU>075\\L]W<3B09,DS MQT&3^M?+XGB2--)T873=DVTE^%V?1X?A^51M59
MVLKM)/Y;GT'J7Q@\(Z#'Y>F6MSJI==X$4>P < '<W;BN*\3?'#Q-JBM%I.G'
M1G(+;HT#L/<D]#CTKRK3G6X:ZLTM9+N_E79;JNXE<=,8Z@#I79Z;X'\1ZU>6
M6G317.F7=Q !!)=/LRW;([Y''2OGGF&;9HI1BI1NGI%6M9VM=]3W8X'+,O:E
M)J5GNW?IV3V%O/$6H:Y!8:GJFKW%XUO]ZSG ;>"/F8#H3TXQ7.O<2V<-Y#:2
M"XMY6&]58YVGE4VCTYX%>KR?LW7VF6T'G7DMY=3,<_9P%6,X/?KC'OBM#5-&
MT7X4C2(_L=MY@*MYBL)'E;HQ)/0YZ5W4N&\9C.1UI*+:=W=MWTOH]-4<LL]P
MN%<E1CS*^BLDK=//T/,=-\)ZMJ4B7.EVZZ?9K"J->WV4#/U)4'GCI6GX7^'>
MB3:M8VNHZK<7$LS_ #2VL!V-D\@L>E>A^//B!IWAG5K(O:"]CFB65[&4 A=P
MZ@CO5S2;K4=2TF76M$:SM=$B4O=6 3,D;J,L,]B:^DPG"67X=*I63F^EW9+T
M1XF)XCQU;W*<N5>6[]6=!8_#WP'\-K.XU06<=Q+" 7ED;>WX#M6Q-#H&K>([
M!EM)!<W-N61]I"!2!^M>8^&]#E\?>++*_P!4==.TBX.Z"W,GS7>WV_STKO/&
MWQDT3P1IZRVD2WY@E^S!(R/E..F?P-?2T<'3PJ5+#QMZ:(\"IB)UWSUI7?=Z
MLI:+9VL?C2;PZ;MH+>P(GB(?#2,3G!]:W?%EJ-<N(=*U(6QTGS#YPE?8_P#L
ME37D?CSQEI6H:OX7\2:=92G6+B96FMXF).T= ?K6W^T'XRTJQTK2Y;K3V.LR
M0B98Y6(6)3USCO79[&4IP[O\SGYDDS2\5?"_0--LY+=]5OGW S0VL<A(4#N*
M\IUGQAJ6J1VVF>&(+CQ#/;JT4DE\.(>.Z=,<5U>G^(-7NO!>C:KIURFI:C<2
M*SF,;@D/=?P%5O#<VE>'OB==3P:U:P6^H _:K21AYOF$?P^U:QND^?5K8RE:
M6VAS'A'3_%GVU95M;'3)0,7B0D9SV( KI-&\(ZA#K.LB.*&VLIHMKS1##O(>
MN?6GZ9I'A[1?&&M^(+/6/,$[B*Y+2YC1NPQV-6_$7Q*L_#7CS1?#L,+2?VI'
MYOG!N!Z5,G*3]U="$DEJ>;^*M.U?P?8W4VJ7$XL8P8++R"2\A(_BI_P\TU)O
M@=JMQKUU+ \A9UEC):9%SQQUKU'5KK5K'Q-)>7\MI+X:2')@F0%E8#[W-</:
MZ;_:WBI-8\+WUO\ V3<OF]B<YC90?NJ.E:QJ*4+/UO\ H*R3/+M&U@?%;5M-
M\(WMO''$#MBU!T_?[%Z9SZUZ1XDOO!OAK4(_"6L6TDBJB1,QB(1N  2:D\5:
M*VI>,Q=Z':1:9JEDJ^5<L D+CN![U;^+'A^]\?:7HUJC6IO(Y%$\H #L, 'G
M\ZTE.$I1OHOR8K:,Y#P_HMAKFJ:Y8P16VG6NA8DL+D#ISG /OC]:U+[XQ6>J
M?#_4KJ[^TV%ZTG]GI+;*24)X# _A4?BZXT7P[_9/@*2UF6/4OD-U&VUUYZL>
M]>D:3H?@^W\+1:=!>V]TMJ1'O11)EQ_>]ZSG*-E)I^7]>8)=$>6_#;P3K7PZ
MNHM7O?%]QJ=G<1Y$<T^ ,\\9[\UROA7XB>)?#GB?4'@O'U+2K^[:)+BXD+E7
MR2%'IU%:?Q0.E^+9[K1-1>;3UL5)M+XR>7&[8Z=LUS?PZ\9>'] TQ=&>99FA
MN517<@^8S'[R^U;I<T7.2NWY&6VB/3;;PWI6M0-J=]';Z;XIG.?M!D!D5NQS
M7)Z]-X;\/^;%XT\,I-=R92.]B4L\_P#MG'2LCXU>$9-%\61:[&TFHHT2>7:P
M,08F*Y#,/2NPOO$":EH.G1:E;W3W=U:$EX8 YMR>-W(_&A+E49)W3_ KR*7P
MO\62V/A74K/1-$FGTI9&AA,C!26<C@Y[#(KF-'^%,DFI:[?ZUKZV%AIER3,U
MFA9!)V4+^E==XFNM(D^&::5I.K+J.JQ,HE4#$SD'EB%QR./RK!M+K7/&6H:)
M:Z?J]UI^G?+;W%PR@&=QU8C&#Z<^E:1D_>DM+AVN6M!U35_B9XRTVWT+4+76
MKM83%)'?QE;:W53\N,]AP<>M>_\ A?3] \*R:AJNJ/80>,-/ COKJS5EB"GH
M &ZDBOGOQ7<2>"?&<7A?POK'VN6XNTFGP-AC?C*,1CCN?K6UXTU"6+XHZ9%J
M6LR36UU&MQ/I]T0+1=@ .#U)],U%2/M+).R:^9I&7+ON<;KGQ0U_0_B9J7B'
M3=0DM[&^G!GLKEOOQ*?D'H >U>@ZM\4+JYTG2O$>I2:-";>9RJKEIDWC]VF0
M?O9KR7QI9:'KNL:O?WZ:IHMD&;9E1Y4HS@,OH!P:C^#Y\"#4+*RU/6'V6EXU
MTZL<QW.,!-Q/OZ5M.,914K;>1ES.]KGK'P^U+5OB!XXT:/Q+JVH3W$4KK<6\
M1P(D8$#)]#[5[9X=^#::/<:O;"UTVQ7>/L6L.!+(V6'R.K=37*^+M#N-7DTF
MYT**TM;:202WGV<[7D Y7##G'M7.^,-=\>:[\1H-$M+PZ=X8:WVM>%.8G*X)
MSUK@<I5'[K2T.A-1WU.J\.^&]1LO'%U'=>8=,@<VX=5_=2$?.24' !QQ]*ZB
MZTW0IM#U*ZT_1OM>EZO:O)<2*VR5W!Q@+_A7%Z/I]QX9UK1?#NL:Z=6MFG:>
MWDM)#YDCA2=K=RN,]:KV_C>TN?%D4MM8WS7/VHI!IUK*R"!CD;F[!?TYJ91<
MG>++32+>B2+9Z7I?@2YLXV"PM>++]M>-MS,Q1-P]L#!K0\1WM_H=Y-_:T\=]
MX2^RD7.GL [1-M[,>2:7XM:Y=V3+>:/HEC=ZM  ;FR<CSXEQG>=IS[UYXNIW
M%OX/T^ZU:5FM->NUMQ%(<B!6;#Y;^5"3DE*V_P"9+=M#O/ ^JP-';:EX/MKJ
M+3)$DW:?=Q';*Z+D%CV&.GK7>V_@>ZUA=*\2:;(NEZY/AKIVBP3%G_5X[5P?
MAW1=0\"_#W7W_M"VNXUN1+IR+<A040YQN!Y[9KJ_!?Q<UN/0]*O_ !18K$FH
MW+HC6L994C ^7D'KFLZBEK*&O3U-(VVD1?&#P+8>.O'?AFPUF7[):*C%)!QY
M[=USV(H;4K%?$]A\.-5T(0:/;P-<1W37&YBL?*LV/7K6QKDUYXLT^YU:[TJ(
M6]A(LVEO.YCWGONSTK(^/0,?PWMM=^S"'5G,2336PRPC.-R@^F*4&Y<D)>GH
M^Y4NLD=SJ6O6&L>&H+70KZ-&OBUI:72P>:B,!@Y]..]?/7BSPO8W'AU/!NOW
M$>A:OHY9K+5;A#LNDR22N/NG-=KX%^)&AS?#N^T&RM[G1[.UTYI4OQ\S\G;N
M '.<FN8\&^-FD\,QVE]H;>.Q;7/DP7L_RN$(SDLWO6U&$J+>FS^9,FI6N6_A
M7X^N)/A9J-CH>H1Q^+],+R2S31>:UW&IXP>_&!6-]BO]+\76OB_6+9+K6M8"
M>1:B;_CR8#F0CN.^*3XC>/KKP7KL*^'_  U96L#M'!.;89D1G .TD=>O:D^)
M_@.ZU;P79>)=1^U://;RB/Y224C<\N<>W-7S>]=*RE]_H9MZ6['L&J:Y!=+]
MMU>*QUM;:%?LR74 0K..K GIDUY_X5\12?%3QM/J[.?"/B'1SY=Q$)"R2VRG
M/3N*BD7PA?>'O#_A]?&XN5F(1I/++SNW\."!P<^M6_'OPAT_X?R66NV5SK6L
M7>^..Z6.=2QB) ^9>I6L814=).S>VG]+4T]YZ]#U3P;\2I?&GB#5+&UL5AL+
M0;8=0:4?OCCJ$ZX]ZT]+;6?#.F:C>>(]4CU6.-C)']E@VE$_NX[FL'Q)\,(M
M8O-!O-+G72+>W7;<PQ+M,L1'W<CH<FIKSPK>QZ.VGV^J_9(K619+%@QW8 ^[
M*3]X$UQRY'\+LG_6YM[W4[>UNDO+6*XCR(Y4#KN&#@^U5='T>/1;62&.>:</
M*TI,SEB">P)[5B>']/U#2Q8P)J*W=JH8W)F^:1W/(VGL!Z5IV?AVTL]9N=3C
M,IN;A0K@R$KQZ#M6#25U<M:FM13'8K&[ ;BH) ]?:L7PCXBNO$EC//=:9-I;
MQS-&(YNK 'AOH:GE=KE&[33S3J94@,D7\J\*_:"TR*UUC3M04CSKJ,Q.G<[>
MA_6O>.N*^=?CQJGVKQD\ ;,=G;J@]F/)_I6U+XC&M\)YW83M#< $\9XQ77V,
MRWME*KMCDLRKU/%<[\-_#W_"6Z]%IGF&(RASY@YVX4G/Z5;U*UOO!VK365_'
MY<\1[]&7LP/<5U7Z')9[G7^!/%USX)U/<BM/I=P?W\'=?]L>XKZ!M;J#4+6.
MYMI%E@E7<CKT(KY?L=474&\QEVMC&W/:NT^'7CH^%=0_L^]?.E7+Y#L>(&/?
MZ'O652'-[R-:=3ET>Q[A10I5E5E(9&&0PY!'K17(=@4444 %%%% !1110 44
M44 %%%.H **** "GTU>M.H ***5: %7I2T44 %*M"TM !1110 Y:6BB@ HHH
MH XUFJ2UMS<MD\(.II+>W:Y;'1!U-:JKL0*!@>E61J"P@J%'RJ.!5.X@V\?J
M*O[L+UJK=7 1=M &9)QQ59\]NE69)F9C\JD=O6HV^[5$E1@<]*1FQ3FZFHVZ
M&@!K+N%14[=2-ZT$"JVVI0R-@8JKN_&I85*MDTI34%J-*XZ2(,W2FV\ 5O7F
MKR*NSD9-(D(#9/6O/J5I3TZ&RBD 0BFMA,]ZDD/R^E09['FN88C2'/M41<G(
M(P*<S!>I-5[B<*N<UEK(![/MZFH)+@*N2?>J4]X6/RG-4I9&DZM71##3GJ#D
MHEBXU(9(!K.DNI9&QG;3F %0LIW5Z%/!PC\6IBZKZ#'7DY.::U2-4;&NV,5'
M2*,&V]QF2IR#BD<C/7--DJ/=ZU1 DCA<D<FLJ^Q]X?>K2D.X53N5##!% %*.
M,MABW;I22(BY; &/:E;,([D=*KR.)F()(6@!A:-LE&^:F+(7SQ@TK0KQM XI
MHXZGFK ;)AN^*K>8\9P>E6)..G(JK(V?8T /^T^II?M 8<539L>]1F;L*5Q6
M)Y9ZK23GFHY-S-UJO)NZ9HN%B;S@2<TWS%]:J-[GIZ57GNMG0YIW"Q8NO*=2
M3S5:/;&/E7;55[U6/)_#-(+[D*L4C'_94F@1>^T$\$5"S=<<4);ZA-_J]-NW
MSTV6[G/Z4\Z'KK\IH6ID_P"S9R'_ -EIW%RD/F#&&56^HJ*2*WDZQJ/PJ=M#
M\1+U\.ZJ1Z_8I?\ XFH)M'UN/EM"U2/_ 'K.3_XFBX<I0FL4ZHH_.J,T*)]Y
M<"M+[/J$>3)IUY&/5X'']*HS7 )(=&V]\J:8:D$-O!YG(;GT:K7_  C\4V=K
MNOXYJNUQ!Q@A3VK8T[4K:0!6P']<U21#?8R)_"$K-B*?/^^N*SKOPU?6^?E6
M0 ?PM_C7?Q;9L!'4;3T[FI#9C=N;#GM[5?*B.=GD=Y9W,/,D+Q#W6J#8.><U
M[4UBDPPZ@KWR.*Q]2\)6^H9V62'/1\8_+%+D'S^1Y-))VJNS'M7H6H?#:,C,
M<SPMZ/R*YO4/ .KV@)C6.Y3_ &&P?R-+E8^9,YMIJKR259OM/OK%B+BSGBQW
M*''YUG-=(<CO4F@DF-QJG(JGWJ:28-FH&D'&* U(9CN7:.#40F=6X^[Z5.Q!
M^M5&DQ)@\>E!);6X&/2IENL5GF0;>*;YA^E6FR.5&L;K%>_?LS^(++Q;H&N_
M#[42IDGW7-FK?Q C#K^@/YU\V_:#WJSHOB34/"/B"PUW29S!J%C()8V[''4'
MU!%3.*J1<)=2H_NY*2/GGXI>&[KX"_M$:]9Z)=2075M<>=]E9=I9&^8@?WA7
M07WBH0S#QWX2MYX@6W:E!&VY4<]21Z&OK3]I+X*Z5^V/X!L?B+X*:'3O'NDI
M_IEJN!(Q ^Z0.V1E3[U\%6_BR]\*^(&MK^-O#'B!,QSCRS]DNST/F(?ND]R!
M7B5,OIU/>J)M)6^79]['N4,RJTVXPLF]?^"CZ+\'?M+:5XBMXTNM]M=@?,N[
M&?IGK7<VOQLTR$#.HS1#_II%G^5?&>N2:9J%TTR6XT>Z)RP@;?;.?52.E&F>
M*[_09E#A+^ ?PLV1^!KYFMPEE==ZMQ]+-?D=RS?&0VBI?>C[HL?C%I=\56+6
M(&9N@8%3_*MR/QA)( 5N8".QWU\=Z1\>="M547FCW%K(/XH55Q7<:'^TEX*A
M4"YO60'^&: Y'Z5X]7P^PU5_N<4EZI&T>(JD?XF'?R?_  &?27_"3RMR;F ?
M604W_A)O[VH6R?\  \UY79?'KX52VL<DOBNRA?&60HQ(_2HYOVE/@QI<@:77
MGNVZXM[*1Q^86N"7AS!;XM?*'_!-H\1-[8=_?_P#UAO$ELV-^K0\?W%)_I2'
MQ1I$/^MU&20^BIBO)9/VTO@MI_\ JK/5KT_],[$*#_WTPK'OOV__ (=6ZLVF
M^ M2O)?X1="*,'ZD%JUI^'F!7\7$2EZ)+_,F6>XA_P .FEZMO_(]/O/'E[JE
MPT&@:+<7ZYV^:_"CWKI?$7BJ;X!Z#IWB#QY>V45E?0EXX;&7,\8*GY=IQDYQ
M7RGXF_;F\=^*(3:>#_"UKX;BDZ3;/,8?B0!7E>I>"]?\=W1UGX@^.(TB4%RU
MS<F:0 ]0B=!]!7T6$X*RO#M3A3<K=6[G'6SO$5%RS:7DEJ>I^)OVQO%/Q/O)
MM/\ !MK-9ZK?7IMK"  /<+&R#,C'!ST<$= #FO=_V7/ OB[PK?>+[7Q3IB7'
MB)%BN'U*]D58)@$#1QJI0D* Q;?QG<!BOFOX*Z''\0O'6F?#WX5V]U:/</NO
M_&"VI-Y'"!\Y3!^1><=1UKZV_:$UZX^%?A_PQX5\*^+5U'5(+=$O88U$DL15
MPJEV!.&8("<D]#7T5; X>G"T(KF]/OU.&EBZTIN+;4>OZ'<:UXZUWP7\*6OK
M32H[KQ"E[/%;0EVE_=DG))9AN"@?+C/%><?#_P#LCXD:A>7-Y%?7=Q%NN+O1
M(5"*%1&+-$V<KD_?X''2K_[.VH>*]7\7W/B"73]3N+J"RDL[+;9F:!68;F(=
MQL0\<$@UUT/P-\6:SH]I%JECHWA:XGE:YF9IL7,@;<7!,6258X..E=N%HQH4
MDF<5>HZT[Q.?71]4^T6:6.FS6?A"SN!<_8;BY=B9BO0L.05(/'TKL8?%1MGT
MK5HYFNK*^'S072^7)=,5QM#>@*]OSKO[;0?#5EX=_P"$?O3<:I:Q3BZ@ALLH
MV]0"2\I.3SWQ52WN=+T;3[:+3+&.WL[.1I1'=R"XEW/SM4MT'7GWKGQ&9X;#
MK65W_74[</EN(K_"K+^NAI>%/!>I:3J5Q/;Q6O\ 9*P/)Y2H\1\Y\Y!)S@;3
MUSSQTJ?[3H]GI\T1OGMYV7SI)+=0WS9.3N& 3@5AZ_XD:_MGN2 EG*H"6K2E
MC'],?Q5RDFH1/9^0%>:YZ+M4M].G>OCLRXHEAY<E"RNKIN^KZ(^JR_AR-://
M7NTG9K31=7N>@/\ $7R6\Z%IK_@/'-</MD&W.W('!/)R.G K+U+XD:GK5FHN
M[IGLRV76%<;"3PA(QU-4M'^'NOZQ>"/3M+N)XO+5I);I#&F>^!UKT/PY^S3J
M6L0%[[58+6W=B7M[=<CKZ=B*XZ%3-LPI.4EJKK5:-W5K7LK(ZJT<KP-1*&WD
M]4M>VIXYJ5X3#=N',<$C*64G)+@>I[58TS2=1\821RZ/:R:B"#OEC4OAO0GI
MUKU+_A#(/!_Q*?3[C2?M4/V9OLBW0&+B0="6Z9-6[*\E\)V-_K.C:T-+BGN
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M\CD/]W.&_*I<6MRE)/8O_P 5'\-.*FDJ2@HHHH *<M-I] !1110 4^D Q2T
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M8T3A!76>!S_Q.F'HM<S;_(,UT_@91_:Q(_NU$MF5'='H?<T445RG4%*M)3J
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MAI9>---T?5_"5K+%/'=JGG>:7&S.=_X'M72>'H['3[[4-/1_[&\8S)Y/VQE
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M6\CEM^WE@,]^^*XWQ99SMIMM';J[.)%+1N/N<YK3O_'2WEI/I\DD]S9R.P2
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M2D=&N(9(G3Y)%*GZ$5)61XPUZ/PWX;O;V0X8(4C'<NW J!GS]X+A*^.]-$;
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M9QSY;7C&[5TK_P!;&3\5OVDO 7A'P[\/-%L/#-KJ7PH\01$R_P"CL5BC#=D
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M%DM%MX+C[1;V.9!;M_"&QENG)X%4GH19L30[K3K[7'75;83Z?Y!01L<B1E&
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M<WI7[.TZH<EP.]0> ]"U+5H_,O9)VOK5VW1MP#GI4N3LVQ6-_1='M/#=@(T
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M]X/45'>>#99I++4-1;RW)\M8>6,C#W^E,U;7;/2?$&GPZE;2P1"$^3QE%_\
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M47.H1[A\L?S'^E0:K/\ :M2E<=-V!^'%=!X:M?)M6F/WI#@?05>R(W9KT^D
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MH _C- $MDNZ^B Y"GFNW7@"N0L8Q'=1*.><DUU]92-8A1114%A1110 4444
M%%%% "8]:6BB@ I-U+2;: #=2444 %%%% !1110 4444 %(S+&C.YVHHR2:6
MN%\>^(W>'[#9NN/^6C9Z^PJHKF=B92Y5<Y#XE>,KC6[C[%9MML5;!]6]Z\ZN
MI1"NQ>M;5]"T;$LW-1:/X7O/$%\MO;)YDS=?11ZDUV*T59'$[R=V<TL+W#X
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MX;(DM+6WB#K->G_5[L\809?Z[?2OU-^,GC>P\13>"/#\DT^G2ZU+'<EE#.$
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MH **** #&:3;2T4 -HS3J* &T4I%)0 4444 %%%% !113)IDMH9)G.$C4L:
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M+Q+JCI$LC&*VN),)M!X(JY?>'+?4-8^V0WT-[9Q8,<:M_JR.])>[N[C?<O\
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MM8YK:>2.*&8+A>,^U7M*_LRUEF*3)+<R'!5CDCVIK26<FHQZ;]E B)\UF7@
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M@%_,UL5S_CJ3;H?EYYDD4?UJH[HF6S//+*/8I;'>K.DVZ:EK%K'(F\&4$\=
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MP_CA+#1-+ULV6JVL0:?:3ACCD9%:^H3W?PY^'KO.R:G>(=KO(/OY/>N1\/\
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MY"?8U=TE=MC'CWJNA/4MT4NVG5)04444 %%%% !0!FC::=0  8HHHH ****
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M8&Y6]ZAZZ(-2UXK\22^'+=19Q+<R;N8/1>YK+\-ZEH?C":ZL8[7R)6CWF15
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MEZ,,U+6)X5NO,M'@/6-B1]":VZP>C-UJ@HHHI#"BBB@!,"DVTNVCF@!M%%%
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M)+O0IIWN+N]CDML3[Y&4GJJ]0/:NZ\0_;/A_X\O]5FAN?$.BZA'L>R@&Y+9
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M_E+'GY6F/W15QJ<T8PBEMKY^0<MFVS4TWP_XHL])TM9=3MU=9?,O69!B2/\
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MUN.>TO[:18D?]U*JXQ@=#1'X4ALY;;54A:,PR[OLC??XZC-7;S7CKFO0V5]
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M^H7#V-];7,1VRQ,)%/H0017Z]@X+&Y33IUE=2IJ_S1Y<VZ>(LOZL?TM*P;#
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MR^T7=P/(G"'[J_WJGM]<ELY+:PM;"8V4QV1RH?EV^IKD9(Y;'Q5/"4DCTN)
M%6-"06QT.*])\+WB>-O"\\$<<FG/#\I**1CZ422BKVT*W,F73-0\-7DGV;2K
MF[L[KYIIV/"CO^%=+?\ A_5_"GAV\U/1]09K18O,@MU.1%W:I4U9= T>/0GO
MY+^ZG7>6D!+(H[$US?BCQ!K6FZ6NG6>!I\X)F=UR%K-7DTAZ)V+6@VI>:QU^
M[EM[&UEV-<K*2<M_>_&I_BIIL.OV-M=^'K9YKN1PLDB+\H!Z']*Q)_"-UXNL
M[?3[.>XN(VMU8[P0H((S@5>UVS?P/X;M;*\FND^RL)S#&QWR'T)':KVDG%ZC
M.5UKP#J.E>&X7S_:$$H/F-$"948=@.WO7'ZC::SXHTZ-GE@6RLR(_+CXE51V
M^M>M^#?%VI6-K>^(M4,4.EW,1,-NN08@.#C/\1.*X/6/&4MCIKZJVEQZ=%<9
M6/;'_K W!8_7)IWGJF&IR_A.^@T76YI;FW%U;(NY?M8W$GM^-='_ ,)K96^K
M1M!"T=])\T(51\A/:L?PKJMUXEDCM1I<;,H;RKIOD1#V8^M1:EX+NM!\0V\"
MW44NJ2L6CNE;*9Z_+2:BWJ/U/7_@[IM[KGB*\UG4SOU-H_):&,'A3@+GWKZZ
M7P&MG\.;<:H79K8F7R4; (/8UY9^R=H[:7I=]KVNFTM89)_LQW+\\S!1R0?<
MU]#>+M'@U#3X1)??8M(0%IHP<;QUKAK5'S*/8[J,/<N<5IFI:MI/A&X%K816
MC7#A(%B7)*G@G-1Z';:;X%MA>Z_%]JU.9\K"OS%1UR:(O&#>?!%IQ#Z9:_(M
MFG+./[V:IZ[K5KK7B",VULHFAP[3/\S/C^$5*C*[36C-#T*'XC:9)]D/E2(T
M_8C[@]ZV-#\00Z^LY@CD5(VV[F&-WTKD;FPFU+2T%II*VDMY\TLLG\&/Y5I^
M&O%$+W5OI%K%YZQ)B:Y487=WKEE"-O=1HF[ZG84<TG#=^*?7,:&'K&I7_P!L
M6TT^',F07D?[NVMM=WEKN^]CGZTOX<T53>E@"BBGU("<4;ATI:3'J* %HI,'
MM2Y'?B@!VVH+1-L9'^VW\S5BH;7_ %;?[[?SH EVCTI NTTZB@ HHHH ***-
MIH *7;2T4 %%%% !5&-=M^?J:O5488O!@4 6Z*** "BBB@ I=II=M+0 4444
M %%%% !1110 4444 %%%% &9+RV!VJ/;4A&:3;0!'M]J-OM3]IHH CVT;:DH
MIZBL1[:3;4FT4;:0R+;[4;14FVD\NK ;MI-OM3Z7F@@;MHVT_;1Q06,VTC#V
MI^VE Q001;32[34M)L- #:*?LI=M $>UF[8H\OUJ;::7:* (E7\:D"T*.:>J
MT '%)2\4;: &?Q5/;C]YFF*O&:FA7YA0!8HHHJ"PHHHH **** "BBB@ HHHH
M **** "D(I:* &^HK\*/V^/@C?? G]I#7)?L[+H'B&9]5TR8#Y65VS)'GU1R
M>/0KZU^[&T5Y=^T)^SSX3_:2\ S^&?%-LVWF2TOX,"XLY<8$D9(_,'@CK7U/
M#F<_V+C/:S5X25I?Y_(Y\11]M&Q^"/P_\=2?#?XE>&?%]HOFR:5?0W?EY^\$
M8$K^(R*_H9^'/Q T3XH^"=(\4^'K^/4=(U.W6>&>-L]1RI'9E.5*GD$$'I7X
M_?%+_@E7\8_!.J3KX:M[/QII&\^3<6LZPS;>V^)R,'Z$BMOX)_L+_M2VXFTB
MSU>^^&_A^X;%T[ZNR)@_>98HF)+8],9]:_1>(J>59[2IXFGBHQE'OV?2V]S@
MP_/1]WE;./\ ^"F6K#6/VR_$<<<L<R6=I8VX,9SC%NCD'GJ"YKYCO+275-2L
M;& ;IKB58D'^TQ 'ZFM[Q]HEMX;^*7BG2K?59M=BL;^:W&IW'^LN"CE6D;D\
MD@GK7HW[&/PQD^,W[3WA+2S!Y^GV,_\ :=]E2RK!!ACN] 6V*#ZN*^WI>SRO
M*XMN\:<%KM>R[>?8X&G4Q']=3]L_!>EMH/@WPYI<@VO8Z9:VKKZ%(54C]*_$
M7]L+X1WOP+_:(\2:9-;M%IFH3-J6G2_PRV\K$@@]RK;E/NIK]U)%W,2.!7F_
MQ^_9A\*?M/>"O[$\30M!/;EGL-4MU'VBTD.,E2>JG RIX.!7X9P[GBRC&2JU
M5>G/27EV?R/9K4?:PY4?B!\(/B,WPG^,GA'QG%EX]+U"*YD5?XHP<.OXJ2*_
M??PYK6F>.-!TS7]"O8=2TJ_A6YMKJW<,CHPR#D5^07Q*_P""6_QK\$ZI+%HU
MC9^,=+W'RKS3[A8V8?[43D%3]"1[UU/P7_89_:<EM6T5M?O?AQX8=LW ?5F
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M6NZ +FU$UC);1L8 R;%9.J_2LWPWX9@\.V>Q6,]RW^LN7'SO]36S1C-',[6
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M@ HI=M+0 FVEHHH **** "BBB@ HHHH *K-_Q^"K-0E?]*'TH FIVWUHVTM
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MX*ACN8=, +C!KG?VB/B=XA_X* ?M4:;X<\(F270UG_L[18FW>6D(.9;MU[9
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M]J])\076N6/CKSM'TJQ>WD*QR7K$;R.X)S5[XJ:XZQZ?H,-S]EN=0;#2J<$
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MB@ HHHH **** "BBB@ HHHH **** "BBEVT )3MM+10 4444 %%%% !1110
M4444 %%%% %;:*-M+10 W;1MIU%.X#**?11<!E%/HHN RG+2T47 ****0!11
M10 4444 %%%% ";12TNVC;0 E%.HH 3;2T44 %*O6DIVV@!5[4^FK3J "BBB
M@ HHHH **** "BBB@ I-HI:* &[:^+?VQ=4:;]I_]G*\M=-U34;/P_JM_+JU
MQ9:=-/%9I-'"D;2,JD $AN_0&OM.C%7&7*[B:NK%>TFBN;6*:#!BE4.I QD$
M9!Q7Q'XN\8^+OV1_VGO&OB+5/!>L^,?ACX\:"[2]T"T-W/I]Y'&$97C4$X(
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MZ5C:E9:IJ/B"[US"6NF7A_X_)I-K%0<#GOG%9.GZE;>)->6[NQ<;I)S$OE*
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M$3*!W/<FO9YOBSI%E(?[+T^:YN;A\.JKM.?4UV,;:?)J$%Q.D*:@T89=V/,
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M%>HZC9^$-1\/RW<_AOP^;>*].HV-OR+B4(Q<+* <L=HCR,]*G_:^\42>./\
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MU2ENK>WNH+:2:..XN-WE1,P#/@9.!WP*^>=8^(?Q)^&O[2W@'P[X@US3=?\
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M@&BD 444N/6@!**=MI-IH 2BG;:-M !Q2TBTM !1110 444NV@!**=MHVB@
MVBEHHH *:U.I&Z4 -HI=M+M% #:7;3J* "BBB@ HHHH **** "BBB@ HHHH
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M<_B[Q+?>$O&OP[/C#X?3:7!+#J4<$4Q2]W2B5&0L'!VB(JRC@DY-</\ #O\
M9[\66/['/C#X;7LTD&H:E#JD&C6M]<^<UG;2E_LL$D@S]U=H.,@9[XKZGYI,
MFE[1VLD5RZW/@SQEX)^+7Q#_ &+-"^&=M\,[S3/$.@KH]K=_;[ZW5+MK6XA+
M&VVNV4(C+%GV8' #9X])_:<^%_Q.U+4/AE\5/AOIUK/XY\'B2.Z\.W-R EY:
M3J@FA$G R"@/X<9Q@_5>:.:?MG>]OZ8**2L>-_!7QS\3_B5='4_&7@./X::7
M:QF--.DU1;^YO9B!ESMC01QI@@<DL2<A0!GV.EW4E9-W>Q25@HHHI#"BBB@
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M,[&[DUU^@W*26_E&>.XN8_EE:,8^:N&4N5MH[8I62,[Q!9>??6[V=M:37:R
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH ***=M% ";:=110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4UJ=2-0 VE6DI5H =1110 4444 %%%% !1110 4444 %%%%
M #6%)3Z90 J_=IU(M+0 4444 %%%% !1110 4W;3J* &44[:*3;0 E%%+MH
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M% !1110 4444 %%%% !1110 4444 %%%% !12[:-M "44[:*-HH ;2[:=10
MW'%.HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH 3:* ,4M% !1110 4444 %%%% !1110 4444 %%%% !3=M.I/
MXJ !:6BB@ HHHH **** "BBB@ HHHH **** "BBB@!-HHVBEHH 3:*3;3J*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
=10 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>figure08_01.jpg
<TEXT>
begin 644 figure08_01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (7!I0# 2(  A$! Q$!_\0
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MA_\ BZD#],J*_,W_ (?<>$O^B>:U_P!_H?\ XNC_ (?<>$O^B>:U_P!_H?\
MXN@#],J*_,W_ (?<>$O^B>:U_P!_H?\ XNE_X?;>$ST^'>M'_MM%_P#%TTF]
M@/TQHK\S?^'V_A,=?AYK0_[;0_\ Q='_  ^X\)?]$]UK_O\ 0_\ Q=+;<#],
MJ*_,^/\ X+;>$Y'51\/=:RQQ_K8C_P"S5+=?\%K/"UKC=\.]<P>C%XP/U84[
M.UQ75['Z5T5^:MO_ ,%IO#]TH:'X9>()E/1HVC8?HU21_P#!:#P\UP(9/AIK
M\+GGYRG\MV:I0E)V2)=2"W9^DU%?FK??\%JO"]A+LD^'>M@]B7C7/YL*DL?^
M"T'A_4/]3\--?=?[RE&'Z,:'"2?*UJ'M(J/,WH?I-17YJ77_  6J\-63%9OA
MOKT7./G>-?YM38/^"UGANZ4F'X:Z]*%ZF-XFQ^35-G>P^:-N:^A^EM%?FA'_
M ,%L?"\F0GPYUQBO7;)$<?\ C],/_!;CPF.OP\UK_O\ 1?\ Q=%F4?IE17YF
M_P##[CPG_P!$\UK_ +_1?_%TX_\ !;/PL(]Y^'6M[/[WFQ8_/?0!^F%%?F;_
M ,/N/"9X'P\UH_\ ;:+_ .+J1_\ @M=X9C3>_P -]=5/[S21 ?\ H5%F%T?I
M=17YGQ_\%M/"LN0OP[ULD<\2Q'_V:F_\/N/"?_1/-:_[_0__ !=%G:X'Z945
M^:]O_P %HO#]U#YD/PR\02IV:,QL#^(:HKC_ (+6>&[,J)_AMKT!;H)'B7/Y
MM1RNUR%.+?*GJ?I;17YF_P##[CPG_P!$]UK_ +_0_P#Q="_\%MO"C, OP[UH
MD] )HO\ XN@L_3*BOSFTO_@L5HFJ2%5^&NO0\9#2E #^(-4-2_X+3>&=+O'M
MIOAWK0=3_P ](QGZ985HZ4U'F:T,8UJ<I\D979^E%%?F<?\ @MMX47K\.]:'
M_;:+_P"+J6U_X+6>&;R39#\-]=E/^P\3?R:HY97M;4U;25V?I917YO7G_!9C
M0+)0S_#77]N,Y^4 ?F16=_P^X\)_]$\UK_O]%_\ %U4J<H.TD3"<:BO%W/TR
MHK\TU_X+6>&F3>/AOKI7U#QX_P#0J1?^"UWAESA?AOKS'V>(_P#LU+DEV'S1
M[GZ6T5^:;?\ !:SPVG+?#;7E^KQ?_%5$O_!;;PHW ^'>M$^TL7_Q=39WL--/
M9GZ8T5^9[?\ !;/PLK 'X=:X">@,L7_Q=6XO^"T'AZ6,O_PK77P!_N'^1I\K
MVL3*<8ZMGZ2T5^9H_P""W/A(')^'>M,/3SX1G\=QQ7I=E^W)\0;FPM[AM'\-
MKYL*R8%O/W4'_GO[U)5];'W/17PQ_P -T>//^@3X=_\  :X_^/TG_#='CWMI
M'AS/_7M<?_'Z5PNC[HHKX6_X;H\?=](\.?\ @-<?_'Z&_;J\?=M(\.?^ UQ_
M\?H"Z/NFBOA'_AN_Q_\ ] CPW_X#7'_Q^D_X;P\??] CPW_X#7'_ ,?JK%\K
M/N^BO@__ (;P^(&[_D#^&\?]>UQ_\?I&_;P^('&W1_#9]?\ 1KC_ ./T6%9G
MWC17P@O[>'C_ +Z/X;_\!KC_ ./T?\-X>/O^@1X;_P# :X_^/T6'RL^[Z*^$
M/^&\/'W_ $"/#?\ X#7'_P ?I&_;P\?@$_V1X;_\!KC_ ./T6#E9]X45\"R?
MM\?$;</*T7PRR]\VUQ_\?J%OV_OB.CA6T7PQG_KUN/\ Y(I$GZ 45\#I^WO\
M0C&&;1O#/_@-<?\ Q^H/^&_OB(S831O#)Y[VMQ_\?H ^_P"BO@@?MY_$;;DZ
M+X9'_;M<?_'Z1/V]?B*^"-&\,X_Z]KC_ ./T ??%%?!R_MX?$#;EM'\-@^UM
M<?\ Q^FK^WMX]DR%TCPV2.O^BW'_ ,?ICL?>=%?!+_M\^/D8(=(\-[CT_P!%
MN/\ X_2_\-Y_$/./[&\,Y_Z]KC_X_0%C[UHKX/7]O#X@;1NT?PV#_P!>UQ_\
M?I?^&[_'W_0(\-_^ UQ_\?HL/E9]WT5\(_\ #=WC_P#Z _AO_P !KC_X_3E_
M;L\?M_S"/#>/^O:X_P#C] K'W917PJ?VZO'_ &TCPW_X#7'_ ,?I5_;J\>'_
M )A'AS_P&N/_ (_2)N?=-%?#<?[<GCV121I'AS_P&G_^/U(O[<'CO;\^D^'0
MWM;3_P#QZ@#[@HKXBA_;>\<R2E3I7A['_7M/_P#'J63]M[QQ$WSZ5X? SC_C
MVG_^/4#/MRBOBG_AMCQNR$KI7A__ ,!Y_P#X]5&3]N/Q\KA5TCPX3[VT_P#\
M?H&]#[DHKX8/[<WC]?O:1X<'_;M/_P#'Z=_PW/X["Y.D^'?_  &G_P#C](FY
M]RT5\)-^W=X]4_\ ((\.8_Z]KC_X_4%U^WQX\AA9ETCPV2/6UN/_ (_3&?>E
M%?GT?^"@WQ#R0-&\,?\ @+<?_'Z='_P4"^(TC8&B^&/_  %N/_DB@#] Z*^'
M-._;@^(%TI,NC^'%Y'W;>?\ ^/UIQ_MH>-Y"/^)5X?\ _ >?_P"/4#/M"BOC
MA/VQO&S==+T''_7O-_\ 'J63]LGQBJC;IFA%N^;>;_X]0(^QJ*^-U_;*\9[3
MG3-!SV_T>?\ ^/4S_ALKQP2!_9>@?^ \_P#\>H ^RZ*^,G_;,\;H2/[+T#_P
M'G_^/5F:C^W!X[L\;-)\.G)Q\UM/_P#'J 6I]P45\0V/[;WCJYSNTGP\,>EM
M/_\ 'JO?\-H^-MI/]EZ!_P" \_\ \>H ^T**^+/^&U/&_;2O#_\ X#S_ /QZ
MG+^VAXY;_F%>'_\ P'G_ /CU,=C[1HKXS7]LKQRV?^)5X?\ _ >?_P"/5%)^
MV=X[7A=)\/$^]O/_ /'J0C[1HKXPB_;)\>NH)TGP]^$$_P#\>H_X;*\>ACG2
M?#V/^N$__P >H ^SZ*^+V_;.\<+_ ,PKP_\ ^ \__P >J/\ X;4\;_\ 0*\/
M_P#@//\ _'J!I7/M2BOBO_AM3QO_ - KP_\ ^ \__P >H_X;4\<?] KP_P#^
M \__ ,>IV'RL^U**^*_^&U/&_P#T"O#_ /X#S_\ QZD;]M7QQM.-*\/Y_P"O
M>?\ ^/46#E9]JT5\1M^VUX[1OGTGPZ%]K>?_ ./5(/VV/'3*"-*\/X/_ $[S
M_P#QZ@5C[8HKXGD_;6\>#&S2?#Q]<V\__P >J#_AM[Q[YBH=)\.Y/_3O/_\
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M **** "BBB@ HHHH **** "BBB@ KRS]J;_DW7XA_P#8'G_]!KU.O+/VIO\
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M?0/&'Q<M?&>OV5AJKVL/EPBXB#LASU&>AKZ*L+&'3;.&UMXUB@A0(B*,  4
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MC1ERBUZIJNEQ++YFU< >E5;B.VDM]JJN?I5JI"2NF3+"5(M)K<\4O-*>*8X
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M ,%\G^%'_#TKX*_\_&K_ /@OD_PKT+_A@GX _P#1,]+_ ._L_P#\<H_X8)^
M/_1,]+_[^S__ !RCVO#?_/NK]\0Y<9_-'\3SW_AZ5\%?^?C5_P#P7R?X4?\
M#TKX*_\ /QJ__@OD_P *]"_X8)^ /_1,]+_[^S__ !RC_A@GX _]$STO_O[/
M_P#'*/:\-_\ /NK]\0Y<9_-'\3SW_AZ5\%?^?C5__!?)_A1_P]*^"O\ S\:O
M_P""^3_"O0O^&"?@#_T3/2_^_L__ ,<H_P"&"?@#_P!$STO_ +^S_P#QRCVO
M#?\ S[J_?$.7&?S1_$\]_P"'I7P5_P"?C5__  7R?X4?\/2O@K_S\:O_ ."^
M3_"O0O\ A@GX _\ 1,]+_P"_L_\ \<H_X8)^ /\ T3/2_P#O[/\ _'*/:\-_
M\^ZOWQ#EQG\T?Q//?^'I7P5_Y^-7_P#!?)_A1_P]*^"O_/QJ_P#X+Y/\*]"_
MX8)^ /\ T3/2_P#O[/\ _'*/^&"?@#_T3/2_^_L__P <H]KPW_S[J_?$.7&?
MS1_$\]_X>E?!7_GXU?\ \%\G^%'_  ]*^"O_ #\:O_X+Y/\ "O0O^&"?@#_T
M3/2_^_L__P <H_X8)^ /_1,]+_[^S_\ QRCVO#?_ #[J_?$.7&?S1_$\]_X>
ME?!7_GXU?_P7R?X4?\/2O@K_ ,_&K_\ @OD_PKT+_A@GX _]$STO_O[/_P#'
M*/\ A@GX _\ 1,]+_P"_L_\ \<H]KPW_ ,^ZOWQ#EQG\T?Q//?\ AZ5\%?\
MGXU?_P %\G^%'_#TKX*_\_&K_P#@OD_PKT+_ (8)^ /_ $3/2_\ O[/_ /'*
M/^&"?@#_ -$STO\ [^S_ /QRCVO#?_/NK]\0Y<9_-'\3SW_AZ5\%?^?C5_\
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M;ZA""LA)Z=*XKV/L/9QAN0>,OBK=^'[[,5Q$NU\?-7L_PK_:3O;7P4Q-[ )
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M:3'';-?I=\+O^29^$?\ L$6?_HE*1+5CIZ***1(4444 %%%% !1110 4444
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M$O\ L$6G_HE*_-0J17Z5_"__ ))GX2_[!%I_Z)2J94CIZ***1(4444 %%%%
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MV;?AK9SC$T&A6J,/<1BOLL5IP]A[]:DOR/-I_P"]S]$>JUY9^U-_R;K\0_\
ML#S_ /H->IUY9^U-_P FZ_$/_L#S_P#H-?&GI',_L+_\FI_#K_L&1_RKWFO!
MOV%_^34_AU_V#(_Y5[S0 4444 %%%% $5U_Q[2_[A_E7Q_\ \$R_^26>,O\
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M;>AC+87ZTFQ.G6JAM+AG^4<?6K\5F,+N'S5M%"<6]61-!'^-311IC;CO5Q;
M*!\E6[;3UDYVUHJ:>YA*36B,];-6'R"J>H:!-<+F/<#Z@UUD.FE5^[Q4OV;:
MNW9S2E3300JRCLSAK?2I880LLCEO=JTM)ADLY"0I(Q6E>:7/N#!1BKFDVZR-
MAER<5R2IQ3L=]/%U8JZ9JV^HE[=4\HGCUJ*[TV6\&1+)%GLK$5K6NGAL!4[5
MKP^'+J3!V#'UK&5&*U.^AC:TW9GF]UX5O+?,EM=W <G/^M-10ZEJ]CN25Y7
M.,[Z]0DT5H>)$YKE/$FG&&.1U4#FN:4;JQ[5#$U827*[F5X?^VZAJ2 ;B&/)
MS7KNDWS:/I^R7.5&>M>;^#)E@99&QN5JV?&VL;[>/8<<'H:\^5SZA3=2USS_
M .-/C34?$EO]FTR*7<%9697QCWKP/PU\/I=2U@1:H)2G4Y?DG/K7O>GPVS6K
M-(Z[CG.37 ^,/$,/A75H9H(UF!'(#5A2J.4US;&68X&'L&Z:]X]5NOV=?"/_
M  C<4RZ<OG&('<.#G'K7CNK?#&P\,Z_')#"RQ*00&8D9_&O3]+_: 35M+BMD
MM,%8P#S[5F7ZS>+)C(8MJ>F:]>K!):(^9PD'!\U1"VK1/&OW>!BN&UZ9WU:2
M-&( ;L:WM0M#INY1E2O'6N3G5EO6EZY-<,H2Z'H^WC'0]%\$ZXNDVJ%UWD'U
MJYXT^)47E1K]F;+9%87P[C@U#6K>*9=R$\BO8-3^'NDWZ*PLU<"ME44%8\U8
M=UI-MGA]OH\6M6Z74T7WN1S7H'PTT>YCO)E"?N@@V\ULS^"XX56*WMPJCMFN
M]\&>&UL1DQ!24Q3YI26AT4<MHJ:DU=G?^%9OL-NF1SL KH?M8N>,8K(T^U4J
MH([5HO&L,>1Q6'DSZNC322L2S;1']X9S69>,L2EN"<U3NGEN&8(#UJA>+)''
M\_'-1RMZ(]!.,!T^H+"K,1^M<=/XJANKK8(^03WJ3Q->K#;J XR<CK7FFFX_
MM4MYF>3QFL94I,Z88VG!VD>K3>(KA]/>%)9%1A@ -7*Z7\/;76M3:YNT>9MO
M!9C70:7I+7EK&57.176:+8QV?WQLXQFN2HG#0]NC4C6^$YC4/AWHL.FN/*PV
M/6N5;X6Z4H\Y8/GZYS78>,-6CM[IH8W5BWH:N:; 9H$,J\$5$9LPQ.'CU/)]
M0T74--ED^S6_F1@\<US>I>/GT'*7]HT(SMW9XKZ3AT6QFSOBS7*>-/A_X>U.
MU*S6:2L3GYJVYF>+/#.+O%GSWI/Q.B@UJ%U9BC$X >O2;7X@"ZA5P'.?]JO'
MOB)\+8M"*W&GVWDDN>C'&*U/ N_R+>.?J!@Y-/5G31J)*TMSU5?%QEC(\IN?
M>N4\3:M->QS6UK"7G9/E&>]:SM;10??4'ZUT/A_1=+FD6>55,C(.2:BQ<IW>
MAX[I_P )-6U.,RZI$6W#("OP*FL='3P#/)Y:L@W L-U>VZMJ$-BI6-UV <<U
MXW\1G&HV]R5;ECV-4HWU.:4I7U9L#QH_B0+''$Q16PQ+<5NP7?V>/9MSFO,_
M ]Q#I-FT>X%RW0GFN^T_SKV$R!, 4,SG+0YOQ_HYO-#OG5<G[/*3_P!\FOI?
MP;,W_"%^'CG_ )AEK_Z)2OG'Q+K"'0]24D!EMI1U_P!@U]"^#^/!^@ 'C^SK
M;_T4M==/56/A\S@G)2ZFZ]P3WJM<7)CC)R>*;)&7.<D5$\0C7>3GZUK8\2W0
MQ]0U265BB.R%3FEATLR+N=E;(S4]DHDU*?@$8]*TH6+,1MV@4!8ROL:6X(*@
MGKQ4?T&*W)!_L_CBJDENJY?>O^[2:(E%F=3)%W5/.PWD 5#4D(C6/O3V8CG-
M.V&FR(6R.E.Y5[O48K?,:#4D<);@9)^E*T)7KG\J-!W6XA7Y34&SWJT%+*33
M=I[<T)V%&5B.-1TI6CSTJ00/(.%;\JDCM7Z8;\J UW*C$*>E'WV&.!6@NFM(
MP[?A6C;:21'SS_P&J+,!(26X-3+9-)_$*Z1+58^, _A4@@Q@[/TI7%S&#!HK
M2?QK^5:=KX?&X*VTGZ5HQL.%V\UIVJ[8QD<_2C<:]XSH=&2W7)5:NQ6,:\E0
M:L21^8N,XH5=O?-458:L$:C 0 4Y85W8 Q3J53@YH*'*H4X-."AN@Q3-V:E1
M<4F9RT&O'TQ2)'FIZ*FY',[6(3&03Z5I6NF!0&)4[@#TIEDH:3!]*VX82P&
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M/_L#S_\ H-?'GI',_L+_ /)J?PZ_[!D?\J]YKP;]A?\ Y-3^'7_8,C_E7O-
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M</#%C]Y,/ID#_@5?2NOZ[8^&-%OM6U*XCM+"SA:>::5@JJJC)))K\>F;7/\
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M07C *KJ:@@?C6D<7.FK)GA8B%/&-QMH<C-^R[%X5TE8+-)FA*9.Y>E>5:/\
MLY:-<:N3Y\WS,=W/0U]SZQXZANM)8I"7Q">GTKX<T[]HS3/#>M7D%_9S1LMP
MX!8=>:SJ8IRC9LZ\MP4XSYXII(U?$GP7T[PY9R&"XE)5"1DUYM9A863+AOF
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M3'_/PGY4NH?#:U\.Z;)<RNCHH)8XZ<4P/0_^$ETK_G_@_P"^Q3E\1:8QP+Z
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M\F$JUB.O797#:QIBVOF2!%7GH!BFJ<8O3J&(S*=5:GB&K^!;KS#-+)N!SQ7
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M61"#70:;<"2,$$&LN735?D8JYIJI -IQG-0SWJ5%P5VRSK#?\2N\_P"N+_\
MH)K](?A]_P D^\*?]@>R_P#2=*_-G7'7^S+K_KB__H)K])_A_P#\D_\ "O\
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M.7_#57[0'_1 [C_P(_\ LJ/^&JOV@/\ H@=Q_P"!'_V5 'V517QK_P -5?M
M?]$#N/\ P(_^RH_X:J_: _Z('<?^!'_V5 'V517QK_PU5^T!_P!$#N/_  (_
M^RH_X:J_: _Z('<?^!'_ -E0!]E45\:_\-5?M ?]$#N/_ C_ .RH_P"&JOV@
M/^B!W'_@1_\ 94 ?95%?&O\ PU5^T!_T0.X_\"/_ +*C_AJK]H#_ *('<?\
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M17GFC_%*YU.;8VBS0C.,L:] B?S(U;&-PSB@!])2T4 ,6)%.0B@^H%.YI:*
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M-.K[ *S+[4PZG*Y-<DCZZGHDC.U.8-8W>>OE/_(U^G?PY7_BWOA3/_0'LO\
MTGCK\N-0C>6PNG POE,?T-?J3\/L?\*]\)[>O]C67_I/'6M,^8SJ5W%&^\8;
MO08QY?'-*B/(I..*<JX&*VV/E]40K'GUIZPCWJU#;F3M^M75T]."5_6GJQ^\
MS-CMG;HK5-':JL@#DK]:U5A2,<#WJK<>4\Q7DO0X@XV*36X:1@,D=B*62V5
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M> ?#1_ZAEM_Z*6OA^OM[X<_\D]\,?]@NU_\ 12U+(9T5%%%(D**** "BBB@
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MTN:3EKBR+$;O91\F![T#/LVBBB@04444 %%%% !1110 4444 %%%% !1110
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MFI&:3"I^M9.H22,#V&/6M."'SN%'-6$T629@&4$5%U$;HU*FAS>DV+3S9*Y
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M,BQJ=V=IZM7H^FWRHJG R5'>D(A\2,^,!L?(:\[U*0Q@KG!Q7J6I1B>!VQ_
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MZ'F@9]IT444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4#/L6BBB@D*XS7M#UV\U1Y+/5&MH.R!<UV=(M 'G_P#PC/B?_H-M_P!\4?\
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M.Z\R2>8 ,_-4>K:[]@C;YR"*X.^\:>==/&)6SGTI0IN+NS5R2:L>@>'6170
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MI(;0VL@(P%'85?JM?\0/]!_.AKJ)KJ6HWX!S4S2945CV4I;"X)XZUHCH*-)
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MB]>(/^^5_P#B:/\ AB/XF_\ 1>O$'_?*_P#Q-?9E% 'QG_PQ'\3?^B]>(/\
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M]\K_ /$U]F5QWQ;^*F@_!?P#JGBSQ'=+:Z=8QDX_BE?!VQJ.[''0>] 'Y_\
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M\(/_ $6M"!&S1113&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %?)G[97[0^LZ?>V'P=^& ;4/B7XE_<L\!!_LVW;
M[TCGHI(/!/'!]17H7[6'[2NG_LZ> ?M,2+J/BO5&^RZ-I*_,\\QX#$#G:#C)
M]Q7(?L:?LTW_ ,.;/4/B'X^D.I_%'Q1_I-]<3'<;*-OF\A?0\C=CC@8P*!GH
MG[,O[.^C_LW_  WMO#]@PO=5FQ/JFJ,/GN[@CYFR>=H). >QKURBB@04444
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MB^U+2+[4 %+110 4444 %%%% !1110 4444 <1\:/^2<:Q_USK^?']I#RO\
MAH#60X&WSDS]=HK^@[XT?\DXU?\ ZYU_/9^TC;O_ ,- :XI.=]S&1[#:H_I6
M]/34YJUKVOT?Y&[H>Z.U41J *TVCDD()(XI_A^.*'3T#8SBI;Z[BC  /-=KW
M/EJ>R+EK,BV9!8 XK)LV::_^0@BE5B\;5%ILBV<NXGFLSI-F\80PG>0"*OZ-
MJT"QX,J@X]:Q;B3[=QGBH+:S'G%.]43K?0T=;UCSIS&C*RFH])@EM[B.=3]U
M@U%]HXAM?,7&[K6?%K%Q""G!I\JDK,J'/":E%ZGLWA_Q[;?9&CFNH4?.,$\U
MW_PO\8:/8>++>YDU*!&YZN*^-+J:Z74#(!]YLCCBK!U#4K&Z292N1_LFO-JX
M"[YHL^WP7$W(E1KJUS]1I_C-:>7]GL[^WF#@CY6!KY3_ &EI8KJ:TG7;*ZAF
MXYQ7E/PM^(\YUJ&"XE3."<5ZQX@F37K-I955QMPO%<#DZ.C6I]CA:M'%6E"5
MT>(Z;;7&K0!F7C'<5TGAMY]%F96Y#<=*]-\*Z!;+:J#%']W^[5^\\-P39"QJ
M#[+63JJ6A[_U=15D8SS1SVB8(W$5Q'B#Q-)HLDG**JG&6KT&;07@3Y3T]J\8
M\>Z!J6J:J;:/<(C*,_(:2DHJ[-(1BM)[%_3?$D_B"Y"#:4SC*UT,UF8%^8BJ
M'A?PZ/"\<:RJ2,YW,M=I;Z;_ ,)!,D40VJW&[%%VSL5&C;F3T.(CNV\P@9-=
M1X?5Y-I(/3N*]+T'X211V<<KLC''=:VH_!L%C@!8_P#OFNJFI'G8JA1^**.>
M\.V?F,<JI&.XKT;2]-2&,$(H) Z"L:ST]+5B0!^ KL-+A\Q0/85O[*5SQ[PB
M3V,)#KQWKNM'6/RN5'6N;MT2->0*O0:JL"E0U*5-F\?>5CJ9I(%0Y*BN3U'R
MR9'&,#)I]QJ$ETH5:8+-I+68,<DJ175AVNIYF*@XTVSRGQ%\3-,T-D$^H6T!
M8D#S& SBL)/C1:,_[F^M7'LPKP3]K'X?72SZ1*DK!?-<G@]\5@_"_P "27P#
MR2,J;>,]Z^H^JPE14^8_,*N9SIU>1*[['T=J?Q5FOMT220LC#DBL6X\5FW@,
MC21BL^X\'I8Z,TB.-ZKQQ6+:Z/)J<.QSQWXKFC3C3V9UO&3JT[*.IQ/CSQO_
M &Y=S6 FB^;CY3S7F;7?B/X<3-J6FM'<)YPD,4P)X]N:] \3?"^>WUQKZ*4[
M-P)7;5J]TU+BSV31Y'3#"NR4J4J?(^IX,:F+IU_:QT:-_P"#O[9.H:M<)IVL
M-9:8-Y7YGQD8[9KZ4\.^/M)\2"-HM2MYW;H$<&OSA\4>#+>XU"X$8$3;C@J*
MM?#SQYJWPGUBU#2*^G9;^$G;D?XU\_B<KG.+E3=S[_*>)(1FH5=S]4[&XADM
MT D7\*J:I"LW"8/%>$?#'X\:?XBTRV?[9&SLN2 *]$A^(%M,V%G4BOEJE"I%
MVDC]4HYI2KQ4HR+=_:F";GA:Y3Q0D<D+\YXK1UCQ9%,K;) 3BN(\0>(MMJY9
MQFL8TI7V-:^,C*F[L\;\9S2Z;J=S-  6#=ZXZ+QE>:]J*6$R(%5\'%;?C#6O
MM-Y<?,"-U<0)AIE]]M& =V<U]3AJ+Y-3\PS#'QC5W/=_"^GI#9K\@'-:>H1J
MBY#5Y=X=^*D0MQ&TZ YZ59U[XI6EM#E[F-<CC-93I,WH9E3IQYKFGKEY%;QE
MVD4  ]37@GQ)^(4SW#V-I)%)&Z8=UYVTGB[XJ7.KM]FT\K('R&;:>*J>$_A?
M)K69)9"25W?=IQI2W1XF99LI_$]#B]-TB;4)DP5.2/O9->Y^"?AG/>6SG]U]
MT?PU:\+_  N%C=!GPP&.J5[EH-K;:7#AD4?+Z5UQARH^!QF/E)^[L<7X(\.I
MX;9X[GRV._.X#I7H$^M:?'@+/&#Z UC7%DNIZ@RQ':&; Q6G'\)9;K][YK<>
MU=$8GS\ZJD]2HU\VH3J(CGT-6V\+W]Y"MP9%VKSCFO0?!W@:&#3T5MC.IQG%
M;>M1VGA^P*3;0&!QQ6JB<7M4G9&5X4,7]EP+A3(!S6=XP\_S"L)5=RUCZ'K,
M[7F+=3Y.3@XXKKKC1Y+ZW$SM\V.E:Q@>?4K2AMN4-&\'&2)))A'(S*#R*O):
MZ=83-'/'$I'J*T=$OA"WE2'E1BL+7--;5-48JV$S5.)S*5ES,PM2D@^WR_9]
MH3=_#TJ.5D=EV %OI6OJWAG^S;-9E;)W#/%7--^R-:DE%W8]*SM8ZO;^TT.7
MO)+F./*%?QJ72[RVCA5I9%6:LW6-6$%P4SA=Q%0G2OMUO]H1]N!D4R_9+=#/
M%ER;ZXCV$,N.<5ER:8OV-G55#XR.*?8W AN#]I(*CBKEWJEK)$R1,,XX%0]R
MXMQT,>/7I(4\J=E4**S-6U"*:$@.IYJ/4462;!ZFF7&DC[.".*1UQ@MT,M+/
M[5'E<8%9FIV$MJP8L-F>E:=KJD%COC=L&L_5M4BN(\*V>:S.R.K,?6[N)="U
M$;Q_Q[2?^@FOT-\ C=\/_"WOI%G_ .B$K\V/$L;+HNH$#K;R?^@FOTW^'>FO
M_P *]\)';S_8]EGG_IW2N3$2V/LLHCR\S+$EEYDBD[ABK"VH4=ZU'L]J$XZ#
MUJL(V88 K@9] [ID"PJ.:D6/'0586.)>'SGO4)DY('2IU)U(VS^%$3%6'I3J
MB9BIXZ4T./8E9B6/%-W4SSN/>F;LMS3Y>XU'N6**89/2@R%E]ZFQ/*Q^:8.]
M1M(P.*3S#5*)7*21MUI^?6H%D*TK2$T.(W&[)3( >HIAD^E1$YI*KE&HHF\S
MCM4;-N--HIV':P44R7S,?(,FFQR-T>F,D8!U(_"J=Q8JL9*EB:N!0.E*1N&#
M2M<35]S'AMA)(4.13_,-NV ,]N:LM%)'<-(B_K4OV5)!EASUZUG8SY>Q1F0S
M8*C/':J[1M'U!%:J0B/( XS3+A(G.W^/M1R]0<>I0C7^*K\*B-<J2<CFFPV?
M/S#Y/K1Q#G/ Z"A*P)<I-#(61LC'-(=ZL,+QZU72Z\D_.<9.:=<:BGEMM;GM
MP:JY5RXK_(">*SYH4W9WYR:C.H>9&!GYOI4!G)-3)DRD%XFV1-O/%1J/6I&D
M,A&:;CG J2&Q*FM[@H6Z=,<U7D!7)J%F9<FFD.,26XD3:WS"N=U!ANR#GBK-
MY>-NP,?E6;,Q8\T_(>E[#(VRW--DQ]:56 H=1@$4^I?4?$WRG-0W#A4;Z4+,
M%R :J7SG:P[8HVU"UM2G-)^\9@:@:3WYI:C,>6)J#,1F^858BMFE93AL=\5$
M  1NK4LYD$6,]_2FBEJ/AM%11R<UGZQ<+&J#<O#8J]<:A'"I^;D>U<?JU^;B
M8@'(#YZ59>BV.FL=0\O&"O..]=+8ZBJQ_?4G/K7!6L@90?2M2UNMC+D]_2D3
MYG:C4<_W:NPRAE!!&<5RT-QYB!@>/I6]ITBLHYYVT:]1Z]34^V.HP *1;IJK
MLP6A6##(IV0^5$S7!+=!4EO=-&QP!5:E5MIHL'*NAT%O<#;\Q S5I"&(P<BN
M?6X+8]JNVM\58!B,?2DI=&2I=&;2G' Z5&WS,:CCFW*&7I2[CDFJ2ZE)=21E
MQ45/\QFIE-#7F%%%%,8JC-2JY7 %1J3VIZ*>XJ6)D\-R8GS_ #K1M]0R.J]/
M6LF1/ESWI8U*U-]"+Z:'31W"N/O"G"0'N*Y];R1>!BIX;Y@R[CCGTI:!H;B2
M;&R"*TK:XW8!('%<XM^K28!_2M"&?:H8'DBF,Z'S!@<BO:O!G_(GZ%_UX0?^
MBUKP2.]5A\Q_2O>O!)SX,T$_]0^W_P#1:TM!:&U1110(**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KCOBY\5=!^"_@'5/%
MGB.Z6UTZQC)Q_%*^#MC4=V..@]ZZ;5M6L]"TRZU#4+B.TLK6-I9IYF"JB@9)
M)-?CG^U-^V=9?'#XP137%C)JOP^\.RLVF:*SF.+49U/$L^"#L.,X!!'YT#2/
MKC]EGX4Z[^T1\1I?VA/BC:,HE)'A309A^[L[?/RS$=SC&#WR2<G%?;]?C_X?
M_P""K/Q2TG6H9KC1- ET=,)_9<$+1QQQC@+&001@<#)Q7Z3?LW_M)>%_VEO
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MKWFO!OV%_P#DU/X=?]@R/^5>\T %%%% !1110!%=?\>TO^X?Y5\?_P#!,O\
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M_P"X?Y5\?_\ !,O_ ))9XR_[&>\_F*^P+K_CVE_W#_*OC_\ X)E_\DL\9?\
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M1SCFK@W%W/.K151.+(?A'XBN=+U!XVD95V@#\Z^V/"DIDM[:4-U12:^!=?\
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ME-W+MP*:S9&*DD=',T>?>OJKP'_R(WAW_L'6_P#Z*6OE+EJ^K/ 7_(B^'/\
ML&VW_HI::&C>HHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&/#ME'8:1IT*PPQ(.P&-S'NQZDGDT#V-VVM8;*WBM[>)(((E"1Q1J%5% P
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M%% !7EG[4W_)NOQ#_P"P//\ ^@UZG7EG[4W_ ";K\0_^P//_ .@T <S^PO\
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M#?\ V#;;_P!%+7R17UO\/_\ D0_#?_8-MO\ T4M*0I&_1114$!1110 4444
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M7:USNK> ](UJ]-U=0;Y3U.: .>_X7)I__/O)1_PN33_^?>2MC_A6>@_\^O\
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M>% 8@@_6FD5&+W,N.TD<?=85H6^G@<DD<5>5 G IWTK2QIRA'$BJ>:4';TH
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M7A_X)?#_ %3Q;XDNUMM/LDRJY^>:0_=C0=68GL.>M?*O[,/PAU_]H3XC2?M
M?%BS=#(3_P (KX?N!^[LX"<K*5]<8QGKDDY(%<]X*T?5?^"A7QE7QEX@MY[3
MX)>%[DC2--D#(-6G4\2,."5XR>XX QDU]]V]O%:PQPPQK##&H1(XU"JJ@8
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M!.C4DO=V?='UO17S+_P\B_9\_P"AY;_P57?_ ,:H_P"'D7[/G_0\M_X*KO\
M^-5\?_8V9?\ 0-/_ ,!E_D>E]8H_SK[T?35%?,O_  \B_9\_Z'EO_!5=_P#Q
MJC_AY%^SY_T/+?\ @JN__C5']C9E_P! T_\ P&7^0?6*/\Z^]'TU17S+_P /
M(OV?/^AY;_P57?\ \:H_X>1?L^?]#RW_ (*KO_XU1_8V9?\ 0-/_ ,!E_D'U
MBC_.OO1]-45\R_\ #R+]GS_H>6_\%5W_ /&J/^'D7[/G_0\M_P""J[_^-4?V
M-F7_ $#3_P# 9?Y!]8H_SK[T?35%?/&A_P#!0#X$>()EBM/'4(9F"#[19W$(
MR?=T%>R^$_B)X7\=P>;X>\0:;K2XR19722LOU"G(_&N2M@<5AE>O2E'U37YE
MQJTY_#),Z*BBBN(U"BBB@ KRS]J;_DW7XA_]@>?_ -!KU.O+/VIO^3=?B'_V
M!Y__ $&@#F?V%_\ DU/X=?\ 8,C_ )5[S7@W["__ ":G\.O^P9'_ "KWF@ H
MHHH **** (KK_CVE_P!P_P J^/\ _@F7_P DL\9?]C/>?S%?8%U_Q[2_[A_E
M7Q__ ,$R_P#DEGC+_L9[S^8H&?8M%%% @HHHH **** "BBB@ HHHH **** "
MBBB@ KE?B'G^R(<?\]EKJJY7XB?\@B'_ *[+0!R/C(?N]$_Z^4JI\4/^0]X<
M_P"NH_E5GQD0(]#_ .OE*I_%!Q_PD'ASG_EI_2F"T-'4%/\ PEFE_P"Z?Y56
MU ?\7'T__KFU3ZC(/^$LTH9_A/\ *J^HL&^(VGX/_+-J0%U_^1\S_P!,_P"M
M9]K_ ,E,U''_ #[K_.K[''CPY_YYUFVLF/B9J'/_ "[K30%C0P1XCU+\*G\(
M_P#(6U7_ 'ZKZ'(#XBU'GTJ?PDP_M75?]\T@*/AW/VC5_P#KLU9^AG]S?9_Y
MZ-6AX=8>=JXS_P MFK-T1QY-]_UT:@!;$YT^7\:;;_\ ("8>QHL9!]AEY]:;
M;R*-";GL: +2 _\ "._\!J&$$6J'VI\<P_X1W@_PU##)_HJ?2@!\(.XUG2\7
M#_6M&"09;)Q69-*OVI^>] [FC;-_H[5J:)G^RYOQK+MI%^SM6IH3#^S)3]:-
MP+=E_P BS-_NM6):Y_X0N3_=-;%DP_X1F;Z-6';3#_A"Y/\ =- B[=?\B#G_
M *9BM"[S_P (O:?[JUG7,@_X5_UX\L5?NI /"]IZ;%H ;XV/_%.V/_71*J>,
MOFL]&_Z^(ZM>-C_Q3]C_ -=$JIXT;;9Z+_U\1T :7C+_ (_]#]?.6K_B3CQ=
MH7/][^59GC-O^)AH?_79?Y5H>(F_XJ[0N?[W\J!$7BX_\5KHO/\ "_\ 2JT/
M_)2%_P"N%3^+F_XK;1?]U_Z57MV'_"R%_P"N']:!EW2_^2G7I_Z=A_.IO"O_
M "/FL?[HJ#3''_"SKT?].P_G4WA5U_X3S6>?X10!2TM?^*NUG_>J'X=\77B3
M_KX;^52Z6X_X2[6?][^E0_#M@UUXE_Z^&_E5+8#1\$KG2]9_ZZ/_ %JO\-\_
M\(EJ'^_)_,U8\$L/[*UGG_EH_P#6J?PYDQX2U#_?D_F:D#F-,S_PB=Q]6_G7
M1:>I_P"$!S_L5SFER#_A$Y_JW\ZZ+3Y/^*! SQY= $.K9_X1-/\ <%.UW_D4
M8O\ =6F:HP_X1-.?X!2Z^P'A&+_=6@9R</\ Q\VG_71?YUW7BC)CM/\ >%<%
M#(/M%IS_ !K_ #KO/%$@\FTY[B@1FZE_KK;ZT7R_Z.WTJ/4) 9K;![U)?L!;
M-SVH KZ3_P @U:LW6?[/?TQ5;1Y%_LM<FK%VX_L]^>,4 )(?^)>GT%)K8/\
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M KZ5\!C'@?PZ/^H=;_\ HI:EF<C=HHHJ20HHHH **** "BBB@ HHHH ****
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MD88&:W;:+RUVXQ2M=DV4F+I>FEF4DMG%:,UJT0'!HL79&&WTK8^S^=&I8>]
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MC/>?S% S[%HHHH$%%%% !1110 4444 %%%% !1110 4444 %<C\2/^05;?\
M7=?YUUU<C\2/^05;?]=U_G0!OZ+_ ,>*?2K]4-%_X\4^E7Z "F3?ZE_H:?3)
MO]2_T- 'F?A7_DH]W_UQKT^O+O"K#_A9%V/^F/\ 6O4: "BBB@#E/B-_R O^
M!?TK-^#7_(KR?]=W_G6E\1O^0'_P+^E9GP9_Y%>3_KN_\S0!WU%%% !7AWQ7
M/_%;6WT7^=>XUX9\6) OCBV&><+_ #H ]JTW_D'V_P#US7^56:K:;_R#[?\
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MJ_>KZD\ _P#(B^'/^P;;?^BEKY;@;?7U-X%_Y$CP]_V#K?\ ]%+5%&Y1110
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MU% !1110!%<?\>\GTKB/AC_K-8_Z^6KN+C_4/]*XCX9?ZS6/^OEJ .[HHHH
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MN,U]1>!.? _A[_L'6_\ Z*6GT'T-VBBB@ HHHH **** "BBB@ HHHH ****
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ML5)626JII[MO^;\CS[RQLDDK4U^/_ .ULK.#3K.&UM8D@MX4$<<<:@*J@8
M%3T45\-N>H%>6?M3?\FZ_$/_ + \_P#Z#7J=>6?M3?\ )NOQ#_[ \_\ Z#0!
MS/["_P#R:G\.O^P9'_*O>:\&_87_ .34_AU_V#(_Y5[S0 4444 %%%% $5U_
MQ[2_[A_E7Q__ ,$R_P#DEGC+_L9[S^8K[ NO^/:7_</\J^/_ /@F7_R2SQE_
MV,]Y_,4#/L6BBB@04444 %%%% !1110 4444 %%%% !1110 5R/Q(_Y!5M_U
MW7^===7(_$C_ )!5M_UW7^= &_HO_'BGTJ_5#1?^/%/I5^@ HHHH **** "B
MLS7?$VE>&;1KK5=0M["!>LD\@4?K7PO?_P#!26:Z_:XT[X5Z'86.JZ'=7:VI
MU:"?=M<J6*@ 8. .N>IQB@#[1^(W_(!/^]_2LSX-?\BO)_UW?^=:_CY?,\/L
M2._]*R/@W_R+,O\ UW?^= '>T444 %%%% !117EOQN^/GAKX+^&9=4U76-/L
M_+D6-OM4RH 3P <GUH ]2J*Z_P"/67_</\J_*R;_ (+*:K#\4)='/AC3_P#A
M&5OC:_VI]H.[8&V^;MQC;GG[W3GVK]"O@_\ '#P_\7O L6N6.J6,Z2J<FWF#
M+T[<T 1_#'_D(R_[[_S->I5YI\.XA'J3D'*LS$'\37I= !1110 4444 %%5=
M2U*WTJU>XN94AB0$EG.!7YN_M.?\%7KGX6^+/[#\&Z=IGB&:&1UN7:8A8L'
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M74;VWM5MHC)^_<*/QK\Q?B-_P60U[P_\0KO3M"\.:;JV@6TRI]M6X.95XW%
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M7?\ P*F_QK]!**/]9LS_ .?B_P# 8_Y!]2H=OQ9^??\ P[%\4?\ 19==_P#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRS]J;_DW7XA
M_P#8'G_]!KU.O+/VIO\ DW7XA_\ 8'G_ /0: .9_87_Y-3^'7_8,C_E7O->#
M?L+_ /)J?PZ_[!D?\J]YH **** "BBB@"*Z_X]I?]P_RKX__ ."9?_)+/&7_
M &,]Y_,5]@77_'M+_N'^5?'_ /P3+_Y)9XR_[&>\_F*!GV+1110(**** "BB
MB@ HHHH **** "BBB@ HHHH *Y'XD?\ (*MO^NZ_SKKJY'XD.$TNU)_Y^%_G
M0!OZ+_QXI]*OUGZ(P:Q3%:% !1110 4444 ,F)6)B!DXK\:_$WPM\8G_ (*B
M+KB^'-2;1WUN&Z&H+;L8/+$"H27QM!W C&<U^R]5&TNU:Y^T&%#+G.[:,T=1
MF-XY/_%.MVY'\JQ_@[_R+,O_ %\/_,UH?$B;RM )SCYJR_@O()/"TI'/[]_Y
MT"/0**** "BBB@ K\W/^"EWQV\8P>$[GPOX6LM9%V;^-/M5A:LX1 "2<@'KC
M'XU^D=<_JW@C2]:E:2XA5F9MQ^4&@#\#OV??B=XV^!EWJFJGP5XBO=9NKC[4
ME_\ 89=Q8CG>67/7G/.<FOTN_9E_:N\;_%KP6L^MZ-J>F7C.T;?:K8J!CN"0
M,CWKZX;X9Z(R[?LRX_W16A9^&-/T?3)8+>!%3:3G:/2F!QWPURURC,<NP))K
MTRO+?AK=";4W4'.UG'ZFO4J0!1110 4444 <UX^\-W'BCP_/:VU[)8S;25DC
M'.<5^2MY^TI^TI^S5\4]2TK5K77/$_A%+V8V\L>G[F:(G*A608XSC#<GGFOV
M/K,U7P[8ZQ&%N+>-O?8,T ?D]K5SXQ_X*/?$CPGHWB;P[XB\->"M-2:YDN+R
MU$)EFP%55]L%\D?I7W=^S[\*;/X)ZM%X8T]V:SMK58X@PQA1P!7O&F:/9Z/;
M)%;01QJ@ZJH!K@!J2S?%C:./]'_K3N!Z;12#H*6D 4444 %<WXV\#V?CBQ%K
M>,50 C@9ZUTE% 'Q_JW_  3=^']UI>K1&20M>*YDP@YSG-?%/A?_ ()IV\/[
M12Z+-/J4WA6"#[4DDD8RTH?A"V.5 [=3W/7/[+5"MK"LQF$:B3&-V.: /"=:
M\%6WACPS86:,W^B(D:[A@X&!7MVA_P#('LO^N2_RKRSXU7WDS)'G&0O\Z]1\
M/MNT.Q/_ $Q7^5 &A1110 4444 1S1^="\>2NX8R.U?G+^W/9_'+X3>.H_%W
MPLU74;NT6UVW>G0VOG!AG.Y0!DD>@Z_H?T>J.2".;B2-7'^TH- 'XK:U^T]^
MTU^T%X9B^'E[X7UK3H=4,=K?ZI_9\L>V)B%=AO4!3@D_>)].>:^__A/^RAH?
MP"\ :=)I4TBLL,8E1UY)P,DGUKZECTVTC;<EM"I]0@KF?BE-Y'A&X/3YEH M
M^!YO.TMC[_TKI*Y'X;2>9HI/N/Y5UU !1110 4444 ?*/[>'[,\'QB^%^O:C
M9O.NNVUN);/[./G$R'<A!'/W@*^&O ?[>G[07@6&R\,:[X+UZYN+6-;96ALG
MW.0, XV;?Q#8K]DF4,"K $'J#6-=>$=,N]02[>UC\U2#]P4 ?!_[%/[/.L^.
M9_'OQ \?6=SI7B3Q!J9N?(GC :.-1B-3@\D+C..YK[1^%-H--TR\L@^\03%=
MQKLW$=K Y5510.BC%<7\,[@3S:R<_P#+TW\Z .ZHHHH **** "BBB@#\O?VW
M[GQUX_\ VCO 7A:UTJ_N?#<.OP74]Q' 6B7RV5@&., 8W')[@=Z_2?PCIJZ3
MX?MH%39M7.,8["I+OPO8WE^EW)$IF5MP.T=:U7XC;Z4=+ >0:>V[XH6/^_)_
M*N.\1.6\0:L">!>SX_[^-75:5,I^*EBN>=\G\JY/Q!_R,6K_ /7[/_Z-:@"A
M0*1FQ4?G#.,<TQVN2,<4FZF^9NJ*3*\[J+#Y1\LA7O3H6+*,FJ[$GK3XY-N!
M56T*<="PS;11GBHFDR.F:5<M[5-B;$@HZ_2H9&*^M$;G:,FBP<NER5E%.7'%
M,7).<U(N%[9I$DK21[3@<XK+O[C:K#..E6[B81J>W%9%U,)86/?_ .O3&4IY
MB<G-5_,/K45Q<!&8'M[TU)!)32*2)PP%+YGO4*YYSS2U5AV'%SG@TJN?6D5=
MU)WH&.(+<TTU,OW#48C-*XKC**DVX&:957&)112T )112T )12T]8\XH CJ&
MX*QKGUJPR[2:SM3FVQKUZXI=!,SIF#$FJDD@12QZ"G%CD\UG:E<>6K(,]*C8
MFW*BGJ%QOD< \9JB6)I[9D8G-'DF@:LMS*OG?S -W&*J,3CD\5N-;!^2H/X5
M&]JO(VC\J31+5V8RS&,\'!J:WN"K$ENM2S:8S,2#@?2H([%PY^:BPK&J(4DV
MDKDU9AMMS 8J&%"N,\UJV-N9&5O>FRG?H6[.U6.-3CG%7%':D5=J@44RMAS+
MMI*<OS<4]5V2 GD4"O8J2QR,QP?EJM<68V9"C=WK6D4,,@8JG<J=N,TM&+21
MPFL0*KC(]:S8\(,+Q6OK .\9YZUF0Q&1ABF'06*$S2>M:MO8A5&Y1T]:EL;,
M*JD@9^E:$=N3T'Z4O45^Y3AMPN<#%6!&15J*T)/_ -:IOL964+U_"E?L+F?0
MCM[AHHP V#6M8WH;&2<XYJC)8';G/Z4VU#1RL*-1*]]3M;&[\P?>Z5IJP<5C
M:6P"GCTK5B;'%/I<JUU<<\?I28P.:O0PAH@W%/DM@RC %&H];&4<L:-I6I9(
M3N]/PJ-D.,FKN5<;FDHI-WL:8Q:*** "J\\S)T..<5.V3P.*KM'ECGFDQ,BB
MOAN(9B><=*O*V[I6,UNV\X]:M12-#PQ+5"D^I"D^II*VVKEKAFY]*RX[A77/
M2I([CYB V/QJFBGJ:L<R+N!_"OJ3P%SX%\.?]@VV_P#12U\E+(>N<U]:> .?
M ?AL_P#4-MO_ $4M39HFUC?HHHI""BBB@ HHHH **** "BBB@ HHHH ****
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M HHHH **** "BBB@ K/UC1;?6X$BN 2JL&&/45H44 0VMJEG"(T^[4NVEHH
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M C_R9A_^+KZ9HI$GS')\&_%[+QI'/_7S#_\ %UE7WP/\;W  71>AS_Q]P?\
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M^?ZV/_M2OO.BF!\56_[./CX8WZ#M_P"WRW_^.5H0_L^^.HAC^PL\?\_=O_\
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2BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>figure09_01.jpg
<TEXT>
begin 644 figure09_01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #D =P# 2(  A$! Q$!_\0
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M2#]\?#C_ ((%_&'2]2M-3\9_%WP);-$XDEATNQOM35<M\T<?VR*%6R#MR<
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M_L?D?_B*2BO5/GA<G_8_(_\ Q%&3_L?D?_B*2B@!<G_8_(__ !%&3_L?D?\
MXBDHH 7)_P!C\C_\11D_['Y'_P"(I** %R?]C\C_ /$49/\ L?D?_B*2B@!<
MG_8_(_\ Q%&3_L?D?_B*2B@!<G_8_(__ !%&3_L?D?\ XBDHH 7)_P!C\C_\
M11D_['Y'_P"(I** %R?]C\C_ /$49/\ L?D?_B*2B@!<G_8_(_\ Q%&3_L?D
M?_B*2B@!<G_8_(__ !%&3_L?D?\ XBDHH 7)_P!C\C_\11D_['Y'_P"(I**
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M&P]/ZOBX9CFO]G8W%SIXJ$EA\1BHT,//V7NSH0BL9RJ*]H?QH^+/&6K?LO\
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ME N?M/AN[$D7D1*P"W19G*)YB'++_!U-^TEXBM!*WA'2K30[BY$FW5M9DO\
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M[+_?#%8ZDU=3S-KNLKKM?^FSV?(]1^8HR/4?F*\7_P"%C?&#_HTSXJ_^'#^
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M:II]IX@LM-7[%?20R37EM'>I%8W$I662QV74RX5Y82D;M&8P&R'!4,/[O?\
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MJUO[EKRW&G1V[0P6TR2ATNKM+2::&4,# Y8@.,AA]E? C]JGQ_\ "+Q+X?\
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M$[4=<HSAD5BRL F7&/WDGS LHWG+(&"^8H_BC);Y)%RC@.49A&Y7XU@_;_\
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M=3FS%.E4A/X9<TTE%Q?O<NE['^G_ (3^(N,XZSSA#A&A@L+CL+PQP5P;D/\
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MRC&56%*,I1I1O-^ZDM47F'&V1^'];*>%\UP6*KU<;.CALJEE])K&XO$32='
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MK8^-M>\4?&W5+'XCZ3X(T7P[^T'XY^$O@?P9X4_9W_9_U+2M-TKP\FCKI/\
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M_MW6/P7L;(7.C>$8?C!X/G\57UW!'9>++4:"]K!IUK;W!BEEM!-<L"@BW#&
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M[(SZ7X%TF\U;0=?M+FY65K;1=3NX_*E<LMQ%87$UJD80G;;K<)%LCD"$D .
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M334:D5*G)IW49Q;2E![23:33=V?F]^76U[:V[VZ#=D;H\,D,$EO-#);3VLT
ME@FMYP5FM;A&F,5Y:2993'=P3(D4K![:Y4-;2?/$'[.UEX-NKJ]^!'Q)\>?
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M &3_ /A@X3_^=8?4</\ RXO_ ,.V;?\ S8>#_P#"-?M7?]'*?#'_ ,1GF_\
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MA3()8L1[9K?MD?"/XC>*+S_A)=!UV9-#@LDANM.=(,01HZF1(W:560RJ2"Z
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M#SQ"3IY;)4\-F,ZL'#V4>58F*2Y;M.*;/TO_ &8_^"8O_!(SP?\ $32/B_\
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MFHWNG>(]9_LBVM-)-RS3S21R+'#).4!78P\Q@HDB4APKL%0,P^1O&&E:!?\
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M//@CI7[/?A7Q?H'QVU7QKXDG\110:GH=YJMWH%LXL(FN-4/E126%@OVY7"K
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M44 %%%% !1110 4444 %%%% !1110 4444 %59_OC_='\S5JJL_WQ_NC^9H
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M]WX_O+_WTO\ C1Q_>7_OI?\ &O"/^&HOV<O^BR^&/^_7B+_Y14?\-1?LY?\
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M%X2U,ZCXAFT36+6^M]2DBB22"8:-_:%G%<QK-_H[VT$XD=&9BCH K?J+>?\
M!:;_ ()J?%?X12Z9%J&J_#_Q0VJZCJFF>&?%'@*!&L=1O7;[<MI=Z;<:O916
MVK+)-&\TMW/Y<%P[,(6_>)_&!XJM=;OK:'Q)>6DDFB7]\[1P6T\\UC;3 $-
MMJT[&!SD QR(G7Y1NQ7)3KI=Y=B.*UA@B:W*&)PL;P2!6*.8S 6"[PN=S#(S
MR6P#%'*::3E5G5J<U_9PNFH.VG,FVUK;>R7J?0<0>*>;YC4P<L-AYT*& J4I
M2A7JX[$8K'UJ4XR3G6J4L.X1J.-G6E%QAS<[NEK_ %1^&_BM\,_%^D)JW@CQ
M!8WFF37U\9[2R>*XGMWNI&D54DC=G^S$E42+:=I8!5! KS3Q'KZ-J=U:Z5:S
M7>L331W#O>/$++2[:-@(P@W#RW8 .^>0,[P!G'\\'P\^)OB;X37=Q=^$[Z1[
MV\5([BS<,]I^XD$L<\#1R;D<%>\9)4;3A.5^C;;]L3XA30NFKM$UM?*POX[2
M&2*^<%<.9;B1%;RP.2$)8J" #FOF<SX8JSJRK8=7D[N,;)\TMTFN9Z-Z/I^1
M_0_ /TBLLP^7T\+FJJY;5I8>TKIU*-1J-N25>2M&,MG)M<JNWM<_07XB@W,<
MMC?^-K6&_FM5N+@1$M:VZ(SB4R21JP!0'$1#'=+LQE<FO@SP?^TGX4^&WQA-
M\DU[=Z/HD\]F-:AMUO?.NS;):W%T8)3'(\6%F16!#1MME16VKGR?XA?M S:S
MIZ6WAR[N6O-0B:"Z6XA M]-MPA3RX9& EG>09W&0%5+9!W 5\[:'81W>HVUO
M>;VM7G1KZ1 /,D,L@,I&[@E@Q7ENAX/KZ>59'*AAZJS.=1<]*480HO6#<6KI
M)Z-7TLKW/A/$KQDEC^(\JCP-/#XS$494JN98K$JEBL'7J3J1E3C3<VZ-:5)M
M)T^9[<KL?OCHG[1OPZ^)<5FNB^*8[-5MBB0PR%99+J02RRS7-E(#+@OUV@[<
M[ER%X^D?#.MVGB?1[&TU"PM"8(+BTDU*T*317]J89$1YWR6BF+%,(,2*Y#.H
M0,P_!'4O@7:[;;5_ ^OM:RM"DN&G-I<PD*#LA,3JID4Y)+E0P!7=G%>O_!']
MK[Q'^S[JDUIX^\-W'C6*TM9;18$O-L%[&RO"INE,AC$ZAUE:>(G=MQG.*\O%
MY"W1<<NK2K3E55Z=5KVNKM=)SU2[Z>A^H<+^.="/+@N.L"\BHT<%.M0SG*X3
MQ>5U\5"GS4X5*$(+'X?$2FDE"4)9>I:59^R39^I_CR>\C\$:EX8U*,ZT/"-W
M?:IIBPR;;J[\/W=G- -.)#I(/*GF1E#D%RNU%?=M/PW\(_&VA7/Q*^%6H?$"
MQO/"^@?#[1K_ $W2=1TJWN9[33-1T'5H9O!=Q>_83 [W0O+&PTV^E9Y(R99@
MY=E:,_*WC+]L3XH^/_&.N:YH^F0Z=I&H"XM-.\+6RS7%M9Z?,CQA9)(P)KB:
M*-C)&SL1'<+')M"QY;U+P)XST#2OAOX>E\4:#>:K!8Z!XD\/^(=,77K:P27Q
M'?PW4.C^(D220RSVD"S07FH6MP8Y9+Q+ED"%XW/93RG%87!U(5O9*<J4X2CS
M4^=<T&GI[1NZOMJ[Z*Y^4<7\;Y/Q9Q53S#+YXROA:+C3GCJ^!GA:<J*DN:4+
MPC&I[B<E%7YEI;6Q^D'QX^&GQ?\ %OQ%TKX]_'SXDZ)XTU+7O!-D9-.E+65W
MI=M;S:@UOX2LK>\/DW%[8:5_9VI&]7RK!QJ@2WO9[JRN;>+\M?&/AI+:\O[F
MPMKK^RC=3MIS738N3;M.2 Y4[7ED\TJSC*>4I^;) /T)\<_ 'QJ^'GA?PO\
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M!.\2-M/S1J 20=I<K@X)('-<%XV^*6R?58KB.^TN"ZBDGTZ"\#!27A1&AMU
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M@9\8)W?[S?\ " ^*E;J"/F?2P.H^;)Y7([U^\[?\'/W[=R[@?@Q^S0&7H?\
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MLOX:Q]2MCO;\JP>)KRK**71R;?+WE9Z6ZG]A^('TK.!LEX>X9H<*XG,ZW&N
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M*%U>M*G%-N$%[SNK-+6Y] _\$U+GX;>"OVR/ACXR^.'AW7_B%\.O#SW.I/\
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M&-'(^=<DD;,D 9) )X)Q74P:K#"7MM3UF.%H+5I9#%=6[Y<1LPS*)2I7<!O
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M;[Z7)]A7O_R-<PDF]8VR^/-Y<W]FKEOMS:6W/)/^%T?%K_HU'XB_^'-^!O\
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MBU_T:C\1?_#F_ W_ .>11_PNCXM?]&H_$7_PYOP-_P#GD5ZW\_\ M?K1\_\
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6<0H29HI""(T12%*I\N[:&+%BB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>figure10_01.jpg
<TEXT>
begin 644 figure10_01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &0 QL# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#U_6;W6/\
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M/_8_&'_0=T/_ ,$TW_R51]C\8?\ 0=T/_P $TW_R57044 <_]C\8?]!W0_\
MP33?_)5'V/QA_P!!W0__  33?_)5=!10!S_V/QA_T'=#_P#!--_\E4?8_&'_
M $'=#_\ !--_\E5T%% '/_8_&'_0=T/_ ,$TW_R51]C\8?\ 0=T/_P $TW_R
M57044 <_]C\8?]!W0_\ P33?_)5'V/QA_P!!W0__  33?_)5=!10!S_V/QA_
MT'=#_P#!--_\E4?8_&'_ $'=#_\ !--_\E5T%% '/_8_&'_0=T/_ ,$TW_R5
M1]C\8?\ 0=T/_P $TW_R57044 <_]C\8?]!W0_\ P33?_)5'V/QA_P!!W0__
M  33?_)5=!10!S_V/QA_T'=#_P#!--_\E4?8_&'_ $'=#_\ !--_\E5T%% '
M/_8_&'_0=T/_ ,$TW_R51]C\8?\ 0=T/_P $TW_R57044 <_]C\8?]!W0_\
MP33?_)5'V/QA_P!!W0__  33?_)5=!10!S_V/QA_T'=#_P#!--_\E4?8_&'_
M $'=#_\ !--_\E5T%% '/_8_&'_0=T/_ ,$TW_R51]C\8?\ 0=T/_P $TW_R
M57044 <_]C\8?]!W0_\ P33?_)5'V/QA_P!!W0__  33?_)5=!10!S_V/QA_
MT'=#_P#!--_\E4?8_&'_ $'=#_\ !--_\E5T%% '/_8_&'_0=T/_ ,$TW_R5
M1]C\8?\ 0=T/_P $TW_R57044 <_]C\8?]!W0_\ P33?_)5'V/QA_P!!W0__
M  33?_)5=!10!S_V/QA_T'=#_P#!--_\E4?8_&'_ $'=#_\ !--_\E5T%% '
M/_8_&'_0=T/_ ,$TW_R51]C\8?\ 0=T/_P $TW_R57044 <_]C\8?]!W0_\
MP33?_)5'V/QA_P!!W0__  33?_)5=!10!S_V/QA_T'=#_P#!--_\E4?8_&'_
M $'=#_\ !--_\E5T%% '/_8_&'_0=T/_ ,$TW_R51]C\8?\ 0=T/_P $TW_R
M57044 <_]C\8?]!W0_\ P33?_)5'V/QA_P!!W0__  33?_)5=!10!S_V/QA_
MT'=#_P#!--_\E4?8_&'_ $'=#_\ !--_\E5T%% '/_8_&'_0=T/_ ,$TW_R5
M1]C\8?\ 0=T/_P $TW_R57044 <_]C\8?]!W0_\ P33?_)5'V/QA_P!!W0__
M  33?_)5=!10!S_V/QA_T'=#_P#!--_\E4?8_&'_ $'=#_\ !--_\E5T%% '
M/_8_&'_0=T/_ ,$TW_R51]C\8?\ 0=T/_P $TW_R57044 <_]C\8?]!W0_\
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M7/\ @3_DGGAK_L%6O_HI:Z"N?\"?\D\\-?\ 8*M?_12T %Y_R4/1O^P5?_\
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M\"?\D\\-?]@JU_\ 12T %Y_R4/1O^P5?_P#HVTKH*Y^\_P"2AZ-_V"K_ /\
M1MI704 %%%% !1110 4444 %%%% !1110 4444 %%%% &?J/WHOQJG5S4?O1
M?C5.@!:*** %%% HH *6DI: "BBB@!:*** %%% HH *44E** "BBB@!:***
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M% &7AO[K?E2X/]UORK3HH S,'^ZWY4 '^Z?RK3HH S,'^Z?RI<'^Z?RK2HH
MS<'^Z?RHP?[I_*M*B@#. /\ =/Y48/\ =/Y5HT4 9V#_ '3^5+@_W3^5:%%
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M]#5FBN\\XK@'T-&#Z&K%% %?!]#2X/H:GHH @Q[4?A4]% $-%344 1"BI:*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT7Y!1117J'DA1110 4444 %%%% !1110 4444 %%%% !1110 4E+24 %%%%
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M>;'_ 'U_.CS8_P"^OYT /KQ2X_X_KO\ Z^)/_0C7M(D0GAA^=>+7'_']=_\
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M*IZ+\V1T445\P?2A1110 4444 %%%% !1110!U'@+_D,7G_7N/\ T*N]K@O
M7_(8O/\ KW'_ *%7>U]IDW^YQ]7^9\=G7^^2]%^0M%%%>H>4 I:04M !2TE+
M0 4444 +1110 "EI!2T % HI10 4444 +1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %87@3_DGGAK_L%6O_ **6MVL+P)_R3SPU_P!@JU_]%+0
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M%G_XFC_A?M[_ -"Q#_X%G_XFM_[*Q?\ +^*)]K#N>VTM>(_\+]O?^A8A_P#
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MBG44 )M%&T4M% ";14=2U#0 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10
MM%)10 M8G@3_ ))YX:_[!5K_ .BEK:K%\"?\D\\-?]@JU_\ 12T %Y_R4/1O
M^P5?_P#HVTKH*Y^\_P"2AZ-_V"K_ /\ 1MI704 %%%% $%XJO8W"O((U,; N
M0"%&.O/%>?Z'<27&J6D*Z_XH:!)5*->Z<D=M/@_=#B('![9(S[UVNIZC#!<6
M^G/;W,TEZ'51"H.U1C<221@#<.:QTT?5H-7M&U'Q'/<Z>D@,5NMG''\P^Z'=
M>3^ &:ZJ+48N_7^NS_0EG54445RE!1110 4444 %%%% !1110 4444 %%%%
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M]@JU_P#12ULUC>!/^2>>&O\ L%6O_HI: "\_Y*'HW_8*O_\ T;:5T%<_>?\
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M00I;6\<$>=D:A%R<G &* )**** "BJ.H.Z-'M=ESG.#BJGFR_P#/5_\ OHT
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M/4]6'PHOT50WO_?;\Z-[_P!]OSKD*+]%4-[_ -]OSI=[_P!]OSH O451WO\
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M)?X$O7]#CQ1)1117KG(%%%% !1110 4444 %(W0TM(W0TP/??@3_ ,D_N/\
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M;^\/RH^S-_>'Y4 1I]\5Y#<?\?MU_P!=Y/\ T(U[&MNP8'</RKQRX_X_KO\
MZ[R?^A&OGN(/@AZL^AX?^*IZ+\V1T445\P?2A1110 4444 %%%% !1110!U'
M@+_D,7G_ %[C_P!"KO:X/P -VLWH_P"G<?\ H5>@>2WJ*^TR;_<X^K_,^.SK
M_?'Z+\AE%2>4?44>4?45ZAY1&*6G^4?44>4?44 ,I:=Y1]12^6?44 ,HI_EG
MU%'EGU% #:*?Y9]:/+/K0 P4M.V'UHV'UH ;2BEV'UHV'UH 2BG;3ZT;3ZT
M)5>K.VJU !1110 4444 %%%% !1110 4444 %%%% !1110 5E>!/^2>>&O\
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M%;P)#!&D44:A41% 50.@ '04^B@ HHHH **** "BBB@ HHHH **** "BBB@
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M Q,[A#GU*MQCVK9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK*LL>2"<9* '/K6MIVELVNZAJ]W;A))C$ENC[6:-$5ANXS@DR2#@],>M;=%
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M:^-Q_P#O53U/5A\*)/M$O]X?E2^?+_>'Y5%2UR%$GGR_WA^5'GR_WA^51T4
M2^?)_>_2CSY/[WZ5'10!*DTA8 G]*\>N/^/Z[_Z[R?\ H1KUY/OBO(;C_C]N
MO^N\G_H1KY[B#X(>K/H>'_BJ>B_-D=%%%?,'TH4444 %%%% !1110 4444 =
M3X!)76;TC_GW'_H5=_YC^OZ5Y_X"_P"0Q>?]>X_]"KO:^TR;_<X^K_,^.SK_
M 'Q^B_(?YC>OZ4>8WK^E-HKU#RA_F-Z_I1YC>M,%+0 [S&]:-[>M-I: ';V]
M:-[>M-HH ?O;UHWMZTVB@!VYO6C<?6FBEH 7<?6EW'UIM** %W'UHW'UI**
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MBBB@ HHHH **** ,_4?O1?C5.KFH_>B_&J= "T444 ***!10 4M)2T %%%%
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MBBB@!:*** %%% HH *44E** .8^(_P#R3C7O^O;_ -F%?+T'^J7Z5]0_$?\
MY)QKW_7M_P"S"OEZ#_5+]*^ER7^!+U_0X\424445[!R!1110 4444 %%%% !
M2-T-+2-T- 'OOP)_Y)_<?]A"3_T!*]-KS+X$_P#)/[C_ +"$G_H"5Z;7QN/_
M -ZJ>IZL/A04M)2UR%!1110 M%%% #D^^*\AN/\ C]NO^N\G_H1KUY/OBO(;
MC_C]NO\ KO)_Z$:^>X@^"'JSZ'A_XZGHOS9'1117S!]*%%%% !1110 4444
M%%%% '4> O\ D,7G_7N/_0J[VN"\!?\ (8O/^O<?^A5WM?:9-_N<?5_F?'9U
M_ODO1?D+1117J'E *6D%+0 4M)2T %%%% "T444  I:04M !2BDI10 4444
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MYF=][G +88GG@=/2KE% "T4E% "T4E% "UG^!/\ DGGAK_L%6O\ Z*6K]4/
MG_)//#7_ &"K7_T4M !>?\E#T;_L%7__ *-M*Z"N?UFRUC_A(=-U;2;:QN?L
M]I<VTD5W=/!_K'A8,"L;YQY)&"!U%'VSQA_T M#_ /!S-_\ (M '045S_P!L
M\8?] +0__!S-_P#(M'VSQA_T M#_ /!S-_\ (M '045S_P!L\8?] +0__!S-
M_P#(M'VSQA_T M#_ /!S-_\ (M '045S_P!L\8?] +0__!S-_P#(M'VSQA_T
M M#_ /!S-_\ (M '045S_P!L\8?] +0__!S-_P#(M'VSQA_T M#_ /!S-_\
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MT/\ \',W_P BT 6_L\__ #R-'V>?_GD:J?;/&'_0"T/_ ,',W_R+1]L\8?\
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M=;^5?B'U>!\T?\*V\=_]"W<_]])_\51_PK;QW_T+=S_WTG_Q5?2_VSQA_P!
M+0__  <S?_(M'VSQA_T M#_\',W_ ,BT?VW6_E7XA]7@?-'_  K;QW_T+=S_
M -])_P#%4'X:^.R/^1;N?^^D_P#BJ^E_MGC#_H!:'_X.9O\ Y%H^V>,/^@%H
M?_@YF_\ D6C^VZW\J_$/J\#DOA!H&KZ!X-GL]5L);6X-Z\@1R,E2JC/!]0:[
M_P J7_GF:S?MGC#_ * 6A_\ @YF_^1:/MGC#_H!:'_X.9O\ Y%KRJU5U:CJ/
M=FR5E8T?*E_YYFE\J3^X:S?MGC#_ * 6A_\ @YF_^1:/MGC#_H!:'_X.9O\
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M .#F;_Y%K@_L+#]V>A_K!5_Y]Q_'_,\]_L#Q#_T [G_ON/\ ^*H_L#Q#_P!
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M?_@YF_\ D6@#>P?2J7ER?W&_*L[[9XP_Z 6A_P#@YF_^1:/MGC#_ * 6A_\
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=M&\*Z1I=PT;3V5E#;R-&25+(@4D9 .,CT% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>figure11_01.jpg
<TEXT>
begin 644 figure11_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" '<!90# 2(  A$! Q$!_\0
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M[_A']0_YZ6__ 'T?\*/^$?U#_GI;_P#?1_PH ;Y@]:/,'K3O^$?U#_GI;_\
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M[_A']0_YZ6__ 'T?\*/^$?U#_GI;_P#?1_PH ;Y@]:/,'K3O^$?U#_GI;_\
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M[_A']0_YZ6__ 'T?\*/^$?U#_GI;_P#?1_PH ;Y@]:/,'K3O^$?U#_GI;_\
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M[_A']0_YZ6__ 'T?\*/^$?U#_GI;_P#?1_PH ;Y@]:/,'K3O^$?U#_GI;_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% "-5>X;Y34[55NB=E '1:,=VF0'V/\S5VJ&A_\@FW
M^A_F:OT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>*W:1>2P7'7M^G:N0A^%5C)<%61LXX&XX'/6N&6.QD7T/LZ/#7#-:',U-/\
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ME\GXI_\ /7P\?^^_\* .]\NCRZX+R_BG_?\ #Q_[[_PHV_%+U\/G_OO_  H
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M(CJ4<6_VTRG#.DC#>2!CZ=A_]:IKYE6!(696#L5^3YN>3GV[5/)H$XA>4HJ
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M*/,IE% #_,H\RF44 /\ ,H\RF44 /\RCS*910 _S*/,IE% #_,H\RF44 /\
M,H\PTRB@">.8JP.:^3?^"CW[,=Y\<OAK8^+O"UG)=^-/"P>1+>W7,EY9D;I(
ME4#+.K ,@'JX )85]5U9MKHQ&O5RK,\1DV.I9AA?C@_DULT_)K0RJTHUH.G+
MJ?@S\'?BYI_@?QEI%]XJT[4/$WAW2;AKYO"?]H/;VTEZB_NI7C.5.UU7((Y
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M^WKJV]6_Q]?#8:5/WZFY!*VYC3***_*ST0HHHH **** "BBB@ HHHH ****
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MZ39W?B;6+72],MI;_4;EMD-O"-S.?_U#/L!6-/-)>7"1QJ99I&"(JC)8DX
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M;ZO--M7T:?Y'TM'?,9E5""&XZY.:OPWB[5W/EF&3D_K7F'AWQU;3-^]<JS8
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M*-ACRK%>?Q^HJS<6;&%265XQA@N<MU/0COWZ5H[/LJH<2,Z]"I)!7C@GW/\
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M?@C\-M9M]!N?#7BCP[8^1%8Q2BYLP8=J;I6;#D; 3A0/F('0$Q?$K26\/_\
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M<6^V4(9"C!5RG0@]\9YQ_7O5_"36Y2W0!Y#SCYO4G!'?_"L]K:&.#=]XQ;B
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M^'MEJCMIWC;[>?[0@TMIC(T/V0Q[3.P8J'W!4+$[7P,X=C\#_BII\G[43?\
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M[%OP/TO0_"5SXIU;7KB^MH\SM;6-DGVNZEDGN[D1R>4@'3Y&))P!U-9_Q_\
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M* .@T#_D#VWT/\S6A6?H'_('MOH?YFM"@ K\>_C% [_MJ?$UPJF,7[>9N/\
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M\+7UMINGGPCJ#ZH^KSS0Q3'""V1HHXUGBWOA\'> &VC./X!_;FTC6OB=\3_
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M_P#X9G^'NN^*]&M_%'C+QI<-;>'K:SU5C/JUR\L\DIN \"I9Q1(A/R&8+&O
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M3QC\:/CK^TOXOUAS=^*_ /B.+4=-=?$L]M'936\U\BVJ.+1S+:[(B&4K'O\
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M+?5M$U!KHZIJ#Q-'#,T9C'V>)-Q<J&9BX0@J%*GRWX7?LZ_%'POXZ^"&MS>
M_"FC+X9MM2LO$MU;:^\MYJ4]Y%;)<:E)+Y(:260Q.X0DL#P9,$8^R?/;UH^T
M-_>HYG:P<JO<^%]2_9L^/.G?LLZU^S]:Z)X7UO0K34('T;Q3)K;6TTME%?PW
M212VWDL/-&Q@7WA=O&TD9;[2US0[OQ9\+]1\.WQAT[4-3T:33YS!(9HH))(#
M&Q5BJEU4L<$JI('0=*UO/;UIOF&CF=[H?*K69\9>!_V9_B_X?^!/P>M8[70=
M+\<_"G5A=:=9KJC2PZO;/YJW4<DOE8A,D<NQ0 VW:6+?, /;_ _PTUW5OVDM
M;^,/B?3(/#US_P (W#X4TS2X;U;IV@$YN9IY750JDR%45!G C+$_/@>O^<?6
MD:0GO2YN@6/E7_@H]\ OB!^U+\-?#_@SP1I%E(;'5X]6FU'4-12"/"P3Q>6J
M8+$_O@<\#COGBE\?/V8?B!^UYK7PX\/^++'3_ _PZ\+R)>:EMU 7M[J<@15:
M*-$4)&N%9=[,3^\W;?EVM]<+,5Z'%.^T-_>I)V!JY\F>(/V=?'__  \ \-_&
M'3-!LG\$:#H3:-'"-2C6YFQ;3HK*A& -TRCDYPI-8'[.O[.OQ:^$GB#]I?6M
M5\+:?/+\2IY+[2;6VUJ(B&1I;QA%*Y48&+Q?F /^K;CD"OM(7##^*E^U-_>I
M\S _/_PI^P]\4F_X)\>*_@AJEKI5AXK;5DU/39TU$2VUROGQ2%&8+F,X1QR"
M,[>>3C:^%?[,WQPM_P!JSX9_$OQAH/AVQTCP[X<@\/7$6EZN9I%$=NT)FPR#
M.YCOVCH& RQ&3]S?:6_O4?:G_O4^9["Y4?%?PQ_8[\:^'_VDO ?Q6?0M)\&Z
MU:6EX_C-] U4FSUZXDA(016^T>7OD;?(&P@9<KD@&O-_!?\ P3M^(VI_LU_%
MSX=>)(M+TC5]=UZ+Q)HE['?B>'SDR/)E"C*Y4L-W(^;/:OT;^T-_>H^T-_>H
MYF.Q\F>%?V;?B!K_ .TQ;_&?Q7H^G:--X?\ !<>A:9H=GJ2W$EY>"*0.QDVA
M43,CJ"><%20.<?,VI?\ !/?XY:A^RW>_#$Z)HD>JW'CD>*_MG]LH85A^QR0&
M+[N=VZ0'.,8%?J9]H;^]0;AO[U',Q<J1#8W%Q-H^GM>6WV*\-O&9[;S!)Y3[
M1N3<.&P<C(ZXHIS,6IM04%%%% !1110 4444 %%%% !1110 UJJ77W3]*MM5
M2Z^Z?I0!T&@?\@>V^A_F:T*S] _Y ]M]#_,UH4 %?BO^T,6;]MKXB@$J1J;G
M*G!_U:<5^U%?BA^T9M;]M7XE!QD?VFX[C^!/3WKR\P^"/J?=\(O_ &FLO[C_
M #1W$:[;./YF9VX;9U'-4+H;HY2(P\()'X4VR<)"@?)&?E#'&?\ &GZC-%)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #6
MJI=?=/TJVU5+K[I^E '0:!_R![;Z'^9K0K/T#_D#VWT/\S6A0 5^(O[33K_P
MVI\1BY "ZLVWKR?+3WK]NJ_$#]IW:/VU/B+N7(_ME\+SS^Z7N*\S,/@CZGW7
M"/\ O=5?W'^AU5I<))#&&8G</E9>W]*GO%CE@9$.R0!<[1Q@$\50T\L85'91
MQN&,?YXJVT;KC *E>5&>!7-'8^BGN8DR^0N]_,RWR\#@?X5Y-\7HY%L7<C&5
M_'%>P7S'[/(&4'&2V1G/O]*\C^)V[4+.9<?)CEAQGBNNG\-CFJ?"SPBWM8KJ
M-W)*A3GI7N/PU_;=\5_"3PKJFCV-H'-]$(=V_ 0#C^5>*6NI0VGG1,H"YY_.
MJL-A#J4S.C[D7M72CY3$2;5D4K.&;5M2GU"Y;#22M,Y/\3,<FNDC:/:-KY_"
MJR1G88T7Y5&.E2QQ;%';Z5O%=3BB_9JR)/,BW#)QSWYK4M]1=HS&%^3'WLUS
M]Q)\IXZ=*?9S21J.2*KE*50N:BPC)\L[F/>J#,DJ#>>:;-)(TN2>*9D,>#TH
MM87QNXBQQAL[N<Y IS*3G%,5/WBU:5<G-(UA1<B*. ]P.*L)"P.0OY4!>IZ5
M;MSE1S6<]#OH4++4:H*MTS^-3+GTS]*;@[L]*>J^E<TI'KTH<I-MX!X^E.5=
MO4_6F+Z=33^,X/'%9[GHP']5'H>]68R5R,<U71ATSD 5*CC<2#S42.VF2E20
M<=,TN&;^$9QQ3/,Z8X&>:=YP*\']*S.ERL*RG@>V>*.F3N./2D$G3FF/,,X
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M&LTFTQ$4^#1W75$@LY&DN,@A02*]*;PS#I]CODBVLHY)'I5OP5I5M+,U]+&
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MIJ\FGLU<7\9OBUX2^ 'P_P!0\7^,]4BTW3+5<(C$>;<RD';#$O5W;' ';).
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M\:>*?%/BZUUG355-..CW5I:"R56WJ(V6V\PX?+ N[$%C@@<5?-I8FW4^6?\
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M1<=S4WE[L<8-.'^L7)SS4C*2W%01&/-J1&W[XIZH1]*>.U/Z<TC>-,@V%I%
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M]G9('T.SAM%B,L:X7+&996.W!<)$!RH-4XVZA?R/LK2M&,+":1LY_AQ6R %
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M,\ _2NS5>YXKFC%V]X\3,J^"JUN; 0<8^??R6MOO*=QI<4@Y4=*Y_5/"%K=
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MMZ'H.*[6TLXUMR#L+89P9B=V[ID9R,<=NE>?5J79Z%&G82!DACB$2J&8@.J
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M!SW% %XC%)3#;K]H,VY]Y79MW';C.<XZ9]Z?0 59M&VR"JU2VDB2730ALR*
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MJSZOI;V5Q:1:<CR?;XIX6>65=A"")@P"$/@G(;(XXZUQ#?M)?"Y,^9XG2/\
MWK2?_P"(IT/[3OPI5L#QA:@X_B@F'\TJ91=AW1XM^RUH.GZK\<?VH1+F34I-
M1MM/='8LT=L890@!/.&.[O\ P"O&O"5Q<Z)9ZK;+:R7-S:/)"+=64.2#CJQ
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MM-9>OV^NS?V:=$N[&TV7B/??;K9YO-M<-O2/:Z[)"=N'.X  _*<Y',-^T?\
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MG=C'5AQG/-,#"\;0M)I[A4W Y#'.,#!Y]^:]6_8&U#S?AAXHTP\-8ZW(0/\
M9>-&!_/=^5>9^+X[MK%?L:0N3(HE\]B,1_Q%<?Q>@/%;/_!/GQ)]I\6?%#1V
MM[FU'F0RQQW4>PMY;RQM(O/*-E"#W&*;^%D+2HF?7DGWJ94LXPQJ*L#K"BBB
M@ HHHH :U5+K[I^E6VJI=?=/TH Z#0/^0/;?0_S-:%9^@?\ ('MOH?YFM"@
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MSMXU'K[BFKI<4S;ABO0ITHR/)J8MQ(=#\-V]["IEP,]<C%=!%X%LHUW_ "L
M<<5%:30V:A=P* <U.OB*V:4Q,Y3TKU*%"$=SQ<5BJE1KE9H0Z#I\<9*1+(4Z
MX KC]>C1[I4C@X)Z@5L:EKT%C&Q%R"2,CGFL.UE?4I1*F3SV%>RJ,.4X(5IM
MZLQ=:T?;"7<^7QD9XKA+K?Y^V-C(OM7K>K6_VB!XY.H'&:X)M)$5PV!BO*Q-
M'5<A[5.IH8IV.H&1N'44XQ;E! )'K4AL]MTP _2M*QMU6/#<BN6GAI-V+]H9
MD*AB% SSTK<TQ6M68B)O+_O8XJ>S^SYP8><\<5T-A9QSIY/0].>U?0T,*XK4
MSJ3V.(NA<7E\1;[@K':2IZ5K+X<@CLQ;RMYCYR'SWK7U+PU_9;&9)=HZ]:R
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M&DT^X4.6@08"L#R.N#5*^^+320Y6YC10,%6PHQ[8Z5X+JNO7%]I)\ZY59_\
M:;'TXK@KK6I[=747ADG5ONG.*KVLHO0P>%YCVKQ3XXN=0+D7R*2<]>OXUY]?
M>+-0WD-<K)D?P'GZ5S&GZ3XF\4.EO9V<\@D. RH<9^M=UX;_ &:?$>L;/M7F
M6TK9RI!Z#'?UK2GC.66K,U@5?5'FOBKQ5/<1O ^XGD'=7HG[!_\ R>)\)?\
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M#CM==N[?4[\AEGGMX/)CD!)QA"3CY<#KVKF;6QB\,0D:Q=:='-=7SPV;PQ&
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M_3;[<_K4UO>,[ &IE+0?*?B_XY^%7C;Q9\=M)\#:?HVH7NIZ8T6K7=@+=?\
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MO:LV6Z$ !B17VKI/@[PSIB!K;P[96[@D9DA5FX.,Y.:WC?\ V>$B*/A1\L:
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M#.<#^A'-+)XBB;[MH)MO(E"CYNV,]_\ Z]6J*EU"<FCII/$"S,C^7]_YMV[
MY/)_S[58MOLVJ1,UO!(\Q*N=IP/;OU_QKRW7?&-S8E9?L654DJ77:.3Z_2LB
M3X\0V.;.",138.[9C)XQQZ]:WAA5?1G*ZSC>YWWB:2YTV,PJH96 .[WST/<_
M_6KC([RW-T6GE\AUY8$CKZUQ&J7?B_QI)'/$9((GZ=3@>F!VJ_9>!-57#7[O
M*Y(+GGK@UZ"BJ<3SO;3J3LD=W#'!<_/'+'*/E \OD]<_A@_RJ;4='*69&"6Q
M^6>_O7/0WL?AJUP;4S,HR<H,Y'(%6;SQM=W5NCQ6[JA7.5YVY[?I7E8C$Z62
M/I,/AI:/N0ZZ&LX6,S%7'S"3(YQZBO&/%6N2PZA<-;7&\ ]%Y"BNQ\0:UJ-]
M"WF *R@C_&O-]<,$,1B0[[@\<]N:\R6)?8^HP^7Q:N<[J&JOJ"OY]UY+8YWM
MCO\ SKSS5M5NY-2>W@N6N5R% 4YY/2O7O"_P9O\ QE<QS2+(R#/&,+G(_3O^
M%>]_"O\ 9+TRUA%S<0A)N!YD@)!X&/\ (KG6,75&\HPHNTCY7\,_ GQ1XRF1
MC%-#$>=S= ">E>\_#_\ 8^T^Q^S3ZN?,N^^XDJISW'>OKK1OAA::*RK;H6#1
M@+W7( YZ=Z[.S\$A;@/+%S_RS##'.><?F/UKCK8EOX4<E3%6^%6/$O#OP;L=
M)9([2R7]V,#"!3GW->DZ'\,(#';[5#F5]JG81M)&?\.:].M?#-O;1%HE8 [2
MQ!)!(./Q_P#K5JP*D>=J!@N -G!4$9YKS8UI7V.&IB)26AP8^'ZV>/,B3R\Y
M )XSGMW^E:7@SPKIMO\ $CPS<E$:>.\4Q;E.Y#@Y^AZY^E=-');F-6E\[RW4
MG?NRJ8SP/>I_"L"KXUT2X495ID&[:!R0<'^E*4E.<+KJOS.5SDT_0^@J***^
M[/!,GQ7_ ,B]>_[H_F*XS3?]6*[/Q7_R+U[_ +H_F*XS3?\ 5B@#6AJXM4X:
MN+0!)1110 4444 %%%% !1110 4444 %%%30PF0XH DM82SCBO@'_@HE\84\
M3_$CPO\ #;X>7R77C6W29-5O(3NCTJ.39MW,.DF YQU&1W(KV/\ :K_:8U[0
M?$-G\&?@W:IK_P 8==CP[1MF+0K9AS<SMT1@"" W0$'!RH;CO%'[+6@?LR_L
MZV,=K,VK^)Y]:@O=<\0W',]].Z2*V2>0@9_E7/N<DDUM6]CA<'/%XB"FU9QB
M]FT[J4O)-7M]K9Z7/3RCVE3,J-*G)Q4GRMK>S5FEYN]K]-SDO@A\,]*^$WA*
M'2]/S/=2MYU[J$@_>W<QZNQZ_0=OSKU>SDW8YKB/#=QYMM$?45V5BWRU^?5J
M];%U98BO+FG)W;?4_:I4:>'@J-*-HQT2.@L6Y6OC3]N/2##\7-.N<%(]0T6+
M+J<'<LDJ'GU VU]CV3?=KY>_;TL2VH>"+W;E3!=0'!P3AD8#]36*=I)^:_,]
MKA2?)G-./\RDO_)6_P!#SWX+W#6_DV=E/')/;B)6%PY9MG3+=\D X)ZFOHG6
M_M36L!M!"3O7S?.S_J_XMN/XO3/%?,'P>OI;C[.DC+I=]<PG";E>1&'<=FVY
M].XKZ=LY)Y]-9)X9$:$^6)9"I,X"C]X O0$YXXZ&NZJN63/1XA2^N+EO9[:6
MMV5MT[;WL>0_%"U-QI]PH.!@Y&,Y&#Q6_P#L%Z@_G>/M-(_= 6=PO/?]ZI_3
M%9/CRS,;:C-+<NZ.!M20 )$,8(![Y(SSZU7_ &';YK/XJ>)]..-MQI1<_P"]
M',H'_H9K"K\,?ZZ'JXA>WX=Q"MJG%_=(^K?$&K6.F_9;>^=T&H3&UBVQNP+%
M&?!90=@VHWS,0.@SDBLK[!!H]E%!$C?8;2"..%6<R%0@P.N23C'S$DFNEF82
M-(NU@ =IW#K]/45R-OK":]I^J;!?:7Y-S-9B6\MQ"P9?EWQAN&3/*L>#62UL
MK>I^61E9-\R3L[-]/77;[C+D::;?),!'N/R*#R%]_>N4\27TVFV-P;=(UN3N
MQ/C) [8SWQ6YJFG:W#I]@MG>VTUW'/$+J>^0GS8 ?WFT)@"1AT.,9/2LCQ7&
MIMW (+;<[>XKU,36=I.AO'2Z^RMDH_\ R6[WT/)RO!1E[.&/NE4NU![U'NYU
M;:-]H?#%66KM;Z9_9EOK_7/A?X;U8RVL5I]EG@N;?[*//EG6;"2^:&X&P'Y=
MISN!R,8KU>2Z9OXJ^>_V#]-L]#^!]WI-D'6&UU:Y(CDE:0KO(<\L2<9)XKWF
M.!+6%8HEV1H-JJ.PKWL#/VF%I2O?1:L_/LTI>PS"O3222D]%LM>A)(WG(R/\
MR,""IZ$&J&AZ?IVBZ1::;I,$-IIMC&MM!;6RA8X40;0B@=  ,8]JMUGW@U9=
M9T[[&ME_9.)3?>:6$^<#R_+ &T\YW9(XQBNT\PT=QI5:FFB@#G]+TC5=+\8:
MU?WGB*\U32]3\D6.DO:1K%IACC(DVR(H9A(<-^\)P> <$ =3;MMD%5LFI8?O
M"D]@/B[4M5U;]E[]N=_$>J06L'@#XKW2:29+6=I3;WJ!%BDE&T!2SOTYPKL<
M_+SZ%^W%9K'?> KX]3/<6Y/L55L?I7'_ /!3#9KNA_"7P?80K/XFUKQ7;_V>
MBD!QM(5F]0,R)DCI7I7[<-D&\#^%KP_>M]85 ?\ >B?_ .)KZ_/)?6LNR_'U
M-*LH2@WW5)\L)>MO=OUY3ABN5U(+9._WGQM\ =;U#PI\0-=^%FI21K!;SS:O
MI\KIN-S:R'=Y8.[Y65F#=#G#CC@UZW\9/!T_CSX8^(]%LY##?SVK-;2*.1,O
MS)^HQ^->/6,G]M_MD^'Q99?^R_#CB]91PF[S,9_[^)^=?2T<GES,7!1$&XR-
MPN._Y5KQ!BIX?,,+FU+W:U2G3JR_Q]7;IS64K?WC.C3BZ3HOX5=?(\F^!_Q*
MF^*WPGL[ZZ7R=9L&^P:E&PY,T8 +8SQN&#[$D=JX/Q#X5U>_74/&'@*:(ZWX
M$=?$D-M;D>7.MO+^_3Y>X4N2.X5AU-7OV4\:E8_%#6K92-+U/Q/<S6;8P&3)
M.1^#+^5>G?#?7M/\#>+/%M]?B*VTF/PWJ4UR<!5VK$7/'<GGZDUIC>7(^*G]
M2IZ1J*T-])I<U/NU[SAW^8DO;44IOY^G4^POA/\ $S3OC1\*_#7C;2\"UUBT
M6<QA@?*D&5DC..Z.K*?=:Z%NM?/W_!.C0;_0OV-_!$>H1/#)<->7<4<@P?)D
MNI6C;Z,I##V85]!/]ZOG<WPM+!9GB<+0?N0J3BO12:1WTY.4(R?5#:***\HT
M"BBB@ HHHH **** "BBB@ I=II47<U>/>-OVIO#GPW^/OAKX7^(](U/36\10
M*VG>(9506,MP6VB#.<YS@9QPS*,<YKIH8>MBI.%&/,TF[+LM_N$Y*.Y[ ORM
M7EW[6'P@G^/7[/?BGPA9$#5)HDNK'.!F>%Q(BY/3=M*_\"KUB:$QM38Y"C4\
M'BZN!Q-+&4'[].2DO5.Z%**G%Q?4\<_9+^.]M\9OAGIUAJUP+3X@:'"NGZ_I
M-T5CN4N(P$:4Q_W7(W @8Y([5T7[46C_ -I? GQ(H7?);I%<(/=95/\ +-<C
M\;?V-? _QNUZ/Q(MUJ7@WQC& %U[P]/]GG;'3?CAC[\'WKP;6/&GQ,_9<\02
M?"[XJ^)&\>?#WQ793VOA_P 6W8Q=6]P$^6*X)RQ^; Y9OO*P;&57Z+'93@<]
MH8FMD]3EJ.,Y.A)--:-R5.6TTMTGRRY>C:*R_$5,'BJ$ZR^&4=5ZK?MYDG@:
M8FQ@/L*X+XM:>FA_M'?!_P 26B"VGO)Y],N[A?E65&3"(Y[GYVQGV]*[GP9A
M;.(#G [59^*7@)_B!X/,-FWE:SI\J7^G38Y2XC(9/U K\NX1QU#"YE2GB)\M
M*K"I2D^B56G*%Y>2<E)^ES]JXFI5:F!G*A'FG!QFDM_=DF[>=DTN^QZU!VKR
M#]K+3XKSPGX6N)^(8-6\MN/^>D+HO_CVVI_@O^T)H7Q(G_X1^_;^P_'%INBO
M=%O/D<R)]\Q9^^O&[CG'45-^UU8_:O@5?S X-I>6TW_C^W_V:N.KA\?PSF,(
MXVDX5:,HRL^MG=-/9Q=M)*Z:U08#ZMGSC0IU/<KITVUNO:1<'\TI;'Q;\)UB
MT'Q0;,3L+B:23;'/*6^93R #V&.@]:^I/%VCZCXH^#.M:8GEG5KO2Y(@(,A#
M*8SPN><$\#/K7R1X/UR6#QA%-=Q) LERL2SR,/G!4$-[$ME??BOLOPA-=I:I
M;R)-=0R(\XO&V*L?S#;#@<G@G!QT7DYKNSB#RG-EF&$ESTZO+B*3?5.3=I><
M91<9+NK]4?25L1+,<MA@L73]G6H7P]5+92C%+FC_ '9IJ<':W+))['C_ ()O
MHM5^%&EK#^[EMXC;2J1RDBD@Y'Y&L?\ 9TF&C?M+:.P&$8W2N <9W6\A/Z\U
MT5GIL4>J>)E@F>."+4Y?]'C ",Q&23]#GZYKDOAE,MM^T9X3D#*8I+](V*G(
M(8,I'ZUS<51I4<YQ$Z:?)4E&K9[KVL54Y7Z<UCU.",14S#A2M2FK2A3J4[]'
M[)RI\R]>6Y]%_ &/2X_#/B_XDWB[]0UC4+JXN[M8VED6W@)58U"@L0NUCM )
M)/?BO1$TNTC>6YL%9H[ZY:ZN=TS%78Q[#E6S@?*HVC !&?7/BO[%^G*+'QQ-
M%J.I76GZ=X@O=,L(VN2UFT(=9-ZITWY;[WH:]KU3Q!'I^JWEH;+4)/L]JER6
M@M"\3[W9=J,/O.,9*]@0>]>OQI&=/B+'1;O:5EY0LN2-NG+&RMTM8_).%X^S
MRO#J>Z6K[OJ[^;NSEM:UA?#XU;6-7U."U\/6ZJRM,@C%MCY6RW\0).<G&*^8
MH_$UO\6?VH=/\1Z=%J5WX;\/P/96FHV:-]FFN0LC'S' XC(9AVSM3UY[SQ;X
M-/Q>\5Z[X0TB_"^%=-EEO]0VL5CFO)CN2!MF"R;@S,<Y'/.2"/1]-\/P>$O#
M-AI%O:V-C%!;JAAL(S'%YF/G*@\X/7G)]:]2IB,/PY@Y05Y8VO2Y5'[%"G42
M;;_FJSAY)1C+=O1<N6X.IG5:52K_  %4=Y/XJKB[65G[M.+NHI/6U^IZO^R#
MJFI^(-2\2QS7%F4L+V.242VN^62)XG"HC[AY>'4'.&R 1QG-?3YE/))"JO)/
M85\9_L/Z;;^&?B]X[M;<,B:Q;+?NK.S%IE<*Q^8G PW & *ZG]M#QIK4FK?#
MWX+>"[[^RM<^(5_)%>WL1_>6=@F&GD R#D@N1R,^6PK/A7!U,X5+"JI_-S2E
M]F,;RE)[M\L4WYG@<3TX8+,*OLX)1]VR6BU2V^9H?%3_ (*"_#+X;^()O#NE
MQ:OX^\0P!O.L_#%K]H2!AQB20D#KQ\N['?%8W[-OQD^+7Q2^(#I'\(+/X;?"
M&&.:9IM3#1W\US(?,!C7<N=S.6)\O;][Y\D"O=?A;\'O!WP/\,V^A^$M$MM.
MAC'[VY$8-Q<R=Y)9?O.Q]2?0#  %;NLSZJT^GG3?L@A^T@WWVK=N\C:V?+V_
MQ[MG7C&?:OJ<3C,IITI4,OPK;>GM*DKR?FH1M&+[?%;NSYF,:KUJ2^2+,SK&
M&9F"JHR6)P *CAFCN88Y8G66*10R.ARK C((/<47$,=U#)#-&LL,BE'CD4,K
M*1@@@]0:J:+:6>GZ5;66GV4>FV%H@MK>TBA$4<,:#:JH@X50   .,8KYLZ#)
MDTG5[?Q\VM/XBNI- FT^.Q3PZEFACCN?-9C=&8#?DJ0A4G: N>IKI*JWNJ6>
MFM;+>7<%JUS,+> 32*GFR$$A%R?F8@'@<\&K+L(XV=N%4$GOP* *>GWEY-J6
MH0SP01VT+H+>2.;>\@*@L77 V$'@<G(YXK@?VKM-35?V>?% D&5MQ#<_39,C
M9_2NT\&^+-+\=>&[+7]&DDFTV^4O#)+"\+, 2N2K@,.0>HK,^-VG#5O@CXUM
M&Y#Z7,?R7/\ 2JCNB9:Q:/D#X>7'G:/ <_P+77MUK@OA9-YFB0X_N"N]:M7N
M<\=B.XYA->=^&+K^R?VB_A[<]-VKQ0$_]=#L_P#9J]&DYCKR#QE?'0_'7A?4
MP.;75;:4>V)5YIQ(GW/TFU 8D-4:T=2'SYK.KG.T**** "BBB@!K54NONGZ5
M;:JEU]T_2@#H- _Y ]M]#_,UH5GZ!_R![;Z'^9K0H *_ W]L3:?VR/BR&^Z-
M;.>__+..OWRK\!/VS)/^,ROBXFX _P!M$X_[9)S7'BU>DSZ;AR2CF,+^?Y$E
MK;P_9%^S[68  #':L^\E_?%$93M&=O<9JQI,+6NG(Y8C:HRV>_I]*J2J!)),
MN-V.2<BN>.Q]?B/B9-:2(TFW<>3R*;<6Y\F0X9E&1UY-)I=JMQ#+,1PO]T_K
M6E#LFC* Y/8'G%:J5G8Y=XL\5U_3GMYY9-I&>1FM70X9-0L=F_8!_%6KXTTT
M#S%QDMZ=2:Q='NC;PR1J#QT!KNIJY\YBX\C;.>NO#=M;^*+)=4NW;2I)0)Y$
M;YE7/-?0_P"TMX5^"UK\*M+NO!=W&VO1HA=870D\ 8;'7G->.)ID6J+*LZY4
M_P![IUJU!X!T[RR8T4L.??Z5V1I*S3/"5;==SG-'T6&_TVTD\D)*OWV Z\58
MO-%*@^6"WTKI4TMK&,*BG'3'2GV\;-, \?'4U7LS3ZP>>W5K)"W0@^AK3T>W
M>3@1L3]*Z?5M*1XW8)AATK,T7%I<,&& #51I7%+$>ZR94:-<[6R/TJ>SO S8
M4CKZ5MZ;):7*R1L1\W SW]JS[BS@L;G='P,XZUT1HGDSK<S)VU!(8]K2*KG@
M;N*;!J$@!^; ]:Q=07[1=0EN55LFM:&WC:/"LO/2M?8C<S0MXYKJX5P&V#&:
MU))]O _^O6=9/)!"^),<=*Q=2U"ZCF54R5SFMXQL8R]X] TVXC:W<-M!9<?-
M1J<*6-FRA]N5_P#K5B:#?1O:DS';)MXS53Q-K#- JQOT]36F[T,)1U*DE[>6
MXD;8Y7U[4><MSI[&3<QZX_I65#X@>8) S Y(&":MWEX(_P!VA'X5U4U(CE.;
MOYK2.&Y#QL'"D#=ZUC?#'P!)\5?B9X<\)1:E::/_ &M>);/J-](J06L9.7E<
ML0,*H8XR,XQU-:VJ6$EQN9ER&/?K7#M;9N&4IGG%;UL/4Q-)4H[MHVHOE;N?
ML=_P46_9X\":[^Q_X;C\(ZKHUK=>!;+[5H"R7T(:^L(T5;E(FR/,;:%D^7.Y
MDQC+"OR-\/PNQ8^=Y2@<\]:^J?VTK4G]EG]D<#@)X=U#_P!#MJ^3])D F\MS
M@,,5T9)AY8>-651-=/+1ZFM;WK)'33 +:DA3(>Q S6?'!)-'G# U:?S?)"Q-
MQ[52FFFA_C.<5Z$GJ9Q]U69:VFUC')W>M;FE6*ZA9_O+A%<CN>:Y#S+F7;@Y
M7/6N@TY)-HPG.<]*PD3)HVM'L?[.O@@&X%\ ]0<UZI<6HL])$@^5L#+'KQ7D
M]M-<1S1-GC<"3GI7LFAM'JVE^5.,G;C)K)HX:]G:QY]XH\=10Z2RP2+-(!@H
MIR?0US7@/Q-IUO=Q_P!H)Y(+9)DX[UUWC;X=VEK&9[:-0Q!Z'G\:\DN-$N?M
M>V5< &K4N4F$5;4^@_$7C3P^-/5X(EE.,KM KR%_$-Q<WJQR;(U9C@_RS69<
M07#0B&(9'I4^FZ9-=749:-N.F1Q[UI[3F-HQ/1=,:VM;/>DD<DK<$KR:]4^'
M&@7,.G27,#*TFTGY>3UZ9KE?A_X9TR[MU%P.1U&1T]*]@L=3T[0M/\F%U&[C
M@@ #')-<E26ARU)]#BUU#5-;U)[&>,+$IV#S%X;W'/\ 7\:]B\-_#,Z+IDGD
MR*TK@$JA[D=L>@S7G]OXGLK'4$FDM!<@G[RJ&'YU[YX7U;3]0CBDE("ITW<9
M^7L/4'^5>+C:C25A89*+=R/2=-O8[+S))&GER/W;# &1WX/TJ]=6^KJ%@%RB
M%CDJ@+$8QP#GBK&L^7;K$\%P S-R=^-O&0>/K5[PQ<&:=A)*K' 'RG<3CG\^
M.U?/2<I2/9A5BCD9M)U/3U%S+8M/)ECG;E2#GJ#^!K!F\37EQ(RRZ8ZD,%8(
M@VCG&1ZUZ/XNUI;-!&TN\N,JH4D+DYZ^OZ5Q%EJ!@$K2,K[R6PH(//MCWKIA
M'N*MB/AL<U>^+]2L%") ;8*F,A#P ><X.*DM/$MNS1Y0AW&XR-R"2<_TK;UA
MK;4(<K$P& !@#(YYZ_2I5\/Z9<*GF0-&2<*R'()(_2M)Q]T]2A4C;4TM%\0+
M-;K"DL<2DA4' !QR<CMT_E74:/+]HMW%PT@*J1\S9+'MSZ5PE[X=/D$6DRG>
M=@7&-N.N._\ ^JHM.U;4;"-WNO,?RVP!CKC@8/\ GK7DRC=Z&\JE-:GN?A>R
ML[]4:3_EF<A8PK#YB.<?0#WZU?U_3X-+ODD<)@$')8#;D?7')KQ_P[\0KJ.[
MP(F@<_-C:<'! S^HKL;KQFNNJL,AV2[?X3D"LW2;,'72V.GFO46,??<9PI&0
MA!&?3VZTR&Y 0AR!&?ERS<%@,<#OVQS6'#J26]O_ **=\+;>,G.['!/MFGVF
MH1?; LDHP!N+,V<'WSWY_6E'#M,SEB-"[-=?8DFQ<-YF3\^06P1Z9'?'M5S2
M]9M_F,\T*[P&+@;"V>H.<YKG->UH*%DV94* N5XXSW^@S6?'>[5D<A9@Q!&.
MX X'OUKHC09RNO=G=:C>!MHM_-6%CM\PY*^I^@/\S5*?45?<LQC3&UG*N.N#
M^9Z=:YJ'QQ)]GCC$&Z0 853NP/?\*W-#LUU21KEXF\L!2RL<JI!P1CMT/-4Z
M+CN=49Z%&^DN+XCRBR+GYH\[<J>IXZ<<UFKX96U5W\PERG0G*]1VXYS^/-=5
MK31Z?_QZ,B)G<#W*C.2#7#7'B S2R0J<'=YA;=P,\C(_,\>M1R\I7-<YC7%^
MUMF(?O&(/'R@Y ]_J,U?T_PW)(B,V"0 [KSEAW^O:I(]*:^O!+),LJ.,;E['
M/TKH)H8M,TL%"'9228R?NGKV[_XU',:TU9G*:IH<4:L?-'F [-V0#CU_6H;3
M[/9@(+0RC(VG:&W$8/7/U[U%DZMJ^,X5<KYBDXYZ>OI^E=O:Z':6=FCLX\[<
M6.U]S'_9Z<=OSK2,B*APOB2QBU*(DV:Q*-RE7 "^N<]O\:\BU+P+IUGKADCC
M0S$C<5PJD]#]:]W\16)G\SROF49^5>,Y[?G_ "KF'\,VS&$R1>9(.N3C!..<
M^F*Z(U53U9QR@Y^ZB/PWIJQZ.6*"(@\/D'G'0?E^M0*QFN&CG;*)P6"X^AZ^
ME:.H:G%IMJRJNP@8"CH6P.,UQ5[K1D4*[[%SN+*.,@]Q_A7/7Q%UH>Q@<#S.
M[-W45M;>UBD=(W5>2JJ&^O\ .N)\4:S9PLSQ1QVX;)52>,_Y_G5'Q#XXMTA,
M9*@L-A51C(']/_KUXWXP\5W>L.+:P#/@@;<<#W^E?+U,0^;4_0,)@HV2L;NL
M:Y=ZEOALYH_-((4!L ]OY_E77_!_X$WWB&9-3U+S)'F +==N!Z5+\&OA%)K
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MW&. /;W%2Z',4\5Z)TDC>YV]^#@XJU+WX>J_,S<7ROT/;J***_0CYTR?%?\
MR+U[_NC^8KC--_U8KL_%?_(O7O\ NC^8KC--_P!70!K0U<6JD(JVM $E%%%
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M.3E:ZW^7YL\L^ +7T?Q>UKP[HFHJ/A[X0TTZ1&J."E_?,5:23D#<^Y968KP
MJ]F%='\3/ANOQ/\ %7AOPW<ZH-'T?4=2_P")G=,^T+9PQO//D]/N1G&>,XKO
MOA=\-]#^&_PYT/3;.U7STB$\EW/%B=[B1/WCG(RI.<8[  5X_P#%SP-<>,=;
M\">!+;4[F"#7-:M]+EO)YB\OE,?WA+?Q';GZXQ7'@\;2Q_%<,3AW[D>9J<DK
M^[!MUI+K*Z=2W>R-*T7##V>^GYK3]#ZK_8$\8>*?B58?$7Q7>7MTOP^EU?\
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MD]6^BW/I'QKXKTOX>^&KG7M<EF@TRV:-)9(+:2X92\BQK\D:LQ&YQDXP!DG
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MGKZ<>G8UR**B[H[>4>P<*V3Y@V<J/7/3CT'X4_PNTG_"5Z2=BJ3<*K;9!\P
M//Z=O2JD+-M,0#%L *WEE=O'3BM?PW&&\3:4Q+ BX5N1U&, ?_7]J:?[R'JO
MS(?PR]&>TT445^EGRID^*_\ D7[W_='\Q7G>I>+/#_@?2%U+Q-KVF>'=-,@A
M%YJUY':PER"0N^1@,G!XSG@UZ)XJ_P"1?O/]T?\ H0KS/XA6D5Y\&?',4T:R
MQ-H5\&1U!4_N'Z@T 5HOVB_@Z/\ FK7@7_PI++_X[7HFGW5GK6EVVHZ9>6^H
MZ==1K-;W=I*LL4R$95T=20RD="#BORA_85^*7PK\#_L-_%O2_B+K>B1-J%U=
M"WT6^FC:ZNV-HJH88"=['<1A@.#SD5]$?\$W?#OBK]E_]DCQAXF^+?VKP[X:
MBGEUJSTW4(V%Q:6RPCS'\L_,ID8#;%@$D9QEZTY58GFUL?;OEGBE\DU\O^'_
M -O%7'PGUCQ/X(3P[X-^)EY<6>BZDNK">Y@*R!(7N8?*5460%6^61BNX9'6L
M'7/V^O&6E_'CXA_"FQ^#]IK6N>$=,FU1[BU\2[(9HHXHYLDR6R[,I*!W^<@=
M#N$\KO8=T?7OEFCRS7S5\-?^"@G@OQG^R;K?QQUK2;CP_::+>/IEYHZ3?:)&
MO!Y1CBB?:N_>)XCG:, L3@*33=/_ &WI_#^J?!U?B#X'A\,:/\4K5)M'O['5
MFO&MI7\LQQ7,;01[21-#DJ6P7QVS1RL+H^E_+-)Y9KYB\!_MK>(=>_:XO/@1
MXG^'>F^%]2MHIIUU0>('G2Y18O,C,*&U3=O4@X)& &ZXP9O&'[<:?"WX$W_Q
M)\:^$(;$76L3:/X9TK3-2>YEUIHWD3SOG@C,,;&)V#%6RNT_QJ"<K"Z/IE82
M:H>)_$FA>!=';5O$NMZ;X>TI76-K[5;N.U@#,<*I>0A02>@SS7CNB_M82Z/\
M?_#OPD^('A6W\,Z_XDTI-3TB\TW4C?6LQ(;="Y:*)E<&-P"%(.WMFOD/]C?7
MX?V\/VQ/'WCWQ\B^(O#OA>W8>&]"U!!)9VD<DQ6-O(8;=VQ,DGDLW.<#!RA<
M_0'0_C%\._%$,\NB^/O"^KQP/''*]AK-M.(VD<)&K%'."SLJJ#U) ')KL%C*
MM7DG[0G[+?ACXY7GA761I]AI_B[PWK-AJ5EK/DXE$4%Q&\D#%<%E:-64!LA3
MM(Z5Y7\:/^"@$WPSUCXJ6VE?#R;5+7X>16KWUSJM[+8"]::=(=ML1;R*VTR*
M?F92P#%00":?*FDUN'J>\>'?@'X)\/?%_7OB?9:,H\:ZW;1VMUJ,LC2$1H ,
M1AB1'D*@.W&=@]\[GC?XC^#_ (=?8SXN\7:%X6^V[_LO]MZE#9^?LV[]GF,N
M[;O7..FX9ZBOB_\ ;:_;&\4/^POX0^)'PZ6/P]:>.KF/3+J:X9FOK)7CG9UA
M(PH.;=T,AYP<J 2&7R[]M*/4[S_@EG\%I=8L[&%K>'P_]BDM;AIV>$Z80'?=
M&FQR"<JNX#^\:;C)ZR"ZMH?IO;30:A9V]Y9W$5W9W$:S0W$#AXY8V&5=6'#*
M0001P0:RO'VGG5OAQXIL>]QI=S&/J8F KY4^!?[9&H:'\1_@[\#?%G@$Z"/$
M'@^QO-(UM-62Y:6,6C;#+"L?[O>UM*H&]B/ESU./LVZL_/L[JW/22-D_,8K.
M<+IP8XU.249KHTS\\_A;)G1[=?[HQ7K&G_=->-_"-I1H\*S?ZT</Q_%WKV+3
M^E?FV&UHQOV1_1N/5JLK&_9UY1^V7:"Y^!+2][?5+63\]Z?^S5ZM9]J\Z_:U
MC\S]GG7V_P">=Q9M_P"3"#^M:R^%^AQ97+DS/#27\\?S1\<?"?4K.\O#);RK
M(89S;2%0>'!P5/T-?4FCW^G0^']5DLT\R>UR]Y'8Q@S&3RPV,#[SE=N/7BOE
MKX9R7;:Q;>6L(L,-YC-N$OF9&,#IC&?TKZFT>34KSPPB6VS3+YF!$DT8G0*K
MC.0&'+)G'/&>^,5Z=2W,?;<6.?.F]6K[*U_2[\^KUU^6!XJ<W6G),BM%YBA]
MLR88 \X(['^M>3?!.0V?[3WAA@?]9=/$1GC!B>O4_&VFO?7MI>I>7%J+<.)+
M5 NV<$$ /D$_*>1@CFO)OAE((/VE_![ C/\ :2*>?52/ZUSU-*6GE^9U97>>
M6XN,E]B7ST/NC7EMM,O)M;N);H+;6[1M%$SNA7(8MY2YW-QP0,XR*YSQ1'J+
M7L5W;FS%C;V[2?O69)3-D8&?NA-N[.><X]ZW]>UJY6_DL[&REFN!UED&V)<]
M\]ZYC3_!_P#8\<HN+^\OA<SO,T,MP61&=F=MNXYVY/"YP    *Z*--X=QKU9
MJ/9;MI^7;U:N?@]:NL?&>#P])U.[ORQC);>\T[M-)^ZI6:U,K49+7^QKVTU&
M]N&6\:1&\R3;(GF9 2-E QC.%/4<<UBQ,+71--$$%Y;;842..Z!>9,+P)""<
MMQR<GGO6_+<&/53:C3)HK41;Q>,5V[]Q'E[<[LXP<XQS6+I?B*#Q(-2_L^:6
M 6%W)93-<6[Q?O$ W;=RC<O(PPR#V-=E3!POS4HSBM]E9>CYM/O#!YS7C3=+
M$U*$W:UG*:DUV<?9MOY12?8V?@3K%]8_%2ZU#2]%C?638/#(TTABCGB+JQ&3
MQN!4'OT-?1[?&BTL]J:SX<UC3[@CD0Q"XCZ_WE/]*^:OAZ@U[X@6NC?;6N)I
MXY,->PE+5,+G). <^G->LR?LWV]Y(7N?%=C$Y_@@4;1^;5[.!Y72?O<SN[NR
M_'E;5_/[SXO-E..*5J;A&RLKR:2\N=1DEV5K+IH=_'\;O"[M@P:HO^]9G_&L
MS2?V@_"=X;N6ZTO6-'E2Z>T7[78_-.J'"R*5)^1LDC.#UR!7#W_[/NBZ3&9;
MGQO9PHO7=MS^ W9-<8G@(1:E<BSU&XUB"9U-DMOI[0N(PH$K%F?YP&.> N 0
M"#7H61XW-(]KU3X_:#;ZEI$5C"US933LM_/<"2%[>(1L5>-!&WFL7"+M)7 8
MMDXP=3_A>7@<G']H3*>^;5^/TKY?UJ\LO \>L7WB758]-TRUQ)',4*F*+:-Q
ME.2,[L].V.]9^J2>'+RX2[&KR17WD20P3J&;:' ).S.&/R@\CM]:.5"YY'U>
M_P >? 4/W]79?K;O_A1'^T5\.8V"_P#"01J?]J)Q_2OD&'2;:ZTVWC2]N-4O
M8XE1KA+9P97 P6VKG;D\X'3-1?\ "H=<U*X\ZR\/ZM=,RXW+9RX]?2IE%6*C
M)G:?LP_'[P%\/_BM\;O#&JZW#9?;?$1U^QN95;%U%-$BL%XS\A1>O]_ZUZA\
M=/CM\/O&GPKUK2-*\26M[J$_DF*WC5]SE9D; R/:OS\^.WPC\4_#7QM\/-<N
M-,U/^U=3U<Z8OGV?E-=))(-D(  W$*Y0=SD$\UZC=?!OQKX:DGU/4?">I6>G
M6[!WN)+5E6->!EB??Z=:^JSZISRPF<T5;VT$VGTG3?LY?)N*DO\ %;H<=.+C
M"5!]/R98_9EUK3?&7PCAM8)TN(;9IM.N!#)Z,PZ@\94@Y'K6Y\8/(\#_  AC
MF@MWCL=$EM)/+5S(R0Q2I_$>3@ <FO+/A;J=GX+_ &K-9T&SF6"Q\2::MVUJ
MO"_:E&_('J1YAX_O&OHN7^Q_'^B:KIP>+4=,F$^GW>TY"L/E="/49_2NG,*M
M'*\^I9FES4JO)6MUY:BYI1]5>27E9F,*;JX5T+[:?=U+<.H0:QHMOJ%A*EW:
MW4"SP2JV5D5EW*0?0@CFO _BGK@\,_$KX4ZG.ZVL-KXLLI)Y68!8T+J&)8]@
M,Y/IFF_L>^+%U#X3MH-Q=LTUGJ=S;:=]H5COC0+)@=#A=W0GOBLS]J;P;;:I
MX7U_4I;F[$L5GYL4/G?NHVAS(&5<<,>5)[@UE0P]#(^(98#$2YZ7-*DVM^2H
MG#F7FHR4K?(NI>O14EH]'\TS]7-0^;##D'I6::\O_9!\<7OQ(_9;^'FO:EYQ
MOY=.^SS23C#RM"[P&3_@7E[L]PU>HM]ZOFL9A9X'%5<)4^*G*47ZQ=OT/1C+
MGBI+J)1117(4%%%% !1110 4444 %/C3=3*EA8 \]* ,WPWXGT'QE;WDOA_7
M--UR.SG:UN6TV[CN!!,OWHW*$[7&1E3SS6@T94U\8?&K]EOQ#^SYXQ?XT_L]
M0W$6H(YE\1>#HY&>#4X2Y9VC0G)/)R@Y'5,'AO;_ (-_MC?"WXSZ+%/'XBL_
M#6N*G^F:%KEPEK=6[@#< '(WJ"?O+D>N#Q7TF(R2K+"1S#+VZU%Z2LO>IR[3
MBKV3Z2V?>Y@JT>;DGH_S]#V 9J2.9E;K7A7C+]O#X">!=8;2]0^(%I=72#+G
M2K>:^B7DC!DA1DR,'(SD>E>I_#SXE>$?B[X?36_!GB&Q\0Z<<!I+.4,T;$ [
M9$/S(V"/E8 UY>)RO'X6BJ^)P\X0>TI1DD_FU8TC4A)VBTV>5?'3]E2+XB^,
M+;XB>!?$,_P_^*%E%Y<6LV:AHKM0,!+B/HXQQG!XP"#@ <$WQ _;/\(PM%=?
M#[P;XM6U'SWEE=E#= =T7S%()_W1]*^MA&RGI5VU9PP!Z5Z^%XBK4Z,,/BZ-
M/$1AI'VD6Y17\JE%QE;LFVET2,945=RBVK]C\S/AO\7!\0OB+XNMM6T*?P?X
MLCOYKB]\/W;EI(-SDG:2JE@"1_".H[$$]I\4?AO/XXL=*U32)Q9^*-"G^UZ;
M<_[0QNC/^RP&".]<U^TU\,[V^_:B\0>)O#=TNG^*-/EB>/SES#=(T*$QR#C@
MY89!'!]A1)^U!HW@G;;>,="UG0KY>&6.U-Q"Y_V'7J/J!7RF%RVK4S"&;\%T
MG4<7)3H7YYTY7<9P<7[TZ,TWRRU]UN,G=7?ZKB,?0G@%EN=S]FYPBX32:4E9
M-.+U2G![Q[J]G%G2>$OVI/"2W":1XQN/^$)\30E8[FQU0%(M_P#>CEQM*'J"
M<'U%;7QK^ /A'XW>%Y=>61K768+"2>QUS2I1ND3RRR@LIQ(A'OT/!K"\.^-_
M@O\ M.A]*E73=9U%(\?8]2MS!>*O?RRP#$#C.PG'>N8^&MAJ?[.GQJO?A<UY
M<7W@+Q1IMS=Z!]K8N;2948O"K?3.1WRAZDY[8X/ZCB*V)R2-; 9A0@ZDJ-3:
M4$KS5-M*32C>3A4C+F@G[SMKY<ZSK0ITL?*%>C)I*<='=[75W9O:\6K/L?)?
MPQO3?7#Z=J:[KJ)=P8YS)'TSGU!R#],U]"_LJWEHL.L6,\EO)=QW<QL)&7]Z
MUN5B:3:3R%WL"1ZD5XGH'AF_L=8T1[81K'J<G$LF0H!E(<<=P<_C7<ZYJVN^
M#_@R=%T&TF35-?U9=+BNHCEAYC.'QCE>$"Y/][VKMQF54L9]:PF#<:=/'5<&
MX+[%.4Z4ZM2272,4VM.FG0^LS3.:E2M@WB&ZE7"PQ<9R:=YQI5XT8)OK)N*;
M;V>O77TOPWK$/B1?%E_9MYEK+J3)%-G(?8NW/TKYP^.,9F\06$"$F<RKOV]@
M#O)_)?UKZ?N/ ,7A?X>P>';:]ELI;&+S#?6<:AY)!\[;0V[[V"IZ\,<5\Y^+
M-!N?MX+HUSJ=UYDCJH+,J\<?0#&:^?CCL)2S2OQ!1;<8Q>&PU/><W[)4E.79
M1@^9KK*2BNK/0X>P>(J4:/#M1<JD_K.(J/2$(^U=5P3_ )G./*NBBG)]$?<7
M[5WB2/0?@'K^J_VE_9EX;139LMR83+*X "#!&_(9CL[X]JSOA)H\>I?!'X;?
M8[.WF%G;65TAU2%MT; $2R+T/FD,^">/FSR#7D_BK6M<_;)&A^"/#^E7.F>
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M>#9VI1L!]G<<5SR=[7(EL/L]<_TY88@=L9SM08(]Z]I\,ZI+-@@_,%#?-R"
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M7(SA1DD\U$MBCY/U);K]IS]O*#3I]O\ PA/P?6.]:( G[1J<@!0MVRK("/\
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M/:'1@=W(ST/2O//%OA3]I'Q5I,^FZKK?AG1M(O"MI<_V5;/<3B*1@C%5V'(
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M(C0EBB!(T4 LQX)).:]8;K6;W&A!5RR^]5.K=G]^A$S^$^$-2C$'Q<\:H/\
MH+7!Z8ZN37=Z7]U:XKQ$?^+S>-?^PG+_ #KM-+^Z*_/%O)>;_,_H9ZX>D_[L
M?R1T-GV^E<%^U61_PSGXJS_>L_\ TKAKO;+^E>??M8L%_9U\2#^]+9K_ .34
M1_I42^%F.7?\C+#?XX?^E(^,/AFL&IW%K/;W\B)9W3K+'&WRNV,%'R.@)SQW
M KZK\,Z-:^?'J8A<7@MO(\P2,$VEMQ&S.,YYSC/O7S%\-XS<+$MK)"&6X'G
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MXN"0?D(!!(^GI7J3?\+4\!VL][:VUU8:,)41+5@+@1[W"* HW,!N8<XX')(
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M4.FM3BR>Z\T!HR67"!,?-O&1G/'XUTRG]=XR=7*I))U^:,MHV4KRE_ALF_\
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MZ'YHK^S_ /'".0RIX)O"><;KFW./_'ZL?\*'_: NHG7_ (0Z[^88RMQ!D?\
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M,=372?M%R-I/PTUK5+RX>XTR&:TF-JL0S&J2J7((Y;=Z'IBO+/@/J&I_#O\
M: UOP9<VC6FA^(HY=4T^W:42[&5F_>*1]T.%?Y3R,+Z<_2GC+PG:>.O">K^'
MK[_CVU&W>W9AU4D<,/<'!_"NS,*U++>)89K>]&K*-==^2H[M6_FB^9>J.:--
MU<(Z#WMR_<231Z;K%OIFJ26T;R*OF6<\T0\V'S$P2I(RA*G!_(U\V_M))'HM
MMX)BN)Y[U8=8C0SW+!I&)4JK,0 ,Y(/3M7<_LI^+M3UCP)J7AK6WDN-6\*ZA
M+I,D[ G<D9 4%NY'*CN0OL:Y/]I[P[)XA^']U;WMS;1ZK#(US9^3\@=DW,J
M,Q)8ID'GKS[5QX/"T\CS]X'&S]Q.5-S7\M2+@IKRM)2]"ZR]O0NO)_<[GZAZ
M&#_PB>B_]></_H I6ZUYG^R7\4I/C3^S7X(\4W"".]EM#:72C@&:!V@=AR>&
M,>X>S"O36^]7S.*PM3 XBIA*WQ4Y.+]4[,]*,E**DNHVBBBN8H**** "BBB@
M HHHH **** "BBB@ I=IJ6& R'@5R'BCXV?#7P)J/]G^(_'_ (:T._'6UO\
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M7[_S8D%DMRD&49U5WWOQA5);'4[<#)Q4OCR;[)\.?%,XZQZ9<M^434^H/8^
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MX=Z"=+\(P2RMMNKLF=^.<= /R'ZU5&CSU-=D9UJSA3TW94U;PY;?9T@AA1(
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M^2OS&B[PNNI_1F)CR)1[)+\#>L>U>#_MT7RVWPZ\-6[':LNIF0L>@"1-R?\
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M+K&_1]4^Z2>ESF?%/AJ/5?#-MI%]J=_-+$8I/ML4_P!GN)FB8-N+1A<9(Y
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MIQ2-)YER$CFCS'S+'U;!!QWXZ?CBI<UG6OAO2M/UW4=;MK"WAU;48H8;N\1
M)9TBW^4KMW"^8^/3<:]\^,-"C-%'0$GM0 "LKQ1X5L/'WA^_T"]NKVWM[@*L
MTFF7LEI<)@AAMEC(=#P.00<&B'Q#::AX9&M+<-I5AY?VAY]2A:W\F-3EC(LF
MTH, _>QCK6WHES::A;P7UC-#=6MTBS17%NP=)4(!5U8<,",8([5,M$!\1?\
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M ^0]R.H_SBO3--A$S_*O# J2ZXZ8'Y?X'UIT_>,Y^ZSCO%[)#'(JG8"<YX+
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M]9L8KV-3U3>H)4^X.1^%:;=:^7G2G0G*E45I1;379K1GIWNKH2BBBH ****
M"BBB@ HHHH **** '+(5IWG'UJ.GQIN-( Y-3QF.WC>>9Q'#&I=W8X"J!DD_
MA7&^/OC/\/OA-M7QCXQT?P_.RK(MM>72B<JQ(#",?,5)!&<8X/I7SG\4/VK!
M^T5:ZA\+/@/:W7B'4-6A:TU3Q4T#16&F6S_+(0S+\[E20. .<@DC ]W+LCQV
M9M2ITW&E]JHU:$5U;D]-%TW>RNS&I6A25V]>W7[CBOA+\,V_X*&^,M9^*GQ)
MN;]OA?8:A+9>&?"*7#0I(B#!FF*'(/(SM.2P89V@;OMSX>_#GPG\+])&D^$/
M#]AX?T_.XPV,(3<?5CU8^Y)K"^#'PKTSX&_"W0/!.DR-/;:9!L>X88::5B6>
M0CW8D_E7=6/+9-=>=YQ/'UY8?"S<<)!VIPU45%;-K^9[MO5MF=.GRQYI+WGN
M?#GC:]&J_'KQM.IW;-0\@GWC54_]EKSFWT]O$'[8]E=J!<6V@^&]KMU$,TKR
M8'LQ1@?H:YCQO\>(]#^(WB'3_#VE3^)O&&J:E<3PV$/W(M[LP:5NPP<X';J1
MP:]D^"W@.Z\(Z3<W^M2K=>)M6D^U:C.HXWGHB^RC@?0>E?!Y11K9/EV*SG&K
MD^M4ZE.C%_'-5':511W5-1YK2=E)M*-]3]FS":Q53"99A5S>Q<'4E]F/)'X;
M[.3=E9;:M['K=IS@5\O?MY_%!;/2="^'%FBR7NKNNH7C,2/+MT8A!_P)E?/L
MA]:^H+'H*^0OVY/A_--\3O!_BB"3<)M+N+66,_PB!B^?Q$Y_[Y]ZC@^%*.9N
MK.*E.E2K5*:EJG4ITY3A=;.S7-9Z-I)FF,5.K6P]&O-QIU*M.$VG9J,YJ+LU
MJKWM==SB/A^]UJSL\3^3=Q.D6^>!O+ &TX49&X;3C(/7UP:[7XS6K>-9/ _@
MBW1OMUUJ"7L\D;'$$,?WC^IP?;WK!^&%Y#=7OV1#(9;=(V=3&0HW D8;&#^'
M2O2M-\B/XR?,H:Z&A,85) S^]3('OC^M<O"=>=+'5\YJWG5HTZE97ZU':*D^
MZ3GSOT['TG'RI0HX7*J"4:52I"C9;1A'F=DMEI#D-?Q%J5G=6DM]#.C0-D>=
MNPO!(/7WS7S9>:#%;_&#0$M9&2UO-2@,EM]X&5[A2TF3SSTQTKZ(\<0VFJ6,
M]A>Q0SQS1YDM9<,&7/<=QFO%/#,/]H_M#>#+4J#%_:<!_P"^6#8Q^%?/\J6&
M<?3\T?>Y-%1IU:\U\$)--7O>SO\ +Y^I[1K'BC3_ (5_MM>)Y?%%Q'I>D^*M
M(MVL;VX;9"\D;* N[IG<K#'N/6O6=0T?2?%&I7OAV_TK4[VQT^YCOVFU#<;:
M:5R94\MRV9%0\;1\HR%(XX?\>/ASX+^*^CVNB>+V2WD>X5=.N_-$4T=PV<")
MCU8X^[SG'3I7F7PD\9:E\-?%NI?"WQKK(O3IT4<FC:Q=#RQ=V[D!4+-PT@+!
M2,GD8R<BON\;[#B+ T\9AI\N*P]*,9TW]N%)<JJ4WU<86YX.S5G)75[?SUAY
M_P!E5_8UU>E5GI+M*7V9+HF]$^]D]SMO'?A'PU\1]0FT3Q+X>CU:&WMUGBN+
MBU8(FYF4JDP_B^7)"D$#![BO'M<TUOV<=L]A>7$G@.>=8I+6X<S-II8@!E)Y
M\O.%Y)(+#)Z8]B\16_BRV\+Z_;VU]87VLW#3KI,TH:V6,,I,:R%0WS*>-RCD
M '&<URGQ3^'EC\2/ 3>&M9GG+M$KK-'.RGSD7"NQ7&\!B#M(P2 <<5Y62YW4
MP,J>$QE1SP,VE4I-MQY7\4HQ?PS5[QDK.Z[73^@S#*88^G*K1CR8B.L)K1J2
MV3:W3V:=TT]2[\+8X];^/7@E8\30M<&X5EY& A<-^E?:1U+3]"\?/I-IH5Y%
M=ZQ ^I76JV]I_HK/'Y<0667_ )ZE=NT'JJ'TK\R_V0OCQI'P=^*NG:)\6KA_
M#<VB6LMI;:A<0LT,RXVQY90<87.&Z$ <YK],+CQ8_C3P?<ZOX NM)UUI[5GT
MZ\ENB;*6;G"NT8+!>F< GGI7KTN',?P^JRQ4>:E*;]G46L*D++EE&2T=UK:]
MT[II-,^*XAS*EF.(I2AI)07-%Z.,KNZ:\BW9>-ENO$.H:&+"^74;.SCO&+P,
M+=U=G542;&QG_=G*@Y4,I/6OB3]M#P[<^'[/P;\;M%\.:MX4^(FAQPW_ (@T
MB&>1H[K3Q,H>&>[AS&SJP4':^XQNYP0@V_<DUW%)<-:I=(+V%5GDMXG4R;"3
MC*GD*Q4C/L:QM:UN73_#_B:[\3Z=#=>'$M\QVEK:R7MQ+"8L2I+ %;>VXL J
MALBO:RG,)Y3C(XJ"YEM*+VG!Z2B_)K[M^A\I4@JD>5F5X7\5)\8['P1XW\*^
M*?L_A6X@>YGTV.&*0Z@7B91%(Q!:(PN0QV')9<'CKJZUHMYK'B30[^R\2WFE
MV>ES2_;=+MXXFAU#>@"K*S(778?F&QAG)SGC'FOPQ_9*\#_!_P"%\WP_T+5?
M$46FWNI1ZN]Q_:CQ71EC,1VK)&%*(?*4,HZAF!ZUZ9XL31+^YT;3=8ADG>XO
M5FLU1)-HGA!E5F9.% VY^8X/3G.*X\0J"K2^K7]G?2^]O/TV\RXWM[VYMR21
M[A&Y7+@X4]QW_G5'1]+TS2K9+?2X(;2U@!B6WM0$BCY+$!!\H.23TSS5R6$O
M-%)NQLW#;M!SGWZC\*:9HX9DBP0\F2-JG''7)KF&9_A6?7+G36?Q%9V-CJ'G
MR@1:?.TT?E!R(VW,JG<4VDC'!)&3UKRO]L^1[3X ZI&ERY:^O[-0K$851(K%
M5P.X0]<]:]IC99690RM@[6 .<>QKYX_;LE%K\,?"NG0GRTDU>/\ =^J+&XQ^
M&1^57'XD95?@9X[X!A\O2X1_L"NO-<WX.B\O3XQC^ 5TC5;,H[ ?NUY/\8IM
MNBW//\)_E7J[_<KQCXV70AT:?<<#O51W(J?"S[S^!,7D_ GP,N,$Z5 V/JH/
M]:ZUNM9O@&Q&E?#7PK:*-JPZ9;J!Z?NUK2/6L'N=D=$D)1112&%%%% #6JI=
M?=/TJVU5+K[I^E '0:!_R![;Z'^9K0K/T#_D#VWT/\S6A0 5\E^-K>)?BEXB
M\I/+9[QC(%7!^Z,O[^E?6E?+_BY8W^(WB(;,3+<G)P 2A [YY'!KQ\RCS1AZ
M_H>E@9<LI>AD>7* [@LT8.0,D%L8)[5'(QFRA8V\C+N?]Z6!!^Z?3UJR7B6+
M<&:*5/NJXY7)QC'^>M5G5[B7.?*58R#&V 3@DX_'/X8KQWH>HB.' Y63**^Y
ME7KQZD>XS5M1YS1MYD?* #*_<&1CG_.,"J,D6VU:)CDM@%OXE)QD\#GM4]I"
MT*YDS,K,-T(&=HY&..]1YE<I>CV-YJA3$PR 6YY/)_2F22E;.4@>850!B" 0
M.F#Z\5(NUMVT#8OS!2O/&.G/'7K[4SS!<3%5C*ER%R ,*>>F?;\>:JQ-K%58
MG9?*)/"80[@3C& ?T_2H/LI,SY82B1E!^7Y0,<YY]_Z=ZNB%EE5MDB-T=';(
M(R<#(]#4S-LMQ\_G>8 &.1N8 Y)%2M!Q>AD2Z<S-,%GRN?G?G: . H(YXY_*
MO;-)W-HNF@L=WV6$MCH?E'YUY#=2#S)$,0'S?*2&&.H[9_45[-I:@Z+8+DY6
MVC&[_@([]Z[<+\3.7$O1%?5$OSI5TNE75M9ZFPQ;W%Y UQ%$^."T2R1EA_LA
MU/N*^9O@7^QAXI^"/Q\\2?%&#XGZ9JUYXHN)Y-:TV;PL\<4L<]R)Y4A87Q,3
M9&%8APO&5;H?J,QL&9ADACD>WH:15E1\,=RX^\,5Z'-))I;,X;)N[/F#P;^Q
M#??"']H;6OB;\-OB''X4TK5Y<WGA2YT0WEM(C%6DCWBYCP"^60[<INQR,Y=X
M/_8FU3X2_$SQ'K/PT^+&J>"?"?B*;SM1\,PZ7%=;&)))@GD<K&1DA6,3$#@[
ML#'TT)FVOLQC)) YS[TS<P.P97&,U?MIK6_Y"4(]CYG^-G[&6L?%?XV>!OB%
M9?$F'1CX+6S_ +)TZ\T.34&)@D$VZXF-VC2EW'/"G;@9SEC7^#G['^J_"7XM
M>/?&FL>.M/\ %=KXY^T-KNC?\(ZULDOG.\A$3_:WV#=(1AE;*DC@X8?41\QE
MX&1TX[_YXJO-;L<C<"."/\^E-UJDE:Y2A%.]CY3B_8463X<R?"V+X@3P?"6;
M6AK!T?\ LO.HJN0QMA>>=M\O?\V3 6]^]>Q?&KX%:#\5O@?J'PR"1Z5I4ME'
M;64ZQ^:;)HBIA=5R,[2B\;AD9&>:]#CB9/G#?EVJQRW"E5SR>.OM2]K.Z;>Q
M?+%75CQ'Q!^SWX:F^$\/@)+3'AVWTQ=,$6<.45 N_/\ >R-V?[W-?+^H?LHW
M-EI7AKPUKWB636/"?A^Y:XLK%;#R)Y.3L2:;S&#JH)'RQIFOT!E@[ =1_$.#
M[_I7'>*/#"W8\QU4J#Z<G_/]*[J&,J4]C.I2C4M<^0?B?\'](\?:EI>M>==:
M+XDTHJ;+5K( O'M.0K*1AESGCCJ>15ZWT#Q9J5F+/7/%\,UJ5VR/I&EFQN)/
M]Z0S2!<_["J>>"*]Z7P_:><4=!UQTXJ=? %G>$F-2GN.:[XXN3BD^ARRPZ3N
M?,_BOX$Q^+OBMX:\;P>)+C1IM&M/L?V6.!9/-3]Y]UV/RDB5@25;.!T/-'PK
M_9[M?AGX5\8>&I_$-SK.C>(C*K1&!87A22,QM\P+%FVD?-P./NU]!ZI\+9\[
MH9.AR,5RNK>&]2TB7+QM(,XX&:OZY5<>2^G^6J,U13=SS/P#^SGJ_A#X,>(_
MA]9^._.L=7CGMH9KG259+6"8$2@(LJEY"&.'+X']VN,U[]B_5M1^&/AKP(WQ
M)M!I.@WDU[;2)X>(F>21BQWDW9! +-C '7FO;)-:N[=E!+1#/W:V;*\^V8E/
MWL5K'$S;;;W)E35K%M+&[ATNV^W3PW-Z(P)KB"(PQN^.65"S%03V+''J:CM=
M22S?<6PV.]66OFN/W;KD= 0*KKX1_M";)8X%6IJQBXL%FDUJ8X)P/05M6DXT
MB,H0.G-/LM"_LJ,;3Q4.JQ_:&P?7K6+J7Z$\I\_>!?V8;SP-X=\4^']*\?"'
M2_%FY=7\_1Q)+AF;/V=Q,HB.QBOSB0=\=J[WXI_L7>'/B-\&_#/@;POKLGA?
M3_#UPES!.\(NFE.U@QD&Y,LQ8MD$<]L<5Z#8:6-H/?WK:L?M%N^$Y3%4I-%1
MC?J> ^&_V:[_ .'OQMU'Q]9>,KB[N[[3?L-S;75A&PF?9& S,I7"YB1MBJIX
MQOQ6?\-?V,_$.C?\+&$7Q$T_/CJSN+74&F\..WD"8R;FBQ>#! E?KGMZ5](:
MHIF8-D!N*WM!@E5,!=H]1TZ_SK&KB*B6YUTJ*9X;X5_8.TK2/@#>?"WQ+XQ_
MMRVAU+^U]&UBRTH6=UIUSCYB=TTJRH<#Y<+QN&>05Z+3O@NT?QCTSXE>./$L
M7B[Q+H]BNFZ5'8Z:;"TME (:5HVFF9Y6W'G<%&3A>F/:[]99K7C:WL.I]JQU
MTF:9E<@'VQBO-]M.5TSO^KP5G8\*_P"&0ISI_P 0=!\(^-O^$7\$^.IH[C5=
M(?2OM$L)W9F%K-YR+$)%^4AHY, <>E7_ ([?L3VOQ;^&/@/X>Z#XL7P;X8\)
M9:&%M)^W3328P'9Q-&!]YR?E.68GCI7T#9V+>6HQCN!DUKQP^7U..>/4'TI^
MTGW%]7IKH?-T/[*?BJ;]I71_C'J?Q)TN]U>SBCLY=.M?##P0S6ZQ^6R!C>N4
M<J6PQW $@[2!M/OUXD-NLMU.RQVZ#S)';HH&3G_/K6ZL*6P>2X98T7YV=B J
M_4U\Y_'7XAWOB&SETW1/]'TF/)EF!P]S@]%'3;D'@]>.E*G4=]3FK4URW1YC
M\1O',7BOQQ=ZI(S16NX06R;ONQJ,#CU/+'ZUG2ZU+.H03;&P-H4_0^G)Q7%Z
MY:WFY0\3 %N,Y..A_P#U5LZ'<K9Z<!(@D4+M.""2P[#_ #UKZ2G24H7/A)U9
M1KM&J=?GM4R21@@(LARN1_+U_&J-KXOCNI@7B2XW-\ZJ!C'0\=#4<FC?VM"[
MJ"P.6!3&.3U^H'%,70(H40%!+@8$?<@^]8.G"+=V?2T8RE&Z9VD/CQKN%(20
M-J]%&%8$X(-:#7QN;<1NNQ6&U79CGGG@8]*\_7R8HMQ1HW&<+G.!^'^-7&\6
ML"$6)VVG=N' 7@\C/&*Y7&#=D=/M)Q6YW.F:P;:ZQ)-O4-E50X).1D_H/UKI
M?[?CDFB9)1C^XIR.O3\JXCPZUM=[095$I&YOE![UV]MH4/G1M&L;DC^]C/05
ME5H)I,="M*#;>IT\=X;J8S2KYL2@,%Q\W3. 2>O^>:;=2&13F$J6.[YCQC(P
M3W_Q(K$^V'3X\RI)'MP?O!ACD9&.^.]:%MK#2<@>9;H@'_ O3^?6N+V:O8Z/
MK3_E*4TDL=FTLF[Y,EM[98L3U'?IGI[5Q<_F+;W%Q*RJF=KG@-D=.G;FNBO-
M:@:\#,YB#2;=V">F<'VYQQ6'JLPU&\DBD03)P!P2#UXP._'ZUU4J<:?O,2J_
M6/=:M8S- .G77G>?'&V&R'\O)QU.>?Y5TVFZ#H[7IE**BS*KK\_&2#Z_4UK>
M&_"]C%IHD>'[/\_+8)X+ ?@/_K5JZAX=L%_?6ZQR@ *.>2 ._P"?Z55;$65H
MH]"A@H7YFRE--8V=NJ16Z@*,G<O/3IG_ #WJUIMP9&5K?8_&2.G)_#UKG+NY
MDFNH(5L6N!D$[8VZ?R[#\Z>TFLW%Q+]DTRZ;'&&A<8QG!! QR,=?6O&YG4D[
MH]KV=."23L=5=NTBPR><(V(*!F W+SEAG-8MU>"R90)HW7.3'D9VY[?H>:J0
M^#_B?K3)]F\/0S09+!KF9D;KCICK5]O@5\3KB%5_L.R5P5#MYI P1CY>#T[U
MC.BV>A1JTX;S1GZ@R21_NH%E<=<8 'X^_P"N*J6?AVSNIGE>%E:8'<<'(';K
M^%=_H?[.?C^.WVS06T:L2ORR_= ^Z1Q^E=)'^S3XRN_*6;4(8 J\@,-N>?09
M/:H=%]$=,<PPU-ZS1XWJGV325E:!4*$XR>A[#IVX_6N+U?QA:^<UNP\N5?E/
MIG_ _I7TM??LBZY?1J1K7E.,#;N#+CL>G48_G7":I_P3LUK4[ZXN&\?:A''-
M)O,,1C 7V'R]*Y*F&K/X8GNX'.LLB_WM5+Y,\"N-6;A@%!8\[ER/?^>*SYM0
M7S)&C^=U(*[< <C'8=J]KUS_ ()Y^+K&S)TGQ1<R3'!.\IRW&21CK]*\Z\3_
M +/_ ,3_  #YD5QH=GJ5O"!BX,Y1W&,L>%P#[>]>96P]:/Q)GV.'SG+L4^7#
MU4VOE^9YQKTQNXRGS;LXY'MZ5P^I:4J[GVX9>?7\Z[_5M2CCM3%?VOV"Y#Y(
MZ\^E<MJ$R>4TBEI2PSNZ9-81GRGT,:JE \KUZS22RFE:,[QD@=.V:SOAUXUF
M\,ZS$JR-&CM@@G KJM>>69"5&5YSP*\[UK0W5!=*#YC#+#WKT(+VRY7H>#BK
MVMNC[A^&GQ"COFB(D#*P^9(R#CT 'J>>*^L_AIKQOK6VF?S6RF5Y ^G;K@"O
MQU\#_$K4/!-SN0L\(8$IN(_*ON7]E_\ :.T_7;>VAN9C'>(-K0L_0>ON.M<5
M3#*F^=2T/S+-\N<DZL#[TM9GDMRRJ%/S9VG-(KF2-<I@<#..V2.!_GK6)X;U
MB*ZM=PPI/*A&!52<_P!/6MIIHF977>Q)V\KG()Q@U<9=#X%Q<6<[XE;=9D1(
M8P<,4(V[@.,9[5\V^+DE_MBXW#8H(";V_BSZ8Y'3\J^E?$EQLLYBJ.=H'R1[
M3N&>>#7S-XXN/M&N2^6^QD4##@[N,\9Z=>]%:/-U.RC*QL^!YGMVCBRJQAB#
MQMZ>Y)R<_P Z]@TC;<,IC3<BX3Y,8(YP?Y\_6O&?#.R&U59"26^90K9/..3^
ME>N:%#&UK;)O\N4\D+U ZYX_SS44H*+T8ZD5N:UU;P3QR(\1?:0/ITZ^G)_6
MN TW1%NOC;X/U!(%:);^,*57+QXSW],@YKT>2$>1(CS>6RG:&)!^@!JMH%@D
M?C[P\ =SI<)\Y &.22.O/:E7I*K*"?\ -'\&C",N5,^C****^_/,,GQ7_P B
M]>_[H_F*XS3?]6*[/Q7_ ,B]>_[H_F*XS3?]6* -:&KBU3AJXM $E%%% !11
M10 4444 %%%% !1110 4444 .3K7E_[6&K#2?@-K*<EKR:WM% [[Y5S^@)_"
MO48_O"OGC]N#6-OAWP7H*/M:]U1KMU'\20QD8/MF4'\*\W,Y*&"JM]5;[]/U
M/<R*E[?-<-#M)/\ \!U_0^8OB+\')_B)X7T[5_#TZZ7X[T/%QI.HH=C$@Y,+
ML.JMR,'@$^A.?1_V>_C%;_&#PO-]IMWTSQ1I,GV36-+F&'@G'!(']UB#C\1V
MK5\)KY5O".G KS+XZ_#_ %?X>>(H?C5X"C5=4TQ/^*ATF-MB:K9 C<2,8+J.
M<GG"@CE0#S9;4IYEAHY1B7:2_@R?1O[#?\DWM_++79L_2<UC+!UY8^@M'_$B
MNJ_F7]Y=>Z/IZQA(D45\$?&*^76/VC_%MR6PD-WY19CP!'$J'\/EKZ@^ /[4
M'A3X_>,=6T;PY%<JNGV-O>>==+L,A<D2IMZ_NR44GH23CC!/Q_JFI+JGQ"\4
M:I/:2WL5YJDL;1PQ^82))BN2/[H')/I7DUL#BL!BEAL73<)I7L]]5I^9]KP3
MB:.(GBL;2E>,(-7]7_P#V_X=QES"Z%&A9<[@<YZ8(]J[6T$'V.[O+'49-6AO
M)C,C-<"2-. I2,@<*"IXYY)KF?!=NFAZ3YBVS_9;>-0D-K$78 < *@]..!71
M:[')X5T>T@TO1S>IYT<)M[,1PK$C-AY<$@87)8@<GM66^BZG-F,W+%WETWW?
MW?CT/-?%]C8:3;:H;"WM[66YE:XN#$H!>5AR[ =2<#D^E3_L :?<_P!L>-[N
M]G6[NH;2VA>=8_+#%Y)&X7)QP@K(^(=A:Z7;ZK>11(EW=*#<7& &D*KA2WT'
M%>B?L)60C\#>+]0Q\UQJ<<(;U"19_P#9ZFL[Q2_K;_@GT>+C['A^K)JS;44D
MW:SDGMM>R[::I.S=_>-9T>#4IEE=I(IHP0LD3E2*Y;7=%NFAAS>W$ZPRK*@C
M)5PPSC)4_,.>AR#W%=#XJ6VN]/;3[C4Y=)DU _9H)[>98I]Y!;$9(/S85CT/
M -4GO ^H7UHEO-"\:))]JD3]U(6!'RG/)&WD>XITL54I**E:45T:3^Z^WR/R
M.KE=#$N4H-TZDOM1;3O;JDTG;^]<Y^6XGDAD:2 ETR NX9? _3/O7)>)O$6H
MZ/HMM=-8W%LT\D4)AMXO/:)Y" -VS/R@GEN@ S6KH<,T6DZ@SZ-_PCMU-?W$
MCQ-*LWG'S"!/P2!YB@-MZKG'6H-<N+./3WAU:?9#,0$52=XR?;M7H4Z].HIQ
MC'V=KN\7RKTE)WMY6^XXL5@<1@U2JU*GUCFLN6I%SEYN$$XIM+5\RO;[70]@
M^#T$5AX%MO[5\%ZAXJU*21Y'O88 T6,X"AC@<8KHM4\9>#]&95U;X=75@[9V
M+)''\W_CU<SX:N-+B\/Z7HYU/6]0F6(00:):L((TP2<E^2<YZ]:W-'^'%WXC
MO)[[_A#M)T"YL+M[-)]6@DN;A]RIEXV+,"C;@-PX^4YZ5]/2A[.G&#>R[W_'
MKZGYI6J>VK3J15DVWHDOP6B]+Z&/?^-- UQ1%I/AW2=$A8X-U?9FD^@1 <'Z
MYK@]>N=+\.ZX[6,MY<W.J'S9YCI@%M'Y850H#397<N<%5QD$GW^@;7X.Z[)(
MRW'B.WL;4C BTRPCB8?1P :T_A_X+\%M]OO=-L)KR]M[N2PN+S589/-:6)B&
MVB0 %<DX91@]B:TNC+E;/E>WTSQ9-;ZW?^%/"UUXDU&9EE-FTK)'Y@15"*SY
M2$$ 'C )R>IKMK7X0_$R_P#)WZ!IUFLI^?SKQ?W?&>=H/TXKZ:UK4)-/O-*L
M(]&O+Z#49V@EN+14\JT58V<2398$*2H0;0QW,O&,D:;1RGUI<Q7LUU/E7_AE
M;Q;'H;QW&H:?,\$+; D[RW$QP2!N95&X],DU-;_L6W^J6\;W/BN.P9D5S&-.
M\QE)'*DB8<CI7U%Y$OO67XEFUG1=#U"_T/2_[>U947[/IDETMNDK9QCS&!"\
M$G//2IE)V&HH_-GX[?LKV-M\<_A1\)_#?B2*]US4-0DUF_2WTWRET^U#;WN'
MQ(<LQ64@'&2.HR*ZOQEX=MO@_P".]7T<W=QKT=B\*/):6;>8S2!.!&K,< OR
M<\ $U[1^S+X9CU[]K/\ :"\;ZB5N-1M;ZUT2R9OO0PB/<X'L0L0_X"?6O'O%
MNI76L?%KQYJ=FBO<F]N! L[%4+)E5!(!PORCD \5]9Q#"%%8/*:.OLJ<;OO*
MK^\E\ES**]+]3@I24XNKW?X+0\_\";/%W[77B/4]- .F^&]&33+B:,_*9V.-
MA]2,/_WQ7M>K7VF6UO>:YKFG"V@\//)=07=T$. (CNEC()VY5G3G!Z\8// ?
ML\Z2^A_".>[L;:&XUK4;FZU"97<HDL[2N%5I-IX&T#."1Z5;_:&FCOOA=?:-
M)<QP76I&"*2!91O,;3(KD#J5!.,^]=F94*6:<04LIB[4Z;A0OUY:?NREZM\S
M2]$8PJJEA7B.ZYOOU.0_9$TVXM_A'J6KSQM!%K6JW%[;QG@"/(4$#L,J?RJ?
MQ]\0=(^':ZUK&K8D"Z5?VUK;D9\ZXFMI(8D^FZ0$^@!KU!= ?PCHNFZ5I<P.
ME6OF*ZW1+R*AR42,C "J2  1PH KS'2_ NG_ !0^/_PWT;5@)=.;71/-"Q&)
M1!#).$([AC& 1Z$UST<31X@XD>-Q$7&E*<JC2W4*:<^6_?EC:_?4JI_L]!06
MKT7S;M^I]H?L>^";[X<_LL_#O0]3,GV^/3OM,J3'YHS/(\_EG_=$@7_@->J-
M]ZK^H?+A5&% P *SS7S.,Q4\?BJN,J?%4E*3]9-O]3TXQ4(J*Z!1117(4%%%
M% !1110 4444 %%%% !4L+[345% 'SYH?[ /P>M?&^O^+M?TV^\;ZWK&H2:A
M)+XBN_/2)G?=L1%"@H.@#[CC@DBO>?#?AK0? ^DII7AO1=/T'38R66TTVV2"
M($G).U !DGO5O<:.37=B<?C,9!4\15E**V3;LO1;+[B(PC%W2'EBQINK7HTK
MPWJEZQVBWM9),GV4FIH(#(W2OGK]KW]ICPI\/?A]K'@S3-6@U3Q[KT#Z;9:5
M8R"22%W!5I9L']VJC)YY)& .I&>%R_%YG4^JX*'--I^B\V]DENV]$MR_:4Z,
MHSK/W;J__#=3XC_8OTM=3A\4>,+V-)M9U349$:Z*_,$R&95/8%CT']U?05]=
M:?\ =%>1?!7P5;^!?!NG:1;?,(4!DD_YZ.>6;\37L&GKTKY/B;&T,SSS%8K"
MRO2YN6';D@E"/+VC9*WD?MF6TZM#+*,*T>6;5Y)[WEJ[^>NOF;]A'\J^E?%_
M[1/QNTOXD>-KG3="N8KS3]'@;3X;F)MPFGE8>>RGN@5%4$=3NQ7T3^T=J][X
M?_9_\:WNG2/#>)I[(LD?#(&(5B/P)KXWU;0=+T/4/!NGZ5"KP6OANQGFDA4$
MSS21F=VXZG,N/P KMR^-/*\DQ&<VYJU63P]/M'FA>I-]WR2Y(K3XF^B+RK 1
MSKB##X*L[4J*]O+^][.2<(^G.DWO=*VFYZ1\-;<&.)8'CD,9"-AL@$$9!QT.
M*N_&VXA\,^(O!GBNPO-U_9:C%IEY:Q.&)BF!.&4<@D ]>H(]*L_"G3X6MX+F
MTL?L4=T?M$D;Q>7)N8<EA_>]<U'XJTO_ (3CXH:$L=G(FGZ; ^LS6SP>3+<S
M1L$B#YQDY P6[$]C4\(J.%S-UJCM1I4JKJ+^:'(XN/GS-J*\VGT.KCO$?6*5
M*GO4JU(*%NDK\RDNNB3;\KHZ'QEI]DNH-J#6T"ZGY)MQ<8!D\H-NV;NN,G./
M4UY+\#]/N-4_:HT03W"S0+=O/!&(]IB6.W9B"<_-\P)_&O2/$T8U."TU>]T]
MK341!E89RK26N\#>FY<@]!G!(XKEOV3[$:S^T5=7(*^98:;>7$;'D*Q*0@D?
M]M#Q7RT;QH)-]O\ /]#]$PR5+*L76M:T7:UU>ZMJM.^SOT>^WV)J5C:^*H67
M4M+>,6]TS0BZ52P9"0LJ$$XSU!X//05\S?M8QQZ/XU^$]U)/,;'^V7L+NXDS
MB-)%C.TN,$9&2,'((SVKZ0OUV65M+KVH1QR:9&EY<7=O(]M$756#LRYP(^IV
MLQ'KTS7F/Q&^&MCX^\)W/A'7;R^UK3[Z7-AJA@#2Z:Z1*ZR/+QNRV[# <APG
MJ:^HX;S:&3YI1Q&)D_8^]&22O:,XN$FD^RE>VE[6/PC,LKIYA0ERP_>-*SO9
MZ.Z3MYZ+>VYTT2:A"UQ;W7DS::43[(4+),J;0"LFXYSGH>..IS7GNNZMJ_A7
MP'J=]JP>_P!4T]9EBNUM-QGR?W;^5$6(7E00#G"D\5R/@+4/$WPW\967AGXB
M6<6J2W5N=-TOQ;"6Q<Q(=P@FR>&YX) )]6ZUZ!<>+XFO]6TY[:Z;[ 4CFDG@
M,<4V]=V8FZ-@'!QT-<N9X".6U%2Q#A*G-7A5IN\)):7MT[2BU&47O'8[<MJ8
MF:E+!U)2E#25*I\2OJN66G:\6W*+LTI+4[#]E_P%!\3-)\;2:UHV@ZY?K8P6
MT<.LV7VBQ^T,I<DHWS; RCC(;'?-8GC==,_83^+FE:[X.U&'_A7VJ7-M9>+_
M  ?!,9!I$MQO\F\A0L61'V284C_EDV"=WR^L_LIZSH'A'1;Y)+R6VBU>[:XA
MFNH]L3X 78'/=2K?G[5)^W1X5MOBM^S+\2["TLYO[0T.VBU2VNGM69)WBQ-M
M@903(Q3?'QT9\'O7VW!6*>5JC@<7/_9:K:J1O>'+-OWETO&_,I+5-'Y_Q'5I
MYACZM>FFG&UKJTDXI*S6_DT>VR:!8W"7>HK:+_:5]:BVDOHE2.YEA4N8U\U.
M<#>Q7GC<3P2:CTNSET#2[73X!=7WDVZK&UY<>8_RJJA7D.69CW8Y).237F7[
M+_CK4/CA\!?AIXLT^Y72O)@%IJ=K=6I>24P!X)8U8L-N9(T</@G ((!)QWNG
MZ7X:\0_$K4]9@MKS_A)M!@&C37$WVB*'RI=D^U%8B*7G;\ZAB#E=PY%<>(P\
M\)7J8>>\&U]SL>7%\R4D1PS70UKQ7J4.E7_]I6T,=M:VMSJ"BWOE2,R))$@9
MA%N>5XF=E#$Q<@JJUI>'-4U74/#&DWNLZ.-(UBYMXGO-,AN5N1:2LH+QB7"A
MPI)&X 9QG%6-<EN-%L[>0Z5=:U+<W4-I(MA&FZ..20+YC[F'[N,,6;!)P#@$
M\5K+IYC545<*HP!7.,QM+TG^Q[6XB6ZN[TRS2S[KJ7>Z[V+;%/95SA1V  J/
MP[?7=]I5G+=Z;<Z9*\(9[>[E226-LXVL4)!/?()'-7Y]!O9=>LKY-1GALX8)
M8I=/5$,<[N4*R,Q&X% K  $ ^8<YP,)KMK?V.FWU]IUF^IZA#;2&WT_SEB6X
MD RJ;FX4D@#<>!F@"OIND:9H=U=S6MK;V4NH7/GW#QJ%,\Q4+N;^\V%49] *
M^:?V\;L2ZE\/=-#?/YMQ<%/4 (N:^J-%@N[K3+&XU&S6QO9(DDGM1()!#(5!
M9 PX;!R,CKBOCK]LJZ_M3X[>';!5R-/TE7S[R2OD?DB_G6E/XC&M\!F>&8]E
MF@]A6PW6L_185MX03\K-@')Z\5+->SV]U90&SEF%PSAYX<>7  I(+Y(// &
M>3Z<U1"V+$WRQFO#_C(%NUAM6Y$\R1$>NXX_K7MUT"JLV\[=N-O8>]>2ZE8K
MXB^+/@K26&];O6K6(K[>:M5'<RJ;6/T?6V^PZ796HX$,"1X^B@?TJM6AJ3?O
M,5GUSG<%%%% !1110 UJJ77W3]*MM52Z^Z?I0!T&@?\ ('MOH?YFM"L_0/\
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M,8E\*F#>VTE[_)'_ )"YYXKI=2^-#S,RKX3$J]<K?CIC/3RZ^9M/MX9(8Y2
M=I*A\ \8Z?I78^'/$,^GXBF0D?ZO=D'<.3W]AW]:VCB)]6<4L/3CLCI/%OQ0
MTQ5+OX25KG.!&NH<;O3/D^M>2>(OCUXST2.66'X5+/;QY^:#Q$I.!WP;<5ZQ
MJEA9>((UCWIYFTD8X*GG/_ZJX"8&QNA:R0*\" X^7.5&/0=ZV^M26YC]7IR6
MB/)KK_@H9?>&6*:A\*+JW(.-TVL%0>O0_9N>AIMK_P %/UCD4+\,V8Y_Z#O_
M -S5[QI/@GPM\5H'T37;*%H9%\H;AV'*Y]Z^>OCQ_P $T?%'A>&Z\0>"2M_I
M"@R&TDD&]!C/!_H?SKKIXGF3N<53#..SOY'03?\ !3:5XUS\+9&W#)_XGA_#
M_EUJO'_P4@GO)C$OPLD#J0&']NXP3TS_ *-7B7[+_B[PGX<\;3:'\3K:2WCE
MD6..6ZC.8W^[AL_=[<]*^D_CS^PWNT=/%_PKDMM2MMGG%4955\XYSWQS^5>C
MAJM-RM5.7$4TU>E^)!8_MZ:C-&?^+8>4YR/+E\0A&/\ Y+UK6_\ P4$U&UL&
M>3X6NF8RP"ZZ&);L/^/?BOG;P_X-3580=5M/.OH&"F&8%2C=^3R1FKVJ:7)I
M\(AY'][+#@]J]NK/#-+DA^+_ ,SSE&I&7O;'H\W_  4QG%X!)\+I8SNZ'7,?
M7_EVKWCX=_MP+XJTT3#P*UONVC_D+!QDY':$?C7Q>OP]34E9R<!^5.>..OXU
MZE\'[6W\.RQA%58T<Y5@,=#R>?K7B8E12;B?59;"C*ZJ*_\ 7D?9NF?M#7&H
MVY9_"'D/T6-M0P2,X)!\JM@?'R./:#X:8-DYQ>Y/ Z8V9/?\J\;.H)<PB1B&
M"@8(&<#/(%6M/O8V,2LJ!1_?QP-W7/IC^=?/2G.,MSZF6$PTHIJ'XO\ S/5/
M^%_3Q<IX68CJ ;T#/7_IG63K'[26J*'2QT:UM".C3RF0YXYQ@#&:Y*_O(X89
MTCB1TD0[@S#H._\ ^JO,/$%C>33;HI,DL2K(> /\_I6L?:3ZGD8JG0IJZC^9
M[%_PG&L>)+I9M6OFNMK!8XE(6-2?11]>O6L[Q#/';+'L4*Z@[6*[E^HY_0?6
MN!T"2^L[>1FP[-S\S#<>.:?)J\6I_*ZB4#!=9>WS'D?Y_I7IX;#.]V?&8K$I
MW2*^J:I;7T;*BDRCY H)7D=R?7BN0O)BL+LJE=TF0%&<#J?H?_K5TFK3+&W[
ME$(8G';"X[Y[\5QUYKT>B396#*XW,5Z9!XKZ&F^6-CXN:YJESO\ 0[PQZ8IE
M1/F'+L<$YS^/UJ1IK1H]@81A2&#%@![#OQWQ7F.J?$:74+#;#;-O&0/+/7GC
M''^<4S3=2O9=.V/D!P<[^2"?TKS\;&2Y7$^MP,XQBU(].\N&Z640LH?(/[PY
MXZG@>@_E5+4(X[A2OF9RH.U<$@>GXUQMII.JW%O(ZW15VQR2H'M[X-;_ (=T
M:^DDD\^*1W498@=6Z#YC7!2YN;4VJ2B]AFGW]W:W?F+(S@9P <+C)]>IQC\S
M^/K'A#Q]:H+>.X*@M\^6(X;V]NOZFN<M;:.[#P36BKM95+=<GO@4@\/:5YD;
MM %VGKD\GIU_$5Z55KD1S4UJSO-<U^SU&W!0QO*"VX(,C!'<YZ\]?YXK$A\2
M1V,)B:1([=1PRY&6'4GVQWZUB[=)TNX55MWWI\JE6/0C/)Z]J]0\ ?#CPSXR
M4)XAD"V3J&VJPVJ,$@D^E>6]SJ4.IYKIT4^M7Q"$WC #8L2%MQZK[9]_2O8_
M"?P0UC6[6*:UADL^ "9(L'&.,'\*]8T?6_@_\,8U@TM;-KEL!A$NYF([GWJG
MK7[8?AZP61;.SE?R\#YP5'3C''^<5K-NR.BG3E%WBB71?V=]0FMF35;_ )9=
MO[L <5U>D_L]^'-,4&X/VAOO-OX&0.HYX[UX#XF_;#U^]61=*\NW9"25"@YZ
MX )_4_A7'WOQ2\;:]^^FU)2&8$)&P!(Q@L>?6L[7.]4J[C=NR/LE?"_@?PX#
M*\5A#(>KDJ&.#GM]*I77QC\"Z+M@6Z1BHPJQ0Y&/KZ?XU\6PQWNI*_\ :%U)
M-O7:#N)__5CU_P :K6^DRQRHTSAU1?D9GW'J/4]P/TJN3L0J#F[29]H2_M!>
M&1N\C<RJ,[F 454N?VAM-MU+?9E. #M\T9YZ5\IM<;)6.\;DZ*2>."#QQZU'
M;:Q;1N=XCD=X^6C],@]_>I<9(ZZ>"I_:/J*\_:(CVX@LL-MSEFX__5_C6=)\
M?[^9F6!8&0@D,.HXZ?H?TKYEU;QU8:;'YUR0 K$$MGH.>F?RKGKKXPZ/'(5W
M?N\G='Z9Z#I]*QDI=SL^JX6FDZA]/77[1&KV\;%FC5P>C,% Y]<'W_*N6US]
MICQ7:@);21E&R ZLN>!D,>..>,=^:\!U+XD:)J4*D2[I$R$"2'&"/\_2J-G?
MV%]) Z.DKL>YZ9!'(^N:YY1EW/2P]'+7\2N>RS?M4^-_,)-TUN=HP&B4@G.#
M@=S6/KG[1WC?6%DBGP\3?*LP &>..*XOSTD2/=;;^-OF=AR3Z]<TZ3R[QI%4
M,L.SA-N,$<YSV]/QKDK4Y./Q'KQC@:3YJ$%<X[Q!X=_MR66_OU$A8X;@>_IW
MXKEM:T>W6T<11;"'Q&NWMW^G-=KKF[3]J;0.3A=W;G/XUQ6J:QN5GV,K+GYE
MZ^WUKR?8>\?4X7,)-6;/*M;T=V5#;Q[0IW9[?A^=<O>Z7+\Q8ED[9Z5ZQJVJ
M"7?&UMM0#[O/UXKD[J%6C8*G#<\]OI7?&ERJYZT<5&>LCQC6M+VNVWY>^TC%
M4O#OBR^\ ZU!J5E(5FC/KP0>H->B>(=(CN&.]3G'/%>>^(?#\MNSE1^[S\M7
M*CS*S6AX>-<9)N&Y^G_[+_QVL?B%H,(:=(KDQ@2('^;> ...2>*^L+6=6A#*
MZK*P5MR@XQCJ5[=>M?@I\,OB)J'PP\60:G:2,C(?F4$@,OI7ZK?LQ_M+:?\
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M7'<^A:***^R. R?%?_(O7O\ NC^8KC--_P!6*[/Q7_R+U[_NC^8KC--_U8H
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M74U4V$FF7"S;O[OEMS]:_.'7_'WA[X,:C;1:S<37=W#I]ND=E;X>4_NUP.2
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M@/AB^N[B;P[\WEV<WS6TJG(RA(RIZ_+^G>OTQ^$?QOM_$$,<#S S*%0X).,
M#)/KS^IJQ^T-^SSI?[1W@6ZL+_8LX >&:,?O$8=#^>*[EB/9M)*Z.:5%WU=F
M?EQ-^T@WQ!\0?:YM.318SP\D)W%V/05T%QJ$&IQK( P"\Y8=:\<^+WPA\1_L
MX>.FTS5(_,3<6@GVD+*H_D>>E=9X'^(FGZ]:QVLA$-RJ[FC;@<>A]*]VC4LK
MK9G'7AS*,7\2W._L]=BAA,9;:-I^4CK5OPKK3O.<,556!(4YQSQFN>75K*\F
M9BT>4RF_/0D?X4_3-6M=*7<)$] 01Z]:[94_:+4,-5E":21] Z3K$S0HOVC+
MD8V$XQG'' Z5T-K>7!SM.>2"I;&#V[=Z\(T/QRFX ,K,HXR 3]*ZEOBA';+L
M>103\N&/?J/TKR*F#2=W(^SHUIR5N4]6DU_[*H60?,5)9@/E7/I@YS]:Q[/6
MHI-S.V",@*H)XR<9]^]>9W'Q/ANG7(5B"5.X_KBI]-\3*T@;?L&_]W@_F!^M
M;49*F[6N>=CJ-24&['I&L:M%:P)Y;("PP#T(R.1G-<I=:^^G!%+J QP.?J>?
MR_6H;_5$N+;Y&"L#G:0,_7OS7,-IK76H,6;;'M.W=VY.1BO:IU5R['YY6P]1
MMIG2?\)%+J'F ,3)TW<_-SC' J2*S.H3'S820H^48P"/QZGO5#2=,DANED6?
M,0QT'/2NGNGCA9-^UD158[CC/H?Y5T1M(\F=!TWS-BVNDV\.,VJL3@^6P_4=
ML_XU?2QM;<*92#&2-RHH(7W.>AK(DUR))%W%0S8 9N,CMBFKKR3L5B :5L#R
MR<;N.![9K6I%-(J-=R5ET/2?#_\ PC,-F99W"L>?E0G'3IG.!5F[\::3:V\L
M5K'YQ/W=BX^;KZ]#S7G$<=U-'#MD(3)R$' !/MV[4EO=I8X$N F<[F]#GH.V
M,]*YGA5\5SHCB''='7-K5Y]L,EE HA8\;6&[..<\>G\ZBOM?OM0N+<HGEN>'
MW'(.,<#'!YK,M=:L;B*-H[C]X1@XR<D#J<'TX_.MK1;2VUI@B*H53M"DDX([
MC^=825_=9UTL4I2LHE11JDFH&1XG$2C&] O#'@DGTX'ZU!/XDU;397^RQ-<1
M8_>*KE-N<GD$^F.E>C6EG_9CI;Q!@K *<\;3S@Y_.N5UYX%N/WP781SY>%YS
MSUKD="VMSUXU.6VAPMQKFALS$R3:?>,^\[<ONYSGM@$U>N/$E[=1P-:2.0N
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M2<;)>.<H[9.[/?\ SWK,U3X;75C]H$<BO#'P!@<8_P _K6_.IGF5J4X?#/\
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M\(K<W*(< 7UN%8D<C!E'Z^M?:U%0\GIM6]I+\/\ (UCF-2/V5^/^9^9WBO\
M9[^/-YJ&ZU^'<\UN$R$CU;3U4D$X7YI\U@_\,[_M$2VH\SX52HV[!6/7M/W
M$@G'[_'<^_%?J?14T\EH4TUSR=_/_@'5_;-2UG2C_P"3?_)'Y?VO[//Q^5HW
MD^&%PKK(K$?VSIS#!P6Q_I _SBNDE^ 'QM:)F_X5]-YFW&%U6QSD<@C]]CT'
M;O[5^CE%$LEI2?\ $DOFO\C&6:3E_P NX_C_ )GY@ZC^S_\ M#7/F+%\.)E@
MD4J%.K:?O4$'C_CXQG/.?I6+'^S;^T1]AO(+GX6SW D5E5!K.FA<<X_Y>/\
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M0[IO_P DU^_E%1ON<\\36J?'-OYGX -_P3#_ &GV^]\-)#]==TW_ .2:0_\
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MIO\ \DU^^%%-4H*7,EJ93QV)J4_8RFW$_G^_X=?_ +3F,?\ "LGQZ?VYIO\
M\DUZW^R3_P $]_V@/AG^TI\._%/B7X?MIN@Z5JT5S>7?]KV$OE1C.6VI.S'Z
M $U^TU%:G"%%%% &3XK_ .1>O?\ ='\Q7&:;_JQ79^+/^1=O?]P?S%<9IO\
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M+Z.#;G'63W;_ "79'Q>;9YB\X<8U;1IQVBMO5O=OS^Y(#R:2BBO2/GPHHHH
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MH+4L>K,L8#,?<G)_&N;\&? +X>?#Z^74-+\/0SZLIR-2U!VNIU/JK.3L_P"
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M/_\ $T?\)IHW_/V?^_3_ /Q- &W16)_PFFC?\_9_[]/_ /$T?\)IHW_/V?\
MOT__ ,30!MT5B?\ "::-_P _9_[]/_\ $T?\)IHW_/V?^_3_ /Q- &W16)_P
MFFC?\_9_[]/_ /$T?\)IHW_/V?\ OT__ ,30!MT5B?\ "::-_P _9_[]/_\
M$T?\)IHW_/V?^_3_ /Q- &W16)_PFFC?\_9_[]/_ /$T?\)IHW_/V?\ OT__
M ,30!MT5B?\ "::-_P _9_[]/_\ $T?\)IHW_/V?^_3_ /Q- &W16)_PFFC?
M\_9_[]/_ /$T?\)IHW_/V?\ OT__ ,30!MT5B?\ "::-_P _9_[]/_\ $T?\
M)IHW_/V?^_3_ /Q- &W16)_PFFC?\_9_[]/_ /$T?\)IHW_/V?\ OT__ ,30
M!MT5B?\ "::-_P _9_[]/_\ $T?\)IHW_/V?^_3_ /Q- &W16)_PFFC?\_9_
M[]/_ /$T?\)IHW_/V?\ OT__ ,30!MT5B?\ "::-_P _9_[]/_\ $T?\)IHW
M_/V?^_3_ /Q- &W16)_PFFC?\_9_[]/_ /$T?\)IHW_/V?\ OT__ ,30!MT5
MB?\ "::-_P _9_[]/_\ $T?\)IHW_/V?^_3_ /Q- &W16)_PFFC?\_9_[]/_
M /$T?\)IHW_/V?\ OT__ ,30!MT5B?\ "::-_P _9_[]/_\ $T?\)IHW_/V?
M^_3_ /Q- &W16)_PFFC?\_9_[]/_ /$T?\)IHW_/V?\ OT__ ,30!MT5B?\
M"::-_P _9_[]/_\ $T?\)IHW_/V?^_3_ /Q- &W16)_PFFC?\_9_[]/_ /$T
M?\)IHW_/V?\ OT__ ,30!MT5B?\ "::-_P _9_[]/_\ $T?\)IHW_/V?^_3_
M /Q- &W16)_PFFC?\_9_[]/_ /$T?\)IHW_/V?\ OT__ ,30!MT5B?\ "::-
M_P _9_[]/_\ $T?\)IHW_/V?^_3_ /Q- &W16)_PFFC?\_9_[]/_ /$T?\)I
MHW_/V?\ OT__ ,30!MT5B?\ "::-_P _9_[]/_\ $T?\)IHW_/V?^_3_ /Q-
M &W16)_PFFC?\_9_[]/_ /$T?\)IHW_/V?\ OT__ ,30!MT5B?\ "::-_P _
M9_[]/_\ $T?\)IHW_/V?^_3_ /Q- &W16)_PFFC?\_9_[]/_ /$T?\)IHW_/
MV?\ OT__ ,30!MT5B?\ "::/_P _9_[\O_\ $TO_  F6D?\ /V?^_3__ !-
M$GBKGP_>C_8'\Q7&Z>,1BNCUGQ!I^H:5<007&^1UP%\MAW'J*P[6/:H'>@#0
MMQQ]:MKVJM"O2K*T /HHHH **** "BBB@ HHHH **** "BBB@ HHHH 7<:42
M'UIM% $JSL.].^T-ZU!13%9$_P!H;UH^TMZ_K4%%%Q<J)FN&/>F&0GN:912'
M9#MQI,FDHH&%%%% !1110 4444 %%%% !3XWVFF44 <W\/\ X:^'_A@WB)M
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MJUO+7TH\M?2@#)_LT>U']FCVK6\M?2CRU]* ,G^S1[4?V:/:M;RU]*/+7TH
MR?[-'M1_9H]JUO+7TH\M?2@#)_LT>U']FCVK6\M?2CRU]* ,G^S1[4?V:/:M
M;RU]*/+7TH R?[-'M1_9H]JUO+7TH\M?2@#)_LT>U']FCVK6\M?2CRU]* ,G
M^S1[4?V:/:M;RU]*/+7TH R?[-'M1_9H]JUO+7TH\M?2@#)_LT>U']FCVK6\
MM?2CRU]* ,G^S1[4?V:/:M;RU]*/+7TH R?[-'M1_9H]JUO+7TH\M?2@#)_L
MT>U']FCVK6\M?2CRU]* ,G^S1[4?V:/:M;RU]*/+7TH R?[-'M1_9H]JUO+7
MTH\M?2@#)_LT>U']FCVK6\M?2CRU]* ,G^S1[4?V:/:M;RU]*/+7TH R?[-'
MM1_9H]JUO+7TH\M?2@#)_LT>U']FCVK6\M?2CRU]* ,G^S5]!3ET]1VK4\M?
M2G+&OI0!GQV@7H*NQ1;:E5!SQ4BJ.* %C6I5IJ]*>* %HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
C **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>figure12_01.jpg
<TEXT>
begin 644 figure12_01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (Y DD# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ K$\2>)$\-6T%S-IM]=Q2RK#NM?*^5V8*H(=UZDXXS[XK;KB/B?J-C9>'[*
M.ZO+>!WU&U=%ED"EE69"Q /4 <D]JUH04ZL8M7NQ/1-^IV5O*\]M'+)!);NZ
M@F*4J60^AVDC/T)%2,P12S'  R:X[7?%]IJ&EWNG^%M1MM1U:2SFDC%E.LAB
M"J?FRIQG<5 &1R?:L'0K'1@+_4Y-;T2?3);%H[ZR@LO)B#@@AYP\KXD['< 3
MWZ5:H/E<I:>5G_7DO,$U=(Z;3/&,E_>Z:)=-$-CJREK"X6Y#N^%+8>,@%?E!
M/!8>I!XK1\2^(H_#&FB_GL+R[@WJCFU\LE"Q"KD.Z]20.,UY5H=AX7>Q^'UX
MECI4@+/%>RI!&Q:80$JLF!DONP0#SG&*[CXJ7]G9^"I4N;J&%Y;B#RUD<*7V
MRH3@'K@ D^U=%3#P5>$$G9NWW.WY$J3=WY7_ #_R.PM9I+BUCFEMI;9V&3#,
M5+I[':S+^1-35R>J>,=/O;2:P\-:E9ZEJT]O,8$M+A9/+*H2&;:3CG:.<<D5
MR&E6<;6%_JNG^);"&;^RY8[J&QL7BD23;D27 ,KMYBD'D@,<FL(X=M.4O=^3
M_P"'MYE+HCUNL'5_$S:3J]IIHT74KR6\#>0]L8 K%1EA\\JD$#GD8],UQW@5
M]-O_ !-%<:=):6445B!+8VVJ1N9Y\C,QCAD*L,'&YQN)(X&*T/&]_9_\)?X:
ML1K\>EWF^<^8KQ;X]T9"Y60$88\#(Y[<U2P_+64'KH^_9]O3\2>:\6_ZZ?YG
M4Z%XAM->2Z$$5Q;W%I+Y-S;7"!9(GQG!P2#D$$$$@^M:U>66VJ:7HGAG7](U
M5YK?Q$4D>]\F?;/>Y&!-$S9X*\\ [,'CBLF.X%B/$4.D/:I:21Z?</#I.=@M
MRY$[QX^\=HY=0,^F15/"<S?+HM+=NG7MKI^.NQS6W/38?$$D_BG4-"6P9)+6
MU2X2:24!9MQ(& ,D#((R>>.GKM1ES&AD55D(&Y5;< >X!P,C\!7BVKW'AFWO
M?%)TF:&#3IO#Z-#)9,T</FAY" '3"@EL#&?F.1@G(I?$E[IFI:"!%);RW$'A
MU)K:6>3>H90<FW4<^8"IW.&^7"\'FJ>$YN6UU>W3R_K0=];?UT_S/7UU*VDU
M6734D#744*S.@/W58D+GZX/Y5/;M,UO&US''',1\Z1N74'T#$ D>^!7EGEZ
MWB_5KZ]%HGVC08)HKO(1B2) [K*,$'&T%@?0$]*K^'[K3;O1_"9UV:SE\.C1
MVCD:Z=3;B[#)\LF?E# 9QN[YQS4O"Z75^G3R>WW;"4[_ ->2_P SU^BO&+=+
M2#7/"EMJ][^Y-_>K;0W5TPS:%7$.Y&/()X!(Y! Y'%=E\,+VTN?#MY#97,,L
M%MJ5S'$L3AECB\PE ,=%P>/;I45,-R0YT[_+SL/FUM_77_([6BBBN4H****
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M_P#/[:?^ JUYG10!Z9_POGQW_P _MI_X"K1_POGQW_S^VG_@*M>9T4 >F?\
M"^?'?_/[:?\ @*M'_"^?'?\ S^VG_@*M>9T4 >F?\+Y\=_\ /[:?^ JT?\+Y
M\=_\_MI_X"K7F=% 'LGA_P",OC?5'OUDN[4^192S+BV4891Q6/\ \+Y\=_\
M/[:?^ JU@^ P"^MY&?\ B5S?RKD: /3/^%\^._\ G]M/_ 5:G@^-OQ$NB?(F
M@DQU*VBXKB;/1X(;%;[4"=LG$4*G#-[GVIMSJ5S>C[/&%MT08$<9P,>_K0%F
M=I)\=/'T3LDEU:JRG!!M5XIG_"^?'?\ S^VG_@*M<,]H8AQ*<'G#=&J&&WBN
MF*9\J7_QTT7"S.__ .%\^._^?VT_\!5H_P"%\^._^?VT_P# 5:\VEB>%RCC!
M%,H ],_X7SX[_P"?VT_\!5H_X7SX[_Y_;3_P%6O,Z* /3/\ A?/CO_G]M/\
MP%6C_A?/CO\ Y_;3_P !5KS.B@#TS_A?/CO_ )_;3_P%6C_A?/CO_G]M/_ 5
M:\SHH ],_P"%\^._^?VT_P# 5:/^%\^._P#G]M/_  %6O,Z* /3/^%\^._\
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MNKA8D&23S["@#:\.Z:9V:Y9<@?*GU]:]%L(#:6P1#B1_O&LC2+-T2)(DPB#
M']XUN?97_C.)&Z+0 V&-O,61R3Z"I3:[YFDD+,I P,<@=ZF0;8XYG/RH,?C2
MR,1-;,%RS,>,=J:1,MC07:9"EHQ=-@&]U^[[5'9Q22/)#"ZCRR065N2/J<U+
M([(N60(H'1!@FJ[)%]@;9%-&SX)VMU_&K2.625]S-E1'=O,LI$: X+6ZG<^>
M[-TX^E4;B.X$EM;2RVU]*Y\H*%^6*+^\2.XK3EE\ZU=+6Z(+,L91QCIU;/\
MGI5)#=W+HOEP%+=Q_HZRC<V.P/?Z59C)SAYHTK6X^PZ481<>=;J=J&4;A,QX
MQN[8K,4^5)*DS_N&80F16W(I/\.[MUQFM"4RB\BB?3;F*TA"L(UCXSG).*S!
M+!<Q7DJRH;YF:2!70HF1TX/&1561A*7,RQJ6G1M;&,10*,IB19"5 S@+&?XC
MZFI(+F6:2"QOX0T#*PBN"OS1@#U[TD"W,S(ZI)("F^6YMQO)DQC:.RU-HS/<
MV<J2M$T@!VQ@YV*#D[O?K2L/VMG9D4L TB[19A)/"PX(;EN>O_UJJQ.CSK>F
M)9;)'.Y)S@G)Q@ =:O1&7+22Q^?:R*4\N3[X'JH_K65&;RWCDEB:0V"DH^,%
M@I]?0TK&G,IK0T+<W2:M<&YF5S=6\A**>8U'W0:YFSB\R-Y;D B.,EHE;'/0
M8_2M8!-*ECNY()U*QO%)+(=P8,.@_"L16,Q6*-E,;X<@*0<= /RYJ)LZ*+:C
M<Z#P]:[;0 =2 &)/?.?QKIILM\RXR!UJMI-J(K94<J4XV(!DXQWI=0F!<*,J
M>@ J4CJ3N4$??JB_NM^P[V3/4#DBJ.K3K<O(R*(UE;(3T'IFK%NTBRSRQR(D
MJ1DX8_>R<<5FNX:8 C)SS6,=9%?,Z&!/+TU(U^XJYKSZZ*MKMY<L<"%0F#WS
MS7?EMMF64Y 7UKS+6)9$^V2J"/.F7!QZ"M;!H.\T^47/S=6(]^U;GAFU:WTM
MIY#^]N3N8^W:L*PMVOKN*R[MAWQV7W_&NU?8!B,8084#TI!<@O&*1E@,Y'Z5
MP>IR&6] SP*[2^,AB98P6X[5Q<EA?M<O(UK-LSUQ0%R#^ ^E6-#>\BOIK^RF
M2&:RB:52WITQC\:KR(X!&PY%26R0IHUY,SR)<&144!L;D/WA[]J&U8+HRYI6
MGF>5^7=BS'U)J.GR$&0XZ=JL2V#16:W!GMV#8^19 6'U% '5?#:].GZEJET%
M#^7ITK%3WXK,UC&G:T9;:-?LTR":+C'RD5=\!C+ZY_V"YOY5'#Y6M>#F@'S7
M]@=PR>3'GH* ,V>4L"8P"LJ$CCBNU^'WB><E=#NI0@4?N7;C\*X>*Y+6Q6&-
MPRGY!MS]177>';*U\2Z.UI-,D&IVQ+1R#A@>U# ]/DB2/ FNF SA<'M41CLB
MP8QO,PZ8.,UA^&]1B3S]%UN3??0@%"1C>/4>M:MO-<K*;4*$4N=C$=12L!=C
M$T<;&();+V\SDFJ\EY--((HUDNY.A"#: :L_8;6'B_F>23J%!W5*;V*)1Y:K
M!&O&Q>&>BP%9+2[+D7=R+>+'S111[FS[L>E9EX^F6$DWV6S$EPH4F=OFSSQS
MWK6*7%S,9#E8E'$*G);ZUSWBB!I([2")_LS&56?:." <XHL!KVSS2[3+.9"3
MG81@+GTIWB[Q+#X;\*R2L US<JT,&T\Y(Y.?:I+=ERI!1FW#!QT^M<+XWL=5
M\8>([>QL4#6UK$=TG1 Q/)_2F!Q&H:[/>Z#9V0=8HK<@K&#EF/\ >)_.M+P9
MX)N/%\MW)).T,5N@.\KDLW8?E7=Z1X0\,FRCTJX:WEOQ&3(0P+<]ZSM.U!OA
MQXA2VGE,FGW&09<[L<\ _I0!?TF[E29M-N/*@GB78'4?*X'^S6[YT3R)"\1C
M./E#G]VY]CV^E3ZWIMCK$2W]H%$C?,"HK.@+[1'("\:\%G_A]L4 :#2;\F4!
M,+LVLNX'\:X?7M+B;Q!9V]FSQ%LN_P _RCGTKI;G^T(E\BR41H6R5/S!O8'M
M2+-I>FV[2F7R=0D!^4_,: $\2,8M%BBM[O:QVI-F,'</Z5>TVW@M[!#%I\(C
M(&YT;!/UK+L-2MKI$;55B93DD2#!/O3I8KJ-MUA)OM6/"D_*!2L!JM=099;=
M&!7L1P/QJ&&)6D63S]S$_P!T\4J1W$!0W14*P& .GYU)+=6=O$\\[JB1\L4;
M[H]:8'$_$_[=]E@VR(UJIPS*>_:N'TBWUF&Y^T:=#*[ <NHRI%>E:GIUUXWN
M+1;2=#I$<FYW<[3)[ =ZW=:U?3O!MG;PM93/;M\NR$#Y?J: /.=%^(.IZ0K6
MUQ )<SY9CP0#U%>CKJD=]YDD5H\;X*L\Z;<X]/6L>TOK+4S/(J6YTZ8$A98L
M2!O:M>S<QVD2/*?+C0 AF!.1THC+H3'J<U<ZC;1>-8[9E7S9$#++C&#Z5TXE
M:XN$G*/CGDG S7*^,(;C^T].U"SEACEASEI2%!%=3I]W%>Z;%<R-Y4O\8SP#
M5.5RE;<M/\[EGC(7MM:I 8A@8(_W1DU MRA#&*5<G@LW"U7%P+8[<EG8\LHS
M4@:2MN('S@'N37*^-;*]OGL&L8DFEA=BP#=0:Z*1XP$:) _J2#@5(DBA\I!(
MQ;OV%)JX'!KINK12O(]H50JP8OP%!%<C=ZQ=O?RB.UCDBB*KM.2ORG(-=[XY
MUZ:UMH]'TW)OKH[75.2%K@;OPUJNDZ8+Z[81J3Q&6SG/K2Y4WJ1R1ZE ZO?Q
MW37,8$4C+M;:O!_.O1O@5=RWWQ6>YF(,CV<I.!C^[7ETLSLK;?E7O@=:]*_9
M]_Y*8/\ KRE_]EIV*LEL?5=%%%,85R?Q._Y)EXB_Z\GKK*Y/XG?\DR\1?]>3
MT ?%E:>E1Z9)#?G4))$=;<FVV=Y.P-9E:'F/!HIBDLEQ/)NCN&7G"\$ T 9]
M=#X>L&=7N/EYX4$_G7/=:[O0[ QV\!9> F3]<T"9V^C6L,,7[T?=^[MZYJRH
M)WLRMD-\I(JJCB-H(PZ@8(-78X6F?9DB)>2V:5A<K(<B0C VI&,D'N:OHDS0
M+.DMON7!&YPI%0/%OD('"#O56[:TB*QR/EI,XW=<TU<F<6T:SKJ$Y?S[F$P8
M' <=:J3)K<JM;PW-K'9A!D[\M68URL^H6EO&LAMV&YA&/O$=JN;AIX80V5PL
MLG\#D=/QJM3EG!]"9+>2.P^RK;Z3(0"I=I#N)/?%5/L$\5@;>6VTMG/ E\TA
ME'J*L+YQB65)8U7;M.\*6!^E43!%#+&EPL !!#2.A8FK2.>=%[R932RAMIYA
M<RRS,578(;H#^8K6^TE/)5K>]"V^!$YF0[L^V*RM0B2R9U%M&78 HY@9"_\
MN@]A5CR!9WT4>9(Y"REF-P'"9]1V^E6C)TX]%<2UD>V$L8TA;K,A<N6. 3Z
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M#$<H )*]_K0!,DGD;DC4RR=-QIOR1D,SCSCV(Z4])E8F*%E-UUY&*<1'$-K
M-(WWW Y%  LLL4I#!)9F&00> *X7X@ZC<V]UI4D$HC3SLG:>=P(_2NSE2%/,
M5$QD[F8G]*XOXC>7/H,$@@"F.0"-ATYZT =U917WB*0QZ8JBY>/8SD\*#W-=
M-8?"PPVO[S42EPPPS(O7UKH?A_H46B>$--C$2K<26Z/*W<D@'K74T >'7'P;
MO-(U7^W+349KB>)LE&(RR^G2F7'V>Y,BZE92;P3MC>'@GZU[G@9S67KNBV>L
MZ9-;W,8^ZQ5QP5..N: /!]!\.W^FW5W,KA([HEHX"Y?RQ[5)=:=J!N]OVS:
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M@B$> 6W<@'/(/6N\AW6]FJ _O" 2!6%I-G^\0 888 P/:MLF2-T.,N&VG/3
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M<FA%"4444P.O\!9\S6^!_P @R;K]*IZ]J%M?6<4=O<.WDMC8ZJ,#'4$=:N>
MCA]<_P"P7-_*N0I-$VUN:&B3QVVM6<TIPBR@D^E6]9@EL-<GMKE5"B4NI/((
M/(_G6)75>8FK^$I)[M-US9LJ++W92<<GOBF49"74VG:A;WL<2(4;<,'@U[C9
MZA!K&CQ36BX:5!DJ>]>#F4S6@BS'A.1UW&NS^'?B>/39O[,N?]7*^4/H3VH
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M@#$KU3]G[_DI@_Z\I?\ V6O*Z]4_9^_Y*8/^O*7_ -EH ^JZ*** "N2^)_\
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M ##+1XYQVP:AN\K#7QF?,BR0R,C%FA8!UP<@'O\ 2LNY:)OW:;%F48Y/!_\
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MR@]L]!]:D2Q"Y"2EF')!.*H:EXFTG1X&DO)E8 ?*J$%B: -"&#<7ENF&0,$
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ME!]3DYIYC(MH  ,J2..XI@8AR0V%SS2CU)I]1QC,$?[N3*GGY^M(.A=3MQ_
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M8LJ7OE*+<NPN 0#)S\J[<Y]LU6DTJ\C@AF,6Y)D,B;"&.T=20.E %+O1110
MH)!R*T6U.[71H=/9Y/($WGJC?=)Z9K.'6K5\95>.WD*GR5"C'IU_K0!M(!*U
MDBDDR'<S'^'Z5ZQ%(]O8);@@@)G'X=/ZUY=X:B6\U&U12,(G(->GK&96EV]O
ME!]L4 9NT2 ,P#!CVJ>&[CMYVG:'S8U0AT9<@9& 3^-01QI"'4'(!^4>W>H'
MDE@TRYG1@8G?RF4MSZYJ9NZ SK^YV+D="0&V\9K&T^*#4M5DDN+J$06[#]V<
M9)IFMW[PV[[A\Y^48/6N9NM(O[25UEA8E(UF=HSN"JPR"2.G6J6P'I\D;'."
MS*#D8-0MGG;]XUYU9:]J-@Q,5P2,8P_(K=M/&H.!>6V"/XH^<_@: .D;<H"D
MYQU-9NIR^7"PW8S4]KJ^G7Q)BN%#-_"W!_&L[7Y=J#HP/<4 <T'\QF=O?DU2
MD/4C(S5J;Y(<@8S55P,;<GIQ@=33 V=)BO[3P_J>J)IT<]A(OV.2=\'RG;D8
M]ZP*TIGDM]%@ABU,20W+&26T0L/+93@%ATR1TK-I %%%% !1110!U_@+[^N?
M]@N;^5<AWKK_  %_K-<_[!<W\JY"F!,P'V=/]XU#3PP*A2.AS4U\]K)<9M(V
MCBP.&.3GO2"Q6HHHH **** +%I?75A,)K6>2*0="K8KJ[;6]'\01>1XAB6"[
MQA+R)<9]VQ7&44 =+J'A;4;",7%J4OK3[RR0D-@>N!R*R4NN"'&),],8HTO6
M;[1KH3V<Q1AU4\JP]"*VY=0T+7SYE^CZ?>D8,L0S&Q]2.U &8) %+]VJ3H=V
MT9_E5JX\(:FL)GM6CO8-NY7B?)Q]*RFG>!S')&ZL!APW!_*@"SYC("!^\]CV
MJ**YOM/E,UG*\);J%-()P0H5E9C_ '>H%/$F&*#G/<T 6!XFUF+ DN1.A'(<
M9!^M5AJX7=Y5L(-WWC Y4GV/M47V7YCAC@GGFI&C12JA%YXH T+CQ9,\")#"
M@/E[&,GS>W\JKQZU+!90JME$9$&$F/)J!H-FU H&T9Y[T0!(%+%=RN>5]* )
M;WQ#JVI0^1+*1&O#+$-N?K4<-KY>TMM!(X'^--$1C+.K8)Y'T]Z='+U5L$XS
MF@"9B>.O_ ::6ZY.[/:H3,$SG(]QTJ)6GN[F.WMHV=W.U5QU- %J:91% "VP
M L!_LTEC8:AK-PL5K"7;=S*!A0/4FM9M!LM&@B;Q#<,LO++:P_,S?4]JJ:KX
MNN;VT^PV<,=E9 8"1_>(]S20HEPVFA^&N;R5-2OQTBC.8U^M8NK^(;[6)<RN
M(X%^Y!%PB#V%95%,84444 %%%% !1110 5ZI^S]_R4P?]>4O_LM>5UZI^S]_
MR4P?]>4O_LM 'U71110 5R7Q/_Y)EXB_Z\GKK:Y/XFJS_#3Q J@LQLW  &2:
M /F/P7X?ANXFN[J%95P=JL,@#UK1\1>'M/EM&:WBC@G0';MX!^M6?#BM#IL0
M:"YBVQ@-^[/-4==N9C9W 6VG^<;!^Z;DG\*\/GKRQ3LW:Y\W[3$SQK:;LG\C
MST]:2K!L;O/_ !ZS_P#?LT?8+S_GUG_[]FO</I"O15C[!>?\^L__ '[-'V"\
M_P"?6?\ []F@"O15C[!>?\^L_P#W[-'V"\_Y]9_^_9H KT58^P7G_/K/_P!^
MS1]@O/\ GUG_ ._9H KU/!>7%J6,$TD99#&2IQE3U'TI?L%Y_P ^L_\ W[-'
MV"\_Y]9_^_9H MPZK"6MUO;"&XB@A:)44>63GHS$<DCWI$M=.N(8A'=M%<')
MD$PPB^P-5?L-Y_SZS_\ ?LT?8;S_ )]9_P#OV: )X]+N-UN[QL8)V.UD^8D
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M\J/^XOY4^B@!GE1_W%_*E$: Y"*/PIU% #?+3^Z/RI/*C_N+^5/HH 9Y4?\
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M%PS9V'C)K7M;E[Z!=[ .IPZ^]9]K%&PVPJW^T6'"_2B^OX-.N80(VD=AP4'
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M]"<I.-MF7)"T>&7(8=".M=WX5\2"XB%EJ+(DQXCD(P&]C[UR"0(ULTS,,@X
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M<2J=M.FXR5SR,34G-7IZE.TMGO@8K/S&N "\@D(55 ZXJL]R;:=X)U*R1G#
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MG=DY]:VY8K<=2K.SC;02^U6W^T%+N55[A!]YS["JD-[J%Q \D&ER1HGRLSR
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M]W'*)4W(N[@]_0^U=E%*T4(,@0N.&PV:I*QYN*Q#>D6%K:QZ:&>.&.&W4;2
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MD'\:^E6?"H$GB^*99./L\@*X[\?K1&-IQ]3EJ.].7H>DBEI%Z4M>N>*%9FO
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MOFS7K#!D50$B(Z9[UA))GITY.",N,2:=I\4*J!,Q*J/?O4:I+!8W!<&7+$R
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M('WB,;OI7E05HH]R6K)HKN2ZAD2#;&K+AY)!@ =\56N+.RGL[<PL)(5<[V'
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ME*82<MW*T>14VDB#YYI2A4,JG=D]<>U7'1MB;0R@KPP''XU;U!#'M<;59AG
M(^8>WO599WNUV03!5*X<'IFDU8QYKF:]NT995!9\_.H;M[5M>#/(?Q7$XD<R
M"!P W!QQD&J4=B8)1MYF')C'/'M70>&EC_X2*-PBJYA8=,-VZTHJ\X^I-1^Y
M+T.\%+117J'DA6#XQ5G\':LBQM(S6[ (O4^U;U8OBI2WA;4P'*9@;YAU%14^
M!^A=+^)'U1Y!I-M=64?FJBV\@&<,V[%7+C497&99TW8[+R:CMWLE58EF\P@
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MYF7Q*TY3:T4Y&<[3M0'T]35">&^NI)XX?*AWJ<NXP@'L.]7--M+L1OYD*QD
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M2OU-*=T]#/DL+:Z"R31()58$;>!D=!3=<U&WM[8")E9RH!3))%3/%Y29$4A
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M*R%3I.$G*>Y0D<ESYF78=\UR?B:X-_=0:/#(R(YW7.S^%/0_6KUYJ<JYCB0
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M<<L%-O21WPS2CRVE%_@>5R>-_M2_Z7=F0 X\D-A?QH?Q+:3.'NIU8=!$G;V
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M]W]['8HW.BZ5>RK+=:993R+&8E>6!6(0C!4$CH1VZ4U=!T=)[>9=*L5EM_\
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M[^\#%'@_PP(TC'AS2 B,7518QX5CC) V\'@<^PJ\ND:8FI'4ETZT6_9=INA
MHE(]-^,X_&KE%-U)O=O[W_F*R*][8V>I6K6M]:P75NWWHIXPZ'Z@\55F\.Z'
M<QVL<^C:?*EH,6ZR6J,(1Q]P$?+T'3TK2HI*4ELQE&PT;2M+EFET_3+.SDG.
M96MX%C,AY^\0!GJ>OK3+7P_HMC?O?VFD6%O>/NWW$5LB2-GDY8#)SWK1HHYY
M=V%C)'A?P\&=AH6F R2"9S]DC^9QDACQRPR>>O)J63P_HLMHUI)I%@]L\AE:
M%K9"C.3DL5QC=[]:T:*?M)]W][_S"QE3>&= N5C6?0]-E$3,\8DM(VV,QRQ&
M1P2>2>]2'P_HIG:<Z18&9I1,TAMDW&0=')Q]X9//6M&BCVD^[^]BLC,N?#FA
MWHE%WHNG3B63S9/-M4;>^,;CD<G'&>M22Z'I$TMK)+I=C)): +;L]NA,('0(
M<?+^%7Z*7/+N_O'8RI_#&@75Q/<7&AZ9-/<#$TDEI&S2#@_,2,GH.OH*LC2-
M-72_[,&G6@T_;M^RB%?*QG.-F,8S[5<HHYY-6NP,2+P;X6AE26+PUH\<B,&1
MUL8@5(Z$';P:O2:1ILNI)J4FG6CWZ#:ETT"F51Z!L9'YU=HINI-[M_>_\Q61
MPT'@N1YYEOM&\/O+)*TG]L1H?M62V=P4Q_*PS@$2<8!QVKN:**<ZDIVN%M;A
;11168PHHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>figure13_01.jpg
<TEXT>
begin 644 figure13_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +/!98# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW:?_ !F@#MZ*XC_A7^M?]#]KW_?NT_\ C-'_  K_ %K_ *'[7O\ OW:?_&:
M.WHKB/\ A7^M?]#]KW_?NT_^,T?\*_UK_H?M>_[]VG_QF@#MZ*XC_A7^M?\
M0_:]_P!^[3_XS1_PK_6O^A^U[_OW:?\ QF@#MZ*XC_A7^M?]#]KW_?NT_P#C
M-'_"O]:_Z'[7O^_=I_\ &: .WHKB/^%?ZU_T/VO?]^[3_P",T?\ "O\ 6O\
MH?M>_P"_=I_\9H [>BN(_P"%?ZU_T/VO?]^[3_XS1_PK_6O^A^U[_OW:?_&:
M .WHKB/^%?ZU_P!#]KW_ '[M/_C-'_"O]:_Z'[7O^_=I_P#&: .WHKB/^%?Z
MU_T/VO?]^[3_ .,T?\*_UK_H?M>_[]VG_P 9H [>BN(_X5_K7_0_:]_W[M/_
M (S1_P *_P!:_P"A^U[_ +]VG_QF@#MZ*XD> =9_Z'W7C_VSM/\ XS7.>'])
M\0:OXL\4:5)XWUA(=+DMTB9(K7<WF1;SN_<^OI0!ZS17$_\ " :U_P!#[KW_
M '[M/_C-)_PK_6O^A^U[_OW:?_&: .WHKB/^%?ZU_P!#]KW_ '[M/_C-'_"O
M]:_Z'[7O^_=I_P#&: .WHKB/^%?ZU_T/VO?]^[3_ .,T?\*_UK_H?M>_[]VG
M_P 9H [>BN(_X5_K7_0_:]_W[M/_ (S1_P *_P!:_P"A^U[_ +]VG_QF@#MZ
M*XC_ (5_K7_0_:]_W[M/_C-'_"O]:_Z'[7O^_=I_\9H [>BN(_X5_K7_ $/V
MO?\ ?NT_^,T?\*_UK_H?M>_[]VG_ ,9H [>BN(_X5_K7_0_:]_W[M/\ XS1_
MPK_6O^A^U[_OW:?_ !F@#MZ*XC_A7^M?]#]KW_?NT_\ C-'_  K_ %K_ *'[
M7O\ OW:?_&: .WHKB/\ A7^M?]#]KW_?NT_^,T?\*_UK_H?M>_[]VG_QF@#M
MZ*XC_A7^M?\ 0_:]_P!^[3_XS1_PK_6O^A^U[_OW:?\ QF@#MZ*XC_A7^M?]
M#]KW_?NT_P#C-'_"O]:_Z'[7O^_=I_\ &: .WHKBE\ ZRIY\>:\?^V=I_P#&
M:XZ._P!:L;N\M+OQ3K-Q)#<21K)$MJ@*!B%R#"><=: L>S45Y!_:NH_]#%KO
M_?5K_P#&*7^U-1_Z&+7?^^K7_P",4AV/7J*\A_M34?\ H8M=_P"^K7_XQ1_:
MFH_]#%KO_?5K_P#&*86/7J*\A_M34?\ H8M=_P"^K7_XQ1_:FH_]#%KO_?5K
M_P#&* L>O45Y#_:FH_\ 0Q:[_P!]6O\ \8H_M34?^ABUW_OJU_\ C% 6/7J*
M\A_M34?^ABUW_OJU_P#C%']J:C_T,6N_]]6O_P 8H"QZ]17D/]J:C_T,6N_]
M]6O_ ,8H_M34?^ABUW_OJU_^,4!8]>HKR'^U-1_Z&+7?^^K7_P",4?VIJ/\
MT,6N_P#?5K_\8H"QZ]17D/\ :FH_]#%KO_?5K_\ &*/[4U'_ *&+7?\ OJU_
M^,4!8]>HKR'^U-1_Z&+7?^^K7_XQ1_:FH_\ 0Q:[_P!]6O\ \8H"QZ]17D/]
MJ:C_ -#%KO\ WU:__&*/[4U'_H8M=_[ZM?\ XQ0%CUZBO(?[4U'_ *&+7?\
MOJU_^,4?VIJ/_0Q:[_WU:_\ QB@+'KU%>.76IZNUK*+;Q)K*7!4^6THM64-V
M) A&1^-2)JFI>6N_Q'KA?')4VH&?^_% K'K]%>0_VIJ/_0Q:[_WU:_\ QBC^
MU-1_Z&+7?^^K7_XQ0.QZ]17D/]J:C_T,6N_]]6O_ ,8H_M34?^ABUW_OJU_^
M,4!8]>HKR'^U-1_Z&+7?^^K7_P",4?VIJ/\ T,6N_P#?5K_\8H"QZ]17D/\
M:FH_]#%KO_?5K_\ &*/[4U'_ *&+7?\ OJU_^,4!8]>HKR'^U-1_Z&+7?^^K
M7_XQ1_:FH_\ 0Q:[_P!]6O\ \8H"QZ]17D/]J:C_ -#%KO\ WU:__&*/[4U'
M_H8M=_[ZM?\ XQ0%CUZBO(?[4U'_ *&+7?\ OJU_^,4?VIJ/_0Q:[_WU:_\
MQB@+'KU%>0_VIJ/_ $,6N_\ ?5K_ /&*/[4U'_H8M=_[ZM?_ (Q0%CUZBO(?
M[4U'_H8M=_[ZM?\ XQ1_:FH_]#%KO_?5K_\ &* L>O45Y#_:FH_]#%KO_?5K
M_P#&*/[4U'_H8M=_[ZM?_C% 6/7J*\A_M34?^ABUW_OJU_\ C%']J:C_ -#%
MKO\ WU:__&* L>O45XW=ZGK+1J+7Q+K$<F]2QE%LPVY^8#$(YQG!_G4W]J:A
M_P!#%KOYVO\ \8H%8]>HKR'^U-1_Z&+7?^^K7_XQ1_:FH_\ 0Q:[_P!]6O\
M\8H'8]>HKR'^U-1_Z&+7?^^K7_XQ1_:FH_\ 0Q:[_P!]6O\ \8H"QZ]17D/]
MJ:C_ -#%KO\ WU:__&*/[4U'_H8M=_[ZM?\ XQ0%CUZBO(?[4U'_ *&+7?\
MOJU_^,4?VIJ/_0Q:[_WU:_\ QB@+'KU%>0_VIJ/_ $,6N_\ ?5K_ /&*/[4U
M'_H8M=_[ZM?_ (Q0%CUZBO(?[4U'_H8M=_[ZM?\ XQ1_:FH_]#%KO_?5K_\
M&* L>O45Y#_:FH_]#%KO_?5K_P#&*/[4U'_H8M=_[ZM?_C% 6/7J*\A_M34?
M^ABUW_OJU_\ C%']J:C_ -#%KO\ WU:__&* L>O45Y#_ &IJ/_0Q:[_WU:__
M !BC^U-1_P"ABUW_ +ZM?_C% 6/7J*\A_M34?^ABUW_OJU_^,4?VIJ/_ $,6
MN_\ ?5K_ /&* L>O45Y#_:FH_P#0Q:[_ -]6O_QBF/J^H*N?^$BUW_OJU_\
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MMC]/Z***XB@HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\_\7?\ )7/
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MOMN?;U%?$/\ P[M\3?\ 18KS_P %\O\ \DT?\.[?$W_18KS_ ,%\O_R37?\
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MN[ TIRQ$5;O^0I3BUHS]2:***\TU"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KS_P 7?\E<\ _]<M0_]%I7H%>?^+O^2N> ?^N6H?\ HM*!GH%%%% @
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\_\#_\
ME-^(G_7>R_\ 2<5Z!7G_ ('_ .2F_$3_ *[V7_I.*!GH%%%% @HHHH ****
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M_P"P->_^CX:],KS/PW_R.WAG_L#7O_H^&O3*"6%%%% @HHHH **** "BBB@
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M!_ZY:A_Z+2O0*\_\7?\ )7/ /_7+4/\ T6E ST"BBB@04444 %%%% !1110
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M]E;TI6M6_NG\J\$TKP'\?O#OQN\/VT'B^;Q3\*]4T0#5=2U+[)%=6-X8VS)
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M$^5)?%V/T+-*?!F9X^OCGFLX^UG*=O8-VYFW:_-K:Y]E?\)AH/\ T&]-_P#
MN/\ QH_X3#0?^@WIO_@7'_C7QK_P[_\ AO\ ]#3XF_[YM_\ XBC_ (=__#?_
M *&GQ-_WS;__ !%;<V;?] Z_\"/,_L[@O_H;S_\ !#_^2/LK_A,-!_Z#>F_^
M!<?^-'_"8:#_ -!O3?\ P+C_ ,:^-?\ AW_\-_\ H:?$W_?-O_\ $4?\._\
MX;_]#3XF_P"^+?\ ^(HYLV_Z!U_X$']G<%_]#>?_ ((?_P D?9?_  F&@_\
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M!_C1_P )_I__ #RN/^^!_C1R2[!='345S/\ PGVG_P#/*X_[X'^-'_"?:?\
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M^>4__?(_QH_X3BQ_YYS_ /?(_P :.5A='145SO\ PG%C_P \I_\ OD?XT?\
M"<6/_/*?_OD?XT<K"Z.BHKGO^$WL?^>4_P#WR/\ &C_A-K'_ )Y3_P#?(_QH
MY6!T-%<]_P )M8_\\Y_^^1_C2_\ ":6/_/.?_OD?XT<K"YT%%<__ ,)I8_\
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M?"G[7GCWXJ^(QX5G\.>,;>_L;K3K/4KB2X@AN'1@1NME5R/+ ()'WCSQS'\
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M<,>]/VC[!RK8=I]_?S:;9/JD%O:ZEY2_:(;29IHDDQ\P1V52PST)4?2OG/\
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MHWB[3T^T'2-4B$4MQ;YP+B @E98B>-RDX(P<&NODMV4]*3TT8;[$-%+M-2+
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MY^]>_P# N/\ ^-TO:9S_ ,^J?WO_ #*^I<!_]!V)_P#!<?\ ,]4_X77\./\
MH>-"_P# Z/\ QJQI_P 7/ NKW\%CI_B_1KR\N'$<4$-XC.['H  >37DJ_L%_
M#-CC[7KW_@7'_P#&Z\4\=?!W0O@O^U!\-M'T"2\DM+B>SNG-Y*KOO-RR\$*.
M,**Y<1C<TPL8U*].'*VEHWU^9Z^6<.<(YU5J8;+L;7=6,)S2E"*7N*^K/NUL
MJW-8OQ,8_P#"I_&O_8%O/_1+UOW2XE_&N>^)G_))_&O_ &!;S_T0]?4I6J+U
M/QWFYJ;?D>)?\$\7/_"@;_\ [#<__HJ&OHMI#D\U\Y?\$\?^2 :A_P!AN?\
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M%%%% !1110 ^BDI: "BBB@ HHHH *5:2E6@!:R_$S?N=-_Z_X?YUJ5E>)O\
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M0^6V*?9_ZY:\<]P_.C]O#_E(]\!O^N>@_P#IWGK])=:_US?6OS:_;P_Y2/?
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M_P!ZC[8_]ZJU% %G[8_K2?:G_O57HH LM=L1UJ!I"QIM%,!ZRE:=]H/K45%
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M<L9:O,_B-^U1\*/A+I/AW5O%7B6;3M+\0VJWFEWT>E7EQ!<Q,H8%7BB90=K
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M=6S1:*0+V"ZM;BVN4)R %@EC620D@C"*>>.M/ED]D*Z[GJ.TT;37,_"'XR>
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M_*W_ (*!?\I.OV>/]S0/_3S<5^J5>EB_@I^B_*)$=V%%%%>:6%%%% !1110
M4444 %>?^+O^2N> O^N6H?\ HM*] K@/%BEOBUX#/81:A_Z+2@9W]%%% @HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\_\  _\
MR4WXB?\ 7>R_])Q7H%>?^!_^2F_$3_KO9?\ I.*!GH%%%% @HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\:OO\ D/ZG_P!?4O\
MZ&:]EKQJ^_Y#^I_]?4O_ *&:"D2#I2TB]*6@84^/[U,HIK0F2NK'RQJW_#49
MUF__ +.E5;#[1)]G!2P_U>X[>JYZ8Z\U6Q^UA_SW3_OC3_\ XFOK-9F'>G?:
M&]:\-94_^@JK_P"!?\ _1UQPXI1_LC!NW>AK_P"E'R2W_#6&.9D_[XT__P")
MKZ#^$G_"7?\ " V/_"<G/B7?)]HXC'R[CM_U?R],=*[+SF]:8S%JZ</@?J]3
MVGMYS\I.Z_(\;-^)'G&'6'^H8>A9I\U*GR2T35F[O37;R0E.C&33:56VFO2/
MDSQG]H[Q!<^)M0\+?"?0+6/6=8\172WVK6 O!;[=(MW5[C>^UMHD;RX@"/F#
MN,CJ/CO_ (*&:1XH^#/[0?P^^/EGX=CT"5KB"&:.&_6X26XM^0&(0;=\(*?1
M#@#'/WG-\"/AQ=>,&\5S^#-)D\2M,+@ZJ8!]H\P'.[?UZUJ^.OA1X$^*5Q;S
M>,O"6E>)I+<;83J=NLWEC_9#<"KYDE9$.+9\\_\ !1OQ]HGQ(_8'/B;1+V&[
MT[6+C3;FW:-PWWI58KP?O+R".H(-> _MA:A#-_P3+_9_19%+,]N  PSQ!)FO
MNUOV<_A')X?CT%OASX=;1([EKQ-/-BA@68J%,@3& Q4 9I+_ /9R^$6I:/8:
M3=?#GP[<:9IYD-I9RV*-%;ER"Y13PN2!G%)225OZZ@XMN_\ 70['X7W4=S\+
M_!TL;J\;:3:D,IR"/*6OSS_:"\&^,/AO\4?B9\=/@?XOAU&TLKZ2U\:^&;TJ
M6A\M5\T2Q,W[V!ATQA@&.WU'Z%^'=#TKP=H=EHNA:?;Z3I%FGEVUE:ILBB7)
M.U5[#)-<MK'P)^&7B2\NKS5O >@:A=7<K37,UQ8QLT[L06,AQ\^2 ?FSTIQD
MDVV#3LD?!'_!07QA'\1OV(_V>O$=IX>;PU:S2,BZ8JGR[55MPBJA/.PA,IGD
MKBM#]JCQ9H7B;_@H9^S@^C:K9ZG':G0(YWM)UD6-C>A@K$' .T@X]"*_0[Q3
MX3\,^.O#0\.^(O#^FZUH(V8TV]MDD@79]W"$8&,#&.E<<W[-7P<S8,OPQ\+Q
MO8 "U:/3(E,.'+C:0./F);/J:(R47S#Y6?+7[3TMI_P]J^"9NO*-O_9=D#YV
M-N?.O=O7WQ^.*F\,Z#?ZM_P6*U_4?"\9&C:=8>9KDUH=L6UK%4V.1P29C$=I
MYRA/\-?7OB[X4^ ?B!J1U#Q+X.T77;_R8[<75_9I+*(XV9HU#D9 5F8C'0DU
MA^+-)?X'?"+Q;??!GP+I'_"4K";FUTRVM@BW<V0"7"E6D(7)QN!., \TE+2P
M-:W/E'X.JG_#XSXB9Z?89O\ TFMJXO\ 92O3JGQD_:7^&_B;Q;I?@W6_%%Y=
M0W#:YIYFGNH3).CB*0SQJ&59 P5@V0V0#@UZ5^SE\,?&VN?MY>*_C!K'AK5/
M#VA7>AP,\NI64EJ)+V6UM5FAC20!BJ2),,X_A')R"?JOQY\%/AI\2M<&L>*?
M ?A_Q!JJJ$^V7^GQRRE1T!8C) ]ZIRY62E='YU?M@^"Y?@-\*OV>['2O$=SX
M]^&WAS6KJ9M0\D)!+*+A9%0A258;1,JL,@C=BOT&\#Z?\#_%OQ:TWXJ^')])
MU+QSX@T[RX-0M;YI99;=54,?*#E5*@*I;:". 3SBNNU[PUX>\4^&'\-ZSH>G
MZGX?9%C.F75LCV^U?NC81C P,>E8_@'X6^!OA2URW@WPCH_AEKK G;3+-(6E
M Z!B!DXR:ER35AJ-F?#/_!+GQ)I&@_&;]H*'5[^"R-Y<QQ112RA))F^T7>50
M$@LV#T%>9>(--\3_ ++NC6WC+P3JEE\5?V=/&FIQW+Z-??O"+AG#HDD>[?'<
MH8QMD5L[HQN''/Z8Z;\)?A_I'C"[\5V7@O0[7Q-=AQ/JT-C&MQ)O&'RX&>1U
M]:S]/^ WPNTG4;._L?A]X=M+NS=9+>2'3XU\IU 564 8#   'K@54912ZB<6
M>3?M8>+/V;[?XF?#IOC!HLEUXLN(XY]+?R9F2WC:0;?/",%9 Y/#!NAXKZ>4
MCSQZ5R7B[X=^#_'FM:3K'B'PQI6MZKI+^987E]:I+);,&# H6''S 'Z@&N@\
MX[LUF]DB^I^?WC:QT_5O^"RG@R"_@@N[46T+F.=0Z>8FFS/&<'C(=58>A -)
M^S7::7<?\%6/C2S06\D<4&JR0[E4A)/,A#,OH>7Z>IK[+NO@1\,M2\6OXJO?
M NB77B5YQ<G5I+13<^8.C^9UR,"ET_X _"K2M>FURS^'^@VNLS&4RZA#9JL[
M^8"),N.3N#,#SSDU2DK6)Y6W<_-;]E^XUR3X._M@Z;X-+"_^Q"6WBM,[S!Y\
MPE$87G/D[P,>U=_\"?A[X4_::_8B\'>%->^+.E>$K?PAJDU[)96M@#J5O.9)
MA'N9I\N&$V5VQ@DX )(-?>O@7X-?#CX7ZM+J?A#P/H?AO4)H3;R7.FV:0N\9
M()0D#D9 X]JJ:7\!_A=H/BQ?$^F?#[PY8^(5E:==2M].B699&SN<,!PQR>1S
MR:MU+[$J%E8^0_"?B)/ /_!6J^D\?7T:0WNA)::+J%^!$C VL/EMD\(3Y<XY
M/WF*]ZR_V5_%GAV]_P""L'Q1OM-U&Q?3+^+4([2:&11%/)NAW!#T8EE<\=<$
MU]R>//ACX%^*CVK^,O"&C>)WM<B!]4LTG:,'J 6' ]JK:-\%_AGX;\0OKVE>
M ?#NG:T^2=0MM-B2;D8)WA<BIYD]RN5GQ=^R+JFFV?\ P40_:&NKV95M([;4
M))&4Y/EK.F\C'7 ]*^>_&'BKPEJG[(7Q8L? %_+H?@J/QE9RVFDZU>I<:IJ,
MKY)<KA1%"J(I4*&8E&W,<&OU+\+? 7X6>!]>37- ^'^@:/K"!P+ZSLDCFPX(
M8;AR<@G/KFF6O[/OPDL=+U33K?X;>&(;'5"IO8$TN(+<%267<-O."21Z57M%
M:UB?9L^0OVHM0MKS_@DG\-'^T1R2M;:*GRL#\X0[A]1@Y'M7C_[6<5CIOPS_
M &*'L%AMI%TG>[085@?,LCDX_P!HN<^N:_275O@C\,M>\,Z7X<U#P'H-WX?T
MMF>RTR2Q0V]NS?>*)C )]:R;[]F7X-ZA;V<%Q\,_#<T5FABMDDL$(A0L6VIQ
M\HW$G [DU/,KW*Y3V"698[H$'(S7Y?>#]!G_ &1O^"G,][XAC:W\*^,[F\%C
MK5WE(,7A,@&_&W<LP$94G@,">HS^DD*QV=O#;P((H(46..->BJ!@ ?A6?XI\
M,:#X\T632/$VBV&OZ9)]ZUU&W6:,_@P-1'0IZGC'_!1GXIZ+X)_98\5Z3<7,
M<^J^)XETO3;.)@TLSNZDLJCDA5!)/T'4BO(_V<6@_8D_9)\%V_Q/LH$TGQ]X
MD9-<LM1A)%A;7-LRH'4X[0QEPP^4._I7T]X>^!/PS\*:S;ZOI/@70K+5+<8@
MO$LD,D0_V6()7\*ZGQ1X=T+QO#:P^(=&L=:@M9?/@COX%F6.3:R;U# @':S#
M/H35)Q6@G=GYZ_MN_L)_#[X7> ;CXQ_";Q!+X<FLIK>>#2K:[\V&9WE54:TD
M!WJX+!@ S#CC&*^]/@_J/B+5?A!X*N_%\?E>*)M(MI-17OYQC4MGWSU]\UDZ
M+\ _AAX;U"TOM+\!:!8W5FYDMGAL4 @8C&Y!C"GW KNY)RS9S2D[Z($M;GQE
M_P %>)D_X9J\-Q[AO/B.$A<\G$$]>@:Y\/W^,'_!,?3O#=A";Z_E\&VEQ:0Q
ML<O/ B2HHQU.Z,#'<\5ZOXP^!_PY^(^J?VEXL\%Z-XBOMJIY^I6JS, !@ 9Z
M<5N>!_ _ACX9Z=+I_A/0;+P_82/O>UL(A'&6QC.T<=*$^6S70+79^<7Q%UJW
MU/\ X)'_  ZTF!@VI3:^MA%:_P#+629;B;*!>N>#Q7UWX7^.G@/]DOP9\&OA
M#XSU.ZA\57FC65O''#:EUC9B(\R$'Y%\S<O?[I]*]/MO@_\ #VS\5#Q-#X*T
M./7UG-R-06R02B8]9 <<,?[W6M'Q1X \)>-M>T?6]?\ #>F:QK&COYFGWUY;
M))-:MD-F-B,KR ?J*IN+T!)GA7[4W@OX0?##Q:/CCJ7BO5O!/Q!L8#' /#=[
M"MUK+[-B0-!+'(),C"DA1@#).%!')_\ !-;X >(OAGX5\5?$/QQ;26OBCQK,
MDZ6]PNV>*W#.Y9UP-C2/(6*]@J].E?2=O\)_ MKXPG\6)X1T<^)ISF35GLT>
MY/3^,@D=!T]*ZN6Y:0\FDY>[RARZW/ O^"B4BG]C/X@9(!*VH'_@5%7Q%\3+
M/2[?_@D?\,)!;VZ7DOBF5PZJ [2;[H$D]2=@Q]!7Z>^,/!'AOXCZ,-(\5Z)9
M>(=*\Q9OL>H1"6+>,X;:>,C)KGYOV=_A+=>';70)OAUX>ET.UG>Z@T][%#!%
M*X =U3H&(49(]*49<HI1<CX/_P""B$>E^&?V>?V4)M+MK2T>VT]9T6"-5Q_H
M]H[' [%N3[UZYJ2W]E_P5O\ #=UXL>,:/<^'V'AR27B,C[*PVH3QO\SS<X[$
M5](ZG^SA\(-8M;"VO_AOX<O;?3XC!:17%@CK;QEBQ1 ?NC))P/6N@\3?#?P5
MXRT72](USPKI.JZ;I:JMC;W5JLBVH5=JB/(RN ,<5?.K6%RN]SXQ^ HU#4_^
M"HWQGO\ PZ7'A:*":+57CSY#2XA50>Q?S5<CO@/[U]V7&-YK'\(^"_#7P\TN
M33O"V@Z?X?LI',KPZ?;K$KN3DLV!R?<UJ,VXU#=RTK"4444AA1110 4444 %
M%%% !1110 4444 %0W'W34U0W'W30!M>&_\ D=O#/_8&O?\ T?#7IE>9^&_^
M1V\,_P#8&O?_ $?#7IE!+"BBB@04444 %%%% !1110 4444 %9/BS_D5=9_Z
M\IO_ $6U:U9/BS_D5=9_Z\IO_1;4 4_AS_R3WPO_ -@NU_\ 1*UT5<[\.?\
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M_P#0/\9?^"N'_P"/T?\ #Y+X#_\ 0/\ &7_@KA_^/U[[_P ,1_ /_HD?A/\
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M7G_@?_DIOQ$_Z[V7_I.*] KS_P #_P#)3?B)_P!=[+_TG% ST"BBB@04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>-7W_(?U/\
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M\?\ VRKNWF_9-^+FR>-@?#-\.&!_Y8M6TMHN>E>?_M86ZK^R9\6>/^9=N_\
MT"M:-->V@O-?F)R=CR[_ () W$$/[(9!GC#+XAOMXWC*G;$<'T.,'\17VO\
MVM9#_E[A_P"_@KX._P""3MF@_9)O& YD\27C'_OU;C^E?5LEHNX\5TX^DH8J
M<.UE^"%"3<;GHG]K6/\ S]P?]_!1_:]C_P _D'_?P5YS]D7TI/L:YZ5P<B*Y
MF>C_ -K6/_/W!_W\%']K67_/W!_W\%>=?9%I1:KZ4N1!S'HG]K67_/W#_P!_
M!1_:UE_S]P_]_!7G?V1?2C[(OI1R(=V>B?VM9?\ /W#_ -_!1_:UE_S]P_\
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MVAO6CSV]:07.)\.I)#XZ\,1RQM%(-%O<JXP1^_A[5Z;7!W#9^+V@?]@2\_\
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MGV3<7AC:HX=0+,.!4-Z#NJO!_K!7T51:GY=AW[B/DG]JN;?^V%\&U_VK,_\
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M)_$:6I #10>U%4 4ZFTZ@:"BBBDQL****DD*?3*?5(I!1110QA1114@%%%%
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M7FY>:VMK[-/:Z[=SZ'AS/'PUFU'-U2]I[/F]V_+?FA*.]G;>^Q\X_"W]L_\
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M6D:DP%HHHI( HHHI@%"]:*%ZU('-_$C_ ) -A_V%;+_T>M=7+U/UKE/B1_R
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M8KH]7K+\4_\ (LZO_P!><W_H!K4K+\4_\BSJ_P#UYS?^@&D,\^O/^2>^"_\
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M2BF[A1N%(#)\=?\ (C:__P!>4W_H)K4L?^099_\ 7!/_ $$5D^.F'_""Z_\
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M5'%#X<L/^8F?^_'_ -E3O^%=M_T$C_WX_P#LJ[.BCVDNX<J.,_X5VW_02/\
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M !"\(VGVW/VB.\.[R^FU%/K[UZS7G_BT_P#%W/ 0_P"F6H?^BTI.3&HHT_\
MA!&S_P A _\ ?G_[*OG/_@HQIK>&OV/O&%Z+DS>3<:>=NS&0;V%?7WKZYKY2
M_P""HG_)D_CK_KOIW_I=!7I9;)RQM!/^:/YHRJPC*G*+V:-[]B_16U[]D_X:
MW7VHQ>=IF_'EYQF1SZU[#_P@;?\ 00_\@_\ V5>8_L%_\F>_"S_L$+_Z,>O?
M*RQLFL552_F?YCIQ2A%+L<C_ ,(&W_00_P#(/_V5'_"!M_T$/_(/_P!E7745
MQ\\B^5')?\(&W_01/_?G_P"RH_X0-O\ H(G_ +\__95UM%'/(=D<E_P@;?\
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MK_P@Y_Y__P#R%_\ 94G_  @Y_P"?\_\ ?G_[*NKHHYF%D<K_ ,(.?^?_ /\
M(7_V5'_"#M_S_G_OU_\ 95U5%',PL<NO@DJ<_;L_]LO_ *]<EX5\.FY\=^-(
M/M>/L\MJ,^7US#GUKU6O/_ Y_P"+F?$3_KO9?^DXHYF,V#X))_Y?C_WZ_P#K
MTG_"$M_S_G_OU_\ 95U-%',Q61R__"$M_P _Y_[]?_7H_P"$*/\ S_?^0O\
M[*NHHHYF%CEO^$);_G_/_?K_ .RH_P"$);_G_/\ WZ_^RKJ:*.9A8Y?_ (0H
M_P#/]_Y"_P#KT?\ "%'_ )_C_P!^O_KUU%%',PL<O_PA1_Y_C_WZ_P#KTO\
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M-YH^J'[5MVZO?1_ZO/W9V7U]J]-KAOA'_P @/6?^P[J/_I2]+F8S6_X1$_\
M/[_Y"_\ KTG_  B!_P"?W_R%_P#7KI**+L1S?_"('_G]_P#(7_UZ7_A$#_S^
M_P#D+_Z]='11=@<[_P (B?\ G\_\A_\ UZ/^$1/_ #^?^0__ *]=%13YF!SO
M_"(G_G\_\A__ %Z/^$1/_/X?^_?_ ->NBHHYF!SO_"(G_G\/_?O_ .O1_P (
MB?\ G\/_ '[_ /KUT5%*[ YW_A$3_P _A_[]_P#UZ/\ A$3_ ,_A_P"_?_UZ
MZ*BGS,#G?^$1/_/X?^_?_P!>G?\ "*G_ )_#_P!^_P#Z]=!12NP.?_X14_\
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M!D_V$W_/S_XY_P#7H_L,_P#/Q_XY_P#7K6HH R?["/\ S\?^.?\ UZ/["/\
MS\?^.?\ UZUJ*!F3_81_Y^/_ !S_ .O2C0R/^7C_ ,<_^O6K10(RO[$/_/?_
M ,<_^O1_8A_Y[_\ CG_UZU:* ,O^Q3_SW_\ '/\ Z]']BG_GO_XY_P#7K4HH
M&9?]BG_GO_XY_P#7H_L4_P#/?_QS_P"O6I10!F?V.?\ GO\ ^.?_ %Z4:.?^
M>_\ XY_]>M*B@1P5W'Y/QET&/.[&AWG/_;:"N]KA-2_Y+9H7_8#O/_1T%=W0
M-A1110(*A^UP&Z-L)HS<J@D,.X;PI) ;'7!((S[&IJ\A^/FC^ ;9=(\3^)_%
MUG\._$.G.T>D>*'O8;6:-F5LQ?O?DGC()+0N&4XS@$!@T(P_B%^T[K7AGQI>
MZ#X5^$'C/X@6^ESK;ZGJND1016T,A17,<1ED4S.JNN0,*"P&[.0/5?AO\0-*
M^*G@?2/%6B^>NG:E$9$CNHC%-"RL4DBD0_=='5D9>S*17R*W@3P?\1?&$.I>
M+O''B/PG?^(GBC@\3_#WQ7-9^'/%4R@0A@(W98+DA%4PLV20 C28;'V'X'\%
M:/\ #GPCI7AGP_:"QT;3(%M[: ,6*J.Y8DEF)))8G)))/)JY1Y58E-MFY111
M6984444 %9/BS_D5=9_Z\IO_ $6U:U9/BS_D5=9_Z\IO_1;4 4_AS_R3WPO_
M -@NU_\ 1*UT5<[\.?\ DGOA?_L%VO\ Z)6NBH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "N'^*G_'OX7_ .QAL/\ T97<5P_Q
M4_X]_"__ &,-A_Z,H&MSN****!!1110 4444 %%%% !1110 5\,?#/\ Y20>
M,/\ KE<_^B(J^YZ^&?ADI;_@H_XR/I%<'_R#%7SN<;X;_KY'\S]2X)_W7.?^
MP6?YQ/N:BBBOHC\M"BBB@ HHHH **** "BBB@ KS_P 7?\E<\ _]<M0_]%I7
MH%>?^+O^2N> ?^N6H?\ HM*!GH%?*7_!43_DR?QU_P!=]._]+H*^K:^>?V_/
MAKXD^+G[*WB_PQX2TQ]8UVZ>SD@LHV56D$=U%(X!8@9VH3U[5Z&72C#&492=
MDI1_-&=3X66OV"^/V/OA9_V"%_\ 1CU[Y7Y5_"_QC^W+\(_A[H?@W0?A5;?V
M1H]N+:V-U9QO+L!)^8^>,GGTKI?^%Z?M_?\ 1+K#_P %T7_R17LXK*95:]2I
M&M3LVW\:ZLYU6225F?I?17YH?\+T_;^_Z)=8?^"Z+_Y(JAXD_:3_ &[/"/AW
M4M<UCX=:7I^DZ=;O=7=U)I\1$42#+,0+@G  )X%<\<EJR=E6IW_QH?UA?RO\
M/\S]/J*\ _89^.7B+]HC]GG2?&7BI+--9GN[JVE-C$8XF$<A52%).#CKS7O]
M>+7HRP]65&>\6T_D=$9<RN@HHHK H**** "BBB@# ^('_(A>)/\ L&7/_HIJ
M_.7_ ((?_P#(G_%C_K_T_P#]%SU^C7Q _P"1"\2?]@RY_P#135^<O_!#_P#Y
M$_XL?]?^G_\ HN>O0H_[O4_KK$E[H_3FBBBO/*"BBB@ HHHH *\_\#_\E-^(
MG_7>R_\ 2<5Z!7G_ ('_ .2F_$3_ *[V7_I.*!GH%%%% @HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X;X0_P#(#UG_ +#NH_\
MI2]=S7#?"'_D!:S_ -AW4?\ TI>@9W-%%% @HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH Y/XL?\ ),/%G_8+N?\ T6U;^B?\@6P_
MZ]X__016!\6/^28>+/\ L%W/_HMJW]$_Y MA_P!>\?\ Z"*!]"[1110(****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .%^,7_(MZ7_
M -AO3O\ TJCKNJX7XQ?\BWI?_8;T[_TJCKNJ!] HHHH$%%%% !1110 4444
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M=A+=2V5BGE0M>W#W$H3)(4R.2S8!P,DG %?+O_#QO2<9_P"%#_'+_P (Y?\
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M+-__ .B&KJPG^\4_\2_,B?PL\=_X)1_\F<Z%_P!A._\ _1QK["KX]_X)0_\
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M0?M@<_LK_%C_ +%F_P#_ $2U=6$_WBG_ (E^9$_A9XY_P2B_Y,XT+_L)W_\
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M==U0/H%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)_W\'^%<MY(]!1Y(]!1R1[!S2[G4_P#"S$_Z!LG_ ']'^%+_ ,+*7_H&R?\
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M .-4OE?MA_\ 0Q6GY:=_\:KZG^T-ZTOVAO6E_8U+_G_5_P# _P#@!_K]BO\
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M/?\ 0R6G_?>B?_&Z_0C^TI/[QIPU&3'WC6GUY_\ /F'_ (#_ ,$7+YGYZ_\
M"._\%'O^ADL_^^]$_P#C='_"._\ !1[_ *&2S_[[T3_XW7Z%?VE)_>H_M*3^
M]2^O/_GU#_P'_@AR^9^>W_"._P#!1[_H9+3_ +[T3_XW2?\ "._\%'O^ADL_
M^^]$_P#C=?H7_:4G]XT?VE)_>-'UU_\ /J'_ (#_ ,$.7S/SV7PY_P %'O\
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M1/\ XW1_PC?_  4?_P"ACM/^^]$_^-U^A?\ :4F?O4O]I2?WJ/KS_P"?4/\
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M]C_"LGRQ1Y8JK(#6_P"$J7_GU;_OL?X4J^*0W_+JW_?8_P *R/+%*J#GBE9
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MN!_XX:]"C%^VAZK\SYW$58.A/7H_R/,?^"?_ /R;+8?]A*\_]#KWMOO5X/\
ML"QF/]FFQ4CD:E>?^AU[R_WC5X__ 'NK_B?YCR]WPE)_W5^0VBBBN$[QU%%+
M02)11104%%+24 %.'2FTY>E "T444 %%%% #X^HKG] _Y&[Q/_OV_P#Z+KH(
M^HKG] _Y&[Q/_OV__HJI>Z&="U)0W6BFA!1113 3^(TM)_$:6I #VHH/:BJ
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M3G_X$?H,_$7.:DG.>'P[;U;=&-V^Y\B?\,__ +27_138O_!O<?\ QNL7X@?
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MA<T>U)FL_P#M)/[PI1J4?]X5/*RKFA15 :E'_>%']I1_WA19A<OT50_M*/\
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M_HE:Z*@"'['!_P \(_\ O@4?8X/^>$?_ 'P*FHH A^QP?\\(_P#O@4?8X/\
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MR*/LL/\ SQC_ .^14M% $7V6'_GC'_WR*/LL/_/&/_OD5+10!%]EA_YXQ_\
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M 'R*/L\7_/-/^^15?^V+#_G^MO\ OZO^-']L6'_/];?]_5_QIV8718^SQ?\
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MG\.?^2>^%_\ L%VO_HE:Z*N=^'/_ "3WPO\ ]@NU_P#1*UT5 !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5P_Q4_P"/?PO_ -C#
M8?\ HRNXKA_BI_Q[^%_^QAL/_1E UN=Q1110(**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "O/_%W_)7/ /\ URU#_P!%I7H%>?\
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M_P B?%/_  [%\/?]#QJ?_@''_P#%4?\ #L7P]_T/&I_^ <?_ ,57VM11_8V
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M^F=?F9_P6]_Y$7X6?]A*]_\ 14=>1A_XB^?Y'2]C]$OAW_R3_P ,?]@NU_\
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MUN!T]%?#?[/_ ,?I_!_P]_:%\5V/Q NOBQ\/?!>Z?0+G6;T3ZI))';%YTD;
M?R6E 6-V49PY7*X)1?&WCKX)Z7\!_B3KGCO5?$K?$+5K/3?$NCWTV=/C^WQ^
M9";.+&(/(.%&W[XSNR3D5RD\Q]RUD^+/^15UG_KRF_\ 1;5K5E>+/^15UG_K
MRF_] -044OAS_P D]\+_ /8+M?\ T2M=%7._#KCX?>&!_P!0NU_]%+714 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7#_%3_CW
M\+_]C#8?^C*[BN+^*$9DM_#./X=?L6_\B4#6YVE%%% @HHHH **** "BBB@
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MS\:M/83_ / 7_D>P45Q__"X_ ?\ T.F@?^#*'_XJD_X7)X"_Z'30/_!E#_\
M%4>WI?SK[T/^S<;_ ,^)_P#@+_R.QHKCO^%R> O^ATT#_P &4/\ \51_PN3P
M%_T.F@?^#*'_ .*H]O2_G7WH/[-QO_/B?_@+_P CL:*X[_A<G@+_ *'30/\
MP90__%4?\+D\!?\ 0Z:!_P"#*'_XJCV]+^=?>@_LW&_\^)_^ O\ R.QHKCO^
M%R> O^ATT#_P90__ !5'_"Y/ 7_0Z:!_X,H?_BJ/;TOYU]Z#^S<;_P ^)_\
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M]O2_G7WH/[-QO_/B?_@+_P CL:*X[_A<G@+_ *'30/\ P90__%4?\+D\!?\
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M_"Y/ 7_0Z:!_X,H?_BJ/K%'^=?>@_LW&_P#/B?\ X"_\CE/VN?\ DU_XI_\
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M==S0/H%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"?ZY_[_-_C1]IO_P#G^N?^_P W^-2T4%$7VJ__ .?ZY_[_ #?XT[[5?_\
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M,W_?PU/8_P#(OZ7_ ->D7_H J*O&ZL]+H,\ZY_Y^)O\ OX?\:59KGG_2)O\
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M/F3_ //>3_OLTBR3G_EM)_WV:?2+0Q!YDW_/:3_OHTGF3?\ /:3_ +Z-.HI
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M5WU V%%%% @HHHH **** "BBB@ HHHH *R_%/_(LZO\ ]><W_H!K4K+\4_\
M(LZO_P!><W_H!H \^O/^2>^"_P#L'P_^B4JA']VK]Y_R3WP7_P!@^'_T2E4(
M_N_A793^!'//XF24+UHH7K6A ZBBBD@"BBBF ^BBBH+"BBB@ HHHH ?1110
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MY6G%I^95.I"K'F@TUY$=*M)2K6;-!U%%%(#'\=?\B-K_ /UY3?\ H)K4L?\
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M.;K3:H04Y:;3EI@+1110 4445!04444 .HHHH)"BBB@H**** "G+TIM.7I0
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MB<&9IF/$'$.%RK.<1/$X:JY*=.K)SA)*$I+FC)N+LTFKK=)G-?#SP'HGP_\
M^"@6AZ1H5H;/3XM.:1(C(TA#2:=O8Y8D\LQ/6ON2]&)#7QQIO_*1[2/^P6G_
M *:Q7V1??ZYJ^US&4IK#SF[MTXW9^$Y1&--8B$%:*JS22V2OLBI2K24JUY#/
M>'4444@,?QU_R(VO_P#7E-_Z":U;'_D%V?\ UP3_ -!%97CK_D1M?_Z\IO\
MT$UJ6/\ R#+/_K@G_H(I 24444P"G4VG4 %%%%(!:=3:=0@"BBBF 4444 %.
M7I3:<O2@!:1J6D:DP%HHHI( HHHI@%"]:*%ZU('-_$C_ ) -A_V%;+_T>M=7
M+U/UKE/B1_R ;#_L*V7_ */6NKEZGZTT,BI%I:1:&(6BBBD 4444 +3J;3J
M"BBB@:"BBB@;"G+3:<M!(M%%% !11104%%%% #J6DI:"3GIO^2OZ!_V!+S_T
M=!7?5P,W_)7] _[ EY_Z.@KOJ!L****!!1110 4444 %)TY-+7(?%'X7Z3\7
MO#(\.Z_)=MH<EPDM[96T[1+?1KD^1*5^8Q,<;E!&X#!X)!8'7*P894@CVHW
ML1D9':O@JQT>?]EO6/VG_$GPNM_[,^'6@^&TDLM,\PR6,6OK"SR&%"3@(K1;
MP, LVW^'C,USPWI_[//@C]F'XC^&UG3Q;KVNZ=8>(M4:1GN-;CU*(O<BZ8\R
MXDPR!N$VC;@#%7RKN3S'Z$UE^*?^19U?_KSF_P#0#6I65XJ_Y%?6/^O.;_T
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M9D;A1N%:_P#PKW5/^?NU_-O\*/\ A7NJ?\_=K^;?X4<T>X6?8R-PI1(*UO\
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M]_S\0?K_ (4G_"'WW_/Q!^O^%.Z[DZF=N%&X5I?\(???\_$'Z_X4?\(???\
M/Q!^O^%.Z&9NX9HW"M'_ (0^_P _\?$'Z_X4?\(???\ /Q!^O^%3= 9^X4FX
M5I?\(???\_$'Z_X4?\(???\ />#]?\*JZ S=PI^X5?\ ^$/OO^>\'Z_X4O\
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MZ_Y[1_K_ (4@*8(IV15K_A';K_GM'^O^%+_PC]U_SVC_ %_PI("IN%&ZK?\
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MW%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*\_\7?\ )7/ /_7+4/\ T6E>@5Y_XN_Y*YX!_P"N6H?^BTH&>@4444""BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS_ ,#_ /)3
M?B)_UWLO_2<5Z!7G_@?_ )*;\1/^N]E_Z3B@9Z!1110(**** "BBB@ HHHH
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M-2_Y+9H7_8#O/_1T%=W7":E_R6S0O^P'>?\ HZ"N[H&PHHHH$%%%% !1110
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ML#6O^>=K_P!^V_\ BJ/92#G1Z717FG_"P-:_YYVO_?MO_BJ/^%@:U_SSM?\
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M_P"$OU/^[!_WP?\ &C_A+]3_ +L'_?!_QHY6.YW%%</_ ,)?J?\ =@_[X/\
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MM_LVT_Y]8?\ OV/\*/[-M/\ GUA_[]C_  KX3_X>A3_]$X3_ ,'?_P!ST?\
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MVY>>D?\ WR?\:/[<O/2/_OD_XT6 Z*BN=_MR\](_^^3_ (TO]MWGI'_WR?\
M&BP'0T5SW]M7?I'_ -\G_&C^W+OTC_[Y/^-%@.AHKG_[:N_2/_OD_P"-']M7
M?I'_ -\G_&@#H**Y_P#MJ[](_P#OD_XT?VU=^D?_ 'R?\:+ =!17/_VU=^D?
M_?)_QH&M7?I'_P!\G_&D!B_& 9\.:7_V&]._]*HZ[JO-?B?J$]QX?TX,$XU>
MQ;@>EPA]?:NODU:Z5B (_P#OD_XT#-NBL#^V+OTC_P"^3_C0NM7?I'_WR?\
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MZ4 &T4;12T4 )M%&T4M% "QJ,U@: H_X2[Q/_OV__HNN@C^]6!H'_(W>)_\
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MRG\".>?Q,DH7K10O6M"!U%%%) %%%%,!]%%%06%%%% !1110 ^BBB@ HHHH
M**** "E6DI5H =65XF_U&F_]?\/_ *%6K65XF_U&F_\ 7_#_ .A4I;,J.YLM
M3:<U-JB0HHHI %%%%!04^F4^DQ,****0(****"@HHHH **** '4444 %%%%
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M?] _XS'_ ,0JXP_Y^0_\#I?_ "9F?\-_?&'_ *(5)^5Y_P#&:/\ AX!\8?\
MHA4G_DW_ /&:T_\ AOGXF_\ 1*&_[]W/_P 11_PWS\3?^B4-_P!^[G_XBC_6
MK)/^@?\ &8?\0JXP_P"?D/\ P.E_\F9G_#P#XP_]$*D_\F__ (S1_P / /C#
M_P!$)D_\F_\ XS6G_P -\_$W_HE#?]^[G_XBC_AOGXF_]$H;_OW<_P#Q%/\
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M **** "BBB@ HHHH *R_%/\ R+.K_P#7G-_Z :U*R_%/_(LZO_UYS?\ H!H
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M_7!/_012 DI5^]24J_>I@</^T\?^,4_B]_V*>J?^DDE?.W_!'6?=^RGKV?\
MEGXKNU_\E;0_UKZ'_:?_ .34_B__ -BEJG_I))7S?_P1Q/\ QBIXF_[&^[_]
M([*O<P\G_9=9?WE^AA.*<XW/MR2\(8\4S[<:JS'YC3*\7F=@]C'L7OMQ]*/M
MQ]*H@TZES,?L8=BY]N/I2B^/H*I49I\S#V,.Q=^VGT%'VT^@JEFC-',Q>QAV
M+OVT^@IWVXXZ50S3ATHYF/V,.Q=^W'TH^W'TJG2-TI<S#V4.Q>^W'T%'VT^@
MJEDT9H4F'L8]B[]M/H*/MI]!5+-&:.9A[*/8O?;*LK/YEK/Z[&_E61FK]O\
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M'[/S,,:3J^/^0;<_]^S2_P!DZO\ ] ZY_P"_9K;_ +5^)?\ T+WAS_P:S?\
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M#4_]J_$S_H7O#G_@UF_^,T?VK\3/^A>\.?\ @UF_^,T<X<I#_9NH_P#/E/\
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M.+>0_P# :9]CN_\ GWD_[YK,.J_$OMX>\.8_["LW_P 9I/[5^)G_ $+WAO\
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M_P"#:;_XQ1<#9^R7/_/"3_OFC[)<_P#/"3_OFL;^U?B;_P!"[X;_ /!M-_\
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ML&A^-?!U^MGJFGVUR;B!XY$$EO<12%5)21#T*@AE8'ID^KT; %%%%( HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKR+XT?'[_A7'B+P
M_P"#/#>@3>,_B+XA#2:?H4,P@CBMTX>[NIB"(8$. 6PS$G"JQH ]=HK&\(S:
M_<>'[63Q/:Z?9ZVP)N+?2YWGMT.3@*[HC-QC)*CFMF@ HHHH **** "BBB@
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M^\-E+XOU:]>#^T71MLOV&!8V,B(0R^8Y121\N[D@LQ'N=%%%(84444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4,
M5Y!/(R131R.OWE5P2/K4M?ES\6+J^_9V_;Z\6_&K2TBLO VCZGH^A>*;2S@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
F**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>figure14_01.jpg
<TEXT>
begin 644 figure14_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +/!98# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/:9_X&1__%4?\)KX>_Z#VF?^!D?_ ,57R%_PZ%_9]_Y]/$G_ (.&_P#B:/\
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M&A3E)151:^3(E/DBY-;'W*WC'0%ZZYIH^MW'_C3?^$T\/?\ 0>TS_P #(_\
MXJOS(_8<_8!^"_[0GP.;Q3XDL-6N=2_M2XM!-;:G)$NQ%3 "CC^(\U[T?^"0
MO[/A/_'IXC'_ '&&_P#B:UKX6%"K*E*HKQ=MF*G4]I!32W/KW_A-?#W_ $'M
M,_\  R/_ .*H_P"$U\/?]![3/_ R/_XJOD+_ (="_L^_\^GB3_P<-_\ $T?\
M.A?V??\ GT\2?^#AO_B:P]E3_P"?B^Y_Y&E_(^O?^$U\/?\ 0>TS_P #(_\
MXJC_ (37P]_T'M,_\#(__BJ^0O\ AT+^S[_SZ>)/_!PW_P 31_PZ%_9]_P"?
M3Q)_X.&_^)H]E3_Y^+[G_D%_(^O?^$U\/?\ 0>TS_P #(_\ XJE_X33P_P#]
M!W3/_ R/_P"*KY!_X="_L^_\^GB3_P '#?\ Q-8'C[_@E-\ O#/A>>^M[+Q
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M^@!I?_@''_A7&]'8HB_X6)X5_P"AETC_ ,#HO_BJ/^%B>%?^AETC_P #HO\
MXJI?^$'\.?\ 0 TO_P  X_\ "C_A!_#G_0 TO_P#C_PI#(O^%B>%?^AETC_P
M.B_^*H_X6)X5_P"AETC_ ,#HO_BJE_X0?PY_T -+_P# ./\ PH_X0?PY_P!
M#2__  #C_P * (O^%B>%?^AETC_P.B_^*H_X6)X5_P"AETC_ ,#HO_BJE_X0
M?PY_T -+_P# ./\ PH_X0?PY_P! #2__  #C_P * (O^%B>%?^AETC_P.B_^
M*H_X6)X5_P"AETC_ ,#HO_BJE_X0?PY_T -+_P# ./\ PH_X0?PY_P! #2__
M  #C_P * (O^%B>%?^AETC_P.B_^*H_X6)X5_P"AETC_ ,#HO_BJE_X0?PY_
MT -+_P# ./\ PH_X0?PY_P! #2__  #C_P * (O^%B>%?^AETC_P.B_^*H_X
M6)X5_P"AETC_ ,#HO_BJE_X0?PY_T -+_P# ./\ PH_X0?PY_P! #2__  #C
M_P * (O^%B>%?^AETC_P.B_^*H_X6)X5_P"AETC_ ,#HO_BJE_X0?PY_T -+
M_P# ./\ PH_X0?PY_P! #2__  #C_P * (O^%B>%?^AETC_P.B_^*I?^%@^%
M_P#H9-)_\#HO_BJD_P"$'\.?] #2_P#P#C_PKBO%7A70X?B9X(MTT:P2&9;W
M?&ML@5\1*1D8YQ0!V'_"P_"O_0RZ1_X'1?\ Q5'_  L3PK_T,ND?^!T7_P 5
M4W_"#^'/^@!IG_@''_A2?\(/X<_Z &E_^ <?^% $7_"Q/"O_ $,ND?\ @=%_
M\51_PL3PK_T,ND?^!T7_ ,54O_"#^'/^@!I?_@''_A1_P@_AS_H :7_X!Q_X
M4 1?\+$\*_\ 0RZ1_P"!T7_Q5'_"Q/"O_0RZ1_X'1?\ Q52_\(/X<_Z &E_^
M <?^%'_"#^'/^@!I?_@''_A0!%_PL3PK_P!#+I'_ ('1?_%4?\+$\*_]#+I'
M_@=%_P#%5+_P@_AS_H :7_X!Q_X4?\(/X<_Z &E_^ <?^% $7_"Q/"O_ $,N
MD?\ @=%_\51_PL3PK_T,ND?^!T7_ ,54O_"#^'/^@!I?_@''_A1_P@_AS_H
M:7_X!Q_X4 1?\+$\*_\ 0RZ1_P"!T7_Q5'_"Q/"O_0RZ1_X'1?\ Q52_\(/X
M<_Z &E_^ <?^%'_"#^'/^@!I?_@''_A0!%_PL3PK_P!#+I'_ ('1?_%4?\+$
M\*_]#+I'_@=%_P#%5+_P@_AS_H :7_X!Q_X4?\(/X<_Z &E_^ <?^% $7_"Q
M/"O_ $,ND?\ @=%_\51_PL3PK_T,ND?^!T7_ ,54O_"#^'/^@!I?_@''_A1_
MP@_AS_H :7_X!Q_X4 1?\+$\*_\ 0RZ1_P"!T7_Q5'_"Q/"O_0RZ1_X'1?\
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M4.U?(A.!QP,D_F: .J_X6)X5_P"AETC_ ,#HO_BJ/^%B>%?^AETC_P #HO\
MXJI?^$'\.?\ 0 TO_P  X_\ "C_A!_#G_0 TO_P#C_PH B_X6)X5_P"AETC_
M ,#HO_BJ/^%B>%?^AETC_P #HO\ XJI?^$'\.?\ 0 TO_P  X_\ "C_A!_#G
M_0 TO_P#C_PH B_X6)X5_P"AETC_ ,#HO_BJ/^%B>%?^AETC_P #HO\ XJI?
M^$'\.?\ 0 TO_P  X_\ "C_A!_#G_0 TO_P#C_PH B_X6)X5_P"AETC_ ,#H
MO_BJ/^%B>%?^AETC_P #HO\ XJI?^$'\.?\ 0 TO_P  X_\ "C_A!_#G_0 T
MO_P#C_PH B_X6)X5_P"AETC_ ,#HO_BJ/^%B>%?^AETC_P #HO\ XJI?^$'\
M.?\ 0 TO_P  X_\ "C_A!_#G_0 TO_P#C_PH B_X6)X5_P"AETC_ ,#HO_BJ
M/^%B>%?^AETC_P #HO\ XJI?^$'\.?\ 0 TO_P  X_\ "C_A!_#G_0 TO_P#
MC_PH B_X6)X5_P"AETC_ ,#HO_BJ/^%B>%?^AETC_P #HO\ XJI?^$'\.?\
M0 TO_P  X_\ "C_A!_#G_0 TO_P#C_PH B_X6)X5_P"AETC_ ,#HO_BJ/^%B
M>%?^AETC_P #HO\ XJI?^$'\.?\ 0 TO_P  X_\ "C_A!_#G_0 TO_P#C_PH
M B_X6)X5_P"AETC_ ,#HO_BJ/^%B>%?^AETC_P #HO\ XJI?^$'\.?\ 0 TO
M_P  X_\ "C_A!_#G_0 TO_P#C_PH B_X6)X5_P"AETC_ ,#HO_BJ/^%B>%?^
MAETC_P #HO\ XJI?^$'\.?\ 0 TO_P  X_\ "C_A!_#G_0 TO_P#C_PH B_X
M6)X5_P"AETC_ ,#HO_BJ/^%B>%?^AETC_P #HO\ XJI?^$'\.?\ 0 TO_P
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M_P# V/\ ^*H_X3GPW_T,&E_^!L?_ ,57F>T?\^MC_P" 4/\ \11M'_/K8_\
M@%#_ /$47#E/3/\ A.?#?_0P:7_X&Q__ !5'_"<^&_\ H8-+_P# V/\ ^*KS
M/:/^?6Q_\ H?_B*-H_Y];'_P"A_^(HN'*>F?\)SX;_Z&#2__  -C_P#BJ/\
MA.?#?_0P:7_X&Q__ !5>9[1_SZV/_@%#_P#$4;1_SZV/_@%#_P#$47#E/3/^
M$Y\-_P#0P:7_ .!L?_Q5'_"<^&_^A@TO_P #8_\ XJO,]H_Y];'_ , H?_B*
M-H_Y];'_ , H?_B*+ARGIG_"<^&_^A@TO_P-C_\ BJ/^$Y\-_P#0P:7_ .!L
M?_Q5>9[1_P ^MC_X!0__ !%&T?\ /K8_^ 4/_P 11<.4],_X3GPW_P!#!I?_
M (&Q_P#Q5'_"<^&_^A@TO_P-C_\ BJ\SVC_GUL?_  "A_P#B*-H_Y];'_P
MH?\ XBBX<IZ9_P )SX;_ .A@TO\ \#8__BJ/^$Y\-_\ 0P:7_P"!L?\ \57F
M>T?\^MC_ . 4/_Q%+M'_ #ZV/_@%#_\ $T"Y3TS_ (3CPY_T,&E_^!L?_P 5
M2?\ "<^&_P#H8-+_ / V/_XJO+[BRANFA:6TLR87\Q,6D0PP!'9>>IX/%3%1
M_P ^MC_X!0__ !-,+'I7_"<^&_\ H8-+_P# V/\ ^*H_X3GPW_T,&E_^!L?_
M ,57F>T?\^MC_P" 4/\ \11M'_/K8_\ @%#_ /$4KCY3TS_A.?#?_0P:7_X&
MQ_\ Q5'_  G/AO\ Z&#2_P#P-C_^*KS/:/\ GUL?_ *'_P"(HVC_ )];'_P"
MA_\ B*+ARGIG_"<^&_\ H8-+_P# V/\ ^*H_X3GPW_T,&E_^!L?_ ,57F>T?
M\^MC_P" 4/\ \11M'_/K8_\ @%#_ /$47#E/3/\ A.?#?_0P:7_X&Q__ !5'
M_"<^&_\ H8-+_P# V/\ ^*KS/:/^?6Q_\ H?_B*-H_Y];'_P"A_^(HN'*>F?
M\)SX;_Z&#2__  -C_P#BJ/\ A.?#?_0P:7_X&Q__ !5>9[1_SZV/_@%#_P#$
M4;1_SZV/_@%#_P#$47#E/3/^$Y\-_P#0P:7_ .!L?_Q5'_"<^&_^A@TO_P #
M8_\ XJO,]H_Y];'_ , H?_B*-H_Y];'_ , H?_B*+ARGIG_"<^&_^A@TO_P-
MC_\ BJ/^$Y\-_P#0P:7_ .!L?_Q5>9[1_P ^MC_X!0__ !%&T?\ /K8_^ 4/
M_P 11<.4],_X3GPW_P!#!I?_ (&Q_P#Q5'_"<^&_^A@TO_P-C_\ BJ\SVC_G
MUL?_  "A_P#B*-H_Y];'_P  H?\ XBBX<IZ9_P )SX;_ .A@TO\ \#8__BJ/
M^$Y\-_\ 0P:7_P"!L?\ \57F>T?\^MC_ . 4/_Q%&T?\^MC_ . 4/_Q%%PY3
MTS_A.?#?_0P:7_X&Q_\ Q5'_  G/AO\ Z&#2_P#P-C_^*KS/:/\ GUL?_ *'
M_P"(HVC_ )];'_P"A_\ B*+ARGIG_"<^&_\ H8-+_P# V/\ ^*H_X3GPW_T,
M&E_^!L?_ ,57F>T?\^MC_P" 4/\ \12A1_SZV/\ X!0__$T"Y3TS_A./#G_0
MP:7_ .!L?_Q5)_PG/AO_ *&#2_\ P-C_ /BJ\O\ L4'VPW7V2S\_R_*W?9(L
M;<YQC;CKWQFI2H_Y];'_ , H?_B:86/2_P#A.?#?_0P:7_X&Q_\ Q5'_  G/
MAO\ Z&#2_P#P-C_^*KS/:/\ GUL?_ *'_P"(HVC_ )];'_P"A_\ B*5Q\IZ9
M_P )SX;_ .A@TO\ \#8__BJ/^$Y\-_\ 0P:7_P"!L?\ \57F>T?\^MC_ . 4
M/_Q%&T?\^MC_ . 4/_Q%%PY3TS_A.?#?_0P:7_X&Q_\ Q5'_  G/AO\ Z&#2
M_P#P-C_^*KS/:/\ GUL?_ *'_P"(HVC_ )];'_P"A_\ B*+ARGIG_"<^&_\
MH8-+_P# V/\ ^*H_X3GPW_T,&E_^!L?_ ,57F>T?\^MC_P" 4/\ \11M'_/K
M8_\ @%#_ /$47#E/3/\ A.?#?_0P:7_X&Q__ !5'_"<^&_\ H8-+_P# V/\
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M_P  H?\ XBBX<IZ9_P )SX;_ .A@TO\ \#8__BJ/^$Y\-_\ 0P:7_P"!L?\
M\57F>T?\^MC_ . 4/_Q%&T?\^MC_ . 4/_Q%%PY3TS_A.?#?_0P:7_X&Q_\
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MQ5]JU\5?\$C/^321_P!A^]_]!BK[5KOS?_D85_\ $_S"G\""BBBO(- HHHH
M*X+XX-M^'5X?^GJT_P#2B.N]K@?CE_R3F[_Z^K3_ -*8Z!K<[ZBBB@04444
M%?FY_P %MO\ DDOPX_[#4_\ Z3FOTCK\V_\ @MO_ ,DF^''_ &&I_P#TG-=&
M'_B(3V/T0\+?\BSI'_7G#_Z *U*R_"W_ "+.D?\ 7G#_ .@"M2L9?$QA1114
M@%%%% !1110 4444 %%%% !1110 4444 %<!XP_Y*MX!_P!V_P#_ $4M=_7
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M2_\ (EQ?]?=W_P"E$E=C7'?"7_D2XO\ K[N__2B2NQH("BBB@ HHHH ****
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7#_#?_ )#'CK_L.O\
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MI$8FN=-U?3Y;*;RB0!(%D ./F7K@_,..17J/EG=C%&VC#<914_EK'CS'6/\
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M1;?Q-,H>+19=0A6]D4YP5A+;R#M;D#L?2G9@='1112 X+X+?\BC>?]A?4?\
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M\2>@ Y).!75:Q^WU\,M$T7PWJ]QI'B\Z5XEDDCT6[CT4E=09'"$1+OW$EB,
M@$YX%?+_ .S[\/YO&G_!+OQM#XV\<6/A[P8+Y[O29OLQ9[*2*;+)+@ R"27
M51DC=QV ]&D_9)\;_'[X2?L]>#]?.D>%M \&P>=?:I:ZLD]Q=1E4\L0(@X8J
M@R6(VD\9Q3Y4VVV',]D>M?M?Z\_C?X.^"?!NE0WUC=_%+5;'2UAN(C;W=O9N
M5GN2\;*2C")2K*P^7><]*WO''[6'PL^ _P 1M'^%GB!-4T.^,-O#92+I^ZS,
M3 )&59#]W(V_=X(/;FJUK_Q<G]N>Y# SZ'\+O#T=O SYPNIWPRS9Z%A; #U
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MZ<$'\:4HI+0<9-O4X#_@II^TQXD^#^A>&O 7@V[DTG6O$R/-<ZI"Y66&W#!
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M7!_\)1JW_/2/_OV*/^$HU;_GI'_W[%'(PYD=Y17!_P#"4:M_STC_ ._8I?\
MA*-6_P">D?\ W[%'*QW.[HKA/^$HU7_GK'_W[%+_ ,)/JO\ STC_ .^!3Y&%
MSNJ*X;_A)M5_YZ1_]\"C_A)M5_YZ1_\ ? I<C%<[FBN&_P"$FU7_ )Z1_P#?
ML4?\)-JO_/2/_OV*.5CN=S7$?#E2NL>.2>^NO_Z3P4L?B;4V/,D?_? KG?!^
MM7]OJ/BDHZ RZHSM\@Z^5&/Y 4N5CN>L45Q!\2ZI_P ](_\ O@4?\)+JG_/1
M/^_8I\K%<[>BN(_X2;5/^>B?]\"C_A)M4_YZ)_WP*.5A<[>BN'_X2;5.?WB?
M]^Q2_P#"2ZI_ST3_ +]BCE87.WHKB?\ A)=4_P">B?\ ? I/^$FU/_GHG_?
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MJ:0;7DL;..%F'H2JC-6LFB@!SN6--HHH **** "BBB@ HHHH **** "BBB@
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M2QO_ $#S_P# )?Y&YM%9'C)?^*=F_P"ND7_HQ:C_ .%F>"/^AQT#_P &</\
M\55+7O&7AG7M*EM-+\1:5J-TSQL(+2]CE<@.N3M5B:3KT)+E52+;\T'U7%T_
M?G1FDMVXM+\CK644W:*DD7;3*Z'N<HFT4;12T4@'P+\PKX9_X+%_\DJ^&W_8
M7N?_ $2*^Z(/O"OAC_@L5@_"GX;#_J+W/_HE:]7*-<PI>K_)BE\+/NG35_XI
M;1/^O&#_ -%K497VKC=)_:-^#7_"-Z1')\6? Z21V<*.C>(K0%2$4$$>9P:<
M?VB/@Q_T5OP-_P"%'9__ !RN!X:O=_NY?<RKKN=?Y?M1Y=<A_P -#_!C_HK?
M@;_PH[/_ ..4?\-$?!C_ **WX&_\*.S_ /CE+ZO7_P"?<ON8M.YV&WVHV^U<
MA_PT1\&/^BM^!O\ PH[/_P".4?\ #1'P8_Z*WX&_\*.S_P#CE'U>O_S[E]S'
M='7[?:DV>U<C_P -$?!C_HK?@;_PH[/_ ..4?\-$?!C_ **WX&_\*.S_ /CE
M'U>O_P ^Y?<PNCK_ "_:C;[5R(_:(^"__17/ W_A1V?_ ,<H_P"&B/@O_P!%
M<\#?^%'9_P#QRCZOB/\ GW+[F%T=AM]J-OM7(?\ #1/P8_Z*WX%_\*.S_P#C
ME'_#1/P8_P"BM^!?_"CL_P#XY1]7K_\ /N7W,+H[#9[4FWVKD?\ AHCX+_\
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MHHH **** "BBB@ HHHH \E\._P#)+]1_[#%Y_P"E;U3M_NBKGAW_ ))?J/\
MV&+S_P!*WJG;_=%==+X#&I\1-1116ID.HHHI( IRMBFT4PW/-/BO^S=X2^-&
MO6FL:[/J5O>V]N+4-8S(@:,,S $,C="[=/6N+_X8-^&__01\0?\ @5#_ /&J
M^@5-+N->94RS UINI5I)R>[U/K<'Q=Q'E^'AA<)CIPIP5E%/1+ML?/P_8-^&
M_P#T$?$'_@5#_P#&J7_A@SX;_P#01\0?^!47_P :KZ"#4;JR_L?+?^?*_'_,
M[/\ 7OBS_H8U/O7^1\^_\,&?#?\ Z"/B#_P*B_\ C5'_  P9\-_^@CX@_P#
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M"?;X7^>/WK_,^?O^'0WP8_Z&KQQ_X&6?_P BT?\ #H?X+_\ 0U>./_ VS_\
MD6OH'_AJKX0?]#[IOY2?_$T?\-3?"-F1%\>:9N<[1GS ,_4K1]>S;^:7W?\
M #V^%_GC]Z/G[_AT/\%_^AI\<?\ @;9__(M'_#HCX+_]#3XX_P# VS_^1:^R
M6DW*KJVY6&X$=P:C\YO6N?\ M;'_ //U_A_D=7)'L?'7_#HCX+_]#3XX_P#
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MT-_P4)\%J/\ D5M>_.#_ .+KZ+'A7PT/^9=TG_P!B_\ B:#X5\-'_F7=)_\
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M#&I\1/12;A1NY%:F0^BC-&120!11D49%,!RTM-4BEW5)8M%)FES2 **,T9H
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M4 M.IF:?F@I!11FC-)@Q:2C-&:DD6G4S-/S5(I!11FBAC"BBBI **,T4 /\
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MD\PTFTTE #O,--R:,44 *&(I=YIM% #MYI-QI** #)IP<BFT4 +O-+O--HH
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M3,:R@LJD.  ,$<YI=Q;VO_!*CXMQZM)%'JJ:GK4-\MP0)!>G4R%5\\^828\
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M'_[*U;_H&77_ 'Z;_"C^RM6_Z!EU_P!^F_PKV"BCVS[![,\@_LO5O^@9=_\
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M?8=0Y_T*?_OV:7[#J'_/G/\ ]^S7H5%+F"QY\;'4/^?.?_OV:3[#J'_/G/\
M]^S7H5%/F"QY[]AU#_GSG_[]FG?8;_\ Y\Y_^_9KT"BCG \_^PW_ /SYS_\
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M8=7T.W:XM[WP^LJQ-L,98-YC$G*RH0<#!!I<KM<=U>Q]/P6YD; KRO5/VGO
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M?_22.OT9K\YOBY_RD#G_ .NMK_Z21UX.;?\ ,/\ ]?(GZ?P-\.;_ /8'7_\
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M S'&95B%BL!5=.HDU=;V>Y\^?\,(_#OOJ6O?^!,7_P :H_X81^'?;4M>_P#
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M0+8****YQA1110 4444 %%%% !1110 4444 %%%% !7#_#?_ )#'CK_L.O\
M^D\%=Q7#_#?_ )#'CK_L.O\ ^D\% SN****!!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!%=?\>LW^XW\J\4T_\ U8KVNZ_X]9O]
MQOY5XII_^K%!2+]+24M PHHHH **** "BBB@ HHHH **** "G;S3:* %W&DH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!&Z5+H__(P:=_U\)_,5$W2I='_Y&#3O^OA/YB@#
MJ_A+_P B7%_U]W?_ *425V-<=\)?^1+B_P"ON[_]*)*[&@@**** "BBB@ HH
MHH ***Q_&&L7N@>%=6U'3=,FUO4K6UDEM=-@(#W4P4[(@3PNYL#<>!G)X%/<
M#8HKY:TOX]?'?1_B9\.O#?C3X:>%=+M?%MY) QTO7Y+JZM(XX6FED=/*"X4
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M'7_8=?\ ])X*[BN'^&__ "&/'7_8=?\ ])X*!G<4444""BBB@ HHHH ****
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M$-3=_P"$YD_Y\/\ R+_]:E'CB0_\N'_D7_ZU8?EBCRQ1RH5V;G_"<2?\^/\
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MX>+I#_RYC_OY_P#6K'V"@**+(9K_ /"7R?\ /F/^_G_UJ7_A+I/^?,?]_/\
MZU8^P4NT4K(#7_X2Z3_GS'_?S_ZU'_"72?\ /F/^_G_UJR-HHVBBR U;KQ8_
MV.X;[(/EC8_?]OI7"^&='&KZ#87[2F$W,*RF,+G;D9QFNCNU_P")?<_]<F_D
M:S/ O_(E:'_UZ1_^@TK*XR3_ (1=/^?IO^^/_KTG_",I_P _;?\ ?'_UZURU
M)DT<J"[,G_A&4_Y^V_[X_P#KT?\ "+H?^7IO^^/_ *]:V32[C1RH+LR?^$73
M_GZ;_OC_ .O1_P (NG_/TW_?'_UZUMU&ZCEB%V97_"*I_P _3?\ ?'_UZ/\
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MH_\ H(/_ -^Q_C1_P@T?_00?_OV/\:Z#<:-QHT P!X%C)_Y"#_\ ?L?XTO\
MP@L?_00?_OV/\:WU8YI=QH"[.?\ ^$#C_P"@@_\ W['^-)_P@<?_ $$'_P"_
M8_QKHMQHW&@:9SO_  @D?_00?_OV/\:/^$#C_P"@@_\ W['^-=#N-+N-(&<[
M_P ()'_T$'_[]C_&G?\ "!1_]!!_^_8_QK?W&G[C3%=G._\ "!1_]!!_^_8_
MQH_X0*/_ *"#_P#?L?XUT6XT;C0%V<[_ ,(%'_T$'_[]C_&C_A H_P#H(/\
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MHHI@%%%% !3Z93Z "D_BI:3^*DP%HHHH0!1110P"G)UIM.3K4@<\O_)4)/\
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M_C+_ )%V;_KI%_Z&M3+X65'XD;K=*;3FZ4VK9(4444@'15\I?MJ?\E7^$?\
MU\G_ -*(:^K8J^4OVU/^2K_"/_KY/_I1#7AYY_N$O\4?S1^E>&__ "5%'_!5
M_P#34SZVOO\ 657JQ??ZRJ]>_4^(_+:'\-!11161T"[C4D+'>*BJ2'[P^M!9
M\D_MMG_B^7P3_P"OM?\ TJ@K[!U+_7&OCW]MO_DN7P3_ .OM?_2J"OL+4O\
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MBBB@!MY_QX77_7)OY5E>!?\ D2M$_P"O2/\ ]!K5O/\ CPNO^N3?RK*\"_\
M(E:)_P!>D?\ Z#1U VJ*** "BBB@ HHHH 5:6D6EH8!1110 4444 *O6G4U>
MM.I, HHHI %%%%4 4Y>E-IR]*3 6A>M%"]:0&!XP_P"/OPO_ -A:/_T7)713
M?>KG?&'_ !]^%_\ L+1_^BY*Z*;[U(!E%%%,!5I:1:6@ HHHI,!5IU-6G4(
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MTNX\TT7BXZUY11:HJK]L7UH^U+ZT 6J*K?:AZT?:AZT 7(^M87A;_D(>(_\
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M?Q5#YU'G#=2 GHJ'SA1YPH0$U%0^<*/.%# FIR=:K^<*?',,U(&&O_)4)/\
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MO_C-'_#(/[=7_1:X_P#PI+K_ .,U^I-%'UJIY?<'*?EM_P ,@_MU?]%KC_\
M"DNO_C-'_#(/[=7_ $6N/_PI+K_XS7ZDT4?6JGE]P<I^7"_LA?MTYY^-<?\
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MP_%_Z(GKM:XKXD?\?_@K_L/Q?^B)Z[6@84444""BBB@ HHHH **** "BBB@
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M4 %%%% !1110!POP5_Y$"W_Z_+S_ -*I:[JN%^"O_(@6_P#U^7G_ *52UW5
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M_P#L+ZA_Z525WM<'\&!CPC=_]A?4/_2J2N\I#>X4444""BBB@ HHHH ****
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MU=K7&?$5=U]X,]M>B/\ Y FKLZ!A1110(**** "BBB@ HHHH **** "BBB@
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MV:M44 5?*F_Y[R?]]FE\J;_GM)_WV:M;>*6G<"IY4W_/:3_OLT>5+G_72?\
M?9JWBC%%QE;R9O\ GO)_WV:/)F_Y[R?]]FK5%(15\F;_ )[R?]]F@12_\]Y?
M^^S5JE6@"KY4O_/:7_OLUC^-(7?PW,K2NP\R+@L?^>BUT=8_C(?\4[-_UTB_
M]#6IE\++C\2--HY?^>TG_?9IGE2_\]I?^^S5PTF*HDJ>5+_SVE_[[-'ER_\
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M  .N?_CE+_PQ'\#O^A&B_P# VY_^.5[&K'/6G;C1]<Q7_/V7WO\ S#ZKA_\
MGW'[D>-K^Q+\#Q_S(\7_ (&W/_QRJ&H?L=?!BVU[1[6/P9&L-P)O,7[;<?-M
M4$?\M*]T5C6)J['_ (2SP]]+C_T 5,L9BK?Q9?>_\P6$PS>M./W(\X;]B7X'
MLW/@>+_P.N?_ (Y7E/[6G[+/PL^'7P!U[7_#GA:/3=6MYK5(K@7,TFT/.B,,
M,Y'*DCI7UWN.ZO$OVYC_ ,8N^)O^OFR_]*HZ[,'B\3+$THRJ2:<EU?<XL;A:
M$<+5<::347T78V/V4[/[/^S+\/XXF9$73R JD@#]Z]>E>7+_ ,]9/^^C7 ?L
MK_\ )M/@'_KP/_HQZ](KBQ/\>IZO\SNPUW0IM]E^15\N3_GK)_WT:/+D_P">
MLG_?1JS1BN<W*WER?\]9/^^C1Y<G_/63_OHU9HJ;E%;RY/\ GK)_WT:7RY/^
M>LG_ 'T:L4M%PL0>7)_SUD_[Z-'ER_\ /63_ +Z-6:,4"*_ER_\ /5_^^C1Y
M<O\ SU?_ +Z-6**117\N7_GJ_P#WT:/+E_YZO_WT:L44 0>7)_SU?_OHTHCD
MQ_K7_P"^C4U.7I3 K^7)_P ]7_[Z-+Y<O_/5_P#OHU8HI 5_+E_YZO\ ]]&C
MRY/^>K_]]&K%% $<:R9_UC_]]&L+PI$ZZAXEP[#.I,3\Q_YYI721]:PO"O\
MR$/$?_81;_T6E)C-8QR?\]7_ .^C2>7)_P ]9/\ OHU8HIHDK^7)_P ]7_[Z
M-'ER?\]7_P"^C5BB@96\N3)_>R?]]&E\N3_GK)_WT:G'4T5($/ER?\]'_P"^
MC2;)/^>C_P#?1JQ15 5]DG_/1_\ OHT[RW_YZ/\ ]]&IJ=04BOY<F?\ 6/\
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M1M;_ )Z-^=344 1;6_YZ-^=.VM_ST;\Z?3Z (=K?\]&_.C:V[[[?G4U)_%2
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MY^*7@GX-_MK?'N+QOX]\#^'HM2DL;VRBO9(8;S)MXT<2738 QL'[@L6&X/M
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M1117LGP 4444 %%%% #J*** "BBB@!5ZTZFKUIU "KUK$U?_ )&SP]]+C_T
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MQ>?^E;U3M_NBKGAW_DE^H_\ 88O/_2MZIV_W1772^ QJ?$34445J9#J***2
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M-'N+E9SOF"E605T/_"MY?^@D/^_/_P!E2CX<2C_F)#_OS_\ 94<T>X<K.?\
M,%8_C*0?\([-_P!=(O\ T8M=S_PKF7_H)#_OS_\ 95S'Q+\'R:1X/N+@WP<+
M- N/+Q]Z9%]?>IE*-GJ7&+NBTT@IOF"NB;X>RG_F(C_OU_\ 7IO_  KN;_H)
M#_OU_P#957/'N3RLY_S!1Y@KH/\ A7<O_01'_?G_ .O1_P *[E_Z"(_[\_\
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M$+D_Y_1_W[_^O2N@L8QD%)Y@K:_X0R3_ )_1_P!^_P#Z]'_"%R?\_H_[]_\
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M_KT?\(P__/R/^^/_ *] &:K<T[<*T!X9<?\ +R/^^/\ Z]+_ ,(V_P#S\_\
MCG_UZ>@&=N%&X5H_\(V__/S_ ..?_7I?^$;?_GY'_?'_ ->DP,Y6%.W"KX\-
MO_S\_P#CG_UZ7_A''_Y^?_'?_KT 9VZEW"M#_A''_P"?G_QW_P"O1_PCK_\
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M$G+_  ;_ .1#@_Z_+S_TIDKMZX?X,'/@*#_K\O/_ $IEKN*!L****!!1110
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M'K'_ "";W_K@_P#Z":YSX/\ _)+/"?\ V#(/_0!0/H=?1110(**** "BBB@
MHHHH **** "BBB@ HHHH *_+_P#:./\ QN ^$G_7KI_\[FOU K\O_P!H[_E,
M!\)/^O73_P"=S79A?C?HR9'Z@4445QE!1110 4444 <7\2#_ *=X*_[#\7_H
MB:NTKBOB1_Q_^"O^P_%_Z(GKM:!A1110(**** "BBB@ HHHH **** "BBB@
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M]#>O?*QQW^]5?\4OS8X_"@HHHKB*"BBB@ HHHH **** "BBB@ HHHH ****
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M&-P['&4B(/4=":]8_P"'E?[./_11H_\ P57W_P 9K=_X8%_9\QC_ (5;HO\
MY%_^+H_X8%_9\_Z)9HO_ )%_^+KV*U7*:U2564:EY-O>/7Y',EB$DDU^)@_\
M/*_V<?\ HHT?_@JOO_C-'_#RO]G'_HHT?_@JOO\ XS6]_P ,"_L^?]$LT7_R
M+_\ %T?\,"_L^?\ 1+-%_P#(O_Q=97RCM4^^/^0?[1W7XF#_ ,/*_P!G'_HH
MT?\ X*K[_P",T?\ #RO]G'_HHT?_ (*K[_XS6]_PP+^SY_T2S1?_ "+_ /%T
M?\,"_L^?]$LT7_R+_P#%T7RCM4^^/^0?[1W7XF#_ ,/*_P!G'_HHT?\ X*K[
M_P",T?\ #RO]G'_HHT?_ (*K[_XS6]_PP+^SY_T2S1?_ "+_ /%T?\,"_L^?
M]$LT7_R+_P#%T7RCM4^^/^0?[1W7XF#_ ,/*_P!G'_HHT?\ X*K[_P",T?\
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MT?\ M&L+PO\ \%"OV>]'O/$<MQX_2!+W4VN(F;3+SYU,,2Y&(?537=+^P/\
ML^KT^%FB?E+_ /%USOA']B#X":I?>)XIOAGH\JVNJM!&'\T[%\F)L#Y^!EB?
MQHOD_:K]\?\ (?\ M/\ =_$D_P"'E7[./_11H_\ P57W_P 9I/\ AY7^SC_T
M4:/_ ,%5]_\ &:WO^&!?V?/^B6:+_P"1?_BZ/^&!?V?/^B6:+_Y%_P#BZ+Y1
MVJ??'_(7^T=U^)@_\/*_V<?^BC1_^"J^_P#C-'_#RO\ 9Q_Z*-'_ ."J^_\
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MY7^SC_T4:/\ \%5]_P#&:WO^&!?V?/\ HEFB_P#D7_XNC_A@7]GS_HEFB_\
MD7_XNB^4=JGWQ_R%_M'=?B8/_#RO]G'_ **-'_X*K[_XS1_P\K_9Q_Z*-'_X
M*K[_ .,UO?\ # O[/G_1+-%_\B__ !='_# O[/G_ $2S1?\ R+_\71?*.U3[
MX_Y!_M'=?B8/_#RO]G'_ **-'_X*K[_XS1_P\K_9Q_Z*-'_X*K[_ .,UO?\
M# O[/G_1+-%_\B__ !='_# O[/G_ $2S1?\ R+_\71?*.U3[X_Y!_M'=?B8/
M_#RO]G'_ **-'_X*K[_XS1_P\K_9Q_Z*-'_X*K[_ .,UO?\ # O[/G_1+-%_
M\B__ !='_# O[/G_ $2S1?\ R+_\71?*.U3[X_Y!_M'=?B8/_#RO]G'_ **-
M'_X*K[_XS1_P\K_9Q_Z*-'_X*K[_ .,UO?\ # O[/G_1+-%_\B__ !='_# O
M[/G_ $2S1?\ R+_\71?*.U3[X_Y!_M'=?B8/_#RO]G'_ **-'_X*K[_XS1_P
M\K_9Q_Z*-'_X*K[_ .,UO?\ # O[/G_1+-%_\B__ !='_# O[/G_ $2S1?\
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M[#\7_HB>NUH&%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH XE/\ DM4O_8OI_P"E+5VU<2G_ "6J7_L7T_\ 2EJ[:@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .%^"O\
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M_A97_4,;_O[_ /6H_P"%E?\ 4,;_ +^__6H]G+L',CMZ*XG_ (65_P!0UO\
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MC_\ A8/_ %#V_P"_O_UJ/^%@_P#4/;_O[_\ 6HY)!S(["BN0_P"%@C_H'O\
M]_?_ *U'_"P1_P! ]_\ O[_]:CDD.Z.OHKD!\0!_T#V_[^__ %J7_A/O^H>W
M_?T?X4<DA<R.NK@?%X_XNMX!/^S?_P#HI:T!X^_ZA[?]_?\ ZU<MXB\4_:/'
M_A&Z^Q,/LZW?R[^NZ,#TI.+&I(]7HKDV\>A?^7!C_P!M?_K4W_A/O^H>W_?T
M?X4^2071UU%<C_PGW_4/;_OZ/\*4>/L_\N#?]_/_ *U')(+HZVBN2_X3S_IP
M;_OY_P#6H_X3S_IP;_OY_P#6HY6+F1UM%<G_ ,)Y_P!.#?\ ?S_ZU'_">?\
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M[^?_ %J.5BNCIZ*YC_A-O^G%O^_G_P!:C_A-O^G%O^_G_P!:CE87.GHKE_\
MA-O^G%O^_G_UJ7_A-O\ IQ;_ +^?_6HY6!T]%<Q_PFO_ $XM_P!_/_K4?\)M
M_P!.+?\ ?S_ZU'*PN=/17,?\)M_TXM_W\_\ K4O_  FG_3DW_?S_ .M1RL9T
MU%<S_P )I_TY-_W\_P#K4?\ ":?].3?]_/\ ZU'*P.FHKF?^$S_Z<F_[^?\
MUJ/^$T_Z<F_[^?\ UJ.5B.FHKF?^$S_Z<F_[^?\ UJ7_ (3+_IR;_OY_]:CE
M8SI:*YK_ (3+_IR;_OY_]:E'C#/_ "YG_OO_ .M1RL#I**YK_A,?^G-O^_G_
M -:E_P"$P_Z<V_[[_P#K4<K Z2BN;_X3#_IS;_OO_P"M2_\ "8?].9_[[_\
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M#_IW/_?7_P!:@1KT5D_V]_T[G_OK_P"M2?V__P!.Y_[Z_P#K4 :]%9']O_\
M3N?^^O\ ZU']O?\ 3N?^^O\ ZU &O162->Y_U!_[Z_\ K4O]N_\ 3 _]]?\
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M16ID)Y(I/)'I4E%) 1^2/2CR1Z5)13 :L*^E+Y(]*>M+2+&+&OI1Y8]*?12
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M_K#4-37'^L-0U[DMS\TI_"@HHHJ34=1110 4444 *O6G4U>M.H 5>M8>K_\
M(V>'OI<?^@"MQ>M8>K_\C9X>^EQ_Z *B6PX[FZU-IS4VJ$%.6FTY:8"T444
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MKHV^]30QC4M(U+0Q!1112 **** %6G4U:=0 4444#04444 PI],I] @HHHH
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M*<M-IRTP%HHI,T +1114%!1110 ZBBB@D****"@HHHH *<O2FTY>E "T444
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MKG)PD<:C.6?/B<=P?!G[%'Q#_9^NX)I/BK<Z]?:'I_AZ-<W%\;N\,\%U&O\
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M** "BBB@ HHHH **** "BBB@ K@?CE_R3F\_Z^K3_P!*8Z[ZN!^.7_).;O\
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ML?\ ()O?^N#_ /H)KG/A!_R2WPG_ -@R#_T 5T>L?\@F]_ZX/_Z":YSX/_\
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M / 7_D/GCW/K"BOD_P#X>D?LY?\ 0ZW?_@DO?_C5'_#TC]G+_H=;O_P27O\
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M_P B!;_]?EY_Z52UW5<+\%?^1 M_^OR\_P#2J6NZH&]PHHHH$%%%% !1110
M4444 %%%% !1110!P7P6_P"11O/^POJ/_I5)7>UP7P6_Y%&\_P"POJ/_ *52
M5WM WN%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@"GK'_ "";W_K@_P#Z":YSX/\ _)+/"?\
MV#(/_0!71ZQ_R";W_K@__H)KG/@__P DL\)_]@R#_P! % ^AU]%%% @HHHH
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M/,/^OM3_ -*84445Z1\<%%%% !1110 4444 %%%% !1110 4444 %</\-_\
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M_JQWAF]O:NH_LZT_Y]8?^_8_PKE/B/\ \?W@K_L/Q?\ HB>NTI:@5O[-M/\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '"_!7_D0+?_K\O/\
MTJEKNJX7X*_\B!;_ /7Y>?\ I5+7=4#>X4444""BBB@ HHHH *0]#CBEI"<
MG&: /FW]G7QMXSU?]I7]H/PKXE\22Z]I'A^ZTDZ/#)!'$+6.>"5V0;%&>57D
MY^[[UXS>?&KXC^)O@+XT_:1TKQ?=V,&@ZW<-IG@]5C&FW.E6MSY$D4X*%_.E
M =_,#?*0H4 9!]<_9YT'Q58?M1_'CQ'K/A'5=$T'Q.^EOI-_>+&$G6VA>.3(
M5RR$EQ@$<@&O*S\"/B/X?_9S\;?L\:?X6FO(M9\07$.G^*A+&+"+2;JX^T/<
M2Y</YL8,B>6%Y;;C(YK5;MHCI8^WO#/B&S\7>&])UW3G,FGZG:17ML[#!:.1
M Z'\F%:=9GAGP_9^$O#>E:'IZ&.PTRTBLK=#U6.- BC\E%:=9NU]"E>VIYO\
M,=6MM!\"WMU=LRPKK%^"54L>;J3'%;Z_$C1&Z2S?]^6KB]!0-\+=1'_49O/_
M $K>L^&V7:.*WIPC*-V1.34K(]%_X6-HO_/6;_ORU+_PL;1?^>LW_?EJ\^^S
M+Z4?9ER.*OV<3/GD>A?\+$T7_GK-_P!^6H_X6)HO_/6;_ORU<!]E7TH^S+Z4
M>SB/G9W_ /PL31?^>LW_ 'Y:C_A8FB_\]9O^_+5P'V9?2C[,OI1[*(<[._\
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MUC&:7RQ0!L?VS;>K?]\T?VQ;>K?]\UD>6/2CRQ0,U_[8MO5O^^:/[8MO5O\
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MI<?^@"HEL..YNM3:<U-JA!3EIM.6F M<1^T%_P D#\=_]@F;^5=O7$?M!?\
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M_!1O_DU'5O\ L)V'_H]:[\M_WVC_ (E^9R8S_=:GHSH_V2_^23?#G_L3K?\
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MM3(=11120!1113 <M+2+2U++"BBBD 4444 .I:2EH **** "BBB@ I5I*5:
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MTBTM# **** "BBB@!5ZTZFKUIU)@%%%%( HHHJ@"G+TIM.7I28"T+UHH7K2
MP/&'_'WX7_["T?\ Z+DKHIOO5SOC#_C[\+_]A:/_ -%R5T4WWJ0#*DA^\*CJ
M2'[PI@?%?_!9#_DUWPE_V-UO_P"D=Y7U#^S?_P FM_"#_L3]'_\ 2*&OE[_@
MLA_R:[X2_P"QNM__ $CO*^H?V;_^36_A!_V)^C_^D4->Y5_Y%5+_ !/]3)?&
MSLV^]3:<WWJ;7A,U%6G4U:=0@"BBBF 4444 %/IE/H *3^*EI/XJ3 6BBBA
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MYPH\X4A$U.JOYPI_G"F4B6BHO.%*LPQUH&245$9A2^</6D!)14?F^]'FCUH
M=>?\>%U_UR;^597@;_D2]$_Z](__ $&M&\E']GW7_7)OY&LKP-,/^$*T,_\
M3I'_ .@TNH&]141F'K1YP]: ):*B\X>M F'K0!+14?FCUH\T>M,"5:6HEE&.
MM+YPI,"2BH_.%'G"@"2BH_.%'G"@"4=:=4"S#<*?YOO28$E%1^;[T>;[T@)*
M*C\WWH\WWJ@)*<O2H?-]Z<LHVBDP):%ZU'YH]:%E'K2 Q/&'_'WX7_["T?\
MZ+DKHIOO5S7C&0?;/"__ &%H_P#T7)7122C=2 *DA^\*K^:*DAE&\4P/B_\
MX+(?\FN^$O\ L;K?_P!([ROJ']F__DUOX/\ _8GZ/_Z10U\N?\%D&S^R[X2_
M[&ZW_P#2.\KZ@_9O<#]ESX/_ /8GZ1_Z115[=5_\)5+_ !/]3)?&SM6^\:2F
MM(,TGF"O#-21:=42R"E\T>M" DHJ/S1ZTOF"F ^BH_,H\R@"2GU#YE.\R@"2
MD_BIGF4>8-U)@244SS*/,H0#Z*9YE'F"A@2Q_>KYW_X*.?\ )J.K?]A.P_\
M1ZU]"K(-U?.W_!1Z4+^R?J[$\?VG8#_R.M>AEO\ OM'_ !+\SDQG^ZU/1G3_
M +)?_))OAS_V)UO_ .C37M$GWJ\4_9*D!^$OPX(/7P=;?^C37M$D@W&N?$_[
MQ4_Q/\S6A_!AZ+\A&I:C:04[S!Q7,S8=13=]&^D ZBF[Z-] #UIU1JXS3M]
M#J*;OHWT#0ZBF[Z-XH!CJ?46^G[Q0(=13=])OH ?13=XHWB@H=2K3-XI5<4
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M_B:/^%@?#7_G\L__  'D_P#B:])VCT%&T>@HYI=PLNQYM_PL#X:_\_EG_P"
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M#;_G]L__  'D_P#B:/\ A87PV_Y_;/\ \!Y/_B:](VCT%&T>@HYGW"R/-_\
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M &?_ (#R?_$UZ/M'H*-H]!1=]PT/./\ A8WPW_Y_[/\ \!Y/_B:/^%C?#?\
MY_[/_P !Y/\ XFO1]H]!1M'H*+ON&AYQ_P +&^&__/\ V?\ X#R?_$T?\+&^
M&_\ S_V?_@/)_P#$UZ/M'H*-H]!1=]PT/.?^%C_#C_G_ +3_ ,!Y/_B:/^%C
M_#C_ )_[3_P'D_\ B:]&VCT%&T>@HN^X:'G/_"R/AQ_T$+3_ ,!Y/_B:/^%D
M?#C_ *"%I_X#R?\ Q->C;1Z"C:/047?<-#SG_A9'PX_Z"%I_X#R?_$T?\+(^
M''_00M/_  'D_P#B:]&VCT%&T>@HNPT/.?\ A9'PX_Z"%I_X#R?_ !-+_P +
M(^'/_00M/_ >3_XFO1=H]!1M'H*+ON&AYU_PLCX<_P#00M/_  'D_P#B:YO7
MO'7@N?QMX7N;>ZA>Q@%U]ID6"3:FZ,!,_+W.:]IVCT%&T>@HNPT/.V^)'PZ[
MZA:_^ \G_P 32?\ "R/AS_T$+3_P'D_^)KT7:/04;1Z"B[[AH>=?\+(^'/\
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M&0?E]:]>VCT%&T>@HU \^_X6E\/?^@I;?]^)/_B:3_A:7P]_Z"=M_P!^)/\
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M?E73+$3E05#HG?\ /_,FRO<X#_A:_@#_ *"UO_WXD_\ B:/^%K^ /^@M;_\
M?B3_ .)KO]H]!1M'H*YBC@/^%K^ /^@M;_\ ?B3_ .)H_P"%L> /^@M;_P#?
MB3_XFN_VCT%&T>@H X#_ (6QX _Z"UO_ -^)/_B:7_A;'@'_ *"UO_WXD_\
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M"_X6YX"_Z#%O_P!^)/\ XFC_ (6[X"_Z#%O_ -^)/_B:[W:/04;1Z"@#@O\
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M*<E8$[A1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"LCQ9XNT3P+X?O==\1:K9Z)HUDF^XO[^9888ER "S,0!DD >I(%:]?%7[1UC
MXA^-/[;_ ,/OAA9W&FV^A^'?#,WC22WURUDO+&\N3<&WB\RV22/S3$P5EW.
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M:8_M>2&3S)KT$=4!VPJW.[RF(.W:3](4Y+E=A(****D84444 %%%% !1110
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MH *Y#XL?"OP]\:O .J>$/%%JUUI&H*N[RV*21.K!DEC8?==6 8'U'<<5U]%
M'F/PP^!%A\._%&K>*K[7]8\9>+]2M8=/EUS7'B\Y+.(DQVT:0QQQH@8LYPNY
MF<EB>,>G444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV#(LOF02K*@RRL,%E&>.E>@457,[WN*RV"BBBI&%%%% !1110 4444 %%%%
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M+;X:7GBRR7X72Z+)K4PO(+>,0I]BDD_X^, A Z!LD]."3UKA_P!H#5K#0_\
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M[3D56OM.BF58DF9,+*/W@V/@,-KAN2:)0Y6U?8.:Y^@%%%%9%A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.,8C0N<G:HX"YP*["BB[V&%%%%( HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>figure15_01.jpg
<TEXT>
begin 644 figure15_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +%!98# 2(  A$! Q$!_\0
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M_@H+_P!";\-_^_P_^2:4>*O^"@O?P=\-O^_P_P#DFOO*BCVL?Y%^/^86?<^
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M=YJ"O+<W.DV;SE8_LDEPA1C,1D^7@Y''-?;\_A;Q^[$Q>.;.,>AT5#_[4KX
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M]#[9?^"-?_CE>B44!<\[_P"$3^(G_0^V7_@C7_XY1_PB?Q$_Z'VR_P#!&O\
M\<KT2B@+GG?_  B?Q$_Z'VR_\$:__'*/^$3^(G_0^V7_ ((U_P#CE>B44!<\
M[_X1/XB?]#[9?^"-?_CE'_")_$3_ *'VR_\ !&O_ ,<KT2B@+GG?_")_$3_H
M?;+_ ,$:_P#QRC_A$_B)_P!#[9?^"-?_ (Y7HE% 7/._^$3^(G_0^V7_ ((U
M_P#CE'_")_$3_H?;+_P1K_\ '*]$HH"YYW_PB?Q$_P"A]LO_  1K_P#'*/\
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M_P".5Z)10%SSO_A$_B)_T/ME_P""-?\ XY1_PB?Q$_Z'VR_\$:__ !RO1**
MN>=_\(G\1/\ H?;+_P $:_\ QRC_ (1/XB?]#[9?^"-?_CE>B44!<\\7PG\0
M^_CVS/\ W T_^.5S^H:KXUT76KFQO/%<$BQA#')!I"$MD9.09!C\":]CKRCQ
MM\WC"Z'^PG_H(I#14_X23Q/_ -#0?_!-%_\ ':7_ (23Q/\ ]#0?_!+%_P#'
M:C5!BG>6*8QW_"2>)_\ H:#_ ."6+_X]1_PDGB?_ *&@_P#@EB_^/4WRQ1Y8
MH =_PDGB?_H:#_X)8O\ X]1_PDGB?_H:#_X)8O\ X]3?+%'EB@!W_"2>)_\
MH:#_ ."6+_X]1_PDGB?_ *&@_P#@EB_^/4WRQ1Y8H =_PDGB?_H:#_X)8O\
MX]1_PDGB?_H:#_X)8O\ X]3?+%'EB@!W_"2>)_\ H:#_ ."6+_X]1_PDGB?_
M *&@_P#@EB_^/4WRQ1Y8H =_PDGB?_H:#_X)8O\ X]1_PDGB?_H:#_X)8O\
MX]3?+%'EB@!W_"2>)_\ H:#_ ."6+_X]1_PDGB?_ *&@_P#@EB_^/4WRQ1Y8
MH =_PDGB?_H:#_X)8O\ X]1_PDGB?_H:#_X)8O\ X]3?+%'EB@!W_"2>)_\
MH:#_ ."6+_X]1_PDGB?_ *&@_P#@EB_^/4WRQ1Y8H =_PDGB?_H:#_X)8O\
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MLO\ T0E> _\ !2S_ )(7H/\ V,<'_I+=5[]\$/\ DC/@7_L!V7_HA*^>I?\
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M>-/^1QNO]R/_ -!% T5$Z4ZFITIU!04444 %%%% !1110 44;31M- !1110
M4444 %%%% !111M- !11M-% !1110 4444 %%%% !1110 4444 %%&TT4 %%
M%% !1110 4444 %%%% !1110 4444 %,DZ4^F2=#0 )_QYZ5_P!C#9?S:O8Z
M\<7_ (\]*_[&&R_FU>QT$L****!!1110 4444 %%%% !1110 4444 <C\7O^
M25>,/^P3=?\ HIJV/"?_ "*NC?\ 7G#_ .@"L?XO?\DJ\8?]@FZ_]%-6QX3_
M .15T;_KSA_] % ^AK4444""BBB@ HHHH **** "BBB@ HHHH **** /DO\
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MEFCRZ\Q^-/[1VF_#7XC>"/AUH6DKXG\>^+G5K/39+K[+#;P$G,\\NURJX5R
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M %%%% 'R7_P4L_Y(7H/_ &,<'_I+=5[]\$/^2,^!?^P'9?\ HA*\!_X*6?\
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M?]_%_P :/[3L_P#G[@_[^+_C2YX]Q\D^Q9HJM_:=G_S]P?\ ?Q?\:/[2M/\
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M-,\W4DU7:HWU*$HHHH&%%%% !3).AI],DZ&@ 7_CSTK_ +&&R_FU>QUXXO\
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M=F=^T/X!\/\ [17@.W\.7&MW.B-;WT=_%=1VAFPZI(F&0D9!61NXYQ7SJO\
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MUD]/G_P YD](FC\$/^"D/A[X_?$K2_!7AWX>:^NH7RR.9IKB#9$B(6+-STX
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MUL^V0&H:%.* /CCXW>$[CX._\%!_AG\9+M2O@WQ G]AZC>Y&VUNFMY((@Y.
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MBJ_VD>OZT?:1Z_K5$DYJ>W^\/K5'[2OK4T%TN\<TX[D3^%GR]XT_Y2!>$/\
MKR7_ -)YZ^K+C_6&OCOXM>+M)\&_MQ>'-<UJ[6RTNSL8S/<,K,$S!,HX4$]6
M';O7N$G[67PD9B?^$O@_\!I__B*^<R[$X>C/%1JU%%^TENTNQ^M<4Y/FF/PN
M2UL%A*E6*PE--PA*23YINUTGK:VAZ=5O3_\ 7K7D?_#5WPD_Z&^#_P !I_\
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M%_9Q_P"BCVW_ ( 7?_QJI6&Q$=Z<ON95UW/;]AHV&O$/^'@O[./_ $4>V_\
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M^?;^YAS+N>Z[#1L->$_\/$?V;?\ HH]M_P" %U_\:H_X>)?LV?\ 11[?_P
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MRC6HQC-72E5C&6]M4]CZN\HTTJ17RF?CY^T5_P!$QMO_  3W?_QZN_\ @?\
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M\#ZAXHC:'Q)=:-:3:@C+M83M$I?(['.:Z.H\BPIDG0T^F2=#0 +_ ,>>E?\
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MX8T%KZ$RF*SCV8=EQE%ST/L*B^+W_)*O&'_8)NO_ $4U;'A/_D5=&_Z\X?\
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M_)6/ /\ USU#_P!%)7>T<TNX61@?\(+HW_/LW_?U_P#&C_A!=&_Y]F_[^O\
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M ,=H_P"'77[-_P#T(DW_ (.+S_X[7U=11[:I_,%D?*/_  ZZ_9O_ .A$F_\
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M^KJ*/;5/Y@LCY1_X=<_LW_\ 0B2_^#B\_P#CM'_#KG]F_P#Z$27_ ,'%Y_\
M':^KJ*/;5/Y@LCY1_P"'7/[-_P#T(DO_ (.+S_X[1_PZY_9O_P"A$E_\'%Y_
M\=KZNHH]M4_F"R/E'_AUS^S?_P!")+_X.+S_ ..U@^+?^":O[.ND3>'UB\$S
M1"[U2.V?;J]V=RE)#M.9>F5'3GBOLRN%^*3%;KP1COXBMQ_Y"FIK$5HZQDT'
M*CPP_P#!+O\ 9O;_ )D27_P<7G_QVD_X=<_LW_\ 0B2_^#B\_P#CM?5U%+VU
M1[R861\H_P##KG]F_P#Z$27_ ,'%Y_\ ':/^'7/[-_\ T(DO_@XO/_CM?5U%
M'MJG\P61\H_\.N?V;_\ H1)?_!Q>?_':/^'7/[-__0B2_P#@XO/_ ([7U=11
M[:I_,%D?*/\ PZY_9O\ ^A$E_P#!Q>?_ !VC_AUS^S?_ -")+_X.+S_X[7U=
M11[:I_,%D?*/_#KG]F__ *$27_P<7G_QVC_AUS^S?_T(DO\ X.+S_P".U]74
M4>VJ?S!9'RC_ ,.N?V;_ /H1)?\ P<7G_P =H_X=<_LW_P#0B2_^#B\_^.U]
M744>VJ?S!9'RDO\ P2[_ &;U.?\ A Y3_P!Q>\_^.U\B-\%_!OP+_P""LGPQ
M\)^"]*;2=#%LMW]E:XDFQ*UI=$MN=BW\*\9K]:*_,CXO?\IGOAK_ -@V+_TC
MNZZ*.)JQO'FT:L2XH_2J;1[2X;+Q9/\ O&H?^$=L/^>1_P"^S_C6G17"69G_
M  CMA_SR/_?9_P :/^$=L/\ GD?^^S_C6G13NP,S_A';#_GD?^^S_C1_PCMA
M_P \C_WV?\:TZ*+L#._X1^Q_YY'_ +Z/^-'_  C]C_SR/_?1_P :T:* ,]=!
MLE.1$?\ OH_XUYQXNC2W\57$<8VJ%0XS_LBO5Z\I\:?\CA=?[B?^@BD-%->E
M.IJ=*=04/64K4GVIO6H**KF:,G3C+5HG^U-ZU&TQ;K3**.9L%2C'9!0IP:*!
MS4FIR/Q2^#OA?XVZ$FB>+XM0O='#;I+"VU&>VAF(((\Q8W428(!&[.",U2^$
M7P \$_ .&[MO ]IJ&DV%T=\EC)J=Q/;;^,N(I'*AB !N R0!7<SZA8:<T:WM
M_:V1D^X+B98]V.N,GFGKJVCS.$CUG3Y)#T5;J,D_AFC45D<A\7O@SX1^//A^
MVT/QM97.I:3;S_:5M(;V:W1I , N(V&[&3C.<9K2\"_#G0?AOX!3P7X?_M"S
MT"-'BAB;49Y)8$88VQRLY= .P4C;VQ7336SQGFHUB9FZ4KC/,?A'^R[\,O@=
MXBOM=\'Z/>:;J-_$T-XTFJ7,T=TK')\U'<JYR2<D$C)]:HW'[(/PBN$FMCX;
MG71YM2_M:70DU.Y73'NL@^8;02>4>@XVXQQBO6(;BWN_-%O<0W#1-LD$4@8H
MWH<'@TI!IION*R['#?&7]G_X?_'[3M(T_P ::1/J.G:3DV=E!>S6T$9("[MD
M;*I(' )' ) ZFNC\&^$]-^'OA73_  YHINAI6GIY5M'>7<ER\:#H@>1BVT#@
M#.   .!6MS1M)HUM89*LBR120RQK-#(I5XY%#*P/4$'J*\DM?V4?AIHWB#4=
M:\/:;J?A&]U$YNU\-:S=Z;#*=N.8H9%3IGH.I)Z\UZA=:EI^E[/MU_:V._[G
MVF98]WTR1FD;Q!H2Q[CKNF;?7[9'_P#%4)M;"T>YSWA+X3>$_ _A_5-(T33I
M-/CU166^OH[F4WUR2"I>2Y+&5GP<!BV1V(KS[0OV(?@QX=T'Q!HVG:#J5GIG
MB"..+5;6+6[P)>*C[U$@\WG#9_,CH37LMG?66J1N]A>V]ZB':S6TJR!3Z$@F
MI<&B[[A9'#>$/V>_AOX'^%^J_#G3?#_F>"]3=WN=)OKF6YB)<#<5\QB4Y /R
MD8//7FLCX4_LK?"KX(Z\FL>$?#;V-]&CI"]Q?3W"P[OO&-)'958]-P&<$C/)
MKT_FCFB[[AH>8:?^RK\,M.^*DWQ(@TW4HO&TTTD[ZNNL77FEG4JP_P!9C;M.
M-N, 8&.*A\)_LB_"GP-JWB#5-#TK5=/U'Q!:SVFJ74>N7GF74<QS)O8RY+$G
M.[J#R#7JP4TXHPHN^X61YU\*?V9_AA\%-.U_3O"?AYK72]>A$&I:?=WDUU;7
M* $8:.5V7HQ&<<@XK)TW]D?X4:/-HQBT"ZNK'1KIKW3=(OM5NKG3K.8DG?':
MR2&)3DDC"\$\5ZS@TF#3N^X61/)=,S9KD?B9\)_!?QHT6/3/&GA^UUN"%M\$
MDH*S6[?WHI5(>,^ZD5TNTTN#4C/+S^RW\-KS6-(U+6=.U/Q3/I/-C%XDUF[U
M*"W(Z%8IY&3(]2.P]*[/XK?#/PO\;O!S>%/%]C-?>'VECF>S@NI+=7*'*!O+
M920#@X/&0#V%;V#2A33;;W8DDMD>*ZK^P[\%M<\+Z+X=U#P_J-WH>C&1M.L)
M=;O&AM3(VYRB^;@9-:WQ"_9#^%/Q;BT*'Q=I6J:[%H=DMAI\=WK=XRP1+QP/
M-Y8X&7/S-M&2<"O565EIT:LQXI\SMN%D?*7Q:_: N]8\7>,/V9E\ :I<+?:/
M%INC:Q>/+>B[641H]Q+N7B.)7=S(SDDQ8ZD5]0>'?#NG^"/"^D>'-'A^SZ5I
M-I'96T6<E8XU"KD]S@<GN:T+C5K'3\K>7]K:$8!\^94ZYQU/?!_*EMVM]4C:
M6RNH;R-3M+V\@< ^F0:'+1)($O,H:QI.F^)]%O=&UFPM]4TF^B:&YL[N,212
MH>"K*>"*\S\-_LH_"OPQJ7AV\M]!NKM?#KM)H]GJ.J75W::>S$L6A@ED:-3D
MYR%X('H*]'37=)EOOL46JV,EYN*?9TN4,FX=1MSG(P?RJZRD4DVM@T9YE\7?
MV7_AI\=/%=IXE\8Z3>ZEK%G$L-K-'JES +=5.X>6J. ISSD#.:]*M(5L+*WM
M8Y)I8X(UC5[B5I9& &,L[$EC[DY-2)&S' I\D<<<T<+RQI/("4B9@&8#J0.I
MI7Z#/./BC\ _"'QFU+2K[Q0NK3S:4PDLEL]7N;5()021*JQ.H$@SP_WAQS7H
MFEJ-)T^WLHY9YXH8Q$)+J9II& &,L[$ECZDG)J2:-+2%YKB5((4Y:25@JK]2
M:CCEMI[%KR&[MY;-02;B.56C '4E@<<4= ,;PWX%\,^$_"-WX6TW1;6#P[=R
MW,LVF,F^!C<2-),NQLC:S.WR]!G  %>>:;^R+\)M+ETGR_#US<:?I-V]]I^C
MWFJ75QIUI.Q)+QVKR&)3DDC"\'I7KIBRBNI#(PR&4Y!'K49S33?1BLB6>;S#
MZ#H!4%%% PIDG0T^F2=#0 +_ ,>>E?\ 8PV7\VKV.O'%_P"//2O^QALOYM7L
M=!+"BBB@04444 %%%% !1110 4444 %%%% '(_%[_DE7C#_L$W7_ **:MCPG
M_P BKHW_ %YP_P#H K'^+W_)*O&'_8)NO_135L>$_P#D5=&_Z\X?_0!0/H:U
M%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X+
MQ;_R5CP#_P!<]1_]%)7>UP7BW_DK'@'_ *YZC_Z*2N]H&%%%% @HHHH ****
M /GG]O;_ )-E\1?]?%G_ .E$==O^S#_R;W\/O^P/;_\ H-<1^WM_R;+XB_Z^
M+/\ ]*(Z[?\ 9A_Y-[^'W_8'M_\ T&O#C_R-9?X%^9^EUO\ DAJ/_85/_P!-
M1/3Z***]P_- HHHH **** "BBB@ HHHH **** "BBB@#@_!/_)2/B'_U\67_
M *3+7>5P?@G_ )*1\0_^OBR_])EKO*!A1110(**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *Y_XA?\B#XF_P"P9<_^BFKH*Y_XA?\ (@^)
MO^P9<_\ HIJ!K<E\#_\ (E>'_P#L'V__ *+6MNL3P/\ \B5X?_[!]O\ ^BUK
M;H$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7!_
M%/\ X^_ _P#V,=O_ .BIJ[RN#^*?_'YX'_[&.W_]%2T#1WE%%% @HHHH ***
M* "BBB@ HHHH **** "OS(^+W_*9_P"&O_8-B_\ 2.[K]-Z_,CXO?\IG_AK_
M -@V+_TCNZTI[_UW$?IO11168PHHHH **** "BBB@ KRCQI_R.%U_N1_^@BO
M5Z\H\:?\CC=?[D?_ *"*!HJ)TIU-3I3J"@HHHH **** "E7[U)2K]Z@#PG]O
MSPCHVO?LB^/;_4-+M+V^TVS2>RN9X5>2V?SHQNC8C*D@D<=0:^%?#VC?#7_A
MUQ>ZAJ<.CK\13KKKHTT8B&J&7[5$-J?QE?+!S_L^X%?>'[?'B+3M'_8]^(=O
M>WUO:SWEG'#;Q2R!6F<S1_*H)R3]*\W_ ."4=QX9U#]F!;9H-+N=;M-9NC.K
MQ1M<(#L96.1NQ@C!]O:M(Z1O_70SDKNQ?_9[^/.I_L__ +$_A#Q?\;H=>GCE
MNGMK>Z^SB:Z2V9C]F,P=E;D X)R<;<]:]'\._MR_"KQ)XK\(:#I(UV_O?%5N
M)M*>/32()W*%C )68*95.%8 D*QVD@YQY_\ \%8-8MU_9)FMI)XXY[C6[,0Q
M,P#/MWD[1WP.>*]/_9!T'P!J'[,_P6\0#3]%N[GP_H,,D&ILL;M87+1#[61)
M_P LWWE]_0YSFL]-VBM=DSQG]@"T^$EAXU^,NH>"O$WB6_NS,EWK4?B6SCM(
M;%?-G. 5<[B#Y@9CCA17J/\ PVM\,I?"]WXMCBUZ3P-::I_8\WBN/3MVGK/D
M '(;S"F2HWA-N2!GFOAG]C6QNOB!H_[7GAKPU?0MXAU_2W.EPQRKONP)KDL(
M^>00ZC(_OCUK6L/%FC0_\$C];\$/<QP^,H_$"Z?)H<@*WGVC^TXY]GE'YB?*
M&>G\)':KY;Z[DWMHC[S^.7[37@/]GKPSX?\ $GB8ZC>>']=;;9:EH\"7,+L4
MWJ,[Q]Y<L" 00#S6#X*_;.^%WQ%^*&D> ]$N=6?6M6M6N[":XTV2*VN8UC:1
MC'(?O#$<GS ;24(#'O\ &'[;'A[5/A__ ,$\?@!X3\3'[-XFM;U7FL9I,S1)
MY$Y"$'GY%DC0]@<#TK[\^$7AOP7JGPY^&GB73-+TF[OM/\.6UEI^JV\2/)!
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MPDY&LZ7H_BV[FL=!UW4K PV.H31MM*HY;<NX_=+JH;M70^-/V@O!G@GQQ?\
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M5XP_[!-U_P"BFK8\)_\ (JZ-_P!></\ Z *Q_B]_R2KQA_V";K_T4U;'A/\
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M X/P3_R4CXA_]?%E_P"DRUWE<'X)_P"2D?$/_KXLO_29:[R@84444""BBB@
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MJ:58ZD\8(1KRV24J#U W XIMM:6NFVZVUE:P65LI)6&WC6-!GKA0 *R_%'Q
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M)](_Z"=I_P!_E_QH_P"$FTC_ *"=K_W^7_&EROL%T:=%9G_"3:1_T$[7_O\
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MO_W\%%F!>HJC_;FG_P#/[;_]_!1_;FG_ //[;_\ ?P468%ZN?^(7_(@^)O\
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M_P _D'_?P468%VBJ7]LV'_/Y!_W\%']LV'_/Y!_W\%%F!=HJG_;%C_S]P_\
M?8H_MBQ_Y_(?^^Q19@7**I_VQ8_\_D/_ 'V*/[8L?^?R'_OL468%RN$^*?\
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M8S$9=^X8X WIR>NX5I&#DK\MS.4N7J?8?BC]O'PQX1^('@C1-5\$>)-/\/\
MC(Q'1?$5TD<:7*.RH)/(+>8J[G7[P#8(.W%>A^./C]I^A?&*V^%7A;0+KQIX
M[:Q;4KJQM9X[>&QM@!AYIGX!8E0% )^=<X!!KX+_ &[/&5GXDF_9<U#2%N+V
M+3=&M[VX:&WD)A3S8?O<9!S$XQU!4UW_ ,5=2O/V=?\ @H!J'Q9\1:=X@U#X
M8^,=,2W77]#>=3;(Z0G!,)#?*\*_(3RK9 )&*MT[/8B-2ZW/IC1?VS/AO>_
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MRGQ8_P"27^+?^P5=?^BFKE_%D(D\.^$\C_ET_P#9(ZZCXK_\DP\6?]@JZ_\
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M5,MAQW*Z]*6D7I2TB@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/F:T^OZ%>I%:S!)6LH-.9KQQR"46+<']0V#G.*^\:4DD]!HY3XL?\DP\6_\
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M>M= / ,/_/[-^0I?^$#A_P"?V;\A1S1%9G/"0>M+YHKH/^$#A_Y_9OR6C_A
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MT$;G_OE?\*/^%6VW_01N?^^5J2M#D?/7UH\]?6NN_P"%6VW_ $$;G_OE:/\
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M!P?@D_\ %Q_B'_U\67_I,M=Y7!^"?^2D?$/_ *^++_TF6N\H&%%%% @HHHH
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M^X?_ .B6H&>A4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M# @C@D>A-;=%%9%A1110 4444 <C\7O^25>,/^P3=?\ HIJV/"?_ "*NC?\
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M PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<_\
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MYXGH=%>>?\+*O_\ GP@_[[:C_A95_P#\^$'_ 'VU/V4@]I$]#HKSS_A95_\
M\^$'_?;4?\+)O_\ H'P_]]M2]E(?.CT.BO/!\2+_ /Y\(/\ OMJ=_P +'O\
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M0_\ ?9H_X6!>_P#/E#_WV:/9R#F1W=%<+_PL"]_Y\H?^^C1_PG][_P ^4/\
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MS'LBU?\ ^$RNO^?2/_OHT<K%='745R/_  F5U_SZ1_\ ?1H_X3*Z_P"?6/\
M[Z-/E871UU%<C_PF5U_SZQ_]]&C_ (3*[_Y](_\ OHTN5A<ZZBN1_P"$RN_^
M?2/_ +Z-'_"977_/K'_WT:.5A<ZZBN1_X3*Z_P"?6/\ [Z-+_P )E=?\^L?_
M 'T:?*PN=;17)?\ "877_/K'_P!]&C_A,+K_ )]8_P#OHTN5C.MHKD_^$PNO
M^?6/_OHT?\)A=?\ /K'_ -]&CE8KG645R?\ PF%U_P ^L?\ WT:/^$PNO^?6
M/_OHT<K ZRBN4_X2ZZ_Y]8_^^C1_PEUU_P ^L?\ WT:?*QG5T5RW_"677_/M
M'^9I/^$NNO\ GVC_ #-+E8'545RW_"677_/M'^9H_P"$LNO^?:/\S1RL#J:X
M3XI#-WX(_P"QBM__ $5-6D/%EU_S[1_F:Y?Q]KL]W<>$RT"#R];AD&">R2#^
MM#BQGJ-%<RWBJX4X^S1_F:9_PEES_P ^T?YFCE8CJ:*Y;_A++G_GVC_,T?\
M"67/_/M'^9HY6!U-%<O_ ,)7<_\ /M'^9I?^$JN?^?:/\S1RL#IZ*YC_ (2N
MY_Y]H_S-'_"57/\ S[1_F:.5@=/17,?\)5<_\^T?YFC_ (2JY_Y]H_S-*S Z
M>BN8_P"$JN?^?:/\S1_PE5S_ ,^T?YFGRL#IZ*YC_A*KG_GVC_,TJ^*+EO\
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MX)^9H_X2*?\ YX)^9IV&=!16!_PD,_\ SP3\S1_PD,__ #P3\S181OT5@?\
M"0S_ //!/S-*/$$Y_P"6*?F:+ ;U%87]OS_\\4_,T?\ "03_ //!/S-%@-VB
ML$>()_\ GBGYFE_M^?\ YXI^9I ;M%87]OS_ //%/S-']OS_ //%/S-.P&[1
M6%_;\_\ SQ3\S1_;\_\ SQ3\S2 VIO\ 5/\ [IKA/@0,?"C0?]R7_P!&O72#
M6I9%8&%1P>YKCO@WJ4EK\,]%C$2D*LG<_P#/5Z!GI=%8G]NS?\\4_,TG]O39
M_P!2GYFF(W**Q/[=F_YXI^9H_MZ;_GBOYFD!MT5B?V]-_P \5_,T?V]-_P \
M5_,T ;=%8G]O3?\ /%?S-.&N38_U*_F: -FBL;^W)?\ GBOYFE_MJ;_GBOYF
M@#8HK&_MR7_GDOYFC^VY?^>2_F:!V-FBL;^VIO\ GBOYFE76I3_RR7\S0(V*
M*R/[9F_YY+^9I/[:E_YY+^9H V**R/[9E_YY+^9H_MB7_GDOYF@9KT5D?VQ+
M_P \E_,T?VQ+_P \E_,T!8UZ*RO[7E_YY+^9H_M:7_GDOYF@1S?Q4^YX2_[&
M*R_]":NYK@/B-<&ZA\*EE"[?$-E_Z$U=_0,****!!1110!SNJ?#KPMK?B[2_
M%6H>'-+OO$VEQM%8:Q<6<;W5JC9W+'*1N4'+=#_$?4U\,^&_"/P)^!'@CP1H
MW[07P7\#^"=5O;"&!-=2"#4;2ZG" ,)'P9XY.-S,ZM&"?]:U?H.WW37Y<_\
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M.7I0 ;12XHHH 3:*,"EHH+$P*50**5:"!<"C:*6B@!,48%+104A-HHVBEHH
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MP^*?_ BV_P#C%+_P[1^''_0P^*?_  (MO_C%=7US,O\ H'C_ .!'E?V)P?\
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MZ_Y]9_\ OVU*L=U_SZS_ /?MJ]"HHY@L>?>7=?\ /K/_ -^VH\NZ_P"?6?\
M[]M7H-%/G&<#Y-U_SZS?]^S_ (4GDW7_ #ZS?]^VKOZ*7,!P/DW/_/M-_P!^
MS_A1Y-S_ ,^TW_?L_P"%=]11S <$(;K_ )]9O^_9_P *Y_QLL\=QX7W6\J[M
M8A490\G8_%>NUPWQ0<K=>"<=_$5N/_(4U)R&$D5SN/\ HTW_ '[-1^7=?\^T
MW_?LUWM%/F$<%Y5U_P ^TW_?MJ/*NO\ GVF_[]M7>T4<P'!^5<_\^TW_ '[-
M'DW/_/M-_P!^S7>44<P'!^3<_P#/M-_W[-.\JY_Y]IO^_9KNJ*.8#A?+NO\
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MC)_WR:/+F_YXR?\ ?)KJ** .7\N;_GC)_P!\FE59<?ZF3_ODUT]% ',[9?\
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M^@"@?0UJ***!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!P7BW_DK'@'_KGJ/_HI*[VN"\6_\E8\ _\ 7/4?_125WM PHHHH$%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '!^"?^2D?$
M/_KXLO\ TF6N\K@_!/\ R4CXA_\ 7Q9?^DRUWE PHHHH$%%%% 'Q'_P4\/\
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M $5+7>5P?Q3_ ./SP/\ ]C';_P#HJ6@:.\HHHH$%%%% !1110 4444 %%%%
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M]SPE_P!C%9?^A-7<UPWQ4^YX2_[&*R_]":NYH&%%%% @HHHH **** "BBB@
MHILDBQH7=@BJ,EF. *;#<17,8>&1)4_O(P(_,4 245%'=0S2/''+&[IPRJP)
M7ZCM4M '(_%[_DE7C#_L$W7_ **:MCPG_P BKHW_ %YP_P#H K'^+W_)*O&'
M_8)NO_135L>$_P#D5=&_Z\X?_0!0/H:U%%% @HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH X+Q;_R5CP#_P!<]1_]%)7>UP7BS_DK
M'@'_ *YZA_Z*2N]H&%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH X/P3_P E(^(?_7Q9?^DRUWE<'X)_Y*1\0_\ KXLO_29:
M[R@84444""BBB@#XB_X*>_\ (M^ ?^ON[_\ 0(Z^U--_Y!]K_P!<E_D*^*_^
M"GO_ "+?@+_K[N__ $".OM33?^0?:_\ 7)?Y"OG,#_R,L9ZP_P#2$?J.>_\
M)(9)ZXC_ -+B6:***^C/RX**** "BBB@ HHHH **** "BBB@ HHHH *Y_P"(
M7_(@^)O^P9<_^BFKH*Y_XA?\B#XF_P"P9<_^BFH&MR7P/_R)7A__ +!]O_Z+
M6MNL3P/_ ,B5X?\ ^P?;_P#HM:VZ!!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5P?Q3_P"/SP/_ -C';_\ HJ:N\KA/BG_Q]^!_
M^QCM_P#T5-0-'=T444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@#XS_
M ."MW_)E^O?]A33_ /T>*]8_88_Y,_\ A)_V+UM_Z#7D_P#P5N_Y,OU[_L*:
M?_Z/%>L?L,?\F?\ PD_[%ZV_]!K67PK^NK%U/=****R&%%%% !7GO@O_ )*Q
M\0_^X?\ ^B6KT*O/O!?_ "5CXA_]P_\ ]$M0,]!HHHH$%%%% !1110 4444
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MM_\ OZO^->5_84_NBA;%/2CV:[AS'J?]L6'_ #^V_P#W]7_&C^V+#_G]M_\
MOZO^->7?84]*/L*>E+V:[BYSU'^V+#_G]M_^_J_XT?VQ8?\ /[;_ /?U?\:\
MN%BGH*7[$GH*/9KN/F9ZA_;%A_S^V_\ W]7_ !H_MBP_Y_;?_OZO^->7_8D]
M!1]A3T%'LUW'S'J']L6'_/[;_P#?U?\ &E_M>Q_Y_;?_ +^K_C7EOV%/04[[
M"GI1[-=Q<S/4/[7L?^?VW_[^K_C1_:UC_P _EO\ ]_5_QKS 6*>E+]A7TH]F
MNX<S/3O[6L?^?RW_ ._J_P"-']K6/_/Y;_\ ?U?\:\Q^PKZ4?85]*/9KN/F/
M3O[6L?\ G\M_^_J_XT?VM8_\_EO_ -_5_P :\Q^Q)Z"E6R7T%+V:[AS'IO\
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MG_OV?\:/8YU_-2^^7^0_KW ?_0-B_P#P*D5?^'@'P=_Z"^H?^"V7_"C_ (>
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M\?\ ,7L#_P"1:]1_8PA#?L<_"?C_ )@4/]:[94E]4C5\[?F1?WFCW_[=;?\
M/Q%_WV*/MUM_S\1?]]BN.:W7/2FBW7(XKCY2SL_MUO\ \_$7_?8H^W6W_/Q%
M_P!]BN/-NOI2?9QZ4K =E]LMS_RWC_[[%<'X/FB3XI>/G,J ,+#'S#_GBU7H
M[==PXKF/#MNO_"?>,#CM9_\ HLTK#/5/MMO_ ,]XO^^Q1]NMO^?B+_OL5R#6
MZ^E-^SCTIV$=C]NMO^?B+_OL4?;;?_GO%_WV*X[[.OI3UMQMZ46 Z_[9;_\
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M_AD_]&/0,].^UP?\]H_^^A1]K@_Y[1_]]"N:, ]*00C=TIB.G^U0_P#/:/\
M[Z%'VJ'_ )[1_P#?0KFO)%'DCTI =+]JA_Y[1_\ ?0H^U0_\]H_^^A7,^2*/
M)% '3?:H/^>T?_?0H^U0?\]H_P#OH5S/DCTIZPC;TH Z/[5#_P ]H_\ OH4?
M:H?^>T?_ 'T*YSR12^2* .B^U0_\]H_^^A1]JA_Y[1_]]"N=\D>E'DCTH'8Z
M+[5#_P ]H_\ OH4?:H?^>T?_ 'T*YWR1Z4JPCTH$=#]JA_YZQ_\ ?0H^U0_\
M]8_^^A7/^2/2CR1Z4 =!]JA_YZI_WT*/M,/_ #U3_OH5@>2/2CRAZ4#L;_VF
M'_GJG_?0H^TP_P#/5/\ OH5@>4/2CRAZ4!8Z#[1%_P ]4_[Z%'VB+_GJG_?0
MK!6$8I?)% C&^*++)'X3VL&QXBLNA_VFKNJ\[\>+B#PQ_P!C#9?S:O1*!A11
M10(**** "BBB@ HHHH **** "BBB@#E/BO\ \DP\6?\ 8*NO_135SGB;_D7O
M"G_7I_[)'71_%?\ Y)AXL_[!5U_Z*:N<\3?\B]X4_P"O3_V2.M*?QHF?P&2G
MW:DIB?=I]=AS OWJ=2+2U/4 HHHJ@"G]J93Z3&A,4M%%(H****0!3L4VGTP"
MBBBD E+110 4444 .7I2BD7I2KUH R-4_P"1FT'Z3_\ H K;:L75/^1FT'Z3
M_P#H K:;M4K=_P!=$4]D-HHHJB1*6BB@:"E7[U)2K0QL=1114DB4M%%!0444
M4#$-+110 +UIU-7K3J "BBB@ IRTVG+0 M.7K3:<G6@#%T7_ )&;Q'_OP?\
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M/NT^NPYA5I:1:6IZ@%%%%4 4^F4^DQH****DH**** "GTRGT %%%% !1110
M4444 .7I2KUI%Z4J]: ,G5/^1FT'Z3_^@"MINU8NJ?\ (S:#])__ $ 5M-VJ
M5N_ZZ(I[(;1115$A1110-!2K24JT,;'4445)(4444%!1110,**** !>M.IJ]
M:=0 4444 %.6FTY: %IR=:;3DZT 8NB_\C-XC_WX/_18K9;K6-HO_(S>(_\
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M?H:Y/X3_ /)/-(_W9/\ T8]'4#JJ;_%3J;_%5,!:***D HHHH *<O2FTY>E
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M<.5'+?\ "N]._P"?B[_[[7_XFC_A7>G?\_%W_P!]K_\ $UU-%'/+N'*CEO\
MA7FG_P#/Q=_]]K_\31_PKS3_ /GXN_\ OM?_ (FNIHHYY=PY4<O_ ,*\T_\
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M*?/+N*R.;_X0.P_Y[W7_ 'VO_P 31_P@=A_SWNO^^U_^)KI**7-+N'*CF_\
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M5J/A_P ,Z1I)^&=W<&PLX;7SOMCKOV(%W8\GC.,XK0_X;^U#_HEUW_X'/_\
M&:^]]H]*-H]*\V.$Q\8J,<6[+^ZC[*?$'"E2<JDLA5V[O]_4W?R/@C_AX!J/
M_1+;K_P.?_XS1_P\ U'_ *);=?\ @<__ ,9K[WVCTHVCTI_5<P_Z"W_X"B/[
M=X2_Z$*_\**G^1\$?\/ -1_Z);=_^!S_ /QFC_AX!J/_ $2VZ_\  Y__ (S7
MWOM'I1M'I1]5S#_H+?\ X"@_MWA+_H0K_P **G^1\$_\/ -1_P"B777_ ('/
M_P#&:K:K^WQJ-]I5[:_\*QNHA-"\?F->N0N5(S_J>U??^T>E8?CI_)\$^(9
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M_P!^3\Q_A6A10!G_ -BP_P!^3\Q_A1_8L/\ ?D_,?X5H44 4/['A_OR?F/\
M"C^QX?[\GYC_  J_10!P7Q*MUM8O"H4L=WB*R^]_O-7>UPWQ4^YX2_[&*R_]
M":NYH&%%%% @HHHH **** "BBB@ HHHH **** .1^+W_ "2KQA_V";K_ -%-
M6QX3_P"15T;_ *\X?_0!6/\ %[_DE7C#_L$W7_HIJV/"?_(JZ-_UYP_^@"@?
M0UJ***!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!P7BW_DK'@'_ *YZC_Z*2N]K@O%O_)6/ /\ USU'_P!%)7>T#"BBB@04444
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M<U%%%>Z?EP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #)O]4_\
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M** "BBB@ HHHH **** .#\$_\E(^(?\ U\67_I,M=Y7!^"?^2D?$/_KXLO\
MTF6N\H&%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M KG_ (A?\B#XF_[!ES_Z*:N@KG_B%_R(/B;_ +!ES_Z*:@:W)? __(E>'_\
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M** "BBB@ HHHH X;XJ?<\)?]C%9?^A-7<UPWQ4^YX2_[&*R_]":NYH&%%%%
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MF?\ [^-_C5NBJ)*F+G_GZG_[^-_C2XNO^?J?_OXW^-6=M+0-%7%U_P _4_\
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MBBD!!^__ .>\O_?PU1\3+,WA;6%,\I!LY@07/]PUJU1\2?\ (L:O_P!>DO\
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M$2^=G_72?]]FL#QHDCW'A?,LAVZQ"1EC_<>NE'6L'QE_Q\>&?^PM%_Z ])[
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M_P"^=/\ \*-O[9'_ #V3_OG3_P#"OM'[6]'VM_6G_9/_ %$U/_ A_P"O4O\
MH48/_P $?_;'Q=M_;(_Y[)_WSI_^%&W]LC_GLG_?.G_X5]I+=OZTOVM_6E_9
M7_434_\  O\ @"_UZE_T*,'_ ."/_MCXLV_MD?\ /9/^^=/_ ,*-O[9'_/9/
M^^=/_P *^T_M;T?:WH_LG_J)J?\ @7_ #_7N7_0HP?\ X(_^V/BW;^V3_P ]
MD_+3_P#"C;^V1_SW0?AI_P#A7VE]K;UJ:"X9V -']D_]1%3_ ,"_X /CN25_
M[(P?_@C_ .V/B#X=_&;XYZ#^T5X6\"?$+5E":@=\UGY%L0T3)(5(>)>#E/7M
M7U?\-86@\ Z4BNP $G&3_P ]'KYF^*W_ "D.\!>UE#_Z!<5]1?#W_D1=,^DG
M_HQJ,IYXJO"<W+EFTFW=VL+CGV%2>68NAAX476P\9RC3BHQYG*6ME^MV:VV3
M_GH__?1I/WF[_6/_ -]&IJ;_ !5[;/S@9^\_YZ/_ -]&E_>?\]'_ #-/HJ0&
M?O/^>C_F:/WG_/1_S-/HH 9^\_YZ/^9I5\S'^L?_ +Z-.IR]* &8D_YZ-^9I
M<2?WV_[Z-/HH CQ)_P ]&_,T8D_YZ-^9J2B@LCP_]]_S-*HD_P">C?F:?2K0
M0-Q)_?;\S1B3_GHWYFI** (QYG]]OS-+^\_YZ/\ F:?104AG[S_GH_YFC]Y_
MST?\S3Z*!B#S,???\S2_O/[[_F:<O2B@@YKQ]N:#PON8M_Q4-EU/NU>AUY[X
M^_U'AC_L8;+^;5Z%0,****!!1110 4444 %%%% !1110 4444 <I\5_^28>+
M/^P5=?\ HIJYSQ-_R+WA3_KT_P#9(ZZ/XK_\DP\6?]@JZ_\ 135SGB;_ )%[
MPI_UZ?\ LD=:4_C1,_A,I/NT^F)]VGUV',*M+2+2U/4 HHHJ@"GTRGTF-!11
M14E!1110 4^F4^@ HHHH **** "BBB@!R]*5>M(O2E7K0!DZI_R,V@_2?_T
M5M-VK%U3_D9M!^D__H K:;M4K=_UT13V0VBBBJ)"BBB@:"E6DI5H8V.HHHJ2
M0HHHH*"BBB@84444 "]:=35ZTZ@ HHHH *<M-IRT +3DZTVG)UH Q=%_Y&;Q
M'_OP?^BQ6RW6L;1?^1F\1_[\'_HL5LMUJ(E,2BBBK)'4M)2T %%%%2QH****
M0Q5I:1:6@EA11104%%%% !1110 ^BBB@ HHHH *H^)/^18U?_KTE_P#0#5ZJ
M/B3_ )%C5_\ KTE_] -)[#6Y-H/_ " --_Z]8O\ T 5;JIH/_( TW_KUB_\
M0!5NDA!1115 %(OW12TB_=%2P%7K10O6BF@"A>M%"]:8QU%%%)C84O\ "*2E
M_A%22)2K24JTT,=1115%!1114 %%%% "KUK"\9?\?'AK_L+1?^@O6ZO6L+QE
M_P ?'AK_ +"T7_H#T/8#HG^\:93W^\:93 ****0!1110 4ZFTZ@ HHHI( HH
MHI@%.6FTY:& M%%%2 44450&QHO^LK\W?^":'_)YG[1G_7Q>?^G%Z_2+1?\
M65^;O_!-#_D\S]HS_KXO/_3B]>CA?]VQ'HOS,Y;H_1:^_P!::K59OO\ 6FJU
M>6MC0?'7,>'O^1]\7_2T_P#19KIXZYCP]_R/OB_Z6G_HLT =*WWJ2E;[U)3
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M5)(4444%!1110,**** !>M.IJ]:=0 4444 %.6FTY: %IR=:;3EZT 8NB_\
M(S>(_P#?@_\ 18K9;K6-HO\ R,WB/_?@_P#18K9;K41*8E%%%62.I:2EH **
M**EC04444ABK2TBTM!+"BBB@H**** "BBB@!]%%% !1110 51\2?\BQJ_P#U
MZ2_^@&KU4?$G_(L:O_UZ2_\ H!I/8:W)M!_Y &F_]>L7_H JW530?^1?TW_K
MUB_] %6Z2$%%%%4 4B_=%+2+]T5+ 5>M%"]:*: *%ZT4+UIC'4444F-A2_PB
MDI?X14DB4JTE*M-#'4445104445 !1110 J]:PO&7_'QX:_["T7_ * ];J]:
MP?&7_'QX:_["T7_H#T/8#HW^\:93W^\:93 ****0!1110 4ZFTZ@ HHHI( H
MHHI@%.6FTY:& M%%%2 44450&QHO^LK\W?\ @FA_R>9^T9_U\7G_ *<7K](M
M%_UE?F[_ ,$T/^3S/VC/^OB\_P#3B]>CA?\ =L1Z+\S.6Z/T6OO]::K59OO]
M::K5Y:V-!\=<QX>_Y'WQ?]+3_P!%FNGCKF/#W_(^^+_I:?\ HLT =*WWJ2E;
M[U)3 *5:2E6@!:*** "GTRGU/4 HHHJ@"BBB@ I5I*5: '4444 (M+2+2U*
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MR+-,YCW;MR)[CTJJ;2FFQ33<;(Y!)!MZT[S1ZUT@^%TP&/[5'_@/_P#94O\
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M9 8V\4@<8%;7_"%O_P _P_[]?_7H_P"$*?\ Y_O_ "%_]>IN@,8/S1O%;/\
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M_P"$1?\ Y_/_ "'_ /7I/^$1?_G\_P#(?_UZ5T!E;A1NK6_X1-_^?S_R'_\
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MN%&ZM+_A'3_S\_\ D/\ ^O1_PCI_Y^?_ "'_ /7H S=U*K5H_P#".G_GY_\
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M:[>B@+G S?!^SN+RVNY?$7B22YM@PAF;4B6CW##8.WN!4_\ PJY?^AK\4_\
M@T;_ .)KMZ* N<1_PJU?^AL\4_\ @T;_ .)H_P"%6K_T-GBG_P &C?\ Q-=O
M10%SB/\ A5J_]#9XI_\ !HW_ ,31_P *M7_H;/%/_@T;_P")KMZ* N<1_P *
MM7_H;/%/_@T;_P")H_X5:O\ T-GBG_P:-_\ $UV]% 7.(_X5:O\ T-GBG_P:
M-_\ $T?\*M7_ *&SQ3_X-&_^)KMZ* N<1_PJU?\ H;/%/_@T;_XFC_A5J_\
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M#@8/@_9VMU=7,/B/Q)%<715IY%U(AI"HPI)V\X'%3_\ "K5_Z&SQ3_X-&_\
MB:[>B@+G#_\ "K5_Z&SQ5_X-&_\ B:/^%6K_ -#9XJ_\&C?_ !-=Q10!P_\
MPJU?^AL\5?\ @T;_ .)H_P"%6K_T-GBK_P &C?\ Q-=Q10!P_P#PJU?^AL\5
M?^#1O_B:/^%6K_T-GBK_ ,&C?_$UW%% '#_\*M7_ *&SQ5_X-&_^)H_X5:O_
M $-GBK_P:-_\37<44 </_P *M7_H;/%7_@T;_P")H_X5:O\ T-GBK_P:-_\
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MM_\ $T?\*K7_ *&SQ5_X-6_^)KN** N</_PJM?\ H;/%7_@U;_XFC_A5B_\
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MJ_\ !JW_ ,37<44!<X?_ (56O_0V>*O_  :M_P#$T?\ "JU_Z&SQ5_X-6_\
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M=+M]/^U2#!E,<84MCMD@\=A6DK6T)5[G94445F4%%%% !1110 4444 %%%%
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MK^]8]+HHHK(L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<DG+$$\GO53[(4>YLT445D6%%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH ***^=OVGOVUM _9-FL9?&/@GQ9=Z+?R>3::UI,=E+;2R[=S1X:Y6
M16 !^\@!P<$XH ^B:*Y[X?>/-)^)O@70?%VAS&;1M:LHK^U=P WER*& 89X8
M9P1V((KYT^$/_!13P1\>/BY=_#_P-X1\6Z[?VDL@N-3CCL4L8[=)1&UUO:Z#
M-%E@1M4L01A2>*=F(^K****0PHHKEYOB-HTDGBNUTN?^W=7\,Q*^HZ7I[*9X
MW:(RQQ9<J@=E (#,/O*20"#0!U%%>&?LJ_M?>$?VO-"UW5?".EZWI=OH]S':
MSKK4,,;,SJ6!3RY9 1@=R*]SIVL 4444@"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
? **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>figure16_01.jpg
<TEXT>
begin 644 figure16_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +#!98# 2(  A$! Q$!_\0
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M]IBGWO(Q_P"S4W_A.O#?_0P:5_X&Q?\ Q5(#<HK#_P"$Z\-_]#!I7_@;%_\
M%4?\)UX;_P"A@TK_ ,#8O_BJ -RBL/\ X3KPW_T,&E?^!L7_ ,51_P )UX;_
M .A@TK_P-B_^*H W**P_^$Z\-_\ 0P:5_P"!L7_Q5'_"=>&_^A@TK_P-B_\
MBJ -RBL/_A.O#?\ T,&E?^!L7_Q5'_"=>&_^A@TK_P #8O\ XJ@#<HK#_P"$
MZ\-_]#!I7_@;%_\ %4?\)UX;_P"A@TK_ ,#8O_BJ -RBL/\ X3KPW_T,&E?^
M!L7_ ,51_P )UX;_ .A@TK_P-B_^*H W**P_^$Z\-_\ 0P:5_P"!L7_Q5'_"
M=>&_^A@TK_P-B_\ BJ -RBL/_A.O#?\ T,&E?^!L7_Q5'_"=>&_^A@TK_P #
M8O\ XJ@#<HK#_P"$Z\-_]#!I7_@;%_\ %4?\)QX</3Q!I9_[?8__ (J@#<HK
M$_X3;P[_ -!_2_\ P,C_ /BJ3_A.O#?_ $,&E?\ @;%_\50!N45A_P#"=>&_
M^A@TK_P-B_\ BJ/^$Z\-_P#0P:5_X&Q?_%4 ;E%8?_"=>&_^A@TK_P #8O\
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M&_\ H8-*_P# V+_XJC_A.O#?_0P:5_X&Q?\ Q5 &Y16'_P )UX;_ .A@TO\
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M !5 &Y16'_PG7AO_ *&#2O\ P-B_^*H_X3KPW_T,&E?^!L7_ ,50!N45A_\
M"=>&_P#H8-*_\#8O_BJ/^$Z\-_\ 0P:5_P"!L7_Q5 &Y16'_ ,)UX;_Z&#2O
M_ V+_P"*H_X3KPW_ -#!I7_@;%_\50!N45A_\)UX;_Z&#2O_  -B_P#BJ/\
MA.O#?_0P:5_X&Q?_ !5 &Y16(OC?PZW37]+/TO(__BJ?_P )CH'_ $'--_\
M N/_ !H V**R/^$PT'_H-Z=_X%Q_XT?\)AH/_0;T[_P+C_QH UZ*R/\ A,-!
M_P"@WIW_ (%Q_P"-'_"8:#_T&]._\"X_\: ->BLC_A,-!_Z#>G?^!<?^-'_"
M8:#_ -!O3O\ P+C_ ,: ->BLC_A,-!_Z#>G?^!<?^-'_  F&@_\ 0;T[_P "
MX_\ &@#7HK(_X3#0?^@WIW_@7'_C1_PF&@_]!O3O_ N/_&@#7HK(_P"$PT'_
M *#>G?\ @7'_ (T?\)AH/_0;T[_P+C_QH UZ*R/^$PT'_H-Z=_X%Q_XT?\)A
MH/\ T&]._P# N/\ QH UZ*R/^$PT'_H-Z=_X%Q_XT?\ "8:#_P!!O3O_  +C
M_P : ->BLC_A,-!_Z#>G?^!<?^-'_"8:#_T&]._\"X_\: ->BLC_ (3#0?\
MH-Z=_P"!<?\ C1_PF&@_]!O3O_ N/_&@#7HK(_X3#0?^@WIW_@7'_C1_PF&@
M_P#0;T[_ ,"X_P#&@#7HK(_X3#0?^@WIW_@7'_C1_P )AH/_ $&]._\  N/_
M !H UZ*R/^$PT'_H-Z=_X%Q_XT?\)AH/_0;T[_P+C_QH UZ*R/\ A,-!_P"@
MWIW_ (%Q_P"-'_"8:#_T&]._\"X_\: ->BLC_A,-!_Z#>G?^!<?^-'_"8:#_
M -!O3O\ P+C_ ,: ->BLC_A,-!_Z#>G?^!<?^-'_  F&@_\ 0;T[_P "X_\
M&@#7HK(_X3#0?^@WIW_@7'_C1_PF&@_]!O3O_ N/_&@#7HK(_P"$PT'_ *#>
MG?\ @7'_ (T?\)AH/_0;T[_P+C_QH UZ*R/^$PT'_H-Z=_X%Q_XT?\)AH/\
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MI3]G+P-^TIXM\%Z%X[L;F_T^S@OKJ".VNGMR)/W"Y)0@D8-><_\ #IO]G/\
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M!I?_ (!Q_P#Q-'_"$^'?^@!I?_@''_\ $UM44 8O_"$^'?\ H :7_P" <?\
M\31_PA/AW_H :7_X!Q__ !-;5% &+_PA/AW_ * &E_\ @''_ /$T?\(3X=_Z
M &E_^ <?_P 36U10!B_\(3X=_P"@!I?_ (!Q_P#Q-'_"$^'?^@!I?_@''_\
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M_P! #2__  #C_P#B:/\ A"?#O_0 TO\ \ X__B:VJ*!&+_PA/AW_ * &E_\
M@''_ /$T?\(3X=_Z &E_^ <?_P 36U10!B_\(3X=_P"@!I?_ (!Q_P#Q-'_"
M$^'?^@!I?_@''_\ $UM44 8O_"$^'?\ H :7_P" <?\ \31_PA/AW_H :7_X
M!Q__ !-;5% &+_PA/AW_ * &E_\ @''_ /$T?\(3X=_Z &E_^ <?_P 36U10
M!B_\(3X=_P"@!I?_ (!Q_P#Q-'_"$^'?^@!I?_@''_\ $UM44 8O_"$^'?\
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M-$DT;3Y%BU@H@:U0A5^SPG XX&23^->DUQ'PZ_Y#OCO_ +#9_P#2:"@9N_\
M"$^'?^@!I?\ X!Q__$T?\(3X=_Z &E_^ <?_ ,36U10(Q?\ A"?#O_0 TO\
M\ X__B:/^$)\._\ 0 TO_P  X_\ XFMJB@#%_P"$)\._] #2_P#P#C_^)H_X
M0GP[_P! #2__  #C_P#B:VJ* ,7_ (0GP[_T -+_ / ./_XFC_A"?#O_ $ -
M+_\  ./_ .)K:HH Q?\ A"?#O_0 TO\ \ X__B:/^$)\._\ 0 TO_P  X_\
MXFMJB@#%_P"$)\._] #2_P#P#C_^)H_X0GP[_P! #2__  #C_P#B:VJ* ,7_
M (0GP[_T -+_ / ./_XFC_A"?#O_ $ -+_\  ./_ .)K:HH Q?\ A"?#O_0
MTO\ \ X__B:/^$)\._\ 0 TO_P  X_\ XFMJB@#%_P"$)\._] #2_P#P#C_^
M)H_X0GP[_P! #2__  #C_P#B:VJ* ,7_ (0GP[_T -+_ / ./_XFC_A"?#O_
M $ -+_\  ./_ .)K:HH Q?\ A"?#O_0 TO\ \ X__B:/^$)\._\ 0 TO_P
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M *[WG_I.:!H[^BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<1\.O^0[X[_[#9_])H*[>N(^'7_(=\=_]AL_^DT% SMZ***!
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!F^)?\
MD7=3_P"O:3_T$UY)8_ZL5ZWXE_Y%W4_^O:3_ -!->26/^K%(I;%VBBBF,***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *JW/W:M55N?
MNT =EX*_Y'KQO_UUL_\ TG6NXKA_!7_(]>-_^NMG_P"DZUW%!(4444""BBB@
M HHHH **** "BBB@ HHHH XK7/\ DK7A3_L':A_Z%;UVM<5KG_)6O"G_ &#M
M0_\ 0K>NUH *CDACE(+QJY'3<H-244 0_9(/^>,?_? H^R0?\\8_^^!4U%.X
M$/V2#_GC'_WP*/LD'_/&/_O@5-10!#]D@_YXQ_\ ? H^R0?\\8_^^!4U% $/
MV2#_ )XQ_P#? I?LL/\ SQC_ .^14M% 'Y=ZQM7_ (+8:*JJ% A/ &/^8-+7
MZB5^7&L?\IM='_ZY?^X62OU'KLQ,G+DO_*B8A1117$4%%%% !1110 4444 %
M%%% '$>!_P#D>/'_ /U_V_\ Z2Q5V]<1X'_Y'CQ__P!?]O\ ^DL5=O0,****
M!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/?$3_ ))_
MXF_[!ES_ .BFKH:Y[XB?\D_\3?\ 8,N?_134#6Y:\'_\BEHG_7C!_P"BUK7K
M(\'_ /(I:)_UXP?^BUK7H$%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7 >./^2E_#S_ *[WG_I.:[^N \<?\E+^'G_7>\_])S0-
M'?T444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M KB/AU_R'?'?_8;/_I-!7;UQ'PZ_Y#OCO_L-G_TF@H&=O1110(**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,WQ+_ ,B[J?\ U[2?
M^@FO)+'_ %8KUOQ+_P B[J?_ %[2?^@FO)+'_5BD4MB[1113&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %5;G[M6JJW/W: 1V7@K
M_D>O&_\ UUL__2=:[BN'\%?\CUXW_P"NMG_Z3K7<4$A1110(**** "BBB@ H
MHHH P/%'Q \+^!VMU\1^)-(T W.?(&J7T5MYN.NW>PW8]JMZMXHT;0=#;6=3
MU>QT[1U57;4+NY2*W"MC:3(Q"X.1@YYR*^6]<LXO"?[7'Q-UCXB^#=0USP5X
MC\*V=AIFLC29=2LH;:(2?;+.;RT=85=I"Y\S:I )SUKP?]G>YU#QM8_L<Z!K
MDES-X7DOO%6K6>GZG$3Y\-D0FF$JW58XYRR'GA5([&M5%-(CF/T@T+Q!I?BC
M2X-2T;4K35M.G!,5Y8SK-#)@X.UU)!Y!Z&M"OE+]E"XDT7]IK]J+PE9V[6_A
MZQU[3=3MD0@11W%W9[[@ =BS(K>E?5M9M692.*US_DK7A3_L':A_Z%;UVM<5
MKG_)6/"A_P"H=J'_ *%;UVM(84444 %%%% !1110 4444 %%%% 'Y=:NO_&[
M32#_ -,C_P"F:2OU%K\>/^"F7A/XB_ 7]J:#XVZ#J2:-#JVRWTC4;.93<12Q
MV@BE5D(XRI89Y!#5^LOPYU2ZUSX>^%]2O9/.O+S2[6XGDP!OD>%68X' R2>E
M>KBZ/+1I5D]&K?F9Q>K1T5%%%>4:!1110 4444 %%%% !1110!Q'@C_D=_'_
M /U_V_\ Z2Q5V]<5X)4KXV\>GUO[?_TEBKM:!A1110(**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *Y[XB?\D_\3?]@RY_]%-70US_ ,0E
MW> ?$H_ZAES_ .BFH&6?!_\ R*6B?]>,'_HM:UZR?"(V^$]%'_3E#_Z+6M:@
M04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<!XX_
MY*5\//\ KO>?^DYKOZX+QLI;XD_#X^D]Y_Z3F@:.]HHHH$%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7$?#K_D.^._^PV?_ $F@
MKMZXGX=KMUSQU[ZV3_Y+04#.VHHHH$%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% &;XE_Y%W4_P#KVD_]!->26/\ JQ7K?B3_ )%W
M4_\ KVD_]!->26/^K%(I%VBBBF,**>L3-VIWV=_[II70$5%2?9V]#3&4KU%%
MP$HHI5&33 <D9:G& CJ*\^_:*^(ES\)_@EXFU[38I+G7VMS::1:PH7DFO)?D
MB"J.6()W8'937C'_  3#^.E]\:O@?>Z/X@U.75/$WA>[,$UQ=3&6XFMY<O#(
M['DG/F)D]?+IV=N85];'U;'9O(.!2R6+JN<<5\'?\% ]8U[P/^T]\#5T#Q%K
M>C6^N7L$5_:V6ISQ07 6\B4;HE<+]UB#QR.M/_:"US7?"?\ P5#^&?A[2_$6
MMVF@:M'975YI*:G/]DED9YU8F$OL (C7Y0,<9Q1RNUQ<Q]RLA4TW::TKFU_>
M-V KRNQ_:6^%>H7T5K#XOMRTU]_9EO.T$RV]S=>8(_)AF*".5]Q VHQ/?I25
MWLBG9;GH>TT](BU<)_PT)\-4^*9^&\GB58O&_F&(:/)9W"R,P0O\I,>T@J,@
M@X(Z9JY\-?CA\-?C9X@USPIX7\1KJVKZ=%(-1L%M[BVFMU#^4X)=%*D,=O!R
M#0[K<#M'M65<D5$(23TK\X?V*/V@M/\ AG\8_C5'\3?B+J$?A_2IS::?%KFH
MW%X5VW4JXCC)=B0JC)4<#D\5][S?$GPAXS^#VK>,?#OBJ*X\/26,^W7-+C>Y
M-J=A!?RT4N&0\E2,C'(%-Q:)4DSJ'A*]1BH]IKYV_P""?=JC?"?Q(Q^+9^+:
M1ZNY.JR?:L6@\F,^5FY^;I\_'RC=]:]/TG]HCX8Z]XDM-#L/%UG/>7EU)8VD
MOER+:W5PF-\,-R5$4D@R/E1R?:E9]!W.YVFEV&N;^(WQ:\$_"6XLK;Q3K\.G
M7MXDDEO91Q27%S)'&I:2011*S[%4$EL8&.37*>*OVL/A5X5^#,WQ,B\3VNL>
M'=S0VQL26EN+@ X@"$!E<]PP&!R<"BS[!H>H&,TW::\"_9@_:_\ "GQ@^$MU
MXA\2Z_8:3K>G0SZCK%NT4D4&GVWG,L8,C*%;"E!D$DGMS7IOA/XW^ _'FNVV
MB:)KZSZS<V[7<.G7%K-;7#P  ^<(Y45C&0PP^-I[$X-.S"Z.Q52U3QVK/T%9
MOBSQ)IO@'PEK/B769OL^E:3:R7ES)C)"(I)P.YXX'O7@/[+UOK'[4/@S5OBK
MXWU35;73M>>XM-#\-Z??36<&F62.4WDQ,IDF<IN\QB<#[NT$BA*ZN]@OK8^E
M6T^15S@U$UJWI7Y.Z+\6/C%^QI\2O#?CG7]=U[QE\+?$$]Q;K%J&H37B- D[
MQM&?,)"7">7O&,;@.N"P'W7XC\.^$?C;\4OA3XOT#Q!K%SX<UZROKR6/2];N
M[>WNO*CB,0DBCD !4E@5P.>#5<CO:Y/.K7/<6C(I5C+5XY?_ +:WP0TZ]GM)
M_&RQSV\C12)_9MX=K*<$9$//(K3\&?M8?"GX@^)+3P]X7\4+JVOWH<6EG]AN
M8O-=49\;WB"CA3U-9ZEGK$=B[+D#BD%F^[&*_-S]LGX5_'[X2^!X_C3?_&34
M8]0-_%]L\.Z3=3V]GIPD?]U%  VV54)"G>@W 9.>A^LA!\5?CY^S1\.$T;6X
M?!&O>)-/MI_$&O+&PN;2(Q;G^SQ_\])&VCDC:&8YSBJY?,5_(]S>Q=5R14#0
M%>U?GC^SW<?%WX _M\0_!S7O'&J>/_#]_;/-<2W]S-<*MN;=I8IL2,QB<,JJ
M<''S=\BO>O%_Q,O/V6_VG/"OA+6M8N]4^'7Q&:1=._M&5IYM'U .JF-)#EC
M[2Q\,3M+\$*,46%<^D"I%)7+^//C)X#^''C+0?"OB/Q-9Z3X@UYE73K&8MOG
M+/L7D A<M\H+$9/ KJY$VFD4,HHHH **** "BBB@ HHHH *JW/W:M55N?NT
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M%"*FVBJ/B)?^*=U3_KUD_P#032:5MAZE_1/$FJ0Z#IJ)*@5;:(#Y!_<%6O\
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M 3_V_J'_ #T7_O@4_P#MR_\ ^>B_]\BJFVGX%2P+']N7_P#ST7_OD4?VY?\
M_/1?^^15?:*-HH L?VY?_P#/1?\ OD4?VY?_ //1?^^15?:*-HJK 6/[<O\
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M9EU?Q/X$T;7]4E^]=:A!YTF/0%CP/8<5ISJUK$<O4^3?^"FDT2_M-_LW$,I
MU*)NO;[;!S4'[4LRM_P5F^#9R,+9Z?G_ +^W5?6VN?LY_";Q0]B^L^ =&U5[
M&%;>U:\A,I@C!R$0L3M )Z"C7/V=OA5XBUR/6M2\":1?:S&(PFH7$1>=-@ 3
M#DY&T 8YXI*2M8=F=S\0;C2H?!?B236YIK;1TTZY:]FMB1+' (F\QD*\[@N2
M,<YK\M-'LO''[(]QX'M"]I\6OV>O$VN6=]H\R DQSF59(FC(^:"X!4-MY1RK
M#J3C]2]0M+75]-N=.O;>.ZL+J%K>>WF&Y)(V4JRL#U!!(/UKD='^!OPVT'4+
M&^L/!&BVMS8R^?:&.U7;;R?WT3[JM_M 9IQDHK4)+F/DSXR7=G8_\%>OAE<7
M<B6UNVD6YWRD*,^7=#DU0_X)VZIIVK?M[?M%7^G7,5YI]U+J$]O<0.&CE1M2
MR&5AP0<Y!'&#7VAX^^$?P_\ BM?6=[XR\&Z/XEN[-2D$^HVBRO&I.< GMGM5
M7PK\#_AIX$\4OXD\-^"-&T+77+EK[3[80R-N.6!VXX/ITI<WN\HN76Y\4?\
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MP!QS5C5OVOO"W@[X*Z)\1_%VB:GX8MM>G%OI.DW;0FYN]PRCY#[(T*@MN=@
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MUKW_ %VC_P#1:UKMUJ([%2W$HHHJB0HHHH*"G4VG4F)BT444A!11106%%%%
M!1110 JTM(M+0 4444 %/IE/H *I>(O^1<U3_KUD_P#035VJ/B+_ )%W5/\
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MY:UJ5CXL\37D*W7PKU%'-Y;.RM*?-1]OF6F0,.X &0P?NOZS^<V[-3+=%>@
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M5OI12/"LB$8\QE)5<\8!X/2OK9KICSWIRWC+UY'O3YWIY!RZ,_,KP/=+H/\
MP5'\%ZBAU^XTW4;&%UU'5K29)[Q7L&7SFCV@JA? ^Z%4CL!FK_PY^)7A=?\
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M<K32V#E/R&\#^.-!M_\ @E+\0?#TFJ6JZW)XK@V6#2 3-NDMG!"]3\L<A_X
M?2ON?_@G9XCLM>_8[\$Q6UY'=3Z?]IM+E$;+0R+.Y",.QV,AQZ,#WKZ3;4">
MR_E566?=[?2DY7CRV#EUN1-]ZDHHJ"@HHHH **** "JMS]VK55;G[M ([+P5
M_P CUXW_ .NMG_Z3K7<5P_@K_D>O&_\ UUL__2=:[B@D****!!1110 4444
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M2J?FJ/\ LW5/^@==?]^6_P *?'INI]].NA_VR;_"@9EZ*?\ B=:]_P!=H_\
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MQ+)!)&<JT; %2/8@BOE+]M'Q-KGQ#^$'Q2T#P?J#Z;X?\*Z3--XCUB%<FXN
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M_P!!->26/^K%>M^)?^1=U/\ Z]I/_037DEC_ *L4BEL7:***8PHHHH ****
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M=C^"+VKU8JK+ 2OLI)?J1=<Q][T5P[_$2=6Q_9RG_MJ?\*;_ ,+'G_Z!R_\
M?W_ZU>3[.1?.CNJ*X7_A9$__ $#E_P"_O_UJ/^%CS_\ 0.7_ +^__6H]G(.=
M'=45PW_"QI_^@<O_ ']/^%*OQ$G;_F'*/^VI_P */9R'S(=X)'_%;>/CZW]O
M_P"DL5=M7DWAGQC+:^)?%<XL58W%U"Y'F=,0(OI[5T1^(<X_YAR_]_?_ *U"
MIR&Y([>BN'_X6)/_ - Y?^_O_P!:C_A8D_\ T#E_[^__ %J/9R["YD=Q17$?
M\+$G_P"@<O\ W]_^M1_PL2?_ *!R_P#?W_ZU'LY=@YD=O17$?\+$G_Z!R_\
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M4_\ 'FO_ 'W_ /6IO_":3?\ /DO_ 'V?\*?*Q71U=%<I_P )I+_SYK_WV?\
M"E_X327_ )\U_P"^S_A1RL+G545RG_":2_\ /D/^^S_A1_PFDO\ SYK_ -]G
M_"ERL9U=%<K_ ,)I+C_CS7_OL_X4?\)I+_SYK_WV?\*?*Q'545RG_":2_P#/
MFO\ WW_]:E_X3.7_ )\U_P"^S_A1RL#JJ*Y7_A,I?^?-?^^S_A2_\)E+_P ^
M8_[[_P#K4N5@=317+?\ "92_\^8_[[_^M1_PF4O_ #YC_OO_ .M1RL+G4T5R
MW_"92_\ /F/^^_\ ZU._X3"7_GS'_??_ -:CE8'3T5S'_"82_P#/F/\ OO\
M^M0OC"4_\NB_]]__ %J.5C.GHKF3XNE_Y]%_[[/^% \72_\ /HO_ 'V?\*.5
M@=-17,_\)=+_ ,^B_P#??_UJ/^$NE_Y]%_[[_P#K4<K Z:N(^'8QKGCK_L-G
M_P!)H*TU\62M_P NH_[[_P#K5R_@OQ ]MJWB]A; ^;JQD^]_TPB'I[4<K&>F
M45S7_"62?\^@_P"^_P#ZU'_"72?\^@_[[_\ K4K,1TM%<U_PETG_ #Z#_OO_
M .M1_P );)_SZ#_OO_ZU%F!TM%<W_P )9)_SZ#_OO_ZU'_"62?\ /H/^^_\
MZU/E8'245S?_  EDG_/H/^^__K4?\)9)_P ^@_[[_P#K4K,#I**YO_A+)/\
MGT'_ 'W_ /6H_P"$LD_Y]!_WW_\ 6HLP.DHKF_\ A+)/^?0?]]__ %J/^$LD
M_P"?0?\ ??\ ]:GRL#I**YO_ (2R3_GT'_??_P!:G?\ "42?\^J_]]__ %J5
MF!T5%<[_ ,)3)_SZK_WW_P#6H_X2F3_GV7_OO_ZU%@.BHKG?^$ID_P"?5?\
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M_"&I_P _K_\ ? _QI?\ A"T_Y_7_ .^!_C1J&AA>8/6CS!6]_P (6G_/Z_\
MWP/\:3_A"T_Y_7_[X'^- &%Y@H\P>M;_ /PA,?\ S_-_WP/\:/\ A"8_^?YO
M^^!_C0%T8'F#UH\P>M;_ /PA,?\ S_-_WP/\:/\ A"8_^?YO^^!_C0%T8'F#
MUH\P5O\ _"$Q_P#/\W_? _QH_P"$)C_Y_F_[X'^- &#O%)Y@J]K.@KI-YHT
MN6D&H7?V8L5QL^1FSUY^[^M:;>!X_P#G^;_O@?XT <]Y@]:/,'K6_P#\(2G_
M #_/_P!\#_&E_P"$(C_Y_P!O^^!_C0!S_F#UH\P>M=!_P@\?_/\ O_WP/\:/
M^$'C_P"?]_\ O@?XT!<Y_P P>M'F#UKH/^$'C_Y_W_[X'^-'_"#Q_P#/^_\
MWP/\: N<_P"8/6CS!ZUT'_"#Q_\ /^__ 'Q_]>E_X06/_G_?_O@?XT!<Y[S!
MZT>8/6NA_P"$%C_Y_P!_^^!_C1_P@D8_Y?W_ ._8_P : .>\P>M'F#UKH?\
MA!8_^?\ ?_O@?XT?\()'_P _[_\ ?L?XT#.>\P>HH\P>HKH?^$$B_P"@@_\
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MB@!/+'I1Y8STI]%(D;Y8H\L4ZB@H;Y8H\L4ZB@!-@I5444Y: $\L4>6*=10
MWRQ1Y8IU% "*@K U]!_PEGA?C_EI/_Z*-="O6L'7O^1K\,?]=+C_ -%&IEL4
MCH9%&ZF;!4DGWJ;3)&[!1L%.HI@,V#(I?+%+W%+4@-\L8I/+%/HI@-V"G",8
MHIR]*8T-\L>E+L%+128V)L%)L%/I*1(W8*?L%)3Z:&AOEB@(/2G44,H3:*-H
MI:*D!-HHVBEHH =&HS6!X54?VEXG_P"PD?\ T5'701U@>%?^0EXG_P"PB?\
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M 4444 %%%% !1110 4444 <AK'_)4/#7_8/OO_0H*X.WZGZUWFL?\E0\-?\
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MYFTE)6/T6N?]8:A7K4UU_K#4*]:^86QJ.IR=:;3DZU0&5HO_ "&M>_Z[1_\
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M_P#GFO\ WR*/(C_YYK_WR*/:+L'+YGDWVY/6C[<GK7K/D1_\\U_[Y%'D1_\
M/-?^^11[1=@Y?,\F%XOK2_;%]:]9\F/_ )YK_P!\BCR8_P#GFOY"E[3R#E?<
M\H6\7'6E^V+ZUZMY,?\ SS7\A1Y,?_/-?R%'M/(.4\I^V+ZT?;%]:]6\F/\
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MF\M?[H_*C:O]T?E0!S/G#UI?.'K72[5_NC\J-J_W1^5 SF?.%+YP]:Z7:O\
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M;KX[_ 6$=9'D7\[J"OU+KX9_X**?L8_$3]J#Q;X"UGP'?Z39-H,$\<K:A=/
MZNSHZ.A5&Z;/;M7HX"<*==2F[(B:O&Q]S45^6R_L>?MRL?F^-SK_ -S1>?\
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<!XX_Y*5\//\
MKO>?^DYKOZX#QQ_R4OX>?]=[S_TG- T=_1110(**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "N(^'7_(=\=_]AL_^DT%=O7$?#K_D
M.^._^PV?_2:"@9V]%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH IZS_R![[_KA)_Z":Y_X3?\DQ\*?]@RW_\ 18KH-9_Y ]]_
MUPD_]!-<_P#";_DF/A3_ +!EO_Z+% ^AUE%%% @HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH XCXB?\A[P)_V&_\ VVGKMZXCXB?\
MA_P)_P!AK_VVGKMZ!A1110(**** "BBB@ HHHH **** "BBB@ HHHH ****
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M*WKM:XK7/^2M>%/^P=J'_H5O7:T %%%% !1110 4444 %%%% !1110 4444
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M=K7%:Y_R5KPI_P!@[4/_ $*WKM: "BBB@ HHHH **** "BBB@ HHHH ****
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MP[>_%J9-5&H07UBTBZ=;++"$>-C<+Y)D&S(+DG:,8Z4WX9_&K]L?5OC1\/\
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M=K_WV_[Z-&U_[[?]]&BP'=45PNU_[[?]]&C:_P#?;_OHT^4#NJ*X7:_]]O\
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M "BBB@!5I:1:6A@%%%% !1110 4^F4^DP"BBBD 44450!2KWI*5:3 =1112
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M/_V$C_Z*CHZH#>/:B@]J* "BBB@ HHHH 5:6D6EH8!1110 4444 %/IE/I,
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MBF[Q1O% #J*;N%&ZF ]:6F*PI=XI,!U%-WBC>* '44W>*-XH =3ZBWT_<*3
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M"1U%)NHW4 +129%&X4%"T+UI,BE4C- #J5:3(I5-!)@>"/\ DHGQ _Z^+/\
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M]'^KQ_RP?WKXG_X(UZ0=4^"?CYQ/Y8/B!4QMSTMHSGK[_I7WU\6/^26^,?\
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M_P#KTO\ PAS_ //X/^_?_P!>NGHHYF,YC_A#G_Y_!_W[_P#KTJ^#W'_+X/\
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M#:Z^'OAN47 7?I\#8V>J ^M=GK'_ ""+[_KA)_Z":P/A.<_#'PK_ -@RW_\
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M'_L%O^>__CO_ ->C^P3_ ,]__'?_ *];%% &/_8)_P">_P#X[_\ 7H_L$_\
M/?\ \=_^O6Q10!C_ -@G_GO_ ..__7IW]AG_ )[_ /CO_P!>M:B@#)_L,_\
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ML=!M-0TN&:?'F2I!J4<2L^ !N(7)P.YK]7J_+_\ X)]G_C8]^TG_ -?&L_\
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M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ' >!?\
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M %%%% !1110 4444 %%%% !1110 5Q'PZ_Y#OCO_ +#9_P#2:"NWKB/AV/\
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M,:3&/[&L./\ EWC_ /014_EBFHQL.[.@_P"$^_ZA[?\ ?W_ZU \?9_YA[?\
M?S_ZU<_Y0I5C%'+'L*[.@_X3S_IP;_OY_P#6H_X3S_IP;_OY_P#6K \H4>4*
M.5!=F_\ \)Y_TX-_W\_^M2_\)Y_TX-_W\_\ K5SXC'I1Y0I<L1ZG0?\ ">?]
M.#?]_/\ ZU)_PGG_ $X-_P!_/_K5@>4*/*%'+$+LZ#_A/!_SX-_W\_\ K4O_
M  G8_P"?!O\ OY_]:L'RA1Y8]*.5"NS>_P"$Z'_/BW_?S_ZU'_"=#_GQ;_OY
M_P#6K!\H4>4*7*BC>_X3H?\ /BW_ '\_^M2_\)T/^?%O^_G_ -:L#RQ1Y8]*
M.5 ;_P#PG0_Y\6_[^?\ UJ7_ (3C_IQ;_OY_]:L 1@=J58Q3Y4!O?\)P/^?%
MO^_G_P!:C_A.!_SXM_W\_P#K5A>6/2CRQZ"ERH6IN_\ "<#_ )\6_P"_G_UJ
M/^$X'_/BW_?S_P"M6%Y8]*/+'I1RH9O?\)L/^?%O^_G_ -:N3\5>)!<>.?!<
M_P!E(\B6Z.-_7,)'I5]8Q6#KT8_X2SPOQ_RTG_\ 11I.*&CO6\:!?^7)O^_G
M_P!:D_X37_IR;_OY_P#6K&DC&:9Y8I\J)NS<_P"$U'_/DW_?S_ZU'_":_P#3
MDW_?S_ZU8?EBCRQ1RH>IN?\ ";#_ )\6_P"_G_UJ/^$V'_/DW_?S_P"M6'Y8
MR*/+'I4V0&Y_PFH_Y\F_[^?_ %J/^$U_Z<F_[^?_ %JP_+&*/+'I5<J W/\
MA-?^G)O^_G_UJ7_A-/\ IR;_ +^?_6K"\L>E.6,8Z4<J&C;_ .$T_P"G)O\
MOY_]:C_A-/\ IR;_ +^?_6K$,8]*7RQ2Y4!M?\)G_P!.3?\ ?S_ZU'_":?\
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M $['_OK_ .M0/$G_ $['_OO_ .M6;MH"BG81I_\ "2#_ )]C_P!]_P#UJ/\
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MDKIG44(9<_X2#_IW/_?7_P!:C_A(/^G<_P#?7_UJH%12!1BFQ&E_;W_3N?\
MOK_ZU)_;_P#T[G_OK_ZU9^T4;12 T/[?_P"G<_\ ?7_UJ/[?_P"G<_\ ?7_U
MJS]HHVB@#1_M[_IW/_?7_P!:E_MS_I@?^^O_ *U9H49%/VB@"_\ V[_TP/\
MWU_]:C^W/^F!_P"^O_K50VBC:*!E_P#MS_I@?^^O_K4?VY_TP/\ WU_]:J&T
M4;10,O\ ]N?],#_WU2_VW_TP/_?59^T4X*,4$E[^VO\ IB?^^J/[:_Z8G_OJ
MJ.T4NT4 7?[:_P"F)_[ZH_MK_IB?^^JI;11MH*+O]M?],3^=*-:_Z8G_ +ZJ
MCMH5>: +_P#; _YXG_OJE&L _P#+$_\ ?54=M*JT$G/^!Q_Q<CXAGUN;/_TF
M6N^K@_!'_)1?B#_U\6?_ *3+7>4#"BBB@04444 %%%% !1110 4444 %%%%
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M "43X@?]?%G_ .DZUWE<'X(_Y*)\0/\ KXL__2=:[R@84444""BBB@ HHHH
M**** "BBB@ HHHH Y#6/^2H>&O\ L'WW_H4%<';]3]:[S6/^2H>&O^P???\
MH4%<';]3]:Z*/4RJ="U2TE+708CJ***E %%%%4 JTZFK3JEE(****0PHHHH
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M[V-'G>QI@6*5>]5O.]C3DF//!I,"S14'F>QH\WV-(!VH?\@N\_ZXO_Z":R_
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M&_XNQX5'_4.U#_T*WKL]H]!7%ZY_R5KPI_V#M0_]"MZ[6D,3:/04;1Z"EHH
M3:/04;1Z"EHH 3:/04;1Z"EHH 3:/04;1Z"EHH 3:/04;1Z4M% ";1Z4;1Z4
MM% ";1Z4;1Z4M% ";1Z4;1Z"EHH 3:/04;1Z"EHH 3:/04;1Z"EHH 3:/04;
M1Z4M% '&>"WW^,O'2D<+?6X'_@+%79;1Z5Q/@C_D=_'_ /U_V_\ Z2Q5V] Q
M-H]*-H]*6B@0FT>E&T>E+10 FT>E&T>E+10 FT>E&T>E+10 FT>E&T>E+10
MFT>E&T>E+10 FT>E&T>E+10 FT>E&T>E+10 FT>E&T>E+10 FT>E&T>E+10
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M .-4?\/&/V;_ /HJ6E_^ MS_ /&JXG_ATQ^SM_T -8_\',_^-'_#IC]G;_H
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MM% "44M% "44M% "44M% '%?$!MNO>!AZZUC_P EIZ[2N)^(G_(>\"?]AO\
M]MIZ[>@8E%+10(2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEH
MH 2BEHH 2BEHH X#P-_R4CXB?]?-G_Z3+7?UP'@7_DI7Q$_Z^;/_ -)EKOZ!
MA1110(**** "BBB@ HHHH **** "BBB@#BM<_P"2M>%/^P=J'_H5O7:UQ6N?
M\E:\*?\ 8.U#_P!"MZ[6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** .(\#_P#(\>/_ /K_ +?_ -)8J[>N(\#_ /(\>/\
M_K_M_P#TEBKMZ!A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *Y_XA-M\ ^)2/^@9<_\ HIJZ"N>^(G_)/_$W_8,N?_134#+7A$[O
M">BG_IRA_P#1:UKUD>#_ /D4M$_Z\8/_ $6M:] @HHHH **** "BBB@ HHHH
M **** "OEK_@I]_R8S\3/]W3?_3E:U]2U\L_\%/O^3&?B9_NZ;_Z<K6NO"?[
MQ3_Q+\R9;,/^"7__ "8Q\,_IJ7_ISNJ^IJ^6?^"8'_)C/PS^FI?^G.ZKZFJ<
M5_'J>K_,([(****YB@HHHH **** "N \<?\ )2_AY_UWO/\ TG-=_7 >./\
MDI7P\_Z[WG_I.:!H[^BBB@04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %<1\.O\ D.^._P#L-G_TF@KMZXCX=?\ (=\=_P#8;/\
MZ304#.WHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<1\1/^0_X$_[#7_MM/7;T#"BBB@04444 %%%% !1110 4444 %%%% !1110
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MF?\ /23_ +]FC_A--,_YZ2?]^S1ROL%T;M%8?_"9:9_STD_[]FC_ (3+3/\
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MBJ7]K0?[?_?!I?[5@_V_^^#0!<HJG_:D'^W_ -\&C^U(/]O_ +X- %RBJ?\
M:D'^W_WP:/[4@_V_^^#0!<HJG_:D'^W_ -\&E_M2'_;_ .^#0!;HJI_:</\
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M.]D7'S5AZ]J$G_"5>&1N/,D__HLU]!//*TM9T:;?=Q;_ %,U36UV?GNWPO\
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M@ HHHH *%ZT4+UH =3DZTVG)UI@96B_\AK7O^NT?_HM:UVZUD:+_ ,AK7O\
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M=_Z'/QI_X$6G_P CU]K><?6CSCZT?VICO^?K_ /9Q['Q3_PYO^#O_0Y^-/\
MO_9__(]'_#F_X._]#GXT_P"_]G_\CU]K><?6CSCZT_[4QW_/U_@'LX]CXI'_
M  1O^#I_YG/QI_W_ +/_ .1Z7_AS=\'?^AS\:?\ @19__(]?:RS-GK2^<?6I
M_M3'?\_7^ >SCV/BC_AS=\'?^AS\:?\ @19__(]'_#FWX._]#GXT_P# BS_^
M1Z^U_./K1YQ]:/[4QW_/U_@'LX]CXH_X<V_!W_H<_&G_ ($6?_R/1_PYM^#O
M_0Y^-/\ P(L__D>OM?SCZT><?6C^U,=_S]?X![./8^*/^'-WP=_Z'/QI_P"!
M%G_\CTO_  YM^#O_ $.7C3_P(L__ )'K[6\YO6G^<?6C^U,=_P _7^ >SCV/
MB;_AS;\'?^AR\:?^!%G_ /(]'_#FSX._]#GXU_\  BS_ /D>OMGSCZT><?6E
M_:F._P"?K_ /9Q['Q-_PYK^#G_0Y^-/_  (M/_D>C_AS7\'/^AS\:?\ @1:?
M_(]?;/G'UH\X^M/^U,=_S]?X![./8^)O^'-?P<_Z'/QI_P"!%I_\CT?\.:_@
MZ?\ F<_&O_@1:?\ R/7VSYS>M*LS<\T?VICO^?K_  #V<>Q\3?\ #FKX._\
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M2_\ Q-'_  L#X:?\_EI_X#2__$TO:Q#V<C$^U)ZT?:D]:V_^%@_#3_G\M/\
MP&E_^)H_X6#\-/\ G\M/_ :7_P")I^VB'LY&*+M?6C[8OK6U_P + ^&G_/Y:
M?^ TO_Q-'_"P/AI_S^6G_@-+_P#$T>UB/V<C'6Z7/6E^U+ZUK_\ "P?AI_S^
MVG_@-+_\32_\+"^&G_/[:?\ @-+_ /$TO:Q#V;,?[4OK1]J7UK8_X6%\-/\
MG]M/_ :7_P")H_X6%\-/^?VT_P# :7_XFCVL0]G(Q_M2^M*+I?6M?_A87PT_
MY_;3_P !I?\ XFC_ (6%\-?^?VU_\!Y?_B:/:Q#V;,G[4OK2?:E]:U_^%A?#
M7_G]M?\ P'E_^)H_X6%\-?\ G]M?_ >7_P")H]K$?(S*^U+ZT?:E]:U?^%A_
M#7_G]M/_  &E_P#B:/\ A8?PU_Y_;3_P&E_^)H]K$7LY&5]J7UI1=+ZUJ?\
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MO_Q-'_"Q?AM_S_6O_@/+_P#$T>UB/E9F_:5]:>+E?6K_ /PL7X;?\_UK_P"
M\O\ \32_\+%^&W_/]:_^ \O_ ,31[2(N1F?]I7UI/M0K1_X6-\-O^?ZU_P#
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MP!;Z'IT5Q?6Z3I;1JZM;RY#!0"#\OK5S_A9/PX_Z"%M_X#R__$T*H@Y65/M
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M/#VI:%K5G%J.D:E;R6EW:3#*31.I5E(]""::W ^,O@QJOBC]D6/X'>$-2L]
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M_D+REVP3@C)S[%2G+F8XJP4445F4%%%% !1110 4444 %%%% !1110 4444
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M>-8888QA410 J@=@  *GK(L**** "BBB@ HHHH **** "BBB@ HHHH ****
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M+2=R["Z&.)&E<1_NU>9G*KP,5JY(BS/<:***Q+"BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>figure17_01.jpg
<TEXT>
begin 644 figure17_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +(!98# 2(  A$! Q$!_\0
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MBB@ HHKQS]H3X_W7P+OOAY"GA2XUZT\6>)K+PY)?)=)#%8M<.55V&&9CQP,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@9@1.0&!W'!]J_36OR__ ."A;?\ &Q;]F=?^GG2#_P"58UI3J0J-IP27E?\
M5L+-=3]!KCPSX[=OW7C2SC'OHZG_ -J5#_PBWQ"_Z'FQ_P#!(O\ \<KT"BO,
M-;GG_P#PBWQ"_P"AZL?_  2+_P#'*/\ A%OB%_T/5C_X)%_^.5Z!13"YY_\
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MM\0O^AZL?_!(O_QRO0** N>?_P#"+?$+_H>K'_P2+_\ '*/^$6^(7_0]6/\
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M?$+_ *'JQ_\ !(O_ ,<KT"B@+GG_ /PBWQ"_Z'JQ_P#!(O\ \<H_X1;XA?\
M0]6/_@D7_P".5Z!10%SS_P#X1;XA?]#U8_\ @D7_ ..4?\(M\0O^AZL?_!(O
M_P <KT"B@+GG_P#PBWQ"_P"AZL?_  2+_P#'*/\ A%OB%_T/5C_X)%_^.5Z!
M10%SS_\ X1;XA?\ 0]6/_@D7_P".4?\ "+?$+_H>K'_P2+_\<KT"B@+GG_\
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MQ"_Z'JQ_\$B__'*/^$6^(7_0]6/_ ()%_P#CE>@44!<\_P#^$6^(7_0]6/\
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M ."1?_CE'_"+?$+_ *'JQ_\ !(O_ ,<KT"B@+GG_ /PBWQ"_Z'JQ_P#!(O\
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ME\3?]#,?_!-%_P#':9Y8]*/+'I0 _P#X27Q-_P!#,?\ P31?_':/^$E\3?\
M0S'_ ,$T7_QVF>6/2CRQZ4 /_P"$E\3?]#,?_!-%_P#':/\ A)?$W_0S'_P3
M1?\ QVF>6/2CRQZ4 /\ ^$E\3?\ 0S'_ ,$T7_QVC_A)?$W_ $,Q_P#!-%_\
M=IGECTH\L>E #_\ A)?$W_0S'_P31?\ QVC_ (27Q-_T,Q_\$T7_ ,=IGECT
MH\L>E #_ /A)?$W_ $,Q_P#!-%_\=H_X27Q-_P!#,?\ P31?_':9Y8]*/+'I
M0 __ (27Q-_T,Q_\$T7_ ,=H_P"$E\3?]#,?_!-%_P#':9Y8]*/+'I0 _P#X
M27Q-_P!#,?\ P31?_':/^$E\3?\ 0S'_ ,$T7_QVF>6/2CRQZ4 2?\)-XE_Z
M&8_^":+_ ..U%#XF\6'S/.\1HOSD)Y>DQME>Q.9!@^W/UI?+'I1Y8I /_P"$
ME\3?]#,?_!-%_P#':/\ A)?$W_0S'_P31?\ QVF>6/2CRQZ4P'_\)+XF_P"A
MF/\ X)HO_CM'_"2^)O\ H9C_ .":+_X[3/+'I1Y8]* '_P#"2^)O^AF/_@FB
M_P#CM'_"2^)O^AF/_@FB_P#CM,\L>E'ECTH ?_PDOB;_ *&8_P#@FB_^.T?\
M)+XF_P"AF/\ X)HO_CM,\L>E'ECTH ?_ ,)+XF_Z&8_^":+_ ..T?\)+XF_Z
M&8_^":+_ ..TSRQZ4>6/2@!__"2^)O\ H9C_ .":+_X[1_PDOB;_ *&8_P#@
MFB_^.TSRQZ4>6/2@!_\ PDOB;_H9C_X)HO\ X[1_PDOB;_H9C_X)HO\ X[3/
M+'I1Y8]* '_\)+XF_P"AF/\ X)HO_CM'_"2^)O\ H9C_ .":+_X[3/+'I1Y8
M]* '_P#"2^)O^AF/_@FB_P#CM'_"2^)O^AF/_@FB_P#CM,\L>E'ECTH ?_PD
MOB;_ *&8_P#@FB_^.T?\)+XF_P"AF/\ X)HO_CM,\L>E'ECTH ?_ ,)+XF_Z
M&8_^":+_ ..TA\3>)A_S,Q_\$T7_ ,=IOECTIK1BD!#J'BKQ?%I&K7EMXEC>
M33[*6\\N;2(U$@09VY$AQGZ5['I\S7-A;3/C?)$KMCID@$UXQ>+CPUXN_P"P
M)=?^@BO9-)_Y!5E_UQ3_ -!% F6Z***9(4444 %%%% !1110 4444 %%%% '
M%_%7_D"Z/_V'--_]*HZ[2N+^*O\ R!='_P"PYIO_ *51UVE ^@4444""BBB@
M HHHH **** "BBB@ HHHH *_+W_@H9_RD8_9G_Z^=(_].YK]0J_+C_@HQJ%E
MH_\ P4(_9SU#4;N"PL+232I[BZNI%CBAB7569W=V("J "23P #79A8.I4Y5_
M6J)D?J/17GDW[1?PHM_];\3O!L?^_K]H/_:E0_\ #3'P@_Z*MX(_\**S_P#C
ME9>PJO:#^YAS+N>DT5YM_P -,?"#_HJW@G_PHK/_ ..4DG[3/P?A0O)\5O!"
M)_>;Q'9@?^C*/J];^1_<PYH]STJBJFE:M8Z[IMMJ&FWEOJ%A<H)8+JUE66*5
M#T974D,#Z@U;K%IIV904444@.#C_ .2YS_\ 8NQ_^E+5WE<''_R7.?\ [%V/
M_P!*6KO* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH XKX<?\A#QM_V'Y?_ $G@KM:XKX<?\A#QM_V'Y?\ TG@KM: "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF/BA_R3;Q5
M_P!@NZ_]%-73US'Q0_Y)MXJ_[!=U_P"BFH&MS1\)_P#(JZ-_UY0_^BUK6K)\
M)_\ (JZ-_P!>4/\ Z+6M:@04444 %%%% !1110 4444 %%%% !1110 4444
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MO8=)_P"059?]<4_]!%!++=%%% @HHHH **** "BBB@ HHHH **** .+^*O\
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M_D:+?_KU7_T-J"HF3'TI],CZ4^D,****8!1110 4444 %%%% !1110 4444
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M\>(-&\0264-G<$I)Y5Q;2Q0JL9&?G1@ 0,ABQP:^C:EJP[G%_%7_ ) NC_\
M8<TW_P!*HZ[2N+^*G_(%T?\ [#FF_P#I5'7:4BN@4444""BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KX[_X*R\_L5^)_P#L(:?_ .E*5]B5\>_\%8.?
MV+?$W_80T_\ ]*4K:C'GJ*/<3V.]_P""?2[?V,OA0/\ J$Y_\BR5]"U\!?\
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M=?\ HIJZ>N8^)_\ R3?Q5_V"[K_T4U UN:/A/_D5=&_Z\H?_ $6M:U9/A/\
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M0K.%8J#CKM./2OE7X)?MVZG\:?A'\6O&%GX MK&Z\ 6L=Y)82ZLS+=QE)GD
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M-O2D]-&,JJI-.,9KSWX^_&ZQ^ ?@^'4GT;4/$^O:A*;72/#^E1-)<W\^TMM
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M#1O^>TG_ 'Z;_"C_ (6!HW_/:3_OTW^%<#]E7TH^RKZ4>SB'-([[_A8&C?\
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M]*.5#NSL?^$PTS_GI)_W[-'_  F&F?\ /23_ +]FN.^SCTH^SCTHY4%SL?\
MA,-,_P">DG_?LT?\)AIG_/23_OV:X[[./2G>2,]*.5!<[#_A+]-_YZ2?]^S1
M_P )?IO_ #TD_P"_9KD/LX]*/LX]*.5!=G7_ /"7Z;_STD_[]FC_ (2[3?\
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MA&ZH_)'I1RH#I_\ A*+#_GH__?!H_P"$HL/^>C_]\&N8\D>E'DCTI<H'4?\
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MOI#X(?L4V/PW\"_&31;R_M+$_$=+FU-CHH<VFE6LB2(D41DY<J)"=Q"C@
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M]I3]HKQ7^SO^T;I'A+QQKOC"Q^%[:##:V/B;31#]HN;O \R]F/D[9G5LAHE
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MMXE^,7CV/Q3K%Q<MJ5YK+SN8H[:*%0D:JX&T@B3Y5 !W#O2^SRI@KWNSP?\
MX)R7U]I'Q3_:/^'>G2)!I.EZS-=:;$%Q';2---$-J] ,1Q\#^Z*]I_96\#_'
M3PA:^*1\:O%%GXB>:XC.E"W97:-1N\QMRHN%;*84Y(P?6N _X)\_"/7-'T7X
ME_%'6X9M#U7XC7\MWI]K<*?.MK4O*\;N#W+2D@>B@]\#M_V2_@5\1/@98>*8
M?'WQ%E\='5+I)K1'>606V V]M\IW OE?E'RC9GG)JIV;8HWLKGN[]:;2L<FD
MJ"PHHHH **** "BBB@ IK4ZFM0!5OO\ D6_%O_8$NO\ T$5[#I/_ ""K+_KB
MG_H(KQZ^_P"1;\6_]@2Z_P#017L.D_\ (*LO^N*?^@B@EENBBB@04444 %%%
M% !1110 4444 %%%% ')?$K_ )!>D?\ 8;T[_P!*8ZY_QW_R,S?]<E_K70?$
MK_D%Z1_V&]._]*8ZY_QW_P C,W_7)?ZUM1^)D5/A,E:?35IU=1SBKWI:1:6E
MU ****8!3Z93Z3*04445(PHHHH 5>M+2+UIU !1110 5I:3_ *]:S15_39-L
MPSZU,M@/@'X0(6_X*\_$+'_/M=_^DT%??VI(5F.17Y3_ +84/QA_9A_:J\6?
M&7P] _AW3M<O39:9KC);7*3A[=-Z"-]^#B-N2HZ<&OU"\(:O=>)_A[X6UJ^*
MF]U+2K6\G*+M4R20J[8'89)KZ#-*/[O#XB,DXN*6F]TM;].O<SB]T6:5:#0M
M>":&2G_(Z2_]@]?_ $8:V6K&3_D=)?\ L'K_ .C#6TU*)4AM%%%,D****"D%
M*O>DI5H8,=1114DA11104%%%% Q*6BB@ 7K3J:O6G4 %%%% !3EIM.6@!:<E
M-IR4 8_AG_CXU[_L(O\ ^@)6NW6LCPS_ ,?.O?\ 81?_ - 2M=NM1$;$HHHJ
MQ#Z*** "BBBI8T%%%%(8JTM(M+02Q:2EI*"@HHHH *6DI: '4444 %%%% !6
M=XL_Y%/6?^O27_T UHUG>+/^13UG_KTE_P#0#2>PUN7-'_Y MA_U[Q_^@BK%
M5]'_ .0-8?\ 7O'_ .@BK%)""BBBJ *1?NBEI%^Z*E@*O6BA>M%- %"]:*%Z
MTQCJ***3&PI?X124O\(J21*5:2E6FACJ***HH****@ HHHH 4=:P_&?_ ![Z
M+_V%;;_T.MQ>M8?C/_CWT7_L*VW_ *'2>P'0O]XTRGO]XTRJ ****0!1110
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M**** %7K3J:O6G4 %%%% !4ULVV05#4EO]\4,#XN_P""PDA;X$^!1G_F8O\
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M4\@YKL/B;^PWX)^*WPY\(>!=7\5^+E\-^%U;[#;I?0R.6(VAG>2%F.U?E !
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M51 021\HQCG/IFNZ3I?B[0;[1-<T^WU72+Z(PW-G=1AXY4/4%3UK'KW->EC
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M+J=F8N5!155%W$G:J@9^@KT*1MQK"3O*YI%65AM%%%(H**** "BBB@ HHHH
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M!:HJO]J7UI/M*^M*PRS4D'WQ5,72^M/CNE# YHL(^-/^"P'/P+\"_P#8Q?\
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M:** %#$4OF&FT4 .\PT;S3:* %+$TE%% !1110 4444 %%%% !1110 4444
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M^%>Z'_SZM_W];_&NDHJN>7<GE78YS_A7^B#_ )=G_P"_K?XT?\*_T3_GV?\
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M1>]=Q_P@^C]?L[?]_6_QKFOV<_\ DWOX8?\ 8K:7_P"DD5>B5G7D_:SUZO\
M,:2L>:1^&=,_X6U-9>2WE?V&DVWS&Z^>P]?05UI\#Z.?^7=O^_C?XUB1J?\
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M]G_&C_A%=._YXM_WV?\ &M>BES,#(_X1;3O^>+?]]G_&C_A%M._YXM_WV?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M JL13P_L8U<.FKMK7_AV"O>S/<****\LL**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** .*^''_ "$/&W_8?E_])X*[6N*^''_(0\;?
M]A^7_P!)X*[6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *YCXH?\DV\5?]@NZ_]%-73US'Q0_Y)MXJ_P"P7=?^BFH&MS1\)_\
M(JZ-_P!>4/\ Z+6M:LGPG_R*NC?]>4/_ *+6M:@04444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %<1\5/^/7PS_P!C#8?^C17;UQ'Q
M4_X]?#/_ &,-A_Z-% T=O1110(**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "O,OB-_R-%O\ ]>J_^AM7IM>9?$;_ )&BW_Z]5_\
M0VH*B9,?2GTR/I3Z0PHHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4UJ=36H JWW_(M^+?^P)=?^@BO8=)_Y!5E_P!<4_\ 017CU]_R
M+?BW_L"77_H(KV'2?^059?\ 7%/_ $$4$LMT444""BBB@ HHHH **** "BBB
M@ HHHH XOXJ_\@71_P#L.:;_ .E4==I7%_%7_D"Z/_V'--_]*HZ[2@?0****
M!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\1?\
M!50_\8V>-?\ KWTK_P!. KVW]A__ )-%^$G_ &+UK_Z!7B7_  53_P"3;?&O
M_7OI7_IQ%>W?L0KM_9%^$H_ZEVU_] KO?^Y1?]Y_D1]H]OHHHK@+"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#BOAQ_R$/&W_8?E
M_P#2>"NUKBOAQ_R$/&W_ &'Y?_2>"NUH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N8^*'_)-O%7_8+NO_ $4U=/7,?%#_ ))M
MXJ_[!=U_Z*:@:W-'PG_R*NC?]>4/_HM:UJR?"?\ R*NC?]>4/_HM:UJ!!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q'Q4_X]?#
M/_8PV'_HT5V]<1\5/^/7PS_V,-A_Z-% T=O1110(**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "O,OB-_R-%O_P!>J_\ H;5Z;7F7
MQ&_Y&BW_ .O5?_0VH*B9,?2GTR/I3Z0PHHHI@%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4UJ=36H JWW_ "+?BW_L"77_ *"*]ATG_D%6
M7_7%/_017CU[_P BUXM_[ EU_P"@BO8=)_Y!5E_UQ3_T$4$LMT444""BBB@
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M15'^WM-_Z"-K_P!_U_QH_MS3?^@A:_\ ?Y?\:+,+EZBJ/]N:;_T$+7_O\O\
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MCR(!GK[&NN_M>Q_Y_;?_ +^K_C2 MT53_MBP_P"?VW_[^K_C1_;%A_S^V_\
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M@"U157^U++_G\M_^_J_XT?VI9?\ /W!_W]7_ !H M455_M2R_P"?N#_OZO\
MC1_:EE_S]P?]_5_QHLP+5%5?[4LO^?N#_OZO^-']J6?_ #]P?]_%_P :-0+5
M%5?[4L_^?N#_ +^+_C1_:EG_ ,_<'_?Q?\: +5%5?[4L_P#G[@_[^+_C1_:=
MG_S]P?\ ?Q?\:0%JBJW]IV?_ #]P?]_%_P :/[3L_P#G[@_[^+_C3 LT56_M
M*T_Y^H?^_@_QH_M*S_Y^H/\ OX/\:0%FBJW]I6G_ #]0_P#?P?XT?VE:?\_4
M/_?P?XTP+-<1\5/^/7PS_P!C#8?^C177?VE:?\_4/_?P?XUQ_P 3+JWFM?#F
MVXB.W7K%CAQT$M(9W-%5_P"T+4=;F$?]M!_C2?VE:?\ /U#_ -_!_C0(LT56
M_M*T_P"?J'_OX/\ &C^TK3_GZA_[^#_&@"S15;^TK3_GZA_[^#_&C^TK3_GZ
MA_[^#_&@"S15;^TK3_GZA_[^#_&C^T;3_GZA_P"_@_QH LT56_M*T_Y^H?\
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MX4 +D49%)_9^H_\ /A<_]^6_PH_L_4?^?"Y_[\M_A0 N11D4G]GZC_SX7/\
MWY;_  H_L_4?^?"Y_P"_+?X4 +D4UFI?[/U'_H'W/_?EO\*:VGZB?^8?=?\
M?EO\* *UZ?\ BFO%O_8$NO\ T$5[%I/_ ""K+_KBG_H(KQW4K.[M?"OBZ2>U
MF@C_ +$NANDC*C.WIS7L6D?\@FR_ZX)_Z"*!,MT444$A1110 4444 %%%% '
M%?&GX<R_%[X4^*/!4>L2Z"NO6,FGS7\$0D>.&0;90%) )9"R^V[-9GQ:^!>A
M?%?X4GP-*[Z-;VRV\FEWMBJB33;BW*M;S1 \91E7CH1D=#7I%%.[0CR+X:_
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M-I>/^8>O_HPUTEK:+YR\=ZQ4_P"1TE_[!Z_^C#71VO\ KEJ%LRF?GA_P4 A
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MN!Q5JD7[HI 5Q:KGI1]E6K(ZT4("M]E'I2BU7/2K%"]:8R#[*OI0+5?2K-%
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M]J)#^)'V[-]XU'4MPNV0CWJ*O(1:"E6DI5IL&.HHHJ20HHHH*"BBB@84444
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M^N$?_H(KCOB1_P DU\6_]@FY_P#0#78Z+_R![#_KA'_Z"* Z%VBBB@04444
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M?\*UB_Z"$O\ WP*/^%:Q?]!"7_O@4N>/<7+(Y?SAZT><OK74?\*UB_Z"$O\
MWP*/^%:Q?]!"7_O@4<\>X<LNQS'G#UIRS#UKIO\ A6T7_00F_P"^!2CX;Q#_
M )?Y?^^!1SQ[CY6<$DP_X3649_YAZ_\ HPUM&89IB>#8O^%I36/VR3']C)-N
MVC/^O9<?I74'X=Q'_E_E_P"^14J<>XW%G/7VCV?B[P[JV@7Y?[#JMG-8W'EM
MAO+E0HV#V.&-?F#^RS\-])^#W_!3Z]\&:)+<3:3H_P#:%M;O=N'E*_8V;YB
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M]\"C_A7<7_/])_WP*.>(<K.:\X9ZTOFCUKI/^%=Q?\_TG_? I?\ A7L7_/\
M2_\ ?(HYXA9G-K*,]:7S1ZUT?_"O8O\ G^D_[Y%+_P *]C_Y_I?^^11SQ"S.
M;\T>M'FCUKI/^%>Q?\_TG_? H_X5[%_S^R?]\"CFB/E9S?FCUIRS#UKHO^%>
MQ_\ /])_WP*5?A_&/^7Z3_O@4N:(69SOFCUI\<@S70?\(#'_ ,_LG_?(IR^
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MS#\P4>9P*W?^$+C_ .?N3_OD4?\ "%Q_\_<G_?(I<R%8PO,%*L@K<_X0N/\
MY^Y/^^11_P (;'_S]/\ ]\BCF0&+Y@I/,%;G_"&I_P _3_\ ?(H_X0U/^?I_
M^^13YD48OF"D\P5N?\(>G_/V_P#WR*3_ (0U/^?M_P#OD5-T!B^8*/,%;?\
MPAZ?\_;_ /?(H_X0]/\ G[?_ +Y%.Z Q XK$\:./L^B_]A6U_P#0Z[;_ (0]
M/^?I_P#OD5S'Q"\/):VN@?Z0QWZW9I]T=Y,4FU8#1DD&XTSS!6XWA-&/_'R_
M_?(IG_"'I_S]/_WR*.9 8WF"CS!ZUL_\(>G_ #]/_P!\BC_A#T_Y^G_[Y%%T
M!C[Q1O%;/_"(I_S]/_WR*/\ A$4_Y^G_ .^13N@,;>*=Y@K7_P"$13_GZ?\
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M/^N$?_H(KE/BG9"T^%_BUPY;_B57 Y'_ $S-=7HO_(&L/^O>/_T$4"+M%%%
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M$NV)7FF9G*HI(5<X&3Q7=444-MZL>QQ?Q4_Y NC_ /8<TW_TJCKM*XOXJ_\
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M!5O_ (T?\/NO /\ T3CQ'_X%6_\ C1[-^7WH#]):*_-K_A]UX!_Z)QXC_P#
MJW_QH_X?=> ?^B<>(_\ P*M_\:/9OR^] ?I+17YM?\/NO /_ $3CQ'_X%6_^
M-'_#[KP#_P!$X\1_^!5O_C1[-^7WH#]):*_-K_A]UX!_Z)QXC_\  JW_ ,:<
M/^"VW@-NGPX\1'_M[M_\:J-&<OA5_N"Y^D=%>9?LW_'33OVDO@]HGQ!TK3;K
M2++5&G1+.\96DC,4SQ')7@Y,9/XUZ;64DXNS&%%%%( HHHH XOX<G.H>-O\
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M==I0/H%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"CHZTIXBMSQO-[]V)Q5MCE/^"6//[#_@$_]-M2_P#2^XKZRKY+_P""5O\
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MV]%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT"BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M<''_ ,ESG_[%V/\ ]*6KO*X./_DN<_\ V+L?_I2U=Y0 4444 %%%% !1110
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MK)\)_P#(JZ-_UY0_^BUK6H$%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7$?%3_CU\,_]C#8?^C17;UQ'Q4_X]?#/_8PV'_HT4#1
MV]%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA?\ A8=U_P ^$?\ W\/^%'_"P[K_ )\(_P#OX?\ "CV<@YD=U17#?\+"N_\
MH'Q_]_#_ (4?\+"N_P#H'Q_]_#_A1[.0<R.YHKAO^%A7?_0/C_[^'_"C_A85
MW_T#X_\ OX?\*/9R#F1W-%<-_P +"N_^@?'_ -_#_A2_\+"NO^?"/_OX?\*/
M9R#F1W%%</\ \+!NO^@?'_W\/^%+_P + NO^?"/_ +^'_"CV<@YD=O17$?\
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M  H_X3"X_P"?1/\ OH_X4^5C.JHKE_\ A+Y_^?5?^^C_ (4G_"83_P#/HO\
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M?\@O2/\ L-Z=_P"E,=<[X^4-XG;C_EDG]:Z+XE?\@O2/^PWIW_I3'7/^._\
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M'_7"/_T$5QWQ(_Y)KXM_[!-S_P"@&NQT7_D#V'_7"/\ ]!% %VBBB@04444
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MIU-6G5U'.*M+2+2TNH!1113 *?3*?292"BBBI&%%%% "KUIU-7K3J "BBB@
MHHHH **** '4JTE*M &2G_(Z2_\ 8/7_ -&&MIJQ4_Y'27_L'K_Z,-;34HE2
M&T444R0HHHH*04JTE*M#!CJ***DD****"@HHHH&%%%%  O6G4U>M.H ****
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MO27_ - -:-9WBS_D4]9_Z])?_0#2>PUN7-'_ .0-8?\ 7O'_ .@BK%5]'_Y
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M/[)FECX4^%+\+=>-5VRS6:*PVW)@9/G* K*RH69%Y^ON'[7OP7_:8\8S>*_
MGPU/AN]^&OCN\6>^OKN7[/?Z7N2-9T=BV&@8QY^1)'P[# XJ?Q/\&_B#\"?V
M:[#X#_"?X9ZGXKL[^V$'B#Q<NIZ?;JRW##[:T$<TZNTI0NB;U55&SEL5NK*W
M^9#U/N:BD7[H[4M8%A1110 4444 <E\2O^07I'_8;T[_ -*8ZY_QW_R,S?\
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M )]Y?^^#7I5%'.%CS;;<?\^\O_?!_P *3;<_\^\O_?!_PKTJBCG%8\UVW/\
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M%',!P>V;_GC)_P!\FEVS_P#/"3_O@UW=%',!PFV?_GA)_P!\&C;/_P \)/\
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MBBB@04444 %%%% !1110 4444 %%%% '%_%7_D"Z/_V'--_]*HZ[2N+^*O\
MR!='_P"PYIO_ *51UVE ^@4444""BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#@X_^2YS_P#8NQ_^E+5WE<''_P ESG_[%V/_ -*6
MKO* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH XKX<?\A#QM_V'Y?\ TG@KM:XKX<?\A#QM_P!A^7_TG@KM: "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "OEK_@I]_R8O\ $[_<T_\
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M*G_'KX9_[&&P_P#1HKMZXCXJ?\>OAG_L8;#_ -&B@:.WHHHH$%%%% !1110
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M_P!T4>R7<?.^Q[%_:%K_ ,_,/_?P4?VA:_\ /S#_ -_!7CO]FQ_W11_9L?\
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M$7_?8KR?[ G]W]*/L"?W1^5+V:[ASGK'VZV_Y^(O^^Q1]NMO^?B+_OL5Y/\
M8$_NC\J7[!'_ '1^5'LUW'S'J_VZV_Y^(O\ OL4?;K;_ )^(O^^Q7E'V"/\
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M_P!]BN<^)$\,WP\\3HLL9+:9<@88?\\FKF_LJ^E9WBRU7_A$M9&/^7.7_P!
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M .BM^#?_  <0_P#Q5>7]7K?R/[F7S(^@/M4/_/6/_OH4?:H?^>L?_?0KY_\
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MLY&0,BKW_!(6,-^R_KY_ZF2X_P#1$%?2_P"T<Y/[,_Q4S_T+&H_^D[U\T_\
M!(/_ )-?U_\ [&6?_P!$05WO$5L1EU3VTG*TEN+E49JQ]C2?>-,J2;[U,KPN
MAJQ*7M24O\(J21*5:2E6FACJ,445104445 !1110 HZUA^,_^/?1?^PK;?\
MH=;B]:P_&?\ Q[Z+_P!A6V_]#I/8#H7^\:93V^]3*H HHHI %%%% !3J;3J
M"BBBD@"BBBF 4J]Z2G+0P%HHHJ0"BBBJ ****& ^BBBI =']ZN<M?^2G:C_V
M"8?_ $;)71Q]:YRU_P"2G:C_ -@F#_T;)2 Z-^M-IS]:;3 *5:2E6@!:***
M"G+3:<M+J M%%%, HHHH *5>M)2KUH =1110 @[TM(.]+4H HHHJ@"BBBH D
MBZBN:\"_\S-_V&[C^25TL-<UX%_YF7_L-W'\DH Z1NM-/WA3FZTT_>%4 M%%
M%2 4444 %.6FTY: %HHHH ****"PHHHH('T444 %%%%!2"BBB@!5I:1:6@3.
M?^)'_)-?%O\ V";G_P! -=CHO_('L/\ KA'_ .@BN.^)'_)-?%O_ &";G_T
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MT?\ Y(/:P[GZ-"V;TK$\9VS_ &?1N/\ F*VW_H5? /\ P^P@_P"B+'_PJ/\
M[CJEJ_\ P6<AU:.S4_!KROL]U'<_\C-G=L.<?\>G>C^P<R:TI?\ DT?_ )(/
M:P[GZ5M;ON/%,^S-Z5^<S?\ !;*'_HBW_ES_ /W'3?\ A]E#_P!$6/\ X4__
M -QT/(LR_P"??_DT?_D@]K#N?HW]E;^[1]E;^[7YR?\ #[&'_HBQ_P#"G_\
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M*C\X4>:/6D,E6EJ%9A2F84$DU)4?FCUI?-%(H?13/.%'G"@!]+4?G"E\P9H
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MU_4C>37,\3E0NV/;CCZBJ/Q4_P"0+H__ &'--_\ 2J.NTHC)Q=T-I-:G&?\
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MKI**.9A9'-_\(/:_\_,__CO^%'_"#VO_ #\S_P#CO^%=)11S,+'.?\(3:_\
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MTH_L>/\ YZ/^E:%% CB/BI9+:_"_Q:RLS'^RK@<_]<S75:+_ ,@:P_Z]X_\
MT$5SOQ@_Y)7XN_[!=Q_Z+:NAT/\ Y NG_P#7O'_Z"*!]"]1110(**** "BBB
M@ HHHH **** "BBB@#B_BK_R!='_ .PYIO\ Z51UVE<7\5?^0+H__8<TW_TJ
MCKM*!] HHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% '!Q_P#)<Y_^Q=C_ /2EJ[RN#C_Y+G/_ -B['_Z4M7>4 %%%% !1110
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M_P"%VSOV_P"$>0?^3+UW% PHHHH$%%%% !1110 4444 %%%% !1110 4444
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M9FV@=!GC QC JTTB6KGSYX@M[O4O^"F/A673W+V^F?#ZY.J>6W$:R71$2O\
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M_G^N/^_K?XU)M%&T50AOVN__ .?ZY_[^M_C1]KO_ /G^N?\ OZW^-2[11M%
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M_&G[12J!FF,;]HO?^?R?_OX?\:07-[_S]S_]_#_C4NT48I#(_M%[_P _<_\
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M%G@__P $EM_\17JX?%8>&&>&KP<O>YM';I8R<7S<R9\OG_@L=\'O^A?\9?\
M?B#_ ./4W_A\=\'O^A?\9?\ ?B#_ ./5]1_\,[_!O_HEG@__ ,$EM_\ $4A_
M9W^#?_1+/!__ ()+;_XBI]I@/^?<OO':?<^7_P#A\?\ ![_H7O&7_?B#_P"/
M4?\ #X_X/?\ 0O>,O^_$'_QZOJ/_ (9U^#G_ $2SP?\ ^"2V_P#B*/\ AG;X
M-_\ 1+?!_P#X)+;_ .(I>TR__GW+[PM/N?+H_P""Q_P>_P"A>\9?]^(/_CU9
M,/\ P5V^$,?C"ZU4^'O%WDRV4=L/W$&[<KNW_/;I\U?7*_LZ_!P_\TM\'_\
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M^B6>#_\ P1VW_P 11[3 ?\^Y?>.T^Y\N_P##Y'X._P#0N^,?_ >#_P"/4?\
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M_@CMO_B*/^&;_@U_T2WPA_X([;_XBCVF _Y]R^\5I=SY;_X?*?!S_H7/&/\
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MI\'/^A=\8?\ @/!_\>H_X?*?!S_H7/&/_@/!_P#'J^I?^&;_ (-_]$M\'_\
M@CMO_B*7_AF_X-_]$M\'_P#@CMO_ (BE[3 ?\^Y?>%I]SY9_X?*?!S_H7/&'
M_@/!_P#'J7_A\G\'/^A=\8_^ \'_ ,>KZE_X9N^#7_1+?!__ (([;_XBK$/[
M,_P>=<K\+_!__@CMO_B*:J8#K3E]X6GW//OV8_VU/!G[6VH>(;'PC8:YIL^B
MPQ3S_P!J1H@=9"P&W8[=U/7%>W.TZL1YTG7^\:_.'_@DO:V]C\>OC_;6D*6]
MK#-'%##&,*B"ZN J@=@  /PK]);E?WC?6HS"A##8B5*GMI^0X2<HW95\Z?\
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MZ2_^@&M&L[Q9_P BGK/_ %Z2_P#H!I/8:W+FC_\ (&L/^O>/_P!!%6*KZ/\
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MCX"^%^JSC7=0E$T\^C/=PRQK/(\;1L"!@[SSWS7IG_#4'[>__1++G_PEI/\
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M74_^?RV_\>_PI?\ A6^I?\_EO_X]_A73S1[F/*^QAI(.>:=Y@K;7X;ZDN?\
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M/?X4?\('?_\ /U!_X]_A1S1[E69C^8*/,%;'_"!W_P#S]0?^/?X4?\('?_\
M/U!_X]_A1S1[A9F/O'K2[A6O_P ('?\ _/U;_P#CW^%+_P ('J'_ #]0?^/?
MX4N:/<+,R XS2^8*UQX$O_\ GZ@_\>_PI?\ A!;_ /Y^H/\ Q[_"GS1[A9F/
MY@H\P5L?\(+?_P#/U!_X]_A1_P (+?\ _/U!_P"/?X4N:/<+,Q_,%*L@K7_X
M06__ .?J#_Q[_"A? U\O_+S!_P"/?X4<R[CLS*\P4]&&:U/^$'O_ /GY@_\
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M'_Q[_"C_ (0N]_Y^8?\ Q[_"E==QZF7NHW"M3_A"[W_GYA_\>_PI?^$+O?\
MGXA_\>_PHNNX:F5NHW#-:O\ PA=[_P _$/\ X]_A2_\ "&WO_/Q#^O\ A1=#
M,S<*-PK3_P"$-O?^?B'_ ,>_PH_X0V]_Y^(?_'O\*+KN+4R]PI=PK3_X0V]_
MY^(?U_PI?^$-O/\ GXA_7_"BZ[@9>X5F^*V'_")ZQ_UYR_\ H!KIO^$-O/\
MGXA_7_"LCQKX7NK7P7KTIGB(CL)W.,]HR:3:L4MQFCM_Q);#_KWC_P#015C<
M*LZ%X6NIM!TUA/%AK:(]_P"X*M_\(?>?\_$/Z_X4)H1E[A1N%:G_  A]Y_S\
M0_K_ (4?\(?>?\]X?U_PIW0M3+W"A6&T5J?\(?>?\_$/Z_X4G_"'WG_/Q#^O
M^%3=#,T-S2;A6H/!]Y_SWA_7_"C_ (0^\_Y^(?U_PIW0&7N%*K#-:?\ PA]Y
M_P _$/Z_X4#PA>?\_$/Z_P"%/F0&=N%)NK3_ .$1N_\ GO#^O^%'_"(WG_/Q
M#^O^%*Z&9NX4;N*TO^$1N_\ GO#^O^%+_P (C=_\]X?U_P *5T(S-PI585H_
M\(C=_P#/>']?\*4>$KO_ )[P_K_A3N@,_<*3=6E_PB=W_P ]X?U_PH_X1.[_
M .>\/Z_X4^9%&=NHW"M/_A%+K_GO%^M)_P (G=?\]XOU_P *BZ S=U&ZM/\
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MWKG_ 'ZM/_C-=I10!Q?_  @>L_\ 0]ZY_P!^K3_XS1_P@>L_]#WKG_?JT_\
MC-=I10!Q?_"!ZS_T/>N?]^K3_P",T?\ "!ZS_P!#WKG_ 'ZM/_C-=I10!Q?_
M  @>L_\ 0]ZY_P!^K3_XS2CP)K/_ $/6N'_ME:?_ !FNSHH X,?"^\&KMJ@\
M9:W]O: 6QFV6V?+#%@N/)QU)/3-63X$UC_H>]<'_ &RM/_C-=G10%SB_^$#U
MG_H>]<_[]6G_ ,9H_P"$#UG_ *'O7/\ OU:?_&:[2B@#B_\ A ]9_P"A[US_
M +]6G_QFC_A ]9_Z'O7/^_5I_P#&:[2B@#B_^$#UG_H>]<_[]6G_ ,9H_P"$
M#UG_ *'O7/\ OU:?_&:[2B@#B_\ A ]9_P"A[US_ +]6G_QFC_A ]9_Z'O7/
M^_5I_P#&:[2B@#B_^$#UG_H>]<_[]6G_ ,9H_P"$#UG_ *'O7/\ OU:?_&:[
M2B@#B_\ A ]9_P"A[US_ +]6G_QFC_A ]9_Z'O7/^_5I_P#&:[2B@#B_^$#U
MG_H>]<_[]6G_ ,9H_P"$#UG_ *'O7/\ OU:?_&:[2B@#B_\ A ]9_P"A[US_
M +]6G_QFC_A ]9_Z'O7/^_5I_P#&:[2B@#B_^$#UG_H>]<_[]6G_ ,9H_P"$
M#UG_ *'O7/\ OU:?_&:[2B@#B_\ A ]9_P"A[US_ +]6G_QFC_A ]9_Z'O7?
M^_5I_P#&:[2B@#B_^$#UG_H>]=_[]6G_ ,9I5\":P/\ F>M</_;*T_\ C-=G
M10!P=C\,;W39+M[;QGKD37<QN)B$M3OD*A2W,/'"J...*L?\('K/_0]ZY_WZ
MM/\ XS7:44 <7_P@>L_]#WKO_?JT_P#C-'_"!ZS_ -#WKO\ WZM/_C-=I10!
MQ?\ P@>L_P#0]Z[_ -^K3_XS1_P@>L_]#WKO_?JT_P#C-=I10%SB_P#A ]9_
MZ'O7?^_5I_\ &:/^$#UG_H?-=_[]6G_QFNTHH"YQ?_"!ZS_T/FN_]^K3_P",
MT?\ "!ZS_P!#YKO_ 'ZM/_C-=I10%SB_^$#UG_H?-=_[]6G_ ,9H_P"$#UG_
M *'S7?\ OU:?_&:[2B@+G%_\('K/_0^:[_WZM/\ XS1_P@>L_P#0^:[_ -^K
M3_XS7:44!<XO_A ]9_Z'S7?^_5I_\9H_X0/6?^A\UW_OU:?_ !FNTHH"YQ?_
M  @>L_\ 0^:[_P!^K3_XS1_P@>L_]#YKO_?JT_\ C-=I10%SB_\ A ]9_P"A
M\UW_ +]6G_QFC_A ]9_Z'S7?^_5I_P#&:[2B@+G%_P#"!ZS_ -#YKO\ WZM/
M_C-'_"!ZS_T/FN_]^K3_ .,UVE% 7.+_ .$#UG_H?-=_[]6G_P 9J&^^&VHZ
MI87-E=^-M<FMKB-H98REJ-RL,$9$.>0:[JB@+G$V_P /=4M;>*"'QQKD<42!
M$7R[4X4# ',/I3O^$#UG_H?-=_[]6G_QFNTHH"YQ?_"!ZS_T/FN_]^K3_P",
MT?\ "!ZS_P!#YKO_ 'ZM/_C-=I10%SB_^$#UG_H?-=_[]6G_ ,9H_P"$#UG_
M *'S7?\ OU:?_&:[2B@+G%_\('K/_0^:[_WZM/\ XS1_P@>L_P#0^:[_ -^K
M3_XS7:44!<XO_A ]9_Z'S7?^_5I_\9H_X0/6?^A\UW_OU:?_ !FNTHH"YQ?_
M  @>L_\ 0^:[_P!^K3_XS1_P@>L_]#YKO_?JT_\ C-=I10%SB_\ A ]9_P"A
M\UW_ +]6G_QFC_A ]9_Z'S7?^_5I_P#&:[2B@+G%_P#"!ZS_ -#YKO\ WZM/
M_C-'_"!ZS_T/FN_]^K3_ .,UVE% 7.+_ .$#UG_H?-=_[]6G_P 9H_X0+6?^
MA\UW_OU:?_&:[2B@+G%?\(%K/_0^:[_WZM/_ (S1_P (%K/_ $/FN_\ ?JT_
M^,UVM% 7.*_X0+6?^A\UW_OU:?\ QFC_ (0+6?\ H?-=_P"_5I_\9KM:* N<
M7_P@>L_]#YKO_?JT_P#C-5M0^%][JR6ZW?C37)A;SI<QY2U&V1#E6XA['\*[
MVB@+G&-X$UANGCO71_VRM/\ XS3?^$"UG_H?-=_[]6G_ ,9KM:* N<5_P@6L
M_P#0^:[_ -^K3_XS1_P@6L_]#YKO_?JT_P#C-=K10%SBO^$"UG_H?-=_[]6G
M_P 9H_X0+6?^A\UW_OU:?_&:[6B@+G%?\(%K/_0^:[_WZM/_ (S1_P (%K/_
M $/FN_\ ?JT_^,UVM% 7.*_X0+6?^A\UW_OU:?\ QFC_ (0+6?\ H?-=_P"_
M5I_\9KM:* N<5_P@6L_]#YKO_?JT_P#C-'_"!:S_ -#YKO\ WZM/_C-=K10%
MSBO^$"UG_H?-=_[]6G_QFC_A M9_Z'S7?^_5I_\ &:[6B@+G%?\ "!:S_P!#
MYKO_ 'ZM/_C-'_"!:S_T/FN_]^K3_P",UVM% 7.*_P"$"UG_ *'S7?\ OU:?
M_&:/^$"UG_H?-=_[]6G_ ,9KM:* N<5_P@6L_P#0^:[_ -^K3_XS1_P@.L_]
M#YKW_?NT_P#C-=K10%SBO^$!UG_H?->_[]VG_P 9H_X0'6?^A\U[_OW:?_&:
M[6B@+G%CP'K(_P"9\UT_]L[3_P",U57X6WD>K2ZHOC/7!?RPK;O-LMN8U8L%
MQY.."Q[=Z[ZB@+G%GP'K/_0^:[_WZM/_ (S2?\(#K/\ T/FO?]^[3_XS7:T4
M!<XK_A =9_Z'S7O^_=I_\9H_X0'6?^A\U[_OW:?_ !FNUHH"YQ7_  @.L_\
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M7_" ZS_T/NO?]^[3_P",T?\ " ZS_P!#[KW_ '[M/_C-=K10!Q7_  @.L_\
M0^Z]_P!^[3_XS1_P@.L_]#[KW_?NT_\ C-=K10!Q7_" ZS_T/NO?]^[3_P",
MT?\ " ZS_P!#[KW_ '[M/_C-=K10!Q7_  @.L_\ 0^Z]_P!^[3_XS1_P@.L_
M]#[KW_?NT_\ C-=K10!Q7_" ZS_T/NO?]^[3_P",T?\ " ZS_P!#[KW_ '[M
M/_C-=K10!Q7_  @.L_\ 0^Z]_P!^[3_XS1_P@.L_]#[KW_?NT_\ C-=K10!Q
M7_" ZS_T/NO?]^[3_P",T?\ " ZS_P!#[KW_ '[M/_C-=K10!QD?@/6%;)\=
MZXWUBM/_ (S7C'[1'["?A_\ :8USPOJWBKQQXJAO/#@?["U@UI'L9W1RQ_<'
MG,:_E7TU151DX2YH[B>IR-QX+U:8Y7QKK47^[%:__&:@_P"$!UG_ *'W7O\
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M;GO6K^$CJ>VT445D6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
? **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>figure18_01.jpg
<TEXT>
begin 644 figure18_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +(!98# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_A3_ .W1_P!%J\!?^"T__(M?<-%'M5_(@MYGP]_PI_\ ;H_Z+5X"_P#!:?\
MY%I?^%/_ +<__1:_ ?\ X+3_ /(M?<%%+VJ_D06\SX?'P@_;G[_&OP'_ ."P
M_P#R+69'\/\ ]N*3Q1-HO_"YO 8>.T6[\W^SCR&<KC'V7V-?>=<):RG_ (7=
MJ,?8:# W_D>2CVO]U!;S/EK_ (4_^W/V^-?@/_P6G_Y%H_X4_P#MT?\ 1:_
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M '[M?_C-0WW@G6K.PN9U\=:XS11,X#1VN,@$_P#/&N]JCKG_ "!=0_Z]Y/\
MT$UD,X+PGX9UWQ#X5T?5)O'&M1S7MG#<.L<=MM#.@8@9BZ<UJ?\ "O\ 6?\
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M8KSWXJ?\?>B?6;^24#1A+JVH,/\ D8-=_P"^K7_XQ2_VM?\ _0P:[_WU:_\
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M** "BBB@ HHHH **** "BBB@ HHHH **** . \5?\E?\"_\ 7MJ/_H$5=_7
M>*O^2O\ @7_KVU'_ - BKOZ!A1110(**** "BBB@ HHHH **** "BBB@ HHH
MH **** (;S_CTG_W&_E7)_!S_DE?A;_L'Q?^@UUEY_QZ3_[C?RKD_@Y_R2OP
MM_V#XO\ T&@?0[*BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %>>
M_%3_ (^]$^LW\DKT*O/?BI_Q]Z)]9OY)0-;G.Q?=%25'#]VI*"@HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *2EI* (H_P#C]MO^NJ?^A5VWPX^[XF_[#MW_ #6N)C_X_;;_ *ZI_P"A
M5VWPX^[XF_[#MW_-:0/8["BBBF0%%%% !1110 4444 %%%% !1110!P&B_\
M);_$_P#V!K#_ -&3UW]<!HO_ "6_Q/\ ]@:P_P#1D]=_0,****!!1110 444
M4 %%%% !1110 4444 ?"7[&7_)W/QA^NH?\ I>M?=M?"7[&7_)W/QA^NH?\
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M_$7QA\"?'_[06B^,+W3%\+ZQ>"V\!SVMK_9[V-I,$>&Y)C,XFDC#,664;6(
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M7 6?_)=M3_[%^#_THDKOZX&S'_%]-2/_ %+\'_I1)0,[ZBBB@04444 %%%%
M!1110 4444 %%%% !7P+_P %I/\ DUGPS_V.-K_Z17M??5? O_!:/_DUGPS_
M -CC:_\ I%>UV83^,OG^3)EL?5'[*O\ R:_\'_\ L3M'_P#2*&O4J\M_95_Y
M-?\ @_\ ]B=H_P#Z10UZE65?^+/U?YCCL@JCKG_($U#_ *]Y/_035ZJ.N?\
M(%U#_KWD_P#036 S&^&'_)-_"O\ V"[;_P!%+73US/PQ_P"2;^%?^P7;?^BE
MKIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X#Q5_R5_P+_U[
M:C_Z!%7?UP'BK_DKW@4_].VH_P#H$5=_0,****!!1110 4444 %%%% !1110
M 4444 %%%% !1110!#>?\>D_^XW\JY/X.?\ )*_"W_8/B_\ 0:ZR\_X])_\
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MR%XZ^E>C:Q^S_P#!OP3I?B_QIKG@G1=5N9!<:SJFH:M;I=R2, TC8:7.T#D
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M[XF_[#MW_-:XF/\ X_;;_KJG_H5=M\./N^)O^P[=_P UI ]CL****9 4444
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MUR%E]P?2NOL/^2O>*?\ L#6?_H<]<A9?<'TKIH[,QJ;HN4M%%;F0X=****E
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MYFIKY>T[N='Z8Y_@K'^S+_\ ,13_ / O^ 5S^3/T&\+Z7)_PC&DC;_RZQ_\
MH(K0_LR3TK\X],TK_@H8VEVAM-246OE+Y0)T?[N..J^E6/[)_P""BG_033\]
M'_\ B*7]EV_YB*?_ (%_P!\_DS]%5TV3^[2_V;)_=K\Z?[)_X**?]!-?^^M'
M_P#B:7^R?^"BO_037_OK1_\ XFC^S/\ J(I_^!?\ GF\F?HM_9LGI1_9LGI7
MYT_V3_P45_Z":?\ ?6C_ /Q%']D_\%%?^@FO_?6C_P#Q-+^S/^HBG_X%_P
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MH,EG<*"%D4'KP64CN&([UEI?0M7:LSJOV?+&VTWX#_#BWLX8[>W7P]8%8XU
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M7Q3H'Q[_ &H_V*_B!H&E_&+[9XI\$ZK=1V[SWDRW: ,V&:*Z4%@ZCGRW/('
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M_H*UOR=36!K'_(\>&_\ KC=?^@K6_)U-);L?88WW32TC?=-+0(%ZT4+UHIH
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M]('--HI@2><?6D\X^M,HH D\X^M-:0FFT4 /60K3FN&/>HJ* '>8:/,--HH
MD\X^M(92>],HH 7<:D6=AWJ*B@";[2WK2?:&]:BHI 2&8GO49;-%%, HHHH
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M>'_$GXS?%+X.WNA2:YX"T;7M U/4K/39=8T74Y$^PO/,D0:6&2,DKE^&#<G
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MQ-_V';O^:UQ,?_'[;?\ 75/_ $*NV^''W?$W_8=N_P":T@>QV%%%%,@****
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M0>!VKZA^"WA?2;[X+^ 9?LQ*R:!8./G;O;1GUKQ;_@I;_P D1\/_ /8Q0_\
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MX'_OL_XT?\(OIW_/ _\ ?9_QK5HHNP,K_A%]._YX'_OL_P"-'_",Z=_SP/\
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MP"",AN>/4O#/PW,/Q/N?BAXONK&?Q0NE_P!DVRV:E+;3[3?YD@#-S(S.,EV
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M&V!K.LO[KI$N*^KKX+$XK X5T*;E92O97^TSFC.,9R39]B45\<?\/8OV??\
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M_"&I:A-K36\ETL-Y8/ K(F-V&/&1GI7T+7!6H5<-/V=:+B^ST+4E+5!1116
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MB2^$?_!3#_\ $T?\,:_ O_HDOA'_ ,%,/_Q->R44?6L1_P _'][#ECV/&_\
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MNV_]%+73US'PP_Y)OX5_[!=M_P"BEKIZ "BBB@ HHHH **** "ORH_X)B_\
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M"3OJ=$_6FT,<T5F:!1110 4444 %%%% !1110 4444 %%%% !1110 4E+24
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M?]_E_P :/[:T_P#Y_K;_ +_+_C19A<NT52_MK3_^?ZV_[_+_ (T?VUI__/\
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M_?Q?\:7^TK3_ )^H?^_@_P :[,/B)8=225[_ )$M7/S!;_@H%^U[V_9[F_\
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M'_OX/\:0%FBJW]I6G_/U#_W\'^-']I6G_/U#_P!_!_C0!9HJM_:5I_S]0_\
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MM?\ GYA_[[% %BBJ_P#:%K_S\P_]]BE^W6W_ #\1?]]B@">BH/MUM_S\1?\
M?8H^W6W_ #\1?]]B@">BH/MUM_S\1?\ ?8H^W6W_ #\1?]]B@">BH/MUM_S\
M1?\ ?8H^W6W_ #\1?]]B@">O/?BI_P ?>B?6;^25W?VZW_Y[Q?\ ?8K@_BA(
MDUWHNQU?_7?=.>R4#6YST/W:DJ.+[M24%!1110 4444 %%%% !G%.\PTVB@!
MWF&C>:;10 NXTOF&FT4 .\PT>8:;10 [S#1YAIM% "ER:3)HHH 7<:-QI**
M%W&C<:2B@ R:=YAIM% "[C1N-)10 NXT;C244 &32AB*2B@!WF&CS#3:* ';
MS3<T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+24 11_\
M?MM_UU3_ -"KMOAQ]WQ-_P!AV[_FM<3'_P ?MM_UU3_T*NV^''W?$W_8=N_Y
MK2!['84444R HHHH **** "BBB@#AM5^&*:W\8M!\<7UZEQ#H6EW-EI^FM;@
M^1<7#IYET)"<[O*C\H  85WY.ZN-^(7[/^KZG\2[_P ?> _&'_"%>)M6T?\
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M !3J;3J "BBBD@"BBBF 4Y:;3EH8#E^]6!XR_P"/O2O]V;_V2M]?O5@>,O\
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M%K_Z.CKUQ.M>1_MR?\F9_%/_ +!:_P#HZ.NC"_[U2_Q1_-"E\+.2_P""9?\
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M:#JMC+;V36>I:3X@TF:VRKLX*D2H%<$'^$GK7K".5^M/:9CW-7TL8];GQ=\
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M_94?\*Y;_H)'_OS_ /94<\>X<K.=\T4><*Z+_A7+?]!(_P#?G_[*C_A7+?\
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M!6__ ,*];_H(_P#D'_Z]'_"O6_Z"/_D'_P"O1S1[CLS \T4Y91BMW_A7K?\
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M(),>7G&8U..OO6Q_P@;?\_Y_[]?_ %Z2E&VX[,PUD%*9!ZUN?\(&W_/_ /\
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M)/\ S^_^0_\ Z]'_  A)_P"?W_R'_P#7HYD!D>8*-XK8_P"$+;_G]_\ (?\
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M%7;?#C[OB;_L.W?\UI ]CL****9 445SWQ \53^!_!NJ:];Z'J/B26QC$O\
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M<DUL444AG :+_P EN\3_ /8'L/\ T9/7?UP&B_\ );_$_P#V!K#_ -&3UW]
MPHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% ''_%Z0P_#7Q XZBV/
M\Q6AX[;;X!\0MZ:9<'_R$U9GQE_Y)?XC_P"O4_S%:7C[_DG_ (C_ .P7<_\
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M',NY]_45^?\ _P /H_@U_P!"KXV_\!+3_P"2:/\ A]'\&O\ H5?&W_@):?\
MR36?U>K_ "L+H_0"BOS_ /\ A]'\&O\ H5?&W_@):?\ R31_P^C^#7_0J^-O
M_ 2T_P#DFCZO5_E871^@%%?G_P#\/H_@U_T*OC;_ ,!+3_Y)H_X?1_!K_H5?
M&W_@):?_ "31]7J_RL+H_0"BOS__ .'T?P:_Z%7QM_X"6G_R31_P^C^#7_0J
M^-O_  $M/_DFCZO5_E871^@%%?G_ /\ #Z/X-?\ 0J^-O_ 2T_\ DFC_ (?1
M_!K_ *%7QM_X"6G_ ,DT?5ZO\K"Z/T HK\__ /A]'\&O^A5\;?\ @):?_)-'
M_#Z/X-?]"KXV_P# 2T_^2:/J]7^5A='Z 45^?_\ P^C^#7_0J^-O_ 2T_P#D
MFC_A]'\&O^A5\;?^ EI_\DT?5ZO\K"Z/T HK\_\ _A]'\&O^A5\;?^ EI_\
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MO"/_ ();?_XBC_AF?X2?]$R\(_\ @EM__B*]*HHYGW \U_X9G^$G_1,O"/\
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M?_XBO2J*7,^X'FO_  S/\)/^B9>$?_!+;_\ Q%'_  S/\)/^B9>$?_!+;_\
MQ%>E44<S[@>:_P##,_PD_P"B9>$?_!+;_P#Q%'_#,_PD_P"B9>$?_!+;_P#Q
M%>E44<S[@>:_\,S_  D_Z)EX1_\ !+;_ /Q%.7]FOX3+]WX9^$A]-%MO_B*]
M(HHYI+J!^57_  3UTZTT?_@I=\?]/L+:&RL;2'7H(+:W0)'%&NLVZJBJ. H
M  '0"OU5K\L?V!?^4H'[1?T\0?\ IZ@K]3J]/,9.52+?;]61#8****\HL***
M* "BBB@ KSWXJ?\ 'WHGUF_DE>A5Y[\5/^/O1/K-_)*!K<YV'[M25'#]VI*"
M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *2EI* (H_^/VV_ZZI_Z%7;?#C[OB;_ +#MW_-:XF/_ (_;
M;_KJG_H5=M\./N^)O^P[=_S6D#V.PHHHID!7F7[2GQ8U#X&_!'Q/XWTK1O\
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MU/\ Z$*T_'W_ "3_ ,1_]@NY_P#135F?&7_DE_B/_KU/_H0K3\??\D_\1_\
M8+N?_135C6_A2]&=F#_WFE_B7YH^9O\ @FC_ ,D7\1?]C!)_Z36]?75?(O\
MP31_Y(OXB_[&"3_TFMZ^NJ\[*?\ <:7H?;>(/_)4X[_'^B"BBBO7/ST****
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M])K>OKFOS;^&OPW_ &F/A'HMQI/A&XM](TZXN#=20B2RFW2E54MF16(^5%&
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M([*BN._X6,G_ $#Y/^_@_P */^%BI_T#Y/\ OX/\*.20<R.QHKCO^%B)_P!
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M[17YM?8?V]?^AJB_[]:/_P#&J3[#^WKV\51_]^M'_P#C5</]D+_H)I_^!/\
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M_P"M1_PF2_\ /F__ 'V/\*.5@=)17._\)@O_ #Z/_P!]C_"D_P"$Q7_GT?\
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M(#CT_P")S :_3>?Q,D+8^SNW_ A7K9E3<*L8OM^K,X;&U17/_P#"6I_SZO\
M]]"C_A+4_P"?5_\ OH5Y-F:'045S_P#PEJ?\^K_]]"C_ (2U/^?5_P#OH468
M'045S_\ PEJ?\^K_ /?0I1XL4_\ +J__ 'T*+,#?KSWXJ?\ 'WHGUF_DE=(O
MBI3_ ,NS?]]"N0\>:@-9USPU9JAB,[SKO8YQA W_ ++2LQK<QHF^4<U)O%:G
M_"'NO'VQ?^^/_KT?\(B__/XO_?'_ ->BS'=&7O%&\5J?\(D__/XO_?'_ ->C
M_A$G_P"?Q?\ OC_Z]%F%T9>\4;Q6K_PA\G_/ZO\ WQ_]>C_A#Y/^?U?^^/\
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M-XK9_P"$)E_Y_D_[]_\ UZ/^$)E_Y_D_[]__ %Z871C;Q1O%;/\ PA,O_/\
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MJ/M3>M5J*!EG[4WK2K=MGK56E7K0!;^U-ZT?:F_O56HH$6?M3>M'VMO6JU%
MRS]K;UH^UMZU6HH MK=MCK3ENF]:J+3EI"*&H73?\)QX<&?^65U_Z"M?)W[;
M[[_VHO@7G_GZM?\ TNCKZIOO^1Y\.?\ 7*Z_]!6OE3]MS_DZ+X%_]?-K_P"E
MT=>KE/\ O7RE_P"DGE9K_NOSC_Z4C[-U2,>8U4#&/2M+5/OM5"O)/68Q8QGI
M2>4*D7K15(1'Y0I5C&:?0O6F,3RA0(QZ4^BDQL9Y8]*/*%/HI$C/*%*L8IU*
MM-#$\H4>6/2GT4RAOEBCRQZ4ZBH )$'V>;C^ _RK$\!H/^$(T4?].RUNR_\
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M** "F7O_ "#KK_KB_P#Z":?3+W_D'77_ %Q?_P!!-2QHI>%O^17TG_KTB_\
M016A6?X6_P"17TG_ *](O_016A4K88JTM(M+3)84444%!1110 4J]:2E7K0
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M@_\ 3Q!7Z3WB'S#7OYU_O,?\*_4RI[%*BG^6?2D*&O!1J-HHHI@%.6FTY:&
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M\[%W1L)3EIM.7O5,!RUS?B;_ )'#PA_UVN/_ $2:Z1:YOQ-_R.'A#_KM<?\
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M"C[%;_\ /"+_ +X%'M%V#D/*/MZ?WA1]O3^\*]7^Q6__ #PB_P"^!1]BM_\
MGA%_WP*/:+L/E/*EOD]:QHKY/^$ZN!G_ )AZ?^C&KV_[';_\\(_^^!7#VL<1
M^->H1>4FT:%"V-HZ^?)2=3R!1,%KY-W6D^W)ZUZO]CM_^>$?_? I/L5O_P \
M(O\ O@4>T\A<K[GE2WR>M+]N3U%>J?8K?_GA%_WP*/L5O_SPB_[X%/VB[!RL
M\K^W)ZBC[<GJ*]4^Q6__ #PB_P"^!1]BM_\ GA%_WP*/:+L/E/*_MR>HIZWR
MXZBO4?L5O_SPB_[X%+]CM_\ GA'_ -\"E[1=@Y3RW[<OJ*/MR^HKU+[';_\
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MOK2K=KGK7HOV6'_GC'_WR*/LL/\ SQC_ .^11SA8\\^UKZT?:U]:]"^R0?\
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M_P"Q@O/_ $):[01H.B*/PKB?A9_J_%G_ &,-[_Z$M '<4444""BBB@ HHHH
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M0 4444 <)XH_Y*SX(_Z]M0_]!BKX:_X*)?\ )ZG[,'_85M/_ $Y05]R^*/\
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M +#NH_\ I0]=G7&_"_\ Y!FN?]AW4?\ TH>NRH **** "BBB@ HHHH ****
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M_P"N?]16LW^K7Z5'VF/H1TM%%4(=M%&VBBF!9L_OBOD7]FO_ ).Y^*G^_?\
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M^T-_>H_M;'?S_@O\A^SB?G+_ ,.6D_Z+!<_^"C_[?2_\.64_Z*_<_P#@H_\
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MY]:[L!7AAZ_M*E[:K3S5CAQ]">)P[ITVKZ/7R=R6^_:@^#SL2?B)H8_[>/\
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M^P_Y*]XI_P"P-9_^ASUQUFXV"NFCLS&INB]2U'YE+YE;F1+131(,"CS!ZU*
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MS*TK_:T_,\D?]KSX.,2?^$R_\I=Y_P#&:9_PUW\'?^AR_P#*7>?_ !JO4/\
MADGX/_\ 0A:7^3__ !5'_#)/P?\ ^A"TO\G_ /BJCVV<=Z?W2.M4N 5]C&?^
M!4?_ )$\P_X:[^#G_0Y?^4N\_P#C5'_#7?P<_P"AR_\ *7>?_&J]/_X9)^#_
M /T(6E_D_P#\51_PR3\'_P#H0M+_ "?_ .*I>USCO3^Z17L^ ?Y,9_X%1_\
MD3S#_AKOX.?]#E_Y2[S_ .-4O_#7GP<_Z'+_ ,I=Y_\ &J]._P"&2?@__P!"
M%I?Y/_\ %4?\,D_!_P#Z$+2_R?\ ^*H]KG'>G]T@]GP#_)C/_ J/_P B>8_\
M->?!S_H<O_*7>?\ QJC_ (:\^#G_ $.7_E+O/_C5>G?\,D_!_P#Z$+2_R?\
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M/_DNNI?]B_!_Z424 7_C%_R2/QQ_V [[_P!)WKYZ_P"":?\ R0W7O^QCF_\
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M^-'_ "2WQ)_UZG^8KLX_]6OT%<9\:/\ DEOB3_KU/\Q79Q_ZM?H*!]!U%%%
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M_P#A2W__ ,CUZM2-*I2A[Z32U(5TWH?J-17Y;?\ #%?[</\ T72V_P#"FO\
M_P",4?\ #%?[</\ T72V_P#"FO\ _P",5Q^QC_.OQ'?R/U)HK\MO^&*_VX?^
MBZ6W_A37_P#\8H_X8K_;A_Z+I;?^%-?_ /QBCV,?YU^(7\C]2:*_+;_ABO\
M;A_Z+I;?^%-?_P#QBE'[%?[<'_1=;;_PIK__ .,4_8Q_G7XA?R/T8\:6C7'B
MCP0X&?)U&5S_ . TPKL*_*?5OV-_VTK?4M%CN?C;;RW$UPZVT@\27V(W$3DD
M_N1_"&'&>M:3?L5_MP'I\=;;_P *6_\ _C%:RPM.*NJL7]X<S['ZC45^6_\
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MZD9!!'4$=ZEI#. T7_DM_B?_ + UA_Z,GKOZX#1?^2W>)S_U![#_ -&3UW]
MPHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% '%?&C_DEOB3_KU/\
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M@/%7_)7_  +_ ->VH_\ H$5=_7 ^*E_XNYX&/I;:A_Z!%7?4#"BBB@04444
M%%%% !1110 4444 %%%% !1110 4444 0WG_ !Z3_P"XW\JY/X.?\DK\+?\
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MKL%V:/\ PG&L?W;;_O@_XT?\)QJ_]VV_[X/^-9VP4;!1RKL5=FC_ ,)QJ_\
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M_P"A+/\ \*9__(GS=_P\TTG_ *%&^_[_ $?^-'_#S32?^A1OO^_T?^-?2/\
M9^G_ /0/M?\ OPO^%+]@T[_H'VO_ 'X7_"CZGF/_ $$Q_P# $/\ MSA#_H2S
M_P#"F?\ \B?-O_#S32?^A1OO^_T?^-+_ ,/--)_Z%&__ ._T?^-?2/V#3O\
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M=/"U)QW2/JOX=ZM=6OPR\(*BQ\:/9CD?],$]ZUSXEO\ ^[%_WS_]>L7P*O\
MQ;?PG_V"+/\ ]$I5\J,UY4_CEZG;'X46_P#A);_TB_[Y_P#KTG_"37_I%_WS
M_P#7JIMHVU-D47!XDO\ TB_[Y_\ KT?\))?^D7_?/_UZI[11M%&@%S_A)+_T
MB_[Y/^-+_P ))?\ ]V+_ +Y_^O5+:*=M%%D!<_X22_\ [L7_ 'S_ /7H_P"$
MDO\ ^[%_WS_]>J>VC;22 N?\))?_ -V+_OG_ .O1_P ))?\ ]V+_ +Y_^O5/
M;1MIV0%S_A)+_P#NQ?\ ?/\ ]>E7Q)?'^&+_ +Y/^-4MM*J]:5@+R^(KX_PQ
M?]\G_&N3\6:I<S>./!,I$>Z*>Z(X]8"/7WKH57FN;\3+_P 5CX0_Z[7'_HDU
M+&=@_B"]7HL?_?)_QIO_  D5]_=B_P"^3_C5>0<TS:*JR$6_^$BOO[L7_?)_
MQH_X2.^_NQ?]\G_&JFT4;:+("[_PD%[Z1_\ ?)_QH_X2"]](_P#OD_XU5VBC
M:*0%K_A(+WTC_P"^3_C1_P )!>^D?_?)_P :J[11M% %K_A(+WTC_P"^3_C1
M_P )!>^D?_?)_P :J[11M% %K_A(+WTC_P"^3_C2KX@O3U6/_OG_ .O53:*5
M5ZT 6_[?O/2/_OG_ .O1_;]YZ1_]\_\ UZK;11M% %G^WKSTC_[Y_P#KTHUZ
M\](_^^?_ *]5<"E514]0+7]NWGI'_P!\_P#UZ?'K5VW41_E_]>J>T5+$*8'/
M_#S5+F/3=7("9;6+YCQZS,?ZUTIUR\_NQ_E_]>N6\!#_ (EFJ_\ 86O/_1K5
MT! H L?V[>?W8_R_^O2_V[>?W8_R_P#KU5VBEVB@"U_;EWZ1_E_]>C^W+OTC
M_+_Z]5]HHVB@"?\ MR[STC_[Y_\ KTO]M7?I'_WS_P#7JMCYJ7:*74"Q_;5W
MZ1_]\_\ UZ/[:N_2/_OG_P"O5?:*-HI@6?[:N_2/_OFC^VKK_IG^55L"C:*0
M%G^VKK_IG^5+_;5UCI'^55=HIQ'RBD!/_;5WZ1_E1_;5WZ1_E4 44,HJAEG^
MV;KTC_*E&L77HGY55P.*<HJ1'-^-KZ>3Q1X'8A<KJ4A''_3O*/ZUUTFK7*G@
M)^5<?XQ'_%2>"_\ L(2?^B)*ZB0<T 2_VQ=>B?E3H]7N6;D)^55<"GQ?>H \
M?_;NF>3]C7XJL0,G1V'YNE<)_P $KY&3]B;PGC'RWNH@?^!<I_K7=_MV?\F:
M_%3_ + [?^AI7"?\$L!_QA/X5_Z_-0_]*Y*].,?^$]R_O_H1]L^I)-5N%8@!
M/RIO]KW7HGY5'*/F-1X%>8:EC^U[GT3\J/[7NO1/RJ#%)M% BU_:USZ)^5']
MK7/HGY5!BC:*!$_]K7/HGY4?VK<^B?E_]>H-HHH&B?\ M:Y]$_+_ .O1_:US
MZ)^7_P!>H-HHVB@98&J7)[)^7_UZ7^U+CT7\JKJ.:=B@3+,6HSLZ@[<$^E<[
M\+AA/%?_ &,-Y_Z$M;D/^L7ZUB?"_P"YXJ_[&"\_]"6@#MJ***!!1110 444
M4 %%%% !1110 4444 <#8?\ )7O%/_8&L_\ T.>N0LON#Z5U]A_R5[Q3_P!@
M:S_]#GKD++[@^E=-'9F-3=%REHHK<R'4445* ****H!5IU-6G5+*04444AA1
M110 JTZFK3J "BBB@#,\6?\ (L7_ /US_J*UF_U:_2LGQ9_R+%__ -<_ZBM9
MO]6OTJ?M,?091115"'4444 *O6G4U>M.H **** "BBB@I!3EIM.6A@Q:***D
MD****"Q5ZUBQ?\CQ<?\ 7@G_ *,-;2UC0_\ (\7'_8/3_P!#:I?0%U-G^*C<
M:1NM%4(<II::M+0 M&3244 +DU)%VJ*I8NU-$RV/D7_@H1_R%OAA_P!=+W_T
M*VK[!F_U,?\ NC^5?'W_  4(_P"0M\,/^NE[_P"A6U?8,W^IC_W1_*O!P?\
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M8ZBBBJ*"BBBI =+_ ,>TW^X?Y5B^ _\ D2-%_P"O9:VI?^/:;_</\JQ? ?\
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M444 %%%% !1110!P-A_R5[Q3_P!@:S_]#GKD++[@^E=?8?\ )7O%/_8&L_\
MT.>N0LON#Z5TT=F8U-T7:***W,AU%%%2@"BBBJ 5:=35IU2RD%%%%(84444
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M(!1110 4444 %*M)2K0 M%%% !3EIM.6EU 6I(NU1U)%VI@<YX#_ .07JO\
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M[-&@!NHR*7^R]3_Z!]Q_W[-']EZG_P ^%Q_W[-&A0FX4Y3Q3?[*U/_GPN/\
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M )\Y_P#O@T )2CK1_9VH?\^<W_?!I1IVH9_X\IO^^#0 N:,T?V??_P#/G/\
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M 7-&:/[/O_\ GTF_[X-+_9]]_P ^DW_?!I#$S1FE^P7W_/I-_P!\&C[!??\
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MX[_Z%G2/_!P__P 8KLZ*DHXS^V/'?_0LZ1_X.'_^,4?VQX[_ .A9TC_P</\
M_&*[.B@#C/[8\=_]"SI'_@X?_P",4?VQX[_Z%G2/_!P__P 8KLZ* .,_MCQW
M_P!"SI'_ (.'_P#C%']L>._^A9TC_P '#_\ QBNSHH XS^V/'?\ T+.D?^#A
M_P#XQ1_;'CO_ *%G2/\ P</_ /&*[.B@#B_[8\=_]"SH_P#X.'_^,4?VQX[_
M .A9T?\ \'#_ /QBNTHH XO^V/'?_0LZ/_X.'_\ C%']L>._^A9T?_P</_\
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MX\_Z%G1__!P__P 8KM** .+_ +8\>?\ 0LZ/_P"#A_\ XQ1_;'CS_H6='_\
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M2B@#B_[8\>?]"SH__@X?_P",4?VQX\_Z%G1__!P__P 8KM** .+_ +8\>?\
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M% '%_P!L>//^A9T?_P '#_\ QBC^V/'G_0LZ/_X.'_\ C%=I10!Q?]L>//\
MH6='_P#!P_\ \8H_MCQY_P!"SH__ (.'_P#C%=I10!Q?]L>//^A9T?\ \'#_
M /QBL;6++QSJ_B#0=3_L+2(CI<DLGE?VHY\W?&4QGR>,9ST->FT4 <6=8\>=
MO#.C_P#@X?\ ^,4G]L>/?^A9T?\ \'#_ /QBNUHH XK^V/'O_0LZ/_X.'_\
MC%']L>/?^A9T?_P</_\ &*[6B@#BO[8\>_\ 0LZ/_P"#A_\ XQ1_;'CW_H6=
M'_\ !P__ ,8KM:* .*_MCQ[_ -"SH_\ X.'_ /C%']L>/?\ H6='_P#!P_\
M\8KM:* .*_MCQ[_T+.C_ /@X?_XQ1_;'CW_H6='_ /!P_P#\8KM:* .*_MCQ
M[_T+.C_^#A__ (Q1_;'CW_H6='_\'#__ !BNUHH XK^V/'O_ $+.C_\ @X?_
M .,4?VQX]_Z%G1__  </_P#&*[6B@#BO[8\>_P#0LZ/_ .#A_P#XQ1_;'CW_
M *%G1_\ P</_ /&*[6B@#BO[8\>_]"SH_P#X.'_^,4Y=8\=]_#.C_P#@X?\
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M&='_ /!P_P#\8I/[9\>_]"QH_P#X.'_^,5VM%0,XK^V?'O\ T+&C_P#@X?\
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M( 1P2D:Y;GY20.M?5]$M&-!1114#"BBB@ HHHH **** "BBB@ HHHH ****
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MX9O]+\4:#K;>%K[PE&XEF.L^8L<=K%(!M<.70AQQ@D]J[+X:_'36]4^+%_\
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M5X=4TCQ5/;QMN^SV.GVK?:'?'W/W@$0SC+G'8XV<5J9W>A]^4445@:A1110
M4444 %%%% !1110 4444 %%%% !1110!X=^UE^U%IW[+_@%=9;2IO$6LW$B+
M;:3;E@?+\Q$DGE<*WEQ(9$!<C&YT7JU2_M"_M$2_!ZQ\(V&CZ?I6K^,/%5V;
M;3=-U?6(M-@*K&7D=II/3Y$"@$LTB@#KCY,_;5TOXQ:1\&?BUK7BCP7X=N[/
M5KVU@37+?Q&[SVFG1WJ&UMX[4VP4#)!<^9DL[-R JCZ-^(6I?!SXB^$]&\(?
MM!IX$TCQ5)I3:@VBZGJT3O9PD.#+;W$BQ./EC8EE"D;6ZA<UMRJZMJ1<]F^%
M^K^+M<\'VM[XWT&P\-^()&?S-.TZ_P#ML4:[B$/F[5!)&#P,#/6BO,/V(=-\
M0:1^S_IEGK=_<:G8P7U['H-W>!OM$VDBX<6;R%N3NB"LI_N%**SEN4MCWNBB
MBI&%%%% !1110 4444 %%%% &18^#]!TW6[K6;/1-.M=7N@5GU"&UC2>4$@D
M-(!N8<#J>PK7HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#$
M\2>"/#OC$VYU[0-,ULV^[R3J-G'<>5NQNV[U.,X&<>@K8BB2&-8XT6.-1M55
M& !Z 4^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,CQ%X1T+
MQA;Q6^O:+I^M01/YD<6H6J3JC8QN <$ X[U-!X<TFUT3^QH=,LXM(\LP_P!G
MI;H(-AZKY8&W;[8Q6C10!G:%X=TGPO8"QT;3+/2;(,6%O8VZ0Q@GJ=J@#)K1
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N?M?A_X7LO$#Z[;^&]
M)@UMW:1M2BL8EN69@0S&0+N).3DYYS7044 8</@;PY;^('UZ+P_I<>N2$E]2
M2SC%RV1@YDV[CQQUK<HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MN?\ $7P]\+>+KJ.ZUWPUI&M7,:>6DVH6,4[JN2=H+J2!DDX]ZZ"B@#'T7P;H
M'AO3KC3](T/3=+L+@DS6ME:1PQ2$C:2RJ #D #GM3_#WA71?"-H]KH>D6&C6
MLC^8\.GVR0(S8 W$( "< <^U:M% !1110 4456DU*TAD,<EU#'(.JM( 1^&:
M +-%)G/(Y%5QJ5HTHB%U"9"=H3S!G/IC- %FBBB@ HHIKNL:EG8*JC)9C@"@
M!U%16]U#=*6AECF4'!,;!@/RJ6@ HHHH *9+$D\;QR(LD;@JRL,@@]013Z*
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MO&L5($)E5P'#'#<2#?C&:^CZQ>Y84444@"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>figure19_01.jpg
<TEXT>
begin 644 figure19_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (G!98# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 5;_ /U2_P"]5.KE_P#ZI?\ >JG5( HHHI@%%%+0 E%+
MM/I3O+/XT@&44O2E"EN@H ;13O+;TI"I7J* $HHHI@%%%.VGKB@!M%%% !11
M10 44O6C!'6@!**** "BBB@ HHHH **** "BBB@ HHHH *5>OI24M 'YX_\
M!0[]I;XP?LK?$#P[:>$/'CW&D:Y8R70M=1TNTD>W=)-I"N(QN4@C (R,'DYX
M^K[[0?B O[/1U"#XEWL?C1=+75#JTFFV;0&00ES'Y(A&(R3Z[A@?-U!^#/\
M@M)_R4#X9_\ 8)NO_1JU^CVK,5_9_NB.H\+L?_)4U]ABX4Z> P-6,(\TV[NR
MUL[*^G_#]3DUO/78_-;X#_\ !37XG>$_BYI.F_&R4W'A;4H8A(?[.BM9;59@
MK0W0VJNZ/:P)_P!DDC)&#]U_M?>)O%?A/X%ZCX]^'OC1M$N=/BAGC"VEO=VM
MW$\BC)WH6SM?(*L!P.*^>_C=^QG!^TI^QS\,?$'AVWAC^(>B>%;!K5R=OVZ
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M1X#.?^"R%S_V']1_]-\U?J3\6_#_ (@\6?#+Q/HWA76/[ \1WVGS06&IX/\
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MC_R1/P'_ -AYO_2>2L^'J<*^:T:56*E&3=TTFMGW*K-QIMHZWX-ZE\</BO\
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M9)%4CE3VYZCBO0=5U2UT33;B_OIEM[2W0R2RL"0JCJ>*MT5Y-249U')*R?\
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M\++9:]<?$'QIIBW=XVFZ9<2RZ8VH2&>\N9=JY1T,\N$)W%QCL37J'@_]C_\
M9EUCP3:ZYIWP[T6ZTE+;)O+NVF67:J_,SJ^&#<<Y&<U]045Q5,PG)/V=XMR<
MFT][_P"73Y]RHT^4_%7X)7^L?LH?MHZKKOAOPUXFU?X9G4;G3Y+FPTBZ:.73
MY'RCJ-GSB,["#SG9QG-?JI\9/BEX=L?@;K>LM<W$UKJ^D7$=A'!:323W+O"P
M1%B"[]QR."!COC%>K45T8[-%F%:G7J4_>C9/7>W?3?S%&GRQ<4]S\@/^"5J7
MOP@^-VOR^--%UKPW;:MI'V.TN=0TJXCA>;SD8(7*84D XR1D\=:_6/QCXTT?
MP#H<NK:Y=&TL8S@LL3RLS=E54!8D]@!S6Y16.9YC_:>)^LU(6>ETGV^6GXE0
MAR*R9^-__!/^\O/A?^UYK/BGQ9X?\0:!X?U:SO[>#4+W1[E(E>6>.1-[;/E!
M5#R>,XKZ[_X*'?L67?[4'AO2?%W@G[.?&FDP[$AE/EC4;5CN$>\\*RDEESQ\
MQ'%?:M%==?/*U3&QQU*/+-*V]TT0J*Y.1['QI\%?VVI?"?PWL/#_ ,6/ 7C?
M0?'&A6J65U';>'[B[BOVC4*)(I(U*[F !() !)P2.:\.T7]F_P ?_MT?M1Q_
M%GQ_X=OO!/PTLGA&GZ9JRB.]N+>$YCB\OJH=]S.3C <A2>#7Z>45C3S18:52
MKAJ:C.>E[WLGO9=/QL-TN9)2>B/E_P#:V^+7A[P?XK^%.ES0ZI=W6D^*[/5[
MR'2]*N+I;6S%O<Q^8QC0J #(OR@YQVXKW]AX>^*G@N>&2.#7/#FL6SPRQ31D
MQSQ,"K*RL.A&1R*Z&BO,G74H0C%-./6_G?L:*-FWW/@#]EK]D/5?V5_VY?$0
ML8+B]\!:UX;NYM*U+RR5@/VFV)M9&Y =<G!/WE&>S ??]%%:8W&U<=456MK*
MR5^]NH1BH*R"BBBN L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH JW_P#J
ME_WJIU<O_P#5+_O53JD 4444P"OE3_@I)XJLKK]F/Q7X&L8KW5?%>L&Q:UTS
M3[*6XD*I>12L[;%(5=L3\GN .]?5=/29H^AKLP>(6$Q-/$<M^1II7MJG==R9
M1YHM'Q+_ ,$M_$UOX=^"+>!-;L]2T+Q1%J-Q.MCJ=A-;F:-OG#1EE 8  YYR
M,?2OM>I))FDZFHZO'XI8[$SQ/+RN;NU>^HH1Y(\HM?GK_P %9-:'Q \(^%/!
MOAC3M5\0Z]IVJ/=WL.FZ=/.EL@B90'=4(#$N,#/3FOT)J1)WCZ&M,MQW]G8J
M&+4>9QV5[>7852'M(\I\%?LU_'CP%X3_ &6/!/@SQ]X8\9#6?#TJW+:?'X:O
MG8SQ7)FA='5-IYVGDCH0:]<_9S_:(USX_?&?QQKUWX=U[P;X'\/Z5#;:=;:U
M:20/=O)(SRW#J1C($:@*I) )R?FP/IO[5)ZTUIW;J:Z,1F-+$.K/V7O3;=W*
M_+=W=E;KL1&FU;4_)[]D5[KPS_P4%\4>,-7TC6-,\,:I=:P;75+O2[B.!Q+(
MSQDL4PH8#C..U:/[(,UUX>_X*&>+/$NJ:-K.G^']<FU*VL-2N=+N(X)7EF5H
MLL4PH8*<$X'(]:_5+[5)TS2-<.PP37K5^(WB/:WI6YX*&_17UVW(C0Y;:['Y
MI?&+X=^)_P!F3_@H5IWQBC\,:MX@\#:U=M/<7.C6<EV]OYL)BG#*N2&!)<=
M0<#.,5YU^U%=>)_B%^W+X3^(6E?#KQE)X;T^?2+I9/[%F,L]O#,LK2! N5R,
MX5L-P,@9Q7ZXK,Z]#3OM3_WJ,/Q)*C*%6=%2G&'L[W:O'T[A*A?1/K<_.#_@
ML??+J?P]^%UXL4UNMQ=3RB&XC*2(&B4X93R&&>1VJW^TQXNN/B%^PG\,OAKX
M8T'6M7\7ZM8Z)$-/@TR9MD<<,;>:9 NP*2$P2V"&/H<='_P4\^$?Q%^/L?@[
M0O G@?5->&E/+=7.H1O#'!\ZA512\@+-P2>,#BOJS]G>;5+/X(^"](UC0]0\
M/:MH^D6FFW5GJ*(&\R*%$8J59@RDKP0>]=RQU+"97@JBM*=.4I6YE=:NU]W8
MCE<IR7<^4OB]^Q'XJUC_ ()[^#?ASIV+WQKX6E36#80LNVXG;S3+"K'@X%P^
M#QDJ/6N2^,7B[5_B[^P7X$^%.D>%]>N?B3)_9^DW&AG2IHWMFL]JO)*S *B$
M1J0Q.#N]CC]&_,;.<\T_[0^.M>-2SVM'E=6"DXS=1/:S>Z\U?7H_,U='L^EC
MX%^/WP=E^ __  3/C^%21W>K^*KXVK?9+"WDN6ENC>Q7-P%\M3A4 ;D\<#DD
MUPO[.6JMX7_X)P?%'PEJNEZQ9>)I!?0PZ5+I=P+B9IT58MB;,L">,C@8.<5^
MF2S,IR#3_M+]<U<,_J+#NC4AS-U/:MWM[VGEMH*5!-II]+'Y,_LKK>^#?V'O
MC_X6UK1M8T[Q#JJ.+#3I]+N!-=>9;B-?+79\WS @XZ=3Q7O?_!(<W'A?X3^+
M_"NM:;J6C:Z-;?4Q:ZC8S6^^W:W@C#JSJ ?GC8$ Y''J*^Z_M4GK36F=^IIX
M[/GC:->E*E;VLE)Z[-)+MY#C1Y6G?8_*;]E'PUXS_9__ &XO&YUSP)X@NI]0
M%_:V#6MD[6T\DLRR1,9\;%C*C)<GCN,\5^JS9[C![CK3_/?;C/%,KSLTS*6:
M58UIP49)).SWM^1=.G[.ZN)1117C&H4444 %%%%  34;,%I6-6M-59(WRH;Y
MNX]J0%!IAZTQKA1WK=\B/_GFO_?(H^SQ?\\D_P"^12N!@_:E]:/M2_WJWOL\
M7_/)/^^11]GB_P">2?\ ?(HN!@_:E_O4?:E_O5O?9XO^>2?]\BC[/%_SR3_O
MD47 P?M2_P!ZC[4O]ZM[[/%_SR3_ +Y%'V>+_GDG_?(HN!@_:E_O4?:E_O5O
M?9XO^>2?]\BC[/%_SR3_ +Y%%P,'[4O]ZC[4O]ZM[[/%_P \D_[Y%'V>+_GD
MG_?(HN!@_:E_O4?:E_O5O?9XO^>2?]\BC[/%_P \D_[Y%%P,'[4O]ZC[4O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ'X$UO1=/GU:XD%]!JNFO=,EK&I:2="LJ8()1 #D$N* /7Z*9"KK$@D8/(%
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M4 %%%% !1110 4444 5;_P#U2_[U4ZN7_P#JE_WJIU2 ****8!1110 4444
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MF>"?$?BR37O"5B(XFM#9)#->01[?+@GD#$,@VC.U5+8Y/6E^+?P0UKXC>+O
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ,A&]_Z[R?\ H1H ['_A9$'_ #XS?]]"C_A9$'_/C-_WT*XNB@#M/^%D0?\
M/C-_WT*/^%D0?\^,W_?0KBZ* .T_X61!_P ^,W_?0H_X61!_SXS?]]"N+HH
M[3_A9$'_ #XS?]]"C_A9$'_/C-_WT*XNB@#M/^%D0?\ /C-_WT*/^%D0?\^,
MW_?0KBZ* .T_X61!_P ^,W_?0H_X61!_SXS?]]"N+HH [3_A9$'_ #XS?]]"
MC_A9$'_/C-_WT*XNB@#M/^%D0?\ /C-_WT*/^%D0?\^,W_?0KBZ* .T_X61!
M_P ^,W_?0H_X61!_SXS?]]"N+HH [3_A9$'_ #XS?]]"C_A9$'_/C-_WT*XN
MB@#M/^%D0?\ /C-_WT*/^%D0?\^,W_?0KBZ* .T_X61!_P ^,W_?0H_X61!_
MSXS?]]"N+HH ]%\/^,(M?OGMDMI(2J%]S,".H&/UKH:\Z^'W_(>F_P"N#?\
MH2UZ+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_K@W_H2UZ)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN8?%2_Z]P_(E7I10O2BO6/*"BBB@ HHHH NV/^H_$U9JM8_ZC\35FH ****
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M[U0_X5'XG_Z*[XM_\!]-_P#D2C_A4?B?_HKOBW_P'TW_ .1*/;5/^?3^^/\
MF'U#"?\ 09#_ ,!J?_*ST^BO,/\ A4?B?_HKOBW_ ,!]-_\ D2C_ (5'XG_Z
M*[XM_P# ?3?_ )$H]M4_Y]/[X_YA]0PG_09#_P !J?\ RL]/HKS#_A4?B?\
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M<?6H;2^M-0W_ &6\M[K9][R)5?;]<'BHX=6TZX8K%J-G(P!)5+A"0!U/7M3
MM9/K1N/K4-K>VM]&\EK=P7,<?WWAE5U7OR0>*2SOK34&9;2\M[IE^\()5<CZ
MX-("?)HR:CDN+>$3&2YAC\G'F[Y%&S/3=SQ^-21;;B-9(G66-AE7C8,I^A%
M!N/K1N/K4%O?V=Y*\5O>6]Q*GWHXI59A]0#4] !N/K1DTE% !1110!8TSPNO
MBZZ>S;5-4T@(OF^=I%VUM*<$#:6'5>>GL*U?^%(P_P#0[^-__![)_A4OP^_Y
M#T__ %P;_P!"6O1*Y:F%HU9<TXW9Z5#,<5A8>SHSLOD>;?\ "D8?^AW\;_\
M@]D_PH_X4C#_ -#OXW_\'LG^%>DT5G]1PW\AT?VSC_\ GZ_N7^1YM_PI&'_H
M=_&__@]D_P */^%(P_\ 0[^-_P#P>R?X5Z311]1PW\@?VSC_ /GZ_N7^1YM_
MPI&'_H=_&_\ X/9/\*/^%(P_]#OXW_\ ![)_A7I-%'U'#?R!_;./_P"?K^Y?
MY'FW_"D8?^AW\;_^#V3_  H_X4C#_P!#OXW_ /![)_A7I-%'U'#?R!_;./\
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M@8J'M8+92=ON1KG$Y594*D]Y4XM^;U"BBBO3/ "BBB@ HHHH **** "BBB@
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MLO?^?J?_ +^&C[9>_P#/U/\ ]_#18#N**X?[9>_\_4__ '\-'VR]_P"?J?\
M[^&BP'<45P_VR]_Y^I_^^S2B[OO^?J?_ +[- ';UP]JG[QO]X_SJ5;F]_P"?
MJ;_OHU);P[6'&:8'#:6O_&0VI_\ 8N0_^CC7IJ]37FVFK_QD1JGK_P (Y#_Z
M/->EKWKRLN^&K_CG^9ZN8?%2_P"O</R'T445ZQY04444 %%%% %VQ_U'XFK-
M5K'_ %'XFK-0 4444 %%%% !1110 4444 %%%% !1110 5YU^T5_R0;X@?\
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M;&QM8]>T^;3?%6G06 F^Q6<KJKZBJ*,+@GG/#$?6O;9OV9=1U/Q[X$\9ZO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/,)/^3FH/^Q0D_\ 2U*]/KS"3_DYJ#_L4)/_ $M2O3Z\[!_%6_QO\D>YFFV'
M_P"O<?U"BBBO1/#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** *M_\ ZI?]ZJ=7+_\ U2_[U4ZI %%%%, HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &L*C=:FIK+0
M!4>+/:H6@]JOE:;Y?M0!0^S^U)]G]JO^5[4>5[4 4/L_M1]G]JO^5[4>5[4
M4/L_M1]G]JO^5[4>5[4 4/L_M1]G]JO^5[4>5[4 4/L_M1]G]JO^5[4>5[4
M4/L_M1]G]JO^5[4>5[4 4/L_M1]G]JO^5[4>5[4 4/L_M1]G]JO^5[4>5[4
M4/L_M1]G]JO^5[4>5[4 4/L_M1]G]JO^5[4>5[4 4/L_M1]G]JO^5[4>5[4
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M7[17_)!OB!_V!+O_ -%-7+BO]WJ>C_(]G)?^1GA?^OD/_2D=GX;_ .1=TO\
MZ]8O_0!6E6;X;_Y%W2_^O6+_ - %:5:TOX<?1'F5OXLO5A1116IB%%%% !11
M10 4444 %%%% !1110 4444 %%%% !7RSJ?_ "'M5_Z_)O\ T,U]35\LZG_R
M'M5_Z_)O_0S0!%1110 4444 %%%0WU];:58W-]>SI;6=K&TTTTAPJ(HR6)]
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M_8H2?^EJ5Z?7G8/XJW^-_DCW,TVP_P#U[C^H4445Z)X84444 %%%% !1110
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M_P ;_)'N9IMA_P#KW']0HHHKT3PPHHHH **** "BBB@ HHHH **** "BBB@
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M +]M_A1NE_Y]YO\ OVW^%?5]% 'RANE_Y]YO^_;?X4;I?^?>;_OVW^%?5]%
M'RANE_Y]YO\ OVW^%&Z7_GWF_P"_;?X5]7T4 ?*&Z7_GWF_[]M_A1NE_Y]YO
M^_;?X5]7T4 ?*&Z7_GWF_P"_;?X4;I?^?>;_ +]M_A7U?10!\H;I?^?>;_OV
MW^%!:7_GWF_[]M_A7U?10!X5\#]__"979:*1!]C;ED('WT]:]UI*6@ HHHH
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MA29<.N10!52:IE>JTEG)#S&=Z^G>F1W'..A]Z -!6IVZJJ2U*K4 344T-2T
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M&^O:3#JNFZ7;W>F2IY@NH]0@V!<<Y._C'?/2N?TGP_?ZYKAT>Q:SFOMQ5?\
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M KA+4_O&S_>_K7=UP5KS(?=C_.F@.6TL_P#&0.I'_J7HO_1QKTM.IKS/2_\
MDX#4O^Q>B_\ 1QKTR/O7E9;\-7_KY/\ ,]7,?BI?]>X?D2T4+THKUSR@HHHH
M **** +MC_J/Q-6:K6/^H_$U9J "BBB@ HI"::6H 7=3&;%,>3%(L;2?[*T
M#2=AR:58"W+G ]!4J1K'T'XT^@!%4*, 8%+110 4444 %%%% !1110 4444
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M(,R;3M CR .20: +/Q&_:!U/Q9^R/KOQ$\%01:7=K:S1SQZE(1)9NDAAE"[
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MX[J%I$*[21G*XQ@\]*VO'7PWN=(\<7.M?#+Q/IJ1R2*WEVFIQ6\EL^/F5@S
M,F>>_7&*L_M->/$\9>'?"6A"^M]1\1:6JW.HZAIY_<K/Y>TK&PZ_-D\=,"OH
M\TJ4<1A*\\1'V=9<J;3O"IJMONOIM;4X,GC5HXK"T*%7VN'ES-*2M4H7B]WV
MUMKO?1=3O_VU!NT+P;G_ )^Y?_18KQ*&%6^"&LC'']O6W_HB2O8/C9JEE\=?
MA]X:U#PSJ>GM>V$S27&FWEW'!.-R;2H#D#((]<$5Y%K6WP_X$3PMY]O>:K>Z
M@M[<"VE#QP!4*(A?[I8[F)P<#CFN7B*49YG4QD'>G*GH^C;C9)>=^@^&XRI9
M3A\%/2K"H^:+W5IN5WV5NNS/8]!T>]US]B&]TW3+1KZ^N+2XCAMD(!D;[2WR
MC)Q5?X0W#_L[?!75C\0\6<^K74LEAHDK!Y''E*OE #(R2"3Z9YJU#HYF_9+O
M_!7]K:5:^)Y[.98K9M3A!5VF+J-P? .,=^M,\#^*M)^-7PGOO!/C^^M-/\1Z
M3B#[;<31\NG"3HV<,01@X///K7V,90ISH.#M6]@E&_PWUO%^=O/U\_G*DI5,
M/BX5%S8>6*E*?+_$4;KEG'=.+>[2OV>NG._L:^+CINL:IX+OGWV.HQ&ZMHI#
MD"0#$BC_ 'E(/_ ?>N6_X0&+X=?&#Q$NH0'^QO#@.J6^[A9-YS:H/^!X'_ &
M%<@T&J?"_P :V-SYMO<WVDW"3I+9SK+',H/9E)X9<C!Y&:]<_:>^(VG>+9-!
ML=$D@G@N;=+V\N(2"QZ^5$Q'IN<X/0D5\-3Q=*IE+AB]*N%E[J>[4NGREJ_+
M0^OQ%"K'.75PFM+&0]YK9.-O>]7!V7F[G&? *XGU/]H3P_J-Y*UQ>7,ES++*
MYR69H9"34G[3LEQ9?'[4[^RF:WOK6"TF@F7JCJ@(/YU+^SWILD/Q4TC7)Y[.
MSTG3S,L]Q=74<6"T3* %9@QY8=!BK7[2>GF\^*%YK]K<V=]I%[#!%%/:W<<I
MWJA#*55BPZ=<8]Z495/]5W/7F]KS>=K;^E^IK[2"XHCMR_5^7ROSWY>U[:V[
M'HGQSAA^,'[/^C^.;! ][ID8NI H^95^[.GX$9_X#7B7B:4^'? ^B>&XI-LM
MXHU?4E4]7<?N4;_=3!Q_M9KTG]FGXD:=X9T#Q7X>U]XO[,6%[^&.9AB4%<21
M 'J3QQWS7G/@_0+GXL>.KB]U"ZLM.M9;C[3>275PD2K'GB- Q!/ VC'0#FM,
MTK0S.G0Q6&=Z]>/+)=G'1ORO9?*YQY51GE<L1@\0K8?#S<X/NI*\8KORZO\
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M .(KH^MK_GW+[CF_LU_\_J?_ (&COZ*X#S/BW_S[^"?^_P#=_P#Q%'F?%O\
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M M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 -:JTW0_2K+56FZ'Z4 6(O\
M5I]!3Z9%_JT^@I] !17D/QJ_:.LO@;?:1#K'A'Q%J=MJUY'I]E>:3';RQR7#
M_=C(:964GU( ]Z]$77KYO#(U3^P+X7ICW_V09(/M&<_=W>9Y>>_W\>] &U2%
M0W!&17GOP@^,'_"W]/O;^W\*:[X>L[6ZFL_,UI8$,DL4C1R*JQRN<!E/) !Q
MQ7H= "*H7@  >PI&56Z@'ZBJ\^I6EK>6UI+<1QW5SN,,+-AI-H!; [X!'YUS
M/_"8ZW_PM$>&O^$2O?[ _L[[9_PDWFI]G\[>1]GV?>W8YS[T =>5#=0#^%)Y
M:?W5_*O,? OQL;QE\8?&O@&7PY>:/<>&;>UN'N[J:)A<B<,5V*C-@ #N<\]!
M7;^+O$$_A?0[C4H-'O=<, +M:V#1"4J 22/,=%.,=,YH V-HXX''2DV+G.T9
M^E>+_#C]II/BQX/7Q/X:^'OBR\TAG:-9)%LXW9E.& 1KC<<$>E=;\,_C9X7^
M*ESJEAI%S-;ZWI+B/4=%U"%H+RS8]/,C;G![,,@YX- '=^6O]T?E0%5>@ _"
MN.\/>-->U;XC>)O#][X0O-+T/2XK=['Q!+,C0ZDT@8NJ(.5*8 .>N:[.@! H
M'08HP,YQS2T4 )M'I2;%.,J./:G44 )M&W&!CTH50O   ]A2T4 -\M?[H_*@
M*J\@ 'Z5YE\;OCM9_ G28M6UCPWK>J:0\B0M>:4L$BQR.<*K*\JMR>X!'O6;
M-^TSHFAZMH5EXKT'7?!<.N2"'3[_ %B&+[-+*P!6,R12.$8YX#8S0![ RAA@
MC(]Z38H.0H!]<4ZB@!NQ<YVC/TH"*#D* ?I3J* $VC.<<TAC5NJ@_A3J* $(
M!ZC-<G\5K'7M4^'^N:?X:L;*^U>^M9;6)+^Z:WA7>A7<SJCG ST"UUM% 'D_
M[+_@GQ3\-?@KX6\(^,+73H]7T.RCLFN-,NVN(KC;D;P6C0KGC@CUIGQ2TSXQ
M:SXRT^P\&ZCX9TKP1=6KQ:G?7L<SZG;R'@/;J#Y9X_O=#@\]*];KD/B9XPUO
MP7H]C=Z%X3O/&%S<7\%K+:64J1M!$[X><ENJH.2!UH W_#^AVOAG0[#2;)-E
MI90)!$.^U0 ,^]:%)2T %%%% !7$?$[QG%X-@TZ671]9U<7$CH$T>Q:Y9, '
M+@'Y1[UV]9&O,5^SX]6_E434I1:@[/[S:C*G"HI58\T>U[?B>8P?'*T4?\B1
MXX/TT&3_ !JXGQZM5_YD7QU_X()/\:[VUD;'6M**0XKC]EBO^?J_\!_X)ZJQ
M67_] K_\&/\ R/,+CX]6TD:@^!?'8Y_Z%^3_ !J'_A>UI_T(_CG_ ,$$G^->
MJWC%8TQZ_P!*K>8WK35+%?\ /U?^ _\ VP/%9=_T"O\ \&/_ "/,S\=K3'_(
MC^.?_!!)_C6?KO[0$.FZ'J%Y#X*\7I+! \BM>Z.\4((&07?/RKZFO6VD;'6H
M+C;<0R13(LL4@*NCC(8'J#4SHXR4&HUDG_A_X(XXO+8R3EA&U_U\?^1\ :YX
MXU_X@7$5YKVI-?M&6:&/:%2$-C(4 =.!U]*H, PP>E>G_M"?#/0OAGJ6B'0H
MI;>/4FN'DA9RR)M*8"@]!\QKRJZD=4"QC=(Y"JOJ3P!7\K9UA,7A<PJ8?%RY
MJBM=WO>Z36K\FC^I,IQ6%QV"I8C 0Y*4K\JLHVLVGHM%JG^9'(+>,_-M%+%/
M!]U2OX5]$>+/"=A^SE\)[/4(+"UU#QKJDB6[7UY&)! S*6;:K9 "@8'J>363
M\$]:M?C/J>I>#?&]I9ZC*UJUW97L4"0W$>T@/AD Z;@:]K_5MQQ%/ 5:UJ\U
M?EMHKZI.5]_1->9YJS^-3"5,PI4G*A!M.5_>:6CE&-M4O.2=KZ'A5PUK$VZ3
M:ON:?#<6\D9*,I7VKW?X&:3J'@OX_:S\/-2:"_TRW@EN%2:!'\P80QODKG.U
MAD9QG-<]^T?K]]8_%BYTVT:&UL=-6&>UAAMXU".5R3]WGZ'(K'$9"L-ESQM6
MHU)3Y''EV:WUYOTW.BEG'UC,5E]*":=-5%+FT<7:VG+OKWV^X\B866XL=F?6
MDFN+$X#M'[9(KW+6?BK>Z#K'@V^U"WMKVTDT!+N2WCLX@);IU<"1N!P#C@5Z
M#^RQK=W\0]#\3W?B2*RU"XM]0$<.;.)1$AB5MH 7IDGK7;@>'\-C\6L'3Q+Y
MM=X=$D_YNM]/0Y,;GV(P&"ECZM"\(VVGK=R<;+W.EKO;<^4X)[<@(C+CT%/\
MZ&#N :[.X^)NL^+?#NM>$;^V@U#4=0OXHM+NH[:.-XF$XRC%0/E*_P O>O2/
MB!I.D?LU^$]$L-+LK34_&VK!C)J=]")=B+CS&13D  LH ]\\UYU/(Z=>$\13
MK?N8*\FXV:;;2BE=W;WWMKK8[ZV9SH588:I2_?5)-1BI7322;FY65HJ[3TO=
M.R9X!(]M<?>VM3E6WM5R-JBO5?A[\6DF\01V_C>TTO4K*1',.H7%I&CVDNT[
M6RJ@;3TYZ9KH?A/\.]+\$?!F]^)_B'3H]9U/[,UW86=P 8HTSB,XZ$MD')Z
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M-"FL^)S*^X;1F]N",GW!!^A%?4-IX/T*PT>?2;;1[&WTR<$2V<=NJQ29Z[E
MP<U@V?P1^'NGZ7=Z;:^!_#UMIUV<W%I#ID*Q3'U= N&_$4 <M^Q_<Q77[+?P
MJ>&5)4'ANQ0LAR-PA4$?4$$?A7K]8OA7P7X?\"Z>;#PYHFGZ%8D[OLVFVR01
MY]=J "MJ@ HHHH **** "BBB@ K@K3_6?\"/\Z[VN"M/]9_P(_SIH3.5TO\
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M+X:?$_Q9XZ^$?BM]&\-Z0WA6><W.DPW[NB"6V>$NL@C&0-_"!1TZU])T4 >
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MW]E'Q_XJ\*7UG8ZIHNH:W?!KVU-PC*EY,Q &X8. >3GZ5-\3OB5\3/AOX?\
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M)5Z44+THKUSR@HHHH **** +MC_J/Q-6:K6/^H_$U9J "BBB@!I6F,M2TF*
M*K156D@]JT2M1M'[4 9$EM\V1P?45/;ZG+ 0LP\Q?[W>K+0U7D@'I0!I0SI<
M+NC8,*DK \MX7WQL5;VJ[:ZL.%G&P_WATH TJ*16#*"#D>HI: "BBB@ HHHH
M ***KW=]#9+F5L'LO<T 6*H7VL0V>5!\R7^ZO]:RKO5I[S*QYAB/I]XU7AMO
MQH =<75QJ#?O&PG_ #S7I2PVP':K,=OSTJU'![4 01V_M5J."IDAJ98Z (TC
MJ95IRK3L4 (%IU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO_X!]#_K[D?>?_@/_!/FW</6C</6OI'_ (9A\(?\_>L?^!*?_$4?\,P^$?\
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M/6OI'_AF'PC_ ,_>L?\ @2G_ ,11_P ,P^$/^?O6/_ E/_B*/^(?9MWA]_\
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M(%RBJ?\ ;%C_ ,_<7_?0I/[8L?\ G[B_[Z% %VBJ7]L6/_/W%_WT*/[8L?\
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M0EW/4DU8CM\8JU';T 016_M5J.WJ>.&K"18H ACAJ=8ZD5:>%H :JT_;2T4
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MU903SQZQIL22N@+*CW<2NH/7#*2".^:]/@T:WTRWCM+.WBM;6(;8X85"JH]
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M"KXAK:G\$?1'FUOXDO5E:."K"0BI5CQ3U6M#(:L=/5:=MI: $Q2T44 %%%%
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M*^D?B19_L]?!?PI\+/$5]\*-1US_ (3/PLM\+&/4W+6Q=%<2L[, \F7"YXP
M3CD"H?A7\.OAWX@OOA5I7A#X<0_$G0M90/XN\0ZM-/$^ERRNJB&*<LD>Z(LW
MR ,S;0!R:Y_[1I^Q^L.E-1UU?*E[M[Z\UEK&RONVK7#ZG4YN7F5_F?.XM8I%
M!"J1]*R=:8V_D6]K:M=7MU*L%O;Q)N>61F"JJ@=220,>]=O\1O!]M\-/C1X\
M\%V$TL^FZ)J36]J\[;G\HJKJ&/<@,!GOC-=9^S-X-OO$'Q U[QW;:%=^)(?
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MH6T9?:TT<KEF5U13N**/GXY%9QS:A3I49U.=J=M6HK>7*KV:3=]U&]EJS2>
M]I-N+2\CP+4/V<+6#]E5_C?9>-X]4":E%ITFBQ:<\8BD8J'1I'(R5W#E5(/K
MZ>:VUE'<6Z/L'S#-?2VD_P#*)C6?^QT7_P!"BKY^TNW_ -!BX_AKIPE>K55?
MVLK\E645LM$E9:)=R,;3A!PY5T,MM+C_ +@_*JUQIL80_(/RKI&M_:JMQ;?(
M>*[5-W/.M;8^HO\ @C]&(OVBO&B@8 \//_Z4PU^O-?D=_P $BUV?M(^-A_U+
MS?\ I1#7ZXU^#\;?\CF?^&/Y'W&"?-0BPHHHKX,[@HHHH **** $VTFVG44
M,V^U&WVI]% #-OM1M]J?10 S;[4;?:GT4 ,V^U&WVI]% #-OM1M]J?10 S;[
M4;?:GT4 ,V^U&WVI]% #-OM1M]J?10!Y5^TE_P DVM^/^8WI/_I=#7J;#VKR
MW]I+_DF]O_V'-)_]+H:]4KAI_P"]5/2/_MQ[V(_Y%.&_QU?RI#-OM1M]J?17
M<>",V^U&WVI]% #-OM1M]J?10 S;[4;?:GT4 ,V^U&WVI]% #-OM1M]J?10
MS;[4;?:GT4 ,V^U&WVI]% #-OM2[:=10 FVEHHH JW_^J7_>JG5R_P#]4O\
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MU4ZN7_\ JE_WJIU2 ****8!1110 4444 %%%% !1110 4444 %%%% !1110
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M/<"O3J\>HJ:E^Z;:\U;]6=$;V]X****S*"BBB@ HHHH **** "BBB@ HHHH
M*5?O"DI5^\* /.['_DXO5/\ L7(?_1YKT2O.['_DXO5/^Q<A_P#1YKT2O(RW
MX:O_ %\G^9ZN8_%1_P"O</R$HHHKUSR@HHHH **** +MC_J/Q-6:K6/^H_$U
M9J "BBB@ HHHH **** "BBB@ HHHH **** "O.OVBO\ D@WQ _[ EW_Z*:O1
M:\Z_:*_Y(-\0/^P)=_\ HIJY<5_N]3T?Y'LY+_R,\+_U\A_Z4CL_#?\ R+NE
M_P#7K%_Z *TJS?#?_(NZ7_UZQ?\ H K2K6E_#CZ(\RM_%EZL****U,0HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ^5O^"D2[OV>;4?\ 4?L?_9Z^&K5/
MW*_2ONC_ (*/?\F^VG_8P67_ +4KX=M5_<K]*_<N%?\ D3Q_QR_]M/D<R_WM
M_P"%?FQI2F&.K16F%*^JN>>5C'3&CJT4II2F!CZI=-:0CRHVFGD81Q0QC+.Y
M.%4#N22!7I7C#X9^$O@;IFF6WQ";5/%'CO5+=;P>'=&NELX=/A/W?.F*L=Q.
M1P.W2N:^'\EK9_&;X>7&H,B:?%KUJ9VEQL"^8.3[9Q79?MLV-SIW[5^N3WJ,
MD=]IEI):2M]UT52IV_1@17+*I*>,I81-J+C*;MHW9I*-]UO=VU^1#BO93J/=
M-)?/KY^5SG[/2?A=XM^'GC+5=&@UWPUXOT*Q6[CT?4-12Z@G4R*K.C[%9MN[
M!! ZBO/+:\:X4B"":Z=0"ZV\32%?KM!Q7JW@/P=\+O%7[/OQ+\>Z[X(O+K7?
M!$:(?L^O744=^64%6958!/FZ@#&!Q71>*=7T7X"?"[X,G3O'>M?#R;6;4Z[=
M2>']%74%U2;<K>7+.\\9*HK!0ASD')J8XA0J2H4XSE)SY4I:I6@I-)QYY-6L
M]5]K79VUIT)2C&=THVO=>MMG9?\ #'@"ZY;S2>5'NEGR1Y*(6?(ZC:!FJ\FO
M01VPN7CF2USM^T-$PCSG&-V,9S7V'\$?BAH'Q$_;DTW6/!FE76F>'_$7A>:Y
MOEU#3(H#=7<$C)Y\1RQ48X.U@"0<YZUQ_P"SG\9_$WQ$TOX_Z'XI72]:\-^'
M](GU'2=%FT^(6MJ\3SE0% !8$QJ3N))(Z\UG+'58*<G0MR1A*2<K-<\G&UN6
MUTUU:T[/0VCA7)+]XM6TM--/F?-W]K(/*:2*:"*7_5R31,B/W^4D8/X4JWAN
M=_V6VN+P(<.;>%I OUV@XKUAOBQXJ^,W_!/[XLZKXUOX=6U/P_KUBFESK:QP
M_8XV>V_=QA%&% D8>N#@DUT'[0/C;7?V5?''PH\.>!+U]$\/Z?HMMJT\$?R)
MK$Y<^;]H?&9 P&"#TW9'.*[%6J2JO#*FO:\TXVYO=]R,97ORWUYDK<O?HC*I
M1]G#VSG[ED[VUU\KGC/PY\8>"=(\8-/XS\+WGC/26M)8TTVPD9)$FR-LAP0<
M#D?CGM4?PV^'?B;XC>&?%&NZ793)H7AZQDO)[QX6D65E^[;QX^\Y]LXQS7T;
M^R=X[UCQ1^USXIN[[PY8^%K;Q!X?EU,Z3;VR;48+"$F1RN\!QN8X(!+DXKS;
M]C?QEXBTW]FG]HT6NOZA:KI6E0W&G>5<NHLY7^T,[Q8/R,2 21C.*PK8FK3C
M6E3@E./L=Y.2_>2<=$E9-=U>^_2Q-&C&IRN4M'S[*VR7S/(]+\7>$;7X>>-=
M/UOPAJ.H^+Y_+_LO5T=XX],Q]X2+D8R?4'/3BNR^)WAKPCIO[-/PB\<>%/#=
MWINMZ_J]U9WV^[DO)9UC5Q@< 8+*& "\9QS76?"'QGKGBK]BG]HI=:U%M5FM
M4MWCNIXT-PQE#,YDE WR$L,Y<DCM23?%;Q/\'?V$/@KJ7A.2RL?$%QK&H0PZ
MI<6J3RV@)D9C%O!568#:3@\$CO715G5]NH4H^^JRBUSRY6G1<NVBV=N5ZJZU
M9O2P]/V7--W3C>]E=:[^IX*?$5A#>VG]IVLTD$%Q$UWI[[HI9(]P+(,X(++D
M ^];7Q \5>$]5^(&HW7@WPU>^%-!F6);;1+K=).CA!O."2?F/('O7T'\7/'_
M /PL#X?_ +.'QP.G6.E>/=4U^/1=3?['&1?Q+)L=BCA@5RA*G&0).".*Z+6O
M$5]I/_!7&PTVV: :?JD$$%U#+;QR;E73G==I924(90<J0>/3BL5CFU*;I6E"
MG5DUSNUZ4DI+:S_NR^6A7U"7\^[5M.C3/CW^WHVA>;[-<BV1_+><PMY:-G&U
MFQ@'/8T_^T5N9/+M()KZ7&XQVL32L!ZD*#7UO\%/C+XC^)G[1GQW^%7B#[#=
M> (])UB:#14LHDCBDBF10X8+N+-YC,Q8D[B",8KSW2$T3X'_ +(_PSURW\?:
MS\/-3\57MS>7VN^']&&HW%RT3XBMFD,\?E(H'W!G<0V>ASI]=<9JC.E:;<.5
M)N2:G&4M;1O=*+NDGK;6VH?49:6GIZ?\&QX1:7\5Y))%AHYHSAXI%*NI]"#R
M*LM#7JO[2OQ'\&?&S7?!7C;P;8:HEW<6<UAK&L7NGBSBU.:$1XD1 [#<"[[O
M0,HR<5YQY/RUV4IRJ4HU)P<&]XO=--IK\/\ @''*/LZDJ=[VZ_B9C0>U02V_
MRGBM9H:AEA^4UJF2>]_\$K(_+_:>\;C'_,NG_P!*(:_5NORM_P""7,?E_M0>
M-!Z^&R?_ "9BK]4J_%.-_P#D</\ PP_])/KLM_W6 4445\">H%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y7^TE_R3>W_[
M#FD_^ET->J5Y7^TE_P DWM_^PYI/_I=#7JE<%/\ WJIZ1_\ ;CWL1_R*<-_C
MJ_E2"BBBN\\$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:RMLK6]+6_ [7P'\?7\#_%Z7XB7/@F*[NK?3QI&C:/IMZ+.STRS[QJOEMN/
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M@P?#&5;3QK(7U&2PUH016X&1$EO&8&V*BXZDY.3WP,?2_'VE7/P6TGX9>,O
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M^[7Z5^T<+SDLJBD_M2_0^3S!7Q3OV7ZE'^PF_P"?@?\ ?%)_8)_Y^!_WQ_\
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M4Y[7$)'\S7Z(U\'?L0ON^/&L#_J R?\ H^&OO&OR3BZ4IYE>6_+'\CZ3*_\
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M)JCXVA\;R:]X4;PK<:1#HZ7I.OKJ2.TTEKMX%N5X#[O[W&* .OHHHH ****
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M -4P^(G_ ((O_LZ/KE#^;\&'^KN:?\^O_)H_YGLM%>-?\-)_]4P^(G_@B_\
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MJE<%/_>JGI'_ -N/>Q'_ "*<-_CJ_E2"BBBN\\$**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH JW_\ JE_WJIU<O_\ 5+_O53JD 4444P"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ I&I:1J (9.AJYHO^IE_W_P"E4Y.AJYHO^IE_W_Z4F!HT445(!7R_
M^PU_J?BU_P!CC>?TKZ7U(W@L9?L"P->8_=BY+"//N0"?RKQ3]FWX)^+?@O=>
M*UUK5]'U>SU[5)M58V,$L4D,C_P#<2&7WX- ''_&B%O@=^TKX-^*5NOE^'O$
M:CPWXA5.%\QC_HUPW^Z<C/I7K/@V%_&'Q.\1>*IXU:QTP'0])?.0P4AKJ0?6
M0*G_ &R]ZT_C7\+K3XS?#'7O"-W-]E_M" K#=*,M;S#F.0>ZL :V/A_X/MOA
M_P""M&\.VA+PZ=;)!YC$EI& ^9R3U);)_&@"]XD>[C\.ZH]@";];64V^WKYF
MP[?UQ7SC_P $[9+>3X!3 %3J7]M7IU#/^L\\R9)?OGFOJ"O$[7]G^^^'OQ%U
M7Q9\-]9M]$AUN03:OX?OX&EL;B7G,T>TAHI#GDC(/<4 4?V@OBEXV^'7C7P#
MIFC6WA^_TGQ-J@L&_M*VE,MLX 8."L@#<9[#D"HM/\077Q*^*GC[1]4L-2U6
MP\,FWTZ"WTNZ6U3S)(1)),P,Z-N)("\D +P<FMGQU\&?$7Q4\;>#-7U_5]/T
MW3O"^H?VE;V>F1.\EQ)MV[7D<@!>>RY]ZR?B1^S[XME^)MQX]^&/C6+P=K6I
M0QP:M:WUG]JM+T(,(Y3((<#C(/:@#RWQMI?Q+\$_LD_$F+Q9J^HZ?J6AWLDN
MA7]KJNZ\>P:5/*$[H>6 9EP23QG/>M[XT^'-1\)Z+\+O%^D^+-?M-?N=7TZP
MNIC?N\-Q#.HC96@)\OC(8$+G(Y)R:[CXE? ?Q;XT^!>N>#(_%%C=^)/$ 7^T
M]>U.U8(<,IQ'#&0  %"@9Z<G)I?BI\&_'7Q \#^"-%L]7T'3KS0;^RU"XN)8
M9I$G:W8$*B@@J&P,DDXH Y_Q%X=G^&?[47PL.DZ_KDUOXE34+35;.^U&6XM[
M@QV[2I+Y;DJC!E_@"C!Z=*V/AS(?CMXB^*<FO7MY]FTG6[GP]I]K:7,EN+2.
M$!3(-C F1FRVX]MH'OJ_$3X5^-_&'Q7^'GB^QU+0;*#PLTTDMG/%-(URTT)B
MD"L"-H 9L<'MFL/5_P!GGQMX8^*'B#Q7\,O&]EX;M/$TJW.L:5JFGF[B:X P
M9XL,NUB.N>* .>_: \)^(?AM^QWJ-B_Q!UK6M?T+R@/$$<QM;F9?M*?)($;G
M"';DG)Z]35_]ICPWIFJ>*/@7>WEFMQ>/XCAMS.S,'$9MY&(!!XR0*Z?XS? O
MQ+XZ^!=YX!T'Q#:0ZAJ)5[W6]:B>9I'\Q9&<(A ^8@C&0 ,8J[\6/@_XG^(O
MAWP+)9:UIND>*/#&J0:FLLEO)-9S,BE&0KE6 96/?@T 4/'FB/:?&+0!?:_)
M/X2BT6:WM?!>FF4WEQ>-*F+EBK F-$#+EB "^2>E>9>!_$&J:M^R[\;K/4[F
M]N8]'U+5=/LUU&4RSPVZQHZ1NY)+%=Y')/ %>HZI\&?&\?QCL/'VC>*]+CN9
M='72-5M;_3WDC<!RXD@"R#8<MT).<#.:I>"OV;=8T'PO\3/#6J^+$O\ 2/%U
MW=7<4D-F([B%YXT5V<YVMC9P  .: /-_B-\-=3T/]F?1OB3H?C7Q#I_BOP]H
M5KJL++?N+.6-(48V[VV?**;<C.W=[UTWQ&\2:IKWB3]G'Q);ZGJ6F+KFHQF^
MT^&X=()U>U,FUX\X.&KL_P#A2_B?Q!\+M-^'?B;6]-N/#D,,5E>W%A;R1W%]
M:1A0L1!8K&6"@,P)R,X S2_%WX.^*?&7BWX;WWAG4=%TC2/!]^+[[)>0RN]P
M!&8Q&"I 0!3P>: .5U;1;_5/VQKS0'\3:Y%H-YX12_ETZ&^=8Q(;F2-MA!R@
M(4?=P?0BN<^'_C;5/@\/VD]/74K[6M+\&WD=QHT.IW+W,D EL(Y_*\QR69 [
M_P 1/%>H-\*?&/\ PT<_Q'&IZ,=)_L5=%72S'*)@@D:3S/,Z9W,>,=*SO!?P
M%\06?COXL:EXGO='U30/'\D9GL+6.59+9$MEMPNYN&RJ DX'- ''>//!_C_5
MOA7X?U[X>VNM?\+"MVM=3^WZCK$4=I?!MKS12@3,OELI8 ;/EXQBOI^W>XFT
MV)V\M+IH@3_$@<CVZC-?._@3]G3XF>#U@\+S?%47_P .+<^7'8-IX&H?9Q_R
M[_:,\+CY<@9QTQ7T=!"EM#'#&NR.-0BJ.P P!0!X#\>+?XAI\.V.I:AX8>W_
M +7TO ALKA6W?VA;[.LI_BQG\:]6\.P>-X]5!UR\T&?3=A^33[6:.7=VY:1A
MC\*T?&'A#3O'&B_V5JBR/:?:+>ZQ&^T[X9DFCY]-\:_6MJ@!:*** "N"M?\
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MGIYD^Y]JG2/=]-Q&:\.\$ZA/X7_;$\9^$;%_)\/:CX:M==%@B@1PW@G>*61
M.GF*8\CU3/<TO[<VCZ?JG[/>K/?6<5U]GOM/EC+Q[F5A=Q'([_EUH ]QT_Q!
MI>K2,ECJ5I>NHRRV\ZR$?4 U?KY9^(WA^\\8_'3X4:CX"\/:IIE]IEP9=;U\
MV,EE;?V?Y>&MY"ZKYK,=NT#.,=J[CQ]^T%JW@'1M:U^_\*_9=$TW6$TQ([VZ
M\B[O8S*L;7$$97#)E\@9R5!/M0![=638^*]&U37M2T2TU.UN=7TT1M>V4<H:
M6W#KN0NO5=PY&>M>.^(_%GBN;]JCPMH5K-IY\/MH%QJ,5O(9$=G+JA9R 02
M.!CN>:U?#/Q)TNS^(OQ4.I^&+/PY/X=M[:XU'6HG1Y+Z'R/,5G(4'Y$& "30
M!['17@-Q^U98Z;JG@EKR/2)=*\4W2V<?V#54N+NRDD4M%YT2CH0,$@_*3WJ[
M'\>/%>L:]\0]&T3P1;3WGA*1%+7FJB**X5HC)U6-BK$#@8/N: /<:*^9_B+\
M9O$7BKPC\%M=\-+!I-AXJUVR2]M;MF\T<EO)W+QMW(03@Y KT/7OBWK%OXNU
MCPKH^F:7?^(M+TF/4FLKF_: W;/OVI -A)'R'+$<$CB@#U6BJ^GW$EU86T\T
M)MY9(E=X6ZHQ )4_0\58H *JZEIMKK.GW%C?6\=U9W"&.6&495U(P015JBE)
M*2::NF5&3BU*+LT?%'[7WP5\+?"+X0R:OX>ANK6[NM6MK4;[EW6.-RVY%!/0
MX[Y-?,-K-B%0/2OM+_@HO)Y?P M#_P!1^R'_ *'7Q#:S?N5^E?K_  ;@<-@<
MG4<-34$YR;LK7>FY\[GF-Q6/S!UL75E.7*E>3;TN^YI>=1YU4_.H\ZOM+'BE
MSSJ/.JGYU'G46 N>=36N-JDYJKYU(TFX8-.P'<>"]/OO#/A/4?B6WAW4?$;V
M4ILM"TRRT^6Z,]]C/GN$4XCBZY(P6P*Z3XT?\)-??L__  'U#6--U>;41:74
MVK3W-G*'@D<J2T_R_NR6)^]BO-;+XD>/?#.C_P!G>'?&>KZ)9(69+:SGVHK'
MDD#%=S\2/CSJWC;X/_#WPW#XKU:ZUBVM98O$_G!E6]8XV[V(P_(/2O,J4:_U
MFE5Y8M<[UN[J/)))/2RW[ZR:Z;:*=/V4H:IV7;5W7]>ARGP]O=-;XD>%+/5M
M'@UW3M1U*WL9+6XD=% ED5-_RD9(SG!X/>O:[63P%_PU[J7P@;X9Z*^CWS.C
M:DQ8SPN+3S1Y0Z1KQC YR2<]J\%\!W&D:?\ $+PSJ>OZG)I.DZ3?0ZA)-#:M
M<.YB=76,*O/S$8SVKU"W^(GPXC_:^D^+K^+;W^QMAF2S&BS^893 8-A..@^]
MG'M6>-IRG4GRJ;_=3MR\]N>ZY?ATOO\ J1"?+RJZ^-7O;X;:[EGX1_\ "%?$
M/Q=\0OA8W@+3[&+P_I=[)9^(_-:346D@D$?F.YXRQ8-@8 QCFN)TV*V^&O[-
M'A?XA76AZ?XB\2>+[\V]HNL1&6VLK=5D8,(\X9F\OJ>S#TKH?@_XP^&OPY^,
MGQ!\87OC.^N;+7[>[M+2"/0YPRK<2+(68XZJ1MQWZUS/AWQ3X1U?X'M\(/%F
MK7L-GX?OS=^&O%MO8/)E26^66#.X<.X^A[8I\LU5?+&?L[TW)-3NURRY[7U?
MO<KDENKZ;D)KV3YFN?WDK6[Z7MIM>S9O^/+7POJ/PM^'GQBTGPU96EM=ZM'H
MVO\ AN*:1+1Y&<QADVD,N#@X! Y&<]_0/%UUX \'_M;:5\,8?AAHMYI>M"WB
MGO+AW+P;XF(,*?=7!')ZG/48KQGQ%XE\-W7A+P+\,])U:\MO!FCZI_;&K^()
M[)C)>7&[>-L .X*"-HSZ@]J[KQI\0?AKXI_:L\/?%2+Q??0:1IZ1236;:).9
M#)$NU4!QT8,3G'&WWKGG1F[QDIN/+6Y;<^FJ]DG;KO:^MK)]#6-2*BK<JE>%
M]NWO6OT].NQJ_!?5G\#ZQ^TCX1L[33[K3?#MI-);/>6BR2RCS) $E;^- % V
MGWKF?@MXHT^X_9C^.&N:YH-G>6/VZRFET?30;.WD(\G:@V\HI;&<<XSZU/X9
M^(WP]T/XN?%_4+K7-2N_#/Q T]D6\M],D26RD9W)0HW+<-D-C%9/@W6OA=H'
MP/\ B)X%C\5:MI\GBB>)[5KK2)9FMQ$(P"Y3Y3O,9; /RA\=J<J3;FY4Y7E*
M@VU&5].3GVU333O_ ,,"DERVFK)36ZZWY1OCRZ\*^*_V>?AO\0X?#FG>!+B_
M\2MHNIIHJE81;!I TF&S\P6,-DYZGK7H_P 2/"O_  @9\17C^ ?#^J_#*XTU
MO[#\3:';F>ZMY=J[&G8$L<DG+8P/45YM'K?PVC_9[\%>!+GQ3=:A?Z%XA37K
MJ)M#F\FZ4N_F6W/'W9",YP<>];O@_P"(G@7X/ZUXTO?"'B_7-;\,:U:3PVO@
M>YTUXK>&:0\,7?Y0J@D *,D$T585+-4HS]V4[)J=G%S3C:6Z:6SE=6NF%.4;
MKF:U4;V:T:3OIU7>VIY38W7F6Z-NSD58\ZLC30UO:HC8R!5OSJ]Z25W8RCLB
MYYU'G53\ZCSJFQ1<\ZD:;CK53SJ0S<4[ >Z?L'2E_P!HC75[?\(Y(?\ R8AK
M]"*_-+]CS2M8\2?'/6K/0_$DOAB]706D:[AM(K@L@GB!3;(" ,D'/7BOM'_A
M5OQ*_P"BQ7G_ ((;/_"OQ?C.M4IYKRQI.2Y(ZKE[><DS[C(,'0Q&"YZN*A3?
M-+22J-[_ -V$E^)ZY17D7_"K?B5_T6.\_P#!#9_X4?\ "K?B5_T6.\_\$-G_
M (5\+]9J_P#/B7WP_P#DCZ/^S,)_T'T_NK?_ "H]=HKR+_A5OQ*_Z+'>?^"&
MS_PH_P"%6_$K_HL=Y_X(;/\ PH^LU?\ GQ+[X?\ R0?V9A/^@^G]U;_Y4>NT
M5Y%_PJWXE?\ 18[S_P $-G_A1_PJWXE?]%CO/_!#9_X4?6:O_/B7WP_^2#^S
M,)_T'T_NK?\ RH]=HKR+_A5OQ*_Z+'>?^"&S_P */^%6_$K_ *+'>?\ @AL_
M\*/K-7_GQ+[X?_)!_9F$_P"@^G]U;_Y4>NT5Y%_PJWXE?]%CO/\ P0V?^%'_
M  JWXE?]%CO/_!#9_P"%'UFK_P ^)??#_P"2#^S,)_T'T_NK?_*CUVBO(O\
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M0 4444 5;_\ U2_[U4ZN7_\ JE_WJIU2 ****8!1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7WG_ ,%2VV_LO(?3Q!IY_P#'FK\]]/NLVL?/\(K]UX35\EC_ (Y?E$^3S/\
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MU4ZN7_\ JE_WJIU2 ****8!1110 4444 %%%% !1110 4444 %%%% !1110
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M /5+_O53JY?_ .J7_>JG5( HHHI@%%%% !1110 4444 %%%% !1110 4444
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M_P"$LN/^?5/^^S_A1_PED_\ SZI_WT?\* .GHKF/^$LG_P"?5/\ OH_X4?\
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M$]%?<9-Q56R;"O"PI*2NWK?K;_(XJ^%AB'>9_.]_PJ'XO_\ 1,O&'_@@N_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!5O\ _5+_ +U4
MZN7_ /JE_P!ZJ=4@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 FVC;110 ;:-M%% !MH
MVT44 &VC;110 ;:-M%% !MHVT44 &VC;110 ;:-M%% !MHVT44 &VC;110 ;
M:-M%% !MHVT44 &VC;110 ;:-M%% !MHVT44 +1110 4444 %%%% !1110!=
ML?\ 4?B:LT45 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5;__
M %2_[U4Z**I %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
7"BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>figure20_01.jpg
<TEXT>
begin 644 figure20_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" */!98# 2(  A$! Q$!_\0
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M#?B#_P &C_X4?V?-_P!!OQ!_X-'_ ,*.278?,CV"BO'QILW_ $&_$'_@U?\
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M\2?^#5O_ (FC_A$3_P!#'XE_\&K?_$T687/3Z*\Q_P"$1/\ T,?B7_P:M_\
M$T?\(B?^AC\2_P#@U;_XFBS ].HKS'_A$3_T,?B7_P &K?\ Q-'_  B)_P"A
MC\2_^#5O_B:+,#TZBO,?^$1/_0Q^)?\ P:M_A1_PAY_Z&/Q+_P"#5O\ "BS"
MZ/3J*\R_X0__ *F/Q+_X-6_PH_X0_P#ZF/Q+_P"#5O\ "BS&>FT5YE_PA_\
MU,?B7_P:M_A1_P (?_U,?B7_ ,&K?X468'IM%>9?\(?_ -3'XE_\&K?X4?\
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M_BC_ ,&K?X4?\("/^AG\4?\ @U;_  IV ]&HKSG_ (0$?]#/XH_\&K?X4?\
M" C_ *&?Q1_X-6_PHL!Z-17G7_"  _\ ,S^*/_!JW^%'_"OQ_P!#1XH_\&K?
MX4@/1:*\Z_X5^/\ H9_%'_@U;_"C_A7X_P"AG\4?^#5O\* /1:*\Z_X5^/\
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MJ?Q,_9C^&WB/6IFNM6O-%@^U7$ARTTBKL:1O=BNX^YKJOC=_R2'Q?_V#9O\
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M@D**** "BBB@84444%!3J;3J!,****"0HHHH&%%%%!04444 *O6G4U>M.J6
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MJD 4444P"BBB@!5I:1:6I8!1112 **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!Z5B_#G_D)^-_^PY_[9VM;25B_#G_D)^-_^PY_[9VM ':T444
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M^,:^)K8^,)O"[Z#M?SAI:RB?=M.S&[C&[&?:MCXF)\1FDL/^$!DT)$PWVO\
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MD\S(Z[N,8S1+$<M7V7)+UMI]Y3K6J*GR/UMI]YZ"L9IQ4UYQ\2H_BX_B"(^
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M3265H-H!9G8G:% (.<]Q7K7B[Q#IO@7PKK'B/6[C['I&DVLEY=S$9V1HI9B
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MAMYS6;-^QS\2(_V&_P#A1,6N>%KC49M2%Q)J$DEQ%## MP)P%(C8R.74#E5
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M3_ 7XG>#?VPO&?QAUB?PE)I7BJ#['<V%C>7)GMH56)8V3= %=L0ID$@?,<=
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MU);R[RZO&5\LI]GZAF)SGI@8[U]\^$_M^F^%]%M=5%N-3MK*&&Y%F[/#YBH
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M.OOV@O _A26>YL-"\>>&[Z'6+&:-GN+-;I,%H68JKM$V,;MH/ ..U0?"_P"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=_\ /G#_ -]&C_A/+O\ Y\XO^^C1R,.9';45Q2^.KL_\N<7_ 'T:7_A.KO\
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M\)?<_P#/M'^9I<K"Z.KHKE/^$ON?^?:/\S1_PE]S_P ^T?YFCE87.KHKE/\
MA+[G_GVC_P"^C3O^$NN/^?:/_OHT<K"YU-%<M_PEMQ_S[1_]]&C_ (2VX_Y]
MH_\ OHT<K"YU-%<M_P );<?\^T?_ 'T:/^$MN/\ GVC_ .^C1RL+G4T5RX\6
M7'_/M'_WT:7_ (2RX_Y]H_\ OHT<K"YT]%<Q_P )9<?\^T?_ 'T:/^$LN/\
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M%?B#3=6NO#/CK1I+S1-4L=.GNHYF*Y-N1&K,C@MM"L!G;Q7B^O?!GQE\._\
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M=:_:L_:AO?$OAOQ')X'\0>'[Z)&CTV>(7RQF/<(690I<A'*\\]NM<!X#\;?
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MPWI.@:5$;?2]*M(K*UB))V11H$09[X %:2WTB]"<5GSZZ;%<I^4FDZ+KEO\
M\$Q=:\#OX7\0#Q7-XN65-+_L>Y\XQYBD\S&S[N$;YNF>.M>Y_%G]HC7O!/[+
MOPK^'_AOP1XOUW4=0\/6,.OR:;IT\+VMJD:QS6XE:)MDKE'3[I*KD\$J:^ZO
M[0D_O&C^T)/4TN;9V'R]#YU_9 ^,VL_%/0]6TYOA=/\ "KPGX=M[:QTS2[I)
M [L0Y8@O&F5 5>@ZGD\U]*_!/_CV\6_]AQ__ $EMJS+BY:13DYK1^"'_ !Z^
M+O\ L.O_ .DMM4;NX;(]*HHHH$%%%% !1110 4444 %0WMVEA9SW,H8Q0QM(
MWEJ6; &3@#DGCH*FHH ^ _ /Q\T+XY?M!6GCGXC:?XL\.Z=X=O&L?!/A*X\*
M:C*@DD4(^I74J6[1B5MVU 6'E ,2><G7\/?%*7]F^Z^/G@C7?"'BS4M4UCQ+
M?ZYX:73='NKV/5X[Z)-B+<(C1H5D#*=[* ..QK[EHK3GZ$\IY3^RK\-]0^$?
M[.GP]\(ZN-FK:9I$$5Y&""(YBNZ1 1U"LQ&?:M_XW?\ )(?%_P#V#9O_ $$U
MV]<1\;O^20^+_P#L&S?^@FHO=W'L<M&@VBGA!GI21_=I]=IB'EBCRQ3Z*E"&
M>6*41C=3J%ZTQ] \L4>6*=14B&[!2B,9I:5>M!0>6*/+%.HH)&[!1L%.HH+$
MVBE5!BBG+TH$)L%&P4ZB@8BJ.*78*%ZTZ@0W8*-@IU% P51S2[!2K2T -V"C
M8*=10 T**?L%)3ZD8W8*-@IU%-"&[13E444JTA] VTFP4ZBD(3:*-M+104+M
MHV4ZB@D3:*-HI:*"A-O(IVT4E/H$QNT4;13J*0QNT4;:=13 7:*-HI:*D2$V
MBC:*6B@8FT4_:*;3Z $VBC:*6B@!-HHVBEHH %44NT4+3J0#=HHVBG44 )M%
M)M%.HI@+M%&T4M%(!-HHVTM% ";:-M+10 [;1M%+120";:-HI:*8";11MI:*
M %"\"C;2TM2 FT4;12T4 )M%&T4M%4 FVG!>E)3J3 -HHVBBBD ;11M%%% !
MM%&VBB@!RJ,4;10O2EH 3:*-HI:* $VBC:*6B@!-HHVBEHH*0[:*-HI:*"1-
MHHVBEHH  .:P_&0_<V7^\W\A6XO6L3QE_J;+_?;^0I/8I;G/Q_=I],C^[3ZD
MT"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% #TK%^'/_(3\;_]AS_VSM:VDK%^'/\ R$_&_P#V'/\ VSM: .UHHHH
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M$-U#8Z=;I9H+AWMK:\CD">8"2XB8##$D<U7+K85S[LKB/C=_R2'Q?_V#9O\
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M_" 7W_/Y!_WR:/\ A +[_G\@_P"^31S1[CLS&W"G!ABMC_A ;[_G\A_)J/\
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M'^1H_L&?_GK'^1IE%/(I^15G^P9_^>L?Y&G?V'-_SU3]:0F5,BC(JW_8<_\
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M )ZK^M']CS?\]5_6@"KD49%6O['F_P">J_K1_8\W_/5?UH JY%&15K^QYO\
MGJOZT?V/-_SU7]:: JY%&15K^QYO^>J_K1_8\W_/5?UI@5<BC(JU_8\W_/5?
MUH_L>;_GJOZT 5U(I=U6!I$W_/5?UH_LF7_GHOZU(%?(HR*L_P!DR_\ /5?U
MH_LF7_GJOZT 5LBC(JS_ &3+_P ]5_6C^R9?^>J_K0!6R*,BK/\ 9,O_ #U7
M]:/[)E_YZK^M %;(HR*L_P!DR_\ /5?UH_LF7_GJOZT 5LBC(JS_ &3+_P ]
M5_6C^R9?^>J_K0!6R*,BK/\ 9,O_ #U7]:/[)E_YZK^M %;(HR*L_P!DR_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% 'Q%_P4J_:V^('[+;?#C_ (0:
M738QKO\ :/VP:A:>?GR/LOE[?F&/]<^?7BOBQ?\ @K5\?/\ GKX:_P#!4?\
MXY7M_P#P6S^]\&/^XU_[8U^9UE:_:I-N<"OW#A;(LOQN6PKXBFI2=]7_ (FC
MR\16E3D]=#[#_P"'M7Q\_P">GAG_ ,%1_P#CE'_#VOX^?\]/#/\ X*C_ /'*
M^3ET6/N6IW]AQ?[5?6?ZMY-_SY7W'G_7_P"\?5__  ]K^/G_ #T\,_\ @J/_
M ,<H_P"'M?Q\_P">GAG_ ,%1_P#CE?*']AQ?[5']AQ?[5+_5O)O^?*^X/[0\
MSZO_ .'M?Q\_YZ>&?_!4?_CE'_#VOX^?\]/#/_@J/_QROE#^PXO]JC^PXO\
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M"BBB@ HHHH *XSXR_P#)+?$W_7D]=G7&?&7_ ));XF_Z\GH [.BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /R^_P""V?WO@Q_W&O\
MVQK\V=#_ -8_T_QK])O^"V?WO@Q_W&O_ &QK\V=#_P!8_P!*_HW@[_D2T_\
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M<J%S,ZC_ (32Q_YY7'_?(_QH_P"$TL?^>5Q_WR/\:Y@1+Z4>4/2CE15V=/\
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M2)@EKX5B/9AICG^<M1+@W-H*\HK[P^L0/V6;7K=>J2_]\C_&D_X2*V_N2_\
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MP6T^6I:6VB2CS+YI;>AZ_P"6:=Y)Q6)X4\/WOA_PA::/?:Y=:W?PPM&^K7(
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M7[6Y>;\+'J!C([4ODGTKE?AEX/U3P+X?;3]9\5W_ (PNVF:7[?J"A9 I P@
M)X&/7O7G.N?L_P#CC5M:U&]M?C=XDTVVN;B2:*RAA4I;HS$K&OS]%! 'THE4
MJJ"DJ3;?2ZT_&P4,'@ZM>I2J8R,(QVDXU&I>B46U\TCV_P LYQBE,) K%O\
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M>Y_]'"OOWXC?!WQ5X\\4KJ6B_%/7/!UGY*1'3=/C5HRP)R^2PY.1V[5^;O\
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MP/<?^CQ7ZGVG^L6ORP_X+0?\E2^&_P#V![C_ -'BOL.$?^1Q2^?Y'-B/X9\
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MX77_ 'X;_"E%I?Y_X\;K_OPW^%>N44>T\A\IY+]EO_\ GQNO^_+?X4?9;_\
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M44N8+'Q!_P %35D7]CV[#QNA_MNQ^\I'=Z_'#1S_ *4/I7[2?\%9O^30K_\
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M]\FE\N7_ )Y2?]\FNAHHN!BVJRB1<QN!G^Z:_+#_ (+0'_BZ?PXX./[&N/\
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MAS_V+NG_ /I.E?EGB%M0^?Z'V6#V9Z#1117XT>D%%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\EO^"T7_)4OAO\
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M.E?EGB%M0^?Z'V6#V9Z#1117XT>D%%%% !1110 4444 %%%% !1110 4444
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M-0_X]Y/I5MJJ:A_Q[R?2M(;HTI_$B7X/?\EB\"?]A^P_]*(Z_I-K^;+X/?\
M)8O G_8?L/\ THCK^DVOQKQ _P![I>C_ $/L\+\+"BBBORL[@HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\EO^"T7_)4OAO_ -@>X_\
M1PK]::_);_@M%_R5+X;_ /8'N/\ T<*^PX3_ .1O2^?Y'/7^!GP'H7WG_"MU
M>U86A?>?\*W5[5_1M7XCXW$_Q&.HHHKG.0**** "D:EI&IH"CJG_ !ZR?[M=
M)^S)_P G,?"3_L;](_\ 2V*N;U3_ (]9/]VND_9D_P"3F/A)_P!C?I'_ *6Q
M5ECO]QJ^C_(]K _J?T8T445_)Q]6%%%% !1110 4444 %%%% !7(>!?^0WXY
M_P"PX/\ TBM:Z^N0\"_\AOQS_P!AP?\ I%:T =?1110 4444 %%%% !1110
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M110 4444 %%%% !1110 5\'?\%E/^38O"_\ V.-K_P"D5[7WC7P=_P %E/\
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OR6_X+1?\E2^&_\
MV![C_P!'"OUIK\EO^"T7_)4OAO\ ]@>X_P#1PK[#A/\ Y&]+Y_D<]?X&? >A
M?>?\*W5[5A:%]Y_PK=7M7]&U?B/C<3_$8ZBBBN<Y HHHH *1J6D:F@*.J?\
M'K)_NUTG[,G_ "<Q\)/^QOTC_P!+8JYO5/\ CUD_W:Z3]F3_ ).8^$G_ &-^
MD?\ I;%66._W&KZ/\CVL#^I_1C1117\G'U84444 %%%% !1110 4444 %<AX
M%_Y#?CG_ +#@_P#2*UKKZY#P+_R&_'/_ &'!_P"D5K0!U]%%% !1110 4444
M %%%% !1110 444E "UQGQE_Y);XF_Z\GKLZXSXR_P#)+?$W_7D] '9T444
M%%%% !1110 4444 %%%% !7RC_P5$_Y,J\;_ /7QIW_I=!7U=7RC_P %1/\
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M\E8K_>*GJ_S/K8[(****Y2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI73U_(]3XY>I];'9!11168PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB@ HHHH **** "BBB@ KD/ O_(;\<_\ 8<'_ *16M=?7(>!?^0WXY_[#@_\
M2*UH Z^BBB@ HHHH **** "BBB@ HHHH *^%=%^$]G^U)XZ_:(UWQIK7B![G
MPSKUQX<\/1:;K-U91:7';VR.)4CBD56=GDW'>&!*]*^ZJ^7-?_9?^(_A_P 9
M?$J]^&7Q$TGPWH7Q!F^V:G:ZMHSWMQ8W31^5+-:N)E7++@X=2 0.PJXDL[']
MB/XF:Q\7?V6?A]XGU^0W&LW%BUO=7#-EIY()7@,K' ^9_+W'W8UWWQF;;\*_
M%#$,0MC(QVJ2< 9/ ]JE^$7PQTCX,?#/PWX(T)6_LO1+*.TBDD #RE1\TCX
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MWV?\*[2BLQG%_P#"YO!'_0S6'_?9_P */^%S>"/^AFL/^^S_ (5VE% '%_\
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M^%'_  N;P1_T,UA_WV?\*[2B@#B_^%S>"/\ H9K#_OL_X4?\+F\$?]#-8?\
M?9_PKM** .+_ .%S>"/^AFL/^^S_ (4?\+F\$?\ 0S6'_?9_PKM** .+_P"%
MS>"/^AFL/^^S_A1_PN;P1_T,UA_WV?\ "NTHH XP?&7P0W3Q+8?]_/\ ZU?&
MO_!5S5(/B;^SIX<T[PB)O$VH1>*K:X>UTJ![B18A:7BERJ D*"ZC/JPK[]HK
MLP>*G@Z\,1!7<7<F4>96/YL%^$'C_P#Z$3Q-_P"":Y_^(IW_  J#X@?]")XG
M_P#!-<__ !%?TFT5^@KC[,(JWLX_C_F<OU6'<_FR_P"%0?$#_H1/$_\ X)KG
M_P"(H_X5!\0/^A$\3_\ @FN?_B*_I-HJO]?\P_Y]Q_'_ #%]5AW/YLO^%0?$
M#_H1/$__ ()KG_XBC_A4'Q _Z$3Q/_X)KG_XBOZ3:*/]?\P_Y]Q_'_,/JL.Y
M_-E_PJ#X@?\ 0B>)_P#P37/_ ,11_P *@^('_0B>)_\ P37/_P 17])M%'^O
M^8?\^X_C_F'U6'<_FR_X5!\0/^A$\3_^":Y_^(J&?X0^/PASX%\3#_N#W/\
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M]6WW\SFG0C4?,S^;+_A4'Q _Z$3Q/_X)KG_XBC_A4'Q _P"A$\3_ /@FN?\
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M  ":_?Z;XN>#;=MLGB*Q0^[_ /UJZ^BOC\XSFOG-2-2M%)Q['13IJFK(XO\
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MYO!'_0S6'_?9_P */^%S>"/^AFL/^^S_ (5VE% '%_\ "YO!!_YF6P_[^?\
MUJB^%^JVFN7'C'4+"9;FRN-:+13H#MD M+920>XRI'U!KN:* "BBB@ HHHH
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M+\^](2J["%0;R<G%?853)6U0XON%%%%04%%%% !1110 4444 %%%% !1110
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MPLTOQU^RC\;_  %\)K[Q:_C[X:^*;*\@T1]1MDCU+1YK2)9=CR1@++$4R,D
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MNH:YI_BCXU>%O&VB66G_ !&L_$::IKU_I4YDL;YKN!7@:W4J&C18D5=K9/\
M$22QQ]7U#5G8:"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\E\5
M_L[V7B[XX>&?BA<>*-<MM8\.PRVVGV-O]G%HD4H(F5E,)9MX/)+9&!@BO6J*
M:;6P'E_BGX"V.M?$B;QWH_B/7/"'B6[TU=)OKC1Y(6CO+=2S1"2*:.1-\9=B
MKJ PS@DCBNJ^&OP[T7X3^!]*\*>'H'@TG3D98Q+(9)'9W:221V/+.[N[LQZL
MQ/>NFHI\SM81Y9\?/@#I_P"T%HNDZ3JWB#6-%LM-U"'5(ETAH49KF$[HG+21
MN?E)S@8![YK4^(WP;TKXG:?X>_M*^OK77?#]W'?Z7X@LC''>6MPJ[6=<H4(=
M20Z%2C \KP,=_10I-;!9,\FL?V9/!:_#?Q?X-U:*[\16GC">:[UZ^U.;==W\
MTF/WC.H7:4"H$"!0@1=H&*3PO^SCI/AW5M5UR?Q'X@UKQ3>Z.F@Q:_?W,9N[
M&S1<!(-D:JC%OG9]I9FP6)P!7K5%',PLCR[PI\!;31=7\-ZIKGBKQ%XWOO#:
M2KI,OB"YC?[.\BE'E81H@EEV,4$DFY@I;!&YL^HT44FV]PV"BBBD,**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RNW^ D%M
M\>[GXK+XLUTZM<:>NDRZ6?LWV)K-69TAV^3OPLCM(&W[LD@MM^6J_B#]G'3-
M2\7>*?$&C>)O$'A&?Q5!%#KEOHLT*17IC78LO[R)S'+Y?R&2,JQ '.0"/7**
MKF8K&/X.\(Z3X!\*:1X;T&T6PT72;6.RL[96+>7$BA57+$DG ZDDGJ:X?XM?
M F'XM>)_!^MS^*]<T*;PK>_VCI\&E_9Q%]IVLGFN)(7+?([IMSMPQXSS7J%%
M*[O<#SWXE?!C3OB-K?AS7UU?5/#GB;P^TWV#6M'>-9UCF39+$ZR(\;QL IVL
MIP44C!%8)_97\"GX3-X!\B]^Q-J']LG5/M3'4/[2\[S_ +;YQY\WS/FZ;<?+
MMV_+7L%%/F861Y-I?[.>E6%AXX>?Q)XBO_$?C"!+;4?$\EXD6H1Q1H5A2W:)
M$2%8]S,H1!\S$G)-7OA[\"[#P3K4.N:CXAU[QMK]M:M8VFI^)+I9I+6!BI=(
MU1$12Q5=S[=[8 9B  /2Z*.9A9!1114C"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *\L\)_ :+PI\9?$7Q''BW7M1U37K>
M*TO+"[-M]D\F+=Y"(JPJRB/>^"&R=QW;LUZG13N(\6UG]EG0-0O/' L/$'B#
M0='\;3"Y\0:-IMQ&MM>2E!'*X+1L\1E155S&R[@!WYKV#3=.MM'T^UL;.%;>
MTM8EAAB3HB* %4>P %6:*+MJP66YY3\0/@#!\0OBMX-\=W/BW7M.O?"<DDNE
MZ?9&W%HCRQF.9G5H69R\9*'+?*"=NTDFKOQ$^!>E>//%VG>++?5M5\+>*K*Q
MN-+76-%DC2:2TFQOA<2(ZL P5U.-RL,J1DY])HI\S"QYUIWP/T7PW\&_^%;>
M&;W4/#>B_99+075I(LMV%E+-,_F3*^7<NY+D$Y8D8-9>A_LV>&;#X _\*>U6
MZU#Q)X0%E_9J#4G03I;@#RT#Q(G*8!5L;@0.3BO6:*5V%CS'PG\";30?%FB^
M(]7\3:[XOU30]/?3=+DUJ6$K:QOM\QP(HT#RN$13(^YL+UY.?3J**&V]P2L%
M%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(
M>00#CWI:* /*/AC^S[9_"_XC^-/&=KXGUO5=0\731SZI;Z@;<PO)&NR-D"1*
MR;4^4 '&.H-8NH?LD^&;^W\2Z1_;NO0^#?$FJ-J^J^%$N(FL;B9W\R506C,L
M<<CC<Z)(H)SZG/N-%5S.]Q60U5$:JJC"J, 5Y3X@_9\M/$'QTT/XIR>*=<M]
M9T:TDL+2PA-O]C6WDYE0JT18[S@EMV[Y1@C%>L44AGE?Q%_9[TGQ]XMG\36N
MNZWX3UR\TE]#O[S09XXFO;)FW".3>CX926V2+M==[889J3Q)^SWX;UCX%O\
M"33)KSPQX0?3_P"RFCTMD\TVI4JZ;Y%?EP3N?[Q))SDFO4**?,]A61P6D_"R
MYT'X5Z?X(T[QAKEFMC:QV4&M1K;?;DA10JJ"8=F0H W;-W?.>:?\(_@SX9^"
MN@3Z;X>@N'EO)C=:AJ>H7#7-[J%P?O33S.2SL??@#@ #BNZHI78!1112&%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 R16D
MC=5<QLP(#J 2ON,\5YA\%/@+:_!-O%0M?%&N^(HO$FIS:S>0ZT\#JMW,<S2)
MY<2;0_&5^Z-HP!SGU*BG<#PO1?V0_#&BZ3IWAU==\07/@;3=7_MJT\)3W,9L
M8YA*9HXR1&)6ACE(D6)I"H95R"!BO=***')RW$>7V/P+CL?CK>_%'_A+=>EU
M.\T]-*ETIS;_ &$VB,[QQ;1"&^221W#;MV6()(.*QO'W[*?A;Q[XB\4ZH=4U
MK0HO%UI#8^)K#2+A(H=9@BR$28E"Z'8SH6B9&*L037M-%/F:"R/$?B1^RSI_
MC_Q!X7U.T\;>+?!T?AFU^RZ3I_AN\BMK:V!0QE@IB;+%/ER2<#@8R<W;']G>
M?2_"MGI-I\3_ !['?P:JVK2:W+JJSW=RY0IY,HDC:,PA<8CV!<J#C/->PT4^
M:6UPY4<;\/OA9I'P[NM?O[22ZU#6_$%V+[5=6OY ]Q=R!%C0' "JB(JJJ(%5
M0.!DDGLJ**EN^XPHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^;=%+&XR,@[AG& /ONDU9@@HHHI#"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%;/BGJWBG5+70-*N_"J6$&H:E((;<W&RPE\OS&PH8I%(>3_":_0S^S+/Y?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ^T.WA/XU?#CX?6GA2\U>+QHLTL&O1WD"6L4<4322$+DNY"A#]U5(<88D$4
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M^.WP-U#XS^.OA3<S7EBGA3PGKO\ ;^H6$ZR>==W$49%J$*G;M5V+$-UP/<4
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M/%'Q!\1K8ZGI46EP&STVT0K/.;,;1*1'&#&TDK/N5MP5#C'?_'C]G+QS\3O
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MI$\KR%_,>,2,\JKN3.(HSC>6K4^!G[(OQ5^$NC_\(-_PLC1;#X>VTS"&_P!
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M4+./QEX#N9S9_P!N>8]M>6US"(;F*5DRRNRJC+( 2&3&,,: /-/B%K3^*O\
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M^%EG<RW=WJ_AF>;4/!XT]%D6;87B\^Y?)C1&DQ)M *"!L;R0M=SX3_::\?\
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MN>QVKD=#@5V%% '(?\*A\%?\)U_PFA\+:6?%>U4&KM;*;@!4**0V."%+*#U
M)'0FNOHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "N9^('PR\)_%;1!H_C'PYIOB73%D$JVNIVRS(C@$!EW#Y
M6P2,CG!-=-10!R/A;X2^#O!>LSZOHOAVQL=7FA%O)J"Q[KAH@<B/S&RVW/\
M#G%==110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
/ 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>figure21_01.jpg
<TEXT>
begin 644 figure21_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ((!98# 2(  A$! Q$!_\0
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M444 %%%% !1110 4444 ![5JUE'M6K4L!:***0!1110 4444 %%%% !1110
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M1NVCSD3+)GCJ.XSBL#X(_MC?#W]HG4[JS\!_VWK"VA475VVE2Q6]ONSMWR.
M 3M/ R>*I83$.FZJ@^5;OI]X<T;VN>XT5\[Z[^WA\*]#^(VL>!HY/$.L^)M)
ME,-U9:+H%U>LK  G'EH<@9ZBL+Q1_P %)/@SX'OEL?$DOBCP]?-&)5M=5\-7
MEM*R$D!@KQ@XR#S[5I' 8N;2C2;Z["YX]SZEHKG_  #XXTWXE>#-'\4:.MT-
M*U:W6ZM3>6[02M&W*L48 C(Y&>H(/>H_B-\0M#^%/@C6/%OB2[^PZ'I,!N+J
M<*6(4<8"CDDD@ #J2*Y/9SY_9V]Z]K=;]BKJUSI**H:!KEEXHT+3M8TV87.G
M:A;QW=M,HP'C=0RM^((KP[Q/^W#\,_"_Q,UCP X\1ZKXJTEPEW8Z-H%U?,A*
MALCRD;(PPYJZ="K5;C3BVUOY"<DMV?0%%?+&C_\ !2CX+>(M=_L32;CQ-JFM
M;G7^S;+PW>37.5SO'EJA;(P<\<8-=Q\,?VPO 'Q@\0>(= \,IKUSK^@VWVN^
MTJZT>:UN43>$P$E"G=EA\O6NBI@,52UJ4VO5"YXO9GM]%?,%G_P4:^#FH>-E
M\'6UQXBE\5->-I_]D#0;G[0+@,5:,J5X8$$'/3!S7TA!K,#:*NIW2OIEOY7G
M2"^ B:%0,G?DX7 Z\UE6PM?#V]M!QOM=#4HO9E^BOFZ3_@H+\&[K7[W2-#U3
M6/%]S9*7G?PSH=UJ,2*.K;XD(*C^\./>NT^"O[5WPP_: FN;7P;XEBN]3ML^
M=I=W$]M=H!W\J0!B/<9JYX+$TXN<Z;26^CT%SQ>S/7:*\B^.G[4/@O\ 9SCM
MKGQO'K5EIUP0L>I6NERW%KO.?D,B A6XZ'&>U:'P)_:/\!?M(:#>ZOX%U<ZE
M;V4_V>YCFA:&:)B,C<C '!'0]#@^E1]5KJE[?D?)WMI]X^97M?4]-HKQ[QY^
MU'X4^'/Q TWP9J^D^*'U[5&8:?#8Z'/<I>!<;VC= 5(7(W$D;0<G YKUVWF^
MT6\<NQXMZAMD@PRY'0CL:SG1J4XJ4U9/;S&FGL24445B,**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH H7O_'P/]W^IJ"I[W_CX'^[_ %-050!1113 **51
MN.*\S^,7[2WPQ^ =FLOC3Q79Z?<N0$L(29[I^G2),MCD') %:T:-3$35.C%R
MD^B5V)R45=GI=%8/CKQ?%X)\":EXF6SFU-;6W$T-G!A9+AV($:#/ +,RCGIF
MN1\-_$[Q5;^/-%\+>.?"=EH%QKEC)=:=>:7J1O83-$ TUM)NCC97",&! *L
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M06;6NES7,0#11)#AKJ0D?PH6<>Y7 ZBOT>^+UI'8?'+]GRVA0)##J&I1HHZ
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M\LG".GS?^74QBI)>UCW?YL^O_P!CA2O@WQ\#_P!%!\28_P#!C+7YL_"/Y?\
M@K1)C_H<=4_] N*^\_\ @F/KE[XF_93TW6=2N6O-3U'6-2N[NYDQNEFDN79W
M..Y))_&O@SX2?-_P5HDQ_P!#CJG_ *!<5IE\/9ULQ@^D)+[DRGM#^NI]3_\
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MH"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.<<M_P %.?VD/&WP3^'47AWPSHDUA9^)%:RF\5M-$50,K^9;Q1Y+B0H.7(
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MNF>'=>\JV!/7"O&[>@Y)X KV#X3_  ,\&?!.QN8O#&F,M]>8-[J]].]S?7C
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M=-&EWL\+;8[F,,K*SKCEQM W>@ ["NSHK"-2<;\KM?1^A5D]Q:2BBH&%%%%
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M45%61YOX!^!.A?"CX<ZAX-\%7NH^&=.N;NXO(9[1HI)K-YI/,98?-C= HSM
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MRVT7;TT)]G#L?,WQ,_X)^^#/BW\0+7QMXE\<^.;KQ-9K"EM?0WMI T'E'*%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 4+W_CX'^[_4U!4][_Q\#_=_J:@J
M@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4<$$$9!&"#WHHH YZ
M'X8^"Q(6/A31]Q.2WV*/.?7I7F_[*?P=U/X2_#Z:V\3Z9IEOXF?4;Q_M-BRR
M$VSR[HEWX!^[C*]B*]II:0'*?%BQUC6/AMXATO0=.34]5U"SEM(89;A8$#.A
M7<S'H!GL"?:O*/ G@7XB>&_V0V^'=[X8LW\5QZ//HZ+#JD9M7\Q'42^80&
M;D;<YKZ"HW'UH ^>-%\ _$73_P!CD?#:7PO9MXMCT1M&7;JL?V1B4*B4R8W!
M>>FS/M5+4_V>_%7C[]GGP+H6H1VOA7XA^"%M7TN[BN1<V[S0(JC+  ['"C/
M(-?2FX^M&X^M%@/$/'7@7Q[\?O"NE^$_&>C:;X6T;[5;W>L366H_:C=>3(L@
MAB7:,*S*,EN0!C'>J7Q*\ ^.M6_:2^'OB_0_#=I<^%?#%I<6D[2:DD4\OF@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH3A'FT:\FG^3-"BBBNDYPHHHH ****  ]JU:RCVK5J6 M%%%( HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BJ4FM6$,C1O>VZ.IP5:0 @_G2?VYIW_ #_V_P#W]7_&@"]15'^W-._Y
M_P"W_P"_J_XT?VYIW_/_ &__ ']7_&@"]15'^W-._P"?^W_[^K_C1_;FG?\
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M: +U%4?[<T[_ )_[?_OZO^-']N:=_P _]O\ ]_5_QH O451_MS3O^?\ M_\
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MJ*;OHWT .HIN^C?0 ZBF[Z-] #J*;OHWT .HIN^C?0 ZBF[Z-] #J*;OHWT
M.HIN^C?0 ZBDW4;J 'J3FN<\'?\ 'SXF_P"PK)_Z E=$G6N=\'?\?/B;_L*R
M?^@)7'6_C4OG^1U4OX57Y?FCH:***[#E"BBB@ HHHH #VK5K*/:M6I8"T444
M@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH \AUZ-6\0:@<?\MF_G53R5]*O:Y_R']0_Z[-52@!GDKZ4
M>2OI3Z* &>2OI1Y*^E/HH 9Y*^E'DKZ4^B@!GDKZ4>2OI3Z* &>2OI1Y*^E/
MHH 9Y*^E'DKZ4^B@!GDKZ4>2OI3Z* &>2OI1Y*^E/HH 9Y*^E'DKZ4^B@!GD
MKZ4>2OI3Z* &>2OI1Y*^E/HH 9Y*^E'DKZ4^B@!GDKZ4>2OI3Z* &>2OI1Y*
M^E/HH 9Y*^E6M#C5?$6FD#GSU_G4%6M$_P"1@TW_ *[K_.@#URBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"A>_\ 'P/]W^IJ
M"I[W_CX'^[_4U!5 %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "F,V*5C3K/#7:@C/!H @:8#O
M4;7"^M;WE)_<7\J/)3^XOY5-P.?^TKZT?:E]:Z#R4_N+^5'DI_<7\J+@<_\
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M.=QV ]N*]>\7?%(V'B30O"WAJP@UKQ7K-DVIPV=[=&U@@M%VAI9I CE1EE4
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M ##^RU_T$4__  +_ (!Z;17F6WXR?\]? O\ WZO?_BJ-OQD_YZ^!?^_5[_\
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M-*])I_\ R$E_W32 W****D HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ5G-NHU:36EO\CZC$U\/@XTJ<<-"5X1;;Y[MM7>TTOP/,/[>^+__ $)_A/\
M\*&?_P"1*/[>^+__ $)_A/\ \*&?_P"1*]/HKH^KR_Y^R_#_ "./^TJ/_0)3
M_P#*G_RP\P_M[XO_ /0G^$__  H9_P#Y$H_M[XO_ /0G^$__  H9_P#Y$KT^
MBCZO+_G[+\/\@_M*C_T"4_\ RI_\L/,/[>^+_P#T)_A/_P *&?\ ^1*/[>^+
M_P#T)_A/_P *&?\ ^1*]/HH^KR_Y^R_#_(/[2H_] E/_ ,J?_+#S#^WOB_\
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MOA9\;+[XB?%KXD^"KSP]'H[>#Y;>(7"7GGFY\U-X)&T!>"/7K7K'EMZ5\U?
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MH\NH; C7 @EVAV  &2/0=J4J3BF[[6_$%*[L>U4445@6%%%% !1110 4444
M%6M#_P"1@TW_ *[K_.JM6M$_Y&#3?^NZ_P Z /7**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q_P-_R<Q\4_P#L$Z)_*ZKV
M"O'_  -_R<S\4_\ L$Z)_*ZKV"N/"_!+_%+_ -*9]%GO^]4_^O5'_P!,P"BB
MBNP^="BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *%[_P ?
M _W?ZFH*GO?^/@?[O]34%4 4444P"BBB@ HHHH **** "BBB@ HHHH ****
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M4FZC=0 M%)NHW4 +12;J,T >0>!O^3F?BG_V"=$_E=5[!7C_ (&_Y.9^*?\
MV"=$_E=5Z_NKCPOP2_Q2_P#2F?19[_O5/_KU1_\ 3,!:*3=1NKL/G1:*3=1N
MH 6BDW4;J %HI-U&Z@!:*3=1NH 6BDW4;J %HI-U&Z@!:*3=1NH 6BDW4;J
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MX3B\<>%K[1)KA[6*Z" RQ@%EVNK<9_W:W(T\N-5SG: ,TZB@ HHHH *X)/\
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MA_SSM_\ OD_XUDT4 :W_  EVH?\ /.W_ .^3_C1_PEVH?\\[?_OD_P"-9-%
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MV^DQ7A?[47P/TKQAX/U3QQ#K6H:#XI\.VCZAI^I1ZA(L$3Q+N \LML7.",J
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M_P!O^E !#)NQ5N-JS+9NE:$3<"@"*\_X^,?[-0U+>?\ 'P/]P5%5 %%%!-,
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MF>&18QC+J#@@X[5[?10!Y];?#'3]+\2:9XN\0:[=ZSJ&AV<MO:7FI&&-+9)
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M5\*O"/\ PA_@^*$>,-2\<I=.;E-8U*Y$[2(P&T*1QM ]*4XU84XRE)Z[;_\
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M4WP_\8O!GB?P=+XJL-;5M CE,!O+B"6 -(#@HJR*K,<\8 .3P*J]=/KI;O\
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M5E.MM=WZVTLEK;2'^&295*)CODC'?%>3_"\G_AMKXZ!#^\_L#0=H[]+JN,^
M6I>#?B-^SEJWA'Q7XYFTF: WVG>)=*N)K2WEAD,K^:Q\R+=\V2P;)SG.: /J
M76OB%H>AW%A;373W-W?Q-/;6UC"]Q++$H!:0*@)VC(^;IR/6K'@WQII'C[0T
MU?1+EKNP:22$2-$T9#QN4=2K $$,I'([5\\7GPIE9? <_P */&-QH/C'PUX>
M^S6%GXB'VF+4=+=P%6X48.<QIAU^9<\]:]'_ &:_B3>?$7PGK8U;P_'X;\1:
M/K%SINKVEM+YMN]VI#/)"W4HVX'GGDT >N4444 %%%% !1110 4444 %<$G^
MNE_WV_G7>UP2?ZZ7_?;^=- :EI6;X,_X^/$O_85D_P#0$K2M*S?!G_'QXE_[
M"LG_ * E<M7^-2^?Y'52_A5?E^:.E7I10O2BNPY0HHHH ****  ]JU:RCVK5
MJ6 M%%%( HHHH **** "BBB@ I*"U,9J '%J8STQI/>D6-I.3\JT #2<X')I
MRPEN7/X5*L:H, 4Z@"LVGVS79NOL\8NC'Y7G[!YFS.=N[KC/.*CEBDAY'SK[
M5=HI));#;;W,])PW>IEDIT]FDV2/D?U%4F62V;YQ\O\ >'2F(T U/W51CFSW
MJPLE %BBHU:G!J '4444 %%%% !1110 4444 ?,OC#_D=M<_Z^W_ )UG5H^,
M/^1VUS_K[?\ G6=0 4444 %2V_\ K!451W-NMU:S0,\D:RH4+PN4< C&58<@
M^XZ4 ?/O[+K*WQP^/P#*3_;5N2,\_P"K-6O@3K3S?M/?&RQUY"GB,2VC6'F#
M&=-5"(PF>JY()QW8UV_@7]GOP3\-?$=YKWAVVU*QU2^;?>3-JUS*+ILDYE5Y
M"'.23R.YK;\5?"GPUXR\06&OW]G-!KMDAC@U/3[J6TN AZH7B92R_P"R<CVK
MOG6ISE+>S27W6_R,8P<4O(^?=!L9](\:?M9VM@!'X:^QI,L2Y\M;M[-FF*]L
MG(+?45K76J>%+?\ 8K^&MGXHL&UN*^L=(M[/3(KGR#<79V>2K2?PIO&6)XP#
MP:]\T/P'H/AOPW=:%8Z9%'IEWYGVJ-R7:Y,F=[2NQ+.S9Y9B2:Y"U_9J^'%O
MX!N_!:^'0_A^YD65[>6YE=P5.5VR%BRA3T"D 9/K6GUF#:O?1I_<K=_F'+*Q
MP>LPZO:_MB?#"76[_3VN9O#^H!K73X]BVZC8=K.3N<9Z$@?=X%6_A/Q^UY\;
MA_TYZ7_Z#)7;V?[.?P]T_5/#VIQZ 6U'0=XLKJ:ZFDD^;KYC,Y,GMOSCMBK.
MA?!'PGX:\?:CXTTZ'4(O$>HDF\NFU.X<3CLKHSE2H[#&!CC%1*M3Y6E?X;;>
M=^X*#6_<XW]M2\U2Q_9M\4R:6)CDP)>>0#O^R&51-T[%>#_LDUE?M3PZ3KO[
M'$U_IIC9(+.PN](FM^624-&(C&1T;G''K7OMU;07]K-:W4,=Q;3(8Y895#*Z
MD8((/4$5PFA? ;P3X<^Q1V>FW!LK&X-U::=<7T\UG;RDY#1P.Y1<'I@8';%1
M2K0C&*E?W7?3K_5BI1;O;J>9_M -J'V3]G#^U3_Q-/\ A)]/^U<_\M?)^?\
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MUG5H^$?^1VT'_K\3^= 'TU1110 C=*ADJ9NE0R4 -M?OR?A5FJUK]^3\*LT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5D^(/]5!_O_TK6K)\0?ZJ#_?_ *4
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MQKX@9_[/TF%P@2-/OW$[_P#+.)>[8R3@ $UZ77R+X/:23_@I!XU.J;?.3PQ
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M_1E?)L/,0KZR_:H_Y(_=_P#7[;?^C*^38?\ 5K7\[^(G_(TA_@7YL_HSP_\
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M0"_1!7F'PI^)]G\'=6\4QZ0VH:AHVI6^;47$2)(ER =K,H<@#D@D$G@<59^
M?Q&\*_"&^U37-7;7=3UW5HPEU';VL1B4AV;<&,@))W>@KV,)G."JXK"UZLTJ
MD4XS=]+1VUZWT>G;L>5C,GQ%/!9AA*$'*E)J5&*6JE.SEZ**36O?N5/!./\
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MDHKF_P#A,#_SYG_OY_\ 6H_X3 _\^9_[^?\ UJ .DHKF_P#A,#_SYG_OY_\
M6H_X3 _\^9_[^?\ UJ .DHKF_P#A,#_SYG_OY_\ 6H_X3 _\^9_[^?\ UJ .
MDHKF_P#A,#_SYG_OY_\ 6H_X3 _\^9_[^?\ UJ .DHKF_P#A,#_SYG_OY_\
M6H_X3 _\^9_[^?\ UJ .DHKF_P#A,#_SYG_OY_\ 6H_X3 _\^9_[^?\ UJ .
MDHKF_P#A,#_SYG_OY_\ 6H_X3 _\^9_[^?\ UJ .DHKF_P#A,#_SYG_OY_\
M6H_X3 _\^9_[^?\ UJ .DHKF_P#A,#_SYG_OY_\ 6H_X3 _\^9_[^?\ UJ .
MDHKF_P#A,#_SYG_OY_\ 6H_X3 _\^9_[^?\ UJ .DHKF_P#A,#_SYG_OY_\
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M  DWQB_Z$3PQ_P"%'+_\C5R?Q7\8?&&Q^&^OSMX5T;242V/F7FFZS)<7$*9
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M'&9,D#W(/- &#X+TV3]J3]HWP_\ %6$)HWASP"+O3K:QF.W49[MUV2>?&/\
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MU#P_;>&T@MGO;#2C>37-U)$)"6_<NBJJLGRC!))Z "K?[+?Q+\8_$?P5JO\
MPG.A7FD:YI.J3Z>+JYL)+--2@5OW5U'&X! =<9 XSFN%\7^"OC+\+_B]JOCG
MX;Z3I7C#2_%4%M_;7AW4;X6;6MU%&$\^&0@@@K@$$_PC%>Y_#>U\4+HC7WC%
M[5->OF$LUCI\C/;68V@"*-FP6QC); R2>.E '6T450O-7AM24!\R7^ZO;ZT
M77V[3NQM[YJBS1^9B+D?I6<UU->-ESA?[HZ5:@7% %Z-JF7M4$=3KVH ?111
M0!RE]\+?#&I7\][<Z8);F=S)(_G2#<QZG ;%0_\ "H?"7_0('_@1+_\ %5V-
M% ''?\*A\)?] @?^!$O_ ,51_P *A\)?] @?^!$O_P 578T4 <=_PJ'PE_T"
M!_X$2_\ Q5'_  J'PE_T"!_X$2__ !5=C10!QW_"H?"7_0('_@1+_P#%4?\
M"H?"7_0('_@1+_\ %5V-% ''?\*A\)?] @?^!$O_ ,51_P *A\)?] @?^!$O
M_P 578T4 <=_PJ'PE_T"!_X$2_\ Q5'_  J'PE_T"!_X$2__ !5=C10!QW_"
MH?"7_0('_@1+_P#%4?\ "H?"7_0('_@1+_\ %5V-% ''?\*A\)?] @?^!$O_
M ,51_P *A\)?] @?^!$O_P 578T4 <=_PJ'PE_T"!_X$2_\ Q5'_  J'PE_T
M"!_X$2__ !5=C10!QW_"H?"7_0('_@1+_P#%4?\ "H?"7_0('_@1+_\ %5V-
M% ''?\*A\)?] @?^!$O_ ,51_P *A\)?] @?^!$O_P 578T4 <=_PJ'PE_T"
M!_X$2_\ Q5'_  J'PE_T"!_X$2__ !5=C10!QW_"H?"7_0('_@1+_P#%4?\
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MPUT/P/<>#?B&O@[Q5J'B.TO]6O;C4+D:M+*UI>%%\R&&0$&-5PN%4X&36/\
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M3\5GUW6-4\8:5XIUJUNM0TU98X+==0ED7RXHFA"^7N8(SY)P.3G- 'T;X?\
MBWX2\3ZXFC:=K,<FK/;?;8[*6*2&66#('F(KJ"Z\CE<]:XGP/^T?I7C7XL>-
MO"B6E_8VWAQK>W-Q=Z=/'YDSJ7=B2N%CVE,,V,Y)Z8KSGQA#J=O^UY\$Y]8N
M;".\.DZFBVE@"%MT,<>4WDY<$@<D <=*Z?X*S(O[4'Q^4NH/VK23C/K8Q@4
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M]Z /M'0_C'X)\2:UKFDZ9XFT^\U#0XEFU*".7FU1AD,Y/&/?-.T7XN^$-?\
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MS?\ /RO_ 'Q_]>C_ (1N;_GY7_OC_P"O0!B>5[T>5[UM_P#"-S?\_*_]\?\
MUZ/^$;F_Y^5_[X_^O0!B>5[T>5[UM_\ "-S?\_*_]\?_ %Z/^$;F_P"?E?\
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MB@#S>]_9W\ :K\,8?A[J6A+JWA&!56&PU&>2X\D+]W8[L77'8@Y%2> OV?\
MP+\,/"NH^'_"^C'1[#405NI(;F4W$HQC!G+&3@<#YN.U>B44 >4:;^R_\/\
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MHNA_$&U\0V?B#PUHFI?V6T"V\\VGQ&7#A\[FQEONCD\UP/PX\81S6][KNO\
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M>*WXZ5;CM_:IXX<592*@"&.&IUCJ14J0+0 P+3PM+2T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% "-TJ&2IFZ5#)0 VU^_)^%6:K6OWY/PJS0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !63X@_U4'^__2M:LGQ!_JH/]_\ I0!6
MM>U:47:LVU[5I1=J ([O_CX'^X*BJ6[_ ./@?[@J*J *B>I:B>F!Y!^U1_R1
M^[_Z_;;_ -&5\FQ#="!7UE^U1_R1^[_Z_;;_ -&5\FP_ZM:_G?Q#_P"1I#_
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MAEO_ $"4_P#P%#^L8G_GZST%OV_OVE%_YB^@_P#@ICJ,_P#!0']I3MK&@_\
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MFDL;B:;Y9OI?K_F>VM_P4P_:27_F,Z6/^X1;_P"%'_#S#]I/_H,Z7_X*+?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(7EB!GG.,Z7[57B3X:_$KX8?"O3/!GC*[U76O NCQ:$]M<Z+/;K>1A$4S*[
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M .!0!\U?L66L^BZW\<=&OB3J5KXZO)96?AI$E1)(WYYP588-<QXW\3:-;_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 12=ZDTG_C\D_W/ZU')WJ32?\ C\D_W/ZTF!KT445(!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5P4?\ KI/]YOYFN]K@H_\ 72?[S?S-- :UK67X,_X^/$O_ &%9/_0$K4M:
MR_!G_'QXE_["LG_H"5RU?XU+Y_D=5+^%5^7YHZ5>E%"]**[#E"BBB@ HHHH
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M;9_\^R_F:/;+L'*SF>*:<5U']FV?_/LM']FV?_/LM'MEV#E.5VKZ4A"UU?\
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MS3%276I/_P!*9]QAY<]&$NZ7Y!1117BG0%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 >1?'[_D,?"G_L<+7_T1/7KM>1?'[_D,?"G_ +'"
MU_\ 1$]>NUP4?]XJ_P#;OY'T./\ ^1=@O2?_ *6PHHHKO/G@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@"A>_\? _W?ZFH*GO?^/@?[O\
M4U!5 %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** (I.]2:3_P ?DG^Y_6HY.]2:3_Q^2?[G]:3
MUZ***D HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M GWFC>:@\RCS*+ 3[S1O-0>91YE%@)]YHWFH/,I/.'M18"QO-&\U!YE'F46
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MBB@"A>_\? _W?ZFH*GO?^/@?[O\ 4U!5 %%%%, HHHH **** "BBB@ HHHH
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MPM?_ $1/7KM>1?'W_D,?"G_L<+7_ -$3UZ[7!1_WBK_V[^1]#C_^1=@O2?\
MZ6PHHHKO/G@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"A
M>_\ 'P/]W^IJ"I[W_CX'^[_4U!5 %%%%, HHHH **** "BBB@ HHHH ****
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M;)][]4B]1117<<84444 %%%%  >U:M91[5JU+ 6BBBD 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH #VK5K*/:M6I8"T444@"BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!0O?\ CX'^[_4U!4][_P ? _W?ZFH*H HHHI@%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  >U:M91[5JU+
M 6BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR3_::?WUH_M-/[ZU];?\.<?BG_T/GA;_ +ZNO_C5'_#G'XI_]#YX6_[ZNO\
MXU1_K%DO_02ON?\ D']F5NY\D_VFG]]:/[33^^M?6W_#G'XI_P#0^>%O^^KK
M_P"-4?\ #G'XI_\ 0^>%O^^KK_XU1_K%DO\ T$K[G_D']F5NY\D_VFG]]:/[
M33^^M?6W_#G'XI_]#YX6_P"^KK_XU1_PYQ^*?_0^>%O^^KK_ .-4?ZQ9+_T$
MK[G_ )!_9E;N?)/]II_?6C^TT_OK7UM_PYQ^*?\ T/GA;_OJZ_\ C5'_  YQ
M^*?_ $/GA;_OJZ_^-4?ZQ9+_ -!*^Y_Y!_9E;N?)/]II_?6C^TT_OK7UM_PY
MQ^*?_0^>%O\ OJZ_^-4?\.<?BG_T/GA;_OJZ_P#C5'^L62_]!*^Y_P"0?V96
M[GR3_::?WUH_M-/[ZU];?\.<?BG_ -#YX6_[ZNO_ (U1_P .<?BG_P!#YX6_
M[ZNO_C5'^L62_P#02ON?^0?V96[GR3_::?WUH_M-/[ZU];?\.<?BG_T/GA;_
M +ZNO_C5'_#G'XI_]#YX6_[ZNO\ XU1_K%DO_02ON?\ D']F5NY\D_VFG]]:
M/[33^^M?6W_#G'XI_P#0^>%O^^KK_P"-4?\ #G'XI_\ 0^>%O^^KK_XU1_K%
MDO\ T$K[G_D']F5NY\D_VFG]]:/[33^^M?6W_#G'XI_]#YX6_P"^KK_XU1_P
MYQ^*?_0^>%O^^KK_ .-4?ZQ9+_T$K[G_ )!_9E;N?)/]II_?6C^TT_OK7UM_
MPYQ^*?\ T/GA;_OJZ_\ C5'_  YQ^*?_ $/GA;_OJZ_^-4?ZQ9+_ -!*^Y_Y
M!_9E;N?)/]II_?6C^TT_OK7UM_PYQ^*?_0^>%O\ OJZ_^-4?\.<?BG_T/GA;
M_OJZ_P#C5'^L62_]!*^Y_P"0?V96[GR3_::?WUH_M-/[ZU];?\.<?BG_ -#Y
MX6_[ZNO_ (U1_P .<?BG_P!#YX6_[ZNO_C5'^L62_P#02ON?^0?V96[GR3_:
MB?WEK$\37ZR:=(H(.<#K[U]H_P##G'XI_P#0^>%O^^KK_P"-4R3_ ((V_%%Q
MSXY\*-_O-=?_ !JKAQ)DL)*7UA?<_P#(J.6U5)-]#[D_X)RG/[%_PV_ZX7?_
M *63U])UY)^RA\(-6^ O[/\ X4\!ZY>V>H:GI"7"2W.GES"^^YEE7;O4-PKJ
M#D=0:];K^>LRJQK8ZO5@[J4Y->C;/J8*T$F%%%%><6%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!0O?^/@?[O\ 4U!4][_Q\#_=_J:@J@"B
MBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ![5JT45+ 6BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4+W
M_CX'^[_4U!115 %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
<* "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>figure22_01.jpg
<TEXT>
begin 644 figure22_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0/!98# 2(  A$! Q$!_\0
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M17_QK<HH P_^$)T7_GS_ /(K_P"-'_"$Z+_SY_\ D5_\:W** ,/_ (0G1?\
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MZ?=0WMC<QK+!<V[AXY489#*PX(([BK5 &'_PA.B_\^?_ )%?_&C_ (0G1?\
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M )\__(K_ .-;E% &'_PA.B_\^?\ Y%?_ !H_X0G1?^?/_P BO_C6Y10!A_\
M"$Z+_P ^?_D5_P#&C_A"=%_Y\_\ R*_^-;E% &'_ ,(3HO\ SY_^17_QH_X0
MG1?^?/\ \BO_ (UN44 8?_"$Z+_SY_\ D5_\:/\ A"=%_P"?/_R*_P#C6Y10
M!A_\(3HO_/G_ .17_P :/^$)T7_GS_\ (K_XUN44 8?_  A.B_\ /G_Y%?\
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M ,:/^$)T7_GS_P#(K_XUN44 8?\ PA.B_P#/G_Y%?_&C_A"=%_Y\_P#R*_\
MC6Y10!A_\(3HO_/G_P"17_QH_P"$)T7_ )\__(K_ .-;E% &'_PA.B_\^?\
MY%?_ !H_X0G1?^?/_P BO_C6Y10!A_\ "$Z+_P ^?_D5_P#&C_A"=%_Y\_\
MR*_^-;E% &'_ ,(3HO\ SY_^17_QH_X0G1?^?/\ \BO_ (UN44 8?_"$Z+_S
MY_\ D5_\:/\ A"=%_P"?/_R*_P#C6Y10!A_\(3HO_/G_ .17_P :/^$)T7_G
MS_\ (K_XUN44 8?_  A.B_\ /G_Y%?\ QH_X0G1?^?/_ ,BO_C6Y10!A_P#"
M$Z+_ ,^?_D5_\:/^$)T7_GS_ /(K_P"-;E% &'_PA.B_\^?_ )%?_&C_ (0G
M1?\ GS_\BO\ XUN44 8?_"$Z+_SY_P#D5_\ &C_A"=%_Y\__ "*_^-;E% &'
M_P (3HO_ #Y_^17_ ,:/^$)T7_GS_P#(K_XUN44 8?\ PA.B_P#/G_Y%?_&C
M_A"=%_Y\_P#R*_\ C6Y10!A_\(3HO_/G_P"17_QH_P"$)T7_ )\__(K_ .-;
ME% &'_PA.B_\^?\ Y%?_ !H_X0G1?^?/_P BO_C6Y10!A_\ "$Z+_P ^?_D5
M_P#&C_A"=%_Y\_\ R*_^-;E% &'_ ,(3HO\ SY_^17_QH_X0G1?^?/\ \BO_
M (UN44 8?_"$Z+_SY_\ D5_\:/\ A"=%_P"?/_R*_P#C6Y10!A_\(3HO_/G_
M .17_P :/^$)T7_GS_\ (K_XUN44 8?_  A.B_\ /G_Y%?\ QH_X0G1?^?/_
M ,BO_C6Y10!A_P#"$Z+_ ,^?_D5_\:/^$)T7_GS_ /(K_P"-;E% &'_PA.B_
M\^?_ )%?_&C_ (0G1?\ GS_\BO\ XUN44 8?_"$Z+_SY_P#D5_\ &C_A"=%_
MY\__ "*_^-;E% &'_P (3HO_ #Y_^17_ ,:/^$)T7_GS_P#(K_XUN44 8?\
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MMQU/N:*N?$[_ )AW_;3_ -EHH WO!/\ R+-G_P #_P#0VK<K#\$_\BS9_P#
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M@?\ "#Z-_P ^TG_?^3_XJC_A!]&_Y]I/^_\ )_\ %4 ;]%8'_"#Z-_S[2?\
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M_A!]&_Y]I/\ O_)_\50!OT5@?\(/HW_/M)_W_D_^*H_X0?1O^?:3_O\ R?\
MQ5 &_16!_P (/HW_ #[2?]_Y/_BJ/^$'T;_GVD_[_P G_P 50!OT5@?\(/HW
M_/M)_P!_Y/\ XJC_ (0?1O\ GVD_[_R?_%4 ;]%8'_"#Z-_S[2?]_P"3_P"*
MH_X0?1O^?:3_ +_R?_%4 ;]%8'_"#Z-_S[2?]_Y/_BJ/^$'T;_GVD_[_ ,G_
M ,50!OT5@?\ "#Z-_P ^TG_?^3_XJC_A!]&_Y]I/^_\ )_\ %4 ;]%8'_"#Z
M-_S[2?\ ?^3_ .*H_P"$'T;_ )]I/^_\G_Q5 &_16!_P@^C?\^TG_?\ D_\
MBJ/^$'T;_GVD_P"_\G_Q5 &_16!_P@^C?\^TG_?^3_XJC_A!]&_Y]I/^_P#)
M_P#%4 ;]%8'_  @^C?\ /M)_W_D_^*H_X0?1O^?:3_O_ "?_ !5 &_16!_P@
M^C?\^TG_ '_D_P#BJ/\ A!]&_P"?:3_O_)_\50!OT5@?\(/HW_/M)_W_ )/_
M (JC_A!]&_Y]I/\ O_)_\50!OT5@?\(/HW_/M)_W_D_^*H_X0?1O^?:3_O\
MR?\ Q5 &_16!_P (/HW_ #[2?]_Y/_BJ/^$'T;_GVD_[_P G_P 50!OT5@?\
M(/HW_/M)_P!_Y/\ XJC_ (0?1O\ GVD_[_R?_%4 ;]%8'_"#Z-_S[2?]_P"3
M_P"*H_X0?1O^?:3_ +_R?_%4 ;]%8'_"#Z-_S[2?]_Y/_BJ/^$'T;_GVD_[_
M ,G_ ,50!OT5@?\ "#Z-_P ^TG_?^3_XJC_A!]&_Y]I/^_\ )_\ %4 ;]%8'
M_"#Z-_S[2?\ ?^3_ .*H_P"$'T;_ )]I/^_\G_Q5 &_16!_P@^C?\^TG_?\
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M]I/^_P#)_P#%4 ;]%8'_  @^C?\ /M)_W_D_^*H_X0?1O^?:3_O_ "?_ !5
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M;_GVD_[_ ,G_ ,50!OT5@?\ "#Z-_P ^TG_?^3_XJC_A!]&_Y]I/^_\ )_\
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M1:/_ -=+G_THDKTJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *\AUK]KCX0>'M=U+1M1\=Z=:ZIIMP]K=VS+*6AE0X9#A,9!KUZOR0^*EI
M"_QU^)S&-2?^$CO.2/\ IH:^HR++*&9SJ1KMI15]+=[=4SQLSQM3!Q@Z:3;=
MM?0_0;_ALSX*_P#10=-_[XE_^(H_X;,^"O\ T4'3?^^)?_B*_-[[##_SS7_O
MD4?88?\ GFO_ 'R*^M_U6P'\T_OC_P#(GA_VSB_Y8_C_ )GZ0_\ #9GP5_Z*
M#IO_ 'Q+_P#$4?\ #9GP5_Z*#IO_ 'Q+_P#$5^;WV&'_ )YK_P!\BC[##_SS
M7_OD4?ZK8#^:?WQ_^1#^V<7_ "Q_'_,_2'_ALSX*_P#10=-_[XE_^(H_X;,^
M"O\ T4'3?^^)?_B*_-[[##_SS7_OD4?88?\ GFO_ 'R*/]5L!_-/[X__ "(?
MVSB_Y8_C_F?I"?VSO@JHR?B#IO\ WQ+_ /$5Z/X!^(7AWXH^&H/$'A758=:T
M:9Y(X[R ,$9D8HX&X \,"/PK\DYK&#RV_=)T_NBOO[_@GS&L7[,>BJHP/[1U
M+_TLEKQ<YR/"Y?@_K%&4F^9+5JVJ;Z)=CT<OS*MBJ[I54K6OI?NO/S/I"BBB
MOA#Z0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#A?B=_P P[_MI_P"RT4?$[_F'?]M/_9:*
M -[P3_R+-G_P/_T-JW*P_!/_ "+-G_P/_P!#:MR@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "O'_VH_\ DG=I_P!A*'_T
M"2O8*\^^.'@?4/'G@=K+2V3[;;W"7:12<>;M# H#V)W<$^GXT 5OV=/^21:/
M_P!=+G_THDKTJOFKX#_%^/PNZ>#]?C^PP+,Z6]Q(NPPR,Q+12@],L3@^^#VK
MZ5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OR6^*/_)<O
MB;_V,=Y_Z&:_6FOR6^*/_)<OB;_V,=Y_Z&:^]X2_BU_\*_-'R^>_#2]7^3,6
MBBBOT8^7"BBB@ HHHH 9-_JF^E??'_!/W_DV71O^PCJ/_I7+7P/-_JF^E??'
M_!/W_DV71O\ L(ZC_P"E<M?+\3?\BS_M^/Y2/9R?_?/^W7^<3Z.HHHK\D/MP
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** .%^)W_ ##O^VG_ ++11\3O^8=_VT_]EHH WO!/
M_(LV?_ __0VK<K#\$_\ (LV?_ __ $-JW* "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** /(/C;\$HO'%O)K&CQI#KT
M:?/'P$O% ^ZWHWHWX'VY#X(_&R71[B/PIXJD>)8W\BVO+G(>%@<>3+GIZ!C]
M#VKZ.KR#XW?!&+QQ;RZQH\:1:]&GSQ\!;Q1_"W^UZ-^!]@#UZEKYQ^"7QMFT
M>XC\*>*I'B6-_(MKRYX>%@<>3+G\@Q^A[&OHV@!:*** "BBB@ HHHH ****
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MS#O^VG_LM%'Q._YAW_;3_P!EHH WO!/_ "+-G_P/_P!#:MRL/P3_ ,BS9_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1.[#^Q#X.;]H"_\ B/>S2ZA83NM]%X=N%#6L=_N):<_WE&%*H> V3S\N,_\
M:V_:JM?AG8W'@GPLT>H>-;Z I*58^7ID3#'F2$'[Y!^5<Y[GC&>C'9I+..3
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH X7XG?\P[_ +:?^RT4?$[_ )AW_;3_ -EHH WO!/\
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M@ K\EOBC_P ER^)O_8QWG_H9K]::_);XH_\ )<OB;_V,=Y_Z&:^]X2_BU_\
M"OS1\OGOPTO5_DS%HHHK]&/EPHHHH **** &3?ZIOI7WQ_P3]_Y-ET;_ +".
MH_\ I7+7P/-_JF^E??'_  3]_P"39=&_[".H_P#I7+7R_$W_ "+/^WX_E(]G
M)_\ ?/\ MU_G$^CJ***_)#[<**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#A?B=_S#O^VG_L
MM%'Q._YAW_;3_P!EHH WO!/_ "+-G_P/_P!#:MRL/P3_ ,BS9_\  _\ T-JW
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *\?_:B_Y)W:?]A*'_T"2O8*\?\ VHO^2=VG_82A_P#0)* -;]G3_DD6C_\
M72Y_]*)*]*KS7]G3_DD6C_\ 72Y_]*)*]*H **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5<>'?"MX=*FUG6;F5$U*_09FAMQ&APD>54RG/S$@*0,GPC]G?Q)/X/\ CO\
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MU 6@R=B)(02B>@!4G [L?6OLZ@ KQ_\ :B_Y)W:?]A*'_P! DKV"O'_VHO\
MDG=I_P!A*'_T"2@#6_9T_P"21:/_ -=+G_THDKTJO(/@-KS:?\+-)A&F7]T%
MDN/WEO$&4YG<\'/O7?\ _"6/_P! 35O_  ''^- '045S_P#PEC_] 35O_ <?
MXT?\)8__ $!-6_\  <?XT =!17/_ /"6/_T!-6_\!Q_C1_PEC_\ 0$U;_P !
MQ_C0!T%%<_\ \)8__0$U;_P''^-'_"6/_P! 35O_  ''^- '045S_P#PEC_]
M 35O_ <?XT?\)8__ $!-6_\  <?XT =!17/_ /"6/_T!-6_\!Q_C1_PEC_\
M0$U;_P !Q_C0!T%%<_\ \)8__0$U;_P''^-'_"6/_P! 35O_  ''^- '045S
M_P#PEC_] 35O_ <?XT?\)8__ $!-6_\  <?XT =!17/_ /"6/_T!-6_\!Q_C
M1_PEC_\ 0$U;_P !Q_C0!T%%<_\ \)8__0$U;_P''^-'_"6/_P! 35O_  ''
M^- '045S_P#PEC_] 35O_ <?XT?\)8__ $!-6_\  <?XT =!17/_ /"6/_T!
M-6_\!Q_C1_PEC_\ 0$U;_P !Q_C0!T%%<_\ \)8__0$U;_P''^-'_"6/_P!
M35O_  ''^- '045S_P#PEC_] 35O_ <?XT?\)8__ $!-6_\  <?XT =!17/_
M /"6/_T!-6_\!Q_C1_PEC_\ 0$U;_P !Q_C0!T%%<_\ \)8__0$U;_P''^-'
M_"6/_P! 35O_  ''^- '045S_P#PEC_] 35O_ <?XT?\)8__ $!-6_\  <?X
MT =!17/_ /"6/_T!-6_\!Q_C1_PEC_\ 0$U;_P !Q_C0!T%%<_\ \)8__0$U
M;_P''^-'_"6/_P! 35O_  ''^- '045S_P#PEC_] 35O_ <?XT?\)8__ $!-
M6_\  <?XT =!17/_ /"6/_T!-6_\!Q_C1_PEC_\ 0$U;_P !Q_C0!T%%<_\
M\)8__0$U;_P''^-'_"6/_P! 35O_  ''^- '045S_P#PEC_] 35O_ <?XT?\
M)8__ $!-6_\  <?XT =!17/_ /"6/_T!-6_\!Q_C1_PEC_\ 0$U;_P !Q_C0
M!T%%<_\ \)8__0$U;_P''^-'_"6/_P! 35O_  ''^- '045S_P#PEC_] 35O
M_ <?XT?\)8__ $!-6_\  <?XT =!17/_ /"6/_T!-6_\!Q_C1_PEC_\ 0$U;
M_P !Q_C0!T%%<_\ \)8__0$U;_P''^-'_"6/_P! 35O_  ''^- '045S_P#P
MEC_] 35O_ <?XT?\)8__ $!-6_\  <?XT =!17/_ /"6/_T!-6_\!Q_C1_PE
MC_\ 0$U;_P !Q_C0!T%%<_\ \)8__0$U;_P''^-'_"6/_P! 35O_  ''^- '
M045S_P#PEC_] 35O_ <?XT?\)8__ $!-6_\  <?XT =!7Y+?%'_DN7Q-_P"Q
MCO/_ $,U^I2^*G9@/[$U4?6W'^-?EG\2Y/.^-?Q)EV/%O\0W9V2###YSU%?>
M\)?Q:_\ A7YH^7SWX:7J_P F8]%%%?HQ\N%%%% !1110 R;_ %3?2OOC_@G[
M_P FRZ-_V$=1_P#2N6O@>;_5M]*^Y_V$]:.E_LWZ/"NG7UV!J&H?O+>(,IS=
M2'KGW_2OE^)O^19_V_'\I'LY/_O?_;K_ #B?3]%<_P#\)8__ $!-6_\  <?X
MT?\ "6/_ - 35O\ P''^-?DA]N=!17/_ /"6/_T!-6_\!Q_C1_PEC_\ 0$U;
M_P !Q_C0!T%%<_\ \)8__0$U;_P''^-'_"6/_P! 35O_  ''^- '045S_P#P
MEC_] 35O_ <?XT?\)8__ $!-6_\  <?XT =!17/_ /"6/_T!-6_\!Q_C1_PE
MC_\ 0$U;_P !Q_C0!T%%<_\ \)8__0$U;_P''^-'_"6/_P! 35O_  ''^- '
M045S_P#PEC_] 35O_ <?XT?\)8__ $!-6_\  <?XT =!17/_ /"6/_T!-6_\
M!Q_C1_PEC_\ 0$U;_P !Q_C0!T%%<_\ \)8__0$U;_P''^-'_"6/_P! 35O_
M  ''^- '045S_P#PEC_] 35O_ <?XT?\)8__ $!-6_\  <?XT =!17/_ /"6
M/_T!-6_\!Q_C1_PEC_\ 0$U;_P !Q_C0!T%%<_\ \)8__0$U;_P''^-'_"6/
M_P! 35O_  ''^- '045S_P#PEC_] 35O_ <?XT?\)8__ $!-6_\  <?XT =!
M17/_ /"6/_T!-6_\!Q_C1_PEC_\ 0$U;_P !Q_C0!T%%<_\ \)8__0$U;_P'
M'^-'_"6/_P! 35O_  ''^- '045S_P#PEC_] 35O_ <?XT?\)8__ $!-6_\
M <?XT =!17/_ /"6/_T!-6_\!Q_C1_PEC_\ 0$U;_P !Q_C0!T%%<_\ \)8_
M_0$U;_P''^-'_"6/_P! 35O_  ''^- '045S_P#PEC_] 35O_ <?XT?\)8__
M $!-6_\  <?XT =!17/_ /"6/_T!-6_\!Q_C1_PEC_\ 0$U;_P !Q_C0!T%%
M<_\ \)8__0$U;_P''^-'_"6/_P! 35O_  ''^- '045S_P#PEC_] 35O_ <?
MXT?\)8__ $!-6_\  <?XT =!17/_ /"6/_T!-6_\!Q_C1_PEC_\ 0$U;_P !
MQ_C0!T%%<_\ \)8__0$U;_P''^-'_"6/_P! 35O_  ''^- '045S_P#PEC_]
M 35O_ <?XT?\)8__ $!-6_\  <?XT =!17/_ /"6/_T!-6_\!Q_C1_PEC_\
M0$U;_P !Q_C0!T%%<_\ \)8__0$U;_P''^-'_"6/_P! 35O_  ''^- '045S
M_P#PEC_] 35O_ <?XT?\)8__ $!-6_\  <?XT =!17/_ /"6/_T!-6_\!Q_C
M1_PEC_\ 0$U;_P !Q_C0!T%%<_\ \)8__0$U;_P''^-'_"6/_P! 35O_  ''
M^- '045S_P#PEC_] 35O_ <?XT?\)8__ $!-6_\  <?XT =!17/_ /"6/_T!
M-6_\!Q_C1_PEC_\ 0$U;_P !Q_C0!T%%<_\ \)8__0$U;_P''^-'_"6/_P!
M35O_  ''^- '045S_P#PEC_] 35O_ <?XT?\)8__ $!-6_\  <?XT =!17/_
M /"6/_T!-6_\!Q_C1_PEC_\ 0$U;_P !Q_C0!T%%<_\ \)8__0$U;_P''^-'
M_"6/_P! 35O_  ''^- '045S_P#PEC_] 35O_ <?XT?\)8__ $!-6_\  <?X
MT =!17/_ /"6/_T!-6_\!Q_C1_PEC\?\2351_P!NX_QH Z"BDI: .%^)W_,.
M_P"VG_LM%'Q._P"8=_VT_P#9:* -[P3_ ,BS9_\  _\ T-JW*P_!/_(LV?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"2@#6_9T_P"21:/_ -=+G_THDKTJO-?V=/\ DD6C_P#72Y_]*)*]*H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OR6^*/_ "7+XF_]C'>?
M^AFOUIK\EOBC_P ER^)O_8QWG_H9K[WA+^+7_P *_-'R^>_#2]7^3,6BBBOT
M8^7"BBB@ HHHH 9-_JF^E??'_!/W_DV71O\ L(ZC_P"E<M? \W^J;Z5]\?\
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M :W[.G_)(M'_ .NES_Z425Z57FO[.G_)(M'_ .NES_Z425Z50 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %?DM\4?\ DN7Q-_[&.\_]#-?K
M37Y+?%'_ )+E\3?^QCO/_0S7WO"7\6O_ (5^:/E\]^&EZO\ )F+1117Z,?+A
M1110 4444 ,F_P!4WTK[X_X)^_\ )LNC?]A'4?\ TKEKX'F_U3?2OOC_ ()^
M_P#)LNC?]A'4?_2N6OE^)O\ D6?]OQ_*1[.3_P"^?]NO\XGT=1117Y(?;GC_
M .UA_P D3U7_ *^K/_THCKY%C^X*^NOVL/\ DB>J_P#7U9_^E$=?(L?W!7XQ
MQ=_R-(_X%_Z5(_<.#O\ D4O_ *^2_P#28#J***^./M0HHHH **** -/P-_R4
M[P7_ -AFU_\ 1JU^@M?GUX&_Y*=X+_[#-K_Z-6OT%K].X)_A8G_$O_24?E''
M/\;#_P"%_F%%%%?I1^8A1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 <+\3O^8=_VT_\ 9:*/B=_S#O\ MI_[+10!O>"?^19L_P#@?_H;
M5N5A^"?^19L_^!_^AM6Y0 4444 %%<G\6M0N=)^%7C.^LYFMKNVT6]FAF7K&
MZP.58>X(!KQ7P%^U!\1_$W@_1]1F_9S\<)<W%K')*HO=-B7<5!RHGN8WP?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M .E$E>E5YK^SI_R2+1_^NES_ .E$E>E4 %%%% !1110 4444 %%%% !1110
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M,VO_ *-6OT%K].X)_A8G_$O_ $E'Y1QS_&P_^%_F%%%%?I1^8A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 <+\3O^8=_P!M/_9:*/B=
M_P P[_MI_P"RT4 ;W@G_ )%FS_X'_P"AM6Y6'X)_Y%FS_P"!_P#H;5N4 %%%
M% '+_%"&UNOASXEM;Z62WLKK3YK6:>.,N84D0QM)@<X4-N/L#4GA3P1X8\/>
M&]-T[1-'TNVTFWMTCMH[.VC6(1A0%V@#&,5T3HLB,CJ&5A@JPR"/2OFSQM\.
MOB_\%[HZC\%+O3O$OAEG::X\"^)9F409W,18W(RT:EC_ *I\J.BE0 * /H;^
MP=,_Z!UI_P!^%_PJS;V=O9J5@@C@!ZB- O\ *O@MO^"CGQ0\(ZA<V7CG]F;Q
M?IUQ;OL=M&22]BZ#D2B,(>?0GZUHZ;^WW\7?B/?Q6/P]_9J\3W$K@%I_$KG3
MH$4_QAV7# 'L#G% 'VKXE\2:=X1T2ZU;5;E;6QMUR[MU))PJJ.[$D  <DD"K
M]K<"ZMHI@CQB1 X61=K#(S@CL:\&^&'P?^(/BC7;+QA\:]>L]1U6SD,NF>%-
M!#)I.G-SME<M\UQ. ?OMA5_A4'FO?J "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KQ_]J+_ ))W:?\ 82A_] DKV"O'_P!J+_DG=I_V$H?_ $"2@#6_
M9T_Y)%H__72Y_P#2B2O2J\U_9T_Y)%H__72Y_P#2B2O2J "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0T'6K/Q)HMAJVGS+<6-] EQ!*IR&1E#*?R-7Z "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KQ_]J+_DG=I_V$H?_0)*]@KQ_P#:B_Y)W:?]A*'_ - D
MH UOV=/^21:/_P!=+G_THDKTJO-?V=/^21:/_P!=+G_THDKTJ@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *_);XH_\ER^)O_8QWG_H9K]:
M:_);XH_\ER^)O_8QWG_H9K[WA+^+7_PK\T?+Y[\-+U?Y,Q:***_1CY<****
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M;8:MI]Q8^<O6/S(V3=^&<UO5G>(]>M?"_A_4]9OFV66GVTEW,PZA$4LWZ T
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M7I5>:_LZ?\DBT?\ ZZ7/_I1)7I5 !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5^2WQ1_P"2Y?$W_L8[S_T,U^M-?DM\4?\ DN7Q-_[&.\_]
M#-?>\)?Q:_\ A7YH^7SWX:7J_P F8M%%%?HQ\N%%%% !1110 R;_ %3?2OOC
M_@G[_P FRZ-_V$=1_P#2N6O@>;_5-]*^^/\ @G[_ ,FRZ-_V$=1_]*Y:^7XF
M_P"19_V_'\I'LY/_ +Y_VZ_SB?1U%%%?DA]N>/\ [6'_ "1/5?\ KZL__2B.
MOD6/[@KZZ_:P_P"2)ZK_ -?5G_Z41U\BQ_<%?C'%W_(TC_@7_I4C]PX._P"1
M2_\ KY+_ -)@.HHHKXX^U"BBB@ HHHH T_ W_)3O!?\ V&;7_P!&K7Z"U^?7
M@;_DIW@O_L,VO_HU:_06OT[@G^%B?\2_])1^4<<_QL/_ (7^84445^E'YB%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^=W[?/_)R&B?\
M8KQ?^E5Q7Z(U^=W[?/\ R<AHG_8KQ?\ I5<5]?PM_P C#_MV1X&=_P"ZK_$O
MS/#:***_5#XX**** "BBB@ KV7]A?_DZ23_L5[S_ -*+6O&J]E_87_Y.DD_[
M%>\_]*+6O/S'_<:_^!G5@_\ >J7K^C/T>HHHK\,/T8**** "BBB@ HHHH **
M** "BBB@ HHHH X7XG?\P[_MI_[+11\3O^8=_P!M/_9:* -[P3_R+-G_ ,#_
M /0VK<K#\$_\BS9_\#_]#:MR@ HHHH *Q?&GA>V\;^#]<\/7AQ:ZK936,K;<
MX61"A./;.:VJS?$FM)X;\.ZIJTD9ECL+66Z:,,%+!$+$9/ X'>@#Y#^('[2$
M?PJ\0?#W3_B-X2\2:/>>&+F;S]0TW2)+RPO8A;/$LT#PAL!BP^1PK*<\8YKQ
M;]HCXZ^//^"@!MOA#\)/ VO:1X1O;J*36?%>NV;6R"!7!RJG'R \D9W-C&!G
M-?;7PU^.5QX\^&\_C;Q/X*U#P#X8%D;]7\03P>:\(&[<T2,Q0%>0&P>1Q7SC
M\,?V]OB1\5)M7\5^$?@?<:A\'-*GDC?5XKT1WLL,9/F2PP%0)"HY,:G/49)X
MH ^T?!?A>V\$^$=%\/V7_'II=G%9Q?[J(%'\JVJI:+K%IXAT>RU2PF6XL;R%
M+B"9#D.C %3^1J[0 4R5BD;LJ[F )"^OM3Z* /@G]AGX8#XHV/QM\2Z[XAUR
MWU#7O&.H6UTFF7K6<T:1.41?-3$@*@#&&& !7;_LU^+O&G@?]H#XH? SQ1X@
MO?%FE:38PZOX;U75'\V]^RR@J8I9.K[6! 9LL<$D\X'4_#WX6^)/V;?C#XYE
M\.>'I?$?PY\;7O\ ;C)8SQB[TO4W&)PRR,H:&0!6!4DJQ8$8Q78_"GX0ZC8_
M%SQM\5/$P2WU[Q%#;Z=9Z8A5QIUA!DHCNI(>1W9W8@X *J,X)(!XS_P3 M?L
M?PM\?P3?\A"+QGJ<=V>_F"4CFF^"S<S_ /!43QXUGD64/@VS2^QSER[%,^G6
MN_\ "OPU\0?L[?%[Q_K/AGPY+XE\$>-[A=8DT_2WABN=/U3;MF;;(R!HI@%;
M<#D-NSP1C<^!'P5U+P?XO^(OQ,\206Z>.?&]TDLMG!)OCL;2",1VUMOSAFVJ
M&=AQN8XR * /1_BQ:W-]\+_%MO9DB[ETFZ2+'7>8F _6OGW_ ()?^1_PQAX(
M\D?Q7.__ 'O.;-=K^S+\4OB;XZG\5Z!\7/"6G^%O$VEO%<0PZ7,9H)+.<RB+
M<VYOG'E.#SSPV%!Q7/\ P@^'WBS]EB3Q?X3T'PK<>+?!.H:G-J_APZ=/!";
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M^?O3?^_3_P"-=!10!S_V?Q/_ ,_>F_\ ?I_\:/L_B?\ Y^]-_P"_3_XUT%%
M'/\ V?Q/_P _>F_]^G_QH^S^)_\ G[TW_OT_^-=!10!S_P!G\3_\_>F_]^G_
M ,:/L_B?_G[TW_OT_P#C7044 <_]G\3_ //WIO\ WZ?_ !H^S^)_^?O3?^_3
M_P"-=!10!S_V?Q/_ ,_>F_\ ?I_\:/L_B?\ Y^]-_P"_3_XUT%% '/\ V?Q/
M_P _>F_]^G_QH^S^)_\ G[TW_OT_^-=!10!S_P!G\3_\_>F_]^G_ ,:/L_B?
M_G[TW_OT_P#C7044 <_]G\3_ //WIO\ WZ?_ !H^S^)_^?O3?^_3_P"-=!10
M!S_V?Q/_ ,_>F_\ ?I_\:/L_B?\ Y^]-_P"_3_XUT%% '/\ V?Q/_P _>F_]
M^G_QH^S^)_\ G[TW_OT_^-=!10!S_P!G\3_\_>F_]^G_ ,:/L_B?_G[TW_OT
M_P#C7044 <_]G\3_ //WIO\ WZ?_ !H^S^)_^?O3?^_3_P"-=!10!S_V?Q/_
M ,_>F_\ ?I_\:/L_B?\ Y^]-_P"_3_XUT%% '/\ V?Q/_P _>F_]^G_QH^S^
M)_\ G[TW_OT_^-=!10!S_P!G\3_\_>F_]^G_ ,:/L_B?_G[TW_OT_P#C7044
M <_]G\3_ //WIO\ WZ?_ !H^S^)_^?O3?^_3_P"-=!10!S_V?Q/_ ,_>F_\
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M9_$__/WIO_?I_P#&N@HH Y_[/XG_ .?O3?\ OT_^-'V?Q/\ \_>F_P#?I_\
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M?@ZP\'VUPEJT]U=74GG7=]>/YEQ<R=-SM@=!P   !P *W:** "BBB@ HHHH
M**** "O'_P!J+_DG=I_V$H?_ $"2O8*\?_:B_P"2=VG_ &$H?_0)* /*_B)_
MR8'XG_Z]IO\ TNKXILO^/:/_ '17VM\1/^3 _$__ %[3?^EU?%-E_P >T?\
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M1GUE!'JS6<1NU4Y EV#?^N:V*16# $'(/((I: "BBB@ HHHH **** "BBB@
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M)?Q:_P#A7YH^7SWX:7J_R9BT445^C'RX4444 %%%% #)O]4WTK[X_P""?O\
MR;+HW_81U'_TKEKX'F_U3?2OOC_@G[_R;+HW_81U'_TKEKY?B;_D6?\ ;\?R
MD>SD_P#OG_;K_.)]'4445^2'VYX_^UA_R1/5?^OJS_\ 2B.OD6/[@KZZ_:P_
MY(GJO_7U9_\ I1'7R+']P5^,<7?\C2/^!?\ I4C]PX._Y%+_ .ODO_28#J**
M*^./M0HHHH **** -/P-_P E.\%_]AFU_P#1JU^@M?GUX&_Y*=X+_P"PS:_^
MC5K]!:_3N"?X6)_Q+_TE'Y1QS_&P_P#A?YA1117Z4?F(4444 %%%% !1110
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M5?XE^9X;1117ZH?'!1110 4444 %>R_L+_\ )TDG_8KWG_I1:UXU7LO["_\
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M HHHH **** "BBB@ K\EOBC_ ,ER^)O_ &,=Y_Z&:_6FOR6^*/\ R7+XF_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M W_)3O!?_89M?_1JU^@M?GUX&_Y*=X+_ .PS:_\ HU:_06OT[@G^%B?\2_\
M24?E''/\;#_X7^84445^E'YB%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5^=W[?/\ R<AHG_8KQ?\ I5<5^B-?G=^WS_R<AHG_ &*\7_I5
M<5]?PM_R,/\ MV1X&=_[JO\ $OS/#:***_5#XX**** "BBB@ KV7]A?_ ).D
MD_[%>\_]*+6O&J]E_87_ .3I)/\ L5[S_P!*+6O/S'_<:_\ @9U8/_>J7K^C
M/T>HHHK\,/T8**** "BBB@ HHHH **** "BBB@ HHHH X7XG?\P[_MI_[+11
M\3O^8=_VT_\ 9:* -[P3_P BS9_\#_\ 0VK<K#\$_P#(LV?_  /_ -#:MR@
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M[IESJMDVFZG+;1O<V;.KF&0J-R;E.#@YY'%:= !1110 4444 %%%% !1110
M4444 %%%% !1110 5X_^U%_R3NT_["4/_H$E>P5X_P#M1?\ ).[3_L)0_P#H
M$E 'E?Q$_P"3 _$__7M-_P"EU?%-E_Q[1_[HK[6^(G_)@?B?_KVF_P#2ZOBF
MR_X]H_\ =%?JO"W^X2_QO_TF)\1G/^]K_"OS9/1117UQXP4444 %%%% &#XX
M_P"16U/_ *X/_(U^Q/@[_D4=#_Z\8/\ T6M?CMXX_P"16U/_ *X/_(U^Q/@[
M_D4=#_Z\8/\ T6M?#\6_P,/ZS_*)]'D?\2KZ1_4V****_-#ZT**** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD=, \5]#ZG^UU^S5\)X$\.'QCX8M1I(%E]AL423R-GR[,(,#&.:P=7_X*/\
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M**_-#ZT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K\EOBC_P ER^)O_8QWG_H9K]::_);XH_\
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ML+_\G22?]BO>?^E%K7GYC_N-?_ SJP?^]4O7]&?H]1117X8?HP4444 %%%%
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MV96"0HXY664YZ'*H&/4BO*O^"9<5KIO[)MC';1^39V^M:NL:9)VQK>R@#GT
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MG':OC.S_ ./>/_=%?JO"W^X2_P ;_P#28GQ.<_[VO\*_-D]%%%?7'BA1110
M4444 87C?GPOJ6/^>#_R-?L1X._Y%'0_^O&#_P!%K7X\^-)#'X9U%AU$#']#
M7ZU^%?"%C<>%=$=I+L'[#!TN7'_+-?>OA^+?X&']9_E$^CR/^)5](_J=G17/
M_P#"$Z?_ ,];S_P*?_&C_A"=/_YZWG_@4_\ C7YH?6G045S_ /PA.G_\];S_
M ,"G_P :/^$)T_\ YZWG_@4_^- '045S_P#PA.G_ //6\_\  I_\:/\ A"=/
M_P">MY_X%/\ XT =!17/_P#"$Z?_ ,];S_P*?_&C_A"=/_YZWG_@4_\ C0!T
M%%<__P (3I__ #UO/_ I_P#&C_A"=/\ ^>MY_P"!3_XT =!17/\ _"$Z?_SU
MO/\ P*?_ !H_X0G3_P#GK>?^!3_XT =!17/_ /"$Z?\ \];S_P "G_QH_P"$
M)T__ )ZWG_@4_P#C0!T%%<__ ,(3I_\ SUO/_ I_\:/^$)T__GK>?^!3_P"-
M '045S__  A.G_\ /6\_\"G_ ,:/^$)T_P#YZWG_ (%/_C0!T%%<_P#\(3I_
M_/6\_P# I_\ &C_A"=/_ .>MY_X%/_C0!T%%<_\ \(3I_P#SUO/_  *?_&C_
M (0G3_\ GK>?^!3_ .- '045S_\ PA.G_P#/6\_\"G_QH_X0G3_^>MY_X%/_
M (T =!17/_\ "$Z?_P ];S_P*?\ QH_X0G3_ /GK>?\ @4_^- '045S_ /PA
M.G_\];S_ ,"G_P :/^$)T_\ YZWG_@4_^- '045S_P#PA.G_ //6\_\  I_\
M:/\ A"=/_P">MY_X%/\ XT =!17/_P#"$Z?_ ,];S_P*?_&C_A"=/_YZWG_@
M4_\ C0!T%%<__P (3I__ #UO/_ I_P#&C_A"=/\ ^>MY_P"!3_XT =!17/\
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M/_C0!T%%<_\ \(3I_P#SUO/_  *?_&C_ (0G3_\ GK>?^!3_ .- '045S_\
MPA.G_P#/6\_\"G_QH_X0G3_^>MY_X%/_ (T =!17/_\ "$Z?_P ];S_P*?\
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M .>MY_X%/_C0!T%%<_\ \(3I_P#SUO/_  *?_&C_ (0G3_\ GK>?^!3_ .-
M'045S_\ PA.G_P#/6\_\"G_QH_X0G3_^>MY_X%/_ (T =!17/_\ "$Z?_P ]
M;S_P*?\ QH_X0G3_ /GK>?\ @4_^- '045S_ /PA.G_\];S_ ,"G_P :/^$)
MT_\ YZWG_@4_^- '045S_P#PA.G_ //6\_\  I_\:/\ A"=/_P">MY_X%/\
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M>MY_X%/_ (T =!1110!POQ._YAW_ &T_]EHH^)W_ ##O^VG_ ++10!O>"?\
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MT\,:5XD\.^$O%VI>%_!WB"[GO+K1[6-&:U:?F=;24_- KDL<#.TL2NVO<:*
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M ";+HW_81U'_ -*Y:^7XF_Y%G_;\?RD>SD_^^?\ ;K_.)]'4445^2'VYX_\
MM8?\D3U7_KZL_P#THCKY%C^X*^NOVL/^2)ZK_P!?5G_Z41U\BQ_<%?C'%W_(
MTC_@7_I4C]PX._Y%+_Z^2_\ 28#J***^./M0HHHH **** -/P-_R4[P7_P!A
MFU_]&K7Z"U^?7@;_ )*=X+_[#-K_ .C5K]!:_3N"?X6)_P 2_P#24?E''/\
M&P_^%_F%%%%?I1^8A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %?G=^WS_R<AHG_8KQ?^E5Q7Z(U^=W[?/_ "<AHG_8KQ?^E5Q7U_"W_(P_
M[=D>!G?^ZK_$OS/#:***_5#XX**** "BBB@ KV7]A?\ Y.DD_P"Q7O/_ $HM
M:\:KV7]A?_DZ23_L5[S_ -*+6O/S'_<:_P#@9U8/_>J7K^C/T>HHHK\,/T8*
M*** "BBB@ HHHH **** "BBB@ HHHH X7XG?\P[_ +:?^RT4?$[_ )AW_;3_
M -EHH WO!/\ R+-G_P #_P#0VK<K#\$_\BS9_P# _P#T-JW* "BBB@ HJEK.
MI'1])N[T6MQ?&WB:06UHF^67 SM1>Y-?GQXM_;L^-OQI^(EU\-O@W\-CX)UM
M8V:2^\=#R;E(P2I=8?N#!QAMSC_9H ^\_$'BCPQ\,O#TU_K6IZ=X;T:V4N\]
MY,D$,8SDG)( [U\'_M._\%5O"$7A/Q-X<^$>GW_C76FLYH9=:BMG6PL5(*-*
M21N<+DD$#:<?>KF/BE_P3\U]_A?XN^)?QT^)NK_$'Q1IFGRWMOI\,ACLK9P%
M/RKT'0C"!5.<XS7WGX!^!?P_\$^ _P#A'O#_ (2TK2-)O+4Q3P6MLB^8KIA]
MQQDYR>M '7>$<_\ ")Z+EMQ^Q0?-Z_NUYK7J"QLXM.LK>T@&V&"-8D!.<*HP
M/T%3T %%%% !1110 4444 %%%% !1110 4444 %%%% !7C_[47_).[3_ +"4
M/_H$E>P5X_\ M1?\D[M/^PE#_P"@24 >5_$3_DP/Q/\ ]>TW_I=7Q39?\>T?
M^Z*^UOB)_P F!^)_^O:;_P!+J^*;+_CVC_W17ZKPM_N$O\;_ /28GQ&<_P"]
MK_"OS9/1117UQXP4444 %%%% &#XX_Y%;4_^N#_R-?L3X._Y%'0_^O&#_P!%
MK7X[>./^16U/_K@_\C7[$^#O^11T/_KQ@_\ 1:U\/Q;_  ,/ZS_*)]'D?\2K
MZ1_4V****_-#ZT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ K\EOBC_ ,ER^)O_ &,=Y_Z&:_6F
MOR6^*/\ R7+XF_\ 8QWG_H9K[WA+^+7_ ,*_-'R^>_#2]7^3,6BBBOT8^7"B
MBB@ HHHH 9-_JF^E??'_  3]_P"39=&_[".H_P#I7+7P/-_JF^E??'_!/W_D
MV71O^PCJ/_I7+7R_$W_(L_[?C^4CV<G_ -\_[=?YQ/HZBBBOR0^W/'_VL/\
MDB>J_P#7U9_^E$=?(L?W!7UU^UA_R1/5?^OJS_\ 2B.OD6/[@K\8XN_Y&D?\
M"_\ 2I'[AP=_R*7_ -?)?^DP'4445\<?:A1110 4444 :?@;_DIW@O\ [#-K
M_P"C5K]!:_/KP-_R4[P7_P!AFU_]&K7Z"U^G<$_PL3_B7_I*/RCCG^-A_P#"
M_P PHHHK]*/S$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK\[OV^?^3D-$_P"Q7B_]*KBOT1K\[OV^?^3D-$_[%>+_ -*KBOK^%O\ D8?]
MNR/ SO\ W5?XE^9X;1117ZH?'!1110 4444 %>R_L+_\G22?]BO>?^E%K7C5
M>R_L+_\ )TDG_8KWG_I1:UY^8_[C7_P,ZL'_ +U2]?T9^CU%%%?AA^C!1110
M 4444 %%%% !1110 4444 %%%% '"_$[_F'?]M/_ &6BCXG?\P[_ +:?^RT4
M ;W@G_D6;/\ X'_Z&U;E8?@G_D6;/_@?_H;5N4 %%%% !7&_$?X.^#/BYI\=
MGXM\.V6LK"ZRP331XGMY%^Z\4HPZ,#R"I!%=E10!\I_%+]FOXJ67PW\1^%O
M'Q%_X230=4LY+8:#X]5KN6%2.%@OU(DY.>9A+VP1BM/7OVV_#?PF\,W:?$_P
M]KOPWURRM7,-MJMDT]I?.B\"WNH-\;[F& I*OCDJ*^F:P/'G@71?B5X0U7PU
MX@L(=1TG4K=[>>">,.,,I&1GH1G(/8T :6B:@VK:+87K((VN;>.8H#G;N4''
MZU=JKI>GII.F6EE&S-';0I"K-U(50!G\JM4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7C_P"U%_R3NT_["4/_ *!)7L%>/_M1?\D[M/\ L)0_^@24
M >5_$3_DP/Q/_P!>TW_I=7Q39?\ 'M'_ +HK[6^(G_)@?B?_ *]IO_2ZOBFR
M_P"/:/\ W17ZKPM_N$O\;_\ 28GQ&<_[VO\ "OS9/1117UQXP4444 %%%% &
M#XX_Y%;4_P#K@_\ (U^Q/@[_ )%'0_\ KQ@_]%K7X[>./^16U/\ ZX/_ "-?
ML3X._P"11T/_ *\8/_1:U\/Q;_ P_K/\HGT>1_Q*OI']38HHHK\T/K0HHHH
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M +47_).[3_L)0_\ H$E 'E?Q$_Y,#\3_ /7M-_Z75\4V7_'M'_NBOM;XB?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW^PU\:/VD_'VC:U^T9\0-*N_"NE3+=1>$O#2.()'!Y5MR@*&'!;YF() *]:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\6O_ (5^:/E\]^&EZO\ )F+1117Z,?+A1110 4444 ,F_P!4WTK[X_X)^_\
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M5]?PM_R,/^W9'@9W_NJ_Q+\SPVBBBOU0^."BBB@ HHHH *]E_87_ .3I)/\
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M@@CTQ0!F^$9&E\*Z,[DL[64+,3U)*#-:U,AACMH4BB18XHU"JBC 4#H *?0
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M/_OEO\*/^$XT/_H(Q_\ ?+?X4 ;M%87_  G&A_\ 01C_ .^6_P */^$XT/\
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MA_\ 01C_ .^6_P */^$XT/\ Z",?_?+?X4 ;M%87_"<:'_T$8_\ OEO\*/\
MA.-#_P"@C'_WRW^% &[16%_PG&A_]!&/_OEO\*/^$XT/_H(Q_P#?+?X4 ;M%
M87_"<:'_ -!&/_OEO\*/^$XT/_H(Q_\ ?+?X4 ;M?DM\4?\ DN7Q-_[&.\_]
M#-?J:OC;1&( U"//^ZW^%?EA\2YH[CXV?$F:)P\<GB*[96'<;S7WO"7\6O\
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MPG&A_P#01C_[Y;_"C_A.-#_Z",?_ 'RW^% &[16%_P )QH?_ $$8_P#OEO\
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M/^$XT/\ Z",?_?+?X4 ;M%87_"<:'_T$8_\ OEO\*/\ A.-#X_XF,?I]UO\
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M[7^%?FR>BBBOKCQ@HHHH **** ,+QLQ7POJ1!P?(?^1K]AO!\:-X1T/*J?\
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M@G_D6;/_ ('_ .AM6Y6'X)_Y%FS_ .!_^AM6Y0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7C_P"U%_R3NT_["4/_ *!)
M7L%>/_M1?\D[M/\ L)0_^@24 >5_$3_DP/Q/_P!>TW_I=7Q39?\ 'M'_ +HK
M[6^(G_)@?B?_ *]IO_2ZOBFR_P"/:/\ W17ZKPM_N$O\;_\ 28GQ&<_[VO\
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M,_$^,O\ D:?]NQ"BBBOMCX8**** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !7YW?M\_P#)R&B?]BO%_P"E5Q7Z(U^=W[?/_)R&B?\
M8KQ?^E5Q7U_"W_(P_P"W9'@9W_NJ_P 2_,\-HHHK]4/C@HHHH **** "O9?V
M%_\ DZ23_L5[S_THM:\:KV7]A?\ Y.DD_P"Q7O/_ $HM:\_,?]QK_P"!G5@_
M]ZI>OZ,_1ZBBBOPP_1@HHHH **** "BBB@ HHHH **** "BBB@#A?B=_S#O^
MVG_LM%'Q._YAW_;3_P!EHH WO!/_ "+-G_P/_P!#:MRL/P3_ ,BS9_\  _\
MT-JW* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *\?_:B_Y)W:?]A*'_T"2O8*\?\ VHO^2=VG_82A_P#0)* /*_B)_P F
M!^)_^O:;_P!+J^*;+_CVC_W17VM\1/\ DP/Q/_U[3?\ I=7Q39?\>T?^Z*_5
M>%O]PE_C?_I,3XC.?][7^%?FR>BBBOKCQ@HHHH **** ,'QQ_P BMJ?_ %P?
M^1K]B?!W_(HZ'_UXP?\ HM:_';QQ_P BMJ?_ %P?^1K]B?!W_(HZ'_UXP?\
MHM:^'XM_@8?UG^43Z/(_XE7TC^IL4445^:'UI\;?M4?\EMA_[ MO_P"C9Z\P
MKT_]JC_DML/_ &!;?_T;/7F%?SYG'_(SQ/\ B_1']'Y/_P BS#?X$%%%%>4>
ML%%%% !1110!ZO\ LF?\E@U+_L"2?^CX:^P:^/OV3/\ DL&I?]@23_T?#7V#
M7[%P?_R*U_BE^9^)\9?\C3_MV(4445]L?#!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7Q2_Z^=/_P#1<U?*;?=-?5G_  3=_P"/KXI?]?.G_P#HN:O#SW_D5U_^W?\
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M ,#_ /0VK<H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KQ_\ :B_Y)W:?]A*'_P! DKV"O'_VHO\ DG=I_P!A*'_T"2@#
MROXB?\F!^)_^O:;_ -+J^*;+_CVC_P!T5]K?$3_DP/Q/_P!>TW_I=7Q39?\
M'M'_ +HK]5X6_P!PE_C?_I,3XC.?][7^%?FR>BBBOKCQ@HHHH **** ,'QQ_
MR*VI_P#7!_Y&OV)\'?\ (HZ'_P!>,'_HM:_';QQ_R*VI_P#7!_Y&OV)\'?\
M(HZ'_P!>,'_HM:^'XM_@8?UG^43Z/(_XE7TC^IL4445^:'UI\;?M4?\ );8?
M^P+;_P#HV>O,*]/_ &J/^2VP_P#8%M__ $;/7F%?SYG'_(SQ/^+]$?T?D_\
MR+,-_@04445Y1ZP4444 %%%% 'J_[)G_ "6#4O\ L"2?^CX:^P:^/OV3/^2P
M:E_V!)/_ $?#7V#7[%P?_P BM?XI?F?B?&7_ "-/^W8A1117VQ\,%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5^2WQ1_Y+E\3?^QCO/_0S
M7ZTU^2WQ1_Y+E\3?^QCO/_0S7WO"7\6O_A7YH^7SWX:7J_R9BT445^C'RX44
M44 %%%% #)O]4WTK[X_X)^_\FRZ-_P!A'4?_ $KEKX'F_P!4WTK[X_X)^_\
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M4/C@HHHH **** "O9?V%_P#DZ23_ +%>\_\ 2BUKQJO9?V%_^3I)/^Q7O/\
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M^19L_P#@?_H;5N5A^"?^19L_^!_^AM6Y0 4444 %%%% !1110 4444 %%%%
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M3 =1117QQ]J%%%% !1110!I^!O\ DIW@O_L,VO\ Z-6OT%K\^O W_)3O!?\
MV&;7_P!&K7Z"U^G<$_PL3_B7_I*/RCCG^-A_\+_,****_2C\Q"BBB@ HHHH
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MW]M?^DR/;R6,8XM\JM[K_-'NM%%%?DQ]R%%%% !1110 4444 %%%% !1110
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MY'PG&G_(MI_XU_Z3(]*HHHK]C/Q4X7XG?\P[_MI_[+11\3O^8=_VT_\ 9:*
M-[P3_P BS9_\#_\ 0VK<K#\$_P#(LV?_  /_ -#:MR@ HHHH **** "BBB@
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MDL\^.E_V]^AT5%%%?<GS@4444 %%%% $-W_J'^AK]%/V'O\ DUKP-_USN_\
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MOSJNF'DOSVK]%?V'?^36? W_ %SN_P#TLGKY/BC_ )%T?\:_])D>SDW^^/\
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M_P#1JU^@M?GUX&8?\+.\%_\ 89M?_1JU^@M?IW!/\+$_XE_Z2C\GXY_C8?\
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MO,VKQE2: .5_X)\S7'_"V_VHX!_R#H_'<S0 = Y:7?C\ E?:U>)_LD? N]^
M_P +'L==N(;WQAKFH7&NZ_=6[%HVO)VW,B$\E$ 51Z[2>]>V4 %<-\8/A_=?
M$KPM#I5I>1V,L=VEP995+#"AAC _WJ[FB@#Q[6O@9-KWP?O_ (;W-TBZ%>QM
M%+<12E;D!I?-)5BA4?-_L]*\BC_X)U^&8T"KXAUT #'_ !_1_P#QBOKZBO2P
MV98S!P=/#U'%-WLNYQUL'A\3)2K03:/D/_AW=X:_Z&'7O_ ^/_XQ1_P[N\-?
M]##KW_@?'_\ &*^O**ZO[<S+_G_(Y_[+P7_/I'R'_P .[O#7_0PZ]_X'Q_\
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M/9'DXK%U\;4]KB9N4MKLY[_BJ?\ J%?^1*/^*I_ZA7_D2NAHKJ.0Y[_BJ?\
MJ%?^1*/^*I_ZA7_D2NAHH Y[_BJ?^H5_Y$H_XJG_ *A7_D2NAHH Y[_BJ?\
MJ%?^1*/^*I_ZA7_D2NAHH Y[_BJ?^H5_Y$H_XJG_ *A7_D2NAHH YNXM_$UU
M;RP2'2PDB%&*^8#@C'%?+FE_\$W/"NDZ?!:0>(=>$<*!%S?QYX'_ %PK['HK
MOPN/Q6"4EAZCBI6O;K;;\V<M?"T<3;VT5*Q\A_\ #N[PU_T,.O?^!\?_ ,8H
M_P"'=WAK_H8=>_\  ^/_ .,5]>45V_VYF7_/^1R_V7@O^?2/D/\ X=W>&O\
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MX$C_ .-4?\,?Z=_T%+S_ ,"1_P#&J^C**/\ 5W*?^@:/W!_K#FW_ $$R/$?
M/[.H^&_BI/$&E7S7%ZMO);!+R;='M<J2<*@.?E'>O3?^*I_ZA7_D2NAHKU\+
MA*&"I^RPT%&/9'E8K&8C'5/:XF;E*UKOL<]_Q5/_ %"O_(E'_%4_]0K_ ,B5
MT-%=9QG/?\53_P!0K_R)1_Q5/_4*_P#(E=#10!SW_%4_]0K_ ,B4?\53_P!0
MK_R)70T4 <]_Q5/_ %"O_(E'_%4_]0K_ ,B5T-% '/?\53_U"O\ R)1_Q5/_
M %"O_(E=#10!S_\ Q5'_ %"O_(E?.7B;]@C0/%GB[7?$=WK>K6]]K%[)?7$=
MK>(L2R.V2%!A) Y[DU]6T5VX7&XC!MRP\W%O>QS5\-1Q*4:T>9(^0_\ AW=X
M:_Z&'7O_  /C_P#C%'_#N[PU_P!##KW_ ('Q_P#QBOKRBN_^W,R_Y_R.3^R\
M%_SZ1\A_\.[O#7_0PZ]_X'Q__&*/^'=WAK_H8=>_\#X__C%?7E%']N9E_P _
MY!_9>"_Y](^0_P#AW=X:_P"AAU[_ ,#X_P#XQ1_P[N\-?]##KW_@?'_\8KZ\
MHH_MS,O^?\@_LO!?\^D?(3?\$[?#3 @^(=>_\#X__C%>S_!WX0WOP-\!VOA'
MP]<PW>F6T\\Z2ZE(TDQ:65I&!*JHP"QQQTQ7JU%<V(S/&8NG[*O5<HWO9]_Z
M9O1P>'P\N:C!)G/?\53_ -0K_P B4?\ %4_]0K_R)70T5YAVGG?Q!\ ZM\3/
M"MQH&K36D%E/)'(TEF[I("CAQ@L".JCM7FR_L?Z<H_Y"EY_X$C_XU7T;17E8
MK*L#CIJIB:*G)*UWV/6PN;8_!4_98:LXQO>R[_TD?.?_  R!I_\ T%;S_P "
M1_\ &J/^&0-/_P"@K>?^!(_^-5]&45Q?ZNY3_P! T?N.O_6'-O\ H)D?.?\
MPR!I_P#T%;S_ ,"1_P#&J/\ AD#3_P#H*WG_ ($C_P"-5]&44?ZNY3_T#1^X
M/]8<V_Z"9'SG_P ,@:?_ -!6\_\  D?_ !JC_AD#3_\ H*WG_@2/_C5?1E%'
M^KN4_P#0-'[@_P!8<V_Z"9'S[HW[*-IH.O:9J]MJ-Q)=:?<QW4237 *%D8,
MP$8)&1ZU[%_Q5'_4*_\ (E=!17J83 X7 1<,+34$]['FXO'XK'M2Q51S:VN<
M]_Q5/_4*_P#(E'_%4_\ 4*_\B5T-%=QP'/?\53_U"O\ R)1_Q5/_ %"O_(E=
M#10!SW_%4_\ 4*_\B4?\53_U"O\ R)70T4 <]_Q5/_4*_P#(E'_%4_\ 4*_\
MB5T-% '/?\53_P!0K_R)1_Q5/_4*_P#(E=#10!SW_%4_]0K_ ,B5X?\ %O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9:S\2=#M]&\3RWMQ>Q:0)UN?[,1G81Q^8.&<)C)' +$ XKTN@ HHHH ****
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M2S)9W&K2 Q:59NY86UM$/E08P"WWFVC)KUZBB@ HHHH **** "BBB@ HHHH
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M ('_ .AM6Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[6/"]BR_9;N_+,%$*D$PKM&Y]N,Y4#C@?4RJ(U"J J@8  P!2JNU0HZ 8I:
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M_0VK<H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK:QPH=\X!!)E\I<L8U RS 84<FN7^+W[-OPT_:B\"K<Q&".]GD_M'2O%VAR
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MQIXH^)_QAU>QNO&NNVL.F6VD:1G['I5C$[NL2$C+,S.6)/?-?1U%% !1110
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M33=.M8K&PM(EA@MH$"1Q(HPJJ!T %6Z* "BBB@ HHHH **** "BBB@ HHHH
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MUY\0[O2KO0_#1MA8^';/48FANYX2VZ2\EC/,?F':$1@&"H"<%L#V&@ HHHH
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M_ __ $-JW*P_!/\ R+-G_P #_P#0VK<H **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ?+'[2_P"Q.?C%J4?CKP[XPUCP_P#%C2',VB:R+EOL]N!DK (?
MNJAZ$@9/.<@XKS[X9_M4>+/BUX@MO@%\3+9_AC\2HP8]9U!9TA75;91TT]MV
M?,F Y89VKO*G<!C[HKQ+]I_]E+PE^TYX7BMM6$FD^)=./G:/XCL3LN["4<J0
MPY*Y )7VR,'F@#KO&WP)\">/OA6_P[UCP[9R^$1;+;0Z?'&%6V51A&B(Y1EP
M"&'.:\8_8I_9U\7_  ;T&_MO$_C?5_$'ARQU"XB\*:/>, MI8AV6*63Y0S.Z
M8(0G8@/ %2_L6W7QVU?P_>Q_%C5--N-,T.]N-+TV\M;8K=ZRL+O$;F9RQ4QG
M;E=JJ6P"3CK]0T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M5YE^TOXIU?P3\"O&.O:):3WU]I]BUP8+7/G-$I!EV8_B$>\CW H JR?M(>$K
MKXXZ?\+=(U&SU?Q";::[U(07D>-/1 -B.,Y,KLPP@Y"Y8X&,^KU\0?$_X=?
M7]JKX$IXN^&=UHFE>,+.%;OP]JVA^7;ZC;:@H#Q02HOSEF?:K*P+<Y'.#7M7
MB[]J+0?A=XB\,^ +^TUGQG\1+JPCN+S2?"]B;N:WC" 27$V"%C3<#U.3D8!H
M H?%[]B/P'\3O&2>-]*N-3^'_P 0(SN7Q-X6G^S7#GC_ %J8V2Y"@'<.1P:Z
MOP3X#^*_AV,6>L_$_3O$EE&-L=U<^'%COGYZN\<ZQDX](Q7I.@:[9>)M%L=6
MTZ;[18WD*SPR8(RK#(R#R#Z@\@\&M"@!D*M'"BN_F.H +XQD^N*?110 4444
M %17$XMK>24J\FQ2^R-=S-@9P!W-0:QK%EX?TF]U34KF.ST^SA>XN+B9MJ1Q
MJ"68GT !KPGQ)X7^(_[0%OH>N:1XFF^$VE65R-0TSRK7[3J%ZNTA?M4;,$2)
MU;)A(9ONDE6&  >*?%3]H[XG?LY_M&1^./BMX2\OX+:E;II5C=Z5)]JDT,EL
MF:<*/OR' 8#/"J%)(PWVUX:\3:5XRT&QUO0]0M]5TF^B6>VO+20212QL,AE8
M<$8K)B\+S>+/ LF@^/K+2=;-W UMJ$,,3-:72G@G8_*[ASMR<9X)QFOA[7O!
MWC[_ ()L>(KKQ-X)@OO''[/EW.9M5\-;S)=Z &;YIH">J#.3V_O8R7 !]K_&
M/Q=#X!^&>O\ B2ZMX;O3]*MS=WEO.FY9+=2#*,>NS<1ZD =ZQO"/PF^%&N-I
MWCC0/"'AN>34;>.[M=4MK&$^9&ZAD=2!CD8.17E%C\0-,_;OTV'3?"HO/^%-
M_*VNZM=6TMJ^L2*0?[.@5PK>6"/WTF,'[BDY8K].6-C;Z79P6=I!';6L"+'%
M#$H5$4# 4 = !0!/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5E^*/$VF>#/#FIZ]K-W'8:3IMM)=W=U)]V*
M)%+.Q]@ 36I7E[?$#X:?&_5O&'PRFU;3]:O]-86NLZ!)*-\D;(K89,_/&P8
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'Q\A!QQD ]C\.^"] \+RWESH^@Z=H]S?R&>[>RM8XGFD/)9V4#<<]S6Y110
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M^)_[._[0"?"?Q9X^NOB;X.UO0+C6](U35%;[=936\\,<L3DLQ*,+A2"6/(
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MO):VL8$< /\ $PR[8&YB !7JU%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 444UW6-&=V"JHR68X 'K0 ZOF_\ :S_9C\6_M!:;:7>@?$34/".M^';E
M-1\/6UH%6S-V@!62YX+,V<A2#A03\K9-=KX'_: _X3SQI=6%AX.UT^$&80Z;
MXR6)7L-0E!(D"*#YBQ@C"S,NQ\$@XVEO6Z /B#X1_ML^,]<U)O@MX[T&'PE\
M?5D^QPS7@"Z;<Q[23>H<@/A02(U)WM@ @9V_27P?_9[\+?!/[7+X<^WI>:D[
MW.K3W%[+*-1NG(9[F2-F*+(S9.4"]<=,8P?VG_V4O"7[4'A..RU@/I/B.P/F
MZ/XDL1MN]/F'(*L,$KD#*Y[9&#@CPC]G_P 6?M">-;[Q3\#_ !Q#';-X5N(K
M+5/B19S%9;FS>-9$C@&,&YDC9/WF1Y:L21O R >[_!'QM+\8+3XH:%J]A/?^
M'=+\1WNC6FJ3,3#J=L<&1%(P66)WD@)&01'C)(8#V>&&.VACAA18HHU"(B#
M4 8  ]*H^&_#NF^$=!L=&T>SBT_3+&)8+>VA&%1 , ?_ %^]:5 !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!POQ._YAW_;3_P!E
MHH^)W_,._P"VG_LM% &]X)_Y%FS_ .!_^AM6Y6'X)_Y%FS_X'_Z&U;E !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4]6TFUUS3
MI["^B\^SG79+"20'7NIQU!Z$=""0>#5I$6-555"JHP% P /2G44 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO!KWB"XUSQYXDTN;0+WQ ((K+1;@@S65C#O\D38) E=I9)& ^[N5>2N:]0H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH X7XG?\P[_MI_[+11\3O^8=_VT_\ 9:* -[P3_P BS9_\#_\ 0VK<K#\$
M_P#(LV?_  /_ -#:MR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\Y;?_A*/#,RW]@<_*'8 Y3<V %."20,5]3?%[X>Q?$[P#J.AF3[->9CNK"[
MRUM>0N)8)1[K(BGWQBO-_@CJ.J?M 16/CKQ=9KIB:3++86WA<R+*MI?PLT5S
M/.1PT@<,J#HJ_-U;@ M> _VN/@=\<-#?^S/&VA7T#P^9/I^J2+#(B<_ZR*7&
M._%=9X!^"_PM\-W2^)/"'@;PWH]W>IYG]HZ=I,-O+*K<Y+! QSG//K7"^//V
M)OA?\0/C'X8\>W_A728[G1FFN)H;>T6/[?<'9Y33X&) FUB P/..V0??E4*H
M & . !0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% '"_$[_F'?\ ;3_V6BCXG?\ ,._[:?\ LM% &]X)_P"1
M9L_^!_\ H;5N5A^"?^19L_\ @?\ Z&U;E !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH J6.DV>F27<EK;I#)=2F>=E',CD ;B>YP /PJW110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% '"_$[_F'?]M/_ &6BCXG?\P[_ +:?^RT4 ;W@G_D6;/\ X'_Z&U;E
M8?@G_D6;/_@?_H;5N4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!^/7A$>'_P#@I)\ [A=8UB^M]22\NVLKZ^DFMX)D#C=%&3M3*R8P!_"*^_J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB6EI=;3E1,L2AP#Z!L@>PH ^4/\ @LM_R;'I?_8<A_\ 06K[HT#_ ) .F_\
M7M'_ .@BOA;_ (++2(O[,NDJ6 9M;A*J3R<*V:^YO#<JS>'=+D0[D>UB8'U!
M04 :5?/7@'9\7/VE/&GC*Y,<OAWP?;'PEHZLWRRW+[9=0F SAAD0PANH,<HK
MN_VBOBD?@_\ "+7-?MD6?665;'2+4G!N+^=A%;1CZR.OX UR'PU_8^\!>%?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '"_$[_F'?]M/
M_9:*/B=_S#O^VG_LM% &]X)_Y%FS_P"!_P#H;5N5A^"?^19L_P#@?_H;5N4
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M^!-'L=/TV_O/$WBG1-/F6>TT;Q'KUQ?643*08_W3MM<(0"H?<%(! !%>XT4
M,\F/R?*V*(MNW9CY<8QC'I7C'PN_8W^$GP;\<:CXL\*>%(].UF]D:7<T\DD5
MNS9W&&-F*QY!(^4#CCIQ7M5% 'SW9_L$_!.P^(^H^-8?"6W4]0G^TW5G]LF^
MPRR[MVYK;=Y;?-\V"",\XKJ-%_92^%WA_P",5_\ $^R\+6\?C"\15:Z+L8XR
MJA0T<1.Q&PHY ["O7** /'/&'[)?PX\>?$"S\;ZYIVH7OBJR</9ZF=5N4DM,
M.S@1;7 0 L>!ZUZW8V:Z?9P6R/+*D*! \SEW..[,>2?<U8HH **** "BBB@
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&?2B@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
